InChIKey14,broad_id_2017,pert_iname_2017,moa_2017,target_2017,broad_id_2018a,pert_iname_2018a,moa_2018a,target_2018a,broad_id_2018b,pert_iname_2018b,moa_2018b,target_2018b,broad_id_2020,pert_iname_2020,moa_2020,target_2020
AAALVYBICLMAMA,BRD-K13087974,CGP-52411,EGFR inhibitor,EGFR,BRD-K13087974,CGP-52411,EGFR inhibitor,EGFR,BRD-K13087974,CGP-52411,EGFR inhibitor,EGFR,BRD-K13087974,CGP-52411,EGFR inhibitor,EGFR
AAAQFGUYHFJNHI,BRD-K08109215,I-BET-762,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K08109215,I-BET-762,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K08109215,I-BET-762,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K08109215,I-BET-762,bromodomain inhibitor,BRD2|BRD3|BRD4
AADCDMQTJNYOSS,BRD-K50417881,eticlopride,dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-K50417881,eticlopride,dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-K50417881,eticlopride,dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-K50417881,eticlopride,dopamine receptor antagonist,DRD2|DRD3|DRD4
AAFJXZWCNVJTMK,BRD-K68502831,dianhydrogalactitol,DNA alkylating agent,,BRD-K68502831,dianhydrogalactitol,DNA alkylating agent,,BRD-K68502831,dianhydrogalactitol,DNA alkylating agent,,BRD-K68502831,dianhydrogalactitol,DNA alkylating agent,
AAGFPTSOPGCENQ,BRD-K10999968|BRD-K66845263,sophocarpine,,,BRD-K10999968|BRD-K66845263,sophocarpine,,,BRD-K10999968|BRD-K66845263,sophocarpine,,,BRD-K10999968|BRD-K66845263,sophocarpine,,
AAKJLRGGTJKAMG,BRD-K70401845,erlotinib,EGFR inhibitor,EGFR|NR1I2,BRD-K70401845,erlotinib,EGFR inhibitor,EGFR|NR1I2,BRD-K70401845,erlotinib,EGFR inhibitor,EGFR|NR1I2,BRD-K70401845,erlotinib,EGFR inhibitor,EGFR|NR1I2
AAORACFZMYMFCG,BRD-K49236613,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1,BRD-K49236613,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1,BRD-K49236613,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1,BRD-K49236613,6-iodo-nordihydrocapsaicin,TRPV antagonist,TRPV1
AAOVKJBEBIDNHE,BRD-K16508793,diazepam,benzodiazepine receptor agonist,ADRA1A|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,BRD-K16508793,diazepam,benzodiazepine receptor agonist,ADRA1A|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,BRD-K16508793,diazepam,benzodiazepine receptor agonist,ADRA1A|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,,,,
AAQOQKQBGPPFNS,BRD-K49669424,bretylium,norepinephrine inhibitor,ATP1A1,BRD-K49669424,bretylium,norepinephrine inhibitor,ATP1A1,BRD-K49669424,bretylium,norepinephrine inhibitor,ATP1A1,BRD-K49669424,bretylium,norepinephrine inhibitor,ATP1A1
ABBADGFSRBWENF,BRD-K08310154,AG-1024,insulin growth factor receptor inhibitor,IGF1R,BRD-K08310154,AG-1024,insulin growth factor receptor inhibitor,IGF1R,BRD-K08310154,AG-1024,insulin growth factor receptor inhibitor,IGF1R,BRD-K08310154,AG-1024,insulin growth factor receptor inhibitor,IGF1R
ABJKWBDEJIDSJZ,BRD-K90630139,butenafine,fungal squalene epoxidase inhibitor,SQLE,BRD-K90630139,butenafine,fungal squalene epoxidase inhibitor,SQLE,BRD-K90630139,butenafine,fungal squalene epoxidase inhibitor,SQLE,BRD-K90630139,butenafine,fungal squalene epoxidase inhibitor,SQLE
ACAKNPKRLPMONU,BRD-K81572616,CK-636,actin related protein inhibitor,ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5,BRD-K81572616,CK-636,actin related protein inhibitor,ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5,BRD-K81572616,CK-636,actin related protein inhibitor,ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5,BRD-K81572616,CK-636,actin related protein inhibitor,ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5
ACCFLVVUVBJNGT,BRD-K82967180,LY3023414,PI3K inhibitor|mTOR inhibitor,MTOR,BRD-K82967180,LY3023414,PI3K inhibitor|mTOR inhibitor,MTOR,BRD-K82967180,LY3023414,PI3K inhibitor|mTOR inhibitor,MTOR,BRD-K82967180,LY3023414,PI3K inhibitor|mTOR inhibitor,MTOR
ACCMWZWAEFYUGZ,BRD-K51937257,bilastine,histamine receptor antagonist,HRH1,BRD-K51937257,bilastine,histamine receptor antagonist,HRH1,BRD-K51937257,bilastine,histamine receptor antagonist,HRH1,BRD-K51937257,bilastine,histamine receptor antagonist,HRH1
ACEWLPOYLGNNHV,BRD-A75224450,ibuprofen-piconol,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A75224450,ibuprofen-piconol,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A75224450,ibuprofen-piconol,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A75224450,ibuprofen-piconol,cyclooxygenase inhibitor,PTGS1|PTGS2
ACGDKVXYNVEAGU,BRD-K62676709,guanethidine,adrenergic inhibitor,SLC6A2,BRD-K62676709,guanethidine,adrenergic inhibitor,SLC6A2,BRD-K62676709|BRD-M18219129,guanethidine,adrenergic inhibitor,SLC6A2,BRD-K62676709|BRD-M18219129,guanethidine,adrenergic inhibitor,SLC6A2
ACGUYXCXAPNIKK,BRD-K99792991,hexachlorophene,potassium channel activator,GLUD1|SDHD,BRD-K99792991,hexachlorophene,potassium channel activator,GLUD1|SDHD,BRD-K99792991,hexachlorophene,potassium channel activator,GLUD1|SDHD,BRD-K99792991,hexachlorophene,potassium channel activator,GLUD1|SDHD
ACOXQYLJOQAHST,BRD-K54538117,LY450108,glutamate receptor modulator,,BRD-K54538117,LY450108,glutamate receptor modulator,,BRD-K54538117,LY450108,glutamate receptor modulator,,BRD-K54538117,LY450108,glutamate receptor modulator,
ACPOUJIDANTYHO,BRD-K01567962,pyrazolanthrone,JNK inhibitor,MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK,BRD-K01567962,pyrazolanthrone,JNK inhibitor,MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK,BRD-K01567962,pyrazolanthrone,JNK inhibitor,MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK,BRD-K01567962,pyrazolanthrone,JNK inhibitor,MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK
ACQBHJXEAYTHCY,BRD-K01767299,ciproxifan,histamine receptor antagonist,ADRA2A|ADRA2C|HRH3|HRH4|HTR3A,BRD-K01767299,ciproxifan,histamine receptor antagonist,ADRA2A|ADRA2C|HRH3|HRH4|HTR3A,BRD-K01767299,ciproxifan,histamine receptor antagonist,ADRA2A|ADRA2C|HRH3|HRH4|HTR3A,BRD-K01767299,ciproxifan,histamine receptor antagonist,ADRA2A|ADRA2C|HRH3|HRH4|HTR3A
ACRHBAYQBXXRTO,BRD-K31385749,ivabradine,HCN channel antagonist|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,BRD-K31385749,ivabradine,HCN channel antagonist|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,BRD-K31385749,ivabradine,HCN channel antagonist|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,BRD-K33972682,ivabradine,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4
ACSIXWWBWUQEHA,BRD-K72542090,clodronic-acid,bone resorption inhibitor,SLC25A4|SLC25A5|SLC25A6,BRD-K72542090,clodronic-acid,bone resorption inhibitor,SLC25A4|SLC25A5|SLC25A6,BRD-K72542090,clodronic-acid,bone resorption inhibitor,SLC25A4|SLC25A5|SLC25A6,BRD-K72542090,clodronic-acid,bone resorption inhibitor,SLC25A4|SLC25A5|SLC25A6
ACTIUHUUMQJHFO,BRD-K75043328,coenzyme-q10,,,BRD-K75043328,coenzyme-q10,,,BRD-K75043328,coenzyme-q10,,,BRD-K75043328,coenzyme-Q10,,
ACTOXUHEUCPTEW,BRD-K14716343|BRD-K35824922|BRD-K77056640,spiramycin,bacterial 50S ribosomal subunit inhibitor,,BRD-K14716343|BRD-K35824922,spiramycin,bacterial 50S ribosomal subunit inhibitor,,BRD-A67305656|BRD-K14716343|BRD-K35824922|BRD-K77056640,spiramycin,bacterial 50S ribosomal subunit inhibitor,,BRD-K00003542,spiramycin,bacterial 50S ribosomal subunit inhibitor,
ACTRVOBWPAIOHC,BRD-K88701661,dimercaptosuccinic-acid,chelating agent,DNMT1,BRD-K88701661,dimercaptosuccinic-acid,chelating agent,DNMT1,BRD-K88701661,dimercaptosuccinic-acid,chelating agent,DNMT1,BRD-K88701661,dimercaptosuccinic-acid,chelating agent,DNMT1
ACVGNKYJVGNLIL,BRD-K79905821,gabazine,GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2,BRD-K79905821,gabazine,GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2,BRD-K79905821,gabazine,GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2,BRD-K79905821,gabazine,GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2
ACVGWSKVRYFWRP,BRD-K94723713,rutaecarpine,cyclooxygenase inhibitor,PTGS2,BRD-K94723713,rutaecarpine,cyclooxygenase inhibitor,PTGS2,BRD-K94723713,rutaecarpine,cyclooxygenase inhibitor,PTGS2,BRD-K94723713,rutaecarpine,cyclooxygenase inhibitor,PTGS2
ACWBQPMHZXGDFX,BRD-K45158365,valsartan,angiotensin receptor antagonist,AGTR1,BRD-K45158365,valsartan,angiotensin receptor antagonist,AGTR1,BRD-K45158365,valsartan,angiotensin receptor antagonist,AGTR1,BRD-K45158365,valsartan,angiotensin receptor antagonist,AGTR1
ACWZRVQXLIRSDF,BRD-K82244583,MEK162,MEK inhibitor,MAP2K1|MAP2K2,BRD-K82244583,MEK162,MEK inhibitor,MAP2K1|MAP2K2,BRD-K82244583,MEK162,MEK inhibitor,MAP2K1|MAP2K2,BRD-K82244583,binimetinib,MEK inhibitor,MAP2K1|MAP2K2
ADEBPBSSDYVVLD,BRD-A49160188,donepezil,acetylcholinesterase inhibitor,ACHE|HTR2A,BRD-A49160188,donepezil,acetylcholinesterase inhibitor,ACHE|HTR2A,BRD-A49160188,donepezil,acetylcholinesterase inhibitor,ACHE|HTR2A,BRD-A49160188,donepezil,acetylcholinesterase inhibitor,ACHE
ADFCQWZHKCXPAJ,BRD-K54847683,equol,estrogen receptor agonist,ESR1|ESR2,BRD-K54847683,equol,estrogen receptor agonist,ESR1|ESR2,BRD-K54847683,equol,estrogen receptor agonist,ESR1|ESR2,BRD-K54847683,equol,estrogen receptor agonist,ESR1|ESR2
ADFOJJHRTBFFOF,BRD-K00077635,estramustine-phosphate,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,BRD-K00077635,estramustine-phosphate,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,BRD-K00077635,estramustine-phosphate,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,BRD-K00077635,estramustine-phosphate,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2
ADGGYDAFIHSYFI,BRD-K62374002,PI3K-IN-2,PI3K inhibitor,,BRD-K62374002,PI3K-IN-2,PI3K inhibitor,,BRD-K62374002,PI3K-IN-2,PI3K inhibitor,,BRD-K62374002,PI3K-IN-2,PI3K inhibitor,
ADIMAYPTOBDMTL,BRD-A50049929,oxazepam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3,BRD-A50049929,oxazepam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3,BRD-A50049929,oxazepam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3,,,,
ADNPLDHMAVUMIW,BRD-K23106423,substance-p,neurokinin receptor antagonist,TACR1|TACR2|TACR3,BRD-K23106423,substance-p,neurokinin receptor antagonist,TACR1|TACR2|TACR3,BRD-K23106423,substance-p,neurokinin receptor antagonist,TACR1|TACR2|TACR3,BRD-K23106423,substance-P,neurokinin receptor antagonist,TACR1|TACR2|TACR3
ADVPTQAUNPRNPO,BRD-A25800195,L-Cysteinesulfinic-acid,glutamate receptor agonist,GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2,BRD-A25800195,L-Cysteinesulfinic-acid,glutamate receptor agonist,GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2,BRD-A25800195,L-Cysteinesulfinic-acid,glutamate receptor agonist,GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2,BRD-A25800195,L-cysteinesulfinic-acid,glutamate receptor agonist,GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2
AEAPORIZZWBIEX,BRD-K11672787,rostafuroxine,ATPase inhibitor,ATP1A1,BRD-K11672787,rostafuroxine,ATPase inhibitor,ATP1A1,BRD-K11672787,rostafuroxine,ATPase inhibitor,ATP1A1,BRD-K11672787,rostafuroxine,ATPase inhibitor,ATP1A1
AECDBHGVIIRMOI,BRD-K24696047,NVP-AEW541,IGF-1 inhibitor,IGF1R|INSR,BRD-K24696047,NVP-AEW541,IGF-1 inhibitor,IGF1R|INSR,BRD-K24696047,NVP-AEW541,IGF-1 inhibitor,IGF1R|INSR,BRD-K24696047,NVP-AEW541,IGF-1 inhibitor,IGF1R|INSR
AEJOEPSMZCEYJN,BRD-K73290745,ICI-199441,opioid receptor agonist,CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R,BRD-K73290745,ICI-199441,opioid receptor agonist,CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R,BRD-K73290745,ICI-199441,opioid receptor agonist,CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R,BRD-K73290745,ICI-199441,opioid receptor agonist,CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R
AELCINSCMGFISI,BRD-A43974575|BRD-K47029922|BRD-K88809146,tranylcypromine,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,BRD-A43974575|BRD-K47029922|BRD-K88809146,tranylcypromine,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,BRD-A43974575|BRD-K47029922|BRD-K88809146|BRD-M46777692,tranylcypromine,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,BRD-K00003699,tranylcypromine,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB
AEOCXXJPGCBFJA,BRD-K51207550,ethionamide,mycolic synthesis inhibitor,,BRD-K51207550,ethionamide,mycolic synthesis inhibitor,,BRD-K51207550,ethionamide,mycolic synthesis inhibitor,,BRD-K33710385,ethionamide,mycolic synthesis inhibitor,
AEQDJSLRWYMAQI,BRD-K35719256,rotundine,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,BRD-K35719256,rotundine,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,BRD-K35719256,rotundine,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,BRD-K35719256,rotundine,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A
AERBNCYCJBRYDG,BRD-K05048137,phytosphingosine,,,BRD-K05048137,phytosphingosine,,,BRD-K05048137,phytosphingosine,,,BRD-K05048137,phytosphingosine,,
AEUTYOVWOVBAKS,BRD-K93231391,ethambutol,bacterial cell wall synthesis inhibitor,,BRD-K93231391,ethambutol,bacterial cell wall synthesis inhibitor,,BRD-K93231391,ethambutol,bacterial cell wall synthesis inhibitor,,BRD-K93231391,ethambutol,bacterial cell wall synthesis inhibitor,
AEZPAUSGTAHLOQ,BRD-K76568384,PHTPP,estrogen receptor antagonist,ESR2,BRD-K76568384,PHTPP,estrogen receptor antagonist,ESR2,BRD-K76568384,PHTPP,estrogen receptor antagonist,ESR2,BRD-K76568384,PHTPP,estrogen receptor antagonist,ESR2
AFCGFAGUEYAMAO,BRD-K26262077,acamprosate,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5,BRD-K26262077,acamprosate,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5,BRD-K26262077|BRD-M41783010,acamprosate,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5,BRD-K26262077|BRD-M41783010,acamprosate,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5
AFDXODALSZRGIH,BRD-K26273521,trans-4-Methoxycinnamic-acid,,,BRD-K26273521,trans-4-Methoxycinnamic-acid,,,BRD-K26273521,trans-4-Methoxycinnamic-acid,,,BRD-K26273521,trans-4-methoxycinnamic-acid,,
AFFZCQDLQIEQGB,BRD-K59998349,aminolevulinic-acid-benzyl-ester,,,BRD-K59998349,aminolevulinic-acid-benzyl-ester,,,BRD-K59998349,aminolevulinic-acid-benzyl-ester,,,BRD-K59998349,aminolevulinic-acid-benzyl-ester,,
AFHJQYHRLPMKHU,BRD-A63615100|BRD-K02074536,aloin,angiogenesis inhibitor,,BRD-A63615100|BRD-K02074536,aloin,angiogenesis inhibitor,,BRD-A63615100|BRD-K02074536,aloin,angiogenesis inhibitor,,BRD-A63615100|BRD-K02074536,aloin,angiogenesis inhibitor,
AFJRDFWMXUECEW,BRD-K25412176,GSK2110183,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K25412176,GSK2110183,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K25412176,GSK2110183,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K25412176,GSK2110183,AKT inhibitor,AKT1|AKT2|AKT3
AFJYYKSVHJGXSN,BRD-A58564983,selamectin,nematocide,,BRD-A58564983,selamectin,nematocide,,BRD-A58564983,selamectin,nematocide,,BRD-K00003549,selamectin,nematocide,
AFLFKFHDSCQHOL,BRD-K03165895,elafibranor,PPAR receptor agonist,PPARA|PPARD,BRD-K03165895,elafibranor,PPAR receptor agonist,PPARA|PPARD,BRD-K03165895,elafibranor,PPAR receptor agonist,PPARA|PPARD,BRD-K03165895,elafibranor,PPAR receptor agonist,PPARA|PPARD|PPARG
AFNXATANNDIXLG,BRD-A70649075,sulconazole,sterol demethylase inhibitor,,BRD-A70649075,sulconazole,sterol demethylase inhibitor,,BRD-A70649075,sulconazole,sterol demethylase inhibitor,,BRD-A70649075,sulconazole,sterol demethylase inhibitor,
AFQQVNXTHGUXEQ,BRD-K64414150,tymazoline,,,BRD-K64414150,tymazoline,,,BRD-K64414150,tymazoline,,,,,,
AFSDNFLWKVMVRB,BRD-K30466858,ellagic-acid,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,BRD-K30466858,ellagic-acid,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,BRD-K30466858,ellagic-acid,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,BRD-K30466858,ellagic-acid,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK
AFSOIHMEOKEZJF,BRD-K82484965,carmoxirole,dopamine receptor agonist,DRD2,BRD-K82484965,carmoxirole,dopamine receptor agonist,DRD2,BRD-K82484965,carmoxirole,dopamine receptor agonist,DRD2,BRD-K82484965,carmoxirole,dopamine receptor agonist,DRD2
AFTZZRFCMOAFCR,BRD-K32289541,EHop-016,Ras GTPase inhibitor,RAC1|RAC3,BRD-K32289541,EHop-016,Ras GTPase inhibitor,RAC1|RAC3,BRD-K32289541,EHop-016,Ras GTPase inhibitor,RAC1|RAC3,BRD-K32289541,EHop-016,Ras GTPase inhibitor,RAC1|RAC3
AFUWQWYPPZFWCO,BRD-K44164034,pumosetrag,serotonin receptor agonist,HTR3A|HTR4,BRD-K44164034,pumosetrag,serotonin receptor agonist,HTR3A|HTR4,BRD-K44164034,pumosetrag,serotonin receptor agonist,HTR3A|HTR4,BRD-K44164034,pumosetrag,serotonin receptor agonist,HTR3A|HTR4
AFZFFLVORLEPPO,BRD-A39056513|BRD-K05878591|BRD-K72167406,cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-A39056513|BRD-K05878591|BRD-K72167406,cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-A39056513|BRD-K05878591|BRD-K72167406,cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-A39056513|BRD-K05878591|BRD-K72167406,cefditoren-pivoxil,bacterial cell wall synthesis inhibitor,
AFZLABYDOCWQBQ,BRD-K15588452,R-96544,serotonin receptor antagonist,HTR2A,BRD-K15588452,R-96544,serotonin receptor antagonist,HTR2A,BRD-K15588452,R-96544,serotonin receptor antagonist,HTR2A,BRD-K15588452,R-96544,serotonin receptor antagonist,HTR2A
AGBQKNBQESQNJD,BRD-A16347691,thioctic-acid,reducing agent,ACHE|LIAS|LIPT1|PTGS2|SLC5A6,BRD-A16347691,thioctic-acid,reducing agent,ACHE|LIAS|LIPT1|PTGS2|SLC5A6,BRD-A16347691,thioctic-acid,reducing agent,ACHE|LIAS|LIPT1|PTGS2|SLC5A6,BRD-A16347691,thioctic-acid,reducing agent,ACHE|PTGS2
AGHANLSBXUWXTB,BRD-K34098590,tienilic-acid,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,CYP2C9|SLC12A1,BRD-K34098590,tienilic-acid,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,CYP2C9|SLC12A1,BRD-K34098590,tienilic-acid,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,CYP2C9|SLC12A1,BRD-K34098590,tienilic-acid,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,CYP2C9|SLC12A1
AGJBLWCLQCKRJP,BRD-A22267103,drofenine,,,BRD-A22267103,drofenine,,,BRD-A22267103,drofenine,,,BRD-A22267103,drofenine,,
AGKAAJMNNVUNDK,BRD-A30590053,MR-16728,acetylcholine release enhancer,,BRD-A30590053,MR-16728,acetylcholine release enhancer,,BRD-A30590053,MR-16728,acetylcholine release enhancer,,BRD-A30590053,MR-16728,acetylcholine release enhancer,
AGMMTXLNIQSRCG,BRD-A59303141,quinethazone,thiazide diuretic,CA1|CA2|SLC12A1|SLC12A2|SLC12A3,BRD-A59303141,quinethazone,thiazide diuretic,CA1|CA2|SLC12A1|SLC12A2|SLC12A3,BRD-A59303141,quinethazone,thiazide diuretic,CA1|CA2|SLC12A1|SLC12A2|SLC12A3,BRD-A59303141,quinethazone,thiazide diuretic,
AGOYDEPGAOXOCK,BRD-K16762525|BRD-K49668410,clarithromycin,bacterial 50S ribosomal subunit inhibitor,CYP3A4,BRD-K49668410,clarithromycin,bacterial 50S ribosomal subunit inhibitor,CYP3A4,BRD-K16762525|BRD-K49668410,clarithromycin,bacterial 50S ribosomal subunit inhibitor,CYP3A4,BRD-K16762525|BRD-K49668410,clarithromycin,bacterial 50S ribosomal subunit inhibitor,CYP3A4
AGPIHNZOZNKRGT,BRD-K11792081,ABT-639,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,BRD-K11792081,ABT-639,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,BRD-K11792081,ABT-639,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,BRD-K11792081,ABT-639,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I
AGPKZVBTJJNPAG,BRD-A02232681,isoleucine,,ACADSB|BCAT1|BCAT2|IARS|IARS2,BRD-A02232681,isoleucine,,ACADSB|BCAT1|BCAT2|IARS|IARS2,BRD-A02232681,isoleucine,,ACADSB|BCAT1|BCAT2|IARS|IARS2,BRD-A02232681,isoleucine,,
AGRCPNMCOXLKFO,BRD-A55902763,2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose,,,BRD-A55902763,2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose,,,BRD-A55902763,2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose,,,,,,
AGYIAWHWIUZNSD,BRD-K72735080,BET-BAY-002,bromodomain inhibitor,,BRD-K72735080,BET-BAY-002,bromodomain inhibitor,,BRD-K72735080,BET-BAY-002,bromodomain inhibitor,,BRD-K72735080,BET-BAY-002,bromodomain inhibitor,
AHBKIEXBQNRDNL,BRD-A41774846,algestone-acetophenide,,,BRD-A41774846,algestone-acetophenide,,,BRD-A41774846,algestone-acetophenide,,,BRD-K00005348,algestone-acetophenide,,
AHCYOTLTLQTPSU,BRD-K86109159,VU0357121,glutamate receptor positive allosteric modulator,GRM5,BRD-K86109159,VU0357121,glutamate receptor positive allosteric modulator,GRM5,BRD-K86109159,VU0357121,glutamate receptor positive allosteric modulator,GRM5,BRD-K86109159,VU0357121,glutamate receptor positive allosteric modulator,GRM5
AHFWIQIYAXSLBA,BRD-K51247865,ipragliflozin-l-proline,sodium/glucose cotransporter inhibitor,SLC5A2,BRD-K51247865,ipragliflozin-l-proline,sodium/glucose cotransporter inhibitor,SLC5A2,BRD-K51247865,ipragliflozin-l-proline,sodium/glucose cotransporter inhibitor,SLC5A2,BRD-K51247865,ipragliflozin-L-proline,sodium/glucose cotransporter inhibitor,SLC5A2
AHFZDNYNXFMRFQ,BRD-K57597776,org-27569,cannabinoid receptor modulator,CNR1,BRD-K57597776,org-27569,cannabinoid receptor modulator,CNR1,BRD-K57597776,org-27569,cannabinoid receptor modulator,CNR1,BRD-K57597776,ORG-27569,cannabinoid receptor modulator,CNR1
AHJRHEGDXFFMBM,BRD-K51313569,palbociclib,CDK inhibitor,CDK4|CDK6,BRD-K51313569,palbociclib,CDK inhibitor,CDK4|CDK6,BRD-K51313569,palbociclib,CDK inhibitor,CDK4|CDK6,BRD-K51313569,palbociclib,CDK inhibitor,CDK4|CDK6
AHKAOMZZTQULDS,BRD-A45929034,benzoclidine,,,BRD-A45929034,benzoclidine,,,BRD-A45929034,benzoclidine,,,BRD-A45929034,benzoclidine,,
AHKBRSQVOSQELW,BRD-K57027742,N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,,,BRD-K57027742,N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,,,BRD-K57027742,N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,,,,,,
AHLBNYSZXLDEJQ,BRD-K63343048|BRD-K94062100,orlistat,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,BRD-K63343048|BRD-K94062100,orlistat,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,BRD-K63343048|BRD-K94062100,orlistat,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,BRD-K63343048,orlistat,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP
AHLPHDHHMVZTML,BRD-A13561534,ornithine,NFkB pathway modulator,ARG1|ARG2|GATM|GPRC6A|OAT|OAZ1|OAZ2|OAZ3|OTC|SLC25A15|SLC25A2|SLC7A1|SLC7A2|SLC7A3|SLC7A4,BRD-A13561534,ornithine,NFkB pathway modulator,ARG1|ARG2|GATM|GPRC6A|OAT|OAZ1|OAZ2|OAZ3|OTC|SLC25A15|SLC25A2|SLC7A1|SLC7A2|SLC7A3|SLC7A4,BRD-A13561534,ornithine,NFkB pathway modulator,ARG1|ARG2|GATM|GPRC6A|OAT|OAZ1|OAZ2|OAZ3|OTC|SLC25A15|SLC25A2|SLC7A1|SLC7A2|SLC7A3|SLC7A4,,,,
AHOUBRCZNHFOSL,BRD-K37991163,paroxetine,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,BRD-K37991163,paroxetine,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,BRD-K37991163,paroxetine,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,BRD-K37991163,paroxetine,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4
AHYMHWXQRWRBKT,BRD-K97963946,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET,BRD-K97963946,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET,BRD-K97963946,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET,BRD-K97963946,EMD-1214063,hepatocyte growth factor receptor inhibitor,MET
AIGAZQPHXLWMOJ,BRD-K34073885,tanshinone-i,AP inhibitor,IFNG,BRD-K34073885,tanshinone-i,AP inhibitor,IFNG,BRD-K34073885,tanshinone-i,AP inhibitor,IFNG,BRD-K34073885,tanshinone-I,AP inhibitor,IFNG
AILRADAXUVEEIR,BRD-K56981171,brigatinib,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR,BRD-K56981171,brigatinib,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR,BRD-K56981171,brigatinib,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR,BRD-K56981171,brigatinib,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR
AIONOLUJZLIMTK,BRD-K30553453,hesperetin,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,BRD-K30553453,hesperetin,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,BRD-K30553453,hesperetin,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,BRD-K30553453,hesperetin,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2
AIZFEOPQVZBNGH,BRD-K89490285,bentazepam,benzodiazepine receptor agonist,,BRD-K89490285,bentazepam,benzodiazepine receptor agonist,,BRD-K89490285,bentazepam,benzodiazepine receptor agonist,,,,,
AJFFBPZYXRNAIC,BRD-K59419204,AM-281,cannabinoid receptor antagonist,CNR1|CNR2|GPR55,BRD-K59419204,AM-281,cannabinoid receptor antagonist,CNR1|CNR2|GPR55,BRD-K59419204,AM-281,cannabinoid receptor antagonist,CNR1|CNR2|GPR55,BRD-K59419204,AM-281,cannabinoid receptor antagonist,CNR1|CNR2|GPR55
AJFTZWGGHJXZOB,BRD-K06221026,DUP-697,cyclooxygenase inhibitor,PTGS2,BRD-K06221026,DUP-697,cyclooxygenase inhibitor,PTGS2,BRD-K06221026,DUP-697,cyclooxygenase inhibitor,PTGS2,BRD-K06221026,DUP-697,cyclooxygenase inhibitor,PTGS2
AJIPIJNNOJSSQC,BRD-K75445017,estetrol,selective estrogen receptor modulator (SERM),ESR1,BRD-K75445017,estetrol,selective estrogen receptor modulator (SERM),ESR1,BRD-K75445017,estetrol,selective estrogen receptor modulator (SERM),ESR1,BRD-K75445017,estetrol,selective estrogen receptor modulator (SERM),ESR1
AJKIRUJIDFJUKJ,BRD-K98765504,taurolidine,apoptosis stimulant,,BRD-K98765504,taurolidine,apoptosis stimulant,,BRD-K98765504,taurolidine,apoptosis stimulant,,BRD-K98765504,taurolidine,apoptosis stimulant,
AJLFOPYRIVGYMJ,BRD-A83177971|BRD-K31414443|BRD-K94441233,mevastatin,HMGCR inhibitor,HMGCR,BRD-A83177971|BRD-K31414443|BRD-K94441233,mevastatin,HMGCR inhibitor,HMGCR,BRD-A83177971|BRD-K31414443|BRD-K94441233,mevastatin,HMGCR inhibitor,HMGCR,BRD-A83177971|BRD-K31414443|BRD-K94441233,mevastatin,HMGCR inhibitor,HMGCR
AJMOLNFDYWTVQW,BRD-K81136890,leucylleucine-methyl-ester,,,BRD-K81136890,leucylleucine-methyl-ester,,,BRD-K81136890,leucylleucine-methyl-ester,,,BRD-K81136890,leucylleucine-methyl-ester,,
AJRGHIGYPXNABY,BRD-K88742110,PCI-34051,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8,BRD-K88742110,PCI-34051,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8,BRD-K88742110,PCI-34051,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8,BRD-K88742110,PCI-34051,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8
AJXPJJZHWIXJCJ,BRD-A57592049,methsuximide,T-type calcium channel binder,CACNA1G|CACNA1H|CACNA1I,BRD-A57592049,methsuximide,T-type calcium channel binder,CACNA1G|CACNA1H|CACNA1I,BRD-A57592049,methsuximide,T-type calcium channel binder,CACNA1G|CACNA1H|CACNA1I,BRD-A57592049,methsuximide,T-type calcium channel blocker,CACNA1G|CACNA1H|CACNA1I
AKCRNFFTGXBONI,BRD-K40175214,torin-1,mTOR inhibitor,MTOR,BRD-K40175214,torin-1,mTOR inhibitor,MTOR,BRD-K40175214,torin-1,mTOR inhibitor,MTOR,BRD-K40175214,torin-1,mTOR inhibitor,MTOR
AKJHMTWEGVYYSE,BRD-K89085489,fenretinide,apoptosis stimulant|retinoid receptor agonist,RARA,BRD-K89085489,fenretinide,apoptosis stimulant|retinoid receptor agonist,RARA,BRD-K89085489,fenretinide,apoptosis stimulant|retinoid receptor agonist,RARA,BRD-K89085489,fenretinide,apoptosis stimulant|retinoid receptor agonist,RARA
AKMNUCBQGHFICM,BRD-K41567364,SB-334867,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K41567364,SB-334867,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K41567364,SB-334867,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K41567364,SB-334867,orexin receptor antagonist,HCRTR1|HCRTR2
AKNNEGZIBPJZJG,BRD-A51393488|BRD-K91301684,noscapine,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,BRD-A51393488|BRD-K91301684,noscapine,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,BRD-A51393488|BRD-K89237706|BRD-K91301684,noscapine,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,BRD-A51393488|BRD-K89237706|BRD-K91301684,noscapine,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1
AKSIZPIFQAYJGF,BRD-K53561341,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA,BRD-K53561341,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA,BRD-K53561341,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA,BRD-K53561341,aurora-a-inhibitor-i,Aurora kinase inhibitor,AURKA
AKUJBENLRBOFTD,BRD-A92177080|BRD-A93424738|BRD-K40063336,betamethasone-acetate|dexamethasone-acetate,glucocorticoid receptor agonist,|NR3C1,BRD-A92177080|BRD-A93424738|BRD-K47635719,betamethasone-acetate|dexamethasone-acetate,glucocorticoid receptor agonist,|NR3C1,BRD-A92177080|BRD-A93424738|BRD-K40063336|BRD-K47635719,betamethasone-acetate|dexamethasone-acetate,glucocorticoid receptor agonist,|NR3C1,BRD-A93424738|BRD-K00025439|BRD-K40063336|BRD-K47635719|BRD-M00025439,betamethasone-acetate|dexamethasone-acetate,glucocorticoid receptor agonist,|NR3C1
AKWRNBWMGFUAMF,BRD-K37151368,adaptavir,CC chemokine receptor antagonist,CCR5,BRD-K37151368,adaptavir,CC chemokine receptor antagonist,CCR5,BRD-K37151368,adaptavir,CC chemokine receptor antagonist,CCR5,BRD-K37151368,adaptavir,CC chemokine receptor antagonist,CCR5
AKXCFAYOTIEFOH,BRD-K70898774,naloxone-benzoylhydrazone,opioid receptor antagonist,OPRK1|OPRM1,BRD-K70898774,naloxone-benzoylhydrazone,opioid receptor antagonist,OPRK1|OPRM1,BRD-K58239851|BRD-K70898774,naloxone-benzoylhydrazone,opioid receptor antagonist,OPRK1|OPRM1,BRD-K58239851|BRD-K70898774,naloxone-benzoylhydrazone,opioid receptor antagonist,OPRK1|OPRM1
ALBKMJDFBZVHAK,BRD-K33882852,ZK-93423,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,BRD-K33882852,ZK-93423,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,BRD-K33882852,ZK-93423,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,BRD-K33882852,ZK-93423,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2
ALCSGJCIESECFD,BRD-K11071038,ICI-162846,histamine receptor antagonist,HRH2,BRD-K11071038,ICI-162846,histamine receptor antagonist,HRH2,BRD-K11071038,ICI-162846,histamine receptor antagonist,HRH2,BRD-K66782112,ICI-162846,histamine receptor antagonist,HRH2
ALEXXDVDDISNDU,BRD-A65767837,hydrocortisone-acetate,glucocorticoid receptor agonist,NR3C1|NR3C2,BRD-A65767837,hydrocortisone-acetate,glucocorticoid receptor agonist,NR3C1|NR3C2,BRD-A65767837,hydrocortisone-acetate,glucocorticoid receptor agonist,NR3C1|NR3C2,BRD-K11612998,hydrocortisone-acetate,glucocorticoid receptor agonist,NR3C1
ALFGDCNSEBJYSP,BRD-A17428743,BW-723C86,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-A17428743,BW-723C86,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-A17428743,BW-723C86,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-K01826747,BW-723C86,serotonin receptor agonist,HTR2A|HTR2B|HTR2C
ALHBJBCQLJZYON,BRD-K59711701,ORY-1001,histone lysine demethylase inhibitor,KDM1A,BRD-K59711701,ORY-1001,histone lysine demethylase inhibitor,KDM1A,BRD-K59711701,ORY-1001,histone lysine demethylase inhibitor,KDM1A,BRD-K59711701,ORY-1001,histone lysine demethylase inhibitor,KDM1A
ALKJNCZNEOTEMP,BRD-K14274271,XL228,Abl kinase inhibitor|insulin growth factor receptor inhibitor|src inhibitor,IGF1R|SRC,BRD-K14274271,XL228,Abl kinase inhibitor|insulin growth factor receptor inhibitor|src inhibitor,IGF1R|SRC,BRD-K14274271,XL228,Abl kinase inhibitor|insulin growth factor receptor inhibitor|src inhibitor,IGF1R|SRC,BRD-K14274271,XL228,Abl kinase inhibitor|SRC inhibitor|insulin growth factor receptor inhibitor,IGF1R|SRC
ALLWOAVDORUJLA,BRD-A15909516,rebamipide,free radical scavenger,FPR1,BRD-A15909516,rebamipide,free radical scavenger,FPR1,BRD-A15909516,rebamipide,free radical scavenger,FPR1,BRD-A15909516,rebamipide,free radical scavenger,FPR1
ALOBUEHUHMBRLE,BRD-A74391928,ibutilide,potassium channel blocker,CACNA1C|CACNA2D1|CACNB1|CACNG1|KCNH2|KCNH6|KCNH7|KCNJ11|KCNK1|KCNK6,BRD-A74391928|BRD-M56587789,ibutilide,potassium channel blocker,CACNA1C|CACNA2D1|CACNB1|CACNG1|KCNH2|KCNH6|KCNH7|KCNJ11|KCNK1|KCNK6,BRD-A74391928|BRD-M56587789,ibutilide,potassium channel blocker,CACNA1C|CACNA2D1|CACNB1|CACNG1|KCNH2|KCNH6|KCNH7|KCNJ11|KCNK1|KCNK6,BRD-A74391928|BRD-M56587789,ibutilide,potassium channel blocker,CACNA1C|KCNH2
ALSKYCOJJPXPFS,BRD-K49811169,NSC-9965,acetylcholine receptor antagonist,CHRNA4|CHRNB2,BRD-K49811169,NSC-9965,acetylcholine receptor antagonist,CHRNA4|CHRNB2,BRD-K49811169,NSC-9965,acetylcholine receptor antagonist,CHRNA4|CHRNB2,BRD-K49811169,NSC-9965,acetylcholine receptor antagonist,CHRNA4|CHRNB2
ALWKGYPQUAPLQC,BRD-K18922609,neostigmine,acetylcholinesterase inhibitor,ACHE,BRD-K18922609,neostigmine,acetylcholinesterase inhibitor,ACHE,BRD-K18922609,neostigmine,acetylcholinesterase inhibitor,ACHE,BRD-K18922609,neostigmine,acetylcholinesterase inhibitor,ACHE
ALYNCZNDIQEVRV,BRD-K58497451,potassium-p-aminobenzoate,,,BRD-K58497451,potassium-p-aminobenzoate,,,BRD-K58497451,potassium-p-aminobenzoate,,,BRD-K58497451,potassium-p-aminobenzoate,,
AMDBBAQNWSUWGN,BRD-A65818372,ioversol,radiopaque medium,,BRD-A65818372,ioversol,radiopaque medium,,BRD-A65818372,ioversol,radiopaque medium,,BRD-A65818372,ioversol,radiopaque medium,
AMDGKLWVCUXONP,BRD-K22010301,JLK-6,gamma secretase inhibitor,PSEN1,BRD-K22010301,JLK-6,gamma secretase inhibitor,PSEN1,BRD-K22010301,JLK-6,gamma secretase inhibitor,PSEN1,BRD-K22010301,JLK-6,gamma secretase inhibitor,PSEN1
AMEROGPZOLAFBN,BRD-K21586122,fimasartan,angiotensin receptor antagonist,AGTR1,BRD-K21586122,fimasartan,angiotensin receptor antagonist,AGTR1,BRD-K21586122|BRD-K76786967,fimasartan,angiotensin receptor antagonist,AGTR1,BRD-K21586122|BRD-K76786967,fimasartan,angiotensin receptor antagonist,AGTR1
AMHZIUVRYRVYBA,BRD-K14379200,cyclocreatine,creatine kinase substrate,,BRD-K14379200,cyclocreatine,creatine kinase substrate,,BRD-K14379200,cyclocreatine,creatine kinase substrate,,BRD-K14379200,cyclocreatine,creatine kinase substrate,
AMKVXSZCKVJAGH,BRD-K61337602,naratriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K61337602,naratriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K61337602,naratriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K61337602,naratriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
AMLYAMJWYAIXIA,BRD-K57252450,cilengitide,integrin antagonist,ITGAV|ITGB3,BRD-K57252450,cilengitide,integrin antagonist,ITGAV|ITGB3,BRD-K57252450,cilengitide,integrin antagonist,ITGAV|ITGB3,BRD-K57252450,cilengitide,integrin antagonist,ITGAV|ITGB3
AMRFVEMXRRPNJH,BRD-K34251960,cibenzoline,sodium channel blocker,,BRD-K34251960,cibenzoline,sodium channel blocker,,BRD-K34251960,cibenzoline,sodium channel blocker,,,,,
AMRSLVJUMUBRSB,BRD-A51799737,thiostrepton,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1,,,,,,,,,,,,
AMTPYFGPPVFBBI,BRD-K97417064,acedapsone,,,BRD-K97417064,acedapsone,,,BRD-K97417064,acedapsone,,,BRD-K97417064,acedapsone,,
ANDGGVOPIJEHOF,BRD-K24771047,ampalex,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K24771047,ampalex,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K24771047,ampalex,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K24771047,ampalex,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4
ANEBWFXPVPTEET,BRD-A90695733,manidipine,calcium channel blocker,CACNA1C|CACNA1D,BRD-A90695733,manidipine,calcium channel blocker,CACNA1C|CACNA1D,BRD-A90695733,manidipine,calcium channel blocker,CACNA1C|CACNA1D,BRD-K01825587,manidipine,calcium channel blocker,CACNA1C|CACNA1D
ANGKOCUUWGHLCE,BRD-A81233518,glycopyrrolate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A81233518,glycopyrrolate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A81233518,glycopyrrolate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A81233518,glycopyrrolate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
ANGUXJDGJCHGOG,BRD-K69669039,GSK163090,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D,BRD-K69669039,GSK163090,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D,BRD-K69669039,GSK163090,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D,BRD-K69669039,GSK163090,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D
ANJTVLIZGCUXLD,BRD-A55579717|BRD-K74186897,cytisine,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,BRD-A55579717|BRD-K74186897,cytisine,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,BRD-A55579717|BRD-K74186897,cytisine,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,BRD-A55579717|BRD-K74186897,cytisine,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4
ANMATWQYLIFGOK,BRD-K15426076,iguratimod,NFkB pathway inhibitor|cyclooxygenase inhibitor,PTGS2,BRD-K15426076,iguratimod,NFkB pathway inhibitor|cyclooxygenase inhibitor,PTGS2,BRD-K15426076,iguratimod,NFkB pathway inhibitor|cyclooxygenase inhibitor,PTGS2,BRD-K15426076,iguratimod,NFkB pathway inhibitor|cyclooxygenase inhibitor,PTGS2
ANMLJLFWUCQGKZ,BRD-A98378129,talniflumate,cyclooxygenase inhibitor,CLCA1,BRD-A98378129,talniflumate,cyclooxygenase inhibitor,CLCA1,BRD-A98378129,talniflumate,cyclooxygenase inhibitor,CLCA1,BRD-A98378129,talniflumate,cyclooxygenase inhibitor,CLCA1
ANOUKFYBOAKOIR,BRD-K59570838,homoveratrylamine,dopamine analog,,BRD-K59570838,homoveratrylamine,dopamine analog,,BRD-K59570838,homoveratrylamine,dopamine analog,,BRD-K59570838,homoveratrylamine,monoamine oxidase inhibitor,
ANZXOIAKUNOVQU,BRD-A17462676,bambuterol,adrenergic receptor agonist,ADRB2|BCHE,BRD-A17462676,bambuterol,adrenergic receptor agonist,ADRB2|BCHE,BRD-A17462676,bambuterol,adrenergic receptor agonist,ADRB2|BCHE,BRD-A17462676,bambuterol,adrenergic receptor agonist,ADRB2|BCHE
AOBORMOPSGHCAX,BRD-A39830855,tocofersolan,antioxidant,,BRD-A39830855,tocofersolan,antioxidant,,BRD-A39830855|BRD-K57305459|BRD-U58371969,tocofersolan,antioxidant,,BRD-K57305459|BRD-U58371969,tocofersolan,antioxidant,
AOCCBINRVIKJHY,BRD-K11630072,carmofur,thymidylate synthase inhibitor,TYMS,BRD-K11630072,carmofur,thymidylate synthase inhibitor,TYMS,BRD-K11630072,carmofur,thymidylate synthase inhibitor,TYMS,BRD-K11630072,carmofur,thymidylate synthase inhibitor,TYMS
AOJJSUZBOXZQNB,BRD-A52530684|BRD-K04548931|BRD-K56844688|BRD-K61468417|BRD-K92093830,doxorubicin|epirubicin,topoisomerase inhibitor,CHD1|TOP2A,BRD-A52530684|BRD-K04548931|BRD-K56844688|BRD-K61468417|BRD-K92093830,doxorubicin|epirubicin,topoisomerase inhibitor,CHD1|TOP2A,BRD-A52530684|BRD-K04548931|BRD-K56844688|BRD-K61468417|BRD-K92093830,doxorubicin|epirubicin,topoisomerase inhibitor,CHD1|TOP2A,BRD-A52530684|BRD-K04548931|BRD-K56844688|BRD-K61468417|BRD-K92093830,doxorubicin|epirubicin,topoisomerase inhibitor,CHD1|TOP2A
AOMUHOFOVNGZAN,BRD-K11548689,lauric-diethanolamide,,,BRD-K11548689,lauric-diethanolamide,,,BRD-K11548689,lauric-diethanolamide,,,BRD-K11548689,lauric-diethanolamide,,
APGDTXUMTIZLCJ,BRD-A78391468,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1,BRD-A78391468,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1,BRD-A78391468,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1,BRD-A78391468,prednisolone-hemisuccinate,glucocorticoid receptor agonist,NR3C1
APHGZZPEOCCYNO,BRD-K73293050,WZ-3146,EGFR inhibitor,EGFR,BRD-K73293050,WZ-3146,EGFR inhibitor,EGFR,BRD-K73293050,WZ-3146,EGFR inhibitor,EGFR,BRD-K73293050,WZ-3146,EGFR inhibitor,EGFR
APKFDSVGJQXUKY,BRD-A75647097|BRD-K27352494|BRD-K69849489|BRD-K94561406,amphotericin-b,membrane permeability enhancer,,BRD-A75647097|BRD-K27352494|BRD-K82702594|BRD-K94561406,amphotericin-b,membrane permeability enhancer,,BRD-A75647097|BRD-K27352494|BRD-K82702594|BRD-K94561406,amphotericin-b,membrane permeability enhancer,,BRD-A75647097|BRD-K27352494|BRD-K82702594|BRD-K94561406,amphotericin-b,membrane permeability enhancer,
APQPGQGAWABJLN,BRD-A23418262,floctafenine,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A23418262,floctafenine,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A23418262,floctafenine,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A23418262,floctafenine,cyclooxygenase inhibitor,PTGS1|PTGS2
APQPVVOYBLOJDY,BRD-K53156626,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE,BRD-K53156626,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE,BRD-K53156626,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE,BRD-K53156626,7-methoxytacrine,acetylcholinesterase inhibitor,ACHE
APSUXPSYBJVPPS,BRD-K36381762,nor-Binaltorphimine-dihydrochloride,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K36381762,nor-Binaltorphimine-dihydrochloride,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K36381762,nor-Binaltorphimine-dihydrochloride,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K36381762,nor-binaltorphimine,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
APTGJECXMIKIET,BRD-K07625016,norethisterone-enanthate,contraceptive agent,,BRD-K07625016,norethisterone-enanthate,contraceptive agent,,BRD-K07625016,norethisterone-enanthate,contraceptive agent,,BRD-K07625016,norethisterone-enanthate,contraceptive agent,
AQASGOHUMGAWJJ,BRD-K62581435,3-MPPI,adrenergic receptor ligand,ADRA1A,BRD-K62581435,3-MPPI,adrenergic receptor ligand,ADRA1A,BRD-K62581435,3-MPPI,adrenergic receptor ligand,ADRA1A,BRD-K62581435,3-MPPI,adrenergic receptor ligand,ADRA1A
AQCHWTWZEMGIFD,BRD-A61793559,metolazone,carbonic anhydrase inhibitor,SLC12A3,BRD-A61793559,metolazone,carbonic anhydrase inhibitor,SLC12A3,BRD-A61793559,metolazone,carbonic anhydrase inhibitor,SLC12A3,BRD-A61793559,metolazone,carbonic anhydrase inhibitor,SLC12A3
AQFFXPQJLZFABJ,BRD-K59339270,AH6809,prostanoid receptor antagonist,PTGDR|PTGER1|PTGER2|PTGER3,BRD-K59339270,AH6809,prostanoid receptor antagonist,PTGDR|PTGER1|PTGER2|PTGER3,BRD-K59339270,AH6809,prostanoid receptor antagonist,PTGDR|PTGER1|PTGER2|PTGER3,BRD-K59339270,AH6809,prostanoid receptor antagonist,PTGDR|PTGER1|PTGER2|PTGER3
AQGNHMOJWBZFQQ,BRD-K16189898,CHIR-99021,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1,BRD-K16189898,CHIR-99021,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1,BRD-K16189898,CHIR-99021,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1,BRD-K16189898,CHIR-99021,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1
AQHHHDLHHXJYJD,BRD-A10070317|BRD-K13994703|BRD-K92830582,propranolol|propranolol-(R)|propranolol-(S),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3|HTR1A|HTR1B|HTR5A|SLC10A1,BRD-A10070317|BRD-K13994703|BRD-K92830582,propranolol|propranolol-(R)|propranolol-(S),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3|HTR1A|HTR1B|HTR5A|SLC10A1,BRD-A10070317|BRD-K13994703|BRD-K92830582,propranolol|propranolol-(R)|propranolol-(S),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3|HTR1A|HTR1B|HTR5A|SLC10A1,BRD-A10070317|BRD-K13994703|BRD-K92830582,propranolol|propranolol-(R)|propranolol-(S),adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3|HTR1A|HTR5A|SLC10A1
AQIXAKUUQRKLND,BRD-K34157611,cimetidine,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,BRD-K34157611,cimetidine,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,BRD-K34157611,cimetidine,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,BRD-K34157611,cimetidine,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2
AQMPIDSGLFVVPL,BRD-K72904818,NNC-63-0532,opioid receptor agonist,OPRL1,BRD-K36009368|BRD-K72904818,NNC-63-0532,opioid receptor agonist,OPRL1,BRD-K36009368|BRD-K72904818,NNC-63-0532,opioid receptor agonist,OPRL1,BRD-K36009368|BRD-K72904818,NNC-63-0532,opioid receptor agonist,OPRL1
AQNDDEOPVVGCPG,BRD-A07395371,esmolol,adrenergic receptor antagonist,ADRB1,BRD-A07395371,esmolol,adrenergic receptor antagonist,ADRB1,BRD-A07395371,esmolol,adrenergic receptor antagonist,ADRB1,BRD-K01825842,esmolol,adrenergic receptor antagonist,ADRB1
AQOKCDNYWBIDND,BRD-A45153512,bimatoprost,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,BRD-A45153512,bimatoprost,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,BRD-A45153512,bimatoprost,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,BRD-K00003616,bimatoprost,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR
AQRLDDAFYYAIJP,BRD-K43837174,pruvanserin,serotonin receptor antagonist,HTR2A|HTR2C,BRD-K43837174,pruvanserin,serotonin receptor antagonist,HTR2A|HTR2C,BRD-K43837174,pruvanserin,serotonin receptor antagonist,HTR2A|HTR2C,BRD-K43837174,pruvanserin,serotonin receptor antagonist,HTR2A|HTR2C
AQSSMEORRLJZLU,BRD-K18424115,TG-100572,VEGFR inhibitor|src inhibitor,KDR|SRC,BRD-K18424115,TG-100572,VEGFR inhibitor|src inhibitor,KDR|SRC,BRD-K18424115,TG-100572,VEGFR inhibitor|src inhibitor,KDR|SRC,BRD-K18424115,TG-100572,SRC inhibitor|VEGFR inhibitor,KDR|SRC
AQVFETGXIRKVAQ,BRD-K48832421,PIM-1-Inhibitor-2,Pim kinase inhibitor,PIM1,BRD-K48832421,PIM-1-Inhibitor-2,Pim kinase inhibitor,PIM1,BRD-K48832421,PIM-1-Inhibitor-2,Pim kinase inhibitor,PIM1,BRD-K48832421,PIM-1-Inhibitor-2,Pim kinase inhibitor,PIM1
ARAIBEBZBOPLMB,BRD-K23067689|BRD-K75153898,zanamivir,neuraminidase inhibitor,NEU2,BRD-K23067689|BRD-K75153898,zanamivir,neuraminidase inhibitor,NEU2,BRD-K23067689|BRD-K75153898,zanamivir,neuraminidase inhibitor,NEU2,BRD-K23067689|BRD-K75153898,zanamivir,neuraminidase inhibitor,NEU2
ARBYGDBJECGMGA,BRD-K62762455,RU-58841,androgen receptor antagonist,AR,BRD-K62762455,RU-58841,androgen receptor antagonist,AR,BRD-K62762455,RU-58841,androgen receptor antagonist,AR,BRD-K62762455,RU-58841,androgen receptor antagonist,AR
ARDYECYBETXQFD,BRD-A67975844,NSC-405020,matrix metalloprotease inhibitor,MMP1,BRD-A67975844,NSC-405020,matrix metalloprotease inhibitor,MMP1,BRD-A67975844,NSC-405020,matrix metalloprotease inhibitor,MMP1,BRD-A67975844,NSC-405020,matrix metalloprotease inhibitor,MMP1
ARFHIAQFJWUCFH,BRD-A00100033,nifurtimox,DNA inhibitor,,BRD-A00100033,nifurtimox,DNA inhibitor,,BRD-A00100033,nifurtimox,DNA inhibitor,,BRD-A84020532,nifurtimox,DNA inhibitor,
ARGIPZKQJGFSGQ,BRD-K66101666,PYR-41,ubiquitin activating enzyme inhibitor,,BRD-K66101666,PYR-41,ubiquitin activating enzyme inhibitor,,BRD-K66101666,PYR-41,ubiquitin activating enzyme inhibitor,,BRD-K66101666,PYR-41,ubiquitin activating enzyme inhibitor,
ARHWPKZXBHOEEE,BRD-K47492008,alclofenac,cyclooxygenase inhibitor,PTGS1,BRD-K47492008,alclofenac,cyclooxygenase inhibitor,PTGS1,BRD-K47492008,alclofenac,cyclooxygenase inhibitor,PTGS1,BRD-K47492008,alclofenac,cyclooxygenase inhibitor,PTGS1
ARIWANIATODDMH,BRD-A10773072,glycerol-monolaurate,beta lactamase inhibitor,,BRD-A10773072,glycerol-monolaurate,beta lactamase inhibitor,,BRD-A10773072,glycerol-monolaurate,beta lactamase inhibitor,,BRD-A10773072,glycerol-monolaurate,beta lactamase inhibitor,
ARJCBSRIPGJMAD,BRD-K06294530,UK-383367,Procollagen C-Endopeptidase Inhibitors,BMP1,BRD-K06294530,UK-383367,Procollagen C-Endopeptidase Inhibitors,BMP1,BRD-K06294530,UK-383367,Procollagen C-Endopeptidase Inhibitors,BMP1,BRD-K06294530,UK-383367,procollagen C-endopeptidase inhibitor,BMP1
ARYQHSWJGHCGJS,BRD-K50699835,ELN-441958,bradykinin receptor antagonist,BDKRB1,BRD-K50699835,ELN-441958,bradykinin receptor antagonist,BDKRB1,BRD-K50699835,ELN-441958,bradykinin receptor antagonist,BDKRB1,BRD-K50699835,ELN-441958,bradykinin receptor antagonist,BDKRB1
ARYUXFNGXHNNDM,BRD-K45462423,VU0361737,glutamate receptor positive allosteric modulator,GRM4,BRD-K45462423,VU0361737,glutamate receptor positive allosteric modulator,GRM4,BRD-K45462423,VU0361737,glutamate receptor positive allosteric modulator,GRM4,BRD-K45462423,VU0361737,glutamate receptor positive allosteric modulator,GRM4
ASFKKFRSMGBFRO,BRD-A85548292,piketoprofen,cyclooxygenase inhibitor,,BRD-A85548292,piketoprofen,cyclooxygenase inhibitor,,BRD-A85548292,piketoprofen,cyclooxygenase inhibitor,,BRD-A85548292,piketoprofen,cyclooxygenase inhibitor,
ASGIQUHBAVIOTI,BRD-K17008822,BD-1008,sigma receptor antagonist,,BRD-K17008822,BD-1008,sigma receptor antagonist,,BRD-K17008822,BD-1008,sigma receptor antagonist,,BRD-K17008822,BD-1008,sigma receptor antagonist,
ASMXXROZKSBQIH,BRD-K74363950,aclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K74363950,aclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K74363950,aclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K74363950,aclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
ASNFTDCKZKHJSW,BRD-K92404805,L-Quisqualic-acid,glutamate receptor agonist,FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8,BRD-K92404805,L-Quisqualic-acid,glutamate receptor agonist,FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8,BRD-K92404805,L-Quisqualic-acid,glutamate receptor agonist,FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8,BRD-K92404805,L-quisqualic-acid,glutamate receptor agonist,FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8
ASOADIZOVZTJSR,BRD-K66192203,opicapone,catechol O methyltransferase inhibitor,COMT,BRD-K66192203,opicapone,catechol O methyltransferase inhibitor,COMT,BRD-K66192203,opicapone,catechol O methyltransferase inhibitor,COMT,BRD-K66192203,opicapone,catechol O methyltransferase inhibitor,COMT
ASSJTMUEFHUKMJ,BRD-K38793468,TAK-220,CC chemokine receptor antagonist,CCR5,BRD-K38793468,TAK-220,CC chemokine receptor antagonist,CCR5,BRD-K38793468,TAK-220,CC chemokine receptor antagonist,CCR5,BRD-K38793468,TAK-220,CC chemokine receptor antagonist,CCR5
ASUGUQWIHMTFJL,BRD-A95300432,decernotinib,JAK inhibitor,JAK3,BRD-A95300432,decernotinib,JAK inhibitor,JAK3,BRD-A95300432,decernotinib,JAK inhibitor,JAK3,BRD-A95300432,decernotinib,JAK inhibitor,JAK3
ASUTZQLVASHGKV,BRD-K49481516,galantamine,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG,BRD-K49481516,galantamine,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG,BRD-K49481516,galantamine,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG,BRD-K49481516,galantamine,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG
ASWVTGNCAZCNNR,BRD-K11640013,sulfamethazine,PABA antagonist,,BRD-K11640013,sulfamethazine,PABA antagonist,,BRD-K11640013,sulfamethazine,PABA antagonist,,BRD-K11640013,sulfamethazine,PABA antagonist,
ASXBYYWOLISCLQ,BRD-A67363467,dihydrostreptomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A67363467,dihydrostreptomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A67363467,dihydrostreptomycin,bacterial 30S ribosomal subunit inhibitor,,,,,
ASXGJMSKWNBENU,BRD-A48015106,8-hydroxy-DPAT,serotonin receptor agonist,CDK1|CHEK1|CHEK2|GSK3B|HTR5A|HTR7|LCK|MAPK14|MARK1|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,BRD-A48015106,8-hydroxy-DPAT,serotonin receptor agonist,CDK1|CHEK1|CHEK2|GSK3B|HTR5A|HTR7|LCK|MAPK14|MARK1|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,BRD-A48015106,8-hydroxy-DPAT,serotonin receptor agonist,CDK1|CHEK1|CHEK2|GSK3B|HTR5A|HTR7|LCK|MAPK14|MARK1|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,BRD-K01826732,8-hydroxy-DPAT,serotonin receptor agonist,HTR5A|HTR7
ATAJVFBUUIBIEO,BRD-K01653460,chlorindanol,,,BRD-K01653460,chlorindanol,,,BRD-K01653460,chlorindanol,,,BRD-K01653460,chlorindanol,,
ATALOFNDEOCMKK,BRD-K65170927,aprepitant,tachykinin antagonist,TACR1,BRD-K65170927,aprepitant,tachykinin antagonist,TACR1,BRD-K65170927,aprepitant,tachykinin antagonist,TACR1,BRD-K52827117,aprepitant,tachykinin antagonist,TACR1
ATCGGEJZONJOCL,BRD-K74195153,irsogladine,phosphodiesterase inhibitor,PDE4A,BRD-K74195153,irsogladine,phosphodiesterase inhibitor,PDE4A,BRD-K74195153,irsogladine,phosphodiesterase inhibitor,PDE4A,BRD-K74195153,irsogladine,phosphodiesterase inhibitor,PDE4A
ATEFPOUAMCWAQS,BRD-K61269089,daphnetin,protein kinase inhibitor,,BRD-K61269089,daphnetin,protein kinase inhibitor,,BRD-K61269089,daphnetin,protein kinase inhibitor,,BRD-K61269089,daphnetin,protein kinase inhibitor,
ATHGHQPFGPMSJY,BRD-K40438880,spermidine,glutamate receptor modulator,KCNJ4|TXNRD1,BRD-K40438880,spermidine,glutamate receptor modulator,KCNJ4|TXNRD1,BRD-K40438880,spermidine,glutamate receptor modulator,KCNJ4|TXNRD1,BRD-K40438880,spermidine,glutamate receptor modulator,KCNJ4|TXNRD1
ATHHXGZTWNVVOU,BRD-K33445938,N-methylformamide,,,BRD-K33445938,N-methylformamide,,,BRD-K33445938,N-methylformamide,,,BRD-K33445938,N-methylformamide,,
ATLJNLYIJOCWJE,BRD-K25970317,resibufogenin,Na/K-ATPase inhibitor,,BRD-K25970317,resibufogenin,Na/K-ATPase inhibitor,,BRD-K25970317,resibufogenin,Na/K-ATPase inhibitor,,BRD-K25970317,resibufogenin,Na/K-ATPase inhibitor,
ATORKVYCKKBNTF,BRD-K02988401,UNC0737,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K02988401,UNC0737,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K02988401,UNC0737,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K02988401,UNC0737,histone lysine methyltransferase inhibitor,EHMT1|EHMT2
ATOTUUBRFJHZQG,BRD-M67659203,pamabrom,diuretic,,BRD-M67659203,pamabrom,diuretic,,BRD-M67659203,pamabrom,diuretic,,BRD-M67659203,pamabrom,diuretic,
ATXHVCQZZJYMCF,BRD-K12872829,allylestrenol,steroidal progestin,ESR1|PGR|SLC6A9,BRD-K12872829,allylestrenol,steroidal progestin,ESR1|PGR|SLC6A9,BRD-K12872829,allylestrenol,steroidal progestin,ESR1|PGR|SLC6A9,BRD-K12872829,allylestrenol,steroidal progestin,ESR1|PGR|SLC6A9
ATZHGRNFEFVDDJ,BRD-K42108215,4-propylbenzoic-acid,,,BRD-K42108215,4-propylbenzoic-acid,,,BRD-K42108215,4-propylbenzoic-acid,,,BRD-K42108215,4-propylbenzoic-acid,,
AUFUWRKPQLGTGF,BRD-K18323388,uridine-triacetate,,,BRD-K18323388,uridine-triacetate,,,BRD-K18323388,uridine-triacetate,,,BRD-K18323388,uridine-triacetate,,
AUGQEEXBDZWUJY,BRD-K45724504,anguidine,protein synthesis inhibitor,SLC5A1,BRD-K45724504,anguidine,protein synthesis inhibitor,SLC5A1,BRD-K45724504,anguidine,protein synthesis inhibitor,SLC5A1,BRD-K45724504,anguidine,protein synthesis inhibitor,SLC5A1
AUJRCFUBUPVWSZ,BRD-A28431708,auranofin,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,BRD-K45995181,auranofin,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,BRD-A28431708|BRD-K45995181|BRD-K63171558,auranofin,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,BRD-A28431708|BRD-K45995181|BRD-K63171558|BRD-U68276368,auranofin,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1
AUJXLBOHYWTPFV,BRD-A68969091,echinomycin,DNA intercalating agent,,BRD-A68969091,echinomycin,DNA intercalating agent,,BRD-A68969091|BRD-M14664499,echinomycin,DNA intercalating agent,,BRD-K00010937,echinomycin,DNA intercalating agent,
AULLUGALUBVBDD,BRD-K74236984,UNC0321,histone lysine methyltransferase inhibitor,EHMT2,BRD-K74236984,UNC0321,histone lysine methyltransferase inhibitor,EHMT2,BRD-K74236984,UNC0321,histone lysine methyltransferase inhibitor,EHMT2,BRD-K74236984,UNC0321,histone lysine methyltransferase inhibitor,EHMT2
AUNGANRZJHBGPY,BRD-K70246307|BRD-K92760278,riboflavin,vitamin B2,BLVRB|RFK,BRD-K70246307|BRD-K92760278,riboflavin,vitamin B2,BLVRB|RFK,BRD-K70246307|BRD-K92760278,riboflavin,vitamin B2,BLVRB|RFK,BRD-K92760278,riboflavin,vitamin B,BLVRB|RFK
AURFZBICLPNKBZ,BRD-K18172896,eltanolone,membrane integrity inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,BRD-A03204438|BRD-K18172896,allopregnanolone|eltanolone|pregnanolone,GABA receptor positive allosteric modulator|membrane integrity inhibitor,|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,BRD-A03204438|BRD-K18172896,allopregnanolone|eltanolone|pregnanolone,GABA receptor positive allosteric modulator|membrane integrity inhibitor,|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,BRD-K30827431,eltanolone,GABA receptor positive allosteric modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2
AUVVAXYIELKVAI,BRD-A25687296|BRD-K03067624,emetine,protein synthesis inhibitor,RPS2,BRD-A25687296|BRD-K03067624,emetine,protein synthesis inhibitor,RPS2,BRD-A25687296|BRD-K03067624,emetine,protein synthesis inhibitor,RPS2,BRD-K03067624,emetine,protein synthesis inhibitor,RPS2
AUXCHYJDVJZEPG,BRD-A52660433,tetrindole,monoamine oxidase inhibitor,MAOA,BRD-A52660433,tetrindole,monoamine oxidase inhibitor,MAOA,BRD-A52660433,tetrindole,monoamine oxidase inhibitor,MAOA,BRD-A52660433,tetrindole,monoamine oxidase inhibitor,MAOA
AUYYCJSJGJYCDS,BRD-K46428823|BRD-K89152108,liothyronine|liothyronine-(isomer),|thyroid hormone stimulant,|THRA|THRB,BRD-K46428823|BRD-K89152108,liothyronine|liothyronine-(isomer),|thyroid hormone stimulant,|THRA|THRB,BRD-K46428823|BRD-K89152108,liothyronine|liothyronine-(isomer),|thyroid hormone stimulant,|THRA|THRB,BRD-K46428823|BRD-K89152108,liothyronine|liothyronine-(isomer),|thyroid hormone stimulant,|THRA|THRB
AUZONCFQVSMFAP,BRD-K32744045,disulfiram,DNA methyltransferase inhibitor|TRPV agonist|aldehyde dehydrogenase inhibitor,ALDH2|DBH,BRD-K32744045,disulfiram,DNA methyltransferase inhibitor|TRPV agonist|aldehyde dehydrogenase inhibitor,ALDH2|DBH,BRD-K32744045,disulfiram,DNA methyltransferase inhibitor|TRPV agonist|aldehyde dehydrogenase inhibitor,ALDH2|DBH,BRD-K32744045,disulfiram,DNA methyltransferase inhibitor|TRPV agonist|aldehyde dehydrogenase inhibitor,ALDH2|DBH
AVAACINZEOAHHE,BRD-K20901660|BRD-K45319714,doripenem,bacterial cell wall synthesis inhibitor,DPEP1,BRD-K20901660|BRD-K45319714,doripenem,bacterial cell wall synthesis inhibitor,DPEP1,BRD-K20901660|BRD-K45319714,doripenem,bacterial cell wall synthesis inhibitor,DPEP1,BRD-K20901660|BRD-K45319714,doripenem,bacterial cell wall synthesis inhibitor,DPEP1
AVDSOVJPJZVBTC,BRD-K73197500,SNX-5422,HSP inhibitor,HSP90AA1,BRD-K73197500,SNX-5422,HSP inhibitor,HSP90AA1,BRD-K73197500,SNX-5422,HSP inhibitor,HSP90AA1,BRD-K73197500,SNX-5422,HSP inhibitor,HSP90AA1|HSP90AB1
AVDUGNCTZRCAHH,BRD-K49519144,LY2140023,glutamate receptor agonist,GRM3,BRD-K49519144,LY2140023,glutamate receptor agonist,GRM3,BRD-K49519144,LY2140023,glutamate receptor agonist,GRM3,BRD-K49519144,LY2140023,glutamate receptor agonist,GRM3
AVFYPHPSIBAAME,BRD-K44471774,bay-w-9798,antioxidant,,BRD-K44471774,bay-w-9798,antioxidant,,BRD-K44471774,bay-w-9798,antioxidant,,BRD-K44471774,BAY-W-9798,antioxidant,
AVKUERGKIZMTKX,BRD-K68432770|BRD-K94927753,ampicillin,bacterial cell wall synthesis inhibitor,,BRD-K68432770|BRD-K94927753,ampicillin,bacterial cell wall synthesis inhibitor,,BRD-K68432770|BRD-K94927753,ampicillin,bacterial cell wall synthesis inhibitor,,BRD-K68432770|BRD-K94927753,ampicillin,bacterial cell wall synthesis inhibitor,
AVOLMBLBETYQHX,BRD-K63630713,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,BRD-K63630713,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,BRD-K63630713,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,BRD-K63630713,etacrynic-acid,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1
AVWWVJUMXRXPNF,BRD-K47878171,bephenium-hydroxynaphthoate,anthelmintic agent,,BRD-K47878171,bephenium-hydroxynaphthoate,anthelmintic agent,,BRD-K47878171,bephenium-hydroxynaphthoate,anthelmintic agent,,BRD-K47878171,bephenium-hydroxynaphthoate,anthelmintic agent,
AVZCPICCWKMZDT,BRD-K32847255,GSK-J1,histone demethylase inhibitor,KDM6B,BRD-K32847255,GSK-J1,histone demethylase inhibitor,KDM6B,BRD-K32847255,GSK-J1,histone demethylase inhibitor,KDM6B,BRD-K32847255,GSK-J1,histone demethylase inhibitor,KDM6B
AWOPBSAJHCUSAS,BRD-K43363084,atglistatin,adipose triglyceride lipase inhibitor,,BRD-K43363084,atglistatin,adipose triglyceride lipase inhibitor,,BRD-K43363084,atglistatin,adipose triglyceride lipase inhibitor,,BRD-K43363084,atglistatin,adipose triglyceride lipase inhibitor,
AWSKBQNOSRREEY,BRD-K24864897,JNJ-26990990,anticonvulsant,,BRD-K24864897,JNJ-26990990,anticonvulsant,,BRD-K24864897,JNJ-26990990,anticonvulsant,,BRD-K24864897,JNJ-26990990,anticonvulsant,
AWSRKKBIPSQHOJ,BRD-K21415491,ALS-8176,RNA polymerase inhibitor,,BRD-K21415491,ALS-8176,RNA polymerase inhibitor,,BRD-K21415491,ALS-8176,RNA polymerase inhibitor,,BRD-K21415491,ALS-8112,,
AXISYYRBXTVTFY,BRD-K13409143,isopropyl-myristate,,,BRD-K13409143,isopropyl-myristate,,,BRD-K13409143,isopropyl-myristate,,,BRD-K13409143,isopropyl-myristate,,
AXKPFOAXAHJUAG,BRD-K26801045,pipamperone,dopamine receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A,BRD-K26801045,pipamperone,dopamine receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A,BRD-K26801045,pipamperone,dopamine receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A,BRD-K26801045,pipamperone,dopamine receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A
AXNGJCOYCMDPQG,BRD-A62057054,MDL-11939,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-A62057054,MDL-11939,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-A62057054,MDL-11939,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-A62057054,MDL-11939,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
AXNVHPCVMSNXNP,BRD-A90796352,escin,nitric oxide synthase stimulant,,BRD-A90796352,escin,nitric oxide synthase stimulant,,BRD-A90796352,escin,nitric oxide synthase stimulant,,BRD-K00010936,escin,nitric oxide synthase stimulant,
AXOIZCJOOAYSMI,BRD-K45497762,succinylcholine-chloride,,CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10,BRD-K45497762,succinylcholine-chloride,,CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10,BRD-K45497762,succinylcholine-chloride,,CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10,BRD-K45497762,succinylcholine-chloride,,CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10
AXRCEOKUDYDWLF,BRD-K79404599,enzastaurin,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,BRD-K79404599,enzastaurin,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,BRD-K79404599,enzastaurin,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,BRD-K79404599,enzastaurin,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG
AXRYRYVKAWYZBR,BRD-K09757388,atazanavir,HIV protease inhibitor,,BRD-K09757388,atazanavir,HIV protease inhibitor,,BRD-K09757388,atazanavir,HIV protease inhibitor,,BRD-K09757388,atazanavir,HIV protease inhibitor,
AXTAPYRUEKNRBA,BRD-K38332599,uprosertib,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K38332599,uprosertib,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K38332599,uprosertib,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K38332599,uprosertib,AKT inhibitor,AKT1|AKT2|AKT3
AXTGDCSMTYGJND,BRD-K35698076,laurocapram,,,BRD-K35698076,laurocapram,,,BRD-K35698076,laurocapram,,,BRD-K35698076,laurocapram,,
AXUZQJFHDNNPFG,BRD-A73679382,MK-571,leukotriene receptor antagonist,ABCC2|CYSLTR1,BRD-A73679382,MK-571,leukotriene receptor antagonist,ABCC2|CYSLTR1,BRD-A73679382,MK-571,leukotriene receptor antagonist,ABCC2|CYSLTR1,BRD-A73679382,MK-571,leukotriene receptor antagonist,ABCC2|CYSLTR1
AYCPARAPKDAOEN,BRD-K37764012,PF-03758309,p21 activated kinase inhibitor,PAK4,BRD-K37764012,PF-03758309,p21 activated kinase inhibitor,PAK4,BRD-K37764012,PF-03758309,p21 activated kinase inhibitor,PAK4,BRD-K37764012,PF-03758309,p21 activated kinase inhibitor,PAK4
AYDXAULLCROVIT,BRD-A16296925,indobufen,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,BRD-A16296925,indobufen,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,BRD-A16296925,indobufen,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,BRD-A16296925,indobufen,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2
AYEKOFBPNLCAJY,BRD-A09994331,thiamine-pyrophosphate,,,BRD-A09994331,thiamine-pyrophosphate,,,BRD-A09994331,thiamine-pyrophosphate,,,BRD-A09994331,thiamine-pyrophosphate,,
AYEOSGBMQHXVER,BRD-K41962502|BRD-K44602126,"2,3-cis/exo-camphanediol|cis-exo-camphanediol-2,3",,,BRD-K41962502|BRD-K44602126,"2,3-cis/exo-camphanediol|cis-exo-camphanediol-2,3",|nitric oxide stimulant,|NOS3,BRD-K41962502|BRD-K44602126,"2,3-cis/exo-camphanediol|cis-exo-camphanediol-2,3",|nitric oxide stimulant,|NOS3,BRD-K41962502|BRD-K44602126,"2,3-cis/exo-camphanediol|cis-exo-camphanediol-2,3",|nitric oxide stimulant,|NOS3
AYFVYJQAPQTCCC,BRD-K75508643,L-threonine,,TARS|TARS2|THNSL1,BRD-K75508643,L-threonine,,TARS|TARS2|THNSL1,BRD-K75508643,L-threonine,,TARS|TARS2|THNSL1,BRD-K75508643,L-threonine,,TARS|TARS2|THNSL1
AYIRNRDRBQJXIF,BRD-A30886737|BRD-K11298197,florfenicol,protein synthesis inhibitor,,BRD-A30886737|BRD-K11298197,florfenicol,protein synthesis inhibitor,,BRD-A30886737|BRD-K11298197,florfenicol,protein synthesis inhibitor,,BRD-K11298197,florfenicol,protein synthesis inhibitor,
AYJRTVVIBJSSKN,BRD-K60341624,GSK1292263,glucose dependent insulinotropic receptor agonist,GRPR,BRD-K60341624,GSK1292263,glucose dependent insulinotropic receptor agonist,GRPR,BRD-K60341624,GSK1292263,glucose dependent insulinotropic receptor agonist,GRPR,BRD-K60341624,GSK1292263,glucose dependent insulinotropic receptor agonist,GRPR
AYMYWHCQALZEGT,BRD-K17497770,butein,EGFR inhibitor|src inhibitor,ACE,BRD-K17497770,butein,EGFR inhibitor|src inhibitor,ACE,BRD-K17497770,butein,EGFR inhibitor|src inhibitor,ACE,BRD-K17497770,butein,EGFR inhibitor|SRC inhibitor,ACE
AYUNIORJHRXIBJ,BRD-K34504123|BRD-K81473043,tanespimycin,HSP inhibitor,HSP90AA1,BRD-K34504123|BRD-K81473043,tanespimycin,HSP inhibitor,HSP90AA1,BRD-K34504123|BRD-K81473043,tanespimycin,HSP inhibitor,HSP90AA1,BRD-K34504123|BRD-K81473043,tanespimycin,HSP inhibitor,HSP90AA1
AYXYPKUFHZROOJ,BRD-K66786476,pregabalin,voltage-gated calcium channel ligand,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,BRD-K66786476,pregabalin,voltage-gated calcium channel ligand,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,BRD-K66786476,pregabalin,voltage-gated calcium channel ligand,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,,,,
AYYCFGDXLUPJAQ,BRD-K31054881,BMY-7378,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A,BRD-K31054881,BMY-7378,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A,BRD-K31054881,BMY-7378,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A,BRD-K31054881,BMY-7378,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A
AZAANWYREOQRFB,BRD-K66911501,MK-3207,calcitonin antagonist,CALCA,BRD-K66911501,MK-3207,calcitonin antagonist,CALCA,BRD-K66911501,MK-3207,calcitonin antagonist,CALCA,BRD-K66911501,MK-3207,calcitonin antagonist,CALCA
AZEXWHKOMMASPA,BRD-K31519811,PF-02545920,phosphodiesterase inhibitor,PDE10A,BRD-K31519811,PF-02545920,phosphodiesterase inhibitor,PDE10A,BRD-K31519811,PF-02545920,phosphodiesterase inhibitor,PDE10A,BRD-K31519811,PF-02545920,phosphodiesterase inhibitor,PDE10A
AZFBLLCNOQPJGJ,BRD-K30563334,rifabutin,protein synthesis inhibitor,HSP90AA1|HSP90B1,BRD-K30563334,rifabutin,protein synthesis inhibitor,HSP90AA1|HSP90B1,BRD-K30563334,rifabutin,protein synthesis inhibitor,HSP90AA1|HSP90B1,,,,
AZFLJNIPTRTECV,BRD-K64504314,dienogest,progesterone receptor agonist,PGR,BRD-K50853363,dienogest,progesterone receptor agonist,PGR,BRD-K50853363|BRD-K64504314,dienogest,progesterone receptor agonist,PGR,BRD-K50853363|BRD-K64504314,dienogest,progesterone receptor agonist,PGR
AZKMWHRDICVYEI,BRD-K09619578,DS2-(806622),,,BRD-K09619578,DS2-(806622),,,BRD-K09619578,DS2-(806622),,,BRD-K09619578,DS2-(806622),,
AZKVWQKMDGGDSV,BRD-K28824103|BRD-K70886785,genipin,choleretic agent,,BRD-K28824103|BRD-K70886785,genipin,choleretic agent,,BRD-K28824103|BRD-K70886785,genipin,choleretic agent,,BRD-K28824103|BRD-K70886785,genipin,choleretic agent,
AZSNMRSAGSSBNP,BRD-A48570745|BRD-K71544586|BRD-K85554912,ivermectin,benzodiazepine receptor agonist,CHRNA7|GABRB3|GLRA3|P2RX7,BRD-A48570745|BRD-K71544586|BRD-K85554912,ivermectin,benzodiazepine receptor agonist,CHRNA7|GABRB3|GLRA3|P2RX7,BRD-A48570745|BRD-K71544586|BRD-K85554912|BRD-M44211600,ivermectin,benzodiazepine receptor agonist,CHRNA7|GABRB3|GLRA3|P2RX7,BRD-A48570745|BRD-K71544586|BRD-K85554912|BRD-M44211600,ivermectin,benzodiazepine receptor agonist,CHRNA7|P2RX7
AZVFIZVKGSPGPK,BRD-K36379990,riodipine,calcium channel blocker,,BRD-K36379990,riodipine,calcium channel blocker,,BRD-K36379990,riodipine,calcium channel blocker,,BRD-K36379990,riodipine,calcium channel blocker,
BAAILVWEAXFTSF,BRD-K08223200,WAY-200070,estrogen receptor agonist,ERBB2|ERBB3|ERBB4|ESR2,BRD-K08223200,WAY-200070,estrogen receptor agonist,ERBB2|ERBB3|ERBB4|ESR2,BRD-K08223200,WAY-200070,estrogen receptor agonist,ERBB2|ERBB3|ERBB4|ESR2,BRD-K08223200,WAY-200070,estrogen receptor agonist,ERBB2|ERBB3|ERBB4|ESR2
BAINIUMDFURPJM,BRD-K02079473,oxatomide,histamine receptor antagonist,HRH1,BRD-K02079473,oxatomide,histamine receptor antagonist,HRH1,BRD-K02079473,oxatomide,histamine receptor antagonist,HRH1,BRD-K22556255,oxatomide,histamine receptor antagonist,HRH1
BALLNEJQLSTPIO,BRD-K70504253,fruquintinib,VEGFR inhibitor,KDR,BRD-K70504253,fruquintinib,VEGFR inhibitor,KDR,BRD-K70504253,fruquintinib,VEGFR inhibitor,KDR,BRD-K70504253,fruquintinib,VEGFR inhibitor,KDR
BANYJBHWTOJQDU,BRD-K52394958,GR-159897,tachykinin antagonist,TAC1|TACR2,BRD-K52394958,GR-159897,tachykinin antagonist,TAC1|TACR2,BRD-K52394958,GR-159897,tachykinin antagonist,TAC1|TACR2,BRD-K52394958,GR-159897,tachykinin antagonist,TAC1|TACR2
BAORCAMWLWRZQG,BRD-K99475619,genz-644282,topoisomerase inhibitor,TOP1,BRD-K99475619,genz-644282,topoisomerase inhibitor,TOP1,BRD-K99475619,genz-644282,topoisomerase inhibitor,TOP1,BRD-K99475619,genz-644282,topoisomerase inhibitor,TOP1
BAQAVOSOZGMPRM,BRD-K23414802|BRD-K58968598,sucralose,,,BRD-K58968598,sucralose,,,BRD-K23414802|BRD-K58968598,sucralose,,,BRD-K23414802|BRD-K58968598,sucralose,,
BAQCROVBDNBEEB,BRD-A45543382,metrizamide,radiopaque medium,,BRD-A45543382,metrizamide,radiopaque medium,,BRD-A45543382,metrizamide,radiopaque medium,,BRD-A45543382,metrizamide,radiopaque medium,
BARDROPHSZEBKC,BRD-K23848629,fosaprepitant-dimeglumine,tachykinin antagonist,TACR1,BRD-K23848629,fosaprepitant-dimeglumine,tachykinin antagonist,TACR1,BRD-K23848629,fosaprepitant-dimeglumine,tachykinin antagonist,TACR1,BRD-K23848629,fosaprepitant-dimeglumine,tachykinin antagonist,TACR1
BATCTBJIJJEPHM,BRD-K86816506,PF-04457845,FAAH inhibitor,FAAH,BRD-K86816506,PF-04457845,FAAH inhibitor,FAAH,BRD-K86816506,PF-04457845,FAAH inhibitor,FAAH,BRD-K86816506,PF-04457845,FAAH inhibitor,FAAH
BATVOUKHGLKDGQ,BRD-A28318179,aminomethyltransferase,nitric oxide synthase inhibitor,NOS2,BRD-A28318179,aminomethyltransferase,nitric oxide synthase inhibitor,NOS2,BRD-A28318179,aminomethyltransferase,nitric oxide synthase inhibitor,NOS2,BRD-A28318179,aminomethyltransferase,nitric oxide synthase inhibitor,NOS2
BAWFJGJZGIEFAR,BRD-A11132253,nadide,electron acceptor,AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2,BRD-A11132253,nadide,electron acceptor,AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2,BRD-A11132253,nadide,electron acceptor,AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2,BRD-K01824972,nadide,free radical scavenger,AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2
BBACKDMGYMXYLE,BRD-A41835910,tenilsetam,AGE inhibitor,,BRD-A41835910,tenilsetam,AGE inhibitor,,BRD-A41835910,tenilsetam,AGE inhibitor,,BRD-A41835910,tenilsetam,AGE inhibitor,
BBAWEDCPNXPBQM,BRD-K72912098|BRD-K83470352,telaprevir,HCV inhibitor,CTSA|PGR,BRD-K72912098|BRD-K83470352,telaprevir,HCV inhibitor,CTSA|PGR,BRD-K72912098|BRD-K83470352,telaprevir,HCV inhibitor,CTSA|PGR,BRD-K72912098|BRD-K83470352,telaprevir,HCV inhibitor,CTSA|PGR
BBDAGFIXKZCXAH,BRD-K80834753|BRD-K81021983,cyclocytidine,DNA synthesis inhibitor|RNA synthesis inhibitor,,BRD-K80834753|BRD-K81021983,cyclocytidine,DNA synthesis inhibitor|RNA synthesis inhibitor,,BRD-K67536197|BRD-K80834753,cyclocytidine,DNA synthesis inhibitor|RNA synthesis inhibitor,,BRD-K67536197|BRD-K80834753,cyclocytidine,DNA synthesis inhibitor|RNA synthesis inhibitor,
BBDGBGOVJPEFBT,BRD-K59831625,LDN-212854,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2,BRD-K59831625,LDN-212854,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2,BRD-K59831625,LDN-212854,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2,BRD-K59831625,LDN-212854,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2
BBGHHIUQOKQCBW,BRD-K68220839,LY2979165,glutamate receptor agonist,GRM2,BRD-K68220839,LY2979165,glutamate receptor agonist,GRM2,BRD-K68220839,LY2979165,glutamate receptor agonist,GRM2,BRD-K68220839,LY2979165,glutamate receptor agonist,GRM2
BBIPVJCGIASXJB,BRD-K77987496,ITI214,phosphodiesterase inhibitor,PDE1A,BRD-K77987496,ITI214,phosphodiesterase inhibitor,PDE1A,BRD-K77987496,ITI214,phosphodiesterase inhibitor,PDE1A,BRD-K77987496,ITI214,phosphodiesterase inhibitor,PDE1A
BBMULGJBVDDDNI,BRD-A72711497,lasalocid,bacterial permeability inducer,,BRD-A72711497,lasalocid,bacterial permeability inducer,,BRD-A72711497,lasalocid,bacterial permeability inducer,,BRD-K10207760,lasalocid,bacterial permeability inducer,
BBQRBOIMSKMFFO,BRD-K56468417|BRD-K67173685,4E1RCat,protein synthesis inhibitor,EIF4E|EIF4G1,BRD-K56468417|BRD-K67173685,4E1RCat,protein synthesis inhibitor,EIF4E|EIF4G1,BRD-K56468417|BRD-K67173685,4E1RCat,protein synthesis inhibitor,EIF4E|EIF4G1,BRD-K56468417|BRD-K67173685,4E1RCat,protein synthesis inhibitor,EIF4E|EIF4G1
BBUVDDPUURMFOX,BRD-K97452254,AMG-925,CDK inhibitor|FLT3 inhibitor,CDK4|CDK6|FLT3,BRD-K97452254,AMG-925,CDK inhibitor|FLT3 inhibitor,CDK4|CDK6|FLT3,BRD-K97452254,AMG-925,CDK inhibitor|FLT3 inhibitor,CDK4|CDK6|FLT3,BRD-K97452254,AMG-925,CDK inhibitor|FLT3 inhibitor,CDK4|CDK6|FLT3
BBVNTTZIOTWDSV,BRD-K40302533,PF-5274857,smoothened receptor antagonist,SMO,BRD-K40302533,PF-5274857,smoothened receptor antagonist,SMO,BRD-K40302533,PF-5274857,smoothened receptor antagonist,SMO,BRD-K40302533,PF-5274857,smoothened receptor antagonist,SMO
BCBIBQWDFMQRSJ,BRD-M87138257,acriflavine,hypoxia inducible factor inhibitor,HIF1A,BRD-M87138257,acriflavine,hypoxia inducible factor inhibitor,HIF1A,BRD-M87138257,acriflavine,hypoxia inducible factor inhibitor,HIF1A,BRD-M87138257,acriflavine,hypoxia inducible factor inhibitor,HIF1A
BCEHBSKCWLPMDN,BRD-K06557128,voriconazole,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1,BRD-K06557128,voriconazole,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1,BRD-K06557128,voriconazole,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1,BRD-K06557128,voriconazole,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1
BCFGMOOMADDAQU,BRD-K19687926,lapatinib,EGFR inhibitor,EGFR|ERBB2,BRD-K19687926,lapatinib,EGFR inhibitor,EGFR|ERBB2,BRD-K19687926,lapatinib,EGFR inhibitor,EGFR|ERBB2,BRD-K19687926,lapatinib,EGFR inhibitor,EGFR|ERBB2
BCGWQEUPMDMJNV,BRD-K38436528,imipramine,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,BRD-K38436528,imipramine,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,BRD-K38436528,imipramine,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,BRD-K38436528,imipramine,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4
BCQTVJKBTWGHCX,BRD-K83245588,pilsicainide,sodium channel blocker,SCN5A,BRD-K83245588,pilsicainide,sodium channel blocker,SCN5A,BRD-K83245588,pilsicainide,sodium channel blocker,SCN5A,BRD-K83245588,pilsicainide,sodium channel blocker,SCN5A
BCQZXOMGPXTTIC,BRD-A20550616,halothane,glutamate receptor antagonist,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GNG2|GRIN2A|GRIN3A|GRIN3B|KCNJ3|KCNJ6|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9|KCNMA1|KCNN4|MT-ND1|NPSR1|RHO,BRD-A20550616,halothane,glutamate receptor antagonist,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GNG2|GRIN2A|GRIN3A|GRIN3B|KCNJ3|KCNJ6|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9|KCNMA1|KCNN4|MT-ND1|NPSR1|RHO,BRD-A20550616,halothane,glutamate receptor antagonist,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GNG2|GRIN2A|GRIN3A|GRIN3B|KCNJ3|KCNJ6|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9|KCNMA1|KCNN4|MT-ND1|NPSR1|RHO,BRD-A20550616,halothane,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9
BCSHRERPHLTPEE,BRD-K72827473,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK,BRD-K72827473,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK,BRD-K72827473,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK,BRD-K72827473,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
BCUGCHZRMKTPMU,BRD-K81729199,AQ-RA741,acetylcholine receptor antagonist,CHRM2,BRD-K81729199,AQ-RA741,acetylcholine receptor antagonist,CHRM2,BRD-K81729199,AQ-RA741,acetylcholine receptor antagonist,CHRM2,BRD-K81729199,AQ-RA741,acetylcholine receptor antagonist,CHRM2
BCZUAADEACICHN,BRD-K19477839,SGX523,hepatocyte growth factor receptor inhibitor,MET,BRD-K19477839,SGX523,hepatocyte growth factor receptor inhibitor,MET,BRD-K19477839,SGX523,hepatocyte growth factor receptor inhibitor,MET,BRD-K19477839,SGX523,hepatocyte growth factor receptor inhibitor,MET
BDABGOLMYNHHTR,BRD-K04643877,perzinfotel,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B,BRD-K04643877,perzinfotel,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B,BRD-K04643877,perzinfotel,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B,BRD-K04643877,perzinfotel,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B
BDBMLMBYCXNVMC,BRD-K80762071,indocyanine-green,contrast agent,SLCO1B1,BRD-K80762071,indocyanine-green,contrast agent,SLCO1B1,BRD-K80762071,indocyanine-green,contrast agent,SLCO1B1,BRD-K80762071,indocyanine-green,contrast agent,SLCO1B1
BDHMSYNBSBZCAF,BRD-K80639402,SB-258585,serotonin receptor antagonist,HTR6,BRD-K80639402,SB-258585,serotonin receptor antagonist,HTR6,BRD-K80639402,SB-258585,serotonin receptor antagonist,HTR6,BRD-K80639402,SB-258585,serotonin receptor antagonist,HTR6
BDJRBEYXGGNYIS,BRD-K08976401,azelaic-acid,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,BRD-K08976401,azelaic-acid,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,BRD-K08976401,azelaic-acid,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,BRD-K08976401,azelaic-acid,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR
BDNFQGRSKSQXRI,BRD-K80451230,zamifenacin,acetylcholine receptor antagonist,CHRM3,BRD-K80451230,zamifenacin,acetylcholine receptor antagonist,CHRM3,BRD-K80451230,zamifenacin,acetylcholine receptor antagonist,CHRM3,BRD-K80451230,zamifenacin,acetylcholine receptor antagonist,CHRM3
BDSYKGHYMJNPAB,BRD-K65877271,halobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-K65877271,halobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-K65877271,halobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-K71487404,halobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B
BDUHCSBCVGXTJM,BRD-A12230535,nutlin-3,MDM inhibitor,MDM2|TP53,BRD-A12230535|BRD-K73255294,nutlin-3,MDM inhibitor,MDM2|TP53,BRD-A12230535|BRD-K73255294,nutlin-3,MDM inhibitor,MDM2|TP53,BRD-K00002882,nutlin-3,MDM inhibitor,MDM2|TP53
BDYHNCZIGYIOGJ,BRD-A90272038,CGP-37849,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A90272038,CGP-37849,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A90272038,CGP-37849,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A90272038,CGP-37849,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D
BDYYDXJSHYEDGB,BRD-K10974103,diloxanide,protein synthesis inhibitor,,BRD-K10974103,diloxanide,protein synthesis inhibitor,,BRD-K10974103,diloxanide,protein synthesis inhibitor,,BRD-K10974103,diloxanide,protein synthesis inhibitor,
BELBBZDIHDAJOR,BRD-K79892937,phenolsulfonphthalein,,,BRD-K79892937,phenolsulfonphthalein,,,BRD-K79892937,phenolsulfonphthalein,,,BRD-K79892937,phenolsulfonphthalein,,
BEMNJULZEQTDJY,BRD-K11683436,CH-5183284,fibroblast growth factor inhibitor,FGFR1|FGFR2|FGFR3,BRD-K11683436,CH-5183284,fibroblast growth factor inhibitor,FGFR1|FGFR2|FGFR3,BRD-K11683436,CH-5183284,fibroblast growth factor inhibitor,FGFR1|FGFR2|FGFR3,BRD-K11683436,CH-5183284,fibroblast growth factor inhibitor,FGFR1|FGFR2|FGFR3
BENFXAYNYRLAIU,BRD-K73451719,terlipressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,BRD-K73451719,terlipressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,BRD-K73451719,terlipressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,BRD-K73451719,terlipressin,vasopressin receptor agonist,AVPR1A
BEPGKLOHQTXUHX,BRD-K82028950,CGH2466,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,BRD-K82028950,CGH2466,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,BRD-K82028950,CGH2466,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,BRD-K82028950,CGH2466,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3
BERLXWPRSBJFHO,BRD-K24566386,SD-208,TGF beta receptor inhibitor,TGFBR1,BRD-K24566386,SD-208,TGF beta receptor inhibitor,TGFBR1,BRD-K24566386,SD-208,TGF beta receptor inhibitor,TGFBR1,BRD-K24566386,SD-208,TGF beta receptor inhibitor,TGFBR1
BEUQXVWXFDOSAQ,BRD-K44844162,taselisib,PI3K inhibitor,PIK3CA,BRD-K44844162,taselisib,PI3K inhibitor,PIK3CA,BRD-K44844162,taselisib,PI3K inhibitor,PIK3CA,BRD-K44844162,taselisib,PI3K inhibitor,PIK3CA
BEZZFPOZAYTVHN,BRD-A33447119,oxfendazole,anthelmintic agent,,BRD-A33447119,oxfendazole,anthelmintic agent,,BRD-A33447119,oxfendazole,anthelmintic agent,,BRD-A33447119,oxfendazole,anthelmintic agent,
BFCDFTHTSVTWOG,BRD-A34205397,suloctidil,adrenergic receptor antagonist,,BRD-A34205397,suloctidil,adrenergic receptor antagonist,,BRD-A34205397,suloctidil,adrenergic receptor antagonist,,BRD-K42635745,suloctidil,adrenergic receptor antagonist,
BFDBKMOZYNOTPK,BRD-K32768103,vonoprazan,potassium-competitive acid antagonist,ATP4A,BRD-K32768103,vonoprazan,potassium-competitive acid antagonist,ATP4A,BRD-K32768103,vonoprazan,potassium-competitive acid antagonist,ATP4A,BRD-K32768103,vonoprazan,potassium-competitive acid antagonist,ATP4A
BFNCJMURTMZBTE,BRD-K63919159,aptiganel,glutamate receptor antagonist,GRIN1,BRD-K63919159,aptiganel,glutamate receptor antagonist,GRIN1,BRD-K63919159,aptiganel,glutamate receptor antagonist,GRIN1,BRD-K63919159,aptiganel,glutamate receptor antagonist,GRIN1
BFNKQTIJVFGCKQ,BRD-K83508485,FK-888,tachykinin antagonist,TACR1|TACR2,BRD-K83508485,FK-888,tachykinin antagonist,TACR1|TACR2,BRD-K83508485,FK-888,tachykinin antagonist,TACR1|TACR2,BRD-K83508485,FK-888,tachykinin antagonist,TACR1|TACR2
BFPSDSIWYFKGBC,BRD-K27062708,chlorotrianisene,estrogenic hormone,ESR1|ESR2,BRD-K27062708,chlorotrianisene,estrogenic hormone,ESR1|ESR2,BRD-K27062708,chlorotrianisene,estrogenic hormone,ESR1|ESR2,BRD-K27062708,chlorotrianisene,estrogenic hormone,ESR1|ESR2
BFPYWIDHMRZLRN,BRD-A02367930|BRD-K42555202|BRD-K48195008,ethinyl-estradiol,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,BRD-A02367930|BRD-K42555202|BRD-K48195008,ethinyl-estradiol,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,BRD-A02367930|BRD-K42555202|BRD-K48195008,ethinyl-estradiol,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,BRD-A02367930|BRD-K42555202|BRD-K48195008,ethinyl-estradiol,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2
BFSMGDJOXZAERB,BRD-K09951645,dabrafenib,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,BRD-K09951645,dabrafenib,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,BRD-K09951645,dabrafenib,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,BRD-K09951645,dabrafenib,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1
BFSRTTWIPACGMI,BRD-K24869513,CNX-2006,EGFR inhibitor,EGFR,BRD-K24869513,CNX-2006,EGFR inhibitor,EGFR,BRD-K24869513,CNX-2006,EGFR inhibitor,EGFR,BRD-K24869513,CNX-2006,EGFR inhibitor,EGFR
BFUJHVVEMMWLHC,BRD-K37688416,fipexide,psychoactive drug,,BRD-K37688416,fipexide,psychoactive drug,,BRD-K37688416,fipexide,psychoactive drug,,BRD-K37688416,fipexide,psychoactive drug,
BFVNEYDCFJNLGN,BRD-K11373525,ZD-7155,angiotensin receptor antagonist,AGTR1,BRD-K11373525,ZD-7155,angiotensin receptor antagonist,AGTR1,BRD-K11373525,ZD-7155,angiotensin receptor antagonist,AGTR1,BRD-K11373525,ZD-7155,angiotensin receptor antagonist,AGTR1
BFYIZQONLCFLEV,BRD-A73741725|BRD-K35247444,exemestane,aromatase inhibitor,CYP19A1,BRD-A73741725|BRD-K33425534|BRD-K93923542,exemestane,aromatase inhibitor,CYP19A1,BRD-A73741725|BRD-K33425534|BRD-K93923542,exemestane,aromatase inhibitor,CYP19A1,BRD-A73741725|BRD-K33425534|BRD-K93923542,exemestane,aromatase inhibitor,CYP19A1
BFZHCUBIASXHPK,BRD-K93900986,stetaderm,,,BRD-K93900986,stetaderm,,,BRD-K93900986,stetaderm,,,BRD-K93900986,stetaderm,,
BGBNULCRKBVAKL,BRD-A09004963,APR-246,p53 activator,TP53,BRD-A09004963,APR-246,p53 activator,TP53,BRD-A09004963,APR-246,p53 activator,TP53,BRD-A09004963,APR-246,p53 activator,TP53
BGBVSGSIXIIREO,BRD-K79595931,bavisant,histamine receptor antagonist,HRH3,BRD-K79595931,bavisant,histamine receptor antagonist,HRH3,BRD-K79595931,bavisant,histamine receptor antagonist,HRH3,BRD-K79595931,bavisant,histamine receptor antagonist,HRH3
BGDKAVGWHJFAGW,BRD-A79672927,tropicamide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A79672927,tropicamide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A79672927,tropicamide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A79672927,tropicamide,acetylcholine receptor antagonist,CHRM3|CHRM4
BGEBZHIAGXMEMV,BRD-K12968785,bergapten,,,BRD-K12968785,bergapten,,,BRD-K12968785,bergapten,,,BRD-K12968785,bergapten,,
BGFHMYJZJZLMHW,BRD-K36739687,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR,BRD-K36739687,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR,BRD-K36739687,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR,BRD-K36739687,stemregenin-1,aryl hydrocarbon receptor antagonist,AHR
BGIHRZPJIYJKAZ,BRD-M78068755,miriplatin,DNA synthesis inhibitor,,BRD-M78068755,miriplatin,DNA synthesis inhibitor,,BRD-M78068755,miriplatin,DNA synthesis inhibitor,,BRD-M78068755,miriplatin,DNA synthesis inhibitor,
BGKFPRIGXAVYNX,BRD-K60287130,"5,7-dichlorokynurenic-acid",,,BRD-K60287130,"5,7-dichlorokynurenic-acid",glutamate receptor antagonist,GLRA2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K60287130,"5,7-dichlorokynurenic-acid",glutamate receptor antagonist,GLRA2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K60287130,"5,7-dichlorokynurenic-acid",glutamate receptor antagonist,GLRA2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
BGLPECHZZQDNCD,BRD-K25835157,PRT062070,JAK inhibitor|syk inhibitor,SYK,BRD-K25835157,PRT062070,JAK inhibitor|syk inhibitor,SYK,BRD-K25835157,PRT062070,JAK inhibitor|syk inhibitor,SYK,BRD-K25835157,PRT062070,JAK inhibitor|SYK inhibitor,SYK
BGOQGUHWXBGXJW,BRD-K31471398,dihydrexidine,dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|DRD5,BRD-K31471398,dihydrexidine,dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|DRD5,BRD-K31471398,dihydrexidine,dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|DRD5,BRD-K31471398,dihydrexidine,dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|DRD5
BGRJTUBHPOOWDU,BRD-A55272860|BRD-K51671335,levosulpiride|sulpiride,dopamine receptor antagonist,|CA1|CA12|CA7|DRD2|DRD3,BRD-A55272860|BRD-K51671335,levosulpiride|sulpiride,dopamine receptor antagonist,|CA1|CA12|CA7|DRD2|DRD3,BRD-A10715913|BRD-A55272860|BRD-K51671335,levosulpiride|sulpiride,dopamine receptor antagonist,|CA1|CA12|CA7|DRD2|DRD3,BRD-A10715913|BRD-A55272860|BRD-K51671335,levosulpiride|sulpiride,dopamine receptor antagonist,|CA1|CA12|CA7|DRD2|DRD3
BGSOJVFOEQLVMH,BRD-A46186775,hydrocortisone-phosphate,,ANXA1|NOS2|NR3C1,BRD-A46186775,hydrocortisone-phosphate,,ANXA1|NOS2|NR3C1,BRD-A46186775,hydrocortisone-phosphate,,ANXA1|NOS2|NR3C1,BRD-K01824977,hydrocortisone-phosphate,,
BGSZAXLLHYERSY,BRD-A82463680|BRD-K07365190,vecuronium,acetylcholine receptor antagonist,CHRNA2,BRD-A82463680|BRD-K07365190,vecuronium,acetylcholine receptor antagonist,CHRNA2,BRD-A82463680|BRD-K07365190|BRD-K20168442,vecuronium,acetylcholine receptor antagonist,CHRNA2,BRD-A82463680|BRD-K07365190|BRD-K20168442,vecuronium,acetylcholine receptor antagonist,CHRNA2
BGVLELSCIHASRV,BRD-K97072811,TG-003,CLK inhibitor,CLK1|CLK4|DYRK1A|DYRK1B,BRD-K97072811,TG-003,CLK inhibitor,CLK1|CLK4|DYRK1A|DYRK1B,BRD-K97072811,TG-003,CLK inhibitor,CLK1|CLK4|DYRK1A|DYRK1B,BRD-K97072811,TG-003,CLK inhibitor,CLK1|CLK4|DYRK1A|DYRK1B
BHAYDBSYOBONRV,BRD-K80403280,alafosfalin,bacterial cell wall synthesis inhibitor,,BRD-K80403280,alafosfalin,bacterial cell wall synthesis inhibitor,,BRD-K80403280,alafosfalin,bacterial cell wall synthesis inhibitor,,BRD-K80403280,alafosfalin,bacterial cell wall synthesis inhibitor,
BHBOSTKQCZEAJM,BRD-K47376733,JNJ-1661010,FAAH inhibitor,FAAH,BRD-K47376733,JNJ-1661010,FAAH inhibitor,FAAH,BRD-K47376733,JNJ-1661010,FAAH inhibitor,FAAH,BRD-K47376733,JNJ-1661010,FAAH inhibitor,FAAH
BHIAIPWSVYSKJS,BRD-A28044053,arotinolol,adrenergic receptor antagonist,ADRB3,BRD-A28044053,arotinolol,adrenergic receptor antagonist,ADRB3,BRD-A28044053,arotinolol,adrenergic receptor antagonist,ADRB3,BRD-A28044053,arotinolol,adrenergic receptor antagonist,ADRB3
BHJIBOFHEFDSAU,BRD-K01662324,priralfinamide,sodium channel blocker,CACNA1B,BRD-K01662324,priralfinamide,sodium channel blocker,CACNA1B,BRD-K01662324,priralfinamide,sodium channel blocker,CACNA1B,BRD-K01662324,priralfinamide,sodium channel blocker,CACNA1B
BHKPHCKISVSDGV,BRD-K70327191,benzoxiquine,antiinfective drug,,BRD-K70327191,benzoxiquine,antiinfective drug,,BRD-K70327191,benzoxiquine,antiinfective drug,,BRD-K70327191,benzoxiquine,antiinfective drug,
BHLXTPHDSZUFHR,BRD-K09711437,varespladib,secretory phospholipase inhibitor,PLA2G2A,BRD-K09711437,varespladib,secretory phospholipase inhibitor,PLA2G2A,BRD-K09711437,varespladib,secretory phospholipase inhibitor,PLA2G2A,BRD-K09711437,varespladib,secretory phospholipase inhibitor,PLA2G2A
BHMHNSQLZKUIMD,BRD-K08927448,nitrosodimethylurea,DNA synthesis inhibitor,,BRD-K08927448,nitrosodimethylurea,DNA synthesis inhibitor,,BRD-K08927448,nitrosodimethylurea,DNA synthesis inhibitor,,,,,
BHQCQFFYRZLCQQ,BRD-K43164539,cholic-acid,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,BRD-K43164539,cholic-acid,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,BRD-K43164539,cholic-acid,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,BRD-K43164539,cholic-acid,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B
BHTRKEVKTKCXOH,BRD-K45245728,ursodeoxycholyltaurine,cholesterol inhibitor,,BRD-K45245728,ursodeoxycholyltaurine,cholesterol inhibitor,,BRD-K45245728,ursodeoxycholyltaurine,cholesterol inhibitor,,BRD-K45245728,ursodeoxycholyltaurine,cholesterol inhibitor,
BHTWDJBVZQBRKP,BRD-K83114366,PF-06447475,serine/threonine kinase inhibitor,LRRK2,BRD-K83114366,PF-06447475,serine/threonine kinase inhibitor,LRRK2,BRD-K83114366,PF-06447475,serine/threonine kinase inhibitor,LRRK2,BRD-K83114366,PF-06447475,serine/threonine kinase inhibitor,LRRK2
BHXLLRXDAYEMPP,BRD-K20284063,cefoselis,bacterial cell wall synthesis inhibitor,,BRD-K20284063,cefoselis,bacterial cell wall synthesis inhibitor,,,,,,,,,
BIAVGWDGIJKWRM,BRD-K47095176,talnetant,tachykinin antagonist,TACR2|TACR3,BRD-K47095176,talnetant,tachykinin antagonist,TACR2|TACR3,BRD-K47095176,talnetant,tachykinin antagonist,TACR2|TACR3,BRD-K47095176,talnetant,tachykinin antagonist,TACR2|TACR3
BIDNLKIUORFRQP,BRD-A51382177,fosinopril,angiotensin converting enzyme inhibitor,ACE,BRD-A51382177,fosinopril,angiotensin converting enzyme inhibitor,ACE,BRD-A51382177,fosinopril,angiotensin converting enzyme inhibitor,ACE,BRD-A51382177,fosinopril,angiotensin converting enzyme inhibitor,ACE
BIIVYFLTOXDAOV,BRD-K87909389,alvocidib,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,BRD-K87909389,alvocidib,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,BRD-K87909389,alvocidib,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,BRD-K87909389,alvocidib,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM
BITHABUTZRAUGT,BRD-A78093359,MRS1845,calcium channel blocker,,BRD-A78093359,MRS1845,calcium channel blocker,,BRD-A78093359,MRS1845,calcium channel blocker,,BRD-A78093359,MRS-1845,calcium channel blocker,
BITWVVLBVUMFHU,BRD-K08791496,fenaclon,,,BRD-K08791496,fenaclon,,,BRD-K08791496,fenaclon,,,BRD-K08791496,fenaclon,,
BIUCOFQROHIAEO,BRD-K02816415,CRT0044876,,,BRD-K02816415,CRT0044876,,,BRD-K02816415,CRT0044876,,,BRD-K02816415,CRT0044876,,
BIXBBIPTYBJTRY,BRD-A78195072,imexon,apoptosis stimulant|ribonucleotide reductase inhibitor,RRM1|RRM2,BRD-A78195072,imexon,apoptosis stimulant|ribonucleotide reductase inhibitor,RRM1|RRM2,BRD-A78195072,imexon,apoptosis stimulant|ribonucleotide reductase inhibitor,RRM1|RRM2,BRD-A78195072,imexon,apoptosis stimulant|ribonucleotide reductase inhibitor,
BIZKIHUJGMSVFD,BRD-K35589454,danegaptide,gap junction modulator,,BRD-K35589454,danegaptide,gap junction modulator,,BRD-K35589454,danegaptide,gap junction modulator,,BRD-K35589454,danegaptide,gap junction modulator,
BJCJYEYYYGBROF,BRD-K68870568,flumatinib,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,BRD-K68870568,flumatinib,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,BRD-K68870568,flumatinib,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,BRD-K68870568,flumatinib,Bcr-Abl kinase inhibitor,ABL1|PDGFRB
BJDCWCLMFKKGEE,BRD-A82452087|BRD-K11421397,dihydroartemisinin,antimalarial agent,,BRD-A82452087|BRD-K45089490,dihydroartemisinin,antimalarial agent,,BRD-A82452087|BRD-K45089490|BRD-K62213621,dihydroartemisinin,antimalarial agent,,BRD-A82452087|BRD-K45089490|BRD-K62213621,dihydroartemisinin,antimalarial agent,
BJEPYKJPYRNKOW,BRD-A18396475,malic-acid,,CS|ME2|PKD2L1,BRD-A18396475,malic-acid,,CS|ME2|PKD2L1,BRD-A18396475,malic-acid,,CS|ME2|PKD2L1,BRD-A18396475,malic-acid,,PKD2L1
BJFIDCADFRDPIO,BRD-K93331255,lypressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,BRD-K93331255,lypressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,BRD-K93331255,lypressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,BRD-K93331255,lypressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2
BJHCGMHPEKLROM,BRD-K25317177,modaline,,,BRD-K25317177,modaline,,,BRD-K25317177,modaline,,,BRD-K25317177,modaline,,
BJHIKXHVCXFQLS,BRD-A73556557|BRD-K18320600|BRD-K42064204,tagatose,phosphorylase inhibitor,PYGL,BRD-A73556557|BRD-K18320600|BRD-K42064204,tagatose,phosphorylase inhibitor,PYGL,BRD-A73556557|BRD-K18320600|BRD-K42064204,tagatose,phosphorylase inhibitor,PYGL,BRD-K18320600,tagatose,phosphorylase inhibitor,PYGL
BJJXHLWLUDYTGC,BRD-K97472745,gestrinone,progesterone receptor antagonist,AR|ESR1|PGR,BRD-K97472745,gestrinone,progesterone receptor antagonist,AR|ESR1|PGR,BRD-K97472745,gestrinone,progesterone receptor antagonist,AR|ESR1|PGR,BRD-K97472745,gestrinone,progesterone receptor antagonist,AR|ESR1|PGR
BJNLLBUOHPVGFT,BRD-K07712545,teicoplanin,bacterial cell wall synthesis inhibitor,,BRD-K07712545,teicoplanin,bacterial cell wall synthesis inhibitor,,BRD-K07712545,teicoplanin,bacterial cell wall synthesis inhibitor,,BRD-K07712545,teicoplanin,bacterial cell wall synthesis inhibitor,
BJRNKVDFDLYUGJ,BRD-K08037784,arbutin,melanin inhibitor,TYR,BRD-K08037784,arbutin,melanin inhibitor,TYR,BRD-K08037784,arbutin,melanin inhibitor,TYR,BRD-K08037784,arbutin,melanin inhibitor,TYR
BJSDNVVWJYDOLK,BRD-K94379058,BML-190,cannabinoid receptor inverse agonist,CNR2,BRD-K94379058,BML-190,cannabinoid receptor inverse agonist,CNR2,BRD-K94379058,BML-190,cannabinoid receptor inverse agonist,CNR2,BRD-K94379058,BML-190,cannabinoid receptor inverse agonist,CNR2
BJYLYJCXYAMOFT,BRD-K73237276,tacalcitol,vitamin D receptor agonist,VDR,BRD-K73237276,tacalcitol,vitamin D receptor agonist,VDR,BRD-K73237276,tacalcitol,vitamin D receptor agonist,VDR,BRD-K73237276,tacalcitol,vitamin D receptor agonist,VDR
BKAYIFDRRZZKNF,BRD-K52523550,N-acetylcarnosine,,,BRD-K52523550,N-acetylcarnosine,,,BRD-K52523550,N-acetylcarnosine,,,BRD-K52523550,N-acetylcarnosine,,
BKCDJTRMYWSXMC,BRD-K06182768,A-366,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K06182768,A-366,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K06182768,A-366,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K06182768,A-366,histone lysine methyltransferase inhibitor,EHMT1|EHMT2
BKCJZNIZRWYHBN,BRD-K12047401,palifosfamide,DNA alkylating agent,,BRD-K12047401,palifosfamide,DNA alkylating agent,,BRD-K12047401,palifosfamide,DNA alkylating agent,,BRD-K12047401,palifosfamide,DNA alkylating agent,
BKJIXTWSNXCKJH,BRD-K82135108,elesclomol,oxidative stress inducer,HSPA1A,BRD-K82135108,elesclomol,oxidative stress inducer,HSPA1A,BRD-K82135108,elesclomol,oxidative stress inducer,HSPA1A,BRD-K82135108,elesclomol,oxidative stress inducer,HSPA1A
BKQFRNYHFIQEKN,BRD-A25004090,erastin,ion channel antagonist,VDAC2,BRD-A25004090,erastin,ion channel antagonist,VDAC2,BRD-A25004090,erastin,ion channel antagonist,VDAC2,BRD-A25004090,erastin,ion channel antagonist,VDAC2
BKRGVLQUQGGVSM,BRD-K67943528,lisuride,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6,BRD-K67943528,lisuride,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6,BRD-K67943528,lisuride,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6,BRD-K67943528,lisuride,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6
BKVIWGRFRKLFIO,BRD-K20742498,RS-39604,serotonin receptor antagonist,HTR4,BRD-K20742498,RS-39604,serotonin receptor antagonist,HTR4,BRD-K20742498,RS-39604,serotonin receptor antagonist,HTR4,BRD-K20742498,RS-39604,serotonin receptor antagonist,HTR4
BKWJAKQVGHWELA,BRD-K54256913,MK-1775,WEE1 kinase inhibitor,WEE1,BRD-K54256913,MK-1775,WEE1 kinase inhibitor,WEE1,BRD-K54256913,MK-1775,WEE1 kinase inhibitor,WEE1,BRD-K54256913,MK-1775,WEE1 kinase inhibitor,WEE1
BKYKPTRYDKTTJY,BRD-A41250306,cyclopenthiazide,thiazide diuretic,,BRD-A41250306,cyclopenthiazide,thiazide diuretic,,BRD-A41250306,cyclopenthiazide,thiazide diuretic,,BRD-A41250306,cyclopenthiazide,thiazide diuretic,
BLCLNMBMMGCOAS,BRD-K99504665,goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,BRD-K99504665,goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,BRD-K99504665,goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,BRD-K99504665,goserelin-acetate,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR
BLFLLBZGZJTVJG,BRD-K75466013,benzocaine,sodium channel blocker,SCN10A,BRD-K75466013,benzocaine,sodium channel blocker,SCN10A,BRD-K75466013,benzocaine,sodium channel blocker,SCN10A,BRD-K75466013,benzocaine,sodium channel blocker,SCN10A
BLGWHBSBBJNKJO,BRD-K73877023,MLN1117,PI3K inhibitor,PIK3CA,BRD-K73877023,MLN1117,PI3K inhibitor,PIK3CA,BRD-K73877023,MLN1117,PI3K inhibitor,PIK3CA,BRD-K73877023,MLN1117,PI3K inhibitor,PIK3CA
BLGXFZZNTVWLAY,BRD-A87445400|BRD-K35586044|BRD-K77474816,yohimbine,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8,BRD-A87445400|BRD-K35586044|BRD-K77474816,yohimbine,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8,BRD-A65053077|BRD-A87445400|BRD-K35586044|BRD-K77474816,rauwolscine|yohimbine,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8,BRD-A65053077|BRD-A87445400|BRD-K35586044|BRD-K77474816,rauwolscine|yohimbine,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
BLIJXOOIHRSQRB,BRD-A01259528|BRD-A44971162,ODM-201,androgen receptor antagonist,AR,BRD-A01259528|BRD-A44971162,ODM-201,androgen receptor antagonist,AR,BRD-A01259528|BRD-A44971162,ODM-201,androgen receptor antagonist,AR,BRD-A01259528|BRD-A44971162,darolutamide,androgen receptor antagonist,AR
BLJRIMJGRPQVNF,BRD-K08806317|BRD-K30421593,timolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-K08806317|BRD-K30421593,timolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-K08806317|BRD-K30421593,timolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-K08806317,timolol,adrenergic receptor antagonist,ADRB1|ADRB2
BLMPQMFVWMYDKT,BRD-K15179879,carfilzomib,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,BRD-K15179879,carfilzomib,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,BRD-K15179879,carfilzomib,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,BRD-K15179879,carfilzomib,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9
BLPUOQGPBJPXRL,BRD-K43873574,ilepcimide,anticonvulsant,,BRD-K43873574,ilepcimide,anticonvulsant,,BRD-K43873574,ilepcimide,anticonvulsant,,BRD-K60480335,ilepcimide,anticonvulsant,
BLQYVHBZHAISJM,BRD-K68488863,ENMD-2076,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,BRD-K68488863,ENMD-2076,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,BRD-K68488863,ENMD-2076,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,BRD-K68488863,ENMD-2076,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC
BLSQLHNBWJLIBQ,BRD-K07400595|BRD-K86204871,terconazole,sterol demethylase inhibitor,,BRD-K07400595|BRD-K86204871,terconazole,sterol demethylase inhibitor,,BRD-K07400595|BRD-K86204871,terconazole,sterol demethylase inhibitor,,BRD-K86204871,terconazole,sterol demethylase inhibitor,
BLTCBVOJNNKFKC,BRD-K41707108,ceramide,phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator,,BRD-K41707108,ceramide,phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator,,BRD-K41707108,ceramide,phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator,,BRD-K41707108,ceramide,phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator,
BLTVBQXJFVRPFK,BRD-K61041538,AZD1080,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K61041538,AZD1080,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K61041538,AZD1080,glycogen synthase kinase inhibitor,GSK3A|GSK3B,,,,
BLUAFEHZUWYNDE,BRD-K01715490|BRD-K13112821|BRD-K27678847,artemisinin,DNA synthesis inhibitor,CYP2B6,BRD-K13112821|BRD-K27678847,artemisinin,DNA synthesis inhibitor,CYP2B6,BRD-K01715490|BRD-K13112821|BRD-K27678847,artemisinin,DNA synthesis inhibitor,CYP2B6,BRD-K01715490|BRD-K13112821|BRD-K27678847,artemisinin,DNA synthesis inhibitor,CYP2B6
BLVQHYHDYFTPDV,BRD-K61688984,RGFP966,HDAC inhibitor,HDAC3,BRD-K61688984,RGFP966,HDAC inhibitor,HDAC3,BRD-K61688984,RGFP966,HDAC inhibitor,HDAC3,BRD-K61688984,RGFP966,HDAC inhibitor,HDAC3
BLXXJMDCKKHMKV,BRD-K65146499,nabumetone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K65146499,nabumetone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K65146499,nabumetone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K65146499,nabumetone,cyclooxygenase inhibitor,PTGS1|PTGS2
BLYDGIISUNWHLF,BRD-K98151021,L-mimosine,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,DBH|EIF5A,BRD-K98151021,L-mimosine,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,DBH|EIF5A,BRD-K98151021,L-mimosine,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,DBH|EIF5A,BRD-K00004529,L-mimosine,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,DBH|EIF5A
BLYMJBIZMIGWFK,BRD-A18795974,7-hydroxy-DPAT,dopamine receptor agonist,DRD2|DRD3,BRD-A18795974,7-hydroxy-DPAT,dopamine receptor agonist,DRD2|DRD3,BRD-A18795974,7-hydroxy-DPAT,dopamine receptor agonist,DRD2|DRD3,BRD-K01826780,7-hydroxy-DPAT,dopamine receptor agonist,DRD2|DRD3
BLZVCIGGICSWIG,BRD-K13346085,2-APB,"1,4,5-trisphosphate inhibitor",TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6,BRD-K13346085,2-APB,"1,4,5-trisphosphate inhibitor",TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6,BRD-K13346085,2-APB,"1,4,5-trisphosphate inhibitor",TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6,BRD-K13346085,2-APB,"1,4,5-trisphosphate inhibitor",TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6
BMCQMVFGOVHVNG,BRD-A34508879|BRD-K99199077,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1,BRD-A34508879|BRD-K99199077,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1,BRD-A34508879|BRD-K99199077,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1,BRD-A34508879|BRD-K99199077,hydrocortisone-butyrate,glucocorticoid receptor agonist,NR3C1
BMGQWWVMWDBQGC,BRD-K13646352,midostaurin,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,BRD-K13646352,midostaurin,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,BRD-K13646352,midostaurin,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,BRD-K13646352,midostaurin,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG
BMKDZUISNHGIBY,BRD-K07265709,dexrazoxane,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,BRD-K07265709,dexrazoxane,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,BRD-K07265709,dexrazoxane,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,BRD-K07265709,dexrazoxane,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B
BMKPVDQDJQWBPD,BRD-K03109492,NSC-663284,CDC inhibitor,CDC25A|CDC25B|CDC25C,BRD-K03109492,NSC-663284,CDC inhibitor,CDC25A|CDC25B|CDC25C,BRD-K03109492,NSC-663284,CDC inhibitor,CDC25A|CDC25B|CDC25C,BRD-K03109492,NSC-663284,CDC inhibitor,CDC25A|CDC25B|CDC25C
BMLMGCPTLHPWPY,BRD-K92413528,procysteine,glutathione synthase stimulant,,BRD-K92413528,procysteine,glutathione synthase stimulant,,BRD-K92413528,procysteine,glutathione synthase stimulant,,BRD-K92413528,procysteine,glutathione synthase stimulant,
BMMXYEBLEBULND,BRD-K29415052,BGT226,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CG,BRD-K29415052,BGT226,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CG,BRD-K29415052,BGT226,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CG,BRD-K29415052,BGT226,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CG
BMOVQUBVGICXQN,BRD-A90625545,clinofibrate,lipase clearing factor inhibitor,LPL,BRD-A90625545,clinofibrate,lipase clearing factor inhibitor,LPL,BRD-A90625545,clinofibrate,lipase clearing factor inhibitor,LPL,BRD-A90625545,clinofibrate,lipase clearing factor inhibitor,LPL
BMPDWHIDQYTSHX,BRD-A22642447,licarbazepine,voltage-gated sodium channel blocker,SCN5A,BRD-A22642447,licarbazepine,voltage-gated sodium channel blocker,SCN5A,BRD-A22642447,licarbazepine,voltage-gated sodium channel blocker,SCN5A,BRD-A22642447,licarbazepine,voltage-gated sodium channel blocker,SCN5A
BMQGVNUXMIRLCK,BRD-K06858286,cabazitaxel,microtubule inhibitor,TUBA4A|TUBB|TUBB1,BRD-K06858286,cabazitaxel,microtubule inhibitor,TUBA4A|TUBB|TUBB1,BRD-K06858286,cabazitaxel,microtubule inhibitor,TUBA4A|TUBB|TUBB1,BRD-K10384176,cabazitaxel,microtubule inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
BMUACLADCKCNKZ,BRD-K26373640,IKK-2-inhibitor,IKK inhibitor|SYK inhibitor,IKBKB,BRD-K26373640,IKK-2-inhibitor,IKK inhibitor|SYK inhibitor,IKBKB,BRD-K26373640,IKK-2-inhibitor,IKK inhibitor|SYK inhibitor,IKBKB,BRD-K26373640,IKK-2-inhibitor,IKK inhibitor|SYK inhibitor,IKBKB
BMUKKTUHUDJSNZ,BRD-A16700644,isoxsuprine,adrenergic receptor agonist,ADRB2,BRD-A16700644,isoxsuprine,adrenergic receptor agonist,ADRB2,BRD-A16700644,isoxsuprine,adrenergic receptor agonist,ADRB2,BRD-K00003690,isoxsuprine,adrenergic receptor agonist,ADRB2
BNFRJXLZYUTIII,BRD-K37355418,efaproxiral,haemoglobin oxygen release stimulant,HBA1|HBB,BRD-K37355418,efaproxiral,haemoglobin oxygen release stimulant,HBA1|HBB,BRD-K37355418,efaproxiral,haemoglobin oxygen release stimulant,HBA1|HBB,BRD-K37355418,efaproxiral,hemoglobin oxygen release stimulant,HBA1|HBB
BNQDCRGUHNALGH,BRD-A61194565,benserazide,DOPA decarboxylase inhibitor,DDC,BRD-A61194565,benserazide,DOPA decarboxylase inhibitor,DDC,BRD-A61194565,benserazide,DOPA decarboxylase inhibitor,DDC,BRD-A61194565,benserazide,DOPA decarboxylase inhibitor,DDC
BNQSTAOJRULKNX,BRD-K04710043,hexamethylenebisacetamide,AKT inhibitor|NFKB pathway inhibitor|differentiation inducer,AKT1,BRD-K04710043,hexamethylenebisacetamide,AKT inhibitor|NFKB pathway inhibitor|differentiation inducer,AKT1,BRD-K04710043,hexamethylenebisacetamide,AKT inhibitor|NFKB pathway inhibitor|differentiation inducer,AKT1,BRD-K04710043,hexamethylenebisacetamide,AKT inhibitor|NFKB pathway inhibitor|differentiation inducer,AKT1
BNRNXUUZRGQAQC,BRD-K79759585,sildenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,BRD-K79759585,sildenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,BRD-K79759585,sildenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,BRD-K79759585,sildenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3
BNYDDAAZMBUFRG,BRD-K96758128,WAY-213613,glutamate inhibitor,SLC1A2,BRD-K96758128,WAY-213613,glutamate inhibitor,SLC1A2,BRD-K96758128,WAY-213613,glutamate inhibitor,SLC1A2,BRD-K96758128,WAY-213613,glutamate inhibitor,SLC1A2
BOBLHFUVNSFZPJ,BRD-A66869276,diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1,BRD-A66869276,diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1,BRD-A66869276,diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1,BRD-A66869276,diflorasone-diacetate,glucocorticoid receptor agonist,NR3C1
BOCUKUHCLICSIY,BRD-A38639147|BRD-A38675539,cyclothiazide,glutamate receptor modulator,CA1|CA2|CA4|FXYD2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3,BRD-A38639147|BRD-A38675539,cyclothiazide,glutamate receptor modulator,CA1|CA2|CA4|FXYD2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3,BRD-A38639147|BRD-A38675539,cyclothiazide,glutamate receptor modulator,CA1|CA2|CA4|FXYD2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3,BRD-A38639147|BRD-A38675539,cyclothiazide,glutamate receptor modulator,CA2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3
BOEGTKLJZSQCCD,BRD-A56858165,cefadroxil,bacterial cell wall synthesis inhibitor,SLC15A1|SLC15A2|SLC22A6|SLC22A8,BRD-A56858165,cefadroxil,bacterial cell wall synthesis inhibitor,SLC15A1|SLC15A2|SLC22A6|SLC22A8,BRD-A56858165,cefadroxil,bacterial cell wall synthesis inhibitor,SLC15A1|SLC15A2|SLC22A6|SLC22A8,BRD-K63242551,cefadroxil,bacterial cell wall synthesis inhibitor,SLC15A1|SLC15A2|SLC22A6|SLC22A8
BOFQWVMAQOTZIW,BRD-K97010173,deferasirox,chelating agent,CYP3A4,BRD-K97010173,deferasirox,chelating agent,CYP3A4,BRD-K97010173,deferasirox,chelating agent,CYP3A4,BRD-K97010173,deferasirox,chelating agent,CYP3A4
BOIPLTNGIAPDBY,BRD-K69832040,GMX1778,NAMPT inhibitor,NAMPT,BRD-K69832040,GMX1778,NAMPT inhibitor,NAMPT,BRD-K69832040,GMX1778,NAMPT inhibitor,NAMPT,BRD-K69832040,GMX1778,NAMPT inhibitor,NAMPT
BOJKULTULYSRAS,BRD-A63236097,andrographolide,tumor necrosis factor production inhibitor,NFKB1,BRD-A86619021,andrographolide,tumor necrosis factor production inhibitor,NFKB1,BRD-A63236097|BRD-A86619021,andrographolide,tumor necrosis factor production inhibitor,NFKB1,BRD-K89282837,andrographolide,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF
BOPGDPNILDQYTO,BRD-A45839132|BRD-A84188517,coenzyme-i,,AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH,BRD-A45839132|BRD-A84188517,coenzyme-i,,AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH,BRD-A45839132|BRD-A84188517,coenzyme-i,,AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH,BRD-A45839132|BRD-K01825730,coenzyme-I,,AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH
BOVGTQGAOIONJV,BRD-A61154809,gliclazide,ATP channel blocker|insulin secretagogue,ABCC8|VEGFA,BRD-A61154809,gliclazide,ATP channel blocker|insulin secretagogue,ABCC8|VEGFA,BRD-A61154809,gliclazide,ATP channel blocker|insulin secretagogue,ABCC8|VEGFA,BRD-A61154809,gliclazide,ATP channel blocker|insulin secretagogue,
BOWVQLFMWHZBEF,BRD-K66956375,oleoylethanolamide,PPAR receptor agonist|cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker,CNR1|GPR119|GPR55|PPARA,BRD-K66956375,oleoylethanolamide,PPAR receptor agonist|cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker,CNR1|GPR119|GPR55|PPARA,BRD-K66956375,oleoylethanolamide,PPAR receptor agonist|cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker,CNR1|GPR119|GPR55|PPARA,BRD-K66956375,oleoylethanolamide,PPAR receptor agonist|cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker,CNR1|GPR119|GPR55|PPARA
BOZRFEQDOFSZBV,BRD-K28861668,A922500,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K28861668|BRD-K81614372,A-922500|A922500,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K28861668|BRD-K81614372,A-922500|A922500,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K28861668|BRD-K81614372,A-922500|A922500,diacylglycerol O acyltransferase inhibitor,DGAT1
BPBPYQWMFCTCNG,BRD-A56592690,PX-12,thioredoxin inhibitor,TXN|TXNRD1,BRD-A56592690,PX-12,thioredoxin inhibitor,TXN|TXNRD1,BRD-A56592690,PX-12,thioredoxin inhibitor,TXN|TXNRD1,BRD-A56592690,PX-12,thioredoxin inhibitor,CNR1|TXN
BPCNEKWROYSOLT,BRD-K44160053,N-phenylacrylamide,,,,,,,,,,,,,,
BPCNGVCAHAIZEE,BRD-K99922388,DPO-1,potassium channel blocker,KCNA5,BRD-K99922388,DPO-1,potassium channel blocker,KCNA5,BRD-K99922388,DPO-1,potassium channel blocker,KCNA5,BRD-K99922388,DPO-1,potassium channel blocker,KCNA5
BPEGJWRSRHCHSN,BRD-K32107296,temozolomide,DNA alkylating agent,MGMT,BRD-K32107296,temozolomide,DNA alkylating agent,MGMT,BRD-K32107296,temozolomide,DNA alkylating agent,MGMT,BRD-K32107296,temozolomide,DNA alkylating agent,MGMT
BPEWUONYVDABNZ,BRD-K69636617,testolactone,aromatase inhibitor,CYP19A1,BRD-K69636617,testolactone,aromatase inhibitor,CYP19A1,BRD-K69636617,testolactone,aromatase inhibitor,CYP19A1,,,,
BPFYOAJNDMUVBL,BRD-K71926323,marbofloxacin,bacterial DNA gyrase inhibitor,,BRD-K71926323,marbofloxacin,bacterial DNA gyrase inhibitor,,BRD-K71926323,marbofloxacin,bacterial DNA gyrase inhibitor,,BRD-K71926323,marbofloxacin,bacterial DNA gyrase inhibitor,
BPICBUSOMSTKRF,BRD-K21565985,xylazine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K21565985,xylazine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K21565985,xylazine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K21565985,xylazine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C
BPKAHTKRCLCHEA,BRD-K60585088,paricalcitol,vitamin D receptor agonist,VDR,BRD-K60585088,paricalcitol,vitamin D receptor agonist,VDR,BRD-K60585088,paricalcitol,vitamin D receptor agonist,VDR,BRD-K60585088,paricalcitol,vitamin D receptor agonist,VDR
BPLBGHOLXOTWMN,BRD-K43966364,penicillin-v-potassium,bacterial cell wall synthesis inhibitor,,BRD-K43966364,penicillin-v-potassium,bacterial cell wall synthesis inhibitor,,BRD-K43966364,penicillin-v-potassium,bacterial cell wall synthesis inhibitor,,BRD-K43966364,penicillin-v-potassium,bacterial cell wall synthesis inhibitor,
BPMVRAQIQQEBLN,BRD-K06386100,carbadox,other antibiotic,,BRD-K06386100,carbadox,other antibiotic,,,,,,,,,
BPNUQXPIQBZCMR,BRD-K78177893,A-674563,AKT inhibitor,AKT1|PKIA|PRKACA,BRD-K78177893,A-674563,AKT inhibitor,AKT1|PKIA|PRKACA,BRD-K78177893,A-674563,AKT inhibitor,AKT1|PKIA|PRKACA,BRD-K78177893,A-674563,AKT inhibitor,AKT1|PKIA|PRKACA
BPPGPYJBCVXILI,BRD-K47659338,EMD-386088,serotonin receptor agonist,HTR6,BRD-K47659338,EMD-386088,serotonin receptor agonist,HTR6,BRD-K47659338,EMD-386088,serotonin receptor agonist,HTR6,BRD-K47659338,EMD-386088,serotonin receptor agonist,HTR6
BPQMGSKTAYIVFO,BRD-K44827188,vismodegib,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,BRD-K44827188,vismodegib,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,BRD-K44827188,vismodegib,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,BRD-K44827188,vismodegib,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO
BPRHUIZQVSMCRT,BRD-K82941592,rosuvastatin,HMGCR inhibitor,HMGCR,BRD-K82941592,rosuvastatin,HMGCR inhibitor,HMGCR,BRD-K82941592|BRD-M41627219,rosuvastatin,HMGCR inhibitor,HMGCR,BRD-K82941592|BRD-M41627219,rosuvastatin,HMGCR inhibitor,HMGCR
BPRNMVDTWIHULJ,BRD-K32322923,LPA2-antagonist-1,lysophosphatidic acid receptor antagonist,LPAR2,BRD-K32322923,LPA2-antagonist-1,lysophosphatidic acid receptor antagonist,LPAR2,BRD-K32322923,LPA2-antagonist-1,lysophosphatidic acid receptor antagonist,LPAR2,BRD-K32322923,LPA2-antagonist-1,lysophosphatidic acid receptor antagonist,LPAR2
BPZKHKAYOKSXAK,BRD-M79902621,terbutaline,adrenergic receptor agonist,ADRB2,BRD-M79902621,terbutaline,adrenergic receptor agonist,ADRB2,,,,,,,,
BPZSYCZIITTYBL,BRD-K54006094,formoterol,adrenergic receptor agonist,ADRB2,BRD-K54006094|BRD-M00539986,formoterol,adrenergic receptor agonist,ADRB2,BRD-K54006094|BRD-M00539986,formoterol,adrenergic receptor agonist,ADRB2,BRD-K54006094|BRD-M00539986,formoterol,adrenergic receptor agonist,ADRB2
BQBSHJUQVIWEFM,BRD-A11813248,AM-92016,potassium channel blocker,GRIN1,BRD-A11813248,AM-92016,potassium channel blocker,GRIN1,BRD-A11813248,AM-92016,potassium channel blocker,GRIN1,BRD-K01826811,AM-92016,potassium channel blocker,GRIN1
BQCNSTFWSKOWMA,BRD-K35573744,erbstatin-analog,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,BRD-K35573744,erbstatin-analog,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,BRD-K35573744,erbstatin-analog,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,BRD-K35573744,erbstatin-analog,EGFR inhibitor|tyrosine kinase inhibitor,EGFR
BQFARKYNYLKHRD,BRD-M56276249,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,,BRD-M56276249,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,,BRD-M56276249,bismuth(iii)-trifluoromethanesulfonate,direct substitution catalyst,,BRD-M56276249,bismuth(III)-trifluoromethanesulfonate,direct substitution catalyst,
BQIPXWYNLPYNHW,BRD-A99388803,metipranolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A99388803,metipranolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A99388803,metipranolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A99388803,metipranolol,adrenergic receptor antagonist,
BQJODPIMMWWMFC,BRD-K38055836,ethamivan,respiratory stimulant,,BRD-K38055836,ethamivan,respiratory stimulant,,BRD-K38055836,ethamivan,respiratory stimulant,,BRD-K38055836,ethamivan,respiratory stimulant,
BQLDGDMKDYAGNE,BRD-A30655177,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A30655177,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A30655177,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A30655177,LFM-A13,Bruton's tyrosine kinase (BTK) inhibitor,BTK
BQSJTQLCZDPROO,BRD-K48367671,febuxostat,xanthine oxidase inhibitor,XDH,BRD-K48367671,febuxostat,xanthine oxidase inhibitor,XDH,BRD-K48367671,febuxostat,xanthine oxidase inhibitor,XDH,BRD-K48367671,febuxostat,xanthine oxidase inhibitor,XDH
BQXQGZPYHWWCEB,BRD-A50675490,carazolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A50675490,carazolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A50675490,carazolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A50675490,carazolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
BQYIXOPJPLGCRZ,BRD-K42019693,pyridoxal-isonicotinoyl-hydrazone,apoptosis stimulant,,BRD-K42019693,pyridoxal-isonicotinoyl-hydrazone,apoptosis stimulant,,BRD-K42019693,pyridoxal-isonicotinoyl-hydrazone,apoptosis stimulant,,BRD-K42019693,pyridoxal-isonicotinoyl-hydrazone,apoptosis stimulant,
BRBKOPJOKNSWSG,BRD-K45086103,sulfaguanidine,bacterial antifolate,,BRD-K45086103,sulfaguanidine,bacterial antifolate,,BRD-K45086103,sulfaguanidine,bacterial antifolate,,BRD-K45086103,sulfaguanidine,bacterial antifolate,
BRZANEXCSZCZCI,BRD-K47407372,nifenazone,analgesic agent,,BRD-K47407372,nifenazone,analgesic agent,,BRD-K47407372,nifenazone,analgesic agent,,BRD-K47407372,nifenazone,analgesic agent,
BSHWLCACYCVCJE,BRD-A72212290,eprazinone,mucolytic agent,,BRD-A72212290,eprazinone,mucolytic agent,,BRD-A72212290,eprazinone,mucolytic agent,,BRD-A72212290,eprazinone,mucolytic agent,
BSMCAPRUBJMWDF,BRD-K03390685,cobimetinib,MEK inhibitor,,BRD-K03390685,cobimetinib,MEK inhibitor,,BRD-K03390685,cobimetinib,MEK inhibitor,,BRD-K03390685,cobimetinib,MEK inhibitor,MAP2K1
BSMNRYCSBFHEMQ,BRD-A68942014,amitifadine,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A68942014,amitifadine,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A68942014,amitifadine,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A68942014,amitifadine,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4
BSYNRYMUTXBXSQ,BRD-K11433652,aspirin,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,BRD-K11433652,aspirin,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,BRD-K11433652,aspirin,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,BRD-K11433652,aspirin,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53
BTCSSZJGUNDROE,BRD-K77245796,gamma-aminobutyric-acid,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1,BRD-K77245796,gamma-aminobutyric-acid,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1,BRD-K77245796,gamma-aminobutyric-acid,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1,BRD-K77245796,gamma-aminobutyric-acid,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1
BTFHLQRNAMSNLC,BRD-K73251053,clorgiline,monoamine oxidase inhibitor,MAOA,BRD-K73251053,clorgiline,monoamine oxidase inhibitor,MAOA,BRD-K73251053,clorgiline,monoamine oxidase inhibitor,MAOA,BRD-K73251053,clorgiline,monoamine oxidase inhibitor,MAOA
BTFMCMVEUCGQDX,BRD-K16277217,piperacetazine,dopamine receptor antagonist,,BRD-K16277217,piperacetazine,dopamine receptor antagonist,,BRD-K16277217,piperacetazine,dopamine receptor antagonist,,BRD-K16277217,piperacetazine,dopamine receptor antagonist,
BTGNGJJLZOIYID,BRD-K02152879,sivelestat,elastase inhibitor,CELA1|ELANE,BRD-K02152879,sivelestat,elastase inhibitor,CELA1|ELANE,BRD-K02152879,sivelestat,elastase inhibitor,CELA1|ELANE,BRD-K02152879,sivelestat,elastase inhibitor,CELA1|ELANE
BTIHMVBBUGXLCJ,BRD-K07691486,roscovitine,CDK inhibitor,CDK2|CDK9,BRD-K07691486,roscovitine,CDK inhibitor,CDK2|CDK9,BRD-K07691486,roscovitine,CDK inhibitor,CDK2|CDK9,BRD-K07691486,roscovitine,CDK inhibitor,CDK2|CDK9
BTNNPSLJPBRMLZ,BRD-K05319475|BRD-K07359318,benfotiamine,antioxidant,AGER,BRD-K05319475|BRD-K07359318,benfotiamine,antioxidant,AGER,BRD-K05319475|BRD-K07359318,benfotiamine,antioxidant,AGER,BRD-K05319475,benfotiamine,antioxidant,AGER
BTOJYCTUJJHANF,BRD-K66715657,UH-232-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR1A,BRD-K66715657,UH-232-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR1A,BRD-K66715657,UH-232-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR1A,BRD-K66715657,UH-232-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR1A
BTTNOGHPGJANSW,BRD-K84683831,radezolid,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,BRD-K84683831,radezolid,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,BRD-K84683831,radezolid,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,BRD-K84683831,radezolid,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,
BTXNYTINYBABQR,BRD-K29673530,hypericin,tyrosine kinase inhibitor,,BRD-K29673530,hypericin,tyrosine kinase inhibitor,,BRD-K29673530,hypericin,tyrosine kinase inhibitor,,BRD-K29673530,hypericin,tyrosine kinase inhibitor,
BTYSIDSTHDDAJW,BRD-K61665160,BYK-204165,PARP inhibitor,PARP1,BRD-K61665160,BYK-204165,PARP inhibitor,PARP1,BRD-K61665160,BYK-204165,PARP inhibitor,PARP1,BRD-K61665160,BYK-204165,PARP inhibitor,PARP1
BUGYDGFZZOZRHP,BRD-A79803969,memantine,glutamate receptor antagonist,CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A,BRD-A79803969,memantine,glutamate receptor antagonist,CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A,BRD-A79803969,memantine,glutamate receptor antagonist,CHRFAM7A|DRD2|GRIN1|GRIN2A|GRIN2B|GRIN3A|HTR3A,BRD-K91938660,memantine,glutamate receptor antagonist,
BUJAGSGYPOAWEI,BRD-A92670106,tocainide,sodium channel blocker,SCN5A,BRD-A92670106,tocainide,sodium channel blocker,SCN5A,BRD-A92670106,tocainide,sodium channel blocker,SCN5A,BRD-K01826767,tocainide,sodium channel blocker,SCN5A
BURHGPHDEVGCEZ,BRD-K61923022,GDC-0810,selective estrogen receptor destabilizer,ESR1,BRD-K61923022,GDC-0810,selective estrogen receptor destabilizer,ESR1,BRD-K61923022,GDC-0810,selective estrogen receptor destabilizer,ESR1,BRD-K61923022,GDC-0810,selective estrogen receptor destabilizer,ESR1
BUROJSBIWGDYCN,BRD-K09078998|BRD-K62304154,deforolimus,mTOR inhibitor,MTOR,BRD-K09078998|BRD-K62304154,deforolimus,mTOR inhibitor,MTOR,BRD-K09078998|BRD-K62304154,deforolimus,mTOR inhibitor,MTOR,BRD-K09078998|BRD-K62304154,deforolimus,mTOR inhibitor,MTOR
BUWFKENPFXXWGV,BRD-K82908348,darglitazone,PPAR receptor antagonist,PPARG,BRD-K82908348,darglitazone,PPAR receptor antagonist,PPARG,BRD-K82908348,darglitazone,PPAR receptor antagonist,PPARG,,,,
BUXRLJCGHZZYNE,BRD-A65440446,cimaterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A65440446,cimaterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A65440446,cimaterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A65440446,cimaterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3
BUZAJRPLUGXRAB,BRD-K92000912,AM-251,cannabinoid receptor antagonist,CNR1|GPR18|GPR55,BRD-K92000912,AM-251,cannabinoid receptor antagonist,CNR1|GPR18|GPR55,BRD-K92000912,AM-251,cannabinoid receptor antagonist,CNR1|GPR18|GPR55,BRD-K92000912,AM-251,cannabinoid receptor antagonist,CNR1|GPR18|GPR55
BVAZQCUMNICBAQ,BRD-K09735259,elbasvir,HCV inhibitor,,BRD-K09735259,elbasvir,HCV inhibitor,,BRD-K09735259,elbasvir,HCV inhibitor,,BRD-K09735259,elbasvir,HCV inhibitor,
BVJSXSQRIUSRCO,BRD-K13949769,tenovin-6,SIRT inhibitor,SIRT1|SIRT2|SIRT3,BRD-K13949769,tenovin-6,SIRT inhibitor,SIRT1|SIRT2|SIRT3,BRD-K13949769,tenovin-6,SIRT inhibitor,SIRT1|SIRT2|SIRT3,BRD-K13949769,tenovin-6,SIRT inhibitor,SIRT1|SIRT2|SIRT3
BVMDRSUIADWFLV,BRD-M89827113,levcromakalim,potassium channel activator,KCNJ5|KCNJ8,BRD-M89827113,levcromakalim,potassium channel activator,KCNJ5|KCNJ8,BRD-M89827113,cromakalim,,KCNJ8,BRD-M89827113,cromakalim,,KCNJ8
BVMYCHKQPGEOSI,BRD-A50764878,MDL-73005EF,serotonin receptor antagonist,HTR1A,BRD-A50764878,MDL-73005EF,serotonin receptor antagonist,HTR1A,BRD-A50764878,MDL-73005EF,serotonin receptor antagonist,HTR1A,BRD-K01826803,MDL-73005EF,serotonin receptor antagonist,HTR1A
BVPWJMCABCPUQY,BRD-K17294426,clebopride,dopamine receptor antagonist,ACHE|DRD2,BRD-K17294426,clebopride,dopamine receptor antagonist,ACHE|DRD2,BRD-K17294426,clebopride,dopamine receptor antagonist,ACHE|DRD2,BRD-K17294426,clebopride,dopamine receptor antagonist,ACHE|DRD2
BVRDQVRQVGRNHG,BRD-K19655798,compound-401,DNA dependent protein kinase inhibitor,MTOR|PRKDC,BRD-K19655798,compound-401,DNA dependent protein kinase inhibitor,MTOR|PRKDC,BRD-K19655798,compound-401,DNA dependent protein kinase inhibitor,MTOR|PRKDC,BRD-K19655798,compound-401,DNA dependent protein kinase inhibitor,MTOR|PRKDC
BWDQBBCUWLSASG,BRD-K56957086,dacinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K56957086,dacinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K56957086,dacinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K56957086,dacinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
BWPIARFWQZKAIA,BRD-K42098891,protriptyline,tricyclic antidepressant,SLC6A2|SLC6A4,BRD-K42098891,protriptyline,tricyclic antidepressant,SLC6A2|SLC6A4,BRD-K42098891,protriptyline,tricyclic antidepressant,SLC6A2|SLC6A4,BRD-K42098891,protriptyline,tricyclic antidepressant,SLC6A2|SLC6A4
BWWVAEOLVKTZFQ,BRD-K41051431,amdinocillin,bacterial cell wall synthesis inhibitor,,BRD-K41051431,amdinocillin,bacterial cell wall synthesis inhibitor,,BRD-K41051431,amdinocillin,bacterial cell wall synthesis inhibitor,,BRD-K41051431,amdinocillin,bacterial cell wall synthesis inhibitor,
BWZJBXAPRCVCKQ,BRD-K14618467,IKK-16,IKK inhibitor,IKBKB,BRD-K14618467,IKK-16,IKK inhibitor,IKBKB,BRD-K14618467,IKK-16,IKK inhibitor,IKBKB,BRD-K14618467,IKK-16,IKK inhibitor,IKBKB
BWZNJVZTAWBIFG,BRD-K96259238,Y-320,interleukin inhibitor,IL17A,BRD-K96259238,Y-320,interleukin inhibitor,IL17A,BRD-K96259238,Y-320,interleukin inhibitor,IL17A,BRD-K96259238,Y-320,interleukin inhibitor,IL17A
BXBNADAPIHHXJQ,BRD-K25140590,CX-516,glutamate receptor modulator,,BRD-K25140590,CX-516,glutamate receptor modulator,,BRD-K25140590,CX-516,glutamate receptor modulator,,BRD-K25140590,CX-516,glutamate receptor modulator,
BXNANOICGRISHX,BRD-K41567533,coumophos,cholinesterase inhibitor,,BRD-K41567533,coumophos,cholinesterase inhibitor,,BRD-K41567533,coumophos,cholinesterase inhibitor,,BRD-K41567533,coumophos,cholinesterase inhibitor,
BXNMTOQRYBFHNZ,BRD-K76210423,resiquimod,toll-like receptor agonist,TLR7|TLR8,BRD-K76210423,resiquimod,toll-like receptor agonist,TLR7|TLR8,BRD-K76210423,resiquimod,toll-like receptor agonist,TLR7|TLR8,BRD-K76210423,resiquimod,toll-like receptor agonist,TLR7|TLR8
BXRNXXXXHLBUKK,BRD-K95941975,piperazinedione,DNA synthesis inhibitor,,BRD-K95941975,piperazinedione,DNA synthesis inhibitor,,BRD-K95941975,piperazinedione,DNA synthesis inhibitor,,BRD-K95941975,piperazinedione,DNA synthesis inhibitor,
BXWNKGSJHAJOGX,BRD-K37203094,1-hexadecanol,,,BRD-K37203094,1-hexadecanol,,,BRD-K37203094,1-hexadecanol,,,BRD-K37203094,1-hexadecanol,,
BXZVVICBKDXVGW,BRD-K99063460,didanosine,nucleoside reverse transcriptase inhibitor,PNP,BRD-K99063460,didanosine,nucleoside reverse transcriptase inhibitor,PNP,BRD-K99063460,didanosine,nucleoside reverse transcriptase inhibitor,PNP,BRD-K99063460,didanosine,nucleoside reverse transcriptase inhibitor,PNP
BYBLEWFAAKGYCD,BRD-A82396632,miconazole,bacterial cell wall synthesis inhibitor,KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5,BRD-A82396632,miconazole,bacterial cell wall synthesis inhibitor,KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5,BRD-A82396632,miconazole,bacterial cell wall synthesis inhibitor,KCNH2|KCNH6|KCNH7|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|NOS2|NOS3|TRPM2|TRPV5,BRD-K01826511,miconazole,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5
BYBYHCOEAFHGJL,BRD-A64553394,DPI-201106,sodium channel activator,ADRB2,BRD-A64553394,DPI-201106,sodium channel activator,ADRB2,BRD-A64553394,DPI-201106,sodium channel activator,ADRB2,BRD-A64553394,DPI-201106,sodium channel activator,ADRB2
BYFMCKSPFYVMOU,BRD-K19515365,bendazac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K19515365,bendazac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K19515365,bendazac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K19515365,bendazac,cyclooxygenase inhibitor,PTGS1|PTGS2
BYGXICRJQZKUPA,BRD-K41143549,N20C,glutamate receptor antagonist,,BRD-K41143549,N20C,glutamate receptor antagonist,,BRD-K41143549,N20C,glutamate receptor antagonist,,BRD-K41143549,N20C,glutamate receptor antagonist,
BYHKGNWKJMGHGE,BRD-K91868854,2-[1-(4-piperonyl)piperazinyl]benzothiazole,serotonin receptor agonist,HTR4,BRD-K91868854,2-[1-(4-piperonyl)piperazinyl]benzothiazole,serotonin receptor agonist,HTR4,BRD-K91868854,2-[1-(4-piperonyl)piperazinyl]benzothiazole,serotonin receptor agonist,HTR4,BRD-K91868854,2-[1-(4-piperonyl)piperazinyl]benzothiazole,serotonin receptor agonist,HTR4
BYJAVTDNIXVSPW,BRD-A28856712,tetrahydrozoline,adrenergic receptor agonist,,BRD-A28856712,tetrahydrozoline,adrenergic receptor agonist,,BRD-A28856712,tetrahydrozoline,adrenergic receptor agonist,,BRD-A28856712,tetrahydrozoline,adrenergic receptor agonist,
BYPFEZZEUUWMEJ,BRD-K57569181,pentoxifylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,BRD-K57569181,pentoxifylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,BRD-K57569181,pentoxifylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,BRD-K57569181,pentoxifylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF
BYPIURIATSUHDW,BRD-A40940854,ibuproxam--cyclodextrin,,,BRD-A40940854,ibuproxam,cyclooxygenase inhibitor|prostaglandin inhibitor,ALOX5,BRD-A40940854,ibuproxam,cyclooxygenase inhibitor|prostaglandin inhibitor,ALOX5,BRD-A40940854,ibuproxam,cyclooxygenase inhibitor|prostaglandin inhibitor,ALOX5
BYTNEISLBIENSA,BRD-K88186167,GW-4064,FXR agonist,NR1H4,BRD-K88186167,GW-4064,FXR agonist,NR1H4,BRD-K88186167,GW-4064,FXR agonist,NR1H4,BRD-K88186167,GW-4064,FXR agonist,NR1H4
BYUKOOOZTSTOOH,BRD-K30126819,dimesna,tubulin polymerization inhibitor,,BRD-K30126819,dimesna,tubulin polymerization inhibitor,,BRD-K30126819,dimesna,tubulin polymerization inhibitor,,BRD-K30126819,dimesna,tubulin polymerization inhibitor,
BYWWNRBKPCPJMG,BRD-K59745944,PHT-427,AKT inhibitor|pyruvate dehydrogenase inhibitor,AKT2|PDPK1,BRD-K59745944,PHT-427,AKT inhibitor|pyruvate dehydrogenase inhibitor,AKT2|PDPK1,BRD-K59745944,PHT-427,AKT inhibitor|pyruvate dehydrogenase inhibitor,AKT2|PDPK1,BRD-K59745944,PHT-427,AKT inhibitor|pyruvate dehydrogenase inhibitor,AKT2|PDPK1
BYYQYXVAWXAYQC,BRD-K37952347,"L-732,138",,,BRD-K37952347,"L-732,138",tachykinin antagonist,TACR1|TACR2,BRD-K37952347,"L-732,138",tachykinin antagonist,TACR1|TACR2,BRD-K37952347,"L-732,138",tachykinin antagonist,TACR1|TACR2
BZCALJIHZVNMGJ,BRD-K58501140,TAK-875,insulin secretagogue,FFAR1,BRD-K58501140,TAK-875,insulin secretagogue,FFAR1,BRD-K58501140|BRD-M64443684,TAK-875,insulin secretagogue,FFAR1,BRD-K58501140|BRD-M64443684,TAK-875,insulin secretagogue,FFAR1
BZEWSEKUUPWQDQ,BRD-K72259270,dyclonine,sodium channel blocker,SCN10A|SCN5A,BRD-K72259270,dyclonine,sodium channel blocker,SCN10A|SCN5A,BRD-K72259270,dyclonine,sodium channel blocker,SCN10A|SCN5A,BRD-K72259270,dyclonine,sodium channel blocker,SCN10A|SCN5A
BZKPWHYZMXOIDC,BRD-K43457670,acetazolamide,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,BRD-K43457670,acetazolamide,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,BRD-K43457670,acetazolamide,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,BRD-K43457670,acetazolamide,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7
BZMKNPGKXJAIDV,BRD-K53720352,cinalukast,leukotriene receptor antagonist,CYSLTR1,BRD-K53720352,cinalukast,leukotriene receptor antagonist,CYSLTR1,BRD-K53720352,cinalukast,leukotriene receptor antagonist,CYSLTR1,BRD-K53720352,cinalukast,leukotriene receptor antagonist,CYSLTR1
BZOQTGADCSFWHV,BRD-K13277760,rifamycin-sv,RNA synthesis inhibitor,,BRD-K13277760,rifamycin-sv,RNA synthesis inhibitor,,BRD-K13277760,rifamycin-sv,RNA synthesis inhibitor,,,,,
BZQFBWGGLXLEPQ,BRD-K30019776,dexfosfoserine,membrane integrity inhibitor,CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2,BRD-K30019776,dexfosfoserine,membrane integrity inhibitor,CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2,BRD-K30019776,dexfosfoserine,membrane integrity inhibitor,CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2,BRD-K30019776,dexfosfoserine,membrane integrity inhibitor,CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2
CAHKINHBCWCHCF,BRD-A24857382,N-acetyl-tyrosine,,,BRD-A24857382,N-acetyl-tyrosine,,,BRD-A24857382,N-acetyl-tyrosine,,,BRD-A24857382,N-acetyl-tyrosine,,
CAJIGINSTLKQMM,BRD-K18250272,propoxycaine,local anesthetic,,BRD-K18250272,propoxycaine,local anesthetic,,BRD-K18250272,propoxycaine,local anesthetic,,BRD-K18250272,propoxycaine,local anesthetic,
CAMYKONBWHRPDD,BRD-K22009844,phenprobamate,muscle relaxant,,BRD-K22009844,phenprobamate,muscle relaxant,,BRD-K22009844,phenprobamate,muscle relaxant,,BRD-K22009844,phenprobamate,muscle relaxant,
CANZROMYQDHYHR,BRD-K01942991,oxotremorine-m,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K01942991,oxotremorine-m,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K01942991,oxotremorine-m,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K01942991,oxotremorine-M,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
CAOSCCRYLYQBES,BRD-K98251413,IOX2,hypoxia inducible factor inhibitor,EGLN1|KDM2A|KDM5C,BRD-K98251413,IOX2,hypoxia inducible factor inhibitor,EGLN1|KDM2A|KDM5C,BRD-K98251413,IOX2,hypoxia inducible factor inhibitor,EGLN1|KDM2A|KDM5C,BRD-K98251413,IOX2,hypoxia inducible factor inhibitor,EGLN1|KDM2A|KDM5C
CAOTVXGYTWCKQE,BRD-A70814879,ABC-294640,sphingosine kinase inhibitor,SPHK2,BRD-A70814879,ABC-294640,sphingosine kinase inhibitor,SPHK2,BRD-A70814879,ABC-294640,sphingosine kinase inhibitor,SPHK2,BRD-K01825984,ABC-294640,sphingosine kinase inhibitor,SPHK2
CBDQOLKNTOMMTL,BRD-K01029106,picolinic-acid,chelating agent,,BRD-K01029106,picolinic-acid,chelating agent,,BRD-K01029106|BRD-M54429190,picolinic-acid,chelating agent,,BRD-K01029106|BRD-M54429190,chromium-picolinate,insulin sensitizer,
CBEQULMOCCWAQT,BRD-K11742128,triprolidine,histamine receptor antagonist,HRH1,BRD-K11742128,triprolidine,histamine receptor antagonist,HRH1,BRD-K11742128,triprolidine,histamine receptor antagonist,HRH1,BRD-K11742128,triprolidine,histamine receptor antagonist,HRH1
CBGUOGMQLZIXBE,BRD-A26095496|BRD-K10799896|BRD-K91981767,clobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A26095496|BRD-K10799896|BRD-K84443303,clobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A26095496|BRD-K10799896|BRD-K91981767,clobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A26095496|BRD-K10799896|BRD-K91981767,clobetasol-propionate,glucocorticoid receptor agonist,NR3C1|PLA2G1B
CBHCDHNUZWWAPP,BRD-A82772293,mepazine,MALT1 inhibitor (JH),MALT1,BRD-A82772293,mepazine,MALT1 inhibitor (JH),MALT1,BRD-A82772293,mepazine,MALT1 inhibitor (JH),MALT1,BRD-K01825575,mepazine,MALT1 inhibitor (JH),MALT1
CBIAKDAYHRWZCU,BRD-K07487750,WHI-P154,JAK inhibitor,EGFR|JAK1|JAK2|JAK3,BRD-K07487750,WHI-P154,JAK inhibitor,EGFR|JAK1|JAK2|JAK3,BRD-K07487750,WHI-P154,JAK inhibitor,EGFR|JAK1|JAK2|JAK3,BRD-K07487750,WHI-P154,JAK inhibitor,EGFR|JAK1|JAK2|JAK3
CBIAWPMZSFFRGN,BRD-K90948141,indiplon,benzodiazepine receptor agonist,GABRA1,BRD-K90948141,indiplon,benzodiazepine receptor agonist,GABRA1,BRD-K90948141,indiplon,benzodiazepine receptor agonist,GABRA1,BRD-K90948141,indiplon,benzodiazepine receptor agonist,GABRA1
CBOQJANXLMLOSS,BRD-K82104468,ethyl-vanillin,,,BRD-K82104468,ethyl-vanillin,,,BRD-K82104468,ethyl-vanillin,,,BRD-K82104468,ethyl-vanillin,,
CBPJQFCAFFNICX,BRD-K15327298|BRD-K65275554,NPC-15199|fmoc-l-leucine,ICAM1 antagonist|PPAR receptor agonist,|PPARG,BRD-K15327298|BRD-K65275554,NPC-15199|fmoc-l-leucine,ICAM1 antagonist|PPAR receptor agonist,|PPARG,BRD-K15327298|BRD-K65275554,NPC-15199|fmoc-l-leucine,ICAM1 antagonist|PPAR receptor agonist,|PPARG,BRD-K15327298|BRD-K65275554,NPC-15199|fmoc-L-leucine,ICAM1 antagonist|PPAR receptor agonist,|PPARG
CBPNZQVSJQDFBE,BRD-K42898655,temsirolimus,mTOR inhibitor,MTOR,BRD-K42898655,temsirolimus,mTOR inhibitor,MTOR,BRD-K42898655,temsirolimus,mTOR inhibitor,MTOR,BRD-K08177763,temsirolimus,mTOR inhibitor,MTOR
CBQGYUDMJHNJBX,BRD-A43974499|BRD-K77224738,reboxetine,adrenergic receptor antagonist,SLC6A2,BRD-A43974499|BRD-K77224738,reboxetine,adrenergic receptor antagonist,SLC6A2,BRD-A43974499|BRD-K77224738,reboxetine,adrenergic receptor antagonist,SLC6A2,BRD-K77224738,reboxetine,adrenergic receptor antagonist,SLC6A2
CBQJSKKFNMDLON,BRD-K53205568,afalanine,dopamine receptor agonist,DRD2,BRD-K53205568,afalanine,dopamine receptor agonist,DRD2,BRD-K53205568,afalanine,dopamine receptor agonist,DRD2,BRD-K53205568,afalanine,dopamine receptor agonist,DRD2
CBVCZFGXHXORBI,BRD-K33226500,indinavir,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,BRD-K33226500,indinavir,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,BRD-K33226500,indinavir,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,BRD-K33226500,indinavir,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7
CCAWRGNYALGPQH,BRD-K04691817,AGI-6780,isocitrate dehydrogenase inhibitor,IDH2,BRD-K04691817,AGI-6780,isocitrate dehydrogenase inhibitor,IDH2,BRD-K04691817,AGI-6780,isocitrate dehydrogenase inhibitor,IDH2,BRD-K04691817,AGI-6780,isocitrate dehydrogenase inhibitor,IDH2
CDAISMWEOUEBRE,BRD-K52618540,inositol,insulin sensitizer,CDIPT|GBA,BRD-K52618540,inositol,insulin sensitizer,CDIPT|GBA,BRD-K52618540,inositol,insulin sensitizer,CDIPT|GBA,BRD-K52618540,inositol,insulin sensitizer,CDIPT
CDJNNOJINJAXPV,BRD-K70463136,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A,BRD-K70463136,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A,BRD-K70463136,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A,BRD-K70463136,BAY-87-2243,hypoxia inducible factor inhibitor,HIF1A
CDMGBJANTYXAIV,BRD-A37704979,SB-203580,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF,BRD-A37704979,SB-203580,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF,BRD-A37704979,SB-203580,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF,BRD-K01826796,SB-203580,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF
CDOOFZZILLRUQH,BRD-A30984645,GDC-0834,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A30984645,GDC-0834,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A30984645,GDC-0834,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A30984645,GDC-0834,Bruton's tyrosine kinase (BTK) inhibitor,BTK
CDOSHBSSFJOMGT,BRD-A43082461,linalool,anticonvulsant,,BRD-A43082461,linalool,anticonvulsant,,BRD-A43082461,linalool,anticonvulsant,,BRD-K01827427,linalool,anticonvulsant,
CDOVNWNANFFLFJ,BRD-K04853698,LDN193189,bone morphogenic protein inhibitor,ACVR1|BMPR1A,BRD-K04853698,LDN193189,bone morphogenic protein inhibitor,ACVR1|BMPR1A,BRD-K04853698,LDN193189,bone morphogenic protein inhibitor,ACVR1|BMPR1A,BRD-K04853698,LDN193189,bone morphogenic protein inhibitor,ACVR1|BMPR1A
CDOZDBSBBXSXLB,BRD-A16311756,profenamine,butyrylcholinesterase inhibitor|cholinergic receptor antagonist,CHRM1|CHRM2|GRIN3A,BRD-A16311756,profenamine,butyrylcholinesterase inhibitor|cholinergic receptor antagonist,CHRM1|CHRM2|GRIN3A,BRD-A16311756,profenamine,butyrylcholinesterase inhibitor|cholinergic receptor antagonist,CHRM1|CHRM2|GRIN3A,BRD-A16311756,profenamine,butyrylcholinesterase inhibitor|cholinergic receptor antagonist,CHRM1
CDRPUGZCRXZLFL,BRD-K91509126,piceatannol,SYK inhibitor,ATP5A1|ATP5B|ATP5C1|IRF3,BRD-K91509126,piceatannol,SYK inhibitor,ATP5A1|ATP5B|ATP5C1|IRF3,BRD-K91509126,piceatannol,SYK inhibitor,ATP5A1|ATP5B|ATP5C1|IRF3,BRD-K91509126,piceatannol,SYK inhibitor,ATP5A1|ATP5B|ATP5C1|IRF3
CEAZRRDELHUEMR,BRD-A89445950,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8|LRP2,BRD-A89445950,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8|LRP2,BRD-A89445950,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8|LRP2,BRD-K97891829,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8
CEBYCSRFKCEUSW,BRD-K96720755,relcovaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K96720755,relcovaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K96720755,relcovaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K96720755,relcovaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR
CEDZURSVVKNCSL,BRD-A29944538,proxodolol,adrenergic receptor antagonist,,BRD-A29944538,proxodolol,adrenergic receptor antagonist,,BRD-A29944538,proxodolol,adrenergic receptor antagonist,,BRD-A29944538,proxodolol,adrenergic receptor antagonist,
CEGSUKYESLWKJP,BRD-K65924316,serdemetan,MDM inhibitor,MDM2,BRD-K65924316,serdemetan,MDM inhibitor,MDM2,BRD-K65924316,serdemetan,MDM inhibitor,MDM2,BRD-K65924316,serdemetan,MDM inhibitor,MDM2
CEHQLKSLMFIHBF,BRD-K90524085,MY-5445,phosphodiesterase inhibitor|platelet aggregation inhibitor,PDE5A,BRD-K90524085,MY-5445,phosphodiesterase inhibitor|platelet aggregation inhibitor,PDE5A,BRD-K90524085,MY-5445,phosphodiesterase inhibitor|platelet aggregation inhibitor,PDE5A,BRD-K90524085,MY-5445,phosphodiesterase inhibitor|platelet aggregation inhibitor,PDE5A
CEIIEALEIHQDBX,BRD-K71731651,PNU-120596,acetylcholine receptor agonist,CHRNA7,BRD-K71731651,PNU-120596,acetylcholine receptor agonist,CHRNA7,BRD-K71731651,PNU-120596,acetylcholine receptor agonist,CHRNA7,BRD-K71731651,PNU-120596,acetylcholine receptor agonist,CHRNA7
CEIJFEGBUDEYSX,BRD-K65904673,tandospirone,serotonin receptor agonist,HTR1A,BRD-K65904673,tandospirone,serotonin receptor agonist,HTR1A,BRD-K65904673,tandospirone,serotonin receptor agonist,HTR1A,BRD-K65904673,tandospirone,serotonin receptor agonist,HTR1A
CEJLBZWIKQJOAT,BRD-K76375510,troclosene,,,BRD-K76375510,troclosene,,,BRD-K76375510,troclosene,,,BRD-K76375510,troclosene,,
CEMAWMOMDPGJMB,BRD-A43671941,oxprenolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A43671941,oxprenolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A43671941|BRD-U77311119,oxprenolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A43671941|BRD-U77311119,oxprenolol,adrenergic receptor antagonist,ADRB1
CESYKOGBSMNBPD,BRD-A95340155,methyclothiazide,chloride reabsorption inhibitor,CA1|CA2|CA4|SLC12A1|SLC12A3,BRD-A95340155,methyclothiazide,chloride reabsorption inhibitor,CA1|CA2|CA4|SLC12A1|SLC12A3,BRD-A95340155,methyclothiazide,chloride reabsorption inhibitor,CA1|CA2|CA4|SLC12A1|SLC12A3,BRD-A95340155,methyclothiazide,chloride reabsorption inhibitor,SLC12A1|SLC12A3
CETRZFQIITUQQL,BRD-M56212252,DMSO,control vehicle,,BRD-M56212252,DMSO,control vehicle,,BRD-K08970894|BRD-M56212252,DMSO,control vehicle,,BRD-K08970894|BRD-M56212252,DMSO,control vehicle,
CEUDWZXMLMKPNN,BRD-K80194255,BW-A4C,lipoxygenase inhibitor,ALOX5,BRD-K80194255,BW-A4C,lipoxygenase inhibitor,ALOX5,BRD-K80194255,BW-A4C,lipoxygenase inhibitor,ALOX5,BRD-K80194255,BW-A4C,lipoxygenase inhibitor,ALOX5
CEUORZQYGODEFX,BRD-K70358946,aripiprazole,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,BRD-K70358946,aripiprazole,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,BRD-K70358946,aripiprazole,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,BRD-K70358946,aripiprazole,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7
CFBUZOUXXHZCFB,BRD-K38473998,cilomilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,BRD-K38473998,cilomilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,BRD-K38473998,cilomilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,BRD-K00003550,cilomilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D
CFCUWKMKBJTWLW,BRD-K36368047,plicamycin,alcohol dehydrogenase inhibitor,,BRD-K36368047,plicamycin,alcohol dehydrogenase inhibitor,,BRD-K36368047,plicamycin,alcohol dehydrogenase inhibitor,,BRD-K36368047,plicamycin,alcohol dehydrogenase inhibitor,
CFJMRBQWBDQYMK,BRD-K06181161,carbetapentane,acetylcholine receptor antagonist,CHRM2,BRD-K06181161,carbetapentane,acetylcholine receptor antagonist,CHRM2,BRD-K06181161,carbetapentane,acetylcholine receptor antagonist,CHRM2,BRD-K06181161,carbetapentane,acetylcholine receptor antagonist,CHRM2
CFKMVGJGLGKFKI,BRD-K89056082,chlorocresol,ryanodine receptor activator,,BRD-K89056082,chlorocresol,ryanodine receptor activator,,BRD-K89056082,chlorocresol,ryanodine receptor activator,,BRD-K89056082,chlorocresol,ryanodine receptor activator,
CFOYWRHIYXMDOT,BRD-K87156652,carbimazole,antithyroid agent,TPO,BRD-K87156652,carbimazole,antithyroid agent,TPO,BRD-K87156652,carbimazole,antithyroid agent,TPO,BRD-K87156652,carbimazole,antithyroid agent,TPO
CFPDEQBPNROZDC,BRD-K11927976,ER-27319,SYK inhibitor|mediator release inhibitor,SYK,BRD-K11927976,ER-27319,SYK inhibitor|mediator release inhibitor,SYK,BRD-K11927976,ER-27319,SYK inhibitor|mediator release inhibitor,SYK,BRD-K11927976,ER-27319,SYK inhibitor|mediator release inhibitor,SYK
CFRPSFYHXJZSBI,BRD-K47887731,nitenpyram,,,BRD-K47887731,nitenpyram,,,BRD-K47887731,nitenpyram,,,BRD-K47887731,nitenpyram,,
CFSOJZTUTOQNIA,BRD-K82823076,Ro-15-4513,,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,BRD-K82823076,Ro-15-4513,,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,BRD-K82823076,Ro-15-4513,,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,BRD-K82823076,Ro-15-4513,GABA benzodiazepine site receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2
CGBJSGAELGCMKE,BRD-K07972848,GSK2126458,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K07972848,GSK2126458,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K07972848,GSK2126458,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K07972848,GSK2126458,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
CGDZXLJGHVKVIE,BRD-K91159026,telcagepant,calcitonin antagonist,CALCRL|RAMP1,BRD-K91159026,telcagepant,calcitonin antagonist,CALCRL|RAMP1,BRD-K91159026,telcagepant,calcitonin antagonist,CALCRL|RAMP1,BRD-K91159026,telcagepant,calcitonin antagonist,CALCRL|RAMP1
CGIGDMFJXJATDK,BRD-K57222227,indomethacin,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,BRD-K57222227,indomethacin,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,BRD-K57222227,indomethacin,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,BRD-K57222227,indomethacin,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1
CGNMLOKEMNBUAI,BRD-A90926615,adrafinil,adrenergic receptor agonist,,BRD-A90926615,adrafinil,adrenergic receptor agonist,,BRD-A90926615,adrafinil,adrenergic receptor agonist,,BRD-A90926615,adrafinil,adrenergic receptor agonist,
CGTADGCBEXYWNE,BRD-K46843573,zotarolimus,mTOR inhibitor,FKBP1A,BRD-K46843573,zotarolimus,mTOR inhibitor,FKBP1A,BRD-K46843573,zotarolimus,mTOR inhibitor,FKBP1A,BRD-K46843573,zotarolimus,mTOR inhibitor,FKBP1A
CGZOGNUFXMNYEI,BRD-A08915912|BRD-A34462049,tigecycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A08915912|BRD-A34462049,tigecycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A08915912|BRD-A34462049,tigecycline,bacterial 30S ribosomal subunit inhibitor,,BRD-K00003349,tigecycline,bacterial 30S ribosomal subunit inhibitor,
CHILCFMQWMQVAL,BRD-K74305673,IKK-2-inhibitor-V,IKK inhibitor|NFkB pathway inhibitor,IKBKB,BRD-K74305673,IKK-2-inhibitor-V,IKK inhibitor|NFkB pathway inhibitor,IKBKB,BRD-K74305673,IKK-2-inhibitor-V,IKK inhibitor|NFkB pathway inhibitor,IKBKB,BRD-K74305673,IKK-2-inhibitor-V,IKK inhibitor|NFkB pathway inhibitor,IKBKB
CHNUOJQWGUIOLD,BRD-K98054437,epalrestat,aldose reductase inhibitor,AKR1B1,BRD-K98054437,epalrestat,aldose reductase inhibitor,AKR1B1,BRD-K98054437,epalrestat,aldose reductase inhibitor,AKR1B1,BRD-K98054437,epalrestat,aldose reductase inhibitor,AKR1B1
CHNXZKVNWQUJIB,BRD-A29111201|BRD-K00456604|BRD-K03981224,ethisterone,progestogen hormone,TYR,BRD-A29111201|BRD-K03981224,ethisterone,progestogen hormone,TYR,BRD-A29111201|BRD-K00456604|BRD-K03981224,ethisterone,progestogen hormone,TYR,BRD-K00456604|BRD-K03981224,ethisterone,progestogen hormone,TYR
CHQKHXJPWDSTPY,BRD-K44091134,fluprazine,serotonin receptor agonist,HTR1A|HTR1B,BRD-K44091134,fluprazine,serotonin receptor agonist,HTR1A|HTR1B,BRD-K44091134,fluprazine,serotonin receptor agonist,HTR1A|HTR1B,BRD-K44091134,fluprazine,serotonin receptor agonist,HTR1A|HTR1B
CHZBCZTXSTWCIG,BRD-K61585876|BRD-K76592088,3-carboxy-4-hydroxyphenylglycine-(R)|3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRM1|GRM5,BRD-K61585876|BRD-K76592088,3-carboxy-4-hydroxyphenylglycine-(R)|3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRM1|GRM5,BRD-K61585876|BRD-K76592088,3-carboxy-4-hydroxyphenylglycine-(R)|3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRM1|GRM5,BRD-K61585876|BRD-K76592088,3-carboxy-4-hydroxyphenylglycine-(R)|3-carboxy-4-hydroxyphenylglycine-(S),glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRM1|GRM5
CIBIXJYFYPFMTN,BRD-A70407468,PSB-36,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-A70407468,PSB-36,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-A70407468,PSB-36,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K00004243,PSB-36,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
CIDUJQMULVCIBT,BRD-A59825838|BRD-A79774694,netilmicin,protein synthesis inhibitor,,BRD-A59825838,netilmicin,protein synthesis inhibitor,,BRD-A59825838|BRD-A79774694|BRD-M29626677,netilmicin,protein synthesis inhibitor,,BRD-K00003604,netilmicin,protein synthesis inhibitor,
CIKWKGFPFXJVGW,BRD-K24715592,ethacridine-lactate-monohydrate,DNA intercalating agent,,BRD-K24715592,ethacridine-lactate-monohydrate,DNA intercalating agent,,BRD-K24715592,ethacridine-lactate-monohydrate,DNA intercalating agent,,BRD-K24715592,ethacridine-lactate-monohydrate,DNA intercalating agent,
CITWCLNVRIKQAF,BRD-K97025174,capadenoson,adenosine receptor agonist,ADORA1,BRD-K97025174,capadenoson,adenosine receptor agonist,ADORA1,BRD-K97025174,capadenoson,adenosine receptor agonist,ADORA1,BRD-K97025174,capadenoson,adenosine receptor agonist,ADORA1
CIUUIPMOFZIWIZ,BRD-K17500877,bropirimine,interferon inducer,,BRD-K17500877,bropirimine,interferon inducer,,BRD-K17500877,bropirimine,interferon inducer,,BRD-K17500877,bropirimine,interferon inducer,
CIWBQSYVNNPZIQ,BRD-A66861218|BRD-K95691366,betamethasone-dipropionate,anti-inflammatory agent,,BRD-A66861218|BRD-K58148589,betamethasone-dipropionate,anti-inflammatory agent,,BRD-A66861218|BRD-K58148589|BRD-K95691366,betamethasone-dipropionate,anti-inflammatory agent,,BRD-A66861218|BRD-K58148589|BRD-K95691366,betamethasone-dipropionate,anti-inflammatory agent,NR3C1
CJAVTWRYCDNHSM,BRD-A22305049,benfluorex,gluconeogenesis inhibitor,HMGCR,BRD-A22305049,benfluorex,gluconeogenesis inhibitor,HMGCR,BRD-A22305049,benfluorex,gluconeogenesis inhibitor,HMGCR,BRD-K00003672,benfluorex,gluconeogenesis inhibitor,HMGCR
CJBJHOAVZSMMDJ,BRD-K84986517,darunavir,HIV protease inhibitor,CYP3A4,BRD-K84986517,darunavir,HIV protease inhibitor,CYP3A4,BRD-K84986517|BRD-M22677129,darunavir,HIV protease inhibitor,CYP3A4,BRD-K84986517|BRD-M22677129,darunavir,HIV protease inhibitor,CYP3A4
CJCSPKMFHVPWAR,BRD-K48578705,methyldopa,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,BRD-K48578705,methyldopa,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,BRD-K48578705,methyldopa,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,BRD-K48578705,methyldopa,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC
CJDRUOGAGYHKKD,BRD-A48300215,ajmaline,sodium channel blocker,SCN5A,BRD-A48300215,ajmaline,sodium channel blocker,SCN5A,BRD-A48300215,ajmaline,sodium channel blocker,SCN5A,BRD-K00005347,ajmaline,sodium channel blocker,
CJGYSWNGNKCJSB,BRD-A15931911|BRD-A94624445,bucladesine,adenosine receptor agonist|cAMP stimulant,PRKACA,BRD-A15931911|BRD-A94624445,bucladesine,adenosine receptor agonist|cAMP stimulant,PRKACA,BRD-A15931911|BRD-A94624445,bucladesine,adenosine receptor agonist|cAMP stimulant,PRKACA,BRD-A94624445|BRD-K01825692,bucladesine,adenosine receptor agonist|cAMP stimulant,PRKACA
CJLMANFTWLNAKC,BRD-K58568447,K02288,bone morphogenic protein inhibitor,BMP1,BRD-K58568447,K02288,bone morphogenic protein inhibitor,BMP1,BRD-K58568447,K02288,bone morphogenic protein inhibitor,BMP1,BRD-K58568447,K02288,bone morphogenic protein inhibitor,BMP1
CJOFXWAVKWHTFT,BRD-K53517854,fluvoxamine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,BRD-K53517854,fluvoxamine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,BRD-K53517854,fluvoxamine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,BRD-K53517854,fluvoxamine,selective serotonin reuptake inhibitor (SSRI),SLC6A4
CJXAEXPPLWQRFR,BRD-K04704168,clemizole,HCV inhibitor,,BRD-K04704168,clemizole,HCV inhibitor,,BRD-K04704168,clemizole,HCV inhibitor,,BRD-K04704168,clemizole,HCV inhibitor,
CKHJPWQVLKHBIH,BRD-K12539416,sulbutiamine,acetylcholine receptor antagonist,,BRD-K12539416,sulbutiamine,acetylcholine receptor antagonist,,BRD-K12539416,sulbutiamine,acetylcholine receptor antagonist,,BRD-K12539416,sulbutiamine,acetylcholine receptor antagonist,
CKLGZXFOLMHCMC,BRD-K24187789,VU0238429,acetylcholine receptor allosteric modulator,CHRM5,BRD-K24187789,VU0238429,acetylcholine receptor allosteric modulator,CHRM5,BRD-K24187789,VU0238429,acetylcholine receptor allosteric modulator,CHRM5,BRD-K24187789,VU0238429,acetylcholine receptor allosteric modulator,CHRM5
CKLJMWTZIZZHCS,BRD-K97163964,L-Aspartic-Acid,metallic radical formation stimulant,ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13,BRD-K97163964,L-Aspartic-Acid,metallic radical formation stimulant,ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13,BRD-K97163964,L-Aspartic-Acid,metallic radical formation stimulant,ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13,BRD-K97163964,L-aspartic-acid,metallic radical formation stimulant,ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13
CKNAQFVBEHDJQV,BRD-K86972824,oltipraz,like (NRF2) activator|nuclear factor erythroid derived,ANG,BRD-K86972824,oltipraz,like (NRF2) activator|nuclear factor erythroid derived,ANG,BRD-K86972824,oltipraz,like (NRF2) activator|nuclear factor erythroid derived,ANG,BRD-K86972824,oltipraz,like (NRF2) activator|nuclear factor erythroid derived,ANG
CKSJXOVLXUMMFF,BRD-K12609457,exalamide,membrane permeability inhibitor,,BRD-K12609457,exalamide,membrane permeability inhibitor,,BRD-K12609457,exalamide,membrane permeability inhibitor,,BRD-K12609457,exalamide,membrane permeability inhibitor,
CKTSBUTUHBMZGZ,BRD-K91822704,torcitabine,DNA polymerase inhibitor,DCK|TK2,BRD-K91822704,torcitabine,DNA polymerase inhibitor,DCK|TK2,BRD-K91822704,torcitabine,DNA polymerase inhibitor,DCK|TK2,BRD-K91822704,torcitabine,DNA polymerase inhibitor,DCK|TK2
CLDJCRWXLDLJLO,BRD-A80280426,AD-5467,aldose reductase inhibitor,AKR1B1,BRD-A80280426,AD-5467,aldose reductase inhibitor,AKR1B1,BRD-A80280426,AD-5467,aldose reductase inhibitor,AKR1B1,BRD-A80280426,AD-5467,aldose reductase inhibitor,AKR1B1
CLIGSMOZKDCDRZ,BRD-K41853443,"1,3-dipropyl-8-phenylxanthine",,,BRD-K41853443,"1,3-dipropyl-8-phenylxanthine",adenosine receptor antagonist,,BRD-K41853443,"1,3-dipropyl-8-phenylxanthine",adenosine receptor antagonist,,BRD-K41853443,"1,3-dipropyl-8-phenylxanthine",adenosine receptor antagonist,
CLMQBVUFKIKYLU,BRD-A67036568,RBC8,Ral GTPase inhibitor,RALA|RALB,BRD-A67036568,RBC8,Ral GTPase inhibitor,RALA|RALB,BRD-A67036568,RBC8,Ral GTPase inhibitor,RALA|RALB,,,,
CLPFFLWZZBQMAO,BRD-A25619068,fadrozole,aromatase inhibitor,CYP11B1|CYP19A1,BRD-A25619068,fadrozole,aromatase inhibitor,CYP11B1|CYP19A1,BRD-A25619068,fadrozole,aromatase inhibitor,CYP11B1|CYP19A1,BRD-A25619068,fadrozole,aromatase inhibitor,CYP11B1|CYP19A1
CLRSLRWKONPSRQ,BRD-K79584249,CGM097,MDM inhibitor,MDM2,BRD-K79584249,CGM097,MDM inhibitor,MDM2,BRD-K79584249,CGM097,MDM inhibitor,MDM2,BRD-K79584249,CGM097,MDM inhibitor,MDM2
CMDKPGRTAQVGFQ,BRD-K17828029,cinoxate,,,BRD-K17828029,cinoxate,,,BRD-K17828029,cinoxate,,,BRD-K17828029,cinoxate,,
CMHHMUWAYWTMGS,BRD-K04185004,oxybuprocaine,local anesthetic,SCN10A,BRD-K04185004,oxybuprocaine,local anesthetic,SCN10A,BRD-K04185004,oxybuprocaine,local anesthetic,SCN10A,BRD-K04185004,oxybuprocaine,local anesthetic,SCN10A
CMHQDSBIBSKHFP,BRD-K67680372,CI-966,GAT inhibitor,SLC6A1,BRD-K67680372,CI-966,GAT inhibitor,SLC6A1,BRD-K67680372,CI-966,GAT inhibitor,SLC6A1,BRD-K67680372,CI-966,GAT inhibitor,SLC6A1
CMJCXYNUCSMDBY,BRD-A56085258,LGX818,RAF inhibitor,BRAF,BRD-A56085258,LGX818,RAF inhibitor,BRAF,BRD-A56085258,LGX818,RAF inhibitor,BRAF,BRD-K00003576,encorafenib,RAF inhibitor,BRAF
CMKFQVZJOWHHDV,BRD-K92377961,catharanthine,tubulin polymerization inhibitor,,BRD-K92377961,catharanthine,tubulin polymerization inhibitor,,BRD-K92377961,catharanthine,tubulin polymerization inhibitor,,BRD-K92377961,catharanthine,tubulin polymerization inhibitor,
CMSGWTNRGKRWGS,BRD-K64622987,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K55675242|BRD-K64622987,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K55675242|BRD-K64622987,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K55675242|BRD-K64622987,torcetrapib,cholesteryl ester transfer protein inhibitor,CETP
CMSMOCZEIVJLDB,BRD-A09722536,cyclophosphamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,BRD-A09722536,cyclophosphamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,BRD-A09722536,cyclophosphamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,BRD-A09722536,cyclophosphamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7
CMWTZPSULFXXJA,BRD-K59197931,naproxen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K59197931,naproxen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K59197931,naproxen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K59197931,naproxen,cyclooxygenase inhibitor,PTGS1|PTGS2
CMYCCJYVZIMDFU,BRD-K55192287,Ro-48-8071,oxidosqualene cyclase inhibitor,LSS,BRD-K55192287,Ro-48-8071,oxidosqualene cyclase inhibitor,LSS,BRD-K55192287,Ro-48-8071,oxidosqualene cyclase inhibitor,LSS,BRD-K55192287,Ro-48-8071,oxidosqualene cyclase inhibitor,LSS
CNBGNNVCVSKAQZ,BRD-K28542495,benzydamine,prostanoid receptor antagonist,,BRD-K28542495,benzydamine,prostanoid receptor antagonist,,BRD-K28542495,benzydamine,prostanoid receptor antagonist,,BRD-K28542495,benzydamine,prostanoid receptor antagonist,
CNIIGCLFLJGOGP,BRD-K77641333,naphazoline,adrenergic receptor agonist,ADRA1A|ADRA2A,BRD-K77641333,naphazoline,adrenergic receptor agonist,ADRA1A|ADRA2A,BRD-K77641333,naphazoline,adrenergic receptor agonist,ADRA1A|ADRA2A,BRD-K77641333,naphazoline,adrenergic receptor agonist,ADRA1A|ADRA2A
CNNRPFQICPFDPO,BRD-K03083257,1-octacosanol,,,BRD-K03083257,1-octacosanol,,,BRD-K03083257,1-octacosanol,,,BRD-K03083257,1-octacosanol,,
CNPVJJQCETWNEU,BRD-K84748119,vicriviroc,CC chemokine receptor antagonist,CCR5,BRD-K84748119,vicriviroc,CC chemokine receptor antagonist,CCR5,BRD-K84748119,vicriviroc,CC chemokine receptor antagonist,CCR5,BRD-K84748119,vicriviroc,CC chemokine receptor antagonist,CCR5
CNTMOLDWXSVYKD,BRD-K87512222,taltobulin,tubulin polymerization inhibitor,,BRD-K87512222,taltobulin,tubulin polymerization inhibitor,,BRD-K87512222,taltobulin,tubulin polymerization inhibitor,,BRD-K87512222,taltobulin,tubulin polymerization inhibitor,
CNUPQURTHORUGH,BRD-K91234829,napirimus,immunosuppressant,,BRD-K91234829,napirimus,immunosuppressant,,BRD-K91234829,napirimus,immunosuppressant,,BRD-K91234829,napirimus,immunosuppressant,
COKMIXFXJJXBQG,BRD-K37872686,tirofiban,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,BRD-K37872686,tirofiban,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,BRD-K37872686,tirofiban,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,BRD-K37872686,tirofiban,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3
COLNVLDHVKWLRT,BRD-K00911807,D-Phenylalanine,enkephalinase inhibitor,CCBL1|CRH|HCAR3,BRD-K00911807,D-Phenylalanine,enkephalinase inhibitor,CCBL1|CRH|HCAR3,BRD-K00911807,D-Phenylalanine,enkephalinase inhibitor,CCBL1|CRH|HCAR3,BRD-K00911807,D-phenylalanine,enkephalinase inhibitor,CCBL1|CRH|HCAR3
CORFWQGVBFFZHF,BRD-K56634222,2-iodohippuric-acid,,,BRD-K56634222,2-iodohippuric-acid,,,BRD-K56634222,2-iodohippuric-acid,,,BRD-K56634222,2-iodohippuric-acid,,
COVZYZSDYWQREU,BRD-K23204545,busulfan,DNA inhibitor,,BRD-K23204545,busulfan,DNA inhibitor,,BRD-K23204545,busulfan,DNA inhibitor,,BRD-K23204545,busulfan,DNA inhibitor,
COXVTLYNGOIATD,BRD-K24548560,evans-blue,glutamate receptor negative allosteric modulator,GRIA1|PTPN1,BRD-K24548560,evans-blue,glutamate receptor negative allosteric modulator,GRIA1|PTPN1,BRD-K24548560,evans-blue,glutamate receptor negative allosteric modulator,GRIA1|PTPN1,,,,
CPEUVMUXAHMANV,BRD-K86003836,flubendazole,tubulin polymerization inhibitor,TUBB,BRD-K86003836,flubendazole,tubulin polymerization inhibitor,TUBB,BRD-K86003836|BRD-K99928247,flubendazole,tubulin polymerization inhibitor,TUBB,BRD-K86003836|BRD-K99928247,flubendazole,tubulin polymerization inhibitor,TUBB
CPJSUEIXXCENMM,BRD-K38323065,phenacetin,cyclooxygenase inhibitor,PTGS1,BRD-K38323065,phenacetin,cyclooxygenase inhibitor,PTGS1,BRD-K38323065,phenacetin,cyclooxygenase inhibitor,PTGS1,BRD-K38323065,phenacetin,cyclooxygenase inhibitor,PTGS1
CPRAGQJXBLMUEL,BRD-A41692738,TGX-221,PI3K inhibitor,PIK3CB|PIK3CD,BRD-A41692738,TGX-221,PI3K inhibitor,PIK3CB|PIK3CD,BRD-A41692738,TGX-221,PI3K inhibitor,PIK3CB|PIK3CD,BRD-A41692738,TGX-221,PI3K inhibitor,PIK3CB|PIK3CD
CPTBDICYNRMXFX,BRD-K13032584,procarbazine,monoamine oxidase inhibitor,,BRD-K13032584,procarbazine,monoamine oxidase inhibitor,,BRD-K13032584,procarbazine,monoamine oxidase inhibitor,,BRD-K13032584,procarbazine,monoamine oxidase inhibitor,
CPUHNROBVJNNPW,BRD-K12413266,casanthranol-variant,,,BRD-K12413266,casanthranol-variant,,,BRD-K12413266,casanthranol-variant,,,,,,
CPZBLNMUGSZIPR,BRD-K08924299,palonosetron,serotonin receptor antagonist,HTR3A,BRD-K08924299,palonosetron,serotonin receptor antagonist,HTR3A,BRD-K08924299,palonosetron,serotonin receptor antagonist,HTR3A,BRD-K08924299,palonosetron,serotonin receptor antagonist,HTR3A
CQDDGMICHZFTFU,BRD-M19407551,tropisetron,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,,,,,,,,,,,,
CQERVFFAOOUFEQ,BRD-K21906513,UNC669,L3MBTL antagonist,L3MBTL1,BRD-K21906513,UNC669,L3MBTL antagonist,L3MBTL1,BRD-K21906513,UNC669,L3MBTL antagonist,L3MBTL1,BRD-K21906513,UNC669,L3MBTL antagonist,L3MBTL1
CQOQDQWUFQDJMK,BRD-K42136116|BRD-K44408410,2-methoxyestradiol,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,BRD-K42136116|BRD-K44408410,2-methoxyestradiol,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,BRD-K42136116|BRD-K44408410,2-methoxyestradiol,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,BRD-K42136116|BRD-K44408410,2-methoxyestradiol,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB
CQOVPNPJLQNMDC,BRD-A96051074,carnosine,antiglycating agent,,BRD-A96051074,carnosine,antiglycating agent,,BRD-A96051074,carnosine,antiglycating agent,,BRD-A96051074,carnosine,antiglycating agent,
CQRYARSYNCAZFO,BRD-K08493205,salicyl-alcohol,,,BRD-K08493205,salicyl-alcohol,,,BRD-K08493205,salicyl-alcohol,,,BRD-K08493205,salicyl-alcohol,,
CQTYJLQESPLSOP,BRD-K28121004,N-acetylglycyl-D-glutamic-acid,glutamate receptor agonist,,BRD-K28121004,N-acetylglycyl-D-glutamic-acid,glutamate receptor agonist,,BRD-K28121004,N-acetylglycyl-D-glutamic-acid,glutamate receptor agonist,,BRD-K28121004,N-acetylglycyl-D-glutamic-acid,glutamate receptor agonist,
CQVJTTOZTTVVBK,BRD-K88759641,EMD-66684,angiotensin receptor antagonist,AGTR1,BRD-K88759641,EMD-66684,angiotensin receptor antagonist,AGTR1,BRD-K88759641,EMD-66684,angiotensin receptor antagonist,AGTR1,BRD-K88759641,EMD-66684,angiotensin receptor antagonist,AGTR1
CQXADFVORZEARL,BRD-K01638814,rilmenidine,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,BRD-K01638814,rilmenidine,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,BRD-K01638814|BRD-M62162320,rilmenidine,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,BRD-K01638814|BRD-M62162320,rilmenidine,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A
CRDNMYFJWFXOCH,BRD-K17894950,indirubin,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,BRD-K17894950,indirubin,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,BRD-K17894950,indirubin,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,BRD-K17894950,indirubin,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A
CSDTZUBPSYWZDX,BRD-K03326591,amyl-nitrite,atrial natriuretic peptide receptor agonist,NPR1,BRD-K03326591,amyl-nitrite,atrial natriuretic peptide receptor agonist,NPR1,BRD-K03326591,amyl-nitrite,atrial natriuretic peptide receptor agonist,NPR1,,,,
CSEZCYBVEGIYNG,BRD-M77041484,TBOA-(DL),excitatory amino acid transporter inhibitor,SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7,BRD-M77041484,TBOA-(DL),excitatory amino acid transporter inhibitor,SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7,BRD-M77041484,TBOA-(DL),excitatory amino acid transporter inhibitor,SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7,BRD-M77041484,TBOA-(DL),excitatory amino acid transporter inhibitor,SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7
CSGAUKGQUCHWDP,BRD-K95053546,tempol,free radical scavenger,,BRD-K95053546,tempol,free radical scavenger,,BRD-K95053546|BRD-U44097393,tempol,free radical scavenger,,BRD-K95053546|BRD-U44097393,tempol,free radical scavenger,
CSGQVNMSRKWUSH,BRD-K76239644,BMS-690514,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|FLT3|KDR,BRD-K76239644,BMS-690514,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|FLT3|KDR,BRD-K76239644,BMS-690514,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|FLT3|KDR,BRD-K76239644,BMS-690514,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|FLT3|KDR
CSHZYWUPJWVTMQ,BRD-K61036791,rucinol,tyrosinase inhibitor,TYR,BRD-K61036791,rucinol,tyrosinase inhibitor,TYR,BRD-K61036791,rucinol,tyrosinase inhibitor,TYR,BRD-K61036791,rucinol,tyrosinase inhibitor,TYR
CSKDFZIMJXRJGH,BRD-K24312986,tecovirimat,orthopoxvirus egress inhibitor,,BRD-K24312986,tecovirimat,orthopoxvirus egress inhibitor,,BRD-K24312986,tecovirimat,orthopoxvirus egress inhibitor,,BRD-K24312986,tecovirimat,orthopoxvirus egress inhibitor,
CSMVOZKEWSOFER,BRD-K48141473,cebranopadol,opioid receptor agonist,OPRL1|OPRM1,BRD-K48141473,cebranopadol,opioid receptor agonist,OPRL1|OPRM1,BRD-K48141473,cebranopadol,opioid receptor agonist,OPRL1|OPRM1,BRD-K48141473,cebranopadol,opioid receptor agonist,OPRL1|OPRM1
CSUNLSYSEQIDMO,BRD-A73566563,tiprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A73566563,tiprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A73566563,tiprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A73566563,tiprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
CTESJDQKVOEUOY,BRD-K41918892,A-769662,AMPK activator,,BRD-K41918892,A-769662,AMPK activator,,BRD-K41918892,A-769662,AMPK activator,,BRD-K41918892,A-769662,AMPK activator,
CTETYYAZBPJBHE,BRD-K13238168,haloprogin,other antifungal,,BRD-K13238168,haloprogin,other antifungal,,BRD-K13238168,haloprogin,other antifungal,,BRD-K13238168,haloprogin,other antifungal,
CTMCWCONSULRHO,BRD-K51911221,nemorubicin,topoisomerase inhibitor,TOP1|TOP2A,BRD-K51911221,nemorubicin,topoisomerase inhibitor,TOP1|TOP2A,BRD-K51911221,nemorubicin,topoisomerase inhibitor,TOP1|TOP2A,BRD-K51911221,nemorubicin,topoisomerase inhibitor,TOP1|TOP2A
CTNPALGJUAXMMC,BRD-K75911534,SU014813,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K75911534,SU014813,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K75911534,SU014813,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K00003547,SU014813,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR
CTQMJYWDVABFRZ,BRD-K46982791,cloxyquin,potassium channel activator,KCNK18,BRD-K46982791,cloxyquin,potassium channel activator,KCNK18,BRD-K46982791,cloxyquin,potassium channel activator,KCNK18,BRD-K46982791,cloxyquin,potassium channel activator,KCNK18
CTRLABGOLIVAIY,BRD-K04196797,oxcarbazepine,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K04196797,oxcarbazepine,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K04196797,oxcarbazepine,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K04196797,oxcarbazepine,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
CUCSSYAUKKIDJV,BRD-K25863791,antagonist-g,neuropeptide receptor antagonist,MAPK8,BRD-K25863791,antagonist-g,neuropeptide receptor antagonist,MAPK8,BRD-K25863791,antagonist-g,neuropeptide receptor antagonist,MAPK8,BRD-K25863791,antagonist-g,neuropeptide receptor antagonist,MAPK8
CUCUKLJLRRAKFN,BRD-A12417644,usniacin-(+),MAP kinase activator,PTPN1,BRD-A12417644,usniacin-(+),MAP kinase activator,PTPN1,BRD-A12417644|BRD-A99182808,usniacin-(+),MAP kinase activator,PTPN1,,,,
CUDVHEFYRIWYQD,BRD-K31309378,lucitanib,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K31309378,lucitanib,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K31309378,lucitanib,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K31309378,lucitanib,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET
CUHVIMMYOGQXCV,BRD-A21607826|BRD-K18423410,medetomidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-A21607826|BRD-K18423410,medetomidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-A21607826|BRD-K18423410,dexmedetomidine|medetomidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-A66563878|BRD-K18423410,dexmedetomidine|medetomidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
CUIHSIWYWATEQL,BRD-K74514084,pazopanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,BRD-K74514084,pazopanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,BRD-K74514084,pazopanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,BRD-K74514084,pazopanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3
CULUWZNBISUWAS,BRD-K56156805,benznidazole,DNA synthesis inhibitor,,BRD-K56156805,benznidazole,DNA synthesis inhibitor,,BRD-K56156805,benznidazole,DNA synthesis inhibitor,,BRD-K56156805,benznidazole,DNA synthesis inhibitor,
CUQCMXFWIMOWRP,BRD-K31491153,1-phenylbiguanide,serotonin receptor agonist,HTR3A|HTR3B,BRD-K31491153,1-phenylbiguanide,serotonin receptor agonist,HTR3A|HTR3B,BRD-K31491153,1-phenylbiguanide,serotonin receptor agonist,HTR3A|HTR3B,BRD-K31491153,1-phenylbiguanide,serotonin receptor agonist,HTR3A|HTR3B
CURUTKGFNZGFSE,BRD-K68507560,dicycloverine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K68507560,dicycloverine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K68507560,dicycloverine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K68507560,dicycloverine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3
CUVGUPIVTLGRGI,BRD-A60832661|BRD-K66094457,CPP,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A60832661|BRD-K66094457,CPP,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A60832661|BRD-K66094457,CPP,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K66094457,CPP,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
CUYLJVJMQPPTOS,BRD-K76139886,compound-58112,,,BRD-K76139886,compound-58112,,,BRD-K76139886,compound-58112,,,BRD-K76139886,compound-58112,,
CVBMAZKKCSYWQR,BRD-K29462201,deserpidine,angiotensin converting enzyme inhibitor,ACE|SLC18A2,BRD-K29462201,deserpidine,angiotensin converting enzyme inhibitor,ACE|SLC18A2,BRD-K29462201,deserpidine,angiotensin converting enzyme inhibitor,ACE|SLC18A2,BRD-K29462201,deserpidine,angiotensin converting enzyme inhibitor,ACE|SLC18A2
CVHGCWVMTZWGAY,BRD-K44942188,fomocaine,voltage-gated sodium channel modulator,,BRD-K44942188,fomocaine,voltage-gated sodium channel modulator,,BRD-K44942188,fomocaine,voltage-gated sodium channel modulator,,BRD-K44942188,fomocaine,voltage-gated sodium channel modulator,
CVHZOJJKTDOEJC,BRD-K46493214,saccharin,DNA polymerase inhibitor,CA1|CA12|CA2|CA9,BRD-K46493214,saccharin,DNA polymerase inhibitor,CA1|CA12|CA2|CA9,BRD-K46493214,saccharin,DNA polymerase inhibitor,CA1|CA12|CA2|CA9,BRD-K46493214,saccharin,DNA polymerase inhibitor,CA1|CA12|CA2|CA9
CVNFYQCHAWFYQI,BRD-M63173034,clonixin-lysinate,cyclooxygenase inhibitor,,BRD-M63173034,clonixin-lysinate,cyclooxygenase inhibitor,,BRD-M63173034,clonixin-lysinate,cyclooxygenase inhibitor,,BRD-M63173034,clonixin-lysinate,cyclooxygenase inhibitor,
CVSVTCORWBXHQV,BRD-K19615002,creatine,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8,BRD-K19615002,creatine,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8,BRD-K19615002,creatine,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8,BRD-K19615002,creatine,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8
CVWXJKQAOSCOAB,BRD-K93918653,quizartinib,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,BRD-K93918653,quizartinib,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,BRD-K93918653,quizartinib,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,BRD-K93918653,quizartinib,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET
CVXBEEMKQHEXEN,BRD-K54208592,carbaril,acetylcholinesterase inhibitor,,BRD-K54208592,carbaril,acetylcholinesterase inhibitor,,BRD-K54208592,carbaril,acetylcholinesterase inhibitor,,BRD-K54208592,carbaril,acetylcholinesterase inhibitor,
CWBZAESOUBENAP,BRD-K13511380,naringin-dihydrochalcone,cytochrome P450 inhibitor,,BRD-K13511380,naringin-dihydrochalcone,cytochrome P450 inhibitor,,BRD-K13511380,naringin-dihydrochalcone,cytochrome P450 inhibitor,,BRD-K72522627,naringin-dihydrochalcone,cytochrome P450 inhibitor,
CWHUFRVAEUJCEF,BRD-K42191735,buparlisib,PI3K inhibitor,PIK3CA|PIK3CG,BRD-K42191735,buparlisib,PI3K inhibitor,PIK3CA|PIK3CG,BRD-K42191735,buparlisib,PI3K inhibitor,PIK3CA|PIK3CG,BRD-K42191735,buparlisib,PI3K inhibitor,PIK3CA|PIK3CG
CWJNMKKMGIAGDK,BRD-K70924353,amtolmetin-guacil,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K70924353,amtolmetin-guacil,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K70924353,amtolmetin-guacil,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K70924353,amtolmetin-guacil,cyclooxygenase inhibitor,PTGS1|PTGS2
CWJSHJJYOPWUGX,BRD-K59590127,chlorpropham,antiviral,,BRD-K59590127,chlorpropham,antiviral,,BRD-K59590127,chlorpropham,antiviral,,BRD-K59590127,chlorpropham,antiviral,
CWRVKFFCRWGWCS,BRD-K57718010,pentylenetetrazol,GABA receptor antagonist,,BRD-K57718010,pentylenetetrazol,GABA receptor antagonist,,BRD-K57718010,pentylenetetrazol,GABA receptor antagonist,,BRD-K57718010,pentylenetetrazol,GABA receptor antagonist,
CWVRJTMFETXNAD,BRD-K46579573|BRD-K47114202,chlorogenic-acid,antioxidant,SLC37A4,BRD-K46579573|BRD-K47114202,chlorogenic-acid,antioxidant,SLC37A4,BRD-K46579573|BRD-K47114202,chlorogenic-acid,antioxidant,SLC37A4,BRD-K46579573|BRD-K47114202,chlorogenic-acid,antioxidant,SLC37A4
CWXYHOHYCJXYFQ,BRD-K82142815,betamipron,panipenem uptake inhibitor,,BRD-K82142815,betamipron,panipenem uptake inhibitor,,BRD-K82142815,betamipron,panipenem uptake inhibitor,,BRD-K82142815,betamipron,panipenem uptake inhibitor,
CXFKOLCMCRBYPL,BRD-K57365211,mangafodipir,contrast agent,,BRD-K57365211,mangafodipir,contrast agent,,BRD-A81339141|BRD-K57365211,mangafodipir,contrast agent,,BRD-A81339141|BRD-K57365211,mangafodipir,contrast agent,
CXGTZJYQWSUFET,BRD-K15507868,tesaglitazar,PPAR receptor agonist|insulin sensitizer,PPARA|PPARG,BRD-K15507868,tesaglitazar,PPAR receptor agonist|insulin sensitizer,PPARA|PPARG,BRD-K15507868,tesaglitazar,PPAR receptor agonist|insulin sensitizer,PPARA|PPARG,BRD-K15507868,tesaglitazar,PPAR receptor agonist|insulin sensitizer,PPARA|PPARG
CXJCGSPAPOTTSF,BRD-K01673854,KH-CB19,CDC inhibitor,CLK1|CLK3|DYRK1A,BRD-K01673854,KH-CB19,CDC inhibitor,CLK1|CLK3|DYRK1A,BRD-K01673854,KH-CB19,CDC inhibitor,CLK1|CLK3|DYRK1A,,,,
CXMXRPHRNRROMY,BRD-K66672047,disodium sebacate,,HBA1|HBB,BRD-K66672047,disodium sebacate,,HBA1|HBB,BRD-K66672047,disodium sebacate,,HBA1|HBB,BRD-K66672047,disodium-sebacate,,HBB
CXOFVDLJLONNDW,BRD-K55930204,phenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K55930204,phenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K55930204,phenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K55930204,phenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
CXOXHMZGEKVPMT,BRD-K52408781,clobazam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K52408781,clobazam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K52408781,clobazam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,,,,
CXQHYVUVSFXTMY,BRD-K03449891,foretinib,VEGFR inhibitor,FLT1|FLT4|KDR|MET,BRD-K03449891,foretinib,VEGFR inhibitor,FLT1|FLT4|KDR|MET,BRD-K03449891,foretinib,VEGFR inhibitor,FLT1|FLT4|KDR|MET,BRD-K03449891,foretinib,VEGFR inhibitor,FLT1|FLT4|KDR|MET
CXQWRCVTCMQVQX,BRD-K94649603,taxifolin,opioid receptor antagonist,ADIPOR2,BRD-K94649603,taxifolin,opioid receptor antagonist,ADIPOR2,BRD-K94649603,taxifolin,opioid receptor antagonist,ADIPOR2,BRD-K94649603,taxifolin,opioid receptor antagonist,ADIPOR2
CXQXSVUQTKDNFP,BRD-K73201113,octamethyltrisiloxane,,,BRD-K73201113,octamethyltrisiloxane,,,BRD-K73201113,octamethyltrisiloxane,,,BRD-K73201113,octamethyltrisiloxane,,
CXSJGNHRBWJXEA,BRD-K80076813,diftalone,cyclooxygenase inhibitor,,BRD-K80076813,diftalone,cyclooxygenase inhibitor,,BRD-K80076813,diftalone,cyclooxygenase inhibitor,,BRD-K80076813,diftalone,cyclooxygenase inhibitor,
CXUCKELNYMZTRT,BRD-K70586315,1-EBIO,potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,BRD-K70586315,1-EBIO,potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,BRD-K70586315,1-EBIO,potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,BRD-K70586315,1-EBIO,potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4
CXVGEDCSTKKODG,BRD-K38602774,sulisobenzone,,,BRD-K38602774,sulisobenzone,,,BRD-K38602774|BRD-K59265707,sulisobenzone,,,BRD-K38602774|BRD-K59265707,sulisobenzone,,
CYFLXLSBHQBMFT,BRD-K19742012,sulfamoxole,PABA antagonist,,BRD-K19742012,sulfamoxole,PABA antagonist,,BRD-K19742012,sulfamoxole,PABA antagonist,,BRD-K19742012,sulfamoxole,PABA antagonist,
CYHWMBVXXDIZNZ,BRD-K89413285,remimazolam,benzodiazepine receptor agonist,GABBR1,BRD-K89413285,remimazolam,benzodiazepine receptor agonist,GABBR1,BRD-K89413285,remimazolam,benzodiazepine receptor agonist,GABBR1,BRD-K89413285,remimazolam,benzodiazepine receptor agonist,GABBR1
CYJPUZLKFAUFHF,BRD-A14985772|BRD-A45419686,L-Ascorbyl-6-palmitate,,,BRD-A14985772|BRD-A45419686,L-Ascorbyl-6-palmitate,,,BRD-A14985772|BRD-A45419686,L-Ascorbyl-6-palmitate,,,BRD-A14985772|BRD-A45419686,L-ascorbyl-6-palmitate,,
CYJQCYXRNNCURD,BRD-A85069489|BRD-K33839500,stobadine,adrenergic receptor antagonist,ADRA1A,BRD-A85069489|BRD-K33839500,stobadine,adrenergic receptor antagonist,ADRA1A,BRD-A85069489|BRD-K33839500,stobadine,adrenergic receptor antagonist,ADRA1A,BRD-K33839500,stobadine,adrenergic receptor antagonist,ADRA1A
CYLWJCABXYDINA,BRD-A15739803,polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3,BRD-A15739803,polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3,BRD-A15739803,polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3,BRD-A15739803,polythiazide,sodium/chloride cotransporter inhibitor,SLC12A3
CYOHGALHFOKKQC,BRD-K57080016,selumetinib,MEK inhibitor,MAP2K1,BRD-K57080016,selumetinib,MEK inhibitor,MAP2K1,BRD-K57080016,selumetinib,MEK inhibitor,MAP2K1,BRD-K57080016,selumetinib,MEK inhibitor,MAP2K1
CYXKNKQEMFBLER,BRD-A19633847,perhexiline,carnitine palmitoyltransferase inhibitor,CPT1A|CPT2,BRD-A19633847,perhexiline,carnitine palmitoyltransferase inhibitor,CPT1A|CPT2,BRD-A19633847,perhexiline,carnitine palmitoyltransferase inhibitor,CPT1A|CPT2,BRD-A19633847,perhexiline,carnitine palmitoyltransferase inhibitor,CPT1A
CZEVQIRNFRBGNT,BRD-M42331949,LCZ696,angiotensin receptor antagonist,,,,,,,,,,,,,
CZFFBEXEKNGXKS,BRD-K05658747,raltegravir,HIV integrase inhibitor,,BRD-K05658747,raltegravir,HIV integrase inhibitor,,BRD-K05658747,raltegravir,HIV integrase inhibitor,,BRD-K05658747,raltegravir,HIV integrase inhibitor,
CZGLBWZXGIAIBU,BRD-A62890442,3-methyl-GABA,GABA aminotransferase activator,ABAT,BRD-A62890442,3-methyl-GABA,GABA aminotransferase activator,ABAT,BRD-A62890442|BRD-M64651705,3-methyl-GABA,GABA aminotransferase activator,ABAT,BRD-K01825682|BRD-M64651705,3-methyl-GABA,GABA aminotransferase activator,ABAT
CZGUSIXMZVURDU,BRD-K45503887,delivert,angiotensin receptor agonist,AGTR1|AGTR2,BRD-K45503887,delivert,angiotensin receptor agonist,AGTR1|AGTR2,BRD-K45503887,delivert,angiotensin receptor agonist,AGTR1|AGTR2,BRD-K45503887,delivert,angiotensin receptor agonist,AGTR1|AGTR2
CZGVOBIGEBDYTP,BRD-K05858796,GSK2330672,bile acid transporter inhibitor,SLC10A2,BRD-K05858796,GSK2330672,bile acid transporter inhibitor,SLC10A2,BRD-K05858796,GSK2330672,bile acid transporter inhibitor,SLC10A2,BRD-K05858796,GSK2330672,bile acid transporter inhibitor,SLC10A2
CZKPOZZJODAYPZ,BRD-A90547603,eptifibatide,platelet aggregation inhibitor,ITGA2B|ITGB3,BRD-A90547603,eptifibatide,platelet aggregation inhibitor,ITGA2B|ITGB3,BRD-A90547603,eptifibatide,platelet aggregation inhibitor,ITGA2B|ITGB3,BRD-K68830460,eptifibatide,platelet aggregation inhibitor,ITGA2B|ITGB3
CZMRCDWAGMRECN,BRD-K74724920,sucrose,,ACTA1|ATOX1|C22orf28|LYZ,BRD-K74724920,sucrose,,ACTA1|ATOX1|C22orf28|LYZ,BRD-K74724920,sucrose,,ACTA1|ATOX1|C22orf28|LYZ,BRD-K74724920,sucrose,,ACTA1|ATOX1|C22orf28|LYZ
CZQHHVNHHHRRDU,BRD-K27305650,LY294002,DNA dependent protein kinase inhibitor|PI3K inhibitor|PLK inhibitor|mTOR inhibitor|phosphodiesterase inhibitor,AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1,BRD-K27305650,LY294002,DNA dependent protein kinase inhibitor|PI3K inhibitor|PLK inhibitor|mTOR inhibitor|phosphodiesterase inhibitor,AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1,BRD-K27305650,LY294002,DNA dependent protein kinase inhibitor|PI3K inhibitor|PLK inhibitor|mTOR inhibitor|phosphodiesterase inhibitor,AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1,BRD-K27305650,LY294002,DNA dependent protein kinase inhibitor|PI3K inhibitor|PLK inhibitor|mTOR inhibitor|phosphodiesterase inhibitor,AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIM1|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1
CZRCFAOMWRAFIC,BRD-K71164191,KD-023,ACAT inhibitor,ACACA|ACACB,BRD-K71164191,KD-023,ACAT inhibitor,ACACA|ACACB,BRD-K71164191,KD-023,ACAT inhibitor,ACACA|ACACB,BRD-K71164191,KD-023,ACAT inhibitor,ACACA|ACACB
CZWCKYRVOZZJNM,BRD-K15360631,dehydroepiandrosterone-sulfate,androgen receptor agonist|estrogen receptor agonist,AR|ESR1|ESR2,BRD-K15360631,dehydroepiandrosterone-sulfate,androgen receptor agonist|estrogen receptor agonist,AR|ESR1|ESR2,BRD-K15360631,dehydroepiandrosterone-sulfate,androgen receptor agonist|estrogen receptor agonist,AR|ESR1|ESR2,BRD-K15360631,dehydroepiandrosterone-sulfate,androgen receptor agonist|estrogen receptor agonist,AR|ESR1|ESR2
CZXUQBVMAUWSBX,BRD-K31329721,centazolone,monoamine oxidase inhibitor,,BRD-K31329721,centazolone,monoamine oxidase inhibitor,,BRD-K31329721,centazolone,monoamine oxidase inhibitor,,BRD-K31329721,centazolone,monoamine oxidase inhibitor,
CZZCAOGIEGXMBZ,BRD-K76259716,CHR-6494,serine/threonine kinase inhibitor,GSG2,BRD-K76259716,CHR-6494,serine/threonine kinase inhibitor,GSG2,BRD-K76259716,CHR-6494,serine/threonine kinase inhibitor,GSG2,BRD-K76259716,CHR-6494,serine/threonine kinase inhibitor,GSG2
DACOQFZGGLCXMA,BRD-K64834129,eterobarb,anticonvulsant,,BRD-K64834129,eterobarb,anticonvulsant,,BRD-K64834129,eterobarb,anticonvulsant,,BRD-K64834129,eterobarb,anticonvulsant,
DAFOCGYVTAOKAJ,BRD-A66920069,fenigam,benzodiazepine receptor agonist,GABBR1|GABBR2,BRD-A66920069,fenigam,benzodiazepine receptor agonist,GABBR1|GABBR2,BRD-A66920069,fenigam,benzodiazepine receptor agonist,GABBR1|GABBR2,BRD-A66920069,fenigam,benzodiazepine receptor agonist,GABBR1|GABBR2
DAKWPKUUDNSNPN,BRD-K24483849,trimethylolpropane-triacrylate,,,BRD-K24483849,trimethylolpropane-triacrylate,,,BRD-K24483849,trimethylolpropane-triacrylate,,,BRD-K24483849,trimethylolpropane-triacrylate,,
DALCQQSLNPLQFZ,BRD-K84925803,T-5224,AP inhibitor,JUN,BRD-K84925803,T-5224,AP inhibitor,JUN,BRD-K84925803,T-5224,AP inhibitor,JUN,BRD-K84925803,T-5224,AP inhibitor,JUN
DALKLAYLIPSCQL,BRD-K24452555,methylprednisolone-aceponate,anti-inflammatory agent|glucocorticoid receptor agonist,NR3C1,BRD-K24452555,methylprednisolone-aceponate,anti-inflammatory agent|glucocorticoid receptor agonist,NR3C1,BRD-K24452555,methylprednisolone-aceponate,anti-inflammatory agent|glucocorticoid receptor agonist,NR3C1,BRD-K24452555,methylprednisolone-aceponate,anti-inflammatory agent|glucocorticoid receptor agonist,NR3C1
DASHZBBQOARCMQ,BRD-K92577649,GBR-13069,dopamine uptake inhibitor,SLC6A3,BRD-K92577649,GBR-13069,dopamine uptake inhibitor,SLC6A3,BRD-K92577649,GBR-13069,dopamine uptake inhibitor,SLC6A3,BRD-K92577649,GBR-13069,dopamine reuptake inhibitor,SLC6A3
DASYMCLQENWCJG,BRD-K21372554,cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-K21372554,cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-K21372554,cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-K21372554,cefetamet-pivoxil,bacterial cell wall synthesis inhibitor,
DATAGRPVKZEWHA,BRD-A08715367,L-Theanine,glutamate receptor antagonist,,BRD-A08715367,L-Theanine,glutamate receptor antagonist,,BRD-A08715367,L-Theanine,glutamate receptor antagonist,,BRD-K04843140,L-theanine,glutamate receptor antagonist,
DBABZHXKTCFAPX,BRD-K95237249,probenecid,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,BRD-K95237249,probenecid,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,BRD-K95237249,probenecid,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,BRD-K95237249,probenecid,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1
DBEPLOCGEIEOCV,BRD-A83081521|BRD-K37882277,finasteride,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,BRD-A83081521|BRD-K37882277,finasteride,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,BRD-A83081521|BRD-K01095011|BRD-K37882277,finasteride,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,BRD-A83081521|BRD-K01095011|BRD-K37882277,finasteride,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2
DBGIVFWFUFKIQN,BRD-K58626373,dexfenfluramine,serotonin receptor agonist,HTR2C|SLC6A4,BRD-K58626373,dexfenfluramine,serotonin receptor agonist,HTR2C|SLC6A4,BRD-K58626373,dexfenfluramine,serotonin receptor agonist,HTR2C|SLC6A4,,,,
DBPWSSGDRRHUNT,BRD-A39791822,hydroxyprogesterone,progesterone receptor agonist,PGR,BRD-A39791822,hydroxyprogesterone,progesterone receptor agonist,PGR,BRD-A39791822,hydroxyprogesterone,progesterone receptor agonist,PGR,BRD-K44932450,hydroxyprogesterone,progesterone receptor agonist,PGR
DBVFKLAGQHYVGQ,BRD-K33814251|BRD-K58693165,lubiprostone,chloride channel activator,CLCN2,BRD-K33814251,lubiprostone,chloride channel activator,CLCN2,BRD-K33814251|BRD-K58693165,lubiprostone,chloride channel activator,CLCN2,BRD-K33814251|BRD-K58693165,lubiprostone,chloride channel activator,CLCN2
DBVJJBKOTRCVKF,BRD-K37949327,etidronic-acid,bone resorption inhibitor,ATP6V1A|PTPRS,BRD-K37949327,etidronic-acid,bone resorption inhibitor,ATP6V1A|PTPRS,BRD-K37949327,etidronic-acid,bone resorption inhibitor,ATP6V1A|PTPRS,BRD-K37949327,etidronic-acid,bone resorption inhibitor,ATP6V1A|PTPRS
DBXFAPJCZABTDR,BRD-K68904758|BRD-K99571587,cephalomannine,DNA polymerase inhibitor,,BRD-A70157906|BRD-K68904758|BRD-K99571587,cephalomannine,DNA polymerase inhibitor,,BRD-A70157906|BRD-K68904758|BRD-K99571587,cephalomannine,DNA polymerase inhibitor,,BRD-A70157906|BRD-K68904758|BRD-K99571587,cephalomannine,DNA polymerase inhibitor,
DBZQFUNLCALWDY,BRD-A79431551,3-deazaadenosine,adenosylhomocysteinase inhibitor,AHCY,BRD-A79431551,3-deazaadenosine,adenosylhomocysteinase inhibitor,AHCY,BRD-A79431551,3-deazaadenosine,adenosylhomocysteinase inhibitor,AHCY,BRD-A79431551,3-deazaadenosine,adenosylhomocysteinase inhibitor,AHCY
DCCSDBARQIPTGU,BRD-K46731503,fesoterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K46731503,fesoterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K46731503,fesoterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K46731503,fesoterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
DCOPUUMXTXDBNB,BRD-K08252256,diclofenac,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,BRD-K08252256,diclofenac,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,BRD-K08252256,diclofenac,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,BRD-K08252256,diclofenac,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A
DCRGHMJXEBSRQG,BRD-K69837166,trap-101,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,OPRL1,BRD-K69837166,trap-101,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,OPRL1,BRD-K69837166,trap-101,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,OPRL1,BRD-K69837166,trap-101,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,OPRL1
DCRZYADKQRHHSF,BRD-K01080633,DAA-1106,benzodiazepine receptor agonist,TSPO,BRD-K01080633,DAA-1106,benzodiazepine receptor agonist,TSPO,BRD-K01080633,DAA-1106,benzodiazepine receptor agonist,TSPO,BRD-K01080633,DAA-1106,benzodiazepine receptor agonist,TSPO
DCSUBABJRXZOMT,BRD-A12896037|BRD-K06895174,cisapride,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,BRD-A12896037|BRD-K06895174,cisapride,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,BRD-A12896037|BRD-K06895174,cisapride,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,BRD-K06895174,cisapride,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2
DCXYFEDJOCDNAF,BRD-K06665116,L-asparagine,,ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3,BRD-K06665116,L-asparagine,,ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3,BRD-K06665116,L-asparagine,,ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3,BRD-K06665116,L-asparagine,,ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3
DCYOADKBABEMIQ,BRD-K29834313,myricitrin,PKC inhibitor,NOS1|PRKCA,BRD-K29834313,myricitrin,PKC inhibitor,NOS1|PRKCA,BRD-K29834313,myricitrin,PKC inhibitor,NOS1|PRKCA,BRD-K48388905,myricitrin,PKC inhibitor,NOS1|PRKCA
DDFOUSQFMYRUQK,BRD-A17009129,isavuconazole,cytochrome P450 inhibitor,CYP3A4,BRD-A17009129,isavuconazole,cytochrome P450 inhibitor,CYP3A4,BRD-A17009129,isavuconazole,cytochrome P450 inhibitor,CYP3A4,BRD-A17009129,isavuconazole,cytochrome P450 inhibitor,CYP3A4
DDHUTBKXLWCZCO,BRD-A70998768,pinaverium,T-type calcium channel blocker,CACNA1C,BRD-A70998768,pinaverium,T-type calcium channel blocker,CACNA1C,BRD-A70998768,pinaverium,T-type calcium channel blocker,CACNA1C,BRD-A13175897,pinaverium,T-type calcium channel blocker,CACNA1C
DDLZLOKCJHBUHD,BRD-K04923131,GSK-3-inhibitor-IX,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,GSK3A|GSK3B,BRD-K04923131,GSK-3-inhibitor-IX,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,GSK3A|GSK3B,BRD-K04923131,GSK-3-inhibitor-IX,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,GSK3A|GSK3B,BRD-K04923131,GSK-3-inhibitor-IX,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,GSK3A|GSK3B
DDNCQMVWWZOMLN,BRD-K25429851|BRD-K53318339,vinpocetine,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,BRD-K25429851|BRD-K53318339,vinpocetine,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,BRD-K25429851|BRD-K53318339,vinpocetine,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,BRD-K25429851|BRD-K53318339,vinpocetine,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C
DDRJAANPRJIHGJ,BRD-K13495773,creatinine,,,BRD-K13495773,creatinine,,,BRD-K13495773,creatinine,,,BRD-K13495773,creatinine,,
DDSFKIFGAPZBSR,BRD-K46585355,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,,BRD-K46585355,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,,BRD-K46585355,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,,BRD-K46585355,acetylsalicylsalicylic-acid,cyclooxygenase inhibitor,
DDTPGANIPBKTNU,BRD-K64857848,ERK5-IN-1,MAP kinase inhibitor,MAPK7,BRD-K64857848,ERK5-IN-1,MAP kinase inhibitor,MAPK7,BRD-K64857848,ERK5-IN-1,MAP kinase inhibitor,MAPK7,BRD-K64857848,ERK5-IN-1,MAP kinase inhibitor,MAPK7
DDUHZTYCFQRHIY,BRD-K08273968|BRD-K12423485,griseofulvin,tubulin polymerization inhibitor,KRT12,BRD-K08273968|BRD-K12423485,griseofulvin,tubulin polymerization inhibitor,KRT12,BRD-K08273968|BRD-K12423485,griseofulvin,tubulin polymerization inhibitor,KRT12,BRD-K08273968|BRD-K12423485,griseofulvin,tubulin polymerization inhibitor,KRT12
DECIPOUIJURFOJ,BRD-K56792340,ethoxyquin,antioxidant,,BRD-K56792340,ethoxyquin,antioxidant,,BRD-K56792340,ethoxyquin,antioxidant,,BRD-K56792340,ethoxyquin,antioxidant,
DEEOXSOLTLIWMG,BRD-K43621685,CP-673451,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB,BRD-K43621685,CP-673451,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB,BRD-K43621685,CP-673451,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB,BRD-K43621685,CP-673451,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB
DEFBCZWQLILOJF,BRD-A80213327,NSC-23766,Ras GTPase inhibitor,,BRD-A80213327,NSC-23766,Ras GTPase inhibitor,,BRD-A80213327,NSC-23766,Ras GTPase inhibitor,,BRD-K01826800,NSC-23766,Ras GTPase inhibitor,
DENMGZODXQRYAR,BRD-K81645907,captamine,,,BRD-K81645907,captamine,,,BRD-K81645907,captamine,,,BRD-K81645907,captamine,,
DEQANNDTNATYII,BRD-A64173453,octreotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,BRD-A64173453,octreotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,BRD-A64173453,octreotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,BRD-A64173453,octreotide,somatostatin receptor agonist,SSTR2|SSTR3|SSTR5
DEQITUUQPICUMR,BRD-K97440753,dihydroergocristine,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,BRD-K97440753,dihydroergocristine,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,BRD-K97440753,dihydroergocristine,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,BRD-K97440753,dihydroergocristine,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7
DEQLGSOHGTZKFB,BRD-K20738689,dazmegrel,thromboxane synthase inhibitor,TBXAS1,BRD-K20738689,dazmegrel,thromboxane synthase inhibitor,TBXAS1,BRD-K20738689,dazmegrel,thromboxane synthase inhibitor,TBXAS1,BRD-K20738689,dazmegrel,thromboxane synthase inhibitor,TBXAS1
DEQZTKGFXNUBJL,BRD-K64191834,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,,BRD-K64191834,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,,BRD-K64191834,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",,,BRD-K64191834,N-cyclohexyl-2-benzothiazolesulfenamide,,
DERZBLKQOCDDDZ,BRD-K07220430,cinnarazine,calcium channel blocker,,BRD-K07220430,cinnarazine,calcium channel blocker,,BRD-K07220430|BRD-K32256916,cinnarazine,calcium channel blocker,,BRD-K07220430|BRD-K32256916,cinnarazine,calcium channel blocker,
DEVSOMFAQLZNKR,BRD-K21361524,selinexor,exportin antagonist,XPO1,BRD-K21361524,selinexor,exportin antagonist,XPO1,BRD-K21361524,selinexor,exportin antagonist,XPO1,BRD-K21361524,selinexor,exportin antagonist,XPO1
DEZZLWQELQORIU,BRD-K14399170|BRD-K67578145,GDC-0879,RAF inhibitor,BRAF,BRD-K14399170|BRD-K67578145,GDC-0879,RAF inhibitor,BRAF,BRD-K14399170|BRD-K67578145,GDC-0879,RAF inhibitor,BRAF,BRD-K14399170|BRD-K67578145,GDC-0879,RAF inhibitor,BRAF
DFBDRVGWBHBJNR,BRD-K73235735,AZD9496,estrogen receptor agonist,ESR1,BRD-K73235735,AZD9496,estrogen receptor agonist,ESR1,BRD-K73235735,AZD9496,estrogen receptor agonist,ESR1,BRD-K73235735,AZD9496,estrogen receptor agonist,ESR1
DFBIRQPKNDILPW,BRD-K81258678,triptolide,RNA polymerase inhibitor,RELA,BRD-K39484304|BRD-K81258678,triptolide,RNA polymerase inhibitor,RELA,BRD-K39484304|BRD-K81258678,triptolide,RNA polymerase inhibitor,RELA,BRD-K39484304|BRD-K81258678,triptolide,RNA polymerase inhibitor,RELA
DFDGRKNOFOJBAJ,BRD-A29520968,acifran,cholesterol inhibitor,HCAR2|HCAR3,BRD-A29520968,acifran,cholesterol inhibitor,HCAR2|HCAR3,BRD-A29520968,acifran,cholesterol inhibitor,HCAR2|HCAR3,BRD-A29520968,acifran,cholesterol inhibitor,HCAR2|HCAR3
DFEYYRMXOJXZRJ,BRD-K05638300,sevoflurane,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1,BRD-K05638300,sevoflurane,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1,BRD-K05638300,sevoflurane,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1,BRD-K05638300,sevoflurane,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1
DFHBBMJTBBLQSA,BRD-K26556907,benzofenac,,,BRD-K26556907,benzofenac,,,BRD-K26556907,benzofenac,,,BRD-K26556907,benzofenac,,
DFJSJLGUIXFDJP,BRD-K98572433,AZD8931,EGFR inhibitor,EGFR|ERBB2|ERBB3,BRD-K98572433,AZD8931,EGFR inhibitor,EGFR|ERBB2|ERBB3,BRD-K98572433,AZD8931,EGFR inhibitor,EGFR|ERBB2|ERBB3,BRD-K98572433,AZD8931,EGFR inhibitor,EGFR|ERBB2|ERBB3
DFOVLSMXPWPCFH,BRD-K59036917,ML161,protease-activated receptor inhibitor,,BRD-K59036917,ML161,protease-activated receptor inhibitor,,BRD-K59036917,ML161,protease-activated receptor inhibitor,,BRD-K59036917,ML161,protease-activated receptor inhibitor,
DFPAKSUCGFBDDF,BRD-K28912512,nicotinamide,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,BRD-K28912512,nicotinamide,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,BRD-K28912512,nicotinamide,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,BRD-K28912512,nicotinamide,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5
DFPMSGMNTNDNHN,BRD-K80718324,naringin,cytochrome P450 inhibitor,SLCO1A2,BRD-K02953697,naringin,cytochrome P450 inhibitor,SLCO1A2,BRD-K02953697|BRD-K80718324,naringin,cytochrome P450 inhibitor,SLCO1A2,BRD-K02953697|BRD-K80718324,naringin,cytochrome P450 inhibitor,SLCO1A2
DFQGDHBGRSTTHX,BRD-K15691453,GSK2190915,lipoxygenase inhibitor,ALOX5AP,BRD-K15691453,GSK2190915,lipoxygenase inhibitor,ALOX5AP,BRD-K15691453,GSK2190915,lipoxygenase inhibitor,ALOX5AP,BRD-K15691453,GSK2190915,lipoxygenase inhibitor,ALOX5AP
DFVSGZHJSIEEQQ,BRD-K49519092,immethridine,histamine receptor agonist,HRH3,BRD-K49519092,immethridine,histamine receptor agonist,HRH3,BRD-K49519092,immethridine,histamine receptor agonist,HRH3,BRD-K49519092,immethridine,histamine receptor agonist,HRH3
DFYRUELUNQRZTB,BRD-K64990520,apocynin,NADPH oxidase inhibitor,NOX4,BRD-K64990520,apocynin,NADPH oxidase inhibitor,NOX4,BRD-K64990520,apocynin,NADPH oxidase inhibitor,NOX4,BRD-K64990520,apocynin,NADPH oxidase inhibitor,NOX4
DGABKXLVXPYZII,BRD-K49031386,hyodeoxycholic-acid,atherosclerosis formation inhibitor,,BRD-K44009692,hyodeoxycholic-acid,atherosclerosis formation inhibitor,,BRD-K44009692|BRD-K49031386,hyodeoxycholic-acid,atherosclerosis formation inhibitor,,BRD-K44009692|BRD-K49031386,hyodeoxycholic-acid,atherosclerosis formation inhibitor,
DGAIEPBNLOQYER,BRD-A72075775,iopromide,radiopaque medium,,BRD-A72075775,iopromide,radiopaque medium,,BRD-A72075775,iopromide,radiopaque medium,,BRD-A72075775,iopromide,radiopaque medium,
DGBIGWXXNGSACT,BRD-K38183498,clonazepam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,BRD-K38183498,clonazepam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,BRD-K38183498,clonazepam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,,,,
DGENZVKCTGIDRZ,BRD-K71534238,GW-9508,G protein-coupled receptor agonist|free fatty acid receptor agonist,FFAR1|FFAR4,BRD-K71534238,GW-9508,G protein-coupled receptor agonist|free fatty acid receptor agonist,FFAR1|FFAR4,BRD-K71534238,GW-9508,G protein-coupled receptor agonist|free fatty acid receptor agonist,FFAR1|FFAR4,BRD-K71534238,GW-9508,G protein-coupled receptor agonist|free fatty acid receptor agonist,FFAR1|FFAR4
DGMKFQYCZXERLX,BRD-A44863528,proglumide,CCK receptor antagonist,CCKAR|CCKBR,BRD-A44863528,proglumide,CCK receptor antagonist,CCKAR|CCKBR,BRD-A44863528,proglumide,CCK receptor antagonist,CCKAR|CCKBR,BRD-K01826553,proglumide,CCK receptor antagonist,CCKAR|CCKBR
DGPGXHRHNRYVDH,BRD-K26325692,API-001,sigma receptor antagonist,SIGMAR1,BRD-K26325692,API-001,sigma receptor antagonist,SIGMAR1,BRD-K26325692,API-001,sigma receptor antagonist,SIGMAR1,BRD-K26325692,API-001,sigma receptor antagonist,SIGMAR1
DGWXOLHKVGDQLN,BRD-K03294269,NU6027,CDK inhibitor,CCNA2|CDK2,BRD-K03294269,NU6027,CDK inhibitor,CCNA2|CDK2,BRD-K03294269,NU6027,CDK inhibitor,CCNA2|CDK2,BRD-K03294269,NU-6027,CDK inhibitor,CCNA2|CDK2
DHCLVCXQIBBOPH,BRD-K39061174,beta-glycerophosphoric-acid,,,BRD-K39061174,beta-glycerophosphoric-acid,,,BRD-K39061174,beta-glycerophosphoric-acid,,,BRD-K39061174,beta-glycerophosphoric-acid,,
DHCNAWNKZMNTIS,BRD-A29289453,PCA-4248,platelet activating factor receptor antagonist,PTAFR,BRD-A29289453,PCA-4248,platelet activating factor receptor antagonist,PTAFR,BRD-A29289453,PCA-4248,platelet activating factor receptor antagonist,PTAFR,BRD-A29289453,PCA-4248,platelet activating factor receptor antagonist,PTAFR
DHHVAGZRUROJKS,BRD-K96319534,phentermine,dopamine uptake inhibitor|serotonin reuptake inhibitor,MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,BRD-K96319534,phentermine,dopamine uptake inhibitor|serotonin reuptake inhibitor,MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,BRD-K96319534,phentermine,dopamine uptake inhibitor|serotonin reuptake inhibitor,MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,,,,
DHKFOIHIUYFSOF,BRD-K57243773,FRAX486,serine/threonine kinase inhibitor,PAK1|PAK2|PAK3|PAK4,BRD-K57243773,FRAX486,serine/threonine kinase inhibitor,PAK1|PAK2|PAK3|PAK4,BRD-K57243773,FRAX486,serine/threonine kinase inhibitor,PAK1|PAK2|PAK3|PAK4,BRD-K57243773,FRAX486,serine/threonine kinase inhibitor,PAK1|PAK2|PAK3|PAK4
DHKKONBXGAAFTB,BRD-K59866480|BRD-K84397942,cyclovalone,breast cancer resistance protein inhibitor,ABCG2,BRD-K59866480|BRD-K84397942,cyclovalone,breast cancer resistance protein inhibitor,ABCG2,BRD-K59866480|BRD-K84397942,cyclovalone,breast cancer resistance protein inhibitor,ABCG2,BRD-K59866480|BRD-K84397942,cyclovalone,breast cancer resistance protein inhibitor,ABCG2
DHMQDGOQFOQNFH,BRD-K72369578,AZD4282,glutamate receptor antagonist,AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9,BRD-K72369578,AZD4282,glutamate receptor antagonist,AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9,BRD-K72369578,AZD4282,glutamate receptor antagonist,AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9,BRD-K72369578,AZD4282,glutamate receptor antagonist,AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9
DHMTURDWPRKSOA,BRD-K41599323,lonafarnib,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,BRD-K41599323,lonafarnib,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,BRD-K41599323,lonafarnib,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,BRD-K41599323,lonafarnib,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS
DHSSDEDRBUKTQY,BRD-K75615183,talipexole,adrenergic receptor agonist|dopamine receptor agonist,ADRA2A|DRD2|HTR3A,BRD-K75615183,talipexole,adrenergic receptor agonist|dopamine receptor agonist,ADRA2A|DRD2|HTR3A,BRD-K75615183,talipexole,adrenergic receptor agonist|dopamine receptor agonist,ADRA2A|DRD2|HTR3A,BRD-K75615183,talipexole,adrenergic receptor agonist|dopamine receptor agonist,ADRA2A|DRD2|HTR3A
DHSUYTOATWAVLW,BRD-K26556168|BRD-K62370608,cilastatin,dehydropeptidase inhibitor,DPEP1,BRD-K26556168|BRD-K62370608,cilastatin,dehydropeptidase inhibitor,DPEP1,BRD-K26556168|BRD-K62370608|BRD-K85518562,cilastatin,dehydropeptidase inhibitor,DPEP1,BRD-K26556168|BRD-K62370608|BRD-K85518562,cilastatin,dehydropeptidase inhibitor,DPEP1
DHZBEENLJMYSHQ,BRD-K80684056,cantharidin,protein phosphatase inhibitor,,BRD-K80684056,cantharidin,protein phosphatase inhibitor,,BRD-K80684056,cantharidin,protein phosphatase inhibitor,,BRD-K80684056,cantharidin,protein phosphatase inhibitor,
DIHXJZHAIHGSAW,BRD-K36965586,m-Chlorophenylbiguanide,,HTR3A|HTR3B,BRD-K36965586,m-Chlorophenylbiguanide,,HTR3A|HTR3B,BRD-K36965586,m-Chlorophenylbiguanide,,HTR3A|HTR3B,BRD-K36965586,m-chlorophenylbiguanide,serotonin receptor agonist,HTR3A|HTR3B
DIIYLGZNZGPXRR,BRD-K38350380,FK-3311,cyclooxygenase inhibitor,PTGS2,BRD-K38350380,FK-3311,cyclooxygenase inhibitor,PTGS2,BRD-K38350380,FK-3311,cyclooxygenase inhibitor,PTGS2,BRD-K38350380,FK-3311,cyclooxygenase inhibitor,PTGS2
DIVDFFZHCJEHGG,BRD-K41809988,oxidopamine,neurotoxin,,BRD-K41809988,oxidopamine,neurotoxin,,BRD-K41809988,oxidopamine,neurotoxin,,BRD-K41809988,oxidopamine,neurotoxin,
DIWRORZWFLOCLC,BRD-A11990600,lorazepam,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,BRD-A11990600,lorazepam,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,BRD-A11990600,lorazepam,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,,,,
DJBNUMBKLMJRSA,BRD-A09472452,flecainide,sodium channel blocker,KCNA5|KCNA7|SCN4A|SCN5A,BRD-A09472452,flecainide,sodium channel blocker,KCNA5|KCNA7|SCN4A|SCN5A,BRD-A09472452,flecainide,sodium channel blocker,KCNA5|KCNA7|SCN4A|SCN5A,BRD-A09472452,flecainide,sodium channel blocker,KCNA5|KCNA7|SCN5A
DJEIHHYCDCTAAH,BRD-K49372556,mofezolac,cyclooxygenase inhibitor,PTGS1,BRD-K49372556,mofezolac,cyclooxygenase inhibitor,PTGS1,BRD-K49372556,mofezolac,cyclooxygenase inhibitor,PTGS1,BRD-K49372556,mofezolac,cyclooxygenase inhibitor,PTGS1
DJHCCTTVDRAMEH,BRD-A17407635,alclometasone-dipropionate,glucocorticoid receptor agonist,CYP3A4|NR3C1|SERPINA6,BRD-A17407635,alclometasone-dipropionate,glucocorticoid receptor agonist,CYP3A4|NR3C1|SERPINA6,BRD-A17407635,alclometasone-dipropionate,glucocorticoid receptor agonist,CYP3A4|NR3C1|SERPINA6,BRD-A17407635,alclometasone-dipropionate,glucocorticoid receptor agonist,CYP3A4|NR3C1|SERPINA6
DJKNRCWSXSZACF,BRD-K11073688,CPI-1189,tumor necrosis factor release inhibitor,TNF,BRD-K11073688,CPI-1189,tumor necrosis factor release inhibitor,TNF,BRD-K11073688,CPI-1189,tumor necrosis factor release inhibitor,TNF,BRD-K11073688,CPI-1189,tumor necrosis factor release inhibitor,TNF
DJKWDKJYFYUEBQ,BRD-K43890836,gemcadiol,antilipemic,,BRD-K43890836,gemcadiol,antilipemic,,BRD-K43890836,gemcadiol,antilipemic,,BRD-K43890836,gemcadiol,antilipemic,
DJNVPMWOJIZWOG,BRD-K01115818,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,BRD-K01115818,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,BRD-K01115818,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,,,,
DJQOOSBJCLSSEY,BRD-K63736853,acipimox,cholesterol inhibitor,HCAR2,BRD-K63736853,acipimox,cholesterol inhibitor,HCAR2,BRD-K63736853,acipimox,cholesterol inhibitor,HCAR2,BRD-K63736853,acipimox,cholesterol inhibitor,HCAR2
DJSXNILVACEBLP,BRD-K88014802,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,BRD-K83146339|BRD-K88014802|BRD-M65265990,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,,,,,,,,
DJUFPMUQJKWIJB,BRD-K73132780,pyronaridine,antimalarial agent,,BRD-K73132780,pyronaridine,antimalarial agent,,BRD-K73132780,pyronaridine,antimalarial agent,,BRD-K73132780,pyronaridine,antimalarial agent,
DJWYOLJPSHDSAL,BRD-A76244192|BRD-K68764924,pantethine,coenzyme A precursor,,BRD-A76244192|BRD-K68764924,pantethine,coenzyme A precursor,,BRD-A76244192|BRD-K68764924,pantethine,coenzyme A precursor,,BRD-K68764924,pantethine,coenzyme A precursor,
DKEZDPGUJMMUCC,BRD-A52169337,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",,,BRD-A52169337,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",,,BRD-A52169337,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",,,BRD-K00003327,hydroxysafflor-yellow-A,antitumor agent,
DKGZKTPJOSAWFA,BRD-K55468218,spiperone,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-K55468218,spiperone,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-K55468218,spiperone,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-K55468218,spiperone,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7
DKHGMERMDICWDU,BRD-K75864342,menatetrenone,bone resorption inhibitor,,BRD-K75864342,menatetrenone,bone resorption inhibitor,,BRD-K75864342,menatetrenone,bone resorption inhibitor,,BRD-K75864342,menatetrenone,bone resorption inhibitor,
DKJJVAGXPKPDRL,BRD-K10845183,tiludronate,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,BRD-K10845183,tiludronate,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,BRD-K10845183,tiludronate,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,BRD-K10845183,tiludronate,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1
DKLKMKYDWHYZTD,BRD-A97730597,hexylcaine,sodium channel blocker,SCN10A|SCN5A,BRD-A97730597,hexylcaine,sodium channel blocker,SCN10A|SCN5A,BRD-A97730597,hexylcaine,sodium channel blocker,SCN10A|SCN5A,BRD-A97730597,hexylcaine,sodium channel blocker,SCN5A
DKMACHNQISHMDN,BRD-K84810405,almorexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K84810405,almorexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K84810405,almorexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K84810405,almorexant,orexin receptor antagonist,HCRTR1|HCRTR2
DKMFBWQBDIGMHM,BRD-K92984783,melperone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,BRD-K92984783,melperone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,BRD-K92984783,melperone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,BRD-K92984783,melperone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A
DKNUPRMJNUQNHR,BRD-K20722021,CEP-32496,RAF inhibitor,BRAF|RAF1,BRD-K20722021,CEP-32496,RAF inhibitor,BRAF|RAF1,BRD-K20722021,CEP-32496,RAF inhibitor,BRAF|RAF1,BRD-K20722021,CEP-32496,RAF inhibitor,BRAF|RAF1
DKNWSYNQZKUICI,BRD-K70330367,amantadine,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,BRD-K70330367,amantadine,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,BRD-K70330367,amantadine,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,BRD-K70330367,amantadine,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A
DKOQGJHPHLTOJR,BRD-K56542719,cefpirome,bacterial cell wall synthesis inhibitor,,BRD-K56542719,cefpirome,bacterial cell wall synthesis inhibitor,,BRD-K56542719,cefpirome,bacterial cell wall synthesis inhibitor,,BRD-K56542719,cefpirome,bacterial cell wall synthesis inhibitor,
DKORMNNYNRPTBJ,BRD-K66097663,TMC-353121,RSV fusion inhibitor,,BRD-K66097663,TMC-353121,RSV fusion inhibitor,,BRD-K66097663,TMC-353121,RSV fusion inhibitor,,BRD-K66097663,TMC-353121,RSV fusion inhibitor,
DKPQHFZUICCZHF,BRD-K37720887,SB-525334,TGF beta receptor inhibitor,TGFBR1,BRD-K37720887,SB-525334,TGF beta receptor inhibitor,TGFBR1,BRD-K37720887,SB-525334,TGF beta receptor inhibitor,TGFBR1,BRD-K37720887,SB-525334,TGF beta receptor inhibitor,TGFBR1
DKULOVKANLVDEA,BRD-K34843150,ACT-132577,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K34843150,ACT-132577,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K34843150,ACT-132577,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K34843150,ACT-132577,endothelin receptor antagonist,EDNRA|EDNRB
DKXHSOUZPMHNIZ,BRD-K50000283,PHA-767491,CDC inhibitor,CDK1|RPS6KB1,BRD-K50000283,PHA-767491,CDC inhibitor,CDK1|RPS6KB1,BRD-K50000283,PHA-767491,CDC inhibitor,CDK1|RPS6KB1,BRD-K50000283,PHA-767491,CDC inhibitor,CDK1|RPS6KB1
DKYWVDODHFEZIM,BRD-A97739905,ketoprofen,cyclooxygenase inhibitor,CXCR1|PTGS1|PTGS2|SLC5A8,BRD-A97739905,ketoprofen,cyclooxygenase inhibitor,CXCR1|PTGS1|PTGS2|SLC5A8,BRD-A97739905,ketoprofen,cyclooxygenase inhibitor,CXCR1|PTGS1|PTGS2|SLC5A8,BRD-A97739905,ketoprofen,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8
DKZYXHCYPUVGAF,BRD-K53417444,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK,BRD-K53417444,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK,BRD-K53417444,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK,BRD-K53417444,OTS167,maternal embryonic leucine zipper kinase inhibitor,MELK
DLEGDLSLRSOURQ,BRD-K56908511,fluroxene,local anesthetic,,BRD-K56908511,fluroxene,local anesthetic,,BRD-K56908511,fluroxene,local anesthetic,,BRD-K56908511,fluroxene,local anesthetic,
DLFCEZOMHBPDGI,BRD-K39171998,STF-118804,NAMPT inhibitor,NAMPT,BRD-K39171998,STF-118804,NAMPT inhibitor,NAMPT,BRD-K39171998,STF-118804,NAMPT inhibitor,NAMPT,BRD-K39171998,STF-118804,NAMPT inhibitor,NAMPT
DLGOEMSEDOSKAD,BRD-K36234266,carmustine,DNA alkylating agent|DNA inhibitor,GSR,BRD-K36234266,carmustine,DNA alkylating agent|DNA inhibitor,GSR,BRD-K36234266,carmustine,DNA alkylating agent|DNA inhibitor,GSR,,,,
DLMYFMLKORXJPO,BRD-K09774593,S-Trityl-L-cysteine,mitotic kinesin inhibitor,,BRD-K09774593,S-Trityl-L-cysteine,mitotic kinesin inhibitor,,BRD-K09774593,S-Trityl-L-cysteine,mitotic kinesin inhibitor,,BRD-K09774593,S-trityl-L-cysteine,mitotic kinesin inhibitor,
DLNKOYKMWOXYQA,BRD-K27853494,"1s,2r-phenylpropanolamine",,,BRD-K27853494,"1s,2r-phenylpropanolamine",adrenergic receptor agonist,ADRA1A|ADRA2A|ADRB1|ADRB2|DRD1,BRD-K27853494,"1s,2r-phenylpropanolamine",adrenergic receptor agonist,ADRA1A|ADRA2A|ADRB1|ADRB2|DRD1,BRD-K27853494,"1S,2R-phenylpropanolamine",adrenergic receptor agonist,
DLZUBMGMHUNDLF,BRD-A16767899|BRD-A23637604,oxymetholone,androgen receptor agonist,AR,BRD-A23637604|BRD-A93291428,oxymetholone,androgen receptor agonist,AR,BRD-A16767899|BRD-A23637604|BRD-A93291428,oxymetholone,androgen receptor agonist,AR,,,,
DMDGGSIALPNSEE,BRD-K36862742,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,BRD-K36862742,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,BRD-K36862742,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,BRD-K36862742,hydroflumethiazide,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3
DMJNNHOOLUXYBV,BRD-A18115130|BRD-A53925737|BRD-K01612348,meropenem,bacterial cell wall synthesis inhibitor,,BRD-A18115130|BRD-A53925737|BRD-K01612348,meropenem,bacterial cell wall synthesis inhibitor,,BRD-A18115130|BRD-A53925737|BRD-K01612348,meropenem,bacterial cell wall synthesis inhibitor,,BRD-A18115130|BRD-A53925737|BRD-K01612348,meropenem,bacterial cell wall synthesis inhibitor,
DMKSVUSAATWOCU,BRD-K39983086|BRD-K43659793,loteprednol,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1,BRD-K39983086,loteprednol,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1,BRD-K39983086|BRD-K43659793,loteprednol,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1,BRD-K39983086|BRD-K43659793,loteprednol,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1
DMMILYKXNCVKOJ,BRD-K49669041,BX-912,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,BRD-K49669041,BX-912,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,BRD-K49669041,BX-912,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,BRD-K49669041,BX-912,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1
DMNOVGJWPASQDL,BRD-K35626314,TRV130,opioid receptor agonist,OPRM1,BRD-K35626314,TRV130,opioid receptor agonist,OPRM1,BRD-K35626314,TRV130,opioid receptor agonist,OPRM1,BRD-K35626314,TRV130,opioid receptor agonist,OPRM1
DMUAPQTXSSNEDD,BRD-K68822425,midecamycin,protein synthesis inhibitor,,BRD-K68822425,midecamycin,protein synthesis inhibitor,,BRD-K68822425,midecamycin,protein synthesis inhibitor,,BRD-K68822425,midecamycin,protein synthesis inhibitor,
DMWVGXGXHPOEPT,BRD-K50495309,SRC-kinase-inhibitor-I,src inhibitor,CSK|LCK|RIPK2,BRD-K50495309,SRC-kinase-inhibitor-I,src inhibitor,CSK|LCK|RIPK2,BRD-K50495309,SRC-kinase-inhibitor-I,src inhibitor,CSK|LCK|RIPK2,BRD-K50495309,SRC-kinase-inhibitor-I,SRC inhibitor,CSK|LCK|RIPK2
DMZCCFMMPHJWQY,BRD-K22025381,U-18666A,oxidosqualene cyclase inhibitor,,BRD-K22025381,U-18666A,oxidosqualene cyclase inhibitor,,BRD-K22025381,U-18666A,oxidosqualene cyclase inhibitor,,BRD-K22025381,U-18666A,oxidosqualene cyclase inhibitor,
DNHCHRGCTVRAFT,BRD-K37687387,RU-28318,cytochrome P450 inhibitor,NR3C2,BRD-K37687387,RU-28318,cytochrome P450 inhibitor,NR3C2,BRD-K37687387,RU-28318,cytochrome P450 inhibitor,NR3C2,BRD-K37687387,RU-28318,cytochrome P450 inhibitor,NR3C2
DNIAPMSPPWPWGF,BRD-A19232309,propylene-glycol,,F13A1,BRD-A19232309,propylene-glycol,,F13A1,BRD-A19232309,propylene-glycol,,F13A1,BRD-A19232309,propylene-glycol,,
DNJVYWXIDISQRD,BRD-K46741531,cafestol,pregnane X receptor agonist,,BRD-K46741531,cafestol,pregnane X receptor agonist,,BRD-K46741531,cafestol,pregnane X receptor agonist,,BRD-K46741531,cafestol,pregnane X receptor agonist,
DNTGGZPQPQTDQF,BRD-K57179821,crotamiton,antipruritic,,BRD-K57179821,crotamiton,antipruritic,,BRD-K57179821,crotamiton,antipruritic,,BRD-K57179821,crotamiton,antipruritic,
DNTSIBUQMRRYIU,BRD-K93258693,GW-9662,PPAR receptor antagonist,NCOA2|PPARG|RXRA,BRD-K93258693,GW-9662,PPAR receptor antagonist,NCOA2|PPARG|RXRA,BRD-K93258693,GW-9662,PPAR receptor antagonist,NCOA2|PPARG|RXRA,BRD-K93258693,GW-9662,PPAR receptor antagonist,NCOA2|PPARG|RXRA
DNTVJEMGHBIUMW,BRD-K16732600,MK-0893,glucagon receptor antagonist,GCGR,BRD-K16732600,MK-0893,glucagon receptor antagonist,GCGR,BRD-K16732600,MK-0893,glucagon receptor antagonist,GCGR,BRD-K16732600,MK-0893,glucagon receptor antagonist,GCGR
DNULYRGWTFLJQL,BRD-K47761761,PD-168077,dopamine receptor agonist,DRD2,BRD-K47761761,PD-168077,dopamine receptor agonist,DRD2,BRD-K47761761,PD-168077,dopamine receptor agonist,DRD2,BRD-K47761761,PD-168077,dopamine receptor agonist,DRD2
DNVPQKQSNYMLRS,BRD-K03039262|BRD-K09161066,ergosterol,vitamin D precursor,,BRD-K03039262|BRD-K09161066,ergosterol,vitamin D precursor,,BRD-K03039262|BRD-K09161066,ergosterol,vitamin D precursor,,BRD-K03039262|BRD-K09161066,ergosterol,vitamin D precursor,
DNVVZWSVACQWJE,BRD-K73157543,phenyl-aminosalicylate,,,BRD-K73157543,phenyl-aminosalicylate,,,BRD-K73157543,phenyl-aminosalicylate,,,BRD-K73157543,phenyl-aminosalicylate,,
DNVXATUJJDPFDM,BRD-K54606188,JQ1-(+),bromodomain inhibitor,BRD4|BRDT,BRD-K54606188,JQ1-(+),bromodomain inhibitor,BRD4|BRDT,BRD-K17588104|BRD-K54606188,JQ1-(+),bromodomain inhibitor,BRD4|BRDT,BRD-K17588104|BRD-K54606188,JQ1-(+),bromodomain inhibitor,BRD4|BRDT
DNXHEGUUPJUMQT,BRD-A37959677|BRD-K15236393|BRD-K81839095,estrone,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,BRD-A37959677|BRD-K15236393|BRD-K81839095,estrone,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,BRD-A37959677|BRD-K15236393|BRD-K81839095,estrone,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,BRD-A37959677|BRD-K15236393|BRD-K81839095,estrone,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2
DNYBIOICMDTDAP,BRD-K31313613,BS-181,CDK inhibitor,CDK7,BRD-K31313613,BS-181,CDK inhibitor,CDK7,BRD-K31313613,BS-181,CDK inhibitor,CDK7,BRD-K31313613,BS-181,CDK inhibitor,CDK7
DNYGXMICFMACRA,BRD-K18552138,micronomicin,protein synthesis inhibitor,,BRD-K18552138,micronomicin,protein synthesis inhibitor,,BRD-K18552138,micronomicin,protein synthesis inhibitor,,BRD-K18552138,micronomicin,protein synthesis inhibitor,
DOAKLVKFURWEDJ,BRD-K25021320|BRD-K94358652,daptomycin,bacterial cell wall synthesis inhibitor,,BRD-K94358652,daptomycin,bacterial cell wall synthesis inhibitor,,BRD-K25021320|BRD-K94358652,daptomycin,bacterial cell wall synthesis inhibitor,,BRD-K00003611,daptomycin,bacterial cell wall synthesis inhibitor,
DOBKQCZBPPCLEG,BRD-K03164761,thiazovivin,rho associated kinase inhibitor,,BRD-K03164761,thiazovivin,rho associated kinase inhibitor,,BRD-K03164761,thiazovivin,rho associated kinase inhibitor,,BRD-K03164761,thiazovivin,rho associated kinase inhibitor,
DOBMPNYZJYQDGZ,BRD-K82236179,dicoumarol,NADPH inhibitor,CRYZ|NQO1|VKORC1,BRD-K82236179,dicoumarol,NADPH inhibitor,CRYZ|NQO1|VKORC1,BRD-K82236179,dicoumarol,NADPH inhibitor,CRYZ|NQO1|VKORC1,BRD-K82236179,dicoumarol,NADPH inhibitor,CRYZ|NQO1|VKORC1
DOCINCLJNAXZQF,BRD-K92517771,acalisib,PI3K inhibitor,PIK3CB|PIK3CD,BRD-K92517771,acalisib,PI3K inhibitor,PIK3CB|PIK3CD,BRD-K92517771,acalisib,PI3K inhibitor,PIK3CB|PIK3CD,BRD-K92517771,acalisib,PI3K inhibitor,PIK3CB|PIK3CD
DOEWDSDBFRHVAP,BRD-K15025317,BAY-11-7082,NFkB pathway inhibitor,RELA,BRD-K15025317,BAY-11-7082,NFkB pathway inhibitor,RELA,BRD-K15025317,BAY-11-7082,NFkB pathway inhibitor,RELA,BRD-K15025317,BAY-11-7082,NFkB pathway inhibitor,RELA
DOIRQSBPFJWKBE,BRD-K73477617,dibutyl-phthalate,,TRPA1,BRD-K73477617,dibutyl-phthalate,,TRPA1,BRD-K73477617,dibutyl-phthalate,,TRPA1,BRD-K73477617,dibutyl-phthalate,,TRPA1
DOMWKUIIPQCAJU,BRD-A29731977,17-hydroxyprogesterone-caproate,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,BRD-A29731977,17-hydroxyprogesterone-caproate,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,BRD-A29731977,17-hydroxyprogesterone-caproate,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,BRD-K70264088,17-hydroxyprogesterone-caproate,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR
DOMXUEMWDBAQBQ,BRD-K68132782,terbinafine,fungal squalene epoxidase inhibitor,SQLE,BRD-K68132782,terbinafine,fungal squalene epoxidase inhibitor,SQLE,BRD-K68132782,terbinafine,fungal squalene epoxidase inhibitor,SQLE,BRD-K68132782,terbinafine,fungal squalene epoxidase inhibitor,SQLE
DOTGPNHGTYJDEP,BRD-K20463415,LY2606368,CHK inhibitor,CHEK1,BRD-K20463415,LY2606368,CHK inhibitor,CHEK1,BRD-K20463415,LY2606368,CHK inhibitor,CHEK1,BRD-K20463415,LY2606368,CHK inhibitor,CHEK1
DOUMFZQKYFQNTF,BRD-K20313525,rosmarinic-acid,GABA transaminase inhibitor,MCL1|TYR,BRD-K20313525,rosmarinic-acid,GABA transaminase inhibitor,MCL1|TYR,BRD-K20313525,rosmarinic-acid,GABA transaminase inhibitor,MCL1|TYR,BRD-K20313525,rosmarinic-acid,GABA transaminase inhibitor,MCL1|TYR
DOUYETYNHWVLEO,BRD-K26657438,imiquimod,interferon inducer|toll-like receptor agonist,TLR7|TLR8,BRD-K26657438,imiquimod,interferon inducer|toll-like receptor agonist,TLR7|TLR8,BRD-K26657438,imiquimod,interferon inducer|toll-like receptor agonist,TLR7|TLR8,BRD-K26657438,imiquimod,interferon inducer|toll-like receptor agonist,TLR7|TLR8
DPDZHVCKYBCJHW,BRD-K09132007,D-4476,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,BRD-K09132007,D-4476,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,BRD-K09132007,D-4476,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,BRD-K09132007,D-4476,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1
DPFHVUSPVHRVFL,BRD-K60946979,CGP-78608,glutamate receptor antagonist,,BRD-K60946979,CGP-78608,glutamate receptor antagonist,,BRD-K60946979,CGP-78608,glutamate receptor antagonist,,BRD-K60946979,CGP-78608,glutamate receptor antagonist,
DPGDRICHXKQXEN,BRD-K50888640,MDL-27531,glycine receptor agonist,,BRD-K50888640,MDL-27531,glycine receptor agonist,,BRD-K50888640,MDL-27531,glycine receptor agonist,,BRD-K50888640,MDL-27531,glycine receptor agonist,
DPHUWDIXHNQOSY,BRD-K22064724,napabucasin,STAT inhibitor,STAT3,BRD-K22064724,napabucasin,STAT inhibitor,STAT3,BRD-K22064724,napabucasin,STAT inhibitor,STAT3,BRD-K22064724,napabucasin,STAT inhibitor,STAT3
DPJNKUOXBZSZAI,BRD-K26989966,UNC1999,histone lysine methyltransferase inhibitor,EZH2,BRD-K26989966,UNC1999,histone lysine methyltransferase inhibitor,EZH2,BRD-K26989966,UNC1999,histone lysine methyltransferase inhibitor,EZH2,BRD-K26989966,UNC1999,histone lysine methyltransferase inhibitor,EZH2
DPLMXAYKJZOTKO,BRD-K24556407,ETP-46464,ATR kinase inhibitor,,BRD-K24556407,ETP-46464,ATR kinase inhibitor,,BRD-K24556407,ETP-46464,ATR kinase inhibitor,,BRD-K24556407,ETP-46464,ATR kinase inhibitor,
DPNNNPAKRZOSMO,BRD-A72401848|BRD-M87846614,gadoteridol,radiopaque medium,,BRD-A72401848|BRD-M87846614,gadoteridol,radiopaque medium,,BRD-A72401848|BRD-M87846614,gadoteridol,radiopaque medium,,BRD-A72401848|BRD-M87846614,gadoteridol,radiopaque medium,
DPSPPJIUMHPXMA,BRD-A69777949,flumequine,topoisomerase inhibitor,,BRD-A69777949,flumequine,topoisomerase inhibitor,,BRD-A69777949,flumequine,topoisomerase inhibitor,,BRD-A69777949,flumequine,topoisomerase inhibitor,
DPWPWRLQFGFJFI,BRD-K83597974,pargyline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K83597974,pargyline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K83597974,pargyline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K83597974,pargyline,monoamine oxidase inhibitor,MAOA|MAOB
DQCKKXVULJGBQN,BRD-A66559694|BRD-K88172511,naltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,BRD-A66559694|BRD-K88172511,naltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,BRD-A66559694|BRD-K88172511,naltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,BRD-A66559694|BRD-K88172511,naltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1
DQDAYGNAKTZFIW,BRD-A49838158,phenprocoumon,vitamin K antagonist,VKORC1,BRD-A49838158,phenprocoumon,vitamin K antagonist,VKORC1,BRD-A49838158,phenprocoumon,vitamin K antagonist,VKORC1,BRD-A49838158,phenprocoumon,vitamin K antagonist,VKORC1
DQKXQSGTHWVTAD,BRD-K46523383,pramoxine,topical anesthetic,,BRD-K46523383,pramoxine,topical anesthetic,,BRD-K46523383,pramoxine,topical anesthetic,,BRD-K46523383,pramoxine,topical anesthetic,
DQLATGHUWYMOKM,BRD-K69172251,cisplatin,DNA alkylating agent|DNA synthesis inhibitor,XIAP,BRD-K69172251,cisplatin,DNA alkylating agent|DNA synthesis inhibitor,XIAP,BRD-K01228321|BRD-K33494261|BRD-K69172251,cisplatin,DNA alkylating agent|DNA synthesis inhibitor,XIAP,BRD-K01228321|BRD-K33494261|BRD-K69172251,cisplatin,DNA alkylating agent|DNA synthesis inhibitor,XIAP
DQMZLTXERSFNPB,BRD-K32247306,primidone,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K32247306,primidone,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K32247306,primidone,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K32247306,primidone,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
DRCMAZOSEIMCHM,BRD-K44849676,capsazepine,TRPV agonist,TRPV1|TRPV4,BRD-K44849676,capsazepine,TRPV agonist,TRPV1|TRPV4,BRD-K44849676,capsazepine,TRPV agonist,TRPV1|TRPV4,BRD-K44849676,capsazepine,TRPV agonist,TRPV1|TRPV4
DREIJXJRTLTGJC,BRD-A59435073|BRD-K21225231,peficitinib,JAK inhibitor,JAK1|JAK2|JAK3,BRD-A59435073|BRD-K21225231,peficitinib,JAK inhibitor,JAK1|JAK2|JAK3,BRD-A14577621|BRD-A59435073|BRD-K21225231,peficitinib,JAK inhibitor,JAK1|JAK2|JAK3,BRD-A14577621|BRD-A59435073,peficitinib,JAK inhibitor,JAK1|JAK2|JAK3
DRHKJLXJIQTDTD,BRD-K74339692,tamsulosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K74339692,tamsulosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K74339692,tamsulosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K74339692,tamsulosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D
DRIMIUYGTDAQOX,BRD-K48535733,VU0155069,phospholipase inhibitor,PLD1,BRD-K48535733,VU0155069,phospholipase inhibitor,PLD1,BRD-K48535733,VU0155069,phospholipase inhibitor,PLD1,BRD-K48535733,VU0155069,phospholipase inhibitor,PLD1
DRLCSJFKKILATL,BRD-K64925568,AMG-232,MDM inhibitor,MDM2,BRD-K64925568,AMG-232,MDM inhibitor,MDM2,BRD-K64925568,AMG-232,MDM inhibitor,MDM2,BRD-K64925568,AMG-232,MDM inhibitor,MDM2
DRLFMBDRBRZALE,BRD-K97530723,melatonin,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,BRD-K97530723,melatonin,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,BRD-K97530723,melatonin,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,BRD-K97530723,melatonin,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB
DRRWBCNQOKKKOL,BRD-K47031502,eupatilin,mucus protecting agent,,BRD-K47031502,eupatilin,mucus protecting agent,,BRD-K47031502,eupatilin,mucus protecting agent,,BRD-K47031502,eupatilin,mucus protecting agent,
DRSJLVGDSNWQBI,BRD-K24968862,SB-683698,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,BRD-K24968862,SB-683698,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,BRD-K24968862,SB-683698,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,BRD-K24968862,SB-683698,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7
DRTQHJPVMGBUCF,BRD-K13050303|BRD-K32566431,uridine,dopamine receptor agonist,LSM6|TYMP,BRD-K13050303|BRD-K32566431,uridine,dopamine receptor agonist,LSM6|TYMP,BRD-K13050303|BRD-K32566431,uridine,dopamine receptor agonist,LSM6|TYMP,BRD-K13050303|BRD-K32566431,uridine,dopamine receptor agonist,LSM6|TYMP
DSCFFEYYQKSRSV,BRD-A69275535,pinitol,gamma secretase inhibitor,,BRD-A69275535,pinitol,gamma secretase inhibitor,,BRD-A69275535,pinitol,gamma secretase inhibitor,,BRD-K87873585,pinitol,gamma secretase inhibitor,
DSFNLJXHXBIKDS,BRD-K84892605,IOWH032,CFTR channel antagonist,CFTR,BRD-K84892605,IOWH032,CFTR channel antagonist,CFTR,BRD-K84892605,IOWH032,CFTR channel antagonist,CFTR,BRD-K84892605,IOWH032,CFTR channel antagonist,CFTR
DSLPMJSGSBLWRE,BRD-K87777313,irosustat,steroid sulfatase inhibitor,CA2|STS,BRD-K87777313,irosustat,steroid sulfatase inhibitor,CA2|STS,BRD-K87777313,irosustat,steroid sulfatase inhibitor,CA2|STS,BRD-K87777313,irosustat,steroid sulfatase inhibitor,CA2|STS
DSLRVRBSNLHVBH,BRD-K29791386,"2,5-furandimethanol",,,BRD-K29791386,"2,5-furandimethanol",hemoglobin modulator,HBB,BRD-K29791386,"2,5-furandimethanol",hemoglobin modulator,HBB,BRD-K29791386,"2,5-furandimethanol",hemoglobin modulator,HBB
DSLZVSRJTYRBFB,BRD-K60150658,glucaric-acid,,,BRD-K60150658,glucaric-acid,,,BRD-K60150658,glucaric-acid,,,BRD-K60150658,glucaric-acid,,
DSOJSZXQRJGBCW,BRD-A46597779|BRD-K26349472,OG-L002,histone lysine demethylase inhibitor,KDM1A,BRD-A46597779|BRD-K26349472,OG-L002,histone lysine demethylase inhibitor,KDM1A,BRD-A46597779|BRD-K26349472,OG-L002,histone lysine demethylase inhibitor,KDM1A,BRD-A46597779|BRD-K26349472,OG-L002,histone lysine demethylase inhibitor,KDM1A
DSRSEEYZGWTODH,BRD-K84895041,BMY-45778,IP1 prostacyclin receptor agonist,PTGIR,BRD-K84895041,BMY-45778,IP1 prostacyclin receptor agonist,PTGIR,BRD-K84895041,BMY-45778,IP1 prostacyclin receptor agonist,PTGIR,BRD-K84895041,BMY-45778,IP1 prostacyclin receptor agonist,PTGIR
DSSYKIVIOFKYAU,BRD-K10034334|BRD-K15714472,camphor-(+)|camphor-(1r),|TRPV activator,|TRPV1,BRD-K10034334|BRD-K15714472,camphor-(+)|camphor-(1r),|TRPV activator,|TRPV1,BRD-K10034334|BRD-K15714472,camphor-(+)|camphor-(1r),|TRPV activator,|TRPV1,BRD-K10034334|BRD-K15714472,camphor-(+)|camphor-(1R),|TRPV activator,|TRPV1
DSTWURHEHMZWEI,BRD-A63546914,Ro-04-5595,,GRIN2B,BRD-A63546914,Ro-04-5595,,GRIN2B,BRD-A63546914,Ro-04-5595,,GRIN2B,BRD-A63546914,Ro-04-5595,glutamate receptor antagonist,GRIN2B
DSXXEELGXBCYNQ,BRD-K06543683,bisindolylmaleimide-ix,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,BRD-K06543683,bisindolylmaleimide-ix,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,BRD-K06543683,bisindolylmaleimide-ix,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,BRD-K06543683,bisindolylmaleimide-IX,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1
DTDZLJHKVNTQGZ,BRD-A87435144,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1,BRD-A87435144,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1,BRD-A87435144,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1,BRD-K52836380,AZD7545,pyruvate dehydrogenase kinase inhibitor,PDK1
DTEKTGDVSARYDS,BRD-A81370665,BI-D1870,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6,BRD-A81370665,BI-D1870,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6,BRD-A81370665,BI-D1870,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6,BRD-A81370665,BI-D1870,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6
DTGLZDAWLRGWQN,BRD-A83029242,prasugrel,purinergic receptor antagonist,P2RY12,BRD-A83029242,prasugrel,purinergic receptor antagonist,P2RY12,BRD-A83029242,prasugrel,purinergic receptor antagonist,P2RY12,BRD-A83029242,prasugrel,purinergic receptor antagonist,P2RY12
DTOSIQBPPRVQHS,BRD-K33396764,alpha-linolenic-acid,omega 3 fatty acid stimulant,ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1,BRD-K33396764,alpha-linolenic-acid,omega 3 fatty acid stimulant,ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1,BRD-K33396764,alpha-linolenic-acid,omega 3 fatty acid stimulant,ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1,BRD-K33396764,alpha-linolenic-acid,omega 3 fatty acid stimulant,ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1
DTOUUUZOYKYHEP,BRD-A18605525,hexetidine,local anesthetic,,BRD-A18605525,hexetidine,local anesthetic,,BRD-A18605525,hexetidine,local anesthetic,,BRD-A18605525,hexetidine,local anesthetic,
DTULOKYBGCTCFP,BRD-M71167108,sucralfate,antacid,EGF|FGA|FGB|FGF2|FGG,BRD-M71167108,sucralfate,antacid,EGF|FGA|FGB|FGF2|FGG,BRD-M71167108,sucralfate,antacid,EGF|FGA|FGB|FGF2|FGG,BRD-M71167108,sucralfate,antacid,
DTXXSJZBSTYZKE,BRD-K81332461,maxacalcitol,vitamin D receptor agonist,VDR,BRD-K81332461,maxacalcitol,vitamin D receptor agonist,VDR,BRD-K81332461,maxacalcitol,vitamin D receptor agonist,VDR,BRD-K47318833,maxacalcitol,vitamin D receptor agonist,VDR
DTYWJKSSUANMHD,BRD-K46290096,preladenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K46290096,preladenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K46290096,preladenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K46290096,preladenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
DTZDSNQYNPNCPK,BRD-K23335153,AMN-082,glutamate receptor modulator,GRM7,BRD-K23335153,AMN-082,glutamate receptor modulator,GRM7,BRD-K23335153,AMN-082,glutamate receptor modulator,GRM7,BRD-K23335153,AMN-082,glutamate receptor modulator,GRM7
DUAGQYUORDTXOR,BRD-K33131085,gentiopicrin,glutamate receptor downregulator,GRIN2B,BRD-K33131085,gentiopicrin,glutamate receptor downregulator,GRIN2B,BRD-K33131085,gentiopicrin,glutamate receptor downregulator,GRIN2B,BRD-K33131085,gentiopicrin,glutamate receptor downregulator,GRIN2B
DUDKAZCAISNGQN,BRD-A58193911,oxyphencyclimine,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A58193911,oxyphencyclimine,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A58193911,oxyphencyclimine,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A58193911,oxyphencyclimine,cholinergic receptor antagonist,
DUGOZIWVEXMGBE,BRD-A19585813,methylphenidate,dopamine-norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A19585813,methylphenidate,dopamine-norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A19585813,methylphenidate,dopamine-norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,,,,
DUHUCHOQIDJXAT,BRD-K41445866,alfaxalone,benzodiazepine receptor agonist|chloride channel agonist,GABBR1,BRD-K41445866,alfaxalone,benzodiazepine receptor agonist|chloride channel agonist,GABBR1,BRD-K41445866,alfaxalone,benzodiazepine receptor agonist|chloride channel agonist,GABBR1,,,,
DUIHHZKTCSNTGM,BRD-K26756394,VE-821,ATR kinase inhibitor,ATR,BRD-K26756394,VE-821,ATR kinase inhibitor,ATR,BRD-K26756394,VE-821,ATR kinase inhibitor,ATR,BRD-K26756394,VE-821,ATR kinase inhibitor,ATR
DURULFYMVIFBIR,BRD-A41304429,practolol,adrenergic receptor antagonist,ADRB1,BRD-A41304429,practolol,adrenergic receptor antagonist,ADRB1,BRD-A41304429,practolol,adrenergic receptor antagonist,ADRB1,BRD-A41304429,practolol,adrenergic receptor antagonist,ADRB1
DUSHUSLJJMDGTE,BRD-A48103086,cyproterone,androgen receptor antagonist,AR,BRD-A48103086,cyproterone,androgen receptor antagonist,AR,BRD-A48103086,cyproterone,androgen receptor antagonist,AR,,,,
DUXZAXCGJSBGDW,BRD-K24603946,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3,BRD-K24603946,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3,BRD-K24603946,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3,BRD-K24603946,5-hydroxymethyl-tolterodine,acetylcholine receptor antagonist,CHRM3
DUYJMQONPNNFPI,BRD-K42805893,osimertinib,EGFR inhibitor,EGFR,BRD-K42805893,osimertinib,EGFR inhibitor,EGFR,BRD-K42805893,osimertinib,EGFR inhibitor,EGFR,BRD-K42805893,osimertinib,EGFR inhibitor,EGFR
DVASNQYQOZHAJN,BRD-A44181516,flumecinol,,,BRD-A44181516,flumecinol,,,BRD-A44181516,flumecinol,,,BRD-A44181516,flumecinol,,
DVEXZJFMOKTQEZ,BRD-K18787491|BRD-K91701654,U-0126,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,BRD-K18787491|BRD-K91701654,U-0126,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,BRD-K18787491|BRD-K91701654|BRD-M37437038|BRD-M92812175,U-0126,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,,,,
DVKQVRZMKBDMDH,BRD-A09554849,8-bromo-cAMP,PKA activator,,BRD-A09554849,8-bromo-cAMP,PKA activator,,BRD-A09554849,8-bromo-cAMP,PKA activator,,BRD-A09554849,8-bromo-cAMP,PKA activator,
DVYASSBBADJRAS,BRD-A00559310,W-54011,anaphylatoxin chemotactic receptor antagonist,C5AR1,BRD-A00559310,W-54011,anaphylatoxin chemotactic receptor antagonist,C5AR1,BRD-A00559310,W-54011,anaphylatoxin chemotactic receptor antagonist,C5AR1,BRD-A00559310,W-54011,anaphylatoxin chemotactic receptor antagonist,C5AR1
DWAFYCQODLXJNR,BRD-A20035137|BRD-K78960041,oxaliplatin,DNA inhibitor,,BRD-A20035137|BRD-K78960041,oxaliplatin,DNA inhibitor,,BRD-A20035137|BRD-K78960041|BRD-M78823677,oxaliplatin,DNA inhibitor,,BRD-A20035137|BRD-K78960041|BRD-M78823677,oxaliplatin,DNA inhibitor,
DWFGGOFPIISJIT,BRD-K62621335,SRPIN340,serine arginine protein kinase inhibitor,SRPK1|SRPK2,BRD-K62621335,SRPIN340,serine arginine protein kinase inhibitor,SRPK1|SRPK2,BRD-K62621335,SRPIN340,serine arginine protein kinase inhibitor,SRPK1|SRPK2,BRD-K62621335,SRPIN340,serine arginine protein kinase inhibitor,SRPK1|SRPK2
DWHVZCLBMTZRQM,BRD-K87932577,CDK1-5-inhibitor,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3B,BRD-K87932577,CDK1-5-inhibitor,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3B,BRD-K87932577,CDK1-5-inhibitor,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3B,BRD-K87932577,CDK1-5-inhibitor,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3B
DWHXUGDWKAIASB,BRD-K27061362,AMG-337,MET inhibitor,MET,BRD-K27061362,AMG-337,MET inhibitor,MET,BRD-K27061362,AMG-337,MET inhibitor,MET,BRD-K27061362,AMG-337,MET inhibitor,MET
DWJXYEABWRJFSP,BRD-K47177710,DAPT,gamma secretase inhibitor,,BRD-K47177710,DAPT,gamma secretase inhibitor,,BRD-K47177710,DAPT,gamma secretase inhibitor,,BRD-K47177710,DAPT,gamma secretase inhibitor,
DWPQODZAOSWNHB,BRD-K41160163,fenobam,glutamate receptor antagonist,GRM5,BRD-K41160163,fenobam,glutamate receptor antagonist,GRM5,BRD-K41160163,fenobam,glutamate receptor antagonist,GRM5,BRD-K41160163,fenobam,glutamate receptor antagonist,GRM5
DWYMPOCYEZONEA,BRD-K99308954,sodium-monofluorophosphate,,PYGM,BRD-K99308954,sodium-monofluorophosphate,,PYGM,BRD-K99308954,sodium-monofluorophosphate,,PYGM,BRD-K99308954,sodium-monofluorophosphate,,PYGM
DWZAEMINVBZMHQ,BRD-K07955840,PF-05212384,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K07955840,PF-05212384,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K07955840,PF-05212384,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K07955840,PF-05212384,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA
DXCUKNQANPLTEJ,BRD-K97764662,PD-173074,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,BRD-K97764662,PD-173074,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,BRD-K97764662,PD-173074,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,BRD-K97764662,PD-173074,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB
DXDRHHKMWQZJHT,BRD-K33583600,isoliquiritigenin,guanylate cyclase activator,GABBR1,BRD-K33583600,isoliquiritigenin,guanylate cyclase activator,GABBR1,BRD-K33583600,isoliquiritigenin,guanylate cyclase activator,GABBR1,BRD-K33583600,isoliquiritigenin,guanylate cyclase activator,GABBR1
DXEATJQGQHDURZ,BRD-K77139516,ESI-09,EPAC inhibitor,RAPGEF3|RAPGEF4,BRD-K77139516,ESI-09,EPAC inhibitor,RAPGEF3|RAPGEF4,BRD-K77139516,ESI-09,EPAC inhibitor,RAPGEF3|RAPGEF4,BRD-K77139516,ESI-09,EPAC inhibitor,RAPGEF3|RAPGEF4
DXGLGDHPHMLXJC,BRD-K59037100,oxybenzone,lipase inhibitor,LIPE,BRD-K59037100,oxybenzone,lipase inhibitor,LIPE,BRD-K59037100,oxybenzone,lipase inhibitor,LIPE,BRD-K59037100,oxybenzone,lipase inhibitor,LIPE
DXLSPTHQGVGVTN,BRD-M29936662,cis-ACPD,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM7|GRM8,BRD-M29936662,cis-ACPD,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM7|GRM8,BRD-M29936662,cis-ACPD,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM7|GRM8,,,,
DXPOSRCHIDYWHW,BRD-A59337442,xamoterol,adrenergic receptor agonist,ADRB1,BRD-A59337442|BRD-M39942365,xamoterol,adrenergic receptor agonist,ADRB1,BRD-A59337442|BRD-M39942365,xamoterol,adrenergic receptor agonist,ADRB1,BRD-A59337442|BRD-M39942365,xamoterol,adrenergic receptor agonist,ADRB1
DXVUYOAEDJXBPY,BRD-A27828834,hetacillin,bacterial cell wall synthesis inhibitor,,BRD-A27828834,hetacillin,bacterial cell wall synthesis inhibitor,,BRD-A27828834,hetacillin,bacterial cell wall synthesis inhibitor,,BRD-K00005353,hetacillin,bacterial cell wall synthesis inhibitor,
DXYUAIFZCFRPTH,BRD-K78303961,glycitein,tumor necrosis factor release inhibitor,TNF,BRD-K78303961,glycitein,tumor necrosis factor release inhibitor,TNF,BRD-K78303961,glycitein,tumor necrosis factor release inhibitor,TNF,BRD-K78303961,glycitein,tumor necrosis factor release inhibitor,TNF
DXZKTRNEOISOCA,BRD-K45662124,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2,BRD-K45662124,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2,BRD-K45662124,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2,BRD-K45662124,3'-fluorobenzylspiperone,dopamine receptor ligand,DRD2
DYAIAHUQIPBDIP,BRD-A65872513|BRD-K34058848,cefonicid,bacterial cell wall synthesis inhibitor,,BRD-A65872513|BRD-K34058848,cefonicid,bacterial cell wall synthesis inhibitor,,BRD-A65872513|BRD-K34058848,cefonicid,bacterial cell wall synthesis inhibitor,,BRD-A65872513|BRD-K34058848,cefonicid,bacterial cell wall synthesis inhibitor,
DYDCUQKUCUHJBH,BRD-K87226815,cycloserine-(d),bacterial cell wall synthesis inhibitor,GRIN1,BRD-K87226815,cycloserine-(d),bacterial cell wall synthesis inhibitor,GRIN1,BRD-K53226837|BRD-K87226815,cycloserine-(d),bacterial cell wall synthesis inhibitor,GRIN1,BRD-K53226837|BRD-K87226815,cycloserine-(D),bacterial cell wall synthesis inhibitor,GRIN1
DYEFUKCXAQOFHX,BRD-K29359156,ebselen,H+/K+-ATPase inhibitor|cyclooxygenase inhibitor|glutathione peroxidase agonist|nitric oxide synthase inhibitor,ALB,BRD-K29359156,ebselen,H+/K+-ATPase inhibitor|cyclooxygenase inhibitor|glutathione peroxidase agonist|nitric oxide synthase inhibitor,ALB,BRD-K29359156,ebselen,H+/K+-ATPase inhibitor|cyclooxygenase inhibitor|glutathione peroxidase agonist|nitric oxide synthase inhibitor,ALB,BRD-K29359156,ebselen,H+/K+-ATPase inhibitor|cyclooxygenase inhibitor|glutathione peroxidase agonist|nitric oxide synthase inhibitor,ALB
DYGBNAYFDZEYBA,BRD-K87454346,NVP-TNKS656,tankyrase inhibitor,TNKS2,BRD-K87454346,NVP-TNKS656,tankyrase inhibitor,TNKS2,BRD-K87454346,NVP-TNKS656,tankyrase inhibitor,TNKS2,BRD-K87454346,NVP-TNKS656,tankyrase inhibitor,TNKS2
DYHAMRNAHTWYKY,BRD-K47409078,LH846,casein kinase inhibitor,CSNK1D,BRD-K47409078,LH846,casein kinase inhibitor,CSNK1D,BRD-K47409078,LH846,casein kinase inhibitor,CSNK1D,BRD-K47409078,LH846,casein kinase inhibitor,CSNK1D
DYLGFOYVTXJFJP,BRD-A05926236|BRD-A58804007,lumefantrine,antimalarial agent,ATP1A1,BRD-A05926236|BRD-A58804007,lumefantrine,antimalarial agent,ATP1A1,BRD-A05926236|BRD-A58804007,lumefantrine,antimalarial agent,ATP1A1,BRD-A05926236|BRD-A58804007,lumefantrine,antimalarial agent,ATP1A1
DYLJVOXRWLXDIG,BRD-K25075681,meclinertant,neurotensin receptor antagonist,NTSR1|NTSR2,BRD-K25075681,meclinertant,neurotensin receptor antagonist,NTSR1|NTSR2,BRD-K25075681,meclinertant,neurotensin receptor antagonist,NTSR1|NTSR2,BRD-K25075681,meclinertant,neurotensin receptor antagonist,NTSR1|NTSR2
DYLUUSLLRIQKOE,BRD-K70601687,enasidenib,isocitrate dehydrogenase inhibitor,IDH1,BRD-K70601687,enasidenib,isocitrate dehydrogenase inhibitor,IDH1,BRD-K70601687,enasidenib,isocitrate dehydrogenase inhibitor,IDH1,BRD-K70601687,enasidenib,isocitrate dehydrogenase inhibitor,IDH1
DYNHJHQFHQTFTP,BRD-K22127577,crenolanib,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,BRD-K22127577,crenolanib,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,BRD-K22127577,crenolanib,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,BRD-K22127577,crenolanib,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB
DYSJMQABFPKAQM,BRD-K75282704,BL-5583,hypercalcaemic agent,,BRD-K75282704,BL-5583,hypercalcaemic agent,,BRD-K75282704,BL-5583,hypercalcaemic agent,,BRD-K75282704,BL-5583,hypercalcaemic agent,
DYTOQURYRYYNOR,BRD-K74371986,NSI-189,neurotrophic agent,,BRD-K74371986,NSI-189,neurotrophic agent,,BRD-K74371986,NSI-189,neurotrophic agent,,BRD-K74371986,NSI-189,neurotrophic agent,
DYZJXZOQQRXDLE,BRD-A98427211,suplatast,histamine release inhibitor|immunoglobulin inhibitor,,BRD-A98427211,suplatast,histamine release inhibitor|immunoglobulin inhibitor,,BRD-A98427211,suplatast,histamine release inhibitor|immunoglobulin inhibitor,,BRD-A98427211,suplatast,histamine release inhibitor|immunoglobulin inhibitor,
DZFZXPPHBWCXPQ,BRD-K67262033,TAK-593,VEGFR inhibitor,PDGFRA,BRD-K67262033,TAK-593,VEGFR inhibitor,PDGFRA,BRD-K67262033,TAK-593,VEGFR inhibitor,PDGFRA,BRD-K67262033,TAK-593,VEGFR inhibitor,PDGFRA
DZLNHFMRPBPULJ,BRD-A38592941,timonacic,antioxidant,ANXA5,BRD-A38592941,timonacic,antioxidant,ANXA5,BRD-A38592941,timonacic,antioxidant,ANXA5,BRD-K00003683,timonacic,antioxidant,
DZLOHEOHWICNIL,BRD-K32405725,etomoxir,carnitine palmitoyltransferase inhibitor,CPT1A,BRD-K32405725,etomoxir,carnitine palmitoyltransferase inhibitor,CPT1A,BRD-K32405725,etomoxir,carnitine palmitoyltransferase inhibitor,CPT1A,BRD-K32405725,etomoxir,carnitine palmitoyltransferase inhibitor,CPT1A
DZQLVVLATXPWBK,BRD-K16664969,GTP-14564,FLT3 inhibitor|tyrosine kinase inhibitor,CSF1R|FLT3|KIT|PDGFRB,BRD-K16664969,GTP-14564,FLT3 inhibitor|tyrosine kinase inhibitor,CSF1R|FLT3|KIT|PDGFRB,BRD-K16664969,GTP-14564,FLT3 inhibitor|tyrosine kinase inhibitor,CSF1R|FLT3|KIT|PDGFRB,BRD-K16664969,GTP-14564,FLT3 inhibitor|tyrosine kinase inhibitor,CSF1R|FLT3|KIT|PDGFRB
DZTKAWPWXGIREW,BRD-A15750551,lymecycline,bacterial 50S ribosomal subunit inhibitor,,BRD-A15750551,lymecycline,bacterial 50S ribosomal subunit inhibitor,,BRD-A15750551|BRD-A58731732,lymecycline,bacterial 50S ribosomal subunit inhibitor,,BRD-K00004536,lymecycline,bacterial 50S ribosomal subunit inhibitor,
DZZWHBIBMUVIIW,BRD-A26423207|BRD-K07612980,sparfloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A26423207|BRD-K07612980,sparfloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A26423207|BRD-K07612980,sparfloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A26423207|BRD-K07612980,sparfloxacin,bacterial DNA gyrase inhibitor,TOP2A
FABPRXSRWADJSP,BRD-K66615216,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K66615216,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K66615216,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K66615216,moxifloxacin,bacterial DNA gyrase inhibitor,TOP2A
FABQUVYDAXWUQP,BRD-K42624714,BML-284,WNT agonist,,BRD-K42624714,BML-284,WNT agonist,,BRD-K42624714,BML-284,WNT agonist,,BRD-K42624714,BML-284,WNT agonist,
FABUFPQFXZVHFB,BRD-K03601870,ixabepilone,microtubule stabilizing agent,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-K03601870,ixabepilone,microtubule stabilizing agent,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-K03601870,ixabepilone,microtubule stabilizing agent,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-K03601870,ixabepilone,microtubule stabilizing agent,TUBB
FAEKWTJYAYMJKF,BRD-K82846253,repaglinide,insulin secretagogue,ABCC8|KCNJ11|PPARG,BRD-K82846253,repaglinide,insulin secretagogue,ABCC8|KCNJ11|PPARG,BRD-K82846253,repaglinide,insulin secretagogue,ABCC8|KCNJ11|PPARG,BRD-K82846253,repaglinide,insulin secretagogue,ABCC8|KCNJ11|PPARG
FAGUFWYHJQFNRV,BRD-K41298358,tetraethylenepentamine,superoxide dismutase inhibitor,SOD1|SOD2,BRD-K41298358,tetraethylenepentamine,superoxide dismutase inhibitor,SOD1|SOD2,BRD-K41298358,tetraethylenepentamine,superoxide dismutase inhibitor,SOD1|SOD2,BRD-K41298358,tetraethylenepentamine,superoxide dismutase inhibitor,SOD1|SOD2
FAIIFDPAEUKBEP,BRD-A84687895,nilvadipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1S|CACNA2D1|CACNA2D3|CACNB2,BRD-A84687895,nilvadipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1S|CACNA2D1|CACNA2D3|CACNB2,BRD-A84687895,nilvadipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1S|CACNA2D1|CACNA2D3|CACNB2,BRD-A84687895,nilvadipine,calcium channel blocker,CACNA1C|CACNA1D
FAKRSMQSSFJEIM,BRD-K54529596|BRD-K96855766,captopril,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9,BRD-K54529596|BRD-K96855766,captopril,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9,BRD-K54529596|BRD-K96855766,captopril,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9,BRD-K54529596|BRD-K96855766,captopril,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9
FAOMZVDZARKPFJ,BRD-K30930903,WIN-18446,aldehyde dehydrogenase inhibitor,ALDH1A2,BRD-K30930903,WIN-18446,aldehyde dehydrogenase inhibitor,ALDH1A2,BRD-K30930903,WIN-18446,aldehyde dehydrogenase inhibitor,ALDH1A2,BRD-K30930903,WIN-18446,aldehyde dehydrogenase inhibitor,ALDH1A2
FAOZLTXFLGPHNG,BRD-A13133631,fluorometholone,glucocorticoid receptor agonist,NR3C1,BRD-A13133631,fluorometholone,glucocorticoid receptor agonist,NR3C1,BRD-A13133631,fluorometholone,glucocorticoid receptor agonist,NR3C1,BRD-K64862097,fluorometholone,glucocorticoid receptor agonist,NR3C1
FARMEEAGJWMFSZ,BRD-K36198571,WAY-170523,metalloproteinase inhibitor,MMP13,BRD-K36198571,WAY-170523,metalloproteinase inhibitor,MMP13,BRD-K36198571,WAY-170523,metalloproteinase inhibitor,MMP13,BRD-K36198571,WAY-170523,metalloproteinase inhibitor,MMP13
FASDKYOPVNHBLU,BRD-K06388322,pramipexole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K06388322,pramipexole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K06388322,pramipexole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K06388322,pramipexole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
FATBGEAMYMYZAF,BRD-K06644925,oleamide,cannabinoid receptor agonist,HTR7|PLA2G2A,BRD-K06644925,oleamide,cannabinoid receptor agonist,HTR7|PLA2G2A,BRD-K06644925,oleamide,cannabinoid receptor agonist,HTR7|PLA2G2A,BRD-K06644925,oleamide,cannabinoid receptor agonist,HTR7|PLA2G2A
FATGTHLOZSXOBC,BRD-K36463073,OC000459,CRTH receptor antagonist,PTGDR2,BRD-K36463073,OC000459,CRTH receptor antagonist,PTGDR2,BRD-K36463073,OC000459,CRTH receptor antagonist,PTGDR2,BRD-K36463073,OC000459,CRTH receptor antagonist,PTGDR2
FAXGPCHRFPCXOO,BRD-K13571841,pepstatin,aspartic protease inhibitor,CTSB|CTSD|CTSL|REN,BRD-K13571841,pepstatin,aspartic protease inhibitor,CTSB|CTSD|CTSL|REN,BRD-K13571841,pepstatin,aspartic protease inhibitor,CTSB|CTSD|CTSL|REN,BRD-K13571841,pepstatin,aspartic protease inhibitor,CTSB|CTSD|CTSL|REN
FAYAUAZLLLJJGH,BRD-K71512533,SNS-314,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K71512533,SNS-314,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K71512533,SNS-314,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K71512533,SNS-314,Aurora kinase inhibitor,AURKA|AURKB|AURKC
FBHSPRKOSMHSIF,BRD-K94177716,deflazacort,glucocorticoid receptor agonist,NR3C1,BRD-K96006502,deflazacort,glucocorticoid receptor agonist,NR3C1,BRD-K94177716|BRD-K96006502,deflazacort,glucocorticoid receptor agonist,NR3C1,BRD-K30468934,deflazacort,glucocorticoid receptor agonist,NR3C1
FBKMWOJEPMPVTQ,BRD-K79450420,INCB-024360,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K79450420,INCB-024360,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-A15458132|BRD-K67385813|BRD-K79450420,INCB-024360|epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-A15458132|BRD-K67385813|BRD-K79450420,epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1
FBLPQCAQRNSVHB,BRD-K14711741,PF-4708671,ribosomal protein inhibitor,RPS6KB1,BRD-K14711741,PF-4708671,ribosomal protein inhibitor,RPS6KB1,BRD-K14711741,PF-4708671,ribosomal protein inhibitor,RPS6KB1,BRD-K14711741,PF-4708671,ribosomal protein inhibitor,RPS6KB1
FBNPHFBYHYNMHC,BRD-K36775483,DMeOB,,GRM5,BRD-K36775483,DMeOB,,GRM5,BRD-K36775483|BRD-K77961099,DMeOB,,GRM5,BRD-K36775483|BRD-K77961099,DMeOB,glutamate receptor modulator,GRM5
FBOUYBDGKBSUES,BRD-K24723746,solifenacin-succinate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K24723746,solifenacin-succinate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K24723746,solifenacin-succinate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K00003600,solifenacin-succinate,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
FBOZXECLQNJBKD,BRD-A55424491|BRD-K59456551,methotrexate,dihydrofolate reductase inhibitor,DHFR,BRD-A55424491|BRD-K59456551,methotrexate,dihydrofolate reductase inhibitor,DHFR,BRD-A55424491|BRD-K59456551,methotrexate,dihydrofolate reductase inhibitor,DHFR,BRD-K59456551,methotrexate,dihydrofolate reductase inhibitor,DHFR
FBPFZTCFMRRESA,BRD-K30374899|BRD-K36513555|BRD-K66035042,mannitol-D|sorbitol,diuretic|mucolytic agent,,BRD-K30374899|BRD-K36513555|BRD-K66035042,mannitol-D|sorbitol,diuretic|mucolytic agent,,BRD-K30374899|BRD-K36513555|BRD-K66035042,mannitol-D|sorbitol,diuretic|mucolytic agent,,BRD-K30374899|BRD-K66035042,mannitol-D|sorbitol,diuretic|mucolytic agent,
FBRAWBYQGRLCEK,BRD-K58810291,clobetasone-butyrate,corticosteroid agonist,NR3C1,BRD-K58810291,clobetasone-butyrate,corticosteroid agonist,NR3C1,BRD-K58810291,clobetasone-butyrate,corticosteroid agonist,NR3C1,BRD-K58810291,clobetasone-butyrate,corticosteroid agonist,NR3C1
FBSKJMQYURKNSU,BRD-K36201510,verbascoside,NFkB pathway inhibitor|PKC inhibitor,,BRD-K36201510,verbascoside,NFkB pathway inhibitor|PKC inhibitor,,BRD-K36201510,verbascoside,NFkB pathway inhibitor|PKC inhibitor,,BRD-K36201510,verbascoside,NFkB pathway inhibitor|PKC inhibitor,
FBVFZWUMDDXLLG,BRD-K85503079,perospirone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|DRD3|DRD4,BRD-K85503079,perospirone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|DRD3|DRD4,BRD-K85503079,perospirone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|DRD3|DRD4,BRD-K85503079,perospirone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|DRD3|DRD4
FBWNMEQMRUMQSO,BRD-K88625236,nonoxynol-9,membrane integrity inhibitor,,BRD-K88625236,nonoxynol-9,membrane integrity inhibitor,,BRD-K88625236,nonoxynol-9,membrane integrity inhibitor,,BRD-K88625236,nonoxynol-9,membrane integrity inhibitor,
FCCDDURTIIUXBY,BRD-A14440173,lipoamide,,,BRD-A14440173,lipoamide,,,BRD-A14440173,lipoamide,,,BRD-A14440173,lipoamide,,
FCDLCPWAQCPTKC,BRD-K27335680,rhein,,HSP90AA1,BRD-K27335680,rhein,,HSP90AA1,BRD-K27335680,rhein,,HSP90AA1,BRD-K27335680,rhein,,HSP90AA1
FCDRFVCGMLUYPG,BRD-K15791587,L-733060,tachykinin antagonist,TACR1,BRD-K15791587,L-733060,tachykinin antagonist,TACR1,BRD-K15791587,L-733060,tachykinin antagonist,TACR1,BRD-K15791587,L-733060,tachykinin antagonist,TACR1
FCEPUTGEUCVRRI,BRD-A65793993,BTS-72664,GABA receptor antagonist,GABBR1,BRD-A65793993,BTS-72664,GABA receptor antagonist,GABBR1,BRD-A65793993,BTS-72664,GABA receptor antagonist,GABBR1,BRD-A65793993,BTS-72664,GABA receptor antagonist,GABBR1
FCKJYANJHNLEEP,BRD-K02965577,secalciferol,vitamin D receptor agonist,VDR,BRD-K02965577,secalciferol,vitamin D receptor agonist,VDR,BRD-K02965577,secalciferol,vitamin D receptor agonist,VDR,BRD-K02965577,secalciferol,vitamin D receptor agonist,VDR
FDAYLTPAFBGXAB,BRD-K29888499,trichlormethine,DNA alkylating agent,,BRD-K29888499,trichlormethine,DNA alkylating agent,,BRD-K29888499,trichlormethine,DNA alkylating agent,,,,,
FDDDEECHVMSUSB,BRD-K02594908,sulfanilamide,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,BRD-K02594908,sulfanilamide,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,BRD-K02594908,sulfanilamide,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,BRD-K02594908,sulfanilamide,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4
FDGQSTZJBFJUBT,BRD-K03739921,hypoxanthine,PARP inhibitor,PNP,BRD-K03739921,hypoxanthine,PARP inhibitor,PNP,BRD-K03739921,hypoxanthine,PARP inhibitor,PNP,BRD-K03739921,hypoxanthine,PARP inhibitor,PNP
FDJAKSHVOONYHX,BRD-A20686268,trebenzomine,,,BRD-A20686268,trebenzomine,,,BRD-A20686268,trebenzomine,,,BRD-A20686268,trebenzomine,,
FDKXTQMXEQVLRF,BRD-K35520305,dacarbazine,DNA alkylating agent,PGD|POLA2,BRD-K35520305,dacarbazine,DNA alkylating agent,PGD|POLA2,BRD-K35520305,dacarbazine,DNA alkylating agent,PGD|POLA2,BRD-K35520305,dacarbazine,DNA alkylating agent,PGD|POLA2
FDLYAMZZIXQODN,BRD-K02113016,olaparib,PARP inhibitor,PARP1|PARP2,BRD-K02113016,olaparib,PARP inhibitor,PARP1|PARP2,BRD-K02113016,olaparib,PARP inhibitor,PARP1|PARP2,BRD-K02113016,olaparib,PARP inhibitor,PARP1|PARP2
FDMBBCOBEAVDAO,BRD-A09062839,amyleine,local anesthetic,,BRD-A09062839,amyleine,local anesthetic,,BRD-A09062839,amyleine,local anesthetic,,BRD-A09062839,amyleine,local anesthetic,
FDMQDKQUTRLUBU,BRD-K60421517,olmutinib,Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor,BTK|EGFR,BRD-K60421517,olmutinib,Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor,BTK|EGFR,BRD-K60421517,olmutinib,Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor,BTK|EGFR,BRD-K60421517,olmutinib,Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor,BTK|EGFR
FDORQEIHOKEJNX,BRD-K53979406,ALX-5407,Glycine transporter 1 inhibitor,SLC6A9,BRD-K53979406,ALX-5407,Glycine transporter 1 inhibitor,SLC6A9,BRD-K53979406,ALX-5407,Glycine transporter 1 inhibitor,SLC6A9,BRD-K53979406,ALX-5407,glycine transporter inhibitor,SLC6A9
FDQAOULAVFHKBX,BRD-A06629414,silymarin,,,BRD-A06629414,silymarin,,,BRD-A06629414,silymarin,,,BRD-A06629414,silymarin,,
FEBLZLNTKCEFIT,BRD-A77824596|BRD-K95627890,fluocinolone-acetonide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A77824596|BRD-K94353609,fluocinolone-acetonide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A77824596|BRD-K94353609|BRD-K95627890,fluocinolone-acetonide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A77824596|BRD-K94353609|BRD-K95627890,fluocinolone-acetonide,glucocorticoid receptor agonist,NR3C1|SERPINA6
FEBOTPHFXYHVPL,BRD-K79425933,benperidol,dopamine receptor antagonist,DRD2,BRD-K79425933,benperidol,dopamine receptor antagonist,DRD2,BRD-K79425933,benperidol,dopamine receptor antagonist,DRD2,BRD-K79425933,benperidol,dopamine receptor antagonist,DRD2
FECGNJPYVFEKOD,BRD-K28822270,resminostat,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,BRD-K28822270,resminostat,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,BRD-K28822270,resminostat,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,BRD-K28822270,resminostat,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8
FECQXVPRUCCUIL,BRD-K67304264,SKA-31,potassium channel activator,KCNN4,BRD-K67304264,SKA-31,potassium channel activator,KCNN4,BRD-K67304264,SKA-31,potassium channel activator,KCNN4,BRD-K67304264,SKA-31,potassium channel activator,KCNN4
FEEOFPAEDSMOTO,BRD-K22631935,neurodazine,neurogenesis of non-pluripotent C2C12 myoblast inducer,,BRD-K22631935,neurodazine,neurogenesis of non-pluripotent C2C12 myoblast inducer,,BRD-K22631935,neurodazine,neurogenesis of non-pluripotent C2C12 myoblast inducer,,BRD-K22631935,neurodazine,neurogenesis of non-pluripotent C2C12 myoblast inducer,
FEJVSJIALLTFRP,BRD-K54863166,darusentan,endothelin receptor antagonist,EDNRA,BRD-K54863166,darusentan,endothelin receptor antagonist,EDNRA,BRD-K54863166,darusentan,endothelin receptor antagonist,EDNRA,BRD-K54863166,darusentan,endothelin receptor antagonist,EDNRA
FELGMEQIXOGIFQ,BRD-A19736161,ondansetron,serotonin receptor antagonist,HTR1A|HTR1B|HTR3A|HTR3B|HTR4|OPRM1,BRD-A19736161,ondansetron,serotonin receptor antagonist,HTR1A|HTR1B|HTR3A|HTR3B|HTR4|OPRM1,BRD-A19736161,ondansetron,serotonin receptor antagonist,HTR1A|HTR1B|HTR3A|HTR3B|HTR4|OPRM1,BRD-K01826546,ondansetron,serotonin receptor antagonist,HTR3A|HTR3B
FELYAZAWTURXNF,BRD-A68478444,nanchangmycin,other antibiotic,,BRD-A73871920,nanchangmycin,other antibiotic,,BRD-A68478444|BRD-A73871920,nanchangmycin,other antibiotic,,BRD-A68478444|BRD-A73871920,nanchangmycin,other antibiotic,
FEPBITJSIHRMRT,BRD-K41024817,4-phenolsulfonic-acid,,,BRD-K41024817,4-phenolsulfonic-acid,,,BRD-K41024817,4-phenolsulfonic-acid,,,BRD-K41024817,4-phenolsulfonic-acid,,
FERIUCNNQQJTOY,BRD-K05878375,sodium-butyrate,HDAC inhibitor,BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8,BRD-K05878375,sodium-butyrate,HDAC inhibitor,BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8,BRD-K05878375,sodium-butyrate,HDAC inhibitor,BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8,BRD-K05878375,sodium-butyrate,HDAC inhibitor,BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8
FEROPKNOYKURCJ,BRD-A65615053,zacopride,serotonin receptor antagonist,HTR3A|HTR3B|HTR4|HTR5A,BRD-A65615053,zacopride,serotonin receptor antagonist,HTR3A|HTR3B|HTR4|HTR5A,BRD-A65615053,zacopride,serotonin receptor antagonist,HTR3A|HTR3B|HTR4|HTR5A,BRD-K01826799,zacopride,serotonin receptor antagonist,HTR3A|HTR3B|HTR4|HTR5A
FEWJPZIEWOKRBE,BRD-K36474365,tartaric-acid,antioxidant,ATP6V1C1|B3GAT1|DDX6|HIF1AN|TREM1,BRD-K36474365,tartaric-acid,antioxidant,ATP6V1C1|B3GAT1|DDX6|HIF1AN|TREM1,BRD-K36474365,tartaric-acid,antioxidant,ATP6V1C1|B3GAT1|DDX6|HIF1AN|TREM1,BRD-K36474365,tartaric-acid,antioxidant,
FEZBIKUBAYAZIU,BRD-K34415467,trimethobenzamide,histamine receptor antagonist,DRD2,BRD-K34415467,trimethobenzamide,histamine receptor antagonist,DRD2,BRD-K34415467,trimethobenzamide,histamine receptor antagonist,DRD2,BRD-K34415467,trimethobenzamide,histamine receptor antagonist,DRD2
FFBDFADSZUINTG,BRD-K01824921,DPCPX,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K01824921,DPCPX,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K01824921,DPCPX,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K01824921,DPCPX,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
FFEARJCKVFRZRR,BRD-A39515206|BRD-K06502269,L-methionine|methionine,|voltage-gated calcium channel ligand,|BHMT|BHMT2|METAP2|MTR|MTRR,BRD-A39515206|BRD-K06502269,L-methionine|methionine,|voltage-gated calcium channel ligand,|BHMT|BHMT2|METAP2|MTR|MTRR,BRD-A39515206|BRD-K06502269,L-methionine|methionine,|voltage-gated calcium channel ligand,|BHMT|BHMT2|METAP2|MTR|MTRR,BRD-A39515206|BRD-K06502269,L-methionine|methionine,|voltage-gated calcium channel ligand,BHMT|BHMT2|METAP2|MTR|MTRR
FFGPTBGBLSHEPO,BRD-K71799949,carbamazepine,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K71799949,carbamazepine,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K71799949,carbamazepine,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K71799949,carbamazepine,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
FFHBJDQSGDNCIV,BRD-K06328344,bremelanotide,melanocortin receptor agonist,MC1R|MC2R|MC3R|MC4R|MC5R,BRD-K06328344,bremelanotide,melanocortin receptor agonist,MC1R|MC2R|MC3R|MC4R|MC5R,BRD-K06328344,bremelanotide,melanocortin receptor agonist,MC1R|MC2R|MC3R|MC4R|MC5R,BRD-K06328344,bremelanotide,melanocortin receptor agonist,MC1R|MC2R|MC3R|MC4R|MC5R
FFINMCNLQNTKLU,BRD-K67261995,iodipamide,radiopaque medium,ALB,BRD-K67261995,iodipamide,radiopaque medium,ALB,BRD-K67261995,iodipamide,radiopaque medium,ALB,BRD-K67261995,iodipamide,radiopaque medium,ALB
FFKUDWZICMJVPA,BRD-K28687144,fosfosal,phosphodiesterase inhibitor,PTGS1|PTGS2,BRD-K28687144,fosfosal,phosphodiesterase inhibitor,PTGS1|PTGS2,BRD-K28687144,fosfosal,phosphodiesterase inhibitor,PTGS1|PTGS2,BRD-K28687144,fosfosal,phosphodiesterase inhibitor,PTGS1|PTGS2
FFNALGMMTUDHGT,BRD-M11664367,silver-sulfadiazine,PABA antagonist,,BRD-M11664367,silver-sulfadiazine,PABA antagonist,,,,,,,,,
FFNWMBDISAYHDC,BRD-K15868788,SDZ-205-557,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K15868788,SDZ-205-557,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K15868788,SDZ-205-557,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K15868788,SDZ-205-557,serotonin receptor antagonist,HTR3A|HTR3B
FFUBTEITUNMMOK,BRD-K29562203,SCH-202676,G protein-coupled receptor modulator,CHRM1|CHRM2|DRD1|DRD2,BRD-K29562203,SCH-202676,G protein-coupled receptor modulator,CHRM1|CHRM2|DRD1|DRD2,BRD-K29562203,SCH-202676,G protein-coupled receptor modulator,CHRM1|CHRM2|DRD1|DRD2,BRD-K29562203,SCH-202676,G protein-coupled receptor modulator,CHRM1|CHRM2|DRD1|DRD2
FFWOKTFYGVYKIR,BRD-K67772619,rheochrysidin,protein tyrosine kinase inhibitor,PTPN1,BRD-K67772619,rheochrysidin,protein tyrosine kinase inhibitor,PTPN1,BRD-K67772619,rheochrysidin,protein tyrosine kinase inhibitor,PTPN1,BRD-K67772619,rheochrysidin,protein tyrosine kinase inhibitor,PTPN1
FFXVTQDGTKEXHF,BRD-K11046126,VUF10166,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K11046126,VUF10166,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K11046126,VUF10166,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K11046126,VUF10166,serotonin receptor antagonist,HTR3A|HTR3B
FFYNAVGJSYHHFO,BRD-A34358106,sarpogrelate,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-A34358106,sarpogrelate,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-A34358106,sarpogrelate,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-A34358106,sarpogrelate,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
FGQFOYHRJSUHMR,BRD-K75024268,lesinurad,uric acid diuretic,SLC22A12,BRD-K75024268,lesinurad,uric acid diuretic,SLC22A12,BRD-K75024268,lesinurad,uric acid diuretic,SLC22A12,BRD-K75024268,lesinurad,uric acid diuretic,SLC22A12
FGSGBQAQSPSRJK,BRD-K95701999,metaphit,phencyclidine receptor acylator,,BRD-K95701999,metaphit,phencyclidine receptor acylator,,BRD-K95701999,metaphit,phencyclidine receptor acylator,,BRD-K95701999,metaphit,phencyclidine receptor acylator,
FGTCROZDHDSNIO,BRD-K25340465,OSI-930,KIT inhibitor|VEGFR inhibitor,KDR|KIT,BRD-K25340465,OSI-930,KIT inhibitor|VEGFR inhibitor,KDR|KIT,BRD-K25340465,OSI-930,KIT inhibitor|VEGFR inhibitor,KDR|KIT,BRD-K25340465,OSI-930,KIT inhibitor|VEGFR inhibitor,FLT1|KDR|KIT
FGXWKSZFVQUSTL,BRD-K38305202,domperidone,dopamine receptor antagonist,DRD2|DRD3,BRD-K38305202,domperidone,dopamine receptor antagonist,DRD2|DRD3,BRD-K38305202,domperidone,dopamine receptor antagonist,DRD2|DRD3,BRD-K38305202,domperidone,dopamine receptor antagonist,DRD2|DRD3
FHBQKTSCJKPYIO,BRD-K96571715,teicoplanin-a2-3,bacterial cell wall synthesis inhibitor,,BRD-K96571715,teicoplanin-a2-3,bacterial cell wall synthesis inhibitor,,BRD-K96571715,teicoplanin-a2-3,bacterial cell wall synthesis inhibitor,,BRD-K96571715,teicoplanin-A2-3,bacterial cell wall synthesis inhibitor,
FHCSBLWRGCOVPT,BRD-K85849709,AZD2858,glycogen synthase kinase inhibitor,GSK3B,BRD-K85849709,AZD2858,glycogen synthase kinase inhibitor,GSK3B,BRD-K85849709,AZD2858,glycogen synthase kinase inhibitor,GSK3B,BRD-K85849709,AZD2858,glycogen synthase kinase inhibitor,GSK3B
FHFYDNQZQSQIAI,BRD-K55034111,pefloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K55034111,pefloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K55034111,pefloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K55034111,pefloxacin,bacterial DNA gyrase inhibitor,TOP2A
FHGJSJFIQNQBCK,BRD-K53852914,menbutone,,,BRD-K53852914,menbutone,,,BRD-K53852914,menbutone,,,BRD-K53852914,menbutone,,
FHHHOYXPRDYHEZ,BRD-K51784806,alacepril,angiotensin converting enzyme inhibitor,ACE,BRD-K51784806,alacepril,angiotensin converting enzyme inhibitor,ACE,BRD-K51784806,alacepril,angiotensin converting enzyme inhibitor,ACE,BRD-K51784806,alacepril,angiotensin converting enzyme inhibitor,ACE
FHIVAFMUCKRCQO,BRD-K60567437,dimpylate,acetylcholinesterase inhibitor,ACHE,BRD-K60567437,dimpylate,acetylcholinesterase inhibitor,ACHE,BRD-K60567437,dimpylate,acetylcholinesterase inhibitor,ACHE,BRD-K60567437,dimpylate,acetylcholinesterase inhibitor,ACHE
FHXBMXJMKMWVRG,BRD-K53319039,estradiol-acetate,estrogen receptor agonist,ESR1,BRD-K53319039,estradiol-acetate,estrogen receptor agonist,ESR1,BRD-K53319039,estradiol-acetate,estrogen receptor agonist,ESR1,BRD-K53319039,estradiol-acetate,estrogen receptor agonist,ESR1
FHYUGAJXYORMHI,BRD-K67298865,SB-431542,TGF beta receptor inhibitor,ACVR1C|TGFBR1,BRD-K67298865,SB-431542,TGF beta receptor inhibitor,ACVR1C|TGFBR1,BRD-K67298865,SB-431542,TGF beta receptor inhibitor,ACVR1C|TGFBR1,BRD-K67298865,SB-431542,TGF beta receptor inhibitor,ACVR1C|TGFBR1
FIADGNVRKBPQEU,BRD-K75958195,pizotifen,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C,BRD-K75958195,pizotifen,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C,BRD-K75958195,pizotifen,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C,BRD-K75958195,pizotifen,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C
FIAFUQMPZJWCLV,BRD-K70327167,suramin,DNA synthesis inhibitor,F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5,BRD-K70327167,suramin,DNA synthesis inhibitor,F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5,BRD-K70327167,suramin,DNA synthesis inhibitor,F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5,BRD-K70327167,suramin,DNA synthesis inhibitor,F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5
FIHJKUPKCHIPAT,BRD-K17944737|BRD-K65768634,artesunate,DNA synthesis inhibitor,,BRD-K17944737|BRD-K54634444,artesunate,DNA synthesis inhibitor,,BRD-K17944737|BRD-K54634444|BRD-K65768634,artesunate,DNA synthesis inhibitor,,BRD-K17944737|BRD-K54634444|BRD-K65768634,artesunate,DNA synthesis inhibitor,
FIIXCJGBCCCOQQ,BRD-A21428877,SNAP-5089,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D,BRD-A21428877,SNAP-5089,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D,BRD-A21428877,SNAP-5089,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D,BRD-A21428877,SNAP-5089,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D
FIKUEZUFASUKAH,BRD-K40002998,org-26576,glutamate receptor modulator,,BRD-K40002998,org-26576,glutamate receptor modulator,,BRD-K40002998,org-26576,glutamate receptor modulator,,BRD-K40002998,ORG-26576,glutamate receptor modulator,
FIMXSEMBHGTNKT,BRD-K75923785,scopine,,,BRD-K75923785,scopine,,,BRD-K75923785,scopine,,,BRD-K75923785,scopine,,
FIMYFEGKMOCQKT,BRD-K64538373,Ro-4987655,MEK inhibitor,MAP2K1,BRD-K64538373,Ro-4987655,MEK inhibitor,MAP2K1,BRD-K64538373,Ro-4987655,MEK inhibitor,MAP2K1,BRD-K64538373,Ro-4987655,MEK inhibitor,MAP2K1
FINHMKGKINIASC,BRD-K25691735,chuanxiongzine,,,BRD-K25691735,chuanxiongzine,,,BRD-K25691735,chuanxiongzine,,,BRD-K25691735,chuanxiongzine,,
FIOIJUCPVZEPFX,BRD-K73746696,HLCL-61,protein arginine N-methyltransferase inhibitor,PRMT5,BRD-K73746696,HLCL-61,protein arginine N-methyltransferase inhibitor,PRMT5,BRD-K73746696,HLCL-61,protein arginine N-methyltransferase inhibitor,PRMT5,BRD-K73746696,HLCL-61,protein arginine N-methyltransferase inhibitor,PRMT5
FIPWRIJSWJWJAI,BRD-K76452401,piperonyl-butoxide,cytochrome P450 inhibitor,,BRD-K76452401,piperonyl-butoxide,cytochrome P450 inhibitor,,BRD-K76452401,piperonyl-butoxide,cytochrome P450 inhibitor,,BRD-K76452401,piperonyl-butoxide,cytochrome P450 inhibitor,
FIQOFIRCTOWDOW,BRD-K10784860,temocapril,angiotensin converting enzyme inhibitor,ACE,BRD-K10784860,temocapril,angiotensin converting enzyme inhibitor,ACE,BRD-K10784860,temocapril,angiotensin converting enzyme inhibitor,ACE,BRD-K10784860,temocapril,angiotensin converting enzyme inhibitor,ACE
FJCDSQATIJKQKA,BRD-K74396648,EW-7197,TGF beta receptor inhibitor,ACVR1B|TGFBR1,BRD-K74396648,EW-7197,TGF beta receptor inhibitor,ACVR1B|TGFBR1,BRD-K74396648,EW-7197,TGF beta receptor inhibitor,ACVR1B|TGFBR1,BRD-K74396648,EW-7197,TGF beta receptor inhibitor,ACVR1B|TGFBR1
FJCFFCXMEXZEIM,BRD-K20417253,oxiniacic-acid,,,BRD-K20417253,oxiniacic-acid,,,BRD-K20417253,oxiniacic-acid,,,BRD-K20417253,oxiniacic-acid,,
FJDDSMSDZHURBJ,BRD-K25649279,2-iodomelatonin,melatonin receptor agonist,MTNR1A|MTNR1B|NQO2,BRD-K25649279,2-iodomelatonin,melatonin receptor agonist,MTNR1A|MTNR1B|NQO2,BRD-K25649279,2-iodomelatonin,melatonin receptor agonist,MTNR1A|MTNR1B|NQO2,BRD-K25649279,2-iodomelatonin,melatonin receptor agonist,MTNR1A|MTNR1B|NQO2
FJHBVJOVLFPMQE,BRD-K89561498,SN-38,topoisomerase inhibitor,TOP1,BRD-K89561498,SN-38,topoisomerase inhibitor,TOP1,BRD-K89561498,SN-38,topoisomerase inhibitor,TOP1,BRD-K89561498,SN-38,topoisomerase inhibitor,TOP1
FJHHZXWJVIEFGJ,BRD-K31553034,zibotentan,endothelin receptor antagonist,EDNRA,BRD-K31553034,zibotentan,endothelin receptor antagonist,EDNRA,BRD-K31553034,zibotentan,endothelin receptor antagonist,EDNRA,BRD-K31553034,zibotentan,endothelin receptor antagonist,EDNRA
FJLBFSROUSIWMA,BRD-K46862739,metyrapone,cytochrome P450 inhibitor,CYP11B1,BRD-K46862739,metyrapone,cytochrome P450 inhibitor,CYP11B1,BRD-K46862739,metyrapone,cytochrome P450 inhibitor,CYP11B1,BRD-K46862739,metyrapone,cytochrome P450 inhibitor,CYP11B1
FJLGEFLZQAZZCD,BRD-K66296774,fluvastatin,HMGCR inhibitor,HMGCR,BRD-K66296774,fluvastatin,HMGCR inhibitor,HMGCR,BRD-K66296774|BRD-M74726084,fluvastatin,HMGCR inhibitor,HMGCR,BRD-K66296774|BRD-M74726084,fluvastatin,HMGCR inhibitor,HMGCR
FJZZPCZKBUKGGU,BRD-K86410485,eliglustat,Glycosyl transferase inhibitor,UGCG,BRD-K86410485,eliglustat,Glycosyl transferase inhibitor,UGCG,BRD-K86410485|BRD-M75840137,eliglustat,Glycosyl transferase inhibitor,UGCG,BRD-K86410485|BRD-M75840137,eliglustat,glycosyl transferase inhibitor,UGCG
FKCMADOPPWWGNZ,BRD-K37419961,talabostat,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,DPP4,BRD-K37419961,talabostat,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,DPP4,BRD-K37419961,talabostat,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,DPP4,BRD-K37419961,talabostat,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,DPP4
FKDHHVKWGRFRTG,BRD-K72922393,linsidomine,nitric oxide donor,,BRD-K72922393,linsidomine,nitric oxide donor,,,,,,,,,
FKENQMMABCRJMK,BRD-A12490291|BRD-K44133266|BRD-K85679373,sulbactam,beta lactamase inhibitor,,BRD-A12490291|BRD-K44133266|BRD-K85679373,sulbactam,beta lactamase inhibitor,,BRD-A12490291|BRD-K44133266|BRD-K85679373,sulbactam,beta lactamase inhibitor,,BRD-K44133266|BRD-K85679373,sulbactam,beta lactamase inhibitor,
FKMJXALNHKIDOD,BRD-K72231366,TAME,,,BRD-K72231366,TAME,,,BRD-K72231366,TAME,,,BRD-K72231366,TAME,,
FKNXQNWAXFXVNW,BRD-K78666826,procaterol,adrenergic receptor agonist,ADRB2,BRD-K78666826,procaterol,adrenergic receptor agonist,ADRB2,BRD-K78666826,procaterol,adrenergic receptor agonist,ADRB2,BRD-K78666826,procaterol,adrenergic receptor agonist,ADRB2
FKPLJWGRBCQLTL,BRD-K13888115,LY2365109,Glycine transporter 1 inhibitor,SLC6A9,BRD-K13888115,LY2365109,Glycine transporter 1 inhibitor,SLC6A9,BRD-K13888115,LY2365109,Glycine transporter 1 inhibitor,SLC6A9,BRD-K13888115,LY2365109,glycine transporter inhibitor,SLC6A9
FKRSSPOQAMALKA,BRD-K82861010,daclatasvir,HCV inhibitor,,BRD-K82861010,daclatasvir,HCV inhibitor,,BRD-K82861010,daclatasvir,HCV inhibitor,,BRD-K82861010,daclatasvir,HCV inhibitor,
FKSFKBQGSFSOSM,BRD-K21867462,GSK2816126,histone lysine methyltransferase inhibitor,EZH2,BRD-K21867462,GSK2816126,histone lysine methyltransferase inhibitor,EZH2,BRD-K21867462,GSK2816126,histone lysine methyltransferase inhibitor,EZH2,BRD-K21867462,GSK2816126,histone lysine methyltransferase inhibitor,EZH2
FKUPPRZPSYCDRS,BRD-K36982194,oxacyclohexadecan-2-one,protein kinase inhibitor,,BRD-K36982194,oxacyclohexadecan-2-one,protein kinase inhibitor,,BRD-K36982194,oxacyclohexadecan-2-one,protein kinase inhibitor,,BRD-K36982194,oxacyclohexadecan-2-one,protein kinase inhibitor,
FLBNLJLONKAPLR,BRD-K37492701,BI-847325,Aurora kinase inhibitor|MEK inhibitor,AURKA|AURKB|AURKC|MAP2K1|MAP2K2,BRD-K37492701,BI-847325,Aurora kinase inhibitor|MEK inhibitor,AURKA|AURKB|AURKC|MAP2K1|MAP2K2,BRD-K37492701,BI-847325,Aurora kinase inhibitor|MEK inhibitor,AURKA|AURKB|AURKC|MAP2K1|MAP2K2,BRD-K37492701,BI-847325,Aurora kinase inhibitor|MEK inhibitor,AURKA|AURKB|AURKC|MAP2K1|MAP2K2
FLNXBVJLPJNOSI,BRD-A80908310,cloperastine,antitussive,,BRD-A80908310,cloperastine,antitussive,,BRD-A80908310,cloperastine,antitussive,,BRD-A80908310|BRD-K00003529,cloperastine|cloperastine-fendizoate,antitussive|potassium channel antagonist,
FLOSMHQXBMRNHR,BRD-K13356952,methazolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,BRD-K13356952,methazolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,BRD-K13356952,methazolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,BRD-K00002562,methazolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7
FLSLEGPOVLMJMN,BRD-K42317111,quinaprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K42317111,quinaprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K42317111,quinaprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K42317111,quinaprilat,angiotensin converting enzyme inhibitor,ACE
FLVRDMUHUXVRET,BRD-K08109516,L-701324,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K08109516,L-701324,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K08109516,L-701324,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K08109516,L-701324,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
FLWQSOHPGISTPX,BRD-M97302542,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,PDK1,BRD-M97302542,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,PDK1,BRD-M97302542,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,PDK1,BRD-M97302542,dichloroacetate,pyruvate dehydrogenase kinase inhibitor,
FMCGSUUBYTWNDP,BRD-K82236108,"N-methyl-(-)ephedrine-[1r,2s]",,,BRD-K82236108,"N-methyl-(-)ephedrine-[1r,2s]",,,BRD-K82236108,"N-methyl-(-)ephedrine-[1r,2s]",,,BRD-K82236108,"N-methyl-(-)ephedrine-[1R,2S]",,
FMCRMSOQAVOHRD,BRD-A75369945|BRD-A97502381,cyanocobalamin|vitamin-b12,|methylmalonyl CoA mutase stimulant|vitamin B,|MMAA|MMACHC|MTHFR|MTR|MTRR|MUT,BRD-A75369945,vitamin-b12,,,BRD-A75369945|BRD-M28180999,vitamin-b12,,,,,,
FMGSKLZLMKYGDP,BRD-A79445307|BRD-K85833139,dehydroepiandrosterone,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,BRD-A79445307|BRD-K85833139,dehydroepiandrosterone,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,BRD-A79445307|BRD-K41256143|BRD-K85833139,dehydroepiandrosterone,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,BRD-A79445307|BRD-K41256143|BRD-K85833139,dehydroepiandrosterone,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1
FMHHVULEAZTJMA,BRD-K54790157,trioxsalen,DNA synthesis inhibitor,,BRD-K54790157,trioxsalen,DNA synthesis inhibitor,,BRD-K54790157,trioxsalen,DNA synthesis inhibitor,,BRD-K54790157,trioxsalen,DNA synthesis inhibitor,
FMJSMJQBSVNSBF,BRD-K39023557,octocrylene,,,BRD-K39023557,octocrylene,,,BRD-K39023557,octocrylene,,,BRD-K00003605,octocrylene,,
FMLJREWZCZHGGW,BRD-K91716465,YM-750,ACAT inhibitor,SOAT1,BRD-K91716465,YM-750,ACAT inhibitor,SOAT1,BRD-K91716465,YM-750,ACAT inhibitor,SOAT1,BRD-K91716465,YM-750,ACAT inhibitor,SOAT1
FMRHJJZUHUTGKE,BRD-K95161686,octisalate,,,BRD-K95161686,octisalate,,,BRD-K95161686,octisalate,,,BRD-K00003664,octisalate,,
FMZXNVLFJHCSAF,BRD-K15514357,cefalonium,bacterial cell wall synthesis inhibitor,,BRD-K15514357,cefalonium,bacterial cell wall synthesis inhibitor,,BRD-K15514357,cefalonium,bacterial cell wall synthesis inhibitor,,BRD-K15514357,cefalonium,bacterial cell wall synthesis inhibitor,
FNDDDNOJWPQCBZ,BRD-K86670086,sutezolid,protein synthesis inhibitor,,BRD-K86670086,sutezolid,protein synthesis inhibitor,,BRD-K86670086,sutezolid,protein synthesis inhibitor,,BRD-K86670086,sutezolid,protein synthesis inhibitor,
FNHKPVJBJVTLMP,BRD-K16730910,regorafenib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,BRD-K16730910,regorafenib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,BRD-K16730910,regorafenib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,BRD-K16730910,regorafenib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK
FNKQXYHWGSIFBK,BRD-K36859431,sapropterin,phenylalanine 4-hydroxylase stimulant,NOS3|PAH|TH|TPH1,BRD-K36859431,sapropterin,phenylalanine 4-hydroxylase stimulant,NOS3|PAH|TH|TPH1,BRD-K36859431,sapropterin,phenylalanine 4-hydroxylase stimulant,NOS3|PAH|TH|TPH1,BRD-K36859431,sapropterin,phenylalanine 4-hydroxylase stimulant,NOS3|PAH|TH|TPH1
FNLNSQHJKVQCBP,BRD-A66788520,2-(3-mercaptopropyl)pentanedioic acid,glutamate carboxypeptidase inhibitor,FOLH1,BRD-A66788520,2-(3-mercaptopropyl)pentanedioic acid,glutamate carboxypeptidase inhibitor,FOLH1,BRD-A66788520,2-(3-mercaptopropyl)pentanedioic acid,glutamate carboxypeptidase inhibitor,FOLH1,BRD-A66788520,2-(3-mercaptopropyl)pentanedioic-acid,glutamate carboxypeptidase inhibitor,FOLH1
FNOMTMVRTBHRET,BRD-K65285700,GP1a,cannabinoid receptor agonist,CNR2,BRD-K65285700,GP1a,cannabinoid receptor agonist,CNR2,BRD-K65285700,GP1a,cannabinoid receptor agonist,CNR2,BRD-K65285700,GP1a,cannabinoid receptor agonist,CNR2
FNPXMHRZILFCKX,BRD-A93963402,prednicarbate,phospholipase activator,NR3C1|PLA2G1B,BRD-A93963402,prednicarbate,phospholipase activator,NR3C1|PLA2G1B,BRD-A93963402,prednicarbate,phospholipase activator,NR3C1|PLA2G1B,BRD-A93963402,prednicarbate,phospholipase activator,PLA2G1B
FNQDSLSOLMXCMU,BRD-K86727142,embelin,HCV inhibitor|XIAP inhibitor,XIAP,BRD-K86727142,embelin,HCV inhibitor|XIAP inhibitor,XIAP,BRD-K86727142,embelin,HCV inhibitor|XIAP inhibitor,XIAP,,,,
FNQQBFNIYODEMB,BRD-K58265391,meticrane,diuretic,,BRD-K58265391,meticrane,diuretic,,BRD-K58265391,meticrane,diuretic,,BRD-K58265391,meticrane,diuretic,
FNYGWXSATBUBER,BRD-A56371469,AGI-5198,isocitrate dehydrogenase inhibitor,IDH1,BRD-A56371469,AGI-5198,isocitrate dehydrogenase inhibitor,IDH1,BRD-A56371469,AGI-5198,isocitrate dehydrogenase inhibitor,IDH1,BRD-A56371469,AGI-5198,isocitrate dehydrogenase inhibitor,IDH1
FNYLWPVRPXGIIP,BRD-K92049597,triamterene,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,BRD-K92049597,triamterene,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,BRD-K92049597,triamterene,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,BRD-K92049597,triamterene,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G
FOCVUCIESVLUNU,BRD-K09631521,thiotepa,cytochrome P450 inhibitor,CYP2B6|CYP3A4,BRD-K09631521,thiotepa,cytochrome P450 inhibitor,CYP2B6|CYP3A4,BRD-K09631521,thiotepa,cytochrome P450 inhibitor,CYP2B6|CYP3A4,BRD-K09631521,thiotepa,cytochrome P450 inhibitor,CYP2B6|CYP3A4
FOFDIMHVKGYHRU,BRD-K66538826,amuvatinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,BRD-K66538826,amuvatinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,BRD-K66538826,amuvatinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,BRD-K66538826,amuvatinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET
FOHHNHSLJDZUGQ,BRD-A51964809,halofantrine,antimalarial agent,KCNH2|KCNN4,BRD-A51964809,halofantrine,antimalarial agent,KCNH2|KCNN4,BRD-A51964809,halofantrine,antimalarial agent,KCNH2|KCNN4,BRD-A51964809,halofantrine,antimalarial agent,KCNN4
FOIPWTMKYXWFGC,BRD-K42991124,creatinol-phosphate,,,BRD-K42991124,creatinol-phosphate,,,BRD-K42991124,creatinol-phosphate,,,BRD-K42991124,creatinol-phosphate,,
FOIVPCKZDPCJJY,BRD-K49685476,TTNPB,retinoid receptor agonist,RARA|RARB|RARG,BRD-K49685476,TTNPB,retinoid receptor agonist,RARA|RARB|RARG,BRD-K49685476,TTNPB,retinoid receptor agonist,RARA|RARB|RARG,BRD-K49685476,TTNPB,retinoid receptor agonist,RARA|RARB|RARG
FOLRUCXBTYDAQK,BRD-A00376169,KBG,neprilysin inhibitor,MME,BRD-A00376169,KBG,neprilysin inhibitor,MME,BRD-A00376169,KBG,neprilysin inhibitor,MME,BRD-A00376169,KBG,neprilysin inhibitor,MME
FONRCZUZCHXWBD,BRD-K95902121,THZ2,CDK inhibitor,CDK7,BRD-K95902121,THZ2,CDK inhibitor,CDK7,BRD-K95902121,THZ2,CDK inhibitor,CDK7,BRD-K95902121,THZ2,CDK inhibitor,CDK7
FONSSTYHKIFEBM,BRD-K19409553,GPR120-modulator-1,G protein-coupled receptor modulator,FFAR4,BRD-K19409553,GPR120-modulator-1,G protein-coupled receptor modulator,FFAR4,BRD-K19409553,GPR120-modulator-1,G protein-coupled receptor modulator,FFAR4,BRD-K19409553,GPR120-modulator-1,G protein-coupled receptor modulator,FFAR4
FOORCIAZMIWALX,BRD-K99741577,SANT-1,smoothened receptor antagonist,SHH|SMO,BRD-K99741577,SANT-1,smoothened receptor antagonist,SHH|SMO,BRD-K99741577,SANT-1,smoothened receptor antagonist,SHH|SMO,BRD-K99741577,SANT-1,smoothened receptor antagonist,SHH|SMO
FOTCGZPFSUWZBN,BRD-K95676198,JAK3-inhibitor-V,JAK inhibitor,JAK3,BRD-K95676198,JAK3-inhibitor-V,JAK inhibitor,JAK3,BRD-K95676198,JAK3-inhibitor-V,JAK inhibitor,JAK3,BRD-K95676198,JAK3-inhibitor-V,JAK inhibitor,JAK3
FOUVTBKPJRMLPE,BRD-K71487808,CH55,retinoid receptor binder,RARA|RARB,BRD-K71487808,CH55,retinoid receptor binder,RARA|RARB,BRD-K71487808,CH55,retinoid receptor binder,RARA|RARB,BRD-K71487808,CH55,retinoid receptor binder,RARA|RARB
FPCCSQOGAWCVBH,BRD-K49671696,ketanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,BRD-K49671696,ketanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,BRD-K49671696,ketanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,BRD-K49671696,ketanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2
FPEIJQLXFHKLJV,BRD-K85920262,WAY-600,mTOR inhibitor,MTOR,BRD-K85920262,WAY-600,mTOR inhibitor,MTOR,BRD-K85920262,WAY-600,mTOR inhibitor,MTOR,BRD-K85920262,WAY-600,mTOR inhibitor,MTOR
FPIPGXGPPPQFEQ,BRD-K22429181,retinol,retinoid receptor ligand,ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG,BRD-K22429181,retinol,retinoid receptor ligand,ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG,BRD-K22429181,retinol,retinoid receptor ligand,ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG,BRD-K22429181,retinol,retinoid receptor ligand,ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG
FPOHNWQLNRZRFC,BRD-K02130563,panobinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K02130563,panobinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K02130563,panobinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K02130563,panobinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9
FPPNZSSZRUTDAP,BRD-A13078313,carbenicillin,bacterial cell wall synthesis inhibitor,,BRD-A13078313,carbenicillin,bacterial cell wall synthesis inhibitor,,BRD-A13078313,carbenicillin,bacterial cell wall synthesis inhibitor,,BRD-A13078313,carbenicillin,bacterial cell wall synthesis inhibitor,
FPUXKXIZEIDQKW,BRD-A94702766,ginkgolide-a,GABA receptor antagonist,GLRA1|GLRB,BRD-A95121829,ginkgolide-a,GABA receptor antagonist,GLRA1|GLRB,BRD-A94702766|BRD-A95121829,ginkgolide-a,GABA receptor antagonist,GLRA1|GLRB,BRD-K42679315,ginkgolide-A,GABA receptor antagonist,GLRA1|GLRB
FPVKHBSQESCIEP,BRD-A17154931|BRD-K91543828,pentostatin,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA,BRD-A17154931|BRD-K91543828,pentostatin,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA,BRD-A17154931|BRD-K91543828,pentostatin,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA,BRD-K91543828,pentostatin,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA
FPXPIEZPAXSELW,BRD-A59709458,PHCCC,glutamate receptor agonist,GRM1|GRM4,BRD-A59709458,PHCCC,glutamate receptor agonist,GRM1|GRM4,BRD-A59709458,PHCCC,glutamate receptor agonist,GRM1|GRM4,BRD-K00004222,PHCCC,glutamate receptor agonist,GRM1|GRM4
FPYJSJDOHRDAMT,BRD-K59067695,SU-11274,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MET,BRD-K02965346|BRD-K59067695,SU-11274,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MET,BRD-K02965346|BRD-K59067695,SU-11274,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MET,BRD-K02965346|BRD-K59067695,SU11274,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MET
FPZMPGPGYQUWQS,BRD-K60902958,ectoine-zwitterion,,,BRD-K60902958,ectoine-zwitterion,,,BRD-K60902958,ectoine-zwitterion,,,,,,
FQGLDGKVKDPVLO,BRD-K07150325,ASP-2535,glycine transporter inhibitor,SLC6A9,BRD-K07150325,ASP-2535,glycine transporter inhibitor,SLC6A9,BRD-K07150325,ASP-2535,glycine transporter inhibitor,SLC6A9,BRD-K07150325,ASP-2535,glycine transporter inhibitor,SLC6A9
FQMSSTZJKSWSMP,BRD-A96485169,EBPC,aldose reductase inhibitor,AKR1B1,BRD-A96485169,EBPC,aldose reductase inhibitor,AKR1B1,BRD-A96485169,EBPC,aldose reductase inhibitor,AKR1B1,BRD-K00004209,EBPC,aldose reductase inhibitor,AKR1B1
FQQIIPAOSKSOJM,BRD-K29713308,"mebhydrolin|mebhydroline-1,5-naphtalenedisulfonate",|antihistamine,,BRD-K29713308,"mebhydrolin|mebhydroline-1,5-naphtalenedisulfonate",|antihistamine,,BRD-K29713308|BRD-M45580279,"mebhydrolin|mebhydroline-1,5-naphtalenedisulfonate",|antihistamine,,BRD-K29713308|BRD-M45580279,mebhydrolin,antihistamine,
FQUNFJULCYSSOP,BRD-K00228584,bisoctrizole,,,BRD-K00228584,bisoctrizole,,,BRD-K00228584,bisoctrizole,,,BRD-K00228584,bisoctrizole,,
FQVLRGLGWNWPSS,BRD-K81795818,exherin,cadherin antagonist,CDH2,BRD-K81795818,exherin,cadherin antagonist,CDH2,BRD-K81795818,exherin,cadherin antagonist,CDH2,BRD-K81795818,exherin,cadherin antagonist,CDH2
FRPJGTNLZNXQEX,BRD-K37714784,ABT-724,dopamine receptor agonist,DRD4,BRD-K37714784,ABT-724,dopamine receptor agonist,DRD4,BRD-K37714784,ABT-724,dopamine receptor agonist,DRD4,BRD-K37714784,ABT-724,dopamine receptor agonist,DRD4
FRPJSHKMZHWJBE,BRD-K31843556,T-0070907,PPAR receptor antagonist,PPARG,BRD-K31843556,T-0070907,PPAR receptor antagonist,PPARG,BRD-K31843556,T-0070907,PPAR receptor antagonist,PPARG,BRD-K31843556,T-0070907,PPAR receptor antagonist,PPARG
FRPJXPJMRWBBIH,BRD-A70858459,estramustine,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,BRD-A70858459,estramustine,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,BRD-A70858459,estramustine,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,BRD-A70858459,estramustine,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2
FRPZMMHWLSIFAZ,BRD-K19189338,undecylenic-acid,other antifungal,,BRD-K19189338,undecylenic-acid,other antifungal,,BRD-K19189338,undecylenic-acid,other antifungal,,BRD-K19189338,undecylenic-acid,other antifungal,
FRQMUZJSZHZSGN,BRD-K99615199,medroxyprogesterone,progesterone receptor agonist,ESR1|PGR,BRD-K99615199,medroxyprogesterone,progesterone receptor agonist,ESR1|PGR,BRD-K99615199,medroxyprogesterone,progesterone receptor agonist,ESR1|PGR,BRD-K99615199,medroxyprogesterone,progesterone receptor agonist,PGR
FRXNXDHFQYZYNA,BRD-A31362467,capreomycin,protein synthesis inhibitor,,BRD-A31362467,capreomycin,protein synthesis inhibitor,,BRD-A31362467,capreomycin,protein synthesis inhibitor,,BRD-K00005140,capreomycin,protein synthesis inhibitor,
FSFZRNZSZYDVLI,BRD-K10705233,GW-405833,cannabinoid receptor agonist,CNR2,BRD-K10705233,GW-405833,cannabinoid receptor agonist,CNR2,BRD-K10705233,GW-405833,cannabinoid receptor agonist,CNR2,BRD-K10705233,GW-405833,cannabinoid receptor agonist,CNR2
FSKFPVLPFLJRQB,BRD-A27732521,tolperisone,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,BRD-A27732521,tolperisone,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,BRD-A27732521,tolperisone,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,BRD-A27732521,tolperisone,voltage-gated sodium channel blocker,CYP2C19|CYP2D6
FSPQCTGGIANIJZ,BRD-K81376179,TCS-359,FLT3 inhibitor,FLT3,BRD-K81376179,TCS-359,FLT3 inhibitor,FLT3,BRD-K81376179,TCS-359,FLT3 inhibitor,FLT3,BRD-K81376179,TCS-359,FLT3 inhibitor,FLT3
FSQKKOOTNAMONP,BRD-K67563174,acemetacin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K67563174,acemetacin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K67563174,acemetacin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K67563174,acemetacin,cyclooxygenase inhibitor,PTGS1|PTGS2
FSVJFNAIGNNGKK,BRD-A21858158,praziquantel,anthelmintic agent,,BRD-A21858158,praziquantel,anthelmintic agent,,BRD-A21858158,praziquantel,anthelmintic agent,,BRD-A21858158,praziquantel,anthelmintic agent,
FSYKKLYZXJSNPZ,BRD-K51263939,sarcosine,Glycine transporter 1 inhibitor,SLC6A9,BRD-K51263939,sarcosine,Glycine transporter 1 inhibitor,SLC6A9,BRD-K51263939,sarcosine,Glycine transporter 1 inhibitor,SLC6A9,BRD-K51263939,sarcosine,glycine transporter inhibitor,SLC6A9
FSZPIAXLCCQFCM,BRD-K20290250,BIX-02188,MEK inhibitor,MAP2K5,BRD-K20290250,BIX-02188,MEK inhibitor,MAP2K5,BRD-K20290250|BRD-K50394339,BIX-02188,MEK inhibitor,MAP2K5,BRD-K20290250|BRD-K50394339,BIX-02188,MEK inhibitor,MAP2K5
FTALBRSUTCGOEG,BRD-K21283037,riluzole,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,BRD-K21283037,riluzole,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,BRD-K21283037,riluzole,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,BRD-K21283037,riluzole,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11
FTCYIGBVOHNHCD,BRD-K95957366,isaxonine,nerve growth factor agonist,,BRD-K95957366,isaxonine,nerve growth factor agonist,,BRD-K95957366,isaxonine,nerve growth factor agonist,,BRD-K95957366,isaxonine,nerve growth factor agonist,
FTFRZXFNZVCRSK,BRD-K70914287,BIBX-1382,EGFR inhibitor,EGFR|ERBB2,BRD-K70914287,BIBX-1382,EGFR inhibitor,EGFR|ERBB2,BRD-K70914287,BIBX-1382,EGFR inhibitor,EGFR|ERBB2,BRD-K70914287,BIBX-1382,EGFR inhibitor,EGFR|ERBB2
FTJXZACAQRDRNT,BRD-K47337578,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,serotonin receptor antagonist,HTR2A,BRD-K47337578,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,serotonin receptor antagonist,HTR2A,BRD-K47337578,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,serotonin receptor antagonist,HTR2A,BRD-K47337578,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,serotonin receptor antagonist,HTR2A
FTLDJPRFCGDUFH,BRD-K56940463,oxethazaine,local anesthetic,,BRD-K56940463,oxethazaine,local anesthetic,,BRD-K56940463,oxethazaine,local anesthetic,,BRD-K56940463,oxethazaine,local anesthetic,
FTOAOBMCPZCFFF,BRD-K83359602,barbital,sedative,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2,BRD-K83359602,barbital,sedative,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2,BRD-K83359602,barbital,sedative,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2,,,,
FTSUPYGMFAPCFZ,BRD-K26548821,quinpirol-(-),dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C,BRD-K26548821,quinpirol-(-),dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C,BRD-K26548821,quinpirol-(-),dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C,BRD-K26548821,quinpirol-(-),dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C
FTVWIRXFELQLPI,BRD-K08832567,naringenin,TRPV antagonist|aromatase inhibitor,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,BRD-K08832567,naringenin,TRPV antagonist|aromatase inhibitor,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,BRD-K08832567,naringenin,TRPV antagonist|aromatase inhibitor,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,BRD-K08832567,naringenin,TRPV antagonist|aromatase inhibitor,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1
FUBVWMNBEHXPSU,BRD-K21548250,moracizine,sodium channel blocker,SCN5A,BRD-K21548250,moracizine,sodium channel blocker,SCN5A,BRD-K21548250,moracizine,sodium channel blocker,SCN5A,BRD-K21548250,moracizine,sodium channel blocker,SCN5A
FULAPETWGIGNMT,BRD-K09090523,firocoxib,cyclooxygenase inhibitor,PTGS2,BRD-K09090523,firocoxib,cyclooxygenase inhibitor,PTGS2,BRD-K09090523,firocoxib,cyclooxygenase inhibitor,PTGS2,BRD-K09090523,firocoxib,cyclooxygenase inhibitor,PTGS2
FURUXTVZLHCCNA,BRD-K34328244,MF-101,estrogen receptor agonist,CYP19A1|XDH,BRD-K34328244,MF-101,estrogen receptor agonist,CYP19A1|XDH,BRD-K34328244,MF-101,estrogen receptor agonist,CYP19A1|XDH,BRD-K34328244,MF-101,estrogen receptor agonist,CYP19A1|XDH
FUSNMLFNXJSCDI,BRD-K44273375,tolnaftate,fungal squalene epoxidase inhibitor,,BRD-K44273375,tolnaftate,fungal squalene epoxidase inhibitor,,BRD-K44273375,tolnaftate,fungal squalene epoxidase inhibitor,,BRD-K44273375,tolnaftate,fungal squalene epoxidase inhibitor,
FUUFQLXAIUOWML,BRD-K56707426,nitarsone,,,BRD-K56707426,nitarsone,,,BRD-K56707426,nitarsone,,,BRD-K56707426,nitarsone,,
FUXVKZWTXQUGMW,BRD-K09291936,9-aminocamptothecin,topoisomerase inhibitor,TOP1,BRD-K09291936,9-aminocamptothecin,topoisomerase inhibitor,TOP1,BRD-K09291936,9-aminocamptothecin,topoisomerase inhibitor,TOP1,BRD-K09291936,9-aminocamptothecin,topoisomerase inhibitor,TOP1
FUZYTVDVLBBXDL,BRD-A73908300,EX-527,SIRT inhibitor,SIRT1,BRD-A73908300,EX-527,SIRT inhibitor,SIRT1,BRD-A73908300,EX-527,SIRT inhibitor,SIRT1,BRD-A73908300,EX-527,SIRT inhibitor,SIRT1
FVIGODVHAVLZOO,BRD-K05919151,dixanthogen,,,BRD-K05919151,dixanthogen,,,BRD-K05919151,dixanthogen,,,BRD-K05919151,dixanthogen,,
FVIZARNDLVOMSU,BRD-K01942833,ginsenoside-c-k,NFkB pathway inhibitor|nitric oxide synthase inhibitor,PTGS2,BRD-K01942833,ginsenoside-c-k,NFkB pathway inhibitor|nitric oxide synthase inhibitor,PTGS2,BRD-K01942833,ginsenoside-c-k,NFkB pathway inhibitor|nitric oxide synthase inhibitor,PTGS2,BRD-K01942833,ginsenoside-C-K,NFkB pathway inhibitor|nitric oxide synthase inhibitor,PTGS2
FVLVBPDQNARYJU,BRD-K13281575,semustine,DNA alkylating agent,,BRD-K13281575,semustine,DNA alkylating agent,,BRD-K13281575,semustine,DNA alkylating agent,,,,,
FVNFBBAOMBJTST,BRD-K26739552,fenspiride,bronchodilator,,BRD-K26739552,fenspiride,bronchodilator,,BRD-K26739552,fenspiride,bronchodilator,,BRD-K26739552,fenspiride,bronchodilator,
FVRWRGBTEHAPDI,BRD-A71725768,metoxibutropate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A71725768,metoxibutropate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A71725768,metoxibutropate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A71725768,metoxibutropate,cyclooxygenase inhibitor,PTGS1|PTGS2
FVRYPYDPKSZGNS,BRD-K33892651,CHR-6494|ML347,ALK tyrosine kinase receptor inhibitor|serine/threonine kinase inhibitor,ACVR1|ACVRL1|BMPR1A|GSG2,BRD-K33892651,CHR-6494|ML347,ALK tyrosine kinase receptor inhibitor|serine/threonine kinase inhibitor,ACVR1|ACVRL1|BMPR1A|GSG2,BRD-K33892651,ML347,ALK tyrosine kinase receptor inhibitor,ACVR1|ACVRL1|BMPR1A,BRD-K33892651,ML347,ALK tyrosine kinase receptor inhibitor,ACVR1|ACVRL1|BMPR1A
FVTCRASFADXXNN,BRD-K09229706|BRD-K58734774,riboflavin-5-phosphate-sodium,,BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1,BRD-K09229706|BRD-K58734774,riboflavin-5-phosphate-sodium,,BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1,BRD-K09229706|BRD-K58734774,riboflavin-5-phosphate-sodium,,BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1,BRD-K09229706,riboflavin-5-phosphate-sodium,,BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1
FVTWTVQXNAJTQP,BRD-K46692793,umeclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K46692793,umeclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K46692793,umeclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K46692793,umeclidinium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3
FVWJYYTZTCVBKE,BRD-K64874225,NSC-4644,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,BRD-K64874225,NSC-4644,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,BRD-K64874225,NSC-4644,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,BRD-K64874225,NSC-4644,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM
FVYXIJYOAGAUQK,BRD-K98493452,honokiol,AKT inhibitor,ALOX5|PTGS1|PTGS2,BRD-K98493452,honokiol,AKT inhibitor,ALOX5|PTGS1|PTGS2,BRD-K98493452,honokiol,AKT inhibitor,ALOX5|PTGS1|PTGS2,BRD-K98493452,honokiol,AKT inhibitor,ALOX5|PTGS1|PTGS2
FWCVZAQENIZVMY,BRD-K43639297,hemoglobin-modulators-1,hemoglobin modulator,,BRD-K43639297,hemoglobin-modulators-1,hemoglobin modulator,,BRD-K43639297,hemoglobin-modulators-1,hemoglobin modulator,,BRD-K43639297,voxelotor,hemoglobin modulator,
FWFGIHPGRQZWIW,BRD-K92241597,tosedostat,peptidase inhibitor,ANPEP|LAP3|NPEPPS,BRD-K92241597,tosedostat,peptidase inhibitor,ANPEP|LAP3|NPEPPS,BRD-K92241597,tosedostat,peptidase inhibitor,ANPEP|LAP3|NPEPPS,BRD-K92241597,tosedostat,peptidase inhibitor,ANPEP|LAP3|NPEPPS
FWIVDMJALNEADT,BRD-K22822991,odanacatib,cathepsin inhibitor,CTSK,BRD-K22822991,odanacatib,cathepsin inhibitor,CTSK,BRD-K22822991,odanacatib,cathepsin inhibitor,CTSK,BRD-K22822991,odanacatib,cathepsin inhibitor,CTSK
FWJKNZONDWOGMI,BRD-K88143662,metharbital,GABA receptor modulator,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,BRD-K88143662,metharbital,GABA receptor modulator,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,BRD-K88143662,metharbital,GABA receptor modulator,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,BRD-K88143662,metharbital,GABA receptor modulator,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2
FWLMVFUGMHIOAA,BRD-K43578482,defactinib,focal adhesion kinase inhibitor,PTK2,BRD-K43578482,defactinib,focal adhesion kinase inhibitor,PTK2,BRD-K43578482,defactinib,focal adhesion kinase inhibitor,PTK2,BRD-K43578482,defactinib,focal adhesion kinase inhibitor,PTK2
FWUQWDCOOWEXRY,BRD-A94033181,AZD6765,glutamate receptor antagonist,GRIN1,BRD-A94033181,AZD6765,glutamate receptor antagonist,GRIN1,BRD-A94033181,AZD6765,glutamate receptor antagonist,GRIN1,BRD-A94033181,AZD6765,glutamate receptor antagonist,GRIN1
FWYSMLBETOMXAG,BRD-K94288301,letermovir,CMV terminase inhibitor,,BRD-K94288301,letermovir,CMV terminase inhibitor,,BRD-K94288301,letermovir,CMV terminase inhibitor,,BRD-K94288301,letermovir,CMV terminase inhibitor,
FXCTZFMSAHZQTR,BRD-A05729358,CPCCOEt,glutamate receptor antagonist,GRM1,BRD-A05729358,CPCCOEt,glutamate receptor antagonist,GRM1,BRD-A05729358,CPCCOEt,glutamate receptor antagonist,GRM1,BRD-K00004223,CPCCOEt,glutamate receptor antagonist,GRM1
FXHHASJVTYRJHH,BRD-K01036220,JNJ-42041935,hypoxia inducible factor prolyl hydroxylase inhibitor,PDK2,BRD-K01036220,JNJ-42041935,hypoxia inducible factor prolyl hydroxylase inhibitor,PDK2,BRD-K01036220,JNJ-42041935,hypoxia inducible factor prolyl hydroxylase inhibitor,PDK2,BRD-K01036220,JNJ-42041935,hypoxia inducible factor prolyl hydroxylase inhibitor,PDK2
FXNFHKRTJBSTCS,BRD-K72327355,baicalein,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH,BRD-K72327355,baicalein,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH,BRD-K72327355,baicalein,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH,,,,
FXUAIOOAOAVCGD,BRD-K15170068,swainsonine,alpha mannosidase inhibitor,MAN2A1,BRD-K15170068,swainsonine,alpha mannosidase inhibitor,MAN2A1,BRD-K15170068,swainsonine,alpha mannosidase inhibitor,MAN2A1,BRD-K15170068,swainsonine,alpha mannosidase inhibitor,MAN2A1
FYBHCRQFSFYWPY,BRD-K73397362,purmorphamine,smoothened receptor agonist,SMO,BRD-K73397362,purmorphamine,smoothened receptor agonist,SMO,BRD-K73397362,purmorphamine,smoothened receptor agonist,SMO,BRD-K73397362,purmorphamine,smoothened receptor agonist,SMO
FYGDTMLNYKFZSV,BRD-A32796301,4-galactosyllactose,,AMY2B,BRD-A32796301,4-galactosyllactose,,AMY2B,BRD-A32796301,4-galactosyllactose,,AMY2B,BRD-A32796301,4-galactosyllactose,,
FYGREZKTJIXWIH,BRD-A13964793,TC1,beta-secretase inhibitor,BACE1,BRD-A13964793,TC1,beta-secretase inhibitor,BACE1,BRD-A13964793,TC1,beta-secretase inhibitor,BACE1,BRD-K01825674,TC1,beta-secretase inhibitor,BACE1
FYIBXBFDXNPBSF,BRD-K09787262,TCN201,glutamate receptor antagonist,GRIN2A,BRD-K09787262,TCN201,glutamate receptor antagonist,GRIN2A,BRD-K09787262,TCN201,glutamate receptor antagonist,GRIN2A,BRD-K09787262,TCN201,glutamate receptor antagonist,GRIN2A
FYMHQCNFKNMJAV,BRD-K98384930,finafloxacin,bacterial DNA gyrase inhibitor,,BRD-K98384930,finafloxacin,bacterial DNA gyrase inhibitor,,BRD-K98384930,finafloxacin,bacterial DNA gyrase inhibitor,,BRD-K98384930,finafloxacin,bacterial DNA gyrase inhibitor,
FYPMFJGVHOHGLL,BRD-K72029282,probucol,atherogenesis inhibitor,ABCA1|ABCB11|CES1,BRD-K72029282,probucol,atherogenesis inhibitor,ABCA1|ABCB11|CES1,BRD-K72029282,probucol,atherogenesis inhibitor,ABCA1|ABCB11|CES1,BRD-K72029282,probucol,atherogenesis inhibitor,ABCA1|ABCB11|CES1
FYSRKRZDBHOFAY,BRD-K07736136,VX-702,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,BRD-K07736136,VX-702,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,BRD-K07736136,VX-702,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,BRD-K07736136,VX-702,p38 MAPK inhibitor,IL1B|IL6|MAPK11|MAPK12|MAPK14|TNF
FYXRSVDHGLUMHB,BRD-K21833260,LY2584702,ribosomal protein inhibitor,RPS6KB1,BRD-K21833260,LY2584702,ribosomal protein inhibitor,RPS6KB1,BRD-K21833260,LY2584702,ribosomal protein inhibitor,RPS6KB1,BRD-K21833260,LY2584702,ribosomal protein inhibitor,RPS6KB1
FZCHYNWYXKICIO,BRD-A25143711,hydrocortisone-valerate,glucocorticoid receptor agonist,,BRD-A25143711,hydrocortisone-valerate,glucocorticoid receptor agonist,,BRD-A25143711,hydrocortisone-valerate,glucocorticoid receptor agonist,,BRD-K09968782,hydrocortisone-valerate,glucocorticoid receptor agonist,NR3C1
FZERHIULMFGESH,BRD-K11094367,acetanilide,hydrogen peroxide decomposition inhibitor,,BRD-K11094367,acetanilide,hydrogen peroxide decomposition inhibitor,,BRD-K11094367,acetanilide,hydrogen peroxide decomposition inhibitor,,BRD-K11094367,acetanilide,hydrogen peroxide decomposition inhibitor,
FZNCGRZWXLXZSZ,BRD-K59331299|BRD-K66850609,voglibose,glucosidase inhibitor,MGAM,BRD-K59331299|BRD-K66850609,voglibose,glucosidase inhibitor,MGAM,BRD-K59331299|BRD-K66850609,voglibose,glucosidase inhibitor,MGAM,BRD-K59331299|BRD-K66850609,voglibose,glucosidase inhibitor,MGAM
FZRIRHAXJWMMFP,BRD-A61767428,ursolic-acid,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,,,,,,,,,,,,
FZSPJBYOKQPKCD,BRD-A14966924,alaproclate,serotonin receptor antagonist,SLC6A4,BRD-A14966924,alaproclate,serotonin receptor antagonist,SLC6A4,BRD-A14966924,alaproclate,serotonin receptor antagonist,SLC6A4,BRD-K01826783,alaproclate,serotonin receptor antagonist,SLC6A4
FZWBNHMXJMCXLU,BRD-K67117832,dextran,,,BRD-K67117832,dextran,,,BRD-K67117832,dextran,,,BRD-K67117832,dextran,,
GAGWJHPBXLXJQN,BRD-A91877226|BRD-K15574380|BRD-K61192372,capecitabine,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,BRD-A91877226|BRD-K15574380|BRD-K61192372,capecitabine,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,BRD-A91877226|BRD-K15574380|BRD-K61192372,capecitabine,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,BRD-A91877226|BRD-K15574380|BRD-K61192372,capecitabine,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS
GAOZTHIDHYLHMS,BRD-A09919099|BRD-A43972623|BRD-A61543962,monensin,bacterial permeability inducer,,BRD-A09919099|BRD-A43972623|BRD-A61543962,monensin,bacterial permeability inducer,,BRD-A06627858|BRD-A09919099|BRD-A43972623|BRD-A61543962,monensin,bacterial permeability inducer,,BRD-K55375480,monensin,bacterial permeability inducer,
GAUHIPWCDXOLCZ,BRD-K20605374,NSC-697923,ubiquitin-conjugating enzyme inhibitor,UBE2N,BRD-K20605374,NSC-697923,ubiquitin-conjugating enzyme inhibitor,UBE2N,BRD-K20605374,NSC-697923,ubiquitin-conjugating enzyme inhibitor,UBE2N,BRD-K20605374,NSC-697923,ubiquitin-conjugating enzyme inhibitor,UBE2N
GAZGHCHCYRSPIV,BRD-A40546373,morinidazole,other antibiotic,CYP51A1,BRD-A40546373,morinidazole,other antibiotic,CYP51A1,BRD-A40546373,morinidazole,other antibiotic,CYP51A1,BRD-A40546373,morinidazole,other antibiotic,CYP51A1
GBABOYUKABKIAF,BRD-K69280563,vinorelbine,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-K69280563,vinorelbine,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-K04269837|BRD-K69280563,vinorelbine,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-K04269837,vinorelbine,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
GBBJCSTXCAQSSJ,BRD-K18948558,clevudine,DNA polymerase inhibitor,,BRD-K18948558,clevudine,DNA polymerase inhibitor,,BRD-K18948558,clevudine,DNA polymerase inhibitor,,BRD-K00003562,clevudine,DNA polymerase inhibitor,
GBBSUAFBMRNDJC,BRD-K29220403,eszopiclone,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,BRD-K29220403,eszopiclone,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,BRD-K29220403,eszopiclone,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO,,,,
GBEUKTWTUSPHEE,BRD-K38868394,MK-0773,androgen receptor modulator,AR,BRD-K38868394,MK-0773,androgen receptor modulator,AR,BRD-K38868394,MK-0773,androgen receptor modulator,AR,BRD-K38868394,MK-0773,androgen receptor modulator,AR
GBFLZEXEOZUWRN,BRD-K33809398,SCMC-Lys,mucolytic agent,GSTP1,BRD-K33809398,SCMC-Lys,mucolytic agent,GSTP1,BRD-K33809398,SCMC-Lys,mucolytic agent,GSTP1,BRD-K33809398,SCMC-Lys,mucolytic agent,GSTP1
GBJVVSCPOBPEIT,BRD-K31928526,barasertib,Aurora kinase inhibitor,AURKA|AURKB,BRD-K31928526,barasertib,Aurora kinase inhibitor,AURKA|AURKB,BRD-K31928526,barasertib,Aurora kinase inhibitor,AURKA|AURKB,BRD-K31928526,barasertib,Aurora kinase inhibitor,AURKA|AURKB
GBOGMAARMMDZGR,BRD-K47000838,cytochalasin-b,microtubule inhibitor,ACTB,BRD-K47000838,cytochalasin-b,microtubule inhibitor,ACTB,BRD-K47000838,cytochalasin-b,microtubule inhibitor,ACTB,BRD-K26664453,cytochalasin-B,microtubule inhibitor,ACTB
GBXSMTUPTTWBMN,BRD-K57545991,enalapril,angiotensin converting enzyme inhibitor,ACE,BRD-K57545991,enalapril,angiotensin converting enzyme inhibitor,ACE,BRD-K57545991,enalapril,angiotensin converting enzyme inhibitor,ACE,BRD-K57545991,enalapril,angiotensin converting enzyme inhibitor,ACE
GCFBRXLSHGKWDP,BRD-A73079885|BRD-K02292852,cefoperazone,bacterial cell wall synthesis inhibitor,,BRD-A73079885|BRD-K02292852,cefoperazone,bacterial cell wall synthesis inhibitor,,BRD-A73079885|BRD-K02292852,cefoperazone,bacterial cell wall synthesis inhibitor,,BRD-A73079885|BRD-K02292852,cefoperazone,bacterial cell wall synthesis inhibitor,
GCHPUOHXXCNSQL,BRD-K33308633,INCA-6,calcineurin inhibitor,NFATC1,BRD-K33308633,INCA-6,calcineurin inhibitor,NFATC1,BRD-K33308633,INCA-6,calcineurin inhibitor,NFATC1,BRD-K33308633,INCA-6,calcineurin inhibitor,NFATC1
GCIKSSRWRFVXBI,BRD-K59369769,tozasertib,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,BRD-K59369769,tozasertib,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,BRD-K59369769,tozasertib,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,BRD-K59369769,tozasertib,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK
GCKFUYQCUCGESZ,BRD-A08302182,etonogestrel,progesterone receptor agonist,ESR1|PGR,BRD-A08302182,etonogestrel,progesterone receptor agonist,ESR1|PGR,BRD-A08302182,etonogestrel,progesterone receptor agonist,ESR1|PGR,BRD-K00003655,etonogestrel,progesterone receptor agonist,ESR1|PGR
GCKMFJBGXUYNAG,BRD-K84036904,17-alpha-methyltestosterone,aromatase inhibitor,AR,BRD-K84036904,17-alpha-methyltestosterone,aromatase inhibitor,AR,BRD-K84036904,17-alpha-methyltestosterone,aromatase inhibitor,AR,,,,
GCUCIFQCGJIRNT,BRD-K35498378,alrestatin,aldose reductase inhibitor,AKR1B1,BRD-K35498378,alrestatin,aldose reductase inhibitor,AKR1B1,BRD-K35498378,alrestatin,aldose reductase inhibitor,AKR1B1,BRD-K35498378,alrestatin,aldose reductase inhibitor,AKR1B1
GCVFQRRBTCHIPK,BRD-K43002771,SR-33805,calcium channel blocker,,BRD-K43002771,SR-33805,calcium channel blocker,,BRD-K43002771,SR-33805,calcium channel blocker,,BRD-K43002771,SR-33805,calcium channel blocker,
GCWIQUVXWZWCLE,BRD-K19871656,CPI-0610,bromodomain inhibitor,BRD4,BRD-K19871656,CPI-0610,bromodomain inhibitor,BRD4,BRD-K19871656,CPI-0610,bromodomain inhibitor,BRD4,BRD-K19871656,CPI-0610,bromodomain inhibitor,BRD4
GCYIGMXOIWJGBU,BRD-K24593301,AZD3463,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R,BRD-K24593301,AZD3463,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R,BRD-K24593301,AZD3463,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R,BRD-K24593301,AZD3463,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R
GDFGTRDCCWFXTG,BRD-K02995728,quinagolide,dopamine receptor agonist,DRD2,BRD-K02995728,quinagolide,dopamine receptor agonist,DRD2,BRD-K02995728,quinagolide,dopamine receptor agonist,DRD2,BRD-K02995728,quinagolide,dopamine receptor agonist,DRD2
GDLBFKVLRPITMI,BRD-K73109821,diazoxide,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,BRD-K73109821,diazoxide,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,BRD-K73109821,diazoxide,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,BRD-K73109821,diazoxide,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3
GDLIGKIOYRNHDA,BRD-K52989797,clomipramine,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,BRD-K52989797,clomipramine,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,BRD-K52989797,clomipramine,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,BRD-K52989797,clomipramine,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4
GDLNHSUSOZEAOR,BRD-K97233161,ABT-491,platelet activating factor receptor antagonist,PTAFR,BRD-K97233161,ABT-491,platelet activating factor receptor antagonist,PTAFR,BRD-K97233161,ABT-491,platelet activating factor receptor antagonist,PTAFR,BRD-K97233161,ABT-491,platelet activating factor receptor antagonist,PTAFR
GDPHPXYFLPDZGH,BRD-A89196962,dalargin,opioid receptor agonist,OPRM1,BRD-A89196962,dalargin,opioid receptor agonist,OPRM1,BRD-A89196962,dalargin,opioid receptor agonist,OPRM1,BRD-A89196962,dalargin,opioid receptor agonist,OPRM1
GDVRVPIXWXOKQO,BRD-K19333160,RKI-1447|SRPIN340,rho associated kinase inhibitor|serine arginine protein kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2|SRPK1|SRPK2,BRD-K19333160,RKI-1447|SRPIN340,rho associated kinase inhibitor|serine arginine protein kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2|SRPK1|SRPK2,BRD-K19333160,RKI-1447,rho associated kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2,BRD-K19333160,RKI-1447,rho associated kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2
GDYUVHBMFVMBAF,BRD-K73027814,oxyfedrine,adrenergic receptor agonist,,BRD-K73027814,oxyfedrine,adrenergic receptor agonist,,BRD-K73027814,oxyfedrine,adrenergic receptor agonist,,BRD-K73027814,oxyfedrine,adrenergic receptor agonist,
GECHUMIMRBOMGK,BRD-K41406082,sulfapyridine,PABA antagonist,,BRD-K41406082,sulfapyridine,PABA antagonist,,BRD-K41406082,sulfapyridine,PABA antagonist,,BRD-K41406082,sulfapyridine,PABA antagonist,
GEFQWZLICWMTKF,BRD-K02976377,levonordefrin,vasodilator,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2,BRD-K02976377,levonordefrin,vasodilator,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2,BRD-K02976377,levonordefrin,vasodilator,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2,BRD-K02976377,levonordefrin,vasodilator,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2
GEGPCGHEPLKDLY,BRD-M12328004,C106,,,BRD-M12328004,C106,,,BRD-M12328004,C106,,,BRD-M12328004,C106,,
GELVZYOEQVJIRR,BRD-K84075000,2-Chloropyrazine,,,BRD-K84075000,2-Chloropyrazine,,,BRD-K84075000,2-Chloropyrazine,,,BRD-K84075000,2-chloropyrazine,,
GEPYBHCJBORHCE,BRD-K24821794,SGC-CBP30,bromodomain inhibitor,CREBBP|EP300,BRD-K24821794,SGC-CBP30,bromodomain inhibitor,CREBBP|EP300,BRD-K24821794,SGC-CBP30,bromodomain inhibitor,CREBBP|EP300,BRD-K24821794,SGC-CBP30,bromodomain inhibitor,CREBBP|EP300
GEVVQZHMFVFGLN,BRD-K30550578,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K30550578,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K30550578,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K30550578,PF-04620110,diacylglycerol O acyltransferase inhibitor,DGAT1
GEZHEQNLKAOMCA,BRD-A76999758|BRD-K08542803,gambogic-acid,caspase activator,BCL2,BRD-A76999758|BRD-K08542803,gambogic-acid,caspase activator,BCL2,BRD-A76999758|BRD-K08542803,gambogic-acid,caspase activator,BCL2,BRD-A76999758|BRD-K08542803,gambogic-acid,caspase activator,BCL2
GFBCWCDNXDKFRH,BRD-A62562325,deoxyarbutin,tyrosinase inhibitor,,BRD-A62562325,deoxyarbutin,tyrosinase inhibitor,,BRD-A62562325,deoxyarbutin,tyrosinase inhibitor,,BRD-A62562325,deoxyarbutin,tyrosinase inhibitor,
GFBKORZTTCHDGY,BRD-K97309399,thiothixene,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,BRD-K97309399,thiothixene,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,BRD-K97309399,thiothixene,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,BRD-K04175245,thiothixene,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A
GFFGJBXGBJISGV,BRD-K26060080,adenine,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2,BRD-K26060080,adenine,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2,BRD-K26060080|BRD-M27046829,adenine,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2,BRD-K26060080|BRD-M27046829,adenine,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2
GFGSZUNNBQXGMK,BRD-K26807903,aklomide,,,BRD-K26807903,aklomide,,,BRD-K26807903,aklomide,,,BRD-K26807903,aklomide,,
GFICWFZTBXUVIG,BRD-K55822903,imeglimin,gluconeogenesis inhibitor,,BRD-K55822903,imeglimin,gluconeogenesis inhibitor,,BRD-K55822903,imeglimin,gluconeogenesis inhibitor,,BRD-K55822903,imeglimin,gluconeogenesis inhibitor,
GFIJNRVAKGFPGQ,BRD-K26323068,leuprolide,gonadotropin releasing factor hormone receptor agonist,GNRHR,BRD-K26323068,leuprolide,gonadotropin releasing factor hormone receptor agonist,GNRHR,BRD-K26323068,leuprolide,gonadotropin releasing factor hormone receptor agonist,GNRHR,BRD-K45300898,leuprolide,gonadotropin releasing factor hormone receptor agonist,GNRHR
GFLQCBTXTRCREJ,BRD-K03289018,CCT137690,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K03289018,CCT137690,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K03289018,CCT137690,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K03289018,CCT137690,Aurora kinase inhibitor,AURKA|AURKB|AURKC
GFMMXOIFOQCCGU,BRD-K05104363,PD-184352,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,BRD-K05104363,PD-184352,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,BRD-K05104363,PD-184352,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,BRD-K05104363,PD-184352,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2
GFNANZIMVAIWHM,BRD-A37780065|BRD-K77554836|BRD-K97780336,triamcinolone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A37780065|BRD-K77554836,triamcinolone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A37780065|BRD-K77554836|BRD-K97780336,triamcinolone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A37780065|BRD-K77554836|BRD-K97780336,triamcinolone,glucocorticoid receptor agonist,NR3C1
GFNNBHLJANVSQV,BRD-K68336408,tyrphostin-AG-1478,EGFR inhibitor,EGFR|MAPK14,BRD-K68336408,tyrphostin-AG-1478,EGFR inhibitor,EGFR|MAPK14,BRD-K68336408,tyrphostin-AG-1478,EGFR inhibitor,EGFR|MAPK14,BRD-K68336408,tyrphostin-AG-1478,EGFR inhibitor,EGFR|MAPK14
GFRUPHOKLBPHTQ,BRD-A14208071,oxyphenonium,cholinergic receptor antagonist,CHRM1,BRD-A14208071,oxyphenonium,cholinergic receptor antagonist,CHRM1,BRD-A14208071,oxyphenonium,cholinergic receptor antagonist,CHRM1,BRD-A14208071,oxyphenonium,cholinergic receptor antagonist,CHRM1|CHRM3
GFUITADOEPNRML,BRD-K95362002,cipemastat,metalloproteinase inhibitor,ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9,BRD-K95362002,cipemastat,metalloproteinase inhibitor,ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9,BRD-K95362002,cipemastat,metalloproteinase inhibitor,ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9,BRD-K95362002,cipemastat,metalloproteinase inhibitor,ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9
GFWRVVCDTLRWPK,BRD-K01039503,sofalcone,mucus protecting agent,CBR1,BRD-K01039503,sofalcone,mucus protecting agent,CBR1,BRD-K01039503,sofalcone,mucus protecting agent,CBR1,BRD-K01039503,sofalcone,mucus protecting agent,CBR1
GGALEXMXDMUMDM,BRD-K55424922,anpirtoline,serotonin receptor agonist,HTR1B,BRD-K55424922,anpirtoline,serotonin receptor agonist,HTR1B,BRD-K55424922,anpirtoline,serotonin receptor agonist,HTR1B,BRD-K55424922,anpirtoline,serotonin receptor agonist,HTR1B
GGCSSNBKKAUURC,BRD-K21547160,sufentanil,opioid receptor modulator,OPRD1|OPRK1|OPRM1,BRD-K21547160,sufentanil,opioid receptor modulator,OPRD1|OPRK1|OPRM1,BRD-K21547160,sufentanil,opioid receptor modulator,OPRD1|OPRK1|OPRM1,,,,
GGGDNPWHMNJRFN,BRD-K99241550,metrizoic-acid,radiopaque medium,,BRD-K99241550,metrizoic-acid,radiopaque medium,,BRD-K99241550,metrizoic-acid,radiopaque medium,,BRD-K99241550,metrizoic-acid,radiopaque medium,
GGGJYJXAFSEWNM,BRD-K73381198,5-fluoro-3-pyridyl-methanol,,,BRD-K73381198,5-fluoro-3-pyridyl-methanol,,,BRD-K73381198,5-fluoro-3-pyridyl-methanol,,,BRD-K73381198,5-fluoro-3-pyridyl-methanol,,
GGLRYZACPLNCKB,BRD-K43419711,Wy-16922,histamine release inhibitor,,BRD-K43419711,Wy-16922,histamine release inhibitor,,BRD-K43419711,Wy-16922,histamine release inhibitor,,BRD-K43419711,WY-16922,histamine release inhibitor,
GGPPBTSXFROGAE,BRD-K38398115,YM-511,aromatase inhibitor,CYP19A1,BRD-K38398115,YM-511,aromatase inhibitor,CYP19A1,BRD-K38398115,YM-511,aromatase inhibitor,CYP19A1,BRD-K38398115,YM-511,aromatase inhibitor,CYP19A1
GGUSQTSTQSHJAH,BRD-A61392169,eliprodil,glutamate receptor antagonist,GRIN1|GRIN2B,BRD-A61392169,eliprodil,glutamate receptor antagonist,GRIN1|GRIN2B,BRD-A61392169,eliprodil,glutamate receptor antagonist,GRIN1|GRIN2B,BRD-A61392169,eliprodil,glutamate receptor antagonist,GRIN1|GRIN2B
GGXICVAJURFBLW,BRD-K10961822,latanoprost,prostanoid receptor agonist,PTGFR,BRD-K10961822,latanoprost,prostanoid receptor agonist,PTGFR,BRD-K10961822,latanoprost,prostanoid receptor agonist,PTGFR,BRD-K10961822,latanoprost,prostanoid receptor agonist,PTGFR
GGXKWVWZWMLJEH,BRD-K45033733,famciclovir,DNA polymerase inhibitor,,BRD-K45033733,famciclovir,DNA polymerase inhibitor,,BRD-K45033733,famciclovir,DNA polymerase inhibitor,,BRD-K45033733,famciclovir,DNA polymerase inhibitor,
GHASVSINZRGABV,BRD-K24844714,5-fluorouracil,thymidylate synthase inhibitor,DPYD|TYMS,BRD-K24844714,5-fluorouracil,thymidylate synthase inhibitor,DPYD|TYMS,BRD-K24844714,5-fluorouracil,thymidylate synthase inhibitor,DPYD|TYMS,BRD-K24844714,5-fluorouracil,thymidylate synthase inhibitor,DPYD|TYMS
GHBFNMLVSPCDGN,BRD-A48938994,monoctanoin,,,BRD-A48938994,monoctanoin,,,BRD-A48938994,monoctanoin,,,BRD-A48938994,monoctanoin,,
GHCCBWMZKJQGLS,BRD-A37347161,BRL-52537,opioid receptor agonist,OPRK1,BRD-A37347161,BRL-52537,opioid receptor agonist,OPRK1,BRD-A37347161,BRL-52537,opioid receptor agonist,OPRK1,BRD-A37347161,BRL-52537,opioid receptor agonist,OPRK1
GHDWIFTUSXQYGK,BRD-A70268693,PG-9,acetylcholine receptor agonist,,BRD-A70268693,PG-9,acetylcholine receptor agonist,,BRD-A70268693,PG-9,acetylcholine receptor agonist,,BRD-K00004212,PG-9,acetylcholine receptor agonist,
GHMLBKRAJCXXBS,BRD-K74190368,resorcinol,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,BRD-K74190368,resorcinol,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,BRD-K74190368,resorcinol,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,BRD-K74190368,resorcinol,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1
GHOKWGTUZJEAQD,BRD-K29392254,pantothenic-acid,coenzyme A precursor,,BRD-K29392254,pantothenic-acid,coenzyme A precursor,,BRD-K29392254,pantothenic-acid,coenzyme A precursor,,BRD-K29392254,pantothenic-acid,coenzyme A precursor,
GHOSNRCGJFBJIB,BRD-A65671304,candesartan-cilextil,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-A65671304,candesartan-cilextil,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-A65671304,candesartan-cilextil,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-A65671304,candesartan-cilexetil,angiotensin receptor antagonist,
GHWJEDJMOVUXEC,BRD-A09828896,SKF-81297,dopamine receptor agonist,DRD1|DRD5,BRD-A09828896,SKF-81297,dopamine receptor agonist,DRD1|DRD5,BRD-A09828896,SKF-81297,dopamine receptor agonist,DRD1|DRD5,BRD-A09828896,SKF-81297,dopamine receptor agonist,DRD1|DRD5
GHXZTYHSJHQHIJ,BRD-K52256627,chlorhexidine,membrane integrity inhibitor,,BRD-K52256627,chlorhexidine,membrane integrity inhibitor,,BRD-K52256627,chlorhexidine,membrane integrity inhibitor,,BRD-K52256627,chlorhexidine,membrane integrity inhibitor,
GHZHWDWADLAOIQ,BRD-A27143604,diarylpropionitrile,estrogen receptor agonist,ESR2,BRD-A27143604,diarylpropionitrile,estrogen receptor agonist,ESR2,BRD-A27143604,diarylpropionitrile,estrogen receptor agonist,ESR2,BRD-A27143604,diarylpropionitrile,estrogen receptor agonist,ESR2
GIBQQARAXHVEGD,BRD-K02206208,rapastinel,glutamate receptor agonist,,BRD-K02206208,rapastinel,glutamate receptor agonist,,BRD-K02206208,rapastinel,glutamate receptor agonist,,BRD-K02206208,rapastinel,glutamate receptor agonist,
GIFYKGIODMXYNT,BRD-K33743361,ML133,potassium channel blocker,,BRD-K33743361,ML133,potassium channel blocker,,BRD-K33743361,ML133,potassium channel blocker,,BRD-K33743361,ML133,potassium channel blocker,
GIIZNNXWQWCKIB,BRD-A01320529,salmeterol,adrenergic receptor agonist,ADRB2,BRD-A01320529,salmeterol,adrenergic receptor agonist,ADRB2,BRD-A01320529,salmeterol,adrenergic receptor agonist,ADRB2,BRD-K01826763,salmeterol,adrenergic receptor agonist,ADRB2
GIJXKZJWITVLHI,BRD-K48061146,benztropine-mesylate,acetylcholine receptor antagonist,CHRM1|HRH1|SLC6A3,BRD-K48061146,benztropine-mesylate,acetylcholine receptor antagonist,CHRM1|HRH1|SLC6A3,BRD-K48061146,benztropine-mesylate,acetylcholine receptor antagonist,CHRM1|HRH1|SLC6A3,BRD-K68804560,benztropine-mesylate,acetylcholine receptor antagonist,CHRM1|HRH1|SLC6A3
GIKNHHRFLCDOEU,BRD-A80871782,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1,BRD-A80871782,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1,BRD-A80871782,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1,BRD-A80871782,hydroxyamphetamine,trace amine associated receptor agonist,TAAR1
GIMNAEMRNXUAQP,BRD-K12261274,zaltidine,histamine receptor antagonist,HRH2,BRD-K12261274,zaltidine,histamine receptor antagonist,HRH2,BRD-K12261274,zaltidine,histamine receptor antagonist,HRH2,BRD-K12261274,zaltidine,histamine receptor antagonist,HRH2
GIMSJJHKKXRFGV,BRD-K07160047,fiacitabine,DNA synthesis inhibitor,,BRD-K07160047,fiacitabine,DNA synthesis inhibitor,,BRD-K07160047,fiacitabine,DNA synthesis inhibitor,,BRD-K07160047,fiacitabine,DNA synthesis inhibitor,
GIUYCYHIANZCFB,BRD-K71106091,fludarabine-phosphate,ribonucleotide reductase inhibitor,DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,BRD-K71106091,fludarabine-phosphate,ribonucleotide reductase inhibitor,DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,BRD-K71106091,fludarabine-phosphate,ribonucleotide reductase inhibitor,DCK|POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,BRD-K71106091,fludarabine-phosphate,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B
GIYAQDDTCWHPPL,BRD-K73642618,bromopride,dopamine receptor antagonist,DRD2,BRD-K73642618,bromopride,dopamine receptor antagonist,DRD2,BRD-K73642618,bromopride,dopamine receptor antagonist,DRD2,BRD-K73642618,bromopride,dopamine receptor antagonist,DRD2
GJAWHXHKYYXBSV,BRD-K51885093,quinolinic-acid,glutamate receptor agonist,,BRD-K51885093,quinolinic-acid,glutamate receptor agonist,,BRD-K51885093,quinolinic-acid,glutamate receptor agonist,,BRD-K51885093,quinolinic-acid,glutamate receptor agonist,
GJJFMKBJSRMPLA,BRD-A15202882|BRD-K02227374,milnacipran,serotoninnorepinephrine reuptake inhibitor (SNRI),GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A4,BRD-A15202882|BRD-K02227374,milnacipran,serotoninnorepinephrine reuptake inhibitor (SNRI),GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A4,BRD-A15202882|BRD-K02227374,milnacipran,serotoninnorepinephrine reuptake inhibitor (SNRI),GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A4,BRD-K00004287,milnacipran,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4
GJNNXIYZWIZFRH,BRD-K64338723,milacemide,monoamine oxidase inhibitor,MAOB,BRD-K64338723,milacemide,monoamine oxidase inhibitor,MAOB,BRD-K64338723,milacemide,monoamine oxidase inhibitor,MAOB,BRD-K64338723,milacemide,monoamine oxidase inhibitor,MAOB
GJOCABIDMCKCEG,BRD-K60984070,PD-166793,collagenase inhibitor|metalloproteinase inhibitor,MMP13|MMP2|MMP3,BRD-K60984070,PD-166793,collagenase inhibitor|metalloproteinase inhibitor,MMP13|MMP2|MMP3,BRD-K60984070,PD-166793,collagenase inhibitor|metalloproteinase inhibitor,MMP13|MMP2|MMP3,BRD-K60984070,PD-166793,collagenase inhibitor|metalloproteinase inhibitor,MMP13|MMP2|MMP3
GJPICJJJRGTNOD,BRD-K74763371,bosentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K74763371,bosentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K74763371,bosentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K74763371,bosentan,endothelin receptor antagonist,EDNRA|EDNRB
GJQPMPFPNINLKP,BRD-K71499074,diclofenamide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7,BRD-K71499074,diclofenamide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7,BRD-K71499074,diclofenamide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7,BRD-K71499074,diclofenamide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7
GJSURZIOUXUGAL,BRD-K98530306,clonidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K98530306,clonidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K98530306,clonidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K98530306,clonidine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
GJSUWVXFIISKPT,BRD-K03871161,5-hydroxyectoine,,,BRD-K03871161,5-hydroxyectoine,,,BRD-K03871161,5-hydroxyectoine,,,,,,
GJUFPAZNBPFNRI,BRD-K45168550,SB-756050,G protein-coupled receptor agonist,GPBAR1,BRD-K45168550,SB-756050,G protein-coupled receptor agonist,GPBAR1,BRD-K45168550,SB-756050,G protein-coupled receptor agonist,GPBAR1,BRD-K45168550,SB-756050,G protein-coupled receptor agonist,GPBAR1
GKCBAIGFKIBETG,BRD-K45071273,tetracaine,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K45071273,tetracaine,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K45071273,tetracaine,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K45071273,tetracaine,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
GKCGWXNLOYTUNC,BRD-K12769093,PNU-37883,ATP-sensitive potassium channel antagonist,,BRD-K12769093,PNU-37883,ATP-sensitive potassium channel antagonist,,BRD-K12769093,PNU-37883,ATP-sensitive potassium channel antagonist,,BRD-K06341478,PNU-37883,ATP-sensitive potassium channel antagonist,
GKDRMWXFWHEQQT,BRD-K85178109,fostamatinib,SYK inhibitor,RET|SYK,BRD-K85178109,fostamatinib,SYK inhibitor,RET|SYK,BRD-K85178109,fostamatinib,SYK inhibitor,SYK,BRD-K85178109,fostamatinib,SYK inhibitor,SYK
GKHIVNAUVKXIIY,BRD-K88506063,KD025,rho associated kinase inhibitor,ROCK2,BRD-K88506063,KD025,rho associated kinase inhibitor,ROCK2,BRD-K88506063,KD025,rho associated kinase inhibitor,ROCK2,BRD-K88506063,KD025,rho associated kinase inhibitor,ROCK2
GKIRPKYJQBWNGO,BRD-K29950728,clomifene,estrogen receptor antagonist,ESR1,BRD-K29950728,clomifene,estrogen receptor antagonist,ESR1,BRD-K29950728,clomifene,estrogen receptor antagonist,ESR1,BRD-K29950728,clomifene,estrogen receptor antagonist,ESR1
GKJCVYLDJWTWQU,BRD-K17203476,LY2874455,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,BRD-K17203476,LY2874455,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,BRD-K17203476,LY2874455,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,BRD-K17203476,LY2874455,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR
GKJZEKSHCJELPL,BRD-A31575449,CGP-20712A,adrenergic receptor antagonist,ADRB1|ADRB3,BRD-A31575449,CGP-20712A,adrenergic receptor antagonist,ADRB1|ADRB3,BRD-A31575449,CGP-20712A,adrenergic receptor antagonist,ADRB1|ADRB3,,,,
GKJZMAHZJGSBKD,BRD-K26222048,"trans-10,cis-12-Conjugated-linoleic-acid",,,BRD-K26222048,"trans-10,cis-12-Conjugated-linoleic-acid",,,BRD-K26222048,"trans-10,cis-12-Conjugated-linoleic-acid",,,BRD-K26222048,"trans-10,cis-12-conjugated-linoleic-acid",,
GKNPSSNBBWDAGH,BRD-A62421304,mepenzolate,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-A62421304,mepenzolate,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-A62421304,mepenzolate,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-A62421304,mepenzolate,acetylcholine receptor antagonist,
GKQPCPXONLDCMU,BRD-K43586850,lacidipine,calcium channel blocker,CACNA1C,BRD-K43586850,lacidipine,calcium channel blocker,CACNA1C,BRD-K43586850,lacidipine,calcium channel blocker,CACNA1C,BRD-K43586850,lacidipine,calcium channel blocker,CACNA1C
GKTWGGQPFAXNFI,BRD-K27721098,clopidogrel,purinergic receptor antagonist,P2RY12,BRD-K27721098,clopidogrel,purinergic receptor antagonist,P2RY12,BRD-K27721098,clopidogrel,purinergic receptor antagonist,P2RY12,BRD-K27721098,clopidogrel,purinergic receptor antagonist,P2RY12
GKWHICIUSVVNGX,BRD-K95899059,LY344864,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7,BRD-K95899059,LY344864,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7,BRD-K95899059,LY344864,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7,BRD-K95899059,LY344864,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7
GKWPCEFFIHSJOE,BRD-K60918217,laquinimod,immunosuppressant,CXCL2,BRD-K60918217,laquinimod,immunosuppressant,CXCL2,BRD-K60918217,laquinimod,immunosuppressant,CXCL2,BRD-K60918217,laquinimod,immunosuppressant,CXCL2
GLBJJMFZWDBELO,BRD-A84575140,pimobendan,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,BRD-A84575140,pimobendan,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,BRD-A84575140,pimobendan,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,BRD-K01826269,pimobendan,calcium sensitizer|phosphodiesterase inhibitor,PDE3A
GLBZSOQDAOLMGC,BRD-K21782625,AMG458,MET inhibitor,MET,BRD-K21782625,AMG458,MET inhibitor,MET,BRD-K21782625,AMG458,MET inhibitor,MET,BRD-K21782625,AMG458,MET inhibitor,MET
GLDOVTGHNKAZLK,BRD-K20501889,octadecan-1-ol,,,BRD-K20501889,octadecan-1-ol,,,BRD-K20501889,octadecan-1-ol,,,BRD-K20501889,octadecan-1-ol,,
GLDSKRNGVVYJAB,BRD-K58122457,hesperadin,Aurora kinase inhibitor,AURKB,BRD-K58122457,hesperadin,Aurora kinase inhibitor,AURKB,BRD-K58122457,hesperadin,Aurora kinase inhibitor,AURKB,BRD-K58122457,hesperadin,Aurora kinase inhibitor,AURKB
GLEVLJDDWXEYCO,BRD-A17846016,trolox,antioxidant,,BRD-A17846016,trolox,antioxidant,,BRD-A17846016,trolox,antioxidant,,BRD-A17846016,trolox,antioxidant,
GLUUGHFHXGJENI,BRD-K13249881,piperazine,benzodiazepine receptor agonist,GABRB3,BRD-K13249881,piperazine,benzodiazepine receptor agonist,GABRB3,BRD-K13249881,piperazine,benzodiazepine receptor agonist,GABRB3,BRD-K13249881,piperazine,benzodiazepine receptor agonist,GABRB3
GLVAUDGFNGKCSF,BRD-K91601245,mercaptopurine,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,BRD-K91601245,mercaptopurine,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,BRD-K91601245,mercaptopurine,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,BRD-K91601245,mercaptopurine,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT
GMBQZIIUCVWOCD,BRD-K62277907,PYM50028,neurotrophic agent,,BRD-K62277907,PYM50028,neurotrophic agent,,BRD-K62277907,PYM50028,neurotrophic agent,,BRD-K62277907,PYM50028,neurotrophic agent,
GMGOZCSXMVXXRS,BRD-A92448440,sari-59-801,,,BRD-A92448440,sari-59-801,,,BRD-A92448440,sari-59-801,,,BRD-A92448440,sari-59-801,,
GMHKMTDVRCWUDX,BRD-A83937277,mephenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A83937277,mephenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A83937277,mephenytoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A83937277,mephenytoin,hydantoin antiepileptic,SCN5A
GMIZZEXBPRLVIV,BRD-K75009076,SCH-900776,CHK inhibitor,CDK2|CHEK1,BRD-K75009076,SCH-900776,CHK inhibitor,CDK2|CHEK1,BRD-K75009076,SCH-900776,CHK inhibitor,CDK2|CHEK1,BRD-K75009076,SCH-900776,CHK inhibitor,CDK2|CHEK1
GMJWAIMJHBTYPD,BRD-A85472596,L-670596,prostanoid receptor antagonist,,BRD-A85472596,L-670596,prostanoid receptor antagonist,,BRD-A85472596,L-670596,prostanoid receptor antagonist,,BRD-A85472596,L-670596,prostanoid receptor antagonist,
GMNAPBAUIVITMI,BRD-K27799744|BRD-K35479987,cyclovirobuxin-d,calcium channel modulator,,BRD-K27799744|BRD-K35479987,cyclovirobuxin-d,calcium channel modulator,,BRD-K27799744|BRD-K35479987,cyclovirobuxin-d,calcium channel modulator,,BRD-K27799744|BRD-K35479987,cyclovirobuxin-D,calcium channel modulator,
GMPKIPWJBDOURN,BRD-K79277568,methoxyamine,DNA repair enzyme inhibitor,APEX1,BRD-K79277568,methoxyamine,DNA repair enzyme inhibitor,APEX1,BRD-K79277568,methoxyamine,DNA repair enzyme inhibitor,APEX1,BRD-K79277568,methoxyamine,DNA repair enzyme inhibitor,APEX1
GMRQFYUYWCNGIN,BRD-K27316855|BRD-K28731095,calcitriol,vitamin D receptor agonist,VDR,BRD-K27316855|BRD-K28731095,calcitriol,vitamin D receptor agonist,VDR,BRD-K27316855|BRD-K28731095,calcitriol,vitamin D receptor agonist,VDR,BRD-K27316855|BRD-K28731095,calcitriol,vitamin D receptor agonist,VDR
GMVPRGQOIOIIMI,BRD-K52459643|BRD-K73691377,alprostadil,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,BRD-K52459643|BRD-K73691377,alprostadil,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,BRD-K52459643|BRD-K73691377,alprostadil,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,BRD-K52459643|BRD-K73691377,alprostadil,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR
GMYLVKUGJMYTFB,BRD-K16755045,CC-115,DNA protein kinase inhibitor|mTOR inhibitor,MTOR,BRD-K16755045,CC-115,DNA protein kinase inhibitor|mTOR inhibitor,MTOR,BRD-K16755045,CC-115,DNA protein kinase inhibitor|mTOR inhibitor,MTOR,BRD-K16755045,CC-115,DNA protein kinase inhibitor|mTOR inhibitor,MTOR
GMZVRMREEHBGGF,BRD-K19456237,piracetam,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K19456237,piracetam,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K19456237,piracetam,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K19456237,piracetam,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4
GNBHRKFJIUUOQI,BRD-K21913543,fluorescein,,SLC22A6,BRD-K21913543,fluorescein,,SLC22A6,BRD-K21913543,fluorescein,,SLC22A6,BRD-K21913543,fluorescein,,SLC22A6
GNMUEVRJHCWKTO,BRD-K43471985,OTX015,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K43471985,OTX015,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-A53775886|BRD-K43471985,OTX015,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-A53775886|BRD-K43471985,OTX015,bromodomain inhibitor,BRD2|BRD3|BRD4
GNNDEPIMDAZHRQ,BRD-K78627070,altiratinib,MET inhibitor|VEGFR inhibitor,KDR|MET|TEK,BRD-K78627070,altiratinib,MET inhibitor|VEGFR inhibitor,KDR|MET|TEK,BRD-K78627070,altiratinib,MET inhibitor|VEGFR inhibitor,KDR|MET|TEK,BRD-K78627070,altiratinib,MET inhibitor|VEGFR inhibitor,KDR|MET|TEK
GNOGSFBXBWBTIG,BRD-K46416130,acetriazoic-acid,,,BRD-K46416130,acetriazoic-acid,,,BRD-K46416130,acetriazoic-acid,,,BRD-K46416130,acetriazoic-acid,,
GNUXVOXXWGNPIV,BRD-A08255417,famprofazone,cyclooxygenase inhibitor,,BRD-A08255417,famprofazone,cyclooxygenase inhibitor,,BRD-A08255417,famprofazone,cyclooxygenase inhibitor,,BRD-A08255417,famprofazone,cyclooxygenase inhibitor,
GNXFOGHNGIVQEH,BRD-A31521121,methocarbamol,muscle relaxant,CA1,BRD-A31521121,methocarbamol,muscle relaxant,CA1,BRD-A31521121,methocarbamol,muscle relaxant,CA1,BRD-A31521121,methocarbamol,muscle relaxant,CA1
GNZCRYWFWKFIDM,BRD-K20431737,benzoylpas,,,BRD-K20431737,benzoylpas,,,BRD-K20431737,benzoylpas,,,BRD-K20431737,benzoylpas,,
GOEMGAFJFRBGGG,BRD-A29260609,acebutolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A29260609,acebutolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A29260609,acebutolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A29260609,acebutolol,adrenergic receptor antagonist,ADRB1
GOFXWTVKPWJNGD,BRD-K45906612,presatovir,RSV fusion inhibitor,,BRD-K45906612,presatovir,RSV fusion inhibitor,,BRD-K45906612,presatovir,RSV fusion inhibitor,,BRD-K45906612,presatovir,RSV fusion inhibitor,
GOHCTCOGYKAJLZ,BRD-K30572193,CTEP,glutamate receptor antagonist,GRM5,BRD-K30572193,CTEP,glutamate receptor antagonist,GRM5,BRD-K30572193,CTEP,glutamate receptor antagonist,GRM5,BRD-K30572193,CTEP,glutamate receptor antagonist,GRM5
GOIFCXRIFSYPFG,BRD-K57416838,MRK-409,benzodiazepine receptor agonist,,BRD-K57416838,MRK-409,benzodiazepine receptor agonist,,BRD-K57416838,MRK-409,benzodiazepine receptor agonist,,BRD-K57416838,MRK-409,benzodiazepine receptor agonist,
GOLXRNDWAUTYKT,BRD-K21071223,VP-20629,beta amyloid antagonist,PLA2G2E|SLC36A1,BRD-K21071223,VP-20629,beta amyloid antagonist,PLA2G2E|SLC36A1,BRD-K21071223,VP-20629,beta amyloid antagonist,PLA2G2E|SLC36A1,BRD-K21071223,VP-20629,beta amyloid antagonist,PLA2G2E|SLC36A1
GOTMKOSCLKVOGG,BRD-K45435259,SCH-23390,dopamine receptor antagonist,DRD1|DRD5|HTR2C|KCNJ4|KCNJ6,BRD-K45435259,SCH-23390,dopamine receptor antagonist,DRD1|DRD5|HTR2C|KCNJ4|KCNJ6,BRD-K45435259,SCH-23390,dopamine receptor antagonist,DRD1|DRD5|HTR2C|KCNJ4|KCNJ6,BRD-K45435259,SCH-23390,dopamine receptor antagonist,DRD1|DRD5|HTR2C|KCNJ4|KCNJ6
GOTYRUGSSMKFNF,BRD-A17883755,lenalidomide,anticancer agent,CDH5|CRBN|PTGS2|TNF|TNFSF11,BRD-A17883755,lenalidomide,anticancer agent,CDH5|CRBN|PTGS2|TNF|TNFSF11,BRD-A17883755,lenalidomide,anticancer agent,CDH5|CRBN|PTGS2|TNF|TNFSF11,BRD-A17883755,lenalidomide,anticancer agent,TNF
GOVWOKSKFSBNGD,BRD-K02475039,ethopabate,antiprotozoal agent,,BRD-K02475039,ethopabate,antiprotozoal agent,,BRD-K02475039,ethopabate,antiprotozoal agent,,BRD-K02475039,ethopabate,antiprotozoal agent,
GOVYBPLHWIEHEJ,BRD-K00627859,tubastatin-a,HDAC inhibitor,HDAC6,BRD-K00627859,tubastatin-a,HDAC inhibitor,HDAC6,BRD-K00627859,tubastatin-a,HDAC inhibitor,HDAC6,BRD-K00627859,tubastatin-A,HDAC inhibitor,HDAC6
GPKJTRJOBQGKQK,BRD-A45889380,mepacrine,NFkB pathway inhibitor|TP53 activator|cytokine production inhibitor,PLA2G1B|PLA2G4A|PLA2G6|PLCL1,BRD-A45889380,mepacrine,NFkB pathway inhibitor|TP53 activator|cytokine production inhibitor,PLA2G1B|PLA2G4A|PLA2G6|PLCL1,BRD-A45889380,mepacrine,NFkB pathway inhibitor|TP53 activator|cytokine production inhibitor,PLA2G1B|PLA2G4A|PLA2G6|PLCL1,BRD-A45889380,mepacrine,NFkB pathway inhibitor|TP53 activator|cytokine production inhibitor,PLA2G1B
GPNHMOZDMYNCPO,BRD-K41779183,CB-03-01,androgen receptor antagonist,AR,BRD-K41779183,CB-03-01,androgen receptor antagonist,AR,BRD-K41779183,CB-03-01,androgen receptor antagonist,AR,BRD-K41779183,CB-03-01,androgen receptor antagonist,AR
GPRBEKHLDVQUJE,BRD-K78364995|BRD-K99586414,cefotaxime,bacterial cell wall synthesis inhibitor,,BRD-K78364995|BRD-K99586414,cefotaxime,bacterial cell wall synthesis inhibitor,,BRD-K78364995|BRD-K99586414,cefotaxime,bacterial cell wall synthesis inhibitor,,BRD-K78364995|BRD-K99586414,cefotaxime,bacterial cell wall synthesis inhibitor,
GPSZYOIFQZPWEJ,BRD-K64866502,CYC116,Aurora kinase inhibitor,AURKA|AURKB|KDR,BRD-K64866502,CYC116,Aurora kinase inhibitor,AURKA|AURKB|KDR,BRD-K64866502,CYC116,Aurora kinase inhibitor,AURKA|AURKB|KDR,BRD-K64866502,CYC116,Aurora kinase inhibitor,AURKA|AURKB|KDR
GPTONYMQFTZPKC,BRD-K87492696,sulfameter,dihydrofolate reductase inhibitor,DHFR,BRD-K87492696,sulfameter,dihydrofolate reductase inhibitor,DHFR,BRD-K87492696,sulfameter,dihydrofolate reductase inhibitor,DHFR,BRD-K87492696,sulfameter,dihydrofolate reductase inhibitor,DHFR
GPTXWRGISTZRIO,BRD-K90374350,chlorquinaldol,other antibiotic,,BRD-K90374350,chlorquinaldol,other antibiotic,,BRD-K90374350,chlorquinaldol,other antibiotic,,BRD-K90374350,chlorquinaldol,other antibiotic,
GPXBXXGIAQBQNI,BRD-K56343971,vemurafenib,RAF inhibitor,BRAF|RAF1,BRD-K56343971,vemurafenib,RAF inhibitor,BRAF|RAF1,BRD-K56343971,vemurafenib,RAF inhibitor,BRAF|RAF1,BRD-K56343971,vemurafenib,RAF inhibitor,BRAF|RAF1
GPXLMGHLHQJAGZ,BRD-K18574842|BRD-K96812051,nafcillin,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6,BRD-K18574842|BRD-K96812051,nafcillin,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6,BRD-K18574842|BRD-K96812051,nafcillin,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6,BRD-K18574842|BRD-K96812051,nafcillin,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6
GQLCLPLEEOUJQC,BRD-K28383148,AP1903,,,BRD-K28383148,AP1903,,,BRD-K28383148,AP1903,,,BRD-K28383148,AP1903,,MTOR
GQMYQEAXTITUAE,BRD-K91904471,SD-169,p38 MAPK inhibitor,MAPK14,BRD-K91904471,SD-169,p38 MAPK inhibitor,MAPK14,BRD-K91904471,SD-169,p38 MAPK inhibitor,MAPK14,BRD-K91904471,SD-169,p38 MAPK inhibitor,MAPK14
GQNZGCARKRHPOH,BRD-K30764557,miocamycin,other antibiotic,,BRD-K30764557,miocamycin,other antibiotic,,BRD-K30764557,miocamycin,other antibiotic,,BRD-K30764557,miocamycin,other antibiotic,
GQPHQLHUIDOQTA,BRD-K90177246,tetroquinone,,,BRD-K90177246,tetroquinone,,,BRD-K90177246,tetroquinone,,,BRD-K90177246,tetroquinone,,
GQYIWUVLTXOXAJ,BRD-K51768138,lomustine,DNA synthesis inhibitor,STMN4,BRD-K51768138,lomustine,DNA synthesis inhibitor,STMN4,BRD-K51768138,lomustine,DNA synthesis inhibitor,STMN4,,,,
GRAJFFFXJYFVOC,BRD-K63150726,JTE-907,cannabinoid receptor inverse agonist,CNR2,BRD-K63150726,JTE-907,cannabinoid receptor inverse agonist,CNR2,BRD-K63150726,JTE-907,cannabinoid receptor inverse agonist,CNR2,BRD-K63150726,JTE-907,cannabinoid receptor inverse agonist,CNR2
GRHLMSBCOPRFNA,BRD-K73469236,nedaplatin,DNA inhibitor,,BRD-K73469236,nedaplatin,DNA inhibitor,,BRD-K34751753|BRD-K73469236,nedaplatin,DNA inhibitor,,,,,
GROJOWHVXQYQGN,BRD-A55664972,sodium-tetradecyl-sulfate,,PROC|PROS1,BRD-A55664972,sodium-tetradecyl-sulfate,,PROC|PROS1,BRD-A55664972,sodium-tetradecyl-sulfate,,PROC|PROS1,BRD-A55664972,sodium-tetradecyl-sulfate,,PROC
GRRNUXAQVGOGFE,BRD-A26049141,hygromycin-b,polypeptide synthesis inhibitor,,,,,,,,,,BRD-A24252652,hygromycin-B,polypeptide synthesis inhibitor,
GRSZFWQUAKGDAV,BRD-A67531813,polyinosine,immunostimulant,ADSSL1|HPRT1|IMPDH2|PYGM,BRD-A67531813,polyinosine,immunostimulant,ADSSL1|HPRT1|IMPDH2|PYGM,BRD-A67531813,polyinosine,immunostimulant,ADSSL1|HPRT1|IMPDH2|PYGM,BRD-A67531813,polyinosine,immunostimulant,HPRT1|IMPDH2|PYGM
GRTBAGCGDOYUBE,BRD-K83914624,C11-Acetate,,ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN,BRD-K83914624,C11-Acetate,,ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN,BRD-K83914624,C11-Acetate,,ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN,BRD-K83914624,C11-Acetate,,ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN
GRZXWCHAXNAUHY,BRD-K71480163,GDC-0068,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,BRD-K71480163,GDC-0068,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,BRD-K71480163,GDC-0068,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,BRD-K43002773,GDC-0068,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1
GSASOFRDSIKDSN,BRD-K26530649,carboxypyridine-disulfide,,,BRD-K26530649,carboxypyridine-disulfide,,,BRD-K26530649,carboxypyridine-disulfide,,,BRD-K26530649,carboxypyridine-disulfide,,
GSCPDZHWVNUUFI,BRD-K08703257,3-amino-benzamide,PARP inhibitor,PARP1,BRD-K08703257,3-amino-benzamide,PARP inhibitor,PARP1,BRD-K08703257,3-amino-benzamide,PARP inhibitor,PARP1,BRD-K08703257,3-amino-benzamide,PARP inhibitor,PARP1
GSDSWSVVBLHKDQ,BRD-A24228527|BRD-K09471561|BRD-K88565300,levofloxacin|ofloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A24228527|BRD-K09471561|BRD-K88565300,levofloxacin|ofloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A24228527|BRD-K09471561|BRD-K88565300,levofloxacin|ofloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K01826479|BRD-K09471561|BRD-K88565300,levofloxacin|ofloxacin,bacterial DNA gyrase inhibitor,|TOP2A
GSGVDKOCBKBMGG,BRD-K75478907,GS-39783,GABA receptor modulator,GABBR1,BRD-K75478907,GS-39783,GABA receptor modulator,GABBR1,BRD-K75478907,GS-39783,GABA receptor modulator,GABBR1,BRD-K75478907,GS-39783,GABA receptor modulator,GABBR1
GSKQMLGAUOTSKT,BRD-A26835809|BRD-K36394566,PX-478|melphalan-n-oxide,hypoxia inducible factor inhibitor,|HIF1A,BRD-A26835809|BRD-K36394566,PX-478|melphalan-n-oxide,hypoxia inducible factor inhibitor,|HIF1A,BRD-A26835809|BRD-K36394566,PX-478|melphalan-n-oxide,hypoxia inducible factor inhibitor,|HIF1A,BRD-A26835809|BRD-K36394566,PX-478|melphalan-n-oxide,hypoxia inducible factor inhibitor,|HIF1A
GSNHKUDZZFZSJB,BRD-A04352665,maraviroc,CC chemokine receptor antagonist,CCR5,BRD-A04352665,maraviroc,CC chemokine receptor antagonist,CCR5,BRD-A04352665,maraviroc,CC chemokine receptor antagonist,CCR5,BRD-K00004293,maraviroc,CC chemokine receptor antagonist,CCR5
GSNOZLZNQMLSKJ,BRD-K95763993,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,BRD-K95763993,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,BRD-K95763993,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,BRD-K95763993,trapidil,PDGFR tyrosine kinase receptor inhibitor,PDGFRA
GSQOBTOAOGXIFL,BRD-K34428485,AG-555,tyrosine kinase inhibitor,CDK2,BRD-K34428485,AG-555,tyrosine kinase inhibitor,CDK2,BRD-K34428485,AG-555,tyrosine kinase inhibitor,CDK2,BRD-K34428485,AG-555,tyrosine kinase inhibitor,CDK2
GSVQIUGOUKJHRC,BRD-A37492983,iocetamic-acid,radiopaque medium,,BRD-A37492983,iocetamic-acid,radiopaque medium,,BRD-A37492983,iocetamic-acid,radiopaque medium,,BRD-A37492983,iocetamic-acid,radiopaque medium,
GSXJSGMDWKPVBY,BRD-K83322645,L-693403,sigma receptor agonist|sigma receptor antagonist,DRD2|SIGMAR1,BRD-K83322645,L-693403,sigma receptor agonist|sigma receptor antagonist,DRD2|SIGMAR1,BRD-K83322645,L-693403,sigma receptor agonist|sigma receptor antagonist,DRD2|SIGMAR1,BRD-K83322645,L-693403,sigma receptor agonist|sigma receptor antagonist,DRD2|SIGMAR1
GSYQNAMOFFWAPF,BRD-A49906757,scopolamine-n-oxide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,BRD-A49906757,scopolamine-n-oxide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,BRD-A49906757,scopolamine-n-oxide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,BRD-A49906757,scopolamine-N-oxide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4
GTUIQNHJSXQMKW,BRD-A44188509,AZD1446,acetylcholine receptor agonist,CHRNA4|CHRNB2,BRD-A44188509,AZD1446,acetylcholine receptor agonist,CHRNA4|CHRNB2,BRD-A44188509,AZD1446,acetylcholine receptor agonist,CHRNA4|CHRNB2,BRD-A44188509,AZD1446,acetylcholine receptor agonist,CHRNA4|CHRNB2
GTUIRORNXIOHQR,BRD-A53037217,BTZ043-racemate,DPRE1 inhibitor,,BRD-A53037217,BTZ043-racemate,DPRE1 inhibitor,,BRD-A53037217,BTZ043-racemate,DPRE1 inhibitor,,BRD-A53037217,BTZ043-racemate,DPRE1 inhibitor,
GTVPOLSIJWJJNY,BRD-K82731415,olomoucine,CDK inhibitor,CDK1|CDK2|CDK5|MAPK1,BRD-K82731415,olomoucine,CDK inhibitor,CDK1|CDK2|CDK5|MAPK1,BRD-K82731415,olomoucine,CDK inhibitor,CDK1|CDK2|CDK5|MAPK1,BRD-K82731415,olomoucine,CDK inhibitor,CDK1|CDK2|CDK5|MAPK1
GTZCVFVGUGFEME,BRD-K71756122,cis-aconitic-acid,,ACO2,BRD-K71756122,cis-aconitic-acid,,ACO2,BRD-K71756122,cis-aconitic-acid,,ACO2,BRD-K71756122,cis-aconitic-acid,,ACO2
GUAZPUYTLMUTMA,BRD-K59929863,CB-10-277,DNA synthesis inhibitor,,BRD-K59929863,CB-10-277,DNA synthesis inhibitor,,BRD-K59929863,CB-10-277,DNA synthesis inhibitor,,BRD-K59929863,CB-10-277,DNA synthesis inhibitor,
GUBGYTABKSRVRQ,BRD-K74377520,D-(+)-maltose,,AMY2B|MGAM,BRD-K74377520,D-(+)-maltose,,AMY2B|MGAM,BRD-K74377520,D-(+)-maltose,,AMY2B|MGAM,BRD-K74377520,D-(+)-maltose,,MGAM
GUCUORSUHTZMBW,BRD-K00256256,AMZ30,protein phosphatase inhibitor,,BRD-K00256256,AMZ30,protein phosphatase inhibitor,,BRD-K00256256,AMZ30,protein phosphatase inhibitor,,BRD-K00256256,AMZ30,protein phosphatase inhibitor,
GUDVQJXODNJRIJ,BRD-K70490179,rimcazole,sigma receptor antagonist,SIGMAR1,BRD-K70490179,rimcazole,sigma receptor antagonist,SIGMAR1,BRD-K70490179,rimcazole,sigma receptor antagonist,SIGMAR1,BRD-K70490179,rimcazole,sigma receptor antagonist,SIGMAR1
GUGOEEXESWIERI,BRD-A06352418,terfenadine,histamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|KCNH1|KCNH2,BRD-A06352418,terfenadine,histamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|KCNH1|KCNH2,BRD-A06352418,terfenadine,histamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|KCNH1|KCNH2,BRD-A06352418,terfenadine,histamine receptor antagonist,HRH1|KCNH1|KCNH2
GUHPRPJDBZHYCJ,BRD-A72988804,tiaprofenic-acid,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A72988804,tiaprofenic-acid,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A72988804,tiaprofenic-acid,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A72988804,tiaprofenic-acid,cyclooxygenase inhibitor,PTGS2
GUJRSXAPGDDABA,BRD-K54094468,remoxipride,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1,BRD-K54094468,remoxipride,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1,BRD-K54094468,remoxipride,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1,BRD-K54094468,remoxipride,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1
GULNIHOSWFYMRN,BRD-K88405679,thonzylamine,antihistamine,,BRD-K88405679,thonzylamine,antihistamine,,BRD-K88405679,thonzylamine,antihistamine,,BRD-K88405679,thonzylamine,antihistamine,
GUOQUXNJZHGPQF,BRD-K00662280,CL-218872,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,BRD-K00662280,CL-218872,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,BRD-K00662280,CL-218872,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,BRD-K00662280,CL-218872,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2
GUTXTARXLVFHDK,BRD-K80859331,haloperidol-decanoate,psychoactive drug,DRD2|DRD3|DRD4|HTR2A,BRD-K80859331,haloperidol-decanoate,psychoactive drug,DRD2|DRD3|DRD4|HTR2A,BRD-K80859331,haloperidol-decanoate,psychoactive drug,DRD2|DRD3|DRD4|HTR2A,BRD-K80859331,haloperidol-decanoate,psychoactive drug,DRD2|DRD3|DRD4|HTR2A
GUTYHDCSDBBMGW,BRD-K45385835,SX-011,MAP kinase inhibitor,MAPK14,BRD-K45385835,SX-011,MAP kinase inhibitor,MAPK14,BRD-K45385835,SX-011,MAP kinase inhibitor,MAPK14,BRD-K45385835,SX-011,MAP kinase inhibitor,MAPK14
GUUIRIMAQGOLHT,BRD-K18834913,LB42708,farnesyltransferase inhibitor,,BRD-K18834913,LB42708,farnesyltransferase inhibitor,,BRD-K18834913,LB42708,farnesyltransferase inhibitor,,BRD-K18834913,LB42708,farnesyltransferase inhibitor,
GUXXEUUYCAYESJ,BRD-K68174511,torin-2,mTOR inhibitor,MTOR,BRD-K68174511,torin-2,mTOR inhibitor,MTOR,BRD-K68174511,torin-2,mTOR inhibitor,MTOR,BRD-K68174511,torin-2,mTOR inhibitor,MTOR
GVEAYVLWDAFXET,BRD-K25166838|BRD-K50817623,pancuronium,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,BRD-K25166838|BRD-K50817623,pancuronium,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,BRD-K25166838|BRD-K50817623,pancuronium,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,BRD-K25166838|BRD-K50817623,pancuronium,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2
GVEZIHKRYBHEFX,BRD-K52075040,cerulenin,fatty acid synthase inhibitor,FASN,BRD-K52075040,cerulenin,fatty acid synthase inhibitor,FASN,BRD-K52075040,cerulenin,fatty acid synthase inhibitor,FASN,BRD-K52075040,cerulenin,fatty acid synthase inhibitor,FASN
GVJHHUAWPYXKBD,BRD-A82892199|BRD-K97091514,alpha-tochopherol|vitamin-E,LDL oxidation inhibitor|PKC inhibitor|antioxidant,|ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4,BRD-A82892199|BRD-K97091514,alpha-tochopherol|vitamin-E,LDL oxidation inhibitor|PKC inhibitor|antioxidant,|ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4,BRD-A82892199|BRD-K97091514,alpha-tochopherol|vitamin-E,LDL oxidation inhibitor|PKC inhibitor|antioxidant,|ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4,BRD-A82892199|BRD-K97091514,alpha-tochopherol|vitamin-E,LDL oxidation inhibitor|PKC inhibitor|antioxidant,|ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4
GVKKJJOMQCNPGB,BRD-K33336844|BRD-K53562481,cryptotanshinone,STAT inhibitor|acetylcholinesterase inhibitor,STAT3,BRD-K33336844|BRD-K53562481,cryptotanshinone,STAT inhibitor|acetylcholinesterase inhibitor,STAT3,BRD-K33336844|BRD-K53562481,cryptotanshinone,STAT inhibitor|acetylcholinesterase inhibitor,STAT3,BRD-K33336844|BRD-K53562481,cryptotanshinone,STAT inhibitor|acetylcholinesterase inhibitor,STAT3
GVPIXRLYKVFFMK,BRD-K36732695,setiptiline,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,BRD-K36732695,setiptiline,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,BRD-K36732695,setiptiline,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,BRD-K36732695,setiptiline,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C
GVTLDPJNRVMCAL,BRD-K33852358,arofylline,phosphodiesterase inhibitor,PDE4A,BRD-K33852358,arofylline,phosphodiesterase inhibitor,PDE4A,BRD-K33852358,arofylline,phosphodiesterase inhibitor,PDE4A,BRD-K33852358,arofylline,phosphodiesterase inhibitor,PDE4A
GVZONAHBJMFJOW,BRD-K65900713,caroverine,calcium channel blocker|glutamate receptor antagonist,,BRD-K65900713,caroverine,calcium channel blocker|glutamate receptor antagonist,,BRD-K65900713,caroverine,calcium channel blocker|glutamate receptor antagonist,,,,,
GWBPFRGXNGPPMF,BRD-K76845197,sulfanitran,,,BRD-K76845197,sulfanitran,,,BRD-K76845197,sulfanitran,,,BRD-K76845197,sulfanitran,,
GWCNJMUSWLTSCW,BRD-K81048131,AG-556,tyrosine kinase inhibitor,,BRD-K81048131,AG-556,tyrosine kinase inhibitor,,BRD-K81048131,AG-556,tyrosine kinase inhibitor,,BRD-K81048131,AG-556,tyrosine kinase inhibitor,
GWEJFLVSOGNLSS,BRD-K98963219,ezatiostat,glutathione transferase inhibitor,GSTP1,BRD-K98963219,ezatiostat,glutathione transferase inhibitor,GSTP1,BRD-K98963219,ezatiostat,glutathione transferase inhibitor,GSTP1,BRD-K98963219,ezatiostat,glutathione transferase inhibitor,GSTP1
GWOFUCIGLDBNKM,BRD-A38076815,glafenine,DeltaF508-CFTR Correctors,CFTR,BRD-A38076815,glafenine,DeltaF508-CFTR Correctors,CFTR,BRD-A38076815,glafenine,DeltaF508-CFTR Correctors,CFTR,BRD-K01826515,glafenine,DeltaF508-CFTR Correctors,CFTR
GWRSATNRNFYMDI,BRD-K48059512,TAK-960,PLK inhibitor,PLK1,BRD-K48059512,TAK-960,PLK inhibitor,PLK1,BRD-K48059512,TAK-960,PLK inhibitor,PLK1,BRD-K48059512,TAK-960,PLK inhibitor,PLK1
GXALXAKNHIROPE,BRD-K20008181,LCQ908,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K20008181,LCQ908,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K20008181,LCQ908,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K20008181,LCQ908,diacylglycerol O acyltransferase inhibitor,DGAT1
GXDALQBWZGODGZ,BRD-K37249724,astemizole,histamine receptor antagonist,HRH1|KCNH1|KCNH2,BRD-K37249724,astemizole,histamine receptor antagonist,HRH1|KCNH1|KCNH2,BRD-K37249724,astemizole,histamine receptor antagonist,HRH1|KCNH1|KCNH2,BRD-K37249724,astemizole,histamine receptor antagonist,HRH1|KCNH1|KCNH2
GXFAIFRPOKBQRV,BRD-A42379279,viomycin,protein synthesis inhibitor,,BRD-A42379279,viomycin,protein synthesis inhibitor,,BRD-A42379279,viomycin,protein synthesis inhibitor,,,,,
GXJABQQUPOEUTA,BRD-K88510285,bortezomib,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,BRD-K88510285,bortezomib,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,BRD-K50691590|BRD-K88510285,bortezomib,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,BRD-K50691590|BRD-K88510285,bortezomib,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA
GXPHKUHSUJUWKP,BRD-A13084692,troglitazone,PPAR receptor agonist|insulin sensitizer,ACSL4|ESRRA|ESRRG|PPARG|SERPINE1|SLC29A1|TRPM3,BRD-A13084692,troglitazone,PPAR receptor agonist|insulin sensitizer,ACSL4|ESRRA|ESRRG|PPARG|SERPINE1|SLC29A1|TRPM3,BRD-A13084692,troglitazone,PPAR receptor agonist|insulin sensitizer,ACSL4|ESRRA|ESRRG|PPARG|SERPINE1|SLC29A1|TRPM3,BRD-A13084692,troglitazone,PPAR receptor agonist|insulin sensitizer,CYP2C8|PPARG|TRPM3
GXPYCYWPUGKQIJ,BRD-A43518428,flumexadol,,,BRD-A43518428,flumexadol,,,BRD-A43518428,flumexadol,,,BRD-A43518428,flumexadol,,
GXQFWSKFVUKJCP,BRD-M47753525,sisomicin,protein synthesis inhibitor,,BRD-M47753525,sisomicin,protein synthesis inhibitor,,,,,,,,,
GXZSAQLJWLCLOX,BRD-A80383043|BRD-K74133873,4-carboxy-3-hydroxyphenylglycine-(RS)|4-carboxy-3-hydroxyphenylglycine-(S),glutamate receptor agonist|glutamate receptor antagonist,GRM1|GRM2,BRD-A80383043|BRD-K74133873,4-carboxy-3-hydroxyphenylglycine-(RS)|4-carboxy-3-hydroxyphenylglycine-(S),glutamate receptor agonist|glutamate receptor antagonist,GRM1|GRM2,BRD-A80383043|BRD-K74133873,4-carboxy-3-hydroxyphenylglycine-(RS)|4-carboxy-3-hydroxyphenylglycine-(S),glutamate receptor agonist|glutamate receptor antagonist,GRM1|GRM2,BRD-A80383043|BRD-K74133873,4-carboxy-3-hydroxyphenylglycine-(RS)|4-carboxy-3-hydroxyphenylglycine-(S),glutamate receptor agonist|glutamate receptor antagonist,GRM1|GRM2
GYBXAGDWMCJZJK,BRD-K70792160,10-DEBC,AKT inhibitor,PIM1,BRD-K70792160,10-DEBC,AKT inhibitor,PIM1,BRD-K70792160,10-DEBC,AKT inhibitor,PIM1,BRD-K70792160,10-DEBC,AKT inhibitor,PIM1
GYCPCOJTCINIFZ,BRD-K62196610,AVN-944,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,BRD-K62196610,AVN-944,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,BRD-K62196610,AVN-944,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,BRD-K62196610,AVN-944,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2
GYDJEQRTZSCIOI,BRD-K15014948|BRD-K79165417,tranexamic-acid,antifibrinolytic|plasminogen activator inhibitor,PLG,BRD-K15014948|BRD-K79165417,tranexamic-acid,antifibrinolytic|plasminogen activator inhibitor,PLG,BRD-K15014948|BRD-K79165417,tranexamic-acid,antifibrinolytic|plasminogen activator inhibitor,PLG,BRD-K15014948|BRD-K79165417,tranexamic-acid,antifibrinolytic|plasminogen activator inhibitor,PLG
GYHCTFXIZSNGJT,BRD-A82035391,tolvaptan,vasopressin receptor antagonist,AVPR1A|AVPR2,BRD-A82035391,tolvaptan,vasopressin receptor antagonist,AVPR1A|AVPR2,BRD-A82035391,tolvaptan,vasopressin receptor antagonist,AVPR1A|AVPR2,BRD-A82035391,tolvaptan,vasopressin receptor antagonist,AVPR1A|AVPR2
GYKLFBYWXZYSOW,BRD-K20504455,pivanex,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K20504455,pivanex,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K20504455,pivanex,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K20504455,pivanex,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8
GYLDXIAOMVERTK,BRD-K59317601,MLN0128,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,BRD-K59317601,MLN0128,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,BRD-K59317601,MLN0128,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,BRD-K59317601,MLN0128,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG
GYNDFOLSPPBBIK,BRD-K38687824,beta-amyloid-synthesis-inhibitor,beta amyloid synthesis inhibitor,APP,BRD-K38687824,beta-amyloid-synthesis-inhibitor,beta amyloid synthesis inhibitor,APP,BRD-K38687824,beta-amyloid-synthesis-inhibitor,beta amyloid synthesis inhibitor,APP,BRD-K38687824,beta-amyloid-synthesis-inhibitor,beta amyloid synthesis inhibitor,APP
GYQYAJJFPNQOOW,BRD-K72280606,gilteritinib,FLT3 inhibitor,FLT3,BRD-K72280606,gilteritinib,FLT3 inhibitor,FLT3,BRD-K72280606,gilteritinib,FLT3 inhibitor,FLT3,BRD-K72280606,gilteritinib,FLT3 inhibitor,FLT3
GYSZUJHYXCZAKI,BRD-A01493904,WB-4101,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A,BRD-A01493904,WB-4101,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A,BRD-A01493904,WB-4101,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A,BRD-A01493904,WB-4101,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A
GYWXTRVEUURNEW,BRD-K40578143,GR-79236,adenosine receptor agonist,ADORA1|ADORA2A,BRD-K40578143,GR-79236,adenosine receptor agonist,ADORA1|ADORA2A,BRD-K40578143,GR-79236,adenosine receptor agonist,ADORA1|ADORA2A,BRD-K40578143,GR-79236,adenosine receptor agonist,ADORA1|ADORA2A
GZCGUPFRVQAUEE,BRD-K51431759,dextrose,,,BRD-K51431759,dextrose,,,BRD-K51431759,dextrose,,,BRD-K51431759,dextrose,,
GZENKSODFLBBHQ,BRD-A20126139|BRD-A59014912,medrysone,glucocorticoid receptor agonist,NR3C1,BRD-A20126139|BRD-A59014912,medrysone,glucocorticoid receptor agonist,NR3C1,BRD-A20126139|BRD-A59014912|BRD-K56515112,medrysone,glucocorticoid receptor agonist,NR3C1,BRD-A20126139|BRD-K56515112,medrysone,glucocorticoid receptor agonist,NR3C1
GZHFODJQISUKAY,BRD-K09859624,methantheline,acetylcholine receptor antagonist,CHRM1|HRH2,BRD-K09859624,methantheline,acetylcholine receptor antagonist,CHRM1|HRH2,BRD-K09859624,methantheline,acetylcholine receptor antagonist,CHRM1|HRH2,BRD-K09859624,methantheline,acetylcholine receptor antagonist,CHRM1|HRH2
GZIFEOYASATJEH,BRD-K04657451,D-delta-Tocopherol,,,BRD-K04657451,D-delta-Tocopherol,,,BRD-K04657451,D-delta-Tocopherol,,,BRD-K04657451,D-delta-tocopherol,,
GZKLJWGUPQBVJQ,BRD-K69116396,sertindole,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,BRD-K69116396,sertindole,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,BRD-K69116396,sertindole,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,BRD-K69116396,sertindole,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2
GZNIYOXWFCDBBJ,BRD-K37865504,LY2183240,FAAH inhibitor|FAAH reuptake inhibitor,FAAH,BRD-K37865504,LY2183240,FAAH inhibitor|FAAH reuptake inhibitor,FAAH,BRD-K37865504,LY2183240,FAAH inhibitor|FAAH reuptake inhibitor,FAAH,BRD-K37865504,LY2183240,FAAH inhibitor|FAAH reuptake inhibitor,FAAH
GZOSMCIZMLWJML,BRD-K00111504,abiraterone,androgen biosynthesis inhibitor,CYP11B1|CYP17A1,BRD-K50071428,abiraterone,androgen biosynthesis inhibitor,CYP11B1|CYP17A1,BRD-K00111504|BRD-K50071428,abiraterone,androgen biosynthesis inhibitor,CYP11B1|CYP17A1,BRD-K00111504|BRD-K50071428,abiraterone,androgen biosynthesis inhibitor,CYP11B1|CYP17A1
GZPJCJKUZPUFAL,BRD-K35936936,ACTB-1003,FGFR inhibitor|VEGFR inhibitor,KDR|TEK,BRD-K35936936,ACTB-1003,FGFR inhibitor|VEGFR inhibitor,KDR|TEK,BRD-K35936936,ACTB-1003,FGFR inhibitor|VEGFR inhibitor,KDR|TEK,BRD-K35936936,ACTB-1003,FGFR inhibitor|VEGFR inhibitor,KDR|TEK
GZSOSUNBTXMUFQ,BRD-K22902927|BRD-K94436377,diosmin,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,BRD-A35279169|BRD-K94436377,diosmin,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,BRD-K22902927|BRD-K94436377,diosmin,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,BRD-K22902927|BRD-K94436377,diosmin,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR
GZTFUVZVLYUPRG,BRD-K01995783,AMG-9810,TRPV antagonist,TRPV1,BRD-K01995783,AMG-9810,TRPV antagonist,TRPV1,BRD-K01995783,AMG-9810,TRPV antagonist,TRPV1,BRD-K01995783,AMG-9810,TRPV antagonist,TRPV1
GZTMFRUGZMZCRD,BRD-K14590126,farnesyl-thiosalicylic-acid-amide,Ras GTPase inhibitor,HRAS,BRD-K14590126,farnesyl-thiosalicylic-acid-amide,Ras GTPase inhibitor,HRAS,BRD-K14590126,farnesyl-thiosalicylic-acid-amide,Ras GTPase inhibitor,HRAS,BRD-K14590126,farnesyl-thiosalicylic-acid-amide,Ras GTPase inhibitor,HRAS
GZUITABIAKMVPG,BRD-K63828191,raloxifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K63828191,raloxifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K63828191,raloxifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K63828191,raloxifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2
GZYBSURBYCLNSM,BRD-K49721826,3-anilinopropan-1-ol,,,BRD-K49721826,3-anilinopropan-1-ol,,,BRD-K49721826,3-anilinopropan-1-ol,,,BRD-K49721826,3-anilinopropan-1-ol,,
HAGHKJDWBDSFKC,BRD-K48449073,Y-29794,prolyl endopeptidase inhibitor,PREP,BRD-K48449073,Y-29794,prolyl endopeptidase inhibitor,PREP,BRD-K48449073,Y-29794,prolyl endopeptidase inhibitor,PREP,BRD-K48449073,Y-29794,prolyl endopeptidase inhibitor,PREP
HAMNKKUPIHEESI,BRD-K25114078,aminoguanidine,nitric oxide synthase inhibitor,NOS2,BRD-K25114078,aminoguanidine,nitric oxide synthase inhibitor,NOS2,BRD-K25114078,aminoguanidine,nitric oxide synthase inhibitor,NOS2,BRD-K25114078,aminoguanidine,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3
HAPOVYFOVVWLRS,BRD-A99633051,ethosuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-A99633051,ethosuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-A99633051,ethosuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-A99633051,ethosuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I
HAQIRIMIVLFYIX,BRD-K40581315,butabindide,tripeptidyl peptidase inhibitor,TPP2,BRD-K40581315,butabindide,tripeptidyl peptidase inhibitor,TPP2,BRD-K40581315,butabindide,tripeptidyl peptidase inhibitor,TPP2,BRD-K40581315,butabindide,tripeptidyl peptidase inhibitor,TPP2
HAVJATCHLFRDHY,BRD-K96358241,harringtonine,protein synthesis inhibitor,,BRD-K96358241,harringtonine,protein synthesis inhibitor,,BRD-K96358241,harringtonine,protein synthesis inhibitor,,BRD-K00003715,harringtonine,protein synthesis inhibitor,
HAWPXGHAZFHHAD,BRD-K12829205,mechlorethamine,DNA inhibitor,,BRD-K12829205,mechlorethamine,DNA inhibitor,,BRD-K12829205,mechlorethamine,DNA inhibitor,,,,,
HAWSQZCWOQZXHI,BRD-K63784565,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1,BRD-K63784565,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1,BRD-K63784565,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1,BRD-K63784565,10-hydroxycamptothecin,topoisomerase inhibitor,TOP1
HAYYBYPASCDWEQ,BRD-K39009484,entrectinib,ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor,ALK|NTRK1|NTRK2|NTRK3|ROS1,BRD-K39009484,entrectinib,ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor,ALK|NTRK1|NTRK2|NTRK3|ROS1,BRD-K39009484,entrectinib,ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor,ALK|NTRK1|NTRK2|NTRK3|ROS1,BRD-K39009484,entrectinib,ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor,ALK|NTRK1|NTRK2|NTRK3|ROS1
HBBVCKCCQCQCTJ,BRD-K98372770,L-165041,PPAR receptor agonist,PPARD,BRD-K40656405|BRD-K98372770,L-165041,PPAR receptor agonist,PPARD,BRD-K40656405|BRD-K98372770,L-165041,PPAR receptor agonist,PPARD,BRD-K40656405|BRD-K98372770,L-165041,PPAR receptor agonist,PPARD
HBDSHCUSXQATPO,BRD-K19136521,indirubin-3-monoxime,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK2|CDK5|CDK5R1|GSK3B,BRD-K19136521,indirubin-3-monoxime,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK2|CDK5|CDK5R1|GSK3B,BRD-K19136521,indirubin-3-monoxime,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK2|CDK5|CDK5R1|GSK3B,BRD-K19136521,indirubin-3-monoxime,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK2|CDK5|CDK5R1|GSK3B
HBEJFHWHFIAMAI,BRD-K77756533,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",,,BRD-K77756533,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",,,BRD-K77756533,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",,,BRD-K77756533,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",,
HBLHLJXFIPCEMW,BRD-K68470841,ST-2825,myeloid differentiation primary response inhibitor,MYD88,BRD-K68470841,ST-2825,myeloid differentiation primary response inhibitor,MYD88,BRD-K68470841,ST-2825,myeloid differentiation primary response inhibitor,MYD88,BRD-K68470841,ST-2825,myeloid differentiation primary response inhibitor,MYD88
HBNPJJILLOYFJU,BRD-K09549677,mibefradil,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,BRD-K09549677,mibefradil,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,BRD-K09549677,mibefradil,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,BRD-K09549677,mibefradil,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4
HBOMLICNUCNMMY,BRD-A33692381|BRD-K72903603,zidovudine,nucleoside reverse transcriptase inhibitor,TERT,BRD-A33692381|BRD-K72903603,zidovudine,nucleoside reverse transcriptase inhibitor,TERT,BRD-A33692381|BRD-K72903603,zidovudine,nucleoside reverse transcriptase inhibitor,TERT,BRD-K72903603,zidovudine,nucleoside reverse transcriptase inhibitor,TERT
HBPXWEPKNBHKAX,BRD-K49055432,A66,PI3K inhibitor,PIK3CA,BRD-K49055432,A66,PI3K inhibitor,PIK3CA,BRD-K49055432,A66,PI3K inhibitor,PIK3CA,BRD-K49055432,A66,PI3K inhibitor,PIK3CA
HBUBKKRHXORPQB,BRD-K51927012|BRD-K66788707,fludarabine,ribonucleotide reductase inhibitor,ADA|RRM1|RRM2,BRD-K51927012|BRD-K66788707,fludarabine,ribonucleotide reductase inhibitor,ADA|RRM1|RRM2,BRD-K51927012|BRD-K66788707,fludarabine,ribonucleotide reductase inhibitor,ADA|RRM1|RRM2,BRD-K51927012|BRD-K66788707,fludarabine,ribonucleotide reductase inhibitor,ADA|DCK|POLA1|RRM1|RRM2
HCAJEUSONLESMK,BRD-K50785021,cyclamic-acid,,,BRD-K50785021,cyclamic-acid,,,BRD-K50785021|BRD-M61995960,cyclamic-acid,,,BRD-K50785021|BRD-M61995960,cyclamic-acid,,
HCFDWZZGGLSKEP,BRD-A44008656,doxylamine,histamine receptor antagonist,CHRM1|HRH1,BRD-A44008656,doxylamine,histamine receptor antagonist,CHRM1|HRH1,BRD-A44008656,doxylamine,histamine receptor antagonist,CHRM1|HRH1,BRD-A44008656,doxylamine,histamine receptor antagonist,HRH1
HCIBTBXNLVOFER,BRD-K51730347,diphencyprone,immunostimulant,,BRD-K51730347,diphencyprone,immunostimulant,,BRD-K51730347,diphencyprone,immunostimulant,,BRD-K51730347,diphencyprone,immunostimulant,
HCKUBNLZMKAEIN,BRD-K41304947|BRD-K58046914,HA-966-(R)-(+)|HA-966-(S)-(-),glutamate receptor agonist|glutamate receptor antagonist,GRIA1,BRD-K41304947|BRD-K58046914,HA-966-(R)-(+)|HA-966-(S)-(-),glutamate receptor agonist|glutamate receptor antagonist,GRIA1,BRD-K41304947|BRD-K58046914,HA-966-(R)-(+)|HA-966-(S)-(-),glutamate receptor agonist|glutamate receptor antagonist,GRIA1,BRD-K41304947|BRD-K58046914,HA-966-(R)-(+)|HA-966-(S)-(-),glutamate receptor agonist|glutamate receptor antagonist,GRIA1
HCRKCZRJWPKOAR,BRD-A82599487|BRD-K74913225,brinzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7,BRD-A82599487|BRD-K74913225,brinzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7,BRD-A82599487|BRD-K74913225,brinzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7,BRD-A82599487|BRD-K74913225,brinzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7
HCVRCHQFYYZPHT,BRD-A17453586,MDL-72832,serotonin receptor agonist,HTR1A,BRD-A17453586,MDL-72832,serotonin receptor agonist,HTR1A,BRD-A17453586,MDL-72832,serotonin receptor agonist,HTR1A,BRD-K01825683,MDL-72832,serotonin receptor agonist,HTR1A
HCXVJBMSMIARIN,BRD-K41422683|BRD-K84424780,stigmasterol,,,BRD-K41422683,stigmasterol,,,BRD-K41422683|BRD-K84424780,stigmasterol,,,BRD-K41422683|BRD-K84424780,stigmasterol,,
HCYAFALTSJYZDH,BRD-K60762818,desipramine,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1,BRD-K60762818,desipramine,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1,BRD-K60762818,desipramine,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1,BRD-K60762818,desipramine,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1
HCYFGRCYSCXKNQ,BRD-K44004064,acefylline,adenosine receptor agonist,ADORA1,BRD-K44004064,acefylline,adenosine receptor agonist,ADORA1,BRD-K44004064,acefylline,adenosine receptor agonist,ADORA1,BRD-K44004064,acefylline,adenosine receptor agonist,ADORA1
HCZHHEIFKROPDY,BRD-K85872723,kynurenic-acid,glutamate receptor antagonist,GPR35|GRIN1|GRIN2A|GRIN2B,BRD-K85872723,kynurenic-acid,glutamate receptor antagonist,GPR35|GRIN1|GRIN2A|GRIN2B,BRD-K85872723,kynurenic-acid,glutamate receptor antagonist,GPR35|GRIN1|GRIN2A|GRIN2B,BRD-K85872723,kynurenic-acid,glutamate receptor antagonist,GPR35|GRIN1|GRIN2A|GRIN2B
HCZKYJDFEPMADG,BRD-A87130939,masoprocol,lipoxygenase inhibitor,ALOX5,BRD-A87130939,masoprocol,lipoxygenase inhibitor,ALOX5,BRD-A87130939,masoprocol,lipoxygenase inhibitor,ALOX5,BRD-A87130939,masoprocol,lipoxygenase inhibitor,ALOX5
HDACQVRGBOVJII,BRD-K01296542|BRD-K89348303,ramipril,angiotensin converting enzyme inhibitor,ACE,BRD-K01296542|BRD-K89348303,ramipril,angiotensin converting enzyme inhibitor,ACE,BRD-K01296542|BRD-K89348303,ramipril,angiotensin converting enzyme inhibitor,ACE,BRD-K01296542|BRD-K89348303,ramipril,angiotensin converting enzyme inhibitor,ACE
HDCLCHNAEZNGNV,BRD-K42452249,EO-1428,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K42452249,EO-1428,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K42452249,EO-1428,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K42452249,EO-1428,p38 MAPK inhibitor,MAPK11|MAPK14
HDDNYFLPWFSBLN,BRD-A84389633,"tropanyl-3,5-dimethylbenzoate",,,BRD-A84389633,"tropanyl-3,5-dimethylbenzoate",serotonin receptor antagonist,HTR3A|HTR3B,BRD-A84389633,"tropanyl-3,5-dimethylbenzoate",serotonin receptor antagonist,HTR3A|HTR3B,BRD-A84389633,"tropanyl-3,5-dimethylbenzoate",serotonin receptor antagonist,HTR3A|HTR3B
HDDSHPAODJUKPD,BRD-K51318897,fenbendazole,tubulin polymerization inhibitor,TUBB,BRD-K51318897,fenbendazole,tubulin polymerization inhibitor,TUBB,BRD-K51318897,fenbendazole,tubulin polymerization inhibitor,TUBB,BRD-K51318897,fenbendazole,tubulin polymerization inhibitor,TUBB
HDOIPCLEKCEANF,BRD-K06014311,DH-97,melatonin receptor antagonist,MTNR1B,BRD-K06014311,DH-97,melatonin receptor antagonist,MTNR1B,BRD-K06014311,DH-97,melatonin receptor antagonist,MTNR1B,BRD-K06014311,DH-97,melatonin receptor antagonist,MTNR1B
HDOUGSFASVGDCS,BRD-K68653965,picolamine,,,BRD-K68653965,picolamine,,,BRD-K68653965,picolamine,,,BRD-K68653965,picolamine,,
HDOVUKNUBWVHOX,BRD-K46435977,valaciclovir,DNA polymerase inhibitor,,BRD-K46435977,valaciclovir,DNA polymerase inhibitor,,BRD-K46435977,valaciclovir,DNA polymerase inhibitor,,BRD-K46435977,valaciclovir,DNA polymerase inhibitor,
HDOZVRUNCMBHFH,BRD-K64557645,zotepine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4,BRD-K64557645,zotepine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4,BRD-K64557645,zotepine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4,BRD-K64557645,zotepine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4
HDTRYLNUVZCQOY,BRD-K54028654,cabaletta,pharmacological chaperone,,BRD-K54028654,cabaletta,pharmacological chaperone,,BRD-K54028654,cabaletta,pharmacological chaperone,,BRD-K54028654,cabaletta,pharmacological chaperone,
HDWIHXWEUNVBIY,BRD-A80017228,bendroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA1|CA2|CA4|KCNMA1|SLC12A1|SLC12A3,BRD-A80017228,bendroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA1|CA2|CA4|KCNMA1|SLC12A1|SLC12A3,BRD-A80017228,bendroflumethiazide,sodium/potassium/chloride transporter inhibitor,CA1|CA2|CA4|KCNMA1|SLC12A1|SLC12A3,BRD-A80017228,bendroflumethiazide,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3
HDWWQELUBWGQGA,BRD-K58894520,ONO-4817,matrix metalloprotease inhibitor,MMP8,BRD-K58894520,ONO-4817,matrix metalloprotease inhibitor,MMP8,BRD-K58894520,ONO-4817,matrix metalloprotease inhibitor,MMP8,BRD-K58894520,ONO-4817,matrix metalloprotease inhibitor,MMP8
HEAHZSUCFKFERC,BRD-A47953250,ecamsule-triethanolamine,,,BRD-A47953250,ecamsule-triethanolamine,,,BRD-A47953250,ecamsule-triethanolamine,,,BRD-A60635434,ecamsule-triethanolamine,,
HEAIZQNMNCHNFD,BRD-K32285926,AMG-208,tyrosine kinase inhibitor,MET,BRD-K32285926,AMG-208,tyrosine kinase inhibitor,MET,BRD-K32285926,AMG-208,tyrosine kinase inhibitor,MET,BRD-K32285926,AMG-208,tyrosine kinase inhibitor,MET
HEAUOKZIVMZVQL,BRD-K55808645,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,BRD-K55808645,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,BRD-K55808645,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,BRD-K55808645,elagolix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
HEBKCHPVOIAQTA,BRD-K49313711,ribitol,,,BRD-K49313711,ribitol,,,BRD-K49313711,ribitol,,,BRD-K49313711,ribitol,,
HEFNNWSXXWATRW,BRD-A17655518|BRD-K14965640,ibuprofen|ibuprofen-(s),cyclooxygenase inhibitor,ASIC1|BCL2|CFTR|FABP2|PLAT|PPARG|PTGS1|PTGS2|SLC5A8|THBD,BRD-A17655518|BRD-K14965640,ibuprofen|ibuprofen-(s),cyclooxygenase inhibitor,ASIC1|BCL2|CFTR|FABP2|PLAT|PPARG|PTGS1|PTGS2|SLC5A8|THBD,BRD-A17655518|BRD-K14965640,ibuprofen|ibuprofen-(s),cyclooxygenase inhibitor,ASIC1|BCL2|CFTR|FABP2|PLAT|PPARG|PTGS1|PTGS2|SLC5A8|THBD,BRD-A17655518|BRD-K14965640,ibuprofen|ibuprofen-(S),cyclooxygenase inhibitor,|ASIC1|PTGS1|PTGS2|SLC5A8
HEKAIDKUDLCBRU,BRD-K52751261,TAK-715,p38 MAPK inhibitor,MAPK14,BRD-K52751261,TAK-715,p38 MAPK inhibitor,MAPK14,BRD-K03865741|BRD-K52751261,TAK-715,p38 MAPK inhibitor,MAPK14,BRD-K03865741|BRD-K52751261,TAK-715,p38 MAPK inhibitor,MAPK14
HEKJYZZSCQBJGB,BRD-K19202888|BRD-K68548958,C646,histone acetyltransferase inhibitor,EP300,BRD-K19202888|BRD-K68548958,C646,histone acetyltransferase inhibitor,EP300,BRD-K19202888|BRD-K68548958|BRD-K73383190,C646,histone acetyltransferase inhibitor,EP300,BRD-K19202888|BRD-K68548958|BRD-K73383190,C646,histone acetyltransferase inhibitor,EP300
HELCSESNNDZLFM,BRD-K62537556,4-IBP,sigma receptor agonist,SIGMAR1,BRD-K62537556,4-IBP,sigma receptor agonist,SIGMAR1,BRD-K62537556,4-IBP,sigma receptor agonist,SIGMAR1,BRD-K62537556,4-IBP,sigma receptor agonist,SIGMAR1
HEMJJKBWTPKOJG,BRD-K11129031,gemfibrozil,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,BRD-K11129031,gemfibrozil,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,BRD-K11129031,gemfibrozil,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,BRD-K11129031,gemfibrozil,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1
HEOCBCNFKCOKBX,BRD-A55464252,3-(4-methylbenzylidene)camphor,endocrine disruptor,,BRD-A55464252,3-(4-methylbenzylidene)camphor,endocrine disruptor,,BRD-A55464252,3-(4-methylbenzylidene)camphor,endocrine disruptor,,BRD-A55464252,3-(4-methylbenzylidene)camphor,endocrine disruptor,
HEQDZPHDVAOBLN,BRD-K73815512,HC-030031,TRPA1 channel blocker,TRPA1,BRD-K73815512,HC-030031,TRPA1 channel blocker,TRPA1,BRD-K73815512,HC-030031,TRPA1 channel blocker,TRPA1,BRD-K73815512,HC-030031,TRPA1 channel blocker,TRPA1
HESCAJZNRMSMJG,BRD-K87031376,epothilone-a,microtubule stabilizing agent,,BRD-K71823332,epothilone-a,microtubule stabilizing agent,,BRD-K71823332|BRD-K87031376,epothilone-a,microtubule stabilizing agent,,BRD-K71823332|BRD-K87031376,epothilone-A,microtubule stabilizing agent,
HESLKTSGTIBHJU,BRD-K79239947,PF-573228,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB,BRD-K79239947,PF-573228,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB,BRD-K79239947,PF-573228,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB,BRD-K79239947,PF-573228,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB
HESSNRGIEVBPRB,BRD-K09456915,gemcitabine-elaidate,DNA synthesis inhibitor|apoptosis inhibitor,CMPK1|RRM1|TYMS,BRD-K09456915,gemcitabine-elaidate,DNA synthesis inhibitor|apoptosis inhibitor,CMPK1|RRM1|TYMS,BRD-K09456915,gemcitabine-elaidate,DNA synthesis inhibitor|apoptosis inhibitor,CMPK1|RRM1|TYMS,BRD-K09456915,gemcitabine-elaidate,DNA synthesis inhibitor|apoptosis inhibitor,CMPK1|RRM1|TYMS
HFGSQOYIOKBQOW,BRD-K27885593,corosolic-acid,PKC inhibitor|protein tyrosine kinase inhibitor,HSD11B1|PTPN1,BRD-K27885593,corosolic-acid,PKC inhibitor|protein tyrosine kinase inhibitor,HSD11B1|PTPN1,BRD-K27885593,corosolic-acid,PKC inhibitor|protein tyrosine kinase inhibitor,HSD11B1|PTPN1,BRD-K27885593,corosolic-acid,PKC inhibitor|protein tyrosine kinase inhibitor,HSD11B1|PTPN1
HFHZKZSRXITVMK,BRD-A33749298,oxyphenbutazone,cyclooxygenase inhibitor,PLA2G2E|PTGS1|PTGS2,BRD-A33749298,oxyphenbutazone,cyclooxygenase inhibitor,PLA2G2E|PTGS1|PTGS2,BRD-A33749298,oxyphenbutazone,cyclooxygenase inhibitor,PLA2G2E|PTGS1|PTGS2,BRD-A33749298,oxyphenbutazone,cyclooxygenase inhibitor,
HFLMLZKGLUEWBU,BRD-K84605263,KHK-IN-1,hexokinase inhibitor,KHK,BRD-K84605263,KHK-IN-1,hexokinase inhibitor,KHK,BRD-K84605263,KHK-IN-1,hexokinase inhibitor,KHK,BRD-K84605263,KHK-IN-1,hexokinase inhibitor,KHK
HFNKQEVNSGCOJV,BRD-K19601669|BRD-K53972329,ruxolitinib|ruxolitinib-(S),JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K19601669|BRD-K53972329,ruxolitinib|ruxolitinib-(S),JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K19601669|BRD-K53972329,ruxolitinib|ruxolitinib-(S),JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K19601669|BRD-K53972329,ruxolitinib|ruxolitinib-(S),JAK inhibitor,JAK1|JAK2|JAK3|TYK2
HFPLHASLIOXVGS,BRD-K06426971,ryuvidine,histone lysine methyltransferase inhibitor,CDK2|CDK4,BRD-K06426971,ryuvidine,histone lysine methyltransferase inhibitor,CDK2|CDK4,BRD-K06426971,ryuvidine,histone lysine methyltransferase inhibitor,CDK2|CDK4,BRD-K06426971,ryuvidine,histone lysine methyltransferase inhibitor,CDK2|CDK4
HFQMYSHATTXRTC,BRD-A19401019,amiflamine,monoamine oxidase inhibitor,MAOA|SLC6A2,BRD-A19401019,amiflamine,monoamine oxidase inhibitor,MAOA|SLC6A2,BRD-A19401019,amiflamine,monoamine oxidase inhibitor,MAOA|SLC6A2,BRD-A19401019,amiflamine,monoamine oxidase inhibitor,MAOA|SLC6A2
HFRFLLYLVAKRMZ,BRD-K60060639,N-methyllidocaine-iodide,antiarrhythmic medication,,BRD-K60060639,N-methyllidocaine-iodide,antiarrhythmic medication,,BRD-K60060639,N-methyllidocaine-iodide,antiarrhythmic medication,,BRD-K60060639,N-methyllidocaine-iodide,antiarrhythmic medication,
HFVMLYAGWXSTQI,BRD-A64011898,androstenone,steroid,,BRD-A64011898,androstenone,steroid,,BRD-A64011898,androstenone,steroid,,BRD-A64011898,androstenone,steroid,
HFZDMKMXPGRKCK,BRD-K24227647,TC2559,acetylcholine receptor agonist,CHRNA4,BRD-K24227647,TC2559,acetylcholine receptor agonist,CHRNA4,BRD-K24227647,TC2559,acetylcholine receptor agonist,CHRNA4,BRD-K24227647,TC2559,acetylcholine receptor agonist,CHRNA4
HGGAKXAHAYOLDJ,BRD-A49622760,faropenem,lactamase inhibitor,,BRD-A49622760,faropenem,lactamase inhibitor,,BRD-A49622760,faropenem,lactamase inhibitor,,BRD-A49622760,faropenem,lactamase inhibitor,
HGVDHZBSSITLCT,BRD-K29322660,edoxaban,coagulation factor inhibitor,F10,BRD-K29322660,edoxaban,coagulation factor inhibitor,F10,BRD-K29322660,edoxaban,coagulation factor inhibitor,F10,BRD-K97058489,edoxaban,coagulation factor inhibitor,F10
HGVNLRPZOWWDKD,BRD-K63068307,ZSTK-474,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,BRD-K63068307,ZSTK-474,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,BRD-K63068307,ZSTK-474,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,BRD-K63068307,ZSTK-474,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG
HGWPFSBHDACWNL,BRD-A70067498,atropine-oxide,acetylcholine receptor antagonist,,BRD-A70067498,atropine-oxide,acetylcholine receptor antagonist,,BRD-A70067498|BRD-U06139252,atropine-oxide,acetylcholine receptor antagonist,,BRD-K00004526,atropine-oxide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
HGXSLPIXNPASGZ,BRD-K22356203,INCB-024360,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K22356203,INCB-024360,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K22356203,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K22356203,IDO5L,"indoleamine 2,3-dioxygenase inhibitor",IDO1
HHBOWXZOLYQFNY,BRD-K18036262,L-168049,glucagon receptor antagonist,GCGR,BRD-K18036262,L-168049,glucagon receptor antagonist,GCGR,BRD-K18036262,L-168049,glucagon receptor antagonist,GCGR,BRD-K18036262,L-168049,glucagon receptor antagonist,GCGR
HHCBMISMPSAZBF,BRD-K38385169,LY3009120,RAF inhibitor,BRAF|RAF1,BRD-K38385169,LY3009120,RAF inhibitor,BRAF|RAF1,BRD-K38385169,LY3009120,RAF inhibitor,BRAF|RAF1,BRD-K38385169,LY3009120,RAF inhibitor,BRAF|RAF1
HHFBDROWDBDFBR,BRD-K83963101,MLN-8054,Aurora kinase inhibitor,AURKA,BRD-K83963101,MLN-8054,Aurora kinase inhibitor,AURKA,BRD-K83963101,MLN-8054,Aurora kinase inhibitor,AURKA,BRD-K83963101,MLN8054,Aurora kinase inhibitor,AURKA
HHHKFGXWKKUNCY,BRD-K65518078,cilazapril,angiotensin converting enzyme inhibitor,ACE,BRD-K65518078,cilazapril,angiotensin converting enzyme inhibitor,ACE,BRD-K65518078,cilazapril,angiotensin converting enzyme inhibitor,ACE,BRD-K96177243,cilazapril,angiotensin converting enzyme inhibitor,ACE
HHJUWIANJFBDHT,BRD-K59753975,vindesine,tubulin polymerization inhibitor,TUBB|TUBB1,BRD-K59753975,vindesine,tubulin polymerization inhibitor,TUBB|TUBB1,BRD-K59753975,vindesine,tubulin polymerization inhibitor,TUBB|TUBB1,BRD-K59753975,vindesine,tubulin polymerization inhibitor,TUBB|TUBB1
HHVJBROTJWPHHX,BRD-A94323479,ki16198,lipoprotein antagonist,LPA,BRD-A94323479,ki16198,lipoprotein antagonist,LPA,BRD-A94323479,ki16198,lipoprotein antagonist,LPA,BRD-A94323479,ki16198,lipoprotein antagonist,LPA
HHZIURLSWUIHRB,BRD-K81528515,nilotinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,BRD-K81528515,nilotinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,BRD-K81528515,nilotinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,BRD-K81528515,nilotinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT
HIANJWSAHKJQTH,BRD-K31731454,pemirolast,mediator release inhibitor,HRH1,BRD-K31731454,pemirolast,mediator release inhibitor,HRH1,BRD-K31731454,pemirolast,mediator release inhibitor,HRH1,BRD-K31731454,pemirolast,mediator release inhibitor,HRH1
HIDWEYPGMLIQSN,BRD-K83063356,RS-102895,CCR antagonist,CCR2,BRD-K83063356,RS-102895,CCR antagonist,CCR2,BRD-K83063356,RS-102895,CCR antagonist,CCR2,BRD-K83063356,RS-102895,CCR antagonist,CCR2
HIFJCPQKFCZDDL,BRD-A45664787,iloprost,platelet aggregation inhibitor|prostanoid receptor agonist,PDE4A|PDE4B|PDE4C|PDE4D|PLAT|PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,BRD-A45664787,iloprost,platelet aggregation inhibitor|prostanoid receptor agonist,PDE4A|PDE4B|PDE4C|PDE4D|PLAT|PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,BRD-A45664787,iloprost,platelet aggregation inhibitor|prostanoid receptor agonist,PDE4A|PDE4B|PDE4C|PDE4D|PLAT|PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,BRD-A45664787,iloprost,platelet aggregation inhibitor|prostanoid receptor agonist,PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R
HIGRLDNHDGYWQJ,BRD-K33588785,obidoxime,cholinesterase reactivator,ACHE,BRD-K33588785,obidoxime,cholinesterase reactivator,ACHE,BRD-K33588785,obidoxime,cholinesterase reactivator,ACHE,BRD-K33588785,obidoxime,cholinesterase reactivator,ACHE
HIINQLBHPIQYHN,BRD-K00926464,IMREG-1,,,BRD-K00926464,IMREG-1,,,BRD-K00926464,IMREG-1,,,BRD-K00926464,IMREG-1,,
HINJNZFCMLSBCI,BRD-K19171642,CP-91149,glycogen phosphorylase inhibitor,PYGL,BRD-K19171642,CP-91149,glycogen phosphorylase inhibitor,PYGL,BRD-K19171642,CP-91149,glycogen phosphorylase inhibitor,PYGL,BRD-K19171642,CP-91149,glycogen phosphorylase inhibitor,PYGL
HIVBATDUVFEJFZ,BRD-A49544621,AC-7954-(+/-),urotensin receptor agonist,UTS2R,BRD-A49544621,AC-7954-(+/-),urotensin receptor agonist,UTS2R,BRD-A49544621,AC-7954-(+/-),urotensin receptor agonist,UTS2R,BRD-A49544621,AC-7954-(+/-),urotensin receptor agonist,UTS2R
HIWVLHPKZNBSBE,BRD-K12198961,G007-LK,tankyrase inhibitor,TNKS|TNKS2,BRD-K12198961,G007-LK,tankyrase inhibitor,TNKS|TNKS2,BRD-K12198961,G007-LK,tankyrase inhibitor,TNKS|TNKS2,BRD-K12198961,G007-LK,tankyrase inhibitor,TNKS|TNKS2
HIXSPVQXXDULHS,BRD-K06712146,YM-90709,IL5 inhibitor,CSF2RB|IL5RA,BRD-K06712146,YM-90709,IL5 inhibitor,CSF2RB|IL5RA,BRD-K06712146,YM-90709,IL5 inhibitor,CSF2RB|IL5RA,BRD-K06712146,YM-90709,IL5 inhibitor,CSF2RB|IL5RA
HJBWBFZLDZWPHF,BRD-K91308639,ARN-509,androgen receptor antagonist,AR,BRD-K91308639,apalutamide,androgen receptor antagonist,,BRD-K91308639,apalutamide,androgen receptor antagonist,,BRD-K91308639,apalutamide,androgen receptor antagonist,
HJCMDXDYPOUFDY,BRD-K11595419,dipeptamin,,,BRD-K11595419,dipeptamin,,,BRD-K11595419,dipeptamin,,,BRD-K11595419,dipeptamin,,
HJGMCDHQPXTGAV,BRD-K12826175,ISRIB,PERK inhibitor|eukaryotic translation initiation factor inhibitor,EIF2A|EIF2AK3,BRD-K12826175,ISRIB,PERK inhibitor|eukaryotic translation initiation factor inhibitor,EIF2A|EIF2AK3,BRD-K12826175,ISRIB,PERK inhibitor|eukaryotic translation initiation factor inhibitor,EIF2A|EIF2AK3,BRD-K12826175,ISRIB,PERK inhibitor|eukaryotic translation initiation factor inhibitor,EIF2A|EIF2AK3
HJJDBAOLQAWBMH,BRD-A20839672,cefmenoxime,bacterial cell wall synthesis inhibitor,,BRD-A20839672,cefmenoxime,bacterial cell wall synthesis inhibitor,,BRD-A20839672,cefmenoxime,bacterial cell wall synthesis inhibitor,,BRD-K00003661,cefmenoxime,bacterial cell wall synthesis inhibitor,
HJJPJSXJAXAIPN,BRD-K88646909,arecoline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K88646909,arecoline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K88646909,arecoline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K88646909,arecoline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
HJLSLZFTEKNLFI,BRD-K89125793,tinidazole,antiprotozoal agent,,BRD-K89125793,tinidazole,antiprotozoal agent,,BRD-K89125793,tinidazole,antiprotozoal agent,,BRD-K89125793,tinidazole,antiprotozoal agent,
HJMQDJPMQIHLPB,BRD-K37561857,zardaverine,phosphodiesterase inhibitor,PDE4D,BRD-K37561857,zardaverine,phosphodiesterase inhibitor,PDE4D,BRD-K37561857,zardaverine,phosphodiesterase inhibitor,PDE4D,BRD-K37561857,zardaverine,phosphodiesterase inhibitor,PDE4D
HJORMJIFDVBMOB,BRD-A34255068|BRD-K65856711|BRD-K75516118,rolipram|rolipram-R(-)|rolipram-S(+),phosphodiesterase inhibitor,|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-A34255068|BRD-K65856711|BRD-K75516118,rolipram|rolipram-R(-)|rolipram-S(+),phosphodiesterase inhibitor,|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-A34255068|BRD-K65856711|BRD-K75516118,rolipram|rolipram-R(-)|rolipram-S(+),phosphodiesterase inhibitor,|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-A34255068|BRD-K65856711|BRD-K75516118,(R)-(-)-rolipram|(S)-(+)-rolipram|rolipram,phosphodiesterase inhibitor,|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
HJQILFPVRNHTIG,BRD-K41772907,tolimidone,src activator,LYN|SRC,BRD-K41772907,tolimidone,src activator,LYN|SRC,BRD-K41772907,tolimidone,src activator,LYN|SRC,BRD-K41772907,tolimidone,SRC activator,LYN|SRC
HJSSPYJVWLTYHG,BRD-K75308783,SAR-245409,PI3K inhibitor,MTOR|PIK3CG,BRD-K75308783,SAR-245409,PI3K inhibitor,MTOR|PIK3CG,BRD-K75308783,SAR-245409,PI3K inhibitor,MTOR|PIK3CG,BRD-K75308783,SAR-245409,PI3K inhibitor,MTOR|PIK3CG
HJXMNVQARNZTEE,BRD-A59378440,butylphthalide,potassium channel antagonist,KCNK2,BRD-A59378440,butylphthalide,potassium channel antagonist,KCNK2,BRD-A59378440,butylphthalide,potassium channel antagonist,KCNK2,BRD-A59378440,butylphthalide,potassium channel antagonist,KCNK2
HJYYPODYNSCCOU,BRD-K38512030,rifamycin,DNA directed RNA polymerase inhibitor,SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1,BRD-K38512030,rifamycin,DNA directed RNA polymerase inhibitor,SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1,BRD-K38512030,rifamycin,DNA directed RNA polymerase inhibitor,SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1,BRD-K38512030|BRD-K66048476,rifamycin|rifamycin-sv,DNA directed RNA polymerase inhibitor|RNA synthesis inhibitor,|SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1
HKDLNTKNLJPAIY,BRD-K55641198,ulipristal,progesterone receptor antagonist,PGR,BRD-K55641198,ulipristal,progesterone receptor antagonist,PGR,,,,,,,,
HKEAFJYKMMKDOR,BRD-A07815743|BRD-K89048337,kakonein|puerarin,GABA receptor antagonist|serotonin receptor antagonist,,BRD-A07815743|BRD-K89048337,kakonein|puerarin,GABA receptor antagonist|serotonin receptor antagonist,,BRD-A07815743|BRD-K85867784|BRD-K89048337,kakonein|puerarin,GABA receptor antagonist|serotonin receptor antagonist,,BRD-A07815743|BRD-K85867784|BRD-K89048337,kakonein|puerarin,GABA receptor antagonist|serotonin receptor antagonist,
HKGWQUVGHPDEBZ,BRD-K13629382,eseroline-(-),acetylcholinesterase inhibitor,OPRD1|OPRM1,BRD-K13629382,eseroline-(-),acetylcholinesterase inhibitor,OPRD1|OPRM1,BRD-K13629382|BRD-K76359782,eseroline-(-),acetylcholinesterase inhibitor,OPRD1|OPRM1,BRD-K13629382|BRD-K76359782,eseroline-(-),acetylcholinesterase inhibitor,OPRD1|OPRM1
HKHOVJYOELRGMV,BRD-K34533029,tyrphostin-AG-494,EGFR inhibitor,EGFR,BRD-K34533029,tyrphostin-AG-494,EGFR inhibitor,EGFR,BRD-K34533029,tyrphostin-AG-494,EGFR inhibitor,EGFR,BRD-K34533029,tyrphostin-AG-494,EGFR inhibitor,EGFR
HKQYGTCOTHHOMP,BRD-K55567017,formononetin,alcohol dehydrogenase inhibitor,ADH1C|SLC5A2,BRD-K55567017,formononetin,alcohol dehydrogenase inhibitor,ADH1C|SLC5A2,BRD-K55567017,formononetin,alcohol dehydrogenase inhibitor,ADH1C|SLC5A2,BRD-K55567017,formononetin,alcohol dehydrogenase inhibitor,ADH1C|SLC5A2
HKVAMNSJSFKALM,BRD-K13154216,everolimus,mTOR inhibitor,MTOR,BRD-K13514097,everolimus,mTOR inhibitor,MTOR,BRD-K13154216|BRD-K13514097,everolimus,mTOR inhibitor,MTOR,BRD-K13154216|BRD-K13514097,everolimus,mTOR inhibitor,MTOR
HKXBNHCUPKIYDM,BRD-K07234650|BRD-K82928892,doxercalciferol,vitamin D receptor agonist,VDR,BRD-K07234650|BRD-K82928892,doxercalciferol,vitamin D receptor agonist,VDR,BRD-K07234650|BRD-K82928892,doxercalciferol,vitamin D receptor agonist,VDR,BRD-K07234650|BRD-K82928892,doxercalciferol,vitamin D receptor agonist,VDR
HKXMQLISPYELRD,BRD-K18816859,L-694247,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,BRD-K18816859,L-694247,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,BRD-K18816859,L-694247,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,BRD-K18816859,L-694247,serotonin receptor agonist,HTR1A|HTR1B|HTR1D
HLAFSNJRKZLMPT,BRD-K47690382,bipenamol,dipeptidyl peptidase inhibitor,CTSC,BRD-K47690382,bipenamol,dipeptidyl peptidase inhibitor,CTSC,BRD-K47690382,bipenamol,dipeptidyl peptidase inhibitor,CTSC,BRD-K47690382,bipenamol,dipeptidyl peptidase inhibitor,CTSC
HLCDNLNLQNYZTK,BRD-A50737080,CGK-733,ATM kinase inhibitor|ATR kinase inhibitor,ATM|ATR,BRD-A50737080,CGK-733,ATM kinase inhibitor|ATR kinase inhibitor,ATM|ATR,BRD-A50737080,CGK-733,ATM kinase inhibitor|ATR kinase inhibitor,ATM|ATR,BRD-A50737080,CGK-733,ATM kinase inhibitor|ATR kinase inhibitor,ATM|ATR
HLDUHCYBUVVDOT,BRD-A90642009,benaxibine,,,BRD-A90642009,benaxibine,,,BRD-A90642009,benaxibine,,,,,,
HLFSDGLLUJUHTE,BRD-A46393198|BRD-K73107279,levamisole|tetramisole,acetylcholine receptor agonist|immunostimulant,|ALPL|ALPPL2|CHRNA3,BRD-A46393198|BRD-K73107279,levamisole|tetramisole,acetylcholine receptor agonist|immunostimulant,|ALPL|ALPPL2|CHRNA3,BRD-A46393198|BRD-K73107279,levamisole|tetramisole,acetylcholine receptor agonist|immunostimulant,|ALPL|ALPPL2|CHRNA3,BRD-A46393198|BRD-K73107279,levamisole|tetramisole,acetylcholine receptor agonist|immunostimulant,ALPL|ALPPL2|CHRNA3
HLMBXBGDBBCYII,BRD-A72703248,SKF-96365,calcium channel blocker,CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2,BRD-A72703248,SKF-96365,calcium channel blocker,CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2,BRD-A72703248,SKF-96365,calcium channel blocker,CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2,BRD-K01826819,SKF-96365,calcium channel blocker,CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2
HLNLBEFKHHCAMV,BRD-K91422571,tromaril,prostanoid receptor antagonist,,BRD-K91422571,tromaril,prostanoid receptor antagonist,,BRD-K91422571,tromaril,prostanoid receptor antagonist,,BRD-K91422571,tromaril,prostanoid receptor antagonist,
HLVVITIHAZBPKB,BRD-A98299281,"hydroxytacrine-maleate-(r,s)",,,BRD-A98299281,"hydroxytacrine-maleate-(r,s)",cholinesterase inhibitor,ACHE,BRD-A98299281,"hydroxytacrine-maleate-(r,s)",cholinesterase inhibitor,ACHE,BRD-K01825165,"hydroxytacrine-maleate-(R,S)",cholinesterase inhibitor,ACHE
HLXSCTYHLQHQDJ,BRD-A62182663,YK-4-279,apoptosis inhibitor,EWSR1|FLI1,BRD-A62182663,YK-4-279,apoptosis inhibitor,EWSR1|FLI1,BRD-A62182663,YK-4-279,apoptosis inhibitor,EWSR1|FLI1,BRD-A62182663,YK-4-279,apoptosis inhibitor,EWSR1|FLI1
HMABYWSNWIZPAG,BRD-K88560311,rucaparib,PARP inhibitor,PARP1|PARP2,BRD-K88560311,rucaparib,PARP inhibitor,PARP1|PARP2,BRD-K88560311,rucaparib,PARP inhibitor,PARP1|PARP2,BRD-K88560311,rucaparib,PARP inhibitor,PARP1|PARP2
HMAFTPZYFJFEHK,BRD-K21920947,AN2718,leucyl-tRNA synthetase inhibitor,,BRD-K21920947,AN2718,leucyl-tRNA synthetase inhibitor,,BRD-K21920947,AN2718,leucyl-tRNA synthetase inhibitor,,BRD-K21920947,AN2718,leucyl-tRNA synthetase inhibitor,
HMCTXMOKMWELFJ,BRD-K10415035,tasuldine,mucolytic agent,,BRD-K10415035,tasuldine,mucolytic agent,,BRD-K10415035,tasuldine,mucolytic agent,,BRD-K10415035,tasuldine,mucolytic agent,
HMEDEBAJARCKCT,BRD-K68770713,azosemide,electrolyte reabsorption inhibitor,SLC12A1|SLC12A2,BRD-K68770713,azosemide,electrolyte reabsorption inhibitor,SLC12A1|SLC12A2,BRD-K68770713,azosemide,electrolyte reabsorption inhibitor,SLC12A1|SLC12A2,BRD-K68770713,azosemide,electrolyte reabsorption inhibitor,SLC12A1|SLC12A2
HMJIYCCIJYRONP,BRD-A90799790,isradipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2,BRD-A90799790,isradipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2,BRD-A90799790,isradipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2,BRD-A90799790,isradipine,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1
HMJSBVCDPKODEX,BRD-K30331124,ASC-J9,androgen receptor enhancer,AR,BRD-K30331124,ASC-J9,androgen receptor enhancer,AR,BRD-K30331124,ASC-J9,androgen receptor enhancer,AR,,,,
HMMGKOVEOFBCAU,BRD-A44696962|BRD-K54907283,AKBA|acetyl-11-keto-beta-boswellic-acid,lipoxygenase inhibitor,ALOX5|HSD11B1|HSD11B2,BRD-A44696962|BRD-K54907283,AKBA|acetyl-11-keto-beta-boswellic-acid,lipoxygenase inhibitor,ALOX5|HSD11B1|HSD11B2,BRD-A44696962|BRD-K54907283,AKBA|acetyl-11-keto-beta-boswellic-acid,lipoxygenase inhibitor,ALOX5|HSD11B1|HSD11B2,BRD-A44696962|BRD-K54907283,AKBA|acetyl-11-keto-beta-boswellic-acid,lipoxygenase inhibitor,ALOX5|HSD11B1|HSD11B2
HMYJLVDKPJHJCF,BRD-A75140635,"isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",,,BRD-A75140635,"isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",,,BRD-A75140635,"isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",,,BRD-K01826521,"Isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",,
HNDVDQJCIGZPNO,BRD-K36449075,copper-histidine,,HAL|HARS|HDC|SLC15A3|SLC15A4|SLC38A3|SLC38A5,BRD-K36449075,copper-histidine,,HAL|HARS|HDC|SLC15A3|SLC15A4|SLC38A3|SLC38A5,BRD-K36449075,copper-histidine,,HAL|HARS|HDC|SLC15A3|SLC15A4|SLC38A3|SLC38A5,BRD-K36449075,copper-histidine,,SLC15A3|SLC15A4|SLC38A5
HNFMVVHMKGFCMB,BRD-K60171656,ARQ-092,AKT inhibitor,AKT2,BRD-K60171656,ARQ-092,AKT inhibitor,AKT2,BRD-K60171656,ARQ-092,AKT inhibitor,AKT2,BRD-K60171656,ARQ-092,AKT inhibitor,AKT2
HNIFCPBQMKPRCX,BRD-K31417912,PF-3274167,oxytocin receptor antagonist,AVPR1A|OXTR,BRD-K31417912,PF-3274167,oxytocin receptor antagonist,AVPR1A|OXTR,BRD-K31417912,PF-3274167,oxytocin receptor antagonist,AVPR1A|OXTR,BRD-K31417912,PF-3274167,oxytocin receptor antagonist,AVPR1A|OXTR
HNJJXZKZRAWDPF,BRD-K47323024,methapyrilene,histamine receptor antagonist,HRH1,BRD-K47323024,methapyrilene,histamine receptor antagonist,HRH1,BRD-K47323024,methapyrilene,histamine receptor antagonist,HRH1,BRD-K47323024,methapyrilene,histamine receptor antagonist,HRH1
HNPAHGHFONBTLV,BRD-A51571244,hypoestoxide,IKK inhibitor,IKBKB|IL1B|TNF,BRD-A51571244,hypoestoxide,IKK inhibitor,IKBKB|IL1B|TNF,BRD-A51571244,hypoestoxide,IKK inhibitor,IKBKB|IL1B|TNF,BRD-K13881745,hypoestoxide,IKK inhibitor,IKBKB|IL1B|TNF
HNSDLXPSAYFUHK,BRD-A00092689,docusate,laxative,,BRD-A00092689,docusate,laxative,,BRD-A00092689,docusate,laxative,,BRD-A00092689,docusate,laxative,
HOBAELRKJCKHQD,BRD-K20152659,dihomo-gamma-linolenic-acid,prostanoid receptor agonist,PTGS1|PTGS2,BRD-K20152659,dihomo-gamma-linolenic-acid,prostanoid receptor agonist,PTGS1|PTGS2,BRD-K20152659,dihomo-gamma-linolenic-acid,prostanoid receptor agonist,PTGS1|PTGS2,BRD-K20152659,dihomo-gamma-linolenic-acid,prostanoid receptor agonist,PTGS1|PTGS2
HOCBJBNQIQQQGT,BRD-K40331046,CR8-(R),CDK inhibitor,CCNA2,BRD-K40331046,CR8-(R),CDK inhibitor,CCNA2,BRD-K40331046,CR8-(R),CDK inhibitor,CCNA2,BRD-K40331046,CR8-(R),CDK inhibitor,CCNA2
HOCFDYZWQYGULA,BRD-K00989047,trovirdine,non-nucleoside reverse transcriptase inhibitor,,BRD-K00989047,trovirdine,non-nucleoside reverse transcriptase inhibitor,,BRD-K00989047,trovirdine,non-nucleoside reverse transcriptase inhibitor,,BRD-K00989047,trovirdine,non-nucleoside reverse transcriptase inhibitor,
HOGVTUZUJGHKPL,BRD-K80431395|BRD-K85975921,triciribine,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K80431395|BRD-K85975921,triciribine,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K80431395|BRD-K85975921,triciribine,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K80431395|BRD-K85975921,triciribine,AKT inhibitor,AKT1|AKT2|AKT3
HOIIHACBCFLJET,BRD-K10031916,lumateperone,dopamine receptor modulator|serotonin receptor antagonist,DRD2|HTR2A,BRD-K10031916,lumateperone,dopamine receptor modulator|serotonin receptor antagonist,DRD2|HTR2A,BRD-K10031916,lumateperone,dopamine receptor modulator|serotonin receptor antagonist,DRD2|HTR2A,BRD-K10031916,lumateperone,dopamine receptor modulator|serotonin receptor antagonist,DRD2|HTR2A
HOKDBMAJZXIPGC,BRD-A67616246,levomequitazine,histamine receptor antagonist,HRH1,BRD-A67616246,levomequitazine,histamine receptor antagonist,HRH1,BRD-A67616246,levomequitazine,histamine receptor antagonist,HRH1,BRD-A67616246,levomequitazine,histamine receptor antagonist,HRH1
HOKKHZGPKSLGJE,BRD-A02508087|BRD-K62414032,NMDA,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A02508087|BRD-K62414032,NMDA,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A02508087|BRD-K62414032,NMDA,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A02508087|BRD-K62414032,NMDA,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
HOMGKSMUEGBAAB,BRD-A67097164,ifosfamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,BRD-A67097164,ifosfamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,BRD-A67097164,ifosfamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,BRD-A67097164,ifosfamide,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1
HOMJAAIVTDVQJA,BRD-K73368362,BIX-02189,MEK inhibitor,MAP2K5|MAPK7,BRD-K73368362,BIX-02189,MEK inhibitor,MAP2K5|MAPK7,BRD-K73368362,BIX-02189,MEK inhibitor,MAP2K5|MAPK7,BRD-K73368362,BIX-02189,MEK inhibitor,MAP2K5|MAPK7
HOMWNUXPSJQSSU,BRD-K62056274,N-methylquipazine,serotonin receptor agonist,HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4,BRD-K62056274,N-methylquipazine,serotonin receptor agonist,HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4,BRD-K62056274,N-methylquipazine,serotonin receptor agonist,HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4,BRD-K62056274,N-methylquipazine,serotonin receptor agonist,
HOOSGZJRQIVJSZ,BRD-A46066006,clidinium,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-A46066006,clidinium,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-A46066006,clidinium,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-K01827265,clidinium,acetylcholine receptor antagonist,CHRM1|CHRM3
HOOWCUZPEFNHDT,BRD-A20589515|BRD-K57796080,"3,5-DHPG-(S)|dihydroxyphenylglycine",|glutamate receptor agonist,|GRM1|GRM5,BRD-A20589515|BRD-K57796080,"3,5-DHPG-(S)|dihydroxyphenylglycine",glutamate receptor agonist,GRM1|GRM5,BRD-A20589515|BRD-K57796080,"3,5-DHPG-(S)|dihydroxyphenylglycine",glutamate receptor agonist,GRM1|GRM5,BRD-A20589515|BRD-K57796080,"3,5-DHPG-(S)|dihydroxyphenylglycine",glutamate receptor agonist,GRM1|GRM5
HPABFFGQPLJKBP,BRD-K34437622,5-FP,thymidylate synthase inhibitor,TYMS,BRD-K34437622,5-FP,thymidylate synthase inhibitor,TYMS,BRD-K34437622,5-FP,thymidylate synthase inhibitor,TYMS,BRD-K34437622,5-FP,thymidylate synthase inhibitor,TYMS
HPBNRIOWIXYZFK,BRD-A14262390,guanadrel,adrenergic inhibitor,SLC6A2,BRD-A14262390,guanadrel,adrenergic inhibitor,SLC6A2,BRD-A14262390,guanadrel,adrenergic inhibitor,SLC6A2,BRD-A14262390,guanadrel,adrenergic inhibitor,
HPFLVTSWRFCPCV,BRD-K67789209,adatanserin,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,BRD-K67789209,adatanserin,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,BRD-K67789209,adatanserin,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,BRD-K67789209,adatanserin,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A
HPHBOJANXDKUQD,BRD-K39371216,cyacetacide,,,BRD-K39371216,cyacetacide,,,BRD-K39371216,cyacetacide,,,BRD-K39371216,cyacetacide,,
HPHUVLMMVZITSG,BRD-K49404994,levetiracetam,calcium channel blocker,CACNA1B|SCN1A|SV2A,BRD-K49404994,levetiracetam,calcium channel blocker,CACNA1B|SCN1A|SV2A,BRD-K49404994,levetiracetam,calcium channel blocker,CACNA1B|SCN1A|SV2A,BRD-K49404994,levetiracetam,calcium channel blocker,CACNA1B|SCN1A|SV2A
HPJKCIUCZWXJDR,BRD-K88789588,letrozole,aromatase inhibitor,CYP19A1,BRD-K88789588,letrozole,aromatase inhibitor,CYP19A1,BRD-K88789588,letrozole,aromatase inhibitor,CYP19A1,BRD-K88789588,letrozole,aromatase inhibitor,CYP19A1
HPLNQCPCUACXLM,BRD-K56301217,ABT-737,BCL inhibitor,BCL2|BCL2L1|BCL2L2,BRD-K56301217,ABT-737,BCL inhibitor,BCL2|BCL2L1|BCL2L2,BRD-K56301217,ABT-737,BCL inhibitor,BCL2|BCL2L1|BCL2L2,BRD-K56301217,ABT-737,BCL inhibitor,BCL2|BCL2L1|BCL2L2
HPMRFMKYPGXPEP,BRD-A18696154,idazoxan,adrenergic receptor antagonist,ADRA2A,BRD-A18696154,idazoxan,adrenergic receptor antagonist,ADRA2A,BRD-A18696154,idazoxan,adrenergic receptor antagonist,ADRA2A,BRD-A18696154,idazoxan,adrenergic receptor antagonist,ADRA2A|PTGS2
HPNSFSBZBAHARI,BRD-K63750851,mycophenolic-acid,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,BRD-K63750851,mycophenolic-acid,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,BRD-K63750851,mycophenolic-acid,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,BRD-K63750851,mycophenolic-acid,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2
HPTXLHAHLXOAKV,BRD-K89391146,RG108,DNA methyltransferase inhibitor,DNMT1|DNMT3B,BRD-K89391146,RG108,DNA methyltransferase inhibitor,DNMT1|DNMT3B,BRD-K89391146,RG108,DNA methyltransferase inhibitor,DNMT1|DNMT3B,BRD-K89391146,RG108,DNA methyltransferase inhibitor,DNMT1|DNMT3B
HQDSAVMTLKVTGJ,BRD-K11244467,ambazone,DNA damage inducer,,BRD-K11244467,ambazone,DNA damage inducer,,BRD-K11244467,ambazone,DNA damage inducer,,BRD-K11244467,ambazone,DNA damage inducer,
HQFWVSGBVLEQGA,BRD-K99622919,butacaine,local anesthetic,,BRD-K99622919,butacaine,local anesthetic,,BRD-K99622919,butacaine,local anesthetic,,BRD-K99622919,butacaine,local anesthetic,
HQGDPZPNAXRCSA,BRD-K78061844,4-PPBP,sigma receptor ligand,SIGMAR1,BRD-K78061844,4-PPBP,sigma receptor ligand,SIGMAR1,BRD-K78061844,4-PPBP,sigma receptor ligand,SIGMAR1,BRD-K78061844,4-PPBP,sigma receptor ligand,SIGMAR1
HQGWKNGAKBPTBX,BRD-A65597028,RX-821002,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-A65597028,RX-821002,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-A65597028,RX-821002,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-A65597028,RX-821002,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
HQIRNZOQPUAHHV,BRD-A48420483,bupranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A48420483,bupranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A48420483,bupranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A48420483,bupranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
HQMNCQVAMBCHCO,BRD-K49076555,etretinate,protein synthesis inhibitor,RARA|RARB|RARG|RXRA|RXRB|RXRG,BRD-K49076555,etretinate,protein synthesis inhibitor,RARA|RARB|RARG|RXRA|RXRB|RXRG,BRD-K49076555,etretinate,protein synthesis inhibitor,RARA|RARB|RARG|RXRA|RXRB|RXRG,BRD-K49076555,etretinate,protein synthesis inhibitor,RARA|RXRG
HQPMJFFEXJELOQ,BRD-K30519779,homoquinolinic-acid,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K30519779,homoquinolinic-acid,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K30519779,homoquinolinic-acid,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K30519779,homoquinolinic-acid,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
HQSBCDPYXDGTCL,BRD-K56565215,vipadenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K56565215,vipadenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K56565215,vipadenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K56565215,vipadenant,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
HQVZOORKDNCGCK,BRD-K02900412,clofoctol,protein synthesis inhibitor,,BRD-K02900412,clofoctol,protein synthesis inhibitor,,BRD-K02900412,clofoctol,protein synthesis inhibitor,,BRD-K02900412,clofoctol,protein synthesis inhibitor,
HQWTUOLCGKIECB,BRD-K94455792,ICG-001,beta-catenin inhibitor,CTNNB1,BRD-K94455792,ICG-001,beta-catenin inhibitor,CTNNB1,BRD-K94455792,ICG-001,beta-catenin inhibitor,CTNNB1,BRD-K73261812,ICG-001,beta-catenin inhibitor,CTNNB1
HRDQQHUKUIKFHT,BRD-K72293620,GSK503,histone lysine methyltransferase inhibitor,EZH2,BRD-K72293620,GSK503,histone lysine methyltransferase inhibitor,EZH2,BRD-K72293620,GSK503,histone lysine methyltransferase inhibitor,EZH2,BRD-K72293620,GSK503,histone lysine methyltransferase inhibitor,EZH2
HRJWTAWVFDCTGO,BRD-K78055238,LY2090314,glycogen synthase kinase inhibitor,GSK3B,BRD-K78055238,LY2090314,glycogen synthase kinase inhibitor,GSK3B,BRD-K78055238,LY2090314,glycogen synthase kinase inhibitor,GSK3B,BRD-K78055238,LY2090314,glycogen synthase kinase inhibitor,GSK3B
HRNLUBSXIHFDHP,BRD-K16485616,mocetinostat,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3,BRD-K16485616,mocetinostat,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3,BRD-K16485616,mocetinostat,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3,BRD-K16485616,mocetinostat,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3
HRPOQXWQRXFQTM,BRD-K05505104,exenatide,GLP receptor agonist,GLP1R,BRD-K05505104,exenatide,GLP receptor agonist,GLP1R,BRD-K05505104|BRD-U88413610,exenatide,GLP receptor agonist,GLP1R,,,,
HRRBJVNMSRJFHQ,BRD-A01787639,naftopidil,adrenergic receptor antagonist,ADRA1A,BRD-A01787639,naftopidil,adrenergic receptor antagonist,ADRA1A,BRD-A01787639,naftopidil,adrenergic receptor antagonist,ADRA1A,BRD-K01826561,naftopidil,adrenergic receptor antagonist,ADRA1A
HRSANNODOVBCST,BRD-A87715314,pronethalol,adrenergic receptor antagonist,,BRD-A87715314,pronethalol,adrenergic receptor antagonist,,BRD-A87715314,pronethalol,adrenergic receptor antagonist,,BRD-K01825804,pronethalol,adrenergic receptor antagonist,
HRVWCNMOEFNEON,BRD-K14762862,I-BZA,,,BRD-K14762862,I-BZA,,,BRD-K14762862,I-BZA,,,BRD-K14762862,I-BZA,,
HRYKZAKEAVZGJD,BRD-K94920105,DR-2313,PARP inhibitor,PARP1|PARP3,BRD-K94920105,DR-2313,PARP inhibitor,PARP1|PARP3,BRD-K94920105,DR-2313,PARP inhibitor,PARP1|PARP3,BRD-K94920105,DR-2313,PARP inhibitor,PARP1|PARP3
HRYLQFBHBWLLLL,BRD-K26833429|BRD-K44887666,costunolide,telomerase inhibitor,,BRD-K26833429|BRD-K44887666,costunolide,telomerase inhibitor,,BRD-K26833429|BRD-K44887666,costunolide,telomerase inhibitor,,BRD-K26833429|BRD-K44887666,costunolide,telomerase inhibitor,
HSHGZXNAXBPPDL,BRD-K15457970|BRD-K65377893,7-aminocephalosporanic-acid,beta lactamase inhibitor,,BRD-K15457970|BRD-K65377893,7-aminocephalosporanic-acid,beta lactamase inhibitor,,BRD-K15457970|BRD-K65377893,7-aminocephalosporanic-acid,beta lactamase inhibitor,,BRD-K15457970|BRD-K65377893,7-aminocephalosporanic-acid,beta lactamase inhibitor,
HSHNITRMYYLLCV,BRD-K46424862,hymecromone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K46424862,hymecromone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K46424862,hymecromone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K46424862,hymecromone,monoamine oxidase inhibitor,MAOA|MAOB
HSHPBORBOJIXSQ,BRD-K69351586,CUDC-427,apoptosis inhibitor,XIAP,BRD-K69351586,CUDC-427,apoptosis inhibitor,XIAP,BRD-K69351586,CUDC-427,apoptosis inhibitor,XIAP,BRD-K69351586,CUDC-427,apoptosis inhibitor,XIAP
HSJFYRYGGKLQBT,BRD-K00739965,guacetisal,immunosuppressant,,BRD-K00739965,guacetisal,immunosuppressant,,BRD-K00739965,guacetisal,immunosuppressant,,BRD-K00739965,guacetisal,immunosuppressant,
HSKAZIJJKRAJAV,BRD-K41783120,STA-5326,interleukin synthesis inhibitor,IL12A,BRD-K41783120,STA-5326,interleukin synthesis inhibitor,IL12A,BRD-K41783120,STA-5326,interleukin synthesis inhibitor,IL12A,BRD-K41783120,STA-5326,interleukin synthesis inhibitor,IL12A
HSMNQINEKMPTIC,BRD-K65544384,4-aminohippuric-acid,,SLC22A6,BRD-K65544384,4-aminohippuric-acid,,SLC22A6,BRD-K65544384,4-aminohippuric-acid,,SLC22A6,BRD-K65544384,4-aminohippuric-acid,,SLC22A6
HSMPDPBYAYSOBC,BRD-K80353807,khellin,vasodilator,,BRD-K80353807,khellin,vasodilator,,BRD-K80353807,khellin,vasodilator,,BRD-K80353807,khellin,vasodilator,
HSRJKNPTNIJEKV,BRD-A90515964,guaifenesin,expectorant,,BRD-A90515964,guaifenesin,expectorant,,BRD-A90515964,guaifenesin,expectorant,,BRD-A90515964,guaifenesin,expectorant,
HSTZMXCBWJGKHG,BRD-K43236057|BRD-K94506759,polydatin,ICAM1 expression inhibitor,ICAM1,BRD-K43236057|BRD-K94506759,polydatin,ICAM1 expression inhibitor,ICAM1,BRD-K43236057|BRD-K94506759,polydatin,ICAM1 expression inhibitor,ICAM1,BRD-K43236057|BRD-K94506759,polydatin,ICAM1 expression inhibitor,ICAM1
HSUGRBWQSSZJOP,BRD-A69636825|BRD-K24023109,diltiazem,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,BRD-A69636825|BRD-K24023109,diltiazem,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,BRD-A69636825|BRD-K24023109,diltiazem,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,BRD-K24023109,diltiazem,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5
HSVZQQYIMKLNLN,BRD-A64808605,AH11110,adrenergic receptor ligand,ADRA1B,BRD-A64808605,AH11110,adrenergic receptor ligand,ADRA1B,BRD-A64808605,AH11110,adrenergic receptor ligand,ADRA1B,BRD-A64808605,AH11110,adrenergic receptor ligand,ADRA1B
HSWPZIDYAHLZDD,BRD-K39252998,atipamezole,adrenergic receptor antagonist,,BRD-K39252998,atipamezole,adrenergic receptor antagonist,,BRD-K39252998,atipamezole,adrenergic receptor antagonist,,BRD-K39252998,atipamezole,adrenergic receptor antagonist,
HSYSSKFCQHXOBP,BRD-K01773560,UNC2250,MER tyrosine kinase inhibitor,MERTK,BRD-K01773560,UNC2250,MER tyrosine kinase inhibitor,MERTK,BRD-K01773560,UNC2250,MER tyrosine kinase inhibitor,MERTK,BRD-K01773560,UNC2250,MER tyrosine kinase inhibitor,MERTK
HTGCJAAPDHZCHL,BRD-A26032986,zaldaride,calmodulin antagonist,CALM1,BRD-A26032986,zaldaride,calmodulin antagonist,CALM1,BRD-A26032986,zaldaride,calmodulin antagonist,CALM1,BRD-A26032986,zaldaride,calmodulin antagonist,CALM1
HTIQEAQVCYTUBX,BRD-A22032524,amlodipine,calcium channel blocker,CA1|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNA2D3|CACNB1|CACNB2|SMPD1,BRD-A22032524,amlodipine,calcium channel blocker,CA1|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNA2D3|CACNB1|CACNB2|SMPD1,BRD-A22032524,amlodipine,calcium channel blocker,CA1|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNA2D3|CACNB1|CACNB2|SMPD1,BRD-K00005329|BRD-K01825117,amlodipine|levamlodipine,calcium channel blocker,|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1
HTJXMOGUGMSZOG,BRD-K27293958,tiaramide,anti-inflammatory agent,,BRD-K27293958,tiaramide,anti-inflammatory agent,,BRD-K27293958,tiaramide,anti-inflammatory agent,,BRD-K27293958,tiaramide,anti-inflammatory agent,
HTKFORQRBXIQHD,BRD-K89634775,allylthiourea,nitrification inhibitor,,BRD-K89634775,allylthiourea,nitrification inhibitor,,BRD-K89634775,allylthiourea,nitrification inhibitor,,BRD-K89634775,allylthiourea,nitrification inhibitor,
HTLIIBRHXAULMB,BRD-K28773847,RLX,,,BRD-K28773847,RLX,,,BRD-K28773847,RLX,,,BRD-K28773847,RLX,,
HTLWRKRZKFAAAH,BRD-A03359064,ICI-89406,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A03359064,ICI-89406,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A03359064,ICI-89406,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A03359064,ICI-89406,adrenergic receptor antagonist,ADRB1|ADRB2
HTQMVQVXFRQIKW,BRD-K84091759,candesartan,angiotensin receptor antagonist,AGTR1,BRD-K84091759,candesartan,angiotensin receptor antagonist,AGTR1,BRD-K84091759,candesartan,angiotensin receptor antagonist,AGTR1,BRD-K84091759,candesartan,angiotensin receptor antagonist,AGTR1
HTQONPPEZULJKY,BRD-A56754222,gepon,,,BRD-A56754222,gepon,,,BRD-A56754222,gepon,,,BRD-A56754222,gepon,,
HTSNFXAICLXZMA,BRD-K02908048,preclamol,dopamine receptor agonist,DRD2,BRD-K02908048,preclamol,dopamine receptor agonist,DRD2,BRD-K02908048,preclamol,dopamine receptor agonist,DRD2,BRD-K02908048,preclamol,dopamine receptor agonist,DRD2
HTTJABKRGRZYRN,BRD-A83644949,ardeparin,thrombin inhibitor,SERPINC1|SERPIND1,BRD-A83644949,ardeparin,thrombin inhibitor,SERPINC1|SERPIND1,BRD-A83644949,ardeparin,thrombin inhibitor,SERPINC1|SERPIND1,,,,
HTUBKQUPEREOGA,BRD-K17702546,PD-168393,EGFR inhibitor,EGFR|ERBB2|SRC,BRD-K17702546,PD-168393,EGFR inhibitor,EGFR|ERBB2|SRC,BRD-K17702546,PD-168393,EGFR inhibitor,EGFR|ERBB2|SRC,BRD-K17702546,PD-168393,EGFR inhibitor,EGFR|ERBB2|SRC
HUCJFAOMUPXHDK,BRD-K08356259,xylometazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K08356259,xylometazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K08356259,xylometazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K08356259,xylometazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
HUCXKZBETONXFO,BRD-K11510141,teprenone,mucus protecting agent,,BRD-K11510141,teprenone,mucus protecting agent,,BRD-K11510141,teprenone,mucus protecting agent,,BRD-K11510141,teprenone,mucus protecting agent,
HUDWXDLBWRHCKO,BRD-K99149715,plurisin-#1,stearoyl-CoA desaturase inhibitor,SCD,BRD-K99149715,plurisin-#1,stearoyl-CoA desaturase inhibitor,SCD,BRD-K99149715,plurisin-#1,stearoyl-CoA desaturase inhibitor,SCD,BRD-K99149715,plurisin-1,stearoyl-CoA desaturase inhibitor,SCD
HUFOZJXAKZVRNJ,BRD-K33610132,rociletinib,EGFR inhibitor,EGFR,BRD-K33610132,rociletinib,EGFR inhibitor,EGFR,BRD-K33610132,rociletinib,EGFR inhibitor,EGFR,BRD-K33610132,rociletinib,EGFR inhibitor,EGFR
HUJXGQILHAUCCV,BRD-K31135544,IB-MECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K31135544,IB-MECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K31135544,IB-MECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K31135544,IB-MECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
HUMXXHTVHHLNRO,BRD-A53151380,prednisolone-tebutate,anti-inflammatory agent,,BRD-A53151380,prednisolone-tebutate,anti-inflammatory agent,,BRD-A53151380,prednisolone-tebutate,anti-inflammatory agent,,BRD-A53151380,prednisolone-tebutate,anti-inflammatory agent,
HUNAOTXNHVALTN,BRD-K38548312,VER-49009,HSP inhibitor,HSP90AA1,BRD-K38548312,VER-49009,HSP inhibitor,HSP90AA1,BRD-K20177260|BRD-K38548312,VER-49009,HSP inhibitor,HSP90AA1,BRD-K20177260|BRD-K38548312,VER-49009,HSP inhibitor,HSP90AA1
HUNGUWOZPQBXGX,BRD-K29968218,KX2-391,src inhibitor|tubulin polymerization inhibitor,SRC,BRD-K29968218,KX2-391,src inhibitor|tubulin polymerization inhibitor,SRC,BRD-K29968218,KX2-391,src inhibitor|tubulin polymerization inhibitor,SRC,BRD-K29968218,KX2-391,SRC inhibitor|tubulin polymerization inhibitor,SRC
HUNIPYLVUPMFCZ,BRD-K20655524,mefexamide,psychoactive drug,,BRD-K20655524,mefexamide,psychoactive drug,,BRD-K20655524,mefexamide,psychoactive drug,,BRD-K20655524,mefexamide,psychoactive drug,
HUNXMJYCHXQEGX,BRD-K92657060,zaleplon,benzodiazepine receptor agonist,GABRA1|GABRB1|GABRG2|TSPO,BRD-K92657060,zaleplon,benzodiazepine receptor agonist,GABRA1|GABRB1|GABRG2|TSPO,BRD-K92657060,zaleplon,benzodiazepine receptor agonist,GABRA1|GABRB1|GABRG2|TSPO,,,,
HUPFGZXOMWLGNK,BRD-K22031190,diflunisal,prostanoid receptor antagonist,PTGS1|PTGS2,BRD-K22031190,diflunisal,prostanoid receptor antagonist,PTGS1|PTGS2,BRD-K22031190,diflunisal,prostanoid receptor antagonist,PTGS1|PTGS2,BRD-K22031190,diflunisal,prostanoid receptor antagonist,PTGS1|PTGS2
HUQJRYMLJBBEDO,BRD-K17774839,JNJ-7777120,histamine receptor antagonist,HRH4,BRD-K17774839,JNJ-7777120,histamine receptor antagonist,HRH4,BRD-K17774839,JNJ-7777120,histamine receptor antagonist,HRH4,BRD-K17774839,JNJ-7777120,histamine receptor antagonist,HRH4
HUUSXLKCTQDPGL,BRD-K55418700,MCC950,NOD like receptor inhibitor,NLRP3,BRD-K55418700,MCC950,NOD like receptor inhibitor,NLRP3,BRD-K55418700,MCC950,NOD like receptor inhibitor,NLRP3,BRD-K55418700,MCC950,NOD like receptor inhibitor,NLRP3
HUXYBQXJVXOMKX,BRD-K64800655,PHA-793887,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,BRD-K64800655,PHA-793887,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,BRD-K64800655,PHA-793887,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,BRD-K64800655,PHA-793887,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9
HUYWAWARQUIQLE,BRD-A24587114,isoetharine,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A24587114,isoetharine,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A24587114,isoetharine,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A24587114,isoetharine,adrenergic receptor agonist,
HVFLCNVBZFFHBT,BRD-A12077521,cefepime,bacterial cell wall synthesis inhibitor,,BRD-A12077521,cefepime,bacterial cell wall synthesis inhibitor,,BRD-A12077521,cefepime,bacterial cell wall synthesis inhibitor,,BRD-A12077521,cefepime,bacterial cell wall synthesis inhibitor,
HVSJHHXUORMCGK,BRD-K27911943,"chromanol-293B-(-)-[3R,4S]",,,BRD-K27911943,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,,BRD-K27911943,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,,BRD-K27911943,"chromanol-293B-(-)-[3R,4S]",potassium channel blocker,
HVUMOYIDDBPOLL,BRD-A70197423,sorbitan-monostearate,,,BRD-A70197423,sorbitan-monostearate,,,BRD-A70197423,sorbitan-monostearate,,,BRD-A70197423,sorbitan-monostearate,,
HVXBOLULGPECHP,BRD-K61195623,combretastatin-A-4,tubulin polymerization inhibitor,,BRD-K61195623,combretastatin-A-4,tubulin polymerization inhibitor,,BRD-K61195623,combretastatin-A-4,tubulin polymerization inhibitor,,BRD-K61195623,combretastatin-A-4,tubulin polymerization inhibitor,
HVXKQKFEHMGHSL,BRD-K03765900,XL-647,EGFR inhibitor|VEGFR inhibitor,EGFR|EPHB4|ERBB2|FLT4|KDR,BRD-K03765900,XL-647,EGFR inhibitor|VEGFR inhibitor,EGFR|EPHB4|ERBB2|FLT4|KDR,BRD-K03765900,XL-647,EGFR inhibitor|VEGFR inhibitor,EGFR|EPHB4|ERBB2|FLT4|KDR,BRD-K03765900,XL647,EGFR inhibitor|VEGFR inhibitor,EGFR|EPHB4|ERBB2|FLT4|KDR
HVYWMOMLDIMFJA,BRD-A42883684,cholesterol,,RORA,BRD-A42883684,cholesterol,,RORA,BRD-A42883684,cholesterol,,RORA,BRD-K19338361,cholesterol,,RORA
HWEOXFSBSQIWSY,BRD-K43975632,terutroban,prostanoid receptor antagonist,TBXA2R,BRD-K43975632,terutroban,prostanoid receptor antagonist,TBXA2R,BRD-K43975632,terutroban,prostanoid receptor antagonist,TBXA2R,BRD-K43975632,terutroban,prostanoid receptor antagonist,TBXA2R
HWGBHCRJGXAGEU,BRD-K11900042,methylthiouracil,,,BRD-K11900042,methylthiouracil,,,BRD-K11900042,methylthiouracil,,,BRD-K11900042,methylthiouracil,,
HWGQMRYQVZSGDQ,BRD-K95142244,talazoparib,PARP inhibitor,PARP2,BRD-K95142244,talazoparib,PARP inhibitor,PARP2,BRD-K95142244,talazoparib,PARP inhibitor,PARP2,BRD-K95142244,talazoparib,PARP inhibitor,PARP2
HWHLPVGTWGOCJO,BRD-A48180038,trihexyphenidyl,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A48180038,trihexyphenidyl,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A48180038,trihexyphenidyl,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K00003691,trihexyphenidyl,acetylcholine receptor antagonist,CHRM1
HWJRIFZDXJKJJN,BRD-K10878147,OAC1,Oct activator,,BRD-K10878147,OAC1,Oct activator,,BRD-K10878147,OAC1,Oct activator,,BRD-K10878147,OAC1,Oct activator,
HWKROQUZSKPIKQ,BRD-K24201553,SB-269970,serotonin receptor antagonist,HTR7,BRD-K24201553,SB-269970,serotonin receptor antagonist,HTR7,BRD-K24201553,SB-269970,serotonin receptor antagonist,HTR7,BRD-K24201553,SB-269970,serotonin receptor antagonist,HTR7
HWNUSGNZBAISFM,BRD-K40853697,STAT3-inhibitor-VI,STAT inhibitor,STAT3,BRD-K40853697,STAT3-inhibitor-VI,STAT inhibitor,STAT3,BRD-K40853697,STAT3-inhibitor-VI,STAT inhibitor,STAT3,BRD-K40853697,STAT3-inhibitor-VI,STAT inhibitor,STAT3
HWVNEWGKWRGSRK,BRD-K82983861,GW-0742,PPAR receptor agonist,PPARD,BRD-K82983861,GW-0742,PPAR receptor agonist,PPARD,BRD-K82983861,GW-0742,PPAR receptor agonist,PPARD,BRD-K82983861,GW-0742,PPAR receptor agonist,PPARD
HWXIGFIVGWUZAO,BRD-K70507123,doxofylline,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,BRD-K70507123,doxofylline,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,BRD-K70507123,doxofylline,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,BRD-K70507123,doxofylline,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D
HWXVIOGONBBTBY,BRD-K19034817,pacritinib,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,BRD-K19034817,pacritinib,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,BRD-K19034817,pacritinib,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,BRD-K19034817,pacritinib,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3
HWYHZTIRURJOHG,BRD-K52559566,monosodium-alpha-luminol,,,BRD-K52559566,monosodium-alpha-luminol,,,BRD-K52559566,monosodium-alpha-luminol,,,BRD-K79926543,monosodium-alpha-luminol,,
HXBKPYIEQLLNBK,BRD-K93176058,AC-55649,retinoid receptor agonist,RARA|RARB,BRD-K93176058,AC-55649,retinoid receptor agonist,RARA|RARB,BRD-K93176058,AC-55649,retinoid receptor agonist,RARA|RARB,BRD-K93176058,AC-55649,retinoid receptor agonist,RARA|RARB
HXCILVUBKWANLN,BRD-K60348325,brilliant-green,,,BRD-K60348325,brilliant-green,,,BRD-K60348325,brilliant-green,,,BRD-K60348325,brilliant-green,,
HXCNRYXBZNHDNE,BRD-K25224017,pirenperone,serotonin receptor antagonist,HTR2A|HTR7,BRD-K25224017,pirenperone,serotonin receptor antagonist,HTR2A|HTR7,BRD-K25224017,pirenperone,serotonin receptor antagonist,HTR2A|HTR7,BRD-K25224017,pirenperone,serotonin receptor antagonist,HTR2A|HTR7
HXGBXQDTNZMWGS,BRD-A01118042|BRD-K95773607,darifenacin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A01118042|BRD-K95773607,darifenacin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K95773607,darifenacin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K95773607,darifenacin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
HXHWSAZORRCQMX,BRD-K79131256,albendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,BRD-K79131256,albendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,BRD-K79131256,albendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,BRD-K79131256,albendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B
HXLAFSUPPDYFEO,BRD-A18233884,bevantolol,adrenergic receptor antagonist,ADRA1A|ADRB1|ADRB2,BRD-A18233884,bevantolol,adrenergic receptor antagonist,ADRA1A|ADRB1|ADRB2,BRD-A18233884,bevantolol,adrenergic receptor antagonist,ADRA1A|ADRB1|ADRB2,BRD-K01825622,bevantolol,adrenergic receptor antagonist,
HXMGCTFLLWPVFM,BRD-K83607951,skepinone-l,p38 MAPK inhibitor,MAPK14,BRD-K83607951,skepinone-l,p38 MAPK inhibitor,MAPK14,BRD-K83607951,skepinone-l,p38 MAPK inhibitor,MAPK14,BRD-K83607951,skepinone-L,p38 MAPK inhibitor,MAPK14
HXNFUBHNUDHIGC,BRD-K31841515,oxypurinol,xanthine oxidase inhibitor,XDH,BRD-K31841515,oxypurinol,xanthine oxidase inhibitor,XDH,BRD-K31841515,oxypurinol,xanthine oxidase inhibitor,XDH,BRD-K31841515,oxypurinol,xanthine oxidase inhibitor,XDH
HXQVQGWHFRNKMS,BRD-K61443650,thiomersal,other antibiotic,OXCT1,BRD-K61443650,thiomersal,other antibiotic,OXCT1,BRD-K61443650,thiomersal,other antibiotic,OXCT1,BRD-K61443650,thiomersal,other antibiotic,OXCT1
HXTGXYRHXAGCFP,BRD-K23647661,volinanserin,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|KCNH2,BRD-K23647661,volinanserin,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|KCNH2,BRD-K23647661,volinanserin,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|KCNH2,BRD-K23647661,volinanserin,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|KCNH2
HXYVTAGFYLMHSO,BRD-K68095457,palmitoylethanolamide,cannabinoid receptor agonist,CNR2|GPR119|GPR55,BRD-K68095457,palmitoylethanolamide,cannabinoid receptor agonist,CNR2|GPR119|GPR55,BRD-K68095457,palmitoylethanolamide,cannabinoid receptor agonist,CNR2|GPR119|GPR55,BRD-K68095457,palmitoylethanolamide,cannabinoid receptor agonist,CNR2|GPR119|GPR55
HYAFETHFCAUJAY,BRD-A48430263,pioglitazone,PPAR receptor agonist|insulin sensitizer,PPARG|TRPM3,BRD-A48430263,pioglitazone,PPAR receptor agonist|insulin sensitizer,PPARG|TRPM3,BRD-A48430263,pioglitazone,PPAR receptor agonist|insulin sensitizer,PPARG|TRPM3,BRD-K01826904,pioglitazone,PPAR receptor agonist|insulin sensitizer,PPARG|TRPM3
HYFHYPWGAURHIV,BRD-K76674262,homoharringtonine,protein synthesis inhibitor,RPL3,BRD-K76674262,homoharringtonine,protein synthesis inhibitor,RPL3,BRD-K76674262,homoharringtonine,protein synthesis inhibitor,RPL3,BRD-K76674262,homoharringtonine,protein synthesis inhibitor,RPL3
HYHMLYSLQUKXKP,BRD-K63177377,ETC-1002,AMPK inhibitor,ACLY,BRD-K63177377,ETC-1002,AMPK inhibitor,ACLY,BRD-K63177377,ETC-1002,AMPK inhibitor,ACLY,BRD-K63177377,bempedoic-acid,AMPK inhibitor,ACLY
HYHSBSXUHZOYLX,BRD-K94780074,S-Nitrosoglutathione,nitric oxide stimulant,PTPN1,BRD-K94780074,S-Nitrosoglutathione,nitric oxide stimulant,PTPN1,BRD-K94780074,S-Nitrosoglutathione,nitric oxide stimulant,PTPN1,BRD-K00024724,S-nitrosoglutathione,nitric oxide stimulant,PTPN1
HYIMSNHJOBLJNT,BRD-K96354014,nifedipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3,BRD-K96354014,nifedipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3,BRD-K96354014,nifedipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3,BRD-K96354014,nifedipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3
HYIZCDMXFDRDFE,BRD-A37348498,candicidin,fungal ergosterol inhibitor,,BRD-A37348498,candicidin,fungal ergosterol inhibitor,,BRD-A37348498,candicidin,fungal ergosterol inhibitor,,BRD-A37348498,candicidin,fungal ergosterol inhibitor,
HYJRTXSYDAFGJK,BRD-K29313239,4-DAMP,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K29313239,4-DAMP,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K29313239,4-DAMP,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K29313239,4-DAMP,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
HYNBNUYQTQIHJK,BRD-K85014146,AZD2461,PARP inhibitor,,BRD-K85014146,AZD2461,PARP inhibitor,,BRD-K85014146,AZD2461,PARP inhibitor,,BRD-K85014146,AZD2461,PARP inhibitor,
HYOGJHCDLQSAHX,BRD-K55029398,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2,BRD-K55029398,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2,BRD-K55029398,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2,BRD-K55029398,JNJ-40411813,glutamate receptor positive allosteric modulator,GRM2
HYSMCRNFENOHJH,BRD-K92908289,medica-16,ATP citrase lyase inhibitor,FFAR1,BRD-K92908289,medica-16,ATP citrase lyase inhibitor,FFAR1,BRD-K92908289,medica-16,ATP citrase lyase inhibitor,FFAR1,BRD-K92908289,medica-16,ATP citrase lyase inhibitor,FFAR1
HYWYRSMBCFDLJT,BRD-K76775527,nimesulide,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,BRD-K76775527,nimesulide,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,BRD-K76775527,nimesulide,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,BRD-K76775527,nimesulide,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2
HYXITZLLTYIPOF,BRD-K00141480,tanshinone-iia,anti-inflammatory agent|interleukin inhibitor,IL1B|NR1I2|TNF,BRD-K00141480,tanshinone-iia,anti-inflammatory agent|interleukin inhibitor,IL1B|NR1I2|TNF,BRD-K00141480,tanshinone-iia,anti-inflammatory agent|interleukin inhibitor,IL1B|NR1I2|TNF,BRD-K00141480,tanshinone-IIA,anti-inflammatory agent|interleukin inhibitor,IL1B|NR1I2|TNF
HYYBABOKPJLUIN,BRD-K92778217,mefenamic-acid,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,BRD-K92778217,mefenamic-acid,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,BRD-K92778217,mefenamic-acid,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,BRD-K92778217,mefenamic-acid,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3
HYZHONGSQNXMPH,BRD-A01907367,FK-33-824,opioid receptor agonist,OPRM1,BRD-A01907367,FK-33-824,opioid receptor agonist,OPRM1,BRD-A01907367,FK-33-824,opioid receptor agonist,OPRM1,BRD-A01907367,FK-33-824,opioid receptor agonist,OPRM1
HZCWPKGYTCJSEB,BRD-K42607789,pyrazoloacridine,topoisomerase inhibitor,TOP1|TOP2A,BRD-K42607789,pyrazoloacridine,topoisomerase inhibitor,TOP1|TOP2A,BRD-K42607789,pyrazoloacridine,topoisomerase inhibitor,TOP1|TOP2A,,,,
HZHFFEYYPYZMNU,BRD-K38140108,gadodiamide,radiopaque medium,,BRD-K38140108,gadodiamide,radiopaque medium,,BRD-K38140108|BRD-M27076668,gadodiamide,radiopaque medium,,BRD-K38140108|BRD-M27076668,gadodiamide,radiopaque medium,
HZIWGOAXOBPQGY,BRD-K48173020,ameltolide,anticonvulsant,,BRD-K48173020,ameltolide,anticonvulsant,,BRD-K48173020,ameltolide,anticonvulsant,,BRD-K48173020,ameltolide,anticonvulsant,
HZQDCMWJEBCWBR,BRD-K05218031|BRD-K88061624,mizoribine,immunosuppressant|inosine monophosphate dehydrogenase inhibitor,IMPDH1,BRD-K05218031|BRD-K88061624,mizoribine,immunosuppressant|inosine monophosphate dehydrogenase inhibitor,IMPDH1,BRD-K05218031|BRD-K88061624,mizoribine,immunosuppressant|inosine monophosphate dehydrogenase inhibitor,IMPDH1,,,,
HZRCCSSSNUKHQG,BRD-K81645297,NKP-1339,HSP inhibitor,,BRD-K81645297,NKP-1339,HSP inhibitor,,BRD-K81645297|BRD-U52007923,NKP-1339,HSP inhibitor,,,,,
HZRXQEVFXXQYFS,BRD-M17926088,FPA-124,AKT inhibitor,,BRD-M17926088,FPA-124,AKT inhibitor,,BRD-M17926088,FPA-124,AKT inhibitor,,BRD-M17926088,FPA-124,AKT inhibitor,
HZTYDQRUAWIZRE,BRD-K06749501,GSK1838705A,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1,BRD-K06749501,GSK1838705A,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1,BRD-K06749501,GSK1838705A,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1,BRD-K06749501,GSK1838705A,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1
HZVLFTCYCLXTGV,BRD-K62050508,grapiprant,prostaglandin inhibitor,PTGER4,BRD-K62050508,grapiprant,prostaglandin inhibitor,PTGER4,BRD-K62050508,grapiprant,prostaglandin inhibitor,PTGER4,BRD-K62050508,grapiprant,prostaglandin inhibitor,PTGER4
HZZVJAQRINQKSD,BRD-K94250879,clavulanate,beta lactamase inhibitor,,BRD-K94250879,clavulanate,beta lactamase inhibitor,,BRD-K94250879,clavulanate,beta lactamase inhibitor,,BRD-K94250879,clavulanate,beta lactamase inhibitor,
HZZZZODVDSHQRG,BRD-K87048468,RS-102221,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K87048468,RS-102221,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K87048468,RS-102221,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K87048468,RS-102221,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
IAIDUHCBNLFXEF,BRD-K46654563,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE,BRD-K46654563,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE,BRD-K46654563|BRD-M85357167,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE,BRD-K46654563|BRD-M85357167,zofenopril-calcium,angiotensin converting enzyme inhibitor,ACE
IAIWVQXQOWNYOU,BRD-K79092138,nitrofurazone,bacterial DNA inhibitor,,BRD-K79092138,nitrofurazone,bacterial DNA inhibitor,,BRD-K79092138,nitrofurazone,bacterial DNA inhibitor,,BRD-K79092138,nitrofurazone,bacterial DNA inhibitor,
IAJBQAYHSQIQRE,BRD-K88219015,asaraldehyde,cyclooxygenase inhibitor,PTGS2,BRD-K88219015,asaraldehyde,cyclooxygenase inhibitor,PTGS2,BRD-K88219015,asaraldehyde,cyclooxygenase inhibitor,PTGS2,BRD-K88219015,asaraldehyde,cyclooxygenase inhibitor,PTGS2
IAJOMYABKVAZCN,BRD-K28010364,PFK-158,phosphofructokinase inhibitor,PFKFB3,BRD-K28010364,PFK-158,phosphofructokinase inhibitor,PFKFB3,BRD-K28010364,PFK-158,phosphofructokinase inhibitor,PFKFB3,BRD-K28010364,PFK-158,phosphofructokinase inhibitor,PFKFB3
IAKHMKGGTNLKSZ,BRD-A46684810|BRD-K00259736,colchicine,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-A46684810|BRD-K00259736,colchicine,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-A46684810|BRD-K00259736,colchicine,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,BRD-A46684810|BRD-K00259736,colchicine,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
IALHTUPVRAQZFI,BRD-K18905250,ST-91,adrenergic receptor agonist,,BRD-K18905250,ST-91,adrenergic receptor agonist,,BRD-K18905250,ST-91,adrenergic receptor agonist,,BRD-K18905250,ST-91,adrenergic receptor agonist,
IAOZJIPTCAWIRG,BRD-K78841970,aspartame,,TAS1R2|TRPV1,BRD-K78841970,aspartame,,TAS1R2|TRPV1,BRD-K78841970,aspartame,,TAS1R2|TRPV1,BRD-K78841970,aspartame,,TAS1R2|TRPV1
IASPBORHOMBZMY,BRD-K95926480,SRT1720,SIRT activator,SIRT1,BRD-K95926480,SRT1720,SIRT activator,SIRT1,BRD-K95926480,SRT1720,SIRT activator,SIRT1,BRD-K95926480,SRT1720,SIRT activator,SIRT1
IAUZTOZLTFSMIE,BRD-K82823804,PD-407824,PKC inhibitor,WEE1,BRD-K82823804,PD-407824,PKC inhibitor,WEE1,BRD-K82823804,PD-407824,PKC inhibitor,WEE1,BRD-K82823804,PD-407824,PKC inhibitor,WEE1
IAVUPMFITXYVAF,BRD-K71075609,dorzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,BRD-K71075609,dorzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,BRD-K71075609,dorzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,BRD-K48617017,dorzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7
IAYGCINLNONXHY,BRD-K86525559,AZD7762,CHK inhibitor,CHEK1|CHEK2,BRD-K86525559,AZD7762,CHK inhibitor,CHEK1|CHEK2,BRD-K86525559,AZD7762,CHK inhibitor,CHEK1|CHEK2,BRD-K86525559,AZD7762,CHK inhibitor,CHEK1|CHEK2
IBAKVEUZKHOWNG,BRD-K68395654,EVP4593,NFkB pathway inhibitor,,BRD-K68395654,EVP4593,NFkB pathway inhibitor,,BRD-K68395654,EVP4593,NFkB pathway inhibitor,,BRD-K68395654,EVP4593,NFkB pathway inhibitor,
IBAQFPQHRJAVAV,BRD-A63310107|BRD-K82665349,miglitol,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,BRD-A63310107|BRD-K44779798|BRD-K82665349,miglitol,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,BRD-A63310107|BRD-K44779798|BRD-K82665349,miglitol,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,BRD-K44779798|BRD-K82665349,miglitol,glucosidase inhibitor,GAA|GANAB|GANC|MGAM
IBCXZJCWDGCXQT,BRD-K06234293,LY364947,TGF beta receptor inhibitor|p38 MAPK inhibitor,TGFBR1,BRD-K06234293,LY364947,TGF beta receptor inhibitor|p38 MAPK inhibitor,TGFBR1,BRD-K06234293,LY364947,TGF beta receptor inhibitor|p38 MAPK inhibitor,TGFBR1,BRD-K06234293,LY364947,TGF beta receptor inhibitor|p38 MAPK inhibitor,TGFBR1
IBFYXTRXDNAPMM,BRD-K35205465|BRD-K57275767,geniposide,GLP receptor agonist,GLP1R,BRD-K35205465|BRD-K57275767,geniposide,GLP receptor agonist,GLP1R,BRD-K35205465|BRD-K57275767,geniposide,GLP receptor agonist,GLP1R,BRD-K35205465|BRD-K57275767,geniposide,GLP receptor agonist,GLP1R
IBGLGMOPHJQDJB,BRD-K48213016,CC-930,JNK inhibitor,,BRD-K48213016,CC-930,JNK inhibitor,,BRD-K48213016,CC-930,JNK inhibitor,,BRD-K48213016,CC-930,JNK inhibitor,
IBLNKMRFIPWSOY,BRD-A72441487,stiripentol,GABA uptake inhibitor,GABRA3,BRD-A72441487,stiripentol,GABA uptake inhibitor,GABRA3,BRD-A72441487,stiripentol,GABA uptake inhibitor,GABRA3,BRD-A72441487,stiripentol,GABA uptake inhibitor,GABRA3
IBPVXAOOVUAOKJ,BRD-K02017404,NVP-BSK805,JAK inhibitor,JAK2,BRD-K02017404,NVP-BSK805,JAK inhibitor,JAK2,BRD-K02017404,NVP-BSK805,JAK inhibitor,JAK2,BRD-K02017404,NVP-BSK805,JAK inhibitor,JAK2
IBXGJPAYWMFXSF,BRD-K42009284,OT-R-antagonist-1,oxytocin receptor antagonist,AVPR1A|OXTR,BRD-K42009284,OT-R-antagonist-1,oxytocin receptor antagonist,AVPR1A|OXTR,BRD-K42009284,OT-R-antagonist-1,oxytocin receptor antagonist,AVPR1A|OXTR,BRD-K42009284,OT-R-antagonist-1,oxytocin receptor antagonist,AVPR1A|OXTR
IBXPYPUJPLLOIN,BRD-K72728560,dimetridazole,bacterial DNA inhibitor,,BRD-K72728560,dimetridazole,bacterial DNA inhibitor,,BRD-K72728560|BRD-U80626937,dimetridazole,bacterial DNA inhibitor,,BRD-K72728560|BRD-U80626937,dimetridazole,bacterial DNA inhibitor,
IBYCYJFUEJQSMK,BRD-A60821666,etifoxine,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,BRD-A60821666,etifoxine,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,BRD-A60821666,etifoxine,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K01826330,etifoxine,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5
ICDMLAQPOAVWNH,BRD-K48830578,OMDM-2,FAAH inhibitor,GPR119,BRD-K48830578,OMDM-2,FAAH inhibitor,GPR119,BRD-K48830578,OMDM-2,FAAH inhibitor,GPR119,BRD-K48830578,OMDM-2,FAAH inhibitor,GPR119
ICFJFFQQTFMIBG,BRD-K11399644,phenformin,AMPK activator,KCNJ8|PRKAA1,BRD-K11399644,phenformin,AMPK activator,KCNJ8|PRKAA1,BRD-K11399644,phenformin,AMPK activator,KCNJ8|PRKAA1,BRD-K11399644,phenformin,AMPK activator,KCNJ8|PRKAA1
ICHJMVMWPKLUKT,BRD-K18316707,O-1918,cannabinoid receptor antagonist,,BRD-K18316707,O-1918,cannabinoid receptor antagonist,,BRD-K18316707,O-1918,cannabinoid receptor antagonist,,BRD-K18316707,O-1918,cannabinoid receptor antagonist,
ICKFFNBDFNZJSX,BRD-K83257731,chloropyramine,histamine receptor antagonist,HRH1,BRD-K83257731,chloropyramine,histamine receptor antagonist,HRH1,BRD-K83257731,chloropyramine,histamine receptor antagonist,HRH1,BRD-K83257731,chloropyramine,histamine receptor antagonist,HRH1
ICMGLRUYEQNHPF,BRD-K73196317,urapidil,adrenergic receptor antagonist,HTR1A,BRD-K73196317,urapidil,adrenergic receptor antagonist,HTR1A,BRD-K73196317,urapidil,adrenergic receptor antagonist,HTR1A,BRD-K73196317,urapidil,adrenergic receptor antagonist,HTR1A
ICMIJSRDISNKOC,BRD-K26997899,D-64131,microtubule inhibitor,TUBB,BRD-K26997899,D-64131,microtubule inhibitor,TUBB,BRD-K26997899,D-64131,microtubule inhibitor,TUBB,BRD-K26997899,D-64131,microtubule inhibitor,TUBB
ICTXHFFSOAJUMG,BRD-A00758722,noretynodrel,progestogen hormone,PGR,BRD-A00758722,noretynodrel,progestogen hormone,PGR,BRD-A00758722,noretynodrel,progestogen hormone,PGR,BRD-A00758722,noretynodrel,progestogen hormone,PGR
ICUTUKXCWQYESQ,BRD-K25029121,triclocarban,other antibiotic,,BRD-K25029121,triclocarban,other antibiotic,,BRD-K25029121,triclocarban,other antibiotic,,BRD-K25029121,triclocarban,other antibiotic,
IDCHQQSVJAAUQQ,BRD-K42596464,oxolamine,antitussive,,BRD-K42596464,oxolamine,antitussive,,BRD-K42596464,oxolamine,antitussive,,BRD-K42596464,oxolamine,antitussive,
IDIDJDIHTAOVLG,BRD-K63123526,S-methylcysteine,,CTSD|MGMT,BRD-K63123526,S-methylcysteine,,CTSD|MGMT,BRD-K63123526,S-methylcysteine,,CTSD|MGMT,BRD-K63123526,S-methylcysteine,,CTSD|MGMT
IDKAKZRYYDCJDU,BRD-A16035238|BRD-K86736469,SAR405838,MDM inhibitor,MDM2,BRD-A16035238|BRD-K86736469,SAR405838,MDM inhibitor,MDM2,BRD-A16035238|BRD-K86736469,SAR405838,MDM inhibitor,MDM2,BRD-K45349653,SAR405838,MDM inhibitor,MDM2
IDLAOWFFKWRNHB,BRD-K27536248,TCID,,,BRD-K27536248,TCID,,,BRD-K27536248,TCID,,,BRD-K27536248,TCID,,
IDOXKFDPDOIUMG,BRD-K38370968,3-AQC,serotonin receptor agonist,HTR3A,BRD-K38370968,3-AQC,serotonin receptor agonist,HTR3A,BRD-K38370968,3-AQC,serotonin receptor agonist,HTR3A,BRD-K38370968,3-AQC,serotonin receptor agonist,HTR3A
IDPUKCWIGUEADI,BRD-K10180294,uracil-mustard,DNA synthesis inhibitor,,BRD-K10180294,uracil-mustard,DNA synthesis inhibitor,,BRD-K10180294,uracil-mustard,DNA synthesis inhibitor,,BRD-K10180294,uracil-mustard,DNA synthesis inhibitor,
IDYKCXHJJGMAEV,BRD-K18157228,fdcyd,DNA methyltransferase inhibitor,,BRD-K18157228,fdcyd,DNA methyltransferase inhibitor,,BRD-K18157228,fdcyd,DNA methyltransferase inhibitor,,BRD-K18157228,fdcyd,DNA methyltransferase inhibitor,
IDYZIJYBMGIQMJ,BRD-K78113049,enoxacin,topoisomerase inhibitor,TOP2A,BRD-K78113049,enoxacin,topoisomerase inhibitor,TOP2A,BRD-K78113049,enoxacin,topoisomerase inhibitor,TOP2A,BRD-K78113049,enoxacin,topoisomerase inhibitor,TOP2A
IDZASIQMRGPBCQ,BRD-A71262238,nafadotride,dopamine receptor antagonist,DRD2|DRD3|HTR1A,BRD-A71262238,nafadotride,dopamine receptor antagonist,DRD2|DRD3|HTR1A,BRD-A71262238,nafadotride,dopamine receptor antagonist,DRD2|DRD3|HTR1A,BRD-A71262238,nafadotride,dopamine receptor antagonist,DRD2|DRD3|HTR1A
IECPWNUMDGFDKC,BRD-A06935312,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,,BRD-A06935312,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,,BRD-A06935312,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,,BRD-K78355918,fusidic-acid,bacterial 30S ribosomal subunit inhibitor,
IEDVJHCEMCRBQM,BRD-K07208025,trimethoprim,dihydrofolate reductase inhibitor,DHFR|TYMS,BRD-K07208025,trimethoprim,dihydrofolate reductase inhibitor,DHFR|TYMS,BRD-K07208025,trimethoprim,dihydrofolate reductase inhibitor,DHFR|TYMS,BRD-K07208025,trimethoprim,dihydrofolate reductase inhibitor,DHFR|TYMS
IEJXVRYNEISIKR,BRD-K38911213,apraclonidine,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C,BRD-K38911213,apraclonidine,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C,BRD-K38911213,apraclonidine,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C,BRD-K38911213,apraclonidine,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C
IEKOTSCYBBDIJC,BRD-A29854054,lorglumide,CCK receptor antagonist,CCKAR|CCKBR,BRD-A29854054,lorglumide,CCK receptor antagonist,CCKAR|CCKBR,BRD-A29854054,lorglumide,CCK receptor antagonist,CCKAR|CCKBR,BRD-K01825818,lorglumide,CCK receptor antagonist,CCKAR|CCKBR
IELOKBJPULMYRW,BRD-K64636206,D-alpha-tocopheryl-succinate,,,BRD-K64636206,D-alpha-tocopheryl-succinate,,,BRD-K64636206,D-alpha-tocopheryl-succinate,,,BRD-K64636206,D-alpha-tocopheryl-succinate,,
IENZFHBNCRQMNP,BRD-K16757695,PRX-08066,serotonin receptor antagonist,HTR2B,BRD-K16757695,PRX-08066,serotonin receptor antagonist,HTR2B,BRD-K16757695,PRX-08066,serotonin receptor antagonist,HTR2B,BRD-K16757695,PRX-08066,serotonin receptor antagonist,HTR2B
IENZQIKPVFGBNW,BRD-K49111258,prazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,BRD-K49111258,prazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,BRD-K49111258,prazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,BRD-K49111258,prazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7
IETKPTYAGKZLKY,BRD-A00147595,balaglitazone,PPAR receptor partial agonist|insulin sensitizer,PPARG,BRD-A00147595,balaglitazone,PPAR receptor partial agonist|insulin sensitizer,PPARG,BRD-A00147595,balaglitazone,PPAR receptor partial agonist|insulin sensitizer,PPARG,BRD-A00147595,balaglitazone,PPAR receptor partial agonist|insulin sensitizer,PPARG
IEZDOKQWPWZVQF,BRD-K38564664,rolziracetam,,,BRD-K38564664,rolziracetam,,,BRD-K38564664,rolziracetam,,,BRD-K38564664,rolziracetam,,
IFFPICMESYHZPQ,BRD-A10662413,prenylamine,calcium channel blocker,CALM1|MYLK2,BRD-A10662413,prenylamine,calcium channel blocker,CALM1|MYLK2,BRD-A10662413,prenylamine,calcium channel blocker,CALM1|MYLK2,BRD-A10662413,prenylamine,calcium channel blocker,
IFIUFCJFLGCQPH,BRD-K84266862,BRL-50481,phosphodiesterase inhibitor,PDE7A|PDE7B,BRD-K84266862,BRL-50481,phosphodiesterase inhibitor,PDE7A|PDE7B,BRD-K84266862,BRL-50481,phosphodiesterase inhibitor,PDE7A|PDE7B,BRD-K84266862,BRL-50481,phosphodiesterase inhibitor,PDE7A|PDE7B
IFKLAQQSCNILHL,BRD-K42417338,butorphanol-(+)-tartrate,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K42417338,butorphanol-(+)-tartrate,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K42417338|BRD-M74255273,butorphanol-(+)-tartrate,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,,,
IFMQODYDAUKKEN,BRD-K46766488,S-14506,serotonin receptor agonist,HTR1A,BRD-K46766488,S-14506,serotonin receptor agonist,HTR1A,BRD-K46766488,S-14506,serotonin receptor agonist,HTR1A,BRD-K46766488,S-14506,serotonin receptor agonist,HTR1A
IFRGXKKQHBVPCQ,BRD-K58435339,AT13387,HSP antagonist,HSP90AA1,BRD-K58435339,AT13387,HSP antagonist,HSP90AA1,BRD-K58435339,AT13387,HSP antagonist,HSP90AA1,BRD-K58435339,AT13387,HSP inhibitor,HSP90AA1
IFSDAJWBUCMOAH,BRD-K60866521,idelalisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K60866521,idelalisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K60866521,idelalisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K60866521,idelalisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
IFXJDEHFADWURH,BRD-K06159959,CCMQ,homoquinolinic acid binding inhibitor,,BRD-K06159959,CCMQ,homoquinolinic acid binding inhibitor,,BRD-K06159959,CCMQ,homoquinolinic acid binding inhibitor,,BRD-K06159959,CCMQ,homoquinolinic acid binding inhibitor,
IGBBVTAVILYDIO,BRD-K42959922,trans-2-Undecenoic-acid,,,BRD-K42959922,trans-2-Undecenoic-acid,,,BRD-K42959922,trans-2-Undecenoic-acid,,,BRD-K42959922,trans-2-undecenoic-acid,,
IGPDWKCUDHIIRL,BRD-A87479750,tenidap,cyclooxygenase inhibitor,KCNJ4|PTGS1,BRD-A87479750,tenidap,cyclooxygenase inhibitor,KCNJ4|PTGS1,BRD-A87479750,tenidap,cyclooxygenase inhibitor,KCNJ4|PTGS1,BRD-K00004279,tenidap,cyclooxygenase inhibitor,KCNJ4|PTGS1
IGUBBWJDMLCRIK,BRD-K09877029,VS-4718,focal adhesion kinase inhibitor,,BRD-K09877029,VS-4718,focal adhesion kinase inhibitor,,BRD-K09877029,VS-4718,focal adhesion kinase inhibitor,,BRD-K09877029,VS-4718,focal adhesion kinase inhibitor,
IHAXLPDVOWLUOS,BRD-K24497734,setipiprant,prostaglandin inhibitor,PTGDR2,BRD-K24497734,setipiprant,prostaglandin inhibitor,PTGDR2,BRD-K24497734,setipiprant,prostaglandin inhibitor,PTGDR2,BRD-K24497734,setipiprant,prostaglandin inhibitor,PTGDR2
IHHXIUAEPKVVII,BRD-M64062803,ibuprofen-lysine,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-M64062803,ibuprofen-lysine,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-M64062803,ibuprofen-lysine,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-M64062803,ibuprofen-lysine,cyclooxygenase inhibitor,
IHIUGIVXARLYHP,BRD-K16551357,evacetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K16551357,evacetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K16551357,evacetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K16551357,evacetrapib,cholesteryl ester transfer protein inhibitor,CETP
IHIWYQYVBNODSV,BRD-K90171280,LY2452473,androgen receptor modulator,AR,BRD-K90171280,LY2452473,androgen receptor modulator,AR,BRD-K90171280,LY2452473,androgen receptor modulator,AR,BRD-K90171280,LY2452473,androgen receptor modulator,AR
IHLAQQPQKRMGSS,BRD-K50677762,oxiracetam,acetylcholine receptor agonist,,BRD-K50677762,oxiracetam,acetylcholine receptor agonist,,BRD-K50677762,oxiracetam,acetylcholine receptor agonist,,BRD-K50677762,oxiracetam,acetylcholine receptor agonist,
IHLVSLOZUHKNMQ,BRD-K47557313,LY2109761,TGF beta receptor inhibitor,TGFBR1|TGFBR2,BRD-K47557313,LY2109761,TGF beta receptor inhibitor,TGFBR1|TGFBR2,BRD-K47557313,LY2109761,TGF beta receptor inhibitor,TGFBR1|TGFBR2,BRD-K47557313,LY2109761,TGF beta receptor inhibitor,TGFBR1|TGFBR2
IHOVFYSQUDPMCN,BRD-K70557564,zosuquidar,P glycoprotein inhibitor,ABCB1|ABCB4,BRD-K70557564,zosuquidar,P glycoprotein inhibitor,ABCB1|ABCB4,BRD-K70557564,zosuquidar,P glycoprotein inhibitor,ABCB1|ABCB4,BRD-K70557564,zosuquidar,P glycoprotein inhibitor,ABCB1|ABCB4
IHOXNOQMRZISPV,BRD-K25095405,carmoterol,adrenergic receptor agonist,ADRB2,BRD-K25095405,carmoterol,adrenergic receptor agonist,ADRB2,BRD-A25157829|BRD-K25095405,carmoterol,adrenergic receptor agonist,ADRB2,BRD-A25157829|BRD-K25095405,carmoterol,adrenergic receptor agonist,ADRB2
IHUNBGSDBOWDMA,BRD-K62012036,acitretin,retinoid receptor agonist,RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3,BRD-K62012036,acitretin,retinoid receptor agonist,RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3,BRD-K62012036,acitretin,retinoid receptor agonist,RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3,BRD-K62012036,acitretin,retinoid receptor agonist,RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3
IHYZMEAZAIFMTN,BRD-K95581532,RN-1734,TRPV antagonist,TRPV4,BRD-K95581532,RN-1734,TRPV antagonist,TRPV4,BRD-K95581532,RN-1734,TRPV antagonist,TRPV4,BRD-K95581532,RN-1734,TRPV antagonist,TRPV4
IIBYAHWJQTYFKB,BRD-K46018455,bezafibrate,PPAR receptor agonist,PPARA|PPARD|PPARG,BRD-K46018455,bezafibrate,PPAR receptor agonist,PPARA|PPARD|PPARG,BRD-K46018455,bezafibrate,PPAR receptor agonist,PPARA|PPARD|PPARG,BRD-K46018455,bezafibrate,PPAR receptor agonist,PPARA|PPARD|PPARG
IICCLYANAQEHCI,BRD-K36163066,rose-bengal-lactone,coloring agent,,BRD-K36163066,rose-bengal-lactone,coloring agent,,BRD-K36163066,rose-bengal-lactone,coloring agent,,BRD-K36163066,rose-bengal-lactone,coloring agent,
IIDJRNMFWXDHID,BRD-K05185389,risedronate,osteoclast inhibitor,FDPS,BRD-K05185389,risedronate,osteoclast inhibitor,FDPS,BRD-K05185389,risedronate,osteoclast inhibitor,FDPS,BRD-K05185389,risedronate,osteoclast inhibitor,FDPS
IIHQNAXFIODVDU,BRD-K95015809,2-cyanopyrimidine,cathepsin inhibitor,,BRD-K95015809,2-cyanopyrimidine,cathepsin inhibitor,,BRD-K95015809,2-cyanopyrimidine,cathepsin inhibitor,,,,,
IIRWNGPLJQXWFJ,BRD-A77091532|BRD-K32127727,AT13148,protein kinase inhibitor,AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3,BRD-A77091532|BRD-K32127727,AT13148,protein kinase inhibitor,AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3,BRD-A77091532|BRD-K32127727,AT13148,protein kinase inhibitor,AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3,BRD-A77091532|BRD-K32127727,AT13148,protein kinase inhibitor,AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3
IISBACLAFKSPIT,BRD-K41494493,bisphenol-a,synthetic estrogen,AR|ESR1|ESR2|ESRRG|PPARG,BRD-K41494493,bisphenol-a,synthetic estrogen,AR|ESR1|ESR2|ESRRG|PPARG,BRD-K41494493,bisphenol-a,synthetic estrogen,AR|ESR1|ESR2|ESRRG|PPARG,BRD-K41494493,bisphenol-A,synthetic estrogen,AR|ESR1|ESR2|ESRRG|PPARG
IIVBFTNIGYRNQY,BRD-K27351809,nomegestrol-acetate,progesterone receptor agonist,PGR,BRD-K27351809,nomegestrol-acetate,progesterone receptor agonist,PGR,BRD-K27351809,nomegestrol-acetate,progesterone receptor agonist,PGR,BRD-K27351809,nomegestrol-acetate,progesterone receptor agonist,PGR
IIXWYSCJSQVBQM,BRD-A23124853|BRD-K99879819,PF-06463922|lorlatinib,ALK tyrosine kinase receptor inhibitor,ALK|FES|ROS1,BRD-A23124853|BRD-K99879819,PF-06463922|lorlatinib,ALK tyrosine kinase receptor inhibitor,ALK|FES|ROS1,BRD-A23124853|BRD-K99879819,PF-06463922|lorlatinib,ALK tyrosine kinase receptor inhibitor,ALK|FES|ROS1,BRD-A23124853|BRD-K99879819,PF-06463922|lorlatinib,ALK tyrosine kinase receptor inhibitor,ALK|FES|ROS1
IJBZOOZRAXHERC,BRD-K55462201,AM-404,FAAH inhibitor|TRPV antagonist|cyclooxygenase inhibitor,CNR1|CNR2|FAAH|TRPV1,BRD-K55462201,AM-404,FAAH inhibitor|TRPV antagonist|cyclooxygenase inhibitor,CNR1|CNR2|FAAH|TRPV1,BRD-K55462201,AM-404,FAAH inhibitor|TRPV antagonist|cyclooxygenase inhibitor,CNR1|CNR2|FAAH|TRPV1,BRD-K55462201,AM-404,FAAH inhibitor|TRPV antagonist|cyclooxygenase inhibitor,CNR1|CNR2|FAAH|TRPV1
IJCMHHSFXFMZAI,BRD-A40257118,BQU57,Ras GTPase inhibitor,RALA|RALB,BRD-A40257118,BQU57,Ras GTPase inhibitor,RALA|RALB,BRD-A40257118,BQU57,Ras GTPase inhibitor,RALA|RALB,,,,
IJHNSHDBIRRJRN,BRD-A23072235,pheniramine,histamine receptor antagonist,HRH1,BRD-A23072235,pheniramine,histamine receptor antagonist,HRH1,BRD-A23072235,pheniramine,histamine receptor antagonist,HRH1,BRD-A23072235,pheniramine,histamine receptor antagonist,HRH1
IJMBOKOTALXLKS,BRD-K01291782,molidustat,hypoxia inducible factor inhibitor,EGLN2,BRD-K01291782,molidustat,hypoxia inducible factor inhibitor,EGLN2,BRD-K01291782,molidustat,hypoxia inducible factor inhibitor,EGLN2,BRD-K01291782,molidustat,hypoxia inducible factor inhibitor,EGLN2
IJTPLVAAROHGGB,BRD-K36222532,broxaldine,,,BRD-K36222532,broxaldine,,,BRD-K36222532,broxaldine,,,BRD-K36222532,broxaldine,,
IJVMOGKBEVRBPP,BRD-A49947412|BRD-K06204668|BRD-K86305586,"3,4-DCPG-(+/-)|3,4-DCPG-(R)|3,4-DCPG-(S)",,,BRD-A49947412|BRD-K06204668|BRD-K86305586,"3,4-DCPG-(+/-)|3,4-DCPG-(R)|3,4-DCPG-(S)",glutamate receptor agonist|glutamate receptor antagonist,|GRM8,BRD-A49947412|BRD-K06204668|BRD-K86305586,"3,4-DCPG-(+/-)|3,4-DCPG-(R)|3,4-DCPG-(S)",glutamate receptor agonist|glutamate receptor antagonist,|GRM8,BRD-A49947412|BRD-K06204668|BRD-K86305586,"3,4-DCPG-(+/-)|3,4-DCPG-(R)|3,4-DCPG-(S)",glutamate receptor agonist|glutamate receptor antagonist,|GRM8
IKBKZGMPCYNSLU,BRD-K88743730,tegaserod,serotonin receptor partial agonist,HTR2A|HTR2B|HTR2C|HTR4,BRD-K88743730,tegaserod,serotonin receptor partial agonist,HTR2A|HTR2B|HTR2C|HTR4,BRD-K88743730,tegaserod,serotonin receptor partial agonist,HTR2A|HTR2B|HTR2C|HTR4,BRD-K88743730,tegaserod,serotonin receptor partial agonist,HTR2A|HTR2B|HTR2C|HTR4
IKENVDNFQMCRTR,BRD-K37385792,conivaptan,vasopressin receptor antagonist,AVPR1A|AVPR2,BRD-K37385792,conivaptan,vasopressin receptor antagonist,AVPR1A|AVPR2,BRD-K37385792,conivaptan,vasopressin receptor antagonist,AVPR1A|AVPR2,BRD-K37385792,conivaptan,vasopressin receptor antagonist,AVPR1A|AVPR2
IKGXIBQEEMLURG,BRD-A76747559|BRD-K20482099|BRD-K22924152,rutin,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,BRD-A76747559|BRD-K20482099,rutin,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,BRD-A76747559|BRD-K20482099|BRD-K22924152,rutin,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,BRD-A76747559|BRD-K20482099|BRD-K22924152,rutin,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3
IKIIZLYTISPENI,BRD-K98733875|BRD-K99455969,baicalin,beta glucuronidase inhibitor,PREP,BRD-K98733875|BRD-K99455969,baicalin,beta glucuronidase inhibitor,PREP,BRD-K49962337|BRD-K98733875|BRD-K99455969,baicalin,beta glucuronidase inhibitor,PREP,,,,
IKMDFBPHZNJCSN,BRD-K43149758,myricetin,androgen receptor agonist|cytochrome P450 inhibitor,PIK3CG,BRD-K43149758,myricetin,androgen receptor agonist|cytochrome P450 inhibitor,PIK3CG,BRD-K43149758,myricetin,androgen receptor agonist|cytochrome P450 inhibitor,PIK3CG,BRD-K43149758,myricetin,androgen receptor agonist|cytochrome P450 inhibitor,PIK3CG
IKOCLISPVJZJEA,BRD-A32597168,letosteine,mucolytic agent,,BRD-A32597168,letosteine,mucolytic agent,,BRD-A32597168,letosteine,mucolytic agent,,BRD-A32597168,letosteine,mucolytic agent,
IKQCSJBQLWJEPU,BRD-K71055333,etamsylate,haemostatic agent,,BRD-K71055333,etamsylate,haemostatic agent,,BRD-K71055333,etamsylate,haemostatic agent,,BRD-K71055333,etamsylate,hemostatic agent,
ILAYIAGXTHKHNT,BRD-K12885236,dapivirine,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,BRD-K12885236,dapivirine,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,BRD-K12885236,dapivirine,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,BRD-K12885236,dapivirine,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5
ILKJAFIWWBXGDU,BRD-A36010170,amcinonide,glucocorticoid receptor agonist,ANXA1|NR3C1,BRD-A36010170,amcinonide,glucocorticoid receptor agonist,ANXA1|NR3C1,BRD-A36010170,amcinonide,glucocorticoid receptor agonist,ANXA1|NR3C1,BRD-A36010170,amcinonide,glucocorticoid receptor agonist,NR3C1
ILNRQFBVVQUOLP,BRD-K35629949,SR-27897,CCK receptor antagonist,CCKAR,BRD-K35629949,SR-27897,CCK receptor antagonist,CCKAR,BRD-K35629949,SR-27897,CCK receptor antagonist,CCKAR,BRD-K35629949,SR-27897,CCK receptor antagonist,CCKAR
ILRCGYURZSFMEG,BRD-K66030860,salidroside,beta amyloid protein neurotoxicity inhibitor,APP,BRD-K66030860,salidroside,beta amyloid protein neurotoxicity inhibitor,APP,BRD-K66030860,salidroside,beta amyloid protein neurotoxicity inhibitor,APP,BRD-K66030860,salidroside,beta amyloid protein neurotoxicity inhibitor,APP
ILVYCEVXHALBSC,BRD-A48465967,mivacurium,acetylcholine receptor antagonist,BCHE|CHRM2|CHRM3|CHRNA2,BRD-A48465967,mivacurium,acetylcholine receptor antagonist,BCHE|CHRM2|CHRM3|CHRNA2,BRD-A48465967,mivacurium,acetylcholine receptor antagonist,BCHE|CHRM2|CHRM3|CHRNA2,BRD-A48465967,mivacurium,acetylcholine receptor antagonist,CHRNA2
ILXMXVFOSIVPSY,BRD-A15458132,epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-A15458132,epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,,,,,,,
ILYCWAKSDCYMBB,BRD-A34455052,dihydrotachysterol,vitamin analog,VDR,BRD-A34455052,dihydrotachysterol,vitamin analog,VDR,BRD-A34455052,dihydrotachysterol,vitamin analog,VDR,BRD-A34455052,dihydrotachysterol,vitamin analog,VDR
IMBXEJJVJRTNOW,BRD-A45044890,methylprednisolone-sodium-succinate,glucocorticoid receptor agonist,,BRD-A45044890,methylprednisolone-sodium-succinate,glucocorticoid receptor agonist,,BRD-A45044890,methylprednisolone-sodium-succinate,glucocorticoid receptor agonist,,BRD-K00003673,methylprednisolone-sodium-succinate,glucocorticoid receptor agonist,
IMKJGXCIJJXALX,BRD-K35504063|BRD-K72925150,sclareolide,other antifungal,,BRD-K35504063|BRD-K72925150,sclareolide,other antifungal,,BRD-K35504063|BRD-K72925150,sclareolide,other antifungal,,BRD-K35504063|BRD-K72925150,sclareolide,other antifungal,
IMONTRJLAWHYGT,BRD-A09349126,norethindrone-acetate,progesterone receptor agonist,,BRD-A09349126,norethindrone-acetate,progesterone receptor agonist,,BRD-A09349126,norethindrone-acetate,progesterone receptor agonist,,BRD-K96037667,norethindrone-acetate,progesterone receptor agonist,PGR
IMOZEMNVLZVGJZ,BRD-K93208532,apremilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K93208532,apremilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K93208532,apremilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K93208532,apremilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D
IMQLKJBTEOYOSI,BRD-K70007857,hexasodium-phytate,,,BRD-K70007857,hexasodium-phytate,,,BRD-K70007857,hexasodium-phytate,,,BRD-K70007857,hexasodium-phytate,,
IMSSROKUHAOUJS,BRD-A14798026|BRD-K92042497,mestranol,estrogen receptor agonist,ESR1,BRD-A14798026|BRD-K92042497,mestranol,estrogen receptor agonist,ESR1,BRD-A14798026|BRD-K31920458|BRD-K92042497,mestranol,estrogen receptor agonist,ESR1,BRD-A14798026|BRD-K31920458|BRD-K92042497,mestranol,estrogen receptor agonist,ESR1
IMWZZHHPURKASS,BRD-A94709349,metaxalone,muscle relaxant,,BRD-A94709349,metaxalone,muscle relaxant,,BRD-A94709349,metaxalone,muscle relaxant,,BRD-A94709349,metaxalone,muscle relaxant,
IMXHGCRIEAKIBU,BRD-K77008974,WYE-354,mTOR inhibitor,MTOR,BRD-K77008974,WYE-354,mTOR inhibitor,MTOR,BRD-K77008974,WYE-354,mTOR inhibitor,MTOR,BRD-K77008974,WYE-354,mTOR inhibitor,MTOR
IMYZQPCYWPFTAG,BRD-A20119038,mecamylamine,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7,BRD-A20119038,mecamylamine,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7,BRD-A20119038,mecamylamine,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7,BRD-A20119038,mecamylamine,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4
IMZMKUWMOSJXDT,BRD-K20920669,cromoglicic-acid,immunosuppressant,KCNMA1|S100P,BRD-K20920669,cromoglicic-acid,immunosuppressant,KCNMA1|S100P,BRD-K20920669,cromoglicic-acid,immunosuppressant,KCNMA1|S100P,BRD-K20920669,cromoglicic-acid,immunosuppressant,KCNMA1|S100P
INAAIJLSXJJHOZ,BRD-K17026858,pibenzimol,DNA inhibitor,,BRD-K17026858,pibenzimol,DNA inhibitor,,BRD-K17026858,pibenzimol,DNA inhibitor,,BRD-K17026858,pibenzimol,DNA inhibitor,
INASOKQDNHHMRE,BRD-K54640016,WAY-362450,FXR agonist,NR1H4,BRD-K54640016,WAY-362450,FXR agonist,NR1H4,BRD-K54640016,WAY-362450,FXR agonist,NR1H4,BRD-K54640016,WAY-362450,FXR agonist,NR1H4
INDBQLZJXZLFIT,BRD-A55913614,primaquine,DNA inhibitor|antimalarial agent,KRT7|NQO2,BRD-A55913614,primaquine,DNA inhibitor|antimalarial agent,KRT7|NQO2,BRD-A55913614,primaquine,DNA inhibitor|antimalarial agent,KRT7|NQO2,BRD-K00003556|BRD-K01826750,primaquine|procyclidine,DNA inhibitor|acetylcholine receptor antagonist|antimalarial agent,
INEHJXCWEVNEDZ,BRD-M93148412,lasofoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-M93148412,lasofoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-M93148412,lasofoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-M93148412,lasofoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2
INJOMKTZOLKMBF,BRD-K32830106,guanfacine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K32830106,guanfacine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K32830106,guanfacine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K32830106,guanfacine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C
INVGWHRKADIJHF,BRD-K66898851,sanguinarium-chloride,apoptosis stimulant,CASP3,BRD-K66898851,sanguinarium-chloride,apoptosis stimulant,CASP3,BRD-K66898851,sanguinarium-chloride,apoptosis stimulant,CASP3,BRD-K66898851,sanguinarium-chloride,apoptosis stimulant,CASP3
INVTYAOGFAGBOE,BRD-K77908580,entinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,BRD-K77908580,entinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,BRD-K77908580,entinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,BRD-K77908580,entinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9
INWLQCZOYSRPNW,BRD-A03216249,mepivacaine,potassium channel blocker|sodium channel blocker,SCN10A,BRD-A03216249,mepivacaine,potassium channel blocker|sodium channel blocker,SCN10A,BRD-A03216249,mepivacaine,potassium channel blocker|sodium channel blocker,SCN10A,BRD-A03216249,mepivacaine,potassium channel blocker|sodium channel blocker,
INYYVPJSBIVGPH,BRD-K83459933,sinomenine,angiogenesis inhibitor,,BRD-K83459933,sinomenine,angiogenesis inhibitor,,BRD-K83459933,sinomenine,angiogenesis inhibitor,,BRD-K83459933,sinomenine,angiogenesis inhibitor,
IOJUJUOXKXMJNF,BRD-K08807999,NO-ASA,cyclooxygenase inhibitor,PTGS2,BRD-K08807999,NO-ASA,cyclooxygenase inhibitor,PTGS2,BRD-K08807999,NO-ASA,cyclooxygenase inhibitor,PTGS2,BRD-K08807999,NO-ASA,cyclooxygenase inhibitor,PTGS2
IOMMMLWIABWRKL,BRD-K22514639,EGF816,EGFR inhibitor,EGFR,BRD-K22514639,EGF816,EGFR inhibitor,EGFR,BRD-K22514639,EGF816,EGFR inhibitor,EGFR,BRD-K22514639,EGF816,EGFR inhibitor,EGFR
IOTXSIGGFRQYKW,BRD-K00312224,PPT,estrogen receptor agonist,ESR1,BRD-K00312224,PPT,estrogen receptor agonist,ESR1,BRD-K00312224,PPT,estrogen receptor agonist,ESR1,BRD-K00312224,PPT,estrogen receptor agonist,ESR1
IOUVKUPGCMBWBT,BRD-K24601397,phlorizin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3,BRD-K24601397,phlorizin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3,BRD-K24601397,phlorizin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3,BRD-K73756878,phlorizin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3
IOVGROKTTNBUGK,BRD-A59174698|BRD-K14003026,ritodrine,adrenergic receptor agonist,ADRB2,BRD-A59174698|BRD-K14003026,ritodrine,adrenergic receptor agonist,ADRB2,BRD-A59174698|BRD-K14003026,ritodrine,adrenergic receptor agonist,ADRB2,BRD-K14003026,ritodrine,adrenergic receptor agonist,
IOYZYMQFUSNATM,BRD-K13387373,thonzonium,ATPase inhibitor,,BRD-K13387373,thonzonium,ATPase inhibitor,,BRD-K13387373,thonzonium,ATPase inhibitor,,BRD-K13387373,thonzonium,ATPase inhibitor,
IPBCWPPBAWQYOO,BRD-K47539947,tetradecylthioacetic-acid,lipid peroxidase inhibitor,,BRD-K47539947,tetradecylthioacetic-acid,lipid peroxidase inhibitor,,BRD-K47539947,tetradecylthioacetic-acid,lipid peroxidase inhibitor,,BRD-K47539947,tetradecylthioacetic-acid,lipid peroxidase inhibitor,
IPEHBUMCGVEMRF,BRD-K28667793,pyrazinamide,fatty acid synthase inhibitor,FASN,BRD-K28667793,pyrazinamide,fatty acid synthase inhibitor,FASN,BRD-K28667793,pyrazinamide,fatty acid synthase inhibitor,FASN,BRD-K28667793,pyrazinamide,fatty acid synthase inhibitor,FASN
IPEXHQGMTHOKQV,BRD-K56912469,SAR407899,rho associated kinase inhibitor,ROCK1,BRD-K56912469,SAR407899,rho associated kinase inhibitor,ROCK1,BRD-K56912469,SAR407899,rho associated kinase inhibitor,ROCK1,BRD-K56912469,SAR407899,rho associated kinase inhibitor,ROCK1
IPOKCKJONYRRHP,BRD-K41410256,balsalazide,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,BRD-K41410256,balsalazide,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,BRD-K41410256,balsalazide,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,BRD-K00003656,balsalazide,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2
IPQVTOJGNYVQEO,BRD-A30370660,sennoside-a,glycoside agonist,,BRD-A30370660,sennoside-a,glycoside agonist,,BRD-A30370660,sennoside-a,glycoside agonist,,,,,
IPSSXIMJJXSJQB,BRD-K81405859,JTE-607,cytokine production inhibitor,IL10|IL1B|IL6|TNF,BRD-K81405859,JTE-607,cytokine production inhibitor,IL10|IL1B|IL6|TNF,BRD-K81405859,JTE-607,cytokine production inhibitor,IL10|IL1B|IL6|TNF,BRD-K81405859,JTE-607,cytokine production inhibitor,IL10|IL1B|IL6|TNF
IPSYPUKKXMNCNQ,BRD-K52396582,CF102,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K52396582,CF102,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K52396582,CF102,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K52396582,CF102,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
IPVQLZZIHOAWMC,BRD-A19924402|BRD-K92731339,perindopril,angiotensin converting enzyme inhibitor,ACE,BRD-A47830685|BRD-K92731339,perindopril,angiotensin converting enzyme inhibitor,ACE,BRD-A19924402|BRD-K92731339,perindopril,angiotensin converting enzyme inhibitor,ACE,BRD-A19924402|BRD-K92731339,perindopril,angiotensin converting enzyme inhibitor,ACE
IPWKIXLWTCNBKN,BRD-A42759514,ornidazole,antiprotozoal agent,,BRD-A42759514,ornidazole,antiprotozoal agent,,BRD-A42759514,ornidazole,antiprotozoal agent,,BRD-A42759514,ornidazole,antiprotozoal agent,
IPZFPROOBOUEIG,BRD-K90027121,amprolium,thiamine uptake blocker,,BRD-K90027121,amprolium,thiamine uptake blocker,,BRD-K90027121,amprolium,thiamine uptake blocker,,BRD-K90027121,amprolium,thiamine uptake blocker,
IPZHFKHGSYRBNT,BRD-K68474505,CCG-63808,G protein signaling inhibitor,RGS4,BRD-K68474505,CCG-63808,G protein signaling inhibitor,RGS4,BRD-K68474505,CCG-63808,G protein signaling inhibitor,RGS4,BRD-K68474505,CCG-63808,G protein signaling inhibitor,RGS4
IQADUMSPOQKAAO,BRD-K17977438,oxelaidin,antitussive,,BRD-K17977438,oxelaidin,antitussive,,BRD-K17977438|BRD-M29157795,oxelaidin,antitussive,,BRD-K17977438|BRD-M29157795,oxelaidin,antitussive,
IQCKJUKAQJINMK,BRD-K69577666,SGC-0946,histone lysine methyltransferase inhibitor,,BRD-K69577666,SGC-0946,histone lysine methyltransferase inhibitor,,BRD-K69577666,SGC-0946,histone lysine methyltransferase inhibitor,,BRD-K69577666,SGC-0946,histone lysine methyltransferase inhibitor,
IQFYYKKMVGJFEH,BRD-K15976406,telbivudine,DNA polymerase inhibitor,TK2,BRD-K15976406,telbivudine,DNA polymerase inhibitor,TK2,BRD-K15976406,telbivudine,DNA polymerase inhibitor,TK2,BRD-K15976406,telbivudine,DNA polymerase inhibitor,
IQHYCZKIFIHTAI,BRD-K43055376,ADD-233089,benzodiazepine receptor agonist,,BRD-K43055376,ADD-233089,benzodiazepine receptor agonist,,BRD-K43055376,ADD-233089,benzodiazepine receptor agonist,,,,,
IQLZWWDXNXZGPK,BRD-K70840370,MDMS,DNA inhibitor,,BRD-K70840370,MDMS,DNA inhibitor,,BRD-K70840370,MDMS,DNA inhibitor,,BRD-K70840370,MDMS,DNA inhibitor,
IQNVEOMHJHBNHC,BRD-K81958169,AZ5104,EGFR inhibitor,EGFR,BRD-K81958169,AZ5104,EGFR inhibitor,EGFR,BRD-K81958169,AZ5104,EGFR inhibitor,EGFR,BRD-K81958169,AZ5104,EGFR inhibitor,EGFR
IQOMYCGTGFGDFN,BRD-K99506538,xenalipin,,,BRD-K99506538,xenalipin,,,BRD-K99506538,xenalipin,,,BRD-K99506538,xenalipin,,
IQPNAANSBPBGFQ,BRD-K05236810,luteolin,glucosidase inhibitor,TOP1,BRD-K05236810,luteolin,glucosidase inhibitor,TOP1,BRD-K05236810,luteolin,glucosidase inhibitor,TOP1,BRD-K05236810,luteolin,glucosidase inhibitor,TOP1
IQPSEEYGBUAQFF,BRD-A22380646,pantoprazole,ATPase inhibitor,ATP4A,BRD-A22380646,pantoprazole,ATPase inhibitor,ATP4A,BRD-A22380646|BRD-A75848474,pantoprazole,ATPase inhibitor,ATP4A,BRD-K00003243,pantoprazole,ATPase inhibitor,ATP4A
IQVQXVFMNOFTMU,BRD-K48875051,ligustilide,tumor necrosis factor production inhibitor,TNF,BRD-K48875051,ligustilide,tumor necrosis factor production inhibitor,TNF,BRD-K48875051,ligustilide,tumor necrosis factor production inhibitor,TNF,BRD-K48875051,ligustilide,tumor necrosis factor production inhibitor,TNF
IQVRBWUUXZMOPW,BRD-K87774949,istradefylline,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K87774949,istradefylline,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K87774949,istradefylline,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K87774949,istradefylline,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
IRJCBFDCFXCWGO,BRD-A04628621,ibotenic-acid,glutamate receptor agonist,GRIN1,BRD-A04628621,ibotenic-acid,glutamate receptor agonist,GRIN1,BRD-A04628621,ibotenic-acid,glutamate receptor agonist,GRIN1,BRD-A02971356,ibotenic-acid,glutamate receptor agonist,GRIN1
IRMTXMJNHRISQH,BRD-K69191882,guanidinoethyldisulfide-bicarbonate,nitric oxide synthase inhibitor,NOS2,BRD-K69191882,guanidinoethyldisulfide-bicarbonate,nitric oxide synthase inhibitor,NOS2,BRD-K69191882,guanidinoethyldisulfide-bicarbonate,nitric oxide synthase inhibitor,NOS2,BRD-K69191882,guanidinoethyldisulfide-bicarbonate,nitric oxide synthase inhibitor,NOS2
IRSCQMHQWWYFCW,BRD-K22662435,ganciclovir,DNA polymerase inhibitor,,BRD-K22662435,ganciclovir,DNA polymerase inhibitor,,BRD-K22662435,ganciclovir,DNA polymerase inhibitor,,BRD-K22662435,ganciclovir,DNA polymerase inhibitor,
IRTDIKMSKMREGO,BRD-K58772419,AZD6482,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K58772419,AZD6482,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K58772419,AZD6482,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K58772419,AZD6482,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
IRYJRGCIQBGHIV,BRD-K16606819,trimethadione,oxazolidine antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-K16606819,trimethadione,oxazolidine antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-K16606819,trimethadione,oxazolidine antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-K16606819,trimethadione,oxazolidine antiepileptic,CACNA1G|CACNA1H|CACNA1I
ISAKRJDGNUQOIC,BRD-K80129304,uracil,,DPYD|UCKL1,BRD-K80129304,uracil,,DPYD|UCKL1,BRD-K80129304,uracil,,DPYD|UCKL1,BRD-K80129304,uracil,,DPYD|UCKL1
ISAOCJYIOMOJEB,BRD-A55748233,benzoin,,CES1,BRD-A55748233,benzoin,,CES1,BRD-A55748233,benzoin,,CES1,BRD-A55748233,benzoin,,CES1
ISEYJGQFXSTPMQ,BRD-A74387232,PMPA,glutamate receptor antagonist,FOLH1,BRD-A74387232,PMPA,glutamate receptor antagonist,FOLH1,BRD-A74387232,PMPA,glutamate receptor antagonist,FOLH1,BRD-A74387232,PMPA,glutamate receptor antagonist,FOLH1
ISFHAYSTHMVOJR,BRD-A33178345,phenindamine,histamine receptor antagonist,HRH1,BRD-A33178345,phenindamine,histamine receptor antagonist,HRH1,BRD-A33178345,phenindamine,histamine receptor antagonist,HRH1,BRD-A33178345,phenindamine,histamine receptor antagonist,HRH1
ISFPDBUKMJDAJH,BRD-K27710560,splitomycin,SIRT inhibitor,SIRT1,BRD-K27710560,splitomycin,SIRT inhibitor,SIRT1,BRD-K27710560,splitomycin,SIRT inhibitor,SIRT1,BRD-K27710560,splitomycin,SIRT inhibitor,SIRT1
ISHXLNHNDMZNMC,BRD-K42504537,norelgestromin,,PGR,BRD-K42504537,norelgestromin,,PGR,BRD-K42504537,norelgestromin,,PGR,BRD-K42504537,norelgestromin,,PGR
ISIVOJWVBJIOFM,BRD-K42325600,AR-C155858,monocarboxylate transporter inhibitor,SLC16A1|SLC16A7,BRD-K42325600,AR-C155858,monocarboxylate transporter inhibitor,SLC16A1|SLC16A7,BRD-K42325600,AR-C155858,monocarboxylate transporter inhibitor,SLC16A1|SLC16A7,BRD-K42325600,AR-C155858,monocarboxylate transporter inhibitor,SLC16A1|SLC16A7
ISOCDPQFIXDIMS,BRD-K04266228,XL019,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K04266228,XL019,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K04266228,XL019,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K04266228,XL019,JAK inhibitor,JAK1|JAK2|JAK3
ISPBCAXOSOLFME,BRD-K44715996,LDC1267,protein tyrosine kinase inhibitor,AXL|MERTK|TYRO3,BRD-K44715996,LDC1267,protein tyrosine kinase inhibitor,AXL|MERTK|TYRO3,BRD-K44715996,LDC1267,protein tyrosine kinase inhibitor,AXL|MERTK|TYRO3,BRD-K44715996,LDC1267,protein tyrosine kinase inhibitor,AXL|MERTK|TYRO3
ISRUGXGCCGIOQO,BRD-K08231299,propoxur,,,BRD-K08231299,propoxur,,,BRD-K08231299,propoxur,,,BRD-K08231299,propoxur,,
ISSSVYKMIIAPTH,BRD-A40413915,NTNCB,neuropeptide receptor antagonist,NPY5R,BRD-A40413915,NTNCB,neuropeptide receptor antagonist,NPY5R,BRD-A40413915,NTNCB,neuropeptide receptor antagonist,NPY5R,BRD-A40413915,NTNCB,neuropeptide receptor antagonist,NPY5R
ISWRGOKTTBVCFA,BRD-K96862998,pirfenidone,TGF beta receptor inhibitor,FURIN|TNF,BRD-K96862998,pirfenidone,TGF beta receptor inhibitor,FURIN|TNF,BRD-K96862998,pirfenidone,TGF beta receptor inhibitor,FURIN|TNF,BRD-K96862998,pirfenidone,TGF beta receptor inhibitor,FURIN|TNF
ISWSIDIOOBJBQZ,BRD-K76549667,phenol,,CA1|CA12|CA14|CA2|CA4|CA9,BRD-K76549667,phenol,,CA1|CA12|CA14|CA2|CA4|CA9,BRD-K76549667,phenol,,CA1|CA12|CA14|CA2|CA4|CA9,BRD-K76549667,phenol,,CA1|CA12|CA14|CA2|CA4|CA9
ISYOIFGRKUYTGX,BRD-M58433298,sodium-dodecyl-sulfate,,ALB|LYZ,BRD-M58433298,sodium-dodecyl-sulfate,,ALB|LYZ,BRD-M58433298,sodium-dodecyl-sulfate,,ALB|LYZ,BRD-M58433298,sodium-dodecyl-sulfate,,ALB
ISZNZKHCRKXXAU,BRD-K25494650,chlorproguanil,dihydrofolate reductase inhibitor,DHFR,BRD-K25494650,chlorproguanil,dihydrofolate reductase inhibitor,DHFR,BRD-K25494650,chlorproguanil,dihydrofolate reductase inhibitor,DHFR,BRD-K25494650,chlorproguanil,dihydrofolate reductase inhibitor,DHFR
ITBGJNVZJBVPLJ,BRD-K61871885,WAY-316606,secreted frizzled related protein inhibitor,SFRP1,BRD-K61871885,WAY-316606,secreted frizzled related protein inhibitor,SFRP1,BRD-K61871885,WAY-316606,secreted frizzled related protein inhibitor,SFRP1,BRD-K61871885,WAY-316606,secreted frizzled related protein inhibitor,SFRP1
ITIXDWVDFFXNEG,BRD-K43927145,BIBN4096,calcitonin antagonist,CALCA|CALCRL|RAMP1,BRD-K43927145,BIBN4096,calcitonin antagonist,CALCA|CALCRL|RAMP1,BRD-K43927145,BIBN4096,calcitonin antagonist,CALCA|CALCRL|RAMP1,BRD-K43927145,BIBN4096,calcitonin antagonist,CALCA|CALCRL|RAMP1
ITJNARMNRKSWTA,BRD-A95696066,nisoxetine,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A95696066,nisoxetine,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A95696066,nisoxetine,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-K01825513,nisoxetine,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4
ITMLWGWTDWJSRZ,BRD-K81865756,Y16,rho associated kinase inhibitor,RHOA,BRD-K81865756,Y16,rho associated kinase inhibitor,RHOA,BRD-K81865756,Y16,rho associated kinase inhibitor,RHOA,BRD-K81865756,Y16,rho associated kinase inhibitor,RHOA
ITNKVODZACVXDS,BRD-K61937613,doconexent-ethyl-ester,omega 3 fatty acid stimulant,,BRD-K61937613,doconexent-ethyl-ester,omega 3 fatty acid stimulant,,BRD-K61937613,doconexent-ethyl-ester,omega 3 fatty acid stimulant,,BRD-K61937613,doconexent-ethyl-ester,omega 3 fatty acid stimulant,
ITNLONMDUMHEOK,BRD-A71765060,picartamide,H+/K+-ATPase inhibitor,ATP4A,BRD-A71765060,picartamide,H+/K+-ATPase inhibitor,ATP4A,BRD-A71765060,picartamide,H+/K+-ATPase inhibitor,ATP4A,BRD-A71765060,picartamide,H+/K+-ATPase inhibitor,ATP4A
ITRJWOMZKQRYTA,BRD-A54487287|BRD-K83872210|BRD-K86161929,cortisone-acetate,glucocorticoid receptor agonist,NR3C1,BRD-A54487287|BRD-K86161929,cortisone-acetate,glucocorticoid receptor agonist,NR3C1,BRD-A54487287|BRD-K83872210|BRD-K86161929,cortisone-acetate,glucocorticoid receptor agonist,NR3C1,BRD-A54487287|BRD-K83872210|BRD-K86161929,cortisone-acetate,glucocorticoid receptor agonist,NR3C1
ITTRLTNMFYIYPA,BRD-K72420232,WZ-4002,EGFR inhibitor,EGFR|ERBB2,BRD-K72420232,WZ-4002,EGFR inhibitor,EGFR|ERBB2,BRD-K72420232,WZ-4002,EGFR inhibitor,EGFR|ERBB2,BRD-K72420232,WZ-4002,EGFR inhibitor,EGFR|ERBB2
ITVGXXMINPYUHD,BRD-K33395461,neohesperidin-dihydrochalcone,,,BRD-K61032563,neohesperidin-dihydrochalcone,,,BRD-K33395461|BRD-K61032563,neohesperidin-dihydrochalcone,,,BRD-K33395461|BRD-K61032563,neohesperidin-dihydrochalcone,,
IUBSYMUCCVWXPE,BRD-A03623303,metoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A03623303|BRD-M45038741,metoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A03623303|BRD-M45038741,metoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-K01826568|BRD-M45038741,metoprolol,adrenergic receptor antagonist,ADRB1|ADRB2
IUJDSEJGGMCXSG,BRD-A72603112,thiopental,GABA receptor antagonist,CHRNA4|CHRNA7|FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2,BRD-A72603112,thiopental,GABA receptor antagonist,CHRNA4|CHRNA7|FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2,BRD-A72603112,thiopental,GABA receptor antagonist,CHRNA4|CHRNA7|FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GRIA2|GRIK2,BRD-A72603112,thiopental,GABA receptor antagonist,FAAH
IULOBWFWYDMECP,BRD-K26813177,daltroban,thromboxane receptor antagonist,TBXA2R,BRD-K26813177,daltroban,thromboxane receptor antagonist,TBXA2R,BRD-K26813177,daltroban,thromboxane receptor antagonist,TBXA2R,BRD-K26813177,daltroban,thromboxane receptor antagonist,TBXA2R
IUMQXQJZIHWLIN,BRD-K61097567,SB-218795,tachykinin antagonist,TACR3,BRD-K61097567,SB-218795,tachykinin antagonist,TACR3,BRD-K61097567,SB-218795,tachykinin antagonist,TACR3,BRD-K61097567,SB-218795,tachykinin antagonist,TACR3
IUPCWCLVECYZRV,BRD-A38799180,rosamicin,protein synthesis inhibitor,,BRD-A38799180,rosamicin,protein synthesis inhibitor,,BRD-A38799180,rosamicin,protein synthesis inhibitor,,BRD-K00004538,rosamicin,protein synthesis inhibitor,
IUVCFHHAEHNCFT,BRD-K52579889,TGR-1202,PI3K inhibitor,,BRD-K52579889,TGR-1202,PI3K inhibitor,,BRD-K52579889,TGR-1202,PI3K inhibitor,,BRD-K52579889,TGR-1202,PI3K inhibitor,
IUVSEUFHPNITEQ,BRD-K34870043,adoprazine,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,BRD-K34870043,adoprazine,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,BRD-K34870043,adoprazine,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,BRD-K34870043,adoprazine,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A
IUWKNLFTJBHTSD,BRD-K75097983,promestriene,estrogen receptor agonist,ESR1,BRD-K75097983,promestriene,estrogen receptor agonist,ESR1,BRD-K75097983,promestriene,estrogen receptor agonist,ESR1,BRD-K75097983,promestriene,estrogen receptor agonist,ESR1
IUWVALYLNVXWKX,BRD-K27217864,butamben,sodium channel blocker,,BRD-K27217864,butamben,sodium channel blocker,,BRD-K27217864,butamben,sodium channel blocker,,BRD-K27217864,butamben,sodium channel blocker,
IVBHGBMCVLDMKU,BRD-A99949740|BRD-K67009182|BRD-K86873305,piperacillin,bacterial cell wall synthesis inhibitor,,BRD-A99949740|BRD-K67009182|BRD-K86873305,piperacillin,bacterial cell wall synthesis inhibitor,,BRD-A99949740|BRD-K67009182|BRD-K86873305,piperacillin,bacterial cell wall synthesis inhibitor,,BRD-K67009182|BRD-K86873305,piperacillin,bacterial cell wall synthesis inhibitor,
IVCMOOBKRRDNHX,BRD-K26160755,RS-45041-190,imidazoline receptor agonist,,BRD-K26160755,RS-45041-190,imidazoline receptor agonist,,BRD-K26160755,RS-45041-190,imidazoline receptor agonist,,BRD-K26160755,RS-45041-190,imidazoline receptor agonist,
IVDUVEGCMXCMSO,BRD-K17472821,GSK2830371,protein phosphatase inhibitor,PPM1D,BRD-K17472821,GSK2830371,protein phosphatase inhibitor,PPM1D,BRD-K17472821,GSK2830371,protein phosphatase inhibitor,PPM1D,BRD-K17472821,GSK2830371,protein phosphatase inhibitor,PPM1D
IVOMOUWHDPKRLL,BRD-A41840684,cyclic-AMP,,CNGA3|HCN2|PRKAR1A|PRKAR2B|TRPM7,BRD-A41840684,cyclic-AMP,,CNGA3|HCN2|PRKAR1A|PRKAR2B|TRPM7,BRD-A41840684,cyclic-AMP,,CNGA3|HCN2|PRKAR1A|PRKAR2B|TRPM7,BRD-A41840684,cyclic-AMP,,CNGA3|TRPM7
IVRXNBXKWIJUQB,BRD-K78118466,LY2157299,TGF beta receptor inhibitor,TGFBR1,BRD-K78118466,LY2157299,TGF beta receptor inhibitor,TGFBR1,BRD-K78118466,LY2157299,TGF beta receptor inhibitor,TGFBR1,BRD-K78118466,LY2157299,TGF beta receptor inhibitor,TGFBR1
IVTVGDXNLFLDRM,BRD-K89839824,raltitrexed,thymidylate synthase inhibitor,FPGS|TYMS,BRD-K89839824,raltitrexed,thymidylate synthase inhibitor,FPGS|TYMS,BRD-K89839824,raltitrexed,thymidylate synthase inhibitor,FPGS|TYMS,BRD-K08151102,raltitrexed,thymidylate synthase inhibitor,FPGS|TYMS
IVUGFMLRJOCGAS,BRD-K21728777,AMG900,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K21728777,AMG900,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K21728777,AMG900,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K21728777,AMG900,Aurora kinase inhibitor,AURKA|AURKB|AURKC
IVVNZDGDKPTYHK,BRD-A43882281,pinacidil,ATP channel activator|potassium channel activator,ABCC8|ABCC9,BRD-A43882281,pinacidil,ATP channel activator|potassium channel activator,ABCC8|ABCC9,BRD-A43882281,pinacidil,ATP channel activator|potassium channel activator,ABCC8|ABCC9,BRD-A43882281,pinacidil,ATP channel activator|potassium channel activator,ABCC8|ABCC9
IVYPNXXAYMYVSP,BRD-K01815685,indole-3-carbinol,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,BRD-K01815685,indole-3-carbinol,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,BRD-K01815685,indole-3-carbinol,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,BRD-K01815685,indole-3-carbinol,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR
IVZKZONQVYTCKC,BRD-K25204779,pritelivir,helicase primase inhibitor,,BRD-K25204779,pritelivir,helicase primase inhibitor,,BRD-K25204779,pritelivir,helicase primase inhibitor,,BRD-K25204779,pritelivir,helicase primase inhibitor,
IWCWQNVIUXZOMJ,BRD-K03353589,ecabet,gastrin inhibitor|urease inhibitor,NOXO1,BRD-K03353589,ecabet,gastrin inhibitor|urease inhibitor,NOXO1,BRD-K03353589,ecabet,gastrin inhibitor|urease inhibitor,NOXO1,BRD-K03353589,ecabet,gastrin inhibitor|urease inhibitor,NOXO1
IWDCLRJOBJJRNH,BRD-K56940914,cresol,,,BRD-K56940914,cresol,,,BRD-K56940914,cresol,,,BRD-K56940914,cresol,,
IWDUZEHNLHFBRZ,BRD-K98557884,suritozole,GABA receptor inverse agonist,GABBR1,BRD-K98557884,suritozole,GABA receptor inverse agonist,GABBR1,BRD-K98557884,suritozole,GABA receptor inverse agonist,GABBR1,BRD-K98557884,suritozole,GABA receptor inverse agonist,GABBR1
IWKXDMQDITUYRK,BRD-K16505263,forodesine,purinergic receptor antagonist,PNP,BRD-K16505263,forodesine,purinergic receptor antagonist,PNP,BRD-K16505263,forodesine,purinergic receptor antagonist,PNP,BRD-K16505263,forodesine,purinergic receptor antagonist,PNP
IWMCPJZTADUIFX,BRD-K01436366,LRRK2-IN-1,leucine rich repeat kinase inhibitor,LRRK2,BRD-K01436366,LRRK2-IN-1,leucine rich repeat kinase inhibitor,LRRK2,BRD-K01436366,LRRK2-IN-1,leucine rich repeat kinase inhibitor,LRRK2,BRD-K01436366,LRRK2-IN-1,leucine rich repeat kinase inhibitor,LRRK2
IWTCFIIOUXJOOV,BRD-K45117373,Y-26763,potassium channel activator,KCNJ8,BRD-K45117373,Y-26763,potassium channel activator,KCNJ8,BRD-K45117373,Y-26763,potassium channel activator,KCNJ8,BRD-K45117373,Y-26763,potassium channel activator,KCNJ8
IWUCXVSUMQZMFG,BRD-K60369935|BRD-K94397152,ribavirin,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,BRD-K60369935|BRD-K94397152,ribavirin,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,BRD-K60369935|BRD-K94397152,ribavirin,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,BRD-K60369935|BRD-K94397152,ribavirin,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2
IWVRVEIKCBFZNF,BRD-A54490543,pirlindole,monoamine oxidase inhibitor,MAOA,BRD-A54490543,pirlindole,monoamine oxidase inhibitor,MAOA,BRD-A54490543,pirlindole,monoamine oxidase inhibitor,MAOA,BRD-K01826702,pirlindole,monoamine oxidase inhibitor,MAOA
IWXNYAIICFKCTM,BRD-K21670884,cariporide,sodium/hydrogen exchanger inhibitor,SLC9A1,BRD-K21670884,cariporide,sodium/hydrogen exchanger inhibitor,SLC9A1,BRD-K21670884,cariporide,sodium/hydrogen exchanger inhibitor,SLC9A1,BRD-K21670884,cariporide,sodium/hydrogen exchanger inhibitor,SLC9A1
IWXUVYOOUMLUTQ,BRD-K50031829,PF-04447943,phosphodiesterase inhibitor,PDE9A,BRD-K50031829,PF-04447943,phosphodiesterase inhibitor,PDE9A,BRD-K50031829,PF-04447943,phosphodiesterase inhibitor,PDE9A,BRD-K50031829,PF-04447943,phosphodiesterase inhibitor,PDE9A
IWYDHOAUDWTVEP,BRD-A91448670,mandelic-acid,,,BRD-A91448670,mandelic-acid,,,BRD-A91448670,mandelic-acid,,,BRD-A91448670,mandelic-acid,,
IWYJYHUNXVAVAA,BRD-A88369366,trelagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A88369366,trelagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A88369366,trelagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K36407194,trelagliptin,dipeptidyl peptidase inhibitor,DPP4
IWYZMMIPAJDJBN,BRD-K13829090,IEM1460,glutamate receptor antagonist,GRIA2,BRD-K13829090,IEM1460,glutamate receptor antagonist,GRIA2,BRD-K13829090,IEM1460,glutamate receptor antagonist,GRIA2,BRD-K13829090,IEM1460,glutamate receptor antagonist,GRIA2
IXHBTMCLRNMKHZ,BRD-A46876182|BRD-K31812033|BRD-K73323637,levobunolol|levobunolol-(+)|levobunolol-(+/-),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3,BRD-A46876182|BRD-K31812033|BRD-K73323637,levobunolol|levobunolol-(+)|levobunolol-(+/-),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3,BRD-A46876182|BRD-K31812033|BRD-K73323637,levobunolol|levobunolol-(+)|levobunolol-(+/-),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3,BRD-A46876182|BRD-K31812033|BRD-K73323637,levobunolol|levobunolol-(+)|levobunolol-(+/-),adrenergic receptor antagonist,|ADRB1|ADRB2|ADRB3
IXHCGJXBIHHIEF,BRD-K72687424,VU0364439,glutamate receptor positive allosteric modulator,GRM4,BRD-K72687424,VU0364439,glutamate receptor positive allosteric modulator,GRM4,BRD-K72687424,VU0364439,glutamate receptor positive allosteric modulator,GRM4,BRD-K72687424,VU0364439,glutamate receptor positive allosteric modulator,GRM4
IXORZMNAPKEEDV,BRD-K92758126,MD-920,NFkB pathway inhibitor,AADACL2,BRD-K92758126,MD-920,NFkB pathway inhibitor,AADACL2,BRD-K92758126,MD-920,NFkB pathway inhibitor,AADACL2,BRD-K92758126,MD-920,NFkB pathway inhibitor,AADACL2
IXOXBSCIXZEQEQ,BRD-K84466663,nelarabine,DNA synthesis inhibitor|T cell inhibitor,POLA1,BRD-K84466663,nelarabine,DNA synthesis inhibitor|T cell inhibitor,POLA1,BRD-K84466663,nelarabine,DNA synthesis inhibitor|T cell inhibitor,POLA1,BRD-K84466663,nelarabine,DNA synthesis inhibitor|T cell inhibitor,POLA1
IXTMWRCNAAVVAI,BRD-K86887724,dofetilide,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,BRD-K86887724,dofetilide,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,BRD-K86887724,dofetilide,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,BRD-K86887724,dofetilide,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2
IXWDUZLHWJKVPX,BRD-K18030938,chlorisondamine-diiodide,acetylcholine receptor antagonist,CHRNA1,BRD-K18030938,chlorisondamine-diiodide,acetylcholine receptor antagonist,CHRNA1,BRD-K18030938,chlorisondamine-diiodide,acetylcholine receptor antagonist,CHRNA1,BRD-K18030938,chlorisondamine-diiodide,acetylcholine receptor antagonist,CHRNA1
IXXFZUPTQVDPPK,BRD-K32256160,solithromycin,protein synthesis inhibitor,,BRD-K32256160,solithromycin,protein synthesis inhibitor,,BRD-K32256160,solithromycin,protein synthesis inhibitor,,BRD-K32256160,solithromycin,protein synthesis inhibitor,
IYCHDNQCHLMLJZ,BRD-K28030264,N-hydroxynicotinamide,,,BRD-K28030264,N-hydroxynicotinamide,,,BRD-K28030264,N-hydroxynicotinamide,,,BRD-K28030264,N-hydroxynicotinamide,,
IYGYMKDQCDOMRE,BRD-A07870296,bicuculline-(+),GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1,BRD-A07870296,bicuculline-(+),GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1,BRD-A07870296,bicuculline-(+),GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1,BRD-K84363966,bicuculline-(+),GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1
IYIKLHRQXLHMJQ,BRD-K17561142,amiodarone,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,BRD-K17561142,amiodarone,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,BRD-K17561142,amiodarone,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,BRD-K17561142,amiodarone,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2
IYOZTVGMEWJPKR,BRD-K44084986,Y-27632,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2,BRD-K44084986,Y-27632,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2,BRD-K44084986,Y-27632,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2,BRD-K44084986,Y-27632,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2
IYRMWMYZSQPJKC,BRD-K12807006,kaempferol,bone resorption inhibitor|estrogen-related receptor inverse agonist,AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1,BRD-K12807006,kaempferol,bone resorption inhibitor|estrogen-related receptor inverse agonist,AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1,BRD-K12807006,kaempferol,bone resorption inhibitor|estrogen-related receptor inverse agonist,AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1,BRD-K12807006,kaempferol,bone resorption inhibitor|estrogen-related receptor inverse agonist,AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1
IYUHJBHUQSINCX,BRD-K63171558,auranofin,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,,,,,,,,,,,,
IYVFNTXFRYQLRP,BRD-A74160776|BRD-K03928833|BRD-K73529671,troxerutin,antioxidant,,BRD-A74160776|BRD-K73529671,troxerutin,antioxidant,,BRD-A74160776|BRD-K03928833|BRD-K73529671,troxerutin,antioxidant,,BRD-A74160776|BRD-K03928833|BRD-K73529671,troxerutin,antioxidant,
IYYZUPMFVPLQIF,BRD-K46863940,dibenzothiophene,,,BRD-K46863940,dibenzothiophene,,,BRD-K46863940,dibenzothiophene,,,BRD-K46863940,dibenzothiophene,,
IZAOBRWCUGOKNH,BRD-K02950022,BMS-299897,gamma secretase inhibitor,,BRD-K02950022,BMS-299897,gamma secretase inhibitor,,BRD-K02950022,BMS-299897,gamma secretase inhibitor,,BRD-K02950022,BMS-299897,gamma secretase inhibitor,
IZEKFCXSFNUWAM,BRD-K86301799,dipyridamole,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,BRD-K86301799,dipyridamole,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,BRD-K86301799,dipyridamole,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,BRD-K86301799,dipyridamole,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1
IZJDOKYDEWTZSO,BRD-K56700933,phenethyl-isothiocyanate,anticancer agent,CYP2E1,BRD-K56700933,phenethyl-isothiocyanate,anticancer agent,CYP2E1,BRD-K56700933,phenethyl-isothiocyanate,anticancer agent,CYP2E1,BRD-K56700933,phenethyl-isothiocyanate,anticancer agent,CYP2E1
IZLRMTJLQCLMKF,BRD-A65248799,EMD-53998,phosphodiesterase inhibitor,TNNC1,BRD-A65248799,EMD-53998,phosphodiesterase inhibitor,TNNC1,BRD-A65248799,EMD-53998,phosphodiesterase inhibitor,TNNC1,BRD-A65248799,EMD-53998,phosphodiesterase inhibitor,TNNC1
IZOOGPBRAOKZFK,BRD-K25106841,gadopentetic-acid,contrast agent,,BRD-K25106841,gadopentetic-acid,contrast agent,,BRD-K25106841|BRD-M44547596,gadopentetic-acid,contrast agent,,BRD-K25106841|BRD-M44547596,gadopentetic-acid,contrast agent,PGD
JABSKGQQWUDVRU,BRD-K18678457,ZD-7288,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,BRD-K18678457,ZD-7288,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,BRD-K18678457,ZD-7288,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,BRD-K18678457,ZD-7288,HCN channel blocker,HCN1|HCN2|HCN3|HCN4
JACAAXNEHGBPOQ,BRD-K80359953,talampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K80359953,talampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K80359953,talampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K80359953,talampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4
JADDQZYHOWSFJD,BRD-K14395568,NECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HSP90B1,BRD-K14395568,NECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HSP90B1,BRD-K14395568,NECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HSP90B1,BRD-K14395568,NECA,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
JAJLKEVKNDUJBG,BRD-K16758059,perfluamine,,,BRD-K16758059,perfluamine,,,BRD-K16758059,perfluamine,,,BRD-K16758059,perfluamine,,
JAKAFSGZUXCHLF,BRD-K39558284,SDZ-WAG-994,adenosine receptor agonist,ADORA1,BRD-K39558284,SDZ-WAG-994,adenosine receptor agonist,ADORA1,BRD-K39558284,SDZ-WAG-994,adenosine receptor agonist,ADORA1,BRD-K39558284,SDZ-WAG-994,adenosine receptor agonist,ADORA1
JAMULYFATHSZJM,BRD-K00337317,NU-7441,DNA dependent protein kinase inhibitor,PRKDC,BRD-K00337317,NU-7441,DNA dependent protein kinase inhibitor,PRKDC,BRD-K00337317,NU-7441,DNA dependent protein kinase inhibitor,PRKDC,BRD-K00337317,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
JAONZGLTYYUPCT,BRD-K65978409,bismuth-subgallate,nitric oxide synthase inhibitor,NOS1,BRD-K65978409,bismuth-subgallate,nitric oxide synthase inhibitor,NOS1,BRD-K65978409,bismuth-subgallate,nitric oxide synthase inhibitor,NOS1,BRD-K65978409,bismuth-subgallate,nitric oxide synthase inhibitor,NOS1
JAPHQRWPEGVNBT,BRD-A04915500|BRD-K28935038,loracarbef,bacterial cell wall synthesis inhibitor,,BRD-A04915500|BRD-K28935038,loracarbef,bacterial cell wall synthesis inhibitor,,BRD-A04915500|BRD-K28935038,loracarbef,bacterial cell wall synthesis inhibitor,,BRD-K28935038,loracarbef,bacterial cell wall synthesis inhibitor,
JARCFMKMOFFIGZ,BRD-K45152786,merbarone,topoisomerase inhibitor,TOP2A,BRD-K45152786,merbarone,topoisomerase inhibitor,TOP2A,BRD-K45152786,merbarone,topoisomerase inhibitor,TOP2A,,,,
JARNORYOPMINDY,BRD-K50891186,GR-103691,dopamine receptor antagonist,DRD3,BRD-K50891186,GR-103691,dopamine receptor antagonist,DRD3,BRD-K50891186,GR-103691,dopamine receptor antagonist,DRD3,BRD-K50891186,GR-103691,dopamine receptor antagonist,DRD3
JAUOIFJMECXRGI,BRD-K82357231,desloratadine,histamine receptor antagonist,HRH1,BRD-K82357231,desloratadine,histamine receptor antagonist,HRH1,BRD-K82357231,desloratadine,histamine receptor antagonist,HRH1,BRD-K82357231,desloratadine,histamine receptor antagonist,HRH1
JAYAGJDXJIDEKI,BRD-A64242993,lanatoside-c,cardiac glycoside,,BRD-A64242993,lanatoside-c,cardiac glycoside,,BRD-A64242993,lanatoside-c,cardiac glycoside,,BRD-A64242993,lanatoside-C,cardiac glycoside,
JAZBEHYOTPTENJ,BRD-K47192521,icosapent,platelet aggregation inhibitor,ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1,BRD-K47192521,icosapent,platelet aggregation inhibitor,ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1,BRD-K47192521,icosapent,platelet aggregation inhibitor,ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1,BRD-K47192521,icosapent,platelet aggregation inhibitor,ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1
JBDGDEWWOUBZPM,BRD-K11223672|BRD-K56558538,ambroxol,sodium channel blocker,CYP3A4,BRD-K11223672|BRD-K56558538,ambroxol,sodium channel blocker,CYP3A4,BRD-K11223672|BRD-K56558538,ambroxol,sodium channel blocker,CYP3A4,BRD-K11223672|BRD-K56558538,ambroxol,sodium channel blocker,CYP3A4
JBHLYIVFFLNISJ,BRD-K46142322,RS-67333,serotonin receptor partial agonist,HTR4,BRD-K46142322,RS-67333,serotonin receptor partial agonist,HTR4,BRD-K46142322,RS-67333,serotonin receptor partial agonist,HTR4,BRD-K46142322,RS-67333,serotonin receptor partial agonist,HTR4
JBIMVDZLSHOPLA,BRD-K06625472,olopatadine,histamine receptor antagonist,HRH1|S100A1|S100A12|S100A13|S100A2|S100B,BRD-K06625472|BRD-K67637637,olopatadine,histamine receptor antagonist,HRH1|S100A1|S100A12|S100A13|S100A2|S100B,BRD-K06625472|BRD-K67637637,olopatadine,histamine receptor antagonist,HRH1|S100A1|S100A12|S100A13|S100A2|S100B,BRD-K06625472|BRD-K67637637,olopatadine,histamine receptor antagonist,HRH1|S100A1|S100A12|S100A13|S100A2|S100B
JBJYTZXCZDNOJW,BRD-K09638361,IC261,casein kinase inhibitor,CSNK1A1|CSNK1D|CSNK1E|CSNK1G2,BRD-K09638361,IC261,casein kinase inhibitor,CSNK1A1|CSNK1D|CSNK1E|CSNK1G2,BRD-K09638361,IC261,casein kinase inhibitor,CSNK1A1|CSNK1D|CSNK1E|CSNK1G2,BRD-K09638361,IC261,casein kinase inhibitor,CSNK1A1|CSNK1D|CSNK1E|CSNK1G2
JBKPUQTUERUYQE,BRD-K61327230|BRD-K84281997,pralidoxime,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K61327230|BRD-K84281997,pralidoxime,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K61327230|BRD-K84281997,pralidoxime,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K61327230|BRD-K84281997,pralidoxime,acetylcholinesterase inhibitor,ACHE|BCHE
JBMKAUGHUNFTOL,BRD-K88682005,chlorothiazide,diuretic,CA1|CA2|CA4|SLC12A3,BRD-K88682005,chlorothiazide,diuretic,CA1|CA2|CA4|SLC12A3,BRD-K88682005,chlorothiazide,diuretic,CA1|CA2|CA4|SLC12A3,BRD-K88682005,chlorothiazide,diuretic,CA1|CA2|CA4|SLC12A3
JBPUGFODGPKTDW,BRD-K09372874,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1,BRD-K09372874,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1,BRD-K09372874,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1,BRD-K09372874,merimepodib,inosine monophosphate dehydrogenase inhibitor,IMPDH1
JBRBWHCVRGURBA,BRD-A08316590,broxaterol,adrenergic receptor agonist,ADRB2,BRD-A08316590,broxaterol,adrenergic receptor agonist,ADRB2,BRD-A08316590,broxaterol,adrenergic receptor agonist,ADRB2,BRD-A08316590,broxaterol,adrenergic receptor agonist,ADRB2
JBSOOFITVPOOSY,BRD-A74347210,minerval,FAAH inhibitor,,BRD-A74347210,minerval,FAAH inhibitor,,BRD-A74347210,minerval,FAAH inhibitor,,BRD-A74347210,minerval,FAAH inhibitor,
JBXSBZBZASARMY,BRD-K24820488,CH-170,,,BRD-K24820488,CH-170,,,BRD-K24820488,CH-170,,,BRD-K24820488,CH-170,,
JBYXPOFIGCOSSB,BRD-K80025777,"cis-9,trans-11-Conjugated-linoleic-acid",,,BRD-K80025777,"cis-9,trans-11-Conjugated-linoleic-acid",,,BRD-K80025777,"cis-9,trans-11-Conjugated-linoleic-acid",,,BRD-K80025777,"cis-9,trans-11-conjugated-linoleic-acid",,
JCAFGYWSIWYMOX,BRD-K18305454,OAC2,Oct activator,POU5F1,BRD-K18305454,OAC2,Oct activator,POU5F1,BRD-K18305454,OAC2,Oct activator,POU5F1,BRD-K18305454,OAC2,Oct activator,POU5F1
JCCNYMKQOSZNPW,BRD-K82795137,loratadine,histamine receptor antagonist,HRH1,BRD-K82795137,loratadine,histamine receptor antagonist,HRH1,BRD-K82795137,loratadine,histamine receptor antagonist,HRH1,BRD-K82795137,loratadine,histamine receptor antagonist,HRH1
JCHAWRDHMUSLMM,BRD-K75352575,KPT-276,exportin antagonist,XPO1,BRD-K75352575,KPT-276,exportin antagonist,XPO1,BRD-K75352575,KPT-276,exportin antagonist,XPO1,BRD-K75352575,KPT-276,exportin antagonist,XPO1
JCKYGMPEJWAADB,BRD-K29458283,chlorambucil,DNA inhibitor,,BRD-K29458283,chlorambucil,DNA inhibitor,,BRD-K29458283,chlorambucil,DNA inhibitor,,BRD-K29458283,chlorambucil,DNA inhibitor,
JCQLYHFGKNRPGE,BRD-K77258318,lactulose,laxative,,BRD-K77258318,lactulose,laxative,,BRD-K77258318,lactulose,laxative,,BRD-K77258318,lactulose,laxative,
JCRIVQIOJSSCQD,BRD-A35667010,propylhexedrine,adrenergic receptor agonist,SLC18A2|TAAR1,BRD-A35667010,propylhexedrine,adrenergic receptor agonist,SLC18A2|TAAR1,BRD-A35667010,propylhexedrine,adrenergic receptor agonist,SLC18A2|TAAR1,BRD-K01825844,propylhexedrine,adrenergic receptor agonist,
JCSGFHVFHSKIJH,BRD-K59184148,SB-216763,glycogen synthase kinase inhibitor,CCNA2|CDK2|GSK3A|GSK3B,BRD-K59184148,SB-216763,glycogen synthase kinase inhibitor,CCNA2|CDK2|GSK3A|GSK3B,BRD-K59184148,SB-216763,glycogen synthase kinase inhibitor,CCNA2|CDK2|GSK3A|GSK3B,BRD-K59184148,SB-216763,glycogen synthase kinase inhibitor,CCNA2|CDK2|GSK3A|GSK3B
JCWVNNMJXQJVNC,BRD-A38747044,KU14R,imidazoline receptor antagonist,,BRD-A38747044,KU14R,imidazoline receptor antagonist,,BRD-A38747044,KU14R,imidazoline receptor antagonist,,BRD-A38747044,KU14R,imidazoline receptor antagonist,
JCYNMRJCUYVDBC,BRD-A24560335,efatutazone,PPAR receptor agonist,PPARG,BRD-A24560335,efatutazone,PPAR receptor agonist,PPARG,BRD-A24560335,efatutazone,PPAR receptor agonist,PPARG,BRD-A24560335,efatutazone,PPAR receptor agonist,PPARG
JDBCWSHYEQUBLW,BRD-K96233303,TMS,,,BRD-K96233303,TMS,,,BRD-K96233303,TMS,,,BRD-K96233303,TMS,,
JDEMVNYMYPJJIM,BRD-K00486786,Ro-08-2750,,NGF,BRD-K00486786,Ro-08-2750,,NGF,BRD-K00486786,Ro-08-2750,,NGF,BRD-K00486786,Ro-08-2750,NGF binding inhibitor,NGF|NGFR
JDLKFOPOAOFWQN,BRD-A60402836,allicin,cytokine production inhibitor,TRPA1|TRPV1,BRD-A60402836,allicin,cytokine production inhibitor,TRPA1|TRPV1,BRD-A60402836,allicin,cytokine production inhibitor,TRPA1|TRPV1,BRD-A60402836,allicin,cytokine production inhibitor,TRPA1|TRPV1
JDLSRXWHEBFHNC,BRD-K84173274,ufenamate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K84173274,ufenamate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K84173274,ufenamate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K84173274,ufenamate,cyclooxygenase inhibitor,PTGS1|PTGS2
JDOZJEUDSLGTLU,BRD-A94523291,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,BRD-A94523291,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,BRD-A94523291,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,BRD-K00003654,prednisolone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1
JDTZAGLGBRRCJT,BRD-A22707317,SB-205384,GABA receptor modulator,GABRA3|GABRA5|GABRA6,BRD-A22707317,SB-205384,GABA receptor modulator,GABRA3|GABRA5|GABRA6,BRD-A22707317,SB-205384,GABA receptor modulator,GABRA3|GABRA5|GABRA6,BRD-A22707317,SB-205384,GABA receptor modulator,GABRA3|GABRA5|GABRA6
JDUBGYFRJFOXQC,BRD-K99023089,AZD5363,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K99023089,AZD5363,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K99023089,AZD5363,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K99023089,AZD5363,AKT inhibitor,AKT1|AKT2|AKT3
JDVVGAQPNNXQDW,BRD-K20897876,castanospermine,glucosidase inhibitor,GAA|GBA,BRD-K20897876,castanospermine,glucosidase inhibitor,GAA|GBA,BRD-K20897876,castanospermine,glucosidase inhibitor,GAA|GBA,BRD-K20897876,castanospermine,glucosidase inhibitor,GAA|GBA
JEDJMKTVUPSHFW,BRD-K06467130,CL316243,adrenergic receptor agonist,ADRB3|UCP1|UCP2|UCP3,BRD-K06467130,CL316243,adrenergic receptor agonist,ADRB3|UCP1|UCP2|UCP3,BRD-K06467130,CL316243,adrenergic receptor agonist,ADRB3|UCP1|UCP2|UCP3,BRD-K06467130,CL316243,adrenergic receptor agonist,ADRB3|UCP1|UCP2|UCP3
JEFVYQYZCAVNTP,BRD-A67748489,K-858,kinesin-like spindle protein inhibitor,KIF11,BRD-A67748489,K-858,kinesin-like spindle protein inhibitor,KIF11,BRD-A67748489,K-858,kinesin-like spindle protein inhibitor,KIF11,BRD-A67748489,K-858,kinesin-like spindle protein inhibitor,KIF11
JEGGQYICWGMXOZ,BRD-A10991937,FCE-22250,DNA directed DNA polymerase inhibitor,,BRD-A10991937,FCE-22250,DNA directed DNA polymerase inhibitor,,BRD-A10991937,FCE-22250,DNA directed DNA polymerase inhibitor,,BRD-K00004537,FCE-22250,DNA directed DNA polymerase inhibitor,
JEGHXKRHKHPBJD,BRD-K28352084,CH5132799,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K28352084,CH5132799,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K28352084,CH5132799,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K28352084,CH5132799,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
JEMJAABFSYOLAP,BRD-K63516691,T-0156,phosphodiesterase inhibitor,PDE5A,BRD-K63516691,T-0156,phosphodiesterase inhibitor,PDE5A,BRD-K63516691,T-0156,phosphodiesterase inhibitor,PDE5A,BRD-K63516691,T-0156,phosphodiesterase inhibitor,PDE5A
JEPAGMKWFWQECH,BRD-K43237107,N-(4-chlorophenyl)acrylamide,,,,,,,,,,,,,,
JFHROPTYMMSOLG,BRD-K37590257,GSK256066,phosphodiesterase inhibitor,PDE4A,BRD-K37590257,GSK256066,phosphodiesterase inhibitor,PDE4A,BRD-K37590257,GSK256066,phosphodiesterase inhibitor,PDE4A,BRD-K37590257,GSK256066,phosphodiesterase inhibitor,PDE4A
JFIBVDBTCDTBRH,BRD-A08772153,SQ-109,bacterial cell wall synthesis inhibitor,FDFT1,BRD-A08772153,SQ-109,bacterial cell wall synthesis inhibitor,FDFT1,BRD-A08772153,SQ-109,bacterial cell wall synthesis inhibitor,FDFT1,BRD-A08772153,SQ-109,bacterial cell wall synthesis inhibitor,FDFT1
JFIFBWVNHLXJFY,BRD-K90756851,K-Ras(G12C)-inhibitor-12,K-ras inhibitor,KRAS,BRD-K90756851,K-Ras(G12C)-inhibitor-12,K-ras inhibitor,KRAS,BRD-K90756851,K-Ras(G12C)-inhibitor-12,K-ras inhibitor,KRAS,BRD-K90756851,K-Ras(G12C)-inhibitor-12,K-Ras inhibitor,KRAS
JFIOVJDNOJYLKP,BRD-K39120595,bithionol,autotaxin inhibitor,ESR1|ESR2|MCL1,BRD-K39120595,bithionol,autotaxin inhibitor,ESR1|ESR2|MCL1,BRD-K39120595,bithionol,autotaxin inhibitor,ESR1|ESR2|MCL1,BRD-K39120595,bithionol,autotaxin inhibitor,ESR1|ESR2|MCL1
JFJZZMVDLULRGK,BRD-K99621550,tubocurarine,acetylcholine receptor antagonist,ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN,BRD-K99621550,tubocurarine,acetylcholine receptor antagonist,ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN,BRD-K99621550,tubocurarine,acetylcholine receptor antagonist,ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN,BRD-K99621550,tubocurarine,acetylcholine receptor antagonist,ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN
JFLIEFSWGNOPJJ,BRD-K70592483,phenylacetylglutamine,DNA methylase inhibitor|protein synthesis inhibitor,,BRD-K70592483,phenylacetylglutamine,DNA methylase inhibitor|protein synthesis inhibitor,,BRD-K70592483,phenylacetylglutamine,DNA methylase inhibitor|protein synthesis inhibitor,,BRD-K70592483,phenylacetylglutamine,DNA methylase inhibitor|protein synthesis inhibitor,
JFMIIMPCFQKAAD,BRD-K21892374,ethyl-2-(carbamoyloxy)benzoate,,,BRD-K21892374,ethyl-2-(carbamoyloxy)benzoate,,,BRD-K21892374,ethyl-2-(carbamoyloxy)benzoate,,,BRD-K21892374,ethyl-2-(carbamoyloxy)benzoate,,
JFNKXGOEOQCXDM,BRD-K93188295,ARC-239,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-K93188295,ARC-239,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-K93188295,ARC-239,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-K93188295,ARC-239,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C
JFNWFXVFBDDWCX,BRD-K84810336,sulfisoxazole-acetyl,folic acid antagonist,,BRD-K84810336,sulfisoxazole-acetyl,folic acid antagonist,,BRD-K05009775|BRD-K84810336,sulfisoxazole-acetyl,folic acid antagonist,,BRD-K05009775|BRD-K84810336,sulfisoxazole-acetyl,folic acid antagonist,
JFOAJUGFHDCBJJ,BRD-K54170555,NMS-P715,protein kinase inhibitor,,BRD-K54170555,NMS-P715,protein kinase inhibitor,,BRD-K54170555,NMS-P715,protein kinase inhibitor,,BRD-K54170555,NMS-P715,protein kinase inhibitor,
JFPVXVDWJQMJEE,BRD-A76746748|BRD-K02733959,cefuroxime,bacterial cell wall synthesis inhibitor,,BRD-A76746748|BRD-K02733959,cefuroxime,bacterial cell wall synthesis inhibitor,,BRD-A76746748|BRD-K02733959,cefuroxime,bacterial cell wall synthesis inhibitor,,BRD-A76746748|BRD-K02733959,cefuroxime,bacterial cell wall synthesis inhibitor,
JFRYYGVYCWYIDQ,BRD-K51770398,JNJ-17203212,TRPV antagonist,TRPV1,BRD-K51770398,JNJ-17203212,TRPV antagonist,TRPV1,BRD-K51770398,JNJ-17203212,TRPV antagonist,TRPV1,BRD-K51770398,JNJ-17203212,TRPV antagonist,TRPV1
JFSXSNSCPNFCDM,BRD-A53134341,Ro-106-9920,NFkB pathway inhibitor,,BRD-A53134341,Ro-106-9920,NFkB pathway inhibitor,,BRD-A53134341,Ro-106-9920,NFkB pathway inhibitor,,BRD-A53134341,Ro-106-9920,NFkB pathway inhibitor,
JFUIMTGOQCQTPF,BRD-K03155172,GSK3787,PPAR receptor antagonist,PPARD,BRD-K03155172,GSK3787,PPAR receptor antagonist,PPARD,BRD-K03155172,GSK3787,PPAR receptor antagonist,PPARD,BRD-K03155172,GSK3787,PPAR receptor antagonist,PPARD
JFVMOLRNQCNLCH,BRD-A53836783,antimony-potassium,,,BRD-A53836783,antimony-potassium,,,BRD-A53836783,antimony-potassium,,,,,,
JFVNFXCESCXMBC,BRD-K29395450,PIK-93,PI3K inhibitor,PI4KB|PIK3C3|PIK3CG,BRD-K29395450,PIK-93,PI3K inhibitor,PI4KB|PIK3C3|PIK3CG,BRD-K29395450,PIK-93,PI3K inhibitor,PI4KB|PIK3C3|PIK3CG,BRD-K29395450,PIK-93,PI3K inhibitor,PI4KB|PIK3C3|PIK3CG
JFVZFKDSXNQEJW,BRD-K61868322,tenofovir-disoproxil,nucleoside reverse transcriptase inhibitor,CYP1A2,BRD-K61868322,tenofovir-disoproxil,nucleoside reverse transcriptase inhibitor,CYP1A2,BRD-K61868322,tenofovir-disoproxil,nucleoside reverse transcriptase inhibitor,CYP1A2,BRD-K61868322,tenofovir-disoproxil,nucleoside reverse transcriptase inhibitor,CYP1A2
JFXBEKISTKFVAB,BRD-K16484091,metocurine,acetylcholine receptor antagonist,CHRM2|CHRNA2,BRD-K16484091,metocurine,acetylcholine receptor antagonist,CHRM2|CHRNA2,BRD-K16484091,metocurine,acetylcholine receptor antagonist,CHRM2|CHRNA2,BRD-K16484091,metocurine,acetylcholine receptor antagonist,CHRM2|CHRNA2
JFZGBMJPJZDNNT,BRD-K88553858,benurestat,urease inhibitor,,BRD-K88553858,benurestat,urease inhibitor,,BRD-K88553858,benurestat,urease inhibitor,,BRD-K88553858,benurestat,urease inhibitor,
JGCMEBMXRHSZKX,BRD-K48812570,macitentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K48812570,macitentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K48812570,macitentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K48812570,macitentan,endothelin receptor antagonist,EDNRA|EDNRB
JGEBLDKNWBUGRZ,BRD-K56405753,MK-2461,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,BRD-K56405753,MK-2461,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,BRD-K56405753,MK-2461,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,BRD-K56405753,MK-2461,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB
JGGVBBYJRQOPPA,BRD-A74208568,CGP-54626,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A74208568,CGP-54626,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A74208568,CGP-54626,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A74208568,CGP-54626,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
JGMOKGBVKVMRFX,BRD-A86597857|BRD-K27038879|BRD-K68620903,dydrogesterone,progesterone receptor agonist,PGR,BRD-A86597857|BRD-K68620903,dydrogesterone,progesterone receptor agonist,PGR,BRD-A86597857|BRD-K27038879|BRD-K68620903,dydrogesterone,progesterone receptor agonist,PGR,BRD-A86597857|BRD-K27038879|BRD-K68620903,dydrogesterone,progesterone receptor agonist,PGR
JGOAIQNSOGZNBX,BRD-K60907894,adiphenine,acetylcholine receptor antagonist,CHRNA1,BRD-K60907894,adiphenine,acetylcholine receptor antagonist,CHRNA1,BRD-K60907894,adiphenine,acetylcholine receptor antagonist,CHRNA1,BRD-K60907894,adiphenine,acetylcholine receptor antagonist,CHRNA1
JGPJQFOROWSRRS,BRD-K28115081,apafant,platelet activating factor receptor antagonist,PTAFR,BRD-K28115081,apafant,platelet activating factor receptor antagonist,PTAFR,BRD-K28115081,apafant,platelet activating factor receptor antagonist,PTAFR,BRD-K28115081,apafant,platelet activating factor receptor antagonist,PTAFR
JGPMMRGNQUBGND,BRD-K37516142,idebenone,calcium channel modulator,,BRD-K37516142,idebenone,calcium channel modulator,,BRD-K37516142,idebenone,calcium channel modulator,,BRD-K37516142,idebenone,calcium channel modulator,
JGRPKOGHYBAVMW,BRD-K70751730,IOX1,histone demethylase inhibitor,EGLN1|KDM3A|KDM4C|KDM6B,BRD-K70751730,IOX1,histone demethylase inhibitor,EGLN1|KDM3A|KDM4C|KDM6B,BRD-K70751730,IOX1,histone demethylase inhibitor,EGLN1|KDM3A|KDM4C|KDM6B,BRD-K70751730,IOX1,histone demethylase inhibitor,EGLN1|KDM3A|KDM4C|KDM6B
JGSARLDLIJGVTE,BRD-K55191674,benzylpenicillin,penicillin binding protein inhibitor,,BRD-K55191674,benzylpenicillin,penicillin binding protein inhibitor,,BRD-K55191674,benzylpenicillin,penicillin binding protein inhibitor,,BRD-K55191674,benzylpenicillin,penicillin binding protein inhibitor,
JGWRKYUXBBNENE,BRD-K54519451,pexidartinib,tyrosine kinase inhibitor,CSF1R|FLT3|KIT,BRD-K54519451,pexidartinib,tyrosine kinase inhibitor,CSF1R|FLT3|KIT,BRD-K54519451,pexidartinib,tyrosine kinase inhibitor,CSF1R|FLT3|KIT,BRD-K54519451,pexidartinib,tyrosine kinase inhibitor,CSF1R|FLT3|KIT
JGZYUDARLHNRKM,BRD-A13668387,colistimethate,bacterial permeability inducer,,BRD-A13668387,colistimethate,bacterial permeability inducer,,BRD-A13668387,colistimethate,bacterial permeability inducer,,,,,
JHAYEQICABJSTP,BRD-K17641316,decoquinate,antiprotozoal agent,,BRD-K17641316,decoquinate,antiprotozoal agent,,BRD-K17641316,decoquinate,antiprotozoal agent,,BRD-K17641316,decoquinate,antiprotozoal agent,
JHBWYQRKOUBPCA,BRD-K07202345,frentizole,immunosuppressant,,BRD-K07202345,frentizole,immunosuppressant,,BRD-K07202345,frentizole,immunosuppressant,,BRD-K07202345,frentizole,immunosuppressant,
JHDKZFFAIZKUCU,BRD-K86797399,SB-939,HDAC inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC5|HDAC9,BRD-K86797399,SB-939,HDAC inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC5|HDAC9,BRD-K86797399,SB-939,HDAC inhibitor,HDAC1|HDAC10|HDAC3|HDAC4|HDAC5|HDAC9,BRD-K86797399,SB-939,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9
JHFOAISYWJRTIM,BRD-A32172948,methiopril,angiotensin converting enzyme inhibitor,ACE,BRD-A32172948,methiopril,angiotensin converting enzyme inhibitor,ACE,BRD-A32172948,methiopril,angiotensin converting enzyme inhibitor,ACE,BRD-K00004541,methiopril,angiotensin converting enzyme inhibitor,ACE
JHOHXJYRVSLQCB,BRD-A34145622|BRD-A50207110,demeclocycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A34145622|BRD-A50207110,demeclocycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A34145622|BRD-A50207110,demeclocycline,bacterial 30S ribosomal subunit inhibitor,,BRD-K00003347,demeclocycline,bacterial 30S ribosomal subunit inhibitor,
JHOTYHDSLIUKCJ,BRD-K63533170,AM-630,cannabinoid receptor antagonist,CNR1|CNR2,BRD-K63533170,AM-630,cannabinoid receptor antagonist,CNR1|CNR2,BRD-K63533170,AM-630,cannabinoid receptor antagonist,CNR1|CNR2,BRD-K63533170,AM-630,cannabinoid receptor antagonist,CNR1|CNR2
JHSXDAWGLCZYSM,BRD-K11558771,droxinostat,HDAC inhibitor,HDAC6|HDAC8,BRD-K11558771,droxinostat,HDAC inhibitor,HDAC6|HDAC8,BRD-K11558771,droxinostat,HDAC inhibitor,HDAC6|HDAC8,BRD-K11558771,droxinostat,HDAC inhibitor,HDAC6|HDAC8
JHVAMHSQVVQIOT,BRD-A75305484,anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A75305484,anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A75305484,anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-K00003560,anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",
JICJBGPOMZQUBB,BRD-A53077924,tianeptine,selective serotonin reuptake enhancer (SSRE),OPRD1|OPRK1|OPRM1,BRD-A53077924,tianeptine,selective serotonin reuptake enhancer (SSRE),OPRD1|OPRK1|OPRM1,BRD-A53077924,tianeptine,selective serotonin reuptake enhancer (SSRE),OPRD1|OPRK1|OPRM1,BRD-K01826304,tianeptine,selective serotonin reuptake enhancer (SSRE),OPRD1|OPRK1|OPRM1
JIEKMACRVQTPRC,BRD-K16077845,fentiazac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K16077845,fentiazac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K16077845,fentiazac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K16077845,fentiazac,cyclooxygenase inhibitor,PTGS1|PTGS2
JIMHYXZZCWVCMI,BRD-K72004355,CFTRinh-172,chloride channel blocker,CFTR,BRD-K72004355,CFTRinh-172,chloride channel blocker,CFTR,BRD-K72004355,CFTRinh-172,chloride channel blocker,CFTR,BRD-K72004355,CFTRinh-172,chloride channel blocker,CFTR
JINQHBRSXWQJAZ,BRD-A09368919,FPL-12495,glutamate receptor antagonist,,BRD-A09368919,FPL-12495,glutamate receptor antagonist,,BRD-A09368919,FPL-12495,glutamate receptor antagonist,,BRD-A09368919,FPL-12495,glutamate receptor antagonist,
JIVPVXMEBJLZRO,BRD-A26384407,chlorthalidone,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA4|CA7|SLC12A1|SLC12A3,BRD-A26384407,chlorthalidone,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA4|CA7|SLC12A1|SLC12A3,BRD-A26384407,chlorthalidone,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA4|CA7|SLC12A1|SLC12A3,BRD-A26384407,chlorthalidone,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1
JIVZKJJQOZQXQB,BRD-K46211610,tolazoline,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2,BRD-K46211610,tolazoline,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2,BRD-K46211610,tolazoline,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2,BRD-K46211610,tolazoline,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2
JJCFRYNCJDLXIK,BRD-K28143534,cyproheptadine,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,BRD-K28143534,cyproheptadine,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,BRD-K28143534,cyproheptadine,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,BRD-K28143534,cyproheptadine,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7
JJCQSGDBDPYCEO,BRD-K48427910,dibekacin,bacterial 30S ribosomal subunit inhibitor,,BRD-K48427910,dibekacin,bacterial 30S ribosomal subunit inhibitor,,BRD-K48427910,dibekacin,bacterial 30S ribosomal subunit inhibitor,,BRD-K48427910,dibekacin,bacterial 30S ribosomal subunit inhibitor,
JJEDWBQZCRESJL,BRD-K30707190,PNU-74654,beta-catenin inhibitor,CTNNB1|TCF4,BRD-K30707190,PNU-74654,beta-catenin inhibitor,CTNNB1|TCF4,BRD-K30707190,PNU-74654,beta-catenin inhibitor,CTNNB1|TCF4,BRD-K30707190,PNU-74654,beta-catenin inhibitor,CTNNB1|TCF4
JJGBXTYGTKWGAT,BRD-K83502127,trofinetide,cytokine production inhibitor,IFNG|IL6|TNF,BRD-K83502127,trofinetide,cytokine production inhibitor,IFNG|IL6|TNF,BRD-K83502127,trofinetide,cytokine production inhibitor,IFNG|IL6|TNF,BRD-K83502127,trofinetide,cytokine production inhibitor,IFNG|IL6|TNF
JJJFUHOGVZWXNQ,BRD-K66918327,enbucrilate,,,BRD-K66918327,enbucrilate,,,BRD-K66918327,enbucrilate,,,BRD-K66918327,enbucrilate,,
JJWLXRKVUJDJKG,BRD-K12511835,BMS-863233,CDC inhibitor,CDC7|PIM1,BRD-K12511835,BMS-863233,CDC inhibitor,CDC7|PIM1,BRD-K12511835,BMS-863233,CDC inhibitor,CDC7|PIM1,BRD-K12511835,BMS-863233,CDC inhibitor,CDC7|PIM1
JJWMRRNGWSITSQ,BRD-K77950083,UPF-1069,PARP inhibitor,PARP2,BRD-K77950083,UPF-1069,PARP inhibitor,PARP2,BRD-K77950083,UPF-1069,PARP inhibitor,PARP2,BRD-K77950083,UPF-1069,PARP inhibitor,PARP2
JJZFWROHYSMCMU,BRD-K78941306,SB-742457,serotonin receptor antagonist,HTR6,BRD-K78941306,SB-742457,serotonin receptor antagonist,HTR6,BRD-K78941306,SB-742457,serotonin receptor antagonist,HTR6,BRD-K78941306,SB-742457,serotonin receptor antagonist,HTR6
JKHRCGUTYDNCLE,BRD-K79107392,delphinidin,membrane permeability inhibitor,GLO1,BRD-K79107392,delphinidin,membrane permeability inhibitor,GLO1,BRD-K79107392,delphinidin,membrane permeability inhibitor,GLO1,BRD-K79107392,delphinidin,membrane permeability inhibitor,GLO1
JKKFKPJIXZFSSB,BRD-A22143024,estropipate,estrogen receptor agonist,ESR1|ESR2,BRD-A22143024,estropipate,estrogen receptor agonist,ESR1|ESR2,BRD-A22143024,estropipate,estrogen receptor agonist,ESR1|ESR2,BRD-K51095933,estropipate,estrogen receptor agonist,ESR1|ESR2
JKOCAAWWDVHWKB,BRD-K28470988,L-690330,inositol monophosphatase inhibitor,IMPA1,BRD-K28470988,L-690330,inositol monophosphatase inhibitor,IMPA1,BRD-K28470988,L-690330,inositol monophosphatase inhibitor,IMPA1,BRD-K28470988,L-690330,inositol monophosphatase inhibitor,IMPA1
JKOQGQFVAUAYPM,BRD-K73947551,amifostine,reducing agent,ALPPL2|ENPP1,BRD-K73947551,amifostine,reducing agent,ALPPL2|ENPP1,BRD-K73947551,amifostine,reducing agent,ALPPL2|ENPP1,BRD-K73947551,amifostine,reducing agent,ALPPL2|ENPP1
JKWKMORAXJQQSR,BRD-K78352627,nandrolone-decanoate,androgenic steroid,AR,BRD-K78352627,nandrolone-decanoate,androgenic steroid,AR,BRD-K78352627,nandrolone-decanoate,androgenic steroid,AR,,,,
JLFSBHQQXIAQEC,BRD-K05444225,E7449,PARP inhibitor,PARP1|PARP2|TNKS|TNKS2,BRD-K05444225,E7449,PARP inhibitor,PARP1|PARP2|TNKS|TNKS2,BRD-K05444225,E7449,PARP inhibitor,PARP1|PARP2|TNKS|TNKS2,BRD-K05444225,E7449,PARP inhibitor,PARP1|PARP2|TNKS|TNKS2
JLGKQTAYUIMGRK,BRD-A95939040,sertaconazole,sterol demethylase inhibitor,,BRD-A95939040,sertaconazole,sterol demethylase inhibitor,,BRD-A95939040|BRD-U65696040,sertaconazole,sterol demethylase inhibitor,,BRD-K01825659|BRD-U65696040,sertaconazole,sterol demethylase inhibitor,
JLICHNCFTLFZJN,BRD-A02710418,meptazinol,opioid receptor agonist,BCHE,BRD-A02710418,meptazinol,opioid receptor agonist,BCHE,BRD-A02710418,meptazinol,opioid receptor agonist,BCHE,BRD-A02710418,meptazinol,opioid receptor agonist,BCHE
JLKIGFTWXXRPMT,BRD-K28494619,sulfamethoxazole,PABA antagonist,,BRD-K28494619,sulfamethoxazole,PABA antagonist,,BRD-K28494619,sulfamethoxazole,PABA antagonist,,BRD-K28494619,sulfamethoxazole,PABA antagonist,
JLOXTZFYJNCPIS,BRD-K12244279,MEK1-2-inhibitor,MEK inhibitor,MAP2K2,BRD-K12244279,MEK1-2-inhibitor,MEK inhibitor,MAP2K2,BRD-K12244279,MEK1-2-inhibitor,MEK inhibitor,MAP2K2,,,,
JLPDBLFIVFSOCC,BRD-K98006098,oleandrin,Na/K-ATPase inhibitor,,BRD-K98006098,oleandrin,Na/K-ATPase inhibitor,,BRD-K98006098,oleandrin,Na/K-ATPase inhibitor,,BRD-K98006098,oleandrin,Na/K-ATPase inhibitor,
JLPULHDHAOZNQI,BRD-A10131665,phosphatidylcholine,,PCTP,BRD-A10131665,phosphatidylcholine,,PCTP,BRD-A10131665,phosphatidylcholine,,PCTP,BRD-A10131665,phosphatidylcholine,,
JLPYLHLUHJOPNL,BRD-K89402695,L-655240,thromboxane receptor antagonist,PTGES,BRD-K89402695,L-655240,thromboxane receptor antagonist,PTGES,BRD-K89402695,L-655240,thromboxane receptor antagonist,PTGES,BRD-K89402695,L-655240,thromboxane receptor antagonist,PTGES
JLRGJRBPOGGCBT,BRD-K85119730,tolbutamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,BRD-K85119730,tolbutamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,BRD-K85119730,tolbutamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,BRD-K85119730,tolbutamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8
JLUUJHIQVIXTGT,BRD-K03301001,A-7,calmodulin antagonist,,BRD-K03301001,A-7,calmodulin antagonist,,BRD-K03301001,A-7,calmodulin antagonist,,BRD-K03301001,A-7,calmodulin antagonist,
JLVHTNZNKOSCNB,BRD-K91336023,mesulergine,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,BRD-K91336023,mesulergine,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,BRD-K91336023,mesulergine,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,BRD-K91336023,mesulergine,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7
JLVSPVFPBBFMBE,BRD-A35379661,sphingosylphosphorylcholine,gene expression stimulant,GPR12,BRD-A35379661,sphingosylphosphorylcholine,gene expression stimulant,GPR12,BRD-A35379661,sphingosylphosphorylcholine,gene expression stimulant,GPR12,BRD-K01825110,sphingosylphosphorylcholine,gene expression stimulant,GPR12
JLVSRWOIZZXQAD,BRD-A22971209,DMPS,chelating agent,,BRD-A22971209,DMPS,chelating agent,,BRD-A22971209,DMPS,chelating agent,,BRD-A22971209,DMPS,chelating agent,
JLYAXFNOILIKPP,BRD-K82746043,navitoclax,BCL inhibitor,BCL2|BCL2L1|BCL2L2,BRD-K82746043,navitoclax,BCL inhibitor,BCL2|BCL2L1|BCL2L2,BRD-K82746043,navitoclax,BCL inhibitor,BCL2|BCL2L1|BCL2L2,BRD-K82746043,navitoclax,BCL inhibitor,BCL2|BCL2L1|BCL2L2
JLYXXMFPNIAWKQ,BRD-K93814253,lindane,,GABRB1|GLRA1|GLRA2|GLRA3|GLRB,BRD-K93814253,lindane,,GABRB1|GLRA1|GLRA2|GLRA3|GLRB,BRD-K93814253,lindane,,GABRB1|GLRA1|GLRA2|GLRA3|GLRB,BRD-K93814253,lindane,,GABRB1|GLRA1|GLRA2|GLRA3|GLRB
JMEYDSHPKCSIJC,BRD-K84996356,AZD3514,androgen receptor modulator,AR,BRD-K84996356,AZD3514,androgen receptor modulator,AR,BRD-K84996356,AZD3514,androgen receptor modulator,AR,BRD-K84996356,AZD3514,androgen receptor modulator,AR
JMGXJHWTVBGOKG,BRD-K12735121,TG-100801,VEGFR inhibitor|src inhibitor,FGFR1|FLT1|KDR|SRC,BRD-K12735121,TG-100801,VEGFR inhibitor|src inhibitor,FGFR1|FLT1|KDR|SRC,BRD-K12735121,TG-100801,VEGFR inhibitor|src inhibitor,FGFR1|FLT1|KDR|SRC,BRD-K12735121,TG-100801,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC
JMIFGARJSWXZSH,BRD-K39381259,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1,BRD-K39381259,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1,BRD-K39381259,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1,BRD-K39381259,DMH1,ALK tyrosine kinase receptor inhibitor,ACVR1
JMNXWOFCUJJYEO,BRD-K70693421,genz-123346,glucosylceramidase inhibitor,UGCG,BRD-K70693421,genz-123346,glucosylceramidase inhibitor,UGCG,BRD-K70693421,genz-123346,glucosylceramidase inhibitor,UGCG,BRD-K70693421,genz-123346,glucosylceramidase inhibitor,UGCG
JMPFSEBWVLAJKM,BRD-A19952358,closantel,NFkB pathway inhibitor|chitinase inhibitor,,BRD-A19952358,closantel,NFkB pathway inhibitor|chitinase inhibitor,,BRD-A19952358,closantel,NFkB pathway inhibitor|chitinase inhibitor,,BRD-K01825680,closantel,NFkB pathway inhibitor|chitinase inhibitor,
JMPOIZCOJJMTHI,BRD-K21612934,leteprinim,nerve growth factor agonist,,BRD-K21612934,leteprinim,nerve growth factor agonist,,BRD-K21612934,leteprinim,nerve growth factor agonist,,BRD-K21612934,leteprinim,nerve growth factor agonist,
JMSUDQYHPSNBSN,BRD-K50865540,PF-8380,autotaxin inhibitor,ENPP2,BRD-K50865540,PF-8380,autotaxin inhibitor,ENPP2,BRD-K50865540,PF-8380,autotaxin inhibitor,ENPP2,BRD-K50865540,PF-8380,autotaxin inhibitor,ENPP2
JMZOMFYRADAWOG,BRD-K26581543,bifendate,,,BRD-K26581543,bifendate,,,BRD-K26581543,bifendate,,,BRD-K26581543,bifendate,,
JNAHVYVRKWKWKQ,BRD-K12737986,veliparib,PARP inhibitor,PARP1|PARP2,BRD-K12737986,veliparib,PARP inhibitor,PARP1|PARP2,BRD-K12737986,veliparib,PARP inhibitor,PARP1|PARP2,BRD-K87142802,veliparib,PARP inhibitor,PARP1|PARP2
JNELGWHKGNBSMD,BRD-K27135764,xanthone,antimalarial agent,,BRD-K27135764,xanthone,antimalarial agent,,BRD-K27135764,xanthone,antimalarial agent,,BRD-K27135764,xanthone,antimalarial agent,
JNGVJMBLXIUVRD,BRD-K29735307,ostarine,androgen receptor modulator,AR,BRD-K29735307,ostarine,androgen receptor modulator,AR,BRD-K29735307,ostarine,androgen receptor modulator,AR,BRD-K29735307,ostarine,androgen receptor modulator,AR
JNIIDKODPGHQSS,BRD-A33801468,capreomycin,protein synthesis inhibitor,,BRD-A33801468,capreomycin,protein synthesis inhibitor,,BRD-A33801468,capreomycin,protein synthesis inhibitor,,,,,
JNMRHUJNCSQMMB,BRD-K14705039,sulfathiazole,dihydropteroate synthase inhibitor,,BRD-K14705039,sulfathiazole,dihydropteroate synthase inhibitor,,BRD-K14705039,sulfathiazole,dihydropteroate synthase inhibitor,,BRD-K14705039,sulfathiazole,dihydropteroate synthase inhibitor,
JNNOSTQEZICQQP,BRD-K10042277,desmethylclozapine,acetylcholine receptor agonist,HTR2C,BRD-K10042277,desmethylclozapine,acetylcholine receptor agonist,HTR2C,BRD-K10042277,desmethylclozapine,acetylcholine receptor agonist,HTR2C,BRD-K10042277,desmethylclozapine,acetylcholine receptor agonist,HTR2C
JNODQFNWMXFMEV,BRD-K55703048,latrepirdine,glutamate receptor antagonist,HRH1|HTR6,BRD-K55703048,latrepirdine,glutamate receptor antagonist,HRH1|HTR6,BRD-K55703048,latrepirdine,glutamate receptor antagonist,HRH1|HTR6,BRD-K55703048,latrepirdine,glutamate receptor antagonist,HRH1|HTR6
JNTOCHDNEULJHD,BRD-K47780086,penciclovir,DNA directed DNA polymerase inhibitor,,BRD-K47780086,penciclovir,DNA directed DNA polymerase inhibitor,,BRD-K47780086,penciclovir,DNA directed DNA polymerase inhibitor,,BRD-K47780086,penciclovir,DNA directed DNA polymerase inhibitor,
JNUGFGAVPBYSHF,BRD-K10958118,L-778123,farnesyltransferase inhibitor,FNTA|FNTB|PGGT1B,BRD-K10958118,L-778123,farnesyltransferase inhibitor,FNTA|FNTB|PGGT1B,BRD-K10958118,L-778123,farnesyltransferase inhibitor,FNTA|FNTB|PGGT1B,BRD-K10958118,L-778123,farnesyltransferase inhibitor,FNTA|FNTB|PGGT1B
JNYSEDHQJCOWQU,BRD-A04506385,stepronin,mucolytic agent,,BRD-A04506385,stepronin,mucolytic agent,,BRD-A04506385,stepronin,mucolytic agent,,BRD-A04506385,stepronin,mucolytic agent,
JOAHPSVPXZTVEP,BRD-A89207210,terguride,dopamine receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-A89207210,terguride,dopamine receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-A89207210,terguride,dopamine receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-A89207210,terguride,dopamine receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
JOATXPAWOHTVSZ,BRD-A95602221,celiprolol,adrenergic receptor antagonist,ADRA2A|ADRB1|ADRB2,BRD-A95602221,celiprolol,adrenergic receptor antagonist,ADRA2A|ADRB1|ADRB2,BRD-A95602221,celiprolol,adrenergic receptor antagonist,ADRA2A|ADRB1|ADRB2,BRD-A95602221,celiprolol,adrenergic receptor antagonist,ADRA2A|ADRB1|ADRB2
JODKFOVZURLVTG,BRD-K06894065,RRx-001,glucose 6-phosphate dehydrogenase inhibitor,G6PD,BRD-K06894065,RRx-001,glucose 6-phosphate dehydrogenase inhibitor,G6PD,BRD-K06894065,RRx-001,glucose 6-phosphate dehydrogenase inhibitor,G6PD,BRD-K06894065,RRx-001,glucose 6-phosphate dehydrogenase inhibitor,G6PD
JOFWLTCLBGQGBO,BRD-K76890464,triazolam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,BRD-K76890464,triazolam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,BRD-K76890464,triazolam,GABA benzodiazepine site receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,,,,
JOGKUKXHTYWRGZ,BRD-K12184916,NVP-BEZ235,PI3K inhibitor|mTOR inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,BRD-K12184916,NVP-BEZ235,PI3K inhibitor|mTOR inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,BRD-K12184916,NVP-BEZ235,PI3K inhibitor|mTOR inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,BRD-K12184916,NVP-BEZ235,PI3K inhibitor|mTOR inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG
JOHZPMXAZQZXHR,BRD-K08999871,pipemidic-acid,topoisomerase inhibitor,,BRD-K08999871,pipemidic-acid,topoisomerase inhibitor,,BRD-K08999871,pipemidic-acid,topoisomerase inhibitor,,BRD-K08999871,pipemidic-acid,topoisomerase inhibitor,
JOLJIIDDOBNFHW,BRD-K72815923,xanomeline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-K72815923,xanomeline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-K72815923,xanomeline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-K72815923,xanomeline,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7
JOLKQWPKJFRPOU,BRD-K41434598,org-9768,adrenergic receptor antagonist,ADRA2A,BRD-K41434598,org-9768,adrenergic receptor antagonist,ADRA2A,BRD-K41434598,org-9768,adrenergic receptor antagonist,ADRA2A,BRD-K41434598,ORG-9768,adrenergic receptor antagonist,ADRA2A
JOOXLOJCABQBSG,BRD-K12502280,TG-101348,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,BRD-K12502280,TG-101348,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,BRD-K12502280,TG-101348,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,BRD-K12502280,fedratinib,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2
JOSXKPZXMVHRKU,BRD-K98143539,compound-w,beta-secretase inhibitor,BACE1,BRD-K98143539,compound-w,beta-secretase inhibitor,BACE1,BRD-K98143539,compound-w,beta-secretase inhibitor,BACE1,BRD-K98143539,compound-w,beta-secretase inhibitor,BACE1
JOWXJLIFIIOYMS,BRD-K77638923,CUDC-907,PI3K inhibitor,HDAC2|PIK3R1,BRD-K77638923,CUDC-907,PI3K inhibitor,HDAC2|PIK3R1,BRD-K77638923,CUDC-907,PI3K inhibitor,HDAC2|PIK3R1,BRD-K77638923,CUDC-907,PI3K inhibitor,HDAC2|PIK3R1
JOYRKODLDBILNP,BRD-K24297741,urethane,local anesthetic,,BRD-K24297741,urethane,local anesthetic,,BRD-K24297741,urethane,local anesthetic,,BRD-K24297741,urethane,local anesthetic,
JOZGNYDSEBIJDH,BRD-K26425819,eniluracil,dihydropyrimidine dehydrogenase inhibitor,AOX1|DPYD|XDH,BRD-K26425819,eniluracil,dihydropyrimidine dehydrogenase inhibitor,AOX1|DPYD|XDH,BRD-K26425819,eniluracil,dihydropyrimidine dehydrogenase inhibitor,AOX1|DPYD|XDH,BRD-K26425819,eniluracil,dihydropyrimidine dehydrogenase inhibitor,AOX1|DPYD|XDH
JPAWFIIYTJQOKW,BRD-K20745393,olprinone,phosphodiesterase inhibitor,PDE3A,BRD-K20745393,olprinone,phosphodiesterase inhibitor,PDE3A,BRD-K20745393,olprinone,phosphodiesterase inhibitor,PDE3A,BRD-K20745393,olprinone,phosphodiesterase inhibitor,PDE3A
JPGDYIGSCHWQCC,BRD-K28982731,emoxipin,,,BRD-K28982731,emoxipin,,,BRD-K28982731,emoxipin,,,BRD-K28982731,emoxipin,,
JPGQOUSTVILISH,BRD-A51831848,enflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|KCNN4,BRD-A51831848,enflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|KCNN4,BRD-A51831848,enflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|KCNN4,BRD-A51831848,enflurane,membrane permeability inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9
JPMOKRWIYQGMJL,BRD-K70177501,INH1,Hec1 inhibitor,NDC80,BRD-K70177501,INH1,Hec1 inhibitor,NDC80,BRD-K70177501,INH1,Hec1 inhibitor,NDC80,BRD-K70177501,INH1,Hec1 inhibitor,NDC80
JPSHPWJJSVEEAX,BRD-A11731518,BAY-85-8050,,,BRD-A11731518,BAY-85-8050,,,BRD-A11731518,BAY-85-8050,,,BRD-A11731518,BAY-85-8050,,
JPYQFYIEOUVJDU,BRD-K44824027,beclamide,anticonvulsant,,BRD-K44824027,beclamide,anticonvulsant,,BRD-K44824027,beclamide,anticonvulsant,,BRD-K44824027,beclamide,anticonvulsant,
JQBKWZPHJOEQAO,BRD-K59045783,faropenem-medoxomil,lactamase inhibitor,,BRD-K59045783,faropenem-medoxomil,lactamase inhibitor,,BRD-K59045783,faropenem-medoxomil,lactamase inhibitor,,BRD-K59045783,faropenem-medoxomil,lactamase inhibitor,
JQSAYKKFZOSZGJ,BRD-K62858456,lomerizine,calcium channel blocker,CACNA1B|SCN5A,BRD-K62858456,lomerizine,calcium channel blocker,CACNA1B|SCN5A,BRD-K62858456,lomerizine,calcium channel blocker,CACNA1B|SCN5A,BRD-K62858456,lomerizine,calcium channel blocker,CACNA1B|SCN5A
JQSHBVHOMNKWFT,BRD-A86216746,varenicline,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,BRD-A86216746,varenicline,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,BRD-A86216746,varenicline,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,BRD-K18855837,varenicline,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7
JQWJJJYHVHNXJH,BRD-A86415025,"1-(1,2-Diphenylethyl)piperidine-(+/-)",,,BRD-A86415025,"1-(1,2-Diphenylethyl)piperidine-(+/-)",glutamate receptor antagonist,,BRD-A86415025,"1-(1,2-Diphenylethyl)piperidine-(+/-)",glutamate receptor antagonist,,BRD-K01825681,"1-(1,2-diphenylethyl)piperidine-(+/-)",glutamate receptor antagonist,
JQXXHWHPUNPDRT,BRD-A23603052|BRD-K56156786|BRD-K66218091,rifampin,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,BRD-A23603052|BRD-K56156786|BRD-K66218091,rifampin,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,BRD-A23603052|BRD-K01507359|BRD-K56156786|BRD-K66218091,rifampin,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,BRD-K01507359|BRD-K56156786|BRD-K66218091,rifampin,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3
JRLOEMCOOZSCQP,BRD-A68281735,REV-5901,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,BRD-A68281735,REV-5901,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,BRD-A68281735,REV-5901,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,BRD-A68281735,REV-5901,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5
JRNJNYBQQYBCLE,BRD-K52233191,R547,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,BRD-K52233191,R547,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,BRD-K52233191,R547,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,BRD-K52233191,R547,CDK inhibitor,CDK1|CDK2|CDK4|CDK7
JRNUKVFYILMMLX,BRD-K30867024,SB-216641,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K30867024,SB-216641,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K30867024,SB-216641,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K30867024,SB-216641,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
JROFGZPOBKIAEW,BRD-K87124298,OSI-027,mTOR inhibitor,MTOR,BRD-K87124298,OSI-027,mTOR inhibitor,MTOR,BRD-K87124298,OSI-027,mTOR inhibitor,MTOR,BRD-K87124298,OSI-027,mTOR inhibitor,MTOR
JRTIDHTUMYMPRU,BRD-K66896751,alpidem,benzodiazepine receptor agonist,GABRA1,BRD-K66896751,alpidem,benzodiazepine receptor agonist,GABRA1,BRD-K66896751,alpidem,benzodiazepine receptor agonist,GABRA1,BRD-K66896751,alpidem,benzodiazepine receptor agonist,GABRA1
JRURYQJSLYLRLN,BRD-K83636919,entacapone,catechol O methyltransferase inhibitor,COMT,BRD-K83636919,entacapone,catechol O methyltransferase inhibitor,COMT,BRD-K83636919,entacapone,catechol O methyltransferase inhibitor,COMT,BRD-K83636919,entacapone,catechol O methyltransferase inhibitor,COMT
JRWCBEOAFGHNNU,BRD-K02123250,JNJ-38877605,tyrosine kinase inhibitor,MET,BRD-K02123250,JNJ-38877605,tyrosine kinase inhibitor,MET,BRD-K02123250,JNJ-38877605,tyrosine kinase inhibitor,MET,BRD-K02123250,JNJ-38877605,tyrosine kinase inhibitor,MET
JRWROCIMSDXGOZ,BRD-K47929404,vercirnon,CC chemokine receptor antagonist,CCR9,BRD-K47929404,vercirnon,CC chemokine receptor antagonist,CCR9,BRD-K47929404,vercirnon,CC chemokine receptor antagonist,CCR9,BRD-K47929404,vercirnon,CC chemokine receptor antagonist,CCR9
JRWZLRBJNMZMFE,BRD-A78322124,dobutamine,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A78322124,dobutamine,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A78322124,dobutamine,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A78322124,dobutamine,adrenergic receptor agonist,ADRB1|ADRB2
JSASWRWALCMOQP,BRD-K40624912,ZM-39923,JAK inhibitor,JAK1|JAK3,BRD-K40624912,ZM-39923,JAK inhibitor,JAK1|JAK3,BRD-K40624912,ZM-39923,JAK inhibitor,JAK1|JAK3,BRD-K40624912,ZM-39923,JAK inhibitor,JAK1|JAK3
JSDRRTOADPPCHY,BRD-K72222507,quinapril,angiotensin converting enzyme inhibitor,ACE,BRD-K72222507,quinapril,angiotensin converting enzyme inhibitor,ACE,BRD-K72222507,quinapril,angiotensin converting enzyme inhibitor,ACE,BRD-K72222507,quinapril,angiotensin converting enzyme inhibitor,ACE
JSDXOWVAHXDYCU,BRD-K77073709,cefminox,bacterial cell wall synthesis inhibitor,,BRD-K77073709,cefminox,bacterial cell wall synthesis inhibitor,,BRD-K77073709,cefminox,bacterial cell wall synthesis inhibitor,,BRD-K77073709,cefminox,bacterial cell wall synthesis inhibitor,
JSFATNQSLKRBCI,BRD-K41234004,icomucret,mucin production enhancer,LTB4R2,BRD-K41234004,icomucret,mucin production enhancer,LTB4R2,BRD-K41234004,icomucret,mucin production enhancer,LTB4R2,BRD-K41234004,icomucret,mucin production enhancer,LTB4R2
JSJCTEKTBOKRST,BRD-A13116749,mabuterol,adrenergic receptor agonist,ADRB2,BRD-A13116749,mabuterol,adrenergic receptor agonist,ADRB2,BRD-A13116749,mabuterol,adrenergic receptor agonist,ADRB2,BRD-A13116749,mabuterol,adrenergic receptor agonist,ADRB2
JSKUWFIZUALZLX,BRD-K90382497,GW-843682X,PLK inhibitor,PLK1|PLK3,BRD-K90382497,GW-843682X,PLK inhibitor,PLK1|PLK3,BRD-K90382497,GW-843682X,PLK inhibitor,PLK1|PLK3,BRD-K90382497,GW-843682X,PLK inhibitor,PLK1|PLK3
JSNQSLSBBZFGBM,BRD-A59329714,epomediol,cholesterol inhibitor,CYP7A1,BRD-A59329714,epomediol,cholesterol inhibitor,CYP7A1,BRD-A59329714,epomediol,cholesterol inhibitor,CYP7A1,BRD-A59329714,epomediol,cholesterol inhibitor,CYP7A1
JSRREMIKIHJGAA,BRD-K03128512|BRD-K66135050,MK-2048,HIV integrase inhibitor,,BRD-K03128512|BRD-K66135050,MK-2048,HIV integrase inhibitor,,BRD-K03128512|BRD-K66135050,MK-2048,HIV integrase inhibitor,,BRD-K03128512|BRD-K66135050,MK-2048,HIV integrase inhibitor,
JSUAJTLKVREZHV,BRD-K08619838,tremorine,acetylcholine receptor agonist,,BRD-K08619838,tremorine,acetylcholine receptor agonist,,BRD-K08619838,tremorine,acetylcholine receptor agonist,,BRD-K08619838,tremorine,acetylcholine receptor agonist,
JSWZEAMFRNKZNL,BRD-K46742498,alosetron,serotonin receptor antagonist,HTR3A,BRD-K46742498,alosetron,serotonin receptor antagonist,HTR3A,BRD-K46742498,alosetron,serotonin receptor antagonist,HTR3A,BRD-K46742498,alosetron,serotonin receptor antagonist,HTR3A
JTAGHJPZEDNHHA,BRD-K47371940,ecabapide,,,BRD-K47371940,ecabapide,,,BRD-K47371940,ecabapide,,,BRD-K47371940,ecabapide,,
JTARFZSNUAGHRB,BRD-K53913732,SB-408124,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K53913732,SB-408124,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K53913732,SB-408124,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K53913732,SB-408124,orexin receptor antagonist,HCRTR1|HCRTR2
JTDYUFSDZATMKU,BRD-K22503835,scriptaid,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K22503835,scriptaid,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K22503835,scriptaid,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K22503835,scriptaid,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
JTEDVYBZBROSJT,BRD-K43187796,3-indolebutyric-acid,,B2M|HLA-A|TRAC|TRBC1,BRD-K43187796,3-indolebutyric-acid,,B2M|HLA-A|TRAC|TRBC1,BRD-K43187796,3-indolebutyric-acid,,B2M|HLA-A|TRAC|TRBC1,BRD-K43187796,3-indolebutyric-acid,,B2M|HLA-A|TRAC|TRBC1
JTEGQNOMFQHVDC,BRD-A02309928|BRD-K02992638,lamivudine,nucleoside reverse transcriptase inhibitor,,BRD-A02309928|BRD-K02992638,lamivudine,nucleoside reverse transcriptase inhibitor,,BRD-A02309928|BRD-K02992638,lamivudine,nucleoside reverse transcriptase inhibitor,,BRD-K02992638,lamivudine,nucleoside reverse transcriptase inhibitor,
JTIGKVIOEQASGT,BRD-K54339150,proquazone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K54339150,proquazone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K54339150,proquazone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K54339150,proquazone,cyclooxygenase inhibitor,PTGS1|PTGS2
JTLXCMOFVBXEKD,BRD-A71157293,fursultiamine,vitamin B,,BRD-A71157293,fursultiamine,vitamin B,,BRD-A71157293,fursultiamine,vitamin B,,BRD-A71157293,fursultiamine,vitamin B,
JTPUMZTWMWIVPA,BRD-K14127446,isopropamide-iodide,acetylcholine receptor antagonist,CHRM3|CHRM4,BRD-K14127446,isopropamide-iodide,acetylcholine receptor antagonist,CHRM3|CHRM4,BRD-K14127446,isopropamide-iodide,acetylcholine receptor antagonist,CHRM3|CHRM4,BRD-K14127446,isopropamide-iodide,acetylcholine receptor antagonist,CHRM3|CHRM4
JTSDBFGMPLKDCD,BRD-K12921935|BRD-K26634012,tilmicosin,bacterial 50S ribosomal subunit inhibitor,,BRD-K26634012,tilmicosin,bacterial 50S ribosomal subunit inhibitor,,BRD-K12921935|BRD-K26634012,tilmicosin,bacterial 50S ribosomal subunit inhibitor,,BRD-K36796419,tilmicosin,bacterial 50S ribosomal subunit inhibitor,
JTUQXGZRVLWBCR,BRD-A42423104,benproperine,antitussive,SCN5A,BRD-A42423104,benproperine,antitussive,SCN5A,BRD-A42423104,benproperine,antitussive,SCN5A,BRD-K01826024,benproperine,antitussive,SCN5A
JTVBXQAYBIJXRP,BRD-K56751279,Y-39983,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K56751279,Y-39983,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K56751279,Y-39983,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K56751279,Y-39983,rho associated kinase inhibitor,ROCK1|ROCK2
JTVPZMFULRWINT,BRD-K57432881,tiapride,dopamine receptor antagonist,DRD2|DRD3,BRD-K57432881,tiapride,dopamine receptor antagonist,DRD2|DRD3,BRD-K57432881,tiapride,dopamine receptor antagonist,DRD2|DRD3,BRD-K57432881,tiapride,dopamine receptor antagonist,DRD2|DRD3
JTWOMNBEOCYFNV,BRD-A46717658|BRD-A95218818,azlocillin,bacterial cell wall synthesis inhibitor,,BRD-A46717658|BRD-A95218818,azlocillin,bacterial cell wall synthesis inhibitor,,BRD-A46717658|BRD-A95218818|BRD-K60663764,azlocillin,bacterial cell wall synthesis inhibitor,,BRD-A46717658|BRD-A95218818|BRD-K60663764,azlocillin,bacterial cell wall synthesis inhibitor,
JTZZSQYMACOLNN,BRD-A68493689,simeprevir,HCV inhibitor,CYP1A2|CYP3A4,BRD-A68493689,simeprevir,HCV inhibitor,CYP1A2|CYP3A4,BRD-A68493689,simeprevir,HCV inhibitor,CYP1A2|CYP3A4,BRD-K00003545,simeprevir,HCV inhibitor,CYP1A2|CYP3A4
JUBNVWGVNWIXMB,BRD-K20995441,U-54494A,opioid receptor agonist,OPRK1,BRD-K20995441,U-54494A,opioid receptor agonist,OPRK1,BRD-K20995441,U-54494A,opioid receptor agonist,OPRK1,BRD-K20995441,U-54494A,opioid receptor agonist,OPRK1
JUDKOGFHZYMDMF,BRD-A88548664,SKF-38393,dopamine receptor agonist,CALY|DRD1|DRD5,BRD-A88548664,SKF-38393,dopamine receptor agonist,CALY|DRD1|DRD5,BRD-A88548664,SKF-38393,dopamine receptor agonist,CALY|DRD1|DRD5,BRD-K01826815,SKF-38393,dopamine receptor agonist,CALY|DRD1|DRD5
JUGSLZCFNSTKBN,BRD-K49294207,BIBU-1361,EGFR inhibitor,EGFR,BRD-K49294207,BIBU-1361,EGFR inhibitor,EGFR,BRD-K49294207,BIBU-1361,EGFR inhibitor,EGFR,BRD-K49294207,BIBU-1361,EGFR inhibitor,EGFR
JUJPKFNFCWJBCX,BRD-K27955832,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,BRD-K27955832,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,BRD-K27955832,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,BRD-K27955832,lomeguatrib,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
JUKPWJGBANNWMW,BRD-K19761926|BRD-K82139003,eplerenone,cytochrome P450 inhibitor,NR3C2,BRD-K19761926,eplerenone,cytochrome P450 inhibitor,NR3C2,BRD-K19761926|BRD-K82139003,eplerenone,cytochrome P450 inhibitor,NR3C2,BRD-K19761926|BRD-K82139003,eplerenone,cytochrome P450 inhibitor,NR3C2
JUOSGGQXEBBCJB,BRD-K79966802,rivanicline,acetylcholine receptor agonist,CHRNA4|CHRNB2|CXCL8,BRD-K79966802,rivanicline,acetylcholine receptor agonist,CHRNA4|CHRNB2|CXCL8,BRD-K79966802,rivanicline,acetylcholine receptor agonist,CHRNA4|CHRNB2|CXCL8,BRD-K79966802,rivanicline,acetylcholine receptor agonist,CHRNA4|CHRNB2|CXCL8
JUQLTPCYUFPYKE,BRD-K40887525,ritanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K40887525,ritanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K40887525,ritanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K40887525,ritanserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
JUQMLSGOTNKJKI,BRD-A73709786,LB-100,protein phosphatase inhibitor,,BRD-A73709786,LB-100,protein phosphatase inhibitor,,BRD-A49767491|BRD-A73709786,LB-100,protein phosphatase inhibitor,,BRD-K00025603,LB-100,protein phosphatase inhibitor,
JURAJLFHWXNPHG,BRD-K62790656,caracemide,ribonucleotide reductase inhibitor,RRM1,BRD-K62790656,caracemide,ribonucleotide reductase inhibitor,RRM1,BRD-K62790656,caracemide,ribonucleotide reductase inhibitor,RRM1,BRD-K62790656,caracemide,ribonucleotide reductase inhibitor,RRM1
JURKNVYFZMSNLP,BRD-K42348709,cyclobenzaprine,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,BRD-K42348709,cyclobenzaprine,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,BRD-K42348709,cyclobenzaprine,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,BRD-K42348709,cyclobenzaprine,adrenergic receptor agonist|serotonin receptor agonist,HTR2A
JUSFANSTBFGBAF,BRD-K99113996,AZD2014,mTOR inhibitor,MTOR,BRD-K99113996,AZD2014,mTOR inhibitor,MTOR,BRD-K99113996,AZD2014,mTOR inhibitor,MTOR,BRD-K99113996,AZD2014,mTOR inhibitor,MTOR
JUUFBMODXQKSTD,BRD-K50720187,flupirtine,glutamate receptor antagonist,ADRA2A|KCNQ1|KCNQ2,BRD-K50720187,flupirtine,glutamate receptor antagonist,ADRA2A|KCNQ1|KCNQ2,BRD-K50720187,flupirtine,glutamate receptor antagonist,ADRA2A|KCNQ1|KCNQ2,BRD-K50720187,flupirtine,glutamate receptor antagonist,ADRA2A|KCNQ1|KCNQ2
JUUUERJZVKCDOT,BRD-M08274809,indium(iii)-isopropoxide,,,BRD-M08274809,indium(iii)-isopropoxide,,,BRD-M08274809,indium(iii)-isopropoxide,,,BRD-M08274809,indium(III)-isopropoxide,,
JUWDSDKJBMFLHE,BRD-K45841694,IU1,ubiquitin C-terminal hydrolase inhibitor,USP14,BRD-K45841694,IU1,ubiquitin C-terminal hydrolase inhibitor,USP14,BRD-K45841694,IU1,ubiquitin C-terminal hydrolase inhibitor,USP14,BRD-K45841694,IU1,ubiquitin C-terminal hydrolase inhibitor,USP14
JUZNIMUFDBIJCM,BRD-A40472231,ertapenem,bacterial cell wall synthesis inhibitor,,BRD-A40472231,ertapenem,bacterial cell wall synthesis inhibitor,,BRD-A40472231,ertapenem,bacterial cell wall synthesis inhibitor,,BRD-A40472231,ertapenem,bacterial cell wall synthesis inhibitor,
JUZYLCPPVHEVSV,BRD-K54472332,elvitegravir,HIV integrase inhibitor,,BRD-K54472332,elvitegravir,HIV integrase inhibitor,,BRD-K54472332,elvitegravir,HIV integrase inhibitor,,BRD-K54472332,elvitegravir,HIV integrase inhibitor,
JVDOKQYTTYUYDV,BRD-K39841531,TG-101209,JAK inhibitor,JAK2|JAK3,BRD-K39841531,TG-101209,JAK inhibitor,JAK2|JAK3,BRD-K39841531,TG-101209,JAK inhibitor,JAK2|JAK3,BRD-K39841531,TG-101209,JAK inhibitor,JAK2|JAK3
JVGBTTIJPBFLTE,BRD-A72483914,spiroxatrine,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B,BRD-A72483914,spiroxatrine,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B,BRD-A72483914,spiroxatrine,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B,BRD-A72483914,spiroxatrine,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B
JVGUNCHERKJFCM,BRD-A93683007,mabuprofen,cyclooxygenase inhibitor,,BRD-A93683007,mabuprofen,cyclooxygenase inhibitor,,BRD-A93683007,mabuprofen,cyclooxygenase inhibitor,,BRD-A93683007,mabuprofen,cyclooxygenase inhibitor,
JVHXJTBJCFBINQ,BRD-K46604138|BRD-K58160573,dapagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K46604138|BRD-K58160573,dapagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K46604138|BRD-K58160573,dapagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K46604138|BRD-K58160573,dapagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2
JVLBPIPGETUEET,BRD-K33732501,methylnaltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K33732501,methylnaltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K33732501,methylnaltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K00003599,methylnaltrexone,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
JVVXZOOGOGPDRZ,BRD-K62289640,lylamine,cannabinoid receptor agonist,CNR1,BRD-K62289640,lylamine,cannabinoid receptor agonist,CNR1,BRD-K62289640,lylamine,cannabinoid receptor agonist,CNR1,BRD-K62289640,lylamine,cannabinoid receptor agonist,CNR1
JWAZRIHNYRIHIV,BRD-K21164796,beta-naphthol,,,BRD-K21164796,beta-naphthol,,,BRD-K21164796,beta-naphthol,,,BRD-K21164796,beta-naphthol,,
JWBOIMRXGHLCPP,BRD-A31204924,mitotane,antineoplastic agent,CYP11A1|CYP11B1|ESR1|FDX1,BRD-A31204924,mitotane,antineoplastic agent,CYP11A1|CYP11B1|ESR1|FDX1,BRD-A31204924,mitotane,antineoplastic agent,CYP11A1|CYP11B1|ESR1|FDX1,BRD-A31204924,mitotane,antineoplastic agent,CYP11A1|CYP11B1|ESR1
JWCSIUVGFCSJCK,BRD-A08899266|BRD-K40831222,latamoxef|moxalactam,bacterial cell wall synthesis inhibitor,,BRD-A08899266|BRD-K40831222,moxalactam,bacterial cell wall synthesis inhibitor,,BRD-A08899266|BRD-K40831222,moxalactam,bacterial cell wall synthesis inhibitor,,BRD-A08899266,moxalactam,bacterial cell wall synthesis inhibitor,
JWCUSQCZMQIBMR,BRD-K47816470,AF38469,sortilin inhibitor,SORT1,BRD-K47816470,AF38469,sortilin inhibitor,SORT1,BRD-K47816470,AF38469,sortilin inhibitor,SORT1,BRD-K47816470,AF38469,sortilin inhibitor,SORT1
JWDYCNIAQWPBHD,BRD-A55469827,mephenesin,muscle relaxant,,BRD-A55469827,mephenesin,muscle relaxant,,BRD-A55469827,mephenesin,muscle relaxant,,BRD-A55469827,mephenesin,muscle relaxant,
JWHAUXFOSRPERK,BRD-A26334849,propafenone,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2|SCN5A,BRD-A26334849,propafenone,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2|SCN5A,BRD-A26334849,propafenone,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2|SCN5A,BRD-K01826541,propafenone,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2
JWJOTENAMICLJG,BRD-K28984613,dutasteride,5 alpha reductase inhibitor,SRD5A1|SRD5A2,BRD-K30373883,dutasteride,5 alpha reductase inhibitor,SRD5A1|SRD5A2,BRD-K28984613|BRD-K30373883,dutasteride,5 alpha reductase inhibitor,SRD5A1|SRD5A2,BRD-K28984613|BRD-K30373883,dutasteride,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3
JWNPDZNEKVCWMY,BRD-K85606544,neratinib,EGFR inhibitor,EGFR|ERBB2|KDR,BRD-K85606544,neratinib,EGFR inhibitor,EGFR|ERBB2|KDR,BRD-K85606544,neratinib,EGFR inhibitor,EGFR|ERBB2|KDR,BRD-K85606544,neratinib,EGFR inhibitor,EGFR|ERBB2|KDR
JWPGJSVJDAJRLW,BRD-K80419150,debrisoquin,adrenergic neuron blocker,SLC6A2,BRD-K80419150,debrisoquin,adrenergic neuron blocker,SLC6A2,BRD-K80419150,debrisoquin,adrenergic neuron blocker,SLC6A2,BRD-K80419150,debrisoquin,adrenergic neuron blocker,SLC6A2
JWQOJVOKBAAAAR,BRD-K53281329,BAY-61-3606,syk inhibitor,SYK,BRD-K53281329,BAY-61-3606,syk inhibitor,SYK,BRD-K53281329,BAY-61-3606,syk inhibitor,SYK,BRD-K53281329,BAY-61-3606,SYK inhibitor,SYK
JWRMHDSINXPDHB,BRD-A50064262,flumethazone-pivalate,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A50064262,flumethasone-pivalate,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A50064262,flumethasone-pivalate,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K00025599,flumethasone-pivalate,glucocorticoid receptor agonist,NR3C1|SERPINA6
JWTNVKZACPRKPF,BRD-K42497885,satraplatin,DNA alkylating agent,,BRD-K42497885,satraplatin,DNA alkylating agent,,BRD-K42497885|BRD-K50134774,satraplatin,DNA alkylating agent,,BRD-K42497885|BRD-K50134774,satraplatin,DNA alkylating agent,
JWUBBDSIWDLEOM,BRD-K34907920|BRD-K77175907,calcifediol,vitamin D receptor agonist,VDR,BRD-K34907920|BRD-K77175907,calcifediol,vitamin D receptor agonist,VDR,BRD-K34907920|BRD-K77175907,calcifediol,vitamin D receptor agonist,VDR,BRD-K34907920|BRD-K77175907,calcifediol,vitamin D receptor agonist,VDR
JWYIGNODXSRKGP,BRD-K83186168,AZD1981,CRTH receptor antagonist,PTGDR2,BRD-K83186168,AZD1981,CRTH receptor antagonist,PTGDR2,BRD-K83186168,AZD1981,CRTH receptor antagonist,PTGDR2,BRD-K83186168,AZD1981,CRTH receptor antagonist,PTGDR2
JWZZKOKVBUJMES,BRD-A04322457,isoprenaline,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|MAPK1|PIK3R1|PIK3R2|PIK3R3,BRD-A04322457,isoprenaline,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|MAPK1|PIK3R1|PIK3R2|PIK3R3,BRD-A04322457,isoprenaline,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|MAPK1|PIK3R1|PIK3R2|PIK3R3,BRD-A04322457,isoprenaline,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3
JXDFEQONERDKSS,BRD-K20075662,betazole,histamine receptor agonist,HRH2,BRD-K20075662,betazole,histamine receptor agonist,HRH2,BRD-K20075662,betazole,histamine receptor agonist,HRH2,BRD-K20075662,betazole,histamine receptor agonist,HRH2
JXEICPOBKSQAIU,BRD-K96684644,spirobromin,,,BRD-K96684644,spirobromin,,,BRD-K96684644,spirobromin,,,BRD-K96684644,spirobromin,,
JXLYSJRDGCGARV,BRD-A39708826|BRD-A55594068|BRD-A66484359|BRD-K01188359|BRD-K12515392,vinblastine,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,BRD-A55594068|BRD-A66484359|BRD-K01188359|BRD-K12515392,vinblastine,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,BRD-A55594068|BRD-A66484359|BRD-K01188359|BRD-K06519765|BRD-K12515392,vinblastine,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,BRD-A55594068|BRD-A66484359|BRD-K01188359|BRD-K06519765|BRD-K12515392,vinblastine,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1
JXOHGGNKMLTUBP,BRD-A92096630,shikimic-acid,,,BRD-A92096630,shikimic-acid,,,BRD-A92096630,shikimic-acid,,,BRD-A92096630,shikimic-acid,,
JXSJBGJIGXNWCI,BRD-A01976766,malathion,cholinesterase inhibitor,ACHE|BCHE,BRD-A01976766,malathion,cholinesterase inhibitor,ACHE|BCHE,BRD-A01976766,malathion,cholinesterase inhibitor,ACHE|BCHE,BRD-A01976766,malathion,cholinesterase inhibitor,ACHE
JXSVIVRDWWRQRT,BRD-K35079116|BRD-K88350560,asiatic-acid,apoptosis stimulant,PYGM,BRD-K35079116,asiatic-acid,apoptosis stimulant,PYGM,BRD-K35079116|BRD-K88350560,asiatic-acid,apoptosis stimulant,PYGM,BRD-K35079116|BRD-K88350560,asiatic-acid,apoptosis stimulant,PYGM
JXZZEXZZKAWDSP,BRD-K76953762,indoramin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,BRD-K76953762,indoramin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,BRD-K76953762,indoramin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,BRD-K76953762,indoramin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C
JYGXADMDTFJGBT,BRD-A75172220|BRD-K97571677,hydrocortisone,glucocorticoid receptor agonist,,BRD-A75172220|BRD-K93568044,hydrocortisone,glucocorticoid receptor agonist,,BRD-A75172220|BRD-K93568044|BRD-K97571677,hydrocortisone,glucocorticoid receptor agonist,,BRD-A75172220|BRD-K93568044|BRD-K97571677,hydrocortisone,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2
JYIJIIVLEOETIQ,BRD-A92826379,lupanine,sodium channel blocker,INS,BRD-A92826379,lupanine,sodium channel blocker,INS,BRD-A92826379,lupanine,sodium channel blocker,INS,BRD-K00004532,lupanine,sodium channel blocker,INS
JYIKNQVWKBUSNH,BRD-A31685486|BRD-K33838583|BRD-K49793107,caspofungin|caspofungin-acetate,"bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A31685486|BRD-K49793107,caspofungin|caspofungin-acetate,"bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A31685486|BRD-K49793107,caspofungin|caspofungin-acetate,"bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-K00002625,caspofungin,"bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor",
JYILLRHXRVTRSH,BRD-K65991129,SB-705498,TRPV antagonist,TRPV1,BRD-K65991129,SB-705498,TRPV antagonist,TRPV1,BRD-K65991129,SB-705498,TRPV antagonist,TRPV1,BRD-K65991129,SB-705498,TRPV antagonist,TRPV1
JYJFNDQBESEHJQ,BRD-K43687498,dimethadione,oxazolidine antiepileptic,,BRD-K43687498,dimethadione,oxazolidine antiepileptic,,BRD-K43687498,dimethadione,oxazolidine antiepileptic,,BRD-K43687498,dimethadione,oxazolidine antiepileptic,
JYJTVFIEFKZWCJ,BRD-A24397426,nadifloxacin,bacterial DNA gyrase inhibitor,,BRD-A24397426,nadifloxacin,bacterial DNA gyrase inhibitor,,BRD-A24397426,nadifloxacin,bacterial DNA gyrase inhibitor,,BRD-A24397426,nadifloxacin,bacterial DNA gyrase inhibitor,
JYLNVJYYQQXNEK,BRD-A24122750,saclofen,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A24122750,saclofen,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A24122750,saclofen,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A24122750,saclofen,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
JYTNQNCOQXFQPK,BRD-K94293891,suvorexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K94293891,suvorexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K94293891,suvorexant,orexin receptor antagonist,HCRTR1|HCRTR2,,,,
JYTUSYBCFIZPBE,BRD-K01624185,maltobionic-acid,matrix metalloprotease inhibitor,,BRD-K01624185,maltobionic-acid,matrix metalloprotease inhibitor,,BRD-K01624185,maltobionic-acid,matrix metalloprotease inhibitor,,BRD-K01624185,maltobionic-acid,matrix metalloprotease inhibitor,
JYVXNLLUYHCIIH,BRD-A05674712,"mevalonic-d,-l-acid-lactone",,,BRD-A05674712,"mevalonic-d,-l-acid-lactone",,,BRD-A05674712,"mevalonic-d,-l-acid-lactone",,,BRD-A05674712,"D,L-mevalonic-acid-lactone",,
JYWIYHUXVMAGLG,BRD-K07283971,oxyclozanide,,,BRD-K07283971,oxyclozanide,,,BRD-K07283971|BRD-K13017451,oxyclozanide,,,BRD-K07283971|BRD-K13017451,oxyclozanide,,
JYXACOFERDBGGQ,BRD-K63835048,cefathiamidine,bacterial cell wall synthesis inhibitor,,BRD-K63835048,cefathiamidine,bacterial cell wall synthesis inhibitor,,BRD-K63835048,cefathiamidine,bacterial cell wall synthesis inhibitor,,BRD-K63835048,cefathiamidine,bacterial cell wall synthesis inhibitor,
JZCPYUJPEARBJL,BRD-K13296708,rimonabant,cannabinoid receptor antagonist,CNR1|GPR55,BRD-K13296708,rimonabant,cannabinoid receptor antagonist,CNR1|GPR55,BRD-K13296708,rimonabant,cannabinoid receptor antagonist,CNR1|GPR55,BRD-K13296708,rimonabant,cannabinoid receptor antagonist,CNR1|GPR55
JZCWLJDSIRUGIN,BRD-K04701033,VE-822,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG,BRD-K04701033,VE-822,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG,BRD-K04701033,VE-822,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG,BRD-K04701033,VE-822,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG
JZFPYUNJRRFVQU,BRD-K98763141,niflumic-acid,cyclooxygenase inhibitor,ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9,BRD-K98763141,niflumic-acid,cyclooxygenase inhibitor,ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9,BRD-K98763141,niflumic-acid,cyclooxygenase inhibitor,ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9,BRD-K98763141,niflumic-acid,cyclooxygenase inhibitor,ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9
JZODKRWQWUWGCD,BRD-K95603879,BHQ,ATPase inhibitor,ATP2A1,BRD-K95603879,BHQ,ATPase inhibitor,ATP2A1,BRD-K95603879,BHQ,ATPase inhibitor,ATP2A1,BRD-K95603879,BHQ,ATPase inhibitor,ATP2A1
JZQKKSLKJUAGIC,BRD-A97701745|BRD-K95598440,pindolol|pindolol-(-),adrenergic receptor antagonist|serotonin receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B|HTR2A|HTR2B,BRD-A97701745|BRD-K95598440,pindolol|pindolol-(-),adrenergic receptor antagonist|serotonin receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B|HTR2A|HTR2B,BRD-A97701745|BRD-K95598440,pindolol|pindolol-(-),adrenergic receptor antagonist|serotonin receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B|HTR2A|HTR2B,BRD-A97701745|BRD-K95598440,pindolol|pindolol-(-),adrenergic receptor antagonist|serotonin receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B
JZRWCGZRTZMZEH,BRD-K95785345,thiamine,vitamin B,SLC19A2|SLC19A3|TPK1,BRD-K95785345,thiamine,vitamin B,SLC19A2|SLC19A3|TPK1,BRD-K95785345,thiamine,vitamin B,SLC19A2|SLC19A3|TPK1,BRD-K95785345,thiamine,vitamin B,SLC19A2|SLC19A3|TPK1
JZUFKLXOESDKRF,BRD-K13078532,hydrochlorothiazide,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3,BRD-K13078532,hydrochlorothiazide,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3,BRD-K13078532,hydrochlorothiazide,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3,BRD-K13078532,hydrochlorothiazide,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3
JZUTXVTYJDCMDU,BRD-K02715688,"hydrastine-(1r,-9s)",,,BRD-K02715688,"hydrastine-(1r,-9s)",tyrosine hydroxylase inhibitor,,BRD-K02715688,"hydrastine-(1r,-9s)",tyrosine hydroxylase inhibitor,,BRD-K02715688,"hydrastine-(1R,9S)",tyrosine hydroxylase inhibitor,
JZWXMCPARMXZQV,BRD-K70402238,nexturastat-a,HDAC inhibitor,HDAC1|HDAC6,BRD-K70402238,nexturastat-a,HDAC inhibitor,HDAC1|HDAC6,BRD-K70402238,nexturastat-a,HDAC inhibitor,HDAC1|HDAC6,BRD-K70402238,nexturastat-A,HDAC inhibitor,HDAC1|HDAC6
JZXRLKWWVNUZRB,BRD-K51486818,lazabemide,monoamine oxidase inhibitor,MAOB,BRD-K51486818,lazabemide,monoamine oxidase inhibitor,MAOB,BRD-K51486818,lazabemide,monoamine oxidase inhibitor,MAOB,BRD-K51486818,lazabemide,monoamine oxidase inhibitor,MAOB
KAATUXNTWXVJKI,BRD-A62798249,cypermethrin,,,BRD-A62798249,cypermethrin,,,BRD-A62798249,cypermethrin,,,BRD-A62798249,cypermethrin,,
KAAZGXDPUNNEFN,BRD-K10990317,clotiapine,,,BRD-K10990317,clotiapine,,,BRD-K10990317,clotiapine,,,BRD-K10990317,clotiapine,,
KABDATZAOUSYES,BRD-K79684402,Ro-10-5824,dopamine receptor agonist,DRD4,BRD-K79684402,Ro-10-5824,dopamine receptor agonist,DRD4,BRD-K79684402,Ro-10-5824,dopamine receptor agonist,DRD4,BRD-K79684402,Ro-10-5824,dopamine receptor agonist,DRD4
KAJXOWFGKYKMMZ,BRD-K72726508,arcyriaflavin-a,CDK inhibitor,CCND1|CDK4,BRD-K72726508,arcyriaflavin-a,CDK inhibitor,CCND1|CDK4,BRD-K72726508,arcyriaflavin-a,CDK inhibitor,CCND1|CDK4,BRD-K72726508,arcyriaflavin-a,CDK inhibitor,CCND1|CDK4
KAQKFAOMNZTLHT,BRD-K64054020,epoprostenol,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS,BRD-K64054020,epoprostenol,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS,BRD-K64054020,epoprostenol,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS,BRD-K64054020,epoprostenol,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS
KASDHRXLYQOAKZ,BRD-K97729603,pimecrolimus,calcineurin inhibitor,FKBP1A|MTOR,BRD-K92107055,pimecrolimus,calcineurin inhibitor,FKBP1A|MTOR,BRD-K92107055|BRD-K97729603,pimecrolimus,calcineurin inhibitor,FKBP1A|MTOR,BRD-K92107055|BRD-K97729603,pimecrolimus,calcineurin inhibitor,
KATNUHQNJGNLPW,BRD-K85479953,STF-62247,autophagy inducer,,BRD-K85479953,STF-62247,autophagy inducer,,BRD-K85479953,STF-62247,autophagy inducer,,BRD-K85479953,STF-62247,autophagy inducer,
KAZSKMJFUPEHHW,BRD-K26011976,licochalcone-a,topoisomerase inhibitor,PTPN1,BRD-K26011976,licochalcone-a,topoisomerase inhibitor,PTPN1,BRD-K26011976,licochalcone-a,topoisomerase inhibitor,PTPN1,BRD-K99667445,licochalcone-A,topoisomerase inhibitor,PTPN1
KBAFPSLPKGSANY,BRD-A67862938,naftidrofuryl,adrenergic receptor antagonist,,BRD-A67862938,naftidrofuryl,adrenergic receptor antagonist,,BRD-A67862938,naftidrofuryl,adrenergic receptor antagonist,,BRD-A67862938,naftidrofuryl,adrenergic receptor antagonist,
KBDSLGBFQAGHBE,BRD-K64094723,limonin,HIV protease inhibitor,,BRD-K05906022,limonin,HIV protease inhibitor,,BRD-K05906022|BRD-K64094723,limonin,HIV protease inhibitor,,BRD-K05906022|BRD-K64094723,limonin,HIV protease inhibitor,
KBEZZLAAKIIPFK,BRD-K29812331,dimemorfan,sigma receptor agonist,SIGMAR1,BRD-K29812331,dimemorfan,sigma receptor agonist,SIGMAR1,BRD-K29812331,dimemorfan,sigma receptor agonist,SIGMAR1,BRD-K29812331,dimemorfan,sigma receptor agonist,SIGMAR1
KBFUQFVFYYBHBT,BRD-K30071764,TRAM-34,potassium channel antagonist,KCNN4,BRD-K30071764,TRAM-34,potassium channel antagonist,KCNN4,BRD-K30071764,TRAM-34,potassium channel antagonist,KCNN4,BRD-K30071764,TRAM-34,potassium channel antagonist,KCNN4
KBOPZPXVLCULAV,BRD-K28849549,mesalazine,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2,BRD-K28849549,mesalazine,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2,BRD-K28849549,mesalazine,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2,BRD-K28849549,mesalazine,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2
KBPHJBAIARWVSC,BRD-K16742848,lutein,antioxidant,,BRD-K16742848,lutein,antioxidant,,BRD-K16742848,lutein,antioxidant,,BRD-K16742848,lutein,antioxidant,
KBPLFHHGFOOTCA,BRD-K09338665,1-octanol,,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1,BRD-K09338665,1-octanol,,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1,BRD-K09338665,1-octanol,,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1,BRD-K09338665,1-octanol,,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1
KBUZBQVCBVDWKX,BRD-K15010214,emedastine,histamine receptor antagonist,HRH1,BRD-K15010214,emedastine,histamine receptor antagonist,HRH1,BRD-K15010214,emedastine,histamine receptor antagonist,HRH1,BRD-K15010214,emedastine,histamine receptor antagonist,HRH1
KBVFRXIGQQRMEF,BRD-K25359048,WZ811,CC chemokine receptor antagonist,CXCR4,BRD-K25359048,WZ811,CC chemokine receptor antagonist,CXCR4,BRD-K25359048,WZ811,CC chemokine receptor antagonist,CXCR4,BRD-K25359048,WZ811,CC chemokine receptor antagonist,CXCR4
KBZOIRJILGZLEJ,BRD-K73028949,vasopressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K73028949,vasopressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K73028949,vasopressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K73028949,vasopressin,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR
KCAJXIDMCNPGHZ,BRD-K95880107,PH-797804,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K95880107,PH-797804,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K95880107,PH-797804,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K95880107,PH-797804,p38 MAPK inhibitor,MAPK11|MAPK14
KCBXOMYXOBVLED,BRD-K59650319,YM-298198,glutamate receptor antagonist,GRM1,BRD-K59650319,YM-298198,glutamate receptor antagonist,GRM1,BRD-K59650319,YM-298198,glutamate receptor antagonist,GRM1,BRD-K59650319,YM-298198,glutamate receptor antagonist,GRM1
KCFYEAOKVJSACF,BRD-K73881242,arbidol,cytochrome P450 inhibitor,CYP3A4,BRD-K73881242,arbidol,cytochrome P450 inhibitor,CYP3A4,BRD-K73881242,arbidol,cytochrome P450 inhibitor,CYP3A4,BRD-K73881242,arbidol,cytochrome P450 inhibitor,CYP3A4
KCGLTUBCAGZLHP,BRD-K89072800,2-TEDC,lipoxygenase inhibitor,ALOX12,BRD-K89072800,2-TEDC,lipoxygenase inhibitor,ALOX12,BRD-K89072800,2-TEDC,lipoxygenase inhibitor,ALOX12,BRD-K89072800,2-TEDC,lipoxygenase inhibitor,ALOX12
KCHIOGFOPPOUJC,BRD-K22261391,pirodavir,,,BRD-K22261391,pirodavir,,,BRD-K22261391,pirodavir,,,BRD-K22261391,pirodavir,,
KCLANYCVBBTKTO,BRD-K79116891,proxymetacaine,sodium channel blocker,SCN10A|SCN5A,BRD-K79116891,proxymetacaine,sodium channel blocker,SCN10A|SCN5A,BRD-K79116891,proxymetacaine,sodium channel blocker,SCN10A|SCN5A,BRD-K79116891,proxymetacaine,sodium channel blocker,SCN10A|SCN5A
KCWZGJVSDFYRIX,BRD-K33141550,L-NAME,nitric oxide synthase inhibitor,NOS3,BRD-K33141550,L-NAME,nitric oxide synthase inhibitor,NOS3,BRD-K33141550,L-NAME,nitric oxide synthase inhibitor,NOS3,BRD-K33141550,L-NAME,nitric oxide synthase inhibitor,NOS3
KCXVZYZYPLLWCC,BRD-K82603084,ethylenediaminetetraacetic-acid,PKC inhibitor,,BRD-K82603084,ethylenediaminetetraacetic-acid,PKC inhibitor,,BRD-K82603084,ethylenediaminetetraacetic-acid,PKC inhibitor,,BRD-K82603084,ethylenediaminetetraacetic-acid,PKC inhibitor,
KDFQABSFVYLGPM,BRD-K34277641,L-365260,CCK receptor antagonist,CCKAR|CCKBR|KCNQ1,BRD-K34277641,L-365260,CCK receptor antagonist,CCKAR|CCKBR|KCNQ1,BRD-K34277641,L-365260,CCK receptor antagonist,CCKAR|CCKBR|KCNQ1,BRD-K34277641,L-365260,CCK receptor antagonist,CCKAR|CCKBR|KCNQ1
KDGFLJKFZUIJMX,BRD-K11267252,alectinib,ALK tyrosine kinase receptor inhibitor,ALK|MET,BRD-K11267252,alectinib,ALK tyrosine kinase receptor inhibitor,ALK|MET,BRD-K11267252,alectinib,ALK tyrosine kinase receptor inhibitor,ALK|MET,BRD-K11267252,alectinib,ALK tyrosine kinase receptor inhibitor,ALK|MET
KDGUIKPOZGYLQJ,BRD-K83022601,CI-844,,,BRD-K83022601,CI-844,,,BRD-K83022601,CI-844,,,BRD-K83022601,CI-844,,
KDKUVYLMPJIGKA,BRD-K11636097,JNJ-7706621,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,BRD-K11636097,JNJ-7706621,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,BRD-K11636097,JNJ-7706621,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,BRD-K11636097,JNJ-7706621,CDK inhibitor,AURKA|AURKB|CDK1|CDK2
KDLRVYVGXIQJDK,BRD-A23034328|BRD-A52252998,clindamycin,protein synthesis inhibitor,,BRD-A23034328|BRD-A43673346,clindamycin,protein synthesis inhibitor,,BRD-A23034328|BRD-A43673346|BRD-K23586533,clindamycin,protein synthesis inhibitor,,BRD-A23034328|BRD-A43673346|BRD-K23586533,clindamycin,protein synthesis inhibitor,
KDXISMANFPJVJY,BRD-K41194171,LY310762,serotonin receptor antagonist,HTR1D,BRD-K41194171,LY310762,serotonin receptor antagonist,HTR1D,BRD-K41194171,LY310762,serotonin receptor antagonist,HTR1D,BRD-K41194171,LY310762,serotonin receptor antagonist,HTR1D
KDXKERNSBIXSRK,BRD-K86016185,L-lysine,serotonin receptor agonist,GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4,BRD-K86016185,L-lysine,serotonin receptor agonist,GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4,BRD-K86016185,L-lysine,serotonin receptor agonist,GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4,BRD-K86016185,L-lysine,serotonin receptor agonist,GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4
KDYFGRWQOYBRFD,BRD-K45238818,succinic-acid,,ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE,BRD-K45238818,succinic-acid,,ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE,BRD-K45238818,succinic-acid,,ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE,BRD-K45238818,succinic-acid,,ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE
KEDQCFRVSHYKLR,BRD-K92446736,zatebradine,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,BRD-K92446736,zatebradine,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,BRD-K92446736,zatebradine,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,BRD-K92446736,zatebradine,HCN channel blocker,HCN1|HCN2|HCN3|HCN4
KEECCEWTUVWFCV,BRD-K07753030,acecainide,polarization inhibitor,SCN5A,BRD-K07753030,acecainide,polarization inhibitor,SCN5A,BRD-K07753030,acecainide,polarization inhibitor,SCN5A,BRD-K07753030,acecainide,polarization inhibitor,SCN5A
KEJCWVGMRLCZQQ,BRD-A22303829|BRD-A36322567,cefuroxime-axetil,bacterial cell wall synthesis inhibitor,,BRD-A22303829|BRD-A36322567,cefuroxime-axetil,bacterial cell wall synthesis inhibitor,,BRD-A22303829|BRD-A36322567,cefuroxime-axetil,bacterial cell wall synthesis inhibitor,,BRD-A22303829|BRD-A36322567,cefuroxime-axetil,bacterial cell wall synthesis inhibitor,
KEJORAMIZFOODM,BRD-K99092662,PS178990,androgen receptor modulator,AR,BRD-K99092662,PS178990,androgen receptor modulator,AR,BRD-K99092662,PS178990,androgen receptor modulator,AR,BRD-K99092662,PS178990,androgen receptor modulator,AR
KFAKESMKRPNZTM,BRD-K62949423,NSC-625987,CDK inhibitor,CDK2|CDK4,BRD-K62949423,NSC-625987,CDK inhibitor,CDK2|CDK4,BRD-K62949423,NSC-625987,CDK inhibitor,CDK2|CDK4,BRD-K62949423,NSC-625987,CDK inhibitor,CDK2|CDK4
KFHMLBXBRCITHF,BRD-K48735772,PD-158780,EGFR inhibitor,EGFR,BRD-K48735772,PD-158780,EGFR inhibitor,EGFR,BRD-K48735772,PD-158780,EGFR inhibitor,EGFR,BRD-K48735772,PD-158780,EGFR inhibitor,EGFR
KFHYZKCRXNRKRC,BRD-K22749967,ABT-239,histamine receptor antagonist,HRH1|HRH2|HRH3,BRD-K22749967,ABT-239,histamine receptor antagonist,HRH1|HRH2|HRH3,BRD-K22749967,ABT-239,histamine receptor antagonist,HRH1|HRH2|HRH3,BRD-K22749967,ABT-239,histamine receptor antagonist,HRH1|HRH2|HRH3
KFLWBZPSJQPRDD,BRD-K42205652,"MNS-(3,4-Methylenedioxy-nitrostyrene)",,,BRD-K42205652,"MNS-(3,4-Methylenedioxy-nitrostyrene)",src inhibitor|syk inhibitor,SRC|SYK,BRD-K42205652,"MNS-(3,4-Methylenedioxy-nitrostyrene)",src inhibitor|syk inhibitor,SRC|SYK,BRD-K42205652,"3,4-methylenedioxy-beta-nitrostyrene",SRC inhibitor|SYK inhibitor,SRC|SYK
KFQYTPMOWPVWEJ,BRD-K91111634,rotigotine,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,BRD-K91111634,rotigotine,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,BRD-K91111634,rotigotine,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,BRD-K91111634,rotigotine,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A
KFRKRECSIYXARE,BRD-K52366702,4EGI-1,protein synthesis inhibitor,EIF4E,BRD-K52366702,4EGI-1,protein synthesis inhibitor,EIF4E,BRD-A42580913|BRD-K52366702,4EGI-1,protein synthesis inhibitor,EIF4E,BRD-K00004308,4EGI-1,protein synthesis inhibitor,EIF4E
KFVUFODCZDRVSS,BRD-A96529864,isosteviol,,,BRD-A96529864,isosteviol,,,BRD-A96529864,isosteviol,,,BRD-A96529864,isosteviol,,
KFZXVMNBUMVKLN,BRD-K04358951,chlorothymol,,,BRD-K04358951,chlorothymol,,,BRD-K04358951,chlorothymol,,,BRD-K04358951,chlorothymol,,
KGEKLUUHTZCSIP,BRD-A41385909,bornyl-acetate,,,BRD-A41385909,bornyl-acetate,,,BRD-A41385909,bornyl-acetate,,,BRD-A41385909,bornyl-acetate,,
KGFYHTZWPPHNLQ,BRD-A50033377|BRD-K37130656,rivaroxaban,coagulation factor inhibitor,F10,BRD-A50033377|BRD-K37130656,rivaroxaban,coagulation factor inhibitor,F10,BRD-A50033377|BRD-K37130656,rivaroxaban,coagulation factor inhibitor,F10,BRD-A50033377|BRD-K37130656,rivaroxaban,coagulation factor inhibitor,F10
KGPGFQWBCSZGEL,BRD-K25325018,GSK690693,AKT inhibitor,AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX,BRD-K25325018,GSK690693,AKT inhibitor,AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX,BRD-K25325018|BRD-K29174426,GSK690693,AKT inhibitor,AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX,BRD-K25325018|BRD-K29174426,GSK690693,AKT inhibitor,AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX
KGPGQDLTDHGEGT,BRD-K30177383,dalbavancin,bacterial cell wall synthesis inhibitor,PNLIP,BRD-K30177383,dalbavancin,bacterial cell wall synthesis inhibitor,PNLIP,BRD-K30177383,dalbavancin,bacterial cell wall synthesis inhibitor,PNLIP,BRD-K30177383,dalbavancin,bacterial cell wall synthesis inhibitor,PNLIP
KGPPDNUWZNWPSI,BRD-K14763542,flurothyl,,,BRD-K14763542,flurothyl,,,BRD-K14763542,flurothyl,,,BRD-K14763542,flurothyl,,
KGRJPLRFGLMQMV,BRD-K15164005,apoptosis-activator-II,carboxylesterase inhibitor,BCHE|CES1,BRD-K15164005,apoptosis-activator-II,carboxylesterase inhibitor,BCHE|CES1,BRD-K15164005,apoptosis-activator-II,carboxylesterase inhibitor,BCHE|CES1,BRD-K15164005,apoptosis-activator-II,carboxylesterase inhibitor,BCHE|CES1
KGSXMPPBFPAXLY,BRD-K81074237,azilsartan,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-K81074237,azilsartan,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-K81074237,azilsartan,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-K81074237,azilsartan,angiotensin receptor antagonist,AGTR1|AGTR2
KGWDUNBJIMUFAP,BRD-M75061779,ethanolamine-oleate,immunostimulant,F12|FABP4|FFAR1|FFAR4|PLD2,BRD-M75061779,ethanolamine-oleate,immunostimulant,F12|FABP4|FFAR1|FFAR4|PLD2,BRD-M75061779,ethanolamine-oleate,immunostimulant,F12|FABP4|FFAR1|FFAR4|PLD2,BRD-M75061779,ethanolamine-oleate,immunostimulant,F12|FABP4|FFAR1|FFAR4|PLD2
KHJFBUUFMUBONL,BRD-K42748308,XE-991,potassium channel blocker,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K42748308,XE-991,potassium channel blocker,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K42748308,XE-991,potassium channel blocker,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K42748308,XE-991,potassium channel blocker,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5
KHKGTPJPBOQECW,BRD-A39255369,DCPIB,chloride channel blocker|gap junction modulator|glutamate inhibitor,SLC1A2,BRD-A39255369,DCPIB,chloride channel blocker|gap junction modulator|glutamate inhibitor,SLC1A2,BRD-A39255369,DCPIB,chloride channel blocker|gap junction modulator|glutamate inhibitor,SLC1A2,BRD-A39255369,DCPIB,chloride channel blocker|gap junction modulator|glutamate inhibitor,SLC1A2
KHOITXIGCFIULA,BRD-K39987650,bisacodyl,laxative,,BRD-K39987650,bisacodyl,laxative,,BRD-K39987650,bisacodyl,laxative,,BRD-K39987650,bisacodyl,laxative,
KHPKQFYUPIUARC,BRD-K26901728,lumiracoxib,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K26901728,lumiracoxib,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K26901728,lumiracoxib,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K26901728,lumiracoxib,cyclooxygenase inhibitor,PTGS1|PTGS2
KHPXUQMNIQBQEV,BRD-K61279411,oxaloacetate,glutamate release inhibitor,CS|SPR,BRD-K61279411,oxaloacetate,glutamate release inhibitor,CS|SPR,BRD-K61279411,oxaloacetate,glutamate release inhibitor,CS|SPR,,,,
KHUUTHZSRXABAC,BRD-K26573499,DMAB-anabaseine,adrenergic receptor agonist,CHRNA7,BRD-K26573499,DMAB-anabaseine,adrenergic receptor agonist,CHRNA7,BRD-K26573499,DMAB-anabaseine,adrenergic receptor agonist,CHRNA7,BRD-K26573499,DMAB-anabaseine,adrenergic receptor agonist,CHRNA7
KHWCPNJRJCNVRI,BRD-K48062199,GSK2801,bromodomain inhibitor,BAZ2A|BAZ2B,BRD-K48062199,GSK2801,bromodomain inhibitor,BAZ2A|BAZ2B,BRD-K48062199,GSK2801,bromodomain inhibitor,BAZ2A|BAZ2B,BRD-K48062199,GSK2801,bromodomain inhibitor,BAZ2A|BAZ2B
KHXBULXCCPIELT,BRD-K91298281,tenylidone,,,BRD-K91298281,tenylidone,,,BRD-K91298281,tenylidone,,,BRD-K91298281,tenylidone,,
KHZOJCQBHJUJFY,BRD-K78455053,wnt-c59,porcupine inhibitor,PORCN,BRD-K78455053,wnt-c59,porcupine inhibitor,PORCN,BRD-K78455053,wnt-c59,porcupine inhibitor,PORCN,BRD-K78455053,wnt-c59,porcupine inhibitor,PORCN
KIAPWMKFHIKQOZ,BRD-K78633253,EXO-1,ARF inhibitor,,BRD-K78633253,EXO-1,ARF inhibitor,,BRD-K78633253,EXO-1,ARF inhibitor,,BRD-K78633253,EXO-1,ARF inhibitor,
KIDHWZJUCRJVML,BRD-K75282878,putrescine,tissue transglutaminase inhibitor,AMD1|KCNJ4|ODC1,BRD-K75282878,putrescine,tissue transglutaminase inhibitor,AMD1|KCNJ4|ODC1,BRD-K75282878,putrescine,tissue transglutaminase inhibitor,AMD1|KCNJ4|ODC1,BRD-K75282878,putrescine,tissue transglutaminase inhibitor,AMD1|KCNJ4|ODC1
KIHYPELVXPAIDH,BRD-K62384160,siponimod,sphingosine phosphate receptor modulator,S1PR1,BRD-K62384160,siponimod,sphingosine phosphate receptor modulator,S1PR1,BRD-K62384160,siponimod,sphingosine phosphate receptor modulator,S1PR1,BRD-K62384160,siponimod,sphingosine 1-phosphate receptor modulator,S1PR1
KIISCIGBPUVZBF,BRD-K81728688,WZ8040,EGFR inhibitor,EGFR,BRD-K81728688,WZ8040,EGFR inhibitor,EGFR,BRD-K81728688,WZ8040,EGFR inhibitor,EGFR,BRD-K81728688,WZ8040,EGFR inhibitor,EGFR
KILNVBDSWZSGLL,BRD-A95886749,colfosceril-palmitate,pulmonary surfactant,,BRD-A95886749,colfosceril-palmitate,pulmonary surfactant,,BRD-A95886749,colfosceril-palmitate,pulmonary surfactant,,BRD-K01825113,colfosceril-palmitate,pulmonary surfactant,
KINMYBBFQRSVLL,BRD-K62427771,AS-77,potassium channel blocker,KCNA3|KCNA5|KCNN4,BRD-K62427771,AS-77,potassium channel blocker,KCNA3|KCNA5|KCNN4,BRD-K62427771,AS-77,potassium channel blocker,KCNA3|KCNA5|KCNN4,BRD-K62427771,AS-77,potassium channel blocker,KCNA3|KCNA5|KCNN4
KINWYTAUPKOPCQ,BRD-K54838207,fudosteine,mucolytic agent,,BRD-K54838207,fudosteine,mucolytic agent,,BRD-K54838207,fudosteine,mucolytic agent,,BRD-K54838207,fudosteine,mucolytic agent,
KIQQMECNKUGGKA,BRD-A04756508,norgestimate,progesterone receptor agonist,ESR1|PGR,BRD-A04756508,norgestimate,progesterone receptor agonist,ESR1|PGR,BRD-A04756508|BRD-A75867198|BRD-K38041788,norgestimate,progesterone receptor agonist,ESR1|PGR,BRD-A04756508|BRD-A75867198|BRD-K38041788,norgestimate,progesterone receptor agonist,ESR1|PGR
KIRAUJWBCMCUBY,BRD-M55321172,potassium-iodide,,,BRD-M55321172,potassium-iodide,,,BRD-M55321172,potassium-iodide,,,BRD-M55321172,potassium-iodide,,
KIVUHCNVDWYUNP,BRD-K00656370,6-aminochrysene,transferase inhibitor,,BRD-K00656370,6-aminochrysene,transferase inhibitor,,BRD-K00656370,6-aminochrysene,transferase inhibitor,,BRD-K00656370,6-aminochrysene,transferase inhibitor,
KIZUBVPJNPVIIN,BRD-K56086081,TUG-770,free fatty acid receptor agonist,FFAR1,BRD-K56086081,TUG-770,free fatty acid receptor agonist,FFAR1,BRD-K56086081,TUG-770,free fatty acid receptor agonist,FFAR1,BRD-K56086081,TUG-770,free fatty acid receptor agonist,FFAR1
KJADKKWYZYXHBB,BRD-K29653726,topiramate,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K29653726,topiramate,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K29653726,topiramate,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K29653726,topiramate,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
KJAMZCVTJDTESW,BRD-K75250001,tiracizine,sodium channel blocker,SCN5A,BRD-K75250001,tiracizine,sodium channel blocker,SCN5A,BRD-K75250001,tiracizine,sodium channel blocker,SCN5A,BRD-K75250001,tiracizine,sodium channel blocker,SCN5A
KJEBULYHNRNJTE,BRD-A02743701,cilnidipine,calcium channel blocker,CACNA1B,BRD-A02743701|BRD-A07875874,cilnidipine,calcium channel blocker,CACNA1B,BRD-A02743701|BRD-A07875874,cilnidipine,calcium channel blocker,CACNA1B,BRD-K00004281,cilnidipine,calcium channel blocker,CACNA1B
KJFBVJALEQWJBS,BRD-K59524082,maribavir,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,BRD-K59524082,maribavir,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,BRD-K59524082,maribavir,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,BRD-K59524082,maribavir,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM
KJFMBFZCATUALV,BRD-K19227686,phenolphthalein,indicator dye,UGT1A9,BRD-K19227686,phenolphthalein,indicator dye,UGT1A9,BRD-K19227686,phenolphthalein,indicator dye,UGT1A9,BRD-K19227686,phenolphthalein,indicator dye,UGT1A9
KJHKTHWMRKYKJE,BRD-K99451608,lopinavir,HIV protease inhibitor,,BRD-K99451608,lopinavir,HIV protease inhibitor,,BRD-K99451608,lopinavir,HIV protease inhibitor,,BRD-K99451608,lopinavir,HIV protease inhibitor,
KJHOZAZQWVKILO,BRD-K57291914,moroxydine,antiviral,,BRD-K57291914,moroxydine,antiviral,,BRD-K57291914,moroxydine,antiviral,,BRD-K88786763,moroxydine,antiviral,
KJNNWYBAOPXVJY,BRD-K51899933,azeliragon,RAGE receptor antagonist,AGER,BRD-K51899933,azeliragon,RAGE receptor antagonist,AGER,BRD-K51899933,azeliragon,RAGE receptor antagonist,AGER,BRD-K51899933,azeliragon,RAGE receptor antagonist,AGER
KJPRLNWUNMBNBZ,BRD-K38088841,cinnamaldehyde,TRPV agonist|aldose reductase inhibitor,TRPA1,BRD-K38088841,cinnamaldehyde,TRPV agonist|aldose reductase inhibitor,TRPA1,BRD-K38088841,cinnamaldehyde,TRPV agonist|aldose reductase inhibitor,TRPA1,BRD-K26875402,cinnamaldehyde,TRPV agonist|aldose reductase inhibitor,TRPA1
KJQFBVYMGADDTQ,BRD-A47706533,buthionine-sulfoximine,glutathione transferase inhibitor,GCLM,BRD-A47706533,buthionine-sulfoximine,glutathione transferase inhibitor,GCLM,BRD-A47706533,buthionine-sulfoximine,glutathione transferase inhibitor,GCLM,BRD-A47706533,buthionine-sulfoximine,glutathione transferase inhibitor,GCLM
KJXSIXMJHKAJOD,BRD-K01614093,dihydromyricetin,,,BRD-K01614093,dihydromyricetin,,,BRD-K01614093,dihydromyricetin,,,BRD-K01614093,dihydromyricetin,,
KKCOGNFFBYOKMA,BRD-K75052463,V-51,adrenergic receptor antagonist,,BRD-K75052463,V-51,adrenergic receptor antagonist,,BRD-K75052463,V-51,adrenergic receptor antagonist,,BRD-K75052463,V-51,adrenergic receptor antagonist,
KKDKAWKYGCUOGR,BRD-K77951111,PD-81723,adenosine receptor agonist,ADORA1,BRD-K77951111,PD-81723,adenosine receptor agonist,ADORA1,BRD-K77951111,PD-81723,adenosine receptor agonist,ADORA1,BRD-K77951111,PD-81723,adenosine receptor agonist,ADORA1
KKGQTZUTZRNORY,BRD-K88025533,fingolimod,immunosuppressant|sphingosine phosphate receptor agonist,S1PR1|S1PR5,BRD-K88025533,fingolimod,immunosuppressant|sphingosine phosphate receptor agonist,S1PR1|S1PR5,BRD-K88025533,fingolimod,immunosuppressant|sphingosine phosphate receptor agonist,S1PR1|S1PR5,BRD-K88025533,fingolimod,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5
KKHJGHLRPBEIBW,BRD-K79856453,pyrethrins,,,BRD-K79856453,pyrethrins,,,BRD-K79856453,pyrethrins,,,,,,
KKKHJYGCTVKQEM,BRD-K53605365,proacipimox,cholesterol inhibitor,,BRD-K53605365,proacipimox,cholesterol inhibitor,,BRD-K53605365,proacipimox,cholesterol inhibitor,,BRD-K53605365,proacipimox,cholesterol inhibitor,
KKTZALUTXUZPSN,BRD-K09537769,NU-7026,DNA dependent protein kinase inhibitor|PI3K inhibitor|mTOR inhibitor,PRKDC,BRD-K09537769,NU-7026,DNA dependent protein kinase inhibitor|PI3K inhibitor|mTOR inhibitor,PRKDC,BRD-K09537769,NU-7026,DNA dependent protein kinase inhibitor|PI3K inhibitor|mTOR inhibitor,PRKDC,BRD-K09537769,NU-7026,DNA dependent protein kinase inhibitor|PI3K inhibitor|mTOR inhibitor,PRKDC
KKYABQBFGDZVNQ,BRD-K56195681,losmapimod,p38 MAPK inhibitor,MAPK14,BRD-K56195681,losmapimod,p38 MAPK inhibitor,MAPK14,BRD-K56195681,losmapimod,p38 MAPK inhibitor,MAPK14,BRD-K56195681,losmapimod,p38 MAPK inhibitor,MAPK14
KKZJGLLVHKMTCM,BRD-K21680192,mitoxantrone,topoisomerase inhibitor,TOP2A,BRD-K21680192,mitoxantrone,topoisomerase inhibitor,TOP2A,BRD-K21680192,mitoxantrone,topoisomerase inhibitor,TOP2A,BRD-K21680192,mitoxantrone,topoisomerase inhibitor,TOP2A
KLBQZWRITKRQQV,BRD-A84481105,thioridazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCNH2,BRD-A84481105,thioridazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCNH2,BRD-A84481105,thioridazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCNH2,BRD-A84481105,thioridazine,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7
KLDXJTOLSGUMSJ,BRD-K47178855|BRD-K57344138,isosorbide,nitric oxide stimulant,,BRD-K47178855|BRD-K57344138,isosorbide,nitric oxide stimulant,,BRD-K47178855|BRD-K57344138,isosorbide,nitric oxide stimulant,,BRD-K47178855|BRD-K57344138,isosorbide,nitric oxide stimulant,
KLGQSVMIPOVQAX,BRD-K12762134,XAV-939,tankyrase inhibitor,TNKS|TNKS2,BRD-K12762134,XAV-939,tankyrase inhibitor,TNKS|TNKS2,BRD-K12762134,XAV-939,tankyrase inhibitor,TNKS|TNKS2,BRD-K12762134,XAV-939,tankyrase inhibitor,TNKS|TNKS2
KLOLZALDXGTNQE,BRD-M36487418,vilanterol,adrenergic receptor agonist,ADRB2,BRD-M36487418,vilanterol,adrenergic receptor agonist,ADRB2,BRD-M36487418|BRD-U26240578,vilanterol,adrenergic receptor agonist,ADRB2,BRD-M36487418,vilanterol,adrenergic receptor agonist,ADRB2
KLPWJLBORRMFGK,BRD-A65280694,molindone,dopamine receptor antagonist,CHRM1|DRD2|HRH1|HTR1A|HTR2A,BRD-A65280694,molindone,dopamine receptor antagonist,CHRM1|DRD2|HRH1|HTR1A|HTR2A,BRD-A65280694,molindone,dopamine receptor antagonist,CHRM1|DRD2|HRH1|HTR1A|HTR2A,BRD-A65280694,molindone,dopamine receptor antagonist,DRD2|HRH1|HTR2A
KLRRGBHZCJLIEL,BRD-K33245965,BMS-833923,smoothened receptor antagonist,SMO,BRD-K33245965,BMS-833923,smoothened receptor antagonist,SMO,BRD-K33245965,BMS-833923,smoothened receptor antagonist,SMO,BRD-K33245965,BMS-833923,smoothened receptor antagonist,SMO
KLWUUPVJTLHYIM,BRD-A14941520,dofequidar,MRP inhibitor|P glycoprotein inhibitor,ABCB1,BRD-A14941520,dofequidar,MRP inhibitor|P glycoprotein inhibitor,ABCB1,BRD-A14941520,dofequidar,MRP inhibitor|P glycoprotein inhibitor,ABCB1,BRD-A14941520,dofequidar,MRP inhibitor|P glycoprotein inhibitor,ABCB1
KLWYPRNPRNPORS,BRD-K15337272,C-751,,,BRD-K15337272,C-751,,,BRD-K15337272,C-751,,,BRD-K15337272,C-751,,
KLZWOWYOHUKJIG,BRD-K34332569,imidapril,angiotensin converting enzyme inhibitor,ACE,BRD-K34332569,imidapril,angiotensin converting enzyme inhibitor,ACE,BRD-K34332569,imidapril,angiotensin converting enzyme inhibitor,ACE,BRD-K11466259,imidapril,angiotensin converting enzyme inhibitor,ACE
KMCZIPGKKBSLEX,BRD-A36057565,bruceantin,protein synthesis inhibitor,,BRD-A36057565,bruceantin,protein synthesis inhibitor,,BRD-A36057565,bruceantin,protein synthesis inhibitor,,BRD-A36057565,bruceantin,protein synthesis inhibitor,
KMPWYEUPVWOPIM,BRD-A54537387|BRD-K14693417|BRD-K39079086,cinchonidine|cinchonine,P glycoprotein inhibitor,|CYP2D6,BRD-A54537387|BRD-K14693417|BRD-K39079086,cinchonidine|cinchonine,P glycoprotein inhibitor,|CYP2D6,BRD-A54537387|BRD-K14693417|BRD-K39079086,cinchonidine|cinchonine,P glycoprotein inhibitor,|CYP2D6,BRD-A54537387|BRD-K36551084|BRD-K39079086,cinchonidine|cinchonine,P glycoprotein inhibitor,|CYP2D6
KMSKQZKKOZQFFG,BRD-K83794624,pirarubicin,topoisomerase inhibitor,TOP2A,BRD-K83794624,pirarubicin,topoisomerase inhibitor,TOP2A,BRD-K83794624,pirarubicin,topoisomerase inhibitor,TOP2A,BRD-K83794624,pirarubicin,topoisomerase inhibitor,TOP2A
KMXXSJLYVJEBHI,BRD-K50781608,guanidinopropionic-acid,creatine kinase inhibitor,CKM,BRD-K50781608,guanidinopropionic-acid,creatine kinase inhibitor,CKM,BRD-K50781608,guanidinopropionic-acid,creatine kinase inhibitor,CKM,BRD-K50781608,guanidinopropionic-acid,creatine kinase inhibitor,CKM
KMZQAVXSMUKBPD,BRD-A67516570,lafutidine,histamine receptor antagonist,HRH2,BRD-A67516570,lafutidine,histamine receptor antagonist,HRH2,BRD-A67516570,lafutidine,histamine receptor antagonist,HRH2,BRD-K00003615,lafutidine,histamine receptor antagonist,HRH2
KNADXBVKFAUMCR,BRD-K61177364,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K61177364,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K61177364,NBI-27914,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K61177364,NBI-27914,corticotropin releasing factor receptor antagonist,CRHR1
KNAHARQHSZJURB,BRD-K48168960,propylthiouracil,thyroid peroxidase inhibitor,DIO1|TPO,BRD-K48168960,propylthiouracil,thyroid peroxidase inhibitor,DIO1|TPO,BRD-K48168960,propylthiouracil,thyroid peroxidase inhibitor,DIO1|TPO,BRD-K48168960,propylthiouracil,thyroid peroxidase inhibitor,DIO1|TPO
KNBSYZNKEAWABY,BRD-K59753853,MDL-29951,glutamate receptor antagonist,FBP1,BRD-K59753853,MDL-29951,glutamate receptor antagonist,FBP1,BRD-K59753853,MDL-29951,glutamate receptor antagonist,FBP1,BRD-K59753853,MDL-29951,glutamate receptor antagonist,FBP1
KNHUKKLJHYUCFP,BRD-K45252063,clofibrate,PPAR receptor agonist,LPL|PPARA,BRD-K45252063,clofibrate,PPAR receptor agonist,LPL|PPARA,BRD-K45252063,clofibrate,PPAR receptor agonist,LPL|PPARA,BRD-K45252063,clofibrate,PPAR receptor agonist,LPL|PPARA
KNIWPHSUTGNZST,BRD-A36456202,colistin-b-sulfate,bacterial permeability inducer,,BRD-A36456202,colistin-b-sulfate,bacterial permeability inducer,,BRD-A36456202,colistin-b-sulfate,bacterial permeability inducer,,,,,
KNOSZBQOKCZXTI,BRD-A03880619,bismuth-subcitrate-potassium,,,BRD-A03880619,bismuth-subcitrate-potassium,,,BRD-A03880619|BRD-M47372415,bismuth-subcitrate-potassium,,,BRD-K01666936,bismuth-subcitrate-potassium,,
KNURFLJTOUGOOQ,BRD-K52512893,SC-19220,prostanoid receptor antagonist,PTGER1,BRD-K52512893,SC-19220,prostanoid receptor antagonist,PTGER1,BRD-K52512893,SC-19220,prostanoid receptor antagonist,PTGER1,BRD-K52512893,SC-19220,prostanoid receptor antagonist,PTGER1
KNWQLFOXPQZGPX,BRD-K53896891,methanesulfonyl-fluoride,acetylcholinesterase inhibitor,ACHE,BRD-K53896891,methanesulfonyl-fluoride,acetylcholinesterase inhibitor,ACHE,BRD-K53896891,methanesulfonyl-fluoride,acetylcholinesterase inhibitor,ACHE,BRD-K53896891,methanesulfonyl-fluoride,acetylcholinesterase inhibitor,ACHE
KOCIMZNSNPOGOP,BRD-K34672903,HEMADO,,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K34672903,HEMADO,,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K34672903,HEMADO,,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K34672903,HEMADO,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
KOCVKGYKBLJEPK,BRD-K07442505,BAM7,BAX activator,BAX,BRD-K07442505,BAM7,BAX activator,BAX,BRD-K07442505,BAM7,BAX activator,BAX,BRD-K07442505,BAM7,BAX activator,BAX
KODQZSCTFAQIRL,BRD-K84459715,zopolrestat,,,BRD-K84459715,zopolrestat,,,BRD-K84459715,zopolrestat,,,,,,
KOHIRBRYDXPAMZ,BRD-A53597562|BRD-K04956647,nebivolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A53597562|BRD-K04956647,nebivolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A53597562|BRD-K04956647,nebivolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-K00003617,nebivolol,adrenergic receptor antagonist,ADRB1
KOMWRBFEDDEWEP,BRD-A87125127,3-MATIDA,,GRM1,BRD-A87125127,3-MATIDA,,GRM1,BRD-A87125127,3-MATIDA,,GRM1,BRD-A87125127,3-MATIDA,glutamate receptor antagonist,GRM1
KOQIAZNBAWFSQM,BRD-K73309154,OSI-420,EGFR inhibitor,EGFR,BRD-K73309154,OSI-420,EGFR inhibitor,EGFR,BRD-K73309154,OSI-420,EGFR inhibitor,EGFR,BRD-K73309154,OSI-420,EGFR inhibitor,EGFR
KORNTPPJEAJQIU,BRD-K86882815,cabergoline,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,BRD-K86882815,cabergoline,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,BRD-K34586087|BRD-K86882815,cabergoline,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,BRD-K34586087|BRD-K86882815,cabergoline,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7
KORPMXSVHOHPMS,BRD-M02899238,beta-hydroxy-beta-methylbutyrate,protein synthesis stimulant,MTOR,BRD-M02899238,beta-hydroxy-beta-methylbutyrate,protein synthesis stimulant,MTOR,BRD-M02899238,beta-hydroxy-beta-methylbutyrate,protein synthesis stimulant,MTOR,BRD-M02899238,beta-hydroxy-beta-methylbutyrate,protein synthesis stimulant,MTOR
KOWVJDFMEZKDDT,BRD-K45437867,5-methylfurmethiodide,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K45437867,5-methylfurmethiodide,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K45437867,5-methylfurmethiodide,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K45437867,5-methylfurmethiodide,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
KOYXXLLNCXWUNF,BRD-K68453341,GS-6201,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K68453341,GS-6201,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K68453341,GS-6201,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K68453341,GS-6201,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
KPBNHDGDUADAGP,BRD-K58550667,FK-866,niacinamide phosphoribosyltransferase inhibitor,NAMPT,BRD-K58550667,FK-866,niacinamide phosphoribosyltransferase inhibitor,NAMPT,BRD-K58550667,FK-866,niacinamide phosphoribosyltransferase inhibitor,NAMPT,BRD-K58550667,FK-866,niacinamide phosphoribosyltransferase inhibitor,NAMPT
KPBZROQVTHLCDU,BRD-A01563671,cleviprex,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,BRD-A01563671,cleviprex,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,BRD-A01563671,cleviprex,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,BRD-A01563671,cleviprex,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S
KPGXRSRHYNQIFN,BRD-K89712525,2-oxoglutaric-acid,,OXGR1,BRD-K89712525,2-oxoglutaric-acid,,OXGR1,BRD-K89712525,2-oxoglutaric-acid,,OXGR1,BRD-K89712525,2-oxoglutaric-acid,,OXGR1
KPJZHOPZRAFDTN,BRD-K35941380,methysergide,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K35941380,methysergide,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K35941380,methysergide,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K35941380,methysergide,serotonin receptor antagonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
KPQZUUQMTUIKBP,BRD-A70083328,secnidazole,acetylcholinesterase inhibitor|microtubule inhibitor,,BRD-A70083328,secnidazole,acetylcholinesterase inhibitor|microtubule inhibitor,,BRD-A70083328,secnidazole,acetylcholinesterase inhibitor|microtubule inhibitor,,BRD-A70083328,secnidazole,acetylcholinesterase inhibitor|microtubule inhibitor,
KPRTURMJVWXURQ,BRD-K62490786,ibrolipim,lipoprotein lipase activator,LPL,BRD-K62490786,ibrolipim,lipoprotein lipase activator,LPL,BRD-K62490786,ibrolipim,lipoprotein lipase activator,LPL,BRD-K62490786,ibrolipim,lipoprotein lipase activator,LPL
KPSRODZRAIWAKH,BRD-A49358627,ciprofibrate,PPAR receptor agonist,PPARA,BRD-A49358627,ciprofibrate,PPAR receptor agonist,PPARA,BRD-A49358627,ciprofibrate,PPAR receptor agonist,PPARA,BRD-A49358627,ciprofibrate,PPAR receptor agonist,PPARA
KPWSJANDNDDRMB,BRD-K57764956,cariprazine,dopamine receptor antagonist,DRD2|DRD3,BRD-K57764956,cariprazine,dopamine receptor antagonist,DRD2|DRD3,BRD-K57764956,cariprazine,dopamine receptor antagonist,DRD2|DRD3,BRD-K57764956,cariprazine,dopamine receptor antagonist,DRD2|DRD3
KPYSYYIEGFHWSV,BRD-A84174873|BRD-K62353271,baclofen|baclofen-(R),benzodiazepine receptor agonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A84174873|BRD-K62353271,baclofen|baclofen-(R),benzodiazepine receptor agonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A84174873|BRD-K62353271,baclofen|baclofen-(R),benzodiazepine receptor agonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-K01826724|BRD-K62353271,(R)-baclofen|baclofen,benzodiazepine receptor agonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
KQCZCINJGIRLCD,BRD-K95292280,SB-657510,urotensin receptor antagonist,UTS2R,BRD-K95292280,SB-657510,urotensin receptor antagonist,UTS2R,BRD-K95292280,SB-657510,urotensin receptor antagonist,UTS2R,BRD-K95292280,SB-657510,urotensin receptor antagonist,UTS2R
KQDBVHKNIYROHU,BRD-K30977212,PIK-293,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K30977212,PIK-293,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K30977212,PIK-293,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K30977212,PIK-293,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
KQDRVXQXKZXMHP,BRD-K58486055,reparixin,CC chemokine receptor antagonist,CXCR1|CXCR2,BRD-K58486055,reparixin,CC chemokine receptor antagonist,CXCR1|CXCR2,BRD-K58486055,reparixin,CC chemokine receptor antagonist,CXCR1|CXCR2,BRD-K58486055,reparixin,CC chemokine receptor antagonist,CXCR1|CXCR2
KQEPIRKXSUIUTH,BRD-A35623999,CGP-37157,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,SLC8A1,BRD-A35623999,CGP-37157,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,SLC8A1,BRD-A35623999,CGP-37157,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,SLC8A1,BRD-A35623999,CGP-37157,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,SLC8A1
KQKPFRSPSRPDEB,BRD-K50938287,sumatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,BRD-K50938287,sumatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,BRD-K50938287,sumatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,BRD-K50938287,sumatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7
KQNZDYYTLMIZCT,BRD-A84228258|BRD-K77841042,brefeldin-a,protein synthesis inhibitor,ARF1|CYTH2,BRD-A84228258|BRD-K77841042,brefeldin-a,protein synthesis inhibitor,ARF1|CYTH2,BRD-A84228258|BRD-K77841042,brefeldin-a,protein synthesis inhibitor,ARF1|CYTH2,BRD-A84228258|BRD-K77841042,brefeldin-A,protein synthesis inhibitor,ARF1|CYTH2
KQOXLKOJHVFTRN,BRD-K27625831,pleconaril,,,BRD-K27625831,pleconaril,,,BRD-K27625831,pleconaril,,,BRD-K27625831,pleconaril,,
KQWVAUSXZDRQPZ,BRD-K29546239,SNC-80,,OPRD1,BRD-K29546239,SNC-80,,OPRD1,BRD-K29546239,SNC-80,,OPRD1,BRD-K29546239,SNC-80,,OPRD1
KQXDHUJYNAXLNZ,BRD-A32757659|BRD-A46641338|BRD-A98605041,salinomycin,,,BRD-A28301258,salinomycin,,,BRD-A28301258|BRD-A46641338|BRD-A98605041,salinomycin,,,BRD-K23414042,salinomycin,,
KQXKVJAGOJTNJS,BRD-K55705469,penbutolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B,BRD-K55705469,penbutolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B,BRD-K55705469,penbutolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B,BRD-K55705469,penbutolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B
KRGQEOSDQHTZMX,BRD-A08112603|BRD-A85242401,ascorbic-acid,antioxidant,ALKBH2|ALKBH3|BBOX1|DBH|EGLN1|EGLN2|EGLN3|KDM5D|LCT|OGFOD1|OGFOD2|P3H1|P3H2|P3H3|P4HA1|P4HTM|PAM|PHYH|PLOD1|PLOD2|PLOD3|SLC23A1|SLC23A2|TMLHE,BRD-A08112603|BRD-A85242401,ascorbic-acid,antioxidant,ALKBH2|ALKBH3|BBOX1|DBH|EGLN1|EGLN2|EGLN3|KDM5D|LCT|OGFOD1|OGFOD2|P3H1|P3H2|P3H3|P4HA1|P4HTM|PAM|PHYH|PLOD1|PLOD2|PLOD3|SLC23A1|SLC23A2|TMLHE,BRD-A08112603|BRD-A85242401,ascorbic-acid,antioxidant,ALKBH2|ALKBH3|BBOX1|DBH|EGLN1|EGLN2|EGLN3|KDM5D|LCT|OGFOD1|OGFOD2|P3H1|P3H2|P3H3|P4HA1|P4HTM|PAM|PHYH|PLOD1|PLOD2|PLOD3|SLC23A1|SLC23A2|TMLHE,BRD-A08112603|BRD-A85242401,ascorbic-acid,antioxidant,SLC23A1|SLC23A2
KRIKILRRJCIWNB,BRD-K75664313,JW-74,WNT signaling inhibitor|tankyrase inhibitor,TNKS|TNKS2,BRD-K75664313,JW-74,WNT signaling inhibitor|tankyrase inhibitor,TNKS|TNKS2,BRD-K75664313,JW-74,WNT signaling inhibitor|tankyrase inhibitor,TNKS|TNKS2,BRD-K75664313,JW-74,WNT signaling inhibitor|tankyrase inhibitor,TNKS|TNKS2
KRKNYBCHXYNGOX,BRD-K76792669,citric-acid,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2,BRD-K76792669,citric-acid,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2,BRD-K76792669|BRD-M87682871,citric-acid,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2,BRD-K76792669|BRD-M87682871,citric-acid,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2
KRKRAOXTGDJWNI,BRD-K72106461,SYM-2081,kainate receptor antagonist,GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2,BRD-K72106461,SYM-2081,kainate receptor antagonist,GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2,BRD-K72106461,SYM-2081,kainate receptor antagonist,GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2,BRD-K72106461,SYM-2081,kainate receptor antagonist,GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2
KRMDCWKBEZIMAB,BRD-K53737926,amitriptyline,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninnorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,BRD-K53737926,amitriptyline,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninnorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,BRD-K53737926,amitriptyline,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninnorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,BRD-K53737926,amitriptyline,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninnorepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4
KRNAOFGYEFKHPB,BRD-K55781385,BMS-927711,calcitonin antagonist,CALCA,BRD-K55781385,BMS-927711,calcitonin antagonist,CALCA,BRD-K55781385,BMS-927711,calcitonin antagonist,CALCA,BRD-K55781385,rimegepant,calcitonin antagonist,CALCA
KRVDMABBKYMBHG,BRD-K66480997,isoguvacine,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,BRD-K66480997,isoguvacine,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,BRD-K66480997,isoguvacine,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,BRD-K66480997,isoguvacine,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3
KRVMLPUDAOWOGN,BRD-K00234327,RU-24969,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6,BRD-K00234327,RU-24969,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6,BRD-K00234327|BRD-M08478673,RU-24969,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6,BRD-K00234327|BRD-M08478673,RU-24969,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6
KRWMERLEINMZFT,BRD-K92041145,O6-Benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,BRD-K92041145,O6-Benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,BRD-K92041145,O6-Benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,BRD-K92041145,O6-benzylguanine,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT
KSCFJBIXMNOVSH,BRD-A00827783,dyphylline,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B,BRD-A00827783,dyphylline,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B,BRD-A00827783,dyphylline,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B,BRD-A00827783,dyphylline,adenosine receptor antagonist|phosphodiesterase inhibitor,PDE4A
KSEBMYQBYZTDHS,BRD-K66295376,ferulic-acid,antioxidant,CA1|CA12|CA14|CA2|CA4|CA6|CA9,BRD-K66295376,ferulic-acid,antioxidant,CA1|CA12|CA14|CA2|CA4|CA6|CA9,BRD-K66295376,ferulic-acid,antioxidant,CA1|CA12|CA14|CA2|CA4|CA6|CA9,BRD-K66295376,ferulic-acid,antioxidant,CA1|CA12|CA14|CA2|CA4|CA6|CA9
KSERXGMCDHOLSS,BRD-K28965160,BVD-523,MAP kinase inhibitor,,BRD-K28965160,BVD-523,MAP kinase inhibitor,,BRD-K28965160,BVD-523,MAP kinase inhibitor,,BRD-K28965160,BVD-523,MAP kinase inhibitor,
KSEYRUGYKHXGFW,BRD-A03061970,alizapride,dopamine receptor antagonist,DRD2,BRD-A03061970,alizapride,dopamine receptor antagonist,DRD2,BRD-A03061970,alizapride,dopamine receptor antagonist,DRD2,BRD-K00003607,alizapride,dopamine receptor antagonist,
KSFOVUSSGSKXFI,BRD-K26813314,protoporphyrin-ix,heme oxygenase inhibitor,HMOX1,BRD-K26813314,protoporphyrin-ix,heme oxygenase inhibitor,HMOX1,BRD-K26813314,protoporphyrin-ix,heme oxygenase inhibitor,HMOX1,,,,
KSGXQBZTULBEEQ,BRD-K57041787,dabigatran-etexilate,thrombin inhibitor,F2,BRD-K57041787,dabigatran-etexilate,thrombin inhibitor,F2,BRD-K57041787,dabigatran-etexilate,thrombin inhibitor,F2,BRD-K57041787,dabigatran-etexilate,thrombin inhibitor,F2
KSMAGQUYOIHWFS,BRD-A02990301,lofexidine,adrenergic receptor agonist,ADRA2A,BRD-A02990301,lofexidine,adrenergic receptor agonist,ADRA2A,BRD-A02990301,lofexidine,adrenergic receptor agonist,ADRA2A,BRD-A02990301,lofexidine,adrenergic receptor agonist,
KSMRODHGGIIXDV,BRD-K13619941,aceglutamide,,,BRD-K13619941,aceglutamide,,,BRD-K13619941,aceglutamide,,,BRD-K13619941,aceglutamide,,
KSMZEXLVHXZPEF,BRD-K36949735,anlotinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR|PDGFRB,BRD-K36949735,anlotinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR|PDGFRB,BRD-K36949735,anlotinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR|PDGFRB,BRD-K36949735,anlotinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR|PDGFRB
KSNUCNRMDYJBKT,BRD-K19426040,OPC-21268,vasopressin receptor antagonist,AVPR1A|AVPR2|OXTR,BRD-K19426040,OPC-21268,vasopressin receptor antagonist,AVPR1A|AVPR2|OXTR,BRD-K19426040,OPC-21268,vasopressin receptor antagonist,AVPR1A|AVPR2|OXTR,BRD-K19426040,OPC-21268,vasopressin receptor antagonist,AVPR1A|AVPR2|OXTR
KSQCNASWXSCJTD,BRD-A62197763,enciprazine,GABA receptor modulator,GABRA1,BRD-A62197763,enciprazine,GABA receptor modulator,GABRA1,BRD-A62197763,enciprazine,GABA receptor modulator,GABRA1,BRD-A62197763,enciprazine,GABA receptor modulator,GABRA1
KSUDUUBCXJUFRL,BRD-A13689093,ONO-4059,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A13689093,ONO-4059,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A13689093,ONO-4059,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,,,
KTBSXLIQKWEBRB,BRD-K67482377,itacitinib,JAK inhibitor,JAK1,BRD-K67482377,itacitinib,JAK inhibitor,JAK1,BRD-K67482377,itacitinib,JAK inhibitor,JAK1,BRD-K67482377,itacitinib,JAK inhibitor,JAK1
KTEIFNKAUNYNJU,BRD-A75349800|BRD-K40308497|BRD-K78431006,crizotinib|crizotinib-(S),ALK tyrosine kinase receptor inhibitor|MTH1 inhibitor,ALK|MET|NUDT1,BRD-A75349800|BRD-K40308497|BRD-K78431006,crizotinib|crizotinib-(S),ALK tyrosine kinase receptor inhibitor|MTH1 inhibitor,ALK|MET|NUDT1,BRD-A75349800|BRD-K40308497|BRD-K78431006,crizotinib|crizotinib-(S),ALK tyrosine kinase receptor inhibitor|MTH1 inhibitor,ALK|MET|NUDT1,BRD-A75349800|BRD-K40308497|BRD-K78431006,crizotinib|crizotinib-(S),ALK tyrosine kinase receptor inhibitor|MTH1 inhibitor,ALK|MET|NUDT1
KTEXNACQROZXEV,BRD-K28120222|BRD-K34851558|BRD-K98548675,parthenolide|parthenolide-(-)|parthenolide-(alternate-stereo),NFkB pathway inhibitor,|HDAC1|IKBKB|RELA,BRD-K28120222|BRD-K34851558|BRD-K98548675,parthenolide|parthenolide-(-)|parthenolide-(alternate-stereo),NFkB pathway inhibitor,|HDAC1|IKBKB|RELA,BRD-K28120222|BRD-K34851558|BRD-K98548675,parthenolide|parthenolide-(-)|parthenolide-(alternate-stereo),NFkB pathway inhibitor,|HDAC1|IKBKB|RELA,BRD-K28120222|BRD-K34851558|BRD-K98548675,parthenolide|parthenolide-(-)|parthenolide-(alternate-stereo),NFkB pathway inhibitor,|HDAC1|IKBKB|RELA
KTHVBAZBLKXIHZ,BRD-A97479839,piperidolate,acetylcholine receptor antagonist,CHRM1,BRD-A97479839,piperidolate,acetylcholine receptor antagonist,CHRM1,BRD-A97479839,piperidolate,acetylcholine receptor antagonist,CHRM1,BRD-A97479839,piperidolate,acetylcholine receptor antagonist,CHRM1
KTIHEFSORPLWRR,BRD-K16136380,pyrithione-zinc,ATP synthase inhibitor,KCNQ1|KCNQ2|KCNQ4|KCNQ5,BRD-K16136380,pyrithione-zinc,ATP synthase inhibitor,KCNQ1|KCNQ2|KCNQ4|KCNQ5,BRD-K16136380|BRD-U31911056|BRD-U32859412|BRD-U63926453,pyrithione-zinc,ATP synthase inhibitor,KCNQ1|KCNQ2|KCNQ4|KCNQ5,BRD-K16136380|BRD-U31911056|BRD-U32859412|BRD-U63926453,pyrithione-zinc,ATP synthase inhibitor,KCNQ1|KCNQ2|KCNQ4|KCNQ5
KTKGACLAXAFYNU,BRD-M01344114,threo-2-methylisocitrate-(DL),isocitrate lyase substrate,,BRD-M01344114,threo-2-methylisocitrate-(DL),isocitrate lyase substrate,,BRD-M01344114,threo-2-methylisocitrate-(DL),isocitrate lyase substrate,,,,,
KTOYYUONFQWSMW,BRD-K48429278,pipotiazine-palmitate,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|DRD2|HTR1A|HTR2A,BRD-K48429278,pipotiazine-palmitate,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|DRD2|HTR1A|HTR2A,BRD-K48429278,pipotiazine-palmitate,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|DRD2|HTR1A|HTR2A,BRD-K48429278,pipotiazine-palmitate,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|DRD2|HTR1A|HTR2A
KTUFNOKKBVMGRW,BRD-K92723993,imatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,BRD-K92723993,imatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,BRD-K92723993,imatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,BRD-K92723993,imatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET
KTXBOOWDLPUROC,BRD-A86871940,nicaraven,free radical scavenger,,BRD-A86871940,nicaraven,free radical scavenger,,BRD-A86871940,nicaraven,free radical scavenger,,BRD-A86871940,nicaraven,free radical scavenger,
KUAZQDVKQLNFPE,BRD-K29254801,thiram,,JAK2,BRD-K29254801,thiram,,JAK2,BRD-K29254801,thiram,,JAK2,BRD-K29254801,thiram,,JAK2
KUBCEEMXQZUPDQ,BRD-K93631643,hordenine,,,BRD-K93631643,hordenine,,,BRD-K93631643,hordenine,,,BRD-K93631643,hordenine,,
KUBONGDXTUOOLM,BRD-K08996725,zolantidine,histamine receptor antagonist,,BRD-K08996725,zolantidine,histamine receptor antagonist,,BRD-K08996725,zolantidine,histamine receptor antagonist,,BRD-K08996725,zolantidine,histamine receptor antagonist,
KUECXUACQOYKNB,BRD-K33864865,LY225910,CCK receptor antagonist,CCKBR,BRD-K33864865,LY225910,CCK receptor antagonist,CCKBR,BRD-K33864865,LY225910,CCK receptor antagonist,CCKBR,BRD-K33864865,LY225910,CCK receptor antagonist,CCKBR
KUEUWHJGRZKESU,BRD-K11256763,niceritrol,NAD precursor,,BRD-K11256763,niceritrol,NAD precursor,,BRD-K11256763,niceritrol,NAD precursor,,BRD-K11256763,niceritrol,NAD precursor,
KUFRQPKVAWMTJO,BRD-K23499943|BRD-K83988098,alvespimycin,HSP inhibitor,HSP90AA1,BRD-K23499943|BRD-K83988098,alvespimycin,HSP inhibitor,HSP90AA1,BRD-K23499943|BRD-K83988098,alvespimycin,HSP inhibitor,HSP90AA1,BRD-K23499943|BRD-K83988098,alvespimycin,HSP inhibitor,HSP90AA1
KUTAVMCJCVADGZ,BRD-K55790047,ON-01500,apoptosis stimulant,,BRD-K55790047,ON-01500,apoptosis stimulant,,BRD-K55790047,ON-01500,apoptosis stimulant,,BRD-K55790047,ON-01500,apoptosis stimulant,
KUUJEXLRLIPQQJ,BRD-A18763547,BAX-channel-blocker,cytochrome C release inhibitor,BAX,BRD-A18763547,BAX-channel-blocker,cytochrome C release inhibitor,BAX,BRD-A18763547,BAX-channel-blocker,cytochrome C release inhibitor,BAX,BRD-K01826533,BAX-channel-blocker,cytochrome C release inhibitor,BAX
KUVIULQEHSCUHY,BRD-A11319535|BRD-K97429934|BRD-K97810537,beclomethasone-dipropionate,glucocorticoid receptor agonist,GPR97|NR3C1,BRD-A11319535|BRD-K76747609|BRD-K97810537,beclomethasone-dipropionate,glucocorticoid receptor agonist,GPR97|NR3C1,BRD-A11319535|BRD-K97429934|BRD-K97810537,beclomethasone-dipropionate,glucocorticoid receptor agonist,GPR97|NR3C1,BRD-A11319535|BRD-K97429934|BRD-K97810537,beclomethasone-dipropionate,glucocorticoid receptor agonist,GPR97|NR3C1
KVCSJPATKXABRQ,BRD-K02750403,piboserod,serotonin receptor antagonist,HTR2B|HTR4,BRD-K02750403,piboserod,serotonin receptor antagonist,HTR2B|HTR4,BRD-K02750403,piboserod,serotonin receptor antagonist,HTR2B|HTR4,BRD-K02750403,piboserod,serotonin receptor antagonist,HTR2B|HTR4
KVDWOQGDMAEJLM,BRD-K22667752,NS-8,potassium channel agonist,KCNMA1,BRD-K22667752,NS-8,potassium channel agonist,KCNMA1,BRD-K22667752,NS-8,potassium channel agonist,KCNMA1,BRD-K22667752,NS-8,potassium channel agonist,KCNMA1
KVHHQGIIZCJATJ,BRD-A43809092,clobutinol,antitussive,,BRD-A43809092,clobutinol,antitussive,,BRD-A43809092,clobutinol,antitussive,,BRD-A43809092,clobutinol,antitussive,
KVHRYLNQDWXAGI,BRD-K57155378,TAK-063,phosphodiesterase inhibitor,PDE10A,BRD-K57155378,TAK-063,phosphodiesterase inhibitor,PDE10A,BRD-K57155378,TAK-063,phosphodiesterase inhibitor,PDE10A,BRD-K57155378,TAK-063,phosphodiesterase inhibitor,PDE10A
KVLFRAWTRWDEDF,BRD-K69932463,AZD8055,mTOR inhibitor,MTOR,BRD-K69932463,AZD8055,mTOR inhibitor,MTOR,BRD-K69932463,AZD8055,mTOR inhibitor,MTOR,BRD-K69932463,AZD8055,mTOR inhibitor,MTOR
KVMCEGAWQYTFKC,BRD-K50813454,amflutizole,xanthine oxidase inhibitor,XDH,BRD-K50813454,amflutizole,xanthine oxidase inhibitor,XDH,BRD-K50813454,amflutizole,xanthine oxidase inhibitor,XDH,BRD-K50813454,amflutizole,xanthine oxidase inhibitor,XDH
KVSKGMLNBAPGKH,BRD-K09118247,tribomsalan,,,BRD-K09118247,tribomsalan,,,BRD-K09118247,tribomsalan,,,BRD-K09118247,tribomsalan,,
KVWDHTXUZHCGIO,BRD-K18895904,olanzapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,BRD-K18895904,olanzapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,BRD-K18895904,olanzapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,BRD-K18895904,olanzapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7
KWBTZIFLQYYPTH,BRD-K82687598,tolonidine,adrenergic receptor antagonist,ADRA2A,BRD-K82687598,tolonidine,adrenergic receptor antagonist,ADRA2A,BRD-K82687598,tolonidine,adrenergic receptor antagonist,ADRA2A,BRD-K82687598,tolonidine,adrenergic receptor antagonist,ADRA2A
KWGRBVOPPLSCSI,BRD-A54236247|BRD-K45014108,ephedrine|ephedrine-(racemic),adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB2|SLC18A2|SLC6A2,BRD-A54236247|BRD-K45014108,ephedrine|ephedrine-(racemic),adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB2|SLC18A2|SLC6A2,BRD-A54236247|BRD-K45014108,ephedrine|ephedrine-(racemic),adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB2|SLC18A2|SLC6A2,BRD-A54236247|BRD-K45014108,ephedrine|ephedrine-(racemic),adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB1|ADRB2|ATF1|ATF2|ATF3|ATF4|ATF5|ATF6|ATF7|FOS|IL2|JDP2|JUN|NFATC1|SLC18A2|SLC6A2|SLC6A3|SLC6A4|TNF
KWIUHFFTVRNATP,BRD-K12014493,betaine,nitric oxide donor,,BRD-K12014493,betaine,nitric oxide donor,,BRD-K12014493|BRD-M80997309,betaine,nitric oxide donor,,BRD-K12014493|BRD-M80997309,betaine,nitric oxide donor,
KWMBIIQCLUIHDI,BRD-A43885598,SID-7969543,steroidogenic factor antagonist,NR5A1,BRD-A43885598,SID-7969543,steroidogenic factor antagonist,NR5A1,BRD-A43885598,SID-7969543,steroidogenic factor antagonist,NR5A1,BRD-A43885598,SID-7969543,steroidogenic factor antagonist,NR5A1
KWMLJOLKUYYJFJ,BRD-K35952844,calcium-gluceptate|sodium-glucoheptonate,,,BRD-K35952844,calcium-gluceptate|sodium-glucoheptonate,,,BRD-K35952844|BRD-K74392481|BRD-M41172429,calcium-gluceptate|sodium-glucoheptonate,,,BRD-K35952844|BRD-K74392481|BRD-M41172429,calcium-gluceptate,,
KWORUUGOSLYAGD,BRD-A56892734,omeprazole-magnesium,proton pump inhibitor,ATP4A|ATP4B,BRD-A56892734,omeprazole-magnesium,proton pump inhibitor,ATP4A|ATP4B,BRD-A56892734,omeprazole-magnesium,proton pump inhibitor,ATP4A|ATP4B,BRD-A56892734,omeprazole-magnesium,proton pump inhibitor,ATP4A|ATP4B
KWQNQSDKCINQQP,BRD-K46648676,gallium-triquinolin-8-olate,,,BRD-K46648676,gallium-triquinolin-8-olate,,,BRD-K46648676,gallium-triquinolin-8-olate,,,BRD-K46648676,gallium-triquinolin-8-olate,,
KWQWBZIGHIOKIO,BRD-K33860217,CP-94253,serotonin receptor agonist,HTR1B,BRD-K33860217,CP-94253,serotonin receptor agonist,HTR1B,BRD-K33860217,CP-94253,serotonin receptor agonist,HTR1B,BRD-K33860217,CP-94253,serotonin receptor agonist,HTR1B
KWRYMZHCQIOOEB,BRD-A58947127|BRD-K21077415,AMG-319|AMG319,PI3K inhibitor,PIK3CD,BRD-A58947127|BRD-K21077415,AMG-319|AMG319,PI3K inhibitor,PIK3CD,BRD-A58947127|BRD-K21077415,AMG-319|AMG319,PI3K inhibitor,PIK3CD,BRD-A58947127|BRD-K21077415,AMG-319|AMG319,PI3K inhibitor,PIK3CD
KWTSXDURSIMDCE,BRD-K21160401,dextroamphetamine,monoamine oxidase inhibitor,ADRA1A|ADRA1B|SLC18A2|SLC6A2|SLC6A3|TAAR1,BRD-K21160401,dextroamphetamine,monoamine oxidase inhibitor,ADRA1A|ADRA1B|SLC18A2|SLC6A2|SLC6A3|TAAR1,BRD-K21160401,dextroamphetamine,monoamine oxidase inhibitor,ADRA1A|ADRA1B|SLC18A2|SLC6A2|SLC6A3|TAAR1,,,,
KWTWDQCKEHXFFR,BRD-K04283354|BRD-K25699529,tapentadol,opioid receptor agonist,HTR3A|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4,BRD-K04283354|BRD-K25699529,tapentadol,opioid receptor agonist,HTR3A|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4,BRD-K04283354|BRD-K25699529,tapentadol,opioid receptor agonist,HTR3A|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4,,,,
KXBDTLQSDKGAEB,BRD-K87782578,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,BRD-K87782578,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,BRD-K87782578,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,BRD-K87782578,AVL-292,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1
KXDONFLNGBQLTN,BRD-K87919739,tyrphostin-AG-825,protein tyrosine kinase inhibitor,ERBB2,BRD-K87919739,tyrphostin-AG-825,protein tyrosine kinase inhibitor,ERBB2,BRD-K87919739,tyrphostin-AG-825,protein tyrosine kinase inhibitor,ERBB2,BRD-K87919739,tyrphostin-AG-825,protein tyrosine kinase inhibitor,ERBB2
KXDROGADUISDGY,BRD-K97688263,benzamil,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,BRD-K87158025|BRD-K97688263,benzamil,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,BRD-K87158025|BRD-K97688263,benzamil,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,BRD-K87158025|BRD-K97688263,benzamil,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1
KXDZWUPUSDCGDD,BRD-K81026553,BMS-817378,VEGFR inhibitor|c-Met inhibitor,KDR|MET,BRD-K81026553,BMS-817378,VEGFR inhibitor|c-Met inhibitor,KDR|MET,BRD-K81026553,BMS-817378,VEGFR inhibitor|c-Met inhibitor,KDR|MET,BRD-K81026553,BMS-817378,VEGFR inhibitor|c-Met inhibitor,KDR|MET
KXGCNMMJRFDFNR,BRD-A55468767,linaclotide,guanylate cyclase activator,GUCY2C,BRD-A55468767,linaclotide,guanylate cyclase activator,GUCY2C,BRD-A55468767,linaclotide,guanylate cyclase activator,GUCY2C,BRD-K00003592,linaclotide,guanylate cyclase activator,GUCY2C
KXGVEGMKQFWNSR,BRD-K41170226,deoxycholic-acid,G protein-coupled receptor agonist|biliverdin reductase A activator,EFTUD1|FPR1|GPBAR1,BRD-K41170226,deoxycholic-acid,G protein-coupled receptor agonist|biliverdin reductase A activator,EFTUD1|FPR1|GPBAR1,BRD-K41170226,deoxycholic-acid,G protein-coupled receptor agonist|biliverdin reductase A activator,EFTUD1|FPR1|GPBAR1,BRD-K41170226,deoxycholic-acid,G protein-coupled receptor agonist|biliverdin reductase A activator,FPR1|GPBAR1
KXMTXZACPVCDMH,BRD-K16546375,bicyclol,NFkB pathway inhibitor,HSPA1A|HSPB1,BRD-K16546375,bicyclol,NFkB pathway inhibitor,HSPA1A|HSPB1,BRD-K16546375,bicyclol,NFkB pathway inhibitor,HSPA1A|HSPB1,BRD-K16546375,bicyclol,NFkB pathway inhibitor,HSPA1A|HSPB1
KXMZDGSRSGHMMK,BRD-K14870255,R-428,AXL kinase inhibitor,AXL,BRD-K14870255,R-428,AXL kinase inhibitor,AXL,BRD-K14870255,R-428,AXL kinase inhibitor,AXL,BRD-K14870255,R-428,AXL kinase inhibitor,AXL
KXNPVXPOPUZYGB,BRD-A10012892,argatroban,thrombin inhibitor,F2,BRD-A10012892|BRD-A48261811,argatroban,thrombin inhibitor,F2,BRD-A10012892|BRD-A48261811,argatroban,thrombin inhibitor,F2,BRD-A10012892|BRD-A48261811,argatroban,thrombin inhibitor,F2
KXRZBTAEDBELFD,BRD-K17205817,sulfametopyrazine,PABA antagonist,,BRD-K17205817,sulfametopyrazine,PABA antagonist,,BRD-K17205817,sulfametopyrazine,PABA antagonist,,BRD-K17205817,sulfametopyrazine,PABA antagonist,
KYAKGJDISSNVPZ,BRD-K49840922,etofylline-clofibrate,platelet aggregation inhibitor,PPARA,BRD-K49840922,etofylline-clofibrate,platelet aggregation inhibitor,PPARA,BRD-K49840922,etofylline-clofibrate,platelet aggregation inhibitor,PPARA,BRD-K49840922,etofylline-clofibrate,platelet aggregation inhibitor,PPARA
KYCBWEZLKCTALM,BRD-K92129045,caroxazone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K92129045,caroxazone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K92129045,caroxazone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K92129045,caroxazone,monoamine oxidase inhibitor,MAOA|MAOB
KYGZCKSPAKDVKC,BRD-K73394555,oxolinic-acid,bacterial DNA gyrase inhibitor,,BRD-K73394555,oxolinic-acid,bacterial DNA gyrase inhibitor,,BRD-K73394555,oxolinic-acid,bacterial DNA gyrase inhibitor,,BRD-K73394555,oxolinic-acid,bacterial DNA gyrase inhibitor,
KYHQZNGJUGFTGR,BRD-A28887267,proxyphylline,,,BRD-A28887267,proxyphylline,,,BRD-A28887267,proxyphylline,,,BRD-A28887267,Proxyphylline,,
KYHRXPHIUFTLNH,BRD-K61230716,sodium-nitrite,nitric oxide donor,,BRD-K61230716,sodium-nitrite,nitric oxide donor,,BRD-K61230716,sodium-nitrite,nitric oxide donor,,,,,
KYHVWHYLKOHLKA,BRD-K40870905,CT-7758,integrin antagonist,ITGA4,BRD-K40870905,CT-7758,integrin antagonist,ITGA4,BRD-K40870905,CT-7758,integrin antagonist,ITGA4,BRD-K40870905,CT-7758,integrin antagonist,ITGA4
KYLIZBIRMBGUOP,BRD-K92490248,anethole-trithione,glutathione transferase stimulant,,BRD-K92490248,anethole-trithione,glutathione transferase stimulant,,BRD-K92490248,anethole-trithione,glutathione transferase stimulant,,BRD-K92490248,anethole-trithione,glutathione transferase stimulant,
KYRVNWMVYQXFEU,BRD-K12539581,nocodazole,tubulin polymerization inhibitor,HPGDS,BRD-K12539581,nocodazole,tubulin polymerization inhibitor,HPGDS,BRD-K12539581,nocodazole,tubulin polymerization inhibitor,HPGDS,BRD-K12539581,nocodazole,tubulin polymerization inhibitor,HPGDS
KYSFUHHFTIGRJN,BRD-K20568871,tifenazoxide,ATP-sensitive potassium channel agonist,ABCC8|KCNJ11,BRD-K20568871,tifenazoxide,ATP-sensitive potassium channel agonist,ABCC8|KCNJ11,BRD-K20568871,tifenazoxide,ATP-sensitive potassium channel agonist,ABCC8|KCNJ11,BRD-K20568871,tifenazoxide,ATP-sensitive potassium channel agonist,ABCC8|KCNJ11
KYWCWBXGRWWINE,BRD-K67277431,picotamide,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,BRD-K67277431,picotamide,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,BRD-K67277431,picotamide,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,BRD-K67277431,picotamide,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R
KYWWJENKIMRJBI,BRD-K54520417,LXR-623,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,BRD-K54520417,LXR-623,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,BRD-K54520417,LXR-623,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,BRD-K54520417,LXR-623,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1
KYYIDSXMWOZKMP,BRD-A98845662,desvenlafaxine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-A98845662,desvenlafaxine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-A98845662,desvenlafaxine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-K01825598,desvenlafaxine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4
KZENBFUSKMWCJF,BRD-K00317371,RITA,MDM inhibitor,MDM2,BRD-K00317371,RITA,MDM inhibitor,MDM2,BRD-K00317371,RITA,MDM inhibitor,MDM2,BRD-K00317371,RITA,MDM inhibitor,MDM2
KZJWDPNRJALLNS,BRD-K16553588|BRD-K79402892,sitosterol,,,BRD-K16553588|BRD-K79402892,sitosterol,,,BRD-K16553588|BRD-K79402892,sitosterol,,,BRD-K16553588|BRD-K79402892,sitosterol,,
KZNIFHPLKGYRTM,BRD-K01493881,apigenin,casein kinase inhibitor|cell proliferation inhibitor,AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1,BRD-K01493881,apigenin,casein kinase inhibitor|cell proliferation inhibitor,AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1,BRD-K01493881,apigenin,casein kinase inhibitor|cell proliferation inhibitor,AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1,BRD-K01493881,apigenin,casein kinase inhibitor|cell proliferation inhibitor,AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1
KZQYIMCESJLPQH,BRD-K84517077,N-demethylantipyrine,,,BRD-K84517077,N-demethylantipyrine,,,BRD-K84517077,N-demethylantipyrine,,,BRD-K35458079,edaravone,nootropic agent,BCL2
KZSNJWFQEVHDMF,BRD-K59424860,val,,BCAT1|PCCB|VARS,BRD-K59424860,val,,BCAT1|PCCB|VARS,BRD-K59424860,val,,BCAT1|PCCB|VARS,BRD-K59424860,L-valine,,
LAINPTZBIXYTIZ,BRD-K14920963,erythrosine,coloring agent,,BRD-K14920963,erythrosine,coloring agent,,BRD-K14920963,erythrosine,coloring agent,,,,,
LAMIXXKAWNLXOC,BRD-K13167095,AR-42,HDAC inhibitor,HDAC1,BRD-K13167095,AR-42,HDAC inhibitor,HDAC1,BRD-K13167095,AR-42,HDAC inhibitor,HDAC1,BRD-K13167095,AR-42,HDAC inhibitor,HDAC1
LAMQVIQMVKWXOC,BRD-K48452630,SRT2104,SIRT activator,SIRT1,BRD-K48452630,SRT2104,SIRT activator,SIRT1,BRD-K48452630,SRT2104,SIRT activator,SIRT1,BRD-K48452630,SRT2104,SIRT activator,SIRT1
LAOLDMMWVYDDID,BRD-K46690591,KP-1212,,,BRD-K46690591,KP-1212,,,BRD-K46690591,KP-1212,,,BRD-K46690591,KP-1212,,
LBBDCJLRQXMUAE,BRD-M30288325,G-15,estrogen receptor antagonist,GPER1,BRD-M30288325,G-15,estrogen receptor antagonist,GPER1,BRD-M30288325,G-15,estrogen receptor antagonist,GPER1,,,,
LBFWTPRSXIRKMZ,BRD-K63792901,arecaidine-but-2-ynyl-ester,acetylcholine receptor agonist,CHRM2,BRD-K63792901,arecaidine-but-2-ynyl-ester,acetylcholine receptor agonist,CHRM2,BRD-K63792901,arecaidine-but-2-ynyl-ester,acetylcholine receptor agonist,CHRM2,BRD-K63792901,arecaidine-but-2-ynyl-ester,acetylcholine receptor agonist,CHRM2
LBHIOVVIQHSOQN,BRD-K97752965,nicorandil,nitric oxide donor|potassium channel activator,KCNJ11,BRD-K97752965,nicorandil,nitric oxide donor|potassium channel activator,KCNJ11,BRD-K97752965,nicorandil,nitric oxide donor|potassium channel activator,KCNJ11,BRD-K97752965,nicorandil,nitric oxide donor|potassium channel activator,KCNJ11
LBHLFPGPEGDCJG,BRD-A78965079,tafenoquine,antimalarial agent,,BRD-A78965079,tafenoquine,antimalarial agent,,BRD-A78965079,tafenoquine,antimalarial agent,,BRD-A78965079,tafenoquine,antimalarial agent,
LBLDMHBSVIVJPM,BRD-K74990253,BW-373U86,opioid receptor agonist,OPRD1,BRD-K74990253,BW-373U86,opioid receptor agonist,OPRD1,BRD-K74990253,BW-373U86,opioid receptor agonist,OPRD1,BRD-K74990253,BW-373U86,opioid receptor agonist,OPRD1
LBOJYSIDWZQNJS,BRD-K23163214|BRD-K58930050,dizocilpine-(+)|dizocilpine-(-),glutamate receptor antagonist,|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K23163214|BRD-K58930050,dizocilpine-(+)|dizocilpine-(-),glutamate receptor antagonist,|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K23163214|BRD-K58930050,dizocilpine-(+)|dizocilpine-(-),glutamate receptor antagonist,|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K23163214|BRD-K58930050,dizocilpine-(+)|dizocilpine-(-),glutamate receptor antagonist,|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
LBPKYPYHDKKRFS,BRD-K80480517,repsox,TGF beta receptor inhibitor,TGFBR1,BRD-K80480517,repsox,TGF beta receptor inhibitor,TGFBR1,BRD-K80480517,repsox,TGF beta receptor inhibitor,TGFBR1,BRD-K80480517,repsox,TGF beta receptor inhibitor,TGFBR1
LBQNBMSPTURKGS,BRD-K63169195,U-0124,MEK inhibitor,,BRD-K63169195,U-0124,MEK inhibitor,,BRD-K63169195,U-0124,MEK inhibitor,,,,,
LBVZWEWTNUDWNS,BRD-K98155362,GR46611,serotonin receptor agonist,HTR1D,BRD-K98155362,GR46611,serotonin receptor agonist,HTR1D,BRD-K98155362,GR46611,serotonin receptor agonist,HTR1D,BRD-K98155362,GR46611,serotonin receptor agonist,HTR1D
LBXHRAWDUMTPSE,BRD-A85651701,clopamide,sodium/chloride cotransporter inhibitor,,BRD-A85651701,clopamide,sodium/chloride cotransporter inhibitor,,BRD-A85651701,clopamide,sodium/chloride cotransporter inhibitor,,BRD-K15567837,clopamide,sodium/chloride cotransporter inhibitor,
LCAFGJGYCUMTGS,BRD-A51355958,nebracetam,acetylcholine receptor agonist,CHRM1,BRD-A51355958,nebracetam,acetylcholine receptor agonist,CHRM1,BRD-A51355958,nebracetam,acetylcholine receptor agonist,CHRM1,BRD-A51355958,nebracetam,acetylcholine receptor agonist,CHRM1
LCFVJGUPQDGYKZ,BRD-A16694057,BADGE,PPAR receptor antagonist,PPARG,BRD-A16694057,BADGE,PPAR receptor antagonist,PPARG,BRD-A16694057,BADGE,PPAR receptor antagonist,PPARG,BRD-A16694057,BADGE,PPAR receptor antagonist,PPARG
LCOIAYJMPKXARU,BRD-A45107007,salubrinal,eukaryotic translation initiation factor inhibitor,EIF2S1,BRD-A45107007,salubrinal,eukaryotic translation initiation factor inhibitor,EIF2S1,BRD-A45107007,salubrinal,eukaryotic translation initiation factor inhibitor,EIF2S1,BRD-A45107007,salubrinal,eukaryotic translation initiation factor inhibitor,EIF2S1
LCQLHJZYVOQKHU,BRD-K60240222,carglumic-acid,carbamoyl phosphate synthase activator,CPS1,BRD-K60240222,carglumic-acid,carbamoyl phosphate synthase activator,CPS1,BRD-K60240222,carglumic-acid,carbamoyl phosphate synthase activator,CPS1,BRD-K60240222,carglumic-acid,carbamoyl phosphate synthase activator,CPS1
LCTONWCANYUPML,BRD-K86587225,2-oxopropanoate,pyruvate dehydrogenase kinase inhibitor,ABAT|AGXT2|PC|PDHB|PKLR|PKM|SLC16A1|SLC16A2|SLC16A3|SLC16A4|SLC16A5|SLC16A6|SLC16A7|SLC16A8,BRD-K86587225,2-oxopropanoate,pyruvate dehydrogenase kinase inhibitor,ABAT|AGXT2|PC|PDHB|PKLR|PKM|SLC16A1|SLC16A2|SLC16A3|SLC16A4|SLC16A5|SLC16A6|SLC16A7|SLC16A8,BRD-K86587225,2-oxopropanoate,pyruvate dehydrogenase kinase inhibitor,ABAT|AGXT2|PC|PDHB|PKLR|PKM|SLC16A1|SLC16A2|SLC16A3|SLC16A4|SLC16A5|SLC16A6|SLC16A7|SLC16A8,,,,
LCTZPQRFOZKZNK,BRD-K93441486,diphemanil,acetylcholine receptor antagonist,CHRM3,BRD-K93441486,diphemanil,acetylcholine receptor antagonist,CHRM3,BRD-K93441486,diphemanil,acetylcholine receptor antagonist,CHRM3,BRD-K93441486,diphemanil,acetylcholine receptor antagonist,CHRM3
LCVIRAZGMYMNNT,BRD-K53665955,MK-5108,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K53665955,MK-5108,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K53665955,MK-5108,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K53665955,MK-5108,Aurora kinase inhibitor,AURKA|AURKB|AURKC
LDBTVAXGKYIFHO,BRD-K97464279,diaveridine,dihydrofolate reductase inhibitor,,BRD-K97464279,diaveridine,dihydrofolate reductase inhibitor,,BRD-K97464279,diaveridine,dihydrofolate reductase inhibitor,,BRD-K97464279,diaveridine,dihydrofolate reductase inhibitor,
LDCRTTXIJACKKU,BRD-K31111078,dimethyl-fumarate,like (NRF2) activator|nuclear factor erythroid derived,KEAP1,BRD-K31111078,dimethyl-fumarate,like (NRF2) activator|nuclear factor erythroid derived,KEAP1,BRD-K31111078,dimethyl-fumarate,like (NRF2) activator|nuclear factor erythroid derived,KEAP1,BRD-K31111078,dimethyl-fumarate,like (NRF2) activator|nuclear factor erythroid derived,KEAP1
LDCXGZCEMNMWIL,BRD-K66241279,cinromide,,,BRD-K66241279,cinromide,,,BRD-K66241279,cinromide,,,BRD-K66241279,cinromide,,
LDCYZAJDBXYCGN,BRD-A73930134,5-hydroxytryptophan,neurotransmitter,SLC36A1|SLC36A2,BRD-A73930134,5-hydroxytryptophan,neurotransmitter,SLC36A1|SLC36A2,BRD-A73930134,5-hydroxytryptophan,neurotransmitter,SLC36A1|SLC36A2,BRD-A73930134,5-hydroxytryptophan,neurotransmitter,SLC36A1|SLC36A2
LDEKQSIMHVQZJK,BRD-A25988899,tenofovir-alafenamide,nucleoside reverse transcriptase inhibitor,,BRD-A25988899,tenofovir-alafenamide,nucleoside reverse transcriptase inhibitor,,BRD-A25988899,tenofovir-alafenamide,nucleoside reverse transcriptase inhibitor,,BRD-A25988899,tenofovir-alafenamide,nucleoside reverse transcriptase inhibitor,
LDGIHZJOIQSHPB,BRD-K28907958,CD-437,retinoid receptor agonist,RARG,BRD-K28907958,CD-437,retinoid receptor agonist,RARG,BRD-K28907958,CD-437,retinoid receptor agonist,RARG,BRD-K28907958,CD-437,retinoid receptor agonist,RARG
LDLCEGCJYSDJLX,BRD-K88956297,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",,,BRD-K88956297,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",,,BRD-K88956297,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",,,BRD-K88956297,"1-((Z)-3-chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",,
LDMWSLGGVTVJPG,BRD-K02867583,minaprine,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,BRD-K02867583,minaprine,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,BRD-K02867583,minaprine,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,BRD-K02867583,minaprine,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4
LDQKDRLEMKIYMC,BRD-K26921335,CP-640186,acetyl-CoA carboxylase inhibitor,ACACA|ACACB,BRD-K26921335,CP-640186,acetyl-CoA carboxylase inhibitor,ACACA|ACACB,BRD-K26921335,CP-640186,acetyl-CoA carboxylase inhibitor,ACACA|ACACB,BRD-K26921335,CP-640186,acetyl-CoA carboxylase inhibitor,ACACA|ACACB
LDVVMCZRFWMZSG,BRD-A79857384,captan,,,BRD-A79857384,captan,,,BRD-A79857384,captan,,,BRD-A79857384,captan,,
LDXDSHIEDAPSSA,BRD-K08586861,ramatroban,prostanoid receptor antagonist,PTGDR2|TBXA2R,BRD-K08586861,ramatroban,prostanoid receptor antagonist,PTGDR2|TBXA2R,BRD-K08586861,ramatroban,prostanoid receptor antagonist,PTGDR2|TBXA2R,BRD-K08586861,ramatroban,prostanoid receptor antagonist,PTGDR2|TBXA2R
LDXSPUSKBDTEKA,BRD-K38938675,morniflumate,anti-inflammatory agent,,BRD-K38938675,morniflumate,anti-inflammatory agent,,BRD-K38938675,morniflumate,anti-inflammatory agent,,BRD-K38938675,morniflumate,anti-inflammatory agent,
LDXYBEHACFJIEL,BRD-K05355328,anagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K05355328,anagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K05355328,anagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K05355328,anagliptin,dipeptidyl peptidase inhibitor,DPP4
LEACJMVNYZDSKR,BRD-A51407134,2-octyldodecan-1-ol,,,BRD-A51407134,2-octyldodecan-1-ol,,,BRD-A51407134,2-octyldodecan-1-ol,,,BRD-A51407134,2-octyldodecan-1-ol,,
LEBVLXFERQHONN,BRD-A01636364,bupivacaine,sodium channel blocker,KCNA5|PTGER1|SCN10A|SCN4A,BRD-A01636364,bupivacaine,sodium channel blocker,KCNA5|PTGER1|SCN10A|SCN4A,BRD-A01636364,bupivacaine,sodium channel blocker,KCNA5|PTGER1|SCN10A|SCN4A,BRD-K00003636,bupivacaine,sodium channel blocker,KCNA5|SCN10A
LECZXZOBEZITCL,BRD-A51497544,revaprazan,potassium-competitive acid antagonist,ATP4A,BRD-A51497544,revaprazan,potassium-competitive acid antagonist,ATP4A,BRD-A51497544,revaprazan,potassium-competitive acid antagonist,ATP4A,BRD-A51497544,revaprazan,potassium-competitive acid antagonist,ATP4A
LEEIJTHMHDMWLJ,BRD-K61567297,resatorvid,toll-like receptor antagonist,TLR4,BRD-K61567297,resatorvid,toll-like receptor antagonist,TLR4,BRD-K61567297,resatorvid,toll-like receptor antagonist,TLR4,BRD-K61567297,resatorvid,toll-like receptor inhibitor,TLR4
LEHOTFFKMJEONL,BRD-K01295354,uric-acid,,PYGL,BRD-K01295354,uric-acid,,PYGL,BRD-K01295354,uric-acid,,PYGL,BRD-K01295354,uric-acid,,PYGL
LENNRXOJHWNHSD,BRD-A68509429,ethylnorepinephrine,bronchodilator,,BRD-A68509429,ethylnorepinephrine,bronchodilator,,BRD-A68509429,ethylnorepinephrine,bronchodilator,,BRD-A68509429,ethylnorepinephrine,bronchodilator,
LENZDBCJOHFCAS,BRD-K47978074,trometamol,,AMD1|CANT1|DCN|NEIL1|VEGFA,BRD-K47978074,trometamol,,AMD1|CANT1|DCN|NEIL1|VEGFA,BRD-K47978074,trometamol,,AMD1|CANT1|DCN|NEIL1|VEGFA,BRD-K47978074,trometamol,,AMD1|CANT1|DCN|NEIL1|VEGFA
LEQAKWQJCITZNK,BRD-K26619122,thiocolchicoside,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,BRD-K26619122,thiocolchicoside,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,BRD-K26619122,thiocolchicoside,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,BRD-K26619122,thiocolchicoside,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB
LERNTVKEWCAPOY,BRD-K62782754,tiotropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K62782754,tiotropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K62782754,tiotropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K62782754,tiotropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3
LEVWYRKDKASIDU,BRD-A15397381|BRD-K99679910,L-Cystine,,CTNS|SLC3A1|SLC7A11|SLC7A9,BRD-A15397381|BRD-K99679910,L-Cystine,,CTNS|SLC3A1|SLC7A11|SLC7A9,BRD-A15397381|BRD-K99679910,L-Cystine,,CTNS|SLC3A1|SLC7A11|SLC7A9,BRD-K99679910,L-cystine,,CTNS|SLC3A1|SLC7A11|SLC7A9
LEZWWPYKPKIXLL,BRD-A51820102,econazole,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,BRD-A51820102,econazole,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,BRD-A51820102,econazole,lanosterol demethylase inhibitor|sterol demethylase inhibitor,CYP51A1|NPY1R|NPY2R|TRPM2|TRPV5,BRD-A51820102,econazole,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5
LFBZZHVSGAHQPP,BRD-K24240364,GYKI-52466,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K24240364,GYKI-52466,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K24240364,GYKI-52466,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K24240364,GYKI-52466,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4
LFDOEFHQLNGBQQ,BRD-K74558903,phortress,aryl hydrocarbon receptor ligand,AHR,BRD-K74558903,phortress,aryl hydrocarbon receptor ligand,AHR,BRD-K74558903,phortress,aryl hydrocarbon receptor ligand,AHR,BRD-K74558903,phortress,aryl hydrocarbon receptor ligand,AHR
LFKQSJNCVRGFCC,BRD-K47150025,KI-8751,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K47150025,KI-8751,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K47150025,KI-8751,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K47150025,KI-8751,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR
LFQDNHWZDQTITF,BRD-K76713213,tavaborole,leucyl-tRNA synthetase inhibitor,,BRD-K76713213,tavaborole,leucyl-tRNA synthetase inhibitor,,BRD-K76713213,tavaborole,leucyl-tRNA synthetase inhibitor,,BRD-K76713213,tavaborole,leucyl-tRNA synthetase inhibitor,
LFTFGCDECFPSQD,BRD-A51747092,moprolol,adrenergic receptor antagonist,,BRD-A51747092,moprolol,adrenergic receptor antagonist,,BRD-A51747092,moprolol,adrenergic receptor antagonist,,BRD-A51747092,moprolol,adrenergic receptor antagonist,
LFVVNPBBFUSSHL,BRD-A27883417,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1,BRD-A27883417,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1,BRD-A27883417,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1,BRD-A42335949,alexidine,phosphatidylglycerophosphatase inhibitor,PTPMT1
LFYJSSARVMHQJB,BRD-K09785578,bakuchiol,DNA polymerase inhibitor,HIF1A,BRD-K09785578,bakuchiol,DNA polymerase inhibitor,HIF1A,BRD-K09785578,bakuchiol,DNA polymerase inhibitor,HIF1A,BRD-K09785578,bakuchiol,DNA polymerase inhibitor,HIF1A
LGCMKPRGGJRYGM,BRD-K39693230,N-salicoylaminophenol,ribonucleotide reductase inhibitor,,BRD-K39693230,N-salicoylaminophenol,ribonucleotide reductase inhibitor,,BRD-K39693230,N-salicoylaminophenol,ribonucleotide reductase inhibitor,,BRD-K39693230,N-salicoylaminophenol,ribonucleotide reductase inhibitor,
LGEQQWMQCRIYKG,BRD-K42352790,anandamide,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,BRD-K42352790,anandamide,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,BRD-K42352790,anandamide,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,BRD-K42352790,anandamide,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1
LGGHDPFKSSRQNS,BRD-K09353376,tariquidar,P glycoprotein inhibitor,ABCB1,BRD-K09353376,tariquidar,P glycoprotein inhibitor,ABCB1,BRD-K09353376,tariquidar,P glycoprotein inhibitor,ABCB1,BRD-K09353376,tariquidar,P glycoprotein inhibitor,ABCB1
LGLFFNDHMLKUMI,BRD-K60025295,crystal-violet,other antibiotic,,BRD-K60025295,crystal-violet,other antibiotic,,BRD-K60025295,crystal-violet,other antibiotic,,BRD-K00003324,crystal-violet,other antibiotic,
LGQCVMYAEFTEFN,BRD-A47364545,SK&F-10047-(+),sigma receptor agonist,SIGMAR1,BRD-A47364545,SK&F-10047-(+),sigma receptor agonist,SIGMAR1,BRD-A47364545,SK&F-10047-(+),sigma receptor agonist,SIGMAR1,BRD-K00004226,SK&F-10047-(+),sigma receptor agonist,SIGMAR1
LGSDFTPAICUONK,BRD-K59271229,elinogrel,purinergic receptor antagonist,P2RY12,BRD-K59271229,elinogrel,purinergic receptor antagonist,P2RY12,BRD-K59271229,elinogrel,purinergic receptor antagonist,P2RY12,BRD-K59271229,elinogrel,purinergic receptor antagonist,P2RY12
LGUUETDTMQTHML,BRD-K35772771,CaMKII-IN-1,calcium/calmodulin dependent protein kinase inhibitor,AKT1|CAMK2A|CAMK4|MYLK,BRD-K35772771,CaMKII-IN-1,calcium/calmodulin dependent protein kinase inhibitor,AKT1|CAMK2A|CAMK4|MYLK,BRD-K35772771,CaMKII-IN-1,calcium/calmodulin dependent protein kinase inhibitor,AKT1|CAMK2A|CAMK4|MYLK,BRD-K35772771,CaMKII-IN-1,calcium/calmodulin dependent protein kinase inhibitor,AKT1|CAMK2A|CAMK4|MYLK
LGYDZXNSSLRFJS,BRD-K06191411,SM-164,XIAP inhibitor,BIRC2|BIRC3|XIAP,BRD-K06191411,SM-164,XIAP inhibitor,BIRC2|BIRC3|XIAP,BRD-K06191411,SM-164,XIAP inhibitor,BIRC2|BIRC3|XIAP,BRD-K06191411,SM-164,XIAP inhibitor,BIRC2|BIRC3|XIAP
LHGUZCKPFXXVPV,BRD-K97181972,CPI-169,histone lysine methyltransferase inhibitor,EZH2,BRD-K97181972,CPI-169,histone lysine methyltransferase inhibitor,EZH2,BRD-K97181972,CPI-169,histone lysine methyltransferase inhibitor,EZH2,BRD-K97181972,CPI-169,histone lysine methyltransferase inhibitor,EZH2
LHGVFZTZFXWLCP,BRD-K96282009,guaiacol,local anesthetic,CA2,BRD-K96282009,guaiacol,local anesthetic,CA2,BRD-K96282009,guaiacol,local anesthetic,CA2,BRD-K96282009,guaiacol,local anesthetic,CA2
LHGVYNDAWRBWGL,BRD-K38458514,diazooxonorleucine,glutamate receptor antagonist,,BRD-K38458514,diazooxonorleucine,glutamate receptor antagonist,,BRD-K38458514,diazooxonorleucine,glutamate receptor antagonist,,,,,
LHGWWAFKVCIILM,BRD-A03506276,XL888,HSP inhibitor,,BRD-A03506276,XL888,HSP inhibitor,,BRD-A03506276,XL888,HSP inhibitor,,BRD-K00003558,XL888,HSP inhibitor,
LHHCSNFAOIFYRV,BRD-A09735281,boceprevir,HCV inhibitor,CMA1|CTSA|CTSF|CTSK|CTSL|CTSS,BRD-A09735281,boceprevir,HCV inhibitor,CMA1|CTSA|CTSF|CTSK|CTSL|CTSS,BRD-A09735281,boceprevir,HCV inhibitor,CMA1|CTSA|CTSF|CTSK|CTSL|CTSS,BRD-A09735281,boceprevir,HCV inhibitor,CMA1|CTSA|CTSF|CTSK|CTSL|CTSS
LHIUZPIDLZYPRL,BRD-K15382985,LY2857785,CDK inhibitor,CDK9,BRD-K15382985,LY2857785,CDK inhibitor,CDK9,BRD-K15382985,LY2857785,CDK inhibitor,CDK9,BRD-K15382985,LY2857785,CDK inhibitor,CDK9
LHNIIDJUOCFXAP,BRD-K52911425,GDC-0941,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K52911425,GDC-0941,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K52911425,GDC-0941,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K52911425,GDC-0941,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
LHUPKWKWYWOMSK,BRD-K70262971,AGN-194310,retinoid receptor antagonist,RXRA|RXRB|RXRG,BRD-K70262971,AGN-194310,retinoid receptor antagonist,RXRA|RXRB|RXRG,BRD-K70262971,AGN-194310,retinoid receptor antagonist,RXRA|RXRB|RXRG,BRD-K70262971,AGN-194310,retinoid receptor antagonist,RXRA|RXRB|RXRG
LHVRFUVVRXGZPV,BRD-K39670393,amthamine,histamine receptor agonist,HRH2,BRD-K39670393,amthamine,histamine receptor agonist,HRH2,BRD-K39670393,amthamine,histamine receptor agonist,HRH2,BRD-K39670393,amthamine,histamine receptor agonist,HRH2
LIAWQASKBFCRNR,BRD-A88684804,bucetin,analgesic agent,,BRD-A88684804,bucetin,analgesic agent,,BRD-A88684804,bucetin,analgesic agent,,BRD-A88684804,bucetin,analgesic agent,
LIBAUACOIKWWKP,BRD-K44590731,TU-2100,,,BRD-K44590731,TU-2100,,,BRD-K44590731,TU-2100,,,BRD-K44590731,TU-2100,,
LIBVHXXKHSODII,BRD-K76244476,AZ505,histone lysine methyltransferase inhibitor,SMYD2,BRD-K76244476,AZ505,histone lysine methyltransferase inhibitor,SMYD2,BRD-K76244476,AZ505,histone lysine methyltransferase inhibitor,SMYD2,BRD-K76244476,AZ505,histone lysine methyltransferase inhibitor,SMYD2
LIDOPKHSVQTSJY,BRD-K43644456,WP1130,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X,BRD-K43644456,WP1130,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X,BRD-K43644456,WP1130,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X,BRD-K43644456,WP1130,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X
LILGMDXLRPEBNH,BRD-K85649978,BMS-688521,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,ICAM1,BRD-K85649978,BMS-688521,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,ICAM1,BRD-K85649978,BMS-688521,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,ICAM1,BRD-K85649978,BMS-688521,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,ICAM1
LIOKMIQQPDDTNO,BRD-K19318328,FR-139317,endothelin receptor antagonist,EDNRA,BRD-K19318328,FR-139317,endothelin receptor antagonist,EDNRA,BRD-K19318328,FR-139317,endothelin receptor antagonist,EDNRA,BRD-K19318328,FR-139317,endothelin receptor antagonist,EDNRA
LIOLIMKSCNQPLV,BRD-K81016934,INC-280,c-Met inhibitor,MET,BRD-K81016934,INC-280,c-Met inhibitor,MET,BRD-K81016934,INC-280,c-Met inhibitor,MET,BRD-K81016934,INC-280,c-Met inhibitor,MET
LIPNXDIBECKOMJ,BRD-K90316462,MK2-IN-1,MAP kinase inhibitor,MAPKAPK2,BRD-K90316462,MK2-IN-1,MAP kinase inhibitor,MAPKAPK2,BRD-K90316462,MK2-IN-1,MAP kinase inhibitor,MAPKAPK2,BRD-K90316462,MK2-IN-1,MAP kinase inhibitor,MAPKAPK2
LIQODXNTTZAGID,BRD-K72533376,etoposide-phosphate,topoisomerase inhibitor,TOP2A,BRD-K72533376,etoposide-phosphate,topoisomerase inhibitor,TOP2A,BRD-K72533376,etoposide-phosphate,topoisomerase inhibitor,TOP2A,BRD-K72533376,etoposide-phosphate,topoisomerase inhibitor,TOP2A
LIRCDOVJWUGTMW,BRD-K25209357,chloramphenicol-sodium-succinate,protein synthesis inhibitor,,BRD-K25209357,chloramphenicol-sodium-succinate,protein synthesis inhibitor,,BRD-K25209357,chloramphenicol-sodium-succinate,protein synthesis inhibitor,,BRD-K25209357,chloramphenicol-sodium-succinate,protein synthesis inhibitor,
LIRYPHYGHXZJBZ,BRD-K12343256,trametinib,MEK inhibitor,MAP2K1|MAP2K2,BRD-K12343256,trametinib,MEK inhibitor,MAP2K1|MAP2K2,BRD-K12343256,trametinib,MEK inhibitor,MAP2K1|MAP2K2,BRD-K12343256,trametinib,MEK inhibitor,MAP2K1|MAP2K2
LITNEAPWQHVPOK,BRD-K76614248,atizoram,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K76614248,atizoram,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K76614248,atizoram,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K76614248,atizoram,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D
LIXBJWRFCNRAPA,BRD-A07164067,meluadrine,,,BRD-A07164067,meluadrine,,,BRD-A07164067,meluadrine,,,BRD-A07164067|BRD-K00003598,HOKU-81|meluadrine,|bronchodilator,
LIYLTQQDABRNRX,BRD-K34508702,CHF5074,gamma secretase modulator,PSEN1,BRD-K34508702,CHF5074,gamma secretase modulator,PSEN1,BRD-K34508702,CHF5074,gamma secretase modulator,PSEN1,BRD-K34508702,CHF5074,gamma secretase modulator,PSEN1
LIZKZVQBLDHKCY,BRD-K49545903,"4,4-pentamethylenepiperidine",,,BRD-K49545903,"4,4-pentamethylenepiperidine",M2 channel blocker,,BRD-K49545903,"4,4-pentamethylenepiperidine",M2 channel blocker,,BRD-K49545903,"4,4-pentamethylenepiperidine",M2 channel blocker,
LJCWONGJFPCTTL,BRD-A86525947|BRD-K30373577,oxfenicine,carnitine palmitoyltransferase inhibitor,CPT1A|CPT1B,BRD-A86525947|BRD-K30373577,oxfenicine,carnitine palmitoyltransferase inhibitor,CPT1A|CPT1B,BRD-A86525947|BRD-K30373577,oxfenicine,carnitine palmitoyltransferase inhibitor,CPT1A|CPT1B,BRD-K30373577,oxfenicine,carnitine palmitoyltransferase inhibitor,CPT1A|CPT1B
LJIFOCRGDDQFJF,BRD-K82484347,GSK-J2,histone demethylase inhibitor,,BRD-K82484347,GSK-J2,histone demethylase inhibitor,,BRD-K82484347,GSK-J2,histone demethylase inhibitor,,BRD-K82484347,GSK-J2,histone demethylase inhibitor,
LJJKNPQAGWVLDQ,BRD-A56012032,thiorphan,membrane metalloendopeptidase inhibitor,MME,BRD-A56012032,thiorphan,membrane metalloendopeptidase inhibitor,MME,BRD-A56012032,thiorphan,membrane metalloendopeptidase inhibitor,MME,BRD-A56012032,thiorphan,membrane metalloendopeptidase inhibitor,MME
LJLXQHHFAKVTNP,BRD-A62209527,ZM-226600,Kir6 channel (KATP) activator,,BRD-A62209527,ZM-226600,Kir6 channel (KATP) activator,,BRD-A62209527,ZM-226600,Kir6 channel (KATP) activator,,BRD-A62209527,ZM-226600,Kir6 channel (KATP) activator,
LJOQGZACKSYWCH,BRD-A06390036,hydroquinidine,antiarrhythmic,,BRD-A06390036,hydroquinidine,antiarrhythmic,,BRD-A06390036,hydroquinidine,antiarrhythmic,,BRD-K65866076,hydroquinidine,antiarrhythmic,
LJVAJPDWBABPEJ,BRD-A94008949|BRD-K82240271,telithromycin,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7,BRD-A94008949|BRD-K82240271,telithromycin,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7,BRD-A94008949|BRD-K82240271,telithromycin,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7,BRD-K82240271,telithromycin,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7
LKAJKIOFIWVMDJ,BRD-K46791647,stanozolol,androgen receptor agonist,AR,BRD-K46791647,stanozolol,androgen receptor agonist,AR,BRD-K46791647,stanozolol,androgen receptor agonist,AR,,,,
LKBSMPFEKIBRGC,BRD-K99174507,cardiogenol-c,cardiomyogenesis inducer,,BRD-K99174507,cardiogenol-c,cardiomyogenesis inducer,,BRD-K99174507,cardiogenol-c,cardiomyogenesis inducer,,BRD-K99174507,cardiogenol-C,cardiomyogenesis inducer,
LKCWBDHBTVXHDL,BRD-A01603276|BRD-A30051119|BRD-K50698959|BRD-K88043978,amikacin,bacterial 30S ribosomal subunit inhibitor,,BRD-A01603276|BRD-A30051119|BRD-K88043978,amikacin,bacterial 30S ribosomal subunit inhibitor,,BRD-A01603276|BRD-A30051119|BRD-K50698959|BRD-K88043978|BRD-U46375448|BRD-U73512331,amikacin,bacterial 30S ribosomal subunit inhibitor,,BRD-K50698959|BRD-K88043978|BRD-U46375448|BRD-U73512331,amikacin,bacterial 30S ribosomal subunit inhibitor,
LKDRXBCSQODPBY,BRD-K89588135,tagatose,phosphorylase inhibitor,PYGL,BRD-K89588135,tagatose,phosphorylase inhibitor,PYGL,BRD-K89588135,tagatose,phosphorylase inhibitor,PYGL,,,,
LKHRMULASXZCLG,BRD-K89299012,DCEBIO,potassium channel activator,KCNN2|KCNN3|KCNN4,BRD-K89299012,DCEBIO,potassium channel activator,KCNN2|KCNN3|KCNN4,BRD-K89299012,DCEBIO,potassium channel activator,KCNN2|KCNN3|KCNN4,BRD-K89299012,DCEBIO,potassium channel activator,KCNN2|KCNN3|KCNN4
LKJPYSCBVHEWIU,BRD-A29485665,bicalutamide,androgen receptor antagonist,AR,BRD-A29485665,bicalutamide,androgen receptor antagonist,AR,BRD-A29485665,bicalutamide,androgen receptor antagonist,AR,BRD-A29485665,bicalutamide,androgen receptor antagonist,AR
LKTNEXPODAWWFM,BRD-K22314899,CH223191,aryl hydrocarbon receptor antagonist,AHR,BRD-K22314899,CH223191,aryl hydrocarbon receptor antagonist,AHR,BRD-K22314899,CH223191,aryl hydrocarbon receptor antagonist,AHR,BRD-K22314899,CH223191,aryl hydrocarbon receptor antagonist,AHR
LKZLGMAAKNEGCH,BRD-K13606314,P5091,ubiquitin specific protease inhibitor,USP7,BRD-K13606314,P5091,ubiquitin specific protease inhibitor,USP7,BRD-K13606314,P5091,ubiquitin specific protease inhibitor,USP7,BRD-K13606314,P5091,ubiquitin specific protease inhibitor,USP7
LLCRBOWRJOUJAE,BRD-K27204852,balicatib,cathepsin inhibitor,CTSK,BRD-K27204852,balicatib,cathepsin inhibitor,CTSK,BRD-K27204852,balicatib,cathepsin inhibitor,CTSK,BRD-K27204852,balicatib,cathepsin inhibitor,CTSK
LLECMGGNFBKPRH,BRD-K05724540,ftaxilide,,,BRD-K05724540,ftaxilide,,,BRD-K05724540,ftaxilide,,,BRD-K05724540,ftaxilide,,
LLIFMNUXGDHTRO,BRD-A25569250,KI-16425,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,BRD-A25569250,KI-16425,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,BRD-A25569250,KI-16425,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,BRD-A25569250,KI-16425,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3
LLJFMFZYVVLQKT,BRD-K80396088,gliquidone,sulfonylurea,ABCC8|KCNJ10|KCNJ8,BRD-K80396088,gliquidone,sulfonylurea,ABCC8|KCNJ10|KCNJ8,BRD-K80396088,gliquidone,sulfonylurea,ABCC8|KCNJ10|KCNJ8,BRD-K80396088,gliquidone,sulfonylurea,ABCC8|KCNJ10|KCNJ8
LLJJDLHGZUOMQP,BRD-K36984403,go-6983,protein kinase inhibitor,PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ,BRD-K36984403,go-6983,protein kinase inhibitor,PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ,BRD-K36984403,go-6983,protein kinase inhibitor,PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ,BRD-K36984403,go-6983,protein kinase inhibitor,PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ
LLLQTDSSHZREGW,BRD-K93480852,KN-93,calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,BRD-K93480852,KN-93,calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,BRD-K93480852,KN-93,calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,BRD-K93480852,KN-93,calcium/calmodulin dependent protein kinase inhibitor,CAMK2A
LLPBUXODFQZPFH,BRD-K68567222,BVT-948,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,BRD-A22713669|BRD-K68567222,BVT-948,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,BRD-A22713669|BRD-K68567222,BVT-948,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,BRD-A22713669|BRD-K68567222,BVT-948,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2
LLVZBTWPGQVVLW,BRD-K76908866,CP-724714,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,BRD-K76908866,CP-724714,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,BRD-K76908866,CP-724714,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,BRD-K76908866,CP-724714,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2
LLXISKGBWFTGEI,BRD-K37379014,filanesib,kinesin inhibitor|kinesin-like spindle protein inhibitor,KIF11,BRD-K37379014,filanesib,kinesin inhibitor|kinesin-like spindle protein inhibitor,KIF11,BRD-K37379014,filanesib,kinesin inhibitor|kinesin-like spindle protein inhibitor,KIF11,BRD-K37379014,filanesib,kinesin inhibitor|kinesin-like spindle protein inhibitor,KIF11
LLYYNOVSVPBRGV,BRD-K33813875,valnemulin,bacterial 50S ribosomal subunit inhibitor,,BRD-K33813875,valnemulin,bacterial 50S ribosomal subunit inhibitor,,BRD-K33813875,valnemulin,bacterial 50S ribosomal subunit inhibitor,,BRD-K22938173,valnemulin,bacterial 50S ribosomal subunit inhibitor,
LMBWSYZSUOEYSN,BRD-K40654626,ditiocarb-sodium-trihydrate,immunostimulant,CA1|CA2|CA4,BRD-K40654626,ditiocarb-sodium-trihydrate,immunostimulant,CA1|CA2|CA4,BRD-K40654626,ditiocarb-sodium-trihydrate,immunostimulant,CA1|CA2|CA4,BRD-K40654626,ditiocarb-sodium-trihydrate,immunostimulant,CA1|CA2|CA4
LMEKQMALGUDUQG,BRD-K32821942,azathioprine,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,BRD-K32821942,azathioprine,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,BRD-K32821942,azathioprine,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,BRD-K32821942,azathioprine,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT
LMHJFKYQYDSOQO,BRD-A96977263,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1,BRD-A96977263,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1,BRD-A96977263,M-14157,ATP-sensitive potassium channel antagonist,KCNQ1,BRD-A96977263|BRD-K01666923,5-hydroxydecanoic-acid|M-14157,|ATP-sensitive potassium channel antagonist,|KCNQ1
LMJFJIDLEAWOQJ,BRD-A57210235|BRD-K47289408,AZD8186,PI3K inhibitor,PIK3CB|PIK3CD,BRD-A57210235|BRD-K47289408,AZD8186,PI3K inhibitor,PIK3CB|PIK3CD,BRD-A57210235|BRD-K47289408,AZD8186,PI3K inhibitor,PIK3CB|PIK3CD,BRD-A57210235|BRD-K47289408,AZD8186,PI3K inhibitor,PIK3CB|PIK3CD
LMJSLTNSBFUCMU,BRD-A28940325,trichlormethiazide,chloride channel blocker,ATP1A1|CA1|CA2|CA4|SLC12A1|SLC12A3,BRD-A28940325,trichlormethiazide,chloride channel blocker,ATP1A1|CA1|CA2|CA4|SLC12A1|SLC12A3,BRD-A28940325,trichlormethiazide,chloride channel blocker,ATP1A1|CA1|CA2|CA4|SLC12A1|SLC12A3,BRD-A28940325,trichlormethiazide,chloride channel blocker,PTGS1|PTGS2|SLC12A1
LMMJFBMMJUMSJS,BRD-K82804538,Ro-5126766,MEK inhibitor|RAF inhibitor,BRAF|MAP2K1|MAP2K2|RAF1,BRD-K82804538,Ro-5126766,MEK inhibitor|RAF inhibitor,BRAF|MAP2K1|MAP2K2|RAF1,BRD-K82804538,Ro-5126766,MEK inhibitor|RAF inhibitor,BRAF|MAP2K1|MAP2K2|RAF1,BRD-K82804538,Ro-5126766,MEK inhibitor|RAF inhibitor,BRAF|MAP2K1|MAP2K2|RAF1
LMOINURANNBYCM,BRD-A07780951,metaproterenol,adrenergic receptor agonist,ADRB2,BRD-A07780951,metaproterenol,adrenergic receptor agonist,ADRB2,BRD-A07780951|BRD-M02190957,metaproterenol,adrenergic receptor agonist,ADRB2,BRD-K01826731|BRD-M02190957,metaproterenol,adrenergic receptor agonist,ADRB2
LMPZHLXYBWGGNT,BRD-K62562723,SR-2640,leukotriene receptor antagonist,CYSLTR1,BRD-K62562723,SR-2640,leukotriene receptor antagonist,CYSLTR1,BRD-K62562723,SR-2640,leukotriene receptor antagonist,CYSLTR1,BRD-K62562723,SR-2640,leukotriene receptor antagonist,CYSLTR1
LMQBMWHHGVZWMR,BRD-A96456596,FPL-55712,leukotriene receptor antagonist,,BRD-A96456596,FPL-55712,leukotriene receptor antagonist,,BRD-A96456596,FPL-55712,leukotriene receptor antagonist,,BRD-A96456596,FPL-55712,leukotriene receptor antagonist,
LMUQHXHWJWQXSD,BRD-K24675965,LY288513,CCK receptor antagonist,CCKBR,BRD-K24675965,LY288513,CCK receptor antagonist,CCKBR,BRD-K24675965,LY288513,CCK receptor antagonist,CCKBR,BRD-K24675965,LY288513,CCK receptor antagonist,CCKBR
LMXOHSDXUQEUSF,BRD-K91100918,sinefungin,DNA methyltransferase inhibitor|RNA synthesis inhibitor,CARM1,BRD-K91100918,sinefungin,DNA methyltransferase inhibitor|RNA synthesis inhibitor,CARM1,BRD-K91100918,sinefungin,DNA methyltransferase inhibitor|RNA synthesis inhibitor,CARM1,BRD-K91100918,sinefungin,DNA methyltransferase inhibitor|RNA synthesis inhibitor,CARM1
LMXYVLFTZRPNRV,BRD-K07859598|BRD-K93653303,GW-5074,RAF inhibitor|leucine rich repeat kinase inhibitor,NTRK1|RAF1,BRD-K07859598|BRD-K93653303,GW-5074,RAF inhibitor|leucine rich repeat kinase inhibitor,NTRK1|RAF1,BRD-K07859598|BRD-K39520573|BRD-K93653303,GW-5074,RAF inhibitor|leucine rich repeat kinase inhibitor,NTRK1|RAF1,BRD-K07859598|BRD-K39520573|BRD-K93653303,GW-5074,RAF inhibitor|leucine rich repeat kinase inhibitor,NTRK1|RAF1
LMYRWZFENFIFIT,BRD-K62412084,para-toluenesulfonamide,,CA12|CA2|CA6|CA9,BRD-K62412084,para-toluenesulfonamide,,CA12|CA2|CA6|CA9,BRD-K62412084,para-toluenesulfonamide,,CA12|CA2|CA6|CA9,BRD-K62412084,para-toluenesulfonamide,,CA12|CA2|CA6|CA9
LNDDRUPAICPXIN,BRD-K23952234,BMS-986020,lysophosphatidic acid receptor antagonist,LPAR1,BRD-K23952234,BMS-986020,lysophosphatidic acid receptor antagonist,LPAR1,BRD-K23952234,BMS-986020,lysophosphatidic acid receptor antagonist,LPAR1,BRD-K23952234,AM095,lysophosphatidic acid receptor antagonist,
LNEPOXFFQSENCJ,BRD-K67783091,haloperidol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,BRD-K67783091,haloperidol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,BRD-K67783091,haloperidol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,BRD-K67783091,haloperidol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1
LNFBAYSBVQBKFR,BRD-K03549949,XL388,mTOR inhibitor,MTOR,BRD-K03549949,XL388,mTOR inhibitor,MTOR,BRD-K03549949,XL388,mTOR inhibitor,MTOR,BRD-K03549949,XL388,mTOR inhibitor,MTOR
LNMRSSIMGCDUTP,BRD-K53405000,pexmetinib,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MAPK14|TEK,BRD-K53405000,pexmetinib,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MAPK14|TEK,BRD-K53405000,pexmetinib,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MAPK14|TEK,BRD-K53405000,pexmetinib,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MAPK14|TEK
LNPDTQAFDNKSHK,BRD-K12994359,valdecoxib,cyclooxygenase inhibitor,CA12|PTGS2,BRD-K12994359,valdecoxib,cyclooxygenase inhibitor,CA12|PTGS2,BRD-K12994359,valdecoxib,cyclooxygenase inhibitor,CA12|PTGS2,BRD-K12994359,valdecoxib,cyclooxygenase inhibitor,CA12|PTGS2
LNTHITQWFMADLM,BRD-K77345217,gallic-acid,PPAR receptor agonist|beta amyloid protein neurotoxicity inhibitor,CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP,BRD-K77345217,gallic-acid,PPAR receptor agonist|beta amyloid protein neurotoxicity inhibitor,CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP,BRD-K77345217,gallic-acid,PPAR receptor agonist|beta amyloid protein neurotoxicity inhibitor,CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP,BRD-K77345217,gallic-acid,PPAR receptor agonist|beta amyloid protein neurotoxicity inhibitor,CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP
LNYKGELUODVSNS,BRD-K75956464,VCH-916,HCV inhibitor,,BRD-K75956464,VCH-916,HCV inhibitor,,BRD-K75956464,VCH-916,HCV inhibitor,,BRD-K75956464,VCH-916,HCV inhibitor,
LOBCDGHHHHGHFA,BRD-A78377521,monastrol,kinesin inhibitor,KIF11,BRD-A78377521,monastrol,kinesin inhibitor,KIF11,BRD-A78377521,monastrol,kinesin inhibitor,KIF11,BRD-A78377521,monastrol,kinesin inhibitor,KIF11
LOCPVWIREQIGNQ,BRD-K98157055,SIB-1757,glutamate receptor antagonist,GRM5,BRD-K98157055,SIB-1757,glutamate receptor antagonist,GRM5,BRD-K98157055,SIB-1757,glutamate receptor antagonist,GRM5,,,,
LOCQRDBFWSXQQI,BRD-K82467063,SB-271046,serotonin receptor antagonist,HTR6,BRD-K82467063,SB-271046,serotonin receptor antagonist,HTR6,BRD-K82467063,SB-271046,serotonin receptor antagonist,HTR6,BRD-K82467063,SB-271046,serotonin receptor antagonist,HTR6
LOIYMIARKYCTBW,BRD-K25146005|BRD-K52670952,cis-urocanic acid|cis-urocanic-acid,serotonin receptor agonist,HTR2A,BRD-K25146005|BRD-K52670952,cis-urocanic acid|cis-urocanic-acid,serotonin receptor agonist,HTR2A,BRD-K25146005|BRD-K52670952,cis-urocanic acid|cis-urocanic-acid,serotonin receptor agonist,HTR2A,BRD-K25146005|BRD-K52670952,cis-urocanic-acid,serotonin receptor agonist,HTR2A
LOLPPWBBNUVNQZ,BRD-K24576554,AT-9283,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,BRD-K24576554,AT-9283,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,BRD-K24576554,AT-9283,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,BRD-K24576554,AT-9283,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A
LORDFXWUHHSAQU,BRD-A92630576,trimebutine,opioid receptor agonist,OPRD1|OPRK1|OPRM1,BRD-A92630576,trimebutine,opioid receptor agonist,OPRD1|OPRK1|OPRM1,BRD-A92630576,trimebutine,opioid receptor agonist,OPRD1|OPRK1|OPRM1,BRD-K00003635,trimebutine,opioid receptor agonist,OPRD1|OPRK1|OPRM1
LOUPRKONTZGTKE,BRD-K48278478|BRD-K59632282|BRD-K99257182,quinidine|quinine,hemozoin biocrystallization inhibitor|sodium channel blocker,GP9|KCNA5|KCNA7|KCNB2|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|KCNN4|SCN5A|SLC29A4,BRD-K48278478|BRD-K59632282|BRD-K99257182,quinidine|quinine,hemozoin biocrystallization inhibitor|sodium channel blocker,GP9|KCNA5|KCNA7|KCNB2|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|KCNN4|SCN5A|SLC29A4,BRD-K07940445|BRD-K48278478|BRD-K59632282|BRD-K99257182,quinidine|quinine,hemozoin biocrystallization inhibitor|sodium channel blocker,GP9|KCNA5|KCNA7|KCNB2|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|KCNN4|SCN5A|SLC29A4,BRD-K07940445|BRD-K59632282|BRD-K99257182,quinidine|quinine,hemozoin biocrystallization inhibitor|sodium channel blocker,GP9|KCNA5|KCNA7|KCNB2|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|KCNN4|SCN5A|SLC29A4
LOUZDJSQOFXLAP,BRD-K94830213,tofisopam,cytochrome P450 inhibitor|phosphodiesterase inhibitor,CYP3A4|PDE10A|PDE2A|PDE3A|PDE4A,BRD-K94830213,tofisopam,cytochrome P450 inhibitor|phosphodiesterase inhibitor,CYP3A4|PDE10A|PDE2A|PDE3A|PDE4A,BRD-K94830213,tofisopam,cytochrome P450 inhibitor|phosphodiesterase inhibitor,CYP3A4|PDE10A|PDE2A|PDE3A|PDE4A,BRD-K94830213,tofisopam,cytochrome P450 inhibitor|phosphodiesterase inhibitor,CYP3A4
LPAHKJMGDSJDRG,BRD-K02490038,BQ-788,endothelin receptor antagonist,EDNRB,BRD-K02490038,BQ-788,endothelin receptor antagonist,EDNRB,BRD-K02490038,BQ-788,endothelin receptor antagonist,EDNRB,BRD-K02490038,BQ-788,endothelin receptor antagonist,EDNRB
LPAUOXUZGSBGDU,BRD-K44030614,ponesimod,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K44030614,ponesimod,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K44030614,ponesimod,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K44030614,ponesimod,sphingosine 1-phosphate receptor agonist,S1PR1
LPEPZBJOKDYZAD,BRD-K44067360,flufenamic-acid,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,BRD-K44067360,flufenamic-acid,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,BRD-K44067360,flufenamic-acid,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,BRD-K44067360,flufenamic-acid,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5
LPFWVDIFUFFKJU,BRD-K50010139,poziotinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K50010139,poziotinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K50010139,poziotinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K50010139,poziotinib,EGFR inhibitor,EGFR|ERBB2|ERBB4
LPLVUJXQOOQHMX,BRD-K15318383|BRD-K70038931,ammonium-glycyrrhizinate,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,BRD-K15318383|BRD-K70038931,ammonium-glycyrrhizinate,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,BRD-K15318383|BRD-K70038931,ammonium-glycyrrhizinate,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,BRD-K83486494,ammonium-glycyrrhizinate,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3
LPMRCCNDNGONCD,BRD-K48738253,selfotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K48738253,selfotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K48738253,selfotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K48738253,selfotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D
LPMXVESGRSUGHW,BRD-A68930007|BRD-K33277808|BRD-K92158972,ouabain,ATPase inhibitor,ATP1A1,BRD-A68930007|BRD-K33277808,ouabain,ATPase inhibitor,ATP1A1,BRD-A68930007|BRD-K33277808,ouabain,ATPase inhibitor,ATP1A1,BRD-A68930007|BRD-K33277808,ouabain,ATPase inhibitor,ATP1A1
LPQZKKCYTLCDGQ,BRD-A18611368,tazobactam,beta lactamase inhibitor,,BRD-A18611368,tazobactam,beta lactamase inhibitor,,BRD-A18611368,tazobactam,beta lactamase inhibitor,,BRD-K14312455,tazobactam,beta lactamase inhibitor,
LPXQRXLUHJKZIE,BRD-K53114651,azaguanine-8,purine antagonist,PNP,BRD-K53114651,azaguanine-8,purine antagonist,PNP,BRD-K53114651,azaguanine-8,purine antagonist,PNP,BRD-K53114651,azaguanine-8,purine antagonist,PNP
LQBVNQSMGBZMKD,BRD-K62391742,venetoclax,BCL inhibitor,BCL2,BRD-K62391742,venetoclax,BCL inhibitor,BCL2,BRD-K62391742,venetoclax,BCL inhibitor,BCL2,BRD-K62391742,venetoclax,BCL inhibitor,BCL2
LQCLVBQBTUVCEQ,BRD-A24297246,troleandomycin,protein synthesis inhibitor,,BRD-A24297246,troleandomycin,protein synthesis inhibitor,,BRD-A24297246,troleandomycin,protein synthesis inhibitor,,BRD-K38310698,troleandomycin,protein synthesis inhibitor,
LQEOPHGPHCWOAC,BRD-K94832621,Y-134,estrogen receptor antagonist,ESR1|ESR2,BRD-K94832621,Y-134,estrogen receptor antagonist,ESR1|ESR2,BRD-K94832621,Y-134,estrogen receptor antagonist,ESR1|ESR2,BRD-K94832621,Y-134,estrogen receptor antagonist,ESR1|ESR2
LQGUBLBATBMXHT,BRD-K59284035,chrysophanic-acid,EGFR inhibitor,EGFR|MTOR,BRD-K59284035,chrysophanic-acid,EGFR inhibitor,EGFR|MTOR,BRD-K59284035,chrysophanic-acid,EGFR inhibitor,EGFR|MTOR,BRD-K59284035,chrysophanic-acid,EGFR inhibitor,EGFR|MTOR
LQHDJQIMETZMPH,BRD-K62738477,GSK2256294A,epoxide hydolase inhibitor,EPHX2,BRD-K62738477,GSK2256294A,epoxide hydolase inhibitor,EPHX2,BRD-K62738477,GSK2256294A,epoxide hydolase inhibitor,EPHX2,BRD-K62738477,GSK2256294A,epoxide hydolase inhibitor,EPHX2
LQOLIRLGBULYKD,BRD-K01244426|BRD-K23933163,cloxacillin,bacterial cell wall synthesis inhibitor,,BRD-K01244426|BRD-K23933163,cloxacillin,bacterial cell wall synthesis inhibitor,,BRD-K01244426|BRD-K23933163,cloxacillin,bacterial cell wall synthesis inhibitor,,BRD-K01244426|BRD-K23933163,cloxacillin,bacterial cell wall synthesis inhibitor,
LQQIZTXSZOYPPS,BRD-K84883208,MR-948,thromboxane synthase inhibitor,TBXAS1,BRD-K84883208,MR-948,thromboxane synthase inhibitor,TBXAS1,BRD-K84883208,MR-948,thromboxane synthase inhibitor,TBXAS1,BRD-K84883208,MR-948,thromboxane synthase inhibitor,TBXAS1
LQUNNCQSFFKSSK,BRD-K73073971,ZLN005,,,BRD-K73073971,ZLN005,,,BRD-K73073971,ZLN005,,,BRD-K73073971,ZLN005,,
LQVXSNNAFNGRAH,BRD-K13049116|BRD-K47200824,BMS-754807,IGF-1 inhibitor,AKT1|IGF1R,BRD-K13049116|BRD-K47200824,BMS-754807,IGF-1 inhibitor,AKT1|IGF1R,BRD-K13049116|BRD-K47200824,BMS-754807,IGF-1 inhibitor,AKT1|IGF1R,BRD-K13049116|BRD-K47200824,BMS-754807,IGF-1 inhibitor,AKT1|IGF1R
LQYJAVWWKTWWKN,BRD-K78299798,mepiroxol,,,BRD-K78299798,mepiroxol,,,BRD-K78299798,mepiroxol,,,BRD-K78299798,mepiroxol,,
LQZAIAZUDWIVPM,BRD-K93869735,taltirelin,thyrotropin releasing hormone receptor agonist,TRHR,BRD-K93869735,taltirelin,thyrotropin releasing hormone receptor agonist,TRHR,BRD-K93869735,taltirelin,thyrotropin releasing hormone receptor agonist,TRHR,BRD-K93869735,taltirelin,thyrotropin releasing hormone receptor agonist,TRHR
LRBQNJMCXXYXIU,BRD-K67392463,tannic-acid,PARG inhibitor,ANO1,BRD-K67392463,tannic-acid,PARG inhibitor,ANO1,BRD-K67392463,tannic-acid,PARG inhibitor,ANO1,BRD-K01584643,tannic-acid,PARG inhibitor,ANO1
LREQLEBVOXIEOM,BRD-A32988684,heptaminol,vasoconstrictor,,BRD-A32988684,heptaminol,vasoconstrictor,,BRD-A32988684,heptaminol,vasoconstrictor,,BRD-A32988684,heptaminol,vasoconstrictor,
LRJOMUJRLNCICJ,BRD-A01643550|BRD-K45664306|BRD-K87234558,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1,BRD-A01643550|BRD-K45664306,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1,BRD-A01643550|BRD-K45664306|BRD-K87234558,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1,BRD-A01643550|BRD-K45664306|BRD-K87234558,prednisolone-acetate,glucocorticoid receptor agonist,NR3C1
LRLKZVMLJBNNPE,BRD-K24507548,cintriamide,,,BRD-K24507548,cintriamide,,,BRD-K24507548,cintriamide,,,BRD-K24507548,cintriamide,,
LRRMQNGSYOUANY,BRD-K61642990,FERb-033,EGFR inhibitor,ERBB2,BRD-K61642990,FERb-033,EGFR inhibitor,ERBB2,BRD-K61642990,FERb-033,EGFR inhibitor,ERBB2,BRD-K61642990,FERb-033,EGFR inhibitor,ERBB2
LRULVYSBRWUVGR,BRD-K09223495,GSK2879552,histone lysine demethylase inhibitor,KDM1A,BRD-K09223495,GSK2879552,histone lysine demethylase inhibitor,KDM1A,BRD-K09223495,GSK2879552,histone lysine demethylase inhibitor,KDM1A,BRD-K09223495,GSK2879552,histone lysine demethylase inhibitor,KDM1A
LRXFKKPEBXIPMW,BRD-A94965935,cicloprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A94965935,cicloprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A94965935,cicloprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A94965935,cicloprofen,cyclooxygenase inhibitor,PTGS1|PTGS2
LSFLAQVDISHMNB,BRD-K15179513,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R,BRD-K15179513,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R,BRD-K15179513,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R,BRD-K15179513,NVP-ADW742,insulin growth factor receptor inhibitor,IGF1R
LSHVYAFMTMFKBA,BRD-K50660797,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,BACE1|FASN,BRD-K50660797,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,BACE1|FASN,BRD-K50660797,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,BACE1|FASN,BRD-K50660797,epicatechin-gallate-(-),bacterial DNA gyrase inhibitor,BACE1|FASN
LSLYOANBFKQKPT,BRD-A97104540,fenoterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A97104540,fenoterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A97104540,fenoterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K00003668,fenoterol,adrenergic receptor agonist,ADRB2
LSNWBKACGXCGAJ,BRD-A39172021,ampiroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A39172021,ampiroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A39172021,ampiroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A39172021,ampiroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2
LSPANGZZENHZNJ,BRD-K26603252,PD-153035,EGFR inhibitor,EGFR|KDR,BRD-K26603252,PD-153035,EGFR inhibitor,EGFR|KDR,BRD-K26603252,PD-153035,EGFR inhibitor,EGFR|KDR,BRD-K26603252,PD-153035,EGFR inhibitor,EGFR|KDR
LSQZJLSUYDQPKJ,BRD-K08635111|BRD-K39234907|BRD-K55044200|BRD-K58632460,amoxicillin,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,BRD-K08635111|BRD-K39234907|BRD-K55044200|BRD-K58632460,amoxicillin,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,BRD-K08635111|BRD-K39234907|BRD-K55044200|BRD-K58632460,amoxicillin,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,BRD-K08635111|BRD-K39234907|BRD-K55044200|BRD-K58632460,amoxicillin,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6
LTEJRLHKIYCEOX,BRD-K57187269,brivanib-alaninate,FGFR inhibitor|VEGFR inhibitor,FGFR3,BRD-K57187269,brivanib-alaninate,FGFR inhibitor|VEGFR inhibitor,FGFR3,BRD-K57187269,brivanib-alaninate,FGFR inhibitor|VEGFR inhibitor,FGFR3,BRD-K57187269,brivanib-alaninate,FGFR inhibitor|VEGFR inhibitor,FGFR3
LTINZAODLRIQIX,BRD-A34205213|BRD-A87387433,cefpodoxime,bacterial cell wall synthesis inhibitor,,BRD-A34205213|BRD-A87387433,cefpodoxime,bacterial cell wall synthesis inhibitor,,BRD-A34205213|BRD-A87387433,cefpodoxime,bacterial cell wall synthesis inhibitor,,BRD-A34205213|BRD-A87387433,cefpodoxime,bacterial cell wall synthesis inhibitor,
LTLYEAJONXGNFG,BRD-K06273313,doxycycline-hyclate,bacterial 30S ribosomal subunit inhibitor,,BRD-A08545410|BRD-K06273313,doxycycline-hyclate,bacterial 30S ribosomal subunit inhibitor,,BRD-A08545410|BRD-K06273313,E-64,calpain inhibitor|cysteine protease inhibitor,CTSS,BRD-K00004314,E-64,calpain inhibitor|cysteine protease inhibitor,CTSS
LTMHDMANZUZIPE,BRD-A94756469,digoxin,ATPase inhibitor,ATP1A1,BRD-A94756469,digoxin,ATPase inhibitor,ATP1A1,BRD-A94756469,digoxin,ATPase inhibitor,ATP1A1,BRD-K00004302,digoxin,ATPase inhibitor,ATP1A1
LTQYSJKGRPGMPO,BRD-K91405252,MK-0354,niacin receptor agonist,HCAR2|HCAR3,BRD-K91405252,MK-0354,niacin receptor agonist,HCAR2|HCAR3,BRD-K91405252,MK-0354,niacin receptor agonist,HCAR2|HCAR3,BRD-K91405252,MK-0354,niacin receptor agonist,HCAR2|HCAR3
LTVDFSLWFKLJDQ,BRD-K57865272,A0001,,,BRD-K57865272,A0001,,,BRD-K57865272,A0001,,,BRD-K57865272,A0001,,
LTXREWYXXSTFRX,BRD-K96550715,linagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K96550715,linagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A23155464|BRD-K96550715,linagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A23155464|BRD-K96550715,linagliptin,dipeptidyl peptidase inhibitor,DPP4
LUBHDINQXIHVLS,BRD-K85693895,tolrestat,aldose reductase inhibitor,AKR1A1|AKR1B1|AKR1B10,BRD-K85693895,tolrestat,aldose reductase inhibitor,AKR1A1|AKR1B1|AKR1B10,BRD-K85693895,tolrestat,aldose reductase inhibitor,AKR1A1|AKR1B1|AKR1B10,BRD-K85693895,tolrestat,aldose reductase inhibitor,AKR1A1|AKR1B1|AKR1B10
LUINDDOUWHRIPW,BRD-K34663752,6-chloromelatonin,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K34663752,6-chloromelatonin,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K34663752,6-chloromelatonin,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K34663752,6-chloromelatonin,melatonin receptor agonist,MTNR1A|MTNR1B
LUJZZYWHBDHDQX,BRD-K07106112,BMS-599626,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4,BRD-K07106112,BMS-599626,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4,BRD-K07106112,BMS-599626,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4,BRD-K07106112,BMS-599626,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4
LUKBXSAWLPMMSZ,BRD-K80738081,resveratrol,SIRT activator|cytochrome P450 inhibitor,CSNK2A1|NQO2|PTGS1|PTGS2,BRD-K80738081,resveratrol,SIRT activator|cytochrome P450 inhibitor,CSNK2A1|NQO2|PTGS1|PTGS2,BRD-K80738081,resveratrol,SIRT activator|cytochrome P450 inhibitor,CSNK2A1|NQO2|PTGS1|PTGS2,BRD-K80738081,resveratrol,SIRT activator|cytochrome P450 inhibitor,CSNK2A1|NQO2|PTGS1|PTGS2
LUKZNWIVRBCLON,BRD-K35245662,ciclesonide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K35245662,ciclesonide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K35245662,ciclesonide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K35245662,ciclesonide,glucocorticoid receptor agonist,NR3C1|SERPINA6
LUMKNAVTFCDUIE,BRD-K44184170,ospemifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K44184170,ospemifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K44184170,ospemifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K44184170,ospemifene,selective estrogen receptor modulator (SERM),ESR1|ESR2
LUZRJRNZXALNLM,BRD-K72166146,dihydroergotamine,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,BRD-K72166146,dihydroergotamine,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,BRD-K72166146,dihydroergotamine,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,BRD-K72166146,dihydroergotamine,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7
LVASCWIMLIKXLA,BRD-K54247840,halofuginone,collagenase inhibitor,COL1A1|MMP2,BRD-K54247840,halofuginone,collagenase inhibitor,COL1A1|MMP2,BRD-K54247840,halofuginone,collagenase inhibitor,COL1A1|MMP2,BRD-K54247840,halofuginone,collagenase inhibitor,COL1A1|MMP2
LVDKZNITIUWNER,BRD-K33457401,bronopol,,,BRD-K33457401,bronopol,,,BRD-K33457401,bronopol,,,BRD-K33457401,bronopol,,
LVGMMVAWLISWJD,BRD-A29844814,ABT-202,acetylcholine receptor agonist,,BRD-A29844814,ABT-202,acetylcholine receptor agonist,,BRD-A29844814,ABT-202,acetylcholine receptor agonist,,BRD-A29844814,ABT-202,acetylcholine receptor agonist,
LVLLALCJVJNGQQ,BRD-K28456624,seocalcitol,vitamin D receptor agonist,VDR,BRD-K28456624,seocalcitol,vitamin D receptor agonist,VDR,BRD-K28456624,seocalcitol,vitamin D receptor agonist,VDR,BRD-K28456624,seocalcitol,vitamin D receptor agonist,VDR
LVQDKIWDGQRHTE,BRD-K36711084,cyromazine,,,BRD-K36711084,cyromazine,,,BRD-K36711084,cyromazine,,,BRD-K36711084,cyromazine,,
LVWZTYCIRDMTEY,BRD-K76812510,metamizole,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,BRD-K76812510,metamizole,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,BRD-K76812510,metamizole,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,BRD-K76812510,metamizole,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1
LVXJQMNHJWSHET,BRD-K57169635,dacomitinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K57169635,dacomitinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K57169635,dacomitinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K57169635,dacomitinib,EGFR inhibitor,EGFR|ERBB2|ERBB4
LVYLCBNXHHHPSB,BRD-K41866823,2-hydroxyethyl-salicylate,,,BRD-K41866823,2-hydroxyethyl-salicylate,,,BRD-K41866823,2-hydroxyethyl-salicylate,,,BRD-K41866823,2-hydroxyethyl-salicylate,,
LWAFSWPYPHEXKX,BRD-A42167015,carteolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A42167015,carteolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A42167015,carteolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A42167015,carteolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
LWANFAFTTOKZAX,BRD-K25486274,DRF053-(R),CDK inhibitor,CSNK1A1,BRD-K25486274,DRF053-(R),CDK inhibitor,CSNK1A1,BRD-K25486274,DRF053-(R),CDK inhibitor,CSNK1A1,BRD-K25486274,DRF053-(R),CDK inhibitor,CSNK1A1
LWCVTMJWLSJYQN,BRD-M52026403,colistin-sulfate,bacterial permeability inducer,,,,,,,,,,,,,
LWJALJDRFBXHKX,BRD-K86358349,bromantan,dopamine reuptake inhibitor|serotonin reuptake inhibitor,,BRD-K86358349,bromantan,dopamine reuptake inhibitor|serotonin reuptake inhibitor,,BRD-K86358349,bromantan,dopamine reuptake inhibitor|serotonin reuptake inhibitor,,BRD-K86358349,bromantan,dopamine reuptake inhibitor|serotonin reuptake inhibitor,
LWJGMYMNSNVCEM,BRD-K54871792,PF-04418948,prostaglandin inhibitor,PTGER2,BRD-K54871792,PF-04418948,prostaglandin inhibitor,PTGER2,BRD-K54871792,PF-04418948,prostaglandin inhibitor,PTGER2,BRD-K54871792,PF-04418948,prostaglandin inhibitor,PTGER2
LWQQLNNNIPYSNX,BRD-K56429665,calcipotriol,vitamin D receptor agonist,VDR,BRD-K56429665,calcipotriol,vitamin D receptor agonist,VDR,BRD-K56429665,calcipotriol,vitamin D receptor agonist,VDR,BRD-K56429665,calcipotriol,vitamin D receptor agonist,VDR
LWUDDYHYYNNIQI,BRD-K96936751,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K96936751,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K96936751,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K96936751,bretazenil,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
LXANPKRCLVQAOG,BRD-A89164055,sorbinil,aldose reductase inhibitor,AKR1B1,BRD-A89164055,sorbinil,aldose reductase inhibitor,AKR1B1,BRD-A89164055,sorbinil,aldose reductase inhibitor,AKR1B1,BRD-A89164055,sorbinil,aldose reductase inhibitor,AKR1B1
LXBGSDVWAMZHDD,BRD-K68534611,2-methylimidazole,cholesterol inhibitor,,BRD-K68534611,2-methylimidazole,cholesterol inhibitor,,BRD-K68534611,2-methylimidazole,cholesterol inhibitor,,BRD-K68534611,2-methylimidazole,cholesterol inhibitor,
LXBIFEVIBLOUGU,BRD-K89665618,1-deoxymannojirimycin,alpha mannosidase inhibitor,MAN2A1,BRD-K89665618,1-deoxymannojirimycin,alpha mannosidase inhibitor,MAN2A1,BRD-K89665618,1-deoxymannojirimycin,alpha mannosidase inhibitor,MAN2A1,BRD-K89665618,1-deoxymannojirimycin,alpha mannosidase inhibitor,MAN2A1
LXCFILQKKLGQFO,BRD-K78321730,methylparaben,other antifungal,,BRD-K78321730,methylparaben,other antifungal,,BRD-K78321730,methylparaben,other antifungal,,BRD-K78321730,methylparaben,other antifungal,
LXENKEWVEVKKGV,BRD-K05531427,briciclib,cyclin D inhibitor,CCND1,BRD-K05531427,briciclib,cyclin D inhibitor,CCND1,BRD-K05531427,briciclib,cyclin D inhibitor,CCND1,BRD-K05531427,briciclib,cyclin D inhibitor,CCND1
LXEZPPZLNVOLDI,BRD-K43978949,PIT,purinergic receptor antagonist,P2RY1,BRD-K43978949,PIT,purinergic receptor antagonist,P2RY1,BRD-K43978949,PIT,purinergic receptor antagonist,P2RY1,BRD-K43978949,PIT,purinergic receptor antagonist,P2RY1
LXFKEVQQSKQXPR,BRD-K13302470,KY02111,Wnt pathway inhibitor,DKK1,BRD-K13302470,KY02111,Wnt pathway inhibitor,DKK1,BRD-K13302470,KY02111,Wnt pathway inhibitor,DKK1,BRD-K13302470,KY02111,WNT pathway inhibitor,DKK1
LXFOLMYKSYSZQS,BRD-K26531771|BRD-K63457253,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L,BRD-K26531771|BRD-K63457253,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L,BRD-K26531771|BRD-K63457253,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L,BRD-K26531771|BRD-K63457253,EPZ-5676,histone lysine methyltransferase inhibitor,DOT1L
LXMSZDCAJNLERA,BRD-A97808748|BRD-K30171400|BRD-K90027355,spironolactone,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,BRD-A71422083|BRD-A97808748|BRD-K90027355,spironolactone,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,BRD-A71422083|BRD-A97808748|BRD-K90027355,spironolactone,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,BRD-A71422083|BRD-A97808748|BRD-K90027355,spironolactone,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG
LXNHXLLTXMVWPM,BRD-K14349461,pyridoxine,vitamin B,DDC|PDXK,BRD-K14349461,pyridoxine,vitamin B,DDC|PDXK,BRD-K14349461,pyridoxine,vitamin B,DDC|PDXK,BRD-K14349461,pyridoxine,vitamin B,DDC|PDXK
LXTZRIBXKVRLOA,BRD-K42336459,p-dimethylinamyl-benzoate,,,BRD-K42336459,p-dimethylinamyl-benzoate,,,BRD-K42336459,p-dimethylinamyl-benzoate,,,BRD-K42336459,p-dimethylinamyl-benzoate,,
LYJSJVYJLZOMCD,BRD-K05151076,ZK-164015,estrogen receptor antagonist,ESR1|ESR2,BRD-K05151076,ZK-164015,estrogen receptor antagonist,ESR1|ESR2,BRD-K05151076,ZK-164015,estrogen receptor antagonist,ESR1|ESR2,BRD-K05151076,ZK-164015,estrogen receptor antagonist,ESR1|ESR2
LYLFQLCLUXOFOL,BRD-K96029467,alagebrium,glycosylation inhibitor,,BRD-K96029467,alagebrium,glycosylation inhibitor,,BRD-K96029467,alagebrium,glycosylation inhibitor,,BRD-K96029467,alagebrium,glycosylation inhibitor,
LYONXVJRBWWGQO,BRD-A65683612,phenylpiracetam,noradrenaline uptake inhibitor,,BRD-A65683612,phenylpiracetam,noradrenaline uptake inhibitor,,BRD-A65683612,phenylpiracetam,noradrenaline uptake inhibitor,,BRD-A65683612,phenylpiracetam,noradrenaline uptake inhibitor,
LYPCGXKCQDYTFV,BRD-A17745711,alpha-methylserotonin,serotonin receptor agonist,HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4,BRD-A17745711,alpha-methylserotonin,serotonin receptor agonist,HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4,BRD-A17745711,alpha-methylserotonin,serotonin receptor agonist,HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4,BRD-K01826806|BRD-K01827294,alpha-methylserotonin|methyl-5-hydroxytryptamine,|serotonin receptor agonist,|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4
LYPFDBRUNKHDGX,BRD-K63712959,temoporfin,radical formation stimulant,,BRD-K63712959,temoporfin,radical formation stimulant,,BRD-K63712959,temoporfin,radical formation stimulant,,,,,
LZAXPYOBKSJSEX,BRD-A75817871|BRD-K61295575,blebbistatin-(+/-)|blebbistatin-(-),ATPase inhibitor,|MYH2,BRD-A75817871|BRD-K61295575,blebbistatin-(+/-)|blebbistatin-(-),ATPase inhibitor,|MYH2,BRD-A75817871|BRD-K61295575,blebbistatin-(+/-)|blebbistatin-(-),ATPase inhibitor,|MYH2,BRD-A75817871|BRD-K61295575,blebbistatin-(+/-)|blebbistatin-(-),ATPase inhibitor,|MYH14|MYH2
LZCDAPDGXCYOEH,BRD-K33127281,adapalene,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,BRD-K33127281,adapalene,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,BRD-K33127281,adapalene,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,BRD-K33127281,adapalene,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG
LZCOQTDXKCNBEE,BRD-A03932035|BRD-K05224916|BRD-K48619321,methscopolamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A03932035|BRD-K05224916|BRD-K48619321,methscopolamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A03932035|BRD-K05224916|BRD-K48619321,methscopolamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K05224916|BRD-K48619321,methscopolamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3
LZFZMUMEGBBDTC,BRD-K99447003,enalaprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K99447003,enalaprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K99447003,enalaprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K99447003,enalaprilat,angiotensin converting enzyme inhibitor,ACE
LZMHWZHOZLVYDL,BRD-K26015241,ODQ,guanylyl cyclase inhibitor,GUCY1A2|GUCY1A3|GUCY1B3,BRD-K26015241,ODQ,guanylyl cyclase inhibitor,GUCY1A2|GUCY1A3|GUCY1B3,BRD-K26015241,ODQ,guanylyl cyclase inhibitor,GUCY1A2|GUCY1A3|GUCY1B3,BRD-K26015241,ODQ,guanylyl cyclase inhibitor,GUCY1A2|GUCY1A3|GUCY1B3
LZMOSYUFVYJEPY,BRD-K12040459,AT7867,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA,BRD-K12040459,AT7867,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA,BRD-K12040459,AT7867,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA,BRD-K12040459,AT7867,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA
LZPZPHGJDAGEJZ,BRD-A78341343,regadenoson,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-A78341343,regadenoson,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-A78341343,regadenoson,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K00003609,regadenoson,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
LZXMUJCJAWVHPZ,BRD-K64838454,dipraglurant,glutamate receptor negative allosteric modulator,GRM5,BRD-K64838454,dipraglurant,glutamate receptor negative allosteric modulator,GRM5,BRD-K64838454,dipraglurant,glutamate receptor negative allosteric modulator,GRM5,BRD-K64838454,dipraglurant,glutamate receptor negative allosteric modulator,GRM5
MAASHDQFQDDECQ,BRD-K68143200,NSC-95397,CDC inhibitor,CDC25A|CDC25B,BRD-K68143200,NSC-95397,CDC inhibitor,CDC25A|CDC25B,BRD-K68143200,NSC-95397,CDC inhibitor,CDC25A|CDC25B,BRD-K68143200,NSC-95397,CDC inhibitor,CDC25A|CDC25B
MADRVGBADLFHMO,BRD-A59747053,indeloxazine,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,,BRD-A59747053,indeloxazine,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,,BRD-A59747053,indeloxazine,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,,BRD-A59747053,indeloxazine,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,
MAEIEVLCKWDQJH,BRD-K38197229,bumetanide,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,BRD-K38197229,bumetanide,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,BRD-K38197229,bumetanide,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,BRD-K38197229,bumetanide,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5
MAFMQEKGGFWBAB,BRD-K91699951,benzonatate,local anesthetic,SCN5A,BRD-K91699951,benzonatate,local anesthetic,SCN5A,BRD-K91699951,benzonatate,local anesthetic,SCN5A,BRD-K91699951,benzonatate,local anesthetic,SCN5A
MAHYXYTYTLCTQD,BRD-K05677083,PACOCF3,phospholipase inhibitor,PLA2G4A,BRD-K05677083,PACOCF3,phospholipase inhibitor,PLA2G4A,BRD-K05677083,PACOCF3,phospholipase inhibitor,PLA2G4A,BRD-K05677083,PACOCF3,phospholipase inhibitor,PLA2G4A
MAKMQGKJURAJEN,BRD-K47049295,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1,BRD-K47049295,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1,BRD-K47049295,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1,BRD-K47049295,BAN-ORL-24,nociceptin/orphanin FQ receptor antagonist,OPRL1
MASKQITXHVYVFL,BRD-K27755542,PF-04937319,glucokinase activator,GCK,BRD-K27755542,PF-04937319,glucokinase activator,GCK,BRD-K27755542,PF-04937319,glucokinase activator,GCK,BRD-K27755542,PF-04937319,glucokinase activator,GCK
MAUCONCHVWBMHK,BRD-K12867552,PCI-24781,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,BRD-K12867552,PCI-24781,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,BRD-K12867552,PCI-24781,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,BRD-K12867552,PCI-24781,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6
MAVDNGWEBZTACC,BRD-K06883221,apratastat,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,ADAM17|MMP1|MMP13|MMP9,BRD-K06883221,apratastat,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,ADAM17|MMP1|MMP13|MMP9,BRD-K06883221,apratastat,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,ADAM17|MMP1|MMP13|MMP9,BRD-K06883221,apratastat,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,ADAM17|MMP1|MMP13|MMP9
MBBCVAKAJPKAKM,BRD-K92213669,lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP,BRD-K92213669,lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP,BRD-K92213669,lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP,BRD-K92213669,lomitapide,microsomal trigylceride transfer protein inhibitor,MTTP
MBBZMMPHUWSWHV,BRD-K28595280,meglumine,excipient,,BRD-K28595280,meglumine,excipient,,BRD-K28595280,meglumine,excipient,,BRD-K28595280,meglumine,excipient,
MBGGBVCUIVRRBF,BRD-A36217750,sulfinpyrazone,uricosuric blocker,ABCC1|ABCC2|FPR1|SLC22A12,BRD-A36217750,sulfinpyrazone,uricosuric blocker,ABCC1|ABCC2|FPR1|SLC22A12,BRD-A36217750,sulfinpyrazone,uricosuric blocker,ABCC1|ABCC2|FPR1|SLC22A12,BRD-K00004525,sulfinpyrazone,uricosuric blocker,ABCC1|FPR1|SLC22A12
MBKDYNNUVRNNRF,BRD-K94072573,medronic-acid,bone resorption inhibitor,,BRD-K94072573,medronic-acid,bone resorption inhibitor,,BRD-K94072573,medronic-acid,bone resorption inhibitor,,BRD-K94072573,medronic-acid,bone resorption inhibitor,
MBKWNJVQSFBLQI,BRD-K06388517,lofemizole,cyclooxygenase inhibitor,,BRD-K06388517,lofemizole,cyclooxygenase inhibitor,,BRD-K06388517,lofemizole,cyclooxygenase inhibitor,,BRD-K06388517,lofemizole,cyclooxygenase inhibitor,
MBLBDJOUHNCFQT,BRD-K80653534,N-acetyl-D-glucosamine,,B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP,BRD-K80653534,N-acetyl-D-glucosamine,,B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP,BRD-K80653534,N-acetyl-D-glucosamine,,B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP,BRD-K80653534,N-acetyl-D-glucosamine,,B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP
MBMBGCFOFBJSGT,BRD-K39965020,doconexent,PPAR receptor agonist,FFAR1|PTGS1|PTGS2,BRD-K39965020,doconexent,PPAR receptor agonist,FFAR1|PTGS1|PTGS2,BRD-K39965020,doconexent,PPAR receptor agonist,FFAR1|PTGS1|PTGS2,BRD-K39965020,doconexent,PPAR receptor agonist,FFAR1|PTGS1|PTGS2
MBNGWHIJMBWFHU,BRD-K26862302,diosmetin,aryl hydrocarbon receptor agonist,CYP1B1,BRD-K26862302,diosmetin,aryl hydrocarbon receptor agonist,CYP1B1,BRD-K26862302,diosmetin,aryl hydrocarbon receptor agonist,CYP1B1,BRD-K26862302,diosmetin,aryl hydrocarbon receptor agonist,CYP1B1
MBOMYENWWXQSNW,BRD-K15203492,MLN9708,proteasome inhibitor,,BRD-K15203492,MLN9708,proteasome inhibitor,,BRD-K15203492,MLN9708,proteasome inhibitor,,BRD-K15203492,MLN9708,proteasome inhibitor,
MBRLOUHOWLUMFF,BRD-K78294846,osthol,calcium channel blocker,,BRD-K78294846,osthol,calcium channel blocker,,BRD-K78294846,osthol,calcium channel blocker,,BRD-K78294846,osthol,calcium channel blocker,
MBUVEWMHONZEQD,BRD-A68888262,azelastine,histamine receptor antagonist,HRH1,BRD-A68888262,azelastine,histamine receptor antagonist,HRH1,BRD-A68888262,azelastine,histamine receptor antagonist,HRH1,BRD-A68888262,azelastine,histamine receptor antagonist,HRH1
MBWUSSKCCUMJHO,BRD-A65562236,solamargine,apoptosis inhibitor,,BRD-A65562236,solamargine,apoptosis inhibitor,,BRD-A65562236,solamargine,apoptosis inhibitor,,BRD-A65562236,solamargine,apoptosis inhibitor,
MBWXNTAXLNYFJB,BRD-K76661572,phytonadione,,BGLAP|GGCX,BRD-K76661572,phytonadione,,BGLAP|GGCX,BRD-K76661572,phytonadione,,BGLAP|GGCX,BRD-K76661572,phytonadione,,BGLAP|GGCX
MCGSCOLBFJQGHM,BRD-A95032015|BRD-K17443395,abacavir,nucleoside reverse transcriptase inhibitor,,BRD-A95032015|BRD-K17443395,abacavir,nucleoside reverse transcriptase inhibitor,,BRD-A95032015|BRD-K17443395|BRD-M42309903|BRD-M55852627,abacavir,nucleoside reverse transcriptase inhibitor,,BRD-A95032015|BRD-K17443395|BRD-M42309903|BRD-M55852627,abacavir,nucleoside reverse transcriptase inhibitor,
MCIACXAZCBVDEE,BRD-K10071630,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2,BRD-K10071630,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2,BRD-K10071630,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2,BRD-K00003574,ertugliflozin,sodium/glucose cotransporter inhibitor,SLC5A2
MCJGNVYPOGVAJF,BRD-K66808046,oxyquinoline,chelating agent,METAP2,BRD-K66808046,oxyquinoline,chelating agent,METAP2,BRD-K66808046,oxyquinoline,chelating agent,METAP2,BRD-K66808046,oxyquinoline,chelating agent,METAP2
MCMSJVMUSBZUCN,BRD-K84663978,trequinsin,phosphodiesterase inhibitor,PDE5A,BRD-K84663978,trequinsin,phosphodiesterase inhibitor,PDE5A,BRD-K84663978,trequinsin,phosphodiesterase inhibitor,PDE5A,BRD-K84663978,trequinsin,phosphodiesterase inhibitor,PDE5A
MCNGUYXRBCIGOV,BRD-K25906698,immepip,histamine receptor agonist,HRH3|HRH4,BRD-K25906698,immepip,histamine receptor agonist,HRH3|HRH4,BRD-K25906698,immepip,histamine receptor agonist,HRH3|HRH4,BRD-K25906698,immepip,histamine receptor agonist,HRH3|HRH4
MCPUZZJBAHRIPO,BRD-K03289534,lersivirine,non-nucleoside reverse transcriptase inhibitor,,BRD-K03289534,lersivirine,non-nucleoside reverse transcriptase inhibitor,,BRD-K03289534,lersivirine,non-nucleoside reverse transcriptase inhibitor,,BRD-K03289534,lersivirine,non-nucleoside reverse transcriptase inhibitor,
MCUJKPPARUPFJM,BRD-K21908111,AZD1208,Pim kinase inhibitor,PIM1|PIM2|PIM3,BRD-K21908111,AZD1208,Pim kinase inhibitor,PIM1|PIM2|PIM3,BRD-K21908111,AZD1208,Pim kinase inhibitor,PIM1|PIM2|PIM3,BRD-K21908111,AZD1208,Pim kinase inhibitor,PIM1|PIM2|PIM3
MCYHPZGUONZRGO,BRD-A77473570,mecysteine,analgesic agent,,BRD-A77473570,mecysteine,analgesic agent,,BRD-A77473570,mecysteine,analgesic agent,,BRD-K81993098,mecysteine,analgesic agent,
MDGVCMGGLSOVIQ,BRD-K08699567,cinoctramide,,,BRD-K08699567,cinoctramide,,,BRD-K08699567|BRD-K15901271,cinoctramide,,,BRD-K08699567|BRD-K15901271,cinoctramide,,
MDJFHRLTPRPZLY,BRD-K79145628,nimorazole,bacterial DNA inhibitor,,BRD-K79145628,nimorazole,bacterial DNA inhibitor,,BRD-K79145628,nimorazole,bacterial DNA inhibitor,,BRD-K79145628,nimorazole,bacterial DNA inhibitor,
MDKCFLQDBWCQCV,BRD-K80253852,benzyl-isothiocyanate,methylazoxymethanol acetate inhibitor,,BRD-K80253852,benzyl-isothiocyanate,methylazoxymethanol acetate inhibitor,,BRD-K80253852,benzyl-isothiocyanate,methylazoxymethanol acetate inhibitor,,BRD-K80253852,benzyl-isothiocyanate,methylazoxymethanol acetate inhibitor,
MDKGKXOCJGEUJW,BRD-A34006693,suprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A34006693,suprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A34006693,suprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A34006693,suprofen,cyclooxygenase inhibitor,PTGS1|PTGS2
MDLAAYDRRZXJIF,BRD-K15409150,penfluridol,T-type calcium channel blocker,CACNA1G,BRD-K15409150,penfluridol,T-type calcium channel blocker,CACNA1G,BRD-K15409150,penfluridol,T-type calcium channel blocker,CACNA1G,BRD-K15409150,penfluridol,T-type calcium channel blocker,CACNA1G
MDMWHKZANMNXTF,BRD-K78959463,FPL-64176,calcium channel activator,CACNA1C|CACNA1S,BRD-K78959463,FPL-64176,calcium channel activator,CACNA1C|CACNA1S,BRD-K78959463,FPL-64176,calcium channel activator,CACNA1C|CACNA1S,BRD-K78959463,FPL-64176,calcium channel activator,CACNA1C|CACNA1S
MDNWOSOZYLHTCG,BRD-K62326629,dichlorophen,anticestodal agent,,BRD-K62326629,dichlorophen,anticestodal agent,,BRD-K62326629,dichlorophen,anticestodal agent,,BRD-K62326629,dichlorophen,anticestodal agent,
MDOJTZQKHMAPBK,BRD-K11153516,iniparib,PARP inhibitor,PARP1,BRD-K11153516,iniparib,PARP inhibitor,PARP1,BRD-K11153516,iniparib,PARP inhibitor,PARP1,BRD-K11153516,iniparib,PARP inhibitor,PARP1
MDSQOJYHHZBZKA,BRD-K94559059,telotristat,serotonin receptor antagonist|serotonin release inhibitor,TPH1,BRD-K94559059,telotristat,serotonin receptor antagonist|serotonin release inhibitor,TPH1,BRD-K94559059,telotristat-ethyl,tryptophan hydroxylase inhibitor,TPH1,BRD-K94559059,telotristat-ethyl,tryptophan hydroxylase inhibitor,TPH1
MDYZKJNTKZIUSK,BRD-M08959712,tyloxapol,NFkB pathway inhibitor,LPL|NFKB2,BRD-M08959712,tyloxapol,NFkB pathway inhibitor,LPL|NFKB2,BRD-M08959712,tyloxapol,NFkB pathway inhibitor,LPL|NFKB2,,,,
MDZCSIDIPDZWKL,BRD-K42973005,CHIR-98014,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K42973005,CHIR-98014,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K42973005,CHIR-98014,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K42973005,CHIR-98014,glycogen synthase kinase inhibitor,GSK3A|GSK3B
MECHNRXZTMCUDQ,BRD-A87199639|BRD-K05243578|BRD-K56155962,ergocalciferol,vitamin analog,VDR,BRD-A87199639|BRD-K05243578|BRD-K56155962,ergocalciferol,vitamin analog,VDR,BRD-A87199639|BRD-K05243578|BRD-K56155962,ergocalciferol,vitamin analog,VDR,BRD-A87199639|BRD-K05243578|BRD-K56155962,ergocalciferol,vitamin analog,VDR
MEEQBDCQPIZMLY,BRD-K60371362,osemozotan,serotonin receptor agonist,HTR1A,BRD-K60371362,osemozotan,serotonin receptor agonist,HTR1A,BRD-K60371362,osemozotan,serotonin receptor agonist,HTR1A,BRD-K60371362,osemozotan,serotonin receptor agonist,HTR1A
MEFKEPWMEQBLKI,BRD-K78185697,ademetionine,methyltransferase stimulant|phosphodiesterase inhibitor,AMD1|CBS|COMT|GNMT|MAT1A|MAT2A,BRD-K78185697,ademetionine,methyltransferase stimulant|phosphodiesterase inhibitor,AMD1|CBS|COMT|GNMT|MAT1A|MAT2A,BRD-K78185697,ademetionine,methyltransferase stimulant|phosphodiesterase inhibitor,AMD1|CBS|COMT|GNMT|MAT1A|MAT2A,BRD-K78185697,ademetionine,methyltransferase stimulant|phosphodiesterase inhibitor,
MEJYDZQQVZJMPP,BRD-A17224697,dimethyl-isosorbide,cosmetic moisturizer,,BRD-A17224697,dimethyl-isosorbide,cosmetic moisturizer,,BRD-A17224697,dimethyl-isosorbide,cosmetic moisturizer,,BRD-A17224697,dimethyl-isosorbide,cosmetic moisturizer,
MEOWKUXNVNJAMY,BRD-K08398903,GSK2838232,HIV gag inhibitor,,BRD-K08398903,GSK2838232,HIV gag inhibitor,,BRD-K08398903,GSK2838232,HIV gag inhibitor,,BRD-K08398903,GSK2838232,HIV gag inhibitor,
MEOYFIHNRBNEPI,BRD-K04993719,LY2334737,antitumor agent|ribonucleotide reductase inhibitor,,BRD-K04993719,LY2334737,antitumor agent|ribonucleotide reductase inhibitor,,BRD-K04993719,LY2334737,antitumor agent|ribonucleotide reductase inhibitor,,BRD-K04993719,LY2334737,antitumor agent|ribonucleotide reductase inhibitor,
METKIMKYRPQLGS,BRD-A20239487|BRD-K44993696|BRD-K68075732,aceclidine|atenolol-(+/-)|atenolol-(-),acetylcholine receptor agonist|adrenergic receptor antagonist,|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A20239487|BRD-K44993696|BRD-K68075732,aceclidine|atenolol-(+/-)|atenolol-(-),acetylcholine receptor agonist|adrenergic receptor antagonist,|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A20239487|BRD-K44993696|BRD-K68075732,atenolol-(+)|atenolol-(+/-)|atenolol-(-),adrenergic receptor antagonist,|ADRB1|ADRB2,BRD-A20239487|BRD-K44993696|BRD-K68075732,atenolol-(+)|atenolol-(+/-)|atenolol-(-),adrenergic receptor antagonist,|ADRB1|ADRB2|LTF|PLA2G2E
METQSPRSQINEEU,BRD-A00938334|BRD-K04394237|BRD-K70875526,drospirenone,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,BRD-A00938334|BRD-K04394237,drospirenone,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,BRD-A00938334|BRD-K04394237|BRD-K70875526,drospirenone,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,BRD-A00938334|BRD-K04394237|BRD-K70875526,drospirenone,mineralocorticoid receptor antagonist,AR|NR3C2|PGR
MEUCPCLKGZSHTA,BRD-A88562598,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,BRD-A88562598,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,BRD-A88562598,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR,BRD-K00003578,degarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
MEUQWHZOUDZXHH,BRD-K46209126,pravadoline,cyclooxygenase inhibitor,CNR1|CNR2,BRD-K46209126,pravadoline,cyclooxygenase inhibitor,CNR1|CNR2,BRD-K46209126,pravadoline,cyclooxygenase inhibitor,CNR1|CNR2,BRD-K46209126,pravadoline,cyclooxygenase inhibitor,CNR1|CNR2
MEXWLVVJOPSWLN,BRD-A00055058,RS-0481,immunostimulant,,BRD-A00055058,RS-0481,immunostimulant,,BRD-A00055058,RS-0481,immunostimulant,,BRD-K00004000,RS-0481,immunostimulant,
MEZLKOACVSPNER,BRD-A28545468,selegiline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-A28545468,selegiline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-A28545468,selegiline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K86434416,selegiline,monoamine oxidase inhibitor,MAOA|MAOB
MEZZCSHVIGVWFI,BRD-K22193694,dioxybenzone,topical sunscreen agent,,BRD-K22193694,dioxybenzone,topical sunscreen agent,,BRD-K22193694,dioxybenzone,topical sunscreen agent,,BRD-K22193694,dioxybenzone,topical sunscreen agent,
MFAQYJIYDMLAIM,BRD-K87112191,PP242,mTOR inhibitor,MTOR|PASK,BRD-K87112191,PP242,mTOR inhibitor,MTOR|PASK,BRD-K87112191,PP242,mTOR inhibitor,MTOR|PASK,BRD-K87112191,PP242,mTOR inhibitor,MTOR|PASK
MFDFERRIHVXMIY,BRD-K24616672,procaine,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,BRD-K24616672,procaine,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,BRD-K24616672,procaine,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,BRD-K24616672,procaine,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3
MFFBXYNKZHTCEY,BRD-K88854110,taprenepag,prostaglandin receptor agonist,PTGER2,BRD-K88854110,taprenepag,prostaglandin receptor agonist,PTGER2,BRD-K88854110,taprenepag,prostaglandin receptor agonist,PTGER2,BRD-K88854110,taprenepag,prostaglandin receptor agonist,PTGER2
MFFMDFFZMYYVKS,BRD-K19416115,sitagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K19416115,sitagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K19416115|BRD-U27206154,sitagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K19416115|BRD-U27206154,sitagliptin,dipeptidyl peptidase inhibitor,DPP4
MFHPPMMWHSHDSI,BRD-K51364817,etoxybamide,,,BRD-K51364817,etoxybamide,,,BRD-K51364817,etoxybamide,,,BRD-K51364817,etoxybamide,,
MFVJXLPANKSLLD,BRD-K54665485,R-59022,diacylglycerol kinase inhibitor|protein kinase inhibitor,DGKA,BRD-K54665485,R-59022,diacylglycerol kinase inhibitor|protein kinase inhibitor,DGKA,BRD-K54665485,R-59022,diacylglycerol kinase inhibitor|protein kinase inhibitor,DGKA,BRD-K54665485,R-59022,diacylglycerol kinase inhibitor|protein kinase inhibitor,DGKA
MFWNKCLOYSRHCJ,BRD-A10967948,granisetron,serotonin receptor antagonist,HTR3A,BRD-A10967948,granisetron,serotonin receptor antagonist,HTR3A,BRD-A10967948,granisetron,serotonin receptor antagonist,HTR3A,BRD-A10967948,granisetron,serotonin receptor antagonist,HTR3A
MFYSYFVPBJMHGN,BRD-A62731508,cortisone,glucocorticoid receptor agonist,NR3C1,BRD-A62731508,cortisone,glucocorticoid receptor agonist,NR3C1,BRD-A62731508|BRD-A95717758|BRD-K43736954,cortisone|cortodoxone,androgen receptor antagonist|glucocorticoid receptor agonist,AR|NR3C1,BRD-A00025572|BRD-K00025572,cortisone,glucocorticoid receptor agonist,NR3C1
MFZCIDXOLLEMOO,BRD-K82800842,inositol-hexanicotinate,,,BRD-K82800842,inositol-hexanicotinate,,,BRD-K82800842,inositol-hexanicotinate,,,BRD-K82800842,inositol-hexanicotinate,,
MFZWMTSUNYWVBU,BRD-K50406511,hycanthone,RNA synthesis inhibitor,,BRD-K50406511,hycanthone,RNA synthesis inhibitor,,BRD-K50406511,hycanthone,RNA synthesis inhibitor,,BRD-K50406511,hycanthone,RNA synthesis inhibitor,
MGGBYMDAPCCKCT,BRD-K06542892,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK,BRD-K06542892,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK,BRD-K06542892,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK,BRD-K06542892,ASP3026,ALK tyrosine kinase receptor inhibitor,ALK
MGNVWUDMMXZUDI,BRD-K11463116,eprodisate,amyloid protein inhibitor|antiamyloidogenic agent,SAA1,BRD-K11463116,eprodisate,amyloid protein inhibitor|antiamyloidogenic agent,SAA1,BRD-K11463116,eprodisate,amyloid protein inhibitor|antiamyloidogenic agent,SAA1,BRD-K11463116,eprodisate,amyloid protein inhibitor|antiamyloidogenic agent,SAA1
MGQLHRYJBWGORO,BRD-A47790386,balofloxacin,bacterial DNA gyrase inhibitor,,BRD-A47790386,balofloxacin,bacterial DNA gyrase inhibitor,,BRD-A47790386,balofloxacin,bacterial DNA gyrase inhibitor,,BRD-A47790386,balofloxacin,bacterial DNA gyrase inhibitor,
MGSRCZKZVOBKFT,BRD-K17458574,thymol,GABA receptor positive allosteric modulator,TRPA1,BRD-K17458574,thymol,GABA receptor positive allosteric modulator,TRPA1,BRD-K17458574,thymol,GABA receptor positive allosteric modulator,TRPA1,BRD-K17458574,thymol,GABA receptor positive allosteric modulator,TRPA1
MGVRNMUKTZOQOW,BRD-K36864847,BD-1047,adrenergic receptor antagonist,SIGMAR1,BRD-K36864847,BD-1047,adrenergic receptor antagonist,SIGMAR1,BRD-K36864847,BD-1047,adrenergic receptor antagonist,SIGMAR1,BRD-K36864847,BD-1047,adrenergic receptor antagonist,SIGMAR1
MHFRGQHAERHWKZ,BRD-A30403214,edelfosine,phospholipase inhibitor,,BRD-A30403214,edelfosine,phospholipase inhibitor,,BRD-A30403214,edelfosine,phospholipase inhibitor,,BRD-K01825687,edelfosine,phospholipase inhibitor,
MHJBZVSGOZTKRH,BRD-K62752296|BRD-K91486246,endoxifen,estrogen receptor antagonist,ESR1,BRD-K62752296|BRD-K91486246,endoxifen,estrogen receptor antagonist,ESR1,BRD-K62752296|BRD-K91486246,endoxifen,estrogen receptor antagonist,ESR1,BRD-K62752296|BRD-K91486246,endoxifen,estrogen receptor antagonist,ESR1
MHKLKWCYGIBEQF,BRD-K97360717,N-oxydiethylenebenzothiazole-2-sulfenamide,,,BRD-K97360717,N-oxydiethylenebenzothiazole-2-sulfenamide,,,BRD-K97360717,N-oxydiethylenebenzothiazole-2-sulfenamide,,,BRD-K97360717,N-oxydiethylenebenzothiazole-2-sulfenamide,,
MHNSOBBJZCWUGS,BRD-A85216385,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,CHRM1|SLC6A2|SLC6A3|SLC6A4,BRD-A85216385,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,CHRM1|SLC6A2|SLC6A3|SLC6A4,BRD-A85216385,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,CHRM1|SLC6A2|SLC6A3|SLC6A4,BRD-K00004218,3-alpha-bis-(4-fluorophenyl)-methoxytropane,dopamine uptake inhibitor,CHRM1|SLC6A2|SLC6A3|SLC6A4
MHOAUIZFSQGCNM,BRD-K24221957,pralidoxime-chloride,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K24221957,pralidoxime-chloride,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K24221957,pralidoxime-chloride,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K24221957,pralidoxime-chloride,acetylcholinesterase inhibitor,ACHE|BCHE
MHPZZZZLAQGTHT,BRD-K96691275,mebrofenin,,,BRD-K96691275,mebrofenin,,,BRD-K96691275,mebrofenin,,,BRD-K96691275,mebrofenin,,
MHUUDVZSPFRUSK,BRD-K70912147,co-102862,,SCN4A|SCN9A,BRD-K70912147,co-102862,,SCN4A|SCN9A,BRD-K70912147,co-102862,,SCN4A|SCN9A,BRD-K70912147,CO-102862,sodium channel blocker,SCN4A|SCN9A
MHWLWQUZZRMNGJ,BRD-K47886988,nalidixic-acid,bacterial DNA gyrase inhibitor,,BRD-K47886988,nalidixic-acid,bacterial DNA gyrase inhibitor,,BRD-K47886988,nalidixic-acid,bacterial DNA gyrase inhibitor,,BRD-K47886988,nalidixic-acid,bacterial DNA gyrase inhibitor,
MHXGEROHKGDZGO,BRD-K80700417,SGI-1776,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,BRD-K80700417,SGI-1776,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,BRD-K80700417,SGI-1776,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,BRD-K80700417,SGI-1776,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3
MIJFNYMSCFYZNY,BRD-K82967685,mirodenafil,phosphodiesterase inhibitor,PDE5A,BRD-K82967685,mirodenafil,phosphodiesterase inhibitor,PDE5A,BRD-K82967685,mirodenafil,phosphodiesterase inhibitor,PDE5A,BRD-K82967685,mirodenafil,phosphodiesterase inhibitor,PDE5A
MIJYXULNPSFWEK,BRD-K90647725,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1,BRD-K90647725,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1,BRD-A00113255|BRD-A65785035|BRD-K90647725,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1,BRD-A00113255|BRD-A65785035|BRD-K90647725,oleanolic-acid,G protein-coupled receptor agonist,GPBAR1
MINDHVHHQZYEEK,BRD-K15262564|BRD-K25394084,mupirocin,isoleucyl-tRNA synthetase inhibitor,,BRD-K15262564,mupirocin,isoleucyl-tRNA synthetase inhibitor,,BRD-K15262564|BRD-K25394084,mupirocin,isoleucyl-tRNA synthetase inhibitor,,BRD-K15262564|BRD-K25394084,mupirocin,isoleucyl-tRNA synthetase inhibitor,
MIQPIUSUKVNLNT,BRD-K10852020,tolcapone,catechol O methyltransferase inhibitor,COMT,BRD-K10852020,tolcapone,catechol O methyltransferase inhibitor,COMT,BRD-K10852020,tolcapone,catechol O methyltransferase inhibitor,COMT,BRD-K10852020,tolcapone,catechol O methyltransferase inhibitor,COMT
MIWWSGDADVMLTG,BRD-K37069697,fexinidazole,,,BRD-K37069697,fexinidazole,,,BRD-K37069697,fexinidazole,,,BRD-K37069697,fexinidazole,,
MIXIIJCBELCMCZ,BRD-K53422148,BI-224436,HIV integrase inhibitor,,BRD-K53422148,BI-224436,HIV integrase inhibitor,,BRD-K53422148,BI-224436,HIV integrase inhibitor,,BRD-K53422148,BI-224436,HIV integrase inhibitor,
MJFJKKXQDNNUJF,BRD-A33711280,metixene,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A33711280,metixene,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A33711280,metixene,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K01826531,metixene,acetylcholine receptor antagonist,CHRM5
MJIHNNLFOKEZEW,BRD-A49172652|BRD-K05900209,dexlansoprazole|lansoprazole,ATPase inhibitor,ATP4A|ATP4B,BRD-A49172652|BRD-K05900209,dexlansoprazole|lansoprazole,ATPase inhibitor,ATP4A|ATP4B,BRD-A49172652|BRD-K05900209,dexlansoprazole|lansoprazole,ATPase inhibitor,ATP4A|ATP4B,BRD-K00004280|BRD-K05900209,dexlansoprazole|lansoprazole,ATPase inhibitor,ATP4A|ATP4B
MJJALKDDGIKVBE,BRD-K13314656,ebastine,histamine receptor antagonist,CYP3A4|HRH1,BRD-K13314656,ebastine,histamine receptor antagonist,CYP3A4|HRH1,BRD-K13314656,ebastine,histamine receptor antagonist,CYP3A4|HRH1,BRD-K13314656,ebastine,histamine receptor antagonist,CYP3A4|HRH1
MJKADKZSYQWGLL,BRD-K42859542,CFM-2,glutamate receptor antagonist,,BRD-K42859542,CFM-2,glutamate receptor antagonist,,BRD-K42859542,CFM-2,glutamate receptor antagonist,,BRD-K42859542,CFM-2,glutamate receptor antagonist,
MJMJERJFCHYXEM,BRD-K05361803,SC-10,protein kinase activator,PRKCA,BRD-K05361803,SC-10,protein kinase activator,PRKCA,BRD-K05361803,SC-10,protein kinase activator,PRKCA,BRD-K05361803,SC-10,protein kinase activator,PRKCA
MJQMRGWYPNIERM,BRD-K94534639,LY2811376,beta-secretase inhibitor,BACE1,BRD-K94534639,LY2811376,beta-secretase inhibitor,BACE1,BRD-K94534639,LY2811376,beta-secretase inhibitor,BACE1,BRD-K94534639,LY2811376,beta-secretase inhibitor,BACE1
MJQUEDHRCUIRLF,BRD-A77494669,BMY-45618,PKC activator,PRKCE,BRD-K47405978,bryostatin-1,protein kinase C inhibitor,PRKCE,BRD-A77494669|BRD-K47405978,bryostatin-1,protein kinase C inhibitor,PRKCE,,,,
MJRGSRRZKSJHOE,BRD-K56509348,BMS-182874,endothelin receptor antagonist,EDNRA,BRD-K56509348,BMS-182874,endothelin receptor antagonist,EDNRA,BRD-K56509348,BMS-182874,endothelin receptor antagonist,EDNRA,BRD-K56509348,BMS-182874,endothelin receptor antagonist,EDNRA
MJRICTKAEYTJAV,BRD-A50016482,CI-923,acetylcholine receptor antagonist,,BRD-A50016482,CI-923,acetylcholine receptor antagonist,,BRD-A50016482,CI-923,acetylcholine receptor antagonist,,BRD-A50016482,CI-923,acetylcholine receptor antagonist,
MJSHVHLADKXCML,BRD-K91283740,UNC2025,FLT3 inhibitor|MER tyrosine kinase inhibitor,FLT3|MERTK,BRD-K91283740,UNC2025,FLT3 inhibitor|MER tyrosine kinase inhibitor,FLT3|MERTK,BRD-K91283740,UNC2025,FLT3 inhibitor|MER tyrosine kinase inhibitor,FLT3|MERTK,BRD-K91283740,UNC2025,FLT3 inhibitor|MER tyrosine kinase inhibitor,FLT3|MERTK
MJUVRTYWUMPBTR,BRD-K97101532,VX-661,CFTR channel agonist,CFTR,BRD-K97101532,tezacaftor,CFTR channel agonist,,BRD-K97101532,tezacaftor,CFTR channel agonist,,BRD-K97101532,tezacaftor,CFTR channel agonist,
MJVAVZPDRWSRRC,BRD-K78126613,menadione,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,BRD-K78126613,menadione,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,BRD-K78126613,menadione,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,BRD-K78126613,menadione,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1
MJVGBKJNTFCUJM,BRD-K18613660,mexeneone,,,BRD-K18613660,mexeneone,,,BRD-K18613660,mexeneone,,,BRD-K18613660,mexeneone,,
MJZJYWCQPMNPRM,BRD-K45973863,WR99210,dihydrofolate reductase inhibitor,TYMS,BRD-K45973863,WR99210,dihydrofolate reductase inhibitor,TYMS,BRD-K45973863,WR99210,dihydrofolate reductase inhibitor,TYMS,BRD-K45973863,WR99210,dihydrofolate reductase inhibitor,TYMS
MKJIEFSOBYUXJB,BRD-K95739795,tetrabenazine,vesicular monoamine transporter inhibitor,DRD2|SLC18A1|SLC18A2,BRD-K95739795,tetrabenazine,vesicular monoamine transporter inhibitor,DRD2|SLC18A1|SLC18A2,BRD-K95739795,tetrabenazine,vesicular monoamine transporter inhibitor,DRD2|SLC18A1|SLC18A2,BRD-K95739795,tetrabenazine,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2
MKMPWKUAHLTIBJ,BRD-K14171291,omarigliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K14171291,omarigliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K14171291,omarigliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K14171291,omarigliptin,dipeptidyl peptidase inhibitor,DPP4
MKPLKVHSHYCHOC,BRD-K23976833,travoprost,prostanoid receptor agonist,PTGFR,BRD-K23976833,travoprost,prostanoid receptor agonist,PTGFR,BRD-K23976833,travoprost,prostanoid receptor agonist,PTGFR,BRD-K23976833,travoprost,prostanoid receptor agonist,PTGFR
MKUXAQIIEYXACX,BRD-K32318651,acyclovir,DNA polymerase inhibitor,PNP,BRD-K32318651,acyclovir,DNA polymerase inhibitor,PNP,BRD-K32318651,acyclovir,DNA polymerase inhibitor,PNP,BRD-K32318651,acyclovir,DNA polymerase inhibitor,PNP
MKVMEJKNLUWFSQ,BRD-K97152684,PD-161570,FGFR inhibitor,FGFR1,BRD-K97152684,PD-161570,FGFR inhibitor,FGFR1,BRD-K97152684,PD-161570,FGFR inhibitor,FGFR1,BRD-K97152684,PD-161570,FGFR inhibitor,FGFR1
MKXKFYHWDHIYRV,BRD-K28307902,flutamide,androgen receptor antagonist,AHR|AR,BRD-K28307902,flutamide,androgen receptor antagonist,AHR|AR,BRD-K28307902,flutamide,androgen receptor antagonist,AHR|AR,BRD-K28307902,flutamide,androgen receptor antagonist,AHR|AR
MKXZASYAUGDDCJ,BRD-K33211335,dextromethorphan,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,BRD-K33211335,dextromethorphan,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,BRD-K33211335,dextromethorphan,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,BRD-K33211335,dextromethorphan,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4
MLBVMOWEQCZNCC,BRD-K59110290,fosamprenavir,HIV protease inhibitor,,BRD-K59110290,fosamprenavir,HIV protease inhibitor,,BRD-K59110290,fosamprenavir,HIV protease inhibitor,,BRD-K59110290,fosamprenavir,HIV protease inhibitor,
MLDQJTXFUGDVEO,BRD-K23984367,sorafenib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,BRD-K23984367,sorafenib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,BRD-K23984367,sorafenib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,BRD-K23984367,sorafenib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET
MLDQTQOMWDNTNN,BRD-K12745498,S1P1-agonist-III,sphingosine kinase inhibitor,S1PR1,BRD-K12745498,S1P1-agonist-III,sphingosine kinase inhibitor,S1PR1,BRD-K12745498,S1P1-agonist-III,sphingosine kinase inhibitor,S1PR1,BRD-K12745498,S1P1-agonist-III,sphingosine kinase inhibitor,S1PR1
MLESJYFEMSJZLZ,BRD-K69726595,mericitabine,HCV inhibitor,,BRD-K69726595,mericitabine,HCV inhibitor,,BRD-K69726595,mericitabine,HCV inhibitor,,BRD-K69726595,mericitabine,HCV inhibitor,
MLKXDPUZXIRXEP,BRD-A13946108,sulindac,cyclooxygenase inhibitor,AKR1B1|MAPK3|PPARD|PTGDR2|PTGS1|PTGS2,BRD-A13946108,sulindac,cyclooxygenase inhibitor,AKR1B1|MAPK3|PPARD|PTGDR2|PTGS1|PTGS2,BRD-A13946108,sulindac,cyclooxygenase inhibitor,AKR1B1|MAPK3|PPARD|PTGDR2|PTGS1|PTGS2,BRD-K01827279,sulindac,cyclooxygenase inhibitor,AKR1B1
MLPSDBJCWIYSEA,BRD-K07061232,BW-616U,monoamine oxidase inhibitor,MAOA,BRD-K07061232,BW-616U,monoamine oxidase inhibitor,MAOA,BRD-K07061232,BW-616U,monoamine oxidase inhibitor,MAOA,BRD-K07061232,BW-616U,monoamine oxidase inhibitor,MAOA
MLSAQOINCGAULQ,BRD-K01253243|BRD-K78809024,SB-590885,RAF inhibitor,BRAF,BRD-K01253243|BRD-K78809024,SB-590885,RAF inhibitor,BRAF,BRD-K01253243|BRD-K78809024,SB-590885,RAF inhibitor,BRAF,BRD-K01253243|BRD-K78809024,SB-590885,RAF inhibitor,BRAF
MLYYVTUWGNIJIB,BRD-K99750640,cefazolin,bacterial cell wall synthesis inhibitor,PON1,BRD-K99750640,cefazolin,bacterial cell wall synthesis inhibitor,PON1,BRD-K99750640,cefazolin,bacterial cell wall synthesis inhibitor,PON1,BRD-K99750640,cefazolin,bacterial cell wall synthesis inhibitor,PON1
MMAIBGHDBYQYDI,BRD-K49504902,SEP-227900,D-Amino Acid Oxidase Inhibitor,DAO,BRD-K49504902,SEP-227900,D-Amino Acid Oxidase Inhibitor,DAO,BRD-K49504902,SEP-227900,D-Amino Acid Oxidase Inhibitor,DAO,BRD-K49504902,SEP-227900,D-amino acid oxidase Inhibitor,DAO
MMDNKTXNUZFVKD,BRD-K39733634,L-161982,prostanoid receptor antagonist,PTGER4,BRD-K39733634,L-161982,prostanoid receptor antagonist,PTGER4,BRD-K39733634,L-161982,prostanoid receptor antagonist,PTGER4,BRD-K39733634,L-161982,prostanoid receptor antagonist,PTGER4
MMGAVKCAGQCFHS,BRD-K52113681,CP-339818,potassium channel blocker,KCNA3,BRD-K52113681,CP-339818,potassium channel blocker,KCNA3,BRD-K52113681,CP-339818,potassium channel blocker,KCNA3,BRD-K00004233,CP-339818,potassium channel blocker,KCNA3
MMHDBUJXLOFTLC,BRD-K00521308,ATN-161,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,BRD-K00521308,ATN-161,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,BRD-K00521308,ATN-161,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,BRD-K00521308,ATN-161,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3
MMMSEONUUDDKJS,BRD-A95114378,cabotegravir,HIV integrase inhibitor,,BRD-A95114378,cabotegravir,HIV integrase inhibitor,,,,,,,,,
MMOXZBCLCQITDF,BRD-K94080537,diethyltoluamide,ionotropic receptor IR40a activator,,BRD-K94080537,diethyltoluamide,ionotropic receptor IR40a activator,,BRD-K94080537,diethyltoluamide,ionotropic receptor IR40a activator,,BRD-K94080537,diethyltoluamide,ionotropic receptor IR40a activator,
MMPAUXMIDJWGFO,BRD-K63932022,2'-MeCCPA,adenosine receptor agonist,ADORA1,BRD-K63932022,2'-MeCCPA,adenosine receptor agonist,ADORA1,BRD-K63932022,2'-MeCCPA,adenosine receptor agonist,ADORA1,BRD-K63932022,2'-MeCCPA,adenosine receptor agonist,ADORA1
MMXSDWJOQSEPSM,BRD-A40302156,A-33903,,,BRD-A40302156,A-33903,,,BRD-A40302156,A-33903,,,BRD-A40302156,A-33903,,
MNDBXUUTURYVHR,BRD-K03194791,roflumilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K03194791,roflumilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K03194791,roflumilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K03194791,roflumilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D
MNHDKMDLOJSCGN,BRD-K17378184,BP-897,dopamine receptor agonist,ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B,BRD-K17378184,BP-897,dopamine receptor agonist,ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B,BRD-K17378184,BP-897,dopamine receptor agonist,ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B,BRD-K17378184,BP-897,dopamine receptor agonist,ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B
MNHXYNNKDDXKNP,BRD-K12932420,YM-976,phosphodiesterase inhibitor,PDE4A,BRD-K12932420,YM-976,phosphodiesterase inhibitor,PDE4A,BRD-K12932420,YM-976,phosphodiesterase inhibitor,PDE4A,BRD-K12932420,YM-976,phosphodiesterase inhibitor,PDE4A
MNIPYSSQXLZQLJ,BRD-K68538666,aceclofenac,prostanoid receptor antagonist,PTGS2,BRD-K68538666,aceclofenac,prostanoid receptor antagonist,PTGS2,BRD-K68538666,aceclofenac,prostanoid receptor antagonist,PTGS2,BRD-K68538666,aceclofenac,prostanoid receptor antagonist,PTGS2
MNJNPLVXBISNSX,BRD-A85587465,bemesetron,serotonin receptor antagonist,HTR3A|HTR3B,BRD-A85587465,bemesetron,serotonin receptor antagonist,HTR3A|HTR3B,BRD-A85587465,bemesetron,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K00004211,bemesetron,serotonin receptor antagonist,HTR3A|HTR3B
MNJVRJDLRVPLFE,BRD-K54770957,etoricoxib,cyclooxygenase inhibitor,PTGS2,BRD-K54770957,etoricoxib,cyclooxygenase inhibitor,PTGS2,BRD-K54770957,etoricoxib,cyclooxygenase inhibitor,PTGS2,BRD-K54770957,etoricoxib,cyclooxygenase inhibitor,PTGS2
MNLNAGRCHNMKKJ,BRD-K07070922,PF-03049423,phosphodiesterase inhibitor,PDE5A,BRD-K07070922,PF-03049423,phosphodiesterase inhibitor,PDE5A,BRD-K07070922,PF-03049423,phosphodiesterase inhibitor,PDE5A,BRD-K07070922,PF-03049423,phosphodiesterase inhibitor,PDE5A
MNNFZYTXMPWOTA,BRD-M00184283,acrylate,mucus protecting agent,,BRD-M00184283,acrylate,mucus protecting agent,,BRD-M00184283,acrylate,mucus protecting agent,,BRD-M00184283,acrylate,mucus protecting agent,
MNNXRVSQOABRRP,BRD-K79930101,GW-583340,EGFR inhibitor,EGFR|ERBB2,BRD-K79930101,GW-583340,EGFR inhibitor,EGFR|ERBB2,BRD-K79930101,GW-583340,EGFR inhibitor,EGFR|ERBB2,BRD-K79930101,GW-583340,EGFR inhibitor,EGFR|ERBB2
MNSCVRXKDINXEY,BRD-A57382968,piroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A57382968,piroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A57382968,piroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,,,,
MNTIJYGEITVWHU,BRD-K02501528,S18986,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K02501528,S18986,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K02501528,S18986,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K02501528,S18986,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4
MNULEGDCPYONBU,BRD-K52536804,oligomycin-a,ATP synthase inhibitor|ATPase inhibitor,ATP5A1,BRD-A81541225,oligomycin-a,ATP synthase inhibitor|ATPase inhibitor,ATP5A1,BRD-A81541225|BRD-K52536804,oligomycin-a,ATP synthase inhibitor|ATPase inhibitor,ATP5A1,BRD-K00003580,oligomycin-A,ATP synthase inhibitor|ATPase inhibitor,ATP5A1
MNYJJHBAEYKXEG,BRD-K38272302,GK921,transglutaminase inhibitor,TGM2,BRD-K38272302,GK921,transglutaminase inhibitor,TGM2,BRD-K38272302,GK921,transglutaminase inhibitor,TGM2,BRD-K38272302,GK921,transglutaminase inhibitor,TGM2
MOHYRCCDARWQRM,BRD-A66143912,3-hydroxy-3-phenylpentanamide,GABA receptor modulator,,BRD-A66143912,3-hydroxy-3-phenylpentanamide,GABA receptor modulator,,BRD-A66143912,3-hydroxy-3-phenylpentanamide,GABA receptor modulator,,BRD-A66143912,3-hydroxy-3-phenylpentanamide,GABA receptor modulator,
MOILFCKRQFQVFS,BRD-A75263867|BRD-K69885552,"2,3-cis/exo-pinanediol|pinanediol",,,BRD-A75263867|BRD-K69885552,"2,3-cis/exo-pinanediol|pinanediol",,,BRD-A75263867|BRD-K69885552,"2,3-cis/exo-pinanediol|pinanediol",,,BRD-A75263867|BRD-K32485706,"2,3-cis/exo-pinanediol|pinanediol",,
MOIWSUQWIOVGRH,BRD-K15086322,JNJ-10191584,histamine receptor antagonist,HRH4,BRD-K15086322,JNJ-10191584,histamine receptor antagonist,HRH4,BRD-K15086322,JNJ-10191584,histamine receptor antagonist,HRH4,BRD-K15086322,JNJ-10191584,histamine receptor antagonist,HRH4
MOLPUWBMSBJXER,BRD-A35837007,bilobalide,GABA receptor modulator,GLRA1|GLRA2|GLRB|HTR3A|HTR3B,BRD-A41714661,bilobalide,GABA receptor modulator,GLRA1|GLRA2|GLRB|HTR3A|HTR3B,BRD-A35837007|BRD-A41714661,bilobalide,GABA receptor modulator,GLRA1|GLRA2|GLRB|HTR3A|HTR3B,BRD-K32039267,bilobalide,GABA receptor modulator,GLRA1|GLRA2|GLRB|HTR3A|HTR3B
MOSKATHMXWSZTQ,BRD-K04833372,GSK1904529A,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR,BRD-K04833372,GSK1904529A,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR,BRD-K04833372,GSK1904529A,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR,BRD-K04833372,GSK1904529A,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR
MOTJMGVDPWRKOC,BRD-K16295392,atrasentan,endothelin receptor antagonist,EDNRA,BRD-K16295392,atrasentan,endothelin receptor antagonist,EDNRA,BRD-K16295392,atrasentan,endothelin receptor antagonist,EDNRA,BRD-K16295392,atrasentan,endothelin receptor antagonist,EDNRA
MOTZDAYCYVMXPC,BRD-K05680146,dodecyl-sulfate,,LYZ,BRD-K05680146,dodecyl-sulfate,,LYZ,BRD-K05680146,dodecyl-sulfate,,LYZ,BRD-K05680146,dodecyl-sulfate,,LYZ
MOVBBVMDHIRCTG,BRD-K02241333,CHIR-124,CHK inhibitor,CHEK1,BRD-K02241333,CHIR-124,CHK inhibitor,CHEK1,BRD-K02241333,CHIR-124,CHK inhibitor,CHEK1,BRD-K02241333,CHIR-124,CHK inhibitor,CHEK1
MOYGZHXDRJNJEP,BRD-A91444184,buclizine,histamine receptor antagonist,CHRM1|HRH1,BRD-A91444184,buclizine,histamine receptor antagonist,CHRM1|HRH1,BRD-A91444184,buclizine,histamine receptor antagonist,CHRM1|HRH1,BRD-A91444184,buclizine,histamine receptor antagonist,HRH1
MOYKHGMNXAOIAT,BRD-K55853390,isosorbide-dinitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1,BRD-K55853390,isosorbide-dinitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1,BRD-K55853390,isosorbide-dinitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1,BRD-K55853390,isosorbide-dinitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1
MOZPSIXKYJUTKI,BRD-K49945136,GR-113808,serotonin receptor antagonist,HTR4,BRD-K49945136,GR-113808,serotonin receptor antagonist,HTR4,BRD-K49945136,GR-113808,serotonin receptor antagonist,HTR4,BRD-K49945136,GR-113808,serotonin receptor antagonist,HTR4
MPBVHIBUJCELCL,BRD-K08681769,ibandronate,bone resorption inhibitor,FDPS,BRD-K08681769,ibandronate,bone resorption inhibitor,FDPS,BRD-K08681769,ibandronate,bone resorption inhibitor,FDPS,BRD-K08681769,ibandronate,bone resorption inhibitor,FDPS
MPDGHEJMBKOTSU,BRD-A20200672|BRD-K80535353,enoxolone,gap junction modulator,HSD11B1,BRD-A20200672|BRD-K80535353,enoxolone,gap junction modulator,HSD11B1,BRD-A20200672|BRD-K80535353|BRD-K96137854,enoxolone,gap junction modulator,HSD11B1,BRD-A20200672|BRD-K80535353|BRD-K96137854,enoxolone,gap junction modulator,HSD11B1
MPHPHYZQRGLTBO,BRD-A70182876,azapropazone,cyclooxygenase inhibitor,PTGS2,BRD-A70182876,azapropazone,cyclooxygenase inhibitor,PTGS2,BRD-A70182876,azapropazone,cyclooxygenase inhibitor,PTGS2,BRD-A70182876,azapropazone,cyclooxygenase inhibitor,PTGS2
MPIPASJGOJYODL,BRD-A93353767,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1,BRD-A93353767,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1,BRD-A93353767,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1,BRD-K01825590,isoconazole,fungal lanosterol demethylase inhibitor,CYP17A1
MPMFCABZENCRHV,BRD-K34568562,tilorone,interferon inducer,,BRD-K34568562,tilorone,interferon inducer,,BRD-K34568562,tilorone,interferon inducer,,BRD-K34568562,tilorone,interferon inducer,
MPPJUDJABRMYJR,BRD-M54096567,sodium-gluconate,,,BRD-M54096567,sodium-gluconate,,,BRD-M54096567,sodium-gluconate,,,,,,
MPTXLVRHYGBOQY,BRD-K04282412,capobenic-acid,,,BRD-K04282412,capobenic-acid,,,BRD-K04282412,capobenic-acid,,,BRD-K04282412,capobenic-acid,,
MPUQHZXIXSTTDU,BRD-K67844266,pevonedistat,nedd activating enzyme inhibitor,NAE1|UBA3,BRD-K67844266,pevonedistat,nedd activating enzyme inhibitor,NAE1|UBA3,BRD-K67844266,pevonedistat,nedd activating enzyme inhibitor,NAE1|UBA3,BRD-K67844266,pevonedistat,nedd activating enzyme inhibitor,NAE1|UBA3
MPVGZUGXCQEXTM,BRD-K99749624,linifanib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,BRD-K99749624,linifanib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,BRD-K99749624,linifanib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,BRD-K99749624,linifanib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK
MPYACSQFXVMWNO,BRD-K69215269,solcitinib,JAK inhibitor,JAK1,BRD-K69215269,solcitinib,JAK inhibitor,JAK1,BRD-K69215269,solcitinib,JAK inhibitor,JAK1,BRD-K69215269,solcitinib,JAK inhibitor,JAK1
MPYLDWFDPHRTEG,BRD-K95412502,istaroxime,ATPase inhibitor,ATP1A1,BRD-K95412502,istaroxime,ATPase inhibitor,ATP1A1,BRD-K95412502,istaroxime,ATPase inhibitor,ATP1A1,BRD-K95412502,istaroxime,ATPase inhibitor,ATP1A1
MPZVHKLZCUEJFO,BRD-K83023055,GR-135531,melatonin receptor agonist,,BRD-K83023055,GR-135531,melatonin receptor agonist,,BRD-K83023055,GR-135531,melatonin receptor agonist,,BRD-K83023055,GR-135531,melatonin receptor agonist,
MPZXLTZVPUSTFY,BRD-K12106308,K145,sphingosine kinase inhibitor,SPHK2,BRD-K12106308,K145,sphingosine kinase inhibitor,SPHK2,BRD-K12106308,K145,sphingosine kinase inhibitor,SPHK2,BRD-K12106308,K145,sphingosine kinase inhibitor,SPHK2
MQBZVUNNWUIPMK,BRD-K61323504,SB-225002,CC chemokine receptor antagonist,CXCR2,BRD-K61323504,SB-225002,CC chemokine receptor antagonist,CXCR2,BRD-K61323504,SB-225002,CC chemokine receptor antagonist,CXCR2,BRD-K61323504,SB-225002,CC chemokine receptor antagonist,CXCR2
MQHLMHIZUIDKOO,BRD-A37390343,amorolfine,membrane integrity inhibitor,,BRD-A37390343,amorolfine,membrane integrity inhibitor,,BRD-A37390343,amorolfine,membrane integrity inhibitor,,BRD-A37390343,amorolfine,membrane integrity inhibitor,
MQHOGPLXAXSQAJ,BRD-K50293352,MM77,serotonin receptor antagonist,HTR1A,BRD-K50293352,MM77,serotonin receptor antagonist,HTR1A,BRD-K50293352,MM77,serotonin receptor antagonist,HTR1A,BRD-K50293352,MM77,serotonin receptor antagonist,HTR1A
MQIMZDXIAHJKQP,BRD-K87316765,prinaberel,estrogen receptor agonist,ESR2|NCOA1,BRD-K87316765,prinaberel,estrogen receptor agonist,ESR2|NCOA1,BRD-K87316765,prinaberel,estrogen receptor agonist,ESR2|NCOA1,BRD-K87316765,prinaberel,estrogen receptor agonist,ESR2|NCOA1
MQJKPEGWNLWLTK,BRD-K62363391,dapsone,bacterial antifolate,DHFR,BRD-K62363391,dapsone,bacterial antifolate,DHFR,BRD-K62363391,dapsone,bacterial antifolate,DHFR,BRD-K62363391,dapsone,bacterial antifolate,DHFR
MQLRYUCJDNBWMV,BRD-K27798832,cefetamet,bacterial cell wall synthesis inhibitor,,BRD-K27798832,cefetamet,bacterial cell wall synthesis inhibitor,,BRD-K27798832,cefetamet,bacterial cell wall synthesis inhibitor,,BRD-K27798832,cefetamet,bacterial cell wall synthesis inhibitor,
MQMKRQLTIWPEDM,BRD-K95901403,XL-147,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,BRD-K95901403,XL-147,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,BRD-K95901403,XL-147,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,BRD-K95901403,XL147,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG
MQNYRKWJSMQECI,BRD-K04414442,SB-222200,tachykinin antagonist,TACR3,BRD-K04414442,SB-222200,tachykinin antagonist,TACR3,BRD-K04414442,SB-222200,tachykinin antagonist,TACR3,BRD-K04414442,SB-222200,tachykinin antagonist,TACR3
MQOBSOSZFYZQOK,BRD-K30213273,fenofibric-acid,cytochrome P450 inhibitor,CLCN1|PPARA,BRD-K30213273,fenofibric-acid,cytochrome P450 inhibitor,CLCN1|PPARA,BRD-K30213273,fenofibric-acid,cytochrome P450 inhibitor,CLCN1|PPARA,BRD-K30213273,fenofibric-acid,cytochrome P450 inhibitor,CLCN1|PPARA
MQQNFDZXWVTQEH,BRD-K06674495,nafamostat,serine protease inhibitor,ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7,BRD-K06674495,nafamostat,serine protease inhibitor,ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7,BRD-K06674495,nafamostat,serine protease inhibitor,ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7,BRD-K06674495,nafamostat,serine protease inhibitor,ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7
MQSSFHXQKUSFIW,BRD-K11696279,BU-239,imidazoline receptor agonist|imidazoline receptor ligand,,BRD-K11696279,BU-239,imidazoline receptor agonist|imidazoline receptor ligand,,BRD-K11696279,BU-239,imidazoline receptor agonist|imidazoline receptor ligand,,BRD-K11696279,BU-239,imidazoline receptor agonist|imidazoline receptor ligand,
MQTOSJVFKKJCRP,BRD-A37438244|BRD-K73794685|BRD-K74501079,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR,BRD-K74501079,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR,BRD-A37438244|BRD-K73794685|BRD-K74501079,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR,BRD-A37438244|BRD-K73794685|BRD-K74501079,azithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR
MQUYTXDAVCOCMX,BRD-K77634909,AEG3482,HSP inducer,,BRD-K77634909,AEG3482,HSP inducer,,BRD-K77634909,AEG3482,HSP inducer,,BRD-K77634909,AEG3482,HSP inducer,
MQZIGYBFDRPAKN,BRD-K51832961,astaxanthin,antioxidant,,BRD-K51832961,astaxanthin,antioxidant,,BRD-K51832961,astaxanthin,antioxidant,,BRD-K51832961,astaxanthin,antioxidant,
MRAUNPAHJZDYCK,BRD-K89223384,NG-nitro-arginine,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K89223384,NG-nitro-arginine,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K89223384,NG-nitro-arginine,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K89223384,NG-nitro-arginine,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3
MRBDMNSDAVCSSF,BRD-K90333595,phentolamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K90333595,phentolamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K90333595,phentolamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,BRD-K90333595,phentolamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
MRBKEAMVRSLQPH,BRD-K93035859,butylated-hydroxyanisole,antioxidant,,BRD-K93035859,butylated-hydroxyanisole,antioxidant,,BRD-K93035859,butylated-hydroxyanisole,antioxidant,,BRD-K93035859,butylated-hydroxyanisole,antioxidant,
MREBEPTUUMTTIA,BRD-K38913877,azimilide,potassium channel blocker,KCNA5|KCNE1|KCNH2|KCNQ1,BRD-K38913877,azimilide,potassium channel blocker,KCNA5|KCNE1|KCNH2|KCNQ1,BRD-K38913877,azimilide,potassium channel blocker,KCNA5|KCNE1|KCNH2|KCNQ1,BRD-K38913877,azimilide,potassium channel blocker,KCNA5
MRIAQLRQZPPODS,BRD-K06753942,nobiletin,MEK inhibitor,MAP2K1,BRD-K06753942,nobiletin,MEK inhibitor,MAP2K1,BRD-K06753942,nobiletin,MEK inhibitor,MAP2K1,BRD-K06753942,nobiletin,MEK inhibitor,MAP2K1
MRMBZHPJVKCOMA,BRD-A80321291,biapenem,bacterial cell wall synthesis inhibitor,,BRD-A80321291,biapenem,bacterial cell wall synthesis inhibitor,,BRD-A66479836|BRD-A80321291,biapenem,bacterial cell wall synthesis inhibitor,,BRD-A66479836|BRD-A80321291,biapenem,bacterial cell wall synthesis inhibitor,
MROJXXOCABQVEF,BRD-K33483813,actarit,interleukin receptor agonist,,BRD-K33483813,actarit,interleukin receptor agonist,,BRD-K33483813,actarit,interleukin receptor agonist,,BRD-K33483813,actarit,interleukin receptor agonist,
MRWFZSLZNUJVQW,BRD-K79878800,saroglitazar,PPAR receptor agonist,PPARA|PPARG,BRD-K79878800,saroglitazar,PPAR receptor agonist,PPARA|PPARG,BRD-K79878800,saroglitazar,PPAR receptor agonist,PPARA|PPARG,BRD-K79878800,saroglitazar,PPAR receptor agonist,PPARA|PPARG
MSBLMBWXUVQCDY,BRD-K97019106,"4-acetyl-1,1-dimethylpiperazinium",,,BRD-K97019106,"4-acetyl-1,1-dimethylpiperazinium",acetylcholine receptor agonist,,BRD-K97019106,"4-acetyl-1,1-dimethylpiperazinium",acetylcholine receptor agonist,,BRD-K97019106,"4-acetyl-1,1-dimethylpiperazinium",acetylcholine receptor agonist,
MSHZHSPISPJWHW,BRD-A78111609|BRD-K53597484,AGM-1470|TNP-470,cell cycle inhibitor|methionine aminopeptidase inhibitor,|METAP2,BRD-A78111609|BRD-K53597484,AGM-1470|TNP-470,cell cycle inhibitor|methionine aminopeptidase inhibitor,|METAP2,BRD-A78111609|BRD-K53597484,AGM-1470|TNP-470,cell cycle inhibitor|methionine aminopeptidase inhibitor,|METAP2,BRD-A78111609|BRD-K53597484,AGM-1470|TNP-470,cell cycle inhibitor|methionine aminopeptidase inhibitor,METAP2
MSJODEOZODDVGW,BRD-K49049886,CGS-15943,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K49049886,CGS-15943,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K49049886,CGS-15943,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K49049886,CGS-15943,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
MSTNYGQPCMXVAQ,BRD-A36978621,tetrahydrofolic-acid,,ALDH1L1|AMT|ATIC|FOLR2|FTCD|MTFMT|MTHFD1|MTHFD2|MTHFR|MTR|SHMT1|SHMT2,BRD-A36978621,tetrahydrofolic-acid,,ALDH1L1|AMT|ATIC|FOLR2|FTCD|MTFMT|MTHFD1|MTHFD2|MTHFR|MTR|SHMT1|SHMT2,BRD-A36978621,tetrahydrofolic-acid,,ALDH1L1|AMT|ATIC|FOLR2|FTCD|MTFMT|MTHFD1|MTHFD2|MTHFR|MTR|SHMT1|SHMT2,BRD-A36978621,tetrahydrofolic-acid,,FOLR2
MSWZFWKMSRAUBD,BRD-K29918010,glucosamine,glycosylated protein precursor,IFNG|IL1B|MMP9|NFKB2|TNF,BRD-K29918010,glucosamine,glycosylated protein precursor,IFNG|IL1B|MMP9|NFKB2|TNF,BRD-K29918010,glucosamine,glycosylated protein precursor,IFNG|IL1B|MMP9|NFKB2|TNF,BRD-K29918010,glucosamine,glycosylated protein precursor,IL1B
MSXVEPNJUHWQHW,BRD-K93502141,amylene-hydrate,local anesthetic,,BRD-K93502141,amylene-hydrate,local anesthetic,,BRD-K93502141,amylene-hydrate,local anesthetic,,BRD-K93502141,amylene-hydrate,local anesthetic,
MSYKRHVOOPPJKU,BRD-K00634421,brivaracetam,voltage-gated sodium channel blocker,SV2A,BRD-K00634421,brivaracetam,voltage-gated sodium channel blocker,SV2A,BRD-K00634421,brivaracetam,voltage-gated sodium channel blocker,SV2A,,,,
MTCFGRXMJLQNBG,BRD-K71822263,D-Serine,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,BRD-K71822263,D-Serine,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,BRD-K71822263,D-Serine,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,BRD-K71822263,D-serine,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3
MTCUAOILFDZKCO,BRD-K49783248,decamethonium,acetylcholine receptor agonist,ACHE|CHRNA2,BRD-K49783248,decamethonium,acetylcholine receptor agonist,ACHE|CHRNA2,BRD-K49783248,decamethonium,acetylcholine receptor agonist,ACHE|CHRNA2,BRD-K49783248,decamethonium,acetylcholine receptor agonist,ACHE|CHRNA2
MTHORRSSURHQPZ,BRD-K36467523,bindarit,NFkB pathway inhibitor,CCL2|CCL7|CCL8,BRD-K36467523,bindarit,NFkB pathway inhibitor,CCL2|CCL7|CCL8,BRD-K36467523,bindarit,NFkB pathway inhibitor,CCL2|CCL7|CCL8,BRD-K36467523,bindarit,NFkB pathway inhibitor,CCL2|CCL7|CCL8
MTJHLONVHHPNSI,BRD-K23363278,CYT-997,tubulin polymerization inhibitor,TUBB,BRD-K23363278,CYT-997,tubulin polymerization inhibitor,TUBB,BRD-K23363278,CYT-997,tubulin polymerization inhibitor,TUBB,BRD-K23363278,CYT-997,tubulin polymerization inhibitor,TUBB
MTMDXAIUENDNDL,BRD-K14175878,MK-0812,CC chemokine receptor antagonist,CCR2,BRD-K14175878,MK-0812,CC chemokine receptor antagonist,CCR2,BRD-K14175878,MK-0812,CC chemokine receptor antagonist,CCR2,BRD-K14175878,MK-0812,CC chemokine receptor antagonist,CCR2
MTPVBMVUENFFLL,BRD-K30159788,RSV604,RSV replication inhibitor,,BRD-K30159788,RSV604,RSV replication inhibitor,,BRD-K30159788,RSV604,RSV replication inhibitor,,BRD-K30159788,RSV604,RSV replication inhibitor,
MTXSIJUGVMTTMU,BRD-A24284985,anabasine,acetylcholine receptor agonist,,BRD-A24284985,anabasine,acetylcholine receptor agonist,,BRD-A24284985,anabasine,acetylcholine receptor agonist,,BRD-K01826509,anabasine,acetylcholine receptor agonist,
MTZBBNMLMNBNJL,BRD-K27393415,xipamide,carbonic anhydrase inhibitor,SLC12A3,BRD-K27393415,xipamide,carbonic anhydrase inhibitor,SLC12A3,BRD-K27393415,xipamide,carbonic anhydrase inhibitor,SLC12A3,BRD-K27393415,xipamide,carbonic anhydrase inhibitor,SLC12A3
MUCZHBLJLSDCSD,BRD-K56575995,isoflurophate,cholinesterase inhibitor,ACHE|BCHE,BRD-K56575995,isoflurophate,cholinesterase inhibitor,ACHE|BCHE,BRD-K56575995,isoflurophate,cholinesterase inhibitor,ACHE|BCHE,BRD-K56575995,isoflurophate,cholinesterase inhibitor,ACHE|BCHE
MUFJHYRCIHHATF,BRD-A32269193,VGX-1027,tumor necrosis factor receptor antagonist,TLR4,BRD-A32269193,VGX-1027,tumor necrosis factor receptor antagonist,TLR4,BRD-A32269193,VGX-1027,tumor necrosis factor receptor antagonist,TLR4,BRD-A32269193,VGX-1027,tumor necrosis factor receptor antagonist,TLR4
MUGXRYIUWFITCP,BRD-K78666663,lemborexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K78666663,lemborexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K78666663,lemborexant,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K78666663,lemborexant,orexin receptor antagonist,HCRTR1|HCRTR2
MUHBBHLZPHKTTR,BRD-A34788695|BRD-A78253580,tetracycline,bacterial 30S ribosomal subunit inhibitor,PRNP,BRD-A34788695|BRD-A78253580,tetracycline,bacterial 30S ribosomal subunit inhibitor,PRNP,BRD-A34788695|BRD-A78253580,tetracycline,bacterial 30S ribosomal subunit inhibitor,PRNP,BRD-K00003352,tetracycline,bacterial 30S ribosomal subunit inhibitor,
MUJBUUDUXGDXLW,BRD-K89274813,DMP-543,acetylcholine release enhancer,,BRD-K89274813,DMP-543,acetylcholine release enhancer,,BRD-K89274813,DMP-543,acetylcholine release enhancer,,BRD-K89274813,DMP-543,acetylcholine release enhancer,
MUMGGOZAMZWBJJ,BRD-A55393291,testosterone,androgen receptor agonist,AR,BRD-A55393291,testosterone,androgen receptor agonist,AR,BRD-A55393291,testosterone,androgen receptor agonist,AR,,,,
MUOKSQABCJCOPU,BRD-K81458380,CX-4945,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,BRD-K81458380,CX-4945,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,BRD-K81458380,CX-4945,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,BRD-K81458380,CX-4945,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3
MUQNGPZZQDCDFT,BRD-A88138582|BRD-K64408465,halcinonide,glucocorticoid receptor agonist,NR3C1,BRD-A88138582|BRD-K81709173,halcinonide,glucocorticoid receptor agonist,NR3C1,BRD-A88138582|BRD-K64408465|BRD-K81709173,halcinonide,glucocorticoid receptor agonist,NR3C1,BRD-K64408465|BRD-K81709173,halcinonide,glucocorticoid receptor agonist,NR3C1
MUQUYTSLDVKIOF,BRD-A84907376,alcuronium,muscle relaxant,CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7,BRD-A84907376,alcuronium,muscle relaxant,CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7,BRD-A84907376,alcuronium,muscle relaxant,CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7,BRD-A84907376,alcuronium,muscle relaxant,CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7
MUTBJZVSRNUIHA,BRD-K86687746,R306465,HDAC inhibitor,,BRD-K86687746,R306465,HDAC inhibitor,,BRD-K86687746,R306465,HDAC inhibitor,,BRD-K86687746,R306465,HDAC inhibitor,
MUTNCGKQJGXKEM,BRD-K36627727,tamibarotene,retinoid receptor agonist,RARA|RARB,BRD-K36627727,tamibarotene,retinoid receptor agonist,RARA|RARB,BRD-K36627727,tamibarotene,retinoid receptor agonist,RARA|RARB,BRD-K36627727,tamibarotene,retinoid receptor agonist,RARA|RARB
MUXFZBHBYYYLTH,BRD-A00578795,zaltoprofen,cyclooxygenase inhibitor,,BRD-A00578795,zaltoprofen,cyclooxygenase inhibitor,,BRD-A00578795,zaltoprofen,cyclooxygenase inhibitor,,BRD-A00578795,zaltoprofen,cyclooxygenase inhibitor,
MVCOAUNKQVWQHZ,BRD-K74065929,doramapimod,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,BRD-K74065929,doramapimod,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,BRD-K74065929,doramapimod,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,BRD-K74065929,doramapimod,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14
MVCQKIKWYUURMU,BRD-K94863486,cetilistat,triacylglycerol lipase inhibitor,PNLIP,BRD-K94863486,cetilistat,triacylglycerol lipase inhibitor,PNLIP,BRD-K94863486,cetilistat,triacylglycerol lipase inhibitor,PNLIP,BRD-K94863486,cetilistat,triacylglycerol lipase inhibitor,PNLIP
MVFGUOIZUNYYSO,BRD-A53952395,prilocaine,local anesthetic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A53952395,prilocaine,local anesthetic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A53952395,prilocaine,local anesthetic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K01825595,prilocaine,local anesthetic,SCN5A
MVGSNCBCUWPVDA,BRD-K37708699,exisulind,phosphodiesterase inhibitor,PDE5A,BRD-K37708699,exisulind,phosphodiesterase inhibitor,PDE5A,BRD-K37708699,exisulind,phosphodiesterase inhibitor,PDE5A,BRD-K37708699,exisulind,phosphodiesterase inhibitor,PDE5A
MVMQESMQSYOVGV,BRD-A54141700|BRD-K83192048,dimethindene-(S)-(+)|dimetindene,acetylcholine receptor antagonist|cholinergic receptor antagonist|histamine receptor antagonist,CHRM2|HRH1,BRD-A54141700|BRD-K83192048,dimethindene-(S)-(+)|dimetindene,acetylcholine receptor antagonist|cholinergic receptor antagonist|histamine receptor antagonist,CHRM2|HRH1,BRD-A54141700|BRD-K83192048,dimethindene-(S)-(+)|dimetindene,acetylcholine receptor antagonist|cholinergic receptor antagonist|histamine receptor antagonist,CHRM2|HRH1,BRD-K01826026|BRD-K83192048,dimethindene-(S)-(+)|dimetindene,acetylcholine receptor antagonist|cholinergic receptor antagonist|histamine receptor antagonist,HRH1
MVNCPACIPXNJIW,BRD-K58937086,glutathione-monoisopropyl-ester,lipid peroxidase inhibitor,,BRD-K58937086,glutathione-monoisopropyl-ester,lipid peroxidase inhibitor,,BRD-K58937086,glutathione-monoisopropyl-ester,lipid peroxidase inhibitor,,BRD-K58937086,glutathione-monoisopropyl-ester,lipid peroxidase inhibitor,
MVOUIYUWRXPNKD,BRD-K29570907,sulmetozine,gastrin inhibitor,GAST,BRD-K29570907,sulmetozine,gastrin inhibitor,GAST,BRD-K29570907,sulmetozine,gastrin inhibitor,GAST,BRD-K29570907,sulmetozine,gastrin inhibitor,GAST
MVQVNTPHUGQQHK,BRD-K76600340,nicotinyl-alcohol-tartrate,,,BRD-K76600340,nicotinyl-alcohol-tartrate,,,BRD-K76600340,nicotinyl-alcohol-tartrate,,,BRD-K76600340,nicotinyl-alcohol-tartrate,,
MVSSJPGNLQPWSW,BRD-K01573278,NVP-231,ceramidase inhibitor,CERK,BRD-K01573278,NVP-231,ceramidase inhibitor,CERK,BRD-K01573278,NVP-231,ceramidase inhibitor,CERK,BRD-K01573278,NVP-231,ceramidase inhibitor,CERK
MVWVFYHBGMAFLY,BRD-K29582115,ziprasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,BRD-K29582115,ziprasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,BRD-K29582115,ziprasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,BRD-K29582115,ziprasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4
MVZGYPSXNDCANY,BRD-K26838195,AST-1306,EGFR inhibitor,EGFR|ERBB2,BRD-K26838195,AST-1306,EGFR inhibitor,EGFR|ERBB2,BRD-K26838195,AST-1306,EGFR inhibitor,EGFR|ERBB2,BRD-K26838195,AST-1306,EGFR inhibitor,EGFR|ERBB2
MWDVCHRYCKXEBY,BRD-K19482962,JNJ-63533054,G protein-coupled receptor agonist,GPR139,BRD-K19482962,JNJ-63533054,G protein-coupled receptor agonist,GPR139,BRD-K19482962,JNJ-63533054,G protein-coupled receptor agonist,GPR139,BRD-K19482962,JNJ-63533054,G protein-coupled receptor agonist,GPR139
MWIASLNTAGRGGA,BRD-A43930669,L-368899,oxytocin receptor antagonist,AVPR1A|AVPR2|OXTR,BRD-A43930669,L-368899,oxytocin receptor antagonist,AVPR1A|AVPR2|OXTR,BRD-A43930669,L-368899,oxytocin receptor antagonist,AVPR1A|AVPR2|OXTR,BRD-K00004282,L-368899,oxytocin receptor antagonist,AVPR1A|AVPR2|OXTR
MWLSOWXNZPKENC,BRD-A56359832,zileuton,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,BRD-A56359832,zileuton,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,BRD-A56359832,zileuton,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,BRD-A56359832,zileuton,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5
MWMPEAHGUXCSMY,BRD-K48996094,pentacosanoic-acid,,,BRD-K48996094,pentacosanoic-acid,,,BRD-K48996094,pentacosanoic-acid,,,BRD-K48996094,pentacosanoic-acid,,
MWOOGOJBHIARFG,BRD-K24258499,vanillin,,ABAT|ALDH5A1,BRD-K24258499,vanillin,,ABAT|ALDH5A1,BRD-K24258499,vanillin,,ABAT|ALDH5A1,BRD-K24258499,vanillin,,ABAT|ALDH5A1
MWSUIZKGNWELRF,BRD-K79555887,RI-1,,RAD51,BRD-K79555887,RI-1,,RAD51,BRD-K79555887,RI-1,,RAD51,BRD-K79555887,RI-1,,RAD51
MWTBKTRZPHJQLH,BRD-K55991142,alcaftadine,histamine receptor antagonist,HRH1,BRD-K55991142,alcaftadine,histamine receptor antagonist,HRH1,BRD-K55991142,alcaftadine,histamine receptor antagonist,HRH1,BRD-K55991142,alcaftadine,histamine receptor antagonist,HRH1
MWULMTACIBZPGN,BRD-K65576800,GW-803430,melanin inhibitor,KCNH2|MCHR1,BRD-K65576800,GW-803430,melanin inhibitor,KCNH2|MCHR1,BRD-K65576800,GW-803430,melanin inhibitor,KCNH2|MCHR1,BRD-K65576800,GW-803430,melanin inhibitor,KCNH2|MCHR1
MWYHLEQJTQJHSS,BRD-K74765201,tomelukast,leukotriene receptor antagonist,CYSLTR1,BRD-K74765201,tomelukast,leukotriene receptor antagonist,CYSLTR1,BRD-K74765201,tomelukast,leukotriene receptor antagonist,CYSLTR1,BRD-K74765201,tomelukast,leukotriene receptor antagonist,CYSLTR1
MXAYKZJJDUDWDS,BRD-K78659596,ixazomib,proteasome inhibitor,,BRD-K78659596,ixazomib,proteasome inhibitor,,BRD-K78659596,ixazomib,proteasome inhibitor,,BRD-K78659596,ixazomib,proteasome inhibitor,
MXDSJQHFFDGFDK,BRD-K41626799,AZD3759,EGFR inhibitor,EGFR,BRD-K41626799,AZD3759,EGFR inhibitor,EGFR,BRD-K41626799,AZD3759,EGFR inhibitor,EGFR,BRD-K41626799,AZD3759,EGFR inhibitor,EGFR
MXEFWCFPCLDOOG,BRD-K10176267,L-701252,glutamate receptor antagonist,GRIN1,BRD-K10176267,L-701252,glutamate receptor antagonist,GRIN1,BRD-K10176267,L-701252,glutamate receptor antagonist,GRIN1,BRD-K10176267,L-701252,glutamate receptor antagonist,GRIN1
MXFWWQICDIZSOA,BRD-A94276798,talinolol,adrenergic receptor antagonist,ADRB1,BRD-A94276798,talinolol,adrenergic receptor antagonist,ADRB1,BRD-A94276798,talinolol,adrenergic receptor antagonist,ADRB1,BRD-A94276798,talinolol,adrenergic receptor antagonist,ADRB1
MXJWRABVEGLYDG,BRD-K36660044,bufexamac,cyclooxygenase inhibitor,HDAC10|HDAC6,BRD-K36660044,bufexamac,cyclooxygenase inhibitor,HDAC10|HDAC6,BRD-K36660044,bufexamac,cyclooxygenase inhibitor,HDAC10|HDAC6,BRD-K36660044,bufexamac,cyclooxygenase inhibitor,HDAC10|HDAC6
MXOAEAUPQDYUQM,BRD-A92262698,chlorphenesin,muscle relaxant,,BRD-A92262698,chlorphenesin,muscle relaxant,,BRD-A92262698,chlorphenesin,muscle relaxant,,BRD-A92262698,chlorphenesin,muscle relaxant,
MXUNKHLAEDCYJL,BRD-A67182178,toloxatone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-A67182178,toloxatone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-A67182178,toloxatone,monoamine oxidase inhibitor,MAOA|MAOB,BRD-A67182178,toloxatone,monoamine oxidase inhibitor,MAOA|MAOB
MXWDSZWTBOCWBK,BRD-K45528773,M-344,HDAC inhibitor,,BRD-K45528773,M-344,HDAC inhibitor,,BRD-K45528773,M-344,HDAC inhibitor,,BRD-K45528773,M-344,HDAC inhibitor,HDAC8
MXWICZOXPUWAHY,BRD-K52487250,"ICI-215,001",,,BRD-K52487250,"ICI-215,001",adrenergic receptor agonist,ADRB3,BRD-K52487250,"ICI-215,001",adrenergic receptor agonist,ADRB3,BRD-K52487250,"ICI-215,001",adrenergic receptor agonist,ADRB3
MXWZRRPNVLCHMY,BRD-K34149328,bonaphthone,,,BRD-K34149328,bonaphthone,,,BRD-K34149328,bonaphthone,,,BRD-K34149328,bonaphthone,,
MXXWOMGUGJBKIW,BRD-K59522102,piperine,monoamine oxidase inhibitor,MAOA|MAOB|TRPV1,BRD-K59522102,piperine,monoamine oxidase inhibitor,MAOA|MAOB|TRPV1,BRD-K59522102,piperine,monoamine oxidase inhibitor,MAOA|MAOB|TRPV1,BRD-K59522102,piperine,monoamine oxidase inhibitor,MAOA|MAOB|TRPV1
MXYUKLILVYORSK,BRD-A65243462|BRD-K66206289,lobeline,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2,BRD-A65243462|BRD-K66206289,lobeline,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2,BRD-A65243462|BRD-K66206289|BRD-M82226456,lobeline,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2,BRD-K66206289|BRD-M82226456,lobeline,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2
MYCMTMIGRXJNSO,BRD-K12742203,moxaverine,phosphodiesterase inhibitor,,BRD-K12742203,moxaverine,phosphodiesterase inhibitor,,BRD-K12742203,moxaverine,phosphodiesterase inhibitor,,BRD-K12742203,moxaverine,phosphodiesterase inhibitor,
MYEJFUXQJGHEQK,BRD-A11815689,proscillaridin-a,,,BRD-A11815689,proscillaridin-a,,,BRD-A11815689,proscillaridin-a,,,BRD-K00005354,proscillaridin-A,,
MYKUKUCHPMASKF,BRD-A24543851,nornicotine,acetylcholine receptor agonist,,BRD-A24543851,nornicotine,acetylcholine receptor agonist,,BRD-A24543851,nornicotine,acetylcholine receptor agonist,,BRD-K00003718,nornicotine,acetylcholine receptor agonist,
MYPYJXKWCTUITO,BRD-K60071190|BRD-K91065602,vancomycin,bacterial cell wall synthesis inhibitor,,BRD-K91065602,vancomycin,bacterial cell wall synthesis inhibitor,,BRD-K60071190|BRD-K91065602,vancomycin,bacterial cell wall synthesis inhibitor,,BRD-K60071190|BRD-K91065602,vancomycin,bacterial cell wall synthesis inhibitor,
MYQAUKPBNJWPIE,BRD-K24242599,GW-2580,cFMS kinase inhibitor,CSF1R,BRD-K24242599,GW-2580,cFMS kinase inhibitor,CSF1R,BRD-K24242599,GW-2580,cFMS kinase inhibitor,CSF1R,BRD-K24242599,GW-2580,cFMS kinase inhibitor,CSF1R
MYSWGUAQZAJSOK,BRD-K04804440,ciprofloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K04804440,ciprofloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K04804440,ciprofloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K04804440,ciprofloxacin,bacterial DNA gyrase inhibitor,TOP2A
MYTWFJKBZGMYCS,BRD-K86932920,bay-60-7550,phosphodiesterase inhibitor,PDE2A,BRD-K86932920,bay-60-7550,phosphodiesterase inhibitor,PDE2A,BRD-K86932920,bay-60-7550,phosphodiesterase inhibitor,PDE2A,BRD-K86932920,BAY-60-7550,phosphodiesterase inhibitor,PDE2A
MYXACKZCYFKMTE,BRD-A10039652,tipranavir,HIV protease inhibitor,,BRD-A10039652,tipranavir,HIV protease inhibitor,,BRD-A10039652,tipranavir,HIV protease inhibitor,,BRD-A10039652,tipranavir,HIV protease inhibitor,
MZCJWLAXZRFUPI,BRD-K20049318,impentamine,histamine receptor antagonist,HRH3,BRD-K20049318,impentamine,histamine receptor antagonist,HRH3,BRD-K20049318,impentamine,histamine receptor antagonist,HRH3,BRD-K20049318,impentamine,histamine receptor antagonist,HRH3
MZDKLVOWGIOKTN,BRD-K99545815,PF-562271,focal adhesion kinase inhibitor,PTK2|PTK2B,BRD-K99545815,PF-562271,focal adhesion kinase inhibitor,PTK2|PTK2B,BRD-K99545815,PF-562271,focal adhesion kinase inhibitor,PTK2|PTK2B,BRD-K99545815,PF-562271,focal adhesion kinase inhibitor,PTK2|PTK2B
MZNDNBFMSVMUCX,BRD-K05434375,HA-1004,calcium channel blocker,,BRD-K05434375,HA-1004,calcium channel blocker,,BRD-K05434375,HA-1004,calcium channel blocker,,BRD-K05434375,HA-1004,calcium channel blocker,
MZOPWQKISXCCTP,BRD-K40255344,tyrphostin-A9,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,BRD-K40255344,tyrphostin-A9,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,BRD-K40255344,tyrphostin-A9,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,BRD-K40255344,tyrphostin-A9,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,
MZRVIHRERYCHBL,BRD-K40269473,cathepsin-inhibitor-1,cathepsin inhibitor,CTSB|CTSL|CTSV,BRD-K40269473,cathepsin-inhibitor-1,cathepsin inhibitor,CTSB|CTSL|CTSV,BRD-K40269473,cathepsin-inhibitor-1,cathepsin inhibitor,CTSB|CTSL|CTSV,BRD-K40269473,cathepsin-inhibitor-1,cathepsin inhibitor,CTSB|CTSL|CTSV
MZZGOOYMKKIOOX,BRD-A67065070,azaserine,purine antagonist,,BRD-A67065070,azaserine,purine antagonist,,BRD-A67065070,azaserine,purine antagonist,,,,,
MZZLGJHLQGUVPN,BRD-K44366189,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K44366189,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K44366189,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K77118600,anacetrapib,cholesteryl ester transfer protein inhibitor,CETP
NABQBYDEMLGCEO,BRD-A42699921,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH,BRD-A42699921,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH,BRD-A42699921,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH,BRD-A42699921,teriflunomide,dihydroorotate dehydrogenase inhibitor,DHODH
NAJVRARAUNYNDX,BRD-K56691760,pikamilone,,,BRD-K56691760,pikamilone,,,BRD-K56691760,pikamilone,,,BRD-K56691760,pikamilone,,
NARHAGIVSFTMIG,BRD-A69917777,aminopentamide,acetylcholine receptor antagonist,CHRM1,BRD-A69917777,aminopentamide,acetylcholine receptor antagonist,CHRM1,BRD-A69917777,aminopentamide,acetylcholine receptor antagonist,CHRM1,BRD-A69917777,aminopentamide,acetylcholine receptor antagonist,CHRM1
NAUWTFJOPJWYOT,BRD-K32501161,vanoxerine,dopamine uptake inhibitor,SLC6A3,BRD-K32501161,vanoxerine,dopamine uptake inhibitor,SLC6A3,BRD-K32501161,vanoxerine,dopamine uptake inhibitor,SLC6A3,BRD-K32501161,vanoxerine,dopamine reuptake inhibitor,SLC6A3
NAVMQTYZDKMPEU,BRD-K92441787,bexarotene,retinoid receptor agonist,RXRA|RXRB|RXRG,BRD-K92441787,bexarotene,retinoid receptor agonist,RXRA|RXRB|RXRG,BRD-K92441787,bexarotene,retinoid receptor agonist,RXRA|RXRB|RXRG,BRD-K92441787,bexarotene,retinoid receptor agonist,RXRA|RXRB|RXRG
NAXSRXHZFIBFMI,BRD-K33818169,GW-3965,LXR agonist,NR1H2|NR1H3,BRD-K33818169,GW-3965,LXR agonist,NR1H2|NR1H3,BRD-K33818169,GW-3965,LXR agonist,NR1H2|NR1H3,BRD-K33818169,GW-3965,LXR agonist,NR1H2|NR1H3
NBHPRWLFLUBAIE,BRD-K50055394,halopemide,phospholipase inhibitor,PLD1|PLD2,BRD-K50055394,halopemide,phospholipase inhibitor,PLD1|PLD2,BRD-K50055394,halopemide,phospholipase inhibitor,PLD1|PLD2,BRD-K50055394,halopemide,phospholipase inhibitor,PLD1|PLD2
NBLBCGUCPBXKOV,BRD-K56077740,MMPX,phosphodiesterase inhibitor,,BRD-K56077740,MMPX,phosphodiesterase inhibitor,,BRD-K56077740,MMPX,phosphodiesterase inhibitor,,BRD-K56077740,MMPX,phosphodiesterase inhibitor,
NBMBIEOUVBHEBM,BRD-K45875383,XBD173,benzodiazepine receptor ligand,TSPO,BRD-K45875383,XBD173,benzodiazepine receptor ligand,TSPO,BRD-K45875383,XBD173,benzodiazepine receptor ligand,TSPO,BRD-K45875383,XBD173,benzodiazepine receptor ligand,TSPO
NBMKJKDGKREAPL,BRD-A73385064,beclomethasone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A73385064,beclomethasone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A73385064,beclomethasone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A73385064,beclomethasone,glucocorticoid receptor agonist,NR3C1|SERPINA6
NBOJHRYUGLRASX,BRD-K68997413,PF-3845,FAAH inhibitor,FAAH,BRD-K68997413,PF-3845,FAAH inhibitor,FAAH,BRD-K68997413,PF-3845,FAAH inhibitor,FAAH,BRD-K68997413,PF-3845,FAAH inhibitor,FAAH
NBOMNTLFRHMDEZ,BRD-K36998189,o-mercapto-benzoic-acid,,,BRD-K36998189,o-mercapto-benzoic-acid,,,BRD-K36998189,o-mercapto-benzoic-acid,,,BRD-K36998189,o-mercapto-benzoic-acid,,
NBQKINXMPLXUET,BRD-K97045029,pranlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,BRD-K97045029,pranlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,BRD-K91497079|BRD-K97045029,pranlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,BRD-K91497079|BRD-K97045029,pranlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF
NBQNWMBBSKPBAY,BRD-A08660406,iodixanol,radiopaque medium,,BRD-A08660406,iodixanol,radiopaque medium,,BRD-A08660406,iodixanol,radiopaque medium,,BRD-A08660406,iodixanol,radiopaque medium,
NBRBXGKOEOGLOI,BRD-K02943813,dasabuvir,HCV inhibitor,,BRD-K02943813,dasabuvir,HCV inhibitor,,BRD-K02943813,dasabuvir,HCV inhibitor,,BRD-K02943813,dasabuvir,HCV inhibitor,
NBSCHQHZLSJFNQ,BRD-A73427433,adaprev,TGF beta receptor inhibitor,IGF2R|M6PR,BRD-A73427433,adaprev,TGF beta receptor inhibitor,IGF2R|M6PR,BRD-A73427433,adaprev,TGF beta receptor inhibitor,IGF2R|M6PR,BRD-A73427433,adaprev,TGF beta receptor inhibitor,AKR1B1|GPI|HK1|M6PR|PYGM
NCDNCNXCDXHOMX,BRD-K51485625,ritonavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,BRD-K51485625,ritonavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,BRD-K51485625,ritonavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,BRD-K51485625,ritonavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7
NCEXYHBECQHGNR,BRD-K10670311,sulfasalazine,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,BRD-K10670311,sulfasalazine,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,BRD-K10670311,sulfasalazine,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,BRD-K10670311,sulfasalazine,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1
NCLGDOBQAWBXRA,BRD-K63178091,telotristat,serotonin receptor antagonist|serotonin release inhibitor,TPH1,BRD-K63178091,telotristat,serotonin receptor antagonist|serotonin release inhibitor,TPH1,BRD-K63178091,telotristat,tryptophan hydroxylase inhibitor,TPH1,BRD-K63178091,telotristat,tryptophan hydroxylase inhibitor,TPH1
NCMIPRCQUMYAEC,BRD-A04203391,piricapiron,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,BRD-A04203391,piricapiron,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,BRD-A04203391,piricapiron,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,BRD-K00004544,piricapiron,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A
NCMZQTLCXHGLOK,BRD-A20758144,prasterone-acetate,,,BRD-A20758144,prasterone-acetate,,,BRD-A20758144,prasterone-acetate,,,BRD-K96527333,prasterone-acetate,,
NCNRHFGMJRPRSK,BRD-K17743125,belinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K17743125,belinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K17743125,belinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K17743125,belinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
NCOOUEIQXVWKTO,BRD-K25154476,cinflumide,muscle relaxant,,BRD-K25154476,cinflumide,muscle relaxant,,BRD-K25154476,cinflumide,muscle relaxant,,BRD-K25154476,cinflumide,muscle relaxant,
NCXMLFZGDNKEPB,BRD-A00398769|BRD-A00773244|BRD-K40312300|BRD-K63692151|BRD-K90563805,natamycin,fungal ergosterol inhibitor,,BRD-A00398769|BRD-A55960065|BRD-K40312300|BRD-K90563805,natamycin,fungal ergosterol inhibitor,,BRD-A00398769|BRD-A55960065|BRD-K40312300|BRD-K90563805,natamycin,fungal ergosterol inhibitor,,BRD-A00398769|BRD-A55960065|BRD-K40312300|BRD-K90563805,natamycin,fungal ergosterol inhibitor,
NCYCYZXNIZJOKI,BRD-K79884267,retinaldehyde,,,BRD-K79884267,retinaldehyde,,,BRD-K79884267,retinaldehyde,,,BRD-K79884267,retinaldehyde,,
NCYVXEGFNDZQCU,BRD-K91544578,nikethamide,immunostimulant,,BRD-K91544578,nikethamide,immunostimulant,,BRD-K91544578,nikethamide,immunostimulant,,BRD-K91544578,nikethamide,immunostimulant,
NDAUXUAQIAJITI,BRD-A88254928|BRD-K34469523,albuterol|levalbuterol,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A88254928|BRD-K34469523,albuterol|levalbuterol,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A88254928|BRD-K34469523,albuterol|levalbuterol,adrenergic receptor agonist,ADRB1|ADRB2,BRD-K01825118|BRD-K34469523,albuterol|levalbuterol,adrenergic receptor agonist,ADRB2
NDAZATDQFDPQBD,BRD-K41859756,NVP-AUY922,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K41859756,NVP-AUY922,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K41859756,NVP-AUY922,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K41859756,NVP-AUY922,HSP inhibitor,HSP90AA1|HSP90AB1
NDCUAPJVLWFHHB,BRD-K85882401,avibactam,beta lactamase inhibitor,,BRD-K85882401,avibactam,beta lactamase inhibitor,,BRD-K85882401,avibactam,beta lactamase inhibitor,,BRD-K85882401,avibactam,beta lactamase inhibitor,
NDDAHWYSQHTHNT,BRD-A95869247,indapamide,thiazide diuretic,KCNE1|KCNQ1|SLC12A3,BRD-A95869247,indapamide,thiazide diuretic,KCNE1|KCNQ1|SLC12A3,BRD-A95869247,indapamide,thiazide diuretic,KCNE1|KCNQ1|SLC12A3,BRD-A95869247,indapamide,thiazide diuretic,CA2|HTR3A|KCNQ1
NDEBZCZEAVMSQF,BRD-K21070437,LY3000328,cathepsin inhibitor,CTSS,BRD-K21070437,LY3000328,cathepsin inhibitor,CTSS,BRD-K21070437,LY3000328,cathepsin inhibitor,CTSS,BRD-K21070437,LY3000328,cathepsin inhibitor,CTSS
NDEXUOWTGYUVGA,BRD-K03063480,PF-477736,CHK inhibitor,CHEK1|CHEK2,BRD-K03063480,PF-477736,CHK inhibitor,CHEK1|CHEK2,BRD-K03063480,PF-477736,CHK inhibitor,CHEK1|CHEK2,BRD-K03063480,PF-477736,CHK inhibitor,CHEK1|CHEK2
NDFKBGWLUHKMFY,BRD-K98684188,GSK-0660,PPAR receptor antagonist,PPARD,BRD-K98684188,GSK-0660,PPAR receptor antagonist,PPARD,BRD-K98684188,GSK-0660,PPAR receptor antagonist,PPARD,BRD-K98684188,GSK0660,PPAR receptor antagonist,PPARD
NDNKNUMSTIMSHQ,BRD-K37864785,GW-311616,elastase inhibitor|leukocyte elastase inhibitor,ELANE,BRD-K37864785,GW-311616,elastase inhibitor|leukocyte elastase inhibitor,ELANE,BRD-K37864785,GW-311616,elastase inhibitor|leukocyte elastase inhibitor,ELANE,BRD-K37864785,GW-311616,elastase inhibitor|leukocyte elastase inhibitor,ELANE
NDPBMCKQJOZAQX,BRD-K12639498,Ro-61-8048,kynurenine 3-monooxygenase inhibitor,KMO,BRD-K12639498,Ro-61-8048,kynurenine 3-monooxygenase inhibitor,KMO,BRD-K12639498,Ro-61-8048,kynurenine 3-monooxygenase inhibitor,KMO,BRD-K12639498,Ro-61-8048,kynurenine 3-monooxygenase inhibitor,KMO
NDTSRXAMMQDVSW,BRD-K21450440,benzthiazide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA9|SLC12A3,BRD-K21450440,benzthiazide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA9|SLC12A3,BRD-K21450440,benzthiazide,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA9|SLC12A3,,,,
NDTYTMIUWGWIMO,BRD-A13323580,perillyl-alcohol,apoptosis stimulant|farnesyltransferase inhibitor,FNTA,BRD-A13323580,perillyl-alcohol,apoptosis stimulant|farnesyltransferase inhibitor,FNTA,BRD-A13323580,perillyl-alcohol,apoptosis stimulant|farnesyltransferase inhibitor,FNTA,BRD-A13323580,perillyl-alcohol,apoptosis stimulant|farnesyltransferase inhibitor,FNTA
NEMGRZFTLSKBAP,BRD-K92613113,safinamide,dopamine uptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,BRD-K92613113,safinamide,dopamine uptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,BRD-K92613113,safinamide,dopamine uptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,BRD-K92613113,safinamide,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB
NEMHKCNXXRQYRF,BRD-K77060810,AZD1283,purinergic receptor antagonist,P2RY12,BRD-K77060810,AZD1283,purinergic receptor antagonist,P2RY12,BRD-K77060810,AZD1283,purinergic receptor antagonist,P2RY12,BRD-K77060810,AZD1283,purinergic receptor antagonist,P2RY12
NENPYTRHICXVCS,BRD-K93767137,oseltamivir-carboxylate,neuraminidase inhibitor,,BRD-K93767137,oseltamivir-carboxylate,neuraminidase inhibitor,,BRD-K93767137,oseltamivir-carboxylate,neuraminidase inhibitor,,BRD-K93767137,oseltamivir-carboxylate,neuraminidase inhibitor,
NEQSWPCDHDQINX,BRD-K21672174,Ro-28-1675,glucokinase activator,GCK,BRD-K21672174,Ro-28-1675,glucokinase activator,GCK,BRD-K21672174,Ro-28-1675,glucokinase activator,GCK,BRD-K21672174,Ro-28-1675,glucokinase activator,GCK
NERXPXBELDBEPZ,BRD-K58811567,HKI-357,EGFR inhibitor,EGFR,BRD-K58811567,HKI-357,EGFR inhibitor,EGFR,BRD-K58811567,HKI-357,EGFR inhibitor,EGFR,BRD-K58811567,HKI-357,EGFR inhibitor,EGFR
NETTXQJYJRFTFS,BRD-K41267922,F351,TGF beta receptor inhibitor,TGFB1,BRD-K41267922,F351,TGF beta receptor inhibitor,TGFB1,BRD-K41267922,F351,TGF beta receptor inhibitor,TGFB1,BRD-K41267922,F351,TGF beta receptor inhibitor,TGFB1
NETXMUIMUZJUTB,BRD-K20001883,apabetalone,apolipoprotein expression enhancer,BRD3,BRD-K20001883,apabetalone,apolipoprotein expression enhancer,BRD3,BRD-K20001883,apabetalone,apolipoprotein expression enhancer,BRD3,BRD-K20001883,apabetalone,apolipoprotein expression enhancer,BRD3
NETZHAKZCGBWSS,BRD-A92651262|BRD-K66404838,nalbuphine,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A92651262|BRD-K66404838,nalbuphine,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A92651262|BRD-K66404838,nalbuphine,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A92651262|BRD-K66404838,nalbuphine,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1
NEUSVAOJNUQRTM,BRD-K87700323,cetylpyridinium,,,BRD-K87700323,cetylpyridinium,,,BRD-K87700323,cetylpyridinium,,,BRD-K87700323,cetylpyridinium,,
NEWKHUASLBMWRE,BRD-K60690191,MPEP,glutamate receptor antagonist,GRM1|GRM4|GRM5,BRD-K60690191,MPEP,glutamate receptor antagonist,GRM1|GRM4|GRM5,BRD-K60690191,MPEP,glutamate receptor antagonist,GRM1|GRM4|GRM5,BRD-K60690191,MPEP,glutamate receptor antagonist,GRM1|GRM4|GRM5
NEYNJQRKHLUJRU,BRD-K78789465,pentagastrin,CCK receptor agonist,CCKBR,BRD-K78789465,pentagastrin,CCK receptor agonist,CCKBR,BRD-K78789465|BRD-K92045627,pentagastrin,CCK receptor agonist,CCKBR,BRD-K78789465|BRD-K92045627,pentagastrin,CCK receptor agonist,CCKBR
NFACJZMKEDPNKN,BRD-A22101059,metrifonate,acetylcholinesterase inhibitor,ACHE,BRD-A22101059,metrifonate,acetylcholinesterase inhibitor,ACHE,BRD-A22101059,metrifonate,acetylcholinesterase inhibitor,ACHE,BRD-A22101059,metrifonate,acetylcholinesterase inhibitor,ACHE
NFBAXHOPROOJAW,BRD-K70592963,phenindione,vitamin K antagonist,VKORC1,BRD-K70592963,phenindione,vitamin K antagonist,VKORC1,BRD-K70592963,phenindione,vitamin K antagonist,VKORC1,BRD-K70592963,phenindione,vitamin K antagonist,VKORC1
NFDFQCUYFHCNBW,BRD-K95309561,dienestrol,estrogen receptor agonist,ESR1,BRD-K95309561,dienestrol,estrogen receptor agonist,ESR1,BRD-K95309561,dienestrol,estrogen receptor agonist,ESR1,BRD-K95309561,dienestrol,estrogen receptor agonist,ESR1
NFDRPXJGHKJRLJ,BRD-K54542929,EDTMP,chelating agent,,BRD-K54542929,EDTMP,chelating agent,,BRD-K54542929,EDTMP,chelating agent,,BRD-K54542929,EDTMP,chelating agent,
NFEZZTICAUWDHU,BRD-A30774155,efinaconazole,lanosterol demethylase inhibitor,CYP51A1,BRD-A30774155,efinaconazole,lanosterol demethylase inhibitor,CYP51A1,BRD-A30774155,efinaconazole,lanosterol demethylase inhibitor,CYP51A1,BRD-A30774155,efinaconazole,lanosterol demethylase inhibitor,CYP51A1
NFGXHKASABOEEW,BRD-K34591242,methoprene-(s),,,BRD-K34591242,methoprene-(s),,,BRD-K34591242,methoprene-(s),,,BRD-K34591242,methoprene-(s),,
NFIVJOSXJDORSP,BRD-K50122911|BRD-K70071822,boronophenylalanine,,,BRD-K50122911|BRD-K70071822,boronophenylalanine,,,BRD-K50122911|BRD-K70071822,boronophenylalanine,,,BRD-K50122911|BRD-K70071822,boronophenylalanine,,
NFIXBCVWIPOYCD,BRD-K80315159,DPPE,histamine receptor antagonist,ABCB1|HRH1,BRD-K80315159,DPPE,histamine receptor antagonist,ABCB1|HRH1,BRD-K80315159,DPPE,histamine receptor antagonist,ABCB1|HRH1,BRD-K80315159,DPPE,histamine receptor antagonist,ABCB1|HRH1
NFLLKCVHYJRNRH,BRD-M98649031,dimenhydrinate,histamine receptor antagonist,HRH1,BRD-M98649031,dimenhydrinate,histamine receptor antagonist,HRH1,BRD-M98649031,dimenhydrinate,histamine receptor antagonist,HRH1,BRD-M98649031,dimenhydrinate,histamine receptor antagonist,HRH1
NFLWUMRGJYTJIN,BRD-A49399758,desmopressin-acetate,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A49399758,desmopressin-acetate,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A49399758,desmopressin-acetate,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-K00003582,desmopressin-acetate,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR
NFONIVRMILHYLH,BRD-A37752546,(1E)-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime,,,BRD-A37752546,1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime,,,BRD-A37752546,1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime,,,BRD-A37752546,1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone-oxime,,
NFSTZPMYAZRZPC,BRD-K24689407,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K24689407,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K24689407,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K24689407,3-bromo-7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3
NFTMKHWBOINJGM,BRD-K32218650,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K32218650,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K32218650,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K32218650,MBX-2982,glucose dependent insulinotropic receptor agonist,GPR119
NGAGMBNBKCDCDJ,BRD-K22385716,LY303511,PI3K inhibitor|casein kinase inhibitor|mTOR inhibitor,BRD2|BRD3|BRD4,BRD-K22385716,LY303511,PI3K inhibitor|casein kinase inhibitor|mTOR inhibitor,BRD2|BRD3|BRD4,BRD-K22385716,LY303511,PI3K inhibitor|casein kinase inhibitor|mTOR inhibitor,BRD2|BRD3|BRD4,BRD-K22385716,LY303511,PI3K inhibitor|casein kinase inhibitor|mTOR inhibitor,BRD2|BRD3|BRD4
NGBFQHCMQULJNZ,BRD-K30480208,torasemide,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,BRD-K30480208,torasemide,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,BRD-K30480208,torasemide,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,BRD-K30480208,torasemide,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1
NGFMICBWJRZIBI,BRD-K64614248,salicin,anti-inflammatory agent,,BRD-K64614248,salicin,anti-inflammatory agent,,BRD-K64614248,salicin,anti-inflammatory agent,,BRD-K64614248,salicin,anti-inflammatory agent,
NGGMYCMLYOUNGM,BRD-A99367815,fumagillin,methionine aminopeptidase inhibitor,METAP2,BRD-A99367815,fumagillin,methionine aminopeptidase inhibitor,METAP2,BRD-A99367815,fumagillin,methionine aminopeptidase inhibitor,METAP2,BRD-A99367815,fumagillin,methionine aminopeptidase inhibitor,METAP2
NGGRGTWYSXYVDK,BRD-K48988407,cytochlor,,,BRD-K48988407,cytochlor,,,BRD-K48988407,cytochlor,,,BRD-K48988407,cytochlor,,
NGHTXZCKLWZPGK,BRD-K65678996,nefiracetam,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,BRD-K65678996,nefiracetam,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,BRD-K65678996,nefiracetam,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,BRD-K65678996,nefiracetam,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1
NGHVIOIJCVXTGV,BRD-K30284967,6-aminopenicillanic-acid,,,BRD-K30284967,6-aminopenicillanic-acid,,,BRD-K30284967,6-aminopenicillanic-acid,,,BRD-K30284967,6-aminopenicillanic-acid,,
NGJLOFCOEOHFKQ,BRD-K70159787,SMI-4a,Pim kinase inhibitor,PIM1,BRD-K70159787,SMI-4a,Pim kinase inhibitor,PIM1,BRD-K70159787,SMI-4a,Pim kinase inhibitor,PIM1,BRD-K98396737,SMI-4a,Pim kinase inhibitor,PIM1
NGKZFDYBISXGGS,BRD-K33151569,deoxyepinephrine,adrenergic receptor agonist|dopamine receptor agonist,ADRA1A|DRD1|DRD2,BRD-K33151569,deoxyepinephrine,adrenergic receptor agonist|dopamine receptor agonist,ADRA1A|DRD1|DRD2,BRD-K33151569,deoxyepinephrine,adrenergic receptor agonist|dopamine receptor agonist,ADRA1A|DRD1|DRD2,BRD-K33151569,deoxyepinephrine,adrenergic receptor agonist|dopamine receptor agonist,ADRA1A|DRD1|DRD2
NGNALWDRPKNJGR,BRD-K42221274,NNC-711,GABA uptake inhibitor,SIGMAR1|SLC6A1,BRD-K42221274,NNC-711,GABA uptake inhibitor,SIGMAR1|SLC6A1,BRD-K42221274,NNC-711,GABA uptake inhibitor,SIGMAR1|SLC6A1,BRD-K42221274,NNC-711,GABA uptake inhibitor,SIGMAR1|SLC6A1
NGOGFTYYXHNFQH,BRD-K76617868,fasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,BRD-K76617868,fasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,BRD-K76617868,fasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,BRD-K76617868,fasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2
NGSWKAQJJWESNS,BRD-K87122641,naringeninic-acid,,HCAR2|PTGR1,BRD-K87122641,naringeninic-acid,,HCAR2|PTGR1,BRD-K87122641,naringeninic-acid,,HCAR2|PTGR1,BRD-K87122641,naringeninic-acid,,HCAR2|PTGR1
NGTDJJKTGRNNAU,BRD-A93477898,PETCM,caspase activator,CASP3,BRD-A93477898,PETCM,caspase activator,CASP3,BRD-A93477898,PETCM,caspase activator,CASP3,BRD-A93477898,PETCM,caspase activator,CASP3
NGVDGCNFYWLIFO,BRD-K50712474,MC-1,,AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1,BRD-K50712474,MC-1,,AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1,BRD-K50712474,MC-1,,AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1,BRD-K50712474,MC-1,,AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1
NGYNBSHYFOFVLS,BRD-K13769342,danirixin,CC chemokine receptor antagonist,CXCR2,BRD-K13769342,danirixin,CC chemokine receptor antagonist,CXCR2,BRD-K13769342,danirixin,CC chemokine receptor antagonist,CXCR2,BRD-K13769342,danirixin,CC chemokine receptor antagonist,CXCR2
NHFDRBXTEDBWCZ,BRD-K55966568,orantinib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,BRD-K55966568,orantinib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,BRD-K55966568,orantinib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,BRD-K55966568,orantinib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB
NHFIAAAMCYVRIW,BRD-A54927599,KF-38789,P selectin inhibitor,SELP,BRD-A54927599,KF-38789,P selectin inhibitor,SELP,BRD-A54927599,KF-38789,P selectin inhibitor,SELP,BRD-A54927599,KF-38789,P selectin inhibitor,SELP
NHHQJBCNYHBUSI,BRD-K20285085,fostamatinib,SYK inhibitor,RET|SYK,BRD-K20285085,fostamatinib,SYK inhibitor,RET|SYK,BRD-K20285085,R406,SYK inhibitor,RET|SYK,BRD-K20285085,R406,SYK inhibitor,RET|SYK
NHPQGZOBHSVTAQ,BRD-K19781342,ACT-462206,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K19781342,ACT-462206,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K19781342,ACT-462206,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K19781342,ACT-462206,orexin receptor antagonist,HCRTR1|HCRTR2
NHTGHBARYWONDQ,BRD-K83766205,metirosine,tyrosine hydroxylase inhibitor,TH,BRD-K83766205,metirosine,tyrosine hydroxylase inhibitor,TH,BRD-K83766205,metirosine,tyrosine hydroxylase inhibitor,TH,BRD-K83766205,metirosine,tyrosine hydroxylase inhibitor,TH
NHUHCSRWZMLRLA,BRD-K50859149,sulfafurazole,bacterial antifolate,,BRD-K50859149,sulfafurazole,bacterial antifolate,,BRD-K50859149,sulfafurazole,bacterial antifolate,,BRD-K50859149,sulfafurazole,bacterial antifolate,
NHXLMOGPVYXJNR,BRD-K14681867,somatostatin,somatostatin receptor agonist,OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5,BRD-K14681867,somatostatin,somatostatin receptor agonist,OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5,BRD-K14681867,somatostatin,somatostatin receptor agonist,OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5,BRD-K14681867,somatostatin,somatostatin receptor agonist,OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5
NHZLNPMOSADWGC,BRD-K71133585,sulfaquinoxaline,vitamin K antagonist,,BRD-K71133585,sulfaquinoxaline,vitamin K antagonist,,BRD-K71133585,sulfaquinoxaline,vitamin K antagonist,,BRD-K71133585,sulfaquinoxaline,vitamin K antagonist,
NHZMQXZHNVQTQA,BRD-K96669468,pyridoxamine,AGE inhibitor,,BRD-K96669468,pyridoxamine,AGE inhibitor,,BRD-K96669468,pyridoxamine,AGE inhibitor,,BRD-K96669468,pyridoxamine,AGE inhibitor,
NIDRNVHMMDAAIK,BRD-K17953908,LY2886721,beta-secretase inhibitor,BACE1,BRD-K17953908,LY2886721,beta-secretase inhibitor,BACE1,BRD-K17953908,LY2886721,beta-secretase inhibitor,BACE1,BRD-K51258098,LY2886721,beta-secretase inhibitor,BACE1
NIGWMJHCCYYCSF,BRD-A81615860,fenclonine-(+/-),tryptophan hydroxylase inhibitor,PAH|TPH1|TPH2,BRD-A81615860,fenclonine-(+/-),tryptophan hydroxylase inhibitor,PAH|TPH1|TPH2,BRD-A81615860,fenclonine-(+/-),tryptophan hydroxylase inhibitor,PAH|TPH1|TPH2,BRD-K01825694,fenclonine-(+/-),tryptophan hydroxylase inhibitor,PAH|TPH1|TPH2
NIJJYAXOARWZEE,BRD-K41260949,divalproex-sodium|valproic-acid,HDAC inhibitor|benzodiazepine receptor agonist,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K41260949,divalproex-sodium|valproic-acid,HDAC inhibitor|benzodiazepine receptor agonist,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K41260949|BRD-M19962486,divalproex-sodium|valproic-acid,HDAC inhibitor|benzodiazepine receptor agonist,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K41260949|BRD-M19962486,valproic-acid,HDAC inhibitor|benzodiazepine receptor agonist,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A
NIOCOJFPGCXNKL,BRD-K89071957,CTS21166,beta-secretase inhibitor,BACE1,BRD-K89071957,CTS21166,beta-secretase inhibitor,BACE1,BRD-K89071957,CTS21166,beta-secretase inhibitor,BACE1,BRD-K89071957,CTS21166,beta-secretase inhibitor,BACE1
NIOYUNMRJMEDGI,BRD-K35114608,1-hexadecanal,sphingosine 1 phosphate receptor substrate,DBI|RHO,BRD-K35114608,1-hexadecanal,sphingosine 1 phosphate receptor substrate,DBI|RHO,BRD-K35114608,1-hexadecanal,sphingosine 1 phosphate receptor substrate,DBI|RHO,BRD-K35114608,1-hexadecanal,sphingosine 1-phosphate receptor substrate,DBI|RHO
NIPUPOUEGOSAAO,BRD-K54098378,NT157,IGF-1 inhibitor,IGF1R,BRD-K54098378,NT157,IGF-1 inhibitor,IGF1R,BRD-K54098378,NT157,IGF-1 inhibitor,IGF1R,BRD-K54098378,NT157,IGF-1 inhibitor,IGF1R
NIRXBXIPHUTNNI,BRD-K68003372,APTO-253,krppel-like factor expression enhancer,KLF4,BRD-K68003372,APTO-253,krppel-like factor expression enhancer,KLF4,BRD-K68003372,APTO-253,krppel-like factor expression enhancer,KLF4,BRD-K68003372,APTO-253,krppel-like factor expression enhancer,KLF4
NITYDPDXAAFEIT,BRD-K51662849,ilomastat,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,BRD-K51662849,ilomastat,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,BRD-K51662849,ilomastat,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,BRD-K51662849,ilomastat,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9
NJBFOOCLYDNZJN,BRD-K15656090,pipobroman,DNA alkylating agent,,BRD-K15656090,pipobroman,DNA alkylating agent,,BRD-K15656090,pipobroman,DNA alkylating agent,,BRD-K15656090,pipobroman,DNA alkylating agent,
NJCJBUHJQLFDSW,BRD-K62374253,rufloxacin,bacterial DNA gyrase inhibitor,,BRD-K62374253,rufloxacin,bacterial DNA gyrase inhibitor,,BRD-K62374253,rufloxacin,bacterial DNA gyrase inhibitor,,BRD-K62374253,rufloxacin,bacterial DNA gyrase inhibitor,
NJDRXTDGYFKORP,BRD-K77038618,garenoxacin,topoisomerase inhibitor,TOP2A,BRD-K77038618,garenoxacin,topoisomerase inhibitor,TOP2A,BRD-K77038618,garenoxacin,topoisomerase inhibitor,TOP2A,BRD-K77038618,garenoxacin,topoisomerase inhibitor,TOP2A
NJDUWAXIURWWLN,BRD-K61802864,chlorindione,,,BRD-K61802864,chlorindione,,,BRD-K61802864,chlorindione,,,BRD-K61802864,chlorindione,,
NJEIOWSBPCZKTL,BRD-A95802703,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,,,BRD-A95802703,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,,,BRD-A95802703,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,,,BRD-A95802703,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,,
NJHZOXLWSHPJPK,BRD-A81339141,mangafodipir,contrast agent,,BRD-A81339141,mangafodipir,contrast agent,,,,,,,,,
NJMYODHXAKYRHW,BRD-K70487031,flupentixol,dopamine receptor antagonist,ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A,BRD-K70487031,flupentixol,dopamine receptor antagonist,ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A,BRD-K70487031,flupentixol,dopamine receptor antagonist,ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A,BRD-K70487031,flupentixol,dopamine receptor antagonist,ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A
NJQADTYRAYFBJN,BRD-A62841832,3-bromocamphor,,,BRD-A62841832,3-bromocamphor,,,BRD-A62841832,3-bromocamphor,,,BRD-K00004535,3-bromocamphor,,
NJRXVEJTAYWCQJ,BRD-A43435802,mercaptosuccinic-acid,,,BRD-A43435802,mercaptosuccinic-acid,,,BRD-A43435802,mercaptosuccinic-acid,,,BRD-A43435802,mercaptosuccinic-acid,,
NJZHEQOUHLZCOX,BRD-A53244165,golgicide-a,ARF inhibitor,GBF1,BRD-A57886255,golgicide-A|golgicide-a,|ARF inhibitor,|GBF1,BRD-A53244165|BRD-A57886255,golgicide-A|golgicide-a,|ARF inhibitor,|GBF1,BRD-A53244165|BRD-A57886255,golgicide-A,ARF inhibitor,GBF1
NKANXQFJJICGDU,BRD-K93754473,tamoxifen,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,BRD-K93754473,tamoxifen,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,BRD-K93754473,tamoxifen,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,BRD-K93754473,tamoxifen,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ
NKDFYOWSKOHCCO,BRD-K28343777,20-hydroxyecdysone,ecdysone receptor modulator,,BRD-K28343777,20-hydroxyecdysone,ecdysone receptor modulator,,BRD-K28343777,20-hydroxyecdysone,ecdysone receptor modulator,,BRD-K28343777,20-hydroxyecdysone,ecdysone receptor modulator,
NKULICGUDKGGRL,BRD-A06016120,bacitracin-zinc,bacterial cell wall synthesis inhibitor,,BRD-A06016120,bacitracin-zinc,bacterial cell wall synthesis inhibitor,,BRD-A06016120|BRD-M36533492|BRD-M97113494,bacitracin-zinc,bacterial cell wall synthesis inhibitor,,,,,
NKYMVQPXXTZHSF,BRD-K33690734,5-BDBD,purinergic receptor antagonist,P2RX4,BRD-K33690734,5-BDBD,purinergic receptor antagonist,P2RX4,BRD-K33690734,5-BDBD,purinergic receptor antagonist,P2RX4,BRD-K33690734,5-BDBD,purinergic receptor antagonist,P2RX4
NLNGWFLRRRYNIL,BRD-K71467466,KPT-185,exportin antagonist,XPO1,BRD-K71467466,KPT-185,exportin antagonist,XPO1,BRD-K71467466,KPT-185,exportin antagonist,XPO1,BRD-K71467466,KPT-185,exportin antagonist,XPO1
NLORYLAYLIXTID,BRD-K20801936,fosfestrol,synthetic estrogen,ESR1|ESR2,BRD-K20801936,fosfestrol,synthetic estrogen,ESR1|ESR2,BRD-K20801936,fosfestrol,synthetic estrogen,ESR1|ESR2,BRD-K20801936,fosfestrol,synthetic estrogen,ESR1|ESR2
NLVFBUXFDBBNBW,BRD-K05619559|BRD-K96342952,tobramycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K05619559,tobramycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K05619559|BRD-K96342952,tobramycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K05619559|BRD-K96342952,tobramycin,bacterial 30S ribosomal subunit inhibitor,
NLYNIRQVMRLPIQ,BRD-K96006160,artemotil,,,BRD-K96006160,artemotil,,,BRD-K96006160,artemotil,,,BRD-K96006160,artemotil,,
NLZUEZXRPGMBCV,BRD-K53153417,butylated-hydroxytoluene,carbonic anhydrase inhibitor,CA2,BRD-K53153417,butylated-hydroxytoluene,carbonic anhydrase inhibitor,CA2,BRD-K53153417,butylated-hydroxytoluene,carbonic anhydrase inhibitor,CA2,BRD-K53153417,butylated-hydroxytoluene,carbonic anhydrase inhibitor,CA2
NMBDIMPYACLUDE,BRD-K63151507,MNITMT,lymphocyte inhibitor,,BRD-K63151507,MNITMT,lymphocyte inhibitor,,BRD-K63151507,MNITMT,lymphocyte inhibitor,,BRD-K63151507,MNITMT,lymphocyte inhibitor,
NMBNQRJDEPOXCP,BRD-A27274504,butofilolol,adrenergic receptor antagonist,,BRD-A27274504,butofilolol,adrenergic receptor antagonist,,BRD-A27274504,butofilolol,adrenergic receptor antagonist,,BRD-A27274504,butofilolol,adrenergic receptor antagonist,
NMDYYWFGPIMTKO,BRD-A52946717|BRD-K10549975,vinflunine,microtubule inhibitor,,BRD-A52946717|BRD-K10549975,vinflunine,microtubule inhibitor,,,,,,,,,
NMFIXEFNQPDISY,BRD-K14287049,AZD3264,IKK inhibitor,IKBKB,BRD-K14287049,AZD3264,IKK inhibitor,IKBKB,BRD-K14287049,AZD3264,IKK inhibitor,IKBKB,BRD-K14287049,AZD3264,IKK inhibitor,IKBKB
NMKSAYKQLCHXDK,BRD-A71033472,fendiline,calcium channel blocker,HTR2B,BRD-A71033472,fendiline,calcium channel blocker,HTR2B,BRD-A71033472,fendiline,calcium channel blocker,HTR2B,BRD-A71033472,fendiline,calcium channel blocker,HTR2B
NMUSYJAQQFHJEW,BRD-K03406345|BRD-K55026842,azacitidine,DNA methyltransferase inhibitor,DNMT1|DNMT3A,BRD-K03406345|BRD-K55026842,azacitidine,DNA methyltransferase inhibitor,DNMT1|DNMT3A,BRD-K03406345|BRD-K55026842,azacitidine,DNA methyltransferase inhibitor,DNMT1|DNMT3A,BRD-K03406345|BRD-K55026842,azacitidine,DNA methyltransferase inhibitor,DNMT1|DNMT3A
NMYAHEULKSYAPP,BRD-K87948281,F-11440,serotonin receptor agonist,HTR1A,BRD-K87948281,F-11440,serotonin receptor agonist,HTR1A,BRD-K87948281,F-11440,serotonin receptor agonist,HTR1A,BRD-K87948281,F-11440,serotonin receptor agonist,HTR1A
NNACHAUCXXVJSP,BRD-K21673112,BF2.649,histamine receptor antagonist,HRH3,BRD-K21673112,BF2.649,histamine receptor antagonist,HRH3,BRD-K21673112,BF2.649,histamine receptor antagonist,HRH3,BRD-K21673112,pitolisant,histamine receptor antagonist,HRH3
NNAIYOXJNVGUOM,BRD-K52397688,amperozide,dopamine receptor antagonist,FAAH|HTR2A,BRD-K52397688,amperozide,dopamine receptor antagonist,FAAH|HTR2A,BRD-K52397688,amperozide,dopamine receptor antagonist,FAAH|HTR2A,BRD-K52397688,amperozide,dopamine receptor antagonist,FAAH|HTR2A
NNJVILVZKWQKPM,BRD-K52662033,lidocaine,histamine receptor agonist,EGFR|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K52662033,lidocaine,histamine receptor agonist,EGFR|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K52662033,lidocaine,histamine receptor agonist,EGFR|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K52662033,lidocaine,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A
NNRFRJQMBSBXGO,BRD-K08859203,DU-728,structural glycoprotein antagonist,ITGA2B|ITGB3,BRD-K08859203,DU-728,structural glycoprotein antagonist,ITGA2B|ITGB3,BRD-K08859203,DU-728,structural glycoprotein antagonist,ITGA2B|ITGB3,BRD-K08859203,DU-728,structural glycoprotein antagonist,ITGA2B|ITGB3
NNULBSISHYWZJU,BRD-K04301924,ceftizoxim,bacterial cell wall synthesis inhibitor,,BRD-K04301924,ceftizoxim,bacterial cell wall synthesis inhibitor,,BRD-K04301924,ceftizoxim,bacterial cell wall synthesis inhibitor,,BRD-K04301924,ceftizoxim,bacterial cell wall synthesis inhibitor,
NNYBQONXHNTVIJ,BRD-A74667430|BRD-K36911961,etodolac,cyclooxygenase inhibitor,PTGS1|PTGS2|RXRA,BRD-A74667430|BRD-K36911961,etodolac,cyclooxygenase inhibitor,PTGS1|PTGS2|RXRA,BRD-A74667430|BRD-K36911961,etodolac,cyclooxygenase inhibitor,PTGS1|PTGS2|RXRA,BRD-A74667430|BRD-K36911961,etodolac,cyclooxygenase inhibitor,PTGS2
NOCJXYPHIIZEHN,BRD-K73923631,difloxacin,bacterial DNA gyrase inhibitor,,BRD-K73923631,difloxacin,bacterial DNA gyrase inhibitor,,BRD-K73923631,difloxacin,bacterial DNA gyrase inhibitor,,BRD-K73923631,difloxacin,bacterial DNA gyrase inhibitor,
NOEGNKMFWQHSLB,BRD-K86799112,5-HMF,,,BRD-K86799112,5-HMF,,,BRD-K86799112,5-HMF,,,BRD-K86799112,5-HMF,,
NOFOAYPPHIUXJR,BRD-K85140930,aphidicolin,RNA synthesis inhibitor,,BRD-K85140930,aphidicolin,RNA synthesis inhibitor,,BRD-K85140930,aphidicolin,RNA synthesis inhibitor,,BRD-K85140930,aphidicolin,RNA synthesis inhibitor,
NOIIUHRQUVNIDD,BRD-K12102668,nialamide,monoamine oxidase inhibitor,COMT|MAOA|MAOB,BRD-K12102668,nialamide,monoamine oxidase inhibitor,COMT|MAOA|MAOB,BRD-K12102668,nialamide,monoamine oxidase inhibitor,COMT|MAOA|MAOB,BRD-K12102668,nialamide,monoamine oxidase inhibitor,COMT|MAOA|MAOB
NOKPBJYHPHHWAN,BRD-K59527975,S-Sulfo-L-cysteine-sodium-salt,glutamate receptor agonist,,BRD-K59527975,S-Sulfo-L-cysteine-sodium-salt,glutamate receptor agonist,,BRD-K59527975,S-Sulfo-L-cysteine-sodium-salt,glutamate receptor agonist,,BRD-K59527975,S-sulfo-L-cysteine,glutamate receptor agonist,
NONJJLVGHLVQQM,BRD-A66025870,phenethicillin,bacterial cell wall synthesis inhibitor,,BRD-A66025870,phenethicillin,bacterial cell wall synthesis inhibitor,,BRD-A66025870,phenethicillin,bacterial cell wall synthesis inhibitor,,BRD-A66025870,phenethicillin,bacterial cell wall synthesis inhibitor,
NOOCSNJCXJYGPE,BRD-K99984802,flunixin-meglumin,prostanoid receptor antagonist,,BRD-K99984802,flunixin-meglumin,prostanoid receptor antagonist,,BRD-K99984802,flunixin-meglumin,prostanoid receptor antagonist,,BRD-K99984802,flunixin-meglumin,prostanoid receptor antagonist,
NOOJLZTTWSNHOX,BRD-A09911125,prolylleucylglycinamide,melanocyte-stimulating hormone release inhibitor,,BRD-A09911125,prolylleucylglycinamide,melanocyte-stimulating hormone release inhibitor,,BRD-A09911125,prolylleucylglycinamide,melanocyte-stimulating hormone release inhibitor,,BRD-A09911125,prolylleucylglycinamide,melanocyte-stimulating hormone release inhibitor,
NOOLISFMXDJSKH,BRD-A54393207|BRD-K50329370,levomenthol,,OPRK1|TRPA1|TRPM8|TRPV3,BRD-A54393207|BRD-K50329370,levomenthol,,OPRK1|TRPA1|TRPM8|TRPV3,BRD-A54393207|BRD-K50329370,levomenthol,,OPRK1|TRPA1|TRPM8|TRPV3,BRD-K50329370,levomenthol,,OPRK1|TRPA1|TRPM8|TRPV3
NOPFSRXAKWQILS,BRD-K50050533,docosanol,lipase clearing factor inhibitor,TLR7,BRD-K50050533,docosanol,lipase clearing factor inhibitor,TLR7,BRD-K50050533,docosanol,lipase clearing factor inhibitor,TLR7,BRD-K50050533,docosanol,lipase clearing factor inhibitor,TLR7
NOSIYYJFMPDDSA,BRD-K37814297,acepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,BRD-K37814297,acepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,BRD-K37814297,acepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,BRD-K37814297,acepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A
NOTIQUSPUUHHEH,BRD-A38706605,dromostanolone-propionate,androgen receptor modulator,AR,BRD-A38706605,dromostanolone-propionate,androgen receptor modulator,AR,BRD-A38706605,dromostanolone-propionate,androgen receptor modulator,AR,BRD-A38706605,dromostanolone-propionate,androgen receptor modulator,AR
NPAGDVCDWIYMMC,BRD-K52080565,nandrolone,imidazoline receptor agonist,AR|CYP19A1|MAOA|MAOB,BRD-K52080565,nandrolone,imidazoline receptor agonist,AR|CYP19A1|MAOA|MAOB,BRD-K52080565,nandrolone,imidazoline receptor agonist,AR|CYP19A1|MAOA|MAOB,,,,
NPEFREDMMVQEPL,BRD-M10279501,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8|LRP2,BRD-M10279501,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8|LRP2,BRD-M10279501,gentamycin,bacterial 50S ribosomal subunit inhibitor,HSPA8|LRP2,,,,
NPFDWHQSDBWQLH,BRD-K03894385,MK-6096,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K03894385,MK-6096,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K03894385,MK-6096,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K03894385,MK-6096,orexin receptor antagonist,HCRTR1|HCRTR2
NPGNOVNWUSPMDP,BRD-K67100011,pivmecillinam,bacterial cell wall synthesis inhibitor,,BRD-K67100011,pivmecillinam,bacterial cell wall synthesis inhibitor,,BRD-K67100011,pivmecillinam,bacterial cell wall synthesis inhibitor,,BRD-K67100011,pivmecillinam,bacterial cell wall synthesis inhibitor,
NPJICTMALKLTFW,BRD-K14276241,daucosterol,apoptosis stimulant,,BRD-K14276241,daucosterol,apoptosis stimulant,,BRD-K14276241,daucosterol,apoptosis stimulant,,BRD-K14276241,daucosterol,apoptosis stimulant,
NPNUFJAVOOONJE,BRD-K26878113,g-caryophyllene,acetylcholinesterase inhibitor,ACHE,BRD-K26878113,g-caryophyllene,acetylcholinesterase inhibitor,ACHE,BRD-K26878113,g-caryophyllene,acetylcholinesterase inhibitor,ACHE,BRD-K26878113,g-caryophyllene,acetylcholinesterase inhibitor,ACHE
NPOAOTPXWNWTSH,BRD-K00495673,meglutol,HMGCR inhibitor,HMGCR,BRD-K00495673,meglutol,HMGCR inhibitor,HMGCR,BRD-K00495673,meglutol,HMGCR inhibitor,HMGCR,BRD-K00495673,meglutol,HMGCR inhibitor,HMGCR
NPPJLSILDPVHCM,BRD-K26404903,felbinac-ethyl,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K26404903,felbinac-ethyl,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K26404903,felbinac-ethyl,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K26404903,felbinac-ethyl,cyclooxygenase inhibitor,PTGS1|PTGS2
NPPQSCRMBWNHMW,BRD-K19180152,meprobamate,,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K19180152,meprobamate,,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K19180152,meprobamate,,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,,,,
NPRHVSBSZMAEIN,BRD-A22152765,tridihexethyl,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A22152765,tridihexethyl,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A22152765,tridihexethyl,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A22152765,tridihexethyl,acetylcholine receptor antagonist,
NPUKDXXFDDZOKR,BRD-A54880345|BRD-K55055802,etomidate,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-A54880345|BRD-K55055802,etomidate,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-A54880345|BRD-K55055802,etomidate,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-A54880345|BRD-K55055802,etomidate,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
NPUZIGSOEWMFKK,BRD-K50490982,bromindione,anticoagulant,,BRD-K50490982,bromindione,anticoagulant,,BRD-K50490982,bromindione,anticoagulant,,BRD-K50490982,bromindione,anticoagulant,
NQDJXKOVJZTUJA,BRD-K15502390,nevirapine,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,BRD-K15502390,nevirapine,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,BRD-K15502390,nevirapine,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,BRD-K15502390,nevirapine,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5
NQFBZYYUAFJYNS,BRD-A72297358,ozolinone,diuretic,,BRD-A72297358,ozolinone,diuretic,,BRD-A72297358,ozolinone,diuretic,,BRD-A72297358,ozolinone,diuretic,
NQHNLNLJPDMBFN,BRD-K85337334,otilonium,acetylcholine receptor antagonist,CACNA1C,BRD-K85337334,otilonium,acetylcholine receptor antagonist,CACNA1C,BRD-K85337334,otilonium,acetylcholine receptor antagonist,CACNA1C,BRD-K85337334,otilonium,acetylcholine receptor antagonist,CACNA1C
NQPDXQQQCQDHHW,BRD-K81916719,triclabendazole,microtubule inhibitor,DNMT1,BRD-K81916719,triclabendazole,microtubule inhibitor,DNMT1,BRD-K81916719,triclabendazole,microtubule inhibitor,DNMT1,BRD-K81916719,triclabendazole,microtubule inhibitor,DNMT1
NQPOCLFSADOXBR,BRD-K42066335,lorediplon,GABA receptor modulator,GABRA1,BRD-K42066335,lorediplon,GABA receptor modulator,GABRA1,BRD-K42066335,lorediplon,GABA receptor modulator,GABRA1,BRD-K42066335,lorediplon,GABA receptor modulator,GABRA1
NQQBNZBOOHHVQP,BRD-K32730239,SU3327,JNK inhibitor,MAPK8,BRD-K32730239,SU3327,JNK inhibitor,MAPK8,BRD-K32730239,SU3327,JNK inhibitor,MAPK8,BRD-K32730239,SU3327,JNK inhibitor,MAPK8
NQWVSMVXKMHKTF,BRD-K53523901,arctigenin,MEK inhibitor,CHUK|MAP2K1,BRD-K53523901,arctigenin,MEK inhibitor,CHUK|MAP2K1,BRD-K53523901,arctigenin,MEK inhibitor,CHUK|MAP2K1,BRD-K53523901,arctigenin,MEK inhibitor,CHUK|MAP2K1
NRFJZTXWLKPZAV,BRD-A57957888,citiolone,lipotropic|mucolytic agent,,BRD-A57957888,citiolone,lipotropic|mucolytic agent,,BRD-A57957888,citiolone,lipotropic|mucolytic agent,,BRD-A57957888,citiolone,lipotropic|mucolytic agent,
NRJKIOCCERLIDG,BRD-K43812936,Mps1-IN-5,protein kinase inhibitor,,BRD-K43812936,Mps1-IN-5,protein kinase inhibitor,,BRD-K43812936,Mps1-IN-5,protein kinase inhibitor,,BRD-K43812936,Mps1-IN-5,protein kinase inhibitor,
NRUKOCRGYNPUPR,BRD-A35588707|BRD-K10362825|BRD-K94631066,teniposide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-A35588707|BRD-K10362825|BRD-K94631066,teniposide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-A35588707|BRD-K10362825|BRD-K94631066,teniposide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K10362825|BRD-K94631066,teniposide,topoisomerase inhibitor,TOP2A|TOP2B
NSBRKSWSLRQPJW,BRD-K97028990,quinine-ethyl-carbonate,,,BRD-K97028990,quinine-ethyl-carbonate,,,BRD-K97028990,quinine-ethyl-carbonate,,,BRD-K97028990,quinine-ethyl-carbonate,,
NSFFHOGKXHRQEW,BRD-A20697603|BRD-A86083681|BRD-A91347104,thiostrepton,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1,BRD-A20697603|BRD-A86083681|BRD-A89819812|BRD-A91347104,thiostrepton,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1,BRD-A20697603|BRD-A86083681|BRD-A89819812|BRD-A91347104|BRD-K58049875,thiostrepton,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1,BRD-A86083681|BRD-A89819812|BRD-A91347104|BRD-K58049875,thiostrepton,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1
NSHMVLOWOAQFTP,BRD-K28453807,nitrocaramiphen,cholinergic receptor antagonist,CHRM1,BRD-K28453807,nitrocaramiphen,cholinergic receptor antagonist,CHRM1,BRD-K28453807,nitrocaramiphen,cholinergic receptor antagonist,CHRM1,BRD-K28453807,nitrocaramiphen,cholinergic receptor antagonist,CHRM1
NSHPHXHGRHSMIK,BRD-K61292460,latrunculin-b,actin polymerization inhibitor,ACTA1|MKL1|SPIRE2,BRD-K61292460,latrunculin-b,actin polymerization inhibitor,ACTA1|MKL1|SPIRE2,BRD-K61292460,latrunculin-b,actin polymerization inhibitor,ACTA1|MKL1|SPIRE2,BRD-K61292460,latrunculin-B,actin polymerization inhibitor,ACTA1|MKL1|SPIRE2
NSKGQURZWSPSBC,BRD-A03826781|BRD-A86073102|BRD-K55188888,ribostamycin|ribostamycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|P4HB,BRD-A03826781|BRD-A86073102|BRD-K55188888,ribostamycin|ribostamycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|P4HB,BRD-A03826781|BRD-A86073102|BRD-K55188888,ribostamycin|ribostamycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|P4HB,BRD-K01826536|BRD-K55188888,ribostamycin|ribostamycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|P4HB
NSMJEHGOMXSLCW,BRD-K48826825,S26948,PPAR receptor agonist,PPARG,BRD-K48826825,S26948,PPAR receptor agonist,PPARG,BRD-K48826825,S26948,PPAR receptor agonist,PPARG,BRD-K48826825,S26948,PPAR receptor agonist,PPARG
NSMXQKNUPPXBRG,BRD-A05334458,lisofylline,STAT inhibitor|interleukin receptor antagonist,,BRD-A05334458,lisofylline,STAT inhibitor|interleukin receptor antagonist,,BRD-A05334458,lisofylline,STAT inhibitor|interleukin receptor antagonist,,BRD-A05334458,lisofylline,STAT inhibitor|interleukin receptor antagonist,
NSOXQYCFHDMMGV,BRD-A78588743,editol,,,BRD-A78588743,editol,,,BRD-A78588743,editol,,,BRD-A78588743,editol,,
NSQSAUGJQHDYNO,BRD-K11215326,tazemetostat,histone lysine methyltransferase inhibitor,EZH2,BRD-K11215326,tazemetostat,histone lysine methyltransferase inhibitor,EZH2,BRD-K11215326,tazemetostat,histone lysine methyltransferase inhibitor,EZH2,BRD-K11215326,tazemetostat,histone lysine methyltransferase inhibitor,EZH2
NSTRIRCPWQHTIA,BRD-K56107812,carbetocin,oxytocin receptor agonist,OXTR,BRD-K56107812,carbetocin,oxytocin receptor agonist,OXTR,BRD-K56107812,carbetocin,oxytocin receptor agonist,OXTR,BRD-K56107812,carbetocin,oxytocin receptor agonist,OXTR
NSVFSAJIGAJDMR,BRD-A39845846,efonidipine-monoethanolate,L-type calcium channel blocker|T-type calcium channel blocker,CACNA1C|CACNA1G,BRD-A39845846|BRD-M92675308,efonidipine-monoethanolate,L-type calcium channel blocker|T-type calcium channel blocker,CACNA1C|CACNA1G,,,,,BRD-K00004292,efonidipine,calcium channel blocker,
NSYZCCDSJNWWJL,BRD-K13846766|BRD-K51677086,erythromycin-ethylsuccinate,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,BRD-K51677086,erythromycin-ethylsuccinate,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,BRD-K13846766|BRD-K51677086,erythromycin-ethylsuccinate,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,BRD-K13846766|BRD-K51677086,erythromycin-ethylsuccinate,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1
NTCCRGGIJNDEAB,BRD-K67068943,ORE1001,angiotensin converting enzyme inhibitor,ACE2,BRD-K67068943,ORE1001,angiotensin converting enzyme inhibitor,ACE2,BRD-K67068943,ORE1001,angiotensin converting enzyme inhibitor,ACE2,BRD-K67068943,ORE1001,angiotensin converting enzyme inhibitor,ACE2
NTHPAPBPFQJABD,BRD-K85046107,ramosetron,serotonin receptor antagonist,HTR3A,BRD-K85046107,ramosetron,serotonin receptor antagonist,HTR3A,BRD-K85046107,ramosetron,serotonin receptor antagonist,HTR3A,BRD-K85046107,ramosetron,serotonin receptor antagonist,HTR3A
NTHXOOBQLCIOLC,BRD-A60217728,iohexol,radiopaque medium,,BRD-A60217728,iohexol,radiopaque medium,,BRD-A60217728,iohexol,radiopaque medium,,BRD-A60217728,iohexol,radiopaque medium,
NTJOBXMMWNYJFB,BRD-A60197193,amisulpride,dopamine receptor antagonist,DRD2|DRD3|HTR2A|HTR7,BRD-A60197193,amisulpride,dopamine receptor antagonist,DRD2|DRD3|HTR2A|HTR7,BRD-A60197193,amisulpride,dopamine receptor antagonist,DRD2|DRD3|HTR2A|HTR7,BRD-A60197193,amisulpride,dopamine receptor antagonist,DRD2
NTNWOCRCBQPEKQ,BRD-K59506194,targinine,nitric oxide synthase inhibitor,NOS3,BRD-K59506194,targinine,nitric oxide synthase inhibitor,NOS3,BRD-K59506194,targinine,nitric oxide synthase inhibitor,NOS3,BRD-K22227508,targinine,nitric oxide synthase inhibitor,NOS3
NTSBZVCEIVPKBJ,BRD-K03273112,1-azakenpaullone,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,BRD-K03273112,1-azakenpaullone,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,BRD-K03273112,1-azakenpaullone,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,BRD-K03273112,1-azakenpaullone,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B
NTWVQPHTOUKMDI,BRD-K20946707,L-monomethylarginine,nitric oxide synthase inhibitor,NOS1|NOS2,BRD-K20946707,L-monomethylarginine,nitric oxide synthase inhibitor,NOS1|NOS2,BRD-K20946707,L-monomethylarginine,nitric oxide synthase inhibitor,NOS1|NOS2,BRD-K20946707,L-monomethylarginine,nitric oxide synthase inhibitor,NOS1|NOS2
NTYJJOPFIAHURM,BRD-K01674964,histamine,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,BRD-K01674964,histamine,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,BRD-K01674964|BRD-U61402069,histamine,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,BRD-K01674964|BRD-U61402069,histamine,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4
NUAQIRUAZSJTAI,BRD-A08791201,norvancomycin,,,BRD-A08791201,norvancomycin,,,BRD-A08791201,norvancomycin,,,BRD-K00003706,norvancomycin,,
NUHPODZZKHQQET,BRD-A62071884,siguazodan,phosphodiesterase inhibitor,PDE3A,BRD-A62071884,siguazodan,phosphodiesterase inhibitor,PDE3A,BRD-A62071884,siguazodan,phosphodiesterase inhibitor,PDE3A,BRD-A62071884,siguazodan,phosphodiesterase inhibitor,PDE3A
NUKYPUAOHBNCPY,BRD-K22482860,dalfampridine,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,BRD-K22482860,dalfampridine,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,BRD-K22482860,dalfampridine,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,BRD-K22482860,dalfampridine,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2
NULMGOSOSZBEQL,BRD-K90982969,etilevodopa,dopamine receptor agonist,DRD3,BRD-K90982969,etilevodopa,dopamine receptor agonist,DRD3,BRD-K90982969,etilevodopa,dopamine receptor agonist,DRD3,BRD-K90982969,etilevodopa,dopamine receptor agonist,DRD3
NUPUDYKEEJNZRG,BRD-K52681925,altinicline,nicotinic receptor agonist,CHRNA4|CHRNB2,BRD-K52681925,altinicline,nicotinic receptor agonist,CHRNA4|CHRNB2,BRD-K52681925,altinicline,nicotinic receptor agonist,CHRNA4|CHRNB2,BRD-K52681925,altinicline,nicotinic receptor agonist,CHRNA4|CHRNB2
NUVBSKCKDOMJSU,BRD-K02464583,ethyl-paraben,,,BRD-K02464583,ethyl-paraben,,,BRD-K02464583,ethyl-paraben,,,BRD-K02464583,ethyl-paraben,,
NUZWLKWWNNJHPT,BRD-K04725460,anthralin,DNA synthesis inhibitor,,BRD-K04725460,anthralin,DNA synthesis inhibitor,,BRD-K04725460,anthralin,DNA synthesis inhibitor,,BRD-K04725460,anthralin,DNA synthesis inhibitor,
NVBNDZZLJRYRPD,BRD-K67831364,ZM-323881,VEGFR inhibitor,KDR,BRD-K67831364,ZM-323881,VEGFR inhibitor,KDR,BRD-K67831364,ZM-323881,VEGFR inhibitor,KDR,BRD-K67831364,ZM-323881,VEGFR inhibitor,KDR
NVDBBGBUTKLRSN,BRD-K78096648,oxiperomide,dopamine receptor antagonist,,BRD-K78096648,oxiperomide,dopamine receptor antagonist,,BRD-K78096648,oxiperomide,dopamine receptor antagonist,,BRD-K78096648,oxiperomide,dopamine receptor antagonist,
NVEPPWDVLBMNMB,BRD-K71454870,morantel,acetylcholine receptor agonist,,BRD-K71454870,morantel,acetylcholine receptor agonist,,BRD-K71454870,morantel,acetylcholine receptor agonist,,BRD-K71454870,morantel,acetylcholine receptor agonist,
NVKAMPJSWMHVDK,BRD-K78092779,2'-c-methylguanosine,HCV inhibitor,,BRD-K78092779,2'-c-methylguanosine,HCV inhibitor,,BRD-K78092779,2'-c-methylguanosine,HCV inhibitor,,BRD-K78092779,2'-C-methylguanosine,HCV inhibitor,
NVKAWKQGWWIWPM,BRD-K22525962,dihydrotestosterone,androgen receptor agonist,AR|HSD17B1,BRD-K22525962,dihydrotestosterone,androgen receptor agonist,AR|HSD17B1,BRD-K22525962,dihydrotestosterone,androgen receptor agonist,AR|HSD17B1,,,,
NVRXTLZYXZNATH,BRD-K81801188,PP-121,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC,BRD-K81801188,PP-121,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC,BRD-K81801188,PP-121,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC,BRD-K81801188,PP-121,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC
NVUGEQAEQJTCIX,BRD-K73700643,N-acetyltryptamine,melatonin receptor agonist,,BRD-K73700643,N-acetyltryptamine,melatonin receptor agonist,,BRD-K73700643,N-acetyltryptamine,melatonin receptor agonist,,BRD-K73700643,N-acetyltryptamine,melatonin receptor agonist,
NVVGCQABIHSJSQ,BRD-K03399463,BIO-1211,integrin antagonist,ITGA4|ITGB1,BRD-K03399463,BIO-1211,integrin antagonist,ITGA4|ITGB1,BRD-K03399463,BIO-1211,integrin antagonist,ITGA4|ITGB1,BRD-K03399463,BIO-1211,integrin antagonist,ITGA4|ITGB1
NVZGJSVPOOILDI,BRD-A79052425,SIB-1553A,acetylcholine receptor agonist,CHRNB4,BRD-A79052425,SIB-1553A,acetylcholine receptor agonist,CHRNB4,BRD-A79052425,SIB-1553A,acetylcholine receptor agonist,CHRNB4,BRD-K01826006,SIB-1553A,acetylcholine receptor agonist,CHRNB4
NWBBZCLIZUATJF,BRD-K47190141,arsenic-trioxide,apoptosis stimulant,AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1,BRD-K47190141,arsenic-trioxide,apoptosis stimulant,AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1,BRD-K47190141,arsenic-trioxide,apoptosis stimulant,AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1,,,,
NWBJYWHLCVSVIJ,BRD-K62929068,6-benzylaminopurine,purinergic receptor activator,,BRD-K62929068,6-benzylaminopurine,purinergic receptor activator,,BRD-K62929068,6-benzylaminopurine,purinergic receptor activator,,BRD-K62929068,6-benzylaminopurine,purinergic receptor activator,
NWBWCXBPKTTZNQ,BRD-A05906449,lappaconite,sodium channel blocker,,BRD-A05906449,lappaconite,sodium channel blocker,,BRD-A05906449,lappaconite,sodium channel blocker,,BRD-K00025602,lappaconite,sodium channel blocker,
NWIBSHFKIJFRCO,BRD-A48237631,mitomycin-c,DNA alkylating agent|DNA synthesis inhibitor,,BRD-A48237631,mitomycin-c,DNA alkylating agent|DNA synthesis inhibitor,,BRD-A48237631,mitomycin-c,DNA alkylating agent|DNA synthesis inhibitor,,BRD-K59670716,mitomycin-C,DNA alkylating agent|DNA synthesis inhibitor,
NWIUTZDMDHAVTP,BRD-A02759312|BRD-K43883465,betaxolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A02759312|BRD-K43883465,betaxolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A02759312|BRD-K43883465,betaxolol|levobetaxolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-K01825592|BRD-K43883465,betaxolol|levobetaxolol,adrenergic receptor antagonist,ADRB1|ADRB2
NWPRCRWQMGIBOT,BRD-K83064458,etofylline,adenosine receptor antagonist,ADORA1,BRD-K83064458,etofylline,adenosine receptor antagonist,ADORA1,BRD-K83064458,etofylline,adenosine receptor antagonist,ADORA1,BRD-K83064458,etofylline,adenosine receptor antagonist,ADORA1
NWVVVBRKAWDGAB,BRD-K45216060,mequinol,,TYR,BRD-K45216060,mequinol,,TYR,BRD-K45216060,mequinol,,TYR,BRD-K45216060,mequinol,,TYR
NWXCDQHBVVPPTL,BRD-K31633810,DAU-5884,acetylcholine receptor antagonist,CHRM3,BRD-K31633810,DAU-5884,acetylcholine receptor antagonist,CHRM3,BRD-K31633810,DAU-5884,acetylcholine receptor antagonist,CHRM3,BRD-K31633810,DAU-5884,acetylcholine receptor antagonist,CHRM3
NXFFJDQHYLNEJK,BRD-K48894757,laropiprant,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,BRD-K48894757,laropiprant,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,BRD-K48894757,laropiprant,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,BRD-K48894757,laropiprant,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R
NXFQHRVNIOXGAQ,BRD-K76927775,nitrofurantoin,DNA inhibitor,,BRD-K76927775,nitrofurantoin,DNA inhibitor,,BRD-K76927775,nitrofurantoin,DNA inhibitor,,BRD-K76927775,nitrofurantoin,DNA inhibitor,
NXLUTEDAEFXMQR,BRD-K96615647,AV-608,tachykinin antagonist,TACR1,BRD-K96615647,AV-608,tachykinin antagonist,TACR1,BRD-K96615647,AV-608,tachykinin antagonist,TACR1,BRD-K96615647,AV-608,tachykinin antagonist,TACR1
NXNKJLOEGWSJGI,BRD-K20093108,BMS-587101,integrin antagonist,ITGAL|ITGB2,BRD-K20093108,BMS-587101,integrin antagonist,ITGAL|ITGB2,BRD-K20093108,BMS-587101,integrin antagonist,ITGAL|ITGB2,BRD-K20093108,BMS-587101,integrin antagonist,ITGAL|ITGB2
NXNQLECPAXXYTR,BRD-K41312087,GW-441756,growth factor receptor inhibitor,NTRK1,BRD-K41312087,GW-441756,growth factor receptor inhibitor,NTRK1,BRD-K41312087,GW-441756,growth factor receptor inhibitor,NTRK1,BRD-K41312087,GW-441756,growth factor receptor inhibitor,NTRK1
NXNRAECHCJZNRF,BRD-K64642496,Ko143,BCRP inhibitor,ABCB1|ABCC1,BRD-K64642496,Ko143,BCRP inhibitor,ABCB1|ABCC1,BRD-K64642496,Ko143,BCRP inhibitor,ABCB1|ABCC1,BRD-K64642496,Ko143,BCRP inhibitor,ABCB1|ABCC1
NXTVQNIVUKXOIL,BRD-K93546328,chloramine-t,,,BRD-K93546328,chloramine-t,,,BRD-K93546328,chloramine-t,,,BRD-K93546328,chloramine-T,,
NXWASIVXQMMPLM,BRD-K81694556,VTP-27999,renin inhibitor,REN,BRD-K81694556,VTP-27999,renin inhibitor,REN,BRD-K81694556,VTP-27999,renin inhibitor,REN,BRD-K81694556,VTP-27999,renin inhibitor,REN
NXZNYBUBXWWKCP,BRD-K28059174|BRD-K67628093,INCB-003284|INCB-3284,CC chemokine receptor antagonist,|CCR2,BRD-K28059174|BRD-K67628093,INCB-003284|INCB-3284,CC chemokine receptor antagonist,|CCR2,BRD-K28059174|BRD-K67628093,INCB-003284|INCB-3284,CC chemokine receptor antagonist,|CCR2,BRD-K28059174|BRD-K67628093,INCB-003284|INCB-3284,CC chemokine receptor antagonist,|CCR2
NYFMSQHOGRWGFD,BRD-A64228451,terreic-acid-(-),Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A64228451,terreic-acid-(-),Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-A64228451,terreic-acid-(-),Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K00024725,terreic-acid-(-),Bruton's tyrosine kinase (BTK) inhibitor,BTK
NYHBQMYGNKIUIF,BRD-K92976206,guanosine,,PNP,BRD-K92976206,guanosine,,PNP,BRD-K92976206,guanosine,,PNP,BRD-K67644125,guanosine,,PNP
NYIZXMGNIUSNKL,BRD-K47608922,dipyrocetyl,chelating agent,,BRD-K47608922,dipyrocetyl,chelating agent,,BRD-K47608922,dipyrocetyl,chelating agent,,BRD-K47608922,dipyrocetyl,chelating agent,
NYKCGQQJNVPOLU,BRD-K28192623,spiradoline,opioid receptor agonist,OPRK1,BRD-K28192623,spiradoline,opioid receptor agonist,OPRK1,BRD-K28192623,spiradoline,opioid receptor agonist,OPRK1,BRD-K28192623,spiradoline,opioid receptor agonist,OPRK1
NYMGNSNKLVNMIA,BRD-K88568253,iproniazid,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K88568253,iproniazid,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K88568253,iproniazid,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K88568253,iproniazid,monoamine oxidase inhibitor,MAOA|MAOB
NYNZQNWKBKUAII,BRD-K36574127,LOXO-101,tropomyosin receptor kinase inhibitor,NTRK1|NTRK2|NTRK3,BRD-K36574127,LOXO-101,tropomyosin receptor kinase inhibitor,NTRK1|NTRK2|NTRK3,BRD-K36574127,LOXO-101,tropomyosin receptor kinase inhibitor,NTRK1|NTRK2|NTRK3,BRD-K36574127,larotrectinib,tropomyosin receptor kinase inhibitor,NTRK1|NTRK2|NTRK3
NYPIRLYMDJMKGW,BRD-K07798980,PSI-6130,RNA polymerase inhibitor,,BRD-K07798980,PSI-6130,RNA polymerase inhibitor,,BRD-K07798980,PSI-6130,RNA polymerase inhibitor,,BRD-K07798980,PSI-6130,RNA polymerase inhibitor,
NYYJKMXNVNFOFQ,BRD-K39359968,L-755507,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K39359968,L-755507,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K39359968,L-755507,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K39359968,L-755507,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3
NYZFUZCCDOSQBG,BRD-K82266792,SDZ-220-040,glutamate receptor antagonist,GRIN1,BRD-K82266792,SDZ-220-040,glutamate receptor antagonist,GRIN1,BRD-K82266792,SDZ-220-040,glutamate receptor antagonist,GRIN1,BRD-K82266792,SDZ-220-040,glutamate receptor antagonist,GRIN1
NZASCBIBXNPDMH,BRD-K36116267,pyrithyldione,psychoactive drug,,BRD-K36116267,pyrithyldione,psychoactive drug,,BRD-K36116267,pyrithyldione,psychoactive drug,,BRD-K36116267,pyrithyldione,psychoactive drug,
NZCRJKRKKOLAOJ,BRD-A62879835|BRD-K45512312,rifaximin,RNA synthesis inhibitor,NR1I2,BRD-K92838188,rifaximin,RNA synthesis inhibitor,NR1I2,BRD-A62879835|BRD-K45512312|BRD-K92838188,rifaximin,RNA synthesis inhibitor,NR1I2,BRD-K53484294,rifaximin,RNA synthesis inhibitor,
NZHGWWWHIYHZNX,BRD-K17849083,tranilast,angiogenesis inhibitor,HPGDS|HRH1,BRD-K17849083,tranilast,angiogenesis inhibitor,HPGDS|HRH1,BRD-K17849083,tranilast,angiogenesis inhibitor,HPGDS|HRH1,BRD-K17849083,tranilast,angiogenesis inhibitor,HPGDS|HRH1
NZJKEVWTYMOYOR,BRD-K61128465,mdivi-1,dynamin inhibitor,DNM1,BRD-K61128465,mdivi-1,dynamin inhibitor,DNM1,BRD-K61128465,mdivi-1,dynamin inhibitor,DNM1,BRD-K61128465,mdivi-1,dynamin inhibitor,DNM1
NZLBHDRPUJLHCE,BRD-K53236343,aprindine,voltage-gated sodium channel blocker,CALM1|SCN5A,BRD-K53236343,aprindine,voltage-gated sodium channel blocker,CALM1|SCN5A,BRD-K53236343,aprindine,voltage-gated sodium channel blocker,CALM1|SCN5A,BRD-K53236343,aprindine,voltage-gated sodium channel blocker,CALM1|SCN5A
NZLVRVYNQYGMAB,BRD-K88090157,pimethixene,antihistamine,,BRD-K88090157,pimethixene,antihistamine,,BRD-K88090157,pimethixene,antihistamine,,BRD-K88090157,pimethixene,antihistamine,
NZOONKHCNQFYCI,BRD-K39503511,quiflapon,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,BRD-K39503511,quiflapon,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,BRD-K39503511,quiflapon,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,BRD-K39503511,quiflapon,leukotriene synthesis inhibitor,ALOX5|ALOX5AP
NZUPCNDJBJXXRF,BRD-A99833829,bethanechol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A99833829,bethanechol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A99833829,bethanechol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K00003637,bethanechol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
NZWOPGCLSHLLPA,BRD-A18056626,methacholine,acetylcholine receptor agonist,CHRM2|CHRM3|CHRM4,BRD-A18056626,methacholine,acetylcholine receptor agonist,CHRM2|CHRM3|CHRM4,BRD-A18056626,methacholine,acetylcholine receptor agonist,CHRM2|CHRM3|CHRM4,BRD-A18056626,methacholine,acetylcholine receptor agonist,CHRM2|CHRM4
OAIJSZIZWZSQBC,BRD-K37083340,lycopene,free radical scavenger,,BRD-K37083340,lycopene,free radical scavenger,,BRD-K37083340,lycopene,free radical scavenger,,BRD-K37083340,lycopene,free radical scavenger,
OAKGNIRUXAZDQF,BRD-K67935717,retaspimycin,HSP inhibitor,HSP90AA1,BRD-K67935717,retaspimycin,HSP inhibitor,HSP90AA1,BRD-K67935717,retaspimycin,HSP inhibitor,HSP90AA1,BRD-K67935717,retaspimycin,HSP inhibitor,HSP90AA1
OAVGBZOFDPFGPJ,BRD-K16761703,sotrastaurin,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,BRD-K16761703,sotrastaurin,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,BRD-K16761703,sotrastaurin,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,BRD-K16761703,sotrastaurin,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ
OAVLEYPTWABFLF,BRD-K25524093,PSN-375963,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K25524093,PSN-375963,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K25524093,PSN-375963,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K25524093,PSN-375963,glucose dependent insulinotropic receptor agonist,GPR119
OAYRYNVEFFWSHK,BRD-K13238618,carsalam,analgesic agent,,BRD-K13238618,carsalam,analgesic agent,,BRD-K13238618,carsalam,analgesic agent,,BRD-K13238618,carsalam,analgesic agent,
OBATZBGFDSVCJD,BRD-K99919177,deslanoside,Na/K-ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,BRD-K99919177,deslanoside,Na/K-ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,BRD-K99919177,deslanoside,Na/K-ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,BRD-K99919177,deslanoside,Na/K-ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2
OBBCSXFCDPPXOL,BRD-A16263897,misonidazole,,,BRD-A16263897,misonidazole,,,BRD-A16263897,misonidazole,,,BRD-A16263897,misonidazole,,
OBDOVFRMEYHSQB,BRD-K82677201,almitrine,neurotransmitter agonist,ATP1A1,BRD-K82677201,almitrine,neurotransmitter agonist,ATP1A1,BRD-K82677201,almitrine,neurotransmitter agonist,ATP1A1,BRD-K82677201,almitrine,neurotransmitter agonist,ATP1A1
OBJNFLYHUXWUPF,BRD-K66401437,THZ1,CDK inhibitor,CDK7,BRD-K66401437,THZ1,CDK inhibitor,CDK7,BRD-K66401437,THZ1,CDK inhibitor,CDK7,BRD-K66401437,THZ1,CDK inhibitor,CDK7
OBKXEAXTFZPCHS,BRD-K67102207,phenylbutyrate,HDAC inhibitor,HDAC1,BRD-K67102207,phenylbutyrate,HDAC inhibitor,HDAC1,BRD-K67102207,phenylbutyrate,HDAC inhibitor,HDAC1,BRD-K67102207,phenylbutyrate,HDAC inhibitor,HDAC1
OBMJQRLIQQTJLR,BRD-K68928792,aldoxorubicin,topoisomerase inhibitor,TOP2A,BRD-K68928792,aldoxorubicin,topoisomerase inhibitor,TOP2A,BRD-K68928792,aldoxorubicin,topoisomerase inhibitor,TOP2A,BRD-K68928792,aldoxorubicin,topoisomerase inhibitor,TOP2A
OBMLHUPNRURLOK,BRD-K02314383,epitiostanol,androgen receptor agonist,AR,BRD-K02314383,epitiostanol,androgen receptor agonist,AR,BRD-K02314383,epitiostanol,androgen receptor agonist,AR,BRD-K02314383,epitiostanol,androgen receptor agonist,AR
OBMNJSNZOWALQB,BRD-K24943235,grazoprevir,HCV inhibitor,,BRD-K24943235,grazoprevir,HCV inhibitor,,BRD-K24943235,grazoprevir,HCV inhibitor,,BRD-K24943235,grazoprevir,HCV inhibitor,
OBSYBRPAKCASQB,BRD-K19284129,salvinorin-a,opioid receptor agonist,OPRD1|OPRK1|OPRM1,BRD-K19284129,salvinorin-a,opioid receptor agonist,OPRD1|OPRK1|OPRM1,BRD-K19284129,salvinorin-a,opioid receptor agonist,OPRD1|OPRK1|OPRM1,BRD-K19284129,salvinorin-A,opioid receptor agonist,OPRD1|OPRK1|OPRM1
OBWASQILIWPZMG,BRD-K53765467,empagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K53765467,empagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K53765467,empagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K53765467,empagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2
OBWNXGOQPLDDPS,BRD-K09443272,PHA-680632,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K09443272,PHA-680632,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K09443272,PHA-680632,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K09443272,PHA-680632,Aurora kinase inhibitor,AURKA|AURKB|AURKC
OBZHEBDUNPOCJG,BRD-A25216804|BRD-A98702003,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,BRD-A25216804|BRD-A98702003,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,BRD-A25216804|BRD-A29700858|BRD-A98702003,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,BRD-K12765235,carbenoxolone,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3
OBZJZDHRXBKKTJ,BRD-A64064900,sangivamycin,DNA inhibitor,,BRD-A64064900,sangivamycin,DNA inhibitor,,BRD-A64064900,sangivamycin,DNA inhibitor,,BRD-K36169695,sangivamycin,DNA inhibitor,
OCAPBUJLXMYKEJ,BRD-A94543220,bifonazole,sterol demethylase inhibitor,CYP2B6,BRD-A94543220,bifonazole,sterol demethylase inhibitor,CYP2B6,BRD-A94543220,bifonazole,sterol demethylase inhibitor,CYP2B6,BRD-A94543220,bifonazole,sterol demethylase inhibitor,
OCAXFDULERPAJM,BRD-A51713165,3-CPMT,dopamine reuptake inhibitor,,BRD-A51713165,3-CPMT,dopamine reuptake inhibitor,,BRD-A51713165,3-CPMT,dopamine reuptake inhibitor,,BRD-K00004217,3-CPMT,dopamine reuptake inhibitor,
OCCZJXAHSUCJSA,BRD-K40715924,medorinone,,,BRD-K40715924,medorinone,,,BRD-K40715924,medorinone,,,BRD-K40715924,medorinone,,
OCDGBSUVYYVKQZ,BRD-K26005076,gramine,norepinephrine reputake inhibitor,,BRD-K26005076,gramine,norepinephrine reputake inhibitor,,BRD-K26005076,gramine,norepinephrine reputake inhibitor,,BRD-K26005076,gramine,norepinephrine reputake inhibitor,
OCINXEZVIIVXFU,BRD-K64514229,toltrazuril,antiprotozoal agent,,BRD-K64514229,toltrazuril,antiprotozoal agent,,BRD-K64514229,toltrazuril,antiprotozoal agent,,BRD-K64514229,toltrazuril,antiprotozoal agent,
OCJYIGYOJCODJL,BRD-A50311610,meclizine,constitutive androstane receptor (CAR) agonist,HRH1|NR1I3,BRD-A50311610,meclizine,constitutive androstane receptor (CAR) agonist,HRH1|NR1I3,BRD-A50311610,meclizine,constitutive androstane receptor (CAR) agonist,HRH1|NR1I3,BRD-K01826560,meclizine,constitutive androstane receptor (CAR) agonist,NR1I3
OCKHRKSTDPOHEN,BRD-K70511574,HMN-214,PLK inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K70511574,HMN-214,PLK inhibitor,PLK1,BRD-K70511574,HMN-214,PLK inhibitor,PLK1,BRD-K70511574,HMN-214,PLK inhibitor,PLK1
OCSMOTCMPXTDND,BRD-K21396683,marimastat,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,BRD-K21396683,marimastat,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,BRD-K21396683,marimastat,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,BRD-K21396683,marimastat,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9
OCUJLLGVOUDECM,BRD-A47494775,dipivefrine,adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB2|BCHE,BRD-A47494775,dipivefrine,adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB2|BCHE,BRD-A47494775,dipivefrine,adrenergic receptor agonist,ACHE|ADRA1A|ADRA2A|ADRB2|BCHE,BRD-A47494775,dipivefrine,adrenergic receptor agonist,
ODADKLYLWWCHNB,BRD-K85776940,delta-Tocotrienol,HMGCR inhibitor,HMGCR,BRD-K85776940,delta-Tocotrienol,HMGCR inhibitor,HMGCR,BRD-K85776940,delta-Tocotrienol,HMGCR inhibitor,HMGCR,BRD-K85776940,delta-tocotrienol,HMGCR inhibitor,HMGCR
ODAIHABQVKJNIY,BRD-K00768353,perindoprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K00768353,perindoprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K00768353,perindoprilat,angiotensin converting enzyme inhibitor,ACE,BRD-K00768353,perindoprilat,angiotensin converting enzyme inhibitor,ACE
ODFJOVXVLFUVNQ,BRD-K99048103,acetarsol,,,BRD-K99048103,acetarsol,,,BRD-K99048103,acetarsol,,,BRD-K99048103,acetarsol,,
ODHCTXKNWHHXJC,BRD-K57313110,pidolic-acid,,ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA,BRD-K57313110,pidolic-acid,,ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA,BRD-K57313110,pidolic-acid,,ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA,BRD-K57313110,pidolic-acid,,ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA
ODJLBQGVINUMMR,BRD-A55312468,k-strophanthidin,ATPase inhibitor,ATP1A1,BRD-A55312468,k-strophanthidin,ATPase inhibitor,ATP1A1,BRD-A55312468,k-strophanthidin,ATPase inhibitor,ATP1A1,BRD-K84595254,K-strophanthidin,ATPase inhibitor,ATP1A1
ODKNJVUHOIMIIZ,BRD-A03757454|BRD-K73088654,floxuridine,DNA synthesis inhibitor,TYMS,BRD-A03757454|BRD-K73088654,floxuridine,DNA synthesis inhibitor,TYMS,BRD-A03757454|BRD-K47832606|BRD-K73088654,floxuridine,DNA synthesis inhibitor,TYMS,BRD-K47832606|BRD-K73088654,floxuridine,DNA synthesis inhibitor,TYMS
ODKSFYDXXFIFQN,BRD-K76811153,L-Arginine,nitric oxide precursor,ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4,BRD-K76811153,L-Arginine,nitric oxide precursor,ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4,BRD-K76811153,L-Arginine,nitric oxide precursor,ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4,BRD-K06033833,L-arginine,nitric oxide precursor,ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4
ODLDHXPJRGNTPC,BRD-K22097830,OCO-1112,cholesterol inhibitor,,BRD-K22097830,OCO-1112,cholesterol inhibitor,,BRD-K22097830,OCO-1112,cholesterol inhibitor,,BRD-K22097830,OCO-1112,cholesterol inhibitor,
ODLGMSQBFONGNG,BRD-K28442028|BRD-K57284066,R-1479|Ro-9187,HCV inhibitor,,BRD-K28442028|BRD-K57284066,R-1479|Ro-9187,HCV inhibitor,,BRD-K28442028|BRD-K57284066,R-1479|Ro-9187,HCV inhibitor,,BRD-K28442028|BRD-K57284066,R-1479|Ro-9187,HCV inhibitor,
ODLHGICHYURWBS,BRD-A01412266,hydroxypropyl-beta-cyclodextrin,,,BRD-A01412266,hydroxypropyl-beta-cyclodextrin,,,BRD-A01412266,hydroxypropyl-beta-cyclodextrin,,,BRD-A01412266,hydroxypropyl-beta-cyclodextrin,,
ODNICNWASXKNNQ,BRD-K87510569,RS-504393,CC chemokine receptor antagonist,CCL2|CCR2,BRD-K87510569,RS-504393,CC chemokine receptor antagonist,CCL2|CCR2,BRD-K87510569,RS-504393,CC chemokine receptor antagonist,CCL2|CCR2,BRD-K87510569,RS-504393,CC chemokine receptor antagonist,CCL2|CCR2
ODQWQRRAPPTVAG,BRD-K37694030,doxepin,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HRH2|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|KCNH2|SLC6A2|SLC6A4,BRD-K37694030,doxepin,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HRH2|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|KCNH2|SLC6A2|SLC6A4,BRD-K37694030,doxepin,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HRH2|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|KCNH2|SLC6A2|SLC6A4,BRD-K37694030,doxepin,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4
ODTKFNUPVBULRJ,BRD-K43905307,"L-798,106",,,BRD-K43905307,"L-798,106",prostanoid receptor antagonist,PTGER3,BRD-K43905307,"L-798,106",prostanoid receptor antagonist,PTGER3,BRD-K43905307,L-798106,prostanoid receptor antagonist,PTGER3
ODUOJXZPIYUATO,BRD-A08187463,racecadotril,enkephalinase inhibitor,MME,BRD-A08187463,racecadotril,enkephalinase inhibitor,MME,BRD-A08187463,racecadotril,enkephalinase inhibitor,MME,BRD-A08187463,racecadotril,enkephalinase inhibitor,MME
ODXQFEWQSHNQNI,BRD-K30882994,tiplaxtinin,plasminogen activator inhibitor,SERPINE1,BRD-K30882994,tiplaxtinin,plasminogen activator inhibitor,SERPINE1,BRD-K30882994,tiplaxtinin,plasminogen activator inhibitor,SERPINE1,BRD-K30882994,tiplaxtinin,plasminogen activator inhibitor,SERPINE1
ODYAQBDIXCVKAE,BRD-K54095730,CMPD-1,p38 MAPK inhibitor,GNRHR|MAPK14,BRD-K54095730,CMPD-1,p38 MAPK inhibitor,GNRHR|MAPK14,BRD-K54095730,CMPD-1,p38 MAPK inhibitor,GNRHR|MAPK14,BRD-K54095730,CMPD-1,p38 MAPK inhibitor,GNRHR|MAPK14
ODZBBRURCPAEIQ,BRD-A63675168,brivudine,DNA directed DNA polymerase inhibitor,,BRD-A63675168,brivudine,DNA directed DNA polymerase inhibitor,,BRD-A63675168,brivudine,DNA directed DNA polymerase inhibitor,,BRD-A63675168,brivudine,DNA directed DNA polymerase inhibitor,
OEBPANQZQGQPHF,BRD-K32311154,nifekalant,potassium channel blocker,,BRD-K32311154,nifekalant,potassium channel blocker,,BRD-K32311154,nifekalant,potassium channel blocker,,BRD-K32311154,nifekalant,potassium channel blocker,
OEBRKCOSUFCWJD,BRD-K23779958,dichlorvos,acetylcholinesterase inhibitor,,BRD-K23779958,dichlorvos,acetylcholinesterase inhibitor,,BRD-K23779958,dichlorvos,acetylcholinesterase inhibitor,,BRD-K23779958,dichlorvos,acetylcholinesterase inhibitor,
OEGDFSLNGABBKJ,BRD-K84971356,etafenone,calcium channel blocker,,BRD-K84971356,etafenone,calcium channel blocker,,BRD-K84971356,etafenone,calcium channel blocker,,BRD-K84971356,etafenone,calcium channel blocker,
OEHAYUOVELTAPG,BRD-A21474126,methoxyphenamine,adrenergic receptor agonist,,BRD-A21474126,methoxyphenamine,adrenergic receptor agonist,,BRD-A21474126,methoxyphenamine,adrenergic receptor agonist,,BRD-A21474126,methoxyphenamine,adrenergic receptor agonist,
OEHFRZLKGRKFAS,BRD-K17219082,droxicam,cyclooxygenase inhibitor,PTGS1,BRD-K17219082,droxicam,cyclooxygenase inhibitor,PTGS1,BRD-K17219082,droxicam,cyclooxygenase inhibitor,PTGS1,BRD-K17219082,droxicam,cyclooxygenase inhibitor,PTGS1
OEKWJQXRCDYSHL,BRD-K44974079,ticagrelor,purinergic receptor antagonist,P2RY12,BRD-K44974079,ticagrelor,purinergic receptor antagonist,P2RY12,BRD-K44974079,ticagrelor,purinergic receptor antagonist,P2RY12,BRD-K25838957,ticagrelor,purinergic receptor antagonist,P2RY12
OELFLUMRDSZNSF,BRD-K44353683|BRD-K84658672,nateglinide,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,BRD-K44353683|BRD-K84658672,nateglinide,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,BRD-K44353683|BRD-K84658672,nateglinide,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,BRD-K44353683,nateglinide,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG
OENHQHLEOONYIE,BRD-K34538779|BRD-K74225533,beta-carotene,,,BRD-K34538779|BRD-K74225533,beta-carotene,,,BRD-K34538779|BRD-K74225533,beta-carotene,,,BRD-K34538779|BRD-K74225533,beta-carotene,,
OETLNMOJNONWOY,BRD-K38018935,OTS514,TOPK inhibitor,,BRD-K38018935,OTS514,TOPK inhibitor,,BRD-K38018935,OTS514,TOPK inhibitor,,BRD-K38018935,OTS514,TOPK inhibitor,
OEXHQOGQTVQTAT,BRD-A05352148|BRD-A65721754|BRD-A96060515,ipratropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A05352148|BRD-A65721754|BRD-A96060515,ipratropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A05352148|BRD-A47449001|BRD-A65721754|BRD-A96060515,ipratropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K01826778,ipratropium,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
OEXMNSOPAKOPEF,BRD-K44777625,FH1,hepatocyte function enhancer,,BRD-K44777625,FH1,hepatocyte function enhancer,,BRD-K44777625,FH1,hepatocyte function enhancer,,BRD-K44777625,FH1,hepatocyte function enhancer,
OEYIOHPDSNJKLS,BRD-K77300776,choline,acetylcholine precursor,ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2,BRD-K77300776,choline,acetylcholine precursor,ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2,BRD-K77300776|BRD-M07056525,choline,acetylcholine precursor,ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2,BRD-K77300776|BRD-M07056525,choline,acetylcholine precursor,ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2
OFAIGZWCDGNZGT,BRD-K59895502,caramiphen,cholinergic receptor antagonist,CHRM1|CHRM2,BRD-K59895502,caramiphen,cholinergic receptor antagonist,CHRM1|CHRM2,BRD-K59895502,caramiphen,cholinergic receptor antagonist,CHRM1|CHRM2,BRD-K59895502,caramiphen,cholinergic receptor antagonist,CHRM1|CHRM2
OFBIFZUFASYYRE,BRD-K98769987,flumazenil,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K98769987,flumazenil,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K98769987,flumazenil,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,BRD-K98769987,flumazenil,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ
OFCLARYYBGKCHN,BRD-K41869275,2-phenylmelatonin,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K41869275,2-phenylmelatonin,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K41869275,2-phenylmelatonin,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K41869275,2-phenylmelatonin,melatonin receptor agonist,MTNR1A|MTNR1B
OFCNXPDARWKPPY,BRD-K86307448,allopurinol,xanthine oxidase inhibitor,XDH,BRD-K86307448,allopurinol,xanthine oxidase inhibitor,XDH,BRD-K86307448,allopurinol,xanthine oxidase inhibitor,XDH,BRD-K86307448,allopurinol,xanthine oxidase inhibitor,XDH
OFCTYBMKKTVKCR,BRD-K13826399,PD-156707,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K13826399,PD-156707,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K13826399,PD-156707,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K13826399,PD-156707,endothelin receptor antagonist,EDNRA|EDNRB
OFDNQWIFNXBECV,BRD-K78567475,dolastatin-10,tubulin polymerization inhibitor,TUBB,BRD-K78567475,dolastatin-10,tubulin polymerization inhibitor,TUBB,BRD-K78567475,dolastatin-10,tubulin polymerization inhibitor,TUBB,BRD-K78567475,dolastatin-10,tubulin polymerization inhibitor,TUBB
OFEZSBMBBKLLBJ,BRD-K65428967,cordycepin,DNA inhibitor,,BRD-K65428967,cordycepin,DNA inhibitor,,BRD-K65428967,cordycepin,DNA inhibitor,,BRD-K65428967,cordycepin,DNA inhibitor,
OFHCOWSQAMBJIW,BRD-K84280765|BRD-K92644009,alfacalcidol,vitamin D receptor agonist,CYP27B1|VDR,BRD-K49522529|BRD-K84280765|BRD-K92644009,alfacalcidol,vitamin D receptor agonist,CYP27B1|VDR,BRD-K49522529|BRD-K84280765|BRD-K92644009,alfacalcidol,vitamin D receptor agonist,CYP27B1|VDR,BRD-K49522529|BRD-K84280765|BRD-K92644009,alfacalcidol,vitamin D receptor agonist,CYP27B1|VDR
OFPXSFXSNFPTHF,BRD-K25394294,oxaprozin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K25394294,oxaprozin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K25394294,oxaprozin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K25394294,oxaprozin,cyclooxygenase inhibitor,PTGS1|PTGS2
OFUDZKKOKPGXOH,BRD-A77218119,SYM-2206,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A77218119,SYM-2206,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A77218119,SYM-2206,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A77218119,SYM-2206,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4
OFZCIYFFPZCNJE,BRD-A99939097,carisoprodol,acetylcholine receptor antagonist,CYP2C19,BRD-A99939097,carisoprodol,acetylcholine receptor antagonist,CYP2C19,BRD-A99939097,carisoprodol,acetylcholine receptor antagonist,CYP2C19,,,,
OFZJKCQENFPZBH,BRD-K68544925,avatrombopag,thrombopoietin receptor agonist,MPL,BRD-K68544925,avatrombopag,thrombopoietin receptor agonist,MPL,BRD-K68544925,avatrombopag,thrombopoietin receptor agonist,MPL,BRD-K68544925,avatrombopag,thrombopoietin receptor agonist,MPL
OGAKLTJNUQRZJU,BRD-K01663662,diphenidol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K01663662,diphenidol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K01663662,diphenidol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K01663662,diphenidol,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
OGCQBCHLFMBCCE,BRD-K10575656,MRS3777,adenosine receptor antagonist,ADORA2A,BRD-K10575656|BRD-M86143595,MRS3777,adenosine receptor antagonist,ADORA2A,BRD-K10575656|BRD-M86143595,MRS3777,adenosine receptor antagonist,ADORA2A,BRD-K10575656|BRD-M86143595,MRS-3777,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
OGHNVEJMJSYVRP,BRD-A10977446,carvedilol,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|GJA1|HIF1A|KCNH2|NDUFC2|NPPB|SELE|VCAM1|VEGFA,BRD-A10977446,carvedilol,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|GJA1|HIF1A|KCNH2|NDUFC2|NPPB|SELE|VCAM1|VEGFA,BRD-A10977446,carvedilol,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|GJA1|HIF1A|KCNH2|NDUFC2|NPPB|SELE|VCAM1|VEGFA,BRD-K01826535,carvedilol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
OGJGQVFWEPNYSB,BRD-K05528470,L-745870,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7,BRD-K05528470,L-745870,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7,BRD-K05528470,L-745870,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7,BRD-K05528470,L-745870,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7
OGJPXUAPXNRGGI,BRD-K11196887,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K11196887,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K11196887,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K11196887,norfloxacin,bacterial DNA gyrase inhibitor,TOP2A
OGMADIBCHLQMIP,BRD-M77687198,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST,BRD-M77687198,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST,BRD-M77687198,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST,,,,
OGNYUTNQZVRGMN,BRD-K72703948,ZM-447439,Aurora kinase inhibitor,AURKA|AURKB,BRD-K72703948,ZM-447439,Aurora kinase inhibitor,AURKA|AURKB,BRD-K72703948,ZM-447439,Aurora kinase inhibitor,AURKA|AURKB,BRD-K72703948,ZM-447439,Aurora kinase inhibitor,AURKA|AURKB
OGQICQVSFDPSEI,BRD-K76841105,tazarotene,retinoid receptor agonist,RARA|RARB|RARG|RXRB,BRD-K76841105,tazarotene,retinoid receptor agonist,RARA|RARB|RARG|RXRB,BRD-K76841105,tazarotene,retinoid receptor agonist,RARA|RARB|RARG|RXRB,BRD-K76841105,tazarotene,retinoid receptor agonist,RARA|RARB|RARG|RXRB
OGSBUKJUDHAQEA,BRD-A74914197,pralatrexate,dihydrofolate reductase inhibitor,DHFR|TYMS,BRD-A74914197,pralatrexate,dihydrofolate reductase inhibitor,DHFR|TYMS,BRD-A74914197,pralatrexate,dihydrofolate reductase inhibitor,DHFR|TYMS,BRD-A74914197,pralatrexate,dihydrofolate reductase inhibitor,DHFR
OGSPWJRAVKPPFI,BRD-K75527158,alendronate,bone resorption inhibitor,ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS,BRD-K75527158,alendronate,bone resorption inhibitor,ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS,BRD-K75527158,alendronate,bone resorption inhibitor,ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS,BRD-K75527158,alendronate,bone resorption inhibitor,ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS
OGWKCGZFUXNPDA,BRD-A60414806|BRD-A60578817|BRD-K49229349|BRD-K98953900,vincristine,tubulin polymerization inhibitor,TUBA4A|TUBB,BRD-A60414806|BRD-A60578817|BRD-K49229349|BRD-K98953900,vincristine,tubulin polymerization inhibitor,TUBA4A|TUBB,BRD-A60414806|BRD-A60578817|BRD-K12251893|BRD-K49229349|BRD-K98953900,vincristine,tubulin polymerization inhibitor,TUBA4A|TUBB,BRD-A60414806|BRD-A60578817|BRD-K12251893|BRD-K49229349|BRD-K98953900,vincristine,tubulin polymerization inhibitor,TUBA4A|TUBB
OGXMGJGFLBSEJW,BRD-K80725821,RS-16566,serotonin receptor antagonist,,BRD-K80725821,RS-16566,serotonin receptor antagonist,,BRD-K80725821,RS-16566,serotonin receptor antagonist,,BRD-K00004221,RS-16566,serotonin receptor antagonist,
OHCFGBLQZMYRTR,BRD-K21771665,merbromin,antiseptic,,BRD-K21771665,merbromin,antiseptic,,BRD-K21771665,merbromin,antiseptic,,BRD-K21771665,merbromin,antiseptic,
OHCQJHSOBUTRHG,BRD-A55416093|BRD-K09602097|BRD-K62498766,colforsin|forskolin,adenylyl cyclase activator,ADCY2|ADCY5|GNAS,BRD-A55416093|BRD-K09602097|BRD-K77830450,colforsin|forskolin,adenylyl cyclase activator,ADCY2|ADCY5|GNAS,BRD-A55416093|BRD-K09602097|BRD-K77830450,colforsin|forskolin,adenylyl cyclase activator,ADCY2|ADCY5|GNAS,BRD-A55416093|BRD-K09602097|BRD-K77830450,colforsin|forskolin,adenylyl cyclase activator,ADCY2|ADCY5|GNAS
OHKOGUYZJXTSFX,BRD-A55051145|BRD-A91757199,ticarcillin,lactamase inhibitor,,BRD-A55051145|BRD-A91757199,ticarcillin,lactamase inhibitor,,BRD-A55051145|BRD-A91757199|BRD-K29229654,ticarcillin,lactamase inhibitor,,BRD-A91757199|BRD-K29229654,ticarcillin,lactamase inhibitor,
OHLHOLGYGRKZMU,BRD-K81844417,N-benzylacrylamide,,,,,,,,,,,,,,
OHMJKMNGYYWCHB,BRD-K56483981,chicago-sky-blue-6b,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MIF,BRD-K56483981,chicago-sky-blue-6b,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MIF,BRD-K56483981,chicago-sky-blue-6b,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MIF,,,,
OHPVYKXTRACOSQ,BRD-A63431791,sulbactam-pivoxil,beta lactamase inhibitor,,BRD-A63431791,sulbactam-pivoxil,beta lactamase inhibitor,,BRD-A63431791,sulbactam-pivoxil,beta lactamase inhibitor,,BRD-A63431791,sulbactam-pivoxil,beta lactamase inhibitor,
OHRURASPPZQGQM,BRD-K61397605,romidepsin,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K61397605,romidepsin,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K61397605,romidepsin,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K61397605,romidepsin,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
OHUHVTCQTUDPIJ,BRD-A36013532,AZD6738,ATR kinase inhibitor,ATR,BRD-A36013532,AZD6738,ATR kinase inhibitor,ATR,BRD-A36013532,AZD6738,ATR kinase inhibitor,ATR,BRD-A36013532,AZD6738,ATR kinase inhibitor,ATR
OHXPGWPVLFPUSM,BRD-A11551002|BRD-A64125466,dehydrocholate|dehydrocholate-acid,,,BRD-A11551002|BRD-A64125466,dehydrocholate|dehydrocholate-acid,,,BRD-A11551002|BRD-A64125466,dehydrocholate|dehydrocholate-acid,,,BRD-A64125466|BRD-K90976994,dehydrocholate|dehydrocholate-acid,,
OIGHTPDWPMLMGT,BRD-K55430733,WAY-629,serotonin receptor agonist,HTR2C,BRD-K55430733,WAY-629,serotonin receptor agonist,HTR2C,BRD-K55430733,WAY-629,serotonin receptor agonist,HTR2C,BRD-K55430733,WAY-629,serotonin receptor agonist,HTR2C
OIGNJSKKLXVSLS,BRD-A27887842|BRD-K00645576,prednisolone,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,BRD-A27887842,prednisolone,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,BRD-A27887842|BRD-K00645576,prednisolone,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,BRD-A27887842|BRD-K00645576,prednisolone,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6
OIPILFWXSMYKGL,BRD-K82381502,acetylcholine,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K82381502,acetylcholine,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K82381502,acetylcholine,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K82381502,acetylcholine,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
OIQJEQLSYJSNDS,BRD-A96510685,piroctone-olamine,,,BRD-A96510685,piroctone-olamine,,,BRD-A96510685|BRD-M95050869,piroctone-olamine,,,BRD-A96510685|BRD-M95050869,piroctone-olamine,,
OIRCOABEOLEUMC,BRD-A64231665|BRD-K73504359,bivalirudin,thrombin inhibitor,F2,BRD-A64231665|BRD-K73504359,bivalirudin,thrombin inhibitor,F2,BRD-A64231665|BRD-K28054654|BRD-K73504359,bivalirudin,thrombin inhibitor,F2,BRD-A64231665|BRD-K73504359,bivalirudin,thrombin inhibitor,F2
OIRDTQYFTABQOQ,BRD-K01577834|BRD-K63038995|BRD-K72093121,adenosine|vidarabine,adenosine receptor agonist|antiviral,ADA|ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,BRD-K01577834|BRD-K63038995|BRD-K72093121,adenosine|vidarabine,adenosine receptor agonist|antiviral,ADA|ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,BRD-K01577834|BRD-K63038995|BRD-K72093121,adenosine|vidarabine,adenosine receptor agonist|antiviral,ADA|ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,BRD-K01577834|BRD-K63038995|BRD-K72093121,adenosine|vidarabine,adenosine receptor agonist|antiviral,ADA|ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4
OIRFJRBSRORBCM,BRD-A42628519,iopanic-acid,thyroid hormone inhibitor,,BRD-A42628519,iopanic-acid,thyroid hormone inhibitor,,BRD-A42628519,iopanic-acid,thyroid hormone inhibitor,,BRD-A42628519,iopanic-acid,thyroid hormone inhibitor,
OIURYJWYVIAOCW,BRD-K02898090,kifunensine,mannosidase inhibitor,MAN1B1|MAN2A1,BRD-K02898090,kifunensine,mannosidase inhibitor,MAN1B1|MAN2A1,BRD-K02898090,kifunensine,mannosidase inhibitor,MAN1B1|MAN2A1,BRD-K02898090,kifunensine,mannosidase inhibitor,MAN1B1|MAN2A1
OJFKUJDRGJSAQB,BRD-K31866293,TAK-632,RAF inhibitor,BRAF,BRD-K31866293,TAK-632,RAF inhibitor,BRAF,BRD-K31866293,TAK-632,RAF inhibitor,BRAF,BRD-K31866293,TAK-632,RAF inhibitor,BRAF
OJFSXZCBGQGRNV,BRD-A29426959,carbinoxamine,histamine receptor antagonist,HRH1,BRD-A29426959,carbinoxamine,histamine receptor antagonist,HRH1,BRD-A29426959,carbinoxamine,histamine receptor antagonist,HRH1,BRD-K01826745,carbinoxamine,histamine receptor antagonist,HRH1
OJGDCBLYJGHCIH,BRD-K47631482,bromhexine,mucolytic agent,,BRD-K47631482,bromhexine,mucolytic agent,,BRD-K47631482,bromhexine,mucolytic agent,,BRD-K47631482,bromhexine,mucolytic agent,
OJICYBSWSZGRFB,BRD-K59853741,Q-203,ATP synthase inhibitor,,BRD-K59853741,Q-203,ATP synthase inhibitor,,BRD-K59853741,Q-203,ATP synthase inhibitor,,BRD-K59853741,Q-203,ATP synthase inhibitor,
OJLOPKGSLYJEMD,BRD-A72351335,misoprostol,prostanoid receptor agonist,PTGER2|PTGER3|PTGER4|PTGIR,BRD-A72351335,misoprostol,prostanoid receptor agonist,PTGER2|PTGER3|PTGER4|PTGIR,BRD-A72351335,misoprostol,prostanoid receptor agonist,PTGER2|PTGER3|PTGER4|PTGIR,BRD-A72351335,misoprostol,prostanoid receptor agonist,PTGER2|PTGER3|PTGER4|PTGIR
OJMMVQQUTAEWLP,BRD-K08033334|BRD-K81447180|BRD-K99816398,lincomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K08033334|BRD-K81447180|BRD-K99816398,lincomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K08033334|BRD-K81447180|BRD-K99816398,lincomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K49384696,lincomycin,bacterial 30S ribosomal subunit inhibitor,
OJPLJFIFUQPSJR,BRD-K22024824,RG4733,gamma secretase inhibitor,PSEN1,BRD-K22024824,RG4733,gamma secretase inhibitor,PSEN1,BRD-K22024824,RG4733,gamma secretase inhibitor,PSEN1,BRD-K22024824,RG4733,gamma secretase inhibitor,PSEN1
OJYGBLRPYBAHRT,BRD-A98174560,chloralose,,,BRD-A98174560,chloralose,,,BRD-A98174560,chloralose,,,BRD-K00004971,chloralose,,
OJYLAHXKWMRDGS,BRD-K33510429,vanillylacetone,,,BRD-K33510429,vanillylacetone,,,BRD-K33510429,vanillylacetone,,,BRD-K33510429,vanillylacetone,,
OJZYRQPMEIEQFC,BRD-K25015158,limaprost-alfadex,prostanoid receptor agonist,PTGER1,BRD-K25015158,limaprost-alfadex,prostanoid receptor agonist,PTGER1,BRD-K25015158,limaprost-alfadex,prostanoid receptor agonist,PTGER1,BRD-K25015158,limaprost-alfadex,prostanoid receptor agonist,PTGER1
OJZZJTLBYXHUSJ,BRD-K77677632,SB-200646,serotonin receptor antagonist,HTR2B|HTR2C,BRD-K77677632,SB-200646,serotonin receptor antagonist,HTR2B|HTR2C,BRD-K77677632,SB-200646,serotonin receptor antagonist,HTR2B|HTR2C,BRD-K77677632,SB-200646,serotonin receptor antagonist,HTR2B|HTR2C
OKBVVJOGVLARMR,BRD-K71059170,cefixime,bacterial cell wall synthesis inhibitor,,BRD-K71059170,cefixime,bacterial cell wall synthesis inhibitor,,BRD-K71059170,cefixime,bacterial cell wall synthesis inhibitor,,BRD-K71059170,cefixime,bacterial cell wall synthesis inhibitor,
OKFDRAHPFKMAJH,BRD-K92303087,oglemilast,phosphodiesterase inhibitor,,BRD-K92303087,oglemilast,phosphodiesterase inhibitor,,BRD-K92303087,oglemilast,phosphodiesterase inhibitor,,BRD-K92303087,oglemilast,phosphodiesterase inhibitor,
OKGPFTLYBPQBIX,BRD-K55773932,BMS-806,HIV attachment inhibitor,,BRD-K55773932,BMS-806,HIV attachment inhibitor,,BRD-K55773932,BMS-806,HIV attachment inhibitor,,BRD-K55773932,BMS-806,HIV attachment inhibitor,
OKOVSTKGUBOSTB,BRD-K15834839,lobendazole,anthelmintic agent,,BRD-K15834839,lobendazole,anthelmintic agent,,BRD-K15834839,lobendazole,anthelmintic agent,,BRD-K15834839,lobendazole,anthelmintic agent,
OKPNYGAWTYOBFZ,BRD-K65992024,pirenoxine,AGE inhibitor,,BRD-K65992024,pirenoxine,AGE inhibitor,,BRD-K65992024,pirenoxine,AGE inhibitor,,BRD-K65992024,pirenoxine,AGE inhibitor,
OLAHOMJCDNXHFI,BRD-K84868168,erdafitinib,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4,BRD-K84868168,erdafitinib,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4,BRD-K84868168,erdafitinib,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4,BRD-K84868168,erdafitinib,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4
OLBCVFGFOZPWHH,BRD-K82255054,propofol,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A,BRD-K82255054,propofol,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A,BRD-K82255054,propofol,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A,BRD-K82255054,propofol,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A
OLHQOJYVQUNWPL,BRD-K23541596,dimaprit,histamine receptor agonist,HRH2|HRH3|HRH4,BRD-K23541596,dimaprit,histamine receptor agonist,HRH2|HRH3|HRH4,BRD-K23541596,dimaprit,histamine receptor agonist,HRH2|HRH3|HRH4,BRD-K23541596,dimaprit,histamine receptor agonist,HRH2|HRH3|HRH4
OLIIUAHHAZEXEX,BRD-A10523515,GSK429286A,rho associated kinase inhibitor,ROCK1,BRD-A10523515,GSK429286A,rho associated kinase inhibitor,ROCK1,BRD-A10523515,GSK429286A,rho associated kinase inhibitor,ROCK1,BRD-A10523515,GSK429286A,rho associated kinase inhibitor,ROCK1
OLNTVTPDXPETLC,BRD-A41519720|BRD-K32180660|BRD-K42260897,ezetimibe,Niemann-Pick C1-like 1 protein antagonist|cholesterol inhibitor,ANPEP|NPC1L1|SOAT1,BRD-A41519720|BRD-K32180660|BRD-K42260897,ezetimibe,Niemann-Pick C1-like 1 protein antagonist|cholesterol inhibitor,ANPEP|NPC1L1|SOAT1,BRD-A41519720|BRD-K32180660|BRD-K42260897,ezetimibe,Niemann-Pick C1-like 1 protein antagonist|cholesterol inhibitor,ANPEP|NPC1L1|SOAT1,BRD-K32180660|BRD-K42260897,ezetimibe,Niemann-Pick C1-like 1 protein antagonist|cholesterol inhibitor,ANPEP|NPC1L1|SOAT1
OLTZHXYLLRJLST,BRD-K66874953,pifithrin-alpha,TP53 inhibitor,TP53,BRD-K66874953,pifithrin-alpha,TP53 inhibitor,TP53,BRD-K66874953,pifithrin-alpha,TP53 inhibitor,TP53,BRD-K66874953,pifithrin-alpha,TP53 inhibitor,TP53
OLVCFLKTBJRLHI,BRD-A23933379|BRD-K27130738,cefamandole,bacterial cell wall synthesis inhibitor,,BRD-A23933379|BRD-K27130738,cefamandole,bacterial cell wall synthesis inhibitor,,BRD-A23933379|BRD-K27130738,cefamandole,bacterial cell wall synthesis inhibitor,,BRD-A23933379|BRD-K27130738,cefamandole,bacterial cell wall synthesis inhibitor,
OMCYEZUIYGPHDJ,BRD-K78496197,SCS,,,BRD-K78496197,SCS,,,BRD-K78496197,SCS,,,BRD-K78496197,SCS,,
OMDMTHRBGUBUCO,BRD-K58262380,sobrepin,mucolytic agent,,BRD-K58262380,sobrepin,mucolytic agent,,BRD-K58262380,sobrepin,mucolytic agent,,BRD-K58262380,sobrepin,mucolytic agent,
OMFNSKIUKYOYRG,BRD-K14658796,drotaverine,phosphodiesterase inhibitor,CACNA1C|PDE4A,BRD-K14658796,drotaverine,phosphodiesterase inhibitor,CACNA1C|PDE4A,BRD-K14658796,drotaverine,phosphodiesterase inhibitor,CACNA1C|PDE4A,,,,
OMFXVFTZEKFJBZ,BRD-K73589401,corticosterone,mineralocorticoid receptor agonist,HSD11B1|NCOA1|NR3C2,BRD-K73589401,corticosterone,mineralocorticoid receptor agonist,HSD11B1|NCOA1|NR3C2,BRD-K73589401,corticosterone,mineralocorticoid receptor agonist,HSD11B1|NCOA1|NR3C2,BRD-K73589401,corticosterone,mineralocorticoid receptor agonist,HSD11B1|NCOA1|NR3C2
OMGLGPKQUFSRNN,BRD-K05464208,JX-401,p38 MAPK inhibitor,MAPK14,BRD-K05464208,JX-401,p38 MAPK inhibitor,MAPK14,BRD-K05464208,JX-401,p38 MAPK inhibitor,MAPK14,BRD-K05464208,JX-401,p38 MAPK inhibitor,MAPK14
OMHBPUNFVFNHJK,BRD-K11292736,ambenonium,cholinesterase inhibitor,ACHE,BRD-K11292736,ambenonium,cholinesterase inhibitor,ACHE,BRD-K11292736,ambenonium,cholinesterase inhibitor,ACHE,BRD-K11292736,ambenonium,cholinesterase inhibitor,ACHE
OMHZFEWYVFWVLI,BRD-K32456483,PRT4165,polycomb repressive complex inhibitor,PRC1,BRD-K32456483,PRT4165,polycomb repressive complex inhibitor,PRC1,BRD-K32456483,PRT4165,polycomb repressive complex inhibitor,PRC1,BRD-K32456483,PRT4165,polycomb repressive complex inhibitor,PRC1
OMKHWTRUYNAGFG,BRD-K55942458|BRD-K77791657,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2,BRD-K55942458|BRD-K77791657,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2,BRD-K55942458|BRD-K77791657,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2,BRD-K55942458|BRD-K77791657,3-deazaneplanocin-A,histone lysine methyltransferase inhibitor,EZH2
OMMKCJLAGTXGLC,BRD-A07947329,buparvaquone,antiprotozoal agent,,BRD-A07947329,buparvaquone,antiprotozoal agent,,BRD-A07947329,buparvaquone,antiprotozoal agent,,BRD-A07947329,buparvaquone,antiprotozoal agent,
OMOMUFTZPTXCHP,BRD-K54698528,valpromide,epoxide hydolase inhibitor,,BRD-K54698528,valpromide,epoxide hydolase inhibitor,,BRD-K54698528,valpromide,epoxide hydolase inhibitor,,BRD-K54698528,valpromide,epoxide hydolase inhibitor,
OMPCVMLFFSQFIX,BRD-K76594255,maropitant,neurokinin receptor antagonist,TACR1,BRD-K76594255,maropitant,neurokinin receptor antagonist,TACR1,BRD-K76594255,maropitant,neurokinin receptor antagonist,TACR1,BRD-K76594255,maropitant,neurokinin receptor antagonist,TACR1
OMPJBNCRMGITSC,BRD-K59986511,benzoyl-peroxide,oxidizing agent,,BRD-K59986511,benzoyl-peroxide,oxidizing agent,,BRD-K59986511,benzoyl-peroxide,oxidizing agent,,BRD-K59986511,benzoyl-peroxide,oxidizing agent,
OMWQUXGVXQELIX,BRD-K77548206,bitoscanate,anthelmintic agent,,BRD-K77548206,bitoscanate,anthelmintic agent,,BRD-K77548206,bitoscanate,anthelmintic agent,,BRD-K77548206,bitoscanate,anthelmintic agent,
OMZCMEYTWSXEPZ,BRD-K50168500,canertinib,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,BRD-K50168500,canertinib,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,BRD-K50168500,canertinib,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,BRD-K50168500,canertinib,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4
OMZYUVOATZSGJY,BRD-K97118047,"4,5,6,7-tetrabromobenzotriazole",,,BRD-K97118047,"4,5,6,7-tetrabromobenzotriazole",casein kinase inhibitor,AKT1|CHEK1|CSNK2A1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-K97118047,"4,5,6,7-tetrabromobenzotriazole",casein kinase inhibitor,AKT1|CHEK1|CSNK2A1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-K97118047,"4,5,6,7-tetrabromobenzotriazole",casein kinase inhibitor,AKT1|CHEK1|CSNK2A1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1
ONBSHRSJOPSEGS,BRD-K20850787,PT-2385,hypoxia inducible factor inhibitor,EPAS1,BRD-K20850787,PT-2385,hypoxia inducible factor inhibitor,EPAS1,BRD-K20850787,PT-2385,hypoxia inducible factor inhibitor,EPAS1,BRD-K20850787,PT-2385,hypoxia inducible factor inhibitor,EPAS1
ONDYALNGTUAJDX,BRD-K14653796,tasquinimod,S100A9 inhibitor|angiogenesis inhibitor,HDAC4,BRD-K14653796,tasquinimod,S100A9 inhibitor|angiogenesis inhibitor,HDAC4,BRD-K14653796,tasquinimod,S100A9 inhibitor|angiogenesis inhibitor,HDAC4,BRD-K14653796,tasquinimod,S100A9 inhibitor|angiogenesis inhibitor,HDAC4
ONEWULDKRWPYMP,BRD-K51041191,PF-03882845,,,BRD-K51041191,PF-03882845,,,BRD-K51041191,PF-03882845,,,,,,
ONIBWKKTOPOVIA,BRD-K01666412,L-proline,glutamate receptor agonist,EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7,BRD-K01666412,L-proline,glutamate receptor agonist,EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7,BRD-K01666412,L-proline,glutamate receptor agonist,EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7,BRD-K01666412,L-proline,glutamate receptor agonist,EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7
ONIQOQHATWINJY,BRD-K51544265,cabozantinib,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET,BRD-K51544265,cabozantinib,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET,BRD-K51544265,cabozantinib,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET,BRD-K51544265,cabozantinib,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET
ONJQDTZCDSESIW,BRD-K35798650,polidocanol,local anesthetic,,BRD-K35798650,polidocanol,local anesthetic,,BRD-K35798650,polidocanol,local anesthetic,,BRD-K35798650,polidocanol,local anesthetic,
ONKUMRGIYFNPJW,BRD-K06056310|BRD-K46331928,ethynodiol-diacetate,,ESR1|PGR,BRD-K06056310|BRD-K46331928,ethynodiol-diacetate,,ESR1|PGR,BRD-K06056310|BRD-K46331928,ethynodiol-diacetate,,ESR1|PGR,BRD-K06056310|BRD-K46331928,ethynodiol-diacetate,,ESR1|PGR
ONNOFKFOZAJDHT,BRD-K24219278,amineptine,dopamine receptor agonist,SLC6A2|SLC6A4,BRD-K24219278,amineptine,dopamine receptor agonist,SLC6A2|SLC6A4,BRD-K24219278,amineptine,dopamine receptor agonist,SLC6A2|SLC6A4,BRD-K24219278,amineptine,dopamine receptor agonist,SLC6A2|SLC6A4
ONSOQRPYFKDOEB,BRD-A04661934,2-PMDQ,adrenergic receptor antagonist,ADRA1A,BRD-A04661934,2-PMDQ,adrenergic receptor antagonist,ADRA1A,BRD-A04661934,2-PMDQ,adrenergic receptor antagonist,ADRA1A,BRD-A04661934,2-PMDQ,adrenergic receptor antagonist,ADRA1A
ONWXNHPOAGOMTG,BRD-K78815826,suxibuzone,cyclooxygenase inhibitor,,BRD-K78815826,suxibuzone,cyclooxygenase inhibitor,,BRD-K78815826,suxibuzone,cyclooxygenase inhibitor,,BRD-K78815826,suxibuzone,cyclooxygenase inhibitor,
ONYFNWIHJBLQKE,BRD-K60036103,L-NIL,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K60036103,L-NIL,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K60036103,L-NIL,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K60036103,L-NIL,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3
OOGJQPCLVADCPB,BRD-K54316499,tolterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K54316499,tolterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K54316499,tolterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K54316499,tolterodine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
OOLLAFOLCSJHRE,BRD-K76197012,ulipristal,progesterone receptor antagonist,PGR,BRD-K76197012,ulipristal,progesterone receptor antagonist,PGR,BRD-K55641198|BRD-K64381438|BRD-K76197012,ulipristal,progesterone receptor antagonist,PGR,BRD-K55641198|BRD-K64381438|BRD-K76197012,ulipristal,progesterone receptor antagonist,PGR
OONFNUWBHFSNBT,BRD-K40718343,AEE788,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,BRD-K40718343,AEE788,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,BRD-K40718343,AEE788,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,BRD-K40718343,AEE788,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR
OOUGLTULBSNHNF,BRD-K94830329,ataluren,CFTR channel agonist|dystrophin stimulant,DMD,BRD-K94830329,ataluren,CFTR channel agonist|dystrophin stimulant,DMD,BRD-K94830329,ataluren,CFTR channel agonist|dystrophin stimulant,DMD,BRD-K94830329,ataluren,CFTR channel agonist|dystrophin stimulant,DMD
OPAHEYNNJWPQPX,BRD-K03503561,ravuconazole,sterol demethylase inhibitor,,BRD-K03503561,ravuconazole,sterol demethylase inhibitor,,BRD-K03503561,ravuconazole,sterol demethylase inhibitor,,BRD-K03503561,ravuconazole,sterol demethylase inhibitor,
OPFTUNCRGUEPRZ,BRD-K21045639|BRD-K79565391,beta-elemene|elemene,VEGFR inhibitor|apoptosis stimulant,|MMP2|MMP9,BRD-K21045639|BRD-K79565391,beta-elemene|elemene,VEGFR inhibitor|apoptosis stimulant,|MMP2|MMP9,BRD-K21045639|BRD-K79565391,beta-elemene|elemene,VEGFR inhibitor|apoptosis stimulant,|MMP2|MMP9,BRD-K21045639|BRD-K79565391,beta-elemene|elemene,VEGFR inhibitor|apoptosis stimulant,|MMP2|MMP9
OPIKUXLJQFYMSC,BRD-K39624409,ADL5859,opioid receptor agonist,OPRD1,BRD-K39624409,ADL5859,opioid receptor agonist,OPRD1,BRD-K39624409,ADL5859,opioid receptor agonist,OPRD1,BRD-K39624409,ADL5859,opioid receptor agonist,OPRD1
OPNUROKCUBTKLF,BRD-K33459542,ditolylguanidine,sigma receptor agonist,GRIN1|GRIN2A|GRIN2B|SIGMAR1,BRD-K33459542,ditolylguanidine,sigma receptor agonist,GRIN1|GRIN2A|GRIN2B|SIGMAR1,BRD-K33459542,ditolylguanidine,sigma receptor agonist,GRIN1|GRIN2A|GRIN2B|SIGMAR1,BRD-K33459542,ditolylguanidine,sigma receptor agonist,GRIN1|GRIN2A|GRIN2B|SIGMAR1
OPQNCARIZFLNLF,BRD-K15898725|BRD-K53252847,ansamitocin-p-3|maytansinol-isobutyrate,|apoptosis stimulant,,BRD-K15898725|BRD-K53252847,ansamitocin-p-3|maytansinol-isobutyrate,|apoptosis stimulant,,BRD-K15898725|BRD-K53252847,ansamitocin-p-3|maytansinol-isobutyrate,|apoptosis stimulant,,BRD-K00003196|BRD-K15898725,ansamitocin-p-3|maytansinol-isobutyrate,|apoptosis stimulant,
OPQRBXUBWHDHPQ,BRD-K64755930,etazolate,phosphodiesterase inhibitor,GABRB3|PDE4A,BRD-K64755930,etazolate,phosphodiesterase inhibitor,GABRB3|PDE4A,BRD-K64755930,etazolate,phosphodiesterase inhibitor,GABRB3|PDE4A,BRD-K64755930,etazolate,phosphodiesterase inhibitor,GABRB3|PDE4A
OPQRFPHLZZPCCH,BRD-K94485812,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,,BRD-K20203690|BRD-K94485812,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,,BRD-K20203690|BRD-K94485812,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,,BRD-K20203690|BRD-K94485812,LDN-57444,ubiquitin C-terminal hydrolase inhibitor,
OPVPGKGADVGKTG,BRD-K68405354,spaglumic-acid,glutamate receptor antagonist,GRM3,BRD-K68405354,spaglumic-acid,glutamate receptor antagonist,GRM3,BRD-K68405354|BRD-K96659869,spaglumic-acid,glutamate receptor antagonist,GRM3,BRD-K68405354|BRD-K96659869,spaglumic-acid,glutamate receptor antagonist,GRM3
OPXLLQIJSORQAM,BRD-K77987382,mebendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,BRD-K77987382,mebendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,BRD-K77987382,mebendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,BRD-K77987382,mebendazole,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B
OPZKBPQVWDSATI,BRD-K31560319,olvanil,TRPV agonist,CNR1|GPR119|TRPV1,BRD-K31560319,olvanil,TRPV agonist,CNR1|GPR119|TRPV1,BRD-K31560319,olvanil,TRPV agonist,CNR1|GPR119|TRPV1,BRD-K31560319,olvanil,TRPV agonist,CNR1|GPR119|TRPV1
OQAHHWOPVDDWHD,BRD-K44869961,GPI-1046,FKBP inhibitor,FKBP1A,BRD-K44869961,GPI-1046,FKBP inhibitor,FKBP1A,BRD-K44869961,GPI-1046,FKBP inhibitor,FKBP1A,BRD-K44869961,GPI-1046,FKBP inhibitor,FKBP1A
OQDPVLVUJFGPGQ,BRD-K47936004,piribedil,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,BRD-K47936004,piribedil,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,BRD-K47936004,piribedil,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,BRD-K47936004,piribedil,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B
OQFCXJDXHCDLHX,BRD-A83650191,A61603,adrenergic receptor agonist,ADRA1A,BRD-A83650191,A61603,adrenergic receptor agonist,ADRA1A,BRD-A83650191,A61603,adrenergic receptor agonist,ADRA1A,BRD-A83650191|BRD-K00004225,A-61603|A61603,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D
OQGWJZOWLHWFME,BRD-K71977764,piroximone,phosphodiesterase inhibitor,PDE3A,BRD-K71977764,piroximone,phosphodiesterase inhibitor,PDE3A,BRD-K71977764,piroximone,phosphodiesterase inhibitor,PDE3A,BRD-K71977764,piroximone,phosphodiesterase inhibitor,PDE3A
OQJFBUOFGHPMSR,BRD-K92581468,ocinaplon,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K92581468,ocinaplon,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K92581468,ocinaplon,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K92581468,ocinaplon,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5
OQQMRKYWJNJBBI,BRD-M28128163,doxycycline-hyclate,bacterial 30S ribosomal subunit inhibitor,,BRD-M28128163,doxycycline-hyclate,bacterial 30S ribosomal subunit inhibitor,,BRD-M28128163,doxycycline-hyclate,bacterial 30S ribosomal subunit inhibitor,,,,,
OQVLOWLEEHYBJH,BRD-K81004638,EC-23,retinoid receptor agonist,RARA|RARB|RARG,BRD-K81004638,EC-23,retinoid receptor agonist,RARA|RARB|RARG,BRD-K81004638,EC-23,retinoid receptor agonist,RARA|RARB|RARG,BRD-K81004638,EC-23,retinoid receptor agonist,RARA|RARB|RARG
OQZOXHCRSXYSPM,BRD-K14807180,SB-221284,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K14807180,SB-221284,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K14807180,SB-221284,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K14807180,SB-221284,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
ORFOPKXBNMVMKC,BRD-A73933229|BRD-K52117081|BRD-K57502136,ceftazidime,bacterial cell wall synthesis inhibitor,,BRD-A73933229|BRD-K52117081|BRD-K57502136,ceftazidime,bacterial cell wall synthesis inhibitor,,BRD-A73933229|BRD-K52117081|BRD-K57502136,ceftazidime,bacterial cell wall synthesis inhibitor,,BRD-A73933229|BRD-K52117081,ceftazidime,bacterial cell wall synthesis inhibitor,
ORNBQBCIOKFOEO,BRD-A35054627|BRD-K52183142,pregnenolone,glutamate receptor modulator,CYP17A1|SULT2B1,BRD-A35054627|BRD-K43880410,pregnenolone,glutamate receptor modulator,CYP17A1|SULT2B1,BRD-A35054627|BRD-K43880410|BRD-K52183142,pregnenolone,glutamate receptor modulator,CYP17A1|SULT2B1,BRD-A35054627|BRD-K43880410|BRD-K52183142,pregnenolone,glutamate receptor modulator,SULT2B1
OROAFUQRIXKEMV,BRD-K67977190,eprosartan,angiotensin receptor antagonist,AGTR1,BRD-K67977190,eprosartan,angiotensin receptor antagonist,AGTR1,BRD-K67977190,eprosartan,angiotensin receptor antagonist,AGTR1,BRD-K67977190,eprosartan,angiotensin receptor antagonist,AGTR1
ORQFDHFZSMXRLM,BRD-K76788410,terameprocol,lipoxygenase inhibitor,BIRC5|CDK1,BRD-K76788410,terameprocol,lipoxygenase inhibitor,BIRC5|CDK1,BRD-K76788410,terameprocol,lipoxygenase inhibitor,BIRC5|CDK1,BRD-K76788410,terameprocol,lipoxygenase inhibitor,BIRC5|CDK1
ORRZGUBHBVWWOP,BRD-K14993104,bemegride,chemoreceptor agonist,GABRA1,BRD-K14993104,bemegride,chemoreceptor agonist,GABRA1,BRD-K14993104,bemegride,chemoreceptor agonist,GABRA1,BRD-K14993104,bemegride,chemoreceptor agonist,GABRA1
ORYDPOVDJJZGHQ,BRD-K92968657,tirapazamine,DNA inhibitor,,BRD-K92968657,tirapazamine,DNA inhibitor,,BRD-K75058612|BRD-K92968657,tirapazamine,DNA inhibitor,,BRD-K75058612|BRD-K92968657,tirapazamine,DNA inhibitor,
OSASVXMJTNOKOY,BRD-K39495750,chlorobutanol,,,BRD-K39495750,chlorobutanol,,,BRD-K39495750,chlorobutanol,,,BRD-K39495750,chlorobutanol,,
OSCCDBFHNMXNME,BRD-K90305467,ID-1101,insulin sensitizer,INS,BRD-K90305467,ID-1101,insulin sensitizer,INS,BRD-K90305467,ID-1101,insulin sensitizer,INS,BRD-K90305467,ID-1101,insulin sensitizer,INS
OSCTXCOERRNGLW,BRD-K76021681,brolitene,muscle relaxant,RYR1,BRD-K76021681,brolitene,muscle relaxant,RYR1,BRD-K76021681,brolitene,muscle relaxant,RYR1,BRD-K76021681,brolitene,muscle relaxant,RYR1
OSDLLIBGSJNGJE,BRD-K17223896,chloroxylenol,ATP synthase inhibitor,,BRD-K17223896,chloroxylenol,ATP synthase inhibitor,,BRD-K17223896,chloroxylenol,ATP synthase inhibitor,,BRD-K17223896,chloroxylenol,ATP synthase inhibitor,
OSERMIPXNLXAPD,BRD-K96104201,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,,BRD-K96104201,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,,BRD-K96104201,azalomycin-b,bacterial 50S ribosomal subunit inhibitor,,BRD-K38292725,azalomycin-B,bacterial 50S ribosomal subunit inhibitor,
OSFCMRGOZNQUSW,BRD-K88807631,elacridar,P glycoprotein inhibitor,ABCB1,BRD-K88807631,elacridar,P glycoprotein inhibitor,ABCB1,BRD-K88807631,elacridar,P glycoprotein inhibitor,ABCB1,BRD-K88807631,elacridar,P glycoprotein inhibitor,ABCB1
OSUVWJGCKQEMHK,BRD-K55344148,BU-224,imidazoline receptor ligand,MAOA|MAOB,BRD-K55344148,BU-224,imidazoline receptor ligand,MAOA|MAOB,BRD-K55344148,BU-224,imidazoline receptor ligand,MAOA|MAOB,BRD-K55344148,BU-224,imidazoline receptor ligand,MAOA|MAOB
OSWPMRLSEDHDFF,BRD-K10103010,methyl-salicylate,,,BRD-K10103010,methyl-salicylate,,,BRD-K10103010,methyl-salicylate,,,BRD-K10103010,methyl-salicylate,,
OSXFATOLZGZLSK,BRD-K26818574,BIX-01294,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K26818574,BIX-01294,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K26818574,BIX-01294,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K26818574,BIX-01294,histone lysine methyltransferase inhibitor,EHMT1|EHMT2
OTBXOEAOVRKTNQ,BRD-K62200014,anagrelide,phosphodiesterase inhibitor,PDE3A,BRD-K62200014,anagrelide,phosphodiesterase inhibitor,PDE3A,BRD-K62200014,anagrelide,phosphodiesterase inhibitor,PDE3A,BRD-K62200014,anagrelide,phosphodiesterase inhibitor,PDE3A
OTDJAMXESTUWLO,BRD-K75649340,tioguanine,purine antagonist,,BRD-K75649340,tioguanine,purine antagonist,,BRD-K75649340,tioguanine,purine antagonist,,BRD-K75649340,tioguanine,purine antagonist,
OTGAHJPFNKQGAE,BRD-K33442414,meta-cresyl-acetate,,,BRD-K33442414,meta-cresyl-acetate,,,BRD-K33442414,meta-cresyl-acetate,,,BRD-K33442414,meta-cresyl-acetate,,
OTGJPAOGHQFBMI,BRD-A22844106,tenoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A22844106,tenoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A22844106,tenoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,,,,
OTGQTQBPQCRNRG,BRD-K90472149,BCX-1470,complement inhibitor|serine protease inhibitor,CFD,BRD-K90472149,BCX-1470,complement inhibitor|serine protease inhibitor,CFD,BRD-K90472149,BCX-1470,complement inhibitor|serine protease inhibitor,CFD,BRD-K90472149,BCX-1470,complement inhibitor|serine protease inhibitor,CFD
OTKJDMGTUTTYMP,BRD-K93944989,safingol,PKC inhibitor,TRPM3,BRD-K93944989,safingol,PKC inhibitor,TRPM3,BRD-K93944989,safingol,PKC inhibitor,TRPM3,BRD-K93944989,safingol,PKC inhibitor,TRPM3
OTKUTGIVEREJLL,BRD-K92588747,2-CMDO,dopamine receptor antagonist,DRD2|DRD4,BRD-K92588747,2-CMDO,dopamine receptor antagonist,DRD2|DRD4,BRD-K92588747,2-CMDO,dopamine receptor antagonist,DRD2|DRD4,BRD-K92588747,2-CMDO,dopamine receptor antagonist,DRD2|DRD4
OTPNDVKVEAIXTI,BRD-A06352508,SB-218078,CHK inhibitor,CHEK1,BRD-A06352508,SB-218078,CHK inhibitor,CHEK1,BRD-A06352508,SB-218078,CHK inhibitor,CHEK1,BRD-A06352508,SB-218078,CHK inhibitor,CHEK1
OTSOOHRUMBRSHZ,BRD-K76703230,YM-155,survivin inhibitor,BIRC5,BRD-K76703230,YM-155,survivin inhibitor,BIRC5,BRD-K76703230|BRD-U99450240,YM-155,survivin inhibitor,BIRC5,BRD-K76703230|BRD-U99450240,YM-155,survivin inhibitor,BIRC5
OTVAEFIXJLOWRX,BRD-K79711234,thiamphenicol,bacterial 50S ribosomal subunit inhibitor,,BRD-K79711234,thiamphenicol,bacterial 50S ribosomal subunit inhibitor,,BRD-K79711234,thiamphenicol,bacterial 50S ribosomal subunit inhibitor,,BRD-K79711234,thiamphenicol,bacterial 50S ribosomal subunit inhibitor,
OTVQCHUIPJYASM,BRD-K28639661,NGD-94-1,dopamine receptor antagonist,DRD4,BRD-K28639661,NGD-94-1,dopamine receptor antagonist,DRD4,BRD-K28639661,NGD-94-1,dopamine receptor antagonist,DRD4,BRD-K28639661,NGD-94-1,dopamine receptor antagonist,DRD4
OTZVBZFYMFTYKH,BRD-K09001147,T-62,adenosine receptor modulator,ADORA2A,BRD-K09001147,T-62,adenosine receptor modulator,ADORA2A,BRD-K09001147,T-62,adenosine receptor modulator,ADORA2A,BRD-K09001147,T-62,adenosine receptor modulator,ADORA2A
OUBCNLGXQFSTLU,BRD-K01109406,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD,BRD-K01109406,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD,BRD-K01109406,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,HPD,,,,
OUDSBRTVNLOZBN,BRD-K32164935,tolazamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,BRD-K32164935,tolazamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,BRD-K32164935,tolazamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,BRD-K32164935,tolazamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11
OUJTZYPIHDYQMC,BRD-K41185545,ambrisentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K41185545,ambrisentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K41185545,ambrisentan,endothelin receptor antagonist,EDNRA|EDNRB,BRD-K41185545,ambrisentan,endothelin receptor antagonist,EDNRA|EDNRB
OUKWLRHRXOPODD,BRD-K87465484,UNC0646,histone lysine methyltransferase inhibitor,EHMT2,BRD-K87465484,UNC0646,histone lysine methyltransferase inhibitor,EHMT2,BRD-K87465484,UNC0646,histone lysine methyltransferase inhibitor,EHMT2,BRD-K87465484,UNC0646,histone lysine methyltransferase inhibitor,EHMT2
OUKYUETWWIPKQR,BRD-K19540840,saracatinib,src inhibitor,ABL1|LCK|SRC|YES1,BRD-K19540840,saracatinib,src inhibitor,ABL1|LCK|SRC|YES1,BRD-K19540840,saracatinib,src inhibitor,ABL1|LCK|SRC|YES1,BRD-K19540840,saracatinib,SRC inhibitor,ABL1|LCK|SRC|YES1
OUPXSLGGCPUZJJ,BRD-K89787693,"[sar9,met(o2)11]-substance-p",,,BRD-K89787693,"[sar9,met(o2)11]-substance-p",tachykinin antagonist,TACR1,BRD-K89787693,"[sar9,met(o2)11]-substance-p",tachykinin antagonist,TACR1,BRD-K89787693,"[sar9,met(o2)11]-substance-p",tachykinin antagonist,TACR1
OUPZKGBUJRBPGC,BRD-A39935389,teroxirone,DNA inhibitor,,BRD-A39935389,teroxirone,DNA inhibitor,,BRD-A39935389,teroxirone,DNA inhibitor,,BRD-A39935389,teroxirone,DNA inhibitor,
OUQVKRKGTAUJQA,BRD-K56807945,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|HIF1A,BRD-K56807945,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|HIF1A,BRD-K56807945,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|HIF1A,BRD-K56807945,FG-2216,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|HIF1A
OUSFTKFNBAZUKL,BRD-K43389698,BMS-387032,CDK inhibitor|MCL1 inhibitor|cell cycle inhibitor,CDK2|CDK7|CDK9,BRD-K43389698,BMS-387032,CDK inhibitor|MCL1 inhibitor|cell cycle inhibitor,CDK2|CDK7|CDK9,BRD-K43389698,BMS-387032,CDK inhibitor|MCL1 inhibitor|cell cycle inhibitor,CDK2|CDK7|CDK9,BRD-K43389698,BMS-387032,CDK inhibitor|MCL1 inhibitor|cell cycle inhibitor,CDK2|CDK7|CDK9
OUYCCCASQSFEME,BRD-A20781140,plovamer-acetate,,TAT|TH|YARS|YARS2,BRD-A20781140,plovamer-acetate,,TAT|TH|YARS|YARS2,BRD-A20781140,plovamer-acetate,,TAT|TH|YARS|YARS2,BRD-A20781140,plovamer-acetate,,TAT|TH|YARS|YARS2
OUZWUKMCLIBBOG,BRD-K18131774,ethoxzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9,BRD-K18131774,ethoxzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9,BRD-K18131774,ethoxzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9,BRD-K18131774,ethoxzolamide,carbonic anhydrase inhibitor,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9
OVBPIULPVIDEAO,BRD-K18673820,folic-acid,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,BRD-K18673820,folic-acid,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,BRD-K18673820,folic-acid,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,BRD-K18673820,folic-acid,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1
OVCDSSHSILBFBN,BRD-K91290917,amodiaquine,histamine receptor agonist,HNMT,BRD-K91290917,amodiaquine,histamine receptor agonist,HNMT,BRD-K73443792|BRD-K91290917,amodiaquine,histamine receptor agonist,HNMT,BRD-K73443792|BRD-K91290917,amodiaquine,histamine receptor agonist,HNMT
OVDSPTSBIQCAIN,BRD-K56032964,AP26113,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,BRD-K56032964,AP26113,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,BRD-K56032964,AP26113,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,BRD-K56032964,AP26113,ALK tyrosine kinase receptor inhibitor,ALK|EGFR
OVGGLBAWFMIPPY,BRD-K56735750,carbadox,other antibiotic,,BRD-K56735750,carbadox,other antibiotic,,BRD-K06386100|BRD-K56735750,carbadox,other antibiotic,,BRD-K06386100|BRD-K56735750,carbadox,other antibiotic,
OVGORFFCBUIFIA,BRD-A66284731,fenipentol,choleretic agent,,BRD-A66284731,fenipentol,choleretic agent,,BRD-A66284731,fenipentol,choleretic agent,,BRD-A66284731,fenipentol,choleretic agent,
OVIWLBQFYMOVOF,BRD-A72591750,omadacycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A72591750,omadacycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A72591750,omadacycline,bacterial 30S ribosomal subunit inhibitor,,BRD-K00003569,omadacycline,bacterial 30S ribosomal subunit inhibitor,
OVJBNYKNHXJGSA,BRD-K45551181,MPI-0479605,mitotic kinase inhibitor,TTK,BRD-K45551181,MPI-0479605,mitotic kinase inhibitor,TTK,BRD-K45551181,MPI-0479605,mitotic kinase inhibitor,TTK,BRD-K45551181,MPI-0479605,mitotic kinase inhibitor,TTK
OVPNQJVDAFNBDN,BRD-K13390322,AT-7519,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,BRD-K13390322,AT-7519,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,BRD-K13390322,AT-7519,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,BRD-K13390322,AT-7519,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9
OVRNDRQMDRJTHS,BRD-A92872453,N-acetylmannosamine,,CHIT1,BRD-A92872453,N-acetylmannosamine,,CHIT1,BRD-A92872453,N-acetylmannosamine,,CHIT1,BRD-A92872453,N-acetylmannosamine,,
OVSQVDMCBVZWGM,BRD-A63780829,hyperin,aldose reductase inhibitor,ACE|AKR1B1,BRD-A63780829,hyperin,aldose reductase inhibitor,ACE|AKR1B1,BRD-A63780829,hyperin,aldose reductase inhibitor,ACE|AKR1B1,BRD-A63780829|BRD-K73991644,hyperin|isoquercitrin,aldose reductase inhibitor|antioxidant,|ACE|AKR1B1
OVTCHWSLKGENKP,BRD-K46133855,NXY-059,free radical scavenger,,BRD-K46133855,NXY-059,free radical scavenger,,BRD-K46133855,NXY-059,free radical scavenger,,BRD-K46133855,NXY-059,free radical scavenger,
OVZWUDZIAAHNFG,BRD-K93806173,N-MPPP,opioid receptor agonist,,BRD-K93806173,N-MPPP,opioid receptor agonist,,BRD-K93806173,N-MPPP,opioid receptor agonist,,BRD-K93806173,N-MPPP,opioid receptor agonist,
OWBFCJROIKNMGD,BRD-K55187425,rigosertib,PLK inhibitor|cell cycle inhibitor,PLK1,BRD-K55187425,rigosertib,PLK inhibitor|cell cycle inhibitor,PLK1,BRD-K55187425,rigosertib,PLK inhibitor|cell cycle inhibitor,PLK1,BRD-K55187425,rigosertib,PLK inhibitor|cell cycle inhibitor,PLK1
OWEGWHBOCFMBLP,BRD-A61676498,climbazole,enzyme inducer,,BRD-A61676498,climbazole,enzyme inducer,,BRD-A61676498,climbazole,enzyme inducer,,BRD-A61676498,climbazole,enzyme inducer,
OWKXRDQRMTVCEX,BRD-K85764479,somantadine,antiviral,,BRD-K85764479,somantadine,antiviral,,BRD-K85764479,somantadine,antiviral,,BRD-K85764479,somantadine,antiviral,
OWPMENVYXDJDOW,BRD-K65503129,CCT018159,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K65503129,CCT018159,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K65503129,CCT018159,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K65503129,CCT018159,HSP inhibitor,HSP90AA1|HSP90AB1
OWQBPOUTHXCWAF,BRD-M57185017,U-50488-(+/-),opioid receptor agonist,OPRK1,,,,,,,,,,,,
OWQUZNMMYNAXSL,BRD-K22936972,diphenylpyraline,dopamine uptake inhibitor,HRH1|SLC6A3,BRD-K22936972,diphenylpyraline,dopamine uptake inhibitor,HRH1|SLC6A3,BRD-K22936972,diphenylpyraline,dopamine uptake inhibitor,HRH1|SLC6A3,BRD-K22936972,diphenylpyraline,dopamine reuptake inhibitor,HRH1|SLC6A3
OWRCNXZUPFZXOS,BRD-K12362304,diphenylguanidine,,,BRD-K12362304,diphenylguanidine,,,BRD-K12362304,diphenylguanidine,,,BRD-K12362304,diphenylguanidine,,
OWWLUIWOFHMHOQ,BRD-A21544762,pipecuronium,neuromuscular blocker,CHRM2|CHRM3|CHRNA2,BRD-A21544762,pipecuronium,neuromuscular blocker,CHRM2|CHRM3|CHRNA2,BRD-A21544762,pipecuronium,neuromuscular blocker,CHRM2|CHRM3|CHRNA2,BRD-A21544762,pipecuronium,neuromuscular blocker,CHRM2|CHRM3|CHRNA2
OWWVHQUOYSPNNE,BRD-K54799382,parethoxycaine,local anesthetic,,BRD-K54799382,parethoxycaine,local anesthetic,,BRD-K54799382,parethoxycaine,local anesthetic,,BRD-K54799382,parethoxycaine,local anesthetic,
OWYLAEYXIQKAOL,BRD-K19462402,buflomedil,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,BRD-K19462402,buflomedil,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,BRD-K19462402,buflomedil,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,BRD-K19462402,buflomedil,adrenergic receptor antagonist|calcium channel blocker,ADRA1A
OXHMDMVBLQNMGP,BRD-K75016267,SNG-1153,selective estrogen receptor modulator (SERM),ESR1,BRD-K75016267,SNG-1153,selective estrogen receptor modulator (SERM),ESR1,BRD-K75016267,SNG-1153,selective estrogen receptor modulator (SERM),ESR1,BRD-K75016267,SNG-1153,selective estrogen receptor modulator (SERM),ESR1
OXLZNBCNGJWPRV,BRD-A33894669,hexoprenaline,adrenergic receptor agonist,ADRB2,BRD-A33894669,hexoprenaline,adrenergic receptor agonist,ADRB2,BRD-A33894669,hexoprenaline,adrenergic receptor agonist,ADRB2,BRD-A33894669,hexoprenaline,adrenergic receptor agonist,ADRB2
OXZMQFKVNVQMLI,BRD-K06208435,YS-035,calcium channel blocker,,BRD-K06208435,YS-035,calcium channel blocker,,BRD-K06208435,YS-035,calcium channel blocker,,BRD-K06208435,YS-035,calcium channel blocker,
OYHQOLUKZRVURQ,BRD-K08973992,linoleic-acid,oxidative stress inducer,FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8,BRD-K08973992,linoleic-acid,oxidative stress inducer,FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8,BRD-K08973992,linoleic-acid,oxidative stress inducer,FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8,BRD-K08973992,linoleic-acid,oxidative stress inducer,FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8
OYINILBBZAQBEV,BRD-K23728266,chlorophyllin,,,BRD-K23728266,chlorophyllin,,,BRD-K23728266,chlorophyllin,,,,,,
OYJABWUHUYVDMJ,BRD-M40700687,paromomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-M40700687,paromomycin,bacterial 30S ribosomal subunit inhibitor,,,,,,,,,
OYMNPJXKQVTQTR,BRD-K15601958,SEW-2871,lysophospholipid receptor agonist,S1PR1,BRD-K15601958,SEW-2871,lysophospholipid receptor agonist,S1PR1,BRD-K15601958,SEW-2871,lysophospholipid receptor agonist,S1PR1,BRD-K15601958,SEW-2871,lysophospholipid receptor agonist,S1PR1
OYONTEXKYJZFHA,BRD-K55218890|BRD-K95435023,PHA-665752,c-Met inhibitor,MET,BRD-K55218890|BRD-K95435023,PHA-665752,c-Met inhibitor,MET,BRD-K55218890|BRD-K95435023,PHA-665752,c-Met inhibitor,MET,BRD-K55218890|BRD-K95435023,PHA-665752,c-Met inhibitor,MET
OYPPVKRFBIWMSX,BRD-K46914825,zimelidine,selective serotonin reuptake inhibitor (SSRI),MAOA|MAOB|SLC6A4,BRD-K46914825,zimelidine,selective serotonin reuptake inhibitor (SSRI),MAOA|MAOB|SLC6A4,BRD-K46914825,zimelidine,selective serotonin reuptake inhibitor (SSRI),MAOA|MAOB|SLC6A4,BRD-K46914825,zimelidine,selective serotonin reuptake inhibitor (SSRI),MAOA|MAOB|SLC6A4
OYSKUZDIHNKWLV,BRD-A76672327,clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,,BRD-A76672327,clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,,BRD-A76672327,clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,,BRD-K10759270,clindamycin-palmitate,bacterial 50S ribosomal subunit inhibitor,
OYTKINVCDFNREN,BRD-K80262108,amifampridine,potassium channel blocker,,BRD-K80262108,amifampridine,potassium channel blocker,,BRD-K80262108,amifampridine,potassium channel blocker,,BRD-K80262108,amifampridine,potassium channel blocker,
OYVAGSVQBOHSSS,BRD-A12918100|BRD-A42083487,bleomycin,DNA synthesis inhibitor,LIG1|LIG3,BRD-A12918100|BRD-A42083487,bleomycin,DNA synthesis inhibitor,LIG1|LIG3,BRD-A12918100|BRD-A42083487,bleomycin,DNA synthesis inhibitor,LIG1|LIG3,BRD-K00003588,bleomycin,DNA synthesis inhibitor,
OYYDSUSKLWTMMQ,BRD-K69469734,trospium,acetylcholine receptor antagonist,CHRM1,BRD-K69469734,trospium,acetylcholine receptor antagonist,CHRM1,BRD-K69469734,trospium,acetylcholine receptor antagonist,CHRM1,BRD-K00003641,trospium,acetylcholine receptor antagonist,CHRM1
OYYVWNDMOQPMGE,BRD-K14988953,AS-252424,PI3K inhibitor,PIK3CG,BRD-K14988953,AS-252424,PI3K inhibitor,PIK3CG,BRD-K14988953,AS-252424,PI3K inhibitor,PIK3CG,BRD-K14988953,AS-252424,PI3K inhibitor,PIK3CG
OZBFBAYESADVDX,BRD-A28329383,MTPG,glutamate receptor antagonist,GRM2|GRM3,BRD-A28329383,MTPG,glutamate receptor antagonist,GRM2|GRM3,BRD-A28329383,MTPG,glutamate receptor antagonist,GRM2|GRM3,BRD-A28329383,MTPG,glutamate receptor antagonist,GRM2|GRM3
OZCACMPSTYQSMM,BRD-A11070335,carbazochrome,,,BRD-A11070335,carbazochrome,,,BRD-A11070335,carbazochrome,,,BRD-A11070335,carbazochrome,,
OZGNYLLQHRPOBR,BRD-K74141488,naftifine,fungal squalene epoxidase inhibitor,SQLE,BRD-K74141488,naftifine,fungal squalene epoxidase inhibitor,SQLE,BRD-K74141488,naftifine,fungal squalene epoxidase inhibitor,SQLE,BRD-K74141488,naftifine,fungal squalene epoxidase inhibitor,
OZLPUNFFCJDMJD,BRD-K43106192,gallamine-triethiodide,acetylcholine receptor antagonist,ACHE|CHRM2|CHRNA1|CHRNA2,BRD-K43106192,gallamine-triethiodide,acetylcholine receptor antagonist,ACHE|CHRM2|CHRNA1|CHRNA2,BRD-K43106192,gallamine-triethiodide,acetylcholine receptor antagonist,ACHE|CHRM2|CHRNA1|CHRNA2,BRD-K43106192,gallamine-triethiodide,acetylcholine receptor antagonist,CHRM2|CHRNA1
OZOMQRBLCMDCEG,BRD-K81272440,dantrolene,calcium channel blocker,RYR1|RYR3,BRD-K81272440,dantrolene,calcium channel blocker,RYR1|RYR3,BRD-K81272440,dantrolene,calcium channel blocker,RYR1|RYR3,BRD-K81272440,dantrolene,calcium channel blocker,RYR1|RYR3
OZPFIJIOIVJZMN,BRD-K00674894,orteronel,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,BRD-K00674894,orteronel,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,BRD-A12409803|BRD-K00674894,orteronel,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,BRD-A12409803|BRD-K00674894,orteronel,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1
OZSMSRIUUDGTEP,BRD-K68402494,ML-9,myosin light chain kinase inhibitor,TRPC6,BRD-K68402494,ML-9,myosin light chain kinase inhibitor,TRPC6,BRD-K68402494,ML-9,myosin light chain kinase inhibitor,TRPC6,BRD-K68402494,ML9,myosin light chain kinase inhibitor,TRPC6
OZVBMTJYIDMWIL,BRD-A80151636|BRD-K14496212,bromocriptine,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-A80151636|BRD-K14496212,bromocriptine,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-A80151636|BRD-K14496212,bromocriptine,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,BRD-A80151636|BRD-K14496212,bromocriptine,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7
OZWKMVRBQXNZKK,BRD-A40639672,ketorolac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A40639672,ketorolac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A40639672,ketorolac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K01825750,ketorolac,cyclooxygenase inhibitor,PTGS1|PTGS2
OZYUPQUCAUTOBP,BRD-K30634073,levallorphan,opioid antagonist,CHRNA2|OPRM1,BRD-K30634073,levallorphan,opioid antagonist,CHRNA2|OPRM1,BRD-K30634073,levallorphan,opioid antagonist,CHRNA2|OPRM1,BRD-K30634073,levallorphan,opioid receptor antagonist,CHRNA2|OPRM1
OZZAYJQNMKMUSD,BRD-A35912562,pregnenolone-succinate,GABA receptor negative allosteric modulator,,BRD-A35912562,pregnenolone-succinate,GABA receptor negative allosteric modulator,,BRD-A35912562,pregnenolone-succinate,GABA receptor negative allosteric modulator,,BRD-A35912562,pregnenolone-succinate,GABA receptor negative allosteric modulator,CYP17A1
PAFKTGFSEFKSQG,BRD-A07986123,galeterone,androgen receptor modulator,AR|CYP17A1,BRD-A07986123,galeterone,androgen receptor modulator,AR|CYP17A1,BRD-A07986123,galeterone,androgen receptor modulator,AR|CYP17A1,BRD-K00004319,galeterone,androgen receptor modulator,AR|CYP17A1
PAFLSMZLRSPALU,BRD-A93699261,sodium-danshensu,,,BRD-A93699261,sodium-danshensu,,,BRD-A93699261,sodium-danshensu,,,BRD-A93699261,sodium-danshensu,,
PAGZCEHLFCJSPV,BRD-K58299615,Ro-90-7501,,APP,BRD-K58299615,Ro-90-7501,,APP,BRD-K58299615,Ro-90-7501,,APP,BRD-K58299615,Ro-90-7501,beta amyloid protein neurotoxicity inhibitor,APP
PAHZPHDAJQIETD,BRD-K78097265,adelmidrol,anti-inflammatory agent,,BRD-K78097265,adelmidrol,anti-inflammatory agent,,BRD-K78097265,adelmidrol,anti-inflammatory agent,,BRD-K78097265,adelmidrol,anti-inflammatory agent,
PAJPWUMXBYXFCZ,BRD-K66465025,ACPC,glutamate receptor antagonist,,BRD-K66465025,ACPC,glutamate receptor antagonist,,BRD-K66465025,ACPC,glutamate receptor antagonist,,BRD-K66465025,ACPC,glutamate receptor antagonist,
PAOANWZGLPPROA,BRD-K12614344,CGS-21680,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K12614344,CGS-21680,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K12614344,CGS-21680,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K27176996,CGS-21680,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
PAWIYAYFNXQGAP,BRD-K83837640,JNJ-26481585,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,BRD-K83837640,JNJ-26481585,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,BRD-K83837640,JNJ-26481585,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,BRD-K83837640,JNJ-26481585,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2
PAXRPWSXCPTPCA,BRD-K79633074,xilobam,,,BRD-K79633074,xilobam,,,BRD-K79633074,xilobam,,,BRD-K79633074,xilobam,,
PAZJSJFMUHDSTF,BRD-A00993607,alprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A,BRD-A00993607,alprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A,BRD-A00993607,alprenolol,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A,BRD-K01825817,alprenolol,adrenergic receptor antagonist,ADRB1|ADRB2
PBAPPPCECJKMCM,BRD-K47949423,mirabegron,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K47949423,mirabegron,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K47949423,mirabegron,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K47949423,mirabegron,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3
PBBGSZCBWVPOOL,BRD-A01078468|BRD-K69253806,hexestrol,synthetic estrogen,AKR1C1|ESR1|ESR2,BRD-A01078468|BRD-K69253806,hexestrol,synthetic estrogen,AKR1C1|ESR1|ESR2,BRD-A01078468|BRD-K69253806,hexestrol,synthetic estrogen,AKR1C1|ESR1|ESR2,BRD-K69253806,hexestrol,synthetic estrogen,AKR1C1|ESR1|ESR2
PBBRWFOVCUAONR,BRD-K95785537,PP-2,src inhibitor,ABL1|LCK|LYN|RIPK2|SRC,BRD-K95785537,PP-2,src inhibitor,ABL1|LCK|LYN|RIPK2|SRC,BRD-K95785537,PP-2,src inhibitor,ABL1|LCK|LYN|RIPK2|SRC,BRD-K95785537,PP-2,SRC inhibitor,ABL1|LCK|RIPK2|SRC
PBCZLFBEBARBBI,BRD-K59983611,sulfabenzamide,bacterial antifolate,,BRD-K59983611,sulfabenzamide,bacterial antifolate,,BRD-K59983611,sulfabenzamide,bacterial antifolate,,BRD-K59983611,sulfabenzamide,bacterial antifolate,
PBCZSGKMGDDXIJ,BRD-K45293975,7-hydroxystaurosporine,CDK inhibitor|CHK inhibitor|PKC inhibitor,CHEK1|MARK3|PDPK1,BRD-K45293975,7-hydroxystaurosporine,CDK inhibitor|CHK inhibitor|PKC inhibitor,CHEK1|MARK3|PDPK1,BRD-K45293975,7-hydroxystaurosporine,CDK inhibitor|CHK inhibitor|PKC inhibitor,CHEK1|MARK3|PDPK1,BRD-K45293975,7-hydroxystaurosporine,CDK inhibitor|CHK inhibitor|PKC inhibitor,CDK1|CHEK1|CHEK2|GSK3B|LCK|MAPK14|MARK1|MARK3|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG
PBHFNBQPZCRWQP,BRD-K46580984,phenserine,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,ACHE|BCHE,BRD-K46580984,phenserine,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,ACHE|BCHE,BRD-K46580984,phenserine,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,ACHE|BCHE,BRD-K46580984,phenserine,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,ACHE|BCHE
PBHVCRIXMXQXPD,BRD-K39805756,TPPS4,,,BRD-K39805756,TPPS4,,,BRD-K39805756,TPPS4,,,BRD-K00004542,TPPS4,,
PBJUNZJWGZTSKL,BRD-K60160658,tiagabine,GABA uptake inhibitor,SLC6A1,BRD-K60160658,tiagabine,GABA uptake inhibitor,SLC6A1,BRD-K60160658,tiagabine,GABA uptake inhibitor,SLC6A1,BRD-K60160658,tiagabine,GABA uptake inhibitor,SLC6A1
PBKZPPIHUVSDNM,BRD-A29322418|BRD-K46556543,potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2,BRD-A29322418|BRD-K46556543,potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2,BRD-A29322418|BRD-K46556543,potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2,BRD-A29322418|BRD-K46556543,potassium-canrenoate,mineralocorticoid receptor antagonist,NR3C2
PBMSWVPMRUJMPE,BRD-K64659768,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,,BRD-K64659768,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,,BRD-K64659768,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,,BRD-K64659768,phthalylsulfathiazole,dihydropteroate synthetase inhibitor,
PBVFROWIWWGIFK,BRD-K51199656,fluoromethylcholine,,,BRD-K51199656,fluoromethylcholine,,,BRD-K51199656,fluoromethylcholine,,,BRD-K51199656,fluoromethylcholine,,
PCGISRHGYLRXSR,BRD-K75114721,AMI-1,protein arginine N-methyltransferase inhibitor,PRMT1,BRD-K75114721,AMI-1,protein arginine N-methyltransferase inhibitor,PRMT1,BRD-K75114721,AMI-1,protein arginine N-methyltransferase inhibitor,PRMT1,BRD-K75114721,AMI-1,protein arginine N-methyltransferase inhibitor,PRMT1
PCHKPVIQAHNQLW,BRD-K54955827,niraparib,PARP inhibitor,PARP1,BRD-K54955827,niraparib,PARP inhibitor,PARP1,BRD-K54955827,niraparib,PARP inhibitor,PARP1,BRD-K54955827,niraparib,PARP inhibitor,PARP1
PCLITLDOTJTVDJ,BRD-K50422030,clomethiazole,GABA receptor antagonist|GABA receptor modulator,GABRA1,BRD-K50422030,clomethiazole,GABA receptor antagonist|GABA receptor modulator,GABRA1,BRD-K50422030,clomethiazole,GABA receptor antagonist|GABA receptor modulator,GABRA1,BRD-K50422030,clomethiazole,GABA receptor antagonist|GABA receptor modulator,GABRA1
PCOBBVZJEWWZFR,BRD-K89917372,retigabine,potassium channel activator,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K89917372,retigabine,potassium channel activator,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K89917372,retigabine,potassium channel activator,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,,,,
PCSWXVJAIHCTMO,BRD-K77685957,dequalinium,PKC inhibitor,KCNN1|KCNN3,BRD-K77685957,dequalinium,PKC inhibitor,KCNN1|KCNN3,BRD-K77685957,dequalinium,PKC inhibitor,KCNN1|KCNN3,BRD-K77685957,dequalinium,PKC inhibitor,KCNN1|KCNN3
PCTRYMLLRKWXGF,BRD-K34154330,tracazolate,GABA receptor modulator,GABRA1,BRD-K34154330,tracazolate,GABA receptor modulator,GABRA1,BRD-K34154330,tracazolate,GABA receptor modulator,GABRA1,BRD-K34154330,tracazolate,GABA receptor modulator,GABRA1
PCVSIMQAFWRUEC,BRD-K65820248,SDZ-NKT-343,tachykinin antagonist,TACR1,BRD-K65820248,SDZ-NKT-343,tachykinin antagonist,TACR1,BRD-K65820248,SDZ-NKT-343,tachykinin antagonist,TACR1,BRD-K65820248,SDZ-NKT-343,tachykinin antagonist,TACR1
PCZOHLXUXFIOCF,BRD-K09416995|BRD-K74251557,lovastatin,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,BRD-K09416995,lovastatin,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,BRD-K09416995|BRD-K74251557,lovastatin,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,BRD-K09416995|BRD-K74251557,lovastatin,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2
PDMMFKSKQVNJMI,BRD-A48720949,testosterone-propionate,androgen receptor agonist,AR,BRD-A48720949,testosterone-propionate,androgen receptor agonist,AR,BRD-A48720949,testosterone-propionate,androgen receptor agonist,AR,,,,
PDMUGYOXRHVNMO,BRD-K73319509,PF-04217903,c-Met inhibitor,MET,BRD-K73319509,PF-04217903,c-Met inhibitor,MET,BRD-K73319509,PF-04217903,c-Met inhibitor,MET,BRD-K73319509,PF-04217903,c-Met inhibitor,MET
PDMUULPVBYQBBK,BRD-A07207424,Ro-20-1724,phosphodiesterase inhibitor,PDE3A|PDE4A|PDE4B|PDE4C|PDE4D,BRD-A07207424,Ro-20-1724,phosphodiesterase inhibitor,PDE3A|PDE4A|PDE4B|PDE4C|PDE4D,BRD-A07207424,Ro-20-1724,phosphodiesterase inhibitor,PDE3A|PDE4A|PDE4B|PDE4C|PDE4D,BRD-A07207424,Ro-20-1724,phosphodiesterase inhibitor,PDE3A|PDE4A|PDE4B|PDE4C|PDE4D
PDOCBJADCWMDGL,BRD-K53195974,sipatrigine,voltage-gated sodium channel blocker,CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A,BRD-K53195974,sipatrigine,voltage-gated sodium channel blocker,CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A,BRD-K53195974,sipatrigine,voltage-gated sodium channel blocker,CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A,BRD-K53195974,sipatrigine,voltage-gated sodium channel blocker,CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A
PDOQBOJDRPLBQU,BRD-K65928735,AZD1480,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K65928735,AZD1480,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K65928735,AZD1480,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K65928735,AZD1480,JAK inhibitor,JAK1|JAK2|JAK3
PDTYLGXVBIWRIM,BRD-K19412355,SB-242235,p38 MAPK inhibitor,HSPB1|MAPK14,BRD-K19412355,SB-242235,p38 MAPK inhibitor,HSPB1|MAPK14,BRD-K19412355,SB-242235,p38 MAPK inhibitor,HSPB1|MAPK14,BRD-K19412355,SB-242235,p38 MAPK inhibitor,HSPB1|MAPK14
PDWUPXJEEYOOTR,BRD-K43860855,iobenguane,antineoplastic agent,,BRD-K43860855,iobenguane,antineoplastic agent,,BRD-K43860855,iobenguane,antineoplastic agent,,BRD-K43860855,iobenguane,antineoplastic agent,
PDYXPCKITKHFOZ,BRD-K27182532,metatinib,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K27182532,metatinib,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K27182532,metatinib,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K27182532,metatinib,Bcr-Abl kinase inhibitor,ABL1|BCR
PEBMBOMJLWXKFI,BRD-M02179497,bismuth-oxalate,,,BRD-M02179497,bismuth-oxalate,,,BRD-M02179497,bismuth-oxalate,,,BRD-M02179497,bismuth-oxalate,,
PEHSVUKQDJULKE,BRD-K33183200,imetit,histamine receptor agonist,HRH3|HRH4,BRD-K33183200,imetit,histamine receptor agonist,HRH3|HRH4,BRD-K33183200,imetit,histamine receptor agonist,HRH3|HRH4,BRD-K33183200,imetit,histamine receptor agonist,HRH3|HRH4
PEYUIKBAABKQKQ,BRD-K04837843|BRD-K11631773,sesamin,NFkB pathway inhibitor,,BRD-K04837843|BRD-K11631773,sesamin,NFkB pathway inhibitor,,BRD-K04837843|BRD-K11631773,sesamin,NFkB pathway inhibitor,,BRD-K04837843|BRD-K11631773,sesamin,NFkB pathway inhibitor,
PEZPMAYDXJQYRV,BRD-K48304345,pixantrone,topoisomerase inhibitor,TOP2A,BRD-K48304345,pixantrone,topoisomerase inhibitor,TOP2A,BRD-K48304345,pixantrone,topoisomerase inhibitor,TOP2A,BRD-K48304345,pixantrone,topoisomerase inhibitor,TOP2A
PFGVNLZDWRZPJW,BRD-K80082640,otamixaban,coagulation factor inhibitor,F10,BRD-K80082640,otamixaban,coagulation factor inhibitor,F10,BRD-K80082640,otamixaban,coagulation factor inhibitor,F10,BRD-K80082640,otamixaban,coagulation factor inhibitor,F10
PFHDWRIVDDIFRP,BRD-K91535048,EI1,histone lysine methyltransferase inhibitor,EZH2,BRD-K91535048,EI1,histone lysine methyltransferase inhibitor,EZH2,BRD-K91535048,EI1,histone lysine methyltransferase inhibitor,EZH2,BRD-K91535048,EI1,histone lysine methyltransferase inhibitor,EZH2
PFMPOBVAYMTUOX,BRD-K38904395,SAR131675,VEGFR inhibitor,FLT4,BRD-K38904395,SAR131675,VEGFR inhibitor,FLT4,BRD-K38904395,SAR131675,VEGFR inhibitor,FLT4,BRD-K38904395,SAR131675,VEGFR inhibitor,FLT4
PFNFFQXMRSDOHW,BRD-K18375018,spermine,,CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5,BRD-K18375018,spermine,,CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5,BRD-K18375018,spermine,,CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5,BRD-K18375018,spermine,,CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5
PFOLLRNADZZWEX,BRD-A10481343|BRD-A41698174,bacampicillin,bacterial cell wall synthesis inhibitor,,BRD-A10481343|BRD-A41698174,bacampicillin,bacterial cell wall synthesis inhibitor,,BRD-A10481343|BRD-A41698174,bacampicillin,bacterial cell wall synthesis inhibitor,,BRD-A10481343|BRD-A41698174,bacampicillin,bacterial cell wall synthesis inhibitor,
PFPSFENQCNMITC,BRD-K18319422,CPI-360,histone lysine methyltransferase inhibitor,EZH2,BRD-K18319422,CPI-360,histone lysine methyltransferase inhibitor,EZH2,BRD-K18319422,CPI-360,histone lysine methyltransferase inhibitor,EZH2,BRD-K18319422,CPI-360,histone lysine methyltransferase inhibitor,EZH2
PFTAWBLQPZVEMU,BRD-K58736316,cianidanol,fatty acid synthase inhibitor,PTGS1,BRD-K58736316,cianidanol,fatty acid synthase inhibitor,PTGS1,BRD-K58736316,cianidanol,fatty acid synthase inhibitor,PTGS1,BRD-K58736316,cianidanol,fatty acid synthase inhibitor,PTGS1
PFWLFWPASULGAN,BRD-K41592905,7-methylxanthine,adenosine receptor antagonist,,BRD-K41592905,7-methylxanthine,adenosine receptor antagonist,,BRD-K41592905,7-methylxanthine,adenosine receptor antagonist,,BRD-K41592905,7-methylxanthine,adenosine receptor antagonist,
PGAVKCOVUIYSFO,BRD-A29125379|BRD-A89637065,INS316|uridine-5'-triphosphate,purinergic receptor activator|purinergic receptor antagonist,|P2RY11|P2RY2|P2RY4|P2RY6|UCK2,BRD-A29125379|BRD-A89637065,INS316|uridine-5'-triphosphate,purinergic receptor activator|purinergic receptor antagonist,|P2RY11|P2RY2|P2RY4|P2RY6|UCK2,BRD-A29125379|BRD-A89637065,INS316|uridine-5'-triphosphate,purinergic receptor activator|purinergic receptor antagonist,|P2RY11|P2RY2|P2RY4|P2RY6|UCK2,BRD-A29125379|BRD-K01825013,INS316|uridine-5'-triphosphate,purinergic receptor activator|purinergic receptor antagonist,|P2RY11|P2RY2|P2RY4|P2RY6|UCK2
PGBHMTALBVVCIT,BRD-A35132579|BRD-A93490927|BRD-A93778806|BRD-K71013094,neomycin|neomycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|CXCR4,BRD-A93490927|BRD-A93778806|BRD-K71013094,neomycin|neomycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|CXCR4,BRD-A35132579|BRD-A93490927|BRD-A93778806|BRD-K71013094|BRD-M08953053,neomycin|neomycin-sulfate,bacterial 30S ribosomal subunit inhibitor,|CXCR4,BRD-A35132579|BRD-A93490927|BRD-A93778806|BRD-K71013094|BRD-M08953053,neomycin,bacterial 30S ribosomal subunit inhibitor,CXCR4
PGFQXGLPJUCTOI,BRD-K04623885,BIBR-1532,telomerase inhibitor,TERT,BRD-K04623885,BIBR-1532,telomerase inhibitor,TERT,BRD-K04623885,BIBR-1532,telomerase inhibitor,TERT,BRD-K04623885,BIBR-1532,telomerase inhibitor,TERT
PGGUOGKHUUUWAF,BRD-K26134695,calpeptin,calpain inhibitor,,BRD-K26134695,calpeptin,calpain inhibitor,,BRD-K26134695,calpeptin,calpain inhibitor,,BRD-K26134695,calpeptin,calpain inhibitor,
PGMIWVSHZMWSSI,BRD-K04603573,"1,12-Besm",,,BRD-K04603573,"1,12-Besm",polyamine biosynthesis inhibitor,,BRD-K04603573,"1,12-Besm",polyamine biosynthesis inhibitor,,BRD-K04603573,"1,12-Besm",polyamine biosynthesis inhibitor,
PGRHXDWITVMQBC,BRD-A17300716,dehydroacetic-acid,,,BRD-A17300716,dehydroacetic-acid,,,BRD-A17300716,dehydroacetic-acid,,,,,,
PGTVWKLGGCQMBR,BRD-K28217197,ganaxolone,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K28217197,ganaxolone,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K28217197,ganaxolone,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K28217197,ganaxolone,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
PGXYIBJJCLWJST,BRD-K68532323,SB-743921,kinesin-like spindle protein inhibitor,KIF11,BRD-K68532323,SB-743921,kinesin-like spindle protein inhibitor,KIF11,BRD-K68532323,SB-743921,kinesin-like spindle protein inhibitor,KIF11,BRD-K68532323,SB-743921,kinesin-like spindle protein inhibitor,KIF11
PHEDXBVPIONUQT,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PKC activator,KCNT2|TRPV4,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PKC activator,KCNT2|TRPV4,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PKC activator,KCNT2|TRPV4,BRD-K68552125,12-O-tetradecanoylphorbol-13-acetate,PKC activator,KCNT2|TRPV4
PHEZJEYUWHETKO,BRD-K96123349,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH,BRD-K96123349,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH,BRD-K96123349,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH,BRD-K96123349,brequinar,dihydroorotate dehydrogenase inhibitor,DHODH
PHFWPIKQCFQPJY,BRD-A98083480,"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",,,BRD-A98083480,"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",,,BRD-A98083480,"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",,,BRD-A98083480,"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",,
PHGWDAICBXUJDU,BRD-A62021152,WAY-161503,serotonin receptor agonist,HTR2C,BRD-A62021152,WAY-161503,serotonin receptor agonist,HTR2C,BRD-A62021152,WAY-161503,serotonin receptor agonist,HTR2C,BRD-A62021152,WAY-161503,serotonin receptor agonist,HTR2C
PHIQHXFUZVPYII,BRD-A89594340|BRD-K59647213,carnitine-(D/L)|levocarnitine,,,BRD-A89594340|BRD-K59647213,carnitine-(D/L)|levocarnitine,,,BRD-A89594340|BRD-K59647213,carnitine-(D/L)|levocarnitine,,,BRD-A89594340|BRD-K59647213,carnitine-(D/L)|levocarnitine,,|CRAT|CROT
PHLBKPHSAVXXEF,BRD-K70778732,trazodone,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,BRD-K70778732,trazodone,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,BRD-K70778732,trazodone,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,BRD-K70778732,trazodone,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4
PHNZIIMWDVXPGG,BRD-K49468759,cot-inhibitor-2,MAPK-interacting kinase inhibitor,MAP3K8,BRD-K49468759,cot-inhibitor-2,MAPK-interacting kinase inhibitor,MAP3K8,BRD-K49468759,cot-inhibitor-2,MAPK-interacting kinase inhibitor,MAP3K8,BRD-K49468759,cot-inhibitor-2,MAPK-interacting kinase inhibitor,MAP3K8
PHOQVHQSTUBQQK,BRD-K04288422,gluconolactone,,LCT,BRD-K04288422,gluconolactone,,LCT,BRD-K04288422,gluconolactone,,LCT,BRD-K04288422,gluconolactone,,LCT
PHSPJQZRQAJPPF,BRD-K64422603,N-alpha-Methylhistamine-dihydrochloride,histamine receptor agonist,HRH4,BRD-K64422603,N-alpha-Methylhistamine-dihydrochloride,histamine receptor agonist,HRH4,BRD-K64422603,N-alpha-Methylhistamine-dihydrochloride,histamine receptor agonist,HRH4,BRD-K75390981,N-alpha-methylhistamine-dihydrochloride,histamine receptor agonist,HRH4
PHTUQLWOUWZIMZ,BRD-K54759182,dosulepin,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,BRD-K54759182,dosulepin,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,BRD-K54759182,dosulepin,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,BRD-K54759182,dosulepin,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4
PHVGLTMQBUFIQQ,BRD-K91263825,nortriptyline,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,BRD-K91263825,nortriptyline,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,BRD-K91263825,nortriptyline,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,BRD-K91263825,nortriptyline,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4
PHWBOXQYWZNQIN,BRD-K00603606,ticlopidine,purinergic receptor antagonist,P2RY12,BRD-K00603606,ticlopidine,purinergic receptor antagonist,P2RY12,BRD-K00603606,ticlopidine,purinergic receptor antagonist,P2RY12,BRD-K00603606,ticlopidine,purinergic receptor antagonist,P2RY12
PHWXUGHIIBDVKD,BRD-K63806092,sitaxentan,endothelin receptor antagonist,EDNRA,BRD-K63806092,sitaxentan,endothelin receptor antagonist,EDNRA,BRD-K63806092,sitaxentan,endothelin receptor antagonist,EDNRA,BRD-K63806092,sitaxentan,endothelin receptor antagonist,EDNRA|EDNRB
PHXJVRSECIGDHY,BRD-K44227013,ponatinib,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,BRD-K44227013,ponatinib,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,BRD-K44227013,ponatinib,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,BRD-K44227013,ponatinib,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK
PIDANAQULIKBQS,BRD-K18207669|BRD-K79233274,meprednisone,,NR3C1,BRD-K18207669|BRD-K79233274,meprednisone,,NR3C1,BRD-K18207669,meprednisone,,NR3C1,BRD-K18207669,meprednisone,,NR3C1
PIDFDZJZLOTZTM,BRD-K11072003,ombitasvir,HCV inhibitor,,BRD-K11072003,ombitasvir,HCV inhibitor,,BRD-K11072003,ombitasvir,HCV inhibitor,,BRD-K11072003,ombitasvir,HCV inhibitor,
PIEUQSKUWLMALL,BRD-A06596811|BRD-A11207520,micafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A06596811|BRD-A11207520,micafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A06596811|BRD-A11207520|BRD-K40407248,micafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,BRD-A06596811|BRD-K40407248,micafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",
PIJVFDBKTWXHHD,BRD-A37052580|BRD-K25650355,physostigmine|physostigmine-salicylate,acetylcholinesterase inhibitor|cholinesterase inhibitor,|ACHE|BCHE,BRD-A37052580|BRD-K25650355,physostigmine|physostigmine-salicylate,acetylcholinesterase inhibitor|cholinesterase inhibitor,|ACHE|BCHE,BRD-A37052580|BRD-K25650355,physostigmine|physostigmine-salicylate,acetylcholinesterase inhibitor|cholinesterase inhibitor,|ACHE|BCHE,BRD-A37052580|BRD-K25650355,physostigmine,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE
PIMQWRZWLQKKBJ,BRD-K13662825,dinaciclib,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,BRD-K13662825,dinaciclib,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,BRD-K13662825,dinaciclib,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,BRD-K13662825,dinaciclib,CDK inhibitor,CDK1|CDK2|CDK5|CDK9
PIMZUZSSNYHVCU,BRD-K36461289,picrotoxinin,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,BRD-K36461289,picrotoxinin,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,BRD-K36461289,picrotoxinin,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,BRD-K36461289,picrotoxinin,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B
PIPAJLPNWZMYQA,BRD-A52460047,methylatropine-nitrate,acetylcholine receptor antagonist,CHRM1,BRD-A52460047,methylatropine-nitrate,acetylcholine receptor antagonist,CHRM1,BRD-A52460047|BRD-M17130441,methylatropine-nitrate,acetylcholine receptor antagonist,CHRM1,BRD-K00004543,methylatropine-nitrate,acetylcholine receptor antagonist,CHRM1
PIQCTGMSNWUMAF,BRD-K85402309,dovitinib,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB,BRD-K85402309,dovitinib,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB,BRD-K85402309,dovitinib,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB,BRD-K85402309,dovitinib,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB
PIWKPBJCKXDKJR,BRD-A31564021,isoflurane,inhaled anaesthetic,ATP2C1|ATP5D|CALM1|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,BRD-A31564021,isoflurane,inhaled anaesthetic,ATP2C1|ATP5D|CALM1|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,BRD-A31564021,isoflurane,inhaled anaesthetic,ATP2C1|ATP5D|CALM1|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,BRD-A31564021,isoflurane,inhaled anaesthetic,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9
PIXJURSCCVBKRF,BRD-A65145453,ATPA,glutamate receptor agonist,GRIA2|GRIK1,BRD-A65145453,ATPA,glutamate receptor agonist,GRIA2|GRIK1,BRD-A65145453,ATPA,glutamate receptor agonist,GRIA2|GRIK1,BRD-A65145453,ATPA,glutamate receptor agonist,GRIK1
PJDFLNIOAUIZSL,BRD-A07893380,vigabatrin,GABA aminotransferase inhibitor,ABAT|GABBR1|SLC32A1,BRD-A07893380,vigabatrin,GABA aminotransferase inhibitor,ABAT|GABBR1|SLC32A1,BRD-A07893380,vigabatrin,GABA aminotransferase inhibitor,ABAT|GABBR1|SLC32A1,BRD-K01825700,vigabatrin,GABA aminotransferase inhibitor,ABAT|SLC32A1
PJNSMUBMSNAEEN,BRD-K22520627,DVD-111,,,BRD-K22520627,DVD-111,,,BRD-K22520627,DVD-111,,,BRD-K22520627,DVD-111,,
PJSFRIWCGOHTNF,BRD-K55250441,sulfadoxine,dihydropteroate synthase inhibitor,,BRD-K55250441,sulfadoxine,dihydropteroate synthase inhibitor,,BRD-K55250441,sulfadoxine,dihydropteroate synthase inhibitor,,BRD-K55250441,sulfadoxine,dihydropteroate synthase inhibitor,
PJVWKTKQMONHTI,BRD-A24514565,warfarin,vitamin K antagonist,VKORC1,BRD-A24514565,warfarin,vitamin K antagonist,VKORC1,BRD-A24514565,warfarin,vitamin K antagonist,VKORC1,BRD-K25991148,warfarin,vitamin K antagonist,VKORC1
PJYVGMRFPFNZCT,BRD-K81876028,CP-93129,serotonin receptor agonist,HTR1A,BRD-K81876028,CP-93129,serotonin receptor agonist,HTR1A,BRD-K81876028,CP-93129,serotonin receptor agonist,HTR1A,BRD-K81876028,CP-93129,serotonin receptor agonist,HTR1A
PKCDDUHJAFVJJB,BRD-K86118762,linsitinib,IGF-1 inhibitor,IGF1R|INSR|INSRR,BRD-K86118762,linsitinib,IGF-1 inhibitor,IGF1R|INSR|INSRR,BRD-K86118762,linsitinib,IGF-1 inhibitor,IGF1R|INSR|INSRR,BRD-K86118762,linsitinib,IGF-1 inhibitor,IGF1R|INSR|INSRR
PKCYYPHSCUSQDK,BRD-K81197548,NSC-632839,ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7,BRD-K81197548,NSC-632839,ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7,BRD-K81197548,NSC-632839,ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7,BRD-K81197548,NSC-632839,ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7
PKNYXWMTHFMHKD,BRD-K96263742,GW-7647,PPAR receptor agonist,PPARA,BRD-K96263742,GW-7647,PPAR receptor agonist,PPARA,BRD-K96263742,GW-7647,PPAR receptor agonist,PPARA,BRD-K96263742,GW-7647,PPAR receptor agonist,PPARA
PKWRMUKBEYJEIX,BRD-K71221037,birinapant,XIAP inhibitor,BIRC2|XIAP,BRD-K71221037,birinapant,XIAP inhibitor,BIRC2|XIAP,BRD-K71221037,birinapant,XIAP inhibitor,BIRC2|XIAP,BRD-K71221037,birinapant,XIAP inhibitor,BIRC2|XIAP
PKXWXXPNHIWQHW,BRD-K81957469,semagacestat,gamma secretase inhibitor,PSEN1,BRD-K81957469,semagacestat,gamma secretase inhibitor,PSEN1,BRD-K81957469,semagacestat,gamma secretase inhibitor,PSEN1,BRD-K65592642,semagacestat,gamma secretase inhibitor,PSEN1
PLDUPXSUYLZYBN,BRD-K55127134,fluphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,BRD-K55127134,fluphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,BRD-K55127134,fluphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,BRD-K55127134,fluphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7
PLDZOHPIBZVDLQ,BRD-A62336573,rolitetracycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A62336573,rolitetracycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A62336573,rolitetracycline,bacterial 30S ribosomal subunit inhibitor,,,,,
PLHJCIYEEKOWNM,BRD-K62965247,tipifarnib,farnesyltransferase inhibitor,FNTA|FNTB,BRD-K62965247,tipifarnib,farnesyltransferase inhibitor,FNTA|FNTB,BRD-K62965247,tipifarnib,farnesyltransferase inhibitor,FNTA|FNTB,BRD-K62965247,tipifarnib,farnesyltransferase inhibitor,FNTA|FNTB
PLHJDBGFXBMTGZ,BRD-K11756522,furazolidone,bacterial DNA inhibitor,,BRD-K11756522,furazolidone,bacterial DNA inhibitor,,BRD-K11756522,furazolidone,bacterial DNA inhibitor,,BRD-K11756522,furazolidone,bacterial DNA inhibitor,
PLIVFNIUGLLCEK,BRD-K41278234,CUDC-101,EGFR inhibitor,EGFR|ERBB2,BRD-K41278234,CUDC-101,EGFR inhibitor,EGFR|ERBB2,BRD-K41278234,CUDC-101,EGFR inhibitor,EGFR|ERBB2,BRD-K41278234,CUDC-101,EGFR inhibitor,EGFR|ERBB2
PLUYFBRIGUAKBR,BRD-K75528696,PI4KIII-beta-inhibitor-1,PI4K inhibitor,PI4K2B,BRD-K75528696,PI4KIII-beta-inhibitor-1,PI4K inhibitor,PI4K2B,BRD-K75528696,PI4KIII-beta-inhibitor-1,PI4K inhibitor,PI4K2B,BRD-K75528696,PI4KIII-beta-inhibitor-1,PI4K inhibitor,PI4K2B
PMATZTZNYRCHOR,BRD-A11864475|BRD-A69815203|BRD-K03152136,cyclosporin-a|cyclosporine,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,BRD-A11864475|BRD-A69815203|BRD-K13533483,cyclosporin-a|cyclosporine,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,BRD-A11864475|BRD-A69815203|BRD-K03152136|BRD-K13533483,cyclosporin-a|cyclosporine,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,BRD-A11864475|BRD-K03152136|BRD-K13533483,cyclosporin-A,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3
PMJIHLSCWIDGMD,BRD-K81330143,tideglusib,glycogen synthase kinase inhibitor,GSK3B,BRD-K81330143,tideglusib,glycogen synthase kinase inhibitor,GSK3B,BRD-K81330143,tideglusib,glycogen synthase kinase inhibitor,GSK3B,BRD-K81330143,tideglusib,glycogen synthase kinase inhibitor,GSK3B
PMKJGGBYYNEYPA,BRD-A66435872,HTMT,histamine receptor agonist,HRH4,BRD-A66435872,HTMT,histamine receptor agonist,HRH4,BRD-A66435872,HTMT,histamine receptor agonist,HRH4,BRD-K01825665,HTMT,histamine receptor agonist,HRH4
PMMURAAUARKVCB,BRD-K97808269,2-deoxyglucose,glycolysis inhibitor,SLC2A1|SLC2A2|SLC2A3|SLC2A4,BRD-K97808269,2-deoxyglucose,glycolysis inhibitor,SLC2A1|SLC2A2|SLC2A3|SLC2A4,BRD-K97808269,2-deoxyglucose,glycolysis inhibitor,SLC2A1|SLC2A2|SLC2A3|SLC2A4,BRD-K97808269,2-deoxyglucose,glycolysis inhibitor,SLC2A1|SLC2A2|SLC2A3|SLC2A4
PMMYEEVYMWASQN,BRD-A12454076,L-Hydroxyproline,,,BRD-A12454076,L-Hydroxyproline,,,BRD-A12454076,L-Hydroxyproline,,,BRD-A12454076,L-hydroxyproline,,
PMRYVIKBURPHAH,BRD-K54416256,methimazole,antithyroid agent,TPO,BRD-K54416256,methimazole,antithyroid agent,TPO,BRD-K54416256,methimazole,antithyroid agent,TPO,BRD-K54416256,methimazole,antithyroid agent,TPO
PMTSPAGBAFCORP,BRD-A72716251,peruvoside,cardiac glycoside,,BRD-A72716251,peruvoside,cardiac glycoside,,BRD-A72716251,peruvoside,cardiac glycoside,,BRD-A72716251,peruvoside,cardiac glycoside,
PMXCMJLOPOFPBT,BRD-K50836978,purvalanol-a,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC,BRD-K50836978,purvalanol-a,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC,BRD-K50836978,purvalanol-a,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC,BRD-K50836978,purvalanol-A,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC
PMXMIIMHBWHSKN,BRD-A99888680|BRD-K00665454,paliperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CYP2D6|CYP3A4|CYP3A5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1D|HTR2A|HTR2C,BRD-A99888680|BRD-K00665454,paliperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CYP2D6|CYP3A4|CYP3A5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1D|HTR2A|HTR2C,BRD-A99888680|BRD-K00665454,paliperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CYP2D6|CYP3A4|CYP3A5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1D|HTR2A|HTR2C,BRD-A99888680|BRD-K00665454,paliperidone,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A
PNAWUIKCVQSLFG,BRD-K32533226,AGN-195183,retinoid receptor agonist,RARA,BRD-K32533226,AGN-195183,retinoid receptor agonist,RARA,BRD-K32533226,AGN-195183,retinoid receptor agonist,RARA,BRD-K32533226,AGN-195183,retinoid receptor agonist,RARA
PNCPYILNMDWPEY,BRD-K10906636,silodosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K10906636,silodosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K10906636,silodosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K10906636,silodosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D
PNIFFZXGBAYVMQ,BRD-K37087535,DPC-681,HIV protease inhibitor,,BRD-K37087535,DPC-681,HIV protease inhibitor,,BRD-K37087535,DPC-681,HIV protease inhibitor,,BRD-K37087535,DPC-681,HIV protease inhibitor,
PNMUAGGSDZXTHX,BRD-K85066592,gly-gln,,,BRD-K85066592,gly-gln,,,BRD-K85066592,gly-gln,,,BRD-K85066592,gly-gln,,
PNMYJIOQIAEYQL,BRD-K01054709,TH588,MTH1 inhibitor,NUDT1,BRD-K01054709,TH588,MTH1 inhibitor,NUDT1,BRD-K01054709,TH588,MTH1 inhibitor,NUDT1,BRD-K01054709,TH-588,MTH1 inhibitor,NUDT1
PNTVCCRNJOGKGA,BRD-K81616657,PNU-142633,serotonin receptor agonist,HTR1D,BRD-K81616657,PNU-142633,serotonin receptor agonist,HTR1D,BRD-K81616657,PNU-142633,serotonin receptor agonist,HTR1D,BRD-K81616657,PNU-142633,serotonin receptor agonist,HTR1D
PNUZDKCDAWUEGK,BRD-K10836013,sitafloxacin,bacterial DNA gyrase inhibitor,,BRD-K10836013,sitafloxacin,bacterial DNA gyrase inhibitor,,BRD-K10836013|BRD-U60340452,sitafloxacin,bacterial DNA gyrase inhibitor,,BRD-K10836013|BRD-U60340452,sitafloxacin,bacterial DNA gyrase inhibitor,
PNVJTZOFSHSLTO,BRD-K67217586,fenthion,cholinesterase inhibitor,,BRD-K67217586,fenthion,cholinesterase inhibitor,,BRD-K67217586,fenthion,cholinesterase inhibitor,,BRD-K67217586,fenthion,cholinesterase inhibitor,
PNVNVHUZROJLTJ,BRD-A51714012,venlafaxine,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-A51714012,venlafaxine,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-A51714012,venlafaxine,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-K01826548,venlafaxine,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4
PODBBOVVOGJETB,BRD-K01423020,ciaftalan-zinc,reactive oxygen species stimulant,,BRD-K01423020,ciaftalan-zinc,reactive oxygen species stimulant,,BRD-K01423020,ciaftalan-zinc,reactive oxygen species stimulant,,BRD-K01423020,ciaftalan-zinc,reactive oxygen species stimulant,
POGQSBRIGCQNEG,BRD-K20079257,rufinamide,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K20079257,rufinamide,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K20079257,rufinamide,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K20079257,rufinamide,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
POJWUDADGALRAB,BRD-A96407378,allantoin,cosmetic,,BRD-A96407378,allantoin,cosmetic,,BRD-A96407378,allantoin,cosmetic,,BRD-A96407378,allantoin,cosmetic,
PONANXDRJJIGPG,BRD-A69126730,CPA-inhibitor,carboxypeptidase inhibitor,CPA1|CPA2,BRD-A69126730,CPA-inhibitor,carboxypeptidase inhibitor,CPA1|CPA2,BRD-A69126730,CPA-inhibitor,carboxypeptidase inhibitor,CPA1|CPA2,BRD-A69126730,CPA-inhibitor,carboxypeptidase inhibitor,CPA1|CPA2
POPFMWWJOGLOIF,BRD-A49765801,fludroxycortide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A49765801,fludroxycortide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-A49765801,fludroxycortide,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K00824317,fludroxycortide,glucocorticoid receptor agonist,NR3C1|SERPINA6
POULHZVOKOAJMA,BRD-K67375056,lauric-acid,bacterial permeability inducer,GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4,BRD-K67375056,lauric-acid,bacterial permeability inducer,GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4,BRD-K67375056,lauric-acid,bacterial permeability inducer,GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4,BRD-K67375056,lauric-acid,bacterial permeability inducer,GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4
POZRVZJJTULAOH,BRD-A92537424,danazol,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,BRD-A92537424,danazol,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,BRD-A92537424,danazol,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,BRD-K48970916,danazol,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR
PPAIMZHKIXDJRN,BRD-K38380126,thiamet-g,GLCNAC phosphotransferase inhibitor,MGEA5,BRD-K38380126,thiamet-g,GLCNAC phosphotransferase inhibitor,MGEA5,BRD-K38380126,thiamet-g,GLCNAC phosphotransferase inhibitor,MGEA5,BRD-K38380126,thiamet-g,GLCNAC phosphotransferase inhibitor,MGEA5
PPHTXRNHTVLQED,BRD-K59391348,lixivaptan,vasopressin receptor antagonist,AVPR2,BRD-K59391348,lixivaptan,vasopressin receptor antagonist,AVPR2,BRD-K59391348,lixivaptan,vasopressin receptor antagonist,AVPR2,BRD-K59391348,lixivaptan,vasopressin receptor antagonist,AVPR2
PPJXIHLNYDVTDI,BRD-A41657926,dicloralurea,,,BRD-A41657926,dicloralurea,,,BRD-A41657926,dicloralurea,,,BRD-A41657926,dicloralurea,,
PPRRDFIXUUSXRA,BRD-K33637378,flibanserin,serotonin receptor agonist,DRD4|HTR1A|HTR2A,BRD-K33637378,flibanserin,serotonin receptor agonist,DRD4|HTR1A|HTR2A,BRD-K33637378,flibanserin,serotonin receptor agonist,DRD4|HTR1A|HTR2A,BRD-K33637378,flibanserin,serotonin receptor agonist,DRD4|HTR1A|HTR2A
PPUDLEUZKVJXSZ,BRD-A66966115,NM107,RNA polymerase inhibitor,,BRD-A66966115,NM107,RNA polymerase inhibitor,,BRD-A66966115,NM107,RNA polymerase inhibitor,,BRD-K79424231,NM107,RNA polymerase inhibitor,
PPUXXDKQNAHHON,BRD-K36338614,VBY-825,cathepsin inhibitor,CTSB|CTSL|CTSS,BRD-K36338614,VBY-825,cathepsin inhibitor,CTSB|CTSL|CTSS,BRD-K36338614,VBY-825,cathepsin inhibitor,CTSB|CTSL|CTSS,BRD-K36338614,VBY-825,cathepsin inhibitor,CTSB|CTSL|CTSS
PQAPVTKIEGUPRN,BRD-K28360340,TW-37,BCL inhibitor,BCL2|BCL2L1|MCL1,BRD-K28360340,TW-37,BCL inhibitor,BCL2|BCL2L1|MCL1,BRD-K28360340,TW-37,BCL inhibitor,BCL2|BCL2L1|MCL1,BRD-K28360340,TW-37,BCL inhibitor,BCL2|BCL2L1|MCL1
PQCAUHUKTBHUSA,BRD-K04430056,7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K04430056,7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K04430056,7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K04430056,7-nitroindazole,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3
PQCXVIPXISBFPN,BRD-K76805682,SB-415286,glycogen synthase kinase inhibitor,GSK3A|GSK3B|RPS6KB1,BRD-K76805682,SB-415286,glycogen synthase kinase inhibitor,GSK3A|GSK3B|RPS6KB1,BRD-K76805682,SB-415286,glycogen synthase kinase inhibitor,GSK3A|GSK3B|RPS6KB1,BRD-K76805682,SB-415286,glycogen synthase kinase inhibitor,GSK3A|GSK3B|RPS6KB1
PQFNWDHABGBCHB,BRD-K50325075,UCL-2077,slow afterhyperpolarization channel blocker,,BRD-K50325075,UCL-2077,slow afterhyperpolarization channel blocker,,BRD-K50325075,UCL-2077,slow afterhyperpolarization channel blocker,,BRD-K50325075,UCL-2077,slow afterhyperpolarization channel blocker,
PQFRTXSWDXZRRS,BRD-K94266545,ronidazole,antiprotozoal agent,,BRD-K94266545,ronidazole,antiprotozoal agent,,BRD-K94266545,ronidazole,antiprotozoal agent,,BRD-K94266545,ronidazole,antiprotozoal agent,
PQKBPHSEKWERTG,BRD-K44777569,fenoxaprop-p-ethyl,,NOS2|NOS3,BRD-K44777569,fenoxaprop-p-ethyl,,NOS2|NOS3,BRD-K44777569,fenoxaprop-p-ethyl,,NOS2|NOS3,BRD-K44777569,fenoxaprop-p-ethyl,,NOS3
PQKHESYTSKMWFP,BRD-K95110148,beta-funaltrexamine,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K95110148,beta-funaltrexamine,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K95110148,beta-funaltrexamine,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K95110148,beta-funaltrexamine,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
PQLXHQMOHUQAKB,BRD-A31811760,miltefosine,membrane integrity inhibitor,PLA2G1B,BRD-A31811760,miltefosine,membrane integrity inhibitor,PLA2G1B,BRD-A31811760,miltefosine,membrane integrity inhibitor,PLA2G1B,BRD-K01824991,miltefosine,membrane integrity inhibitor,PLA2G1B
PQOOIERVZAXHBP,BRD-K83189926,UNC1215,L3MBTL antagonist,L3MBTL3,BRD-K83189926,UNC1215,L3MBTL antagonist,L3MBTL3,BRD-K83189926,UNC1215,L3MBTL antagonist,L3MBTL3,BRD-K83189926,UNC1215,L3MBTL antagonist,L3MBTL3
PQUGCKBLVKJMNT,BRD-K14767410,SC-560,cyclooxygenase inhibitor,PTGS1,BRD-K14767410,SC-560,cyclooxygenase inhibitor,PTGS1,BRD-K14767410,SC-560,cyclooxygenase inhibitor,PTGS1,BRD-K14767410,SC-560,cyclooxygenase inhibitor,PTGS1
PQXGNJKJMFUPPM,BRD-K10667240,ethacizin,anticonvulsant,,BRD-K10667240,ethacizin,anticonvulsant,,BRD-K10667240,ethacizin,anticonvulsant,,BRD-K10667240,ethacizin,anticonvulsant,
PQXKDMSYBGKCJA,BRD-K51143828,lurasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,BRD-K51143828,lurasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,BRD-K51143828,lurasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,BRD-K51143828,lurasidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7
PRAAPINBUWJLGA,BRD-K58070273,CB-839,glutaminase inhibitor,GLS,BRD-K58070273,CB-839,glutaminase inhibitor,GLS,BRD-K58070273,CB-839,glutaminase inhibitor,GLS,BRD-K58070273,CB-839,glutaminase inhibitor,GLS
PRDJGNVQBVXXEO,BRD-K61339991,kevetrin,p53 activator,,BRD-K61339991,kevetrin,p53 activator,,BRD-K61339991,kevetrin,p53 activator,,BRD-K61339991,kevetrin,p53 activator,
PRMWGUBFXWROHD,BRD-K41438959,perampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K41438959,perampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K41438959,perampanel,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,,,,
PRNXOFBDXNTIFG,BRD-K25210703,AZD3965,monocarboxylate transporter inhibitor,SLC16A1,BRD-K25210703,AZD3965,monocarboxylate transporter inhibitor,SLC16A1,BRD-K25210703,AZD3965,monocarboxylate transporter inhibitor,SLC16A1,BRD-K25210703,AZD3965,monocarboxylate transporter inhibitor,SLC16A1
PROQIPRRNZUXQM,BRD-A18620900|BRD-A63433173|BRD-K03411175|BRD-K17016787,estriol,estrogen receptor agonist,ESR1|ESR2,BRD-A18620900|BRD-A63433173|BRD-K03411175|BRD-K17016787,estriol,estrogen receptor agonist,ESR1|ESR2,BRD-A18620900|BRD-A63433173|BRD-K03411175|BRD-K17016787,estriol,estrogen receptor agonist,ESR1|ESR2,BRD-A18620900|BRD-K00005352|BRD-K03411175|BRD-K17016787,epiestriol|estriol,|estrogen receptor agonist,|ESR1|ESR2
PRRZDZJYSJLDBS,BRD-K92980438,3-bromopyruvate,hexokinase inhibitor,HK2,BRD-K92980438,3-bromopyruvate,hexokinase inhibitor,HK2,BRD-K92980438,3-bromopyruvate,hexokinase inhibitor,HK2,,,,
PRWSIEBRGXYXAJ,BRD-K41104902,GSK2656157,PERK inhibitor,,BRD-K41104902,GSK2656157,PERK inhibitor,,BRD-K41104902,GSK2656157,PERK inhibitor,,BRD-K41104902,GSK2656157,PERK inhibitor,
PRXXYMVLYKJITB,BRD-K11773281,4SC-202,HDAC inhibitor,HDAC1,BRD-K11773281,4SC-202,HDAC inhibitor,HDAC1,BRD-K11773281,4SC-202,HDAC inhibitor,HDAC1,BRD-K11773281,4SC-202,HDAC inhibitor,HDAC1
PSFDQSOCUJVVGF,BRD-K12630395,harmane,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K12630395,harmane,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K12630395,harmane,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K12630395,harmane,monoamine oxidase inhibitor,MAOA|MAOB
PSGAAPLEWMOORI,BRD-A61221616|BRD-K44848460,medroxyprogesterone-acetate,progesterone receptor agonist,,BRD-A61221616,medroxyprogesterone-acetate,progesterone receptor agonist,,BRD-A61221616|BRD-K44848460,medroxyprogesterone-acetate,progesterone receptor agonist,,BRD-K82216340,medroxyprogesterone-acetate,progesterone receptor agonist,ESR1|PGR
PSIFNNKUMBGKDQ,BRD-K76205745,losartan,angiotensin receptor antagonist,AGTR1,BRD-K76205745,losartan,angiotensin receptor antagonist,AGTR1,BRD-K76205745,losartan,angiotensin receptor antagonist,AGTR1,BRD-K76205745,losartan,angiotensin receptor antagonist,AGTR1
PSPANKCQVWSVHM,BRD-A33514596,N-benzylnaltrindole,opioid receptor antagonist,,BRD-A33514596,N-benzylnaltrindole,opioid receptor antagonist,,BRD-A33514596,N-benzylnaltrindole,opioid receptor antagonist,,BRD-K00004214,N-benzylnaltrindole,opioid receptor antagonist,
PSPFQEBFYXJZEV,BRD-K13566078,BMS-345541,IKK inhibitor,CHUK|IKBKB,BRD-K13566078,BMS-345541,IKK inhibitor,CHUK|IKBKB,BRD-K13566078,BMS-345541,IKK inhibitor,CHUK|IKBKB,BRD-K13566078,BMS-345541,IKK inhibitor,CHUK|IKBKB
PSPGQHXMUKWNDI,BRD-K23672206,BCI-540,glutamate receptor agonist,,BRD-K23672206,BCI-540,glutamate receptor agonist,,BRD-K23672206,BCI-540,glutamate receptor agonist,,BRD-K23672206,BCI-540,glutamate receptor agonist,
PSXOKXJMVRSARX,BRD-K58319700,begacestat,gamma secretase inhibitor,PSEN1,BRD-K58319700,begacestat,gamma secretase inhibitor,PSEN1,BRD-K58319700,begacestat,gamma secretase inhibitor,PSEN1,BRD-K58319700,begacestat,gamma secretase inhibitor,PSEN1
PTGXAUBQBSGPKF,BRD-A36267905,buphenine,adrenergic receptor agonist,ADRB2,BRD-A36267905,buphenine,adrenergic receptor agonist,ADRB2,BRD-A36267905,buphenine,adrenergic receptor agonist,ADRB2,BRD-A36267905,buphenine,adrenergic receptor agonist,ADRB2
PTHLEKANMPKYDB,BRD-K43383936,flopropione,serotonin receptor antagonist,HTR1A,BRD-K43383936,flopropione,serotonin receptor antagonist,HTR1A,BRD-K43383936,flopropione,serotonin receptor antagonist,HTR1A,BRD-K43383936,flopropione,serotonin receptor antagonist,HTR1A
PTJGLFIIZFVFJV,BRD-K11663430,pyroxamide,HDAC inhibitor,HDAC1,BRD-K11663430,pyroxamide,HDAC inhibitor,HDAC1,BRD-K11663430,pyroxamide,HDAC inhibitor,HDAC1,BRD-K11663430,pyroxamide,HDAC inhibitor,HDAC1
PTKRUDMLGIIORX,BRD-M06409173,NADPH,,AASS|DPYD|GHSR|TXNRD1,BRD-M06409173,NADPH,,AASS|DPYD|GHSR|TXNRD1,BRD-M06409173,NADPH,,AASS|DPYD|GHSR|TXNRD1,BRD-M06409173,NADPH,,DRD2|DRD3|DRD4|GHSR|HTR2A|HTR2C
PTKSEFOSCHHMPD,BRD-A79981887,midodrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-A79981887,midodrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-A79981887,midodrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-A79981887,midodrine,adrenergic receptor agonist,
PTOAARAWEBMLNO,BRD-K93034159,cladribine,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,BRD-K93034159,cladribine,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,BRD-K93034159,cladribine,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,BRD-K93034159,cladribine,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B
PTOIAAWZLUQTIO,BRD-K62971431,tasimelteon,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K62971431,tasimelteon,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K62971431,tasimelteon,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K62971431,tasimelteon,melatonin receptor agonist,MTNR1A|MTNR1B
PTPNCCWOTBBVJR,BRD-K23614267,GW-1100,G protein-coupled receptor agonist,FFAR1,BRD-K23614267,GW-1100,G protein-coupled receptor agonist,FFAR1,BRD-K23614267,GW-1100,G protein-coupled receptor agonist,FFAR1,BRD-K23614267,GW-1100,G protein-coupled receptor agonist,FFAR1
PTQXTEKSNBVPQJ,BRD-K67901620,avasimibe,ACAT inhibitor,CES1,BRD-K67901620,avasimibe,ACAT inhibitor,CES1,BRD-K67901620,avasimibe,ACAT inhibitor,CES1,BRD-K67901620,avasimibe,ACAT inhibitor,CES1
PTRATZCAGVBFIQ,BRD-K65498798,abametapir,metalloproteinase inhibitor,MMP9,BRD-K65498798,abametapir,metalloproteinase inhibitor,MMP9,BRD-K65498798,abametapir,metalloproteinase inhibitor,MMP9,BRD-K65498798,abametapir,metalloproteinase inhibitor,MMP9
PTVWPYVOOKLBCG,BRD-A29349577|BRD-K60537263|BRD-K83551379,dropropizine|levodropropizine,antitussive,,BRD-A29349577|BRD-K60537263|BRD-K83551379,dropropizine|levodropropizine,antitussive,,BRD-A29349577|BRD-K60537263|BRD-K83551379,dropropizine|levodropropizine,antitussive,,BRD-A29349577|BRD-K60537263|BRD-K83551379,dropropizine|levodropropizine,antitussive,
PTXGHCGBYMQQIG,BRD-A19458515,proglumetacin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A19458515,proglumetacin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A19458515,proglumetacin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A19458515,proglumetacin,cyclooxygenase inhibitor,PTGS1|PTGS2
PTYJGLZVOMGTRG,BRD-M41245765,lithium-citrate,,,BRD-M41245765,lithium-citrate,,,BRD-M41245765|BRD-M83658881,lithium-citrate,,,BRD-M41245765|BRD-M83658881,lithium-citrate,,
PUETUDUXMCLALY,BRD-K91733562,secoisolariciresinol-(-),,,BRD-K91733562,secoisolariciresinol-(-),,,BRD-K91733562,secoisolariciresinol-(-),,,BRD-K91733562,secoisolariciresinol-(-),,
PUFQVTATUTYEAL,BRD-K99121711,cinchocaine,sodium channel blocker,CALM1|SCN10A|SCN5A,BRD-K99121711,cinchocaine,sodium channel blocker,CALM1|SCN10A|SCN5A,BRD-K99121711,cinchocaine,sodium channel blocker,CALM1|SCN10A|SCN5A,BRD-K99121711,cinchocaine,sodium channel blocker,CALM1|SCN10A|SCN5A
PUHSRMSFDASMAE,BRD-A78952587,A740003,purinergic receptor antagonist,P2RX7,BRD-A78952587,A740003,purinergic receptor antagonist,P2RX7,BRD-A78952587,A740003,purinergic receptor antagonist,P2RX7,BRD-A78952587,A740003,purinergic receptor antagonist,P2RX7
PULGYDLMFSFVBL,BRD-K05717154,orphanin-fq,opioid receptor agonist,OPRL1|OPRM1,BRD-K05717154,orphanin-fq,opioid receptor agonist,OPRL1|OPRM1,BRD-K05717154,orphanin-fq,opioid receptor agonist,OPRL1|OPRM1,BRD-K05717154,orphanin-fq,opioid receptor agonist,OPRL1|OPRM1
PUOAETJYKQITMO,BRD-K50564936,E-2012,gamma secretase modulator,APH1B,BRD-K50564936,E-2012,gamma secretase modulator,APH1A|APH1B|PSENEN,BRD-K50564936,E-2012,gamma secretase modulator,APH1A|APH1B|PSENEN,BRD-K50564936,E-2012,gamma secretase modulator,APH1A|APH1B|PSENEN
PUPNJSIFIXXJCH,BRD-K20548681,SCP-1,analgesic agent,,BRD-K20548681,SCP-1,analgesic agent,,BRD-K20548681,SCP-1,analgesic agent,,BRD-K20548681,SCP-1,analgesic agent,
PUQSUZTXKPLAPR,BRD-K81613478,gastrodin,,,BRD-K81613478,gastrodin,,,BRD-K81613478,gastrodin,,,BRD-K15447284,gastrodin,,
PURKAOJPTOLRMP,BRD-K52818472,ivacaftor,CFTR channel potentiator,CFTR,BRD-K52818472,ivacaftor,CFTR channel potentiator,CFTR,BRD-K52818472,ivacaftor,CFTR channel potentiator,CFTR,BRD-K52818472,ivacaftor,CFTR channel potentiator,CFTR
PUUSSSIBPPTKTP,BRD-K60212747,neridronic-acid,bone resorption inhibitor,FDPS,BRD-K60212747,neridronic-acid,bone resorption inhibitor,FDPS,BRD-K60212747,neridronic-acid,bone resorption inhibitor,FDPS,BRD-K60212747,neridronic-acid,bone resorption inhibitor,FDPS
PUXBGTOOZJQSKH,BRD-A17411484,carprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A17411484,carprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A17411484,carprofen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A17411484,carprofen,cyclooxygenase inhibitor,PTGS2
PUYOAVGNCWPANW,BRD-K96714749,isobutamben,local anesthetic,,BRD-K96714749,isobutamben,local anesthetic,,BRD-K96714749,isobutamben,local anesthetic,,BRD-K96714749,isobutamben,local anesthetic,
PVBQYTCFVWZSJK,BRD-K79392608,meldonium,gamma butyrobetaine hydroxylase inhibitor,BBOX1,BRD-K79392608,meldonium,gamma butyrobetaine hydroxylase inhibitor,BBOX1,BRD-K79392608,meldonium,gamma butyrobetaine hydroxylase inhibitor,BBOX1,BRD-K79392608,meldonium,gamma butyrobetaine hydroxylase inhibitor,BBOX1
PVHLMTREZMEJCG,BRD-K36040345,TXA127,angiotensin receptor agonist,,BRD-K36040345,TXA127,angiotensin receptor agonist,,BRD-K36040345,TXA127,angiotensin receptor agonist,,BRD-K36040345,TXA127,angiotensin receptor agonist,
PVHUJELLJLJGLN,BRD-A02006392,nitrendipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CACNG1|KCNN4,BRD-A02006392,nitrendipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CACNG1|KCNN4,BRD-A02006392,nitrendipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CACNG1|KCNN4,BRD-A02006392,nitrendipine,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4
PVJGDYDNVNCGBT,BRD-A13598753,5'-Chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1,BRD-A13598753,5'-Chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1,BRD-A13598753,5'-Chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1,BRD-K00004289,5'-chloro-5'-deoxy-ENBA-(+/-),adenosine receptor agonist,ADORA1
PVLJETXTTWAYEW,BRD-K21884483,mizolastine,histamine receptor antagonist,HRH1,BRD-K21884483,mizolastine,histamine receptor antagonist,HRH1,BRD-K21884483,mizolastine,histamine receptor antagonist,HRH1,BRD-K21884483,mizolastine,histamine receptor antagonist,HRH1
PVNIIMVLHYAWGP,BRD-K60237333,niacin,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,BRD-K60237333,niacin,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,BRD-K60237333,niacin,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,BRD-K60237333,niacin,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT
PVWVKJZCXALBAI,BRD-M55114534,pyrvinium|pyrvinium-pamoate,androgen receptor antagonist,|AR,BRD-M55114534,pyrvinium|pyrvinium-pamoate,androgen receptor antagonist,|AR,BRD-M55114534,pyrvinium|pyrvinium-pamoate,androgen receptor antagonist,|AR,,,,
PWACSDKDOHSSQD,BRD-K50163129,acrivastine,histamine receptor antagonist,HRH1,BRD-K50163129,acrivastine,histamine receptor antagonist,HRH1,BRD-K50163129,acrivastine,histamine receptor antagonist,HRH1,BRD-K50163129,acrivastine,histamine receptor antagonist,HRH1
PWAUCHMQEXVFJR,BRD-A39975020|BRD-K92872987,cefpiramide,bacterial cell wall synthesis inhibitor,,BRD-A39975020|BRD-K92872987,cefpiramide,bacterial cell wall synthesis inhibitor,,BRD-A39975020|BRD-K92872987,cefpiramide,bacterial cell wall synthesis inhibitor,,BRD-A39975020|BRD-K92872987,cefpiramide,bacterial cell wall synthesis inhibitor,
PWHROYKAGRUWDQ,BRD-K96206066,difenpiramide,cyclooxygenase inhibitor|prostaglandin inhibitor,,BRD-K96206066,difenpiramide,cyclooxygenase inhibitor|prostaglandin inhibitor,,BRD-K96206066,difenpiramide,cyclooxygenase inhibitor|prostaglandin inhibitor,,BRD-K96206066,difenpiramide,cyclooxygenase inhibitor|prostaglandin inhibitor,
PWKSKIMOESPYIA,BRD-K59058747|BRD-K67174965,acetylcysteine,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,BRD-K59058747|BRD-K67174965,acetylcysteine,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,BRD-K59058747|BRD-K67174965,acetylcysteine,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,BRD-K59058747|BRD-K67174965,acetylcysteine,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11
PWLXJBSAUKKGCM,BRD-A77118605,D609,phospholipase inhibitor,,BRD-A77118605,D609,phospholipase inhibitor,,BRD-A77118605,D609,phospholipase inhibitor,,BRD-A77118605,D609,phospholipase inhibitor,
PWNMXPDKBYZCOO,BRD-A92341659,prulifloxacin,bacterial DNA gyrase inhibitor,,BRD-A92341659,prulifloxacin,bacterial DNA gyrase inhibitor,,BRD-A92341659|BRD-A96891111,prulifloxacin,bacterial DNA gyrase inhibitor,,BRD-A92341659|BRD-A96891111,prulifloxacin,bacterial DNA gyrase inhibitor,
PWPJGUXAGUPAHP,BRD-A71774530,lufenuron,chitin inhibitor,,BRD-A71774530,lufenuron,chitin inhibitor,,BRD-A71774530,lufenuron,chitin inhibitor,,BRD-A71774530,lufenuron,chitin inhibitor,
PWPNYABQEOGNNC,BRD-K21038058,LX7101,LIM kinase inhibitor|rho associated kinase inhibitor,LIMK2|ROCK1|ROCK2,BRD-K21038058,LX7101,LIM kinase inhibitor|rho associated kinase inhibitor,LIMK2|ROCK1|ROCK2,BRD-K21038058,LX7101,LIM kinase inhibitor|rho associated kinase inhibitor,LIMK2|ROCK1|ROCK2,BRD-K21038058,LX7101,LIM kinase inhibitor|rho associated kinase inhibitor,LIMK2|ROCK1|ROCK2
PWPWEYFVLITGNU,BRD-A02933148,isotiquimide,,,BRD-A02933148,isotiquimide,,,BRD-A02933148,isotiquimide,,,BRD-A02933148,isotiquimide,,
PWTBZOIUWZOPFT,BRD-K19605405,ZM-241385,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K19605405,ZM-241385,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K19605405,ZM-241385,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K19605405,ZM-241385,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
PWVXXGRKLHYWKM,BRD-K30652337,eletriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,BRD-K30652337,eletriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,BRD-K30652337,eletriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,BRD-K30652337,eletriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7
PWWDCRQZITYKDV,BRD-K62398570,lerisetron,serotonin receptor antagonist,HTR3A,BRD-K62398570,lerisetron,serotonin receptor antagonist,HTR3A,BRD-K62398570,lerisetron,serotonin receptor antagonist,HTR3A,BRD-K62398570,lerisetron,serotonin receptor antagonist,HTR3A
PWWKJRFUJIFGGD,BRD-K49119234,TMPH,,,BRD-K49119234,TMPH,,,BRD-K49119234,TMPH,,,BRD-K49119234,TMPH,,
PWWVAXIEGOYWEE,BRD-A46335897,promethazine,histamine receptor antagonist,ADRA1A|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A,BRD-A46335897,promethazine,histamine receptor antagonist,ADRA1A|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A,BRD-A46335897,promethazine,histamine receptor antagonist,ADRA1A|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A,BRD-A46335897,promethazine,histamine receptor antagonist,HRH1
PWZUUYSISTUNDW,BRD-A16439188,quinestrol,estrogen receptor agonist,ESR1,BRD-A16439188,quinestrol,estrogen receptor agonist,ESR1,BRD-A16439188,quinestrol,estrogen receptor agonist,ESR1,BRD-K63794707,quinestrol,estrogen receptor agonist,ESR1|ESR2
PXGPLTODNUVGFL,BRD-K81672972,dinoprost,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,BRD-K81672972,dinoprost,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,BRD-K81672972,dinoprost,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,BRD-K81672972,dinoprost,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R
PXINDYJACXPZIN,BRD-K58146797,"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",,,BRD-K58146797,"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",,,BRD-K58146797,"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",,,BRD-K58146797,"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",,
PXKHGMGELZGJQE,BRD-K96424892,chloramphenicol-palmitate,protein synthesis inhibitor,,BRD-K96424892,chloramphenicol-palmitate,protein synthesis inhibitor,,BRD-K96424892,chloramphenicol-palmitate,protein synthesis inhibitor,,BRD-K33742430,chloramphenicol-palmitate,protein synthesis inhibitor,
PXQPEWDEAKTCGB,BRD-K32572029,orotic-acid,,DHODH,BRD-K32572029,orotic-acid,,DHODH,BRD-K32572029,orotic-acid,,DHODH,BRD-K32572029,orotic-acid,,DHODH
PXZXYRKDDXKDTK,BRD-K25143390,MSX-122,CC chemokine receptor antagonist,CXCR4,BRD-K25143390,MSX-122,CC chemokine receptor antagonist,CXCR4,BRD-K25143390,MSX-122,CC chemokine receptor antagonist,CXCR4,BRD-K25143390,MSX-122,CC chemokine receptor antagonist,CXCR4
PYEBKOFMWAMBFV,BRD-K56596464,QX-314,sodium channel blocker,MAPK14|TGFBR1,BRD-K56596464,QX-314,sodium channel blocker,MAPK14|TGFBR1,BRD-K56596464,QX-314,sodium channel blocker,MAPK14|TGFBR1,BRD-K56596464,QX-314,sodium channel blocker,MAPK14|TGFBR1
PYEFPDQFAZNXLI,BRD-K73789395,ZM-336372,RAF inhibitor,BRAF|LCK|MAPK14|RAF1,BRD-K73789395,ZM-336372,RAF inhibitor,BRAF|LCK|MAPK14|RAF1,BRD-K73789395,ZM-336372,RAF inhibitor,BRAF|LCK|MAPK14|RAF1,BRD-K73789395,ZM-336372,RAF inhibitor,BRAF|LCK|MAPK14|RAF1
PYGWGZALEOIKDF,BRD-K74717603,etravirine,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,BRD-K74717603,etravirine,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,BRD-K74717603,etravirine,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,BRD-K74717603,etravirine,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4
PYKJFEPAUKAXNN,BRD-K55748775,SCH-28080,ATPase inhibitor,ATP4A,BRD-K55748775,SCH-28080,ATPase inhibitor,ATP4A,BRD-K55748775,SCH-28080,ATPase inhibitor,ATP4A,BRD-K55748775,SCH-28080,ATPase inhibitor,ATP4A
PYMYPHUHKUWMLA,BRD-K10759144,xylose,,,BRD-K10759144,xylose,,,BRD-K10759144,xylose,,,BRD-K10759144,xylose,,
PYNXFZCZUAOOQC,BRD-K91456750,sacubitril,neprilysin inhibitor,MME,BRD-K91456750,sacubitril,neprilysin inhibitor,MME,BRD-K91456750|BRD-M32063731,sacubitril,neprilysin inhibitor,MME,BRD-K91456750|BRD-M32063731,sacubitril,neprilysin inhibitor,MME
PYTOHIUBXSJKQH,BRD-K16183658,MN-64,tankyrase inhibitor,TNKS,BRD-K16183658,MN-64,tankyrase inhibitor,TNKS,BRD-K16183658,MN-64,tankyrase inhibitor,TNKS,BRD-K16183658,MN-64,tankyrase inhibitor,TNKS
PYVFWTPEBMRKSR,BRD-K99604664,tanaproget,progesterone receptor agonist,PGR,BRD-K99604664,tanaproget,progesterone receptor agonist,PGR,BRD-K99604664,tanaproget,progesterone receptor agonist,PGR,BRD-K99604664,tanaproget,progesterone receptor agonist,PGR
PYXFVCFISTUSOO,BRD-K60005752,S-111,PARP inhibitor,PARP1,BRD-K60005752,S-111,PARP inhibitor,PARP1,BRD-K60005752,S-111,PARP inhibitor,PARP1,BRD-K60005752,S-111,PARP inhibitor,PARP1
PYZRQGJRPPTADH,BRD-K93460210,lamotrigine,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K93460210,lamotrigine,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K93460210,lamotrigine,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K93460210,lamotrigine,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
PZASAAIJIFDWSB,BRD-A94640958,autotaxin-modulator-1,autotaxin inhibitor,ENPP2,BRD-A94640958,autotaxin-modulator-1,autotaxin inhibitor,ENPP2,BRD-A94640958,autotaxin-modulator-1,autotaxin inhibitor,ENPP2,BRD-A94640958,autotaxin-modulator-1,autotaxin inhibitor,ENPP2
PZBCKZWLPGJMAO,BRD-K24666289,copanlisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K24666289,copanlisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K24666289,copanlisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K24666289,copanlisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
PZBPKYOVPCNPJY,BRD-A11776908,enilconazole,sterol demethylase inhibitor,CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2,BRD-A11776908,enilconazole,sterol demethylase inhibitor,CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2,BRD-A11776908,enilconazole,sterol demethylase inhibitor,CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2,BRD-K01825690,enilconazole,sterol demethylase inhibitor,CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2
PZMVOUYYNKPMSI,BRD-K82343404,adrenalone,adrenergic receptor agonist,ADRA1A,BRD-K82343404,adrenalone,adrenergic receptor agonist,ADRA1A,BRD-K82343404,adrenalone,adrenergic receptor agonist,ADRA1A,BRD-K82343404,adrenalone,adrenergic receptor agonist,ADRA1A
PZNQZSRPDOEBMS,BRD-K66664625,4-iodo-L-phenylalanine,,DPP4,BRD-K66664625,4-iodo-L-phenylalanine,,DPP4,BRD-K66664625,4-iodo-L-phenylalanine,,DPP4,BRD-K66664625,4-iodo-L-phenylalanine,,DPP4
PZRHRDRVRGEVNW,BRD-K67080878,milrinone,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,BRD-K67080878,milrinone,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,BRD-K67080878,milrinone,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,BRD-K67080878,milrinone,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A
PZUJQWHTIRWCID,BRD-K75506300,NPS-2143,calcium receptor antagonist,CASR,BRD-K75506300,NPS-2143,calcium receptor antagonist,CASR,BRD-K75506300,NPS-2143,calcium receptor antagonist,CASR,BRD-K75506300,NPS-2143,calcium receptor antagonist,CASR
PZZOEXPDTYIBPI,BRD-A24429032,BE-2254,adrenergic receptor antagonist,ADRA1A,BRD-A24429032,BE-2254,adrenergic receptor antagonist,ADRA1A,BRD-A24429032,BE-2254,adrenergic receptor antagonist,ADRA1A,BRD-A24429032,BE-2254,adrenergic receptor antagonist,ADRA1A
QADPYRIHXKWUSV,BRD-K42728290,NVP-BGJ398,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|KDR,BRD-K42728290,NVP-BGJ398,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|KDR,BRD-K42728290,NVP-BGJ398,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|KDR,BRD-K42728290,NVP-BGJ398,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|KDR
QAGYKUNXZHXKMR,BRD-K74117820,nelfinavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,BRD-K74117820,nelfinavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,BRD-K74117820,nelfinavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,BRD-K74117820,nelfinavir,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7
QAIMUUJJAJBPCL,BRD-K59204667,DBeQ,ATPase inhibitor,CASP3,BRD-K59204667,DBeQ,ATPase inhibitor,CASP3,BRD-K59204667,DBeQ,ATPase inhibitor,CASP3,BRD-K59204667,DBeQ,ATPase inhibitor,CASP3
QAIPRVGONGVQAS,BRD-K09900591,caffeic-acid,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,ALOX5|MIF,BRD-K09900591,caffeic-acid,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,ALOX5|MIF,BRD-K09900591,caffeic-acid,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,ALOX5|MIF,BRD-K09900591,caffeic-acid,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,ALOX5|MIF
QANMHLXAZMSUEX,BRD-K65667145,kinetin,cell division inducer,,BRD-K65667145,kinetin,cell division inducer,,BRD-K65667145,kinetin,cell division inducer,,BRD-K65667145,kinetin,cell division inducer,
QAOBBBBDJSWHMU,BRD-K92301463,"16,16-dimethylprostaglandin-e2",,,BRD-K92301463,"16,16-dimethylprostaglandin-e2",prostanoid receptor agonist,HPGD,BRD-K92301463,"16,16-dimethylprostaglandin-e2",prostanoid receptor agonist,HPGD,BRD-K92301463,"16,16-dimethylprostaglandin-e2",prostanoid receptor agonist,HPGD
QAPAJIZPZGWAND,BRD-K50387473,XMD8-92,MAP kinase inhibitor,DCLK2|MAPK7|PLK4|TNK1,BRD-K50387473,XMD8-92,MAP kinase inhibitor,DCLK2|MAPK7|PLK4|TNK1,BRD-K50387473,XMD8-92,MAP kinase inhibitor,DCLK2|MAPK7|PLK4|TNK1,BRD-K50387473,XMD8-92,MAP kinase inhibitor,DCLK2|MAPK7|PLK4|TNK1
QAWBIEIZDDIEMW,BRD-K00152668,adarotene,retinoid receptor agonist,RARB|RARG,BRD-K00152668,adarotene,retinoid receptor agonist,RARB|RARG,BRD-K00152668,adarotene,retinoid receptor agonist,RARB|RARG,BRD-K00152668,adarotene,retinoid receptor agonist,RARB|RARG
QAWIHIJWNYOLBE,BRD-K13050541,acivicin,gamma glutamyltransferase Inhibitors,CTPS1,BRD-K13050541,acivicin,gamma glutamyltransferase Inhibitors,CTPS1,BRD-K13050541,acivicin,gamma glutamyltransferase Inhibitors,CTPS1,BRD-K13050541,acivicin,gamma glutamyltransferase inhibitor,CTPS1
QAXBVGVYDCAVLV,BRD-A30582499,tiletamine,glutamate receptor antagonist,,BRD-A30582499,tiletamine,glutamate receptor antagonist,,BRD-A30582499,tiletamine,glutamate receptor antagonist,,,,,
QBGKPEROWUKSBK,BRD-A78210457,RG7112,MDM inhibitor,MDM2,BRD-A78210457,RG7112,MDM inhibitor,MDM2,BRD-A78210457,RG7112,MDM inhibitor,MDM2,BRD-K13178532,RG7112,MDM inhibitor,MDM2
QBKSWRVVCFFDOT,BRD-K19295594,gossypol,BCL inhibitor|MCL1 inhibitor,BCL2,BRD-K19295594,gossypol,BCL inhibitor|MCL1 inhibitor,BCL2,BRD-K19295594,gossypol,BCL inhibitor|MCL1 inhibitor,BCL2,BRD-K19295594,gossypol,BCL inhibitor|MCL1 inhibitor,BCL2
QBPFLULOKWLNNW,BRD-K10065684,dantron,laxative,,BRD-K10065684,dantron,laxative,,BRD-K10065684,dantron,laxative,,BRD-K10065684,dantron,laxative,
QBUVZVXIRYFENV,BRD-A64227845,SKF-77434,dopamine receptor agonist,DRD1,BRD-A64227845,SKF-77434,dopamine receptor agonist,DRD1,BRD-A64227845,SKF-77434,dopamine receptor agonist,DRD1,BRD-A64227845,SKF-77434,dopamine receptor agonist,DRD1
QBXHUZJZYDSLRH,BRD-A60594020,8-hydroxy-PIPAT,dopamine receptor ligand,DRD2|DRD3,BRD-A60594020,8-hydroxy-PIPAT,dopamine receptor ligand,DRD2|DRD3,BRD-A60594020,8-hydroxy-PIPAT,dopamine receptor ligand,DRD2|DRD3,BRD-A60594020,8-hydroxy-PIPAT,dopamine receptor ligand,DRD2|DRD3
QCAWBJDECIOVBU,BRD-K19741031,EUK-134,catalase stimulant,APP|SOD2,BRD-K19741031,EUK-134,catalase stimulant,APP|SOD2,BRD-K19741031|BRD-U78472365|BRD-U78671345,EUK-134,catalase stimulant,APP|SOD2,BRD-K19741031|BRD-U78472365|BRD-U78671345,EUK-134,catalase stimulant,APP|SOD2
QCBUAKLOWCOUCR,BRD-K54093161,CGS-9896,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,BRD-K54093161,CGS-9896,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,BRD-K54093161,CGS-9896,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,BRD-K54093161,CGS-9896,GABA receptor antagonist,GABRA1|GABRB2|GABRG2
QCDFBFJGMNKBDO,BRD-K09255212,clioquinol,chelating agent,OPRK1,BRD-K09255212,clioquinol,chelating agent,OPRK1,BRD-K09255212,clioquinol,chelating agent,OPRK1,BRD-K09255212,clioquinol,chelating agent,OPRK1
QCDYQQDYXPDABM,BRD-K00405906,phloroglucin,,,BRD-K00405906,phloroglucin,,,BRD-K00405906,phloroglucin,,,BRD-K00405906,phloroglucin,,
QCGUSIANLFXSGE,BRD-K89121095,tedizolid-phosphate,protein synthesis inhibitor,,BRD-K89121095,tedizolid-phosphate,protein synthesis inhibitor,,BRD-K89121095,tedizolid-phosphate,protein synthesis inhibitor,,BRD-K89121095,tedizolid-phosphate,protein synthesis inhibitor,
QCHFTSOMWOSFHM,BRD-K85090592,pilocarpine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K85090592,pilocarpine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K85090592,pilocarpine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K85090592,pilocarpine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
QCLFSYYUWPUWQR,BRD-K03044000,80841-78-7,,,BRD-K03044000,80841-78-7,,,BRD-K03044000,80841-78-7,,,BRD-K03044000,80841-78-7,,
QCVNMNYRNIMDKV,BRD-K50489389,ranirestat,aldose reductase inhibitor,AKR1B1,BRD-K50489389,ranirestat,aldose reductase inhibitor,AKR1B1,BRD-K50489389,ranirestat,aldose reductase inhibitor,AKR1B1,BRD-K50489389,ranirestat,aldose reductase inhibitor,AKR1B1
QCXJEYYXVJIFCE,BRD-K47195926,acedoben,,,BRD-K47195926,acedoben,,,BRD-K47195926,acedoben,,,BRD-K47195926,acedoben,,
QCYCDKUNJFKYEI,BRD-M80207679,nemonapride,dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-M80207679,nemonapride,dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-M80207679,nemonapride,dopamine receptor antagonist,DRD2|DRD3|DRD4,,,,
QDBVSOZTVKXUES,BRD-K25611237,ML324,histone lysine demethylase inhibitor,KDM4A,BRD-K25611237,ML324,histone lysine demethylase inhibitor,KDM4A,BRD-K25611237,ML324,histone lysine demethylase inhibitor,KDM4A,BRD-K25611237,ML324,histone lysine demethylase inhibitor,KDM4A
QDDILOVMGWUNGD,BRD-K94948151,macelignan,antiinflammatory agent|antioxidant,,BRD-K94948151,macelignan,antiinflammatory agent|antioxidant,,BRD-K94948151,macelignan,antiinflammatory agent|antioxidant,,BRD-K94948151,macelignan,anti-inflammatory agent|antioxidant,
QDGZDCVAUDNJFG,BRD-K08206212,entecavir,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-K08206212,entecavir,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-K08206212,entecavir,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-K08206212,entecavir,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,
QDITZBLZQQZVEE,BRD-K06750613,GSK1059615,PI3K inhibitor,PIK3CG,BRD-K06750613,GSK1059615,PI3K inhibitor,PIK3CG,BRD-K06750613,GSK1059615,PI3K inhibitor,PIK3CG,BRD-K06750613,GSK1059615,PI3K inhibitor,PIK3CG
QDLHCMPXEPAAMD,BRD-K62662086|BRD-K87343924,wortmannin,PI3K inhibitor,PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC,BRD-A75409952|BRD-K87343924,wortmannin,PI3K inhibitor,PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC,BRD-K62662086|BRD-K87343924,wortmannin,PI3K inhibitor,PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC,BRD-K62662086|BRD-K87343924,wortmannin,PI3K inhibitor,PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC
QDMAKDIDFJTXEL,BRD-K13211965,L-741742,dopamine receptor antagonist,DRD3|DRD4|SCN1A|SCN3A,BRD-K13211965,L-741742,dopamine receptor antagonist,DRD3|DRD4|SCN1A|SCN3A,BRD-K13211965,L-741742,dopamine receptor antagonist,DRD3|DRD4|SCN1A|SCN3A,BRD-K13211965,L-741742,dopamine receptor antagonist,DRD3|DRD4|SCN1A|SCN3A
QDMXVKKPYBGIAS,BRD-K60952143,SR-3306,JNK inhibitor,MAPK10|MAPK8|MAPK9,BRD-K60952143,SR-3306,JNK inhibitor,MAPK10|MAPK8|MAPK9,BRD-K60952143,SR-3306,JNK inhibitor,MAPK10|MAPK8|MAPK9,BRD-K60952143,SR-3306,JNK inhibitor,MAPK10|MAPK8|MAPK9
QDUIJCOKQCCXQY,BRD-K46970505,cefozopran,bacterial cell wall synthesis inhibitor,,BRD-K46970505,cefozopran,bacterial cell wall synthesis inhibitor,,BRD-K46970505,cefozopran,bacterial cell wall synthesis inhibitor,,BRD-K46970505,cefozopran,bacterial cell wall synthesis inhibitor,
QDYLMAYUEZBUFO,BRD-K23403298,benzyldimethylhexadecylammonium,cationic surfactant,,BRD-K23403298,benzyldimethylhexadecylammonium,cationic surfactant,,BRD-K23403298,benzyldimethylhexadecylammonium,cationic surfactant,,BRD-K23403298,benzyldimethylhexadecylammonium,cationic surfactant,
QECMENZMDBOLDR,BRD-K15811707,CPI-203,bromodomain inhibitor,BRD4,BRD-K15811707,CPI-203,bromodomain inhibitor,BRD4,BRD-K15811707,CPI-203,bromodomain inhibitor,BRD4,BRD-K15811707,CPI-203,bromodomain inhibitor,BRD4
QEFAQIPZVLVERP,BRD-K04112579,nepafenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K04112579,nepafenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K04112579,nepafenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K04112579,nepafenac,cyclooxygenase inhibitor,PTGS1|PTGS2
QELSKZZBTMNZEB,BRD-K60783397,propylparaben,,,BRD-K60783397,propylparaben,,,BRD-K60783397,propylparaben,,,BRD-K60783397,propylparaben,,
QELUYTUMUWHWMC,BRD-K35458079,edaravone,nootropic agent,BCL2,BRD-K35458079,edaravone,nootropic agent,BCL2,BRD-K35458079,edaravone,nootropic agent,BCL2,,,,
QEMSVZNTSXPFJA,BRD-K38158531,traxoprodil,glutamate receptor antagonist,GRIN2B,BRD-K38158531,traxoprodil,glutamate receptor antagonist,GRIN2B,BRD-K38158531,traxoprodil,glutamate receptor antagonist,GRIN2B,BRD-K38158531,traxoprodil,glutamate receptor antagonist,GRIN2B
QESQGTFWEQMCMH,BRD-K53234107,IWP-L6,porcupine inhibitor,PORCN,BRD-K53234107,IWP-L6,porcupine inhibitor,PORCN,BRD-K53234107,IWP-L6,porcupine inhibitor,PORCN,BRD-K53234107,IWP-L6,porcupine inhibitor,PORCN
QEVHRUUCFGRFIF,BRD-K95921201,reserpine,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,BRD-K95921201,reserpine,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,BRD-K95921201,reserpine,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,BRD-K95921201,reserpine,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2
QEYNZJBVNYDZKZ,BRD-K44825564,ZAPA,,,BRD-K44825564,ZAPA,,,BRD-K44825564,ZAPA,,,BRD-K44825564,ZAPA,,
QFCXANHHBCGMAS,BRD-K84564571,telatinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K84564571,telatinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K84564571,telatinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,BRD-K84564571,telatinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR
QFFGVLORLPOAEC,BRD-K10196357,besifloxacin,bacterial DNA gyrase inhibitor,,BRD-K10196357,besifloxacin,bacterial DNA gyrase inhibitor,,BRD-K10196357,besifloxacin,bacterial DNA gyrase inhibitor,,BRD-K10196357,besifloxacin,bacterial DNA gyrase inhibitor,
QFGMXJOBTNZHEL,BRD-K92116564,isoxepac,anti-inflammatory agent,,BRD-K92116564,isoxepac,anti-inflammatory agent,,BRD-K92116564,isoxepac,anti-inflammatory agent,,BRD-K92116564,isoxepac,anti-inflammatory agent,
QFJCIRLUMZQUOT,BRD-A79768653|BRD-K84937637,sirolimus,mTOR inhibitor,FGF2|FKBP1A|MTOR,BRD-A79768653|BRD-K84937637,sirolimus,mTOR inhibitor,FGF2|FKBP1A|MTOR,BRD-A79768653|BRD-K79988249|BRD-K84937637,sirolimus,mTOR inhibitor,FGF2|FKBP1A|MTOR,BRD-K79988249|BRD-K84937637,sirolimus,mTOR inhibitor,FKBP1A|MTOR
QFJIQUOMKJNYLI,BRD-A53504839,sennoside-protonated,,,BRD-A53504839,sennoside-protonated,,,BRD-A53504839,sennoside-protonated,,,BRD-A30370660|BRD-A53504839,sennoside-A|sennoside-protonated,|glycoside agonist,
QFLOJAMZLQXHFS,BRD-A06784547,MRS1334,adenosine receptor antagonist,ADORA3,BRD-A06784547,MRS1334,adenosine receptor antagonist,ADORA3,BRD-A06784547,MRS1334,adenosine receptor antagonist,ADORA3,BRD-A06784547,MRS-1334,adenosine receptor antagonist,ADORA3
QFNHIDANIVGXPE,BRD-K39560679,eluxadoline,opioid receptor modulator,OPRD1|OPRK1|OPRM1,BRD-K39560679,eluxadoline,opioid receptor modulator,OPRD1|OPRK1|OPRM1,BRD-K39560679,eluxadoline,opioid receptor modulator,OPRD1|OPRK1|OPRM1,BRD-K39560679,eluxadoline,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1
QFOHBWFCKVYLES,BRD-K08287586,butyl-paraben,DNA synthesis inhibitor,,BRD-K08287586,butyl-paraben,DNA synthesis inhibitor,,BRD-K08287586,butyl-paraben,DNA synthesis inhibitor,,BRD-K08287586,butyl-paraben,DNA synthesis inhibitor,
QFQZKISCBJKVHI,BRD-K06817181,"1,2,3,4,5,6-hexabromocyclohexane",,,BRD-K06817181,"1,2,3,4,5,6-hexabromocyclohexane",JAK inhibitor,JAK2,BRD-K06817181,"1,2,3,4,5,6-hexabromocyclohexane",JAK inhibitor,JAK2,BRD-K06817181,"1,2,3,4,5,6-hexabromocyclohexane",JAK inhibitor,JAK2
QFRLDZGQEZCCJZ,BRD-K73982490,BI-78D3,JNK inhibitor,MAPK8,BRD-K73982490,BI-78D3,JNK inhibitor,MAPK8,BRD-K73982490,BI-78D3,JNK inhibitor,MAPK8,BRD-K73982490,BI-78D3,JNK inhibitor,MAPK8
QFVAWNPSRQWSDU,BRD-K72384124,sulbentine,other antifungal,,BRD-K72384124,sulbentine,other antifungal,,BRD-K72384124|BRD-K73698987,sulbentine,other antifungal,,BRD-K72384124|BRD-K73698987,sulbentine,other antifungal,
QFWCYNPOPKQOKV,BRD-K62810658,PD-98059,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,BRD-K62810658,PD-98059,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,BRD-K62810658,PD-98059,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,BRD-K62810658,PD-98059,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1
QFWSRMACUIYPGS,BRD-A35868371,troventol,,,BRD-A35868371,troventol,,,BRD-A35868371,troventol,,,BRD-A35868371,troventol,,
QFXKXRXFBRLLPQ,BRD-K65814004,diphenyleneiodonium,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K65814004,diphenyleneiodonium,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K65814004,diphenyleneiodonium,nitric oxide synthase inhibitor,NOS2|NOS3,,,,
QGEGSJUSWLLZLH,BRD-K12120659,GR-144053,integrin antagonist,ITGA2B|ITGB3,BRD-K12120659,GR-144053,integrin antagonist,ITGA2B|ITGB3,BRD-K12120659,GR-144053,integrin antagonist,ITGA2B|ITGB3,BRD-K12120659,GR-144053,integrin antagonist,ITGA2B|ITGB3
QGFORSXNKQLDNO,BRD-A05515753,erdosteine,mucolytic agent,,BRD-A05515753,erdosteine,mucolytic agent,,BRD-A05515753,erdosteine,mucolytic agent,,BRD-A05515753,erdosteine,mucolytic agent,
QGHREAKMXXNCOA,BRD-K90168339,thiophanate,,,BRD-K90168339,thiophanate,,,BRD-K90168339,thiophanate,,,BRD-K90168339,thiophanate,,
QGJUIPDUBHWZPV,BRD-A82156122,saxagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A81513827,saxagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A81513827|BRD-A82156122,saxagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K00003546,saxagliptin,dipeptidyl peptidase inhibitor,DPP4
QGJZLNKBHJESQX,BRD-K38744518|BRD-K45401373,betulinic-acid,NFkB pathway inhibitor|apoptosis stimulant,GPBAR1,BRD-K38744518|BRD-K45401373,betulinic-acid,NFkB pathway inhibitor|apoptosis stimulant,GPBAR1,BRD-K15168723|BRD-K38744518|BRD-K45401373,betulinic-acid,NFkB pathway inhibitor|apoptosis stimulant,GPBAR1,BRD-K15168723|BRD-K38744518|BRD-K45401373,betulinic-acid,NFkB pathway inhibitor|apoptosis stimulant,GPBAR1
QGNJRVVDBSJHIZ,BRD-K65331431,retinyl-acetate,,,BRD-K65331431,retinyl-acetate,,,BRD-K65331431,retinyl-acetate,,,BRD-K65331431,retinyl-acetate,,
QGPKADBNRMWEQR,BRD-A93964801,clinafloxacin,bacterial DNA gyrase inhibitor,,BRD-A93964801,clinafloxacin,bacterial DNA gyrase inhibitor,,BRD-A93964801,clinafloxacin,bacterial DNA gyrase inhibitor,,BRD-K01825499,clinafloxacin,bacterial DNA gyrase inhibitor,
QGXBDMJGAMFCBF,BRD-A43598550|BRD-K12329651|BRD-K42756753,3-alpha-Hydroxy-5-beta-androstan-17-one|androsterone|epiandrosterone,|androgen receptor agonist|steroid,|G6PD,BRD-A43598550|BRD-K12329651|BRD-K42756753,3-alpha-Hydroxy-5-beta-androstan-17-one|androsterone|epiandrosterone,|androgen receptor agonist|steroid,|G6PD,BRD-A43598550|BRD-K12329651|BRD-K42756753,3-alpha-Hydroxy-5-beta-androstan-17-one|androsterone|epiandrosterone,|androgen receptor agonist|steroid,|G6PD,BRD-A43598550|BRD-K03972660|BRD-K12329651,3-alpha-hydroxy-5-beta-androstan-17-one|androsterone|epiandrosterone,|androgen receptor agonist|steroid,|G6PD|HSD17B11|IGHG2|SULT2A1
QGZYDVAGYRLSKP,BRD-K82928847,ACY-1215,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,BRD-K82928847,ACY-1215,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,BRD-K82928847,ACY-1215,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,BRD-K82928847,ACY-1215,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8
QHADVLVFMKEIIP,BRD-K18961567,LY2801653,MET inhibitor,MET,BRD-K18961567,LY2801653,MET inhibitor,MET,BRD-K18961567,LY2801653,MET inhibitor,MET,BRD-K18961567,LY2801653,MET inhibitor,MET
QHGUCRYDKWKLMG,BRD-A14240607,octopamine,trace amine associated receptor agonist,F10|TAAR1,BRD-A14240607,octopamine,trace amine associated receptor agonist,F10|TAAR1,BRD-A14240607,octopamine,trace amine associated receptor agonist,F10|TAAR1,BRD-A14240607,octopamine,trace amine associated receptor agonist,F10|TAAR1
QHHSCLARESIWBH,BRD-K18280217,Nampt-IN-1,,,BRD-K18280217,Nampt-IN-1,,,BRD-K18280217,Nampt-IN-1,,,BRD-K18280217,Nampt-IN-1,,
QHKYPYXTTXKZST,BRD-K54330070,SB-202190,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-K54330070,SB-202190,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-K54330070,SB-202190,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-K54330070,SB-202190,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1
QHLVBNKYJGBCQJ,BRD-K83699324,NMS-1286937,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,BRD-K83699324,NMS-1286937,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,BRD-K83699324,NMS-1286937,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,BRD-K83699324,NMS-1286937,PLK inhibitor,FLT3|PLK1|PLK2|PLK3
QHMWCHQXCUNUAK,BRD-A00218260,flutrimazole,sterol demethylase inhibitor,,BRD-A00218260,flutrimazole,sterol demethylase inhibitor,,BRD-A00218260,flutrimazole,sterol demethylase inhibitor,,BRD-A00218260,flutrimazole,sterol demethylase inhibitor,
QHPQWRBYOIRBIT,BRD-K06338106,4-tert-butylphenol,,,BRD-K06338106,4-tert-butylphenol,,,BRD-K06338106,4-tert-butylphenol,,,BRD-K06338106,4-tert-butylphenol,,
QIAFMBKCNZACKA,BRD-K62914667,hippuric-acid,,,BRD-K62914667,hippuric-acid,,,BRD-K62914667,hippuric-acid,,,BRD-K62914667,hippuric-acid,,
QIALRBLEEWJACW,BRD-K61237927,eslicarbazepine-acetate,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K61237927,eslicarbazepine-acetate,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K61237927,eslicarbazepine-acetate,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K61237927,eslicarbazepine-acetate,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
QIGBRXMKCJKVMJ,BRD-K11227669,hydroquinone,melanin inhibitor,TYR,BRD-K11227669,hydroquinone,melanin inhibitor,TYR,BRD-K11227669,hydroquinone,melanin inhibitor,TYR,BRD-K11227669,hydroquinone,melanin inhibitor,TYR
QIHBWVVVRYYYRO,BRD-A63444178,ME0328,PARP inhibitor,PARP3,BRD-A63444178|BRD-K24283677,ME-0328|ME0328,PARP inhibitor|PPAR receptor antagonist,PARP3,BRD-A63444178|BRD-K24283677,ME-0328|ME0328,PARP inhibitor|PPAR receptor antagonist,PARP3,BRD-A63444178|BRD-K24283677,ME-0328|ME0328,PARP inhibitor|PPAR receptor antagonist,PARP3
QIHLUZAFSSMXHQ,BRD-K18324993,budipine,glutamate receptor antagonist,GRIN1,BRD-K18324993,budipine,glutamate receptor antagonist,GRIN1,BRD-K18324993,budipine,glutamate receptor antagonist,GRIN1,BRD-K18324993,budipine,glutamate receptor antagonist,GRIN1
QIIVJLHCZUTGSD,BRD-K12068470|BRD-K69247090,LY2608204,glucokinase activator,GCK,BRD-K12068470|BRD-K69247090,LY2608204,glucokinase activator,GCK,BRD-K12068470|BRD-K69247090,LY2608204,glucokinase activator,GCK,BRD-K12068470|BRD-K69247090,LY2608204,glucokinase activator,GCK
QINPEPAQOBZPOF,BRD-K49456274,pilaralisib,PI3K inhibitor,,BRD-K49456274,pilaralisib,PI3K inhibitor,,BRD-K49456274,pilaralisib,PI3K inhibitor,,BRD-K49456274,pilaralisib,PI3K inhibitor,
QIPQASLPWJVQMH,BRD-K63001556|BRD-K68153448,orbifloxacin,bacterial DNA gyrase inhibitor,,BRD-K63001556|BRD-K68153448,orbifloxacin,bacterial DNA gyrase inhibitor,,BRD-K63001556|BRD-K68153448,orbifloxacin,bacterial DNA gyrase inhibitor,,BRD-K63001556|BRD-K68153448,orbifloxacin,bacterial DNA gyrase inhibitor,
QIVBCDIJIAJPQS,BRD-K83776863,tryptophan,serotonin receptor partial agonist,CASR|IDO1|SLC36A1|WARS|WARS2,BRD-K83776863,tryptophan,serotonin receptor partial agonist,CASR|IDO1|SLC36A1|WARS|WARS2,BRD-K83776863,tryptophan,serotonin receptor partial agonist,CASR|IDO1|SLC36A1|WARS|WARS2,BRD-K83776863,tryptophan,serotonin receptor partial agonist,CASR|IDO1|SLC36A1|WARS|WARS2
QJERBBQXOMUURJ,BRD-A87983072,benzotript,CCK receptor antagonist,CCKAR|CCKBR,BRD-A87983072,benzotript,CCK receptor antagonist,CCKAR|CCKBR,BRD-A87983072,benzotript,CCK receptor antagonist,CCKAR|CCKBR,BRD-K33219230,benzotript,CCK receptor antagonist,CCKAR|CCKBR
QJFSABGVXDWMIW,BRD-K25723200,azilsartan-medoxomil,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-K25723200,azilsartan-medoxomil,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-K25723200,azilsartan-medoxomil,angiotensin receptor antagonist,AGTR1|AGTR2,BRD-K25723200,azilsartan-medoxomil,angiotensin receptor antagonist,AGTR1|AGTR2
QJHCTHPYUOXOGM,BRD-A51829654,BRL-15572,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,BRD-A51829654,BRL-15572,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,BRD-A51829654,BRL-15572,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,BRD-K01826777,BRL-15572,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6
QJJXYPPXXYFBGM,BRD-A96754982|BRD-K54509797|BRD-K69608737,tacrolimus,calcineurin inhibitor,FKBP1A,BRD-A96754982|BRD-K69608737,tacrolimus,calcineurin inhibitor,FKBP1A,BRD-A96754982|BRD-K54509797|BRD-K69608737,tacrolimus,calcineurin inhibitor,FKBP1A,BRD-A96754982|BRD-K54509797|BRD-K69608737,tacrolimus,calcineurin inhibitor,FKBP1A
QJMCKEPOKRERLN,BRD-K94146583,didox,ribonucleotide reductase inhibitor,RRM1,BRD-K94146583,didox,ribonucleotide reductase inhibitor,RRM1,BRD-K94146583,didox,ribonucleotide reductase inhibitor,RRM1,BRD-K94146583,didox,ribonucleotide reductase inhibitor,RRM1
QJQORSLQNXDVGE,BRD-K36395411,SB-206553,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K36395411,SB-206553,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K36395411,SB-206553,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K36395411,SB-206553,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
QJRYYOWARFCJQZ,BRD-K90042229,N-cyanopyrrolidine,,CTSK,BRD-K90042229,N-cyanopyrrolidine,,CTSK,BRD-K90042229,N-cyanopyrrolidine,,CTSK,,,,
QJZQFVRFJCGDKF,BRD-K27983781,MK-2894,prostaglandin inhibitor,PTGER4,BRD-K27983781,MK-2894,prostaglandin inhibitor,PTGER4,BRD-K27983781,MK-2894,prostaglandin inhibitor,PTGER4,BRD-K27983781,MK-2894,prostaglandin inhibitor,PTGER4
QJZRFPJCWMNVAV,BRD-K64881305,ispinesib,kinesin inhibitor,KIF11,BRD-K64881305,ispinesib,kinesin inhibitor,KIF11,BRD-K64881305,ispinesib,kinesin inhibitor,KIF11,BRD-K64881305,ispinesib,kinesin inhibitor,KIF11
QKDDJDBFONZGBW,BRD-K63874012,thioperamide,histamine receptor antagonist,HRH3|HRH4,BRD-K63874012,thioperamide,histamine receptor antagonist,HRH3|HRH4,BRD-K63874012,thioperamide,histamine receptor antagonist,HRH3|HRH4,,,,
QKDRXGFQVGOQKS,BRD-K05850076,sotagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K05850076,sotagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K05850076,sotagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K05850076,sotagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2
QKKIWEILHCXECO,BRD-K66908976,URMC-099,mixed lineage kinase inhibitor,CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2,BRD-K66908976,URMC-099,mixed lineage kinase inhibitor,CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2,BRD-K66908976,URMC-099,mixed lineage kinase inhibitor,CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2,BRD-K66908976,URMC-099,mixed lineage kinase inhibitor,CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2
QKOWACXSXTXRKA,BRD-K95609758,BMS-191011,potassium channel activator,KCNMA1,BRD-K95609758,BMS-191011,potassium channel activator,KCNMA1,BRD-K95609758,BMS-191011,potassium channel activator,KCNMA1,BRD-K95609758,BMS-191011,potassium channel activator,KCNMA1
QLFZZSKTJWDQOS,BRD-A16350940,doramectin,,,BRD-A16350940,doramectin,,,BRD-A16350940,doramectin,,,BRD-K00003581,doramectin,,
QLGKMLRGKPKGKI,BRD-K42140276,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1,BRD-K42140276,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1,BRD-K42140276,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1,BRD-K42140276,alarelin,gonadotropin releasing factor hormone receptor antagonist,GNRH1
QLHHRYZMBGPBJG,BRD-A45498368,WYE-125132,mTOR inhibitor,MTOR,BRD-A45498368,WYE-125132,mTOR inhibitor,MTOR,BRD-A45498368,WYE-125132,mTOR inhibitor,MTOR,BRD-K00003540,WYE-125132,mTOR inhibitor,MTOR
QLIIKPVHVRXHRI,BRD-K50265942,mometasone,glucocorticoid receptor agonist,NR3C1,BRD-K50265942,mometasone,glucocorticoid receptor agonist,NR3C1,BRD-K50265942,mometasone,glucocorticoid receptor agonist,NR3C1,BRD-K50265942,mometasone,glucocorticoid receptor agonist,NR3C1
QLJOSZATCBCBDR,BRD-K72226571,A77636,dopamine receptor agonist,CALY,BRD-K72226571,A77636,dopamine receptor agonist,CALY,BRD-K72226571,A77636,dopamine receptor agonist,CALY,BRD-K72226571,A77636,dopamine receptor agonist,CALY
QLLGKCJUPWYJON,BRD-K66213167,RX-3117,CDK inhibitor|DNA synthesis inhibitor,CDK2|DNMT1,BRD-K66213167,RX-3117,CDK inhibitor|DNA synthesis inhibitor,CDK2|DNMT1,BRD-K66213167,RX-3117,CDK inhibitor|DNA synthesis inhibitor,CDK2|DNMT1,BRD-K66213167,RX-3117,CDK inhibitor|DNA synthesis inhibitor,CDK2|DNMT1
QLNWXBAGRTUKKI,BRD-K16474819,metacetamol,analgesic agent,,BRD-K16474819,metacetamol,analgesic agent,,BRD-K16474819,metacetamol,analgesic agent,,BRD-K16474819,metacetamol,analgesic agent,
QLTVVOATEHFXLT,BRD-A78134170,cadralazine,adrenergic receptor antagonist,,BRD-A78134170,cadralazine,adrenergic receptor antagonist,,BRD-A78134170,cadralazine,adrenergic receptor antagonist,,BRD-A78134170,cadralazine,adrenergic receptor antagonist,
QLUYMIVVAYRECT,BRD-K51791723,P276-00,CDK inhibitor,CDK1|CDK4|CDK9,BRD-K51791723,P276-00,CDK inhibitor,CDK1|CDK4|CDK9,BRD-K51791723,P276-00,CDK inhibitor,CDK1|CDK4|CDK9,BRD-K51791723,P276-00,CDK inhibitor,CDK1|CDK4|CDK9
QLYHOWIZHHZGPV,BRD-K61695967,MKT-077,HSP inhibitor,,BRD-K61695967,MKT-077,HSP inhibitor,,BRD-K61695967,MKT-077,HSP inhibitor,,BRD-K61695967,MKT-077,HSP inhibitor,
QLYKJCMUNUWAGO,BRD-K35169477,taranabant,cannabinoid receptor inverse agonist,CNR1,BRD-K35169477,taranabant,cannabinoid receptor inverse agonist,CNR1,BRD-K35169477,taranabant,cannabinoid receptor inverse agonist,CNR1,BRD-K35169477,taranabant,cannabinoid receptor inverse agonist,CNR1
QMBJSIBWORFWQT,BRD-A01593789,chlormadinone-acetate,5 alpha reductase inhibitor,PGR,BRD-A01593789,chlormadinone-acetate,5 alpha reductase inhibitor,PGR,BRD-A01593789,chlormadinone-acetate,5 alpha reductase inhibitor,PGR,BRD-K38704569,chlormadinone-acetate,5 alpha reductase inhibitor,PGR
QMCOPDWHWYSJSA,BRD-K61951118,FG-7142,GABA benzodiazepine site receptor inverse agonist,,BRD-K61951118,FG-7142,GABA benzodiazepine site receptor inverse agonist,,BRD-K61951118,FG-7142,GABA benzodiazepine site receptor inverse agonist,,BRD-K61951118,FG-7142,GABA benzodiazepine site receptor inverse agonist,
QMDKVNSQXPVCRD,BRD-K33586289,EPZ020411,protein arginine N-methyltransferase inhibitor,PRMT6,BRD-K33586289,EPZ020411,protein arginine N-methyltransferase inhibitor,PRMT6,BRD-K33586289,EPZ020411,protein arginine N-methyltransferase inhibitor,PRMT6,BRD-K33586289,EPZ020411,protein arginine N-methyltransferase inhibitor,PRMT6
QMGUOJYZJKLOLH,BRD-K31342827,GF109203X,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,BRD-K31342827,GF109203X,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,BRD-K31342827,GF109203X,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,BRD-K31342827,GF109203X,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ
QMGVPVSNSZLJIA,BRD-A09094913,strychnine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB,BRD-A09094913,strychnine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB,BRD-A09094913,strychnine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB,BRD-K72572686,strychnine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB
QMHSXPLYMTVAMK,BRD-K39479472,pyrvinium-pamoate,androgen receptor antagonist,AR,BRD-K39479472,pyrvinium-pamoate,androgen receptor antagonist,AR,BRD-K39479472,pyrvinium-pamoate,androgen receptor antagonist,AR,BRD-K39479472,pyrvinium-pamoate,androgen receptor antagonist,AR
QMLVECGLEOSESV,BRD-K45916615,danofloxacin,bacterial DNA gyrase inhibitor,,BRD-K45916615,danofloxacin,bacterial DNA gyrase inhibitor,,BRD-K45916615,danofloxacin,bacterial DNA gyrase inhibitor,,BRD-K45916615,danofloxacin,bacterial DNA gyrase inhibitor,
QMNUDYFKZYBWQX,BRD-K91758890,4-HQN,PARP inhibitor,PARP1,BRD-K91758890,4-HQN,PARP inhibitor,PARP1,BRD-K91758890,4-HQN,PARP inhibitor,PARP1,BRD-K91758890,4-HQN,PARP inhibitor,PARP1
QMNWISYXSJWHRY,BRD-K56653660,astragaloside-a,antiinflammatory agent,,BRD-K08188887,astragaloside-a,antiinflammatory agent,,BRD-K08188887|BRD-K56653660,astragaloside-a,antiinflammatory agent,,BRD-K08188887|BRD-K56653660,astragaloside-a,anti-inflammatory agent,
QNAYBMKLOCPYGJ,BRD-A33317514|BRD-K25125382,L-alanine|alanine,,|AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8,BRD-A33317514|BRD-K25125382,L-alanine|alanine,,|AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8,BRD-A33317514|BRD-K25125382,L-alanine|alanine,,|AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8,BRD-A33317514|BRD-K25125382,L-alanine|alanine,,|AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8
QNAZTOHXCZPOSA,BRD-K85406984,sobetirome,thyroid hormone receptor agonist,THRA|THRB,BRD-K85406984,sobetirome,thyroid hormone receptor agonist,THRA|THRB,BRD-K85406984,sobetirome,thyroid hormone receptor agonist,THRA|THRB,BRD-K85406984,sobetirome,thyroid hormone receptor agonist,THRA|THRB
QNIVIMYXGGFTAK,BRD-A37873789,octodrine,antitumor agent,,BRD-A37873789,octodrine,antitumor agent,,BRD-A37873789,octodrine,antitumor agent,,BRD-A37873789,octodrine,antitumor agent,
QNJKSUYWBCNWFI,BRD-A27249758|BRD-A49035384,methacycline,protein synthesis inhibitor,,BRD-A27249758|BRD-A49035384,methacycline,protein synthesis inhibitor,,BRD-A27249758|BRD-A49035384,methacycline,protein synthesis inhibitor,,BRD-K00003351,methacycline,protein synthesis inhibitor,
QNOCRUSVMMAKSC,BRD-K14529030,meisoindigo,STAT inhibitor,STAT3,BRD-K14529030,meisoindigo,STAT inhibitor,STAT3,BRD-K14529030,meisoindigo,STAT inhibitor,STAT3,BRD-K14529030,meisoindigo,STAT inhibitor,STAT3
QNOXYUNHIGOWNY,BRD-K76064317,tyrphostin-AG-1296,FLT3 inhibitor,FLT3,BRD-K76064317,tyrphostin-AG-1296,FLT3 inhibitor,FLT3,BRD-K76064317,tyrphostin-AG-1296,FLT3 inhibitor,FLT3,BRD-K76064317,tyrphostin-AG-1296,FLT3 inhibitor,FLT3
QNQZBKQEIFTHFZ,BRD-K07609981,dexloxiglumide,CCK receptor antagonist,CCKAR,BRD-K07609981,dexloxiglumide,CCK receptor antagonist,CCKAR,BRD-K07609981,dexloxiglumide,CCK receptor antagonist,CCKAR,BRD-K07609981,dexloxiglumide,CCK receptor antagonist,CCKAR
QNQZWEGMKJBHEM,BRD-K31476763,AZD9668,elastase inhibitor,ELANE,BRD-K31476763,AZD9668,elastase inhibitor,ELANE,BRD-K31476763,AZD9668,elastase inhibitor,ELANE,BRD-K31476763,AZD9668,elastase inhibitor,ELANE
QNTASHOAVRSLMD,BRD-A33931310|BRD-K18210059,TRO19622|olesoxime,apoptosis inhibitor|apoptosis stimulant,,BRD-K18210059,olesoxime,apoptosis stimulant,,BRD-A33931310|BRD-K18210059,olesoxime,apoptosis stimulant,,BRD-A33931310|BRD-K18210059,olesoxime,apoptosis stimulant,
QNUBRHYSSHJWDH,BRD-A74648924,K-247,,,BRD-A74648924,K-247,,,BRD-A74648924,K-247,,,BRD-A74648924,K-247,,
QNUKRWAIZMBVCU,BRD-K94883909,SU9516,CDK inhibitor,CDK1|CDK2|CDK4|CDK5,BRD-K94883909,SU9516,CDK inhibitor,CDK1|CDK2|CDK4|CDK5,BRD-K94883909,SU9516,CDK inhibitor,CDK1|CDK2|CDK4|CDK5,BRD-K94883909,SU9516,CDK inhibitor,CDK1|CDK2|CDK4|CDK5
QNZCBYKSOIHPEH,BRD-K67121414,apixaban,coagulation factor inhibitor,F10,BRD-K67121414,apixaban,coagulation factor inhibitor,F10,BRD-K67121414,apixaban,coagulation factor inhibitor,F10,BRD-K67121414,apixaban,coagulation factor inhibitor,F10
QOECJCJVIMVJGX,BRD-K86856088,UNC0638,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K86856088,UNC0638,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K86856088,UNC0638,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K86856088,UNC0638,histone lysine methyltransferase inhibitor,EHMT1|EHMT2
QOEJDHLJOKRPJG,BRD-K10029415,enisamium-iodide,,,BRD-K10029415,enisamium-iodide,,,BRD-K10029415,enisamium-iodide,,,BRD-K10029415,enisamium-iodide,,
QOFQTBTZCJVITI,BRD-A90551241,lornoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A90551241,lornoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A90551241,lornoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,,,,
QOHNRGHTJPFMSL,BRD-K91135178,MRS2578,purinergic receptor antagonist,P2RY6,BRD-K91135178,MRS2578,purinergic receptor antagonist,P2RY6,BRD-K91135178,MRS2578,purinergic receptor antagonist,P2RY6,BRD-K91135178,MRS-2578,purinergic receptor antagonist,P2RY6
QOTAQTRFJWLFCR,BRD-K25596805,JNJ-16259685,glutamate receptor antagonist,GRM1,BRD-K25596805,JNJ-16259685,glutamate receptor antagonist,GRM1,BRD-K25596805,JNJ-16259685,glutamate receptor antagonist,GRM1,BRD-K25596805,JNJ-16259685,glutamate receptor antagonist,GRM1
QOVTVIYTBRHADL,BRD-K97521363,clorsulon,glycolysis inhibitor,,BRD-K97521363,clorsulon,glycolysis inhibitor,,BRD-K97521363,clorsulon,glycolysis inhibitor,,BRD-K97521363,clorsulon,glycolysis inhibitor,
QOYHHIBFXOOADH,BRD-K77947974,fluspirilene,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,BRD-K77947974,fluspirilene,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,BRD-K77947974,fluspirilene,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,BRD-K77947974,fluspirilene,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A
QPCDCPDFJACHGM,BRD-K40621224,pentetic-acid,chelating agent,PGD,BRD-K40621224,pentetic-acid,chelating agent,PGD,BRD-K40621224,pentetic-acid,chelating agent,PGD,BRD-K40621224,pentetic-acid,chelating agent,
QPCVHQBVMYCJOM,BRD-K91244729,propiverine,acetylcholine receptor antagonist,CHRM1,BRD-K91244729,propiverine,acetylcholine receptor antagonist,CHRM1,BRD-K91244729,propiverine,acetylcholine receptor antagonist,CHRM1,BRD-K91244729,propiverine,acetylcholine receptor antagonist,CHRM1
QPFYXYFORQJZEC,BRD-K76304753,phenazopyridine,local anesthetic,SCN1A,BRD-K76304753,phenazopyridine,local anesthetic,SCN1A,BRD-K76304753,phenazopyridine,local anesthetic,SCN1A,BRD-K76304753,phenazopyridine,local anesthetic,SCN1A
QPGGEKPRGVJKQB,BRD-K79145749,dibenzepine,norepinephrine reputake inhibitor,,BRD-K79145749,dibenzepine,norepinephrine reputake inhibitor,,BRD-K79145749,dibenzepine,norepinephrine reputake inhibitor,,BRD-K79145749,dibenzepine,norepinephrine reputake inhibitor,
QPJBWNIQKHGLAU,BRD-A30703952,ganglioside-gm1,,,BRD-A30703952,ganglioside-gm1,,,BRD-A30703952,ganglioside-gm1,,,,,,
QPPBRPIAZZHUNT,BRD-K93524252,sulfamerazine,bacterial antifolate,,BRD-K93524252,sulfamerazine,bacterial antifolate,,BRD-K93524252,sulfamerazine,bacterial antifolate,,BRD-K93524252,sulfamerazine,bacterial antifolate,
QQBDLJCYGRGAKP,BRD-K57853941,olsalazine,cyclooxygenase inhibitor,IFNG|TPMT,BRD-K57853941,olsalazine,cyclooxygenase inhibitor,IFNG|TPMT,BRD-K57853941,olsalazine,cyclooxygenase inhibitor,IFNG|TPMT,BRD-K57853941,olsalazine,cyclooxygenase inhibitor,IFNG|TPMT
QQBPLXNESPTPNU,BRD-K95523387,OLDA,TRPV agonist,GPR119,BRD-K95523387,OLDA,TRPV agonist,GPR119,BRD-K95523387,OLDA,TRPV agonist,GPR119,BRD-K95523387,OLDA,TRPV agonist,GPR119
QQDIFLSJMFDTCQ,BRD-K24031866,MC1568,HDAC inhibitor,HDAC2,BRD-K24031866,MC1568,HDAC inhibitor,HDAC2,BRD-K24031866|BRD-K94335714,MC1568,HDAC inhibitor,HDAC2,BRD-K24031866|BRD-K94335714,MC1568,HDAC inhibitor,HDAC2
QQGWEXFLMJGCAL,BRD-K77627880,A205804,ICAM1 expression inhibitor,ICAM1|SELE,BRD-K77627880,A205804,ICAM1 expression inhibitor,ICAM1|SELE,BRD-K77627880,A205804,ICAM1 expression inhibitor,ICAM1|SELE,BRD-K77627880,A205804,ICAM1 expression inhibitor,ICAM1|SELE
QQHMKNYGKVVGCZ,BRD-K11973162,tipiracil,thymidine phosphorylase inhibitor,TYMP,BRD-K11973162,tipiracil,thymidine phosphorylase inhibitor,TYMP,BRD-K11973162,tipiracil,thymidine phosphorylase inhibitor,TYMP,BRD-K11973162,tipiracil,thymidine phosphorylase inhibitor,
QQJIYKXTEMDJFM,BRD-K48905682,madrasin,cell splicing inhibitor,,BRD-K48905682,madrasin,cell splicing inhibitor,,BRD-K48905682,madrasin,cell splicing inhibitor,,BRD-K48905682,madrasin,cell splicing inhibitor,
QQLKULDARVNMAL,BRD-K31698212,icotinib,EGFR inhibitor,EGFR,BRD-K31698212,icotinib,EGFR inhibitor,EGFR,BRD-K31698212,icotinib,EGFR inhibitor,EGFR,BRD-K31698212,icotinib,EGFR inhibitor,EGFR
QQQIECGTIMUVDS,BRD-K96740444,itopride,dopamine receptor antagonist,CHRM3|DRD2,BRD-K96740444,itopride,dopamine receptor antagonist,CHRM3|DRD2,BRD-K96740444,itopride,dopamine receptor antagonist,CHRM3|DRD2,BRD-K96740444,itopride,dopamine receptor antagonist,CHRM3|DRD2
QQUXFYAWXPMDOE,BRD-K37312348,kenpaullone,CDK inhibitor|glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,BRD-K37312348,kenpaullone,CDK inhibitor|glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,BRD-K37312348,kenpaullone,CDK inhibitor|glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,BRD-K37312348,kenpaullone,CDK inhibitor|glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B
QQWUGDVOUVUTOY,BRD-K50140147,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,ALK|INSR,BRD-K50140147,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,ALK|INSR,BRD-K50140147,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,ALK|INSR,BRD-K50140147,NVP-TAE684,ALK tyrosine kinase receptor inhibitor,ALK|INSR
QRCJOCOSPZMDJY,BRD-A96644976,valnoctamide,arachidonic acid acylation inhibitor|benzodiazepine receptor agonist,,BRD-A96644976,valnoctamide,arachidonic acid acylation inhibitor|benzodiazepine receptor agonist,,BRD-A96644976,valnoctamide,arachidonic acid acylation inhibitor|benzodiazepine receptor agonist,,BRD-A96644976,valnoctamide,arachidonic acid acylation inhibitor|benzodiazepine receptor agonist,
QRJJEGAJXVEBNE,BRD-K56104152,oxiconazole,bacterial cell wall synthesis inhibitor,,BRD-K56104152,oxiconazole,bacterial cell wall synthesis inhibitor,,BRD-K56104152,oxiconazole,bacterial cell wall synthesis inhibitor,,BRD-K56104152,oxiconazole,bacterial cell wall synthesis inhibitor,
QRJOQYLXZPQQMX,BRD-K51751936,alfadolone-acetate,benzodiazepine receptor agonist,,BRD-K51751936,alfadolone-acetate,benzodiazepine receptor agonist,,BRD-K51751936,alfadolone-acetate,benzodiazepine receptor agonist,,BRD-K51751936,alfadolone-acetate,benzodiazepine receptor agonist,
QRMPRVXWPCLVNI,BRD-K07241895|BRD-K41933240,curcumol,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K07241895|BRD-K41933240,curcumol,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K07241895|BRD-K41933240,curcumol,JAK inhibitor,JAK1|JAK2|JAK3,BRD-K07241895|BRD-K41933240,curcumol,JAK inhibitor,JAK1|JAK2|JAK3
QRPZBKAMSFHVRW,BRD-K97883416,BMS-626529,HIV attachment inhibitor,,BRD-K97883416,BMS-626529,HIV attachment inhibitor,,BRD-K97883416,BMS-626529,HIV attachment inhibitor,,BRD-K97883416,BMS-626529,HIV attachment inhibitor,
QRXWMOHMRWLFEY,BRD-K87202646,isoniazid|pasiniazid,FABI inhibitor|cyclooxygenase inhibitor,|CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,BRD-K87202646,isoniazid|pasiniazid,FABI inhibitor|cyclooxygenase inhibitor,|CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,BRD-K87202646,isoniazid|pasiniazid,FABI inhibitor|cyclooxygenase inhibitor,|CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,BRD-K87202646,isoniazid,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4
QRZAKQDHEVVFRX,BRD-K91740057,felbinac,cyclooxygenase inhibitor,CTSL,BRD-K91740057,felbinac,cyclooxygenase inhibitor,CTSL,BRD-K91740057,felbinac,cyclooxygenase inhibitor,CTSL,BRD-K91740057,felbinac,cyclooxygenase inhibitor,CTSL
QSAVEGSLJISCDF,BRD-A37942872,eucatropine,acetylcholine receptor antagonist,,BRD-A37942872,eucatropine,acetylcholine receptor antagonist,,BRD-A37942872,eucatropine,acetylcholine receptor antagonist,,BRD-A37942872,eucatropine,acetylcholine receptor antagonist,
QSHGISMANBKLQL,BRD-K04622161,YO-01027,gamma secretase inhibitor,,BRD-K04622161,YO-01027,gamma secretase inhibitor,,BRD-K04622161,YO-01027,gamma secretase inhibitor,,BRD-K04622161,YO-01027,gamma secretase inhibitor,
QSKQVZWVLOIIEV,BRD-K53814070,ripasudil,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K53814070,ripasudil,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K53814070,ripasudil,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K53814070,ripasudil,rho associated kinase inhibitor,ROCK1|ROCK2
QSKVYHYMQQQAFS,BRD-A96466199,nuclomedone,immunosuppressant,,BRD-A96466199,nuclomedone,immunosuppressant,,BRD-A96466199,nuclomedone,immunosuppressant,,BRD-A96466199,nuclomedone,immunosuppressant,
QSLJIVKCVHQPLV,BRD-K92467929,oxandrolone,androgen receptor agonist,AR,BRD-K92467929,oxandrolone,androgen receptor agonist,AR,BRD-K92467929,oxandrolone,androgen receptor agonist,AR,,,,
QSLMDECMDJKHMQ,BRD-K25433859,maprotiline,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2,BRD-K25433859,maprotiline,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2,BRD-K25433859,maprotiline,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR2A|HTR2C|HTR7|SLC6A2,BRD-K03319035,maprotiline,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2
QSNOWCXXECLALL,BRD-A64406146,timofibrate,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,BRD-A64406146,timofibrate,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,BRD-A64406146,timofibrate,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,BRD-A64406146,timofibrate,cholesterol inhibitor|lipase clearing factor inhibitor,LPL
QSPOQCXMGPDIHI,BRD-K11785681,motolimod,toll-like receptor agonist,TLR8,BRD-K11785681,motolimod,toll-like receptor agonist,TLR8,BRD-K11785681,motolimod,toll-like receptor agonist,TLR8,BRD-K11785681,motolimod,toll-like receptor agonist,TLR8
QSQQPMHPCBLLGX,BRD-K18779551,bifemelane,acetylcholine release enhancer,MAOA|MAOB,BRD-K18779551,bifemelane,acetylcholine release enhancer,MAOA|MAOB,BRD-K18779551,bifemelane,acetylcholine release enhancer,MAOA|MAOB,BRD-K18779551,bifemelane,acetylcholine release enhancer,MAOA|MAOB
QSUSKMBNZQHHPA,BRD-K07074923,RWJ-67657,MAP kinase inhibitor,MAPK14|PTGS2,BRD-K07074923,RWJ-67657,MAP kinase inhibitor,MAPK14|PTGS2,BRD-K07074923,RWJ-67657,MAP kinase inhibitor,MAPK14|PTGS2,BRD-K07074923,RWJ-67657,MAP kinase inhibitor,MAPK14|PTGS2
QSYLKMKIVWJAAK,BRD-K61228301,SGI-1027,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B,BRD-K61228301,SGI-1027,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B,BRD-K61228301,SGI-1027,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B,BRD-K61228301,SGI-1027,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B
QTANTQQOYSUMLC,BRD-K28354016,homidium,,,BRD-K28354016,homidium,,,BRD-K28354016,homidium,,,BRD-K28354016,homidium,,
QTBWCSQGBMPECM,BRD-K36740062,GSK1070916,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,BRD-K36740062,GSK1070916,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,BRD-K36740062,GSK1070916,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,BRD-K36740062,GSK1070916,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4
QTDZOWFRBNTPQR,BRD-K01980392,guvacine,GABA uptake inhibitor,SLC6A1|SLC6A11|SLC6A12|SLC6A13,BRD-K01980392,guvacine,GABA uptake inhibitor,SLC6A1|SLC6A11|SLC6A12|SLC6A13,BRD-K01980392,guvacine,GABA uptake inhibitor,SLC6A1|SLC6A11|SLC6A12|SLC6A13,BRD-K01980392,guvacine,GABA uptake inhibitor,SLC6A1|SLC6A11|SLC6A12|SLC6A13
QTGAJCQTLIRCFL,BRD-K54496168,propacetamol,cyclooxygenase inhibitor,PTGS2,BRD-K54496168,propacetamol,cyclooxygenase inhibitor,PTGS2,BRD-K54496168,propacetamol,cyclooxygenase inhibitor,PTGS2,BRD-K54496168,propacetamol,cyclooxygenase inhibitor,PTGS2
QTGIAADRBBLJGA,BRD-A70514680,articaine,local anesthetic,,BRD-A70514680,articaine,local anesthetic,,BRD-A70514680,articaine,local anesthetic,,BRD-A70514680,articaine,local anesthetic,
QTHCAAFKVUWAFI,BRD-K49371609,PIK-75,DNA protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,BRD-K49371609,PIK-75,DNA protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,BRD-K49371609,PIK-75,DNA protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,BRD-K49371609,PIK-75,DNA protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC
QTOZBSNPDCWHPV,BRD-K36154108,AVE-0991,angiotensin receptor agonist,MRGPRX1,BRD-K36154108,AVE-0991,angiotensin receptor agonist,MRGPRX1,BRD-K36154108,AVE-0991,angiotensin receptor agonist,MRGPRX1,BRD-K36154108,AVE-0991,angiotensin receptor agonist,MRGPRX1
QTQAWLPCGQOSGP,BRD-K43570081|BRD-K82847623,geldanamycin,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-A77524860|BRD-K43570081,geldanamycin,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K43570081|BRD-K82847623,geldanamycin,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K43570081|BRD-K82847623,geldanamycin,HSP inhibitor,HSP90AA1
QTQMRBZOBKYXCG,BRD-A15415227,GW-1929,PPAR receptor agonist,PPARG,BRD-A15415227,GW-1929,PPAR receptor agonist,PPARG,BRD-A15415227,GW-1929,PPAR receptor agonist,PPARG,BRD-K00004238,GW-1929,PPAR receptor agonist,PPARG
QTRXIFVSTWXRJJ,BRD-K54264768,ETC-159,beta catenin inhibitor|porcupine inhibitor,PORCN,BRD-K54264768,ETC-159,beta catenin inhibitor|porcupine inhibitor,PORCN,BRD-K54264768,ETC-159,beta catenin inhibitor|porcupine inhibitor,PORCN,BRD-K54264768,ETC-159,beta catenin inhibitor|porcupine inhibitor,PORCN
QTSJJDIDTYFLFC,BRD-K86435560,perchlozone,,,BRD-K86435560,perchlozone,,,BRD-K86435560,perchlozone,,,BRD-K00004530,perchlozone,,
QTTRZHGPGKRAFB,BRD-K31627533,rimexolone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K31627533,rimexolone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K31627533,rimexolone,glucocorticoid receptor agonist,NR3C1|SERPINA6,BRD-K31627533,rimexolone,glucocorticoid receptor agonist,NR3C1|SERPINA6
QTWZICCBKBYHDM,BRD-K27460187,leucomethylene-blue,nitric oxide production inhibitor|tau aggregation inhibitor,MAPT,BRD-K27460187,leucomethylene-blue,nitric oxide production inhibitor|tau aggregation inhibitor,MAPT,BRD-K27460187,leucomethylene-blue,nitric oxide production inhibitor|tau aggregation inhibitor,MAPT,BRD-K27460187,leucomethylene-blue,nitric oxide production inhibitor|tau aggregation inhibitor,MAPT
QUCQEUCGKKTEBI,BRD-K58466253,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4,BRD-K58466253,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4,BRD-K58466253,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4,BRD-K58466253,palmatine-chloride,dopamine synthesis inhibitor,CYP3A4
QUHARGDBJJUOEB,BRD-K72078047,MUT056399,FABI inhibitor,,BRD-K72078047,MUT056399,FABI inhibitor,,BRD-K72078047,MUT056399,FABI inhibitor,,BRD-K72078047,MUT056399,FABI inhibitor,
QUIIIYITNGOFEI,BRD-K08893438,CCG-50014,G protein signaling inhibitor,RGS4|RGS8,BRD-K08893438,CCG-50014,G protein signaling inhibitor,RGS4|RGS8,BRD-K08893438,CCG-50014,G protein signaling inhibitor,RGS4|RGS8,BRD-K08893438,CCG-50014,G protein signaling inhibitor,RGS4|RGS8
QUIJNHUBAXPXFS,BRD-K90817094,bedaquiline,ATPase inhibitor,,BRD-K90817094,bedaquiline,ATPase inhibitor,,BRD-K90817094,bedaquiline,ATPase inhibitor,,BRD-K90817094,bedaquiline,ATPase inhibitor,
QUKGLNCXGVWCJX,BRD-K94837153,aminothiadiazole,inosine monophosphate dehydrogenase inhibitor,ADORA3|IMPDH1,BRD-K94837153,aminothiadiazole,inosine monophosphate dehydrogenase inhibitor,ADORA3|IMPDH1,BRD-K94837153,aminothiadiazole,inosine monophosphate dehydrogenase inhibitor,ADORA3|IMPDH1,BRD-K94837153,aminothiadiazole,inosine monophosphate dehydrogenase inhibitor,ADORA3|IMPDH1
QULDDKSCVCJTPV,BRD-K51967704,BIIB021,HSP inhibitor,HSP90AA1,BRD-K51967704,BIIB021,HSP inhibitor,HSP90AA1,BRD-K51967704,BIIB021,HSP inhibitor,HSP90AA1,BRD-K51967704,BIIB021,HSP inhibitor,HSP90AA1
QUNWUDVFRNGTCO,BRD-K24084088,paraxanthine,adenosine receptor antagonist,,BRD-K24084088,paraxanthine,adenosine receptor antagonist,,BRD-K24084088,paraxanthine,adenosine receptor antagonist,,BRD-K24084088,paraxanthine,adenosine receptor antagonist,
QUQPHWDTPGMPEX,BRD-K43382661|BRD-K93633846,hesperidin,flavanone glycoside,CACNA1B,BRD-K43382661|BRD-K53229386,hesperidin,flavanone glycoside,CACNA1B,BRD-K38903228|BRD-K43382661|BRD-K53229386,hesperidin,flavanone glycoside,CACNA1B,BRD-K38903228|BRD-K43382661|BRD-K53229386,hesperidin,flavanone glycoside,AURKB|CACNA1B
QURWXBZNHXJZBE,BRD-K63772874,icatibant-acetate,bradykinin receptor antagonist,ANPEP|BDKRB2,BRD-K63772874,icatibant-acetate,bradykinin receptor antagonist,ANPEP|BDKRB2,BRD-K63772874,icatibant-acetate,bradykinin receptor antagonist,ANPEP|BDKRB2,BRD-K63772874,icatibant-acetate,bradykinin receptor antagonist,BDKRB2
QUSLYAPLTMMCFE,BRD-K08534264,LY393558,serotonin receptor antagonist,HTR1B|HTR1D|HTR2A|HTR2B,BRD-K08534264,LY393558,serotonin receptor antagonist,HTR1B|HTR1D|HTR2A|HTR2B,BRD-K08534264,LY393558,serotonin receptor antagonist,HTR1B|HTR1D|HTR2A|HTR2B,BRD-K08534264,LY393558,serotonin receptor antagonist,HTR1B|HTR1D|HTR2A|HTR2B
QVEIRCZEBQRCTR,BRD-K61734568,"2,3-DCPE",,,BRD-K61734568,"2,3-DCPE",Bcl-XL downregulator,BCL2L1,BRD-K61734568,"2,3-DCPE",Bcl-XL downregulator,BCL2L1,BRD-K61734568,"2,3-DCPE",BCL-XL downregulator,BCL2L1
QVKPEMXUBULFBM,BRD-K34801930,AZD5069,CC chemokine receptor antagonist,CXCR2,BRD-K34801930,AZD5069,CC chemokine receptor antagonist,CXCR2,BRD-K34801930,AZD5069,CC chemokine receptor antagonist,CXCR2,BRD-K34801930,SRT3190,CC chemokine receptor antagonist,
QVKSGMJGGSXIQM,BRD-M58473998,trimeprazine,histamine receptor antagonist|histamine receptor ligand,HRH1,BRD-M58473998,trimeprazine,histamine receptor antagonist|histamine receptor ligand,HRH1,BRD-M58473998,trimeprazine,histamine receptor antagonist|histamine receptor ligand,HRH1,,,,
QVMNYGOVNWWFKF,BRD-K89709433,HER2-Inhibitor-1,EGFR inhibitor,,BRD-K89709433,HER2-Inhibitor-1,EGFR inhibitor,,BRD-K89709433,HER2-Inhibitor-1,EGFR inhibitor,,BRD-K89709433,HER2-Inhibitor-1,EGFR inhibitor,
QVMPZNRFXAKISM,BRD-K75058612,tirapazamine,DNA inhibitor,,BRD-K75058612,tirapazamine,DNA inhibitor,,,,,,,,,
QVVOZYKELHAIPX,BRD-A99899486,cimetropium,acetylcholine receptor antagonist,CHRM1,BRD-A99899486,cimetropium,acetylcholine receptor antagonist,CHRM1,BRD-A99899486,cimetropium,acetylcholine receptor antagonist,CHRM1,BRD-A99899486,cimetropium,acetylcholine receptor antagonist,CHRM1
QVYRGXJJSLMXQH,BRD-A53576514,orphenadrine,acetylcholine receptor antagonist,GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2,BRD-A53576514,orphenadrine,acetylcholine receptor antagonist,GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2,BRD-A53576514,orphenadrine,acetylcholine receptor antagonist,GRIN1|GRIN2D|GRIN3A|GRIN3B|HRH1|SCN10A|SLC6A2,BRD-A53576514,orphenadrine,acetylcholine receptor antagonist,
QVZCXCJXTMIDME,BRD-K48722258,dilazep,adenosine reuptake inhibitor,SLC29A1,BRD-K48722258,dilazep,adenosine reuptake inhibitor,SLC29A1,BRD-K48722258,dilazep,adenosine reuptake inhibitor,SLC29A1,BRD-K48722258,dilazep,adenosine reuptake inhibitor,SLC29A1
QWAXKHKRTORLEM,BRD-A26690767,saquinavir,HIV protease inhibitor,CYP3A4,BRD-A26690767|BRD-K09963420,saquinavir,HIV protease inhibitor,CYP3A4,BRD-A26690767|BRD-K09963420,saquinavir,HIV protease inhibitor,CYP3A4,BRD-K09963420,saquinavir,HIV protease inhibitor,CYP3A4
QWCJHSGMANYXCW,BRD-K10671814,sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS,BRD-K10671814,sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS,BRD-K10671814,sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS,BRD-K10671814,sulfaphenazole,dihydropteroate synthetase inhibitor,DHPS
QWCRAEMEVRGPNT,BRD-K93461745,buspirone,serotonin receptor agonist,DRD2|HTR1A,BRD-K93461745,buspirone,serotonin receptor agonist,DRD2|HTR1A,BRD-K93461745,buspirone,serotonin receptor agonist,DRD2|HTR1A,BRD-K93461745,buspirone,serotonin receptor agonist,DRD2|HTR1A
QWDCYFDDFPWISL,BRD-K69144501,E-2012,gamma secretase modulator,APH1B,BRD-K69144501,E-2012,gamma secretase modulator,APH1A|APH1B|PSENEN,BRD-K69144501,E-2012,gamma secretase modulator,APH1A|APH1B|PSENEN,,,,
QWGDMFLQWFTERH,BRD-K02265150,amoxapine,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K02265150,amoxapine,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K02265150,amoxapine,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K02265150,amoxapine,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4
QWZFVMCWPLMLTL,BRD-K67445247,flurofamide,urease inhibitor,,BRD-K67445247,flurofamide,urease inhibitor,,BRD-K67445247,flurofamide,urease inhibitor,,BRD-K67445247,flurofamide,urease inhibitor,
QXAITBQSYVNQDR,BRD-K33335792,amitraz,adrenergic receptor agonist,ADRA1A|ADRA2A,BRD-K33335792,amitraz,adrenergic receptor agonist,ADRA1A|ADRA2A,BRD-K33335792,amitraz,adrenergic receptor agonist,ADRA1A|ADRA2A,BRD-K33335792,amitraz,adrenergic receptor agonist,ADRA1A|ADRA2A
QXDAEKSDNVPFJG,BRD-K81092066,phenacaine,local anesthetic,,BRD-K81092066,phenacaine,local anesthetic,,BRD-K81092066,phenacaine,local anesthetic,,BRD-K81092066,phenacaine,local anesthetic,
QXHHHPZILQDDPS,BRD-A33084557,tioconazole,sterol demethylase inhibitor,CYP51A1,BRD-A33084557,tioconazole,sterol demethylase inhibitor,CYP51A1,BRD-A33084557,tioconazole,sterol demethylase inhibitor,CYP51A1,BRD-K00003630,tioconazole,sterol demethylase inhibitor,
QXIUMMLTJVHILT,BRD-A47884604,cyanopindolol,adrenergic receptor antagonist,ADRB1|HTR1A|HTR1D,BRD-A47884604,cyanopindolol,adrenergic receptor antagonist,ADRB1|HTR1A|HTR1D,BRD-A47884604|BRD-M87382116,cyanopindolol,adrenergic receptor antagonist,ADRB1|HTR1A|HTR1D,BRD-K01825675|BRD-M87382116,cyanopindolol,adrenergic receptor antagonist,ADRB1|HTR1A|HTR1D
QXKHYNVANLEOEG,BRD-K63430059,methoxsalen,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,BRD-K63430059,methoxsalen,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,BRD-K63430059,methoxsalen,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,BRD-K63430059,methoxsalen,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4
QXKYWSDUVAJHNZ,BRD-A54654253,AZD3839,beta-secretase inhibitor,BACE1,BRD-A54654253,AZD3839,beta-secretase inhibitor,BACE1,BRD-A54654253,AZD3839,beta-secretase inhibitor,BACE1,,,,
QXLPXWSKPNOQLE,BRD-A11662333,meparfylon,,,BRD-A11662333,meparfylon,,,BRD-A11662333,meparfylon,,,BRD-A11662333,meparfylon,,
QXRSDHAAWVKZLJ,BRD-K68164687,epothilone-b,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,BRD-K68164687,epothilone-b,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,BRD-K68164687,epothilone-b,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,BRD-K48935217,epothilone-B,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB
QXTWSUQCXCWEHF,BRD-K23791635,AFN-1252,FABI inhibitor,,BRD-K23791635,AFN-1252,FABI inhibitor,,BRD-K23791635,AFN-1252,FABI inhibitor,,BRD-K23791635,AFN-1252,FABI inhibitor,
QXWKHSSBFQDQPR,BRD-K86954340,cetaben,ACAT inhibitor|cholesterol inhibitor,PPARA,BRD-K86954340,cetaben,ACAT inhibitor|cholesterol inhibitor,PPARA,BRD-K86954340,cetaben,ACAT inhibitor|cholesterol inhibitor,PPARA,BRD-K86954340,cetaben,ACAT inhibitor|cholesterol inhibitor,PPARA
QXWYKJLNLSIPIN,BRD-K20372197,droxidopa,norepinephrine precursor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH,BRD-K20372197,droxidopa,norepinephrine precursor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH,BRD-K20372197,droxidopa,norepinephrine precursor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH,BRD-K20372197,droxidopa,norepinephrine precursor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH
QXWZQTURMXZVHJ,BRD-K21191422,selexipag,IP1 prostacyclin receptor agonist|platelet aggregation inhibitor,PTGIR,BRD-K21191422,selexipag,IP1 prostacyclin receptor agonist|platelet aggregation inhibitor,PTGIR,BRD-K21191422,selexipag,IP1 prostacyclin receptor agonist|platelet aggregation inhibitor,PTGIR,BRD-K21191422,selexipag,IP1 prostacyclin receptor agonist|platelet aggregation inhibitor,PTGIR
QYBGBLQCOOISAR,BRD-K98795921,SB-2343,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K98795921,SB-2343,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K98795921,SB-2343,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K98795921,SB-2343,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG
QYIYFLOTGYLRGG,BRD-K20338176,cefaclor,bacterial cell wall synthesis inhibitor,,BRD-K20338176,cefaclor,bacterial cell wall synthesis inhibitor,,BRD-K20338176,cefaclor,bacterial cell wall synthesis inhibitor,,BRD-K20338176,cefaclor,bacterial cell wall synthesis inhibitor,
QYKHWEFPFAGNEV,BRD-K57136142,CCT129202,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K57136142,CCT129202,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K57136142,CCT129202,Aurora kinase inhibitor,AURKA|AURKB|AURKC,BRD-K57136142,CCT129202,Aurora kinase inhibitor,AURKA|AURKB|AURKC
QYOAUOAXCQAEMW,BRD-A94813917,bleomycetin,EGFR expression inhibitor,,BRD-A94813917,bleomycetin,EGFR expression inhibitor,,BRD-A94813917,bleomycetin,EGFR expression inhibitor,,BRD-K00004533,bleomycetin,EGFR expression inhibitor,
QYPPJABKJHAVHS,BRD-K49738308,agmatine,nitric oxide synthase inhibitor,ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH,BRD-K49738308,agmatine,nitric oxide synthase inhibitor,ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH,BRD-K49738308,agmatine,nitric oxide synthase inhibitor,ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH,BRD-K49738308,agmatine,nitric oxide synthase inhibitor,ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH
QYQDKDWGWDOFFU,BRD-K02275692,cefotiam,bacterial cell wall synthesis inhibitor,,BRD-K02275692,cefotiam,bacterial cell wall synthesis inhibitor,,BRD-K02275692,cefotiam,bacterial cell wall synthesis inhibitor,,BRD-K02275692,cefotiam,bacterial cell wall synthesis inhibitor,
QYSXJUFSXHHAJI,BRD-A56749456|BRD-K32793810|BRD-K62779383,cholecalciferol,,VDR,BRD-A56749456|BRD-K62779383,cholecalciferol,,VDR,BRD-A56749456|BRD-K32793810|BRD-K62779383,cholecalciferol,,VDR,BRD-A56749456|BRD-K32793810|BRD-K62779383,cholecalciferol,,VDR
QYSYOGCIDRANAR,BRD-K44022883,MRK-016,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K44022883,MRK-016,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K44022883,MRK-016,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K44022883,MRK-016,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5
QYUXPWDVDMSTKR,BRD-K40782193,QX-222,sodium channel blocker,,BRD-K40782193,QX-222,sodium channel blocker,,BRD-K40782193,QX-222,sodium channel blocker,,BRD-K40782193,QX-222,sodium channel blocker,
QYZOGCMHVIGURT,BRD-K63923597,barasertib-HQPA,Aurora kinase inhibitor,AURKB,BRD-K63923597,barasertib-HQPA,Aurora kinase inhibitor,AURKB,BRD-K63923597,barasertib-HQPA,Aurora kinase inhibitor,AURKB,BRD-K63923597,barasertib-HQPA,Aurora kinase inhibitor,AURKB
QZAYGJVTTNCVMB,BRD-K38580127,serotonin,growth factor receptor activator,DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1,BRD-K38580127,serotonin,growth factor receptor activator,DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1,BRD-K38580127,serotonin,growth factor receptor activator,DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1,BRD-K38580127,serotonin,growth factor receptor activator,DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1
QZPQTZZNNJUOLS,BRD-K28061410,beta-lapachone,topoisomerase inhibitor,TOP1,BRD-K28061410,beta-lapachone,topoisomerase inhibitor,TOP1,BRD-K28061410,beta-lapachone,topoisomerase inhibitor,TOP1,BRD-K28061410,beta-lapachone,topoisomerase inhibitor,TOP1
QZUDBNBUXVUHMW,BRD-K37289225,clozapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,BRD-K37289225,clozapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,BRD-K37289225,clozapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,BRD-K37289225,clozapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7
QZVCTJOXCFMACW,BRD-A67799922,phenoxybenzamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB2|CALM1,BRD-A67799922,phenoxybenzamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB2|CALM1,BRD-A67799922,phenoxybenzamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB2|CALM1,BRD-A67799922,phenoxybenzamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
QZVNQOLPLYWLHQ,BRD-K97181463,benidipine,calcium channel blocker,CACNA1C|CACNA1G,BRD-K97181463,benidipine,calcium channel blocker,CACNA1C|CACNA1G,BRD-K97181463,benidipine,calcium channel blocker,CACNA1C|CACNA1G,BRD-K97181463,benidipine,calcium channel blocker,CACNA1C|CACNA1G
QZYYPQAYSFBKPW,BRD-K07409305,Org-12962,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-K07409305,Org-12962,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-K07409305,Org-12962,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-K07409305,ORG-12962,serotonin receptor agonist,HTR2A|HTR2B|HTR2C
QZZUEBNBZAPZLX,BRD-K89208535,indacaterol,adrenergic receptor agonist,ADRB1|ADRB2,BRD-K89208535,indacaterol,adrenergic receptor agonist,ADRB1|ADRB2,BRD-K89208535,indacaterol,adrenergic receptor agonist,ADRB1|ADRB2,BRD-K89208535,indacaterol,adrenergic receptor agonist,ADRB1|ADRB2
RADKZDMFGJYCBB,BRD-K76204040,pyridoxal,,PDXK,BRD-K76204040,pyridoxal,,PDXK,BRD-K76204040,pyridoxal,,PDXK,BRD-K76204040,pyridoxal,,PDXK
RADMJHVVIZTENA,BRD-K20468903,BNC105,tubulin polymerization inhibitor,,BRD-K20468903,BNC105,tubulin polymerization inhibitor,,BRD-K20468903,BNC105,tubulin polymerization inhibitor,,BRD-K20468903,BNC105,tubulin polymerization inhibitor,
RAGOYPUPXAKGKH,BRD-K06222852,posaconazole,sterol demethylase inhibitor,CYP3A4,BRD-K06222852,posaconazole,sterol demethylase inhibitor,CYP3A4,BRD-K06222852,posaconazole,sterol demethylase inhibitor,CYP3A4,BRD-K06222852,posaconazole,sterol demethylase inhibitor,CYP3A4
RAHBGWKEPAQNFF,BRD-K99616396,motesanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT,BRD-K99616396,motesanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT,BRD-K99616396,motesanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT,BRD-K99616396,motesanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT
RAIPHJJURHTUIC,BRD-K13421763,aminothiazole,cyclin D inhibitor,NOS2,BRD-K13421763,aminothiazole,cyclin D inhibitor,NOS2,BRD-K13421763,aminothiazole,cyclin D inhibitor,NOS2,BRD-K13421763,aminothiazole,cyclin D inhibitor,NOS2
RALGCAOVRLYSMA,BRD-K32804101,valrocemide,,,BRD-K32804101,valrocemide,,,BRD-K32804101,valrocemide,,,BRD-K32804101,valrocemide,,
RAMROQQYRRQPDL,BRD-K07762753,aminopurvalanol-a,CDK inhibitor|tyrosine kinase inhibitor,CDK1|CDK2|CDK5|CDK6,BRD-K07762753,aminopurvalanol-a,CDK inhibitor|tyrosine kinase inhibitor,CDK1|CDK2|CDK5|CDK6,BRD-K07762753,aminopurvalanol-a,CDK inhibitor|tyrosine kinase inhibitor,CDK1|CDK2|CDK5|CDK6,BRD-K07762753,aminopurvalanol-a,CDK inhibitor|tyrosine kinase inhibitor,CDK1|CDK2|CDK5
RANYIWAZSQWERN,BRD-K22316123,BMS-983970,notch signaling inhibitor,,BRD-K22316123,BMS-983970,notch signaling inhibitor,,BRD-K22316123,BMS-983970,notch signaling inhibitor,,BRD-K22316123,BMS-983970,notch signaling inhibitor,
RAOCRURYZCVHMG,BRD-K52075715,oxibendazole,tubulin polymerization inhibitor,TUBB|TUBB4B,BRD-K52075715,oxibendazole,tubulin polymerization inhibitor,TUBB|TUBB4B,BRD-K52075715,oxibendazole,tubulin polymerization inhibitor,TUBB|TUBB4B,BRD-K52075715,oxibendazole,tubulin polymerization inhibitor,TUBB|TUBB4B
RAPZEAPATHNIPO,BRD-K53857191,risperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,BRD-K53857191,risperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,BRD-K53857191,risperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,BRD-K53857191,risperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7
RAQPOZGWANIDQT,BRD-K50135270,GBR-12935,dopamine uptake inhibitor,AGTR1|SLC6A3,BRD-K50135270,GBR-12935,dopamine uptake inhibitor,AGTR1|SLC6A3,BRD-K50135270,GBR-12935,dopamine uptake inhibitor,AGTR1|SLC6A3,BRD-K50135270,GBR-12935,dopamine reuptake inhibitor,AGTR1|SLC6A3
RARSHUDCJQSEFJ,BRD-K07441213,paroxypropione,gonadotropin inhibitor,,BRD-K07441213,paroxypropione,gonadotropin inhibitor,,BRD-K07441213,paroxypropione,gonadotropin inhibitor,,BRD-K07441213,paroxypropione,gonadotropin inhibitor,
RATZLMXRALDSJW,BRD-A10739734,efaroxan,adrenergic receptor antagonist,ADORA2A,BRD-A10739734,efaroxan,adrenergic receptor antagonist,ADORA2A,BRD-A10739734,efaroxan,adrenergic receptor antagonist,ADORA2A,BRD-A10739734,efaroxan,adrenergic receptor antagonist,ADORA2A
RAVIZVQZGXBOQO,BRD-A41451487,PK-11195,benzodiazepine receptor antagonist,TSPO,BRD-A41451487,PK-11195,benzodiazepine receptor antagonist,TSPO,BRD-A41451487,PK-11195,benzodiazepine receptor antagonist,TSPO,BRD-A41451487,PK-11195,benzodiazepine receptor antagonist,TSPO
RBNWAMSGVWEHFP,BRD-K93396439,terpene,,,BRD-K93396439,terpene,,,BRD-K93396439,terpene,,,BRD-K00003674,terpene,,
RBQOQRRFDPXAGN,BRD-K59273480,propentofylline,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,BRD-K59273480,propentofylline,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,BRD-K59273480,propentofylline,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,BRD-K59273480,propentofylline,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A
RBTBFTRPCNLSDE,BRD-K16406336|BRD-K54770538,methylene-blue,guanylyl cyclase inhibitor|nitric oxide production inhibitor,ACHE,BRD-K16406336|BRD-K54770538,methylene-blue,guanylyl cyclase inhibitor|nitric oxide production inhibitor,ACHE,BRD-K16406336|BRD-K54770538,methylene-blue,guanylyl cyclase inhibitor|nitric oxide production inhibitor,ACHE,BRD-K54770538,methylene-blue,guanylyl cyclase inhibitor|nitric oxide production inhibitor,ACHE
RBZNJGHIKXAKQE,BRD-K34445261,SLV-320,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K34445261,SLV-320,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K34445261,SLV-320,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K34445261,SLV-320,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
RCEFMOGVOYEGJN,BRD-K48869804,icilin,TRPV agonist,TRPA1|TRPM8,BRD-K48869804,icilin,TRPV agonist,TRPA1|TRPM8,BRD-K48869804,icilin,TRPV agonist,TRPA1|TRPM8,BRD-K48869804,icilin,TRPV agonist,TRPA1|TRPM8
RCIMBBZXSXFZBV,BRD-K37682401,piromidic-acid,bacterial DNA gyrase inhibitor,,BRD-K37682401,piromidic-acid,bacterial DNA gyrase inhibitor,,BRD-K37682401,piromidic-acid,bacterial DNA gyrase inhibitor,,BRD-K37682401,piromidic-acid,bacterial DNA gyrase inhibitor,
RCINICONZNJXQF,BRD-A28746609|BRD-A63610676,paclitaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1,BRD-A28746609|BRD-A63610676|BRD-K62008436,paclitaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1,BRD-A28746609|BRD-A63610676|BRD-K62008436,paclitaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBB|TUBB1,BRD-A28746609|BRD-A63610676|BRD-K62008436,paclitaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
RCKMWOKWVGPNJF,BRD-K45542189,diethylcarbamazine,lipoxygenase inhibitor,ALOX5|PTGS1,BRD-K45542189,diethylcarbamazine,lipoxygenase inhibitor,ALOX5|PTGS1,BRD-K45542189,diethylcarbamazine,lipoxygenase inhibitor,ALOX5|PTGS1,BRD-K45542189,diethylcarbamazine,lipoxygenase inhibitor,ALOX5|PTGS1
RCKYSTKYIVULEK,BRD-A50028488,TCS2002,glycogen synthase kinase inhibitor,GSK3B,BRD-A50028488,TCS2002,glycogen synthase kinase inhibitor,GSK3B,BRD-A50028488,TCS2002,glycogen synthase kinase inhibitor,GSK3B,BRD-K00004294,TCS-2002,glycogen synthase kinase inhibitor,GSK3B
RCLQNICOARASSR,BRD-K26667523,TAK-733,MEK inhibitor,MAP2K1,BRD-K26667523,TAK-733,MEK inhibitor,MAP2K1,BRD-K26667523,TAK-733,MEK inhibitor,MAP2K1,BRD-K26667523,TAK-733,MEK inhibitor,MAP2K1
RCOBKSKAZMVBHT,BRD-K13394247,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3,BRD-K13394247,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3,BRD-K13394247,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3,BRD-K13394247,radafaxine,dopamine-norepinephrine reuptake inhibitor,SLC6A3
RCOBWVAGWYRNHZ,BRD-K08640512,RS-100329,adrenergic receptor antagonist,ADRA1A|ADRA1D,BRD-K08640512,RS-100329,adrenergic receptor antagonist,ADRA1A|ADRA1D,BRD-K08640512,RS-100329,adrenergic receptor antagonist,ADRA1A|ADRA1D,BRD-K08640512,RS-100329,adrenergic receptor antagonist,ADRA1A|ADRA1D
RCORNHOUCUDCAC,BRD-K52914072,LTA,,,BRD-K52914072,LTA,,,BRD-K52914072,LTA,,,BRD-K52914072,LTA,,
RCTGMCJBQGBLKT,BRD-K65989725,sudan-iv,,,BRD-K65989725,sudan-iv,,,BRD-K65989725,sudan-iv,,,BRD-K00004524,sudan-IV,,
RCUDFXMNPQNBDU,BRD-K46839850,cinepazide,calcium channel activator,,BRD-K46839850,cinepazide,calcium channel activator,,BRD-K46839850,cinepazide,calcium channel activator,,BRD-K46839850,cinepazide,calcium channel activator,
RCYLUNPFECYGDW,BRD-A67482312,4-P-PDOT,melatonin receptor antagonist,MTNR1A|MTNR1B,BRD-A67482312,4-P-PDOT,melatonin receptor antagonist,MTNR1A|MTNR1B,BRD-A67482312,4-P-PDOT,melatonin receptor antagonist,MTNR1A|MTNR1B,BRD-K00004224,4-P-PDOT,melatonin receptor antagonist,MTNR1A|MTNR1B
RDALZZCKQFLGJP,BRD-K49048664,CB-5083,valosin-containing protein inhibitor,VCP,BRD-K49048664,CB-5083,valosin-containing protein inhibitor,VCP,BRD-K49048664,CB-5083,valosin-containing protein inhibitor,VCP,BRD-K49048664,CB-5083,valosin-containing protein inhibitor,VCP
RDJGLLICXDHJDY,BRD-A81129465,fenoprofen,prostaglandin inhibitor,PTGS1|PTGS2|SLC5A8,BRD-A81129465,fenoprofen,prostaglandin inhibitor,PTGS1|PTGS2|SLC5A8,BRD-A81129465|BRD-M61246020|BRD-U45213318,fenoprofen,prostaglandin inhibitor,PTGS1|PTGS2|SLC5A8,BRD-K01827286,fenoprofen,prostaglandin inhibitor,PTGS1|SLC5A8
RDJQCOBTKKAQAH,BRD-K24610819,amibegron,adrenergic receptor agonist,ADRB3,BRD-K24610819,amibegron,adrenergic receptor agonist,ADRB3,BRD-K24610819,amibegron,adrenergic receptor agonist,ADRB3,BRD-K24610819,amibegron,adrenergic receptor agonist,ADRB3
RDLPVSKMFDYCOR,BRD-A90807417|BRD-K13797099,cefradine|cephradine,bacterial cell wall synthesis inhibitor,|CYP3A4,BRD-A90807417|BRD-K13797099,cefradine|cephradine,bacterial cell wall synthesis inhibitor,|CYP3A4,BRD-A90807417|BRD-K13797099,cefradine|cephradine,bacterial cell wall synthesis inhibitor,|CYP3A4,BRD-A90807417|BRD-K13797099,cefradine|cephradine,bacterial cell wall synthesis inhibitor,|CYP3A4
RDOIQAHITMMDAJ,BRD-K61250553,loperamide,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,BRD-K61250553,loperamide,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,BRD-K61250553,loperamide,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,BRD-K61250553,loperamide,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC
RDSACQWTXKSHJT,BRD-K85751432,refametinib,MEK inhibitor,MAP2K1|MAP2K2,BRD-K85751432,refametinib,MEK inhibitor,MAP2K1|MAP2K2,BRD-K85751432,refametinib,MEK inhibitor,MAP2K1|MAP2K2,BRD-K85751432,refametinib,MEK inhibitor,MAP2K1|MAP2K2
RDXLYGJSWZYTFJ,BRD-K53123955,niridazole,phosphofructokinase inhibitor,,BRD-K53123955,niridazole,phosphofructokinase inhibitor,,BRD-K53123955,niridazole,phosphofructokinase inhibitor,,BRD-K53123955,niridazole,phosphofructokinase inhibitor,
RECUKUPTGUEGMW,BRD-K15541734,antioxine,,,BRD-K15541734,antioxine,,,BRD-K15541734,antioxine,,,BRD-K15541734,antioxine,,
REFJWTPEDVJJIY,BRD-K97399794,quercetin,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,BRD-K97399794,quercetin,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,BRD-K97399794,quercetin,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,BRD-K97399794,quercetin,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1
REQCZEXYDRLIBE,BRD-K75089421,procainamide,sodium channel blocker,DNMT1|SCN5A,BRD-K75089421,procainamide,sodium channel blocker,DNMT1|SCN5A,BRD-K75089421,procainamide,sodium channel blocker,DNMT1|SCN5A,BRD-K75089421,procainamide,sodium channel blocker,DNMT1|SCN5A
REQPQFUJGGOFQL,BRD-K36889451,tetramethylthiuram-monosulfide,,,BRD-K36889451,tetramethylthiuram-monosulfide,,,BRD-K36889451,tetramethylthiuram-monosulfide,,,BRD-K36889451,tetramethylthiuram-monosulfide,,
RESPXSHDJQUNTN,BRD-K28042756,1-(piperidin-1-yl)prop-2-en-1-one,,,,,,,,,,,,,,
REYFJDPCWQRWAA,BRD-K99300445,antazoline,antihistamine,HRH1,BRD-K99300445,antazoline,antihistamine,HRH1,BRD-K99300445,antazoline,antihistamine,HRH1,BRD-K99300445,antazoline,antihistamine,HRH1
REZGGXNDEMKIQB,BRD-K16542329,zaprinast,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,BRD-K16542329,zaprinast,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,BRD-K16542329,zaprinast,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,BRD-K16542329,zaprinast,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A
RFAXLXKIAKIUDT,BRD-K38727704,IPA-3,p21 activated kinase inhibitor,PAK1,BRD-K38727704,IPA-3,p21 activated kinase inhibitor,PAK1,BRD-K38727704,IPA-3,p21 activated kinase inhibitor,PAK1,BRD-K38727704,IPA-3,p21 activated kinase inhibitor,PAK1
RFBVBRVVOPAAFS,BRD-K15318909,PRIMA1,TP53 inhibitor,ACHE,BRD-K15318909,PRIMA1,TP53 inhibitor,ACHE,BRD-K15318909,PRIMA1,TP53 inhibitor,ACHE,BRD-K15318909,PRIMA1,TP53 inhibitor,ACHE
RFGAQTOFZHCFHG,BRD-K50691590,bortezomib,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,,,,,,,,,,,,
RFHAOTPXVQNOHP,BRD-K05977355,fluconazole,sterol demethylase inhibitor,CYP51A1,BRD-K05977355,fluconazole,sterol demethylase inhibitor,CYP51A1,BRD-K05977355,fluconazole,sterol demethylase inhibitor,CYP51A1,BRD-K05977355,fluconazole,sterol demethylase inhibitor,CYP51A1
RFKMCNOHBTXSMU,BRD-K06152156,methoxyflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1,BRD-K06152156,methoxyflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1,BRD-K06152156,methoxyflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1,BRD-K06152156,methoxyflurane,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1
RFKQJTRWODZPHF,BRD-K67186445,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE,BRD-K67186445,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE,BRD-K67186445,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE,BRD-K67186445,dehydrocorydaline,acetylcholinesterase inhibitor,ACHE
RFSMUFRPPYDYRD,BRD-K67566344,ku-0063794,mTOR inhibitor,MTOR,BRD-K67566344,ku-0063794,mTOR inhibitor,MTOR,BRD-K67566344,ku-0063794,mTOR inhibitor,MTOR,BRD-K67566344,KU-0063794,mTOR inhibitor,MTOR
RFTSSZJZXOSICM,BRD-K15600710,obatoclax,BCL inhibitor,BCL2,BRD-K15600710,obatoclax,BCL inhibitor,BCL2,BRD-K15600710,obatoclax,BCL inhibitor,BCL2,BRD-K15600710,obatoclax,BCL inhibitor,BCL2
RFUBTTPMWSKEIW,BRD-K36680103,omecamtiv-mecarbil,cardiac myosin activator,MYBPC3,BRD-K36680103,omecamtiv-mecarbil,cardiac myosin activator,MYBPC3,BRD-K36680103,omecamtiv-mecarbil,cardiac myosin activator,MYBPC3,BRD-K36680103,omecamtiv-mecarbil,cardiac myosin activator,MYBPC3
RFWGABANNQMHMZ,BRD-A00842753,oleuropein,estrogen receptor agonist,GPER1,BRD-A00842753,oleuropein,estrogen receptor agonist,GPER1,BRD-A00842753,oleuropein,estrogen receptor agonist,GPER1,BRD-A00842753,oleuropein,estrogen receptor agonist,GPER1
RFWVETIZUQEJEF,BRD-K46908090,GDC-0623,MEK inhibitor,,BRD-K46908090,GDC-0623,MEK inhibitor,,BRD-K46908090,GDC-0623,MEK inhibitor,,BRD-K46908090,GDC-0623,MEK inhibitor,
RFWZESUMWJKKRN,BRD-K33133047,dapiprazole,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K33133047,dapiprazole,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K33133047,dapiprazole,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K33133047,dapiprazole,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D
RFZKSQIFOZZIAQ,BRD-K37237504,CEP-33779,JAK inhibitor,JAK2,BRD-K37237504,CEP-33779,JAK inhibitor,JAK2,BRD-K37237504,CEP-33779,JAK inhibitor,JAK2,BRD-K37237504,CEP-33779,JAK inhibitor,JAK2
RFZPGNRLOKVZJY,BRD-K61936403,AS-1949490,SHIP2 phosphatase inhibitor,INPP5D,BRD-K61936403,AS-1949490,SHIP2 phosphatase inhibitor,INPP5D,BRD-K61936403,AS-1949490,SHIP2 phosphatase inhibitor,INPP5D,BRD-K61936403,AS-1949490,SHIP2 phosphatase inhibitor,INPP5D
RFZQYGBLRIKROZ,BRD-K38627885,APY0201,phosphoinositide dependent kinase inhibitor,IL12A|IL12B|PIKFYVE,BRD-K38627885,APY0201,phosphoinositide dependent kinase inhibitor,IL12A|IL12B|PIKFYVE,BRD-K38627885,APY0201,phosphoinositide dependent kinase inhibitor,IL12A|IL12B|PIKFYVE,BRD-K38627885,APY0201,phosphoinositide dependent kinase inhibitor,IL12A|IL12B|PIKFYVE
RGCKGOZRHPZPFP,BRD-K73191876,alizarin,,,BRD-K73191876,alizarin,,,BRD-K73191876,alizarin,,,BRD-K73191876,alizarin,,
RGCVKNLCSQQDEP,BRD-K10995081,perphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7,BRD-K10995081,perphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7,BRD-K10995081,perphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7,BRD-K10995081,perphenazine,dopamine receptor antagonist,CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7
RGDHRCXUMURWBJ,BRD-K10177585,PSB-11,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA3,BRD-K10177585,PSB-11,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA3,BRD-K10177585,PSB-11,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA3,BRD-K10177585,PSB-11,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA3
RGHNJXZEOKUKBD,BRD-A63267145|BRD-K93201765,hexonic-acid|sodium-gluconate,,,BRD-A63267145|BRD-K93201765|BRD-M54096567,hexonic-acid|sodium-gluconate,,,BRD-A63267145|BRD-K93201765|BRD-M54096567|BRD-M98748937,hexonic-acid|sodium-gluconate,,,BRD-A63267145|BRD-K93201765|BRD-M54096567|BRD-M98748937,hexonic-acid|sodium-gluconate,,
RGHYDLZMTYDBDT,BRD-K56291712,voxtalisib,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K56291712,voxtalisib,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K56291712,voxtalisib,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K56291712,voxtalisib,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA
RGJOEKWQDUBAIZ,BRD-A67956599,coenzyme-a,,ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5,BRD-A67956599,coenzyme-a,,ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5,BRD-A67956599,coenzyme-a,,ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5,BRD-A67956599,coenzyme-A,,ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5
RGJOJUGRHPQXGF,BRD-K43187018,GDC-0349,Pim kinase inhibitor,PIK3CA,BRD-K43187018,GDC-0349,Pim kinase inhibitor,PIK3CA,BRD-K43187018,GDC-0349,Pim kinase inhibitor,PIK3CA,BRD-K43187018,GDC-0349,Pim kinase inhibitor,PIK3CA
RGLYKWWBQGJZGM,BRD-K45330754,diethylstilbestrol,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,BRD-K45330754,diethylstilbestrol,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,BRD-K45330754,diethylstilbestrol,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,BRD-K45330754,diethylstilbestrol,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG
RGOVYLWUIBMPGK,BRD-K05907307,nonivamide,TRPV agonist,TRPV1,BRD-K05907307,nonivamide,TRPV agonist,TRPV1,BRD-K05907307,nonivamide,TRPV agonist,TRPV1,BRD-K05907307,nonivamide,TRPV agonist,TRPV1
RGPDEAGGEXEMMM,BRD-A78877355,nefopam,cyclooxygenase inhibitor,,BRD-A78877355,nefopam,cyclooxygenase inhibitor,,BRD-A78877355,nefopam,cyclooxygenase inhibitor,,BRD-K01826512,nefopam,cyclooxygenase inhibitor,
RGSVXQJPSWZXOP,BRD-K15519488,CS-110266,dopamine receptor agonist,SLC6A3,BRD-K15519488,CS-110266,dopamine receptor agonist,SLC6A3,BRD-K15519488,CS-110266,dopamine receptor agonist,SLC6A3,BRD-K15519488,CS-110266,dopamine receptor agonist,SLC6A3
RGVPOXRFEPSFGH,BRD-A56241705,trimethoquinol,adrenergic receptor antagonist,ADRB2|ADRB3,BRD-A56241705,trimethoquinol,adrenergic receptor antagonist,ADRB2|ADRB3,BRD-A56241705,trimethoquinol,adrenergic receptor antagonist,ADRB2|ADRB3,BRD-A56241705,trimethoquinol,adrenergic receptor antagonist,ADRB2|ADRB3
RGYQPQARIQKJKH,BRD-K79710622,GKT137831,NADPH oxidase inhibitor,NOX1|NOX4,BRD-K79710622,GKT137831,NADPH oxidase inhibitor,NOX1|NOX4,BRD-K79710622,GKT137831,NADPH oxidase inhibitor,NOX1|NOX4,BRD-K79710622,GKT137831,NADPH oxidase inhibitor,NOX1|NOX4
RGZSQWQPBWRIAQ,BRD-K62751771,levomenol,,,BRD-K62751771,levomenol,,,BRD-K62751771,levomenol,,,BRD-K62751771,levomenol,,
RHAXSHUQNIEUEY,BRD-K39339537,epirizole,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K39339537,epirizole,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K39339537,epirizole,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K39339537,epirizole,cyclooxygenase inhibitor,PTGS1|PTGS2
RHDJRPPFURBGLQ,BRD-K77597856,detomidine,adrenergic receptor agonist,ADRA2A,BRD-K77597856,detomidine,adrenergic receptor agonist,ADRA2A,BRD-K77597856,detomidine,adrenergic receptor agonist,ADRA2A,BRD-K77597856,detomidine,adrenergic receptor agonist,ADRA2A
RHFUXPCCELGMFC,BRD-K42679050,Y-27152,potassium channel activator,KCNJ8,BRD-K42679050,Y-27152,potassium channel activator,KCNJ8,BRD-K42679050,Y-27152,potassium channel activator,KCNJ8,BRD-K42679050,Y-27152,potassium channel activator,KCNJ8
RHGKLRLOHDJJDR,BRD-A12237696,L-Citrulline,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,BRD-A12237696,L-Citrulline,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,BRD-A12237696,L-Citrulline,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,BRD-A12237696,L-citrulline,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6
RHKCFWGPEDXSNT,BRD-A21002158|BRD-A30186914,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,BRD-A30186914,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,BRD-A30186914,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,,,,
RHLJLALHBZGAFM,BRD-K35034482,bunazosin,adrenergic receptor antagonist,ADRA1A,BRD-K35034482,bunazosin,adrenergic receptor antagonist,ADRA1A,BRD-K35034482,bunazosin,adrenergic receptor antagonist,ADRA1A,BRD-K35034482,bunazosin,adrenergic receptor antagonist,ADRA1A
RHMXXJGYXNZAPX,BRD-K58685305,emodin,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1,BRD-K58685305,emodin,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1,BRD-K58685305,emodin,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1,BRD-K58685305,emodin,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1
RHWKPHLQXYSBKR,BRD-K36386086,dolutegravir,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,BRD-K36386086,dolutegravir,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,BRD-K36386086,dolutegravir,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,BRD-K67463151,dolutegravir,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1
RHXHGRAEPCAFML,BRD-K36788280,ribociclib,CDK inhibitor,CDK4|CDK6,BRD-K36788280,ribociclib,CDK inhibitor,CDK4|CDK6,BRD-K36788280,ribociclib,CDK inhibitor,CDK4|CDK6,BRD-K36788280,ribociclib,CDK inhibitor,CDK4|CDK6
RICZEKWVNZFTNZ,BRD-K38287497,narlaprevir,HCV inhibitor,,BRD-K38287497,narlaprevir,HCV inhibitor,,BRD-K38287497,narlaprevir,HCV inhibitor,,BRD-K38287497,narlaprevir,HCV inhibitor,
RIJFNUHYNBVLOZ,BRD-A79226577,tropisetron,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,BRD-A79226577,tropisetron,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,,,,,,,,
RIJLVEAXPNLDTC,BRD-K16803204,filgotinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K16803204,filgotinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K16803204,filgotinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K16803204,filgotinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2
RIKMMFOAQPJVMX,BRD-K56810756,fomepizole,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,BRD-K56810756,fomepizole,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,BRD-K56810756,fomepizole,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,BRD-K56810756,fomepizole,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT
RITAVMQDGBJQJZ,BRD-K29905972,axitinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,BRD-K29905972,axitinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,BRD-K29905972,axitinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,BRD-K29905972,axitinib,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4
RIUORJCWAHCMSA,BRD-K04254814,sulfanilate-zinc,,,BRD-K04254814,sulfanilate-zinc,,,BRD-K04254814|BRD-M62362637,sulfanilate-zinc,,,BRD-K04254814|BRD-M62362637,sulfanilate-zinc,,
RJCWBNBKOKFWNY,BRD-A96383502|BRD-K56211775,RTA-408,nitric oxide production inhibitor,NFE2L2,BRD-A96383502|BRD-K56211775,RTA-408,nitric oxide production inhibitor,NFE2L2,BRD-A96383502|BRD-K56211775,RTA-408,nitric oxide production inhibitor,NFE2L2,BRD-A96383502|BRD-K56211775,RTA-408,nitric oxide production inhibitor,NFE2L2
RJFAYQIBOAGBLC,BRD-A18774709|BRD-K74664543,selenomethionine,,,BRD-A18774709|BRD-K74664543,selenomethionine,,,BRD-A18774709|BRD-K74664543,selenomethionine,,,BRD-K74664543,selenomethionine,,
RJIWZDNTCBHXAL,BRD-K97534525,nitroxoline,cathepsin inhibitor,METAP2,BRD-K97534525,nitroxoline,cathepsin inhibitor,METAP2,BRD-K97534525,nitroxoline,cathepsin inhibitor,METAP2,BRD-K97534525,nitroxoline,cathepsin inhibitor,METAP2
RJKFOVLPORLFTN,BRD-A67479912|BRD-K37762555,progesterone,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,BRD-A67479912|BRD-K37762555,progesterone,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,BRD-A67479912|BRD-K37762555|BRD-K64994968,progesterone,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,BRD-A67479912|BRD-K37762555|BRD-K64994968,progesterone,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5
RJMIEHBSYVWVIN,BRD-A44090213,indoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,BRD-A44090213,indoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,BRD-A44090213,indoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,BRD-A44090213,indoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2
RJMUSRYZPJIFPJ,BRD-K35960502,niclosamide,DNA replication inhibitor|STAT inhibitor,STAT3,BRD-K35960502,niclosamide,DNA replication inhibitor|STAT inhibitor,STAT3,BRD-K35960502,niclosamide,DNA replication inhibitor|STAT inhibitor,STAT3,BRD-K35960502,niclosamide,DNA replication inhibitor|STAT inhibitor,STAT3
RJOUHGWLHPOQSA,BRD-K90727284,pincainide,antiarrhythmic,,BRD-K90727284,pincainide,antiarrhythmic,,BRD-K90727284,pincainide,antiarrhythmic,,BRD-K90727284,pincainide,antiarrhythmic,
RJQXTJLFIWVMTO,BRD-K34388247,methicillin,bacterial cell wall synthesis inhibitor,,BRD-K34388247,methicillin,bacterial cell wall synthesis inhibitor,,BRD-K34388247,methicillin,bacterial cell wall synthesis inhibitor,,BRD-K34388247,methicillin,bacterial cell wall synthesis inhibitor,
RJURFGZVJUQBHK,BRD-A42383464|BRD-K70578146,actinomycin-d|dactinomycin,RNA polymerase inhibitor,|POLR2A,BRD-A42383464|BRD-K70578146,actinomycin-d|dactinomycin,RNA polymerase inhibitor,|POLR2A,BRD-A42383464|BRD-K16547679|BRD-K70578146,actinomycin-d|dactinomycin,RNA polymerase inhibitor,|POLR2A,BRD-K16547679|BRD-K70578146,actinomycin-d|dactinomycin,RNA polymerase inhibitor,|POLR2A
RJVLFQBBRSMWHX,BRD-A81177136,KN-62,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-A81177136,KN-62,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-A81177136,KN-62,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1,BRD-A81177136,KN-62,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1
RKEWSXXUOLRFBX,BRD-K83405785,pimavanserin,serotonin receptor inverse agonist,DRD2|HTR2A,BRD-K83405785,pimavanserin,serotonin receptor inverse agonist,DRD2|HTR2A,BRD-K83405785,pimavanserin,serotonin receptor inverse agonist,DRD2|HTR2A,BRD-K83405785,pimavanserin,serotonin receptor inverse agonist,DRD2|HTR2A
RKFAZBXYICVSKP,BRD-K72536715,alpha-Asarone,HMGCR inhibitor|cytochrome P450 inhibitor,HMGCR,BRD-K72536715,alpha-Asarone,HMGCR inhibitor|cytochrome P450 inhibitor,HMGCR,BRD-K72536715,alpha-Asarone,HMGCR inhibitor|cytochrome P450 inhibitor,HMGCR,BRD-K72536715,alpha-asarone,HMGCR inhibitor|cytochrome P450 inhibitor,HMGCR
RKKFQJXGAQWHBZ,BRD-K35945299,SJ-172550,MDM inhibitor,MDM4,BRD-K35945299,SJ-172550,MDM inhibitor,MDM4,BRD-K35945299,SJ-172550,MDM inhibitor,MDM4,BRD-K35945299,SJ-172550,MDM inhibitor,MDM4
RKLNONIVDFXQRX,BRD-K78643075,bromperidol,dopamine receptor antagonist,DRD2,BRD-K78643075,bromperidol,dopamine receptor antagonist,DRD2,BRD-K78643075,bromperidol,dopamine receptor antagonist,DRD2,BRD-K78643075,bromperidol,dopamine receptor antagonist,DRD2
RKUNBYITZUJHSG,BRD-A27290375|BRD-A78303415|BRD-A93739713|BRD-A97674763,atropine|hyoscyamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A27290375|BRD-A78303415|BRD-A93739713|BRD-A97674763,atropine|hyoscyamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A27290375|BRD-A78303415|BRD-A93739713|BRD-A97674763|BRD-K40530731,atropine|hyoscyamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A27290375|BRD-A78303415|BRD-A93739713|BRD-A97674763|BRD-K01825666|BRD-K40530731,atropine|hyoscyamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4
RKUQLAPSGZJLGP,BRD-A21446384,xibenolol,adrenergic receptor antagonist,,BRD-A21446384,xibenolol,adrenergic receptor antagonist,,BRD-A21446384,xibenolol,adrenergic receptor antagonist,,BRD-A21446384,xibenolol,adrenergic receptor antagonist,
RKVRGRXOYDTUEY,BRD-K90065682,5-iodo-A-85380,acetylcholine receptor agonist,,BRD-K90065682,5-iodo-A-85380,acetylcholine receptor agonist,,BRD-K90065682,5-iodo-A-85380,acetylcholine receptor agonist,,BRD-K90065682,5-iodo-A-85380,acetylcholine receptor agonist,
RKWGIWYCVPQPMF,BRD-K97746869,chlorpropamide,ATP channel blocker,ABCC8|KCNJ10|KCNJ11,BRD-K97746869,chlorpropamide,ATP channel blocker,ABCC8|KCNJ10|KCNJ11,BRD-K97746869,chlorpropamide,ATP channel blocker,ABCC8|KCNJ10|KCNJ11,BRD-K97746869,chlorpropamide,ATP channel blocker,ABCC8|KCNJ10
RKWHWFONKJEUEF,BRD-K51337109,kuromanin,ribosyl cyclase inhibitor,CD38,BRD-K51337109,kuromanin,ribosyl cyclase inhibitor,CD38,BRD-K51337109,kuromanin,ribosyl cyclase inhibitor,CD38,BRD-K51337109,kuromanin,ribosyl cyclase inhibitor,CD38
RKZSNTNMEFVBDT,BRD-K30485548,sumanirole,dopamine receptor agonist,DRD2,BRD-K30485548,sumanirole,dopamine receptor agonist,DRD2,BRD-K30485548,sumanirole,dopamine receptor agonist,DRD2,BRD-K30485548,sumanirole,dopamine receptor agonist,DRD2
RLAWWYSOJDYHDC,BRD-K67966701,lisinopril,angiotensin converting enzyme inhibitor,ACE|ACE2,BRD-K67966701,lisinopril,angiotensin converting enzyme inhibitor,ACE|ACE2,BRD-K67966701,lisinopril,angiotensin converting enzyme inhibitor,ACE|ACE2,BRD-K67966701,lisinopril,angiotensin converting enzyme inhibitor,ACE|ACE2
RLDVZILFNVRJTL,BRD-A84810646,ginsenoside-rd,calcium channel blocker,,BRD-A84810646,ginsenoside-rd,calcium channel blocker,,BRD-A84810646,ginsenoside-rd,calcium channel blocker,,BRD-A84810646,ginsenoside-RD,calcium channel blocker,
RLFWWDJHLFCNIJ,BRD-K20484910,ampyrone,cyclooxygenase inhibitor,,BRD-K20484910,ampyrone,cyclooxygenase inhibitor,,BRD-K20484910,ampyrone,cyclooxygenase inhibitor,,BRD-K20484910,ampyrone,cyclooxygenase inhibitor,
RLGQACBPNDBWTB,BRD-K47079459,cetrimonium,,,BRD-K47079459,cetrimonium,,,BRD-K47079459,cetrimonium,,,BRD-K47079459,cetrimonium,,
RLJFTICUTYVZDG,BRD-A07932845,metitepine,anti-HCVE2,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-A07932845,metitepine,anti-HCVE2,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-A07932845,metitepine,anti-HCVE2,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K01826545,metitepine,anti-HCVE2,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
RLLPVAHGXHCWKJ,BRD-A25366096,permethrin,,SCN1A,BRD-A25366096,permethrin,,SCN1A,BRD-A25366096,permethrin,,SCN1A,BRD-A25366096,permethrin,,
RLQVKDVIBJCQGE,BRD-A04497688|BRD-A66155091|BRD-A99644790,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,ESR1|ESR2|HSD3B1|HSD3B2,BRD-A04497688,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,ESR1|ESR2|HSD3B1|HSD3B2,BRD-A04497688|BRD-A66155091|BRD-A99644790,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,ESR1|ESR2|HSD3B1|HSD3B2,BRD-A04497688|BRD-A66155091|BRD-A99644790,trilostane,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,
RLSGBCUXLRMTPF,BRD-K01868942,RS-23597-190,serotonin receptor antagonist,HTR4,BRD-K01868942,RS-23597-190,serotonin receptor antagonist,HTR4,BRD-K01868942,RS-23597-190,serotonin receptor antagonist,HTR4,BRD-K01868942,RS-23597-190,serotonin receptor antagonist,HTR4
RLSSMJSEOOYNOY,BRD-K22518984,metacresol,,INS,BRD-K22518984,metacresol,,INS,BRD-K22518984,metacresol,,INS,BRD-K22518984,metacresol,,INS
RMAMGGNACJHXHO,BRD-K97714174,P22077,ubiquitin specific protease inhibitor,USP7,BRD-K97714174,P22077,ubiquitin specific protease inhibitor,USP7,BRD-K97714174,P22077,ubiquitin specific protease inhibitor,USP7,BRD-K97714174,P22077,ubiquitin specific protease inhibitor,USP7
RMEDXOLNCUSCGS,BRD-K97158071,droperidol,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,BRD-K97158071,droperidol,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,BRD-K97158071,droperidol,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,BRD-K97158071,droperidol,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A
RMHMFHUVIITRHF,BRD-K89375097,pirenzepine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K89375097,pirenzepine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K89375097,pirenzepine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K89375097,pirenzepine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
RMMXLENWKUUMAY,BRD-K73999723,telmisartan,angiotensin receptor antagonist,AGTR1|PPARG,BRD-K73999723,telmisartan,angiotensin receptor antagonist,AGTR1|PPARG,BRD-K73999723,telmisartan,angiotensin receptor antagonist,AGTR1|PPARG,BRD-K73999723,telmisartan,angiotensin receptor antagonist,AGTR1|PPARG
RMMXTBMQSGEXHJ,BRD-K12568846,amidopyrine,analgesic agent,,BRD-K12568846,amidopyrine,analgesic agent,,BRD-K12568846,amidopyrine,analgesic agent,,BRD-K12568846,amidopyrine,analgesic agent,
RMQJECWPWQIIPW,BRD-K91614056,trans-4-Hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,,BRD-K91614056,trans-4-Hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,,BRD-K91614056,trans-4-Hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,,BRD-K91614056,trans-4-hydroxycrotonic-acid,gamma hydroxybutyric acid ligand,
RMUCZJUITONUFY,BRD-K87024524,phenelzine,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,BRD-K87024524,phenelzine,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,BRD-K87024524,phenelzine,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,BRD-K87024524,phenelzine,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4
RMWVZGDJPAKBDE,BRD-K71696703,triflusal,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1,BRD-K71696703,triflusal,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1,BRD-K71696703,triflusal,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1,BRD-K71696703,triflusal,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1
RNAMYOYQYRYFQY,BRD-K60130390,UNC0642,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K60130390,UNC0642,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K60130390,UNC0642,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K60130390,UNC0642,histone lysine methyltransferase inhibitor,EHMT1|EHMT2
RNBGYGVWRKECFJ,BRD-A19086570,fosfructose,fructose diphosphate stimulant,PKLR,BRD-A19086570,fosfructose,fructose diphosphate stimulant,PKLR,BRD-A19086570,fosfructose,fructose diphosphate stimulant,PKLR,,,,
RNCNPRCUHHDYPC,BRD-K77943374,NVP-BVU972,MET inhibitor,MET,BRD-K77943374,NVP-BVU972,MET inhibitor,MET,BRD-K77943374,NVP-BVU972,MET inhibitor,MET,BRD-K77943374,NVP-BVU972,MET inhibitor,MET
RNGRUHWJJPTYNR,BRD-K68633617,ACDPP,glutamate receptor antagonist,GRM5,BRD-K68633617,ACDPP,glutamate receptor antagonist,GRM5,BRD-K68633617,ACDPP,glutamate receptor antagonist,GRM5,BRD-K68633617,ACDPP,glutamate receptor antagonist,GRM5
RNLQIBCLLYYYFJ,BRD-K45924332,amrinone,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,BRD-K45924332,amrinone,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,BRD-K45924332,amrinone,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,BRD-K45924332,amrinone,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF
RNPLSXLZRGPQCU,BRD-A25492003|BRD-A41555725,chlortetracycline,protein synthesis inhibitor,,BRD-A25492003|BRD-A41555725,chlortetracycline,protein synthesis inhibitor,,BRD-A25492003|BRD-A41555725,chlortetracycline,protein synthesis inhibitor,,BRD-K00003353,chlortetracycline,protein synthesis inhibitor,
RNSLRQNDXRSASX,BRD-K43330982,JTE-013,lysophospholipid receptor antagonist,P2RY10|S1PR2,BRD-K43330982,JTE-013,lysophospholipid receptor antagonist,P2RY10|S1PR2,BRD-K43330982,JTE-013,lysophospholipid receptor antagonist,P2RY10|S1PR2,BRD-K43330982,JTE-013,lysophospholipid receptor antagonist,P2RY10|S1PR2
RNUXIZKXJOGYQP,BRD-K19316653,WIKI4,Wnt pathway inhibitor|tankyrase inhibitor,TNKS2,BRD-K19316653,WIKI4,Wnt pathway inhibitor|tankyrase inhibitor,TNKS2,BRD-K19316653,WIKI4,Wnt pathway inhibitor|tankyrase inhibitor,TNKS2,BRD-K19316653,WIKI4,WNT pathway inhibitor|tankyrase inhibitor,TNKS2
ROBVIMPUHSLWNV,BRD-A25234499,aminoglutethimide,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,BRD-A25234499,aminoglutethimide,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,BRD-A25234499,aminoglutethimide,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,BRD-A25234499,aminoglutethimide,glucocorticoid receptor antagonist,CYP11A1|CYP19A1
ROCFOIBAEVAOLQ,BRD-K64835161,ML167,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,BRD-K64835161,ML167,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,BRD-K64835161,ML167,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,BRD-K64835161,ML167,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B
RODUKNYOEVZQPR,BRD-K30237152,1400W,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K30237152,1400W,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K30237152,1400W,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,BRD-K30237152,1400W,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3
ROFVXGGUISEHAM,BRD-K92169341,URB597,FAAH inhibitor,FAAH|FAAH2|TRPA1,BRD-K92169341,URB597,FAAH inhibitor,FAAH|FAAH2|TRPA1,BRD-K92169341,URB597,FAAH inhibitor,FAAH|FAAH2|TRPA1,BRD-K92169341,URB597,FAAH inhibitor,FAAH|FAAH2|TRPA1
ROHFNLRQFUQHCH,BRD-K12853841,L-leucine,,BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2,BRD-K12853841,L-leucine,,BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2,BRD-K12853841,L-leucine,,BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2,BRD-K12853841,L-leucine,,BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2
RONQPWQYDRPRGG,BRD-K32292990,CGP-53353,EGFR inhibitor|PKC inhibitor,EGFR|PRKCB,BRD-K32292990,CGP-53353,EGFR inhibitor|PKC inhibitor,EGFR|PRKCB,BRD-K32292990,CGP-53353,EGFR inhibitor|PKC inhibitor,EGFR|PRKCB,BRD-K32292990,CGP-53353,EGFR inhibitor|PKC inhibitor,EGFR|PRKCB
RONZAEMNMFQXRA,BRD-A64977602,mirtazapine,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2A|HTR2B|HTR2C|HTR3A|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,BRD-A64977602,mirtazapine,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2A|HTR2B|HTR2C|HTR3A|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,BRD-A64977602,mirtazapine,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD5|HRH1|HRH3|HTR2A|HTR2B|HTR2C|HTR3A|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,BRD-A64977602,mirtazapine,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C
ROSNVSQTEGHUKU,BRD-K53508936,CTS-1027,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,BRD-K53508936,CTS-1027,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,BRD-K53508936,CTS-1027,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,BRD-K53508936,CTS-1027,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9
ROWSTIYZUWEOMM,BRD-K09426783,TAS-103,topoisomerase inhibitor,TOP1,BRD-K09426783,TAS-103,topoisomerase inhibitor,TOP1,BRD-K09426783,TAS-103,topoisomerase inhibitor,TOP1,BRD-K09426783,TAS-103,topoisomerase inhibitor,TOP1
ROYXIPOUVGDTAO,BRD-K38860038,JK-184,hedgehog pathway inhibitor,,BRD-K38860038,JK-184,hedgehog pathway inhibitor,,BRD-K38860038,JK-184,hedgehog pathway inhibitor,,BRD-K38860038,JK-184,hedgehog pathway inhibitor,
ROZOEEGFKDFEFP,BRD-A64698388,levo-phencynonate,acetylcholine receptor antagonist,CHRM1,BRD-A64698388,levo-phencynonate,acetylcholine receptor antagonist,CHRM1,BRD-A64698388,levo-phencynonate,acetylcholine receptor antagonist,CHRM1,BRD-A64698388,levo-phencynonate,acetylcholine receptor antagonist,CHRM1
RPLCPCMSCLEKRS,BRD-K46061689,desogestrel,progesterone receptor agonist,ESR1|PGR,BRD-K46061689,desogestrel,progesterone receptor agonist,ESR1|PGR,BRD-K46061689,desogestrel,progesterone receptor agonist,ESR1|PGR,BRD-K46061689,desogestrel,progesterone receptor agonist,ESR1|PGR
RPLTXWVLGFJQNR,BRD-M41172429,calcium-gluceptate,,,BRD-M41172429,calcium-gluceptate,,,,,,,,,,
RPOBPHCDIPHDQL,BRD-A60786380,sodium-stibogluconate,tyrosine phosphatase inhibitor,PTPN6|TOP1,BRD-A60786380,sodium-stibogluconate,tyrosine phosphatase inhibitor,PTPN6|TOP1,BRD-A60786380,sodium-stibogluconate,tyrosine phosphatase inhibitor,PTPN6|TOP1,BRD-K00003543,sodium-stibogluconate,tyrosine phosphatase inhibitor,PTPN6
RPQZTTQVRYEKCR,BRD-A01145011|BRD-K58673634|BRD-K87714311,zebularine,DNA methyltransferase inhibitor,CDA|DNMT1,BRD-A01145011|BRD-K58673634|BRD-K87714311,zebularine,DNA methyltransferase inhibitor,CDA|DNMT1,BRD-A01145011|BRD-K58673634|BRD-K87714311,zebularine,DNA methyltransferase inhibitor,CDA|DNMT1,BRD-A01145011|BRD-K58673634|BRD-K87714311,zebularine,DNA methyltransferase inhibitor,CDA|DNMT1
RPTUSVTUFVMDQK,BRD-K82103381,hydralazine,vasodilator,AOC3|P4HA1,BRD-K82103381,hydralazine,vasodilator,AOC3|P4HA1,BRD-K82103381,hydralazine,vasodilator,AOC3|P4HA1,BRD-K82103381,hydralazine,vasodilator,
RPXVIAFEQBNEAX,BRD-K19438463,CNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K19438463,CNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K19438463,CNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,BRD-K19438463,CNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4
RPYWXZCFYPVCNQ,BRD-K14235254,GTS21,cholinergic receptor agonist,CHRNA7,BRD-K14235254,GTS21,cholinergic receptor agonist,CHRNA7,BRD-K14235254,GTS21,cholinergic receptor agonist,CHRNA7,BRD-K14235254,GTS21,cholinergic receptor agonist,CHRNA7
RQANARBNMTXCDM,BRD-K16229414,SR-11302,,,BRD-K16229414,SR-11302,,,BRD-K16229414,SR-11302,,,BRD-K16229414,SR-11302,,
RQCXKDWOCUJWQZ,BRD-K36021395,ABT-702,adenosine kinase inhibitor,ADK,BRD-K36021395,ABT-702,adenosine kinase inhibitor,ADK,BRD-K36021395,ABT-702,adenosine kinase inhibitor,ADK,BRD-K36021395,ABT-702,adenosine kinase inhibitor,ADK
RQHKZUBCUZVZEF,BRD-K57304726,PRE-084,sigma receptor agonist,SIGMAR1,BRD-K57304726,PRE-084,sigma receptor agonist,SIGMAR1,BRD-K57304726,PRE-084,sigma receptor agonist,SIGMAR1,BRD-K57304726,PRE-084,sigma receptor agonist,SIGMAR1
RQKXQCSEZPQBNZ,BRD-K81548480,AC-264613,PAR agonist,F2RL1,BRD-K81548480,AC-264613,PAR agonist,F2RL1,BRD-K81548480,AC-264613,PAR agonist,F2RL1,BRD-K81548480,AC-264613,PAR agonist,F2RL1
RQNADZJRELIICT,BRD-K94882685,tolonium,,,BRD-K94882685,tolonium,,,BRD-K94882685,tolonium,,,,,,
RQPUEHDQLXIPNI,BRD-K40767677,RP67580,,,BRD-K40767677,RP67580,,,BRD-K40767677,RP67580,,,,,,
RQTOOFIXOKYGAN,BRD-K64716392,nedocromil,histamine receptor antagonist,CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR,BRD-K64716392,nedocromil,histamine receptor antagonist,CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR,BRD-K64716392,nedocromil,histamine receptor antagonist,CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR,BRD-K64716392,nedocromil,histamine receptor antagonist,CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR
RQVGFDBMONQTBC,BRD-K29895144,SKLB1002,VEGFR inhibitor,KDR,BRD-K29895144,SKLB1002,VEGFR inhibitor,KDR,BRD-K29895144,SKLB1002,VEGFR inhibitor,KDR,BRD-K29895144,SKLB1002,VEGFR inhibitor,KDR
RQVKVJIRFKVPBF,BRD-K86673452,AMG-548,MAP kinase inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,BRD-K86673452,AMG-548,MAP kinase inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,BRD-K86673452,AMG-548,MAP kinase inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,BRD-K86673452,AMG-548,MAP kinase inhibitor,MAPK11|MAPK12|MAPK13|MAPK14
RQXCLMGKHJWMOA,BRD-K17565903,pridinol,muscle relaxant,,BRD-K17565903,pridinol,muscle relaxant,,BRD-K17565903,pridinol,muscle relaxant,,BRD-K17565903,pridinol,muscle relaxant,
RQZAXGRLVPAYTJ,BRD-A35989968|BRD-K19507340|BRD-K29344105,megestrol-acetate,progesterone receptor agonist,NR3C1|PGR,BRD-A35989968|BRD-K19507340,megestrol-acetate,progesterone receptor agonist,NR3C1|PGR,BRD-A35989968|BRD-K19507340|BRD-K29344105,megestrol-acetate,progesterone receptor agonist,NR3C1|PGR,BRD-K19507340|BRD-K29344105,megestrol-acetate,progesterone receptor agonist,NR3C1|PGR
RRAFCDWBNXTKKO,BRD-K32977963,eugenol,androgen receptor antagonist,AR,BRD-K32977963,eugenol,androgen receptor antagonist,AR,BRD-K32977963,eugenol,androgen receptor antagonist,AR,BRD-K32977963,eugenol,androgen receptor antagonist,AR
RRGUKTPIGVIEKM,BRD-K67017579,cilostazol,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K67017579,cilostazol,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K67017579,cilostazol,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K67017579,cilostazol,phosphodiesterase inhibitor,PDE3A|PDE3B
RRHJHSBDJDZUGL,BRD-K68693535,lidamidine,adrenergic receptor agonist,,BRD-K68693535,lidamidine,adrenergic receptor agonist,,BRD-K68693535,lidamidine,adrenergic receptor agonist,,BRD-K68693535,lidamidine,adrenergic receptor agonist,
RRJHESVQVSRQEX,BRD-A02439449|BRD-K17903788,cefamandole-nafate,bacterial cell wall synthesis inhibitor,,BRD-A02439449|BRD-K17903788,cefamandole-nafate,bacterial cell wall synthesis inhibitor,,BRD-A02439449|BRD-K17903788,cefamandole-nafate,bacterial cell wall synthesis inhibitor,,BRD-A02439449|BRD-K17903788,cefamandole-nafate,bacterial cell wall synthesis inhibitor,
RRJLJKRFFRZRAF,BRD-K15424032,SB-228357,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K15424032,SB-228357,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K15424032,SB-228357,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K15424032,SB-228357,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
RRKTZKIUPZVBMF,BRD-A41995253,brucine,glycine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A41995253,brucine,glycine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A41995253,brucine,glycine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K68077509,brucine,glycine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
RRRUXBQSQLKHEL,BRD-K47642186,piclamilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K47642186,piclamilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K47642186,piclamilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,BRD-K47642186,piclamilast,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D
RRUDCFGSUDOHDG,BRD-K21615095,acetohydroxamic-acid,urease inhibitor,MMP12,BRD-K21615095,acetohydroxamic-acid,urease inhibitor,MMP12,BRD-K21615095,acetohydroxamic-acid,urease inhibitor,MMP12,BRD-K21615095,acetohydroxamic-acid,urease inhibitor,MMP12
RRZXIRBKKLTSOM,BRD-A25579302,abamectin,benzodiazepine receptor agonist,GABBR1|GABBR2,BRD-A25579302,abamectin,benzodiazepine receptor agonist,GABBR1|GABBR2,BRD-A25579302,abamectin,benzodiazepine receptor agonist,GABBR1|GABBR2,,,,
RSAQARAFWMUYLL,BRD-K19939891,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,BRD-K19939891,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,BRD-K19939891,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,BRD-K19939891,TIC10,AKT inhibitor|TRAIL modulator,AKT1|MAPK1
RSDOPYMFZBJHRL,BRD-K21936341,oxotremorine-sesquifumarate,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K21936341|BRD-M50913522,oxotremorine-sesquifumarate,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K21936341|BRD-M50913522,oxotremorine-sesquifumarate,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K21936341|BRD-M50913522,oxotremorine-sesquifumarate,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
RSEPBGGWRJCQGY,BRD-A39747742|BRD-K12790232,estradiol-valerate,estrogen receptor agonist,ESR1,BRD-A39747742|BRD-K12790232,estradiol-valerate,estrogen receptor agonist,ESR1,BRD-A39747742|BRD-K12790232|BRD-K66766661,estradiol-valerate,estrogen receptor agonist,ESR1,BRD-A39747742|BRD-K12790232|BRD-K66766661,estradiol-valerate,estrogen receptor agonist,ESR1
RSIPQHOWTCNEBI,BRD-K11984358,ZAMI-633,urease inhibitor,,BRD-K11984358,ZAMI-633,urease inhibitor,,BRD-K11984358,ZAMI-633,urease inhibitor,,BRD-K11984358,ZAMI-633,urease inhibitor,
RSLFQCNAOMQAIH,BRD-K86063171,EN460,endoplasmic reticulum oxidation inhibitor,ERO1A,BRD-K86063171,EN460,endoplasmic reticulum oxidation inhibitor,ERO1A,BRD-K86063171,EN460,endoplasmic reticulum oxidation inhibitor,ERO1A,BRD-K86063171,EN460,endoplasmic reticulum oxidation inhibitor,ERO1A
RSOZZQTUMVBTMR,BRD-K19388745,colforsin-daproate,adenylyl cyclase activator,,BRD-K19388745,colforsin-daproate,adenylyl cyclase activator,,BRD-K19388745,colforsin-daproate,adenylyl cyclase activator,,BRD-K19388745,colforsin-daproate,adenylyl cyclase activator,
RSQGZEAXODVTOL,BRD-K51087630,tirasemtiv,troponin activator,,BRD-K51087630,tirasemtiv,troponin activator,,BRD-K51087630,tirasemtiv,troponin activator,,BRD-K51087630,tirasemtiv,troponin activator,
RSTKLPZEZYGQPY,BRD-K09109825,indole-3-pyrubate,melatonin receptor agonist,,BRD-K09109825,indole-3-pyrubate,melatonin receptor agonist,,BRD-K09109825,indole-3-pyrubate,melatonin receptor agonist,,,,,
RSUVYMGADVXGOU,BRD-K40901640,cinanserin,serotonin receptor antagonist,HTR2A,BRD-K40901640,cinanserin,serotonin receptor antagonist,HTR2A,BRD-K40901640,cinanserin,serotonin receptor antagonist,HTR2A,BRD-K40901640,cinanserin,serotonin receptor antagonist,HTR2A
RTFADALJKSFJDZ,BRD-K92426617,esaprazole,,,BRD-K92426617,esaprazole,,,BRD-K92426617,esaprazole,,,BRD-K92426617,esaprazole,,
RTGDFNSFWBGLEC,BRD-K92428153,mycophenolate-mofetil,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,BRD-K92428153,mycophenolate-mofetil,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,BRD-K92428153,mycophenolate-mofetil,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,BRD-K92428153,mycophenolate-mofetil,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2
RTHCYVBBDHJXIQ,BRD-A31159102,fluoxetine,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,BRD-A31159102,fluoxetine,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,BRD-A31159102,fluoxetine,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,BRD-A31159102,fluoxetine,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4
RTHHSXOVIJWFQP,BRD-K81316007,4-mu-8C,IRE1 inhibitor,ERN1,BRD-K81316007,4-mu-8C,IRE1 inhibitor,ERN1,BRD-K81316007,4-mu-8C,IRE1 inhibitor,ERN1,BRD-K81316007,4-mu-8C,IRE1 inhibitor,ERN1
RTIXKCRFFJGDFG,BRD-K22861715,chrysin,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,BRD-K22861715,chrysin,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,BRD-K22861715,chrysin,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,BRD-K22861715,chrysin,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1
RTKIYFITIVXBLE,BRD-K68202742,trichostatin-a,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K68202742,trichostatin-a,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K68202742,trichostatin-a,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K68202742,trichostatin-a,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
RTMIJLQPWFKAFE,BRD-A01295252,7-hydroxy-PIPAT,dopamine receptor ligand,DRD3,BRD-A01295252,7-hydroxy-PIPAT,dopamine receptor ligand,DRD3,BRD-A01295252,7-hydroxy-PIPAT,dopamine receptor ligand,DRD3,BRD-K01825667,7-hydroxy-PIPAT,dopamine receptor ligand,DRD3
RTRQQBHATOEIAF,BRD-K04797704|BRD-K53448858,acadesine,AMPK activator,,BRD-K04797704|BRD-K53448858,acadesine,AMPK activator,,BRD-K04797704|BRD-K53448858,acadesine,AMPK activator,,BRD-K04797704|BRD-K53448858,acadesine,AMPK activator,
RTXOFQZKPXMALH,BRD-K15766189,cefdinir,bacterial cell wall synthesis inhibitor,MPO,BRD-K15766189,cefdinir,bacterial cell wall synthesis inhibitor,MPO,BRD-K15766189,cefdinir,bacterial cell wall synthesis inhibitor,MPO,BRD-K15766189,cefdinir,bacterial cell wall synthesis inhibitor,MPO
RTZKSTLPRTWFEV,BRD-K86294588,schisandrin-b,antioxidant,ATR,BRD-K86294588,schisandrin-b,antioxidant,ATR,BRD-K86294588,schisandrin-b,antioxidant,ATR,BRD-K00003711,schisandrin-B,antioxidant,ATR
RUDATBOHQWOJDD,BRD-K15697815|BRD-K18135438|BRD-K43723251|BRD-K87300616,chenodeoxycholic-acid|chenodiol|ursodiol,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist|like (NRF2) activator|nuclear factor erythroid derived,HSD11B1|NR1H4,BRD-K15697815|BRD-K18135438|BRD-K43723251,chenodeoxycholic-acid|ursodiol,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist|like (NRF2) activator|nuclear factor erythroid derived,HSD11B1|NR1H4,BRD-K15697815|BRD-K18135438|BRD-K43723251|BRD-K87300616,chenodeoxycholic-acid|ursodiol,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist|like (NRF2) activator|nuclear factor erythroid derived,HSD11B1|NR1H4,BRD-K15697815|BRD-K18135438|BRD-K43723251|BRD-K87300616,chenodeoxycholic-acid|ursodiol,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist|like (NRF2) activator|nuclear factor erythroid derived,AKR1C2|HSD11B1|NR1H4
RUEYEZADQJCKGV,BRD-K06455935,daprodustat,hypoxia inducible factor inhibitor,EGLN1,BRD-K06455935,daprodustat,hypoxia inducible factor inhibitor,EGLN1,BRD-K06455935,daprodustat,hypoxia inducible factor inhibitor,EGLN1,,,,
RUOKEQAAGRXIBM,BRD-K58114536|BRD-K58826770,rasagiline,monoamine oxidase inhibitor,BCL2|MAOB,BRD-K58114536|BRD-K58826770,rasagiline,monoamine oxidase inhibitor,BCL2|MAOB,BRD-K58114536|BRD-K58826770,rasagiline,monoamine oxidase inhibitor,BCL2|MAOB,BRD-K58114536|BRD-K58826770,rasagiline,monoamine oxidase inhibitor,BCL2|MAOB
RUTVRAJKELSHCC,BRD-K15196155,IBC-293,hydroxycarboxylic acid receptor agonist,HCAR3,BRD-K15196155,IBC-293,hydroxycarboxylic acid receptor agonist,HCAR3,BRD-K15196155,IBC-293,hydroxycarboxylic acid receptor agonist,HCAR3,BRD-K15196155,IBC-293,hydroxycarboxylic acid receptor agonist,HCAR3
RUTYAHFAKWVMNH,BRD-K19309090,SR-95639A,acetylcholine receptor agonist,CHRM1,BRD-K19309090,SR-95639A,acetylcholine receptor agonist,CHRM1,BRD-K19309090,SR-95639A,acetylcholine receptor agonist,CHRM1,BRD-K19309090,SR-95639A,acetylcholine receptor agonist,CHRM1
RUVINXPYWBROJD,BRD-K49060658,anethole,glutathione transferase stimulant,,BRD-K49060658,anethole,glutathione transferase stimulant,,BRD-K49060658,anethole,glutathione transferase stimulant,,BRD-K49060658,anethole,glutathione transferase stimulant,
RUZYUOTYCVRMRZ,BRD-A13188892,doxazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,BRD-A13188892,doxazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,BRD-A13188892,doxazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,BRD-K01825125,doxazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D
RVAQIUULWULRNW,BRD-K38852836,ganetespib,HSP inhibitor,HSP90AA1,BRD-K38852836,ganetespib,HSP inhibitor,HSP90AA1,BRD-K38852836,ganetespib,HSP inhibitor,HSP90AA1,BRD-K38852836,ganetespib,HSP inhibitor,HSP90AA1
RVGLGHVJXCETIO,BRD-K66937583,lodoxamide,histamine receptor antagonist,,BRD-K66937583,lodoxamide,histamine receptor antagonist,,BRD-K66937583,lodoxamide,histamine receptor antagonist,,BRD-K66937583,lodoxamide,histamine receptor antagonist,
RVIGBTUDFAGRTQ,BRD-A07232941,8-M-PDOT,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-A07232941,8-M-PDOT,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-A07232941,8-M-PDOT,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-A07232941,8-M-PDOT,melatonin receptor agonist,MTNR1A|MTNR1B
RVMBDLSFFNKKLG,BRD-K28971625,ZD-7114,adrenergic receptor agonist,ADRB3,BRD-K28971625,ZD-7114,adrenergic receptor agonist,ADRB3,BRD-K28971625,ZD-7114,adrenergic receptor agonist,ADRB3,BRD-K28971625,ZD-7114,adrenergic receptor agonist,ADRB3
RVMGXWBCQGAWBR,BRD-K94720315,chromocarb,antispasmodic,,BRD-K94720315,chromocarb,antispasmodic,,BRD-K94720315,chromocarb,antispasmodic,,BRD-K94720315,chromocarb,antispasmodic,
RVOLLAQWKVFTGE,BRD-K69688083,mestinon,cholinesterase inhibitor,ACHE|BCHE,BRD-K69688083,mestinon,cholinesterase inhibitor,ACHE|BCHE,BRD-K69688083,mestinon,cholinesterase inhibitor,ACHE|BCHE,BRD-K69688083,mestinon,cholinesterase inhibitor,ACHE|BCHE
RVWNMGKSNGWLOL,BRD-K35304636,examorelin,growth hormone releasing factor agonist,GHRHR|GHSR,BRD-K35304636,examorelin,growth hormone releasing factor agonist,GHRHR|GHSR,BRD-K35304636,examorelin,growth hormone releasing factor agonist,GHRHR|GHSR,BRD-K35304636,examorelin,growth hormone releasing factor agonist,GHRHR|GHSR
RWEVIPRMPFNTLO,BRD-K37687095,AZD8330,MEK inhibitor,,BRD-K37687095,AZD8330,MEK inhibitor,,BRD-K37687095,AZD8330,MEK inhibitor,,BRD-K37687095,AZD8330,MEK inhibitor,MAP3K1
RWLALWYNXFYRGW,BRD-A55455283,"2-ethyl-1,3-hexanediol",,,BRD-A55455283,"2-ethyl-1,3-hexanediol",,,BRD-A55455283,"2-ethyl-1,3-hexanediol",,,BRD-A55455283,"2-ethyl-1,3-hexanediol",,
RWLOGRLTDKDANT,BRD-A00047421,ARV-825,bromodomain inhibitor,BRD4,BRD-A00047421,ARV-825,bromodomain inhibitor,BRD4,BRD-A00047421,ARV-825,bromodomain inhibitor,BRD4,BRD-A00047421,ARV-825,bromodomain inhibitor,BRD4
RWSXRVCMGQZWBV,BRD-K69346723,glutathione,antioxidant,ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12,BRD-K69346723,glutathione,antioxidant,ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12,BRD-K69346723,glutathione,antioxidant,ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12,BRD-K69346723,glutathione,antioxidant,ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12
RWTNPBWLLIMQHL,BRD-A73368467,fexofenadine,histamine receptor antagonist,HRH1,BRD-A73368467,fexofenadine,histamine receptor antagonist,HRH1,BRD-A73368467,fexofenadine,histamine receptor antagonist,HRH1,BRD-A73368467,fexofenadine,histamine receptor antagonist,HRH1
RWVIMCIPOAXUDG,BRD-K64400208,DNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B,BRD-K64400208,DNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B,BRD-K64400208,DNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B,BRD-K64400208,DNQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B
RWXIFXNRCLMQCD,BRD-A44511856,ginsenoside-rg3,angiogenesis inhibitor|apoptosis stimulant,KCNH2,BRD-A44511856,ginsenoside-rg3,angiogenesis inhibitor|apoptosis stimulant,KCNH2,BRD-A44511856,ginsenoside-rg3,angiogenesis inhibitor|apoptosis stimulant,KCNH2,BRD-A44511856,ginsenoside-RE3,angiogenesis inhibitor|apoptosis stimulant,KCNH2
RWZVPVOZTJJMNU,BRD-K51471001,demecarium,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K51471001,demecarium,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K51471001,demecarium,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K51471001,demecarium,acetylcholinesterase inhibitor,ACHE|BCHE
RXIUEIPPLAFSDF,BRD-K82850175,navarixin,CC chemokine receptor antagonist,CXCR1|CXCR2,BRD-K82850175,navarixin,CC chemokine receptor antagonist,CXCR1|CXCR2,BRD-K82850175,navarixin,CC chemokine receptor antagonist,CXCR1|CXCR2,BRD-K82850175,navarixin,CC chemokine receptor antagonist,CXCR1|CXCR2
RXKJFZQQPQGTFL,BRD-K18637542,dihydroxyacetone,,,BRD-K18637542,dihydroxyacetone,,,BRD-K18637542,dihydroxyacetone,,,BRD-K18637542,dihydroxyacetone,,
RXPRRQLKFXBCSJ,BRD-K89704198,vincamine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K89704198,vincamine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K89704198,vincamine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K40902647,vincamine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4
RXQCGGRTAILOIN,BRD-K18194590,mephentermine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,BRD-K18194590,mephentermine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,BRD-K18194590,mephentermine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,BRD-K18194590,mephentermine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3
RXRZPHQBTHQXSV,BRD-K01377300,CZC24832,PI3K inhibitor,PIK3CG,BRD-K01377300,CZC24832,PI3K inhibitor,PIK3CG,BRD-K01377300,CZC24832,PI3K inhibitor,PIK3CG,BRD-K01377300,CZC24832,PI3K inhibitor,PIK3CG
RXSVYGIGWRDVQC,BRD-K56047318,RHC-80267,triacylglycerol lipase inhibitor,DAGLA|DAGLB,BRD-K56047318,RHC-80267,triacylglycerol lipase inhibitor,DAGLA|DAGLB,BRD-K56047318,RHC-80267,triacylglycerol lipase inhibitor,DAGLA|DAGLB,BRD-K56047318,RHC-80267,triacylglycerol lipase inhibitor,DAGLA|DAGLB
RXWNCPJZOCPEPQ,BRD-A28970875,puromycin,protein synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,BRD-A28970875,puromycin,protein synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,BRD-A28970875,puromycin,protein synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,BRD-K36007650,puromycin,protein synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1
RXZBMPWDPOLZGW,BRD-K38684403|BRD-K58211978,roxithromycin,bacterial 50S ribosomal subunit inhibitor,ABCB1|MLNR,BRD-K38684403|BRD-K58211978,roxithromycin,bacterial 50S ribosomal subunit inhibitor,ABCB1|MLNR,BRD-K38684403|BRD-K58211978,roxithromycin,bacterial 50S ribosomal subunit inhibitor,ABCB1|MLNR,BRD-K38684403|BRD-K58211978,roxithromycin,bacterial 50S ribosomal subunit inhibitor,MLNR
RXZMYLDMFYNEIM,BRD-K60997853,PHA-848125,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,BRD-K60997853,PHA-848125,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,BRD-K60997853,PHA-848125,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,BRD-K60997853,PHA-848125,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1
RYAMDQKWNKKFHD,BRD-K61536336,SB-366791,TRPV antagonist,TRPV1,BRD-K61536336,SB-366791,TRPV antagonist,TRPV1,BRD-K61536336,SB-366791,TRPV antagonist,TRPV1,BRD-K61536336,SB-366791,TRPV antagonist,TRPV1
RYEFFICCPKWYML,BRD-A91822151,picrotin,GABA receptor antagonist,GABRA1|GABRR1|GLRA1|GLRA2|GLRA3|GLRB,BRD-A91822151,picrotin,GABA receptor antagonist,GABRA1|GABRR1|GLRA1|GLRA2|GLRA3|GLRB,BRD-A91822151,picrotin,GABA receptor antagonist,GABRA1|GABRR1|GLRA1|GLRA2|GLRA3|GLRB,BRD-A91822151,picrotin,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB
RYMCFYKJDVMSIR,BRD-K55172746,apricitabine,nucleoside reverse transcriptase inhibitor,,BRD-K55172746,apricitabine,nucleoside reverse transcriptase inhibitor,,BRD-K55172746,apricitabine,nucleoside reverse transcriptase inhibitor,,BRD-K55172746,apricitabine,nucleoside reverse transcriptase inhibitor,
RYMZZMVNJRMUDD,BRD-K22134346|BRD-K94986873,simvastatin,HMGCR inhibitor,HMGCR|ITGB2,BRD-K22134346,simvastatin,HMGCR inhibitor,HMGCR|ITGB2,BRD-K22134346|BRD-K94986873,simvastatin,HMGCR inhibitor,HMGCR|ITGB2,BRD-K22134346|BRD-K94986873,simvastatin,HMGCR inhibitor,HMGCR|ITGB2
RYNSGDFWBJWWSZ,BRD-K78637815,LY320135,cannabinoid receptor antagonist,CNR1,BRD-K78637815,LY320135,cannabinoid receptor antagonist,CNR1,BRD-K78637815,LY320135,cannabinoid receptor antagonist,CNR1,BRD-K78637815,LY320135,cannabinoid receptor antagonist,CNR1
RYOOHIUJEJZCFT,BRD-A91733352,camylofine-chlorhydrate,,,BRD-A91733352,camylofine-chlorhydrate,,,BRD-A91733352,camylofine-chlorhydrate,,,BRD-A91733352,camylofine-chlorhydrate,,
RYQOILLJDKPETL,BRD-K73753850,hexaminolevulinate,,,BRD-K73753850,hexaminolevulinate,,,BRD-K73753850,hexaminolevulinate,,,BRD-K73753850,hexaminolevulinate,,
RYRFAMRQBZNEPX,BRD-K19672466,ethimizol,,,BRD-K19672466,ethimizol,,,BRD-K19672466,ethimizol,,,BRD-K19672466,ethimizol,,
RYYCJUAHISIHTL,BRD-K31468676,oxonic-acid,uricase inhibitor,,BRD-K31468676,oxonic-acid,uricase inhibitor,,BRD-K13516279|BRD-K31468676,oxonic-acid,uricase inhibitor,,BRD-K13516279|BRD-K31468676,oxonic-acid,uricase inhibitor,
RYYNGWLOYLRZLK,BRD-K68747584,PF-03814735,Aurora kinase inhibitor,AURKA|AURKB,BRD-K68747584,PF-03814735,Aurora kinase inhibitor,AURKA|AURKB,BRD-K68747584,PF-03814735,Aurora kinase inhibitor,AURKA|AURKB,BRD-K68747584,PF-03814735,Aurora kinase inhibitor,AURKA|AURKB
RYYVLZVUVIJVGH,BRD-K02404261,caffeine,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,BRD-K02404261,caffeine,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,BRD-K02404261,caffeine,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,BRD-K02404261,caffeine,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3
RZEKVGVHFLEQIL,BRD-K02637541,celecoxib,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,BRD-K02637541,celecoxib,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,BRD-K02637541,celecoxib,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,BRD-K02637541,celecoxib,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2
RZIDZIGAXXNODG,BRD-K76406695,CCT128930,AKT inhibitor,PKIA|PRKACA,BRD-K76406695,CCT128930,AKT inhibitor,PKIA|PRKACA,BRD-K76406695,CCT128930,AKT inhibitor,PKIA|PRKACA,BRD-K76406695,CCT128930,AKT inhibitor,
RZJQGNCSTQAWON,BRD-K21733600,rofecoxib,cyclooxygenase inhibitor,ELN|PTGS2,BRD-K21733600,rofecoxib,cyclooxygenase inhibitor,ELN|PTGS2,BRD-K21733600,rofecoxib,cyclooxygenase inhibitor,ELN|PTGS2,BRD-K21733600,rofecoxib,cyclooxygenase inhibitor,ELN|PTGS2
RZKDEGZIFSJVNA,BRD-K23248433,camicinal,motilin receptor agonist,MLNR,BRD-K23248433,camicinal,motilin receptor agonist,MLNR,BRD-K23248433,camicinal,motilin receptor agonist,MLNR,BRD-K23248433,camicinal,motilin receptor agonist,MLNR
RZKSQRIPRKWVBU,BRD-K68474068,MM-102,WDR5/MLL interaction inhibitor,,BRD-K68474068,MM-102,WDR5/MLL interaction inhibitor,,BRD-K68474068,MM-102,WDR5/MLL interaction inhibitor,,BRD-K68474068,MM-102,WDR5/MLL interaction inhibitor,
RZOBLYBZQXQGFY,BRD-M29182745,ammonium-lactate,,HCAR1,BRD-M29182745,ammonium-lactate,,HCAR1,BRD-M29182745,ammonium-lactate,,HCAR1,BRD-M29182745,ammonium-lactate,,HCAR1
RZRPTBIGEANTGU,BRD-K17368287,adrenosterone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1|HSD11B2,BRD-K17368287,adrenosterone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1|HSD11B2,BRD-K17368287,adrenosterone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1|HSD11B2,BRD-K17368287,adrenosterone,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1|HSD11B2
RZRPZWGIOOZIBE,BRD-K77012840,AY-9944,hedgehog pathway modulator,,BRD-K77012840,AY-9944,hedgehog pathway modulator,,BRD-K77012840,AY-9944,hedgehog pathway modulator,,BRD-K77012840,AY-9944,hedgehog pathway modulator,
RZTAMFZIAATZDJ,BRD-A30815329,felodipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2,BRD-A30815329,felodipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2,BRD-A30815329,felodipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNA2D2|CACNB2|CALM1|CFTR|NR3C2|PDE1A|PDE1B|TNNC1|TNNC2,BRD-A30815329,felodipine,calcium channel blocker,CFTR
RZUOCXOYPYGSKL,BRD-A20830788|BRD-K86309810,GDC-0994|ravoxertinib,ERK1 and ERK2 phosphorylation inhibitor|MAP kinase inhibitor,MAPK1|MAPK3,BRD-A20830788|BRD-K86309810,GDC-0994|ravoxertinib,ERK1 and ERK2 phosphorylation inhibitor|MAP kinase inhibitor,MAPK1|MAPK3,BRD-A20830788|BRD-K86309810,GDC-0994|ravoxertinib,ERK1 and ERK2 phosphorylation inhibitor|MAP kinase inhibitor,MAPK1|MAPK3,BRD-A20830788|BRD-K86309810,GDC-0994|ravoxertinib,ERK1 and ERK2 phosphorylation inhibitor|MAP kinase inhibitor,MAPK1|MAPK3
RZVAJINKPMORJF,BRD-K41524689,paracetamol,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,BRD-K41524689,paracetamol,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,BRD-K41524689,paracetamol,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,BRD-K41524689,paracetamol,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1
RZVHIXYEVGDQDX,BRD-K15957397,anthraquinone,CDC inhibitor,CDC25B,BRD-K15957397,anthraquinone,CDC inhibitor,CDC25B,BRD-K15957397,anthraquinone,CDC inhibitor,CDC25B,BRD-K15957397,anthraquinone,CDC inhibitor,CDC25B
RZWRYPGAUIOOMK,BRD-K13169950,NSC-3852,HDAC inhibitor,HDAC1,BRD-K13169950,NSC-3852,HDAC inhibitor,HDAC1,BRD-K13169950,NSC-3852,HDAC inhibitor,HDAC1,BRD-K13169950,NSC-3852,HDAC inhibitor,HDAC1
RZXLPPRPEOUENN,BRD-K89409436,chlorfenson,other antifungal,,BRD-K89409436,chlorfenson,other antifungal,,BRD-K89409436,chlorfenson,other antifungal,,BRD-K89409436,chlorfenson,other antifungal,
RZZPDXZPRHQOCG,BRD-A74441166|BRD-A91728607,citicoline,glutathione transferase stimulant|membrane permeability enhancer,ACHE|SLC1A2,BRD-A74441166|BRD-A91728607,citicoline,glutathione transferase stimulant|membrane permeability enhancer,ACHE|SLC1A2,BRD-A74441166|BRD-A91728607,citicoline,glutathione transferase stimulant|membrane permeability enhancer,ACHE|SLC1A2,BRD-A74441166|BRD-K01827268,citicoline,glutathione transferase stimulant|membrane permeability enhancer,ACHE|SLC1A2
SADQVAVFGNTEOD,BRD-K64973364,indalpine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,BRD-K64973364,indalpine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,BRD-K64973364,indalpine,selective serotonin reuptake inhibitor (SSRI),SLC6A4,BRD-K64973364,indalpine,selective serotonin reuptake inhibitor (SSRI),SLC6A4
SAGZIBJAQGBRQA,BRD-K78086729,GW-788388,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1,BRD-K78086729,GW-788388,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1,BRD-K78086729,GW-788388,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1,BRD-K78086729,GW-788388,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1
SAMRUMKYXPVKPA,BRD-A77582494|BRD-K32007074,enocitabine,DNA synthesis inhibitor,CMPK1|RRM1|TYMS,BRD-A77582494|BRD-K32007074,enocitabine,DNA synthesis inhibitor,CMPK1|RRM1|TYMS,BRD-A77582494|BRD-K32007074,enocitabine,DNA synthesis inhibitor,CMPK1|RRM1|TYMS,BRD-A77582494|BRD-K32007074,enocitabine,DNA synthesis inhibitor,CMPK1|RRM1|TYMS
SANOUVWGPVYVAV,BRD-K90069354,isovaleramide,alcohol dehydrogenase inhibitor,,BRD-K90069354,isovaleramide,alcohol dehydrogenase inhibitor,,BRD-K90069354,isovaleramide,alcohol dehydrogenase inhibitor,,BRD-K90069354,isovaleramide,alcohol dehydrogenase inhibitor,
SAOHCSVJQIAGDD,BRD-A57806482,BRL-26314,cholesterol inhibitor,LPL,BRD-A57806482,BRL-26314,cholesterol inhibitor,LPL,BRD-A57806482,BRL-26314,cholesterol inhibitor,LPL,BRD-A57806482,BRL-26314,cholesterol inhibitor,LPL
SAPNXPWPAUFAJU,BRD-K82147103,lofepramine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR1A|SLC6A2|SLC6A4,BRD-K82147103,lofepramine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR1A|SLC6A2|SLC6A4,BRD-K82147103,lofepramine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR1A|SLC6A2|SLC6A4,BRD-K82147103,lofepramine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR1A|SLC6A2|SLC6A4
SAYGKHKXGCPTLX,BRD-K51575138,TPCA-1,IKK inhibitor,IKBKB,BRD-K51575138,TPCA-1,IKK inhibitor,IKBKB,BRD-K51575138,TPCA-1,IKK inhibitor,IKBKB,BRD-K51575138,TPCA-1,IKK inhibitor,IKBKB
SBDNJUWAMKYJOX,BRD-K50398167,meclofenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,BRD-K50398167,meclofenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,BRD-K50398167,meclofenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,BRD-K50398167,meclofenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2
SBNFWQZLDJGRLK,BRD-A22106989,phenothrin,,,BRD-A22106989,phenothrin,,,BRD-A22106989,phenothrin,,,BRD-A22106989,phenothrin,,
SBNKFTQSBPKMBZ,BRD-K88308881,ethenzamide,analgesic agent,,BRD-K88308881,ethenzamide,analgesic agent,,BRD-K88308881,ethenzamide,analgesic agent,,BRD-K88308881,ethenzamide,analgesic agent,
SBNPWPIBESPSIF,BRD-K76315403,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR|LHCGR,BRD-K76315403,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR|LHCGR,BRD-K76315403,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR|LHCGR,BRD-K76315403,cetrorelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR|LHCGR
SBPBAQFWLVIOKP,BRD-K08303368,chlorpyrifos,acetylcholinesterase inhibitor,ACHE,BRD-K08303368,chlorpyrifos,acetylcholinesterase inhibitor,ACHE,BRD-K08303368,chlorpyrifos,acetylcholinesterase inhibitor,ACHE,BRD-K08303368,chlorpyrifos,acetylcholinesterase inhibitor,ACHE
SBPRIAGPYFYCRT,BRD-K69812556,WAY-100635,serotonin receptor antagonist,HTR1A,BRD-K69812556,WAY-100635,serotonin receptor antagonist,HTR1A,BRD-K69812556,WAY-100635,serotonin receptor antagonist,HTR1A,BRD-K69812556,WAY-100635,serotonin receptor antagonist,HTR1A
SBUJHOSQTJFQJX,BRD-A53533407|BRD-K08327065,kanamycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A53533407|BRD-K08327065,kanamycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A53533407|BRD-K08327065,kanamycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A53533407|BRD-K08327065,kanamycin,bacterial 30S ribosomal subunit inhibitor,
SBVBJPHMDABKJV,BRD-K77320845,secoisolariciresinol-diglucoside,antioxidant,,BRD-K77320845,secoisolariciresinol-diglucoside,antioxidant,,BRD-K77320845,secoisolariciresinol-diglucoside,antioxidant,,BRD-K77320845,secoisolariciresinol-diglucoside,antioxidant,
SCELLOWTHJGVIC,BRD-K36016295,KU-60019,ATM kinase inhibitor,ATM,BRD-K36016295,KU-60019,ATM kinase inhibitor,ATM,BRD-K36016295,KU-60019,ATM kinase inhibitor,ATM,BRD-K36016295,KU-60019,ATM kinase inhibitor,ATM
SCFMWQIQBVZOQR,BRD-K62814476,BMS-265246,CDK inhibitor,CDK1|CDK2,BRD-K62814476,BMS-265246,CDK inhibitor,CDK1|CDK2,BRD-K62814476,BMS-265246,CDK inhibitor,CDK1|CDK2,BRD-K62814476,BMS-265246,CDK inhibitor,CDK1|CDK2
SCGCBAAYLFTIJU,BRD-K42436189,AZ20,ATR kinase inhibitor,ATR|MTOR,BRD-K42436189,AZ20,ATR kinase inhibitor,ATR|MTOR,BRD-K42436189,AZ20,ATR kinase inhibitor,ATR|MTOR,BRD-K42436189,AZ20,ATR kinase inhibitor,ATR|MTOR
SCKYRAXSEDYPSA,BRD-K13044802,ciclopirox,membrane integrity inhibitor,ATP1A1,BRD-K13044802,ciclopirox,membrane integrity inhibitor,ATP1A1,BRD-K13044802,ciclopirox,membrane integrity inhibitor,ATP1A1,BRD-K13044802,ciclopirox,membrane integrity inhibitor,ATP1A1
SCMSYZJDIQPSDI,BRD-A44872635|BRD-K21937671,loxistatin-acid,cysteine peptidase inhibitor,CTSB,BRD-A44872635|BRD-K21937671,loxistatin-acid,cysteine peptidase inhibitor,CTSB,BRD-A44872635|BRD-K21937671,loxistatin-acid,cysteine peptidase inhibitor,CTSB,BRD-A44872635|BRD-K21937671,loxistatin-acid,cysteine peptidase inhibitor,CTSB
SCNILGOVBBRMBK,BRD-K49197823,CV-1808,adenosine receptor agonist,ADORA2A,BRD-K49197823,CV-1808,adenosine receptor agonist,ADORA2A,BRD-K49197823,CV-1808,adenosine receptor agonist,ADORA2A,BRD-K49197823,CV-1808,adenosine receptor agonist,ADORA2A
SCTZUZTYRMOMKT,BRD-K21295289,senicapoc,intermediate conductance potassium channel blocker,KCNN4,BRD-K21295289,senicapoc,intermediate conductance potassium channel blocker,KCNN4,BRD-K21295289,senicapoc,intermediate conductance potassium channel blocker,KCNN4,BRD-K21295289,senicapoc,intermediate conductance potassium channel blocker,KCNN4
SDEAXTCZPQIFQM,BRD-K26026438,tucatinib,EGFR inhibitor,ERBB2,BRD-K26026438,tucatinib,EGFR inhibitor,ERBB2,BRD-K26026438,tucatinib,EGFR inhibitor,ERBB2,BRD-K26026438,tucatinib,EGFR inhibitor,ERBB2
SDGJBAUIGHSMRI,BRD-K45909031,WZ4003,AMPK inhibitor,NUAK1|NUAK2,BRD-K45909031,WZ4003,AMPK inhibitor,NUAK1|NUAK2,BRD-K45909031,WZ4003,AMPK inhibitor,NUAK1|NUAK2,BRD-K45909031,WZ4003,AMPK inhibitor,NUAK1|NUAK2
SDGKUVSVPIIUCF,BRD-A21276153,"2,6-dimethylpiperidine",,,BRD-A21276153,"2,6-dimethylpiperidine",,,BRD-A21276153,"2,6-dimethylpiperidine",,,BRD-A21276153,"2,6-dimethylpiperidine",,
SDHTXBWLVGWJFT,BRD-A09838294|BRD-A99499647,oridonin,BCL inhibitor,BCL2,BRD-A09838294|BRD-K35776642,oridonin,BCL inhibitor,BCL2,,,,,BRD-K00003710,oridonin,BCL inhibitor,BCL2
SDKXUWMRKYQIFU,BRD-A11725667,terciprazine,,,BRD-A11725667,terciprazine,,,BRD-A11725667,terciprazine,,,BRD-K01826018,terciprazine,,
SDUQYLNIPVEERB,BRD-K11238904|BRD-K15108141,gemcitabine,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,BRD-K11238904|BRD-K15108141,gemcitabine,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,BRD-K11238904|BRD-K15108141|BRD-K67681739,gemcitabine,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,BRD-K11238904|BRD-K15108141|BRD-K67681739,gemcitabine,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS
SEBFKMXJBCUCAI,BRD-K47267049|BRD-K80353138,silibinin,cytochrome P450 inhibitor,ALOX5,BRD-K47267049|BRD-K80353138,silibinin,cytochrome P450 inhibitor,ALOX5,BRD-K47267049|BRD-K80353138,silibinin,cytochrome P450 inhibitor,ALOX5,BRD-K47267049|BRD-K80353138,silibinin,cytochrome P450 inhibitor,ALOX5
SEBMTIQKRHYNIT,BRD-K77821588,azatadine,histamine receptor antagonist,HRH1,BRD-K77821588,azatadine,histamine receptor antagonist,HRH1,BRD-K77821588,azatadine,histamine receptor antagonist,HRH1,BRD-K77821588,azatadine,histamine receptor antagonist,HRH1
SEBPXHSZHLFWRL,BRD-K07449869,APC-100,androgen receptor antagonist|anti-inflammatory agent,AR,BRD-K07449869,APC-100,androgen receptor antagonist|anti-inflammatory agent,AR,BRD-K07449869,APC-100,androgen receptor antagonist|anti-inflammatory agent,AR,BRD-K07449869,APC-100,androgen receptor antagonist|anti-inflammatory agent,AR
SECKRCOLJRRGGV,BRD-K13926615,vardenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,BRD-K13926615,vardenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,BRD-K13926615,vardenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,BRD-K13926615,vardenafil,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H
SECPZKHBENQXJG,BRD-K91356052,palmitoleic-acid,,,BRD-K91356052,palmitoleic-acid,,,BRD-K91356052,palmitoleic-acid,,,BRD-K91356052,palmitoleic-acid,,
SECXISVLQFMRJM,BRD-K52732207,N-methylpyrrolidone,,,BRD-K52732207,N-methylpyrrolidone,,,BRD-K52732207,N-methylpyrrolidone,,,BRD-K52732207,N-methylpyrrolidone,,
SEEPANYCNGTZFQ,BRD-K32273377,sulfadiazine,bacterial antifolate,,BRD-K32273377,sulfadiazine,bacterial antifolate,,BRD-K32273377,sulfadiazine,bacterial antifolate,,BRD-K32273377,sulfadiazine,bacterial antifolate,
SEGYOKHGGFKMCX,BRD-K45446451,JZL-184,monoacylglucerol lipase inhibitor,MGLL,BRD-K45446451,JZL-184,monoacylglucerol lipase inhibitor,MGLL,BRD-K45446451,JZL-184,monoacylglucerol lipase inhibitor,MGLL,BRD-K45446451,JZL-184,monoacylglucerol lipase inhibitor,MGLL
SEHSPJCWCBQHPF,BRD-K39230570,clomesone,DNA inhibitor,,BRD-K39230570,clomesone,DNA inhibitor,,BRD-K39230570,clomesone,DNA inhibitor,,BRD-K39230570,clomesone,DNA inhibitor,
SEKJSSBJKFLZIT,BRD-K00615600,AG-14361,PARP inhibitor,PARP1,BRD-K00615600,AG-14361,PARP inhibitor,PARP1,BRD-K00615600,AG-14361,PARP inhibitor,PARP1,BRD-K00615600,AG-14361,PARP inhibitor,PARP1
SEQDDYPDSLOBDC,BRD-A93093700,temazepam,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,BRD-A93093700,temazepam,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,BRD-A93093700,temazepam,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GABRR1|GABRR2|GABRR3|TSPO,,,,
SERHTTSLBVGRBY,BRD-K38527262,atiprimod,JAK inhibitor|STAT inhibitor,JAK2|STAT3,BRD-K38527262,atiprimod,JAK inhibitor|STAT inhibitor,JAK2|STAT3,BRD-K38527262,atiprimod,JAK inhibitor|STAT inhibitor,JAK2|STAT3,BRD-K38527262,atiprimod,JAK inhibitor|STAT inhibitor,JAK2|STAT3
SESFRYSPDFLNCH,BRD-K52072429,benzyl-benzoate,lipase inhibitor,LIPE,BRD-K52072429,benzyl-benzoate,lipase inhibitor,LIPE,BRD-K52072429,benzyl-benzoate,lipase inhibitor,LIPE,BRD-K52072429,benzyl-benzoate,lipase inhibitor,LIPE
SETFNECMODOHTO,BRD-K17610631,indisulam,CDK inhibitor,CA1|CA12|CA14|CA2|CA6|CA7|CA9,BRD-K17610631,indisulam,CDK inhibitor,CA1|CA12|CA14|CA2|CA6|CA7|CA9,BRD-K17610631,indisulam,CDK inhibitor,CA1|CA12|CA14|CA2|CA6|CA7|CA9,BRD-K17610631,indisulam,CDK inhibitor,CA1|CA12|CA14|CA2|CA6|CA7|CA9
SETMGIIITGNLAS,BRD-K94934625,spizofurone,,,BRD-K94934625,spizofurone,,,BRD-K94934625,spizofurone,,,BRD-K94934625,spizofurone,,
SFBODOKJTYAUCM,BRD-K93618743,ipriflavone,bone resorption inhibitor,,BRD-K93618743,ipriflavone,bone resorption inhibitor,,BRD-K93618743,ipriflavone,bone resorption inhibitor,,BRD-K93618743,ipriflavone,bone resorption inhibitor,
SFLSHLFXELFNJZ,BRD-K87349682,norepinephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2,BRD-K87349682,norepinephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2,BRD-K87349682,norepinephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2,BRD-K87349682,norepinephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2
SFNSLLSYNZWZQG,BRD-K34341643,glasdegib,hedgehog pathway inhibitor,SMO,BRD-K34341643,glasdegib,hedgehog pathway inhibitor,SMO,BRD-K34341643,glasdegib,hedgehog pathway inhibitor,SMO,BRD-K34341643,glasdegib,hedgehog pathway inhibitor,SMO
SFOVDSLXFUGAIV,BRD-K48195801,tecastemizole,histamine receptor antagonist,KCNH2,BRD-K48195801,tecastemizole,histamine receptor antagonist,KCNH2,BRD-K48195801,tecastemizole,histamine receptor antagonist,KCNH2,BRD-K48195801,tecastemizole,histamine receptor antagonist,KCNH2
SGAWOGXMMPSZPB,BRD-K90582192,safranal,benzodiazepine receptor agonist,GABBR1,BRD-K90582192,safranal,benzodiazepine receptor agonist,GABBR1,BRD-K90582192,safranal,benzodiazepine receptor agonist,GABBR1,BRD-K90582192,safranal,benzodiazepine receptor agonist,GABBR1
SGDBTWWWUNNDEQ,BRD-K87827419,melphalan,DNA alkylating agent|DNA inhibitor,,BRD-K87827419,melphalan,DNA alkylating agent|DNA inhibitor,,BRD-K87827419,melphalan,DNA alkylating agent|DNA inhibitor,,BRD-K87827419,melphalan,DNA alkylating agent|DNA inhibitor,
SGEGOXDYSFKCPT,BRD-K58010567,vilazodone,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,BRD-K58010567,vilazodone,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,BRD-K58010567,vilazodone,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,BRD-K58010567,vilazodone,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4
SGIWFELWJPNFDH,BRD-K23383398,T-0901317,LXR agonist,NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB,BRD-K23383398,T-0901317,LXR agonist,NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB,BRD-K23383398,T-0901317,LXR agonist,NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB,BRD-K23383398,T-0901317,LXR agonist,NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB
SGJLINMLDNLWOS,BRD-K36274133,SUN-B-8155,calcitonin agonist,CALCR,BRD-K36274133,SUN-B-8155,calcitonin agonist,CALCR,BRD-K36274133,SUN-B-8155,calcitonin agonist,CALCR,BRD-K36274133,SUN-B-8155,calcitonin agonist,CALCR
SGOFAUSEYBZKDQ,BRD-A67949680,BRL-44408,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-A67949680,BRL-44408,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-A67949680,BRL-44408,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-K01825677,BRL-44408,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C
SGOIRFVFHAKUTI,BRD-K15891719,tenofovir,HIV integrase inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-K15891719,tenofovir,HIV integrase inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-K15891719,tenofovir,HIV integrase inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-K15891719,tenofovir,HIV integrase inhibitor|nucleoside reverse transcriptase inhibitor,
SGOOQMRIPALTEL,BRD-K03384561,roquinimex,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,BRD-K03384561,roquinimex,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,BRD-K03384561,roquinimex,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,BRD-K03384561,roquinimex,angiogenesis inhibitor|tumor necrosis factor production inhibitor,
SGRYPYWGNKJSDL,BRD-K29530284,amlexanox,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,BRD-K29530284,amlexanox,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,BRD-K29530284,amlexanox,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,BRD-K29530284,amlexanox,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13
SGTNSNPWRIOYBX,BRD-A09533288,verapamil,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,BRD-A09533288,verapamil,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,BRD-A09533288,verapamil,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,BRD-A09533288,verapamil,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4
SGUAFYQXFOLMHL,BRD-A07440155,labetalol,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2,BRD-A07440155,labetalol,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2,BRD-A07440155,labetalol,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRB1|ADRB2,BRD-K01825098,labetalol,adrenergic receptor antagonist,ADRA1D|ADRB1|ADRB2
SGXXNSQHWDMGGP,BRD-K46652470|BRD-K73589491,nizatidine,histamine receptor antagonist,HRH2,BRD-K46652470|BRD-K73589491,nizatidine,histamine receptor antagonist,HRH2,BRD-K46652470|BRD-K73589491,nizatidine,histamine receptor antagonist,HRH2,BRD-K46652470|BRD-K73589491,nizatidine,histamine receptor antagonist,HRH2
SHCBCKBYTHZQGZ,BRD-K15231341,hemomex-s,,PPARG,BRD-K15231341,hemomex-s,,PPARG,BRD-K15231341,hemomex-s,,PPARG,BRD-K15231341,hemomex-s,,PPARG
SHFLYPPECXRCFO,BRD-K11576103,benzyldimethyloctylammonium,,,BRD-K11576103,benzyldimethyloctylammonium,,,BRD-K11576103,benzyldimethyloctylammonium,,,BRD-K11576103,benzyldimethyloctylammonium,,
SHGAZHPCJJPHSC,BRD-K71879491|BRD-K76723084|BRD-K95366153,isotretinoin|tretinoin,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG,BRD-K71879491|BRD-K76723084|BRD-K95366153,isotretinoin|tretinoin,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG,BRD-K71879491|BRD-K76723084|BRD-K95366153,isotretinoin|tretinoin,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG,BRD-K71879491|BRD-K76723084|BRD-K95366153,isotretinoin|tretinoin,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG
SHHUPGSHGSNPDB,BRD-K68810443,adiporon,adiponectin receptor agonist,ADIPOR1|ADIPOR2,BRD-K68810443,adiporon,adiponectin receptor agonist,ADIPOR1|ADIPOR2,BRD-K68810443,adiporon,adiponectin receptor agonist,ADIPOR1|ADIPOR2,BRD-K68810443,adiporon,adiponectin receptor agonist,ADIPOR1|ADIPOR2
SHIBSTMRCDJXLN,BRD-K18619710,digoxigenin,steroid,,BRD-K18619710,digoxigenin,steroid,,BRD-K18619710,digoxigenin,steroid,,BRD-K18619710,digoxigenin,steroid,
SHNUBALDGXWUJI,BRD-K28492574,piconol,,,BRD-K28492574,piconol,,,BRD-K28492574,piconol,,,BRD-K28492574,piconol,,
SHOKWSLXDAIZPP,BRD-K36617478,thymol-iodide,,,BRD-K36617478,thymol-iodide,,,BRD-K36617478,thymol-iodide,,,BRD-K36617478,thymol-iodide,,
SHUKQGIGCAITKX,BRD-A75867198,norgestimate,progesterone receptor agonist,ESR1|PGR,BRD-A75867198,norgestimate,progesterone receptor agonist,ESR1|PGR,,,,,,,,
SHXVJSFOJHMEEQ,BRD-A79038507,AGN-192403,imidazoline receptor ligand,NISCH,BRD-A79038507,AGN-192403,imidazoline receptor ligand,NISCH,BRD-A18074780|BRD-A79038507,AGN-192403,imidazoline receptor ligand,NISCH,BRD-A18074780|BRD-A79038507,AGN-192403,imidazoline receptor ligand,NISCH
SHZGCJCMOBCMKK,BRD-A86354194,L-(+)-Rhamnose-Monohydrate,,,BRD-A86354194,L-(+)-Rhamnose-Monohydrate,,,BRD-A86354194,L-(+)-Rhamnose-Monohydrate,,,BRD-K00003714,L-(+)-rhamnose-monohydrate,,
SHZKQBHERIJWAO,BRD-K53061490,ozagrel,thromboxane synthase inhibitor,TBXAS1,BRD-K53061490,ozagrel,thromboxane synthase inhibitor,TBXAS1,BRD-K53061490,ozagrel,thromboxane synthase inhibitor,TBXAS1,BRD-K53061490,ozagrel,thromboxane synthase inhibitor,TBXAS1
SIGSPDASOTUPFS,BRD-K81077266,gestodene,contraceptive agent,,BRD-K97197005,gestodene,contraceptive agent,,BRD-K81077266|BRD-K97197005,gestodene,contraceptive agent,,BRD-K81077266|BRD-K97197005,gestodene,contraceptive agent,
SIMWTRCFFSTNMG,BRD-K47554101,eperezolid,bacterial 30S ribosomal subunit inhibitor,,BRD-K47554101,eperezolid,bacterial 30S ribosomal subunit inhibitor,,BRD-K47554101,eperezolid,bacterial 30S ribosomal subunit inhibitor,,BRD-K47554101,eperezolid,bacterial 30S ribosomal subunit inhibitor,
SINAMTXBCYKFDL,BRD-K07395323,17-PA,glucocorticoid receptor agonist,,BRD-A34299591|BRD-K07395323,17-PA,glucocorticoid receptor agonist,,BRD-A34299591|BRD-K07395323,17-PA,glucocorticoid receptor agonist,,BRD-A34299591|BRD-K07395323,17-PA,glucocorticoid receptor agonist,
SINQIEAULQKUPD,BRD-A92800748,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,KDR|MAPK14,BRD-A92800748,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,KDR|MAPK14,BRD-A92800748,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,KDR|MAPK14,BRD-A92800748,tie2-kinase-inhibitor,TIE tyrosine kinase inhibitor,KDR|MAPK14
SIOXPEMLGUPBBT,BRD-K60612034,picolinic-acid,chelating agent,,BRD-K60612034,picolinic-acid,chelating agent,,BRD-K60612034,picolinic-acid,chelating agent,,BRD-K60612034,picolinic-acid,chelating agent,
SIQPXVQCUCHWDI,BRD-K35007173,enprofylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,BRD-K35007173,enprofylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,BRD-K35007173,enprofylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,BRD-K35007173,enprofylline,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B
SISOFUCTXZKSOQ,BRD-K14561059,SIB-1893,glutamate receptor antagonist,GRM4|GRM5,BRD-K14561059,SIB-1893,glutamate receptor antagonist,GRM4|GRM5,BRD-K14561059,SIB-1893,glutamate receptor antagonist,GRM4|GRM5,BRD-K14561059,SIB-1893,glutamate receptor antagonist,GRM4|GRM5
SIXLXDIJGIWWFU,BRD-K82181219,pyritinol,,,BRD-K82181219,pyritinol,,,BRD-K82181219,pyritinol,,,BRD-K82181219,pyritinol,,
SIXVRXARNAVBTC,BRD-K81689258,GSK2606414,protein kinase inhibitor,EIF2AK3|MYLK2,BRD-K81689258,GSK2606414,protein kinase inhibitor,EIF2AK3|MYLK2,BRD-K81689258,GSK2606414,protein kinase inhibitor,EIF2AK3|MYLK2,BRD-K81689258,GSK2606414,protein kinase inhibitor,EIF2AK3|MYLK2
SIYLLGKDQZGJHK,BRD-K72723676,benzethonium,sodium channel blocker,SCN10A,BRD-K72723676,benzethonium,sodium channel blocker,SCN10A,BRD-K72723676,benzethonium,sodium channel blocker,SCN10A,BRD-K72723676,benzethonium,sodium channel blocker,SCN10A
SJDDOCKBXFJEJB,BRD-K26712974,VX-765,caspase inhibitor,CASP1,BRD-K26712974,VX-765,caspase inhibitor,CASP1,BRD-K26712974,VX-765,caspase inhibitor,CASP1,BRD-K78430341,VX-765,caspase inhibitor,CASP1
SJDOMIRMMUGQQK,BRD-K69195780,NAN-190,serotonin receptor agonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F,BRD-K69195780,NAN-190,serotonin receptor agonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F,BRD-K69195780,NAN-190,serotonin receptor agonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F,BRD-K69195780,NAN-190,serotonin receptor agonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F
SJFBTAPEPRWNKH,BRD-K59325863,delanzomib,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,BRD-K59325863,delanzomib,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,BRD-K59325863|BRD-K84591635,delanzomib,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,BRD-K59325863|BRD-K84591635,delanzomib,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE
SJMYMKPBODEZSH,BRD-K36515744,ITX3,GEF inhibitor,TRIO,BRD-K36515744,ITX3,GEF inhibitor,TRIO,BRD-K36515744,ITX3,GEF inhibitor,TRIO,BRD-K36515744,ITX3,GEF inhibitor,TRIO
SJVQHLPISAIATJ,BRD-K93468883,IPI-145,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K93468883,IPI-145,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K93468883,IPI-145,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K93468883,duvelisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
SJYFDORQYYEJLB,BRD-A15530910,SDZ-21009,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A|HTR1B,BRD-A15530910,SDZ-21009,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A|HTR1B,BRD-A15530910,SDZ-21009,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A|HTR1B,BRD-A15530910,SDZ-21009,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A|HTR1B
SJZRECIVHVDYJC,BRD-K82166906,sodium-oxybate,benzodiazepine receptor agonist,GABRB1|HCAR1|SLC52A2,BRD-K82166906,sodium-oxybate,benzodiazepine receptor agonist,GABRB1|HCAR1|SLC52A2,BRD-K82166906,sodium-oxybate,benzodiazepine receptor agonist,GABRB1|HCAR1|SLC52A2,,,,
SKIVFJLNDNKQPD,BRD-K21520694,sulfacetamide,PABA antagonist,,BRD-K21520694,sulfacetamide,PABA antagonist,,BRD-K21520694,sulfacetamide,PABA antagonist,,BRD-K21520694,sulfacetamide,PABA antagonist,
SKJJIFRWCCSXGL,BRD-K46384212,o-3M3FBS,phospholipase activator,,BRD-K46384212,o-3M3FBS,phospholipase activator,,BRD-K46384212,o-3M3FBS,phospholipase activator,,BRD-K46384212,o-3M3FBS,phospholipase activator,
SKKLOUVUUNMCJE,BRD-K73425385,bekanamycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K73425385,bekanamycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K47908102|BRD-K73425385,bekanamycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K47908102|BRD-K73425385,bekanamycin,bacterial 30S ribosomal subunit inhibitor,
SKOLRLSBMUGVOY,BRD-K96391852,aloperine,,,BRD-K96391852,aloperine,,,BRD-K96391852,aloperine,,,BRD-K96391852,aloperine,,
SKPLBLUECSEIFO,BRD-A39230911,chlorphensin-carbamate,muscle relaxant,,BRD-A39230911,chlorphensin-carbamate,muscle relaxant,,BRD-A39230911,chlorphensin-carbamate,muscle relaxant,,BRD-A39230911,chlorphensin-carbamate,muscle relaxant,
SKQDKFOTIPJUSV,BRD-A60498477,tolamolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A60498477,tolamolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A60498477,tolamolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A60498477,tolamolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
SKVLYVHULOWXTD,BRD-K01950558,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR,BRD-K01950558,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR,BRD-K01950558,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR,BRD-K01950558,succinylsulfathiazole,dihydrofolate reductase inhibitor,DHFR
SKVPTPMWXJSBTF,BRD-K49759007,4-hydroxy-phenazone,,,BRD-K49759007,4-hydroxy-phenazone,,,BRD-K49759007,4-hydroxy-phenazone,,,BRD-K49759007,4-hydroxy-phenazone,,
SKYSRIRYMSLOIN,BRD-A77291778,cyclopentolate,acetylcholine receptor antagonist,CHRM1,BRD-A77291778,cyclopentolate,acetylcholine receptor antagonist,CHRM1,BRD-A77291778,cyclopentolate,acetylcholine receptor antagonist,CHRM1,BRD-A77291778,cyclopentolate,acetylcholine receptor antagonist,
SKZKKFZAGNVIMN,BRD-K81130846,salicylamide,analgesic agent,,BRD-K81130846,salicylamide,analgesic agent,,BRD-K81130846,salicylamide,analgesic agent,,BRD-K81130846,salicylamide,analgesic agent,
SLAYUXIURFNXPG,BRD-A38738672|BRD-K37848908,ceforanide,penicillin binding protein inhibitor,,BRD-A38738672|BRD-K37848908,ceforanide,penicillin binding protein inhibitor,,BRD-A38738672|BRD-K37848908,ceforanide,penicillin binding protein inhibitor,,BRD-A38738672|BRD-K37848908,ceforanide,penicillin binding protein inhibitor,
SLFGIOIONGJGRT,BRD-A42881122,cyamemazine,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C|HTR7,BRD-A42881122,cyamemazine,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C|HTR7,BRD-A42881122,cyamemazine,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C|HTR7,BRD-A42881122,cyamemazine,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C|HTR7
SLRCCWJSBJZJBV,BRD-K32847234,sparteine-sulfate,,,BRD-K32847234,sparteine-sulfate,,,BRD-K32847234,sparteine-sulfate,,,BRD-K32847234|BRD-K38203080|BRD-K86872788,sparteine-(+)|sparteine-(-)|sparteine-sulfate,,
SLVMESMUVMCQIY,BRD-A14395271,mesoridazine,dopamine receptor antagonist,DRD2|HTR2A,BRD-A14395271,mesoridazine,dopamine receptor antagonist,DRD2|HTR2A,BRD-A14395271,mesoridazine,dopamine receptor antagonist,DRD2|HTR2A,BRD-K01827307,mesoridazine,dopamine receptor antagonist,DRD2|HTR2A
SLXKOJJOQWFEFD,BRD-K64931368,aminocaproic-acid,plasminogen activator inhibitor,LPA|PLAT|PLG,BRD-K64931368,aminocaproic-acid,plasminogen activator inhibitor,LPA|PLAT|PLG,BRD-K64931368,aminocaproic-acid,plasminogen activator inhibitor,LPA|PLAT|PLG,BRD-K64931368,aminocaproic-acid,plasminogen activator inhibitor,LPA|PLAT|PLG
SLYPOVJCSQHITR,BRD-K41876534,tioxolone,carbonic anhydrase inhibitor,CA2,BRD-K41876534,tioxolone,carbonic anhydrase inhibitor,CA2,BRD-K41876534,tioxolone,carbonic anhydrase inhibitor,CA2,BRD-K41876534,tioxolone,carbonic anhydrase inhibitor,CA2
SMANXXCATUTDDT,BRD-K29582677,flunarizine,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1,BRD-K29582677,flunarizine,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1,BRD-K29582677,flunarizine,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1,BRD-K29582677,flunarizine,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1
SMDHCQAYESWHAE,BRD-K33903083,benfluralin,,CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1,BRD-K33903083,benfluralin,,CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1,BRD-K33903083,benfluralin,,CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1,BRD-K33903083,benfluralin,,CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1
SMEROWZSTRWXGI,BRD-K04497194,lithocholic-acid,FXR antagonist|vitamin D receptor agonist,GPBAR1|NR1H4|NR1I2|VDR,BRD-K04497194,lithocholic-acid,FXR antagonist|vitamin D receptor agonist,GPBAR1|NR1H4|NR1I2|VDR,BRD-K04497194,lithocholic-acid,FXR antagonist|vitamin D receptor agonist,GPBAR1|NR1H4|NR1I2|VDR,BRD-K20986251,lithocholic-acid,FXR antagonist|vitamin D receptor agonist,GPBAR1|NR1H4|NR1I2|VDR
SMIKIPXIDLITMP,BRD-K01231377,BMS-191095,KATP activator|potassium channel agonist,,BRD-K01231377,BMS-191095,KATP activator|potassium channel agonist,,BRD-K01231377,BMS-191095,KATP activator|potassium channel agonist,,BRD-K01231377,BMS-191095,KATP activator|potassium channel agonist,
SMOBCLHAZXOKDQ,BRD-K63018010,relebactam,beta lactamase inhibitor,,BRD-K63018010,relebactam,beta lactamase inhibitor,,BRD-K63018010,relebactam,beta lactamase inhibitor,,BRD-K63018010,relebactam,beta lactamase inhibitor,
SMTZFNFIKUPEJC,BRD-K81855038,roxatidine-acetate,histamine receptor antagonist,HRH2,BRD-K81855038,roxatidine-acetate,histamine receptor antagonist,HRH2,BRD-K81855038,roxatidine-acetate,histamine receptor antagonist,HRH2,BRD-K81855038,roxatidine-acetate,histamine receptor antagonist,HRH2
SMYALUSCZJXWHG,BRD-K00610438,altanserin,serotonin receptor antagonist,HTR2A,BRD-K00610438,altanserin,serotonin receptor antagonist,HTR2A,BRD-K00610438,altanserin,serotonin receptor antagonist,HTR2A,BRD-K00610438,altanserin,serotonin receptor antagonist,HTR2A
SNBUBQHDYVFSQF,BRD-A97040294|BRD-K48470486,cefmetazole,bacterial cell wall synthesis inhibitor,,BRD-A97040294|BRD-K48470486,cefmetazole,bacterial cell wall synthesis inhibitor,,BRD-A97040294|BRD-K48470486,cefmetazole,bacterial cell wall synthesis inhibitor,,BRD-A97040294|BRD-K48470486,cefmetazole,bacterial cell wall synthesis inhibitor,
SNFYYXUGUBUECJ,BRD-A95755460,talarozole,cytochrome P450 inhibitor,CYP26A1,BRD-A95755460,talarozole,cytochrome P450 inhibitor,CYP26A1,BRD-A95755460,talarozole,cytochrome P450 inhibitor,CYP26A1,BRD-A95755460,talarozole,cytochrome P450 inhibitor,CYP26A1
SNGREZUHAYWORS,BRD-K32531356,ammonium-perfluorocaprylate,Pim kinase inhibitor,PIM1,BRD-K32531356,ammonium-perfluorocaprylate,Pim kinase inhibitor,PIM1,BRD-K32531356,ammonium-perfluorocaprylate,Pim kinase inhibitor,PIM1,BRD-K32531356,ammonium-perfluorocaprylate,Pim kinase inhibitor,PIM1
SNHCRNMVYDHVDT,BRD-K42673188,verubulin,tubulin polymerization inhibitor,TUBB,BRD-K42673188,verubulin,tubulin polymerization inhibitor,TUBB,BRD-K42673188,verubulin,tubulin polymerization inhibitor,TUBB,BRD-K42673188,verubulin,tubulin polymerization inhibitor,TUBB
SNHRLVCMMWUAJD,BRD-A80594172|BRD-K34032314|BRD-K57769959,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1,BRD-A80594172|BRD-K34032314,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1,BRD-A80594172|BRD-K34032314|BRD-K57769959,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1,BRD-A80594172|BRD-K34032314|BRD-K57769959,betamethasone-valerate,glucocorticoid receptor agonist,NR3C1
SNICXCGAKADSCV,BRD-A93695607|BRD-K05395900,nicotine,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1,BRD-A93695607|BRD-K05395900,nicotine,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1,BRD-A93695607|BRD-K05395900,nicotine,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1,BRD-K05395900,nicotine,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1
SNKFFCBZYFGCQN,BRD-K18898553,salvianolic-acid-B,EGFR inhibitor|metalloproteinase inhibitor,MMP9,BRD-K18898553,salvianolic-acid-B,EGFR inhibitor|metalloproteinase inhibitor,MMP9,BRD-K18898553,salvianolic-acid-B,EGFR inhibitor|metalloproteinase inhibitor,MMP9,BRD-K18898553,salvianolic-acid-B,EGFR inhibitor|metalloproteinase inhibitor,MMP9
SNKZJIOFVMKAOJ,BRD-K82234479,tramiprosate,beta amyloid protein neurotoxicity inhibitor,APP,BRD-K82234479,tramiprosate,beta amyloid protein neurotoxicity inhibitor,APP,BRD-K82234479,tramiprosate,beta amyloid protein neurotoxicity inhibitor,APP,BRD-K82234479,tramiprosate,beta amyloid protein neurotoxicity inhibitor,APP
SNMCWIDCSPHZRD,BRD-K65890018,SSR128129E,,,BRD-K65890018,SSR128129E,,,BRD-K65890018,SSR128129E,,,BRD-K65890018,SSR128129E,,
SNPLKNRPJHDVJA,BRD-A59413292|BRD-K71210479,dexpanthenol,,,BRD-A59413292|BRD-K71210479,dexpanthenol,,,BRD-A59413292|BRD-K71210479,dexpanthenol,,,BRD-K71210479,dexpanthenol,,
SNPPWIUOZRMYNY,BRD-A05186015,bupropion,dopamine uptake inhibitor,CHRNA3|SLC6A2|SLC6A3,BRD-A05186015,bupropion,dopamine uptake inhibitor,CHRNA3|SLC6A2|SLC6A3,BRD-A05186015,bupropion,dopamine uptake inhibitor,CHRNA3|SLC6A2|SLC6A3,BRD-K01826729,bupropion,dopamine reuptake inhibitor,SLC6A2|SLC6A3
SNTQPLDRUZOSDP,BRD-K46317332,proadifen,nitric oxide synthase inhibitor,NOS1,BRD-K46317332,proadifen,nitric oxide synthase inhibitor,NOS1,BRD-K46317332,proadifen,nitric oxide synthase inhibitor,NOS1,BRD-K46317332,proadifen,nitric oxide synthase inhibitor,NOS1
SNUDIPVBUUXCDG,BRD-K06900071,tebipenem,bacterial cell wall synthesis inhibitor,CNR1,BRD-K06900071,tebipenem,bacterial cell wall synthesis inhibitor,CNR1,BRD-K06900071,tebipenem,bacterial cell wall synthesis inhibitor,CNR1,BRD-K28224173,tebipenem,bacterial cell wall synthesis inhibitor,CNR1
SNWQKAWITMVCQW,BRD-K77115421,phthalylsulfacetamide,,,BRD-K77115421,phthalylsulfacetamide,,,BRD-K77115421,phthalylsulfacetamide,,,BRD-K77115421,phthalylsulfacetamide,,
SOHCKWZVTCTQBG,BRD-K31092604,donitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,BRD-K31092604,donitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,BRD-K31092604,donitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,BRD-K31092604,donitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6
SOLIIYNRSAWTSQ,BRD-K74057757,indibulin,tubulin polymerization inhibitor,,BRD-K74057757,indibulin,tubulin polymerization inhibitor,,BRD-K74057757,indibulin,tubulin polymerization inhibitor,,BRD-K74057757,indibulin,tubulin polymerization inhibitor,
SONNWYBIRXJNDC,BRD-K73381542,phenylephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-K73381542,phenylephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-K73381542,phenylephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-K73381542,phenylephrine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D
SOYCMDCMZDHQFP,BRD-K82122102,amfenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K82122102,amfenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K82122102,amfenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K82122102,amfenac,cyclooxygenase inhibitor,PTGS1|PTGS2
SOYKEARSMXGVTM,BRD-A04553218|BRD-K39462424,chlorphenamine|dexchlorpheniramine,histamine receptor antagonist,|HRH1|SLC6A2|SLC6A3|SLC6A4,BRD-A04553218|BRD-K39462424,chlorphenamine|dexchlorpheniramine,histamine receptor antagonist,|HRH1|SLC6A2|SLC6A3|SLC6A4,BRD-A04553218|BRD-K39462424,chlorphenamine|dexchlorpheniramine,histamine receptor antagonist,|HRH1|SLC6A2|SLC6A3|SLC6A4,BRD-K01826567|BRD-K39462424,chlorphenamine|dexchlorpheniramine,histamine receptor antagonist,
SPEFJYZGXZENAF,BRD-K34608650,GP2a,cannabinoid receptor agonist,CNR2,BRD-K34608650,GP2a,cannabinoid receptor agonist,CNR2,BRD-K34608650,GP2a,cannabinoid receptor agonist,CNR2,BRD-K34608650,GP2a,cannabinoid receptor agonist,CNR2
SPFYMRJSYKOXGV,BRD-K76534306,enrofloxacin,bacterial DNA gyrase inhibitor,,BRD-K76534306,enrofloxacin,bacterial DNA gyrase inhibitor,,BRD-K76534306,enrofloxacin,bacterial DNA gyrase inhibitor,,BRD-K76534306,enrofloxacin,bacterial DNA gyrase inhibitor,
SPHRJZBOFYIKMC,BRD-K23922020,arecaidine-propargyl-ester,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K23922020,arecaidine-propargyl-ester,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K23922020,arecaidine-propargyl-ester,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K23922020,arecaidine-propargyl-ester,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4
SPIUTQOUKAMGCX,BRD-K47639036,flavoxate,acetylcholine receptor antagonist,CHRM1|CHRM2,BRD-K47639036,flavoxate,acetylcholine receptor antagonist,CHRM1|CHRM2,BRD-K47639036,flavoxate,acetylcholine receptor antagonist,CHRM1|CHRM2,BRD-K47639036,flavoxate,acetylcholine receptor antagonist,CHRM1|CHRM2
SPMVMDHWKHCIDT,BRD-K53414658,tivozanib,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,BRD-K53414658,tivozanib,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,BRD-K53414658,tivozanib,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,BRD-K53414658,tivozanib,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB
SPPTWHFVYKCNNK,BRD-K58794715,bentiromide,,HPN,BRD-K58794715,bentiromide,,HPN,BRD-K58794715,bentiromide,,HPN,BRD-K58794715,bentiromide,,HPN
SPTMROWPYQRZSX,BRD-A75552914,isoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A75552914,isoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A75552914,isoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,,,,
SQKXYSGRELMAAU,BRD-K29626940,imidafenacin,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-K29626940,imidafenacin,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-K29626940,imidafenacin,acetylcholine receptor antagonist,CHRM1|CHRM3,BRD-K29626940,imidafenacin,acetylcholine receptor antagonist,CHRM1|CHRM3
SQMWSBKSHWARHU,BRD-K60150510,N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1,BRD-K60150510,N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1,BRD-K60150510,N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1,BRD-K60150510,N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1
SQOJOAFXDQDRGF,BRD-A59001851|BRD-A82395837,ginkgolide-b,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,BRD-A08430411|BRD-A59001851,ginkgolide-b,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,BRD-A08430411|BRD-A59001851|BRD-A82395837,ginkgolide-b,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,BRD-A82395837|BRD-K93816012,ginkgolide-B,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B
SQSZANZGUXWJEA,BRD-K25630527,LY2784544,JAK inhibitor,JAK2|JAK3,BRD-K25630527,LY2784544,JAK inhibitor,JAK2|JAK3,BRD-K25630527,LY2784544,JAK inhibitor,JAK2|JAK3,BRD-K25630527,LY2784544,JAK inhibitor,JAK2|JAK3
SQUNAWUMZGQQJD,BRD-A04252265,eperisone,acetylcholine receptor antagonist,CYP2J2,BRD-A04252265,eperisone,acetylcholine receptor antagonist,CYP2J2,BRD-A04252265,eperisone,acetylcholine receptor antagonist,CYP2J2,BRD-K01825729,eperisone,acetylcholine receptor antagonist,CYP2J2
SQVIAVUSQAWMKL,BRD-A09925278,etilefrine,adrenergic receptor agonist,ADRA1A|ADRB1,BRD-A09925278,etilefrine,adrenergic receptor agonist,ADRA1A|ADRB1,BRD-A09925278,etilefrine,adrenergic receptor agonist,ADRA1A|ADRB1,BRD-A09925278,etilefrine,adrenergic receptor agonist,ADRA1A|ADRB1
SQVRNKJHWKZAKO,BRD-K36262466,aceneuramic-acid,,AZGP1|CES1|MBL2|REG1A|SELE|SELP|SIGLEC1,BRD-K36262466,aceneuramic-acid,,AZGP1|CES1|MBL2|REG1A|SELE|SELP|SIGLEC1,BRD-K36262466,aceneuramic-acid,,AZGP1|CES1|MBL2|REG1A|SELE|SELP|SIGLEC1,BRD-K36262466,aceneuramic-acid,,CES1|SELE|SELP
SRBPKVWITYPHQR,BRD-K64157027,ZD-2079,adrenergic receptor agonist,ADRB3,BRD-K64157027,ZD-2079,adrenergic receptor agonist,ADRB3,BRD-K64157027,ZD-2079,adrenergic receptor agonist,ADRB3,BRD-K64157027,ZD-2079,adrenergic receptor agonist,ADRB3
SRFABRWQVPCPRG,BRD-K89306950,ML130,NOD1 inhibitor,,BRD-K89306950,ML130,NOD1 inhibitor,,BRD-K89306950,ML130,NOD1 inhibitor,,BRD-K89306950,ML130,NOD1 inhibitor,
SRIJFPBZWUFLFD,BRD-K99077012,befuraline,,,BRD-K99077012,befuraline,,,BRD-K99077012,befuraline,,,BRD-K99077012,befuraline,,
SRLVNYDXMUGOFI,BRD-K63915849,AS-604850,PI3K inhibitor,PIK3CA|PIK3CG,BRD-K63915849,AS-604850,PI3K inhibitor,PIK3CA|PIK3CG,BRD-K63915849,AS-604850,PI3K inhibitor,PIK3CA|PIK3CG,BRD-K63915849,AS-604850,PI3K inhibitor,PIK3CA|PIK3CG
SRPNQDXRVRCTNK,BRD-K62264492,pivagabine,corticosteroid releasing factor receptor antagonist,CRHR1|CRHR2,BRD-K62264492,pivagabine,corticosteroid releasing factor receptor antagonist,CRHR1|CRHR2,BRD-K62264492,pivagabine,corticosteroid releasing factor receptor antagonist,CRHR1|CRHR2,BRD-K62264492,pivagabine,corticotropin releasing factor receptor antagonist,CRHR1|CRHR2
SRQKTCXJCCHINN,BRD-A71407503,inimur,other antifungal,,BRD-A71407503,inimur,other antifungal,,BRD-A71407503,inimur,other antifungal,,BRD-A71407503,inimur,other antifungal,
SRSGVKWWVXWSJT,BRD-K62040061,toceranib,protein tyrosine kinase inhibitor,FLT1|FLT3|KDR|PDGFRA|PDGFRB,BRD-K62040061,toceranib,protein tyrosine kinase inhibitor,FLT1|FLT3|KDR|PDGFRA|PDGFRB,BRD-K62040061,toceranib,protein tyrosine kinase inhibitor,FLT1|FLT3|KDR|PDGFRA|PDGFRB,BRD-K62040061,toceranib,protein tyrosine kinase inhibitor,FLT1|FLT3|KDR|PDGFRA|PDGFRB
SRUISGSHWFJION,BRD-K41713976,E-4031,potassium channel blocker,KCNH1|KCNH2,BRD-K41713976,E-4031,potassium channel blocker,KCNH1|KCNH2,BRD-K41713976,E-4031,potassium channel blocker,KCNH1|KCNH2,BRD-K41713976,E-4031,potassium channel blocker,KCNH1|KCNH2
SRVFFFJZQVENJC,BRD-A12987505|BRD-K91188791,aloxistatin,protease inhibitor,CTSG,BRD-A12987505|BRD-K91188791,aloxistatin,protease inhibitor,CTSG,BRD-A12987505|BRD-K91188791,aloxistatin,protease inhibitor,CTSG,BRD-A12987505|BRD-K91188791,aloxistatin,protease inhibitor,CTSG
SRZNHPXWXCNNDU,BRD-A78723049,cefotetan,bacterial cell wall synthesis inhibitor,,BRD-A78723049,cefotetan,bacterial cell wall synthesis inhibitor,,BRD-A78723049,cefotetan,bacterial cell wall synthesis inhibitor,,BRD-A78723049,cefotetan,bacterial cell wall synthesis inhibitor,
SSISHJJTAXXQAX,BRD-K26341917,L-ergothioneine,free radical scavenger,,BRD-K26341917,L-ergothioneine,free radical scavenger,,BRD-K26341917,L-ergothioneine,free radical scavenger,,BRD-K26341917,L-ergothioneine,free radical scavenger,
SSMSBSWKLKKXGG,BRD-A29281099,clorprenaline,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A29281099,clorprenaline,adrenergic receptor agonist,ADRB1|ADRB2,BRD-A29281099,clorprenaline,adrenergic receptor agonist,ADRB1|ADRB2,BRD-K01825579,clorprenaline,adrenergic receptor agonist,ADRB1|ADRB2
SSOLNOMRVKKSON,BRD-K28183345,proguanil,dihydrofolate reductase inhibitor,DHFR,BRD-K28183345,proguanil,dihydrofolate reductase inhibitor,DHFR,BRD-K28183345,proguanil,dihydrofolate reductase inhibitor,DHFR,BRD-K28183345,proguanil,dihydrofolate reductase inhibitor,DHFR
SSPCCAYAIDNNJX,BRD-K62594868,GR125487,serotonin receptor antagonist,HTR4,BRD-K62594868,GR125487,serotonin receptor antagonist,HTR4,BRD-K62594868,GR125487,serotonin receptor antagonist,HTR4,BRD-K62594868,GR125487,serotonin receptor antagonist,HTR4
SSQPWTVBQMWLSZ,BRD-K31139048,omega-3-acid-esters,cholesterol inhibitor,,BRD-K31139048,omega-3-acid-esters,cholesterol inhibitor,,BRD-K31139048,omega-3-acid-esters,cholesterol inhibitor,,BRD-K31139048,omega-3-acid-esters,cholesterol inhibitor,
SSRDSYXGYPJKRR,BRD-K71603915,EVP-6124,acetylcholine receptor agonist,CHRNA7,BRD-K71603915,EVP-6124,acetylcholine receptor agonist,CHRNA7,BRD-K71603915,EVP-6124,acetylcholine receptor agonist,CHRNA7,BRD-K71603915,EVP-6124,acetylcholine receptor agonist,CHRNA7
SSXYXSMMVMVYEV,BRD-K73799155,NSC5844,CC chemokine receptor agonist,CCR1,BRD-K73799155,NSC5844,CC chemokine receptor agonist,CCR1,BRD-K73799155,NSC5844,CC chemokine receptor agonist,CCR1,BRD-K73799155,NSC-5844,CC chemokine receptor agonist,CCR1
STECJAGHUSJQJN,BRD-A62035778|BRD-K89923877,scopolamine,acetylcholine receptor antagonist,,BRD-A62035778|BRD-K89923877,scopolamine,acetylcholine receptor antagonist,,BRD-A62035778|BRD-K64990126|BRD-K89923877,scopolamine,acetylcholine receptor antagonist,,BRD-K89923877,scopolamine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI
STJMRWALKKWQGH,BRD-A75726477,clenbuterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|NGF|TNF,BRD-A75726477,clenbuterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|NGF|TNF,BRD-A75726477,clenbuterol,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3|NGF|TNF,BRD-K00003701,clenbuterol,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11
STQGQHZAVUOBTE,BRD-A68009927|BRD-K43389675|BRD-K91966436,daunorubicin,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,BRD-A68009927|BRD-K43389675|BRD-K91966436,daunorubicin,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,BRD-K43389675|BRD-K79347022|BRD-K91966436,daunorubicin,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,BRD-K43389675|BRD-K79347022|BRD-K91966436,daunorubicin,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B
STUWGJZDJHPWGZ,BRD-K54997624,alpelisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K54997624,alpelisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K54997624,alpelisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K54997624,alpelisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
STWTUEAWRAIWJG,BRD-K08532119,LMI070,survival motor neuron protein modulator,SMN1,BRD-K08532119,LMI070,survival motor neuron protein modulator,SMN1,BRD-K08532119,LMI070,survival motor neuron protein modulator,SMN1,BRD-K08532119,LMI070,survival motor neuron protein modulator,SMN1
STZYTFJPGGDRJD,BRD-K17930269,retapamulin,protein synthesis inhibitor,,BRD-K33082088,retapamulin,protein synthesis inhibitor,,BRD-K17930269|BRD-K33082088,retapamulin,protein synthesis inhibitor,,BRD-K17930269|BRD-K33082088,retapamulin,protein synthesis inhibitor,
SUBDBMMJDZJVOS,BRD-A55962179|BRD-K61443506,esomeprazole|omeprazole,ATPase inhibitor,ATP4A|CLCN2,BRD-A55962179|BRD-K61443506,esomeprazole|omeprazole,ATPase inhibitor,ATP4A|CLCN2,BRD-A55962179|BRD-K61443506|BRD-M04732511,esomeprazole|omeprazole,ATPase inhibitor,ATP4A|CLCN2,BRD-A55962179|BRD-K61443506,esomeprazole|omeprazole,ATPase inhibitor,ATP4A|CLCN2
SUDAHWBOROXANE,BRD-K49865102,PD-0325901,MEK inhibitor,MAP2K1,BRD-K49865102,PD-0325901,MEK inhibitor,MAP2K1,BRD-K49865102,PD-0325901,MEK inhibitor,MAP2K1,BRD-K49865102,PD-0325901,MEK inhibitor,MAP2K1
SUHOQUVVVLNYQR,BRD-A72390365,choline-alfoscerate,acetylcholine precursor,GM2A,BRD-A72390365,choline-alfoscerate,acetylcholine precursor,GM2A,BRD-A72390365,choline-alfoscerate,acetylcholine precursor,GM2A,BRD-K00003587,choline-alfoscerate,acetylcholine precursor,
SUIZRDJCBVPASY,BRD-K29668683,BD-1063,sigma receptor antagonist,SIGMAR1,BRD-K29668683,BD-1063,sigma receptor antagonist,SIGMAR1,BRD-K29668683,BD-1063,sigma receptor antagonist,SIGMAR1,BRD-K29668683,BD-1063,sigma receptor antagonist,SIGMAR1
SUNXHXDJOIXABJ,BRD-K64888243,AZ960,JAK inhibitor,JAK2,BRD-K64888243,AZ960,JAK inhibitor,JAK2,BRD-K64888243,AZ960,JAK inhibitor,JAK2,BRD-K64888243,AZ960,JAK inhibitor,JAK2
SUPKOOSCJHTBAH,BRD-K77484724,adefovir,DNA polymerase inhibitor,,BRD-K77484724,adefovir,DNA polymerase inhibitor,,BRD-K77484724,adefovir,DNA polymerase inhibitor,,BRD-K77484724,adefovir,DNA polymerase inhibitor,
SUPVGFZUWFMATN,BRD-K36529613,PU-H71,HSP inhibitor,HSP90AA1,BRD-K36529613,PU-H71,HSP inhibitor,HSP90AA1,BRD-K36529613,PU-H71,HSP inhibitor,HSP90AA1,BRD-K36529613,PU-H71,HSP inhibitor,HSP90AA1
SUVMJBTUFCVSAD,BRD-A58955223,sulforaphane,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,BRD-A58955223,sulforaphane,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,BRD-A58955223,sulforaphane,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,BRD-A58955223,sulforaphane,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2
SUXQDLLXIBLQHW,BRD-A61633223,ulifloxacin,,,BRD-A61633223,ulifloxacin,,,BRD-A61633223,ulifloxacin,,,BRD-A61633223,ulifloxacin,,
SUYUTNCKIOLMAJ,BRD-K66527818,VU0364770,glutamate receptor positive allosteric modulator,GRM4,BRD-K66527818,VU0364770,glutamate receptor positive allosteric modulator,GRM4,BRD-K66527818,VU0364770,glutamate receptor positive allosteric modulator,GRM4,BRD-K66527818,VU0364770,glutamate receptor positive allosteric modulator,GRM4
SVEBYYWCXTVYCR,BRD-K82259334,methyldopate,,,BRD-K82259334,methyldopate,,,BRD-K82259334,methyldopate,,,BRD-K82259334,methyldopate,,
SVFXPTLYMIXFRX,BRD-K01649396,indatraline,norepinephrine transporter inhibitor,MAOA|MAOB,BRD-K01649396,indatraline,norepinephrine transporter inhibitor,MAOA|MAOB,BRD-K01649396,indatraline,norepinephrine transporter inhibitor,MAOA|MAOB,BRD-K01649396,indatraline,norepinephrine transporter inhibitor,MAOA|MAOB
SVJMLYUFVDMUHP,BRD-K44309363|BRD-K59333713,dexniguldipine|niguldipine-(S)-(+),adrenergic receptor antagonist|calmodulin antagonist,ADORA3|ADRA1A,BRD-K44309363|BRD-K59333713,dexniguldipine|niguldipine-(S)-(+),adrenergic receptor antagonist|calmodulin antagonist,ADORA3|ADRA1A,BRD-K44309363|BRD-K59333713,dexniguldipine|niguldipine-(S)-(+),adrenergic receptor antagonist|calmodulin antagonist,ADORA3|ADRA1A,BRD-K01825503|BRD-K44309363|BRD-K59333713,dexniguldipine|niguldipine-(R)-(-)|niguldipine-(S)-(+),|adrenergic receptor antagonist|calmodulin antagonist,|ADORA3|ADRA1A
SVTBMSDMJJWYQN,BRD-A14234430,hexylene-glycol,,AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP,BRD-A14234430,hexylene-glycol,,AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP,BRD-A14234430,hexylene-glycol,,AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP,BRD-A14234430,hexylene-glycol,,AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP
SVURIXNDRWRAFU,BRD-A61188230|BRD-K96362839,cedrol|cedrol-(+),|sedative,,BRD-A61188230|BRD-K96362839,cedrol|cedrol-(+),|sedative,,BRD-A61188230|BRD-K96362839,cedrol|cedrol-(+),|sedative,,BRD-A61188230|BRD-K96362839,cedrol|cedrol-(+),|sedative,
SVXDHPADAXBMFB,BRD-K49460120,10058-F4,c-Myc inhibitor,,BRD-K49460120,10058-F4,c-Myc inhibitor,,BRD-K49460120,10058-F4,c-Myc inhibitor,,BRD-K49460120,10058-F4,c-Myc inhibitor,
SWEOAXMICIJCQC,BRD-K92606079,ML314,neurotensin agonist,NTSR1,BRD-K92606079,ML314,neurotensin agonist,NTSR1,BRD-K92606079,ML314,neurotensin agonist,NTSR1,BRD-K92606079,ML314,neurotensin agonist,NTSR1
SWLAMJPTOQZTAE,BRD-K51324732,meglitinide,potassium channel blocker,CCR2,BRD-K51324732,meglitinide,potassium channel blocker,CCR2,BRD-K51324732,meglitinide,potassium channel blocker,CCR2,BRD-K51324732,meglitinide,potassium channel blocker,CCR2
SWLMUYACZKCSHZ,BRD-A16665823,butoconazole,bacterial cell wall synthesis inhibitor,,BRD-A16665823,butoconazole,bacterial cell wall synthesis inhibitor,,BRD-A16665823,butoconazole,bacterial cell wall synthesis inhibitor,,BRD-K01824994,butoconazole,bacterial cell wall synthesis inhibitor,
SWUARLUWKZWEBQ,BRD-K96188950,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA,BRD-K96188950,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA,BRD-K96188950,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA,BRD-K96188950,caffeic-acid-phenethyl-ester,HIV integrase inhibitor,RELA
SWWVFYHSSOWZMF,BRD-A44500574,FLI-06,notch signaling inhibitor,,BRD-A44500574,FLI-06,notch signaling inhibitor,,BRD-A44500574,FLI-06,notch signaling inhibitor,,,,,
SWZMSZQQJRKFBP,BRD-K49071277,securinine,GABA receptor antagonist|TP53 activator,GABRA1,BRD-K49071277,securinine,GABA receptor antagonist|TP53 activator,GABRA1,BRD-K49071277,securinine,GABA receptor antagonist|TP53 activator,GABRA1,BRD-K49071277,securinine,GABA receptor antagonist|TP53 activator,GABRA1
SWZXEVABPLUDIO,BRD-A36331462,oprozomib,proteasome inhibitor,,BRD-A36331462,oprozomib,proteasome inhibitor,,BRD-A36331462,oprozomib,proteasome inhibitor,,BRD-K91438851,oprozomib,proteasome inhibitor,
SXHQLPHDBLTFPM,BRD-K46734292,KML29,monoacylglucerol lipase inhibitor,MGLL,BRD-K46734292,KML29,monoacylglucerol lipase inhibitor,MGLL,BRD-K46734292,KML29,monoacylglucerol lipase inhibitor,MGLL,BRD-K46734292,KML29,monoacylglucerol lipase inhibitor,MGLL
SXJDCULZDFWMJC,BRD-A13807286|BRD-K18163608,HA-14-1|HA14-1,BCL inhibitor,BCL2,BRD-A13807286|BRD-K18163608,HA-14-1|HA14-1,BCL inhibitor,BCL2,BRD-A13807286|BRD-K18163608,HA-14-1|HA14-1,BCL inhibitor,BCL2,BRD-K18163608,HA14-1,BCL inhibitor,BCL2
SXJIZQPZESTWLD,BRD-K02764365,methiazole,anthelmintic agent,,BRD-K02764365,methiazole,anthelmintic agent,,BRD-K02764365,methiazole,anthelmintic agent,,BRD-K02764365,methiazole,anthelmintic agent,
SXNJFOWDRLKDSF,BRD-K69776681,volasertib,PLK inhibitor,PLK1,BRD-K69776681,volasertib,PLK inhibitor,PLK1,BRD-K69776681,volasertib,PLK inhibitor,PLK1,BRD-K69776681,volasertib,PLK inhibitor,PLK1
SXVBURQVABOIKZ,BRD-M75840137,eliglustat,Glycosyl transferase inhibitor,UGCG,BRD-M75840137,eliglustat,Glycosyl transferase inhibitor,UGCG,,,,,,,,
SXYIRMFQILZOAM,BRD-A45966947|BRD-K12393844|BRD-K17916327|BRD-K39621635,artemether,antimalarial agent,ATP1A1,BRD-A45966947|BRD-K17916327|BRD-K39621635,artemether,antimalarial agent,ATP1A1,BRD-A45966947|BRD-K12393844|BRD-K17916327|BRD-K39621635,artemether,antimalarial agent,ATP1A1,BRD-A45966947|BRD-K12393844|BRD-K17916327|BRD-K39621635,artemether,antimalarial agent,ATP1A1
SXYZQZLHAIHKKY,BRD-K38003476,clocortolone-pivalate,steroid,NR3C1|PLA2G1B,BRD-K38003476,clocortolone-pivalate,steroid,NR3C1|PLA2G1B,BRD-K38003476,clocortolone-pivalate,steroid,NR3C1|PLA2G1B,BRD-K38003476,clocortolone-pivalate,steroid,NR3C1|PLA2G1B
SXZYCXMUPBBULW,BRD-A67265925,sodium-ascorbate,,,BRD-A67265925,sodium-ascorbate,,,BRD-A67265925,sodium-ascorbate,,,BRD-A67265925,sodium-ascorbate,,
SYLKGLMBLAAGSC,BRD-A86462796|BRD-K03907181,cefsulodin,bacterial cell wall synthesis inhibitor,,BRD-A86462796|BRD-K03907181,cefsulodin,bacterial cell wall synthesis inhibitor,,BRD-A86462796|BRD-K03907181,cefsulodin,bacterial cell wall synthesis inhibitor,,BRD-A86462796|BRD-K03907181,cefsulodin,bacterial cell wall synthesis inhibitor,
SYNDQCRDGGCQRZ,BRD-K87718015,dynasore,dynamin inhibitor,DNM1|DNM1L|DNM2,BRD-K87718015,dynasore,dynamin inhibitor,DNM1|DNM1L|DNM2,BRD-K87718015,dynasore,dynamin inhibitor,DNM1|DNM1L|DNM2,BRD-K87718015,dynasore,dynamin inhibitor,DNM1|DNM1L|DNM2
SYOKIDBDQMKNDQ,BRD-A94993966,vildagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A94993966,vildagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A94993966,vildagliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K00003565,vildagliptin,dipeptidyl peptidase inhibitor,DPP4
SYTBZMRGLBWNTM,BRD-A86044036|BRD-K69907333,flurbiprofen-(+/-)|flurbiprofen-(S)-(+),cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A86044036|BRD-K69907333|BRD-K75410565,flurbiprofen-(+/-)|flurbiprofen-(S)-(+)|flurizan,cyclooxygenase inhibitor|gamma secretase inhibitor,APH1B|BACE1|IKBKG|PSEN1|PSEN2|PTGS1|PTGS2,BRD-A86044036|BRD-K69907333|BRD-K75410565,flurbiprofen-(+/-)|flurbiprofen-(S)-(+)|flurizan,cyclooxygenase inhibitor|gamma secretase inhibitor,APH1B|BACE1|IKBKG|PSEN1|PSEN2|PTGS1|PTGS2,BRD-A86044036|BRD-K69907333|BRD-K75410565,flurbiprofen-(+/-)|flurbiprofen-(S)-(+)|flurizan,cyclooxygenase inhibitor|gamma secretase inhibitor,|APH1B|BACE1|IKBKG|PSEN1|PSEN2|PTGS1|PTGS2
SYWHXTATXSMDSB,BRD-A38749782|BRD-K06408664,fludrocortisone-acetate,,AR|NR3C1|NR3C2,BRD-A38749782|BRD-K06408664,fludrocortisone-acetate,,AR|NR3C1|NR3C2,BRD-A38749782|BRD-K06408664,fludrocortisone-acetate,,AR|NR3C1|NR3C2,BRD-A38749782|BRD-K06408664,fludrocortisone-acetate,,NR3C2
SYYBDNPGDKKJDU,BRD-K14109347,LY2603618,CHK inhibitor,CHEK1,BRD-K14109347,LY2603618,CHK inhibitor,CHEK1,BRD-K14109347,LY2603618,CHK inhibitor,CHEK1,BRD-K14109347,LY2603618,CHK inhibitor,CHEK1
SYZSSLLFRVDRHL,BRD-K35367061,LY223982,leukotriene receptor antagonist,LTB4R,BRD-K35367061,LY223982,leukotriene receptor antagonist,LTB4R,BRD-K35367061,LY223982,leukotriene receptor antagonist,LTB4R,BRD-K35367061,LY223982,leukotriene receptor antagonist,LTB4R
SZBGQDXLNMELTB,BRD-K50498985,taladegib,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K50498985,taladegib,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K50498985,taladegib,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K50498985,taladegib,smoothened receptor antagonist,DHH|IHH|SMO
SZFPYBIJACMNJV,BRD-A89082344,perifosine,AKT inhibitor,AKT1,BRD-A89082344,perifosine,AKT inhibitor,AKT1,BRD-A89082344,perifosine,AKT inhibitor,AKT1,BRD-A89082344,perifosine,AKT inhibitor,AKT1
SZQIFWWUIBRPBZ,BRD-A30205217,ethotoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A30205217,ethotoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A30205217,ethotoin,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-A30205217,ethotoin,hydantoin antiepileptic,SCN5A
SZRPDCCEHVWOJX,BRD-K01902415,pirinixic-acid,PPAR receptor agonist,PPARA,BRD-K01902415,pirinixic-acid,PPAR receptor agonist,PPARA,BRD-K01902415,pirinixic-acid,PPAR receptor agonist,PPARA,BRD-K01902415,pirinixic-acid,PPAR receptor agonist,PPARA
SZWKGOZKRMMLAJ,BRD-K06854232,AM-580,retinoid receptor agonist,RARA,BRD-K06854232,AM-580,retinoid receptor agonist,RARA,BRD-K06854232,AM-580,retinoid receptor agonist,RARA,BRD-K06854232,AM-580,retinoid receptor agonist,RARA
TTWJBBZEZQICBI,BRD-K75641298,metoclopramide,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,BRD-K75641298,metoclopramide,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,BRD-K75641298,metoclopramide,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,BRD-K75641298,metoclopramide,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4
TTZHDVOVKQGIBA,BRD-K05674516,PSI-7976|sofosbuvir,HCV inhibitor|RNA polymerase inhibitor,,BRD-K05674516,PSI-7976|sofosbuvir,HCV inhibitor|RNA polymerase inhibitor,,BRD-K05674516,PSI-7976|sofosbuvir,HCV inhibitor|RNA polymerase inhibitor,,BRD-K00026984|BRD-K05674516,PSI-7976|sofosbuvir,HCV inhibitor,
TUCIOBMMDDOEMM,BRD-K47105409,AG-490,EGFR inhibitor|JAK inhibitor,EGFR|JAK2|JAK3,BRD-K47105409,AG-490,EGFR inhibitor|JAK inhibitor,EGFR|JAK2|JAK3,BRD-K47105409,AG-490,EGFR inhibitor|JAK inhibitor,EGFR|JAK2|JAK3,BRD-K47105409,AG-490,EGFR inhibitor|JAK inhibitor,EGFR|JAK2|JAK3
TUERFPPIPKZNKE,BRD-K02135007,THZ1-R,CDK inhibitor,CDK7,BRD-K02135007,THZ1-R,CDK inhibitor,CDK7,BRD-K02135007,THZ1-R,CDK inhibitor,CDK7,BRD-K02135007,THZ1-R,CDK inhibitor,CDK7
TUESWZZJYCLFNL,BRD-K62186992,hydroxystilbamidine,,,BRD-K62186992,hydroxystilbamidine,,,BRD-K62186992,hydroxystilbamidine,,,BRD-K62186992,hydroxystilbamidine,,
TUEWQXNXQFRUTK,BRD-A22740840|BRD-A56621826|BRD-A78694248,oxytetracycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A22740840|BRD-A56621826,oxytetracycline,bacterial 30S ribosomal subunit inhibitor,,BRD-A22740840|BRD-A56621826|BRD-A78694248,oxytetracycline,bacterial 30S ribosomal subunit inhibitor,,,,,
TUFADSGTJUOBEH,BRD-K13261168,quinelorane,dopamine receptor agonist,DRD2|DRD3,BRD-K13261168,quinelorane,dopamine receptor agonist,DRD2|DRD3,BRD-K13261168,quinelorane,dopamine receptor agonist,DRD2|DRD3,BRD-K13261168,quinelorane,dopamine receptor agonist,DRD2|DRD3
TUPKOWFPVAXQFP,BRD-K36611520,CP-532623,cholesteryl ester transfer protein inhibitor,CETP,BRD-K36611520,CP-532623,cholesteryl ester transfer protein inhibitor,CETP,BRD-K36611520,CP-532623,cholesteryl ester transfer protein inhibitor,CETP,BRD-K36611520,CP-532623,cholesteryl ester transfer protein inhibitor,CETP
TUUXBSASAQJECY,BRD-K24476327,icaritin,PPAR receptor antagonist,PDE5A,BRD-K24476327,icaritin,PPAR receptor antagonist,PDE5A,BRD-K24476327,icaritin,PPAR receptor antagonist,PDE5A,BRD-K24476327,icaritin,PPAR receptor antagonist,PDE5A
TUVCWJQQGGETHL,BRD-K67868012,PI-103,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,BRD-K67868012,PI-103,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,BRD-K67868012,PI-103,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,BRD-K67868012,PI-103,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC
TUZYXOIXSAXUGO,BRD-A71816415|BRD-K31447894|BRD-K60511616,pravastatin,HMGCR inhibitor,HMGCR|SLCO1B1,BRD-A71816415|BRD-K31447894|BRD-K60511616,pravastatin,HMGCR inhibitor,HMGCR|SLCO1B1,BRD-A71816415|BRD-K31447894|BRD-K60511616,pravastatin,HMGCR inhibitor,HMGCR|SLCO1B1,BRD-K31447894|BRD-K60511616,pravastatin,HMGCR inhibitor,HMGCR|SLCO1B1
TVGLGJWCZSCAEM,BRD-K88153212,myristyl-nicotinate,topical sunscreen agent,,BRD-K88153212,myristyl-nicotinate,topical sunscreen agent,,BRD-K88153212,myristyl-nicotinate,topical sunscreen agent,,BRD-K88153212,myristyl-nicotinate,topical sunscreen agent,
TVIVJHZHPKNDAQ,BRD-K13049524,STF-083010,serine/threonine kinase inhibitor,ERN1,BRD-K13049524,STF-083010,serine/threonine kinase inhibitor,ERN1,BRD-K13049524,STF-083010,serine/threonine kinase inhibitor,ERN1,BRD-K13049524,STF-083010,serine/threonine kinase inhibitor,ERN1
TVKGTSHBQZEFEE,BRD-K23902832,R112,syk inhibitor,SYK,BRD-K23902832,R112,syk inhibitor,SYK,BRD-K23902832,R112,syk inhibitor,SYK,BRD-K23902832,R112,SYK inhibitor,SYK
TVMXJQZBKOMFQK,BRD-A44936478,cephalosporin-c-zn,bacterial cell wall synthesis inhibitor,,BRD-A44936478,cephalosporin-c-zn,bacterial cell wall synthesis inhibitor,,BRD-A44936478|BRD-M47474198,cephalosporin-c-zn,bacterial cell wall synthesis inhibitor,,BRD-K00025564,cephalosporin-c-zn,bacterial cell wall synthesis inhibitor,
TVNBASWNLOIQML,BRD-A45869167,sal003,eukaryotic translation initiation factor inhibitor,EIF2A,BRD-A45869167,sal003,eukaryotic translation initiation factor inhibitor,EIF2A,BRD-A45869167,sal003,eukaryotic translation initiation factor inhibitor,EIF2A,BRD-K01828772,sal003,eukaryotic translation initiation factor inhibitor,EIF2A
TVQZAMVBTVNYLA,BRD-A64610707,pranoprofen,cyclooxygenase inhibitor,,BRD-A64610707,pranoprofen,cyclooxygenase inhibitor,,BRD-A64610707,pranoprofen,cyclooxygenase inhibitor,,BRD-A64610707,pranoprofen,cyclooxygenase inhibitor,
TVSNVPGPFGAKPT,BRD-A14574269,UB-165,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNB2,BRD-A14574269,UB-165,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNB2,BRD-A14574269,UB-165,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNB2,BRD-A14574269,UB-165,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNB2
TVTXCJFHQKSQQM,BRD-K62627508,idasanutlin,MDM inhibitor,MDM2|TP53,BRD-K62627508,idasanutlin,MDM inhibitor,MDM2|TP53,BRD-K62627508,idasanutlin,MDM inhibitor,MDM2|TP53,BRD-K62627508,idasanutlin,MDM inhibitor,MDM2|TP53
TVURRHSHRRELCG,BRD-A50684349,fenoldopam,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD4|DRD5,BRD-A50684349,fenoldopam,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD4|DRD5,BRD-A50684349,fenoldopam,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD4|DRD5,BRD-K01826790,fenoldopam,dopamine receptor agonist,DRD1|DRD4
TVYLLZQTGLZFBW,BRD-K51033547,tramadol,norepinephrine reputake inhibitor|opioid receptor agonist|serotonin reuptake inhibitor,CHRFAM7A|CHRM3|GRIN3A|HTR2C|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4,BRD-K51033547,tramadol,norepinephrine reputake inhibitor|opioid receptor agonist|serotonin reuptake inhibitor,CHRFAM7A|CHRM3|GRIN3A|HTR2C|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4,BRD-K51033547,tramadol,norepinephrine reputake inhibitor|opioid receptor agonist|serotonin reuptake inhibitor,CHRFAM7A|CHRM3|GRIN3A|HTR2C|OPRD1|OPRK1|OPRM1|SLC6A2|SLC6A4,,,,
TVZCRIROJQEVOT,BRD-K24526313,levcromakalim,potassium channel activator,KCNJ5|KCNJ8,BRD-K24526313,levcromakalim,potassium channel activator,KCNJ5|KCNJ8,BRD-K24526313,levcromakalim,potassium channel activator,KCNJ5,BRD-K24526313,levcromakalim,potassium channel activator,KCNJ5
TVZGACDUOSZQKY,BRD-A86736466|BRD-K87544030,aminopterin,dihydrofolate reductase inhibitor,DHFR|SLC46A1,BRD-A86736466|BRD-K87544030,aminopterin,dihydrofolate reductase inhibitor,DHFR|SLC46A1,BRD-A86736466|BRD-K87544030,aminopterin,dihydrofolate reductase inhibitor,DHFR|SLC46A1,BRD-A86736466|BRD-K87544030,aminopterin,dihydrofolate reductase inhibitor,DHFR|SLC46A1
TWAZWVPPDIUVOD,BRD-K49617926,neohesperidin,,,BRD-K96299080,neohesperidin,,,BRD-K49617926|BRD-K96299080,neohesperidin,,,,,,
TWFZGCMQGLPBSX,BRD-K12906202,carbendazim,microtubule inhibitor|tubulin polymerization inhibitor,TP53|TUBB,BRD-K12906202,carbendazim,microtubule inhibitor|tubulin polymerization inhibitor,TP53|TUBB,BRD-K12906202,carbendazim,microtubule inhibitor|tubulin polymerization inhibitor,TP53|TUBB,BRD-K12906202,carbendazim,microtubule inhibitor|tubulin polymerization inhibitor,TP53|TUBB
TWPJJJZCYVFUOA,BRD-K79856806,TA-01,MAP kinase inhibitor|casein kinase inhibitor,CSNK1D|CSNK1E|MAPK14,BRD-K79856806,TA-01,MAP kinase inhibitor|casein kinase inhibitor,CSNK1D|CSNK1E|MAPK14,BRD-K79856806,TA-01,MAP kinase inhibitor|casein kinase inhibitor,CSNK1D|CSNK1E|MAPK14,BRD-K79856806,TA-01,MAP kinase inhibitor|casein kinase inhibitor,CSNK1D|CSNK1E|MAPK14
TWQYWUXBZHPIIV,BRD-K26823213,GW-842166,cannabinoid receptor agonist,CNR2,BRD-K26823213,GW-842166,cannabinoid receptor agonist,CNR2,BRD-K26823213,GW-842166,cannabinoid receptor agonist,CNR2,BRD-K26823213,GW-842166,cannabinoid receptor agonist,CNR2
TWWFAXQOKNBUCR,BRD-K37618799,MRS-1220,adenosine receptor antagonist,ADORA2B|ADORA3,BRD-K37618799,MRS-1220,adenosine receptor antagonist,ADORA2B|ADORA3,BRD-K37618799,MRS-1220,adenosine receptor antagonist,ADORA2B|ADORA3,BRD-K37618799,MRS-1220,adenosine receptor antagonist,ADORA2B|ADORA3
TXCGAZHTZHNUAI,BRD-K19111024,clofibric-acid,PPAR receptor agonist,PPARA,BRD-K19111024,clofibric-acid,PPAR receptor agonist,PPARA,BRD-K19111024,clofibric-acid,PPAR receptor agonist,PPARA,BRD-K19111024,clofibric-acid,PPAR receptor agonist,PPARA
TXDUTHBFYKGSAH,BRD-A68631409,evodiamine,ATPase inhibitor|TRPV agonist,TRPV1,BRD-A68631409,evodiamine,ATPase inhibitor|TRPV agonist,TRPV1,BRD-A68631409,evodiamine,ATPase inhibitor|TRPV agonist,TRPV1,BRD-A68631409,evodiamine,ATPase inhibitor|TRPV agonist,TRPV1
TXEBNKKOLVBTFK,BRD-K72898849,BLU9931,FGFR inhibitor,FGFR4,BRD-K72898849,BLU9931,FGFR inhibitor,FGFR4,BRD-K72898849,BLU9931,FGFR inhibitor,FGFR4,BRD-K72898849,BLU9931,FGFR inhibitor,FGFR4
TXEIIPDJKFWEEC,BRD-K23728141,tafamidis-meglumine,transthyretin amyloid inhibitor,TTR,BRD-K23728141,tafamidis-meglumine,transthyretin amyloid inhibitor,TTR,BRD-K23728141,tafamidis-meglumine,transthyretin amyloid inhibitor,TTR,BRD-K23728141,tafamidis-meglumine,transthyretin amyloid inhibitor,TTR
TXGKRVFSSHPBAJ,BRD-K53734668|BRD-K98804570,PRT062607,syk inhibitor,FGR|MAP3K9|SYK,BRD-K53734668|BRD-K98804570,PRT062607,syk inhibitor,FGR|MAP3K9|SYK,BRD-K53734668|BRD-K98804570,PRT062607,syk inhibitor,FGR|MAP3K9|SYK,BRD-K53734668|BRD-K98804570,PRT062607,SYK inhibitor,FGR|MAP3K9|SYK
TXGZJQLMVSIZEI,BRD-K20545304,bardoxolone,like (NRF2) activator|nuclear factor erythroid derived,NOS2|PPARG,BRD-K20545304,bardoxolone,like (NRF2) activator|nuclear factor erythroid derived,NOS2|PPARG,BRD-K20545304,bardoxolone,like (NRF2) activator|nuclear factor erythroid derived,NOS2|PPARG,BRD-K20545304,bardoxolone,like (NRF2) activator|nuclear factor erythroid derived,NOS2|PPARG
TXQKSMSLZVKQBI,BRD-A49046702,SKF-89976A,GABA uptake inhibitor,SLC6A1,BRD-A49046702,SKF-89976A,GABA uptake inhibitor,SLC6A1,BRD-A49046702,SKF-89976A,GABA uptake inhibitor,SLC6A1,BRD-K01826728,SKF-89976A,GABA uptake inhibitor,SLC6A1
TXUWMXQFNYDOEZ,BRD-A36318220,necrostatin-1,RIPK inhibitor,RIPK1,BRD-A36318220,necrostatin-1,RIPK inhibitor,RIPK1,BRD-A36318220,necrostatin-1,RIPK inhibitor,RIPK1,BRD-K01825019,necrostatin-1,RIPK inhibitor,RIPK1
TXUZVZSFRXZGTL,BRD-K04210847,afimoxifene,estrogen receptor antagonist,ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ,BRD-K04210847,afimoxifene,estrogen receptor antagonist,ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ,BRD-K04210847,afimoxifene,estrogen receptor antagonist,ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ,BRD-K04210847,afimoxifene,estrogen receptor antagonist,ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ
TXZPMHLMPKIUGK,BRD-K13094524,PFI-1,bromodomain inhibitor,BRD4,BRD-K13094524,PFI-1,bromodomain inhibitor,BRD4,BRD-K13094524,PFI-1,bromodomain inhibitor,BRD4,BRD-K13094524,PFI-1,bromodomain inhibitor,BRD4
TYBHXIFFPVFXQW,BRD-K77432251,abafungin,sterol methyltransferase inhibitor,,BRD-K77432251,abafungin,sterol methyltransferase inhibitor,,BRD-K77432251,abafungin,sterol methyltransferase inhibitor,,BRD-K77432251,abafungin,sterol methyltransferase inhibitor,
TYEFSRMOUXWTDN,BRD-K20828910,GW-6471,PPAR receptor antagonist,PPARA,BRD-K20828910,GW-6471,PPAR receptor antagonist,PPARA,BRD-K20828910,GW-6471,PPAR receptor antagonist,PPARA,BRD-K20828910,GW-6471,PPAR receptor antagonist,PPARA
TYMRLRRVMHJFTF,BRD-K30649484,mafenide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA4|CA6|CA9,BRD-K30649484,mafenide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA4|CA6|CA9,BRD-K30649484,mafenide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA4|CA6|CA9,BRD-K30649484,mafenide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA4|CA6|CA9
TYNLGDBUJLVSMA,BRD-K69122748,diacerein,interleukin inhibitor,IL1B,BRD-K69122748,diacerein,interleukin inhibitor,IL1B,BRD-K69122748,diacerein,interleukin inhibitor,IL1B,BRD-K69122748,diacerein,interleukin inhibitor,IL1B
TYQXKHPOXXXCTP,BRD-K39746403,erythromycin-estolate,bacterial 50S ribosomal subunit inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,BRD-K39746403,erythromycin-estolate,bacterial 50S ribosomal subunit inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,BRD-K39746403,erythromycin-estolate,bacterial 50S ribosomal subunit inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,BRD-K39746403,erythromycin-estolate,bacterial 50S ribosomal subunit inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1
TYYBFXNZMFNZJT,BRD-K79124250,ioxaglic-acid,radiopaque medium,,BRD-K79124250,ioxaglic-acid,radiopaque medium,,BRD-K79124250,ioxaglic-acid,radiopaque medium,,BRD-K79124250,ioxaglic-acid,radiopaque medium,
TYZROVQLWOKYKF,BRD-K66876909,linezolid,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,BRD-K66876909,linezolid,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,BRD-K66876909,linezolid,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,BRD-K66876909,linezolid,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB
TZBDEVBNMSLVKT,BRD-A57877027,idramantone,,,BRD-A57877027,idramantone,,,BRD-A57877027,idramantone,,,BRD-K00003671,idramantone,,
TZBJGXHYKVUXJN,BRD-K43797669,genistein,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,BRD-K43797669,genistein,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,BRD-K43797669,genistein,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,BRD-K43797669,genistein,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5
TZCOBUQKVNFIQF,BRD-A10420615,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,BRD-A10420615,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,BRD-A10420615|BRD-K93666001,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,,,,
TZDUHAJSIBHXDL,BRD-A86665761,gabapentin-enacarbil,adrenergic receptor agonist,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,BRD-A86665761,gabapentin-enacarbil,adrenergic receptor agonist,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,BRD-A86665761,gabapentin-enacarbil,adrenergic receptor agonist,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8,BRD-A86665761,gabapentin-enacarbil,adrenergic receptor agonist,CACNA1G
TZFNLOMSOLWIDK,BRD-A69512159|BRD-K78712176,carbidopa,aromatic L-amino acid decarboxylase inhibitor,DDC,BRD-A69512159|BRD-K78712176,carbidopa,aromatic L-amino acid decarboxylase inhibitor,DDC,BRD-A69512159|BRD-K78712176,carbidopa,aromatic L-amino acid decarboxylase inhibitor,DDC,BRD-A69512159|BRD-K78712176,carbidopa,aromatic L-amino acid decarboxylase inhibitor,DDC
TZFWDZFKRBELIQ,BRD-K98174813,chlorzoxazone,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4,BRD-K98174813,chlorzoxazone,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4,BRD-K98174813,chlorzoxazone,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4,BRD-K98174813,chlorzoxazone,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4
TZJALUIVHRYQQB,BRD-A06210771|BRD-A88583207,icariin,phosphodiesterase inhibitor,PDE5A,BRD-A06210771|BRD-K65639003,icariin,phosphodiesterase inhibitor,PDE5A,BRD-A06210771|BRD-A88583207|BRD-K65639003,icariin,phosphodiesterase inhibitor,PDE5A,BRD-A06210771|BRD-A88583207|BRD-K65639003,icariin,phosphodiesterase inhibitor,PDE5A
TZJUVVIWVWFLCD,BRD-K90574421,ipsapirone,serotonin receptor agonist,HTR1A,BRD-K90574421,ipsapirone,serotonin receptor agonist,HTR1A,BRD-K90574421,ipsapirone,serotonin receptor agonist,HTR1A,BRD-K90574421,ipsapirone,serotonin receptor agonist,HTR1A
TZKBVRDEOITLRB,BRD-K35329391,GZD824,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K35329391,GZD824,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K35329391,GZD824,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K35329391,GZD824,Bcr-Abl kinase inhibitor,ABL1|BCR
TZRHLKRLEZJVIJ,BRD-K13800121,parecoxib,cyclooxygenase inhibitor,LTF,BRD-K13800121,parecoxib,cyclooxygenase inhibitor,LTF,BRD-K13800121,parecoxib,cyclooxygenase inhibitor,LTF,BRD-K13800121,parecoxib,cyclooxygenase inhibitor,LTF
TZXKOCQBRNJULO,BRD-K06878038,deferiprone,chelating agent,UGT1A6,BRD-K06878038,deferiprone,chelating agent,UGT1A6,BRD-K06878038,deferiprone,chelating agent,UGT1A6,BRD-K06878038,deferiprone,chelating agent,UGT1A6
TZYVRXZQAWPIAB,BRD-K87535339,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,,BRD-K87535339,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,,BRD-A99177285|BRD-K87535339,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,,BRD-A99177285|BRD-K87535339,"5-amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",,TLR7
TZYWCYJVHRLUCT,BRD-K60230970,MG-132,proteasome inhibitor,PSMB1,BRD-K60230970,MG-132,proteasome inhibitor,PSMB1,BRD-K60230970,MG-132,proteasome inhibitor,PSMB1,BRD-K60230970,MG-132,proteasome inhibitor,PSMB1
TZZNWMJZDWYJAZ,BRD-K35882976,mitoflaxone,antitumor agent,VWF,BRD-K35882976,mitoflaxone,antitumor agent,VWF,BRD-K35882976,mitoflaxone,antitumor agent,VWF,BRD-K35882976,mitoflaxone,antitumor agent,VWF
UACOQEQOBAQRDQ,BRD-K24443618,etebenecid,uricosuric blocker,,BRD-K24443618,etebenecid,uricosuric blocker,,BRD-K24443618,etebenecid,uricosuric blocker,,BRD-K24443618,etebenecid,uricosuric blocker,
UADIKEUOAMACNA,BRD-K84507776,PNU-89843,benzodiazepine receptor agonist,GABBR1,BRD-K84507776,PNU-89843,benzodiazepine receptor agonist,GABBR1,BRD-K84507776,PNU-89843,benzodiazepine receptor agonist,GABBR1,BRD-K84507776,PNU-89843,benzodiazepine receptor agonist,GABBR1
UADPGHINQMWEAG,BRD-A85025557,NCS-382,GABA receptor antagonist,GABBR1|GABBR2|SLC52A2,BRD-A85025557,NCS-382,GABA receptor antagonist,GABBR1|GABBR2|SLC52A2,BRD-A85025557,NCS-382,GABA receptor antagonist,GABBR1|GABBR2|SLC52A2,BRD-K01826782,NCS-382,GABA receptor antagonist,GABBR1|GABBR2|SLC52A2
UAIYNMRLUHHRMF,BRD-A55946879,BW-B70C,lipoxygenase inhibitor,ALOX5,BRD-A55946879,BW-B70C,lipoxygenase inhibitor,ALOX5,BRD-A55946879,BW-B70C,lipoxygenase inhibitor,ALOX5,BRD-A55946879,BW-B70C,lipoxygenase inhibitor,ALOX5
UAJUXJSXCLUTNU,BRD-K91497079,pranlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,,,,,,,,,,,,
UAKWLVYMKBWHMX,BRD-K20287671,SU-4312,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor|tyrosine kinase inhibitor,KDR|PDGFRB,BRD-K20287671,SU-4312,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor|tyrosine kinase inhibitor,KDR|PDGFRB,BRD-K20287671,SU-4312,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor|tyrosine kinase inhibitor,KDR|PDGFRB,BRD-K20287671,SU4312,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor|tyrosine kinase inhibitor,KDR|PDGFRB
UAORFCGRZIGNCI,BRD-A21280314,nifenalol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A21280314,nifenalol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A21280314,nifenalol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A21280314,nifenalol,adrenergic receptor antagonist,ADRB1|ADRB2
UATDVRSFFGFTAI,BRD-K50018155,RS-67506,serotonin receptor partial agonist,HTR4,BRD-K50018155,RS-67506,serotonin receptor partial agonist,HTR4,BRD-K50018155,RS-67506,serotonin receptor partial agonist,HTR4,BRD-K50018155,RS-67506,serotonin receptor partial agonist,HTR4
UAUHEPXILIZYCU,BRD-A53539450,neo-gilurytmal,,,BRD-A53539450,neo-gilurytmal,,,BRD-A53539450,neo-gilurytmal,,,BRD-A53539450,neo-gilurytmal,,
UAUIUKWPKRJZJV,BRD-K89920762,paritaprevir,HCV inhibitor,,BRD-K89920762,paritaprevir,HCV inhibitor,,BRD-K89920762,paritaprevir,HCV inhibitor,,BRD-K89920762,paritaprevir,HCV inhibitor,
UAWVRVFHMOSAPU,BRD-K84214706,7-chlorokynurenic-acid,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C,BRD-K84214706,7-chlorokynurenic-acid,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C,BRD-K84214706,7-chlorokynurenic-acid,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C,BRD-K84214706,7-chlorokynurenic-acid,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C
UAWXGRJVZSAUSZ,BRD-K08439945,licofelone,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5|PLA2G2E|PTGS2,BRD-K08439945,licofelone,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5|PLA2G2E|PTGS2,BRD-K08439945,licofelone,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5|PLA2G2E|PTGS2,BRD-K08439945,licofelone,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5|PLA2G2E|PTGS2
UBAJTZKNDCEGKL,BRD-K77564118,fenoverine,acetylcholine receptor antagonist,,BRD-K77564118,fenoverine,acetylcholine receptor antagonist,,BRD-K77564118,fenoverine,acetylcholine receptor antagonist,,BRD-K77564118,fenoverine,acetylcholine receptor antagonist,
UBCHPRBFMUDMNC,BRD-A75479906,rimantadine,RNA synthesis inhibitor|antiviral,,BRD-A75479906,rimantadine,RNA synthesis inhibitor|antiviral,,BRD-A75479906,rimantadine,RNA synthesis inhibitor|antiviral,,BRD-K01825586,rimantadine,RNA synthesis inhibitor|antiviral,
UBHKJRYGKOSQDJ,BRD-K30990140,FR-122047,cyclooxygenase inhibitor,,BRD-K30990140,FR-122047,cyclooxygenase inhibitor,,BRD-K30990140,FR-122047,cyclooxygenase inhibitor,,BRD-K30990140,FR-122047,cyclooxygenase inhibitor,
UBHYDQAARZKHEZ,BRD-K51918615,iodophenpropit,histamine receptor antagonist,HRH3|HRH4,BRD-K51918615,iodophenpropit,histamine receptor antagonist,HRH3|HRH4,BRD-K51918615,iodophenpropit,histamine receptor antagonist,HRH3|HRH4,BRD-K51918615,iodophenpropit,histamine receptor antagonist,HRH3|HRH4
UBNYRXMKIIGMKK,BRD-K37851352,isopentyl-4-methoxycinnamate,,,BRD-K37851352,isopentyl-4-methoxycinnamate,,,BRD-K37851352,isopentyl-4-methoxycinnamate,,,BRD-K37851352,isopentyl-4-methoxycinnamate,,
UBPYILGKFZZVDX,BRD-K99964838,bosutinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,BRD-K99964838,bosutinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,BRD-K99964838,bosutinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|src inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,BRD-K99964838,bosutinib,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK
UBQNRHZMVUUOMG,BRD-K48300629,zonisamide,T-type calcium channel blocker|sodium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K48300629,zonisamide,T-type calcium channel blocker|sodium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K48300629,zonisamide,T-type calcium channel blocker|sodium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K48300629,zonisamide,T-type calcium channel blocker|sodium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A
UBQYURCVBFRUQT,BRD-K09821361,deferoxamine-mesylate,chelating agent,,BRD-K09821361,deferoxamine-mesylate,chelating agent,,BRD-K09821361,deferoxamine-mesylate,chelating agent,,BRD-K09821361,deferoxamine-mesylate,chelating agent,
UBRKDAVQCKZSPO,BRD-A00520476,otenzepad,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A00520476,otenzepad,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A00520476,otenzepad,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A00520476,otenzepad,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
UBVZQGOVTLIHLH,BRD-K77561571,topiroxostat,xanthine oxidase inhibitor,XDH,BRD-K77561571,topiroxostat,xanthine oxidase inhibitor,XDH,BRD-K77561571,topiroxostat,xanthine oxidase inhibitor,XDH,BRD-K77561571,topiroxostat,xanthine oxidase inhibitor,XDH
UCAGLBKTLXCODC,BRD-K09295674,carzenide,,CA1|CA12|CA14|CA2|CA6|CA9,BRD-K09295674,carzenide,,CA1|CA12|CA14|CA2|CA6|CA9,BRD-K09295674,carzenide,,CA1|CA12|CA14|CA2|CA6|CA9,BRD-K09295674,carzenide,,CA1|CA12|CA14|CA2|CA6|CA9
UCAIEVHKDLMIFL,BRD-K71430621,clobenpropit,histamine receptor antagonist,HRH1|HRH2|HRH3|HRH4,BRD-K71430621,clobenpropit,histamine receptor antagonist,HRH1|HRH2|HRH3|HRH4,BRD-K71430621,clobenpropit,histamine receptor antagonist,HRH1|HRH2|HRH3|HRH4,BRD-K71430621,clobenpropit,histamine receptor antagonist,HRH1|HRH2|HRH3|HRH4
UCCJWNPWWPJKGL,BRD-A34603619,tropesin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A34603619,tropesin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A34603619,tropesin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A34603619,tropesin,cyclooxygenase inhibitor,PTGS1|PTGS2
UCEQXRCJXIVODC,BRD-K33379087,tivantinib,tyrosine kinase inhibitor,MET,BRD-K33379087,tivantinib,tyrosine kinase inhibitor,MET,BRD-K33379087,tivantinib,tyrosine kinase inhibitor,MET,BRD-K33379087,tivantinib,tyrosine kinase inhibitor,MET
UCFGDBYHRUNTLO,BRD-K55696337,topotecan,topoisomerase inhibitor,TOP1|TOP1MT,BRD-K55696337,topotecan,topoisomerase inhibitor,TOP1|TOP1MT,BRD-K55696337,topotecan,topoisomerase inhibitor,TOP1|TOP1MT,BRD-K55696337,topotecan,topoisomerase inhibitor,TOP1|TOP1MT
UCGWYCMPZXDHNR,BRD-K72264770,BRD4770,histone lysine methyltransferase inhibitor,EHMT2,BRD-K72264770,BRD4770,histone lysine methyltransferase inhibitor,EHMT2,BRD-K72264770,BRD4770,histone lysine methyltransferase inhibitor,EHMT2,BRD-K72264770,BRD4770,histone lysine methyltransferase inhibitor,EHMT2
UCHDWCPVSPXUMX,BRD-K69470111,montelukast,leukotriene receptor antagonist,ALOX5|CYSLTR1,BRD-K69470111,montelukast,leukotriene receptor antagonist,ALOX5|CYSLTR1,BRD-K69470111,montelukast,leukotriene receptor antagonist,ALOX5|CYSLTR1,BRD-K69470111,montelukast,leukotriene receptor antagonist,ALOX5|CYSLTR1
UCJGJABZCDBEDK,BRD-K90195324,bazedoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K90195324,bazedoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K90195324,bazedoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2,BRD-K90195324,bazedoxifene,selective estrogen receptor modulator (SERM),ESR1|ESR2
UCKHICKHGAOGAP,BRD-K74284736,L-689560,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K74284736,L-689560,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K74284736,L-689560,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K74284736,L-689560,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
UCKYOOZPSJFJIZ,BRD-A86248581,tetrahydrouridine,cytidine deaminase inhibitor,CDA,BRD-A86248581,tetrahydrouridine,cytidine deaminase inhibitor,CDA,BRD-A86248581,tetrahydrouridine,cytidine deaminase inhibitor,CDA,BRD-A86248581,tetrahydrouridine,cytidine deaminase inhibitor,CDA
UCRHFBCYFMIWHC,BRD-K27382019,piperaquine-phosphate,antimalarial agent,,BRD-K27382019,piperaquine-phosphate,antimalarial agent,,BRD-K27382019,piperaquine-phosphate,antimalarial agent,,BRD-K27382019,piperaquine-phosphate,antimalarial agent,
UCRLQOPRDMGYOA,BRD-M45010341,bacitracin-zinc,bacterial cell wall synthesis inhibitor,,BRD-M45010341,bacitracin-zinc,bacterial cell wall synthesis inhibitor,,BRD-M45010341,bacitracin-zinc,bacterial cell wall synthesis inhibitor,,BRD-K00003625,bacitracin-zinc,bacterial cell wall synthesis inhibitor,
UCSJYZPVAKXKNQ,BRD-A98954669|BRD-K91768078,streptomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A98954669|BRD-K07166362,streptomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A98954669|BRD-K07166362|BRD-K91768078,streptomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K07166362|BRD-K91768078,streptomycin,bacterial 30S ribosomal subunit inhibitor,
UCTWMZQNUQWSLP,BRD-A07765530|BRD-K63126190,epinephrine|epinephrine-(racemic),adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,|ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,BRD-A07765530|BRD-K63126190,epinephrine|epinephrine-(racemic),adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,|ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,BRD-A07765530|BRD-K63126190,epinephrine|epinephrine-(racemic),adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,|ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,BRD-K63126190,epinephrine,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF
UCUHFWIFSHROPY,BRD-A27911617,AC-55541,PARP inhibitor,PARP2,BRD-A27911617,AC-55541,PARP inhibitor,PARP2,BRD-A27911617,AC-55541,PARP inhibitor,PARP2,BRD-A27911617,AC-55541,PARP inhibitor,PARP2
UDEWPOVQBGFNGE,BRD-K15329706,propyl-benzoate,,,BRD-K15329706,propyl-benzoate,,,BRD-K15329706,propyl-benzoate,,,BRD-K15329706,propyl-benzoate,,
UDIIBEDMEYAVNG,BRD-K74759733,isepamicin,protein synthesis inhibitor,,BRD-K74759733,isepamicin,protein synthesis inhibitor,,BRD-K74759733,isepamicin,protein synthesis inhibitor,,BRD-K74759733,isepamicin,protein synthesis inhibitor,
UDKABVSQKJNZBH,BRD-A42746051,melengestrol-acetate,progesterone receptor agonist,,BRD-A42746051,melengestrol-acetate,progesterone receptor agonist,,BRD-A42746051,melengestrol-acetate,progesterone receptor agonist,,BRD-A42746051,melengestrol-acetate,progesterone receptor agonist,
UDMBCSSLTHHNCD,BRD-A10111329,adenosine-phosphate,adenosine receptor agonist,ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4,BRD-A10111329,adenosine-phosphate,adenosine receptor agonist,ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4,BRD-A10111329,adenosine-phosphate,adenosine receptor agonist,ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4,BRD-K85767870,adenosine-phosphate,adenosine receptor agonist,ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4
UDSFVOAUHKGBEK,BRD-K70650177,testosterone-undecanoate,androgen receptor agonist,AR,BRD-K70650177,testosterone-undecanoate,androgen receptor agonist,AR,BRD-K70650177,testosterone-undecanoate,androgen receptor agonist,AR,,,,
UEADAWQSJOWXBK,BRD-K55305701,SC-144,P glycoprotein inhibitor,,BRD-K55305701,SC-144,P glycoprotein inhibitor,,BRD-K55305701,SC-144,P glycoprotein inhibitor,,BRD-K55305701,SC-144,P glycoprotein inhibitor,
UEJJHQNACJXSKW,BRD-A93255169,thalidomide,tumor necrosis factor production inhibitor,CRBN|FGFR2|NFKB1|ORM1|ORM2|PTGS2|TNF,BRD-A93255169,thalidomide,tumor necrosis factor production inhibitor,CRBN|FGFR2|NFKB1|ORM1|ORM2|PTGS2|TNF,BRD-A93255169,thalidomide,tumor necrosis factor production inhibitor,CRBN|FGFR2|NFKB1|ORM1|ORM2|PTGS2|TNF,BRD-A93255169,thalidomide,tumor necrosis factor production inhibitor,TNF
UEJSSZHHYBHCEL,BRD-K68379918,silver-sulfadiazine,PABA antagonist,,BRD-K68379918,silver-sulfadiazine,PABA antagonist,,BRD-K68379918|BRD-M11664367,silver-sulfadiazine,PABA antagonist,,BRD-K68379918|BRD-M11664367,silver-sulfadiazine,PABA antagonist,
UEQUQVLFIPOEMF,BRD-A19661776,mianserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,BRD-A19661776,mianserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,BRD-A19661776,mianserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7|OPRK1|SLC6A2|SLC6A3|SLC6A4,BRD-A19661776,mianserin,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7
UEWSIIBPZOBMBL,BRD-K70053378,SM-108,,,BRD-K70053378,SM-108,,,BRD-K70053378,SM-108,,,,,,
UFAHZIUFPNSHSL,BRD-K84366268,levocarnitine-propionate,carnitine palmitoyltransferase inhibitor,CRAT,BRD-K84366268,levocarnitine-propionate,carnitine palmitoyltransferase inhibitor,CRAT,BRD-K84366268,levocarnitine-propionate,carnitine palmitoyltransferase inhibitor,CRAT,BRD-K84366268,levocarnitine-propionate,carnitine palmitoyltransferase inhibitor,CRAT
UFBJCMHMOXMLKC,BRD-K21910317,"2,4-dinitrophenol",,,BRD-K21910317,"2,4-dinitrophenol",ATP synthase inhibitor,APP,BRD-K21910317,"2,4-dinitrophenol",ATP synthase inhibitor,APP,BRD-K21910317,"2,4-dinitrophenol",ATP synthase inhibitor,APP
UFBTYTGRUBUUIL,BRD-K40366680,CAY10505,PI3K inhibitor,PIK3CG,BRD-K40366680,CAY10505,PI3K inhibitor,PIK3CG,BRD-K40366680,CAY10505,PI3K inhibitor,PIK3CG,BRD-K40366680,CAY10505,PI3K inhibitor,PIK3CG
UFICVEHDQUKCEA,BRD-K56277358,MGCD-265,VEGFR inhibitor,AXL|MET,BRD-K56277358,MGCD-265,VEGFR inhibitor,AXL|MET,BRD-K56277358,MGCD-265,VEGFR inhibitor,AXL|MET,BRD-K56277358,MGCD-265,VEGFR inhibitor,AXL|MET
UFJGFNHRMPMALC,BRD-K61918008,NQDI-1,caspase inhibitor,CASP3,BRD-K61918008,NQDI-1,caspase inhibitor,CASP3,BRD-K61918008,NQDI-1,caspase inhibitor,CASP3,BRD-K61918008,NQDI-1,caspase inhibitor,CASP3
UFKLYTOEMRFKAD,BRD-K88737571,CC-223,mTOR inhibitor,MTOR,BRD-K88737571,CC-223,mTOR inhibitor,MTOR,BRD-K88737571,CC-223,mTOR inhibitor,MTOR,BRD-K88737571,CC-223,mTOR inhibitor,MTOR
UFLGIAIHIAPJJC,BRD-K57033106,tripelennamine,histamine receptor antagonist,HRH1,BRD-K57033106,tripelennamine,histamine receptor antagonist,HRH1,BRD-K57033106,tripelennamine,histamine receptor antagonist,HRH1,BRD-K57033106,tripelennamine,histamine receptor antagonist,HRH1
UFPFGVNKHCLJJO,BRD-K08248804,LCL-161,XIAP inhibitor,BIRC2|XIAP,BRD-K08248804,LCL-161,XIAP inhibitor,BIRC2|XIAP,BRD-K08248804,LCL-161,XIAP inhibitor,BIRC2|XIAP,BRD-K08248804,LCL-161,XIAP inhibitor,BIRC2|XIAP
UFSKUSARDNFIRC,BRD-K69236721,lumacaftor,CFTR channel agonist,CFTR,BRD-K69236721,lumacaftor,CFTR channel agonist,CFTR,BRD-K69236721,lumacaftor,CFTR channel agonist,CFTR,BRD-K69236721,lumacaftor,CFTR channel agonist,CFTR
UFULAYFCSOUIOV,BRD-K92611362,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST,BRD-K92611362|BRD-M77687198,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST,BRD-K92611362|BRD-M77687198,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST,BRD-K92611362|BRD-M77687198,cysteamine,tissue transglutaminase inhibitor,NPY2R|SST
UFUVLHLTWXBHGZ,BRD-K52542745,clindamycin-phosphate,protein synthesis inhibitor,,BRD-K27771035,clindamycin-phosphate,protein synthesis inhibitor,,BRD-K27771035|BRD-K52542745,clindamycin-phosphate,protein synthesis inhibitor,,BRD-K27771035|BRD-K52542745,clindamycin-phosphate,protein synthesis inhibitor,
UFYJLJINUGVUHO,BRD-K49776472,SKF-91488,histamine N-methyltransferase inhibitor,HNMT,BRD-K49776472,SKF-91488,histamine N-methyltransferase inhibitor,HNMT,BRD-K49776472,SKF-91488,histamine N-methyltransferase inhibitor,HNMT,BRD-K49776472,SKF-91488,histamine N-methyltransferase inhibitor,HNMT
UGDPYGKWIHHBMB,BRD-K55847762,lobenzarit,immunosuppressant,,BRD-K55847762,lobenzarit,immunosuppressant,,BRD-K55847762,lobenzarit,immunosuppressant,,BRD-K55847762,lobenzarit,immunosuppressant,
UGJMXCAKCUNAIE,BRD-K62737565,gabapentin,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-K62737565,gabapentin,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-K62737565,gabapentin,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-K62737565,gabapentin,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
UGJWRPJDTDGERK,BRD-K20958582,TH-302,DNA alkylating agent,,BRD-K20958582,TH-302,DNA alkylating agent,,BRD-K20958582,TH-302,DNA alkylating agent,,BRD-K20958582,TH-302,DNA alkylating agent,
UGQMRVRMYYASKQ,BRD-A28787076|BRD-K14210676|BRD-K79612754,inosine,neurotrophic agent,PARP1|PNP,BRD-A28787076|BRD-K14210676|BRD-K79612754,inosine,neurotrophic agent,PARP1|PNP,BRD-A28787076|BRD-K14210676|BRD-K79612754,inosine,neurotrophic agent,PARP1|PNP,BRD-A28787076|BRD-K14210676|BRD-K79612754,inosine,neurotrophic agent,PARP1|PNP
UGYXPZQILZRKJJ,BRD-K70821460,4-methylhistamine,histamine receptor agonist,HRH4,BRD-K70821460,4-methylhistamine,histamine receptor agonist,HRH4,BRD-K70821460,4-methylhistamine,histamine receptor agonist,HRH4,BRD-K70821460,4-methylhistamine,histamine receptor agonist,HRH4
UHAXDAKQGVISBZ,BRD-K88677950,PD-198306,MAP kinase inhibitor|MEK inhibitor,MAP2K1|MAP2K2,BRD-K88677950,PD-198306,MAP kinase inhibitor|MEK inhibitor,MAP2K1|MAP2K2,BRD-K88677950,PD-198306,MAP kinase inhibitor|MEK inhibitor,MAP2K1|MAP2K2,BRD-K88677950,PD-198306,MAP kinase inhibitor|MEK inhibitor,MAP2K1|MAP2K2
UHDGCWIWMRVCDJ,BRD-A57371185|BRD-K33106058|BRD-K71847383,cytarabine,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,BRD-A57371185|BRD-K33106058|BRD-K71847383,cytarabine,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,BRD-A57371185|BRD-K33106058|BRD-K71847383,cytarabine,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,BRD-K33106058|BRD-K71847383,cytarabine|cytidine,|ribonucleotide reductase inhibitor,|POLA1|POLB|POLD1|POLE
UHSKFQJFRQCDBE,BRD-K15933101,ropinirole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K15933101,ropinirole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K15933101,ropinirole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K15933101,ropinirole,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
UHTHHESEBZOYNR,BRD-K77625799,vandetanib,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,BRD-K77625799,vandetanib,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,BRD-K77625799,vandetanib,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,BRD-K77625799,vandetanib,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA
UHWVSEOVJBQKBE,BRD-K88366685,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2,BRD-K88366685,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2,BRD-K88366685,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2,BRD-K88366685,trimetazidine,3-ketoacyl CoA thiolase inhibitor,ACAA2
UHZGYDZTDCTJBO,BRD-A96503329,safflower-yellow,anti-inflammatory agent,,BRD-A96503329,safflower-yellow,anti-inflammatory agent,,BRD-A96503329,safflower-yellow,anti-inflammatory agent,,,,,
UIAGMCDKSXEBJQ,BRD-A58048407,nimodipine,calcium channel blocker,AHR|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR|NR3C2,BRD-A58048407,nimodipine,calcium channel blocker,AHR|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR|NR3C2,BRD-A58048407,nimodipine,calcium channel blocker,AHR|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CFTR|NR3C2,BRD-A58048407,nimodipine,calcium channel blocker,CFTR|NR3C2
UIARLYUEJFELEN,BRD-A27376179,lestaurtinib,FLT3 inhibitor|JAK inhibitor|growth factor receptor inhibitor,FLT3|NTRK1,BRD-A27376179,lestaurtinib,FLT3 inhibitor|JAK inhibitor|growth factor receptor inhibitor,FLT3|NTRK1,BRD-A27376179,lestaurtinib,FLT3 inhibitor|JAK inhibitor|growth factor receptor inhibitor,FLT3|NTRK1,BRD-A27376179,lestaurtinib,FLT3 inhibitor|JAK inhibitor|growth factor receptor inhibitor,FLT3|NTRK1
UIAYVIIHMORPSJ,BRD-K28578425,cilostamide,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K28578425,cilostamide,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K28578425,cilostamide,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K28578425,cilostamide,phosphodiesterase inhibitor,PDE3A|PDE3B
UIEATEWHFDRYRU,BRD-A91008255,bepridil,calcium channel blocker,ATP1A1|CACNA1A|CACNA1H|CACNA2D2|CALM1|KCNQ1|KCNQ4|PDE1A|PDE1B|TNNC1,BRD-A91008255,bepridil,calcium channel blocker,ATP1A1|CACNA1A|CACNA1H|CACNA2D2|CALM1|KCNQ1|KCNQ4|PDE1A|PDE1B|TNNC1,BRD-A91008255,bepridil,calcium channel blocker,ATP1A1|CACNA1A|CACNA1H|CACNA2D2|CALM1|KCNQ1|KCNQ4|PDE1A|PDE1B|TNNC1,BRD-A91008255,bepridil,calcium channel blocker,KCNQ4
UIFFUZWRFRDZJC,BRD-A67709388,antimycin-a,ATP synthase inhibitor,CYCS,BRD-A67709388,antimycin-a,ATP synthase inhibitor,CYCS,BRD-A67709388,antimycin-a,ATP synthase inhibitor,CYCS,BRD-K90152265,antimycin-A,ATP synthase inhibitor,CYCS
UIKROCXWUNQSPJ,BRD-K94144010,cotinine,nicotine metabolite,,BRD-K94144010,cotinine,nicotine metabolite,,BRD-K94144010,cotinine,nicotine metabolite,,BRD-K94144010,cotinine,nicotine metabolite,
UILPJVPSNHJFIK,BRD-K94239562,paeonol,anti-inflammatory agent,,BRD-K94239562,paeonol,anti-inflammatory agent,,BRD-K94239562,paeonol,anti-inflammatory agent,,BRD-K94239562,paeonol,anti-inflammatory agent,
UIMOJFJSJSIGLV,BRD-K71026158,carumonam,bacterial cell wall synthesis inhibitor,,BRD-K71026158,carumonam,bacterial cell wall synthesis inhibitor,,BRD-K71026158,carumonam,bacterial cell wall synthesis inhibitor,,BRD-K71026158,carumonam,bacterial cell wall synthesis inhibitor,
UIOFUWFRIANQPC,BRD-A13650332|BRD-K27871792,flucloxacillin,bacterial cell wall synthesis inhibitor,,BRD-A13650332|BRD-K27871792,flucloxacillin,bacterial cell wall synthesis inhibitor,,BRD-A13650332|BRD-K27871792,flucloxacillin,bacterial cell wall synthesis inhibitor,,BRD-A13650332|BRD-K27871792,flucloxacillin,bacterial cell wall synthesis inhibitor,
UISARWKNNNHPGI,BRD-A33479817,terodiline,cholinergic receptor antagonist,,BRD-A33479817,terodiline,cholinergic receptor antagonist,,BRD-A33479817,terodiline,cholinergic receptor antagonist,,BRD-A33479817,terodiline,cholinergic receptor antagonist,
UJAOSPFULOFZRR,BRD-K93611241,diacetamate,,,BRD-K93611241,diacetamate,,,BRD-K93611241,diacetamate,,,BRD-K93611241,diacetamate,,
UJCACMLMPLLRGW,BRD-K84798689,sodium-tanshinone-ii-a-sulfonate,potassium channel activator,,BRD-K84798689,sodium-tanshinone-ii-a-sulfonate,potassium channel activator,,BRD-K84798689,sodium-tanshinone-ii-a-sulfonate,potassium channel activator,,BRD-K84798689,sodium-tanshinone-II-A-sulfonate,potassium channel activator,
UJEAABFSXKCSGI,BRD-K29656036,MK-8245,stearoyl-CoA desaturase inhibitor,SCD,BRD-K29656036,MK-8245,stearoyl-CoA desaturase inhibitor,SCD,BRD-K29656036,MK-8245,stearoyl-CoA desaturase inhibitor,SCD,BRD-K29656036,MK-8245,stearoyl-CoA desaturase inhibitor,SCD
UJEWTUDSLQGTOA,BRD-K87990216,piretanide,glucocorticoid receptor agonist,SLC12A1|SLC12A2,BRD-K87990216,piretanide,glucocorticoid receptor agonist,SLC12A1|SLC12A2,BRD-K87990216,piretanide,glucocorticoid receptor agonist,SLC12A1|SLC12A2,BRD-K87990216,piretanide,glucocorticoid receptor agonist,SLC12A1|SLC12A2
UJGTUKMAJVCBIS,BRD-K26253904,NMS-873,ATPase inhibitor,VCP,BRD-K26253904,NMS-873,ATPase inhibitor,VCP,BRD-K26253904,NMS-873,ATPase inhibitor,VCP,BRD-K26253904,NMS-873,ATPase inhibitor,VCP
UJHBVMHOBZBWMX,BRD-K97375133,ferrostatin-1,ferroptosis inhibitor,,BRD-K97375133,ferrostatin-1,ferroptosis inhibitor,,BRD-K97375133,ferrostatin-1,ferroptosis inhibitor,,BRD-K97375133,ferrostatin-1,ferroptosis inhibitor,
UJIAQDJKSXQLIT,BRD-K64785675,TG100-115,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K64785675,TG100-115,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K64785675,TG100-115,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K64785675,TG100-115,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
UJIDKYTZIQTXPM,BRD-K77251551,sodium-picosulfate,,,BRD-K77251551,sodium-picosulfate,,,BRD-K77251551,sodium-picosulfate,,,BRD-K77251551,sodium-picosulfate,,
UJINBEQCDMOAHM,BRD-K03886848,MK-5046,bombesin receptor agonist,BRS3|GRPR|NMBR,BRD-K03886848,MK-5046,bombesin receptor agonist,BRS3|GRPR|NMBR,BRD-K03886848,MK-5046,bombesin receptor agonist,BRS3|GRPR|NMBR,BRD-K03886848,MK-5046,bombesin receptor agonist,BRS3|GRPR|NMBR
UJJUKZPBUMCSJZ,BRD-K95573441,PFK-015,phosphofructokinase inhibitor,PFKFB3,BRD-K95573441,PFK-015,phosphofructokinase inhibitor,PFKFB3,BRD-K95573441,PFK-015,phosphofructokinase inhibitor,PFKFB3,BRD-K95573441,PFK-015,phosphofructokinase inhibitor,PFKFB3
UJKPHYRXOLRVJJ,BRD-A44995766,hematoporphyrin,,,BRD-A44995766,hematoporphyrin,,,BRD-A44995766,hematoporphyrin,,,,,,
UJLAWZDWDVHWOW,BRD-K36280065,tofacitinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K31283835|BRD-K36280065,tofacitinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K31283835|BRD-K36280065,tofacitinib,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K31283835|BRD-K36280065,tofacitinib,JAK inhibitor,JAK1|JAK2|JAK3
UJRRDDHEMZLWFI,BRD-K39467894,nithiamide,bacterial DNA inhibitor,,BRD-K39467894,nithiamide,bacterial DNA inhibitor,,BRD-K39467894,nithiamide,bacterial DNA inhibitor,,BRD-K39467894,nithiamide,bacterial DNA inhibitor,
UJVLDDZCTMKXJK,BRD-A20644369,canrenone,mineralocorticoid receptor antagonist,NR3C2,BRD-A20644369,canrenone,mineralocorticoid receptor antagonist,NR3C2,BRD-A20644369,canrenone,mineralocorticoid receptor antagonist,NR3C2,BRD-K81644801,canrenone,mineralocorticoid receptor antagonist,NR3C2
UKBRUIZWQZHXFL,BRD-A14757586,tetrazol-5-yl-glycine-(RS),glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A14757586,tetrazol-5-yl-glycine-(RS),glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A14757586,tetrazol-5-yl-glycine-(RS),glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-A14757586,tetrazol-5-yl-glycine-(RS),glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D
UKHMZCMKHPHFOT,BRD-A56987319,SQ-22536,adenylyl cyclase inhibitor,ADCY1,BRD-A56987319,SQ-22536,adenylyl cyclase inhibitor,ADCY1,BRD-A56987319,SQ-22536,adenylyl cyclase inhibitor,ADCY1,BRD-A56987319,SQ-22536,adenylyl cyclase inhibitor,ADCY1
UKMJWGFHXMGRNG,BRD-K22662557,WIN-64338,bradykinin receptor antagonist,BDKRB2,BRD-K22662557,WIN-64338,bradykinin receptor antagonist,BDKRB2,BRD-K22662557,WIN-64338,bradykinin receptor antagonist,BDKRB2,BRD-K22662557,WIN-64338,bradykinin receptor antagonist,BDKRB2
UKMSUNONTOPOIO,BRD-K91495480,AGP-103,membrane permeability inhibitor,,BRD-K91495480,AGP-103,membrane permeability inhibitor,,BRD-K91495480,AGP-103,membrane permeability inhibitor,,BRD-K91495480,AGP-103,membrane permeability inhibitor,
UKNHQPDCWMADJW,BRD-A93407926,allopurinol-riboside,anti-leishmanial agent,,BRD-A93407926,allopurinol-riboside,anti-leishmanial agent,,BRD-A93407926,allopurinol-riboside,anti-leishmanial agent,,,,,
UKNSBNVKSFTZOJ,BRD-K25837718,josamycin,bacterial 50S ribosomal subunit inhibitor,,BRD-K25837718,josamycin,bacterial 50S ribosomal subunit inhibitor,,BRD-K25837718,josamycin,bacterial 50S ribosomal subunit inhibitor,,,,,
UKOQVLAXCBRRGH,BRD-K68805147,pafuramidine,DNA synthesis inhibitor,,BRD-K68805147,pafuramidine,DNA synthesis inhibitor,,BRD-K68805147,pafuramidine,DNA synthesis inhibitor,,BRD-K68805147,pafuramidine,DNA synthesis inhibitor,
UKTAZPQNNNJVKR,BRD-K34008116,dolasetron,serotonin receptor antagonist,HTR3A,BRD-K34008116|BRD-K37792492,dolasetron,serotonin receptor antagonist,HTR3A,BRD-K28029915|BRD-K34008116|BRD-K37792492,dolasetron,serotonin receptor antagonist,HTR3A,BRD-K28029915|BRD-K34008116|BRD-K37792492,dolasetron,serotonin receptor antagonist,HTR3A
ULDXWLCXEDXJGE,BRD-K68065987,MK-2206,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K68065987,MK-2206,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K68065987,MK-2206,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K68065987,MK-2206,AKT inhibitor,AKT1|AKT2|AKT3
ULFRLSNUDGIQQP,BRD-K75699339,rizatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K75699339,rizatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K75699339,rizatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K75699339,rizatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
ULGZDMOVFRHVEP,BRD-A20485507|BRD-K05127550|BRD-K63550407,erythromycin,NFkB pathway inhibitor,MLNR,BRD-K05127550|BRD-K63550407,erythromycin,NFkB pathway inhibitor,MLNR,BRD-K05127550|BRD-K63550407,erythromycin,NFkB pathway inhibitor,MLNR,BRD-K05127550|BRD-K63550407,erythromycin,NFkB pathway inhibitor,MLNR
ULLNJSBQMBKOJH,BRD-A60294240,tribenoside,anti-inflammatory agent|capillary stabilizing agent,,BRD-A60294240,tribenoside,anti-inflammatory agent|capillary stabilizing agent,,BRD-A60294240,tribenoside,anti-inflammatory agent|capillary stabilizing agent,,BRD-A60294240,tribenoside,anti-inflammatory agent|capillary stabilizing agent,
ULRDYYKSPCRXAJ,BRD-K42981054,mibampator,glutamate receptor modulator,GRIA1,BRD-K42981054,mibampator,glutamate receptor modulator,GRIA1,BRD-K42981054,mibampator,glutamate receptor modulator,GRIA1,BRD-K42981054,mibampator,glutamate receptor modulator,GRIA1
ULSDMUVEXKOYBU,BRD-K54314721,zolmitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K54314721,zolmitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K54314721,zolmitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,BRD-K54314721,zolmitriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F
ULSSJYNJIZWPSB,BRD-K20013301,LY411575,gamma secretase inhibitor,,BRD-K20013301,LY411575,gamma secretase inhibitor,,BRD-K20013301,LY411575,gamma secretase inhibitor,,BRD-K20013301,LY411575,gamma secretase inhibitor,
ULSUXBXHSYSGDT,BRD-K25186396,tangeritin,cell cycle inhibitor,,BRD-K25186396,tangeritin,cell cycle inhibitor,,BRD-K25186396,tangeritin,cell cycle inhibitor,,BRD-K25186396,tangeritin,cell cycle inhibitor,
ULXXDDBFHOBEHA,BRD-K66175015,afatinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K66175015,afatinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K66175015,afatinib,EGFR inhibitor,EGFR|ERBB2|ERBB4,BRD-K66175015,afatinib,EGFR inhibitor,EGFR|ERBB2|ERBB4
ULYONBAOIMCNEH,BRD-K56740996,flindokalner,potassium channel agonist,KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5,BRD-K56740996,flindokalner,potassium channel agonist,KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5,BRD-K56740996,flindokalner,potassium channel agonist,KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5,BRD-K56740996,flindokalner,potassium channel agonist,KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5
UMFDLIXUUJMPSI,BRD-K22327730,2-methyl-5-nitrophenol,,,BRD-K22327730,2-methyl-5-nitrophenol,,,BRD-K22327730,2-methyl-5-nitrophenol,,,BRD-K22327730,2-methyl-5-nitrophenol,,
UMGBFFAJXFXOIL,BRD-K86600316,RS-79948,adrenergic receptor antagonist,ADRA2A,BRD-K86600316,RS-79948,adrenergic receptor antagonist,ADRA2A,BRD-K86600316,RS-79948,adrenergic receptor antagonist,ADRA2A,BRD-K86600316,RS-79948,adrenergic receptor antagonist,ADRA2A
UMGQVUWXNOJOSJ,BRD-K17415526,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR,BRD-K17415526,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR,BRD-K17415526,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR,BRD-K17415526,tyrphostin-AG-835,protein tyrosine kinase inhibitor,EGFR
UMJHTFHIQDEGKB,BRD-K60102752,alibendol,antispasmodic,,BRD-K60102752,alibendol,antispasmodic,,BRD-K60102752,alibendol,antispasmodic,,BRD-K60102752,alibendol,antispasmodic,
UMJUNUMSJDTYTM,BRD-K17743697,KB-R7943,sodium/calcium exchange inhibitor,SLC8A1|TRPC3|TRPC5|TRPC6,BRD-K17743697,KB-R7943,sodium/calcium exchange inhibitor,SLC8A1|TRPC3|TRPC5|TRPC6,BRD-K17743697,KB-R7943,sodium/calcium exchange inhibitor,SLC8A1|TRPC3|TRPC5|TRPC6,BRD-K17743697,KB-R7943,sodium/calcium exchange inhibitor,SLC8A1|TRPC3|TRPC5|TRPC6
UMQUQWCJKFOUGV,BRD-A40084411,CGP-12177,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A40084411,CGP-12177,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A40084411,CGP-12177,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-A40084411,CGP-12177,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3
UMUPQWIGCOZEOY,BRD-K44771174,ibutamoren,growth hormone secretagogue receptor agonist,GHR|GHSR,BRD-K44771174,ibutamoren,growth hormone secretagogue receptor agonist,GHR|GHSR,BRD-K44771174,ibutamoren,growth hormone secretagogue receptor agonist,GHR|GHSR,BRD-K44771174,ibutamoren,growth hormone secretagogue receptor agonist,GHR|GHSR
UNAANXDKBXWMLN,BRD-A23359898,sibutramine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-A23359898,sibutramine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,BRD-A23359898,sibutramine,serotoninnorepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,,,,
UNAZAADNBYXMIV,BRD-K09090949,"CP-945,598",,,BRD-K09090949,"CP-945,598",cannabinoid receptor antagonist,CNR1,BRD-K09090949,"CP-945,598",cannabinoid receptor antagonist,CNR1,BRD-K09090949,"CP-945,598",cannabinoid receptor antagonist,CNR1
UNBRKDKAWYKMIV,BRD-K34685430,methylergometrine,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C,BRD-K34685430,methylergometrine,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C,BRD-K34685430,methylergometrine,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C,BRD-K34685430,methylergometrine,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C
UNFWWIHTNXNPBV,BRD-K11905747|BRD-K38300715,spectinomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K11905747|BRD-K38300715,spectinomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K11905747|BRD-K38300715,spectinomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K11905747|BRD-K38300715,spectinomycin,bacterial 30S ribosomal subunit inhibitor,
UNIDAFCQFPGYJJ,BRD-A19381518,CHPG,glutamate receptor agonist,GRM5,BRD-A19381518,CHPG,glutamate receptor agonist,GRM5,BRD-A19381518,CHPG,glutamate receptor agonist,GRM5,BRD-A19381518,CHPG,glutamate receptor agonist,GRM5
UNJFKXSSGBWRBZ,BRD-K11124378,ceftibuten,bacterial cell wall synthesis inhibitor,,BRD-K11124378,ceftibuten,bacterial cell wall synthesis inhibitor,,BRD-K11124378,ceftibuten,bacterial cell wall synthesis inhibitor,,BRD-K11124378,ceftibuten,bacterial cell wall synthesis inhibitor,
UNRCMCRRFYFGFX,BRD-K99498722,plinabulin,tubulin polymerization inhibitor,,BRD-K99498722,plinabulin,tubulin polymerization inhibitor,,BRD-K99498722,plinabulin,tubulin polymerization inhibitor,,BRD-K99498722,plinabulin,tubulin polymerization inhibitor,
UNXHWFMMPAWVPI,BRD-K79315489,erythritol,,,BRD-K79315489,erythritol,,,BRD-K79315489,erythritol,,,BRD-K79315489,erythritol,,
UOACKFBJUYNSLK,BRD-A91452556,estradiol-cypionate,estrogen receptor agonist,ESR1,BRD-A91452556,estradiol-cypionate,estrogen receptor agonist,ESR1,BRD-A91452556,estradiol-cypionate,estrogen receptor agonist,ESR1,BRD-K64984393,estradiol-cypionate,estrogen receptor agonist,ESR1
UOBYJVFBFSLCTQ,BRD-K49659468,TMC647055,RNA polymerase inhibitor,,BRD-K49659468,TMC647055,RNA polymerase inhibitor,,BRD-K49659468,TMC647055,RNA polymerase inhibitor,,BRD-K49659468,TMC647055,RNA polymerase inhibitor,
UOLJKAPABHXFRE,BRD-K70281171,U-99194,dopamine receptor antagonist,DRD3,BRD-K70281171,U-99194,dopamine receptor antagonist,DRD3,BRD-K70281171,U-99194,dopamine receptor antagonist,DRD3,BRD-K70281171,U-99194,dopamine receptor antagonist,DRD3
UOMKBIIXHQIERR,BRD-K97939847,cridanimod,progesterone receptor agonist,PGR,BRD-K97939847,cridanimod,progesterone receptor agonist,PGR,BRD-K97939847,cridanimod,progesterone receptor agonist,PGR,BRD-K97939847,cridanimod,progesterone receptor agonist,PGR
UOORQSPLBHUQDQ,BRD-K46392623,TG-100713,PI3K inhibitor,,BRD-K46392623,TG-100713,PI3K inhibitor,,BRD-K46392623,TG-100713,PI3K inhibitor,,BRD-K46392623,TG-100713,PI3K inhibitor,
UOVCGJXDGOGOCZ,BRD-K32942258,RG1530,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2,BRD-K32942258,RG1530,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2,BRD-K32942258,RG1530,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2,,,,
UOWGYMNWMDNSTL,BRD-K58413118,3PO,phosphofructokinase inhibitor,PFKFB3,BRD-K58413118,3PO,phosphofructokinase inhibitor,PFKFB3,BRD-K58413118,3PO,phosphofructokinase inhibitor,PFKFB3,BRD-K58413118,3PO,phosphofructokinase inhibitor,PFKFB3
UOWZUVNAGUAEQC,BRD-K61236135,tiratricol,thyroid hormone stimulant,THRA|THRB,BRD-K61236135,tiratricol,thyroid hormone stimulant,THRA|THRB,BRD-K61236135,tiratricol,thyroid hormone stimulant,THRA|THRB,BRD-K61236135,tiratricol,thyroid hormone stimulant,THRA|THRB
UOZODPSAJZTQNH,BRD-A20920572|BRD-K25359791|BRD-K36524108,paromomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A20920572|BRD-K36524108,paromomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A20920572|BRD-K25359791|BRD-K36524108|BRD-M40700687,paromomycin,bacterial 30S ribosomal subunit inhibitor,,BRD-A20920572|BRD-K25359791|BRD-K36524108|BRD-M40700687,paromomycin,bacterial 30S ribosomal subunit inhibitor,
UPABQMWFWCMOFV,BRD-K13473780,benethamine,,,BRD-K13473780,benethamine,,,BRD-K13473780|BRD-M11305712,benethamine,,,BRD-K13473780|BRD-M11305712,benethamine,,
UPALIKSFLSVKIS,BRD-K56334280,amonafide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K56334280,amonafide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K56334280,amonafide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K56334280,amonafide,topoisomerase inhibitor,TOP2A|TOP2B
UPJSUQWHUVLLNW,BRD-K43436647,ARQ-621,kinesin-like spindle protein inhibitor,KIF11,BRD-K43436647,ARQ-621,kinesin-like spindle protein inhibitor,KIF11,BRD-K43436647,ARQ-621,kinesin-like spindle protein inhibitor,KIF11,BRD-K43436647,ARQ-621,kinesin-like spindle protein inhibitor,KIF11
UPKULXKXQDCEPE,BRD-K21237892,semapimod,cytokine production inhibitor|p38 MAPK inhibitor,MAPK14,BRD-K21237892,semapimod,cytokine production inhibitor|p38 MAPK inhibitor,MAPK14,BRD-K21237892,semapimod,cytokine production inhibitor|p38 MAPK inhibitor,MAPK14,,,,
UPMRZALMHVUCIN,BRD-K75551531,nitecapone,catechol O methyltransferase inhibitor,COMT,BRD-K75551531,nitecapone,catechol O methyltransferase inhibitor,COMT,BRD-K75551531,nitecapone,catechol O methyltransferase inhibitor,COMT,BRD-K75551531,nitecapone,catechol O methyltransferase inhibitor,COMT
UPNUIXSCZBYVBB,BRD-K07857022,alvimopan,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K07857022,alvimopan,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K07857022,alvimopan,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K07857022,alvimopan,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
UPPMZCXMQRVMME,BRD-A56613951,valethamate,acetylcholine receptor antagonist,CHRM1|CHRM4|CHRM5,BRD-A56613951,valethamate,acetylcholine receptor antagonist,CHRM1|CHRM4|CHRM5,BRD-A56613951,valethamate,acetylcholine receptor antagonist,CHRM1|CHRM4|CHRM5,BRD-A56613951,valethamate,acetylcholine receptor antagonist,CHRM1|CHRM4|CHRM5
UPSPUYADGBWSHF,BRD-K82562631,tolmetin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K82562631,tolmetin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K82562631,tolmetin,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K82562631,tolmetin,cyclooxygenase inhibitor,PTGS1|PTGS2
UPTYCYWTFGTCCG,BRD-K72462751,C-1,protein kinase inhibitor,PRKCA,BRD-K72462751,C-1,protein kinase inhibitor,PRKCA,BRD-K72462751,C-1,protein kinase inhibitor,PRKCA,BRD-K72462751,C-1,protein kinase inhibitor,PRKCA
UPWGQKDVAURUGE,BRD-K77087341,2-Oleoylglycerol,glucose dependent insulinotropic receptor ligand,GPR119,BRD-K77087341,2-Oleoylglycerol,glucose dependent insulinotropic receptor ligand,GPR119,BRD-K77087341,2-Oleoylglycerol,glucose dependent insulinotropic receptor ligand,GPR119,BRD-K77087341,2-oleoylglycerol,glucose dependent insulinotropic receptor ligand,GPR119
UPZFHUODAYGHDZ,BRD-K17874929,bromebric-acid,DNA synthesis inhibitor|purine antagonist,,BRD-K17874929,bromebric-acid,DNA synthesis inhibitor|purine antagonist,,BRD-K17874929,bromebric-acid,DNA synthesis inhibitor|purine antagonist,,BRD-K17874929,bromebric-acid,DNA synthesis inhibitor|purine antagonist,
UPZWINBEAHDTLA,BRD-K62387885,basimglurant,glutamate receptor antagonist,GRM5,BRD-K62387885,basimglurant,glutamate receptor antagonist,GRM5,BRD-K62387885,basimglurant,glutamate receptor antagonist,GRM5,BRD-K62387885,basimglurant,glutamate receptor antagonist,GRM5
UQDVRVNMIJAGRK,BRD-K52219182,ICI-63197,phosphodiesterase inhibitor,,BRD-K52219182,ICI-63197,phosphodiesterase inhibitor,,BRD-K52219182,ICI-63197,phosphodiesterase inhibitor,,BRD-K52219182,ICI-63197,phosphodiesterase inhibitor,
UQEAIHBTYFGYIE,BRD-K26674746,dimethicone,,,BRD-K26674746,dimethicone,,,BRD-K26674746,dimethicone,,,BRD-K26674746,dimethicone,,
UQGKUQLKSCSZGY,BRD-K78485176,olmesartan-medoxomil,angiotensin receptor antagonist,AGTR1,BRD-K78485176,olmesartan-medoxomil,angiotensin receptor antagonist,AGTR1,BRD-K78485176,olmesartan-medoxomil,angiotensin receptor antagonist,AGTR1,BRD-K78485176,olmesartan-medoxomil,angiotensin receptor antagonist,AGTR1
UQLLWWBDSUHNEB,BRD-K25085912|BRD-K49880111,cephapirin,bacterial cell wall synthesis inhibitor,,BRD-K25085912|BRD-K49880111,cephapirin,bacterial cell wall synthesis inhibitor,,BRD-K25085912|BRD-K49880111,cephapirin,bacterial cell wall synthesis inhibitor,,BRD-K25085912|BRD-K49880111,cephapirin,bacterial cell wall synthesis inhibitor,
UQNAFPHGVPVTAL,BRD-K11796549,NBQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B,BRD-K11796549,NBQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B,BRD-K11796549,NBQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B,BRD-K11796549,NBQX,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B
UQOOPIMXBSPVJI,BRD-K46531780,methylbenzethonium-chloride,other antibiotic,,BRD-K46531780,methylbenzethonium-chloride,other antibiotic,,BRD-K46531780,methylbenzethonium-chloride,other antibiotic,,BRD-K46531780,methylbenzethonium-chloride,other antibiotic,
UQOSBPRTQFFUOA,BRD-K89053832,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14,BRD-K89053832,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14,BRD-K89053832,VLX600,ubiquitin C-terminal hydrolase inhibitor,USP14,BRD-K26122255,VLX600,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,TP53|USP14
UQPMANVRZYYQMD,BRD-K42500029,CGP-57380,MAP kinase inhibitor,AURKB|LCK|MKNK1|MKNK2|SGK1,BRD-K42500029,CGP-57380,MAP kinase inhibitor,AURKB|LCK|MKNK1|MKNK2|SGK1,BRD-K42500029,CGP-57380,MAP kinase inhibitor,AURKB|LCK|MKNK1|MKNK2|SGK1,BRD-K42500029,CGP-57380,MAP kinase inhibitor,AURKB|LCK|MKNK1|MKNK2|SGK1
UQRCJCNVNUFYDX,BRD-K69001009,golvatinib,VEGFR inhibitor,KDR|MET,BRD-K69001009,golvatinib,VEGFR inhibitor,KDR|MET,BRD-K69001009,golvatinib,VEGFR inhibitor,KDR|MET,BRD-K69001009,golvatinib,VEGFR inhibitor,KDR|MET
UQRORFVVSGFNRO,BRD-K33251802,miglustat,Glycosyl transferase inhibitor,UGCG,BRD-K33251802,miglustat,Glycosyl transferase inhibitor,UGCG,BRD-K33251802,miglustat,Glycosyl transferase inhibitor,UGCG,BRD-K33251802,miglustat,glycosyl transferase inhibitor,UGCG
UQTPDWDAYHAZNT,BRD-K21865955,NS-018,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K21865955,NS-018,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K21865955,NS-018,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,BRD-K21865955,NS-018,JAK inhibitor,JAK1|JAK2|JAK3|TYK2
URAYPUMNDPQOKB,BRD-K92844263,triacetin,,,BRD-K92844263,triacetin,,,BRD-K92844263,triacetin,,,BRD-K92844263,triacetin,,
URCVCIZFVQDVPM,BRD-K91623615,ABT-751,tubulin polymerization inhibitor,TUBB,BRD-K91623615,ABT-751,tubulin polymerization inhibitor,TUBB,BRD-K91623615,ABT-751,tubulin polymerization inhibitor,TUBB,BRD-K91623615,ABT-751,tubulin polymerization inhibitor,TUBB
UREBDLICKHMUKA,BRD-A02180903|BRD-A10188456|BRD-A27572786|BRD-K12955147|BRD-K45192137,betamethasone|dexamethasone,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,BRD-A02180903|BRD-A10188456|BRD-A27572786|BRD-K12955147|BRD-K45192137,betamethasone|dexamethasone,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,BRD-A02180903|BRD-A10188456|BRD-A27572786|BRD-K12955147|BRD-K38775274|BRD-K45192137,betamethasone|dexamethasone,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,BRD-A27572786|BRD-K38775274|BRD-K39188321|BRD-K45192137,betamethasone|dexamethasone,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2
URFCJEUYXNAHFI,BRD-K94689771,pinocembrin,cytochrome P450 inhibitor,CYP1B1,BRD-K94689771,pinocembrin,cytochrome P450 inhibitor,CYP1B1,BRD-K94689771,pinocembrin,cytochrome P450 inhibitor,CYP1B1,BRD-K94689771,pinocembrin,cytochrome P450 inhibitor,CYP1B1
URJQOOISAKEBKW,BRD-K90629600,emorfazone,antiinflammatory agent|cyclooxygenase inhibitor,,BRD-K90629600,emorfazone,antiinflammatory agent|cyclooxygenase inhibitor,,BRD-K90629600,emorfazone,antiinflammatory agent|cyclooxygenase inhibitor,,BRD-K90629600,emorfazone,anti-inflammatory agent|cyclooxygenase inhibitor,
URKOMYMAXPYINW,BRD-K68867920,quetiapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,BRD-K68867920|BRD-M66874015,quetiapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,BRD-K68867920|BRD-M66874015,quetiapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,BRD-K68867920|BRD-M66874015,quetiapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2
URLJMZWTXZTZRR,BRD-K84544951,sodium-tetradecyl-sulfate,,PROC|PROS1,BRD-K84544951,sodium-tetradecyl-sulfate,,PROC|PROS1,BRD-K84544951,sodium-tetradecyl-sulfate,,PROC|PROS1,,,,
URWAJWIAIPFPJE,BRD-A29840884|BRD-A68997559,sisomicin|sisomicin-sulfate,bacterial 30S ribosomal subunit inhibitor|protein synthesis inhibitor,,BRD-A29840884|BRD-A68997559,sisomicin|sisomicin-sulfate,bacterial 30S ribosomal subunit inhibitor|protein synthesis inhibitor,,BRD-A29840884|BRD-A68997559|BRD-K71772032|BRD-M47753525|BRD-M71798497,sisomicin|sisomicin-sulfate,bacterial 30S ribosomal subunit inhibitor|protein synthesis inhibitor,,BRD-A29840884|BRD-A68997559|BRD-K71772032|BRD-M47753525|BRD-M71798497,sisomicin|sisomicin-sulfate,bacterial 30S ribosomal subunit inhibitor|protein synthesis inhibitor,
URXWVWVPMJSAJD,BRD-K48329353,"6,_7-dehydro-17-acetoxy-progesterone",,,BRD-K48329353,"6,_7-dehydro-17-acetoxy-progesterone",steroidal progestin,,BRD-K48329353,"6,_7-dehydro-17-acetoxy-progesterone",steroidal progestin,,BRD-K48329353,"6,7-dehydro-17-acetoxy-progesterone",steroidal progestin,
USOXQZNJFMKTKJ,BRD-K60184833,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR,BRD-K60184833,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR,BRD-K60184833,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR,BRD-K60184833,tyrphostin-AG-99,tyrosine kinase inhibitor,EGFR
USRHYDPUVLEVMC,BRD-K51579475,dapoxetine,selective serotonin reuptake inhibitor (SSRI),HTR1A|HTR1B|HTR2C|SLC6A4,BRD-K51579475,dapoxetine,selective serotonin reuptake inhibitor (SSRI),HTR1A|HTR1B|HTR2C|SLC6A4,BRD-K51579475,dapoxetine,selective serotonin reuptake inhibitor (SSRI),HTR1A|HTR1B|HTR2C|SLC6A4,BRD-K51579475,dapoxetine,selective serotonin reuptake inhibitor (SSRI),HTR1A|HTR1B|HTR2C|SLC6A4
USYRQXDHKXGTCK,BRD-K80021413,ML204,transient receptor potential channel antagonist,TRPC4|TRPC5,BRD-K80021413,ML204,transient receptor potential channel antagonist,TRPC4|TRPC5,BRD-K80021413,ML204,transient receptor potential channel antagonist,TRPC4|TRPC5,BRD-K80021413,ML204,transient receptor potential channel antagonist,TRPC4|TRPC5
USZAGAREISWJDP,BRD-K43230258,crisaborole,phosphodiesterase inhibitor,PDE4B,BRD-K43230258,crisaborole,phosphodiesterase inhibitor,PDE4B,BRD-K43230258,crisaborole,phosphodiesterase inhibitor,PDE4B,BRD-K43230258,crisaborole,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D
USZYSDMBJDPRIF,BRD-A80805100,aclarubicin,topoisomerase inhibitor,TOP1|TOP2A,BRD-A80805100,aclarubicin,topoisomerase inhibitor,TOP1|TOP2A,BRD-A80805100,aclarubicin,topoisomerase inhibitor,TOP1|TOP2A,BRD-K31965398,aclarubicin,topoisomerase inhibitor,TOP1|TOP2A
UTLPKQYUXOEJIL,BRD-K81225797,SCH-58261,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K81225797,SCH-58261,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K81225797,SCH-58261,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K81225797,SCH-58261,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
UTWSZXBGTLNPOV,BRD-K46989997,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",,,BRD-K46989997,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",,,BRD-K46989997,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",,,BRD-K46989997,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",,
UUBHZHZSIKRVIV,BRD-K99431849,peretinoin,retinoid receptor agonist,RXRA,BRD-K99431849,peretinoin,retinoid receptor agonist,RXRA,BRD-K99431849,peretinoin,retinoid receptor agonist,RXRA,BRD-K99431849,peretinoin,retinoid receptor agonist,RXRA
UUDAMDVQRQNNHZ,BRD-A34716233|BRD-K92493880,AMPA-(RS)|AMPA-(S),glutamate receptor agonist,GRIN1,BRD-A34716233|BRD-K92493880,AMPA-(RS)|AMPA-(S),glutamate receptor agonist,GRIN1,BRD-A34716233|BRD-K92493880,AMPA-(RS)|AMPA-(S),glutamate receptor agonist,GRIN1,BRD-K01826817|BRD-K92493880,AMPA-(RS)|AMPA-(S),glutamate receptor agonist,GRIA2|GRIN1
UUIYULWYHDSXHL,BRD-A45499626|BRD-K79753741,UBP-302,glutamate receptor antagonist,GRIK1,BRD-A45499626|BRD-K79753741,UBP-302,glutamate receptor antagonist,GRIK1,BRD-A45499626|BRD-K79753741,UBP-296|UBP-302,glutamate receptor antagonist,GRIK1,BRD-A45499626|BRD-K79753741,UBP-296|UBP-302,glutamate receptor antagonist,GRIK1
UUKPIWYXWLJPJF,BRD-K82421491,IPAG,,,BRD-K82421491,IPAG,,,BRD-K82421491,IPAG,,,BRD-K82421491,IPAG,,
UUKWKUSGGZNXGA,BRD-K76381435,nitromide,,,BRD-K76381435,nitromide,,,BRD-K76381435,nitromide,,,BRD-K76381435,nitromide,,
UULIGRNKXHCLQN,BRD-K34321528,CGP-71683,neuropeptide receptor antagonist,NPY5R,BRD-K34321528,CGP-71683,neuropeptide receptor antagonist,NPY5R,BRD-K34321528,CGP-71683,neuropeptide receptor antagonist,NPY5R,BRD-K34321528,CGP-71683,neuropeptide receptor antagonist,NPY5R
UULSXYSSHHRCQK,BRD-A46136514,butibufen,cyclooxygenase inhibitor,,BRD-A46136514,butibufen,cyclooxygenase inhibitor,,BRD-A46136514,butibufen,cyclooxygenase inhibitor,,BRD-A46136514,butibufen,cyclooxygenase inhibitor,
UUMLTINZBQPNGF,BRD-A09370961,ioxilan,radiopaque medium,,BRD-A09370961,ioxilan,radiopaque medium,,BRD-A09370961,ioxilan,radiopaque medium,,BRD-A09370961,ioxilan,radiopaque medium,
UUOJIACWOAYWEZ,BRD-A07563059,bopindolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3|HTR1A|HTR1B,BRD-A07563059,bopindolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3|HTR1A|HTR1B,BRD-A07563059,bopindolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3|HTR1A|HTR1B,BRD-K01825685,bopindolol,adrenergic receptor antagonist,
UUQMNUMQCIQDMZ,BRD-K91315211,betahistine,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,BRD-K91315211,betahistine,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,BRD-K91315211,betahistine,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,BRD-K91315211,betahistine,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3
UUTKICFRNVKFRG,BRD-K44442813,pidotimod,interferon receptor agonist|interleukin receptor agonist,,BRD-K44442813,pidotimod,interferon receptor agonist|interleukin receptor agonist,,BRD-K44442813,pidotimod,interferon receptor agonist|interleukin receptor agonist,,BRD-K44442813,pidotimod,interferon receptor agonist|interleukin receptor agonist,
UUVWYPNAQBNQJQ,BRD-K67043667,altretamine,DNA synthesis inhibitor,,BRD-K67043667,altretamine,DNA synthesis inhibitor,,BRD-K67043667,altretamine,DNA synthesis inhibitor,,BRD-K67043667,altretamine,DNA synthesis inhibitor,
UVCJGUGAGLDPAA,BRD-K02729857,phenylbenzimidazole-sulfonic-acid,,,BRD-K02729857,phenylbenzimidazole-sulfonic-acid,,,BRD-K02729857,phenylbenzimidazole-sulfonic-acid,,,BRD-K02729857,phenylbenzimidazole-sulfonic-acid,,
UVIQSJCZCSLXRZ,BRD-K16133773|BRD-K24048528,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1,BRD-K16133773|BRD-K24048528,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1,BRD-K16133773|BRD-K24048528,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1,BRD-K16133773|BRD-K24048528,abiraterone-acetate,androgen biosynthesis inhibitor,CYP17A1
UVJYAKBJSGRTHA,BRD-K62734952,arglabin,farnesyltransferase inhibitor,FNTA|NFKB1,BRD-K62734952,arglabin,farnesyltransferase inhibitor,FNTA|NFKB1,BRD-K62734952,arglabin,farnesyltransferase inhibitor,FNTA|NFKB1,BRD-K62734952,arglabin,farnesyltransferase inhibitor,FNTA|NFKB1
UVKZSORBKUEBAZ,BRD-K79501723,cyclizine,histamine receptor modulator,HRH1|SULT1E1,BRD-K79501723,cyclizine,histamine receptor modulator,HRH1|SULT1E1,BRD-K79501723,cyclizine,histamine receptor modulator,HRH1|SULT1E1,BRD-K79501723,cyclizine,histamine receptor modulator,HRH1|SULT1E1
UVSMNLNDYGZFPF,BRD-A12994259,pomalidomide,angiogenesis inhibitor|tumor necrosis factor production inhibitor,CRBN|PTGS2|TNF,BRD-A12994259,pomalidomide,angiogenesis inhibitor|tumor necrosis factor production inhibitor,CRBN|PTGS2|TNF,BRD-A12994259,pomalidomide,angiogenesis inhibitor|tumor necrosis factor production inhibitor,CRBN|PTGS2|TNF,BRD-A12994259,pomalidomide,angiogenesis inhibitor|tumor necrosis factor production inhibitor,
UVSWWUWQVAQPJR,BRD-K90777969,cutamesine,sigma receptor agonist,SIGMAR1,BRD-K90777969,cutamesine,sigma receptor agonist,SIGMAR1,BRD-K90777969,cutamesine,sigma receptor agonist,SIGMAR1,BRD-K90777969,cutamesine,sigma receptor agonist,SIGMAR1
UVTNFZQICZKOEM,BRD-A29734509,disopyramide,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,BRD-A29734509,disopyramide,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,BRD-A29734509,disopyramide,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,BRD-A29734509,disopyramide,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A
UVUYWJWYRLJHEN,BRD-K31802667,JNJ-37822681,dopamine receptor antagonist,DRD2,BRD-K31802667,JNJ-37822681,dopamine receptor antagonist,DRD2,BRD-K31802667,JNJ-37822681,dopamine receptor antagonist,DRD2,BRD-K31802667,JNJ-37822681,dopamine receptor antagonist,DRD2
UWEYRJFJVCLAGH,BRD-K55401595,perfluorodecalin,,,BRD-K55401595,perfluorodecalin,,,BRD-K55401595,perfluorodecalin,,,BRD-K55401595,perfluorodecalin,,
UWFYSQMTEOIJJG,BRD-A95207036|BRD-K41141507|BRD-K59573506,cyproterone-acetate,androgen receptor antagonist,ADORA1|AR,BRD-A95207036|BRD-K41141507,cyproterone-acetate,androgen receptor antagonist,ADORA1|AR,BRD-A95207036|BRD-K41141507|BRD-K59573506,cyproterone-acetate,androgen receptor antagonist,ADORA1|AR,BRD-A95207036|BRD-K41141507|BRD-K59573506,cyproterone-acetate,androgen receptor antagonist,ADORA1|AR
UWKQSNNFCGGAFS,BRD-K08547377|BRD-K72035773,irinotecan,topoisomerase inhibitor,TOP1|TOP1MT,BRD-K08547377|BRD-K72035773,irinotecan,topoisomerase inhibitor,TOP1|TOP1MT,BRD-K08547377|BRD-K72035773,irinotecan,topoisomerase inhibitor,TOP1|TOP1MT,BRD-K08547377|BRD-K72035773,irinotecan,topoisomerase inhibitor,TOP1|TOP1MT
UWWDHYUMIORJTA,BRD-K34441861,moexipril,angiotensin converting enzyme inhibitor,ACE|ACE2,BRD-K34441861,moexipril,angiotensin converting enzyme inhibitor,ACE|ACE2,BRD-K34441861,moexipril,angiotensin converting enzyme inhibitor,ACE|ACE2,BRD-K34441861,moexipril,angiotensin converting enzyme inhibitor,ACE|ACE2
UWWMQHVWAYFCDT,BRD-K80060353,IEM1754,glutamate receptor antagonist,GRIA1,BRD-K80060353,IEM1754,glutamate receptor antagonist,GRIA1,BRD-K80060353,IEM1754,glutamate receptor antagonist,GRIA1,BRD-K80060353,IEM1754,glutamate receptor antagonist,GRIA1
UWXSAYUXVSFDBQ,BRD-K46386702,ARRY-334543,EGFR inhibitor,ERBB2,BRD-K46386702,ARRY-334543,EGFR inhibitor,ERBB2,BRD-K46386702,ARRY-334543,EGFR inhibitor,ERBB2,BRD-K46386702,ARRY-334543,EGFR inhibitor,ERBB2
UWYHMGVUTGAWSP,BRD-A66481418|BRD-K71213463|BRD-K96786677,oxacillin,bacterial cell wall synthesis inhibitor,,BRD-A66481418|BRD-K71213463|BRD-K96786677,oxacillin,bacterial cell wall synthesis inhibitor,,BRD-A66481418|BRD-K71213463|BRD-K96786677,oxacillin,bacterial cell wall synthesis inhibitor,,BRD-A66481418|BRD-K71213463|BRD-K96786677,oxacillin,bacterial cell wall synthesis inhibitor,
UXABARREKCJULM,BRD-A10903566,imiloxan,adrenergic receptor antagonist,ADRA2A|ADRA2B,BRD-A10903566,imiloxan,adrenergic receptor antagonist,ADRA2A|ADRA2B,BRD-A10903566,imiloxan,adrenergic receptor antagonist,ADRA2A|ADRA2B,BRD-A10903566,imiloxan,adrenergic receptor antagonist,ADRA2A|ADRA2B
UXIGWFXRQKWHHA,BRD-K98250023,iothalamic-acid-d3,radiopaque medium,,BRD-K98250023,iothalamic-acid-d3,radiopaque medium,,BRD-K98250023,iothalamic-acid-d3,radiopaque medium,,BRD-K98250023,iothalamic-acid-d3,radiopaque medium,
UXJFDYIHRJGPFS,BRD-A23747351,sirtinol,SIRT inhibitor,SIRT1|SIRT2,BRD-A23747351,sirtinol,SIRT inhibitor,SIRT1|SIRT2,BRD-A23747351,sirtinol,SIRT inhibitor,SIRT1|SIRT2,BRD-A23747351,sirtinol,SIRT inhibitor,SIRT1|SIRT2
UXOWGYHJODZGMF,BRD-K30020243,aliskiren-hemifumarate,renin inhibitor,REN,BRD-K30020243,aliskiren-hemifumarate,renin inhibitor,REN,BRD-K30020243|BRD-M18497616,aliskiren-hemifumarate,renin inhibitor,REN,BRD-K30020243|BRD-M18497616,aliskiren-hemifumarate,renin inhibitor,REN
UXXQOJXBIDBUAC,BRD-K89162000,tandutinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,BRD-K89162000,tandutinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,BRD-K89162000,tandutinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,BRD-K89162000,tandutinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB
UXZDMXYRRQJIBJ,BRD-K59390331,tarafenacin,acetylcholine receptor antagonist,CHRM3,BRD-K59390331,tarafenacin,acetylcholine receptor antagonist,CHRM3,BRD-K59390331|BRD-M06471014,tarafenacin,acetylcholine receptor antagonist,CHRM3,BRD-K00003568,tarafenacin,acetylcholine receptor antagonist,CHRM3
UXZFQZANDVDGMM,BRD-K75855670,iodoquinol,antiseptic,,BRD-K75855670,iodoquinol,antiseptic,,BRD-K75855670,iodoquinol,antiseptic,,BRD-K75855670,iodoquinol,antiseptic,
UYBRROMMFMPJAN,BRD-K44665581,bromosporine,bromodomain inhibitor,,BRD-K44665581,bromosporine,bromodomain inhibitor,,BRD-K44665581,bromosporine,bromodomain inhibitor,,BRD-K44665581,bromosporine,bromodomain inhibitor,
UYDRRQPGDSIMNU,BRD-K49027941,PSB-1115,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,BRD-K49027941,PSB-1115,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,BRD-K49027941,PSB-1115,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,BRD-K49027941,PSB-1115,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3
UYFLKEIEOREOFC,BRD-A19795905,atovaquone,mitochondrial electron transport inhibitor,DHODH,BRD-A19795905,atovaquone,mitochondrial electron transport inhibitor,DHODH,BRD-A19795905,atovaquone,mitochondrial electron transport inhibitor,DHODH,BRD-A19795905,atovaquone,mitochondrial electron transport inhibitor,
UYGONJYYUKVHDD,BRD-A79643124,flosequinan,phosphodiesterase inhibitor,,BRD-A79643124,flosequinan,phosphodiesterase inhibitor,,BRD-A79643124,flosequinan,phosphodiesterase inhibitor,,BRD-A79643124,flosequinan,phosphodiesterase inhibitor,
UYIFTLBWAOGQBI,BRD-A74765037,estradiol-benzoate,contraceptive agent,ESR1,BRD-A74765037,estradiol-benzoate,contraceptive agent,ESR1,BRD-A74765037,estradiol-benzoate,contraceptive agent,ESR1,BRD-K44412991,estradiol-benzoate,contraceptive agent,ESR1
UYJNQQDJUOUFQJ,BRD-K21025364,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2,BRD-K21025364,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2,BRD-K21025364,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2,BRD-K21025364,NVP-TAE226,protein tyrosine kinase inhibitor,PTK2
UYJZZVDLGDDTCL,BRD-K11853856,PJ-34,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,BRD-K11853856,PJ-34,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,BRD-K11853856,PJ-34,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,BRD-K11853856,PJ-34,PARP inhibitor,EEF2|PARP1|PARP15|PARP3
UYNVMODNBIQBMV,BRD-A24191444,ifenprodil,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN1|GRIN2B,BRD-A24191444,ifenprodil,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN1|GRIN2B,BRD-A24191444|BRD-M01603234|BRD-M20547247,ifenprodil,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN1|GRIN2B,BRD-K00004210,ifenprodil,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B
UYXTWWCETRIEDR,BRD-K38969488,tributyrin,HDAC inhibitor,,BRD-K38969488,tributyrin,HDAC inhibitor,,BRD-K38969488,tributyrin,HDAC inhibitor,,BRD-K38969488,tributyrin,HDAC inhibitor,
UZDORQWMYRRLQV,BRD-K98357249,IRL-2500,endothelin receptor antagonist,EDNRB,BRD-K98357249,IRL-2500,endothelin receptor antagonist,EDNRB,BRD-K98357249,IRL-2500,endothelin receptor antagonist,EDNRB,BRD-K98357249,IRL-2500,endothelin receptor antagonist,EDNRB
UZHSEJADLWPNLE,BRD-A23195370|BRD-K67511046,naloxone,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,BRD-A23195370|BRD-K67511046,naloxone,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,BRD-A23195370|BRD-K67511046,naloxone,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,BRD-A23195370|BRD-K67511046,naloxone,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4
UZKQTCBAMSWPJD,BRD-K90033078,zeatin,,,BRD-K90033078,zeatin,,,BRD-K90033078,zeatin,,,BRD-K90033078,zeatin,,
UZVHFVZFNXBMQJ,BRD-K71350836,butalbital,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,BRD-K71350836,butalbital,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,BRD-K71350836,butalbital,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,BRD-K71350836,butalbital,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2
UZWDCWONPYILKI,BRD-K33622447,LY2835219,CDK inhibitor,CDK4|CDK6,BRD-K33622447,abemaciclib,CDK inhibitor,CDK4|CDK6,BRD-K33622447,abemaciclib,CDK inhibitor,CDK4|CDK6,BRD-K33622447,abemaciclib,CDK inhibitor,CDK4|CDK6
VAAUVRVFOQPIGI,BRD-K38010979|BRD-K96734425,ceftriaxone,bacterial cell wall synthesis inhibitor,,BRD-K38010979|BRD-K96734425,ceftriaxone,bacterial cell wall synthesis inhibitor,,BRD-K38010979|BRD-K96734425,ceftriaxone,bacterial cell wall synthesis inhibitor,,BRD-K38010979|BRD-K96734425,ceftriaxone,bacterial cell wall synthesis inhibitor,
VABCILAOYCMVPS,BRD-A65051990,acenocoumarol,vitamin K antagonist,VKORC1,BRD-A65051990,acenocoumarol,vitamin K antagonist,VKORC1,BRD-A65051990,acenocoumarol,vitamin K antagonist,VKORC1,BRD-A65051990,acenocoumarol,vitamin K antagonist,VKORC1
VACCAVUAMIDAGB,BRD-K31682896,sulfamethizole,bacterial antifolate,,BRD-K31682896,sulfamethizole,bacterial antifolate,,BRD-K31682896,sulfamethizole,bacterial antifolate,,BRD-K31682896,sulfamethizole,bacterial antifolate,
VADOZMZXXRBXNY,BRD-K88554883,ON123300,CDK inhibitor,CDK4|NUAK1|PDGFRB,BRD-K88554883,ON123300,CDK inhibitor,CDK4|NUAK1|PDGFRB,BRD-K88554883,ON123300,CDK inhibitor,CDK4|NUAK1|PDGFRB,BRD-K88554883,ON123300,CDK inhibitor,CDK4|NUAK1|PDGFRB
VAJGULUVTFDTAS,BRD-K04643927|BRD-K15893360,GLPG0492|GLPG0492-R-enantiomer,androgen receptor modulator,AR,BRD-K04643927|BRD-K15893360,GLPG0492|GLPG0492-R-enantiomer,androgen receptor modulator,AR,BRD-K04643927|BRD-K15893360,GLPG0492|GLPG0492-R-enantiomer,androgen receptor modulator,AR,BRD-K04643927|BRD-K15893360,GLPG0492|GLPG0492-R-enantiomer,androgen receptor modulator,AR
VAOCPAMSLUNLGC,BRD-K52020312,metronidazole,DNA inhibitor,CYP2C9|CYP3A4,BRD-K52020312,metronidazole,DNA inhibitor,CYP2C9|CYP3A4,BRD-K52020312,metronidazole,DNA inhibitor,CYP2C9|CYP3A4,BRD-K52020312,metronidazole,DNA inhibitor,CYP2C9|CYP3A4
VAPDZNUFNKUROY,BRD-K59013864,AM-24,lipoxygenase inhibitor,ALOX5,BRD-K59013864,AM-24,lipoxygenase inhibitor,ALOX5,BRD-K59013864,AM-24,lipoxygenase inhibitor,ALOX5,BRD-K59013864,AM-24,lipoxygenase inhibitor,ALOX5
VAVXGGRQQJZYBL,BRD-K47983010,BX-795,IKK inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,BRD-K47983010,BX-795,IKK inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,BRD-K47983010,BX-795,IKK inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,BRD-K47983010,BX-795,IKK inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1
VAZAPHZUAVEOMC,BRD-K52313696,tacedinaline,HDAC inhibitor,HDAC1,BRD-K52313696,tacedinaline,HDAC inhibitor,HDAC1,BRD-K52313696,tacedinaline,HDAC inhibitor,HDAC1,BRD-K52313696,tacedinaline,HDAC inhibitor,HDAC1
VBHQKCBVWWUUKN,BRD-K19741547,vernakalant,potassium channel blocker,KCNA5,BRD-K19741547,vernakalant,potassium channel blocker,KCNA5,BRD-K19741547,vernakalant,potassium channel blocker,KCNA5,BRD-K19741547,vernakalant,potassium channel blocker,KCNA5
VBHVOHJOTMCSBQ,BRD-K80607346,FK-962,somatostatin receptor agonist,,BRD-K80607346,FK-962,somatostatin receptor agonist,,BRD-K80607346,FK-962,somatostatin receptor agonist,,BRD-K80607346,FK-962,somatostatin receptor agonist,
VBICKXHEKHSIBG,BRD-A31454688,monostearin,,,BRD-A31454688,monostearin,,,BRD-A31454688,monostearin,,,BRD-A31454688,monostearin,,
VBRJFXSFCYEZMQ,BRD-K27168049,SDZ-220-581,glutamate receptor antagonist,GRIN1,BRD-K27168049,SDZ-220-581,glutamate receptor antagonist,GRIN1,BRD-K27168049,SDZ-220-581,glutamate receptor antagonist,GRIN1,BRD-K27168049,SDZ-220-581,glutamate receptor antagonist,GRIN1
VCIPBXUEKWCJAU,BRD-M02075109,chromanol-(+/-),potassium channel blocker,,BRD-M02075109,chromanol-(+/-),potassium channel blocker,,BRD-M02075109,chromanol-(+/-),potassium channel blocker,,BRD-M02075109,chromanol-(+/-),potassium channel blocker,
VCKUSRYTPJJLNI,BRD-A22256192,terazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,BRD-A22256192,terazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,BRD-A22256192,terazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7,BRD-K01826569,terazosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D
VCPMZDWBEWTGNW,BRD-K16037980,Z160,N-type calcium channel blocker,CACNA2D1,BRD-K16037980,Z160,N-type calcium channel blocker,CACNA2D1,BRD-K16037980,Z160,N-type calcium channel blocker,CACNA2D1,BRD-K16037980,Z160,N-type calcium channel blocker,CACNA2D1
VCQGNUWOMLYNNG,BRD-K09619322,CD-1530,retinoid receptor agonist,RARG,BRD-K09619322,CD-1530,retinoid receptor agonist,RARG,BRD-K09619322|BRD-K25737009,CD-1530,retinoid receptor agonist,RARG,BRD-K09619322|BRD-K25737009,CD-1530,retinoid receptor agonist,RARG
VCRYFUBRFYUNTM,BRD-A45201156,colistin-sulfate,bacterial permeability inducer,,BRD-A45201156,colistin-sulfate,bacterial permeability inducer,,BRD-A45201156,colistin-sulfate,bacterial permeability inducer,,,,,
VCZSWYIFCKGTJI,BRD-A48376327,igmesine,sigma receptor agonist,SIGMAR1,BRD-A48376327,igmesine,sigma receptor agonist,SIGMAR1,BRD-A48376327,igmesine,sigma receptor agonist,SIGMAR1,BRD-A48376327,igmesine,sigma receptor agonist,SIGMAR1
VDANGULDQQJODZ,BRD-K86864073,chloroprocaine,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3,BRD-K86864073,chloroprocaine,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3,BRD-K86864073,chloroprocaine,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3,BRD-K86864073,chloroprocaine,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3
VDCDWNDTNSWDFJ,BRD-K18602506,OR-486,catechol O methyltransferase inhibitor,COMT,BRD-K18602506,OR-486,catechol O methyltransferase inhibitor,COMT,BRD-K18602506,OR-486,catechol O methyltransferase inhibitor,COMT,BRD-K18602506,OR-486,catechol O methyltransferase inhibitor,COMT
VDCRFBBZFHHYGT,BRD-K00091711,RWJ-21757,toll-like receptor agonist,TLR7,BRD-K00091711,RWJ-21757,toll-like receptor agonist,TLR7,BRD-K00091711,RWJ-21757,toll-like receptor agonist,TLR7,BRD-K00091711,RWJ-21757,toll-like receptor agonist,TLR7
VDDUJINYXKGZLV,BRD-A89337244,PD-102807,acetylcholine receptor antagonist,CHRM4,BRD-A89337244,PD-102807,acetylcholine receptor antagonist,CHRM4,BRD-A89337244,PD-102807,acetylcholine receptor antagonist,CHRM4,BRD-A89337244,PD-102807,acetylcholine receptor antagonist,CHRM4
VDHAWDNDOKGFTD,BRD-K73838513,cinacalcet,calcium channel activator,CASR,BRD-K73838513,cinacalcet,calcium channel activator,CASR,BRD-K73838513,cinacalcet,calcium channel activator,CASR,BRD-K73838513,cinacalcet,calcium channel activator,CASR
VDJHFHXMUKFKET,BRD-K93779381,ingenol-mebutate,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,BRD-K93779381,ingenol-mebutate,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,BRD-K93779381,ingenol-mebutate,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,BRD-K93779381,ingenol-mebutate,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG
VDKBIFPJULZUPU,BRD-K17896185,FIT,opioid receptor agonist,OPRD1,BRD-K17896185,FIT,opioid receptor agonist,OPRD1,BRD-K17896185,FIT,opioid receptor agonist,OPRD1,BRD-K17896185,FIT,opioid receptor agonist,OPRD1
VDNLFJGJEQUWRB,BRD-K33623053,rose-bengal|rose-bengal-disodium,contrast agent|immunostimulant,,BRD-K33623053|BRD-K36163066,rose-bengal,contrast agent,,BRD-K33623053|BRD-K36163066,rose-bengal,contrast agent,,BRD-K33623053|BRD-K36163066,rose-bengal,contrast agent|immunostimulant,
VDOSWXIDETXFET,BRD-K69247067,afloqualone,acetylcholine receptor antagonist,,BRD-K69247067,afloqualone,acetylcholine receptor antagonist,,BRD-K69247067,afloqualone,acetylcholine receptor antagonist,,BRD-K69247067,afloqualone,acetylcholine receptor antagonist,
VDQLKIBLTMPAHI,BRD-K08953028,U-0521,catechol O methyltransferase inhibitor,COMT,BRD-K08953028,U-0521,catechol O methyltransferase inhibitor,COMT,BRD-K08953028,U-0521,catechol O methyltransferase inhibitor,COMT,BRD-K08953028,U-0521,catechol O methyltransferase inhibitor,COMT
VDUWPHTZYNWKRN,BRD-K14704277,cinoxacin,topoisomerase inhibitor,,BRD-K14704277,cinoxacin,topoisomerase inhibitor,,BRD-K14704277,cinoxacin,topoisomerase inhibitor,,BRD-K14704277,cinoxacin,topoisomerase inhibitor,
VEPKQEUBKLEPRA,BRD-K91900765,VX-745,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,BRD-K91900765,VX-745,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,BRD-K91900765,VX-745,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,BRD-K91900765,VX-745,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14
VEQOALNAAJBPNY,BRD-K46937689,phenazone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K46937689,phenazone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K46937689,phenazone,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K46937689,phenazone,cyclooxygenase inhibitor,PTGS1|PTGS2
VERWOWGGCGHDQE,BRD-K22149900,ceritinib,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B,BRD-K22149900,ceritinib,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B,BRD-K22149900,ceritinib,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B,BRD-K22149900,ceritinib,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B
VEVMYTDOWUQLGI,BRD-K13664493,naphthoquine-phosphate,antimalarial agent,,BRD-K13664493,naphthoquine-phosphate,antimalarial agent,,BRD-K13664493,naphthoquine-phosphate,antimalarial agent,,BRD-K13664493,naphthoquine-phosphate,antimalarial agent,
VEZJRJGLFIXQHG,BRD-K79132813,pibenzimol,DNA inhibitor,,BRD-K79132813,pibenzimol,DNA inhibitor,,BRD-K79132813,pibenzimol,DNA inhibitor,,,,,
VEZXCJBBBCKRPI,BRD-K76867903,propiolactone,,,BRD-K76867903,propiolactone,,,BRD-K76867903,propiolactone,,,BRD-K76867903,propiolactone,,
VFCRKLWBYMDAED,BRD-K61691541,PF-03084014,gamma secretase inhibitor,,BRD-K61691541,PF-03084014,gamma secretase inhibitor,,BRD-K61691541,PF-03084014,gamma secretase inhibitor,,BRD-K61691541,PF-03084014,gamma secretase inhibitor,
VFDHMSXXELYMRW,BRD-K35430135,SR-59230A,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-K35430135,SR-59230A,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-K35430135,SR-59230A,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-K35430135,SR-59230A,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
VFEDRRNHLBGPNN,BRD-K13240081,nimustine,DNA alkylating agent,,BRD-K13240081,nimustine,DNA alkylating agent,,BRD-K13240081,nimustine,DNA alkylating agent,,,,,
VFFZWMWTUSXDCB,BRD-K77396579,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4,BRD-K77396579,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4,BRD-K77396579,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4,BRD-K77396579,NVP-DPP728,dipeptidyl peptidase inhibitor,DPP4
VFIDUCMKNJIJTO,BRD-K74603273,"ICI-118,551",,,BRD-K74603273,"ICI-118,551",adrenergic receptor antagonist,ADRB2|ADRB3,BRD-K74603273,"ICI-118,551",adrenergic receptor antagonist,ADRB2|ADRB3,BRD-K74603273,"ICI-118,551",adrenergic receptor antagonist,ADRB2|ADRB3
VFIZBHJTOHUOEK,BRD-K81623406,EIT-hydrobromide,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K81623406,EIT-hydrobromide,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K81623406,EIT-hydrobromide,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K81623406,EIT-hydrobromide,nitric oxide synthase inhibitor,NOS2|NOS3
VFLDPWHFBUODDF,BRD-K07572174,curcumin,NFkB pathway inhibitor|cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,BRD-K07572174,curcumin,NFkB pathway inhibitor|cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,BRD-K07572174|BRD-K69690935,curcumin,NFkB pathway inhibitor|cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,,,,
VFOKSTCIRGDTBR,BRD-K73585091,GS-9620,toll-like receptor agonist,TLR7,BRD-K73585091,GS-9620,toll-like receptor agonist,TLR7,BRD-K73585091,GS-9620,toll-like receptor agonist,TLR7,BRD-K73585091,GS-9620,toll-like receptor agonist,TLR7
VFSVKVQMZDJFQX,BRD-K26970495,CCG-63802,G protein signaling inhibitor,RGS4,BRD-K26970495,CCG-63802,G protein signaling inhibitor,RGS4,BRD-K26970495,CCG-63802,G protein signaling inhibitor,RGS4,BRD-K26970495,CCG-63802,G protein signaling inhibitor,RGS4
VFTRKSBEFQDZKX,BRD-K37846922,"3,3'-diindolylmethane",,,BRD-K37846922,"3,3'-diindolylmethane","CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,BRD-K37846922,"3,3'-diindolylmethane","CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,BRD-K37846922,"3,3'-diindolylmethane","CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3
VFUAJMPDXIRPKO,BRD-K05445342,WP1066,STAT inhibitor,STAT3,BRD-K05445342,WP1066,STAT inhibitor,STAT3,BRD-K05445342,WP1066,STAT inhibitor,STAT3,BRD-K05445342,WP1066,STAT inhibitor,STAT3
VFUXSYAXEKYYMB,BRD-K41213548,KW-2478,HSP inhibitor,,BRD-K41213548,KW-2478,HSP inhibitor,,BRD-K41213548,KW-2478,HSP inhibitor,,BRD-K41213548,KW-2478,HSP inhibitor,
VGEREEWJJVICBM,BRD-K15563106,phloretin,sodium/glucose cotransporter inhibitor,AQP9|CLCN3|SLC23A1,BRD-K15563106,phloretin,sodium/glucose cotransporter inhibitor,AQP9|CLCN3|SLC23A1,BRD-K15563106,phloretin,sodium/glucose cotransporter inhibitor,AQP9|CLCN3|SLC23A1,BRD-K15563106,phloretin,sodium/glucose cotransporter inhibitor,AQP9|CLCN3|SLC23A1
VGGGPCQERPFHOB,BRD-K59574735,ubenimex,leukotriene synthesis inhibitor,LTA4H|RNPEP,BRD-K59574735,ubenimex,leukotriene synthesis inhibitor,LTA4H|RNPEP,BRD-K59574735,ubenimex,leukotriene synthesis inhibitor,LTA4H|RNPEP,BRD-K59574735,ubenimex,leukotriene synthesis inhibitor,LTA4H|RNPEP
VGIGHGMPMUCLIQ,BRD-K08998509,fananserin,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,BRD-K08998509,fananserin,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,BRD-K08998509,fananserin,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,BRD-K08998509,fananserin,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A
VGKDLMBJGBXTGI,BRD-K70464547|BRD-K82036761,sertraline,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,BRD-K70464547|BRD-K82036761,sertraline,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,BRD-K70464547|BRD-K82036761,sertraline,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,BRD-K70464547|BRD-K82036761,sertraline,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4
VGLGVJVUHYTIIU,BRD-A56675431,althiazide,diuretic,,BRD-A56675431,althiazide,diuretic,,BRD-A56675431,althiazide,diuretic,,BRD-A56675431,althiazide,diuretic,
VGYFMXBACGZSIL,BRD-K75958547,pitavastatin,HMGCR inhibitor,HMGCR,BRD-K75958547|BRD-M62817595,pitavastatin,HMGCR inhibitor,HMGCR,BRD-K75958547|BRD-M62817595,pitavastatin,HMGCR inhibitor,HMGCR,BRD-K75958547|BRD-M62817595,pitavastatin,HMGCR inhibitor,HMGCR
VGZSUPCWNCWDAN,BRD-K52960356,acetohexamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,BRD-K52960356,acetohexamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,BRD-K52960356,acetohexamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,BRD-K52960356,acetohexamide,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11
VHFGEBVPHAGQPI,BRD-A33352494,oritavancin,bacterial cell wall synthesis inhibitor,,BRD-A33352494,oritavancin,bacterial cell wall synthesis inhibitor,,BRD-A33352494,oritavancin,bacterial cell wall synthesis inhibitor,,BRD-K00003704,oritavancin,bacterial cell wall synthesis inhibitor,
VHFVKMTVMIZMIK,BRD-K75844781,mCPP,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,BRD-K75844781,mCPP,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,BRD-K75844781,mCPP,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,BRD-K75844781,mCPP,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6
VHGCDTVCOLNTBX,BRD-K20141153,atomoxetine,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,BRD-K20141153,atomoxetine,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,BRD-K20141153,atomoxetine,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,BRD-K20141153,atomoxetine,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4
VHHVPDKNKPNKHY,BRD-K78122587,NNC-55-0396,T-type calcium channel blocker,CATSPER1|CATSPER2|CATSPER3|CATSPER4,BRD-K78122587,NNC-55-0396,T-type calcium channel blocker,CATSPER1|CATSPER2|CATSPER3|CATSPER4,BRD-K78122587,NNC-55-0396,T-type calcium channel blocker,CATSPER1|CATSPER2|CATSPER3|CATSPER4,BRD-K78122587,NNC-55-0396,T-type calcium channel blocker,CATSPER1|CATSPER2|CATSPER3|CATSPER4
VHKBTPQDHDSBSP,BRD-K28570407,A-803467,sodium channel blocker,SCN10A,BRD-K28570407,A-803467,sodium channel blocker,SCN10A,BRD-K28570407,A-803467,sodium channel blocker,SCN10A,BRD-K28570407,A-803467,sodium channel blocker,SCN10A
VHKXXVVRRDYCIK,BRD-A25608658,narasin,antiprotozoal agent,,BRD-A25608658,narasin,antiprotozoal agent,,BRD-A25608658,narasin,antiprotozoal agent,,BRD-A25608658,narasin,antiprotozoal agent,
VHKZGNPOHPFPER,BRD-K48684885,BAY-11-7085,NFkB pathway inhibitor,NFKBIA,BRD-K48684885,BAY-11-7085,NFkB pathway inhibitor,NFKBIA,BRD-K48684885,BAY-11-7085,NFkB pathway inhibitor,NFKBIA,BRD-K48684885,BAY-11-7085,NFkB pathway inhibitor,NFKBIA
VHOGYURTWQBHIL,BRD-K78692225,leflunomide,PDGFR tyrosine kinase receptor inhibitor|dihydroorotate dehydrogenase inhibitor,AHR|DHODH|PTK2B,BRD-K78692225,leflunomide,PDGFR tyrosine kinase receptor inhibitor|dihydroorotate dehydrogenase inhibitor,AHR|DHODH|PTK2B,BRD-K78692225,leflunomide,PDGFR tyrosine kinase receptor inhibitor|dihydroorotate dehydrogenase inhibitor,AHR|DHODH|PTK2B,BRD-K78692225,leflunomide,PDGFR tyrosine kinase receptor inhibitor|dihydroorotate dehydrogenase inhibitor,AHR|DHODH|PTK2B
VHRSUDSXCMQTMA,BRD-A53176877|BRD-K99443616,methylprednisolone,glucocorticoid receptor agonist,NR3C1,BRD-A53176877|BRD-K35240538,methylprednisolone,glucocorticoid receptor agonist,NR3C1,BRD-A53176877|BRD-K35240538|BRD-K99443616,methylprednisolone,glucocorticoid receptor agonist,NR3C1,BRD-A53176877|BRD-K35240538|BRD-K99443616,methylprednisolone,glucocorticoid receptor agonist,NR3C1
VHSVKVWHYFBIFJ,BRD-K62696033,G-1,G protein-coupled receptor agonist,GPER1,BRD-K62696033,G-1,G protein-coupled receptor agonist,GPER1,BRD-K62696033,G-1,G protein-coupled receptor agonist,GPER1,BRD-K62696033,G-1,G protein-coupled receptor agonist,GPER1
VHVPQPYKVGDNFY,BRD-A23067620,itraconazole,cytochrome P450 inhibitor,CYP51A1,BRD-A23067620,itraconazole,cytochrome P450 inhibitor,CYP51A1,BRD-A23067620,itraconazole,cytochrome P450 inhibitor,CYP51A1,BRD-K00004318,itraconazole,cytochrome P450 inhibitor,
VHWFITPGPFLBGT,BRD-K55529781,furegrelate,thromboxane synthase inhibitor,TBXAS1,BRD-K55529781,furegrelate,thromboxane synthase inhibitor,TBXAS1,BRD-K55529781,furegrelate,thromboxane synthase inhibitor,TBXAS1,BRD-K55529781,furegrelate,thromboxane synthase inhibitor,TBXAS1
VHXNKPBCCMUMSW,BRD-K79821389,rubitecan,topoisomerase inhibitor,TOP1,BRD-K79821389,rubitecan,topoisomerase inhibitor,TOP1,BRD-K79821389,rubitecan,topoisomerase inhibitor,TOP1,BRD-K79821389,rubitecan,topoisomerase inhibitor,TOP1
VHYCDWMUTMEGQY,BRD-A89175223,bisoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A89175223,bisoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A89175223|BRD-M21493215,bisoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,BRD-A89175223|BRD-M21493215,bisoprolol,adrenergic receptor antagonist,ADRB1
VIJCCFFEBCOOIE,BRD-K17295893,nastorazepide,CCK receptor antagonist,CCKBR,BRD-K17295893,nastorazepide,CCK receptor antagonist,CCKBR,BRD-K17295893,nastorazepide,CCK receptor antagonist,CCKBR,BRD-K17295893,nastorazepide,CCK receptor antagonist,CCKBR
VIKNJXKGJWUCNN,BRD-A39415247|BRD-A83260288|BRD-K01123092,norethindrone|norethisterone,progesterone receptor agonist|progestogen hormone,PGR,BRD-A39415247|BRD-K01123092,norethindrone,progesterone receptor agonist,PGR,BRD-A39415247|BRD-K01123092|BRD-K92073408,norethindrone,progesterone receptor agonist,PGR,BRD-A39415247|BRD-K01123092|BRD-K92073408,norethindrone,progesterone receptor agonist,PGR
VILCJCGEZXAXTO,BRD-K37111771,trientine,chelating agent,CA14,BRD-K37111771,trientine,chelating agent,CA14,BRD-K37111771,trientine,chelating agent,CA14,BRD-K37111771,trientine,chelating agent,CA14
VIQCGTZFEYDQMR,BRD-K27898013,fluphenazine-decanoate,dopamine receptor antagonist,DRD2|HTR1B|HTR4,BRD-K27898013,fluphenazine-decanoate,dopamine receptor antagonist,DRD2|HTR1B|HTR4,BRD-K27898013,fluphenazine-decanoate,dopamine receptor antagonist,DRD2|HTR1B|HTR4,BRD-K27898013,fluphenazine-decanoate,dopamine receptor antagonist,DRD2|HTR1B|HTR4
VIUAUNHCRHHYNE,BRD-K89014967,AS-703026,MEK inhibitor,MAP2K1|MAP2K2,BRD-K89014967,AS-703026,MEK inhibitor,MAP2K1|MAP2K2,BRD-K89014967,AS-703026,MEK inhibitor,MAP2K1|MAP2K2,BRD-K89014967,AS-703026,MEK inhibitor,MAP2K1|MAP2K2
VIZBSVDBNLAVAW,BRD-K31394475,CP-376395,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K31394475,CP-376395,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K31394475,CP-376395,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K31394475,CP-376395,corticotropin releasing factor receptor antagonist,CRHR1
VIZXMHCBZLGUET,BRD-K80043866,sodium-gualenate,antacid,,BRD-K80043866,sodium-gualenate,antacid,,BRD-K80043866,sodium-gualenate,antacid,,BRD-K80043866,sodium-gualenate,antacid,
VJGGHXVGBSZVMZ,BRD-K17850764,cloprostenol-(+/-),prostaglandin receptor agonist,PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R,BRD-K17850764,cloprostenol-(+/-),prostaglandin receptor agonist,PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R,BRD-K17850764,cloprostenol-(+/-),prostaglandin receptor agonist,PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R,BRD-K17850764,cloprostenol-(+/-),prostaglandin receptor agonist,PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R
VJJPUSNTGOMMGY,BRD-A33280134|BRD-K37798499,etoposide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-A33280134|BRD-K37798499,etoposide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-A26175277|BRD-A33280134|BRD-K36186323|BRD-K37798499,etoposide,topoisomerase inhibitor,TOP2A|TOP2B,BRD-A26175277|BRD-A33280134|BRD-K36186323|BRD-K37798499,etoposide,topoisomerase inhibitor,TOP2A|TOP2B
VJZITPJGSQKZMX,BRD-K13843533,amrubicin,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K13843533,amrubicin,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K13843533,amrubicin,topoisomerase inhibitor,TOP2A|TOP2B,BRD-K13843533,amrubicin,topoisomerase inhibitor,TOP2A|TOP2B
VKHAHZOOUSRJNA,BRD-A79939557|BRD-K37270826|BRD-K46504237,mifepristone,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,BRD-A79939557|BRD-K37270826|BRD-K46504237,mifepristone,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,BRD-A79939557|BRD-K37270826|BRD-K46504237,mifepristone,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,BRD-A79939557|BRD-K37270826|BRD-K46504237,mifepristone,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR
VKMFDKYCIKEDMR,BRD-K55677650,CO-101244,glutamate receptor antagonist,GRIN2B,BRD-K55677650,CO-101244,glutamate receptor antagonist,GRIN2B,BRD-K55677650,CO-101244,glutamate receptor antagonist,GRIN2B,BRD-K55677650,CO-101244,glutamate receptor antagonist,GRIN2B
VKQFCGNPDRICFG,BRD-A84465106,nisoldipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNB2,BRD-A84465106,nisoldipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNB2,BRD-A84465106,nisoldipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1|CACNB2,BRD-A84465106,nisoldipine,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S
VKSPIPWLHGKJQO,BRD-K51700582,bupicomide,adrenergic receptor antagonist,ADRB1,BRD-K51700582,bupicomide,adrenergic receptor antagonist,ADRB1,BRD-K51700582,bupicomide,adrenergic receptor antagonist,ADRB1,BRD-K51700582,bupicomide,adrenergic receptor antagonist,ADRB1
VKXWOLCNTHXCLF,BRD-K47976015,balapiravir,RNA polymerase inhibitor,,BRD-K47976015,balapiravir,RNA polymerase inhibitor,,BRD-K47976015,balapiravir,RNA polymerase inhibitor,,BRD-K47976015,balapiravir,RNA polymerase inhibitor,
VKYKSIONXSXAKP,BRD-K30114692,methenamine,bacterial DNA inhibitor,,BRD-K30114692,methenamine,bacterial DNA inhibitor,,BRD-K30114692,methenamine,bacterial DNA inhibitor,,BRD-K30114692,methenamine,bacterial DNA inhibitor,
VLCYCQAOQCDTCN,BRD-A96292436,eflornithine,ornithine decarboxylase inhibitor,ARG2|ODC1,BRD-A96292436,eflornithine,ornithine decarboxylase inhibitor,ARG2|ODC1,BRD-A96292436,eflornithine,ornithine decarboxylase inhibitor,ARG2|ODC1,BRD-A96292436,eflornithine,ornithine decarboxylase inhibitor,ARG2|ODC1
VLEUZFDZJKSGMX,BRD-K53097745,pterostilbene,PPAR receptor agonist|cyclooxygenase inhibitor,PTGS2,BRD-K53097745,pterostilbene,PPAR receptor agonist|cyclooxygenase inhibitor,PTGS2,BRD-K53097745,pterostilbene,PPAR receptor agonist|cyclooxygenase inhibitor,PTGS2,BRD-K92870997,pterostilbene,PPAR receptor agonist|cyclooxygenase inhibitor,PTGS2
VLNHDKDBGWXJEE,BRD-K64748124,GNTI,opioid receptor antagonist,OPRK1|OPRM1,BRD-K64748124,GNTI,opioid receptor antagonist,OPRK1|OPRM1,BRD-A80271098|BRD-K64748124,GNTI,opioid receptor antagonist,OPRK1|OPRM1,BRD-A80271098|BRD-K64748124,GNTI,opioid receptor antagonist,OPRK1|OPRM1
VLPFTAMPNXLGLX,BRD-K24790130,tricaprylin,,,BRD-K24790130,tricaprylin,,,BRD-K24790130,tricaprylin,,,BRD-K24790130,tricaprylin,,
VLPIATFUUWWMKC,BRD-A64092382,mexiletine,sodium channel blocker,AHR|SCN4A|SCN5A,BRD-A64092382,mexiletine,sodium channel blocker,AHR|SCN4A|SCN5A,BRD-A64092382,mexiletine,sodium channel blocker,AHR|SCN4A|SCN5A,BRD-A64092382,mexiletine,sodium channel blocker,PLAU|SCN4A|SCN5A
VLQTUNDJHLEFEQ,BRD-K08864679,fexaramine,FXR agonist,NR1H4,BRD-K08864679,fexaramine,FXR agonist,NR1H4,BRD-K08864679,fexaramine,FXR agonist,NR1H4,BRD-K08864679,fexaramine,FXR agonist,NR1H4
VLSMHEGGTFMBBZ,BRD-K52459018,kainic-acid,kainate receptor agonist,GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5,BRD-K52459018,kainic-acid,kainate receptor agonist,GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5,BRD-K52459018,kainic-acid,kainate receptor agonist,GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5,BRD-K52459018,kainic-acid,kainate receptor agonist,GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5
VLULRUCCHYVXOH,BRD-K58529924,ONC201,AKT inhibitor|MAP kinase inhibitor,TNFSF10,BRD-K58529924,ONC201,AKT inhibitor|MAP kinase inhibitor,TNFSF10,BRD-K58529924,ONC201,AKT inhibitor|MAP kinase inhibitor,TNFSF10,BRD-K58529924,ONC201,AKT inhibitor|MAP kinase inhibitor,TNFSF10
VLYWMPOKSSWJAL,BRD-K00938507,sulfamethoxypyridazine,bacterial antifolate,,BRD-K00938507,sulfamethoxypyridazine,bacterial antifolate,,BRD-K00938507,sulfamethoxypyridazine,bacterial antifolate,,BRD-K00938507,sulfamethoxypyridazine,bacterial antifolate,
VMAKIACTLSBBIY,BRD-K19859123,CCMI,acetylcholine receptor allosteric modulator,CHRNA7,BRD-K16338837|BRD-K19859123,CCMI,acetylcholine receptor allosteric modulator,CHRNA7,BRD-K16338837|BRD-K19859123,CCMI,acetylcholine receptor allosteric modulator,CHRNA7,BRD-K16338837|BRD-K19859123,CCMI,acetylcholine receptor allosteric modulator,CHRNA7
VMAQYKGITHDWKL,BRD-K06050544|BRD-K56033645,5-methylhydantoin-(D)|5-methylhydantoin-(L),,,BRD-K06050544|BRD-K56033645,5-methylhydantoin-(D)|5-methylhydantoin-(L),,,BRD-K06050544|BRD-K56033645,5-methylhydantoin-(D)|5-methylhydantoin-(L),,,BRD-K06050544|BRD-K56033645,5-methylhydantoin-(D)|5-methylhydantoin-(L),,
VMDUABMKBUKKPG,BRD-K68392338,ZK-93426,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K68392338,ZK-93426,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K68392338,ZK-93426,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K68392338,ZK-93426,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5
VMFGCGRAIBLAFY,BRD-K78720403,SB-328437,CCR antagonist,,BRD-K78720403,SB-328437,CCR antagonist,,BRD-K78720403,SB-328437,CCR antagonist,,BRD-K78720403,SB-328437,CCR antagonist,
VMJFTOSOFDEKTM,BRD-K55512740,MK-8033,c-Met inhibitor,MET,BRD-K55512740,MK-8033,c-Met inhibitor,MET,BRD-K55512740,MK-8033,c-Met inhibitor,MET,BRD-K55512740,MK-8033,c-Met inhibitor,MET
VMLZFUVIKCGATC,BRD-K49702221,SNAP-94847,,ADRA1A|DRD2,BRD-K49702221,SNAP-94847,,ADRA1A|DRD2,BRD-K49702221,SNAP-94847,,ADRA1A|DRD2,BRD-K49702221,SNAP-94847,,ADRA1A|DRD2
VMMKGHQPQIEGSQ,BRD-K89337853,minodronic-acid,bone resorption inhibitor,FDPS|GGPS1,BRD-K89337853,minodronic-acid,bone resorption inhibitor,FDPS|GGPS1,BRD-K89337853,minodronic-acid,bone resorption inhibitor,FDPS|GGPS1,BRD-K89337853,minodronic-acid,bone resorption inhibitor,FDPS|GGPS1
VMWNQDUVQKEIOC,BRD-A35931254|BRD-K76022557,r(-)-apomorphine,dopamine receptor agonist,DRD2|HTR5A,BRD-A35931254|BRD-K76022557,r(-)-apomorphine,dopamine receptor agonist,DRD2|HTR5A,BRD-A35931254|BRD-K76022557,r(-)-apomorphine,dopamine receptor agonist,DRD2|HTR5A,BRD-K76022557,(R)-(-)-apomorphine,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A
VMXUWOKSQNHOCA,BRD-K14204120|BRD-K70505054,ranitidine,histamine receptor antagonist,HRH2,BRD-K14204120|BRD-K70505054,ranitidine,histamine receptor antagonist,HRH2,BRD-K14204120|BRD-K70505054,ranitidine,histamine receptor antagonist,HRH2,,,,
VMZMNAABQBOLAK,BRD-K59715032,pasireotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,BRD-K59715032,pasireotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,BRD-K59715032,pasireotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,BRD-K59715032,pasireotide,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5
VMZUTJCNQWMAGF,BRD-K68232413,etizolam,benzodiazepine receptor agonist,GABRA1,BRD-K68232413,etizolam,benzodiazepine receptor agonist,GABRA1,BRD-K68232413,etizolam,benzodiazepine receptor agonist,GABRA1,BRD-K68232413,etizolam,benzodiazepine receptor agonist,GABRA1
VNBRGSXVFBYQNN,BRD-K40738845,BMS-777607,AXL kinase inhibitor|FLT3 inhibitor|c-Met inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,BRD-K40738845,BMS-777607,AXL kinase inhibitor|FLT3 inhibitor|c-Met inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,BRD-K40738845,BMS-777607,AXL kinase inhibitor|FLT3 inhibitor|c-Met inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,BRD-K40738845,BMS-777607,AXL kinase inhibitor|FLT3 inhibitor|c-Met inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3
VNFPBHJOKIVQEB,BRD-K15916496,clotrimazole,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,BRD-K15916496,clotrimazole,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,BRD-K15916496,clotrimazole,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,BRD-K15916496,clotrimazole,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8
VNIWZCGZPBJWBI,BRD-K49555808,BMS-707035,HIV integrase inhibitor,,BRD-K49555808,BMS-707035,HIV integrase inhibitor,,BRD-K49555808,BMS-707035,HIV integrase inhibitor,,BRD-K49555808,BMS-707035,HIV integrase inhibitor,
VNONINPVFQTJOC,BRD-K37723606,dioscin,apoptosis stimulant,CXCR3,BRD-K37723606,dioscin,apoptosis stimulant,CXCR3,BRD-K37723606,dioscin,apoptosis stimulant,CXCR3,BRD-K67340225,dioscin,apoptosis stimulant,CXCR3
VNYSSYRCGWBHLG,BRD-K53124401,LTB4,leukocyte activator,LTB4R|LTB4R2,BRD-K53124401,LTB4,leukocyte activator,LTB4R|LTB4R2,BRD-K53124401,LTB4,leukocyte activator,LTB4R|LTB4R2,BRD-K53124401,LTB4,leukocyte activator,LTB4R|LTB4R2
VOCBWIIFXDYGNZ,BRD-K89657519,testosterone-enanthate,androgen receptor agonist,AR,BRD-K89657519,testosterone-enanthate,androgen receptor agonist,AR,BRD-K89657519,testosterone-enanthate,androgen receptor agonist,AR,,,,
VOPDXHFYDJAYNS,BRD-K02389548,RG2833,HDAC inhibitor,HDAC1|HDAC3,BRD-K02389548,RG2833,HDAC inhibitor,HDAC1|HDAC3,BRD-K02389548,RG2833,HDAC inhibitor,HDAC1|HDAC3,BRD-K02389548,RG2833,HDAC inhibitor,HDAC1|HDAC3
VOVIALXJUBGFJZ,BRD-A34299591|BRD-A60571864|BRD-K17742695|BRD-K90758956,budesonide,glucocorticoid receptor agonist,NR3C1,BRD-A34299591|BRD-A60571864|BRD-K90758956,budesonide,glucocorticoid receptor agonist,NR3C1,BRD-A34299591|BRD-A60571864|BRD-K17742695|BRD-K90758956,budesonide,glucocorticoid receptor agonist,NR3C1,BRD-A34299591|BRD-A60571864|BRD-K17742695,budesonide,glucocorticoid receptor agonist,NR3C1
VOXZDWNPVJITMN,BRD-A18917088|BRD-K18910433|BRD-K60633875,estradiol,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,BRD-A18917088|BRD-K18910433|BRD-K60633875,estradiol,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,BRD-A18917088|BRD-K18910433|BRD-K60633875,estradiol,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,BRD-A18917088|BRD-K18910433|BRD-K60633875,estradiol,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2
VPBYZLCHOKSGRX,BRD-K90993449,KRN-633,VEGFR inhibitor,FLT1|FLT4|KDR,BRD-K90993449,KRN-633,VEGFR inhibitor,FLT1|FLT4|KDR,BRD-K90993449,KRN-633,VEGFR inhibitor,FLT1|FLT4|KDR,BRD-K90993449,KRN-633,VEGFR inhibitor,FLT1|FLT4|KDR
VPGRYOFKCNULNK,BRD-A75402480|BRD-K24556098|BRD-K54733518,deoxycorticosterone-acetate,progestogen hormone,NR3C2,BRD-A75402480|BRD-K24556098,deoxycorticosterone-acetate,progestogen hormone,NR3C2,BRD-A75402480|BRD-K24556098|BRD-K54733518,deoxycorticosterone-acetate,progestogen hormone,NR3C2,BRD-A75402480|BRD-K24556098|BRD-K54733518,deoxycorticosterone-acetate,progestogen hormone,NR3C2
VPHPQNGOVQYUMG,BRD-K35775715,liranaftate,fungal squalene epoxidase inhibitor,,BRD-K35775715,liranaftate,fungal squalene epoxidase inhibitor,,BRD-K35775715,liranaftate,fungal squalene epoxidase inhibitor,,BRD-K35775715,liranaftate,fungal squalene epoxidase inhibitor,
VPJXQGSRWJZDOB,BRD-K75037734,carbachol,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K75037734,carbachol,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K75037734,carbachol,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K75037734,carbachol,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2
VPPJLAIAVCUEMN,BRD-K68232650,lacosamide,collapsin response mediator protein inhibitor|collapsin response mediator protein stimulant|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K68232650,lacosamide,collapsin response mediator protein inhibitor|collapsin response mediator protein stimulant|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K68232650,lacosamide,collapsin response mediator protein inhibitor|collapsin response mediator protein stimulant|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,,,,
VPVLEBIVXZSOMQ,BRD-K94176593,TWS-119,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC,BRD-K94176593,TWS-119,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC,BRD-K94176593,TWS-119,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC,BRD-K94176593,TWS-119,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC
VQASKUSHBVDKGU,BRD-A22128695,paramethadione,anticonvulsant,CACNA1G|CACNA1H|CACNA1I,BRD-A22128695,paramethadione,anticonvulsant,CACNA1G|CACNA1H|CACNA1I,BRD-A22128695,paramethadione,anticonvulsant,CACNA1G|CACNA1H|CACNA1I,BRD-A22128695,paramethadione,anticonvulsant,CACNA1G
VQAYFKKCNSOZKM,BRD-K81807412,N6-methyladenosine,,,BRD-K81807412,N6-methyladenosine,,,BRD-K81807412,N6-methyladenosine,,,BRD-K81807412,N6-methyladenosine,,
VQGBOYBIENNKMI,BRD-K38019854,A-317491,purinergic receptor antagonist,P2RX3,BRD-K38019854,A-317491,purinergic receptor antagonist,P2RX3,BRD-K38019854,A-317491,purinergic receptor antagonist,P2RX3,BRD-K38019854,A-317491,purinergic receptor antagonist,P2RX3
VQHSOMBJVWLPSR,BRD-A34513497|BRD-K40787673,lacitol,osmosis stimulant,,BRD-A34513497|BRD-K40787673,lacitol,osmosis stimulant,,BRD-A34513497|BRD-K40787673,lacitol,osmosis stimulant,,BRD-A34513497|BRD-K40787673,lacitol,laxative,
VQHUQHAPWMNBLP,BRD-A72066420,mifobate,PPAR receptor antagonist,PPARG,BRD-A72066420,mifobate,PPAR receptor antagonist,PPARG,BRD-A72066420,mifobate,PPAR receptor antagonist,PPARG,BRD-K00004244,mifobate,PPAR receptor antagonist,PPARG
VQKSCYBKUIDZEI,BRD-K83020231,DBPR108,dipeptidyl peptidase inhibitor,DPP4,BRD-K83020231,DBPR108,dipeptidyl peptidase inhibitor,DPP4,BRD-K83020231,DBPR108,dipeptidyl peptidase inhibitor,DPP4,BRD-K83020231,DBPR108,dipeptidyl peptidase inhibitor,DPP4
VQLPLYSROCPWFF,BRD-K53532120,U-50488-(-),opioid receptor agonist,OPRK1,BRD-K53532120,U-50488-(-),opioid receptor agonist,OPRK1,BRD-K53532120|BRD-M57185017,U-50488-(-),opioid receptor agonist,OPRK1,BRD-K53532120|BRD-M57185017,U-50488-(-),opioid receptor agonist,OPRK1
VQODGRNSFPNSQE,BRD-A79380603|BRD-A83802939,dexamethasone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,BRD-A79380603|BRD-A83802939,dexamethasone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,BRD-A79380603|BRD-A83802939,dexamethasone-sodium-phosphate,glucocorticoid receptor agonist,NR3C1,BRD-K00005349,betamethasone-phosphate,,
VQOJFGFKIVFMDH,BRD-K35781423,SANT-2,smoothened receptor antagonist,SHH|SMO,BRD-K35781423,SANT-2,smoothened receptor antagonist,SHH|SMO,BRD-K35781423,SANT-2,smoothened receptor antagonist,SHH|SMO,BRD-K35781423,SANT-2,smoothened receptor antagonist,SHH|SMO
VQOXZBDYSJBXMA,BRD-A78080706|BRD-K25770965|BRD-K33243830|BRD-K45107378|BRD-K82677637,nystatin,fungal ergosterol inhibitor,,BRD-A78080706|BRD-K25770965|BRD-K33243830|BRD-K45107378|BRD-K82677637,nystatin,fungal ergosterol inhibitor,,BRD-A78080706|BRD-K21656326|BRD-K25770965|BRD-K33243830|BRD-K45107378|BRD-K82677637,nystatin,fungal ergosterol inhibitor,,BRD-K21656326|BRD-K33243830|BRD-K82677637,nystatin,fungal ergosterol inhibitor,
VQPFSIRUEPQQPP,BRD-K01174345,anamorelin,growth hormone secretagogue receptor agonist,GHSR,BRD-K01174345,anamorelin,growth hormone secretagogue receptor agonist,GHSR,BRD-K01174345,anamorelin,growth hormone secretagogue receptor agonist,GHSR,BRD-K01174345,anamorelin,growth hormone secretagogue receptor agonist,GHSR
VQQVWGVXDIPORV,BRD-K76973696,tryptanthrin,cyclooxygenase inhibitor,IDO1,BRD-K76973696,tryptanthrin,cyclooxygenase inhibitor,IDO1,BRD-K76973696,tryptanthrin,cyclooxygenase inhibitor,IDO1,BRD-K76973696,tryptanthrin,cyclooxygenase inhibitor,IDO1
VRBKIVRKKCLPHA,BRD-K90789829,nefazodone,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,BRD-K90789829,nefazodone,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,BRD-K90789829,nefazodone,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,BRD-K90789829,nefazodone,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4
VRDIULHPQTYCLN,BRD-K75360161,protionamide,,,BRD-K75360161,protionamide,,,BRD-K75360161,protionamide,,,BRD-K97863768,protionamide,,
VRKHYMXTJQCIND,BRD-A49374018,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,BRD-A49374018,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,BRD-A49374018,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,,,,
VRQMAABPASPXMW,BRD-K28392481,AZD4547,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,BRD-K28392481,AZD4547,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,BRD-K28392481,AZD4547,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,BRD-K28392481,AZD4547,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR
VRQVVMDWGGWHTJ,BRD-K35559145,levomepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C,BRD-K35559145,levomepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C,BRD-K35559145,levomepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C,BRD-K35559145,levomepromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C
VRTWBAAJJOHBQU,BRD-K05446112,ledipasvir,HCV inhibitor,,BRD-K05446112,ledipasvir,HCV inhibitor,,BRD-K05446112,ledipasvir,HCV inhibitor,,BRD-K05446112,ledipasvir,HCV inhibitor,
VRYKTHBAWRESFI,BRD-K66019333,oxantel,anthelmintic agent,,BRD-K66019333,oxantel,anthelmintic agent,,BRD-K66019333,oxantel,anthelmintic agent,,BRD-K66019333,oxantel,anthelmintic agent,
VRYMTAVOXVTQEF,BRD-K81144366,moxisylyte,adrenergic receptor antagonist,,BRD-K81144366,moxisylyte,adrenergic receptor antagonist,,BRD-K81144366,moxisylyte,adrenergic receptor antagonist,,BRD-K81144366,moxisylyte,adrenergic receptor antagonist,
VSJKWCGYPAHWDS,BRD-K37890730,camptothecin,topoisomerase inhibitor,TOP1,BRD-K37890730,camptothecin,topoisomerase inhibitor,TOP1,BRD-K37890730,camptothecin,topoisomerase inhibitor,TOP1,BRD-K37890730,camptothecin,topoisomerase inhibitor,TOP1
VSLIUWLPFRVCDL,BRD-K45125084,zolimidine,mucus protecting agent,,BRD-K45125084,zolimidine,mucus protecting agent,,BRD-K45125084,zolimidine,mucus protecting agent,,BRD-K45125084,zolimidine,mucus protecting agent,
VSNHCAURESNICA,BRD-K51747290,hydroxyurea,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,BRD-K51747290,hydroxyurea,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,BRD-K51747290,hydroxyurea,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,BRD-K51747290,hydroxyurea,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B
VSOUDUXMPUHJEU,BRD-K95828359,MK-3697,orexin receptor antagonist,HCRTR2,BRD-K95828359,MK-3697,orexin receptor antagonist,HCRTR2,BRD-K95828359,MK-3697,orexin receptor antagonist,HCRTR2,BRD-K95828359,MK-3697,orexin receptor antagonist,HCRTR2
VSQQQLOSPVPRAZ,BRD-A64485570|BRD-K03243820,trifluridine,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,BRD-A64485570|BRD-K03243820,trifluridine,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,BRD-A64485570|BRD-K03243820,trifluridine,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,BRD-A64485570|BRD-K03243820,trifluridine,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS
VSRBKQFNFZQRBM,BRD-A19958636,tuaminoheptane,,,BRD-A19958636,tuaminoheptane,,,BRD-A19958636,tuaminoheptane,,,BRD-A19958636,tuaminoheptane,,
VSTBFMUUCAUPAF,BRD-M75036822,hemin,enzyme inducer,,BRD-M75036822,hemin,enzyme inducer,,BRD-M75036822,hemin,enzyme inducer,,,,,
VSWBSWWIRNCQIJ,BRD-K95260951,asenapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K95260951|BRD-M82363962,asenapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K95260951|BRD-M82363962,asenapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K00003551,asenapine,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A
VSWDORGPIHIGNW,BRD-K80970344,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor,HSD11B1|RELA,BRD-K80970344,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor,HSD11B1|RELA,BRD-K80970344,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor,HSD11B1|RELA,BRD-K80970344,pyrrolidine-dithiocarbamate,NFkB pathway inhibitor,HSD11B1|RELA
VSWPGAIWKHPTKX,BRD-K06147391,telenzepine,acetylcholine receptor antagonist,CHRM1,BRD-K06147391,telenzepine,acetylcholine receptor antagonist,CHRM1,BRD-K06147391,telenzepine,acetylcholine receptor antagonist,CHRM1,BRD-K06147391,telenzepine,acetylcholine receptor antagonist,CHRM1
VSZGPKBBMSAYNT,BRD-K76011241,oseltamivir-phosphate,neuraminidase inhibitor,CES1|NEU1|NEU2,BRD-K76011241,oseltamivir-phosphate,neuraminidase inhibitor,CES1|NEU1|NEU2,BRD-K76011241|BRD-U75584406,oseltamivir-phosphate,neuraminidase inhibitor,CES1|NEU1|NEU2,BRD-K76011241|BRD-U75584406,oseltamivir-phosphate,neuraminidase inhibitor,CES1|NEU1|NEU2
VTAARTQTOOYTES,BRD-K65359424,eglumetad,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM8,BRD-K65359424,eglumetad,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM8,BRD-K65359424,eglumetad,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM8,BRD-K65359424,eglumetad,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM8
VTANGSDRFFLTSQ,BRD-K43316319,MK-2295,TRPV antagonist,TRPV1,BRD-K43316319,MK-2295,TRPV antagonist,TRPV1,BRD-K43316319,MK-2295,TRPV antagonist,TRPV1,BRD-K43316319,MK-2295,TRPV antagonist,TRPV1
VTGBZWHPJFMTKS,BRD-K17705806,JTC-801,opioid receptor antagonist,OPRL1,BRD-K17705806,JTC-801,opioid receptor antagonist,OPRL1,BRD-K17705806,JTC-801,opioid receptor antagonist,OPRL1,BRD-K17705806,JTC-801,opioid receptor antagonist,OPRL1
VTHUYJIXSMGYOQ,BRD-K92902018,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR,BRD-K92902018,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR,BRD-K92902018,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR,BRD-K92902018,hydroxyprogesterone-acetate,progesterone receptor agonist,PGR
VTJXFTPMFYAJJU,BRD-K49657628,tyrphostin-AG-18,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,BRD-K49657628,tyrphostin-AG-18,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,BRD-K49657628,tyrphostin-AG-18,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,BRD-K49657628,tyrphostin-AG-18,EGFR inhibitor|tyrosine kinase inhibitor,EGFR
VTRAEEWXHOVJFV,BRD-K83144676,olmesartan,angiotensin receptor antagonist,AGTR1,BRD-K83144676,olmesartan,angiotensin receptor antagonist,AGTR1,BRD-K83144676,olmesartan,angiotensin receptor antagonist,AGTR1,BRD-K83144676,olmesartan,angiotensin receptor antagonist,AGTR1
VUAFHZCUKUDDBC,BRD-K24697665,bucillamine,immunosuppressant,,BRD-K24697665,bucillamine,immunosuppressant,,BRD-K24697665,bucillamine,immunosuppressant,,BRD-K24697665,bucillamine,immunosuppressant,
VUAXHMVRKOTJKP,BRD-K44963273,HQK-1001,,,BRD-K44963273,HQK-1001,,,BRD-K44963273,HQK-1001,,,BRD-K44963273,HQK-1001,,
VUBILPOZTRGZJK,BRD-K36258877,AZ-10417808,caspase inhibitor,CASP3,BRD-K36258877,AZ-10417808,caspase inhibitor,CASP3,BRD-K36258877,AZ-10417808,caspase inhibitor,CASP3,BRD-K36258877,AZ-10417808,caspase inhibitor,CASP3
VUIRVWPJNKZOSS,BRD-K93942811,ML-323,ubiquitin specific protease inhibitor,USP1,BRD-K93942811,ML-323,ubiquitin specific protease inhibitor,USP1,BRD-K93942811,ML-323,ubiquitin specific protease inhibitor,USP1,BRD-K93942811,ML323,ubiquitin specific protease inhibitor,USP1
VUPOTURDKDMIGQ,BRD-K54708045,nTZDpa,PPAR receptor agonist,PPARG,BRD-K54708045,nTZDpa,PPAR receptor agonist,PPARG,BRD-K54708045,nTZDpa,PPAR receptor agonist,PPARG,BRD-K54708045,nTZDpa,PPAR receptor agonist,PPARG
VUSNBQDZGKZEDL,BRD-K45479396,BP-554,serotonin receptor agonist,HTR1A,BRD-K45479396,BP-554,serotonin receptor agonist,HTR1A,BRD-K45479396,BP-554,serotonin receptor agonist,HTR1A,BRD-K45479396,BP-554,serotonin receptor agonist,HTR1A
VUVUVNZRUGEAHB,BRD-K36363294,I-BET151,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K36363294,I-BET151,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K36363294,I-BET151,bromodomain inhibitor,BRD2|BRD3|BRD4,BRD-K36363294,I-BET151,bromodomain inhibitor,BRD2|BRD3|BRD4
VUWXAQFLTSBUDB,BRD-K09778810,FGIN-1-27,inositol monophosphatase inhibitor,TSPO,BRD-K09778810,FGIN-1-27,inositol monophosphatase inhibitor,TSPO,BRD-K09778810,FGIN-1-27,inositol monophosphatase inhibitor,TSPO,BRD-K09778810,FGIN-1-27,inositol monophosphatase inhibitor,TSPO
VVBFISAUNSXQGZ,BRD-K57774929,foropafant,platelet activating factor receptor antagonist,PTAFR,BRD-K57774929,foropafant,platelet activating factor receptor antagonist,PTAFR,BRD-K57774929,foropafant,platelet activating factor receptor antagonist,PTAFR,BRD-K57774929,foropafant,platelet activating factor receptor antagonist,PTAFR
VVFDMWZLBPUKTD,BRD-A76661185,cefotiam-cilexetil,bacterial cell wall synthesis inhibitor,,BRD-A76661185,cefotiam-cilexetil,bacterial cell wall synthesis inhibitor,,BRD-A76661185,cefotiam-cilexetil,bacterial cell wall synthesis inhibitor,,BRD-A76661185,cefotiam-cilexetil,bacterial cell wall synthesis inhibitor,
VVIAGPKUTFNRDU,BRD-A75919782|BRD-K97009491,calcium-levofolinate|leucovorin,|folate receptor ligand,|TYMS,BRD-A75919782|BRD-K97009491,calcium-levofolinate|leucovorin,|folate receptor ligand,|TYMS,BRD-A75919782|BRD-K97009491,calcium-levofolinate|leucovorin,|folate receptor ligand,|TYMS,BRD-K01825581|BRD-K97009491,calcium-levofolinate|leucovorin,|folate receptor ligand,
VVLHQJDAUIPZFH,BRD-K48443249,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K48443249,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K48443249,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K48443249,CNX-774,Bruton's tyrosine kinase (BTK) inhibitor,BTK
VVNCNSJFMMFHPL,BRD-A16376407|BRD-K17518951,penicillamine-(D)|penicillamine-(racemic),|chelating agent,,BRD-A16376407|BRD-K17518951,penicillamine-(D)|penicillamine-(racemic),|chelating agent,,BRD-A16376407|BRD-K17518951,penicillamine-(D)|penicillamine-(racemic),|chelating agent,,BRD-K01825697|BRD-K17518951,penicillamine-(D)|penicillamine-(racemic),|chelating agent,
VVOAZFWZEDHOOU,BRD-K26168087,magnolol,PPAR receptor agonist,GABRA1|PPARG,BRD-K26168087,magnolol,PPAR receptor agonist,GABRA1|PPARG,BRD-K26168087,magnolol,PPAR receptor agonist,GABRA1|PPARG,BRD-K26168087,magnolol,PPAR receptor agonist,GABRA1|PPARG
VVOIQBFMTVCINR,BRD-K26024145,desoxycorticosterone-pivalate,corticosteroid agonist,NR3C2,BRD-K26024145,desoxycorticosterone-pivalate,corticosteroid agonist,NR3C2,BRD-K26024145,desoxycorticosterone-pivalate,corticosteroid agonist,NR3C2,BRD-K26024145,desoxycorticosterone-pivalate,corticosteroid agonist,NR3C2
VVSMJVQHDZUPIL,BRD-K07785030,7-keto-DHEA,steroid,,BRD-K07785030,7-keto-DHEA,steroid,,BRD-K07785030,7-keto-DHEA,steroid,,BRD-K07785030,7-keto-DHEA,steroid,
VVWYOYDLCMFIEM,BRD-K90885812,propantheline,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K90885812,propantheline,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K90885812,propantheline,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K90885812,propantheline,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4
VVZBFOKBSDGVGZ,BRD-K34234316,benzalkonium,Cationic surfactant,,BRD-K34234316,benzalkonium,Cationic surfactant,,BRD-K34234316,benzalkonium,Cationic surfactant,,BRD-K34234316,benzalkonium,cationic surfactant,
VVZNWYXIOADGSW,BRD-K39166528,ID-8,,,BRD-K39166528,ID-8,,,BRD-K39166528,ID-8,,,BRD-K39166528,ID-8,,
VWAUPFMBXBWEQY,BRD-A27554692|BRD-K14619660,altrenogest,progestogen hormone,PGR,BRD-A27554692|BRD-K14619660,altrenogest,progestogen hormone,PGR,BRD-A27554692|BRD-K14619660,altrenogest,progestogen hormone,PGR,BRD-K50276048,altrenogest,progestogen hormone,PGR
VWFCHDSQECPREK,BRD-K96153583,cidofovir,DNA polymerase inhibitor,,BRD-K96153583,cidofovir,DNA polymerase inhibitor,,BRD-K96153583,cidofovir,DNA polymerase inhibitor,,BRD-K96153583,cidofovir,DNA polymerase inhibitor,
VWLHWLSRQJQWRG,BRD-K81128206,edrophonium,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K81128206,edrophonium,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K81128206,edrophonium,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K81128206,edrophonium,acetylcholinesterase inhibitor,ACHE|BCHE
VWMJHAFYPMOMGF,BRD-K43410529,MLN2480,RAF inhibitor,,BRD-K43410529,MLN2480,RAF inhibitor,,BRD-K43410529,MLN2480,RAF inhibitor,,BRD-K43410529,MLN2480,RAF inhibitor,
VWOMTTIMBHBPBI,BRD-K48059230,YM-298198,glutamate receptor antagonist,GRM1,BRD-K48059230,YM-298198,glutamate receptor antagonist,GRM1,BRD-K48059230,YM-298198-desmethyl,,,BRD-K48059230,YM-298198-desmethyl,glutamate receptor antagonist,GRM1
VWPOSFSPZNDTMJ,BRD-A87606379,nadolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A87606379,nadolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A87606379,nadolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A87606379,nadolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
VWQWXZAWFPZJDA,BRD-A07000685,hydrocortisone-hemisuccinate,,,BRD-A07000685,hydrocortisone-hemisuccinate,,,BRD-A07000685,hydrocortisone-hemisuccinate,,,BRD-K00025601,hydrocortisone-hemisuccinate,,
VWQZJJZGISNFOE,BRD-K74236708,acitazanolast,mediator release inhibitor,,BRD-K74236708,acitazanolast,mediator release inhibitor,,BRD-K74236708,acitazanolast,mediator release inhibitor,,BRD-K74236708,acitazanolast,mediator release inhibitor,
VWUXBMIQPBEWFH,BRD-A03249105|BRD-A50947932|BRD-A52958897,fulvestrant,estrogen receptor antagonist,ESR1|ESR2|GPER1,BRD-A03249105|BRD-A17828570|BRD-A50947932,fulvestrant,estrogen receptor antagonist,ESR1|ESR2|GPER1,BRD-A03249105|BRD-A17828570|BRD-A50947932|BRD-A85667082,fulvestrant,estrogen receptor antagonist,ESR1|ESR2|GPER1,BRD-A03249105|BRD-A17828570|BRD-A50947932|BRD-A85667082,fulvestrant,estrogen receptor antagonist,ESR1|ESR2|GPER1
VWVKUNOPTJGDOB,BRD-K96344439,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK,BRD-K96344439,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK,BRD-K96344439,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK,BRD-K96344439,tofogliflozin,sodium/glucose cotransporter inhibitor,GCK
VWVSBHGCDBMOOT,BRD-A49447682,desoximetasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A49447682,desoximetasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A49447682,desoximetasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-K30697463,desoximetasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B
VWWQXMAJTJZDQX,BRD-A86545589,flavin-adenine-dinucleotide,,ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH,BRD-A86545589,flavin-adenine-dinucleotide,,ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH,BRD-A86545589,flavin-adenine-dinucleotide,,ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH,BRD-K01666925,flavin-adenine-dinucleotide,,ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH
VWXRQYYUEIYXCZ,BRD-A85261566,atosiban,oxytocin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A85261566,atosiban,oxytocin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A85261566,atosiban,oxytocin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A85261566,atosiban,oxytocin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR
VXBAJLGYBMTJCY,BRD-K14560436,TG-02,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,CDK1|CDK2|CDK7|CDK9|FLT3|JAK2,BRD-K14560436,TG-02,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,CDK1|CDK2|CDK7|CDK9|FLT3|JAK2,BRD-K14560436,TG-02,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,CDK1|CDK2|CDK7|CDK9|FLT3|JAK2,BRD-K14560436,TG-02,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,CDK1|CDK2|CDK7|CDK9|FLT3|JAK2
VXFJYXUZANRPDJ,BRD-A32505112,trandolapril,angiotensin converting enzyme inhibitor,ACE,BRD-A32505112,trandolapril,angiotensin converting enzyme inhibitor,ACE,BRD-A32505112,trandolapril,angiotensin converting enzyme inhibitor,ACE,BRD-K28550399,trandolapril,angiotensin converting enzyme inhibitor,ACE
VXJABHHJLXLNMP,BRD-K65417056,meprylcaine,local anesthetic,,BRD-K65417056,meprylcaine,local anesthetic,,BRD-K65417056,meprylcaine,local anesthetic,,BRD-K65417056,meprylcaine,local anesthetic,
VXKHXGOKWPXYNA,BRD-K62685538,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR,BRD-K62685538,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR,BRD-K62685538,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR,BRD-K62685538,triptorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR
VXLBSYHAEKDUSU,BRD-K52598503,mofegiline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K52598503,mofegiline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K52598503,mofegiline,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K52598503,mofegiline,monoamine oxidase inhibitor,MAOA|MAOB
VXMOONUMYLCFJD,BRD-K78781788,barnidipine,calcium channel blocker,,BRD-K78781788,barnidipine,calcium channel blocker,,BRD-K78781788,barnidipine,calcium channel blocker,,BRD-K78781788,barnidipine,calcium channel blocker,
VXMVXDITZWJXJN,BRD-A45906415,K-MAP,,,BRD-A45906415,K-MAP,,,BRD-A45906415,K-MAP,,,BRD-A45906415|BRD-K00004531,K-MAP|benaxibine,,
VXQCCZHCFBHTTD,BRD-K56543881,ADX-47273,glutamate receptor modulator,GRM5,BRD-K56543881,ADX-47273,glutamate receptor modulator,GRM5,BRD-K56543881,ADX-47273,glutamate receptor modulator,GRM5,BRD-K56543881,ADX-47273,glutamate receptor modulator,GRM5
VXROHTDSRBRJLN,BRD-K51387999,amezinium,adrenergic receptor agonist,ADRB2,BRD-K51387999,amezinium,adrenergic receptor agonist,ADRB2,BRD-K51387999,amezinium,adrenergic receptor agonist,ADRB2,BRD-K51387999,amezinium,adrenergic receptor agonist,ADRB2
VXTGHWHFYNYFFV,BRD-A67060370,albendazole-oxide,anthelmintic agent,,BRD-A67060370,albendazole-oxide,anthelmintic agent,,BRD-A67060370,albendazole-oxide,anthelmintic agent,,BRD-A67060370,albendazole-oxide,anthelmintic agent,
VXVNYCRICCVPTD,BRD-A08545410|BRD-A36632888,doxycycline,metalloproteinase inhibitor,MMP8,BRD-A08545410|BRD-M28128163,doxycycline,metalloproteinase inhibitor,MMP8,BRD-A08545410|BRD-A36632888|BRD-M28128163,doxycycline,metalloproteinase inhibitor,MMP8,,,,
VYCMAAOURFJIHD,BRD-A59961917,BQ-123,endothelin receptor antagonist,EDNRA,BRD-A59961917,BQ-123,endothelin receptor antagonist,EDNRA,BRD-A59961917,BQ-123,endothelin receptor antagonist,EDNRA,BRD-K00003554,BQ-123,endothelin receptor antagonist,EDNRA
VYFYYTLLBUKUHU,BRD-K43887077,dopamine,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K43887077,dopamine,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K43887077,dopamine,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K43887077,dopamine,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4
VYGQUTWHTHXGQB,BRD-K80595380,retinyl-palmitate,,,BRD-K80595380,retinyl-palmitate,,,BRD-K80595380,retinyl-palmitate,,,BRD-K80595380,retinyl-palmitate,,
VYMDGNCVAMGZFE,BRD-K10843433,phenylbutazone,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,BRD-K10843433,phenylbutazone,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,BRD-K10843433,phenylbutazone,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,BRD-K10843433,phenylbutazone,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2
VYQNWZOUAUKGHI,BRD-K54262262,monobenzone,melanin inhibitor,TYR,BRD-K54262262,monobenzone,melanin inhibitor,TYR,BRD-K54262262,monobenzone,melanin inhibitor,TYR,BRD-K54262262,monobenzone,melanin inhibitor,TYR
VYVKHNNGDFVQGA,BRD-A09467419,mebeverine,acetylcholine receptor antagonist,CHRM1,BRD-A09467419,mebeverine,acetylcholine receptor antagonist,CHRM1,BRD-A09467419,mebeverine,acetylcholine receptor antagonist,CHRM1,BRD-A09467419,mebeverine,acetylcholine receptor antagonist,CHRM1
VYXWHVDEWWHDLH,BRD-K88443722,AM679,cannabinoid receptor agonist|lipoxygenase inhibitor,ALOX5AP|CNR1|CNR2,BRD-K88443722,AM679,cannabinoid receptor agonist|lipoxygenase inhibitor,ALOX5AP|CNR1|CNR2,BRD-K88443722,AM679,cannabinoid receptor agonist|lipoxygenase inhibitor,ALOX5AP|CNR1|CNR2,BRD-K88443722,AM679,cannabinoid receptor agonist|lipoxygenase inhibitor,ALOX5AP|CNR1|CNR2
VYZAHLCBVHPDDF,BRD-K97833335,"2,4-dinitrochlorobenzene",,,BRD-K97833335,"2,4-dinitrochlorobenzene",thioredoxin inhibitor,TXN,BRD-K97833335,"2,4-dinitrochlorobenzene",thioredoxin inhibitor,TXN,BRD-K97833335,"2,4-dinitrochlorobenzene",thioredoxin inhibitor,TXN
VZCCETWTMQHEPK,BRD-K18059238,gamma-linolenic-acid,cyclooxygenase inhibitor|prostanoid receptor agonist,PTGS1|PTGS2,BRD-K18059238,gamma-linolenic-acid,cyclooxygenase inhibitor|prostanoid receptor agonist,PTGS1|PTGS2,BRD-K18059238,gamma-linolenic-acid,cyclooxygenase inhibitor|prostanoid receptor agonist,PTGS1|PTGS2,BRD-K18059238,gamma-linolenic-acid,cyclooxygenase inhibitor|prostanoid receptor agonist,PTGS1|PTGS2
VZJFGSRCJCXDSG,BRD-K10598093,hexamethonium,cholinergic receptor antagonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6,BRD-K10598093,hexamethonium,cholinergic receptor antagonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6,BRD-K10598093,hexamethonium,cholinergic receptor antagonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6,BRD-K10598093,hexamethonium,cholinergic receptor antagonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6
VZMSCIKIANDZNI,BRD-K69690935,curcumin,NFkB pathway inhibitor|cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,BRD-K69690935,curcumin,NFkB pathway inhibitor|cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,,,,,,,,
VZRNTCHTJRLTMU,BRD-A14344385,IDRA-21,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A14344385,IDRA-21,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A14344385,IDRA-21,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A14344385,IDRA-21,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4
VZXMZMJSGLFKQI,BRD-K45163704,midafotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K45163704,midafotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K45163704,midafotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,BRD-K45163704,midafotel,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D
VZXPDPZARILFQX,BRD-K63247785,o-acetyl-L-serine,,PTGS1,BRD-K63247785,o-acetyl-L-serine,,PTGS1,BRD-K63247785,o-acetyl-L-serine,,PTGS1,BRD-K63247785,O-acetyl-L-serine,,PTGS1
VZXULFIUJKSVJY,BRD-K10226125,AC1NDSS5,,,BRD-K10226125,AC1NDSS5,,,BRD-K10226125,AC1NDSS5,,,BRD-K10226125,AC1NDSS5,,
VZYCZNZBPPHOFY,BRD-K08619574,thioproperazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,BRD-K08619574,thioproperazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,BRD-K08619574,thioproperazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,BRD-K08619574,thioproperazine,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A
VZZJRYRQSPEMTK,BRD-K19796430,sonidegib,smoothened receptor antagonist,SMO,BRD-K19796430,sonidegib,smoothened receptor antagonist,SMO,BRD-K19796430,sonidegib,smoothened receptor antagonist,SMO,BRD-K19796430,sonidegib,smoothened receptor antagonist,SMO
WAAPEIZFCHNLKK,BRD-A63752151,fidarestat,aldose reductase inhibitor,AKR1B1,BRD-A63752151,fidarestat,aldose reductase inhibitor,AKR1B1,BRD-A63752151,fidarestat,aldose reductase inhibitor,AKR1B1,BRD-A63752151,fidarestat,aldose reductase inhibitor,AKR1B1
WAEXFXRVDQXREF,BRD-K81418486,vorinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,BRD-K81418486,vorinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,BRD-K81418486,vorinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,BRD-K81418486,vorinostat,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9
WAFNZAURAWBNDZ,BRD-K88544581,CI-976,ACAT inhibitor,ACAT1|CES1,BRD-K88544581,CI-976,ACAT inhibitor,ACAT1|CES1,BRD-K88544581,CI-976,ACAT inhibitor,ACAT1|CES1,BRD-K88544581,CI-976,ACAT inhibitor,ACAT1|CES1
WAOBCCBUTHNTFO,BRD-K61250484,FPH1-(BRD-6125),hepatocyte function enhancer,,BRD-K61250484,FPH1-(BRD-6125),hepatocyte function enhancer,,BRD-K61250484,FPH1-(BRD-6125),hepatocyte function enhancer,,BRD-K61250484,FPH1-(BRD-6125),hepatocyte function enhancer,
WAOQONBSWFLFPE,BRD-K04111260,raclopride,dopamine receptor antagonist,DRD2|DRD3|HTR1A,BRD-K04111260,raclopride,dopamine receptor antagonist,DRD2|DRD3|HTR1A,BRD-K04111260,raclopride,dopamine receptor antagonist,DRD2|DRD3|HTR1A,BRD-K04111260,raclopride,dopamine receptor antagonist,DRD2|DRD3|HTR1A
WAXQNWCZJDTGBU,BRD-K97428065,netupitant,tachykinin antagonist,TACR1,BRD-K97428065,netupitant,tachykinin antagonist,TACR1,BRD-K97428065,netupitant,tachykinin antagonist,TACR1,BRD-K97428065,netupitant,tachykinin antagonist,TACR1
WAZQAZKAZLXFMK,BRD-K68558722,deracoxib,cyclooxygenase inhibitor,PTGS2,BRD-K68558722,deracoxib,cyclooxygenase inhibitor,PTGS2,BRD-K68558722,deracoxib,cyclooxygenase inhibitor,PTGS2,BRD-K68558722,deracoxib,cyclooxygenase inhibitor,PTGS2
WBGKWQHBNHJJPZ,BRD-A26858303|BRD-K21528677|BRD-K30131328,desonide,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A26858303|BRD-K21528677,desonide,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A26858303|BRD-K21528677|BRD-K30131328,desonide,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A26858303|BRD-K21528677|BRD-K30131328,desonide,glucocorticoid receptor agonist,NR3C1|PLA2G1B
WBHHMMIMDMUBKC,BRD-K33682646,ricinoleic-acid,prostanoid receptor agonist,PTGER3,BRD-K33682646,ricinoleic-acid,prostanoid receptor agonist,PTGER3,BRD-K33682646,ricinoleic-acid,prostanoid receptor agonist,PTGER3,BRD-K33682646,ricinoleic-acid,prostanoid receptor agonist,PTGER3
WBKCKEHGXNWYMO,BRD-K98203492,GSK-J4,histone lysine demethylase inhibitor,KDM6A|KDM6B,BRD-K98203492,GSK-J4,histone lysine demethylase inhibitor,KDM6A|KDM6B,BRD-K98203492,GSK-J4,histone lysine demethylase inhibitor,KDM6A|KDM6B,BRD-K98203492,GSK-J4,histone lysine demethylase inhibitor,KDM6A|KDM6B
WBPYTXDJUQJLPQ,BRD-K37753391|BRD-K90749417,tylosin,protein synthesis inhibitor,,BRD-K37753391|BRD-K90749417,tylosin,protein synthesis inhibitor,,BRD-K37753391|BRD-K90749417,tylosin,protein synthesis inhibitor,,BRD-K37753391|BRD-K90749417,tylosin,protein synthesis inhibitor,
WBSMIPAMAXNXFS,BRD-K89272762,NPPB,chloride channel blocker,ANO1|CLCN2|CLCN7|TRPA1,BRD-K89272762,NPPB,chloride channel blocker,ANO1|CLCN2|CLCN7|TRPA1,BRD-K89272762,NPPB,chloride channel blocker,ANO1|CLCN2|CLCN7|TRPA1,BRD-K89272762,NPPB,chloride channel blocker,ANO1|CLCN2|CLCN7|TRPA1
WBSMZVIMANOCNX,BRD-A27924917,2-hydroxysaclofen,GABA receptor antagonist,GABBR1|GABBR2,BRD-A27924917,2-hydroxysaclofen,GABA receptor antagonist,GABBR1|GABBR2,BRD-A27924917,2-hydroxysaclofen,GABA receptor antagonist,GABBR1|GABBR2,BRD-A27924917,2-hydroxysaclofen,GABA receptor antagonist,GABBR1|GABBR2
WBWWGRHZICKQGZ,BRD-K81062487,taurocholate,G protein-coupled receptor agonist,CEL|FABP6|SLCO1C1,BRD-K81062487,taurocholate,G protein-coupled receptor agonist,CEL|FABP6|SLCO1C1,BRD-K81062487,taurocholate,G protein-coupled receptor agonist,CEL|FABP6|SLCO1C1,BRD-K81062487,taurocholate,G protein-coupled receptor agonist,CEL|FABP6|SLCO1C1
WBXPDJSOTKVWSJ,BRD-K32842773|BRD-K55395145,pemetrexed,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,BRD-K32842773|BRD-K55395145,pemetrexed,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,BRD-K32842773|BRD-K55395145|BRD-M17920320|BRD-M18147244,pemetrexed,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,BRD-K32842773|BRD-K55395145|BRD-M17920320|BRD-M18147244,pemetrexed,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS
WCDDVEOXEIYWFB,BRD-K59788572,hyaluronic-acid,,C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN,BRD-K59788572,hyaluronic-acid,,C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN,BRD-K59788572,hyaluronic-acid,,C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN,BRD-K59788572,hyaluronic-acid,,C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN
WCDWBPCFGJXFJZ,BRD-K96042922,etanidazole,bacterial cell wall synthesis inhibitor,,BRD-K96042922,etanidazole,bacterial cell wall synthesis inhibitor,,BRD-K96042922,etanidazole,bacterial cell wall synthesis inhibitor,,BRD-K96042922,etanidazole,bacterial cell wall synthesis inhibitor,
WCGUUGGRBIKTOS,BRD-K68185022,ursolic-acid,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,BRD-K68185022,ursolic-acid,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,BRD-A61767428|BRD-K68185022,ursolic-acid,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,BRD-A61767428|BRD-K68185022,ursolic-acid,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM
WCGXJPFHTHQNJL,BRD-K92492521,LY255283,leukotriene receptor antagonist,LTB4R|LTB4R2,BRD-K92492521,LY255283,leukotriene receptor antagonist,LTB4R|LTB4R2,BRD-K92492521,LY255283,leukotriene receptor antagonist,LTB4R|LTB4R2,BRD-K92492521,LY255283,leukotriene receptor antagonist,LTB4R|LTB4R2
WCKZRLOUKYFJDY,BRD-K30933884,UNBS-5162,CC chemokine receptor antagonist,,BRD-K30933884,UNBS-5162,CC chemokine receptor antagonist,,BRD-K30933884,UNBS-5162,CC chemokine receptor antagonist,,BRD-K30933884,unbs-5162,CC chemokine receptor antagonist,
WCMWVYQHPUQKHW,BRD-K78844995,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,,BRD-K78844995,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,,BRD-K78844995,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,,BRD-K78844995,N-[2-(piperidinylamino)ethyl]-4-iodobenzamide,sigma receptor ligand,
WCWSTNLSLKSJPK,BRD-A07738941,cabotegravir,HIV integrase inhibitor,,BRD-A07738941,cabotegravir,HIV integrase inhibitor,,BRD-A07738941|BRD-A95114378|BRD-K76819217,cabotegravir,HIV integrase inhibitor,,BRD-A07738941|BRD-A95114378|BRD-K76819217,cabotegravir,HIV integrase inhibitor,
WCWUXEGQKLTGDX,BRD-K28428262,brivanib,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,BRD-K28428262,brivanib,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,BRD-K28428262,brivanib,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,BRD-K28428262,brivanib,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR
WDDPHFBMKLOVOX,BRD-K34022604,clofarabine,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,BRD-K34022604,clofarabine,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,BRD-K34022604,clofarabine,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,BRD-K34022604,clofarabine,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B
WDEABJKSGGRCQA,BRD-K08290224,docebenone,lipoxygenase inhibitor,ALOX5,BRD-K08290224,docebenone,lipoxygenase inhibitor,ALOX5,BRD-K08290224,docebenone,lipoxygenase inhibitor,ALOX5,BRD-K08290224,docebenone,lipoxygenase inhibitor,ALOX5
WDENQIQQYWYTPO,BRD-K64034691,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K64034691,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K64034691,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K64034691,acalabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BTK
WDFKMLRRRCGAKS,BRD-K17075857,chloroxine,opioid receptor antagonist,OPRK1,BRD-K17075857,chloroxine,opioid receptor antagonist,OPRK1,BRD-K17075857,chloroxine,opioid receptor antagonist,OPRK1,BRD-K17075857,chloroxine,opioid receptor antagonist,OPRK1
WDIQXKYUSINZME,BRD-A57798559,bicuculline-methochloride-(-),GABA receptor antagonist,,BRD-A57798559,bicuculline-methochloride-(-),GABA receptor antagonist,,BRD-A57798559,bicuculline-methochloride-(-),GABA receptor antagonist,,BRD-K19094907,bicuculline-methochloride-(-),GABA receptor antagonist,
WDJHALXBUFZDSR,BRD-K73234506,lithium-acetoacetate,,,BRD-K73234506,lithium-acetoacetate,,,BRD-K73234506,lithium-acetoacetate,,,BRD-K73234506,lithium-acetoacetate,,FAH
WDJUZGPOPHTGOT,BRD-A93236127,digitoxin,ATPase inhibitor,ATP1A1,BRD-A93236127,digitoxin,ATPase inhibitor,ATP1A1,BRD-A93236127,digitoxin,ATPase inhibitor,ATP1A1,BRD-K63668566,digitoxin,ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2
WDLRUFUQRNWCPK,BRD-K11099631,gadoterate-meglumine,radiopaque medium,,BRD-K11099631,gadoterate-meglumine,radiopaque medium,,BRD-K11099631,gadoterate-meglumine,radiopaque medium,,BRD-K11099631,gadoterate-meglumine,radiopaque medium,
WDLWHQDACQUCJR,BRD-A85137183|BRD-K24871708,cefprozil,bacterial cell wall synthesis inhibitor,,BRD-A85137183|BRD-K24871708,cefprozil,bacterial cell wall synthesis inhibitor,,BRD-A85137183|BRD-K24871708,cefprozil,bacterial cell wall synthesis inhibitor,,BRD-A85137183|BRD-K24871708,cefprozil,bacterial cell wall synthesis inhibitor,
WDOGQTQEKVLZIJ,BRD-K06814349,fosbretabulin,VE-cadherin antagonist|tubulin polymerization inhibitor,CDH5,BRD-K06814349|BRD-K68399195,fosbretabulin,VE-cadherin antagonist|tubulin polymerization inhibitor,CDH5,BRD-K06814349|BRD-K68399195,fosbretabulin,VE-cadherin antagonist|tubulin polymerization inhibitor,CDH5,BRD-K06814349,fosbretabulin,VE-cadherin antagonist|tubulin polymerization inhibitor,CDH5
WDPFJWLDPVQCAJ,BRD-K19085898,darapladib,phospholipase inhibitor,PLA2G7,BRD-K19085898,darapladib,phospholipase inhibitor,PLA2G7,BRD-K19085898,darapladib,phospholipase inhibitor,PLA2G7,BRD-K19085898,darapladib,phospholipase inhibitor,PLA2G7
WDQPAMHFFCXSNU,BRD-K56614220,clofazimine,GK0582 inhibitor,,BRD-K56614220,clofazimine,GK0582 inhibitor,,BRD-K56614220,clofazimine,GK0582 inhibitor,,BRD-K56614220,clofazimine,GK0582 inhibitor,
WDRYRZXSPDWGEB,BRD-K78513633,lonidamine,glucokinase inhibitor,GCK,BRD-K78513633,lonidamine,glucokinase inhibitor,GCK,BRD-K78513633,lonidamine,glucokinase inhibitor,GCK,BRD-K78513633,lonidamine,glucokinase inhibitor,GCK
WDSCBUNMANHPFH,BRD-K72215350,acexamic-acid,5 alpha reductase inhibitor,GAST,BRD-K72215350,acexamic-acid,5 alpha reductase inhibitor,GAST,BRD-K72215350,acexamic-acid,5 alpha reductase inhibitor,GAST,BRD-K72215350,acexamic-acid,5 alpha reductase inhibitor,GAST
WDVSHHCDHLJJJR,BRD-K68408467,proflavine-hemisulfate,topical anesthetic,F2,BRD-K68408467,proflavine-hemisulfate,topical anesthetic,F2,BRD-K68408467,proflavine-hemisulfate,topical anesthetic,F2,BRD-K68408467,proflavine-hemisulfate,topical anesthetic,F2
WDWIMDKOXZZYHH,BRD-K78318619,PF-4981517,cytochrome P450 inhibitor,CYP3A4,BRD-K78318619,PF-4981517,cytochrome P450 inhibitor,CYP3A4,BRD-K78318619,PF-4981517,cytochrome P450 inhibitor,CYP3A4,BRD-K78318619,PF-4981517,cytochrome P450 inhibitor,CYP3A4
WDXRGPWQVHZTQJ,BRD-K26674531,GR-235,FXR antagonist|estrogen receptor agonist|progesterone receptor agonist,NR1H4,BRD-K26674531,GR-235,FXR antagonist|estrogen receptor agonist|progesterone receptor agonist,NR1H4,BRD-K26674531,GR-235,FXR antagonist|estrogen receptor agonist|progesterone receptor agonist,NR1H4,BRD-K00004242,GR-235,FXR antagonist|estrogen receptor agonist|progesterone receptor agonist,NR1H4
WDZCUPBHRAEYDL,BRD-K42569090|BRD-K55889443|BRD-K62325629,rifapentine,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4,BRD-K42569090|BRD-K55889443|BRD-K62325629,rifapentine,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4,BRD-K28346421|BRD-K42569090|BRD-K55889443|BRD-K62325629,rifapentine,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4,BRD-K28346421|BRD-K42569090|BRD-K55889443|BRD-K62325629,rifapentine,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4
WDZVGELJXXEGPV,BRD-K56800335|BRD-K62736196,guanaben-acetate,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K56800335|BRD-K62736196,guanaben-acetate,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K56800335|BRD-K62736196,guanaben-acetate,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K56800335|BRD-K62736196,guanaben-acetate,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C
WEAJZXNPAWBCOA,BRD-K65781196,avanafil,phosphodiesterase inhibitor,PDE5A,BRD-K65781196,avanafil,phosphodiesterase inhibitor,PDE5A,BRD-K65781196,avanafil,phosphodiesterase inhibitor,PDE5A,BRD-K65781196,avanafil,phosphodiesterase inhibitor,PDE5A
WECKJONDRAUFDD,BRD-K28863208,PNU-282987,cholinergic receptor agonist,CHRNA7,BRD-K28863208,PNU-282987,cholinergic receptor agonist,CHRNA7,BRD-K28863208,PNU-282987,cholinergic receptor agonist,CHRNA7,BRD-K28863208,PNU-282987,cholinergic receptor agonist,CHRNA7
WEEGYLXZBRQIMU,BRD-K15671046|BRD-K29996876,eucalyptol,acetylcholinesterase inhibitor,ACHE,BRD-K15671046|BRD-K29996876,eucalyptol,acetylcholinesterase inhibitor,ACHE,BRD-K15671046|BRD-K29996876,eucalyptol,acetylcholinesterase inhibitor,ACHE,BRD-K15671046|BRD-K29996876,eucalyptol,acetylcholinesterase inhibitor,ACHE
WEEYMMXMBFJUAI,BRD-K60798049,fanetizole,neutrophil superoxide production,,BRD-K60798049,fanetizole,neutrophil superoxide production,,BRD-K60798049,fanetizole,neutrophil superoxide production,,BRD-K60798049,fanetizole,neutrophil superoxide production,
WEJRSYKFMCUCRQ,BRD-K90215590,caricotamide,NADPH quinone oxidoreductase inhibitor,NQO2,BRD-K90215590,caricotamide,NADPH quinone oxidoreductase inhibitor,NQO2,BRD-K90215590,caricotamide,NADPH quinone oxidoreductase inhibitor,NQO2,BRD-K90215590,caricotamide,NADPH quinone oxidoreductase inhibitor,NQO2
WEQAYVWKMWHEJO,BRD-A20348246,chlormezanone,GABA receptor modulator,GABRA1|TSPO,BRD-A20348246,chlormezanone,GABA receptor modulator,GABRA1|TSPO,BRD-A20348246,chlormezanone,GABA receptor modulator,GABRA1|TSPO,BRD-A20348246,chlormezanone,GABA receptor modulator,GABRA1
WERYXYBDKMZEQL,BRD-K22346679,"1,4-butanediol",,,BRD-K22346679,"1,4-butanediol",benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MAN1B1|PLA2G2A|PLA2G2E,BRD-K22346679,"1,4-butanediol",benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MAN1B1|PLA2G2A|PLA2G2E,BRD-K22346679,"1,4-butanediol",benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MAN1B1|PLA2G2A|PLA2G2E
WEUCDJCFJHYFRL,BRD-A22769835,homochlorcyclizine,antihistamine,HRH1,BRD-A22769835,homochlorcyclizine,antihistamine,HRH1,BRD-A22769835,homochlorcyclizine,antihistamine,HRH1,BRD-K01826562,homochlorcyclizine,antihistamine,HRH1
WEVYNIUIFUYDGI,BRD-K97056771,GNF-2,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K97056771,GNF-2,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K97056771,GNF-2,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K97056771,GNF-2,Bcr-Abl kinase inhibitor,ABL1|BCR
WEXRUCMBJFQVBZ,BRD-A44448661,pentobarbital,GABA receptor modulator|barbiturate antiepileptic,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-A44448661,pentobarbital,GABA receptor modulator|barbiturate antiepileptic,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-A44448661,pentobarbital,GABA receptor modulator|barbiturate antiepileptic,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,,,,
WFJIVOKAWHGMBH,BRD-K99946902,hexylresorcinol,local anesthetic,TYR,BRD-K99946902,hexylresorcinol,local anesthetic,TYR,BRD-K99946902,hexylresorcinol,local anesthetic,TYR,BRD-K99946902,hexylresorcinol,local anesthetic,TYR
WFKAJVHLWXSISD,BRD-K54057105,isobutyramide,gene expression stimulant,HBE1|HBG1,BRD-K54057105,isobutyramide,gene expression stimulant,HBE1|HBG1,BRD-K54057105,isobutyramide,gene expression stimulant,HBE1|HBG1,BRD-K54057105,isobutyramide,gene expression stimulant,HBE1|HBG1
WFNAKBGANONZEQ,BRD-A57133233,chlorcyclizine,histamine receptor antagonist,HRH1,BRD-A57133233,chlorcyclizine,histamine receptor antagonist,HRH1,BRD-A57133233,chlorcyclizine,histamine receptor antagonist,HRH1,BRD-A57133233,chlorcyclizine,histamine receptor antagonist,
WFPIAZLQTJBIFN,BRD-K28761384,zuclopenthixol,dopamine receptor antagonist,ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A,BRD-K28761384,zuclopenthixol,dopamine receptor antagonist,ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A,BRD-K28761384,zuclopenthixol,dopamine receptor antagonist,ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A,BRD-K28761384,zuclopenthixol,dopamine receptor antagonist,ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A
WFSLJOPRIJSOJR,BRD-K50631926,PIK-294,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,BRD-K50631926,PIK-294,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,BRD-K50631926,PIK-294,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,BRD-K50631926,PIK-294,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG
WFWLQNSHRPWKFK,BRD-K99383816,ftorafur,thymidylate synthase inhibitor,TYMS,BRD-K99383816,ftorafur,thymidylate synthase inhibitor,TYMS,BRD-K99383816,ftorafur,thymidylate synthase inhibitor,TYMS,BRD-K99383816,ftorafur,thymidylate synthase inhibitor,TYMS
WFZPJYYCTSHDJI,BRD-K13005598,foxy-5,WNT5a peptide mimetic,WNT5A,BRD-K13005598,foxy-5,WNT5a peptide mimetic,WNT5A,BRD-K13005598,foxy-5,WNT5a peptide mimetic,WNT5A,BRD-K13005598,foxy-5,WNT5a peptide mimetic,WNT5A
WGEWUYACXPEFPO,BRD-K06357403,velneperit,neuropeptide receptor antagonist,NPY5R,BRD-K06357403,velneperit,neuropeptide receptor antagonist,NPY5R,BRD-K06357403,velneperit,neuropeptide receptor antagonist,NPY5R,BRD-K06357403,velneperit,neuropeptide receptor antagonist,NPY5R
WGNGIELOOKACSB,BRD-K87349602,beta-CCB,benzodiazepine receptor ligand,GABRA1|GABRG2,BRD-K87349602,beta-CCB,benzodiazepine receptor ligand,GABRA1|GABRG2,BRD-K87349602,beta-CCB,benzodiazepine receptor ligand,GABRA1|GABRG2,BRD-K87349602,beta-CCB,benzodiazepine receptor ligand,GABRA1|GABRG2
WGRQANOPCQRCME,BRD-K48068743,teneligliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K48068743,teneligliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K48068743,teneligliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K48068743,teneligliptin,dipeptidyl peptidase inhibitor,DPP4
WGZDBVOTUVNQFP,BRD-K68553471,todralazine,antihypertensive agent,,BRD-K68553471,todralazine,antihypertensive agent,,BRD-K68553471,todralazine,antihypertensive agent,,BRD-K68553471,todralazine,antihypertensive agent,
WGZOTBUYUFBEPZ,BRD-K40109029,SB-505124,ALK tyrosine kinase receptor inhibitor,TGFBR1,BRD-K40109029,SB-505124,ALK tyrosine kinase receptor inhibitor,TGFBR1,BRD-K40109029,SB-505124,ALK tyrosine kinase receptor inhibitor,TGFBR1,BRD-K40109029,SB-505124,ALK tyrosine kinase receptor inhibitor,TGFBR1
WHBHBVVOGNECLV,BRD-A95717758|BRD-K32891457,cortodoxone,androgen receptor antagonist,AR,BRD-A95717758|BRD-K32891457,cortodoxone,androgen receptor antagonist,AR,BRD-K32891457,cortodoxone,androgen receptor antagonist,AR,BRD-K32891457,cortodoxone,androgen receptor antagonist,AR
WHBIGIKBNXZKFE,BRD-K34068325,delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4,BRD-K34068325,delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4,BRD-K34068325,delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4,BRD-K34068325,delavirdine,non-nucleoside reverse transcriptase inhibitor,CYP3A4
WHBMMWSBFZVSSR,BRD-A41387824,beta-Hydroxybutyrate,,HCAR2,BRD-A41387824,beta-Hydroxybutyrate,,HCAR2,BRD-A41387824,beta-Hydroxybutyrate,,HCAR2,BRD-A41387824,beta-hydroxybutyrate,,HCAR2
WHGYBXFWUBPSRW,BRD-A08079565,CDBA,,,BRD-A08079565,CDBA,,,BRD-A08079565,CDBA,,,BRD-A08079565,CDBA,,
WHMXDBPHBVLYRC,BRD-K89015388,GSK923295,centromere associated protein inhibitor,CENPE,BRD-K89015388,GSK923295,centromere associated protein inhibitor,CENPE,BRD-K89015388,GSK923295,centromere associated protein inhibitor,CENPE,BRD-K89015388,GSK923295,centromere associated protein inhibitor,CENPE
WHPAGCJNPTUGGD,BRD-K73701464,croconazole,bacterial cell wall synthesis inhibitor,,BRD-K73701464,croconazole,bacterial cell wall synthesis inhibitor,,BRD-K73701464,croconazole,bacterial cell wall synthesis inhibitor,,BRD-K73701464,croconazole,bacterial cell wall synthesis inhibitor,
WHQCHUCQKNIQEC,BRD-K11717138,benzbromarone,chloride channel blocker,ABCC1,BRD-K11717138,benzbromarone,chloride channel blocker,ABCC1,BRD-K11717138,benzbromarone,chloride channel blocker,ABCC1,BRD-K11717138,benzbromarone,chloride channel blocker,ABCC1
WHQOKFZWSDOTQP,BRD-A76533773,lisadimate,topical sunscreen agent,,BRD-A76533773,lisadimate,topical sunscreen agent,,BRD-A76533773,lisadimate,topical sunscreen agent,,BRD-A76533773,lisadimate,topical sunscreen agent,
WHSXTWFYRGOBGO,BRD-K75608666,hydroxytoluic-acid,,,BRD-K75608666,hydroxytoluic-acid,,,BRD-K75608666,hydroxytoluic-acid,,,BRD-K75608666,hydroxytoluic-acid,,
WHTVZRBIWZFKQO,BRD-A91699651,chloroquine,antimalarial agent,GSTA2|MRGPRX1|TLR9|TNF,BRD-A91699651,chloroquine,antimalarial agent,GSTA2|MRGPRX1|TLR9|TNF,BRD-A91699651,chloroquine,antimalarial agent,GSTA2|MRGPRX1|TLR9|TNF,BRD-A91699651,chloroquine,antimalarial agent,MRGPRX1
WHUIENZXNGAHQI,BRD-K59433843,ICI-192605,thromboxane receptor antagonist,TBXA2R,BRD-K59433843,ICI-192605,thromboxane receptor antagonist,TBXA2R,BRD-K59433843,ICI-192605,thromboxane receptor antagonist,TBXA2R,BRD-K59433843,ICI-192605,thromboxane receptor antagonist,TBXA2R
WHUUTDBJXJRKMK,BRD-K62309135,L-glutamic-acid,glutamate receptor agonist,AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT,BRD-K62309135,L-glutamic-acid,glutamate receptor agonist,AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT,BRD-K62309135|BRD-M12235055,L-glutamic-acid,glutamate receptor agonist,AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT,BRD-K62309135|BRD-M12235055,L-glutamic-acid,glutamate receptor agonist,AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT
WHUWQSQEVISUMC,BRD-K06762493,isbufylline,phosphodiesterase inhibitor,,BRD-K06762493,isbufylline,phosphodiesterase inhibitor,,BRD-K06762493,isbufylline,phosphodiesterase inhibitor,,BRD-K06762493,isbufylline,phosphodiesterase inhibitor,
WHWZLSFABNNENI,BRD-A98990573,epinastine,histamine receptor antagonist,ADRA1A|ADRA2A|HRH1|HRH2|HTR2A|HTR7,BRD-A98990573,epinastine,histamine receptor antagonist,ADRA1A|ADRA2A|HRH1|HRH2|HTR2A|HTR7,BRD-A98990573,epinastine,histamine receptor antagonist,ADRA1A|ADRA2A|HRH1|HRH2|HTR2A|HTR7,BRD-A98990573,epinastine,histamine receptor antagonist,HRH1
WHXMKTBCFHIYNQ,BRD-K03095347,levosimendan,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,BRD-K03095347,levosimendan,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,BRD-K03095347,levosimendan,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,BRD-K03095347,levosimendan,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1
WIGIZIANZCJQQY,BRD-K34776109,glimepiride,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,BRD-K34776109,glimepiride,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,BRD-K34776109,glimepiride,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,BRD-K34776109,glimepiride,insulin secretagogue,ABCC8|KCNJ1|KCNJ11
WIIZWVCIJKGZOK,BRD-K08111712|BRD-K22969690,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55,BRD-K08111712|BRD-K22969690,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55,BRD-K08111712|BRD-K22969690,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55,BRD-K08111712|BRD-K22969690,chloramphenicol,bacterial 50S ribosomal subunit inhibitor,CD55
WIJZXSAJMHAVGX,BRD-K93073858,ivosidenib,isocitrate dehydrogenase inhibitor,IDH1,BRD-K93073858,ivosidenib,isocitrate dehydrogenase inhibitor,IDH1,BRD-K93073858,ivosidenib,isocitrate dehydrogenase inhibitor,IDH1,BRD-K93073858,ivosidenib,isocitrate dehydrogenase inhibitor,IDH1
WIKGAEMMNQTUGL,BRD-K68851986,necrostatin-2,RIPK inhibitor|necroptosis inhibitor,RIPK2,BRD-K68851986,necrostatin-2,RIPK inhibitor|necroptosis inhibitor,RIPK2,BRD-K68851986,necrostatin-2,RIPK inhibitor|necroptosis inhibitor,RIPK2,BRD-K68851986,necrostatin-2,RIPK inhibitor|necroptosis inhibitor,RIPK2
WIKYUJGCLQQFNW,BRD-K19352500,prochlorperazine,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,BRD-K19352500,prochlorperazine,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,BRD-K19352500,prochlorperazine,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,BRD-K19352500,prochlorperazine,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4
WINHZLLDWRZWRT,BRD-K42828737,sunitinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,,BRD-K42828737,sunitinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K42828737,sunitinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K42828737,sunitinib,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET
WIQRCHMSJFFONW,BRD-A79769222,norfluoxetine,selective serotonin reuptake inhibitor (SSRI),HTR2B,BRD-A79769222,norfluoxetine,selective serotonin reuptake inhibitor (SSRI),HTR2B,BRD-A79769222,norfluoxetine,selective serotonin reuptake inhibitor (SSRI),HTR2B,BRD-A79769222,norfluoxetine,selective serotonin reuptake inhibitor (SSRI),HTR2B
WIRVQQCUKDPURA,BRD-A26105646,3-deazauridine,cytidine deaminase inhibitor,,BRD-A26105646,3-deazauridine,cytidine deaminase inhibitor,,BRD-A26105646,3-deazauridine,cytidine deaminase inhibitor,,,,,
WIXFIQKTHUVFDI,BRD-A19777893,menadione-bisulfite,vitamin K,GGCX|VKORC1|VKORC1L1,BRD-A19777893,menadione-bisulfite,vitamin K,GGCX|VKORC1|VKORC1L1,BRD-A19777893,menadione-bisulfite,vitamin K,GGCX|VKORC1|VKORC1L1,BRD-K01826025,menadione-bisulfite,vitamin K,GGCX|VKORC1|VKORC1L1
WIYUZYBFCWCCQJ,BRD-A47342814,naltrindole,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A47342814,naltrindole,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A47342814,naltrindole,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K34088084,naltrindole,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
WJAJPNHVVFWKKL,BRD-A39189014,methoxamine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-A39189014,methoxamine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-A39189014,methoxamine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-A39189014,methoxamine,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D
WJBHHTPFTVKZCV,BRD-K52721684,PCO-400,potassium channel activator,KCNJ8,BRD-K52721684,PCO-400,potassium channel activator,KCNJ8,BRD-K52721684,PCO-400,potassium channel activator,KCNJ8,BRD-K52721684,PCO-400,potassium channel activator,KCNJ8
WJBLNOPPDWQMCH,BRD-A72767275,nalmefene,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A72767275|BRD-K68407436,nalmefene,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A72767275|BRD-K68407436,nalmefene,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K68407436,nalmefene,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
WJBSSBFGPKTMQQ,BRD-K89899948,AI-10-49,core binding factor inhibitor,CBFB,BRD-K89899948,AI-10-49,core binding factor inhibitor,CBFB,BRD-K89899948,AI-10-49,core binding factor inhibitor,CBFB,BRD-K89899948,AI-10-49,core binding factor inhibitor,CBFB
WJCNZQLZVWNLKY,BRD-K77695569,tiabendazole,angiogenesis inhibitor,,BRD-K77695569,tiabendazole,angiogenesis inhibitor,,BRD-K77695569,tiabendazole,angiogenesis inhibitor,,BRD-K77695569,tiabendazole,angiogenesis inhibitor,
WJEOLQLKVOPQFV,BRD-K71035033,masitinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,BRD-K71035033,masitinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,BRD-K71035033,masitinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|src inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,BRD-K71035033,masitinib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB
WJFKNYWRSNBZNX,BRD-K59597909,phenothiazine,dopamine receptor antagonist,,BRD-K59597909,phenothiazine,dopamine receptor antagonist,,BRD-K59597909,phenothiazine,dopamine receptor antagonist,,BRD-K59597909,phenothiazine,dopamine receptor antagonist,
WJJYZXPHLSLMGE,BRD-K88358234,xaliproden,serotonin receptor agonist,HTR1A,BRD-K88358234,xaliproden,serotonin receptor agonist,HTR1A,BRD-K88358234,xaliproden,serotonin receptor agonist,HTR1A,BRD-K88358234,xaliproden,serotonin receptor agonist,HTR1A
WJLRTFJPHDSXAF,BRD-A46813902,iododexetimide,acetylcholine receptor antagonist,,BRD-A46813902,iododexetimide,acetylcholine receptor antagonist,,BRD-A46813902,iododexetimide,acetylcholine receptor antagonist,,BRD-A46813902,iododexetimide,acetylcholine receptor antagonist,
WJOHZNCJWYWUJD,BRD-A15297126|BRD-K68865937,fluocinolone-acetonide|fluocinonide,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,BRD-A15297126|BRD-K57886322,fluocinolone-acetonide|fluocinonide,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,BRD-A15297126|BRD-K57886322|BRD-K68865937,fluocinolone-acetonide|fluocinonide,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,BRD-K57886322|BRD-K68865937,fluocinonide,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO
WJRRGYBTGDJBFX,BRD-K72414522,AZD5438,CDK inhibitor,KCNH2,BRD-K72414522,AZD5438,CDK inhibitor,KCNH2,BRD-K72414522,AZD5438,CDK inhibitor,KCNH2,BRD-K72414522,AZD5438,CDK inhibitor,KCNH2
WJRWSLORVIHRNX,BRD-K27074404,VU-0240551,potassium/chloride cotransporter inhibitor,SLC12A5,BRD-K27074404,VU-0240551,potassium/chloride cotransporter inhibitor,SLC12A5,BRD-K27074404,VU-0240551,potassium/chloride cotransporter inhibitor,SLC12A5,BRD-K27074404,VU0240551,potassium/chloride cotransporter inhibitor,SLC12A5
WKDACQVEJIVHMZ,BRD-K01683783,TAK-901,Aurora kinase inhibitor,AURKB,BRD-K01683783,TAK-901,Aurora kinase inhibitor,AURKB,BRD-K01683783,TAK-901,Aurora kinase inhibitor,AURKB,BRD-K01683783,TAK-901,Aurora kinase inhibitor,AURKB
WKEDVNSFRWHDNR,BRD-K83036479,salicylanilide,other antibiotic,,BRD-K83036479,salicylanilide,other antibiotic,,BRD-K83036479,salicylanilide,other antibiotic,,BRD-K83036479,salicylanilide,other antibiotic,
WKEMJKQOLOHJLZ,BRD-K67601717,almotriptan,serotonin receptor agonist,HTR1B|HTR1D,BRD-K67601717,almotriptan,serotonin receptor agonist,HTR1B|HTR1D,BRD-K67601717,almotriptan,serotonin receptor agonist,HTR1B|HTR1D,BRD-K67601717,almotriptan,serotonin receptor agonist,HTR1B|HTR1D
WKGXYQFOCVYPAC,BRD-K99107520,felbamate,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-K99107520,felbamate,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-K99107520,felbamate,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,BRD-K99107520,felbamate,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
WKLGNFJHVJIZPK,BRD-K59875992,FPL-62064,cyclooxygenase inhibitor|lipoxygenase inhibitor,,BRD-K59875992,FPL-62064,cyclooxygenase inhibitor|lipoxygenase inhibitor,,BRD-K59875992,FPL-62064,cyclooxygenase inhibitor|lipoxygenase inhibitor,,BRD-K59875992,FPL-62064,cyclooxygenase inhibitor|lipoxygenase inhibitor,
WKNFADCGOAHBPG,BRD-K17868609,BRL-54443,serotonin receptor agonist,HTR1E|HTR1F,BRD-K17868609,BRL-54443,serotonin receptor agonist,HTR1E|HTR1F,BRD-K17868609,BRL-54443,serotonin receptor agonist,HTR1E|HTR1F,BRD-K17868609,BRL-54443,serotonin receptor agonist,HTR1E|HTR1F
WKRLQDKEXYKHJB,BRD-A88080608,equilin,estrogen receptor agonist,HSD17B1,BRD-A88080608,equilin,estrogen receptor agonist,HSD17B1,BRD-A88080608,equilin,estrogen receptor agonist,HSD17B1,BRD-A88080608,equilin,estrogen receptor agonist,HSD17B1
WKSAUQYGYAYLPV,BRD-K88429204,pyrimethamine,dihydrofolate reductase inhibitor,DHFR|SLC47A1,BRD-K88429204,pyrimethamine,dihydrofolate reductase inhibitor,DHFR|SLC47A1,BRD-K88429204,pyrimethamine,dihydrofolate reductase inhibitor,DHFR|SLC47A1,BRD-K88429204,pyrimethamine,dihydrofolate reductase inhibitor,DHFR|SLC47A1
WKWOJBUWWZTUQV,BRD-A43999749,homatropine-methylbromide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A43999749,homatropine-methylbromide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A43999749,homatropine-methylbromide,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A54234250,homatropine-methylbromide,acetylcholine receptor antagonist,CHRM5
WKZLNEWVIAGNAW,BRD-K92382976,5-carboxamidotryptamine,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K92382976,5-carboxamidotryptamine,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K92382976,5-carboxamidotryptamine,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K92382976,5-carboxamidotryptamine,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
WLJNZVDCPSBLRP,BRD-K82118441,pyrantel,nicotinic receptor agonist,,BRD-K82118441,pyrantel,nicotinic receptor agonist,,BRD-K82118441,pyrantel,nicotinic receptor agonist,,BRD-K82118441,pyrantel,acetylcholine receptor agonist|nicotinic receptor agonist,
WLKOCYWYAWBGKY,BRD-K58343622,DY131,estrogen-related receptor agonist,ESRRB|ESRRG,BRD-K58343622,DY131,estrogen-related receptor agonist,ESRRB|ESRRG,BRD-K58343622,DY131,estrogen-related receptor agonist,ESRRB|ESRRG,BRD-K58343622,DY131,estrogen-related receptor agonist,ESRRB|ESRRG
WLMCRYCCYXHPQF,BRD-K88767641,AZD5582,XIAP inhibitor,BIRC2|BIRC3|XIAP,BRD-K88767641,AZD5582,XIAP inhibitor,BIRC2|BIRC3|XIAP,BRD-K88767641,AZD5582,XIAP inhibitor,BIRC2|BIRC3|XIAP,BRD-K88767641,AZD5582,XIAP inhibitor,BIRC2|BIRC3|XIAP
WLOHNSSYAXHWNR,BRD-A44120870|BRD-A77786295|BRD-A83603976|BRD-K15706428|BRD-K52756523,dirithromycin,bacterial 50S ribosomal subunit inhibitor,,BRD-A44120870|BRD-K15706428|BRD-K52756523,dirithromycin,bacterial 50S ribosomal subunit inhibitor,,BRD-A44120870|BRD-A77786295|BRD-A83603976|BRD-K15706428|BRD-K52756523,dirithromycin,bacterial 50S ribosomal subunit inhibitor,,BRD-A44120870|BRD-A77786295|BRD-A83603976|BRD-K15706428|BRD-K52756523,dirithromycin,bacterial 50S ribosomal subunit inhibitor,
WLWFNJKHKGIJNW,BRD-A18043272,phensuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-A18043272,phensuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-A18043272,phensuximide,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,BRD-A18043272,phensuximide,succinimide antiepileptic,
WMBWREPUVVBILR,BRD-K55591206,epigallocatechin-gallate-(-),bacterial DNA gyrase inhibitor,ELANE|EP300|FASN|KAT2B|MMP14|MMP2,BRD-K55591206,epigallocatechin-gallate-(-),bacterial DNA gyrase inhibitor,ELANE|EP300|FASN|KAT2B|MMP14|MMP2,BRD-K55591206,epigallocatechin-gallate-(-),bacterial DNA gyrase inhibitor,ELANE|EP300|FASN|KAT2B|MMP14|MMP2,BRD-K55591206,epigallocatechin-gallate-(-),bacterial DNA gyrase inhibitor,ELANE|EP300|FASN|KAT2B|MMP14|MMP2
WMDSZGFJQKSLLH,BRD-K86436199,landiolol,adrenergic receptor antagonist,ADRB1,BRD-K86436199,landiolol,adrenergic receptor antagonist,ADRB1,BRD-K86436199,landiolol,adrenergic receptor antagonist,ADRB1,BRD-K86436199,landiolol,adrenergic receptor antagonist,ADRB1
WMPXPUYPYQKQCX,BRD-K14116214,sulfamonomethoxine,bacterial antifolate,,BRD-K14116214,sulfamonomethoxine,bacterial antifolate,,BRD-K14116214,sulfamonomethoxine,bacterial antifolate,,BRD-K14116214,sulfamonomethoxine,bacterial antifolate,
WMWTYOKRWGGJOA,BRD-A45538101|BRD-K40517875|BRD-K62310379,fluticasone-propionate,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,BRD-A45538101|BRD-K62310379,fluticasone-propionate,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,BRD-A45538101|BRD-K40517875|BRD-K62310379,fluticasone-propionate,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,BRD-K40517875|BRD-K62310379,fluticasone-propionate,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A
WNAQOLSMVPFGTE,BRD-K60443845,chlormidazole,fungal lanosterol demethylase inhibitor,,BRD-K60443845,chlormidazole,fungal lanosterol demethylase inhibitor,,BRD-K60443845,chlormidazole,fungal lanosterol demethylase inhibitor,,BRD-K60443845,chlormidazole,fungal lanosterol demethylase inhibitor,
WNBSDCKJFDZMHT,BRD-K61693562,pyrazinoylguanidine,diuretic,,BRD-K61693562,pyrazinoylguanidine,diuretic,,BRD-K61693562,pyrazinoylguanidine,diuretic,,BRD-K61693562,pyrazinoylguanidine,diuretic,
WNDWKKPBLAKXMI,BRD-K37933329,BTB06584,ATPase inhibitor,ATP5F1,BRD-K37933329,BTB06584,ATPase inhibitor,ATP5F1,BRD-K37933329,BTB06584,ATPase inhibitor,ATP5F1,BRD-K37933329,BTB06584,ATPase inhibitor,ATP5F1
WNIDXAKKFOKNEF,BRD-K63979671,etifenin,renal function diagnostic agent,,BRD-K63979671,etifenin,renal function diagnostic agent,,BRD-K63979671,etifenin,renal function diagnostic agent,,BRD-K63979671,etifenin,renal function diagnostic agent,
WNLRTRBMVRJNCN,BRD-K10656395,adipic-acid,solute carrier family member inhibitor,SLC22A6,BRD-K10656395,adipic-acid,solute carrier family member inhibitor,SLC22A6,BRD-K10656395,adipic-acid,solute carrier family member inhibitor,SLC22A6,BRD-K10656395,adipic-acid,solute carrier family member inhibitor,SLC22A6
WNMJYKCGWZFFKR,BRD-A09056319,alfuzosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2,BRD-A09056319,alfuzosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2,BRD-A09056319,alfuzosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|KCNH2,BRD-K01826519,alfuzosin,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
WNRZHQBJSXRYJK,BRD-K68408772,carboxyamidotriazole,calcium channel blocker,CXCL8,BRD-K68408772,carboxyamidotriazole,calcium channel blocker,CXCL8,BRD-K68408772,carboxyamidotriazole,calcium channel blocker,CXCL8,BRD-K68408772,carboxyamidotriazole,calcium channel blocker,CXCL8
WNSWOZIBBVUJBI,BRD-K71698503,I-BZA2,,,BRD-K71698503,I-BZA2,,,BRD-K71698503,I-BZA2,,,BRD-K71698503,I-BZA2,,
WNTYBHLDCKXEOT,BRD-K42938903,acetophenazine,dopamine receptor antagonist,DRD1|DRD2,BRD-K42938903,acetophenazine,dopamine receptor antagonist,DRD1|DRD2,BRD-K42938903|BRD-K92986184,acetophenazine,dopamine receptor antagonist,DRD1|DRD2,BRD-K42938903|BRD-K92986184,acetophenazine,dopamine receptor antagonist,DRD1|DRD2
WNWALBVQAAIULR,BRD-K77171813,proxyfan,histamine receptor modulator,HRH3,BRD-K77171813,proxyfan,histamine receptor modulator,HRH3,BRD-K77171813,proxyfan,histamine receptor modulator,HRH3,BRD-K77171813,proxyfan,histamine receptor modulator,HRH3
WOCXQMCIOTUMJV,BRD-K08748705,tretazicar,DNA replication inhibitor,NQO2,BRD-K08748705,tretazicar,DNA replication inhibitor,NQO2,BRD-K08748705,tretazicar,DNA replication inhibitor,NQO2,BRD-K08748705,tretazicar,DNA replication inhibitor,NQO2
WOFMFGQZHJDGCX,BRD-A01139232|BRD-K28476963,mometasone-furoate,glucocorticoid receptor agonist,NR3C1,BRD-A01139232|BRD-K28476963,mometasone-furoate,glucocorticoid receptor agonist,NR3C1,BRD-A01139232|BRD-K28476963|BRD-K60640630,mometasone-furoate,glucocorticoid receptor agonist,NR3C1,BRD-A01139232|BRD-K28476963|BRD-K60640630,mometasone-furoate,glucocorticoid receptor agonist,NR3C1
WOHRHWDYFNWPNG,BRD-K11452913,evatanepag,prostaglandin inhibitor,PTGER2|PTGER4,BRD-K11452913,evatanepag,prostaglandin inhibitor,PTGER2|PTGER4,BRD-K11452913,evatanepag,prostaglandin inhibitor,PTGER2|PTGER4,BRD-K11452913,evatanepag,prostaglandin inhibitor,PTGER2|PTGER4
WOIWWYDXDVSWAZ,BRD-A33506612,fosinoprilat,angiotensin converting enzyme inhibitor,ACE,BRD-A33506612,fosinoprilat,angiotensin converting enzyme inhibitor,ACE,BRD-A33506612,fosinoprilat,angiotensin converting enzyme inhibitor,ACE,BRD-A33506612,fosinoprilat,angiotensin converting enzyme inhibitor,ACE
WONYMNWUJVKVII,BRD-K36802417,diiodothyropropionic-acid,thyroid hormone stimulant,,BRD-K36802417,diiodothyropropionic-acid,thyroid hormone stimulant,,BRD-K36802417,diiodothyropropionic-acid,thyroid hormone stimulant,,BRD-K36802417,diiodothyropropionic-acid,thyroid hormone stimulant,
WOPFJTZIQBVJPY,BRD-M18147244,pemetrexed,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,BRD-M18147244,pemetrexed,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,,,,,,,,
WOSKHXYHFSIKNG,BRD-K39974922,lenvatinib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,BRD-K39974922,lenvatinib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,BRD-K39974922,lenvatinib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,BRD-K39974922,lenvatinib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR
WOUOLAUOZXOLJQ,BRD-K00573984,delapril,angiotensin converting enzyme inhibitor,ACE,BRD-K00573984,delapril,angiotensin converting enzyme inhibitor,ACE,BRD-K00573984,delapril,angiotensin converting enzyme inhibitor,ACE,BRD-K00573984,delapril,angiotensin converting enzyme inhibitor,ACE
WOVKYSAHUYNSMH,BRD-K79095980,broxuridine,antimetabolite,,BRD-K79095980,broxuridine,antimetabolite,,BRD-K79095980,broxuridine,antimetabolite,,BRD-K79095980,broxuridine,antimetabolite,
WOWJIWFCOPZFGV,BRD-K05977823,tenovin-1,SIRT inhibitor|TP53 activator,SIRT1,BRD-K05977823,tenovin-1,SIRT inhibitor|TP53 activator,SIRT1,BRD-K05977823,tenovin-1,SIRT inhibitor|TP53 activator,SIRT1,BRD-K05977823,tenovin-1,SIRT inhibitor|TP53 activator,SIRT1
WOXKDUGGOYFFRN,BRD-K93645900,tadalafil,phosphodiesterase inhibitor,PDE11A|PDE5A,BRD-K93645900,tadalafil,phosphodiesterase inhibitor,PDE11A|PDE5A,BRD-K93645900,tadalafil,phosphodiesterase inhibitor,PDE11A|PDE5A,BRD-K93645900,tadalafil,phosphodiesterase inhibitor,PDE11A|PDE5A
WOZSCQDILHKSGG,BRD-K96159438,adefovir-dipivoxil,DNA polymerase inhibitor,,BRD-K96159438,adefovir-dipivoxil,DNA polymerase inhibitor,,BRD-K96159438,adefovir-dipivoxil,DNA polymerase inhibitor,,BRD-K96159438,adefovir-dipivoxil,DNA polymerase inhibitor,
WPDCHTSXOPUOII,BRD-K86226872,APD597,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K86226872,APD597,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K86226872,APD597,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K86226872,APD597,glucose dependent insulinotropic receptor agonist,GPR119
WPEWQEMJFLWMLV,BRD-K25244359,apatinib,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,BRD-K25244359,apatinib,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,BRD-K25244359,apatinib,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,BRD-K25244359,apatinib,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET
WPGGHFDDFPHPOB,BRD-K52959329,mitiglinide,insulin secretagogue,ABCC8|KCNJ10|PPARG,BRD-K52959329,mitiglinide,insulin secretagogue,ABCC8|KCNJ10|PPARG,BRD-K52959329|BRD-M71049352,mitiglinide,insulin secretagogue,ABCC8|KCNJ10|PPARG,BRD-K52959329|BRD-M71049352,mitiglinide,insulin secretagogue,ABCC8|KCNJ10|PPARG
WPHXYKUPFJRJDK,BRD-K69624312,CUR-61414,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K69624312,CUR-61414,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K69624312,CUR-61414,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K69624312,CUR-61414,smoothened receptor antagonist,DHH|IHH|SMO
WPKPLSFHHBBLRY,BRD-K96436774,pelanserin,serotonin receptor antagonist,HTR2A,BRD-K96436774,pelanserin,serotonin receptor antagonist,HTR2A,BRD-K96436774,pelanserin,serotonin receptor antagonist,HTR2A,BRD-K96436774,pelanserin,serotonin receptor antagonist,HTR2A
WPMJNLCLKAKMLA,BRD-K70610771,VX-222,HCV inhibitor,,BRD-K70610771,VX-222,HCV inhibitor,,BRD-K70610771,VX-222,HCV inhibitor,,BRD-K70610771,VX-222,HCV inhibitor,
WPNJAUFVNXKLIM,BRD-K77771411,moxonidine,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K77771411,moxonidine,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K77771411,moxonidine,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K77771411,moxonidine,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C
WPSYTTKBGAZSCX,BRD-K02680176,clofilium,potassium channel blocker,KCNA5|KCNH1,BRD-K02680176,clofilium,potassium channel blocker,KCNA5|KCNH1,BRD-K02680176,clofilium,potassium channel blocker,KCNA5|KCNH1,BRD-K02680176,clofilium,potassium channel blocker,KCNA5|KCNH1
WPTTVJLTNAWYAO,BRD-K22848513,bardoxolone-methyl,like (NRF2) activator|nuclear factor erythroid derived,PPARG|STAT3,BRD-K69694239,bardoxolone-methyl,like (NRF2) activator|nuclear factor erythroid derived,PPARG|STAT3,BRD-K22848513|BRD-K69694239,bardoxolone-methyl,like (NRF2) activator|nuclear factor erythroid derived,PPARG|STAT3,BRD-K22848513|BRD-K69694239,bardoxolone-methyl,like (NRF2) activator|nuclear factor erythroid derived,PPARG|STAT3
WPUKUEMZZRVAKZ,BRD-A53561827,pipenzolate,cholinergic receptor antagonist,CHRM1,BRD-A53561827,pipenzolate,cholinergic receptor antagonist,CHRM1,BRD-A53561827,pipenzolate,cholinergic receptor antagonist,CHRM1,BRD-A53561827,pipenzolate,cholinergic receptor antagonist,CHRM1
WPVFJKSGQUFQAP,BRD-A50922295,valganciclovir,DNA synthesis inhibitor,,BRD-A50922295,valganciclovir,DNA synthesis inhibitor,,BRD-A08013053|BRD-A50922295,valganciclovir,DNA synthesis inhibitor,,BRD-A08013053|BRD-K01825663,valganciclovir,DNA synthesis inhibitor,
WPVVMKYQOMJPIN,BRD-K09397065,SR-57227A,serotonin receptor agonist,HTR3A,BRD-K09397065,SR-57227A,serotonin receptor agonist,HTR3A,BRD-K09397065,SR-57227A,serotonin receptor agonist,HTR3A,BRD-K09397065,SR-57227A,serotonin receptor agonist,HTR3A
WPYMKLBDIGXBTP,BRD-K53397409,benzoic-acid,food preservative,DAO|HRSP12|PRDX5|RAB9A,BRD-K53397409,benzoic-acid,food preservative,DAO|HRSP12|PRDX5|RAB9A,BRD-K53397409,benzoic-acid,food preservative,DAO|HRSP12|PRDX5|RAB9A,BRD-K53397409,benzoic-acid,food preservative,DAO|HRSP12|PRDX5|RAB9A
WPYWMXNXEZFMAK,BRD-K73440166,cinaciguat,guanylate cyclase activator,GUCY1A3|GUCY1B3,BRD-K73440166,cinaciguat,guanylate cyclase activator,GUCY1A3|GUCY1B3,BRD-K73440166,cinaciguat,guanylate cyclase activator,GUCY1A3|GUCY1B3,BRD-K73440166,cinaciguat,guanylate cyclase activator,GUCY1A3|GUCY1B3
WQABCVAJNWAXTE,BRD-A56152450,dimercaprol,chelating agent,,BRD-A56152450,dimercaprol,chelating agent,,BRD-A56152450,dimercaprol,chelating agent,,BRD-A56152450,dimercaprol,chelating agent,
WQAVPPWWLLVGFK,BRD-K60446698,ONX-0914,proteasome inhibitor,,BRD-K60446698,ONX-0914,proteasome inhibitor,,BRD-K60446698,ONX-0914,proteasome inhibitor,,BRD-K00003557,ONX-0914,proteasome inhibitor,
WQEVDHBJGNOKKO,BRD-K60600693,sodium-orthovanadate,,,BRD-K60600693,sodium-orthovanadate,,,BRD-K60600693,sodium-orthovanadate,,,BRD-K60600693,sodium-orthovanadate,,
WQLVFSAGQJTQCK,BRD-K15864401,diosgenin,steroid,,BRD-K28690501,diosgenin,steroid,,BRD-K15864401|BRD-K28690501,diosgenin,steroid,,BRD-K15864401|BRD-K28690501,diosgenin,steroid,
WQNYIWJBDGLKEB,BRD-K85804405,LY231617,lipid peroxidase inhibitor,,BRD-K85804405,LY231617,lipid peroxidase inhibitor,,BRD-K85804405,LY231617,lipid peroxidase inhibitor,,BRD-K85804405,LY231617,lipid peroxidase inhibitor,
WQSACWZKKZPCHN,BRD-A68304895,BTS-54505,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A68304895,BTS-54505,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A68304895,BTS-54505,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,BRD-A68304895,BTS-54505,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4
WQTKNBPCJKRYPA,BRD-K90239174,AMG-487,CC chemokine receptor antagonist,CXCR3,BRD-A01307728|BRD-K90239174,AMG-487|AMG-487-(+/-),CC chemokine receptor antagonist,|CXCR3,BRD-A01307728|BRD-K90239174,AMG-487|AMG-487-(+/-),CC chemokine receptor antagonist,|CXCR3,BRD-A01307728|BRD-K90239174,AMG-487|AMG-487-(+/-),CC chemokine receptor antagonist,|CXCR3
WQVJHHACXVLGBL,BRD-A08641215,polymyxin-b-sulfate,bacterial permeability inducer,,BRD-A08641215,polymyxin-b-sulfate,bacterial permeability inducer,,BRD-A08641215,polymyxin-b-sulfate,bacterial permeability inducer,,BRD-A08641215,polymyxin-B-sulfate,bacterial permeability inducer,
WQYRHRAZNNRDIA,BRD-K26502378,vanitiolide,,,BRD-K26502378,vanitiolide,,,BRD-K26502378,vanitiolide,,,BRD-K26502378,vanitiolide,,
WQZGKKKJIJFFOK,BRD-K87424134,alpha-D-glucopyranose,,,BRD-K87424134,alpha-D-glucopyranose,,,BRD-K87424134,alpha-D-glucopyranose,,,BRD-K87424134,alpha-D-glucopyranose,,
WRCHFMBCVFFYEQ,BRD-A15687940,clofedanol,histamine receptor antagonist,HRH1,BRD-A15687940,clofedanol,histamine receptor antagonist,HRH1,BRD-A15687940,clofedanol,histamine receptor antagonist,HRH1,BRD-A15687940,clofedanol,histamine receptor antagonist,HRH1
WREGKURFCTUGRC,BRD-K85925969,zalcitabine,nucleoside reverse transcriptase inhibitor,,BRD-K85925969,zalcitabine,nucleoside reverse transcriptase inhibitor,,BRD-K85925969,zalcitabine,nucleoside reverse transcriptase inhibitor,,BRD-K85925969,zalcitabine,nucleoside reverse transcriptase inhibitor,
WRIPKYOZKAJHRL,BRD-K25570267,ezutromid,utrophin enhancer,UTRN,BRD-K25570267,ezutromid,utrophin enhancer,UTRN,BRD-K25570267,ezutromid,utrophin enhancer,UTRN,BRD-K25570267,ezutromid,utrophin enhancer,UTRN
WRJPSSPFHGNBMG,BRD-A32673558|BRD-A80567352,aceclidine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A32673558|BRD-A80567352,aceclidine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-A32673558|BRD-A80567352,aceclidine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,BRD-K01825000,aceclidine,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
WRMNZCZEMHIOCP,BRD-K42371134,phenylethyl-alcohol,,,BRD-K42371134,phenylethyl-alcohol,,,BRD-K42371134,phenylethyl-alcohol,,,BRD-K42371134,phenylethyl-alcohol,,
WRNKIDLXXXIELU,BRD-K79353516,CY208-243,dopamine receptor agonist,CALY,BRD-K79353516,CY208-243,dopamine receptor agonist,CALY,BRD-K79353516,CY208-243,dopamine receptor agonist,CALY,BRD-K79353516,CY208-243,dopamine receptor agonist,CALY
WRNXUQJJCIZICJ,BRD-A31095847,mozavaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,BRD-A31095847,mozavaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,BRD-A31095847,mozavaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,BRD-A31095847,mozavaptan,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2
WRUUGTRCQOWXEG,BRD-K58513245,pamidronate,bone resorption inhibitor,FDPS,BRD-K58513245,pamidronate,bone resorption inhibitor,FDPS,BRD-K58513245,pamidronate,bone resorption inhibitor,FDPS,BRD-K58513245,pamidronate,bone resorption inhibitor,FDPS
WRUWGLUCNBMGPS,BRD-K04972057,I-BRD9,bromodomain inhibitor,BRD9,BRD-K04972057,I-BRD9,bromodomain inhibitor,BRD9,BRD-K04972057,I-BRD9,bromodomain inhibitor,BRD9,BRD-K04972057,I-BRD9,bromodomain inhibitor,BRD9
WSCUHXPGYUMQEX,BRD-K58277159,NPC-01,steroid,,BRD-K58277159,NPC-01,steroid,,BRD-K58277159,NPC-01,steroid,,BRD-K58277159,NPC-01,steroid,
WSEQXVZVJXJVFP,BRD-A47598013|BRD-K70301876,citalopram|escitalopram,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,BRD-A47598013|BRD-K70301876,citalopram|escitalopram,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,BRD-A47598013|BRD-K70301876,citalopram|escitalopram,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,BRD-A47598013|BRD-K70301876,citalopram|escitalopram,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4
WSMQUUGTQYPVPD,BRD-K67915505,NVP-HSP990,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K67915505,NVP-HSP990,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K67915505,NVP-HSP990,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K67915505,NVP-HSP990,HSP inhibitor,HSP90AA1|HSP90AB1
WSPOMRSOLSGNFJ,BRD-K36207157|BRD-K59058766,chlorprothixene,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,BRD-K36207157|BRD-K59058766,chlorprothixene,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,BRD-K36207157|BRD-K59058766,chlorprothixene,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,BRD-K36207157|BRD-K59058766,chlorprothixene,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C
WSSJONWNBBTCMG,BRD-A34751532,homosalate,HSP inducer,,BRD-A34751532,homosalate,HSP inducer,,BRD-A34751532,homosalate,HSP inducer,,BRD-A34751532,homosalate,HSP inducer,
WSWCOQWTEOXDQX,BRD-K55892330,sorbic-acid,,,BRD-K55892330,sorbic-acid,,,BRD-K55892330,sorbic-acid,,,BRD-K88734090,sorbic-acid,,
WSYVIAQNTFPTBI,BRD-A87673115,moguisteine,ATP-sensitive potassium channel inhibitor,,BRD-A87673115,moguisteine,ATP-sensitive potassium channel inhibitor,,BRD-A87673115,moguisteine,ATP-sensitive potassium channel inhibitor,,BRD-A87673115,moguisteine,ATP-sensitive potassium channel inhibitor,
WTDGMHYYGNJEKQ,BRD-A04447196,gepefrine,adrenergic receptor agonist,,BRD-A04447196,gepefrine,adrenergic receptor agonist,,BRD-A04447196,gepefrine,adrenergic receptor agonist,,BRD-A04447196,gepefrine,adrenergic receptor agonist,
WTDRDQBEARUVNC,BRD-K34730807,levodopa,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143,BRD-K34730807,levodopa,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143,BRD-K34730807,levodopa,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143,BRD-K34730807,levodopa,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143
WTDWVLJJJOTABN,BRD-K79989959,nesbuvir,RNA polymerase inhibitor,,BRD-K79989959,nesbuvir,RNA polymerase inhibitor,,BRD-K79989959,nesbuvir,RNA polymerase inhibitor,,BRD-K79989959,nesbuvir,RNA polymerase inhibitor,
WTHKAJZQYNKTCJ,BRD-K64178227,BTS,,,BRD-K64178227,BTS,,,BRD-K64178227,BTS,,,BRD-K64178227,BTS,,
WTISQLWAPBSCSF,BRD-K48526231,sodium-nitroprusside,nitric oxide donor,,BRD-K48526231,sodium-nitroprusside,nitric oxide donor,,BRD-K48526231|BRD-U32870953,sodium-nitroprusside,nitric oxide donor,,BRD-K00003606,sodium-nitroprusside,nitric oxide donor,
WTPAXDRULIZRDJ,BRD-A92933783,SM-21,sigma receptor antagonist,PGRMC1,BRD-A92933783,SM-21,sigma receptor antagonist,PGRMC1,BRD-A92933783,SM-21,sigma receptor antagonist,PGRMC1,BRD-K00004213,SM-21,sigma receptor antagonist,PGRMC1
WTQYWNWRJNXDEG,BRD-A29623586,anisodamine,lipid peroxidase inhibitor,ADRA1A,BRD-A29623586,anisodamine,lipid peroxidase inhibitor,ADRA1A,BRD-A29623586,anisodamine,lipid peroxidase inhibitor,ADRA1A,BRD-A29623586,anisodamine,lipid peroxidase inhibitor,ADRA1A
WTWWXOGTJWMJHI,BRD-K92988025,perflubron,contrast agent,,BRD-K92988025,perflubron,contrast agent,,BRD-K92988025,perflubron,contrast agent,,BRD-K92988025,perflubron,contrast agent,
WUADCCWRTIWANL,BRD-K73303757,4-methylgenistein,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN,BRD-K73303757,4-methylgenistein,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN,BRD-K73303757,4-methylgenistein,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN,BRD-K73303757,4-methylgenistein,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN
WUBBRNOQWQTFEX,BRD-K80267133,aminosalicylate,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,BRD-K80267133,aminosalicylate,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,BRD-K80267133|BRD-M65097687,aminosalicylate,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,BRD-K80267133|BRD-M65097687,aminosalicylate,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2
WUDBUIUHVNECTM,BRD-K96295391,PF-670462,casein kinase inhibitor,CSNK1D|CSNK1E,BRD-K96295391,PF-670462,casein kinase inhibitor,CSNK1D|CSNK1E,BRD-K96295391,PF-670462,casein kinase inhibitor,CSNK1D|CSNK1E,BRD-K96295391,PF-670462,casein kinase inhibitor,CSNK1D|CSNK1E
WUFQLZTXIWKION,BRD-K13819402,desoxypeganine,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,BRD-K13819402,desoxypeganine,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,BRD-K13819402,desoxypeganine,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,BRD-K13819402,desoxypeganine,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE
WUILNKCFCLNXOK,BRD-K98453471,salirasib,mTOR inhibitor,TRPA1,BRD-K98453471,salirasib,mTOR inhibitor,TRPA1,BRD-K98453471,salirasib,mTOR inhibitor,TRPA1,BRD-K98453471,salirasib,mTOR inhibitor,TRPA1
WUKMIBOGGXMBAC,BRD-K97365803,PI-828,PI3K inhibitor,,BRD-K97365803,PI-828,PI3K inhibitor,,BRD-K97365803,PI-828,PI3K inhibitor,,BRD-K97365803,PI-828,PI3K inhibitor,
WUKZPHOXUVCQOR,BRD-A44133049,azasetron,serotonin receptor antagonist,HTR3A|HTR3B,BRD-A44133049,azasetron,serotonin receptor antagonist,HTR3A|HTR3B,BRD-A44133049,azasetron,serotonin receptor antagonist,HTR3A|HTR3B,BRD-K01826751,azasetron,serotonin receptor antagonist,HTR3A|HTR3B
WURGZWOTGMLDJP,BRD-K53600683,tabimorelin,growth hormone secretagogue receptor agonist,GHSR,BRD-K53600683,tabimorelin,growth hormone secretagogue receptor agonist,GHSR,BRD-K53600683|BRD-M26279695,tabimorelin,growth hormone secretagogue receptor agonist,GHSR,BRD-K53600683|BRD-M26279695,tabimorelin,growth hormone secretagogue receptor agonist,GHSR
WUTVMXLIGHTZJC,BRD-K93725829,VX-11e,MAP kinase inhibitor,MAPK1,BRD-K93725829,VX-11e,MAP kinase inhibitor,MAPK1,BRD-K93725829,VX-11e,MAP kinase inhibitor,MAPK1,BRD-K93725829,VX-11e,MAP kinase inhibitor,MAPK1
WUWDLXZGHZSWQZ,BRD-K63504947,semaxanib,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K63504947,semaxanib,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K63504947,semaxanib,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,BRD-K63504947,semaxanib,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET
WUWFMDMBOJLQIV,BRD-A41450521,tosufloxacin,bacterial DNA gyrase inhibitor,,BRD-A41450521,tosufloxacin,bacterial DNA gyrase inhibitor,,BRD-A41450521,tosufloxacin,bacterial DNA gyrase inhibitor,,BRD-K01825158,tosufloxacin,bacterial DNA gyrase inhibitor,
WUZYKBABMWJHDL,BRD-K98004573,rupatadine,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,BRD-K98004573,rupatadine,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,BRD-K98004573,rupatadine,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,BRD-K98004573,rupatadine,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR
WVAKABMNNSMCDK,BRD-K13486660,sulfacarbamide,,,BRD-K13486660,sulfacarbamide,,,BRD-K13486660,sulfacarbamide,,,BRD-K13486660,sulfacarbamide,,
WVDDGKGOMKODPV,BRD-K98494274,benzyl-alcohol,local anesthetic,,BRD-K98494274,benzyl-alcohol,local anesthetic,,BRD-K98494274,benzyl-alcohol,local anesthetic,,BRD-K98494274,benzyl-alcohol,local anesthetic,
WVLHGCRWEHCIOT,BRD-K86171477,eltoprazine,serotonin receptor agonist,HTR1A|HTR1B,BRD-K86171477,eltoprazine,serotonin receptor agonist,HTR1A|HTR1B,BRD-K86171477,eltoprazine,serotonin receptor agonist,HTR1A|HTR1B,BRD-K86171477,eltoprazine,serotonin receptor agonist,HTR1A|HTR1B
WVLHHLRVNDMIAR,BRD-K42948882,AMD11070,CC chemokine receptor antagonist,CXCR4,BRD-K42948882,AMD11070,CC chemokine receptor antagonist,CXCR4,BRD-K42948882,AMD11070,CC chemokine receptor antagonist,CXCR4,BRD-K42948882,AMD11070,CC chemokine receptor antagonist,CCR5|CXCR4
WVPAABNYMHNFJG,BRD-K27515606,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-K27515606,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-K27515606,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,,BRD-K27515606,cefcapene-pivoxil,bacterial cell wall synthesis inhibitor,
WVPSKSLAZQPAKQ,BRD-K00494077,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K00494077,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K00494077,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K00494077,trovafloxacin,bacterial DNA gyrase inhibitor,TOP2A
WVSBGSNVCDAMCF,BRD-K14991967,GSK650394,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2,BRD-K14991967,GSK650394,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2,BRD-K14991967,GSK650394,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2,BRD-K14991967,GSK650394,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2
WVTKBKWTSCPRNU,BRD-K08078237|BRD-K59640580,tetrandrine,calcium channel blocker,SLC6A3,BRD-K08078237|BRD-K59640580,tetrandrine,calcium channel blocker,SLC6A3,BRD-K08078237|BRD-K59640580,tetrandrine,calcium channel blocker,SLC6A3,BRD-K08078237|BRD-K59640580,tetrandrine,calcium channel blocker,SLC6A3
WVUNYSQLFKLYNI,BRD-K08799216,pelitinib,EGFR inhibitor,EGFR,BRD-K08799216,pelitinib,EGFR inhibitor,EGFR,BRD-K08799216,pelitinib,EGFR inhibitor,EGFR,BRD-K08799216,pelitinib,EGFR inhibitor,EGFR
WVVSZNPYNCNODU,BRD-A26387268,ergonovine,adrenergic receptor agonist|serotonin receptor agonist,ADRA1A|HTR1E,BRD-A26387268,ergonovine,adrenergic receptor agonist|serotonin receptor agonist,ADRA1A|HTR1E,BRD-A26387268,ergonovine,adrenergic receptor agonist|serotonin receptor agonist,ADRA1A|HTR1E,BRD-K17311468,ergonovine,adrenergic receptor agonist|serotonin receptor agonist,ADRA1A|HTR1E
WVVXBPKOIZGVNS,BRD-K67013324,luzindole,melatonin receptor antagonist,MTNR1A|MTNR1B,BRD-K67013324,luzindole,melatonin receptor antagonist,MTNR1A|MTNR1B,BRD-K67013324,luzindole,melatonin receptor antagonist,MTNR1A|MTNR1B,BRD-K67013324,luzindole,melatonin receptor antagonist,MTNR1A|MTNR1B
WVWOOAYQYLJEFD,BRD-A67521319,pimonidazole,,,BRD-A67521319,pimonidazole,,,BRD-A67521319,pimonidazole,,,BRD-A67521319,pimonidazole,,
WVXNSAVVKYZVOE,BRD-K76694128,rebastinib,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BCR|FGR|FLT3|HCK|LYN|SRC,BRD-K76694128,rebastinib,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BCR|FGR|FLT3|HCK|LYN|SRC,BRD-K76694128,rebastinib,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BCR|FGR|FLT3|HCK|LYN|SRC,BRD-K76694128,rebastinib,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BCR|FGR|FLT3|HCK|LYN|SRC
WVXRAFOPTSTNLL,BRD-K84794093,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,,BRD-K84794093,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,,BRD-K84794093,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,,BRD-K84794093,dideoxyadenosine,nucleoside reverse transcriptase inhibitor,
WVYADZUPLLSGPU,BRD-K48892307,sasapyrine,NFkB pathway inhibitor,PTGS1|PTGS2,BRD-K48892307,sasapyrine,NFkB pathway inhibitor,PTGS1|PTGS2,BRD-K48892307,sasapyrine,NFkB pathway inhibitor,PTGS1|PTGS2,BRD-K48892307,sasapyrine,NFkB pathway inhibitor,PTGS1|PTGS2
WVZSEUPGUDIELE,BRD-K51541829,Ro-25-6981,,GRIN2B,BRD-K51541829,Ro-25-6981,,GRIN2B,BRD-K51541829,Ro-25-6981,,GRIN2B,BRD-K51541829,Ro-25-6981,glutamate receptor antagonist|monamine transporter modulator,GRIN2B
WWJZWCUNLNYYAU,BRD-K51805276,temefos,cholinesterase inhibitor,,BRD-K51805276,temefos,cholinesterase inhibitor,,BRD-K51805276,temefos,cholinesterase inhibitor,,BRD-K51805276,temefos,cholinesterase inhibitor,
WWNNZCOKKKDOPX,BRD-K69231085,trigonelline,,,BRD-K69231085,trigonelline,,,BRD-K69231085,trigonelline,,,BRD-K69231085,trigonelline,,
WWNUCVSRRUDYPP,BRD-K37793595,afobazole,anxiolytic,,BRD-K37793595,afobazole,anxiolytic,,BRD-K37793595,afobazole,anxiolytic,,BRD-K37793595,afobazole,anxiolytic,
WWONFUQGBVOKOF,BRD-K42495768,tasisulam,apoptosis stimulant,,BRD-K42495768,tasisulam,apoptosis stimulant,,BRD-K42495768,tasisulam,apoptosis stimulant,,BRD-K42495768,tasisulam,apoptosis stimulant,
WWOXKWLDMLMYQY,BRD-K49246350,DCC-2618,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA,BRD-K49246350,DCC-2618,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA,BRD-K49246350,DCC-2618,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA,BRD-K49246350,DCC-2618,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA
WWVANQJRLPIHNS,BRD-K07954936,2-iminobiotin,nitric oxide synthase inhibitor,NOS1|NOS2,BRD-K07954936,2-iminobiotin,nitric oxide synthase inhibitor,NOS1|NOS2,BRD-K07954936,2-iminobiotin,nitric oxide synthase inhibitor,NOS1|NOS2,BRD-K07954936,2-iminobiotin,nitric oxide synthase inhibitor,NOS1|NOS2
WWXBHTZSYYGCSG,BRD-K94848716,carbarsone,antiprotozoal agent,,BRD-K94848716,carbarsone,antiprotozoal agent,,BRD-K94848716,carbarsone,antiprotozoal agent,,BRD-K94848716,carbarsone,antiprotozoal agent,
WWYNJERNGUHSAO,BRD-A14886633|BRD-K10086084|BRD-K35189033,levonorgestrel|norgestrel,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,AR|ESR1|PGR|SRD5A1,BRD-A14886633|BRD-K35189033,levonorgestrel|norgestrel,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,AR|ESR1|PGR|SRD5A1,BRD-A14886633|BRD-K10086084|BRD-K35189033,levonorgestrel|norgestrel,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,AR|ESR1|PGR|SRD5A1,BRD-A14886633|BRD-K10086084|BRD-K35189033,levonorgestrel|norgestrel,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,AR|ESR1|PGR|SRD5A1
WWZKQHOCKIZLMA,BRD-K35170555,caprylic-acid,,,BRD-K35170555,caprylic-acid,,,BRD-K35170555,caprylic-acid,,,BRD-K35170555,caprylic-acid,,
WXCXUHSOUPDCQV,BRD-K56851771,enzalutamide,androgen receptor antagonist,AR,BRD-K56851771,enzalutamide,androgen receptor antagonist,AR,BRD-K56851771,enzalutamide,androgen receptor antagonist,AR,BRD-K56851771,enzalutamide,androgen receptor antagonist,AR
WXFIGDLSSYIKKV,BRD-K96253961,metaraminol,adrenergic receptor agonist,ADRA1A,BRD-K96253961,metaraminol,adrenergic receptor agonist,ADRA1A,BRD-K96253961,metaraminol,adrenergic receptor agonist,ADRA1A,BRD-K96253961,metaraminol,adrenergic receptor agonist,ADRA1A
WXHHICFWKXDFOW,BRD-K28537285,chidamide,HDAC inhibitor,HDAC10|HDAC3,BRD-K28537285,chidamide,HDAC inhibitor,HDAC10|HDAC3,BRD-K28537285,chidamide,HDAC inhibitor,HDAC10|HDAC3,BRD-K28537285,chidamide,HDAC inhibitor,HDAC10|HDAC3
WXNRAKRZUCLRBP,BRD-K26665484,avridine,immunostimulant,,BRD-K26665484,avridine,immunostimulant,,BRD-K26665484,avridine,immunostimulant,,BRD-K26665484,avridine,immunostimulant,
WXNXCEHXYPACJF,BRD-K27406233,acetyl-l-leucine,,,BRD-K27406233,acetyl-l-leucine,,,BRD-K27406233,acetyl-l-leucine,,,BRD-K27406233,acetyl-l-leucine,,
WXNZTHHGJRFXKQ,BRD-K40992116,parachlorophenol,antiinfective drug,,BRD-K40992116,parachlorophenol,antiinfective drug,,BRD-K40992116,parachlorophenol,antiinfective drug,,BRD-K40992116,parachlorophenol,antiinfective drug,
WXOUFNFMPVMGFZ,BRD-A55484088,BNTX,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A55484088,BNTX,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A55484088,BNTX,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K18722736,BNTX,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
WXRGFPHDRFQODR,BRD-K69070623,EPZ004777,histone lysine methyltransferase inhibitor,DOT1L,BRD-K69070623,EPZ004777,histone lysine methyltransferase inhibitor,DOT1L,BRD-K69070623,EPZ004777,histone lysine methyltransferase inhibitor,DOT1L,BRD-K69070623,EPZ004777,histone lysine methyltransferase inhibitor,DOT1L
WXURHACBFYSXBI,BRD-A01346607|BRD-K09237689,flumetasone|flumethasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A01346607|BRD-K61496577,flumethasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A01346607|BRD-K09237689|BRD-K61496577,flumethasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B,BRD-A01346607|BRD-K09237689|BRD-K61496577,flumethasone,glucocorticoid receptor agonist,NR3C1|PLA2G1B
WXUUCRLKXQMWRY,BRD-A28467416,PKI-179,PI3K inhibitor|mTOR inhibitor,MTOR,BRD-A28467416,PKI-179,PI3K inhibitor|mTOR inhibitor,MTOR,BRD-A28467416,PKI-179,PI3K inhibitor|mTOR inhibitor,MTOR,BRD-A28467416,PKI-179,PI3K inhibitor|mTOR inhibitor,MTOR
WXXSNCNJFUAIDG,BRD-K84783599,riociguat,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,BRD-K84783599,riociguat,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,BRD-K84783599,riociguat,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,BRD-K84783599,riociguat,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3
WYDUSKDSKCASEF,BRD-A31800922,procyclidine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A31800922,procyclidine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-A31800922,procyclidine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,,,,
WYJAPUKIYAZSEM,BRD-K40227168,vinburnine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K40227168,vinburnine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K40227168,vinburnine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K40227168,vinburnine,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4
WYJCYXOCHXWTHG,BRD-K07682953,palosuran,urotensin receptor antagonist,UTS2R,BRD-K07682953,palosuran,urotensin receptor antagonist,UTS2R,BRD-K07682953,palosuran,urotensin receptor antagonist,UTS2R,BRD-K07682953,palosuran,urotensin receptor antagonist,UTS2R
WYQPLTPSGFELIB,BRD-K33720171,difluprednate,glucocorticoid receptor agonist,NR3C1,BRD-K33720171,difluprednate,glucocorticoid receptor agonist,NR3C1,BRD-K33720171,difluprednate,glucocorticoid receptor agonist,NR3C1,BRD-K72992801,difluprednate,glucocorticoid receptor agonist,NR3C1
WYWHKKSPHMUBEB,BRD-K49350383,thioguanine,purine antagonist,IMPDH1|IMPDH2,BRD-K49350383,thioguanine,purine antagonist,IMPDH1|IMPDH2,BRD-K49350383,thioguanine,purine antagonist,IMPDH1|IMPDH2,BRD-K49350383,thioguanine,purine antagonist,IMPDH1|IMPDH2
WYWIFABBXFUGLM,BRD-K16195444,oxymetazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,BRD-K16195444,oxymetazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,BRD-K16195444,oxymetazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,BRD-K16195444,oxymetazoline,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C
WYWNEDARFVJQSG,BRD-K64137799,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6,BRD-K64137799,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6,BRD-K64137799,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6,BRD-K64137799,2-methyl-5-hydroxytryptamine,serotonin receptor agonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6
WZBNEZWCNKUOSM,BRD-K81981783,gavestinel,glutamate receptor antagonist,GLRB,BRD-K81981783,gavestinel,glutamate receptor antagonist,GLRB,BRD-K81981783,gavestinel,glutamate receptor antagonist,GLRB,BRD-K81981783,gavestinel,glutamate receptor antagonist,GLRB|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B
WZBWBNCQUTXYEL,BRD-K36851334,TRIM,,,BRD-K36851334,TRIM,,,BRD-K36851334,TRIM,,,BRD-K36851334,TRIM,,
WZDGZWOAQTVYBX,BRD-A82522119,tibolone,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,BRD-A82522119,tibolone,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,BRD-A82522119,tibolone,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,BRD-A82522119,tibolone,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1
WZGBZLHGOVJDET,BRD-K84011460,nizofenone,ion channel antagonist,,BRD-K84011460,nizofenone,ion channel antagonist,,BRD-K84011460,nizofenone,ion channel antagonist,,BRD-K84011460,nizofenone,ion channel antagonist,
WZHCOOQXZCIUNC,BRD-A27370296,cyclandelate,calcium channel blocker,CACNA2D1|CES1,BRD-A27370296,cyclandelate,calcium channel blocker,CACNA2D1|CES1,BRD-A27370296,cyclandelate,calcium channel blocker,CACNA2D1|CES1,BRD-A27370296,cyclandelate,calcium channel blocker,
WZHJKEUHNJHDLS,BRD-A72309220|BRD-K56699285,metergoline,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-A72309220|BRD-K56699285,metergoline,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-A72309220|BRD-K56699285,metergoline,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-K56699285,metergoline,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7
WZHKXNSOCOQYQX,BRD-K77070363,U-75799E,growth hormone releasing factor agonist,GHSR,BRD-K77070363,U-75799E,growth hormone releasing factor agonist,GHSR,BRD-K77070363,U-75799E,growth hormone releasing factor agonist,GHSR,BRD-K77070363,U-75799E,growth hormone releasing factor agonist,GHSR
WZMQMKNCWDCCMT,BRD-K67525671,ZK-200775,kainate receptor antagonist,,BRD-K67525671,ZK-200775,kainate receptor antagonist,,BRD-K67525671,ZK-200775,kainate receptor antagonist,,BRD-K67525671,ZK-200775,kainate receptor antagonist,
WZNJWVWKTVETCG,BRD-K67642028,mimosine,DNA replication inhibitor,CCL2|SHMT1|SHMT2|TYR,BRD-K67642028,mimosine,DNA replication inhibitor,CCL2|SHMT1|SHMT2|TYR,BRD-K67642028,mimosine,DNA replication inhibitor,CCL2|SHMT1|SHMT2|TYR,BRD-K67642028,mimosine,DNA replication inhibitor,CCL2|SHMT1|SHMT2|TYR
WZOZEZRFJCJXNZ,BRD-K70976396,cefoxitin,bacterial cell wall synthesis inhibitor,,BRD-K70976396,cefoxitin,bacterial cell wall synthesis inhibitor,,BRD-K70976396,cefoxitin,bacterial cell wall synthesis inhibitor,,BRD-K70976396,cefoxitin,bacterial cell wall synthesis inhibitor,
WZPBZJONDBGPKJ,BRD-K36547807|BRD-K41270709|BRD-K62607865,aztreonam,bacterial cell wall synthesis inhibitor,,BRD-K36547807|BRD-K41270709|BRD-K62607865,aztreonam,bacterial cell wall synthesis inhibitor,,BRD-K36547807|BRD-K41270709|BRD-K62607865,aztreonam,bacterial cell wall synthesis inhibitor,,BRD-K36547807|BRD-K41270709|BRD-K62607865,aztreonam,bacterial cell wall synthesis inhibitor,
WZRCQWQRFZITDX,BRD-A55204514,higenamine,adrenergic receptor agonist,ADRB2,BRD-A55204514,higenamine,adrenergic receptor agonist,ADRB2,BRD-A55204514,higenamine,adrenergic receptor agonist,ADRB2,BRD-A55204514,higenamine,adrenergic receptor agonist,ADRB2
WZRFLSDVFPIXOV,BRD-K68938568,GDC-0152,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,BRD-K68938568,GDC-0152,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,BRD-K68938568,GDC-0152,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,BRD-K68938568,GDC-0152,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP
WZUVPPKBWHMQCE,BRD-K78342372,hematoxylin,,,BRD-K78342372,hematoxylin,,,BRD-K78342372,hematoxylin,,,BRD-K78342372,hematoxylin,,
XACKNLSZYYIACO,BRD-K86892782,edoxudine,DNA directed DNA polymerase inhibitor,,BRD-K86892782,edoxudine,DNA directed DNA polymerase inhibitor,,BRD-A62505706|BRD-K86892782,edoxudine,DNA directed DNA polymerase inhibitor,,BRD-A62505706|BRD-K86892782,edoxudine,DNA directed DNA polymerase inhibitor,
XAGMUUZPGZWTRP,BRD-K66412701,pazufloxacin,topoisomerase inhibitor,,BRD-K66412701,pazufloxacin,topoisomerase inhibitor,,BRD-K66412701,pazufloxacin,topoisomerase inhibitor,,BRD-K66412701,pazufloxacin,topoisomerase inhibitor,
XASIMHXSUQUHLV,BRD-K43806473,camostat-mesilate,protease inhibitor,PRSS1,BRD-K43806473,camostat-mesilate,protease inhibitor,PRSS1,BRD-K43806473,camostat-mesilate,protease inhibitor,PRSS1,BRD-K43806473,camostat-mesilate,protease inhibitor,PRSS1
XAUDJQYHKZQPEU,BRD-K79254416,decitabine,DNA methyltransferase inhibitor,DNMT1|DNMT3A,BRD-K79254416,decitabine,DNA methyltransferase inhibitor,DNMT1|DNMT3A,BRD-K79254416,decitabine,DNA methyltransferase inhibitor,DNMT1|DNMT3A,BRD-K79254416,decitabine,DNA methyltransferase inhibitor,DNMT1|DNMT3A
XBBDACCLCFWBSI,BRD-A25827085|BRD-K18749874,melevodopa,dopamine precursor|dopamine receptor agonist,DDC,BRD-A25827085|BRD-K18749874,melevodopa,dopamine precursor|dopamine receptor agonist,DDC,BRD-A25827085|BRD-K18749874,melevodopa,dopamine precursor|dopamine receptor agonist,DDC,BRD-K18749874,melevodopa,dopamine precursor|dopamine receptor agonist,DDC
XBEQSQDCBSKCHJ,BRD-K26701552,tegobuvir,HCV inhibitor|protease inhibitor,,BRD-K26701552,tegobuvir,HCV inhibitor|protease inhibitor,,BRD-K26701552,tegobuvir,HCV inhibitor|protease inhibitor,,BRD-K26701552,tegobuvir,HCV inhibitor|protease inhibitor,
XBHBWNFJWIASRO,BRD-K08525451,sarafloxacin,bacterial DNA gyrase inhibitor,,BRD-K08525451,sarafloxacin,bacterial DNA gyrase inhibitor,,BRD-K08525451,sarafloxacin,bacterial DNA gyrase inhibitor,,BRD-K08525451,sarafloxacin,bacterial DNA gyrase inhibitor,
XBJBPGROQZJDOJ,BRD-K61717546,fleroxacin,topoisomerase inhibitor,,BRD-K61717546,fleroxacin,topoisomerase inhibitor,,BRD-K61717546,fleroxacin,topoisomerase inhibitor,,BRD-K61717546,fleroxacin,topoisomerase inhibitor,TOP2A
XBJWOGLKABXFJE,BRD-A05523972,telmesteine,mucolytic agent,,BRD-A05523972,telmesteine,mucolytic agent,,BRD-A05523972,telmesteine,mucolytic agent,,BRD-A05523972,telmesteine,mucolytic agent,
XBNRCMFFZFCWMH,BRD-K60914966,etosalamide,anti-inflammatory agent,,BRD-K60914966,etosalamide,anti-inflammatory agent,,BRD-K60914966,etosalamide,anti-inflammatory agent,,BRD-K60914966,etosalamide,anti-inflammatory agent,
XBPCUCUWBYBCDP,BRD-K57091285,dicyclohexylamine,,,BRD-K57091285,dicyclohexylamine,,,BRD-K57091285,dicyclohexylamine,,,BRD-K57091285,dicyclohexylamine,,
XBPUDTAATCFDRE,BRD-M92352362,talc,,,BRD-M92352362,talc,,,BRD-M92352362,talc,,,,,,
XBPZXDSZHPDXQU,BRD-K49841478,rosoxacin,topoisomerase inhibitor,,BRD-K49841478,rosoxacin,topoisomerase inhibitor,,BRD-K49841478,rosoxacin,topoisomerase inhibitor,,BRD-K49841478,rosoxacin,topoisomerase inhibitor,
XCGJIFAKUZNNOR,BRD-K18850819,MK-0752,gamma secretase inhibitor,,BRD-K18850819,MK-0752,gamma secretase inhibitor,,BRD-K18850819,MK-0752,gamma secretase inhibitor,,BRD-K18850819,MK-0752,gamma secretase inhibitor,
XCGSFFUVFURLIX,BRD-A43227343,ergotamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2,BRD-A43227343,ergotamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2,BRD-A43227343,ergotamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2,BRD-K15380626,ergotamine,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2
XCPGHVQEEXUHNC,BRD-K68346641,amsacrine,topoisomerase inhibitor,KCNH2|TOP2A,BRD-K68346641,amsacrine,topoisomerase inhibitor,KCNH2|TOP2A,BRD-K68346641|BRD-K98490050,amsacrine,topoisomerase inhibitor,KCNH2|TOP2A,BRD-K68346641|BRD-K98490050,amsacrine,topoisomerase inhibitor,KCNH2|TOP2A
XCPPIJCBCWUBNT,BRD-A53813595,PGL5001,JNK inhibitor,MAPK10|MAPK8|MAPK9,BRD-A53813595,PGL5001,JNK inhibitor,MAPK10|MAPK8|MAPK9,BRD-A53813595,PGL5001,JNK inhibitor,MAPK10|MAPK8|MAPK9,BRD-A53813595,PGL5001,JNK inhibitor,MAPK10|MAPK8|MAPK9
XCTYLCDETUVOIP,BRD-K69600043,thiethylperazine,dopamine receptor antagonist,DRD1|DRD2|DRD4,BRD-K69600043,thiethylperazine,dopamine receptor antagonist,DRD1|DRD2|DRD4,BRD-K69600043,thiethylperazine,dopamine receptor antagonist,DRD1|DRD2|DRD4,BRD-K69600043,thiethylperazine,dopamine receptor antagonist,DRD1|DRD2|DRD4
XDAOLTSRNUSPPH,BRD-K17480742,delamanid,bacterial cell wall synthesis inhibitor,,BRD-K17480742,delamanid,bacterial cell wall synthesis inhibitor,,BRD-K17480742,delamanid,bacterial cell wall synthesis inhibitor,,BRD-K17480742,delamanid,bacterial cell wall synthesis inhibitor,
XDBMBHVYXPBOPL,BRD-A07704283,isofloxythepin,dopamine receptor antagonist,,BRD-A07704283,isofloxythepin,dopamine receptor antagonist,,BRD-A07704283,isofloxythepin,dopamine receptor antagonist,,BRD-A07704283,isofloxythepin,dopamine receptor antagonist,
XDFKWGIBQMHSOH,BRD-K87691185,FPS-ZM1,RAGE receptor antagonist,AGER,BRD-K87691185,FPS-ZM1,RAGE receptor antagonist,AGER,BRD-K87691185,FPS-ZM1,RAGE receptor antagonist,AGER,BRD-K87691185,FPS-ZM1,RAGE receptor antagonist,AGER
XDHBUMNIQRLHGO,BRD-K99170882,NSC-319726,p53 activator,,BRD-K99170882,NSC-319726,p53 activator,,BRD-K99170882,NSC-319726,p53 activator,,BRD-K99170882,NSC-319726,p53 activator,
XDJCLCLBSGGNKS,BRD-K45746021,CC-401,JNK inhibitor,MAPK8,BRD-K45746021,CC-401,JNK inhibitor,MAPK8,BRD-K45746021,CC-401,JNK inhibitor,MAPK8,BRD-K00004320,CC-401,JNK inhibitor,MAPK8
XDJYMJULXQKGMM,BRD-A44942307,colistimethate,bacterial permeability inducer,,BRD-A44942307,colistimethate,bacterial permeability inducer,,BRD-A44942307,colistimethate,bacterial permeability inducer,,,,,
XDLYKKIQACFMJG,BRD-K07310275,PF-04691502,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K07310275,PF-04691502,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K07310275,PF-04691502,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA,BRD-K07310275,PF-04691502,PI3K inhibitor|mTOR inhibitor,MTOR|PIK3CA
XDRYMKDFEDOLFX,BRD-K13183738,pentamidine,anti-pneumocystis agent,TRDMT1,BRD-K13183738,pentamidine,anti-pneumocystis agent,TRDMT1,BRD-K13183738,pentamidine,anti-pneumocystis agent,TRDMT1,BRD-K13183738,pentamidine,anti-pneumocystis agent,TRDMT1
XDSSPSLGNGIIHP,BRD-K74227499,se-methylselenocysteine,,,BRD-K74227499,se-methylselenocysteine,,,BRD-K74227499,se-methylselenocysteine,,,BRD-K74227499,Se-methylselenocysteine,,
XDUOTWNXVDBCDY,BRD-K00531707,cinepazet,vasodilator,,BRD-K00531707,cinepazet,vasodilator,,BRD-K00531707,cinepazet,vasodilator,,BRD-K00531707,cinepazet,vasodilator,
XDXDZDZNSLXDNA,BRD-K63126143|BRD-K69650333,idarubicin,topoisomerase inhibitor,TOP2A,BRD-K63126143|BRD-K69650333,idarubicin,topoisomerase inhibitor,TOP2A,BRD-K63126143|BRD-K69650333,idarubicin,topoisomerase inhibitor,TOP2A,BRD-K63126143|BRD-K69650333,idarubicin,topoisomerase inhibitor,TOP2A
XDXWLKQMMKQXPV,BRD-K40496271,eltrombopag,thrombopoietin receptor agonist,MPL,BRD-K40496271,eltrombopag,thrombopoietin receptor agonist,MPL,BRD-K40496271,eltrombopag,thrombopoietin receptor agonist,MPL,BRD-K00003572,eltrombopag,thrombopoietin receptor agonist,MPL
XDZKBRJLTGRPSS,BRD-A42969929|BRD-K72150952,cefodizime,bacterial cell wall synthesis inhibitor,,BRD-A42969929|BRD-K72150952,cefodizime,bacterial cell wall synthesis inhibitor,,BRD-A42969929|BRD-K22641081|BRD-K72150952,cefodizime,bacterial cell wall synthesis inhibitor,,BRD-A42969929|BRD-K22641081|BRD-K72150952,cefodizime,bacterial cell wall synthesis inhibitor,
XDZMPRGFOOFSBL,BRD-K04843302,2-ethoxybenzoic-acid,analgesic agent,,BRD-K04843302,2-ethoxybenzoic-acid,analgesic agent,,BRD-K04843302,2-ethoxybenzoic-acid,analgesic agent,,BRD-K04843302,2-ethoxybenzoic-acid,analgesic agent,
XEABSBMNTNXEJM,BRD-K53382462,propagermanium,CCR agonist|interferon receptor agonist,CCR2,BRD-K53382462,propagermanium,CCR agonist|interferon receptor agonist,CCR2,BRD-K53382462,propagermanium,CCR agonist|interferon receptor agonist,CCR2,BRD-K53382462,propagermanium,CCR agonist|interferon receptor agonist,CCR2
XEAOPVUAMONVLA,BRD-K83720053,avagacestat,gamma secretase inhibitor,PSEN1,BRD-K83720053,avagacestat,gamma secretase inhibitor,PSEN1,BRD-K83720053,avagacestat,gamma secretase inhibitor,PSEN1,BRD-K83720053,avagacestat,gamma secretase inhibitor,PSEN1
XEBWQGVWTUSTLN,BRD-K74193284,phenylmercuric-acetate,other antifungal,,BRD-K74193284,phenylmercuric-acetate,other antifungal,,BRD-K74193284,phenylmercuric-acetate,other antifungal,,BRD-K74193284,phenylmercuric-acetate,other antifungal,
XECQQDXTQRYYBH,BRD-K63165456,norcyclobenzaprine,adrenergic receptor agonist|serotonin receptor antagonist,,BRD-K63165456,norcyclobenzaprine,adrenergic receptor agonist|serotonin receptor antagonist,,BRD-K63165456,norcyclobenzaprine,adrenergic receptor agonist|serotonin receptor antagonist,,BRD-K63165456,norcyclobenzaprine,adrenergic receptor agonist|serotonin receptor antagonist,
XEDWWPGWIXPVRQ,BRD-K65716359,exifone,nootropic agent,TYR,BRD-K65716359,exifone,nootropic agent,TYR,BRD-K65716359,exifone,nootropic agent,TYR,BRD-K65716359,exifone,nootropic agent,TYR
XEEQGYMUWCZPDN,BRD-A89585551,mefloquine,adenosine receptor antagonist|hemoglobin antagonist,ADORA2A|HBA1,BRD-A89585551,mefloquine,adenosine receptor antagonist|hemoglobin antagonist,ADORA2A|HBA1,BRD-A89585551,mefloquine,adenosine receptor antagonist|hemoglobin antagonist,ADORA2A|HBA1,BRD-K40645748,mefloquine,adenosine receptor antagonist|hemoglobin antagonist,
XEFQLINVKFYRCS,BRD-K41731458,triclosan,antibacterial agent,DNMT1,BRD-K41731458,triclosan,antibacterial agent,DNMT1,BRD-K41731458,triclosan,antibacterial agent,DNMT1,BRD-K41731458,triclosan,antibacterial agent,DNMT1
XEYBRNLFEZDVAW,BRD-K26521938,dinoprostone,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,BRD-K26521938,dinoprostone,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,BRD-K26521938,dinoprostone,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,BRD-K26521938,dinoprostone,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R
XFALPSLJIHVRKE,BRD-K59436580,tedizolid,bacterial 50S ribosomal subunit inhibitor,,BRD-K59436580,tedizolid,bacterial 50S ribosomal subunit inhibitor,,BRD-K59436580,tedizolid,bacterial 50S ribosomal subunit inhibitor,,BRD-K59436580,tedizolid,bacterial 50S ribosomal subunit inhibitor,
XFAXSWXKPQWHDW,BRD-K13060017,UNC0631,histone lysine methyltransferase inhibitor,EHMT2,BRD-K13060017,UNC0631,histone lysine methyltransferase inhibitor,EHMT2,BRD-K13060017,UNC0631,histone lysine methyltransferase inhibitor,EHMT2,BRD-K13060017,UNC0631,histone lysine methyltransferase inhibitor,EHMT2
XFBDGHFDKJITGC,BRD-K92015269,GBR-12783,dopamine uptake inhibitor,,BRD-K92015269,GBR-12783,dopamine uptake inhibitor,,BRD-K92015269,GBR-12783,dopamine uptake inhibitor,,BRD-K92015269,GBR-12783,dopamine reuptake inhibitor,
XFCLJVABOIYOMF,BRD-K51350053,toremifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,BRD-K51350053,toremifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,BRD-K51350053,toremifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,BRD-K51350053,toremifene,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1
XFDJYSQDBULQSI,BRD-A46179541,doxapram,potassium channel blocker,KCNK3|KCNK9,BRD-A46179541,doxapram,potassium channel blocker,KCNK3|KCNK9,BRD-A46179541|BRD-A47978079,doxapram,potassium channel blocker,KCNK3|KCNK9,BRD-A47978079|BRD-K01825594,doxapram,potassium channel blocker,
XFILPEOLDIKJHX,BRD-K25361343|BRD-K82818427,batimastat,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,BRD-K82818427,batimastat,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,BRD-K25361343|BRD-K82818427,batimastat,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,BRD-K25361343|BRD-K82818427,batimastat,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8
XFTVOHWWEQGXLS,BRD-A52588987,SKF-83566,dopamine receptor antagonist,DRD1|DRD5,BRD-A52588987,SKF-83566,dopamine receptor antagonist,DRD1|DRD5,BRD-A52588987,SKF-83566,dopamine receptor antagonist,DRD1|DRD5,BRD-A52588987,SKF-83566,dopamine receptor antagonist,DRD1|DRD5
XFYDIVBRZNQMJC,BRD-K06335600,tizanidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH,BRD-K06335600,tizanidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH,BRD-K06335600,tizanidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH,BRD-K06335600,tizanidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH
XFZJEEAOWLFHDH,BRD-K72093555,procyanidin-b-2,,,BRD-K72093555,procyanidin-b-2,,,BRD-K72093555,procyanidin-b-2,,,BRD-K72093555,procyanidin-B-2,,
XGALLCVXEZPNRQ,BRD-K64052750,gefitinib,EGFR inhibitor,EGFR,BRD-K64052750,gefitinib,EGFR inhibitor,EGFR,BRD-K64052750,gefitinib,EGFR inhibitor,EGFR,BRD-K64052750,gefitinib,EGFR inhibitor,EGFR
XGGHHHBGPSNXFE,BRD-A06771424,anisotropine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A06771424,anisotropine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A06771424,anisotropine,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K71125570,anisotropine,acetylcholine receptor antagonist,
XGHOVGYJHWQGCC,BRD-K49554218,carebastine,histamine receptor antagonist,HRH1,BRD-K49554218,carebastine,histamine receptor antagonist,HRH1,BRD-K49554218,carebastine,histamine receptor antagonist,HRH1,BRD-K49554218,carebastine,histamine receptor antagonist,HRH1
XGIYOABXZNJOHV,BRD-K33067152,INT-767,FXR agonist,GPBAR1,BRD-K33067152,INT-767,FXR agonist,GPBAR1,BRD-K33067152,INT-767,FXR agonist,GPBAR1,BRD-K33067152,INT-767,FXR agonist,GPBAR1
XGLHZTBDUXXHOM,BRD-K09659835,loreclezole,benzodiazepine receptor agonist,GABRB2|GABRB3,BRD-K09659835,loreclezole,benzodiazepine receptor agonist,GABRB2|GABRB3,BRD-K09659835,loreclezole,benzodiazepine receptor agonist,GABRB2|GABRB3,BRD-K09659835,loreclezole,benzodiazepine receptor agonist,GABRB2|GABRB3
XGOYIMQSIKSOBS,BRD-K27938825,ASA-404,angiogenesis inhibitor,,BRD-K27938825,ASA-404,angiogenesis inhibitor,,BRD-K27938825,ASA-404,angiogenesis inhibitor,,BRD-K27938825,ASA-404,angiogenesis inhibitor,
XGPBJCHFROADCK,BRD-K12787259,CX-5461,RNA polymerase inhibitor,,BRD-K12787259,CX-5461,RNA polymerase inhibitor,,BRD-K12787259,CX-5461,RNA polymerase inhibitor,,BRD-K12787259,CX-5461,RNA polymerase inhibitor,
XGSCYTRLSDKRRZ,BRD-M39350793,reboxetine,adrenergic receptor antagonist,SLC6A2,BRD-M39350793,reboxetine,adrenergic receptor antagonist,SLC6A2,BRD-M39350793,reboxetine,adrenergic receptor antagonist,SLC6A2,,,,
XGWATTXMMMANFJ,BRD-K95851186,CGP-13501,GABA receptor modulator,GABBR1,BRD-K95851186,CGP-13501,GABA receptor modulator,GABBR1,BRD-K95851186,CGP-13501,GABA receptor modulator,GABBR1,BRD-K95851186,CGP-13501,GABA receptor modulator,GABBR1
XGWFJBFNAQHLEF,BRD-K62607075,9-anthracenecarboxylic-acid,,ANO1|CLCN1,BRD-K62607075,9-anthracenecarboxylic-acid,,ANO1|CLCN1,BRD-K62607075,9-anthracenecarboxylic-acid,,ANO1|CLCN1,BRD-K62607075,9-anthracenecarboxylic-acid,,ANO1|CLCN1
XGZZHZMWIXFATA,BRD-K89272869,nalfurafine,opioid receptor agonist,OPRK1|OPRM1,BRD-K89272869,nalfurafine,opioid receptor agonist,OPRK1|OPRM1,BRD-K89272869,nalfurafine,opioid receptor agonist,OPRK1|OPRM1,BRD-K89272869,nalfurafine,opioid receptor agonist,OPRK1|OPRM1
XHCADAYNFIFUHF,BRD-K36270037,esculin,antioxidant,,BRD-K36270037,esculin,antioxidant,,BRD-K36270037,esculin,antioxidant,,BRD-K51742987,esculin,antioxidant,
XHEFDIBZLJXQHF,BRD-K31836715,fisetin,Aurora kinase inhibitor,CDK6|FASN,BRD-K31836715,fisetin,Aurora kinase inhibitor,CDK6|FASN,BRD-K31836715,fisetin,Aurora kinase inhibitor,CDK6|FASN,BRD-K31836715,fisetin,Aurora kinase inhibitor,CDK6|FASN
XHGLVMDBZZZXDP,BRD-A49952467,salsolinol-1-carboxylic-acid,,,BRD-A49952467,salsolinol-1-carboxylic-acid,,,BRD-A49952467,salsolinol-1-carboxylic-acid,,,BRD-A49952467,salsolinol-1-carboxylic-acid,,
XHOLNRLADUSQLD,BRD-K45275534,betrixaban,coagulation factor inhibitor,KCNH2,BRD-K45275534,betrixaban,coagulation factor inhibitor,KCNH2,BRD-K45275534,betrixaban,coagulation factor inhibitor,KCNH2,BRD-K45275534,betrixaban,coagulation factor inhibitor,KCNH2
XHVAWZZCDCWGBK,BRD-A89825407,aurothioglucose,PKC inhibitor,PRKCI,BRD-A89825407,aurothioglucose,PKC inhibitor,PRKCI,BRD-A89825407,aurothioglucose,PKC inhibitor,PRKCI,BRD-K00003601,aurothioglucose,PKC inhibitor,PRKCI
XHWRWCSCBDLOLM,BRD-K36636143,nolatrexed,thymidylate synthase inhibitor,TYMS,BRD-K36636143,nolatrexed,thymidylate synthase inhibitor,TYMS,BRD-K36636143,nolatrexed,thymidylate synthase inhibitor,TYMS,BRD-K36636143,nolatrexed,thymidylate synthase inhibitor,TYMS
XIESSJVMWNJCGZ,BRD-K80608265,erteberel,estrogen receptor agonist,ESR1|ESR2,BRD-K80608265,erteberel,estrogen receptor agonist,ESR1|ESR2,BRD-K80608265,erteberel,estrogen receptor agonist,ESR1|ESR2,BRD-K80608265,erteberel,estrogen receptor agonist,ESR1|ESR2
XILVEPYQJIOVNB,BRD-K73541271,etofenamate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K73541271,etofenamate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K73541271,etofenamate,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K73541271,etofenamate,cyclooxygenase inhibitor,PTGS1|PTGS2
XIQVNETUBQGFHX,BRD-A65013509,oxybutynin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A65013509,oxybutynin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-A65013509,oxybutynin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,BRD-K01825580,oxybutynin,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3
XIURVHNZVLADCM,BRD-K28210218,cephalothin,bacterial cell wall synthesis inhibitor,,BRD-K28210218,cephalothin,bacterial cell wall synthesis inhibitor,,BRD-K28210218,cephalothin,bacterial cell wall synthesis inhibitor,,BRD-K28210218,cephalothin,bacterial cell wall synthesis inhibitor,
XIUUSFJTJXFNGH,BRD-K76606751,mebicar,anxiolytic,,BRD-K76606751,mebicar,anxiolytic,,BRD-K76606751,mebicar,anxiolytic,,BRD-K76606751,mebicar,anxiolytic,
XIVUGRBSBIXXJE,BRD-K77428767,UNC0224,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K77428767,UNC0224,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K77428767,UNC0224,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,BRD-K77428767,UNC0224,histone lysine methyltransferase inhibitor,EHMT1|EHMT2
XIXXNJFWPAVKFR,BRD-K63631219,quazinone,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K63631219,quazinone,phosphodiesterase inhibitor,PDE3A|PDE3B,BRD-K63631219,quazinone,phosphodiesterase inhibitor,PDE3A|PDE3B,,,,
XJDKPLZUXCIMIS,BRD-A08840375,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3,BRD-A08840375,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3,BRD-A08840375,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3,,,,
XJGFWWJLMVZSIG,BRD-K00535541,9-aminoacridine,,,BRD-K00535541,9-aminoacridine,,,BRD-K00535541,9-aminoacridine,,,BRD-K00535541,9-aminoacridine,,
XJGVXQDUIWGIRW,BRD-K39915878,loxapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K39915878,loxapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K39915878,loxapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,BRD-K39915878,loxapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4
XJGZGUSMZSXHJI,BRD-K41262162,DHBP,ryanodine receptor blocker,,BRD-K41262162,DHBP,ryanodine receptor blocker,,BRD-K41262162,DHBP,ryanodine receptor blocker,,BRD-K41262162,DHBP,ryanodine receptor blocker,
XJJZQXUGLLXTHO,BRD-K28007504,Ro-60-0175,,HTR2A|HTR2B|HTR2C,BRD-K28007504,Ro-60-0175,,HTR2A|HTR2B|HTR2C,BRD-K28007504,Ro-60-0175,,HTR2A|HTR2B|HTR2C,BRD-K28007504,Ro-60-0175,serotonin receptor agonist,HTR2A|HTR2B|HTR2C
XJMYIJPPDSZOPN,BRD-K35601925,CS-917,fructose biphosphate inhibitor,FBP1,BRD-K35601925,CS-917,fructose biphosphate inhibitor,FBP1,BRD-K35601925,CS-917,fructose biphosphate inhibitor,FBP1,BRD-K35601925,CS-917,fructose biphosphate inhibitor,FBP1
XKFPYPQQHFEXRZ,BRD-K93332168,isocarboxazid,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K93332168,isocarboxazid,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K93332168,isocarboxazid,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K93332168,isocarboxazid,monoamine oxidase inhibitor,MAOA|MAOB
XKFTZKGMDDZMJI,BRD-K07881437,danusertib,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,BRD-K07881437,danusertib,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,BRD-K07881437,danusertib,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,BRD-K07881437,danusertib,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK
XKFZYVWWXHCHIX,BRD-K48963429,riodoxol,other antibiotic,,BRD-K48963429,riodoxol,other antibiotic,,BRD-K48963429,riodoxol,other antibiotic,,BRD-K48963429,riodoxol,other antibiotic,
XKLMZUWKNUAPSZ,BRD-A97674275,ranolazine,sodium channel blocker,SCN10A|SCN4A|SCN5A|SCN9A,BRD-A97674275,ranolazine,sodium channel blocker,SCN10A|SCN4A|SCN5A|SCN9A,BRD-A97674275,ranolazine,sodium channel blocker,SCN10A|SCN4A|SCN5A|SCN9A,BRD-K01825102,ranolazine,sodium channel blocker,SCN10A|SCN9A
XKLWATAZDMHTSH,BRD-K60284353,titanocene-dichloride,apoptosis stimulant,,BRD-K60284353,titanocene-dichloride,apoptosis stimulant,,BRD-K60284353,titanocene-dichloride,apoptosis stimulant,,BRD-K60284353,titanocene-dichloride,apoptosis stimulant,
XKNKHVGWJDPIRJ,BRD-K24179883,arsanilic-acid,,LYZ,BRD-K24179883,arsanilic-acid,,LYZ,BRD-K24179883,arsanilic-acid,,LYZ,BRD-K24179883,arsanilic-acid,,LYZ
XKZDWYDHEBCGCG,BRD-K22829793,ZCL-278,CDC inhibitor,CDC42,BRD-K22829793,ZCL-278,CDC inhibitor,CDC42,BRD-K22829793,ZCL-278,CDC inhibitor,CDC42,BRD-K22829793,ZCL-278,CDC inhibitor,CDC42
XKZLSYWCDJZTMW,BRD-K75167327,anthranilic-acid,,,BRD-K75167327,anthranilic-acid,,,BRD-K75167327,anthranilic-acid,,,BRD-K75167327,2-(1-adamantylamino)benzoic-acid,,
XLFLNLAIJULEFF,BRD-A59561452,cyanocobalamin,methylmalonyl CoA mutase stimulant|vitamin B,MMAA|MMACHC|MTHFR|MTR|MTRR|MUT,BRD-A59561452,cyanocobalamin,methylmalonyl CoA mutase stimulant|vitamin B,MMAA|MMACHC|MTHFR|MTR|MTRR|MUT,,,,,,,,
XLFWDASMENKTKL,BRD-K63861289,molsidomine,guanylate cyclase stimulant,GUCY1A3,BRD-K63861289,molsidomine,guanylate cyclase stimulant,GUCY1A3,BRD-K63861289,molsidomine,guanylate cyclase stimulant,GUCY1A3,BRD-K63861289,molsidomine,guanylate cyclase stimulant,GUCY1A3
XLGCMZLSEXRBSG,BRD-K22588750,gidazepam,GABA benzodiazepine site receptor agonist,,BRD-K22588750,gidazepam,GABA benzodiazepine site receptor agonist,,BRD-K22588750,gidazepam,GABA benzodiazepine site receptor agonist,,,,,
XLIIRNOPGJTBJD,BRD-K36970462,tonabersat,gap junction modulator|nitric oxide production inhibitor,,BRD-K36970462,tonabersat,gap junction modulator|nitric oxide production inhibitor,,BRD-K36970462,tonabersat,gap junction modulator|nitric oxide production inhibitor,,BRD-K36970462,tonabersat,gap junction modulator|nitric oxide production inhibitor,
XLMALTXPSGQGBX,BRD-A54635441,levopropoxyphene,antitussive,OPRD1|OPRK1|OPRM1,BRD-A54635441,levopropoxyphene,antitussive,OPRD1|OPRK1|OPRM1,BRD-A54635441,levopropoxyphene,antitussive,OPRD1|OPRK1|OPRM1,BRD-A54635441,levopropoxyphene,antitussive,
XLOMZPUITCYLMJ,BRD-A23970436,thiamylal,glutamate receptor antagonist,GABRA1|KCNJ11|KCNJ8,BRD-A23970436,thiamylal,glutamate receptor antagonist,GABRA1|KCNJ11|KCNJ8,BRD-A23970436,thiamylal,glutamate receptor antagonist,GABRA1|KCNJ11|KCNJ8,BRD-A23970436,thiamylal,glutamate receptor antagonist,GABRA1
XLSYZSRXVVCHLS,BRD-K20986415,RGB-286638,CDK inhibitor,CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9,BRD-K20986415,RGB-286638,CDK inhibitor,CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9,BRD-K20986415,RGB-286638,CDK inhibitor,CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9,BRD-K20986415,RGB-286638,CDK inhibitor,CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9
XLTANAWLDBYGFU,BRD-A29043702,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7,BRD-A29043702|BRD-A32164164,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7,BRD-A29043702|BRD-K43192255,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7,BRD-A29043702|BRD-K43192255,methyllycaconitine,acetylcholine receptor antagonist,CHRNA7
XLUKOGNIEDDIMV,BRD-K63651590,pirquinozol,histamine release inhibitor,,BRD-K63651590,pirquinozol,histamine release inhibitor,,BRD-K63651590,pirquinozol,histamine release inhibitor,,BRD-K63651590,pirquinozol,histamine release inhibitor,
XLWJPQQFJNGUPA,BRD-K65786282,CGP-7930,GABA receptor modulator,GABBR1,BRD-K65786282,CGP-7930,GABA receptor modulator,GABBR1,BRD-K65786282,CGP-7930,GABA receptor modulator,GABBR1,BRD-K65786282,CGP-7930,GABA receptor modulator,GABBR1
XLXSAKCOAKORKW,BRD-K96874295,gonadorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR|GNRHR2,BRD-K96874295,gonadorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR|GNRHR2,BRD-K96874295,gonadorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR|GNRHR2,BRD-K96874295,gonadorelin,gonadotropin releasing factor hormone receptor agonist,GNRHR
XLZHXAXXJVKTFM,BRD-K76840893,RS-17053,adrenergic receptor antagonist,ADRA1A|ADRA1D,BRD-K76840893,RS-17053,adrenergic receptor antagonist,ADRA1A|ADRA1D,BRD-K76840893,RS-17053,adrenergic receptor antagonist,ADRA1A|ADRA1D,BRD-K76840893,RS-17053,adrenergic receptor antagonist,ADRA1A|ADRA1D
XMAYWYJOQHXEEK,BRD-A38350138|BRD-K29113274,ketoconazole,sterol demethylase inhibitor,AR|CYP19A1|CYP21A2|KCNA10,BRD-A38350138|BRD-K29113274,ketoconazole,sterol demethylase inhibitor,AR|CYP19A1|CYP21A2|KCNA10,BRD-A38350138|BRD-K29113274,ketoconazole,sterol demethylase inhibitor,AR|CYP19A1|CYP21A2|KCNA10,BRD-K29113274,ketoconazole,sterol demethylase inhibitor,KCNA10
XMFCOYRWYYXZMY,BRD-A22081593,sulmazole,adenosine receptor antagonist,,BRD-A22081593,sulmazole,adenosine receptor antagonist,,BRD-A22081593,sulmazole,adenosine receptor antagonist,,BRD-K01824719,sulmazole,adenosine receptor antagonist,
XMFXTXKSWIDMER,BRD-K83335125,chloroxoquinoline,,,BRD-K83335125,chloroxoquinoline,,,BRD-K83335125,chloroxoquinoline,,,BRD-K83335125,chloroxoquinoline,,
XMGQYMWWDOXHJM,BRD-A81494260|BRD-K20879694,D-limonene,,,BRD-A81494260|BRD-K20879694,D-limonene,,,BRD-A81494260|BRD-K20879694,D-limonene,,,BRD-A81494260|BRD-K20879694,D-limonene,,
XMOVWXSCYLINBJ,BRD-K82903013,"3,3'-dichlorobenzaldazine",,,BRD-K82903013,"3,3'-dichlorobenzaldazine",glutamate receptor allosteric ligand,GRM5,BRD-K50339813|BRD-K82903013,"3,3'-dichlorobenzaldazine",glutamate receptor allosteric ligand,GRM5,BRD-K50339813|BRD-K82903013,"3,3'-dichlorobenzaldazine",glutamate receptor modulator,GRM5
XMVJITFPVVRMHC,BRD-K22685337,roxarsone,antiprotozoal agent,,BRD-K22685337,roxarsone,antiprotozoal agent,,BRD-K22685337,roxarsone,antiprotozoal agent,,BRD-K22685337,roxarsone,antiprotozoal agent,
XMXHEBAFVSFQEX,BRD-K48722833,iloperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7,BRD-K48722833,iloperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7,BRD-K48722833,iloperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7,BRD-K48722833,iloperidone,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7
XMYKNCNAZKMVQN,BRD-K01669786,triapine,ribonucleotide reductase inhibitor,RRM1|RRM2,BRD-K01669786,triapine,ribonucleotide reductase inhibitor,RRM1|RRM2,BRD-K01669786,triapine,ribonucleotide reductase inhibitor,RRM1|RRM2,BRD-K01669786,triapine,ribonucleotide reductase inhibitor,RRM1|RRM2
XNBRWUQWSKXMPW,BRD-K93045741,tozadenant,adenosine receptor antagonist,ADORA2A,BRD-K93045741,tozadenant,adenosine receptor antagonist,ADORA2A,BRD-K93045741,tozadenant,adenosine receptor antagonist,ADORA2A,BRD-K93045741,tozadenant,adenosine receptor antagonist,ADORA2A
XNEFYCZVKIDDMS,BRD-K14401183,avobenzone,UV blocker,TYR,BRD-K14401183,avobenzone,UV blocker,TYR,BRD-K14401183,avobenzone,UV blocker,TYR,,,,
XNKCCCKFOQNXKV,BRD-K41458421,naloxegol,opioid receptor antagonist,OPRM1,BRD-K41458421,naloxegol,opioid receptor antagonist,OPRM1,BRD-K41458421,naloxegol,opioid receptor antagonist,OPRM1,BRD-K41458421,naloxegol,opioid receptor antagonist,OPRM1
XNKLLVCARDGLGL,BRD-A06317634|BRD-K93880783,stavudine,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-A06317634|BRD-K93880783,stavudine,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-A06317634|BRD-K93880783,stavudine,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,BRD-A06317634|BRD-K93880783,stavudine,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,
XNMUICFMGGQSMZ,BRD-K32101625,LX1031,tryptophan hydroxylase inhibitor,TPH1,BRD-K32101625,LX1031,tryptophan hydroxylase inhibitor,TPH1,BRD-K32101625,LX1031,tryptophan hydroxylase inhibitor,TPH1,BRD-K32101625,LX1031,tryptophan hydroxylase inhibitor,TPH1
XNMYNYSCEJBRPZ,BRD-K73391359,dimethisoquin,local anesthetic,,BRD-K73391359,dimethisoquin,local anesthetic,,BRD-K73391359,dimethisoquin,local anesthetic,,BRD-K73391359,dimethisoquin,local anesthetic,
XNOPRXBHLZRZKH,BRD-A80365673|BRD-K25243230,oxytocin,oxytocin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A80365673|BRD-K25243230,oxytocin,oxytocin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A80365673|BRD-K25243230,oxytocin,oxytocin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,BRD-A80365673|BRD-K25243230,oxytocin,oxytocin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR
XNQIOISZPFVUFG,BRD-K28308851|BRD-K80028314,alpha-methylhistamine-dihydrobromide-(R)-(-)|alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3,BRD-K28308851|BRD-K80028314,alpha-methylhistamine-dihydrobromide-(R)-(-)|alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3,BRD-K28308851|BRD-K80028314,alpha-methylhistamine-dihydrobromide-(R)-(-)|alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3,BRD-K28308851|BRD-K80028314,alpha-methylhistamine-dihydrobromide-(R)-(-)|alpha-methylhistamine-dihydrobromide-(S)-(+),histamine receptor agonist,HRH3
XNSAINXGIQZQOO,BRD-A16997652,protirelin,thyrotropin releasing hormone receptor agonist,TRHR,BRD-A16997652,protirelin,thyrotropin releasing hormone receptor agonist,TRHR,BRD-A16997652,protirelin,thyrotropin releasing hormone receptor agonist,TRHR,BRD-K00003716,protirelin,thyrotropin releasing hormone receptor agonist,TRHR
XNYZHCFCZNMTFY,BRD-K92848252,diminazene-aceturate,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,BRD-K92848252,diminazene-aceturate,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,BRD-K92848252|BRD-M65846159,diminazene-aceturate,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,BRD-K92848252|BRD-M65846159,diminazene-aceturate,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1
XOAAWQZATWQOTB,BRD-K51474575,taurine,antioxidant,,BRD-K51474575,taurine,antioxidant,,BRD-K51474575,taurine,antioxidant,,BRD-K51474575,taurine,antioxidant,
XOFYZVNMUHMLCC,BRD-A62525898|BRD-K60679745|BRD-K85883481,prednisone,glucocorticoid receptor agonist,HSD11B1|NR3C1,BRD-A62525898|BRD-K85883481,prednisone,glucocorticoid receptor agonist,HSD11B1|NR3C1,BRD-A62525898|BRD-K60679745|BRD-K85883481,prednisone,glucocorticoid receptor agonist,HSD11B1|NR3C1,BRD-A62525898|BRD-K60679745|BRD-K85883481,prednisone,glucocorticoid receptor agonist,HSD11B1|NR3C1
XOKJUSAYZUAMGJ,BRD-K26420709,toyocamycin,serine/threonine kinase inhibitor,ERN1,BRD-K26420709,toyocamycin,serine/threonine kinase inhibitor,ERN1,BRD-K26420709,toyocamycin,serine/threonine kinase inhibitor,ERN1,BRD-K26420709,toyocamycin,serine/threonine kinase inhibitor,ERN1
XOMRRQXKHMYMOC,BRD-A77577770,palmitoylcarnitine,protein kinase inhibitor,,BRD-A77577770,palmitoylcarnitine,protein kinase inhibitor,,BRD-A77577770,palmitoylcarnitine,protein kinase inhibitor,,BRD-K01826784,palmitoylcarnitine,protein kinase inhibitor,
XONRRGIRSGNWFP,BRD-K66584608,TY-52156,sphingosine 1-phosphate receptor antagonist,S1PR3,BRD-K66584608,TY-52156,sphingosine 1-phosphate receptor antagonist,S1PR3,BRD-K66584608,TY-52156,sphingosine 1-phosphate receptor antagonist,S1PR3,BRD-K66584608,TY-52156,sphingosine 1-phosphate receptor antagonist,S1PR3
XOXHILFPRYWFOD,BRD-K32021043,sulfachlorpyridazine,bacterial antifolate,,BRD-K32021043,sulfachlorpyridazine,bacterial antifolate,,BRD-K32021043,sulfachlorpyridazine,bacterial antifolate,,BRD-K32021043,sulfachlorpyridazine,bacterial antifolate,
XOZIUKBZLSUILX,BRD-K52762805,epothilone-d,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,BRD-K52762805,epothilone-d,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,BRD-K52762805,epothilone-d,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA4A|TUBA8|TUBB|TUBB1|TUBB3|TUBB4A|TUBB4B,BRD-K52762805,epothilone-D,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB
XOZLRRYPUKAKMU,BRD-K85333151,ramifenazone,cyclooxygenase inhibitor,,BRD-K85333151,ramifenazone,cyclooxygenase inhibitor,,BRD-K85333151,ramifenazone,cyclooxygenase inhibitor,,BRD-K85333151,ramifenazone,cyclooxygenase inhibitor,
XOZUGNYVDXMRKW,BRD-K87036601,azodicarbonamide,DNA synthesis inhibitor,,BRD-K87036601,azodicarbonamide,DNA synthesis inhibitor,,BRD-K87036601,azodicarbonamide,DNA synthesis inhibitor,,BRD-K87036601,azodicarbonamide,DNA synthesis inhibitor,
XPCFTKFZXHTYIP,BRD-K49807096,benazepril,angiotensin converting enzyme inhibitor,ACE,BRD-K49807096,benazepril,angiotensin converting enzyme inhibitor,ACE,BRD-K49807096,benazepril,angiotensin converting enzyme inhibitor,ACE,BRD-K49807096,benazepril,angiotensin converting enzyme inhibitor,ACE
XPDVQPODLRGWPL,BRD-K68091065,halazone,,,BRD-K68091065,halazone,,,BRD-K68091065,halazone,,,BRD-K68091065,halazone,,
XPFRXWCVYUEORT,BRD-K40905133,phenacemide,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K40905133,phenacemide,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K40905133,phenacemide,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,BRD-K40905133,phenacemide,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A
XPJOMFBGKIABQW,BRD-K87696786,LY456236,glutamate receptor antagonist,GRM1,BRD-K87696786,LY456236,glutamate receptor antagonist,GRM1,BRD-K87696786,LY456236,glutamate receptor antagonist,GRM1,BRD-K87696786,LY456236,glutamate receptor antagonist,GRM1
XPOQHMRABVBWPR,BRD-K40758068,efavirenz,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,BRD-K40758068,efavirenz,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,BRD-K40758068,efavirenz,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,BRD-K40758068,efavirenz,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4
XPPBBJCBDOEXDN,BRD-K59227464,LY2228820,p38 MAPK inhibitor,MAPK14,BRD-K59227464,LY2228820,p38 MAPK inhibitor,MAPK14,BRD-K59227464,LY2228820,p38 MAPK inhibitor,MAPK14,BRD-K59227464,LY2228820,p38 MAPK inhibitor,MAPK14
XPQIPUZPSLAZDV,BRD-K17874705,2-pyridylethylamine,histamine receptor agonist,HRH1,BRD-K17874705,2-pyridylethylamine,histamine receptor agonist,HRH1,BRD-K17874705,2-pyridylethylamine,histamine receptor agonist,HRH1,BRD-K17874705,2-pyridylethylamine,histamine receptor agonist,HRH1
XPRDUGXOWVXZLL,BRD-K40797222,SC-12267,dihydroorotate dehydrogenase inhibitor,IL17A,BRD-K40797222,SC-12267,dihydroorotate dehydrogenase inhibitor,IL17A,BRD-K40797222,SC-12267,dihydroorotate dehydrogenase inhibitor,IL17A,BRD-K40797222,SC-12267,dihydroorotate dehydrogenase inhibitor,IL17A
XPRZIORDEVHURQ,BRD-K42563464,YM-58483,calcium channel blocker,TRPC3|TRPC5|TRPM4,BRD-K42563464,YM-58483,calcium channel blocker,TRPC3|TRPC5|TRPM4,BRD-K42563464,YM-58483,calcium channel blocker,TRPC3|TRPC5|TRPM4,BRD-K42563464,YM-58483,calcium channel blocker,TRPC3|TRPC5|TRPM4
XPSQPHWEGNHMSK,BRD-K08255599,frovatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,BRD-K08255599,frovatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,BRD-K08255599,frovatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,BRD-K08255599,frovatriptan,serotonin receptor agonist,HTR1A|HTR1B|HTR1D
XPYGGHVSFMUHLH,BRD-K08251020,falecalcitriol,vitamin D receptor agonist,VDR,BRD-K08251020,falecalcitriol,vitamin D receptor agonist,VDR,BRD-K08251020,falecalcitriol,vitamin D receptor agonist,VDR,BRD-K08251020,falecalcitriol,vitamin D receptor agonist,VDR
XQDXIHYKAGHZRX,BRD-A42553870,L-152804,neuropeptide receptor antagonist,NPY5R,BRD-A42553870,L-152804,neuropeptide receptor antagonist,NPY5R,BRD-A42553870,L-152804,neuropeptide receptor antagonist,NPY5R,BRD-K01827100,L-152804,neuropeptide receptor antagonist,NPY5R
XQFINGFCBFHOPE,BRD-K87468701,EPZ011989,histone lysine methyltransferase inhibitor,EZH2,BRD-K87468701,EPZ011989,histone lysine methyltransferase inhibitor,EZH2,BRD-K87468701,EPZ011989,histone lysine methyltransferase inhibitor,EZH2,BRD-K87468701,EPZ011989,histone lysine methyltransferase inhibitor,EZH2
XQFRJNBWHJMXHO,BRD-A85439007|BRD-K76634210,idoxuridin|idoxuridine,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,BRD-A85439007|BRD-K76634210,idoxuridine,DNA directed DNA polymerase inhibitor,,BRD-A85439007|BRD-K76634210,idoxuridine,DNA directed DNA polymerase inhibitor,,BRD-A85439007|BRD-K76634210,idoxuridine,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,
XQGZSYKGWHUSDH,BRD-K82767007,dazoxiben,thromboxane synthase inhibitor,TBXAS1,BRD-K82767007,dazoxiben,thromboxane synthase inhibitor,TBXAS1,BRD-K82767007,dazoxiben,thromboxane synthase inhibitor,TBXAS1,BRD-K82767007,dazoxiben,thromboxane synthase inhibitor,TBXAS1
XQLWNAFCTODIRK,BRD-A52922642,gallopamil,L-type calcium channel blocker,ATP2A2,BRD-A52922642,gallopamil,L-type calcium channel blocker,ATP2A2,BRD-A52922642,gallopamil,L-type calcium channel blocker,ATP2A2,BRD-A52922642,gallopamil,L-type calcium channel blocker,ATP2A2
XQSPYNMVSIKCOC,BRD-K61452026,emtricitabine,nucleoside reverse transcriptase inhibitor,,BRD-K61452026,emtricitabine,nucleoside reverse transcriptase inhibitor,,BRD-K61452026,emtricitabine,nucleoside reverse transcriptase inhibitor,,BRD-K61452026,emtricitabine,nucleoside reverse transcriptase inhibitor,
XQVVPGYIWAGRNI,BRD-K64890080,BI-2536,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,BRD-K64890080,BI-2536,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,BRD-K64890080,BI-2536,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,BRD-K64890080,BI-2536,PLK inhibitor,BRD4|PLK1|PLK2|PLK3
XQYASZNUFDVMFH,BRD-K91825936,ZK811752,CC chemokine receptor antagonist,CCR1,BRD-K91825936,ZK811752,CC chemokine receptor antagonist,CCR1,BRD-K91825936,ZK811752,CC chemokine receptor antagonist,CCR1,BRD-K91825936,ZK-811752,CC chemokine receptor antagonist,CCR1
XQYZDYMELSJDRZ,BRD-K15567136,papaverine,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,BRD-K15567136,papaverine,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,BRD-K15567136,papaverine,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,BRD-K15567136,papaverine,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A
XQZXYNRDCRIARQ,BRD-K75868704,iopamidol,radiopaque medium,,BRD-K75868704,iopamidol,radiopaque medium,,BRD-K75868704,iopamidol,radiopaque medium,,BRD-K75868704,iopamidol,radiopaque medium,
XRASPMIURGNCCH,BRD-K84253429,zoledronic-acid,bone resorption inhibitor,FDPS|GGPS1,BRD-K84253429,zoledronic-acid,bone resorption inhibitor,FDPS|GGPS1,BRD-K84253429,zoledronic-acid,bone resorption inhibitor,FDPS|GGPS1,BRD-K84253429,zoledronic-acid,bone resorption inhibitor,FDPS|GGPS1
XRBMKGUDDJPAMH,BRD-K58648841,cresopirine,,,BRD-K58648841,cresopirine,,,BRD-K58648841,cresopirine,,,BRD-K58648841,cresopirine,,
XRCFXMGQEVUZFC,BRD-K47458712,anisindione,vitamin K antagonist,GGCX,BRD-K47458712,anisindione,vitamin K antagonist,GGCX,BRD-K47458712,anisindione,vitamin K antagonist,GGCX,BRD-K47458712,anisindione,vitamin K antagonist,GGCX
XRECTZIEBJDKEO,BRD-K82143716,flucytosine,other antifungal,DNMT1,BRD-K82143716,flucytosine,other antifungal,DNMT1,BRD-K82143716,flucytosine,other antifungal,DNMT1,BRD-K82143716,flucytosine,other antifungal,DNMT1
XRKYMMUGXMWDAO,BRD-K25311561,KU-55933,ATM kinase inhibitor,ATM|PRKDC,BRD-K25311561,KU-55933,ATM kinase inhibitor,ATM|PRKDC,BRD-K25311561,KU-55933,ATM kinase inhibitor,ATM|PRKDC,BRD-K25311561,KU-55933,ATM kinase inhibitor,ATM|PRKDC
XRQDFNLINLXZLB,BRD-K00519864,peramivir,neuraminidase inhibitor,,BRD-K00519864,peramivir,neuraminidase inhibitor,,BRD-K00519864,peramivir,neuraminidase inhibitor,,BRD-K00519864,peramivir,neuraminidase inhibitor,
XRUUVUYJUULCBQ,BRD-K68103045,CGS-20625,GABA benzodiazepine site receptor partial agonist|benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K68103045,CGS-20625,GABA benzodiazepine site receptor partial agonist|benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,BRD-K68103045,CGS-20625,GABA benzodiazepine site receptor partial agonist|benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,,,,
XRVDGNKRPOAQTN,BRD-K46625559,ozanimod,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K46625559,ozanimod,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K46625559,ozanimod,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K46625559,ozanimod,sphingosine 1-phosphate receptor agonist,S1PR1
XRVMPTWWKLKLPB,BRD-K01129913,walrycin-b,transcriptional regulatory protein WalR,,BRD-K01129913,walrycin-b,transcriptional regulatory protein WalR,,BRD-K01129913,walrycin-b,transcriptional regulatory protein WalR,,BRD-K01129913,walrycin-B,transcriptional regulatory protein WalR,
XRWSZZJLZRKHHD,BRD-K87028197,asunaprevir,HCV inhibitor,,BRD-K87028197,asunaprevir,HCV inhibitor,,BRD-K87028197,asunaprevir,HCV inhibitor,,BRD-K87028197,asunaprevir,HCV inhibitor,
XRXDAJYKGWNHTQ,BRD-K77925998,quipazine,serotonin receptor agonist,,BRD-K77925998,quipazine,serotonin receptor agonist,,BRD-K77925998,quipazine,serotonin receptor agonist,,BRD-K77925998,quipazine,serotonin receptor agonist,HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4
XRYJULCDUUATMC,BRD-K10115470,PKI-166,EGFR inhibitor,EGFR,BRD-K10115470,PKI-166,EGFR inhibitor,EGFR,BRD-K10115470,PKI-166,EGFR inhibitor,EGFR,BRD-K10115470,PKI-166,EGFR inhibitor,EGFR
XRYLGRGAWQSVQW,BRD-A19053834,clorotepine,adrenergic receptor antagonist|dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6,BRD-A19053834,clorotepine,adrenergic receptor antagonist|dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6,BRD-A19053834,clorotepine,adrenergic receptor antagonist|dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6,BRD-A19053834,clorotepine,adrenergic receptor antagonist|dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6
XRZYELWZLNAXGE,BRD-K59469039,tyrphostin-AG-879,tyrosine kinase inhibitor,ERBB2|KDR|NTRK1,BRD-K59469039,tyrphostin-AG-879,tyrosine kinase inhibitor,ERBB2|KDR|NTRK1,BRD-K59469039,tyrphostin-AG-879,tyrosine kinase inhibitor,ERBB2|KDR|NTRK1,BRD-K59469039,tyrphostin-AG-879,tyrosine kinase inhibitor,ERBB2|KDR|NTRK1
XSBSKEQEUFOSDD,BRD-K44942604,pentolinium,cholinergic receptor antagonist,CHRNA10|CHRNA3|CHRNA4|CHRNB4,BRD-K44942604,pentolinium,cholinergic receptor antagonist,CHRNA10|CHRNA3|CHRNA4|CHRNB4,BRD-K44942604,pentolinium,cholinergic receptor antagonist,CHRNA10|CHRNA3|CHRNA4|CHRNB4,BRD-K44942604,pentolinium,cholinergic receptor antagonist,CHRNA10|CHRNA3|CHRNA4|CHRNB4
XSCGXQMFQXDFCW,BRD-K63675182,triflupromazine,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,BRD-K63675182,triflupromazine,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,BRD-K63675182,triflupromazine,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,BRD-K63675182,triflupromazine,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B
XSDFWTIKVXKOGJ,BRD-K66437909,KT-433,uricosuric agent,,BRD-K66437909,KT-433,uricosuric agent,,BRD-K66437909,KT-433,uricosuric agent,,BRD-K66437909,KT-433,uricosuric agent,
XSDQTOBWRPYKKA,BRD-K97181089,amiloride,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,BRD-K97181089,amiloride,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,BRD-K97181089,amiloride,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,BRD-K97181089,amiloride,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2
XSFJVAJPIHIPKU,BRD-A65449987,flunisolide,cytochrome P450 inhibitor,NR3C1,BRD-A65449987,flunisolide,cytochrome P450 inhibitor,NR3C1,BRD-A65449987,flunisolide,cytochrome P450 inhibitor,NR3C1,BRD-K49577446,flunisolide,cytochrome P450 inhibitor,NR3C1
XSHQBIXMLULFEV,BRD-K29542628,1-naphthyl-PP1,src inhibitor,SRC,BRD-K29542628,1-naphthyl-PP1,src inhibitor,SRC,BRD-K29542628,1-naphthyl-PP1,src inhibitor,SRC,BRD-K29542628,1-naphthyl-PP1,SRC inhibitor,SRC
XSIOKTWDEOJMGG,BRD-K97874492,acriflavinium,hypoxia inducible factor inhibitor,HIF1A,BRD-K97874492,acriflavinium,hypoxia inducible factor inhibitor,HIF1A,BRD-K97874492,acriflavinium,hypoxia inducible factor inhibitor,HIF1A,BRD-K97874492,acriflavinium,hypoxia inducible factor inhibitor,HIF1A
XSMSNFMDVXXHGJ,BRD-K76719364,GS-9973,syk inhibitor,SYK,BRD-K76719364,GS-9973,syk inhibitor,SYK,BRD-K76719364,GS-9973,syk inhibitor,SYK,BRD-K76719364,GS-9973,SYK inhibitor,SYK
XSMYYYQVWPZWIZ,BRD-K70088346,2-chloro-N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K70088346,2-chloro-N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K70088346,2-chloro-N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K70088346,2-chloro-N6-cyclopentyladenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
XSQUKJJJFZCRTK,BRD-K88052444,urea,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,BRD-K88052444,urea,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,BRD-K88052444,urea,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,BRD-K88052444,urea,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1
XSSNABKEYXKKMK,BRD-K10673031,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3,BRD-K10673031,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3,BRD-K10673031,S-Isopropylisothiourea,nitric oxide synthase inhibitor,NOS3,BRD-K10673031,S-isopropylisothiourea,nitric oxide synthase inhibitor,NOS3
XSTXAVWGXDQKEL,BRD-K46435528,trichloroethylene,,,BRD-K46435528,trichloroethylene,,,BRD-K46435528,trichloroethylene,,,BRD-K46435528,trichloroethylene,,
XSVMFMHYUFZWBK,BRD-K10706131,rivastigmine,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K10706131,rivastigmine,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K10706131,rivastigmine,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K10706131,rivastigmine,acetylcholinesterase inhibitor,ACHE|BCHE
XTFPDGZNWTZCMF,BRD-A68083442,pranidipine,calcium channel blocker,CACNA1C,BRD-A68083442,pranidipine,calcium channel blocker,CACNA1C,BRD-A68083442,pranidipine,calcium channel blocker,CACNA1C,BRD-A68083442,pranidipine,calcium channel blocker,CACNA1C
XTKDAFGWCDAMPY,BRD-K45861246,azaperone,dopamine receptor antagonist,DRD2|DRD3,BRD-K45861246,azaperone,dopamine receptor antagonist,DRD2|DRD3,BRD-K45861246,azaperone,dopamine receptor antagonist,DRD2|DRD3,BRD-K45861246,azaperone,dopamine receptor antagonist,DRD2|DRD3
XTKIDERFOUYBDE,BRD-M31057929|BRD-M75836831,LCZ696|valsartan-sacubitril-combination,angiotensin receptor antagonist|neprilysin inhibitor,|AGTR1,BRD-M31057929,LCZ696,angiotensin receptor antagonist,,BRD-M31057929|BRD-M42331949|BRD-M75836831,LCZ696,angiotensin receptor antagonist,,BRD-M31057929|BRD-M42331949|BRD-M75836831,LCZ696,angiotensin receptor antagonist,
XTKLTGBKIDQGQL,BRD-K49215523,GSK2636771,PI3K inhibitor,PIK3CB,BRD-K49215523,GSK2636771,PI3K inhibitor,PIK3CB,BRD-K49215523,GSK2636771,PI3K inhibitor,PIK3CB,BRD-K49215523,GSK2636771,PI3K inhibitor,PIK3CB
XTNGUQKDFGDXSJ,BRD-K90868879,canagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K90868879,canagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K90868879,canagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,BRD-K90868879,canagliflozin,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2
XTRUQJBVQBUKSQ,BRD-K10859802,APD668,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K10859802,APD668,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K10859802,APD668,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K10859802,APD668,glucose dependent insulinotropic receptor agonist,GPR119
XTTZERNUQAFMOF,BRD-K55013654,lorcaserin,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-K55013654,lorcaserin,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,BRD-K55013654,lorcaserin,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,,,,
XTURYZYJYQRJDO,BRD-K79437791,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG,BRD-K79437791,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG,BRD-K79437791,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG,BRD-K79437791,acetyl-farnesyl-cysteine,methyltransferase inhibitor,PPARG
XTZUPNNVXIMWAR,BRD-K66093087,FGIN-1-43,benzodiazepine receptor agonist,TSPO,BRD-K66093087,FGIN-1-43,benzodiazepine receptor agonist,TSPO,BRD-K66093087,FGIN-1-43,benzodiazepine receptor agonist,TSPO,BRD-K66093087,FGIN-1-43,benzodiazepine receptor agonist,TSPO
XUBOMFCQGDBHNK,BRD-A74980173,gatifloxacin,bacterial DNA gyrase inhibitor,,BRD-A74980173,gatifloxacin,bacterial DNA gyrase inhibitor,,BRD-A74980173,gatifloxacin,bacterial DNA gyrase inhibitor,,BRD-K01825698,gatifloxacin,bacterial DNA gyrase inhibitor,
XUCIJNAGGSZNQT,BRD-K03504028|BRD-K11478426,amygdalin,caspase activator,CASP3,BRD-K03504028|BRD-K11478426,amygdalin,caspase activator,CASP3,BRD-K03504028|BRD-K11478426,amygdalin,caspase activator,CASP3,BRD-K03504028|BRD-K11478426,amygdalin,caspase activator,CASP3
XUFQPHANEAPEMJ,BRD-K00673382,famotidine,histamine receptor antagonist,HRH2,BRD-K00673382,famotidine,histamine receptor antagonist,HRH2,BRD-K00673382,famotidine,histamine receptor antagonist,HRH2,BRD-K00673382,famotidine,histamine receptor antagonist,HRH2
XUFXOAAUWZOOIT,BRD-A16444946|BRD-K01621533|BRD-K44276885,acarbose,glucosidase inhibitor,AMY2A|GAA|MGAM|SI,BRD-A16444946|BRD-K44276885,acarbose,glucosidase inhibitor,AMY2A|GAA|MGAM|SI,BRD-A16444946|BRD-K01621533|BRD-K44276885,acarbose,glucosidase inhibitor,AMY2A|GAA|MGAM|SI,BRD-A16444946|BRD-K01621533|BRD-K44276885,acarbose,glucosidase inhibitor,AMY2A|MGAM
XUGNVMKQXJXZCD,BRD-K30758549,isopropyl-palmitate,cosmetic moisturizer,,BRD-K30758549,isopropyl-palmitate,cosmetic moisturizer,,BRD-K30758549,isopropyl-palmitate,cosmetic moisturizer,,BRD-K30758549,isopropyl-palmitate,cosmetic moisturizer,
XUIIKFGFIJCVMT,BRD-K30685142,levothyroxine,thyroid hormone stimulant,THRA|THRB,BRD-K30685142,levothyroxine,thyroid hormone stimulant,THRA|THRB,BRD-K30685142,levothyroxine,thyroid hormone stimulant,THRA|THRB,BRD-K30685142,levothyroxine,thyroid hormone stimulant,THRA|THRB
XUJNEKJLAYXESH,BRD-K00795468,L-cysteine,,CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3,BRD-K00795468,L-cysteine,,CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3,BRD-K00795468,L-cysteine,,CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3,BRD-K00795468,L-cysteine,,CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3
XUKUURHRXDUEBC,BRD-K69726342,atorvastatin,HMGCR inhibitor,AHR|DPP4|HMGCR,BRD-K69726342|BRD-M94983326,atorvastatin,HMGCR inhibitor,AHR|DPP4|HMGCR,BRD-K69726342|BRD-M94983326,atorvastatin,HMGCR inhibitor,AHR|DPP4|HMGCR,BRD-K69726342|BRD-M94983326,atorvastatin,HMGCR inhibitor,AHR|DPP4|HMGCR
XULIXFLCVXWHRF,BRD-K71075093,pempidine,ganglionic blocker,,BRD-K71075093,pempidine,ganglionic blocker,,BRD-K71075093,pempidine,ganglionic blocker,,BRD-K71075093,pempidine,ganglionic blocker,
XUOLEICXAPEOSI,BRD-K16180792,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1,BRD-K16180792,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1,BRD-K16180792,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1,BRD-K16180792,bis(maltolato)oxovanadium(IV),tyrosine phosphatase inhibitor,PTPN1
XURCIPRUUASYLR,BRD-K69035426,omeprazole-sulfide,ATPase inhibitor,,BRD-K69035426,omeprazole-sulfide,ATPase inhibitor,,BRD-K69035426,omeprazole-sulfide,ATPase inhibitor,,BRD-K69035426,omeprazole-sulfide,ATPase inhibitor,
XUZMWHLSFXCVMG,BRD-K53581288,baricitinib,JAK inhibitor,JAK1|JAK2,BRD-K53581288,baricitinib,JAK inhibitor,JAK1|JAK2,BRD-K53581288,baricitinib,JAK inhibitor,JAK1|JAK2,BRD-K53581288,baricitinib,JAK inhibitor,JAK1|JAK2
XVAMCHGMPYWHNL,BRD-A92974210,bemotrizinol,,,BRD-A92974210,bemotrizinol,,,BRD-A92974210,bemotrizinol,,,BRD-A92974210,bemotrizinol,,
XVBGRTMNFNMINE,BRD-K48449981,XMD17-109,MAP kinase inhibitor,MAPK7,BRD-K48449981,XMD17-109,MAP kinase inhibitor,MAPK7,BRD-K48449981,XMD17-109,MAP kinase inhibitor,MAPK7,BRD-K48449981,XMD17-109,MAP kinase inhibitor,MAPK7
XVECMUKVOMUNLE,BRD-K68756823,FR-180204,MAP kinase inhibitor,MAPK1|MAPK3,BRD-K68756823,FR-180204,MAP kinase inhibitor,MAPK1|MAPK3,BRD-K68756823,FR-180204,MAP kinase inhibitor,MAPK1|MAPK3,BRD-K68756823,FR-180204,MAP kinase inhibitor,MAPK1|MAPK3
XVGOZDAJGBALKS,BRD-K25943794,blonanserin,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,BRD-K25943794,blonanserin,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,BRD-K25943794,blonanserin,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,BRD-K25943794,blonanserin,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A
XVOOCQSWCCRVDY,BRD-K83834509,PTC-209,BMI-1 inhibitor,,BRD-K83834509,PTC-209,BMI-1 inhibitor,,BRD-K83834509,PTC-209,BMI-1 inhibitor,,BRD-K83834509,PTC-209,BMI-1 inhibitor,
XVPBINOPNYFXID,BRD-A57833392,oxymatrine,,,BRD-A57833392,oxymatrine,,,BRD-A57833392,oxymatrine,,,BRD-K00003713,oxymatrine,,
XVQUOJBERHHONY,BRD-A64743628,isometheptene-mucate,,ADRA1A|SLC18A2,BRD-A64743628,isometheptene-mucate,,ADRA1A|SLC18A2,BRD-A64743628|BRD-M48029916,isometheptene-mucate,,ADRA1A|SLC18A2,BRD-A64743628|BRD-M48029916,isometheptene-mucate,,
XVTVPGKWYHWYAD,BRD-A26845397,isamoltane,adrenergic receptor antagonist,HTR1A|HTR1B,BRD-A26845397,isamoltane,adrenergic receptor antagonist,HTR1A|HTR1B,BRD-A26845397|BRD-M60365050,isamoltane,adrenergic receptor antagonist,HTR1A|HTR1B,BRD-K01825673|BRD-M60365050,isamoltane,adrenergic receptor antagonist,HTR1A|HTR1B
XVULBTBTFGYVRC,BRD-A23127772,sclareol,,,BRD-A23127772,sclareol,,,BRD-A23127772,sclareol,,,BRD-A23127772,sclareol,,
XVWPFYDMUFBHBF,BRD-K19669037,GGTI-298,GGTase inhibitor,CDKN1A,BRD-K19669037,GGTI-298,GGTase inhibitor,CDKN1A,BRD-K19669037,GGTI-298,GGTase inhibitor,CDKN1A,BRD-K19669037,GGTI-298,GGTase inhibitor,CDKN1A
XWAONOGAGZNUSF,BRD-K51333959,siramesine,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K51333959,siramesine,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K51333959,siramesine,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,BRD-K51333959,siramesine,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D
XWLUWCNOOVRFPX,BRD-K53809807,fosphenytoin,sodium channel blocker,SCN5A,BRD-K53809807,fosphenytoin,sodium channel blocker,SCN5A,BRD-K53809807,fosphenytoin,sodium channel blocker,SCN5A,BRD-K53809807,fosphenytoin,sodium channel blocker,SCN5A
XWQVQSXLXAXOPJ,BRD-K43914553,CDK9-IN-6,CDK inhibitor,CDK9,BRD-K43914553,CDK9-IN-6,CDK inhibitor,CDK9,BRD-K43914553,CDK9-IN-6,CDK inhibitor,CDK9,BRD-K43914553,CDK9-IN-6,CDK inhibitor,CDK9
XWTYSIMOBUGWOL,BRD-A50157456,terbutaline,adrenergic receptor agonist,ADRB2,BRD-A50157456,terbutaline,adrenergic receptor agonist,ADRB2,BRD-A50157456|BRD-M79902621,terbutaline,adrenergic receptor agonist,ADRB2,BRD-A50157456|BRD-M79902621,terbutaline,adrenergic receptor agonist,ADRB2
XWVBOPKUSVZZPJ,BRD-K75080769,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,,BRD-K75080769,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,,BRD-K75080769,"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,,BRD-K75080769,"trans-4-[8-(3-fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",,
XWVOEFLBOSSYGM,BRD-K53220666,trimetozine,sedative,,BRD-K53220666,trimetozine,sedative,,BRD-K53220666,trimetozine,sedative,,BRD-K53220666,trimetozine,sedative,
XWXVKXXKKLBDDJ,BRD-A53472930,seclazone,anti-inflammatory agent,,BRD-A53472930,seclazone,anti-inflammatory agent,,BRD-A53472930,seclazone,anti-inflammatory agent,,BRD-A53472930,seclazone,anti-inflammatory agent,
XWXYUMMDTVBTOU,BRD-K23566484,nilutamide,androgen receptor antagonist,AR,BRD-K23566484,nilutamide,androgen receptor antagonist,AR,BRD-K23566484,nilutamide,androgen receptor antagonist,AR,BRD-K23566484,nilutamide,androgen receptor antagonist,AR
XXEPPPIWZFICOJ,BRD-A37288617,amfepramone,adrenergic receptor agonist,SLC6A2|SLC6A3,BRD-A37288617,amfepramone,adrenergic receptor agonist,SLC6A2|SLC6A3,BRD-A37288617,amfepramone,adrenergic receptor agonist,SLC6A2|SLC6A3,,,,
XXJWYDDUDKYVKI,BRD-K86930074,cediranib,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,BRD-K86930074,cediranib,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,BRD-K86930074,cediranib,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,BRD-K86930074,cediranib,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB
XXPANQJNYNUNES,BRD-A29644307,nomifensine,dopamine uptake inhibitor|noradrenaline uptake inhibitor,DRD2|MAOA|MAOB|MPO|SLC6A2|SLC6A3,BRD-A29644307,nomifensine,dopamine uptake inhibitor|noradrenaline uptake inhibitor,DRD2|MAOA|MAOB|MPO|SLC6A2|SLC6A3,BRD-A29644307,nomifensine,dopamine uptake inhibitor|noradrenaline uptake inhibitor,DRD2|MAOA|MAOB|MPO|SLC6A2|SLC6A3,BRD-A29644307,nomifensine,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,DRD2|SLC6A2|SLC6A3
XXRCUYVCPSWGCC,BRD-K47738867,ethyl-pyruvate,tumor necrosis factor production inhibitor,HMGB1|TNF,BRD-K47738867,ethyl-pyruvate,tumor necrosis factor production inhibitor,HMGB1|TNF,BRD-K47738867,ethyl-pyruvate,tumor necrosis factor production inhibitor,HMGB1|TNF,,,,
XXRVYAFBUDSLJX,BRD-K49338325,etofibrate,PPAR receptor agonist,PPARA,BRD-K49338325,etofibrate,PPAR receptor agonist,PPARA,BRD-K49338325,etofibrate,PPAR receptor agonist,PPARA,BRD-K49338325,etofibrate,PPAR receptor agonist,PPARA
XXSMGPRMXLTPCZ,BRD-A99117172,hydroxychloroquine,antimalarial agent,TLR7|TLR9,BRD-A99117172,hydroxychloroquine,antimalarial agent,TLR7|TLR9,BRD-A99117172,hydroxychloroquine,antimalarial agent,TLR7|TLR9,BRD-A99117172,hydroxychloroquine,antimalarial agent,TLR7|TLR9
XXSSGBYXSKOLAM,BRD-A57798112,PD-318088,MEK inhibitor,MAP2K1,BRD-A57798112,PD-318088,MEK inhibitor,MAP2K1,BRD-A57798112,PD-318088,MEK inhibitor,MAP2K1,BRD-A57798112,PD-318088,MEK inhibitor,
XXUXXCZCUGIGPP,BRD-K85757157,nifursol,bacterial DNA inhibitor,,BRD-K85757157,nifursol,bacterial DNA inhibitor,,BRD-K85757157,nifursol,bacterial DNA inhibitor,,BRD-K85757157,nifursol,bacterial DNA inhibitor,
XXUZFRDUEGQHOV,BRD-K83146339,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,BRD-K83146339,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,BRD-K83146339|BRD-K88014802|BRD-M65265990,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,,,,
XXYGTCZJJLTAGH,BRD-K16810791,LGK-974,porcupine inhibitor,PORCN,BRD-K16810791,LGK-974,porcupine inhibitor,PORCN,BRD-K16810791,LGK-974,porcupine inhibitor,PORCN,BRD-K16810791,LGK-974,porcupine inhibitor,PORCN
XYCMOTOFHFTUIU,BRD-A04971881,cloranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A04971881,cloranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A04971881,cloranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,BRD-A04971881,cloranolol,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3
XYDNMOZJKOGZLS,BRD-K98028353,savolitinib,c-Met inhibitor,MET,BRD-K98028353,savolitinib,c-Met inhibitor,MET,BRD-K98028353,savolitinib,c-Met inhibitor,MET,BRD-K98028353,savolitinib,c-Met inhibitor,MET
XYFPWWZEPKGCCK,BRD-K70301465,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,BRD-K70301465,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,BRD-K70301465,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,BRD-K70301465,ibrutinib,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK
XYKWNRUXCOIMFZ,BRD-K89714990,tepoxalin,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5,BRD-K89714990,tepoxalin,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5,BRD-K89714990,tepoxalin,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5,BRD-K89714990,tepoxalin,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5
XYLJNLCSTIOKRM,BRD-K68264559,brimonidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K68264559,brimonidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K68264559|BRD-M06829359,brimonidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K68264559|BRD-M06829359,brimonidine,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C
XYWJNTOURDMTPI,BRD-K54824716,procodazole,immunostimulant,,BRD-K54824716,procodazole,immunostimulant,,BRD-K54824716,procodazole,immunostimulant,,BRD-K54824716,procodazole,immunostimulant,
XZAFZXJXZHRNAQ,BRD-K23677682,voreloxin,topoisomerase inhibitor,TOP2A,BRD-K23677682,voreloxin,topoisomerase inhibitor,TOP2A,BRD-K23677682,voreloxin,topoisomerase inhibitor,TOP2A,BRD-K23677682,voreloxin,topoisomerase inhibitor,TOP2A
XZNUGFQTQHRASN,BRD-K36062294,apramycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K36062294,apramycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K36062294,apramycin,bacterial 30S ribosomal subunit inhibitor,,BRD-K96737756,apramycin,bacterial 30S ribosomal subunit inhibitor,
XZTUSOXSLKTKJQ,BRD-K18518344,digitoxigenin,ATPase inhibitor,ATP1A1,BRD-K18518344,digitoxigenin,ATPase inhibitor,ATP1A1,BRD-K18518344,digitoxigenin,ATPase inhibitor,ATP1A1,BRD-K18518344,digitoxigenin,ATPase inhibitor,ATP1A1
XZTYGFHCIAKPGJ,BRD-K10314788,meclofenoxate,nootropic agent,,BRD-K10314788,meclofenoxate,nootropic agent,,BRD-K10314788,meclofenoxate,nootropic agent,,BRD-K10314788,meclofenoxate,nootropic agent,
XZWYZXLIPXDOLR,BRD-K79602928,metformin,insulin sensitizer,ACACB|PRKAB1,BRD-K79602928,metformin,insulin sensitizer,ACACB|PRKAB1,BRD-K79602928,metformin,insulin sensitizer,ACACB|PRKAB1,BRD-K79602928,metformin,insulin sensitizer,ACACB|PRKAB1
XZXHXSATPCNXJR,BRD-K49075727,nintedanib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,BRD-K49075727,nintedanib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,BRD-K49075727,nintedanib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,BRD-K49075727,nintedanib,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB
XZYRDNUZENBYFI,BRD-K86344238,linsidomine,nitric oxide donor,,BRD-K86344238,linsidomine,nitric oxide donor,,BRD-K72922393|BRD-K86344238,linsidomine,nitric oxide donor,,BRD-K72922393,linsidomine,nitric oxide donor,
XZZYCJOGZYEPPW,BRD-K85015012,NNC-05-2090,GABA uptake inhibitor|GAT inhibitor,SLC6A12,BRD-K85015012,NNC-05-2090,GABA uptake inhibitor|GAT inhibitor,SLC6A12,BRD-K85015012,NNC-05-2090,GABA uptake inhibitor|GAT inhibitor,SLC6A12,BRD-K85015012,NNC-05-2090,GABA uptake inhibitor|GAT inhibitor,SLC6A12
YABJJWZLRMPFSI,BRD-K93123848,RAF265,RAF inhibitor|VEGFR inhibitor,BRAF,BRD-K93123848,RAF265,RAF inhibitor|VEGFR inhibitor,BRAF,BRD-K93123848,RAF265,RAF inhibitor|VEGFR inhibitor,BRAF,BRD-K93123848,RAF265,RAF inhibitor|VEGFR inhibitor,BRAF
YACHGFWEQXFSBS,BRD-K63876426,elactocin,exportin antagonist,XPO1,BRD-K63876426,elactocin,exportin antagonist,XPO1,BRD-K63876426,elactocin,exportin antagonist,XPO1,BRD-K63876426,elactocin,exportin antagonist,XPO1
YAEMHJKFIIIULI,BRD-K67860401,AR-A014418,glycogen synthase kinase inhibitor,GSK3B,BRD-K67860401,AR-A014418,glycogen synthase kinase inhibitor,GSK3B,BRD-K67860401,AR-A014418,glycogen synthase kinase inhibitor,GSK3B,BRD-K67860401,AR-A014418,glycogen synthase kinase inhibitor,GSK3B
YAKWPXVTIGTRJH,BRD-A62893078,fotemustine,thioredoxin inhibitor,TXNRD1,BRD-A62893078,fotemustine,thioredoxin inhibitor,TXNRD1,BRD-A62893078,fotemustine,thioredoxin inhibitor,TXNRD1,,,,
YALNUENQHAQXEA,BRD-K13810148,givinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K13810148,givinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K13810148,givinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,BRD-K13810148,givinostat,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
YAMVZYRZAMBCED,BRD-K08837089,actinoquinol,,,BRD-K08837089,actinoquinol,,,BRD-K08837089,actinoquinol,,,BRD-K08837089,actinoquinol,,
YAONEUNUMVOKNQ,BRD-K53156781,omega-(4-Iodophenyl)pentadecanoic acid,,,BRD-K53156781,omega-(4-Iodophenyl)pentadecanoic acid,,,BRD-K53156781,omega-(4-Iodophenyl)pentadecanoic acid,,,BRD-K53156781,omega-(4-iodophenyl)pentadecanoic-acid,,
YAORIDZYZDUZCM,BRD-K54142781,cirazoline,adrenergic receptor agonist,ADRA1A,BRD-K54142781,cirazoline,adrenergic receptor agonist,ADRA1A,BRD-K54142781,cirazoline,adrenergic receptor agonist,ADRA1A,BRD-K54142781,cirazoline,adrenergic receptor agonist,ADRA1A
YAPQBXQYLJRXSA,BRD-K34888156,theobromine,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,BRD-K34888156,theobromine,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,BRD-K34888156,theobromine,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,BRD-K34888156,theobromine,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B
YASAKCUCGLMORW,BRD-A97437073,rosiglitazone,PPAR receptor agonist|insulin sensitizer,ACSL4|FFAR1|PPARG|TRPC5|TRPM3,BRD-A97437073,rosiglitazone,PPAR receptor agonist|insulin sensitizer,ACSL4|FFAR1|PPARG|TRPC5|TRPM3,BRD-A97437073,rosiglitazone,PPAR receptor agonist|insulin sensitizer,ACSL4|FFAR1|PPARG|TRPC5|TRPM3,BRD-K01826734,rosiglitazone,PPAR receptor agonist|insulin sensitizer,FFAR1|PPARG|TRPC5|TRPM3
YASBOGFWAMXINH,BRD-K31339597,SDZ-SER-082,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K31339597,SDZ-SER-082,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K31339597,SDZ-SER-082,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K31339597,SDZ-SER-082,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
YASYAEVZKXPYIZ,BRD-K23005288,SP-420,,,BRD-K23005288,SP-420,,,BRD-K23005288,SP-420,,,BRD-K23005288,SP-420,,
YAYRGNWWLMLWJE,BRD-K90947825,carboplatin,DNA alkylating agent|DNA inhibitor,,BRD-K90947825,carboplatin,DNA alkylating agent|DNA inhibitor,,BRD-K11626735|BRD-K64763651|BRD-K90947825|BRD-M80278122,carboplatin,DNA alkylating agent|DNA inhibitor,,BRD-K11626735|BRD-K64763651|BRD-K90947825|BRD-M80278122,carboplatin,DNA alkylating agent|DNA inhibitor,
YAZSBRQTAHVVGE,BRD-K32681104,2-aminobenzenesulfonamide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA6|CA9,BRD-K32681104,2-aminobenzenesulfonamide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA6|CA9,BRD-K32681104,2-aminobenzenesulfonamide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA6|CA9,BRD-K32681104,2-aminobenzenesulfonamide,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA6|CA9
YBAWYTYNMZWMMJ,BRD-K79102359,idalopirdine,serotonin receptor antagonist,HTR6,BRD-K79102359,idalopirdine,serotonin receptor antagonist,HTR6,BRD-K79102359,idalopirdine,serotonin receptor antagonist,HTR6,BRD-K79102359,idalopirdine,serotonin receptor antagonist,HTR6
YBBLVLTVTVSKRW,BRD-K52172416,anastrozole,aromatase inhibitor,CYP19A1,BRD-K52172416,anastrozole,aromatase inhibitor,CYP19A1,BRD-K52172416,anastrozole,aromatase inhibitor,CYP19A1,BRD-K52172416,anastrozole,aromatase inhibitor,CYP19A1
YBCNXCRZPWQOBR,BRD-A53951045,butylscopolamine-bromide,cholinergic receptor antagonist,,BRD-A53951045,butylscopolamine-bromide,cholinergic receptor antagonist,,BRD-A53951045,butylscopolamine-bromide,cholinergic receptor antagonist,,BRD-K01825841,butylscopolamine-bromide,cholinergic receptor antagonist,
YBGZDTIWKVFICR,BRD-K19972289,octinoxate,,,BRD-K19972289,octinoxate,,,BRD-K19972289,octinoxate,,,BRD-K00003688,octinoxate,,
YBHILYKTIRIUTE,BRD-K14796088,berberine,LDL receptor activator,LDLR,BRD-K14796088,berberine,LDL receptor activator,LDLR,BRD-K14796088,berberine,LDL receptor activator,LDLR,BRD-K14796088,berberine,LDL receptor activator,LDLR
YBJHBAHKTGYVGT,BRD-A36603537|BRD-K95496960,biotin,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,BRD-A36603537|BRD-K95496960,biotin,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,BRD-A36603537|BRD-K89210380|BRD-K95496960,biotin,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,BRD-A36603537|BRD-K89210380|BRD-K95496960,biotin,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6
YBLIQJGXRLZBCZ,BRD-K11443721,NE-100,sigma receptor antagonist,SIGMAR1,BRD-K11443721,NE-100,sigma receptor antagonist,SIGMAR1,BRD-K11443721,NE-100,sigma receptor antagonist,SIGMAR1,BRD-K11443721,NE-100,sigma receptor antagonist,SIGMAR1
YBLWOZUPHDKFOT,BRD-K67537649,PQ-401,IGF-1 inhibitor,IGF1R,BRD-K67537649,PQ-401,IGF-1 inhibitor,IGF1R,BRD-K67537649,PQ-401,IGF-1 inhibitor,IGF1R,BRD-K67537649,PQ-401,IGF-1 inhibitor,IGF1R
YBPIBGNBHHGLEB,BRD-K48488978,YM-201636,PI3K inhibitor,,BRD-K48488978,YM-201636,PI3K inhibitor,,BRD-K48488978,YM-201636,PI3K inhibitor,,BRD-K48488978,YM-201636,PI3K inhibitor,
YBSJFWOBGCMAKL,BRD-K38168441,dabigatran,thrombin inhibitor,F2,BRD-K38168441,dabigatran,thrombin inhibitor,F2,BRD-K38168441,dabigatran,thrombin inhibitor,F2,BRD-K38168441,dabigatran,thrombin inhibitor,F2
YBWLTKFZAOSWSM,BRD-K19203487,SPP301,endothelin receptor antagonist,EDNRA,BRD-K19203487,SPP301,endothelin receptor antagonist,EDNRA,BRD-K19203487,SPP301,endothelin receptor antagonist,EDNRA,BRD-K19203487,SPP301,endothelin receptor antagonist,EDNRA
YBYRMVIVWMBXKQ,BRD-K33422401,phenylmethylsulfonyl-fluoride,serine protease inhibitor,,BRD-K33422401,phenylmethylsulfonyl-fluoride,serine protease inhibitor,,BRD-K33422401,phenylmethylsulfonyl-fluoride,serine protease inhibitor,,BRD-K33422401,phenylmethylsulfonyl-fluoride,serine protease inhibitor,
YCLREGRRHGLOAK,BRD-K48888725,CG-400549,FABI inhibitor,,BRD-K48888725,CG-400549,FABI inhibitor,,BRD-K48888725,CG-400549,FABI inhibitor,,BRD-K48888725,CG-400549,FABI inhibitor,
YCNMAPLPQYQJFC,BRD-A52551912,ATB-346,cyclooxygenase inhibitor,PTGER2,BRD-A52551912,ATB-346,cyclooxygenase inhibitor,PTGER2,BRD-A52551912,ATB-346,cyclooxygenase inhibitor,PTGER2,BRD-A52551912,ATB-346,cyclooxygenase inhibitor,PTGER2
YCOYDOIWSSHVCK,BRD-K70163715,vatalanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB,BRD-K70163715,vatalanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB,BRD-K70163715,vatalanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB,BRD-K70163715,vatalanib,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB
YCPOZVAOBBQLRI,BRD-K20902145,treosulfan,DNA synthesis inhibitor,,BRD-K20902145,treosulfan,DNA synthesis inhibitor,,BRD-K20902145,treosulfan,DNA synthesis inhibitor,,BRD-K20902145,treosulfan,DNA synthesis inhibitor,
YCRFPWKUUNKNDN,BRD-K25279140,MK-8745,Aurora kinase inhibitor,AURKA,BRD-K25279140,MK-8745,Aurora kinase inhibitor,AURKA,BRD-K25279140,MK-8745,Aurora kinase inhibitor,AURKA,BRD-K25279140,MK-8745,Aurora kinase inhibitor,AURKA
YCWROMXNZZIJDQ,BRD-K14571191,zometapine,,,BRD-K14571191,zometapine,,,BRD-K14571191,zometapine,,,BRD-K14571191,zometapine,,
YCWSUKQGVSGXJO,BRD-K68188368,nifuroxazide,bacterial DNA inhibitor,,BRD-K68188368,nifuroxazide,bacterial DNA inhibitor,,BRD-K68188368,nifuroxazide,bacterial DNA inhibitor,,BRD-K68188368,nifuroxazide,bacterial DNA inhibitor,
YCXFHPUBGMMWJQ,BRD-K09436144,YM022,CCK receptor antagonist,CCKBR,BRD-K09436144,YM022,CCK receptor antagonist,CCKBR,BRD-K09436144,YM022,CCK receptor antagonist,CCKBR,BRD-K09436144,YM-022,CCK receptor antagonist,CCKBR
YCYMCMYLORLIJX,BRD-K49223707,arundic-acid,astrocyte modulating agent,PTGS2|S100B,BRD-K49223707,arundic-acid,astrocyte modulating agent,PTGS2|S100B,BRD-K49223707,arundic-acid,astrocyte modulating agent,PTGS2|S100B,BRD-K49223707,arundic-acid,astrocyte modulating agent,PTGS2|S100B
YDBCEBYHYKAFRX,BRD-K11911061,GR-127935,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,BRD-K11911061,GR-127935,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,BRD-K11911061,GR-127935,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,BRD-K11911061,GR-127935,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6
YDBLKRPLXZNVNB,BRD-K14880289,GW-501516,PPAR receptor agonist,PPARA|PPARD,BRD-K14880289,GW-501516,PPAR receptor agonist,PPARA|PPARD,BRD-K14880289,GW-501516,PPAR receptor agonist,PPARA|PPARD,BRD-K14880289,GW-501516,PPAR receptor agonist,PPARA|PPARD
YDBYJHTYSHBBAU,BRD-K41504985,cabagin,,,BRD-K41504985,cabagin,,,BRD-K41504985,cabagin,,,BRD-K41504985,cabagin,,
YDCMWLQSPFTWCS,BRD-K26362911,basic-fuchsin,,,BRD-K26362911,basic-fuchsin,,,BRD-K26362911,basic-fuchsin,,,BRD-K26362911,basic-fuchsin,,
YDDUMTOHNYZQPO,BRD-K53083666,"1,5-dicaffeoylquinic-acid",,,BRD-K53083666,"1,5-dicaffeoylquinic-acid",,,BRD-K53083666,"1,5-dicaffeoylquinic-acid",,,BRD-K53083666,"1,5-dicaffeoylquinic-acid",,
YDDXVAXDYKBWDX,BRD-K15071410,tiotidine,histamine receptor antagonist,HRH2,BRD-K15071410,tiotidine,histamine receptor antagonist,HRH2,BRD-K15071410,tiotidine,histamine receptor antagonist,HRH2,BRD-K11107424,tiotidine,histamine receptor antagonist,HRH2
YDGMGEXADBMOMJ,BRD-K36269323,asymmetrical-dimethylarginine,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K36269323,asymmetrical-dimethylarginine,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K36269323,asymmetrical-dimethylarginine,nitric oxide synthase inhibitor,NOS2|NOS3,BRD-K36269323,asymmetrical-dimethylarginine,nitric oxide synthase inhibitor,NOS2|NOS3
YDKJSAXEBRKYLM,BRD-K87269850,N-(3-methoxyphenyl)prop-2-enamide,,,,,,,,,,,,,,
YDPRNGAPPNPYQQ,BRD-K01742705,BVT-2733,11-beta hydroxysteroid dehydrogenase inhibitor,HSD17B1,BRD-K01742705,BVT-2733,11-beta hydroxysteroid dehydrogenase inhibitor,HSD17B1,BRD-K01742705,BVT-2733,11-beta hydroxysteroid dehydrogenase inhibitor,HSD17B1,BRD-K01742705,BVT-2733,11-beta hydroxysteroid dehydrogenase inhibitor,HSD17B1
YDQWDHRMZQUTBA,BRD-K04851519,aloe-emodin,anticancer agent,CASP8,BRD-K04851519,aloe-emodin,anticancer agent,CASP8,BRD-K04851519,aloe-emodin,anticancer agent,CASP8,BRD-K04851519,aloe-emodin,anticancer agent,CASP8
YEAHTLOYHVWAKW,BRD-A50998626,palomid-529,AKT inhibitor|mTOR inhibitor,MTOR,BRD-A50998626,palomid-529,AKT inhibitor|mTOR inhibitor,MTOR,BRD-A50998626,palomid-529,AKT inhibitor|mTOR inhibitor,MTOR,BRD-A50998626,palomid-529,AKT inhibitor|mTOR inhibitor,MTOR
YECBIJXISLIIDS,BRD-K97564742,mepyramine,histamine receptor antagonist,HRH1,BRD-K97564742,mepyramine,histamine receptor antagonist,HRH1,BRD-K97564742,mepyramine,histamine receptor antagonist,HRH1,BRD-K97564742,mepyramine,histamine receptor antagonist,HRH1
YEEZWCHGZNKEEK,BRD-K71289571,zafirlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,BRD-K71289571,zafirlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,BRD-K71289571,zafirlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,BRD-K71289571,zafirlukast,leukotriene receptor antagonist,CYSLTR1|CYSLTR2
YEHCICAEULNIGD,BRD-K38689957|BRD-K60770992,pergolide,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K38689957|BRD-K60770992,pergolide,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K38689957|BRD-K60770992,pergolide,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,BRD-K38689957|BRD-K60770992,pergolide,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C
YEJCDKJIEMIWRQ,BRD-K59332007,linopirdine,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K59332007,linopirdine,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K59332007,linopirdine,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,BRD-K59332007,linopirdine,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5
YEOTYALSMRNXLJ,BRD-A78277353,metazosin,adrenergic receptor antagonist,ADRA1A,BRD-A78277353,metazosin,adrenergic receptor antagonist,ADRA1A,BRD-A78277353,metazosin,adrenergic receptor antagonist,ADRA1A,BRD-A78277353,metazosin,adrenergic receptor antagonist,ADRA1A
YERABYSOHUZTPQ,BRD-K18772613,benzoquinonium-dibromide,cholinergic receptor antagonist,CHRNA1,BRD-K18772613,benzoquinonium-dibromide,cholinergic receptor antagonist,CHRNA1,BRD-K18772613,benzoquinonium-dibromide,cholinergic receptor antagonist,CHRNA1,BRD-K18772613,benzoquinonium-dibromide,cholinergic receptor antagonist,CHRNA1
YEZNLOUZAIOMLT,BRD-K50133271,tolfenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,,BRD-K50133271,tolfenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,,BRD-K50133271,tolfenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,,BRD-K50133271,tolfenamic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,
YFAGHNZHGGCZAX,BRD-K05673000|BRD-K59843513,dicloxacillin,bacterial cell wall synthesis inhibitor,,BRD-K05673000|BRD-K59843513,dicloxacillin,bacterial cell wall synthesis inhibitor,,BRD-K05673000|BRD-K59843513,dicloxacillin,bacterial cell wall synthesis inhibitor,,BRD-K05673000|BRD-K59843513,dicloxacillin,bacterial cell wall synthesis inhibitor,
YFDSDPIBEUFTMI,BRD-K69632891,tribromoethanol,analgesic agent,,BRD-K69632891,tribromoethanol,analgesic agent,,BRD-K69632891,tribromoethanol,analgesic agent,,BRD-K69632891,tribromoethanol,analgesic agent,
YFGBQHOOROIVKG,BRD-A38218502,metenkephalin,immunostimulant,OPRD1,BRD-A38218502,metenkephalin,immunostimulant,OPRD1,BRD-A38218502,metenkephalin,immunostimulant,OPRD1,BRD-A38218502,metenkephalin,immunostimulant,OPRD1
YFGHCGITMMYXAQ,BRD-A16332958|BRD-K87278688,armodafinil|modafinil,adrenergic receptor agonist,ADRA1B|SLC6A3,BRD-A16332958|BRD-K87278688,armodafinil|modafinil,adrenergic receptor agonist,ADRA1B|SLC6A3,BRD-A16332958|BRD-K87278688,armodafinil|modafinil,adrenergic receptor agonist,ADRA1B|SLC6A3,,,,
YFHYNLHGFKXAIQ,BRD-K57427145,ripazepam,benzodiazepine receptor agonist,GABRA1,BRD-K57427145,ripazepam,benzodiazepine receptor agonist,GABRA1,BRD-K57427145,ripazepam,benzodiazepine receptor agonist,GABRA1,BRD-K57427145,ripazepam,benzodiazepine receptor agonist,GABRA1
YFLRYAVDPKONNX,BRD-K30360804,buramate,antiepileptic,,BRD-K30360804,buramate,antiepileptic,,BRD-K30360804,buramate,antiepileptic,,BRD-K30360804,buramate,antiepileptic,
YFUATOCFMCWUEH,BRD-K15045219,salazodine,,,BRD-K15045219,salazodine,,,BRD-K15045219,salazodine,,,BRD-K15045219,salazodine,,
YGCFIWIQZPHFLU,BRD-K50850824,acesulfame-potassium,,,BRD-K50850824,acesulfame-potassium,,,BRD-K50850824,acesulfame-potassium,,,BRD-K50850824,acesulfame-potassium,,
YGCODSQDUUUKIV,BRD-K66353228,zoxazolamine,myorelaxant,,BRD-K66353228,zoxazolamine,myorelaxant,,BRD-K66353228,zoxazolamine,myorelaxant,,BRD-K66353228,zoxazolamine,myorelaxant,
YGCQFKVNIBDJFW,BRD-A26458246,CKD-712,NFkB pathway inhibitor,JAK2|STAT1,BRD-A26458246,CKD-712,NFkB pathway inhibitor,JAK2|STAT1,BRD-A26458246,CKD-712,NFkB pathway inhibitor,JAK2|STAT1,BRD-A26458246,CKD-712,NFkB pathway inhibitor,JAK2|STAT1
YGFYZZQGVSUXJE,BRD-K46254452,GABA-linoleamide,benzodiazepine receptor agonist,,BRD-K46254452,GABA-linoleamide,benzodiazepine receptor agonist,,BRD-K46254452,GABA-linoleamide,benzodiazepine receptor agonist,,BRD-K46254452,GABA-linoleamide,benzodiazepine receptor agonist,
YGHLYBIUVOLKCV,BRD-K76677554,AJ76-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-K76677554,AJ76-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-K76677554,AJ76-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4,BRD-K76677554,AJ76-(+),dopamine receptor antagonist,DRD2|DRD3|DRD4
YGKPIROTKVQCCU,BRD-K27141178,SB-203186,serotonin receptor antagonist,HTR4,BRD-K27141178,SB-203186,serotonin receptor antagonist,HTR4,BRD-K27141178,SB-203186,serotonin receptor antagonist,HTR4,BRD-K27141178,SB-203186,serotonin receptor antagonist,HTR4
YGSDEFSMJLZEOE,BRD-K93632104,salicylic-acid|sodium-salicylate,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2,BRD-K93632104,salicylic-acid|sodium-salicylate,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2,BRD-K93632104|BRD-M30512773,salicylic-acid|sodium-salicylate,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2,BRD-K93632104|BRD-M30512773,salicylic-acid,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2
YHHFKWKMXWRVTJ,BRD-K76180386,JIB04,histone lysine demethylase inhibitor,KDM4E,BRD-K76180386,JIB04,histone lysine demethylase inhibitor,KDM4E,BRD-K76180386,JIB04,histone lysine demethylase inhibitor,KDM4E,BRD-K76180386,JIB04,histone lysine demethylase inhibitor,KDM4E
YHUIUSRCUKUUQA,BRD-K41337261,ZM-306416,Abl kinase inhibitor|VEGFR inhibitor|src inhibitor,EGFR|FLT1|FLT4|KDR,BRD-K41337261,ZM-306416,Abl kinase inhibitor|VEGFR inhibitor|src inhibitor,EGFR|FLT1|FLT4|KDR,BRD-K41337261,ZM-306416,Abl kinase inhibitor|VEGFR inhibitor|src inhibitor,EGFR|FLT1|FLT4|KDR,BRD-K41337261,ZM-306416,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR
YHUOJWACHJLNCJ,BRD-A61299447,"5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione",,,BRD-A61299447,"5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione",,,BRD-A61299447,"5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione",,,,,,
YHXISWVBGDMDLQ,BRD-K07237224,moclobemide,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K07237224,moclobemide,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K07237224,moclobemide,monoamine oxidase inhibitor,MAOA|MAOB,BRD-K07237224,moclobemide,monoamine oxidase inhibitor,MAOA|MAOB
YIBOMRUWOWDFLG,BRD-K06240250,rilpivirine,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A,BRD-K06240250,rilpivirine,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A,BRD-K06240250,rilpivirine,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A,BRD-K06240250,rilpivirine,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A
YIMFXBPXUPTIEJ,BRD-K03128577,MG-624,acetylcholine receptor antagonist,CHRNA7,BRD-K03128577,MG-624,acetylcholine receptor antagonist,CHRNA7,BRD-K03128577,MG-624,acetylcholine receptor antagonist,CHRNA7,BRD-K03128577,MG-624,acetylcholine receptor antagonist,CHRNA7
YIMYDTCOUQIDMT,BRD-K87386013,diroximel-fumarate,anti-inflammatory agent,,BRD-K87386013,diroximel-fumarate,anti-inflammatory agent,,BRD-K87386013,diroximel-fumarate,anti-inflammatory agent,,BRD-K87386013,diroximel-fumarate,anti-inflammatory agent,
YIQPUIGJQJDJOS,BRD-K33240821,plerixafor,CC chemokine receptor antagonist,ACKR3|CCR4|CXCR4,BRD-K33240821,plerixafor,CC chemokine receptor antagonist,ACKR3|CCR4|CXCR4,BRD-K33240821,plerixafor,CC chemokine receptor antagonist,ACKR3|CCR4|CXCR4,BRD-K33240821,plerixafor,CC chemokine receptor antagonist,ACKR3|CCR4|CXCR4
YJDAOHJWLUNFLX,BRD-K48692744,NU-1025,PARP inhibitor,PARP1,BRD-K48692744,NU-1025,PARP inhibitor,PARP1,BRD-K48692744,NU-1025,PARP inhibitor,PARP1,BRD-K48692744,NU-1025,PARP inhibitor,PARP1
YJDYDFNKCBANTM,BRD-K19412342,valspodar,P glycoprotein inhibitor,ABCB1,BRD-K19412342,valspodar,P glycoprotein inhibitor,ABCB1,BRD-K19412342,valspodar,P glycoprotein inhibitor,ABCB1,BRD-K19412342,valspodar,P glycoprotein inhibitor,ABCB1
YJEJKUQEXFSVCJ,BRD-K16898998,bevirimat-dimeglumine,HIV capsid assembly inhibitor,,BRD-K16898998,bevirimat-dimeglumine,HIV capsid assembly inhibitor,,BRD-K16898998,bevirimat-dimeglumine,HIV capsid assembly inhibitor,,BRD-K16898998,bevirimat-dimeglumine,HIV capsid assembly inhibitor,
YJGVMLPVUAXIQN,BRD-K47869605,podophyllotoxin,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,BRD-K47869605,podophyllotoxin,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,BRD-K47869605,podophyllotoxin,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,BRD-K47869605,podophyllotoxin,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB
YJPOIBSDHKWDGX,BRD-A09283158,chlorophyllide-cu-complex-na-salt,,,,,,,,,,,,,,
YJPWVCIGSHWNON,BRD-K05181084,NGB-2904,dopamine receptor antagonist,DRD3,BRD-K05181084,NGB-2904,dopamine receptor antagonist,DRD3,BRD-K05181084,NGB-2904,dopamine receptor antagonist,DRD3,BRD-K05181084,NGB-2904,dopamine receptor antagonist,DRD3
YJQPYGGHQPGBLI,BRD-K85307935,novobiocin,bacterial DNA gyrase inhibitor,,BRD-K85307935,novobiocin,bacterial DNA gyrase inhibitor,,BRD-K85307935,novobiocin,bacterial DNA gyrase inhibitor,,BRD-K85307935,novobiocin,bacterial DNA gyrase inhibitor,
YJQZNWPYLCNRLP,BRD-K77867004,U-104,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA9,BRD-K77867004,U-104,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA9,BRD-K77867004,U-104,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA9,BRD-K77867004,U-104,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA9
YJQZYXCXBBCEAQ,BRD-A86414188,ractopamine,adrenergic receptor agonist,,BRD-A86414188,ractopamine,adrenergic receptor agonist,,BRD-A86414188,ractopamine,adrenergic receptor agonist,,BRD-K01825837,ractopamine,adrenergic receptor agonist,
YJXDGWUNRYLINJ,BRD-K02703275,gedunin,HSP inhibitor,HSP90AA1,BRD-K02703275,gedunin,HSP inhibitor,HSP90AA1,BRD-K02703275,gedunin,HSP inhibitor,HSP90AA1,BRD-K02703275,gedunin,HSP inhibitor,HSP90AA1
YJYPHIXNFHFHND,BRD-K84698278,agomelatine,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,BRD-K84698278,agomelatine,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,BRD-K84698278,agomelatine,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,BRD-K84698278,agomelatine,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B
YKDRHKCETNMLHL,BRD-K37747025,sanazole,,,BRD-K37747025,sanazole,,,BRD-K37747025,sanazole,,,BRD-K37747025,sanazole,,
YKGYIDJEEQRWQH,BRD-K59256312,gabexate,serine protease inhibitor,PRSS1|TPSAB1,BRD-K59256312,gabexate,serine protease inhibitor,PRSS1|TPSAB1,BRD-K59256312,gabexate,serine protease inhibitor,PRSS1|TPSAB1,BRD-K59256312,gabexate,serine protease inhibitor,PRSS1|TPSAB1
YKJYKKNCCRKFSL,BRD-K91370081,anisomycin,DNA synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,BRD-K91370081,anisomycin,DNA synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,BRD-K91370081,anisomycin,DNA synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,BRD-K91370081,anisomycin,DNA synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1
YKPUWZUDDOIDPM,BRD-K50590187,capsaicin,TRPV agonist,CFTR|TRPV1,BRD-K50590187,capsaicin,TRPV agonist,CFTR|TRPV1,BRD-K50590187,capsaicin,TRPV agonist,CFTR|TRPV1,BRD-K50590187,capsaicin,TRPV agonist,CFTR|TRPV1
YKQOSKADJPQZHB,BRD-A18924964,colistin,bacterial permeability inducer,,BRD-A18924964,colistin,bacterial permeability inducer,,BRD-A18924964,colistin,bacterial permeability inducer,,BRD-K01666935,colistin,bacterial permeability inducer,
YKRGDOXKVOZESV,BRD-K77265172|BRD-K83631119,paeoniflorin,anticonvulsant,,BRD-K83631119,paeoniflorin,anticonvulsant,,BRD-K77265172|BRD-K83631119,paeoniflorin,anticonvulsant,,BRD-K77265172|BRD-K83631119,paeoniflorin,anticonvulsant,
YKYBWGJKLYMCFI,BRD-A07600638,meclocycline-sulfosalicylate,bacterial 50S ribosomal subunit inhibitor,,BRD-A07600638,meclocycline-sulfosalicylate,bacterial 50S ribosomal subunit inhibitor,,BRD-A07600638,meclocycline-sulfosalicylate,bacterial 50S ribosomal subunit inhibitor,,,,,
YKYOQIXTECBVBB,BRD-K13474508,"L-655,708",,,BRD-K13474508,"L-655,708",GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRG2,BRD-K13474508,"L-655,708",GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRG2,BRD-K13474508,"L-655,708",GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRG2
YLFZHHDVRSYTKT,BRD-K17513304,firategrast,integrin antagonist,ITGA4,BRD-K17513304,firategrast,integrin antagonist,ITGA4,BRD-K17513304,firategrast,integrin antagonist,ITGA4,BRD-K17513304,firategrast,integrin antagonist,ITGA4
YLJREFDVOIBQDA,BRD-K81473089,tacrine,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K81473089,tacrine,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K81473089,tacrine,acetylcholinesterase inhibitor,ACHE|BCHE,BRD-K81473089,tacrine,acetylcholinesterase inhibitor,ACHE|BCHE
YLQODGGPIHWTHR,BRD-K58770988,NMS-E973,HSP inhibitor,,BRD-K58770988,NMS-E973,HSP inhibitor,,BRD-K29587137|BRD-K58770988,NMS-E973,HSP inhibitor,,BRD-K29587137|BRD-K58770988,NMS-E973,HSP inhibitor,
YLRFCQOZQXIBAB,BRD-K24255045,fluoxymesterone,androgen receptor modulator,AR|ESR1|NR3C1|PRLR,BRD-K24255045,fluoxymesterone,androgen receptor modulator,AR|ESR1|NR3C1|PRLR,BRD-K24255045,fluoxymesterone,androgen receptor modulator,AR|ESR1|NR3C1|PRLR,,,,
YLUSMKAJIQOXPV,BRD-K66896231,ipidacrine,acetylcholinesterase inhibitor,ACHE,BRD-K66896231,ipidacrine,acetylcholinesterase inhibitor,ACHE,BRD-K66896231,ipidacrine,acetylcholinesterase inhibitor,ACHE,BRD-K66896231,ipidacrine,acetylcholinesterase inhibitor,ACHE
YLXDSYKOBKBWJQ,BRD-K28761891,ramelteon,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K28761891,ramelteon,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K28761891,ramelteon,melatonin receptor agonist,MTNR1A|MTNR1B,BRD-K28761891,ramelteon,melatonin receptor agonist,MTNR1A|MTNR1B
YMARZQAQMVYCKC,BRD-K47827687,amprenavir,HIV protease inhibitor,,BRD-K47827687,amprenavir,HIV protease inhibitor,,BRD-K47827687,amprenavir,HIV protease inhibitor,,BRD-K47827687,amprenavir,HIV protease inhibitor,
YMBXTVYHTMGZDW,BRD-A43082555,loxoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,BRD-A43082555,loxoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,BRD-A18039798|BRD-A43082555,loxoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,BRD-A18039798|BRD-K01825691,loxoprofen,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2
YMCOHQVWOBMDCZ,BRD-K13330768,zinc-undecylenate,other antifungal,,BRD-K13330768,zinc-undecylenate,other antifungal,,BRD-K13330768|BRD-K86452172,zinc-undecylenate,other antifungal,,BRD-K13330768|BRD-K86452172,zinc-undecylenate,other antifungal,
YMDXZJFXQJVXBF,BRD-A10652366|BRD-K48461310,fosfomycin,bacterial cell wall synthesis inhibitor,,BRD-A10652366|BRD-K48461310,fosfomycin,bacterial cell wall synthesis inhibitor,,BRD-A10652366|BRD-K48461310|BRD-K81101512,fosfomycin,bacterial cell wall synthesis inhibitor,,BRD-K48461310|BRD-K81101512,fosfomycin,bacterial cell wall synthesis inhibitor,
YMFNPBSZFWXMAD,BRD-K83354763,NFKB-activation-inhibitor-II,NFkB pathway inhibitor,RELA,BRD-K83354763,NFKB-activation-inhibitor-II,NFkB pathway inhibitor,RELA,BRD-K83354763,NFKB-activation-inhibitor-II,NFkB pathway inhibitor,RELA,BRD-K83354763,NFKB-activation-inhibitor-II,NFkB pathway inhibitor,RELA
YMHDGRAROYGJLT,BRD-K44321941,N-(4-Methoxyphenyl)acrylamide,,,,,,,,,,,,,,
YMMKDPCCYMGDHD,BRD-M98279124,cevimeline,acetylcholine receptor agonist,CHRM1|CHRM3,BRD-M98279124,cevimeline,acetylcholine receptor agonist,CHRM1|CHRM3,BRD-M98279124,cevimeline,acetylcholine receptor agonist,CHRM1|CHRM3,,,,
YMTINGFKWWXKFG,BRD-K50388907,fenofibrate,PPAR receptor agonist,MMP25|PPARA,BRD-K50388907,fenofibrate,PPAR receptor agonist,MMP25|PPARA,BRD-K50388907,fenofibrate,PPAR receptor agonist,MMP25|PPARA,BRD-K50388907,fenofibrate,PPAR receptor agonist,MMP25|PPARA
YMWQIYMUNZBOOV,BRD-A09761158,teicoplanin-A2-1,bacterial cell wall synthesis inhibitor,,BRD-A09761158,teicoplanin-A2-1,bacterial cell wall synthesis inhibitor,,BRD-A09761158,teicoplanin-A2-1,bacterial cell wall synthesis inhibitor,,BRD-A09761158,teicoplanin-A2-1,bacterial cell wall synthesis inhibitor,
YNBADRVTZLEFNH,BRD-K10132944,methyl-nicotinate,,,BRD-K10132944,methyl-nicotinate,,,BRD-K10132944,methyl-nicotinate,,,BRD-K10132944,methyl-nicotinate,,
YNDXUCZADRHECN,BRD-A92439610|BRD-K41708980,triamcinolone-acetonide,glucocorticoid receptor agonist|immunosuppressant,NR3C1,BRD-A92439610,triamcinolone-acetonide,glucocorticoid receptor agonist|immunosuppressant,NR3C1,BRD-A92439610|BRD-K41708980,triamcinolone-acetonide,glucocorticoid receptor agonist|immunosuppressant,NR3C1,BRD-K53790871,triamcinolone-acetonide,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6
YNJBWRMUSHSURL,BRD-K42090719,trichloroacetic-acid,,,BRD-K42090719,trichloroacetic-acid,,,BRD-K42090719,trichloroacetic-acid,,,BRD-K42090719,trichloroacetic-acid,,
YNMUTYLWSRFTPX,BRD-A04649065,LM11A-31,neurotrophic agent,NGFR,BRD-A04649065,LM11A-31,neurotrophic agent,NGFR,BRD-A04649065,LM11A-31,neurotrophic agent,NGFR,BRD-A04649065,LM11A-31,neurotrophic agent,NGFR
YNNURTVKPVJVEI,BRD-A40195998|BRD-K54187111,dichlorisone-acetate,,,BRD-A40195998|BRD-K54187111,dichlorisone-acetate,,,BRD-A40195998|BRD-K54187111,dichlorisone-acetate,,,BRD-A40195998|BRD-K54187111,dichlorisone-acetate,,
YNNUSGIPVFPVBX,BRD-K30240666,clemastine,histamine receptor antagonist,HRH1,BRD-K30240666,clemastine,histamine receptor antagonist,HRH1,BRD-K30240666,clemastine,histamine receptor antagonist,HRH1,BRD-K30240666,clemastine,histamine receptor antagonist,HRH1
YNVGQYHLRCDXFQ,BRD-K39707084,lynestrenol,progestogen hormone,,BRD-K39707084,lynestrenol,progestogen hormone,,BRD-K39707084,lynestrenol,progestogen hormone,,BRD-K39707084,lynestrenol,progestogen hormone,
YNZFUWZUGRBMHL,BRD-K43786866,opipramol,sigma receptor agonist,,BRD-K43786866,opipramol,sigma receptor agonist,,BRD-K43786866,opipramol,sigma receptor agonist,,BRD-K43786866,opipramol,sigma receptor agonist,
YOAHKNVSNCMZGQ,BRD-A15035311,diadenosine-tetraphosphate,adenosine kinase inhibitor,P2RY13|P2RY2,BRD-A15035311,diadenosine-tetraphosphate,adenosine kinase inhibitor,P2RY13|P2RY2,BRD-A15035311,diadenosine-tetraphosphate,adenosine kinase inhibitor,P2RY13|P2RY2,BRD-A52394261,diadenosine-tetraphosphate,adenosine kinase inhibitor,P2RY13|P2RY2
YODZTKMDCQEPHD,BRD-K54521836,thiodiglycol,,,BRD-K54521836,thiodiglycol,,,BRD-K54521836,thiodiglycol,,,BRD-K54521836,thiodiglycol,,
YOELZIQOLWZLQC,BRD-K96809896,SKF-86002,p38 MAPK inhibitor,ALOX5|MAPK14,BRD-K96809896,SKF-86002,p38 MAPK inhibitor,ALOX5|MAPK14,BRD-K96809896,SKF-86002,p38 MAPK inhibitor,ALOX5|MAPK14,BRD-K96809896,SKF-86002,p38 MAPK inhibitor,ALOX5|MAPK14
YOILXOMTHPUMRG,BRD-K20260086|BRD-K38797369|BRD-K62456038,PD-128907,dopamine receptor agonist,DRD2|DRD3,BRD-K20260086|BRD-K38797369|BRD-K62456038,PD-128907,dopamine receptor agonist,DRD2|DRD3,BRD-K20260086|BRD-K38797369|BRD-K62456038,PD-128907,dopamine receptor agonist,DRD2|DRD3,BRD-K62456038,PD-128907,dopamine receptor agonist,DRD2|DRD3
YOJQZPVUNUQTDF,BRD-A57900429,hydrastinine,haemostatic agent,,BRD-A57900429,hydrastinine,haemostatic agent,,BRD-A57900429,hydrastinine,haemostatic agent,,,,,
YOSHYTLCDANDAN,BRD-K60038276,irbesartan,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,BRD-K60038276,irbesartan,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,BRD-K60038276,irbesartan,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,BRD-K60038276,irbesartan,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1
YOVVNQKCSKSHKT,BRD-K23228615,GDC-0980,PI3K inhibitor|mTOR inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,BRD-K23228615,GDC-0980,PI3K inhibitor|mTOR inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,BRD-K23228615,GDC-0980,PI3K inhibitor|mTOR inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,BRD-K23228615,GDC-0980,PI3K inhibitor|mTOR inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK
YOZBGTLTNGAVFU,BRD-K14385366,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2,BRD-K14385366,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2,BRD-K14385366,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN2,BRD-K14385366,FG-4592,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|EGLN3
YPBATNHYBCGSSN,BRD-K45114938|BRD-K53064842,mezlocillin,bacterial cell wall synthesis inhibitor,,BRD-K45114938,mezlocillin,bacterial cell wall synthesis inhibitor,,BRD-K45114938|BRD-K53064842,mezlocillin,bacterial cell wall synthesis inhibitor,,BRD-K45114938|BRD-K53064842,mezlocillin,bacterial cell wall synthesis inhibitor,
YPBKTZBXSBLTDK,BRD-K67385813,epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K67385813,epacadostat,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,,,,,,,
YPELFRMCRYSPKZ,BRD-A39052811,mosapride,serotonin receptor agonist,HTR4,BRD-A39052811,mosapride,serotonin receptor agonist,HTR4,BRD-A39052811,mosapride,serotonin receptor agonist,HTR4,BRD-A39052811,mosapride,serotonin receptor agonist,HTR4
YPFLFUJKZDAXRA,BRD-K31339321,lirimilast,phosphodiesterase inhibitor,,BRD-K31339321,lirimilast,phosphodiesterase inhibitor,,BRD-K31339321,lirimilast,phosphodiesterase inhibitor,,BRD-K31339321,lirimilast,phosphodiesterase inhibitor,
YPHMISFOHDHNIV,BRD-K36055864,cycloheximide,protein synthesis inhibitor,RPL3,BRD-K36055864,cycloheximide,protein synthesis inhibitor,RPL3,BRD-K36055864,cycloheximide,protein synthesis inhibitor,RPL3,BRD-K36055864,cycloheximide,protein synthesis inhibitor,RPL3
YPIQVCUJEKAZCP,BRD-K97884852,malotilate,protein synthesis stimulant,,BRD-K97884852,malotilate,protein synthesis stimulant,,BRD-K97884852,malotilate,protein synthesis stimulant,,BRD-K97884852,malotilate,protein synthesis stimulant,
YPQLFJODEKMJEF,BRD-K82027074,2-hydroxyflutamide,androgen receptor antagonist,AR,BRD-K82027074,2-hydroxyflutamide,androgen receptor antagonist,AR,BRD-K82027074,2-hydroxyflutamide,androgen receptor antagonist,AR,BRD-K82027074,2-hydroxyflutamide,androgen receptor antagonist,AR
YPTFHLJNWSJXKG,BRD-K37543758,trepibutone,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K37543758,trepibutone,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K37543758,trepibutone,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,BRD-K37543758,trepibutone,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4
YPZRWBKMTBYPTK,BRD-K11411329,NOV-002,,GSR|GSTM2,BRD-K11411329,NOV-002,,GSR|GSTM2,BRD-K11411329,NOV-002,,GSR|GSTM2,BRD-K11411329,NOV-002,,GSR
YQGDEPYYFWUPGO,BRD-A40777960,aminohydroxybutyric-acid,,,BRD-A40777960,aminohydroxybutyric-acid,,,BRD-A40777960,aminohydroxybutyric-acid,,,BRD-A40777960,aminohydroxybutyric-acid,,
YQNFBOJPTAXAKV,BRD-K51956333,iopodic-acid,,,BRD-K51956333,iopodic-acid,,,BRD-K51956333,iopodic-acid,,,BRD-K51956333,iopodic-acid,,
YQNQNVDNTFHQSW,BRD-K96471533,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,,BRD-K96471533,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,,BRD-K96471533,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,,BRD-K96471533,nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,
YQNRVGJCPCNMKT,BRD-K92991072,PAC-1,caspase activator,CASP3,BRD-K92991072,PAC-1,caspase activator,CASP3,BRD-K92991072,PAC-1,caspase activator,CASP3,BRD-K92991072,PAC-1,caspase activator,CASP3
YQNWZWMKLDQSAC,BRD-K53963539,vortioxetine,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,BRD-K53963539,vortioxetine,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,BRD-K53963539,vortioxetine,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,BRD-K53963539,vortioxetine,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4
YRCWQPVGYLYSOX,BRD-A04327189,synephrine,adrenergic receptor agonist,ADRA1A,BRD-A04327189,synephrine,adrenergic receptor agonist,ADRA1A,BRD-A04327189,synephrine,adrenergic receptor agonist,ADRA1A,BRD-K01825585,synephrine,adrenergic receptor agonist,ADRA1A
YREYEVIYCVEVJK,BRD-A39390670,rabeprazole,ATPase inhibitor|gastrin inhibitor,ATP4A,BRD-A39390670,rabeprazole,ATPase inhibitor|gastrin inhibitor,ATP4A,BRD-A39390670,rabeprazole,ATPase inhibitor|gastrin inhibitor,ATP4A,BRD-K01826765,rabeprazole,ATPase inhibitor|gastrin inhibitor,ATP4A
YREYLAVBNPACJM,BRD-A37441042,tulobuterol,adrenergic receptor agonist,ADRB2,BRD-A37441042,tulobuterol,adrenergic receptor agonist,ADRB2,BRD-A37441042,tulobuterol,adrenergic receptor agonist,ADRB2,BRD-K00003719,tulobuterol,adrenergic receptor agonist,ADRB2
YRFXGQHBPBMFHW,BRD-K02528732,fluorometholone-acetate,,NR3C1,BRD-K02528732,fluorometholone-acetate,,NR3C1,BRD-K02528732,fluorometholone-acetate,,NR3C1,BRD-K02528732,fluorometholone-acetate,,NR3C1
YRFYIORBFFGPPZ,BRD-A85876464,nibentan,potassium channel blocker,,BRD-A85876464,nibentan,potassium channel blocker,,BRD-A85876464,nibentan,potassium channel blocker,,BRD-A85876464,nibentan,potassium channel blocker,
YRIZYWQGELRKNT,BRD-K33642804,symclosene,,,BRD-K33642804,symclosene,,,BRD-K33642804,symclosene,,,BRD-K33642804,symclosene,,
YRVIKLBSVVNSHF,BRD-K79803033,pozanicline,acetylcholine receptor antagonist,CHRNA4|CHRNB2,BRD-K79803033,pozanicline,acetylcholine receptor antagonist,CHRNA4|CHRNB2,BRD-K79803033,pozanicline,acetylcholine receptor antagonist,CHRNA4|CHRNB2,BRD-K79803033,pozanicline,acetylcholine receptor antagonist,CHRNA4|CHRNB2
YRWLZFXJFBZBEY,BRD-K02407574,parbendazole,tubulin polymerization inhibitor,TUBB,BRD-K02407574,parbendazole,tubulin polymerization inhibitor,TUBB,BRD-K02407574,parbendazole,tubulin polymerization inhibitor,TUBB,BRD-K02407574,parbendazole,tubulin polymerization inhibitor,TUBB
YRZQHIVOIFJEEE,BRD-K21452876,chlorazanil,,,BRD-K21452876,chlorazanil,,,BRD-K21452876|BRD-K44275059,chlorazanil,,,BRD-K21452876|BRD-K44275059,chlorazanil,,
YSAUAVHXTIETRK,BRD-K20672254,pyrantel-pamoate|pyrantel-tartrate,acetylcholine receptor agonist|neuromuscular blocker,|CHRNA1,BRD-K20672254,pyrantel-pamoate|pyrantel-tartrate,acetylcholine receptor agonist|neuromuscular blocker,|CHRNA1,BRD-K20672254,pyrantel-pamoate|pyrantel-tartrate,acetylcholine receptor agonist|neuromuscular blocker,|CHRNA1,BRD-K20672254,pyrantel-pamoate,neuromuscular blocker,
YSDBJKNOEWSFGA,BRD-K96055017,1-acetyl-4-methylpiperazine,acetylcholine receptor agonist,,BRD-K96055017,1-acetyl-4-methylpiperazine,acetylcholine receptor agonist,,BRD-K96055017,1-acetyl-4-methylpiperazine,acetylcholine receptor agonist,,BRD-K96055017,1-acetyl-4-methylpiperazine,acetylcholine receptor agonist,
YSDQQAXHVYUZIW,BRD-A48274390,liraglutide,GLP receptor agonist,GLP1R,BRD-A48274390,liraglutide,GLP receptor agonist,GLP1R,BRD-A48274390,liraglutide,GLP receptor agonist,GLP1R,BRD-K00003717,liraglutide,GLP receptor agonist,GLP1R
YSEXMKHXIOCEJA,BRD-K76810206,nicergoline,adrenergic receptor antagonist,ADRA1A,BRD-K76810206,nicergoline,adrenergic receptor antagonist,ADRA1A,BRD-A58096341|BRD-K76810206,nicergoline,adrenergic receptor antagonist,ADRA1A,BRD-A58096341|BRD-K76810206,nicergoline,adrenergic receptor antagonist,ADRA1A
YSGASDXSLKIKOD,BRD-A36074203,remacemide,glutamate receptor antagonist,GRIN1,BRD-A36074203,remacemide,glutamate receptor antagonist,GRIN1,BRD-A36074203,remacemide,glutamate receptor antagonist,GRIN1,BRD-A36074203,remacemide,glutamate receptor antagonist,GRIN1
YSIITVVESCNIPR,BRD-A68589262,troxipide,glucosamine synthetase stimulant,,BRD-A68589262,troxipide,glucosamine synthetase stimulant,,BRD-A68589262,troxipide,glucosamine synthetase stimulant,,BRD-A68589262,troxipide,glucosamine synthetase stimulant,
YSSBJODGIYRAMI,BRD-K14765469,vesamicol,acetylcholinesterase inhibitor,SLC18A3,BRD-K14765469,vesamicol,acetylcholinesterase inhibitor,SLC18A3,BRD-K14765469,vesamicol,acetylcholinesterase inhibitor,SLC18A3,BRD-K14765469,vesamicol,acetylcholinesterase inhibitor,SLC18A3
YSTVFDAKLDMYCR,BRD-K34713073,PD-123319,angiotensin antagonist,AGTR2,BRD-K34713073,PD-123319,angiotensin antagonist,AGTR2,BRD-K34713073,PD-123319,angiotensin antagonist,AGTR2,BRD-K34713073,PD-123319,angiotensin antagonist,AGTR2
YSUUAJQQWBEIMR,BRD-M65265990,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,BRD-M65265990,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR,,,,,,,,
YSXKPIUOCJLQIE,BRD-A00546892,biperiden,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-A00546892,biperiden,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-A00546892,biperiden,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,BRD-K01824983,biperiden,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5
YTAOBBFIOAEMLL,BRD-K71058253,luliconazole,sterol demethylase inhibitor,,BRD-K71058253,luliconazole,sterol demethylase inhibitor,,BRD-K71058253,luliconazole,sterol demethylase inhibitor,,BRD-K71058253,luliconazole,sterol demethylase inhibitor,
YTBNTDMBGXAOCG,BRD-K28405228,mecarbinate,,,BRD-K28405228,mecarbinate,,,BRD-K28405228,mecarbinate,,,BRD-K28405228,mecarbinate,,
YTFHCXIPDIHOIA,BRD-K83794243,palovarotene,retinoid receptor agonist,RARG,BRD-K83794243,palovarotene,retinoid receptor agonist,RARG,BRD-K83794243,palovarotene,retinoid receptor agonist,RARG,BRD-K83794243,palovarotene,retinoid receptor agonist,RARG
YTGJWQPHMWSCST,BRD-A85295731,tiopronin,chelating agent|reducing agent,,BRD-A85295731,tiopronin,chelating agent|reducing agent,,BRD-A85295731,tiopronin,chelating agent|reducing agent,,BRD-A85295731,tiopronin,chelating agent|reducing agent,
YTJOHEUHUVBKSB,BRD-K22745370,2-BFI,imidazoline receptor ligand,ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB,BRD-K22745370,2-BFI,imidazoline receptor ligand,ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB,BRD-K22745370,2-BFI,imidazoline receptor ligand,ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB,BRD-K22745370,2-BFI,imidazoline receptor ligand,ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB
YTKUWDBFDASYHO,BRD-K17068645,bendamustine,DNA inhibitor,,BRD-K17068645,bendamustine,DNA inhibitor,,BRD-K17068645,bendamustine,DNA inhibitor,,BRD-K17068645,bendamustine,DNA inhibitor,
YTPQSLLEROSACP,BRD-K32372024,D-7193,,,BRD-K32372024,D-7193,,,BRD-K32372024,D-7193,,,BRD-K32372024,D-7193,,
YTRMTPPVNRALON,BRD-K72915123,cinchophen,analgesic agent,,BRD-K72915123,cinchophen,analgesic agent,,BRD-K72915123,cinchophen,analgesic agent,,BRD-K72915123,cinchophen,analgesic agent,
YTRRAUACYORZLX,BRD-A62133859,NLG919,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-A62133859,NLG919,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-A62133859,NLG919,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-A62133859,NLG919,"indoleamine 2,3-dioxygenase inhibitor",IDO1
YTXSYWAKVMZICI,BRD-A66419424,ixazomib-citrate,proteasome inhibitor,,BRD-A66419424,ixazomib-citrate,proteasome inhibitor,,BRD-A66419424,ixazomib-citrate,proteasome inhibitor,,BRD-A66419424,ixazomib-citrate,proteasome inhibitor,
YTZALCGQUPRCGW,BRD-K81849500,verteporfin,photosensitizing agent,,BRD-K81849500,verteporfin,photosensitizing agent,,BRD-K81849500,verteporfin,photosensitizing agent,,,,,
YUAALFPUEOYPNX,BRD-K84034737,TP-0903,AXL kinase inhibitor,AXL,BRD-K84034737,TP-0903,AXL kinase inhibitor,AXL,BRD-K84034737,TP-0903,AXL kinase inhibitor,AXL,BRD-K84034737,TP-0903,AXL kinase inhibitor,AXL
YUFCOOWNNHGGOD,BRD-A00077618,8-bromo-cGMP,PKA activator,PRKG1,BRD-A00077618,8-bromo-cGMP,PKA activator,PRKG1,BRD-A00077618,8-bromo-cGMP,PKA activator,PRKG1,BRD-A00077618,8-bromo-cGMP,PKA activator,PRKG1
YUGZHQHSNYIFLG,BRD-A30693873,diperodon,local anesthetic,,BRD-A30693873,diperodon,local anesthetic,,BRD-A30693873,diperodon,local anesthetic,,BRD-A30693873,diperodon,local anesthetic,
YUKWVHPTFRQHMF,BRD-K59146805,AZ3146,monopolar spindle 1 kinase inhibitor,,BRD-K59146805,AZ3146,monopolar spindle 1 kinase inhibitor,,BRD-K59146805,AZ3146,monopolar spindle 1 kinase inhibitor,,BRD-K59146805,AZ3146,monopolar spindle 1 kinase inhibitor,
YULUCECVQOCQFQ,BRD-K90497590,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1,BRD-K90497590,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1,BRD-K90497590,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1,BRD-K90497590,AR-12,phosphoinositide dependent kinase inhibitor,PDPK1
YUTIXVXZQIQWGY,BRD-K34185671,AMG-517,TRPV antagonist,TRPV1,BRD-K34185671,AMG-517,TRPV antagonist,TRPV1,BRD-K34185671,AMG-517,TRPV antagonist,TRPV1,BRD-K34185671,AMG-517,TRPV antagonist,TRPV1
YUTJCNNFTOIOGT,BRD-K51807679,dithranol,DNA synthesis inhibitor,,BRD-K51807679,dithranol,DNA synthesis inhibitor,,BRD-K51807679,dithranol,DNA synthesis inhibitor,,BRD-K51807679,dithranol,DNA synthesis inhibitor,
YUUAYBAIHCDHHD,BRD-K01292611,methyl-aminolevulinate,oxidizing agent,FCGR1A|FECH,BRD-K01292611,methyl-aminolevulinate,oxidizing agent,FCGR1A|FECH,BRD-K01292611,methyl-aminolevulinate,oxidizing agent,FCGR1A|FECH,BRD-K01292611,methyl-aminolevulinate,oxidizing agent,FCGR1A|FECH
YUUGYIUSCYNSQR,BRD-K13756951,bitopertin,GlyT-1 inhibitor|glycine transporter inhibitor,SLC6A5|SLC6A9,BRD-K13756951,bitopertin,GlyT-1 inhibitor|glycine transporter inhibitor,SLC6A5|SLC6A9,BRD-K13756951,bitopertin,GlyT-1 inhibitor|glycine transporter inhibitor,SLC6A5|SLC6A9,BRD-K13756951,bitopertin,glycine transporter inhibitor,SLC6A5|SLC6A9
YUVNGBZROXQYQH,BRD-K12079898,PD-160170,neuropeptide receptor antagonist,NPY1R,BRD-K12079898,PD-160170,neuropeptide receptor antagonist,NPY1R,BRD-K12079898,PD-160170,neuropeptide receptor antagonist,NPY1R,BRD-K12079898,PD-160170,neuropeptide receptor antagonist,NPY1R
YUWPMEXLKGOSBF,BRD-A53566267,anecortave-acetate,angiogenesis inhibitor,,BRD-A53566267,anecortave-acetate,angiogenesis inhibitor,,BRD-A53566267,anecortave-acetate,angiogenesis inhibitor,,BRD-K00005346,anecortave-acetate,angiogenesis inhibitor,
YUXMTDYHFPRPLG,BRD-K25875056,SC-9,protein tyrosine kinase activator,PRKCA,BRD-K25875056,SC-9,protein tyrosine kinase activator,PRKCA,BRD-K25875056,SC-9,protein tyrosine kinase activator,PRKCA,BRD-K25875056,SC-9,protein tyrosine kinase activator,PRKCA
YVAFBXLHPINSIK,BRD-K83029223,litronesib,kinesin-like spindle protein inhibitor,KIF11,BRD-K83029223,litronesib,kinesin-like spindle protein inhibitor,KIF11,BRD-K83029223,litronesib,kinesin-like spindle protein inhibitor,KIF11,BRD-K83029223,litronesib,kinesin-like spindle protein inhibitor,KIF11
YVGGHNCTFXOJCH,BRD-K51799616,"4,4'-DDT",,,BRD-K51799616,"4,4'-DDT",,,BRD-K51799616,"4,4'-DDT",,,BRD-K51799616,"4,4'-DDT",,
YVKDUIAAPBKHMJ,BRD-K31168993,McN-5652-(+/-),selective serotonin reuptake inhibitor (SSRI),,BRD-K31168993,McN-5652-(+/-),selective serotonin reuptake inhibitor (SSRI),,BRD-K31168993,McN-5652-(+/-),selective serotonin reuptake inhibitor (SSRI),,BRD-K31168993,McN-5652-(+/-),selective serotonin reuptake inhibitor (SSRI),
YVPGZQLRPAGKLA,BRD-K82522873,N6022,alcohol dehydrogenase inhibitor,ADH5,BRD-K82522873,N6022,alcohol dehydrogenase inhibitor,ADH5,BRD-K82522873,N6022,alcohol dehydrogenase inhibitor,ADH5,BRD-K82522873,N6022,alcohol dehydrogenase inhibitor,ADH5
YVPUUUDAZYFFQT,BRD-K11851476,pardoprunox,dopamine receptor agonist|serotonin receptor agonist,DRD2|DRD3|DRD4|HTR1A|HTR7,BRD-K11851476,pardoprunox,dopamine receptor agonist|serotonin receptor agonist,DRD2|DRD3|DRD4|HTR1A|HTR7,BRD-K11851476,pardoprunox,dopamine receptor agonist|serotonin receptor agonist,DRD2|DRD3|DRD4|HTR1A|HTR7,BRD-K11851476,pardoprunox,dopamine receptor agonist|serotonin receptor agonist,DRD2|DRD3|DRD4|HTR1A|HTR7
YVPXVXANRNDGTA,BRD-K78936063|BRD-K96194081,cepharanthine,NFkB pathway inhibitor,,BRD-K78936063|BRD-K96194081,cepharanthine,NFkB pathway inhibitor,,BRD-K78936063|BRD-K96194081,cepharanthine,NFkB pathway inhibitor,,BRD-K78936063|BRD-K96194081,cepharanthine,NFkB pathway inhibitor,
YVPYQUNUQOZFHG,BRD-K48247567,diatrizoic-acid,,,BRD-K48247567,diatrizoic-acid,,,BRD-K48247567,diatrizoic-acid,,,BRD-K48247567,diatrizoic-acid,,
YVQVOQKFMFRVGR,BRD-A67514145,furaltadone,bacterial DNA inhibitor,,BRD-A67514145,furaltadone,bacterial DNA inhibitor,,BRD-A67514145,furaltadone,bacterial DNA inhibitor,,BRD-K01824979,furaltadone,bacterial DNA inhibitor,
YVUQSNJEYSNKRX,BRD-K01292756,pimozide,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,BRD-K01292756,pimozide,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,BRD-K01292756,pimozide,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,BRD-K01292756,pimozide,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2
YVXVTLGIDOACBJ,BRD-K82164249,andarine,androgen receptor modulator,AR,BRD-K82164249,andarine,androgen receptor modulator,AR,BRD-K82164249,andarine,androgen receptor modulator,AR,BRD-K82164249,andarine,androgen receptor modulator,AR
YWGDOWXRIALTES,BRD-K98624455,bepotastine,histamine receptor antagonist,HRH1,BRD-K98624455,bepotastine,histamine receptor antagonist,HRH1,BRD-K98624455,bepotastine,histamine receptor antagonist,HRH1,BRD-K98624455,bepotastine,histamine receptor antagonist,HRH1
YWGYNGCRVZLMCS,BRD-K70330032,JNJ-42165279,FAAH inhibitor,FAAH,BRD-K70330032,JNJ-42165279,FAAH inhibitor,FAAH,BRD-K70330032,JNJ-42165279,FAAH inhibitor,FAAH,BRD-K70330032,JNJ-42165279,FAAH inhibitor,FAAH
YWJXCIXBAKGUKZ,BRD-K04176066|BRD-K18550767,bergenin,interleukin inhibitor,IL1B|TNF,BRD-K04176066|BRD-K18550767,bergenin,interleukin inhibitor,IL1B|TNF,BRD-K04176066|BRD-K18550767,bergenin,interleukin inhibitor,IL1B|TNF,BRD-K04176066|BRD-K18550767,bergenin,interleukin inhibitor,IL1B|TNF
YWLXLRUDGLRYDR,BRD-K61920224|BRD-K96631475,10-deacetylbaccatin,antitumor agent,,BRD-K61920224|BRD-K96631475,10-deacetylbaccatin,antitumor agent,,BRD-K61920224|BRD-K96631475,10-deacetylbaccatin,antitumor agent,,BRD-K61920224|BRD-K96631475,10-deacetylbaccatin,antitumor agent,
YWPHCCPCQOJSGZ,BRD-A59198242,viloxazine,norepinephrine reuptake inhibitor,SLC6A2,BRD-A59198242,viloxazine,norepinephrine reuptake inhibitor,SLC6A2,BRD-A59198242,viloxazine,norepinephrine reuptake inhibitor,SLC6A2,BRD-A59198242,viloxazine,norepinephrine reuptake inhibitor,SLC6A2
YWSPWKXREVSQCA,BRD-K03564313,DMNB,DNA dependent protein kinase inhibitor,,BRD-K03564313,DMNB,DNA dependent protein kinase inhibitor,,BRD-K03564313,DMNB,DNA dependent protein kinase inhibitor,,BRD-K03564313,DMNB,DNA dependent protein kinase inhibitor,
YWTYJOPNNQFBPC,BRD-K76609936,imidacloprid,acetylcholine receptor antagonist,CHRFAM7A,BRD-K76609936,imidacloprid,acetylcholine receptor antagonist,CHRFAM7A,BRD-K76609936,imidacloprid,acetylcholine receptor antagonist,CHRFAM7A,BRD-K76609936,imidacloprid,acetylcholine receptor antagonist,
YWXYYJSYQOXTPL,BRD-K82225283,isosorbide-mononitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,BRD-K82225283,isosorbide-mononitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,BRD-K82225283,isosorbide-mononitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,BRD-K82225283,isosorbide-mononitrate,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3
YXBQLONCIPUQKO,BRD-K97643133,amiprilose,CD antagonist,,BRD-K97643133,amiprilose,CD antagonist,,BRD-K97643133,amiprilose,CD antagonist,,BRD-K97643133,amiprilose,CD antagonist,
YXEWPGYLMHXLPS,BRD-K39706510,MIRA-1,apoptosis stimulant,,BRD-K39706510,MIRA-1,apoptosis stimulant,,BRD-K39706510,MIRA-1,apoptosis stimulant,,BRD-K39706510,MIRA-1,apoptosis stimulant,
YXFNPRHZMOGREC,BRD-K31495718,AZD7687,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K31495718,AZD7687,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K31495718,AZD7687,diacylglycerol O acyltransferase inhibitor,DGAT1,BRD-K31495718,AZD7687,diacylglycerol O acyltransferase inhibitor,DGAT1
YXIWHUQXZSMYRE,BRD-K55160477,benzo[d]thiazole-2(3h)-thione,,,BRD-K55160477,benzo[d]thiazole-2(3h)-thione,,,BRD-K55160477,benzo[d]thiazole-2(3h)-thione,,,BRD-K55160477,benzo[d]thiazole-2(3H)-thione,,
YXOLAZRVSSWPPT,BRD-K11590034,morin,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12,BRD-K11590034,morin,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12,BRD-K11590034,morin,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12,BRD-K11590034,morin,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12
YXRDKMPIGHSVRX,BRD-A40127632|BRD-K58951486,rocuronium,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,BRD-A40127632|BRD-K58951486,rocuronium,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,BRD-A40127632|BRD-K43305603|BRD-K58951486,rocuronium,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,BRD-A40127632|BRD-K43305603|BRD-K58951486,rocuronium,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A
YXSLJKQTIDHPOT,BRD-A75935363|BRD-K17498618,atracurium,acetylcholine receptor antagonist,CHRNA2,BRD-A75935363|BRD-K17498618,atracurium,acetylcholine receptor antagonist,CHRNA2,BRD-A75935363|BRD-K17498618,atracurium|betaxolol|cisatracurium,acetylcholine receptor antagonist|adrenergic receptor antagonist,ADRB1|ADRB2|CHRNA2,BRD-K01826774|BRD-K17498618,atracurium|cisatracurium,acetylcholine receptor antagonist,|CHRNA2
YXUPZGKORWTXID,BRD-K30431096,domiphen,,,BRD-K30431096,domiphen,,,BRD-K30431096,domiphen,,,BRD-K30431096,domiphen,,
YXWQTVWJNHKSCC,BRD-A91831168,tetrahydropapaverine,,,BRD-A91831168,tetrahydropapaverine,,,BRD-A91831168,tetrahydropapaverine,,,BRD-K01825583,tetrahydropapaverine,,
YYACLQUDUDXAPA,BRD-K53723268,PLX8394,serine/threonine kinase inhibitor,BRAF,BRD-K53723268,PLX8394,serine/threonine kinase inhibitor,BRAF,BRD-K53723268,PLX8394,serine/threonine kinase inhibitor,BRAF,BRD-K53723268,PLX8394,serine/threonine kinase inhibitor,BRAF
YYBOLPLTQDKXPM,BRD-K36741660,verinurad,urate transporter inhibitor,SLC22A12,BRD-K36741660,verinurad,urate transporter inhibitor,SLC22A12,BRD-K36741660,verinurad,urate transporter inhibitor,SLC22A12,BRD-K36741660,verinurad,urate transporter inhibitor,SLC22A12
YYCOJKPDBCMVPP,BRD-M10474530,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",,,BRD-M10474530,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",dopamine release inhibitor,,BRD-M10474530,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",dopamine release inhibitor,,,,,
YYFGRAGNYHYWEZ,BRD-K17979676,eprobemide,monoamine oxidase inhibitor,MAOA,BRD-K17979676,eprobemide,monoamine oxidase inhibitor,MAOA,BRD-K17979676,eprobemide,monoamine oxidase inhibitor,MAOA,BRD-K17979676,eprobemide,monoamine oxidase inhibitor,MAOA
YYHWOTFWBVRTQD,BRD-K26598477,zindotrine,phosphodiesterase inhibitor,,BRD-K26598477,zindotrine,phosphodiesterase inhibitor,,BRD-K26598477,zindotrine,phosphodiesterase inhibitor,,BRD-K26598477,zindotrine,phosphodiesterase inhibitor,
YYLKKYCXAOBSRM,BRD-K21718444,KW-2449,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,BRD-K21718444,KW-2449,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,BRD-K21718444,KW-2449,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,BRD-K21718444,KW-2449,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3
YYMCVDNIIFNDJK,BRD-K82002057,DFB,glutamate receptor agonist,GRM5,BRD-K82002057,DFB,glutamate receptor agonist,GRM5,BRD-K82002057,DFB,glutamate receptor agonist,GRM5,BRD-K82002057,DFB,glutamate receptor agonist,GRM5
YYOOFJZTRCPVFD,BRD-K60659193,CVT-10216,aldehyde dehydrogenase inhibitor,ALDH2,BRD-K60659193,CVT-10216,aldehyde dehydrogenase inhibitor,ALDH2,BRD-K60659193,CVT-10216,aldehyde dehydrogenase inhibitor,ALDH2,BRD-K60659193,CVT-10216,aldehyde dehydrogenase inhibitor,ALDH2
YZBLFMPOMVTDJY,BRD-K61988078,moxidectin,chloride channel antagonist,,BRD-K61988078,moxidectin,chloride channel antagonist,,BRD-K61988078,moxidectin,chloride channel antagonist,,BRD-K00003660,moxidectin,chloride channel antagonist,
YZCSJBGQLATPMH,BRD-K64341947,CFM-1571,guanylate cyclase activator,,BRD-K64341947,CFM-1571,guanylate cyclase activator,,BRD-K64341947,CFM-1571,guanylate cyclase activator,,BRD-K64341947,CFM-1571,guanylate cyclase activator,
YZDJQTHVDDOVHR,BRD-K16478699,PLX-4720,RAF inhibitor,BRAF|KDR,BRD-K16478699,PLX-4720,RAF inhibitor,BRAF|KDR,BRD-K16478699,PLX-4720,RAF inhibitor,BRAF|KDR,BRD-K16478699,PLX4720,RAF inhibitor,BRAF|KDR
YZEUHQHUFTYLPH,BRD-K26824830,azomycin-(2-nitroimidazole),protein synthesis inhibitor,,BRD-K26824830,azomycin-(2-nitroimidazole),protein synthesis inhibitor,,BRD-K26824830,azomycin-(2-nitroimidazole),protein synthesis inhibitor,,BRD-K26824830,azomycin-(2-nitroimidazole),protein synthesis inhibitor,
YZFWTZACSRHJQD,BRD-A93000692,ciglitazone,PPAR receptor agonist,PPARG,BRD-A93000692,ciglitazone,PPAR receptor agonist,PPARG,BRD-A93000692,ciglitazone,PPAR receptor agonist,PPARG,BRD-A93000692,ciglitazone,PPAR receptor agonist,PPARG
YZNNBIPIQWYLDM,BRD-K61536264,fagomine,glucosidase inhibitor,GLB1,BRD-K61536264,fagomine,glucosidase inhibitor,GLB1,BRD-K61536264,fagomine,glucosidase inhibitor,GLB1,BRD-K61536264,fagomine,glucosidase inhibitor,GLB1
YZODJQFXMFEJRM,BRD-M49658242,acrisorcin,other antifungal,,BRD-M49658242,acrisorcin,other antifungal,,BRD-M49658242,acrisorcin,other antifungal,,BRD-M49658242,acrisorcin,other antifungal,
YZQLWPMZQVHJED,BRD-K18849474,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K18849474,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K18849474,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP,BRD-K18849474,dalcetrapib,cholesteryl ester transfer protein inhibitor,CETP
YZXBAPSDXZZRGB,BRD-K03070961,arachidonic-acid,cytochrome P450 inhibitor,CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2,BRD-K03070961,arachidonic-acid,cytochrome P450 inhibitor,CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2,BRD-K03070961,arachidonic-acid,cytochrome P450 inhibitor,CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2,BRD-K03070961,arachidonic-acid,cytochrome P450 inhibitor,CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2
YZZAIQOVMHVWBS,BRD-K06593056,LE-135,retinoid receptor agonist,RARB,BRD-K06593056,LE-135,retinoid receptor agonist,RARB,BRD-K06593056,LE-135,retinoid receptor agonist,RARB,BRD-K06593056,LE-135,retinoid receptor agonist,RARB
YZZCJYJBCUJISI,BRD-K56276053,propatylnitrate,,,BRD-K56276053,propatylnitrate,,,BRD-K56276053,propatylnitrate,,,BRD-K56276053,propatylnitrate,,
YZZVIKDAOTXDEB,BRD-K09126848,nepicastat,dopamine beta hydroxylase inhibitor,DBH,BRD-K09126848,nepicastat,dopamine beta hydroxylase inhibitor,DBH,BRD-K09126848,nepicastat,dopamine beta hydroxylase inhibitor,DBH,BRD-K09126848,nepicastat,dopamine beta hydroxylase inhibitor,DBH
ZADGGFKUEYIBJC,BRD-A56320380,decamethoxine,antiseptic,,BRD-A56320380,decamethoxine,antiseptic,,BRD-A56320380,decamethoxine,antiseptic,,BRD-A56320380,decamethoxine,antiseptic,
ZADWXFSZEAPBJS,BRD-K93255255,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K93255255,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K93255255,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1,BRD-K93255255,indoximod,"indoleamine 2,3-dioxygenase inhibitor",IDO1
ZAFYATHCZYHLPB,BRD-K44876623,zolpidem,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3,BRD-K44876623,zolpidem,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3,BRD-K44876623,zolpidem,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3,,,,
ZAHQBPYQBHTECE,BRD-A84174393,meloxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A84174393,meloxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-A84174393,meloxicam,cyclooxygenase inhibitor,PTGS1|PTGS2,,,,
ZAIPMKNFIOOWCQ,BRD-A37536726|BRD-K64997193|BRD-K90733503,cephalexin,bacterial cell wall synthesis inhibitor,,BRD-A37536726|BRD-K64997193|BRD-K90733503,cephalexin,bacterial cell wall synthesis inhibitor,,BRD-A37536726|BRD-K64997193|BRD-K90733503,cephalexin,bacterial cell wall synthesis inhibitor,,BRD-A37536726|BRD-K64997193|BRD-K90733503,cephalexin,bacterial cell wall synthesis inhibitor,
ZAJXXUDARPGGOC,BRD-K23190681,AV-412,protein tyrosine kinase inhibitor,EGFR|ERBB2,BRD-K23190681,AV-412,protein tyrosine kinase inhibitor,EGFR|ERBB2,BRD-K23190681,AV-412,protein tyrosine kinase inhibitor,EGFR|ERBB2,BRD-K23190681,AV-412,protein tyrosine kinase inhibitor,EGFR|ERBB2
ZAKKIVMLUCPABA,BRD-K39576764,mivobulin,microtubule inhibitor,,BRD-K39576764,mivobulin,microtubule inhibitor,,BRD-K39576764,mivobulin,microtubule inhibitor,,,,,
ZAKOWWREFLAJOT,BRD-A61850409,alpha-tochopheryl-acetate,antioxidant,,BRD-A61850409,alpha-tochopheryl-acetate,antioxidant,,BRD-A61850409,alpha-tochopheryl-acetate,antioxidant,,BRD-A61850409,alpha-tochopheryl-acetate,antioxidant,
ZAVGJDAFCZAWSZ,BRD-K77793136,hydroxyfasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1,BRD-K77793136,hydroxyfasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1,BRD-K77793136,hydroxyfasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1,BRD-K77793136,hydroxyfasudil,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1
ZAWXOCUFQSQDJS,BRD-K92524032,ochromycinone,STAT inhibitor,STAT3,BRD-K92524032,ochromycinone,STAT inhibitor,STAT3,BRD-K92524032,ochromycinone,STAT inhibitor,STAT3,BRD-K92524032,ochromycinone,STAT inhibitor,STAT3
ZBBHBTPTTSWHBA,BRD-A26711594,nicardipine,calcium channel blocker,ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1C|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B,BRD-A26711594,nicardipine,calcium channel blocker,ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1C|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B,BRD-A26711594,nicardipine,calcium channel blocker,ADORA3|ADRA1A|ADRA1B|ADRA1D|CACNA1C|CACNA1D|CACNA2D1|CACNB2|CALM1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|PDE1A|PDE1B,BRD-A26711594,nicardipine,calcium channel blocker,ADORA3
ZBFDAUIVDSSISP,BRD-A42270467,tenatoprazole,ATPase inhibitor,IDO1,BRD-A42270467,tenatoprazole,ATPase inhibitor,IDO1,BRD-A42270467,tenatoprazole,ATPase inhibitor,IDO1,BRD-A42270467,tenatoprazole,ATPase inhibitor,IDO1
ZBGXUVOIWDMMJE,BRD-K93442924,vorapaxar,thrombin receptor antagonist,F2R,BRD-K93442924,vorapaxar,thrombin receptor antagonist,F2R,BRD-K93442924,vorapaxar,thrombin receptor antagonist,F2R,BRD-K93442924,vorapaxar,thrombin inhibitor,F2R
ZBHXIWJRIFEVQY,BRD-K15436267|BRD-K21017401|BRD-K82960980,ceftiofur,bacterial cell wall synthesis inhibitor,,BRD-K15436267|BRD-K21017401|BRD-K82960980,ceftiofur,bacterial cell wall synthesis inhibitor,,BRD-K15436267|BRD-K21017401|BRD-K75097379|BRD-K82960980,ceftiofur,bacterial cell wall synthesis inhibitor,,BRD-K15436267|BRD-K21017401|BRD-K75097379|BRD-K82960980,ceftiofur,bacterial cell wall synthesis inhibitor,
ZBIAKUMOEKILTF,BRD-K62996583,lidoflazine,calcium channel blocker,SCN1A|SCN3A|SLC29A1,BRD-K62996583,lidoflazine,calcium channel blocker,SCN1A|SCN3A|SLC29A1,BRD-K62996583,lidoflazine,calcium channel blocker,SCN1A|SCN3A|SLC29A1,BRD-K62996583,lidoflazine,calcium channel blocker,SCN1A|SCN3A|SLC29A1
ZBJWWKFMHOAPNS,BRD-K52284881,chiniofon,antiprotozoal agent,,BRD-K52284881,chiniofon,antiprotozoal agent,,BRD-K52284881,chiniofon,antiprotozoal agent,,BRD-K52284881,chiniofon,antiprotozoal agent,
ZBMZVLHSJCTVON,BRD-A33168282,sotalol,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,BRD-A33168282,sotalol,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,BRD-A33168282,sotalol,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,BRD-A33168282,sotalol,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2
ZBNZXTGUTAYRHI,BRD-K49328571,dasatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|ephrin inhibitor|src inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,BRD-K49328571,dasatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|ephrin inhibitor|src inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,BRD-K49328571,dasatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|ephrin inhibitor|src inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,BRD-K49328571,dasatinib,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|ephrin inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1
ZBOYJODMIAUJHH,BRD-K04032780,PD1-PDL-inhibitor-1,programmed death ligand inhibitor,CD274,BRD-K04032780,PD1-PDL-inhibitor-1,programmed death ligand inhibitor,CD274,BRD-K04032780,PD1-PDL-inhibitor-1,programmed death ligand inhibitor,CD274,BRD-K04032780,PD1-PDL-inhibitor-1,programmed death ligand inhibitor,CD274
ZBPLOVFIXSTCRZ,BRD-K47679368,bromfenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K47679368,bromfenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K47679368,bromfenac,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K47679368,bromfenac,cyclooxygenase inhibitor,PTGS1|PTGS2
ZBRAJOQFSNYJMF,BRD-K72005722,VT-464,cytochrome P450 inhibitor,CYP17A1,BRD-K72005722,VT-464,cytochrome P450 inhibitor,CYP17A1,BRD-K72005722,VT-464,cytochrome P450 inhibitor,CYP17A1,BRD-K72005722,VT-464,cytochrome P450 inhibitor,CYP17A1
ZBVKEHDGYSLCCC,BRD-A60765580,seratrodast,prostanoid receptor antagonist,TBXA2R,BRD-A60765580,seratrodast,prostanoid receptor antagonist,TBXA2R,BRD-A60765580,seratrodast,prostanoid receptor antagonist,TBXA2R,BRD-A60765580,seratrodast,prostanoid receptor antagonist,TBXA2R
ZBXDOQWPGBISAR,BRD-K16551401,PNU-22394,serotonin receptor agonist,HTR2A|HTR2B|HTR2C|MAOA|MAOB,BRD-K16551401,PNU-22394,serotonin receptor agonist,HTR2A|HTR2B|HTR2C|MAOA|MAOB,BRD-K16551401,PNU-22394,serotonin receptor agonist,HTR2A|HTR2B|HTR2C|MAOA|MAOB,BRD-K16551401,PNU-22394,serotonin receptor agonist,HTR2A|HTR2B|HTR2C|MAOA|MAOB
ZBYVTTSIVDYQSO,BRD-K82178523,L-asparagine-n-hydroxy,,,BRD-K82178523,L-asparagine-n-hydroxy,,,BRD-K82178523,L-asparagine-n-hydroxy,,,BRD-K82178523,L-asparagine-N-hydroxy,,
ZCCPLJOKGAACRT,BRD-K79259477,NVP-BHG712,ephrin inhibitor,EPHB4,BRD-K79259477,NVP-BHG712,ephrin inhibitor,EPHB4,BRD-K79259477,NVP-BHG712,ephrin inhibitor,EPHB4,BRD-K79259477,NVP-BHG712,ephrin inhibitor,EPHB4
ZCCUUQDIBDJBTK,BRD-K47264279,psoralen,,MAOA|MAOB,BRD-K47264279,psoralen,,MAOA|MAOB,BRD-K47264279,psoralen,,MAOA|MAOB,BRD-K47264279,psoralen,,MAOA|MAOB
ZCCUWMICIWSJIX,BRD-K37252028,ceftaroline-fosamil,bacterial cell wall synthesis inhibitor,,BRD-K37252028,ceftaroline-fosamil,bacterial cell wall synthesis inhibitor,,BRD-K37252028,ceftaroline-fosamil,bacterial cell wall synthesis inhibitor,,BRD-K37252028,ceftaroline-fosamil,bacterial cell wall synthesis inhibitor,
ZCGNOVWYSGBHAU,BRD-K04264130,favipiravir,RNA polymerase inhibitor,,BRD-K04264130,favipiravir,RNA polymerase inhibitor,,BRD-K04264130,favipiravir,RNA polymerase inhibitor,,BRD-K04264130,favipiravir,RNA polymerase inhibitor,
ZCGOMHNNNFPNMX,BRD-K33453211,levocabastine,histamine receptor antagonist,HRH1|NTSR2,BRD-K33453211,levocabastine,histamine receptor antagonist,HRH1|NTSR2,BRD-K33453211,levocabastine,histamine receptor antagonist,HRH1|NTSR2,BRD-K33453211,levocabastine,histamine receptor antagonist,HRH1|NTSR2
ZCIGNRJZKPOIKD,BRD-K51040301,cobicistat,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,BRD-K51040301,cobicistat,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,BRD-K51040301,cobicistat,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,BRD-K51040301,cobicistat,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7
ZCIXFSVENQDMCK,BRD-A74328360,antimonyl,,,BRD-A74328360,antimonyl,,,BRD-A74328360|BRD-U39828521,antimonyl,,,BRD-A74328360|BRD-K00003675|BRD-U39828521,antimony-potassium|antimonyl,,
ZCJYUTQZBAIHBS,BRD-A33697453,fenticonazole,bacterial cell wall synthesis inhibitor,,BRD-A33697453,fenticonazole,bacterial cell wall synthesis inhibitor,,BRD-A33697453,fenticonazole,bacterial cell wall synthesis inhibitor,,BRD-A33697453,fenticonazole,bacterial cell wall synthesis inhibitor,
ZCQOSCDABPVAFB,BRD-K34657753,PD-118057,potassium channel activator,KCNH2,BRD-K34657753,PD-118057,potassium channel activator,KCNH2,BRD-K34657753,PD-118057,potassium channel activator,KCNH2,BRD-K34657753,PD-118057,potassium channel activator,KCNH2
ZCTJIMXXSXQXRI,BRD-K87548127,thaliblastine,DNA inhibitor,,BRD-K87548127,thaliblastine,DNA inhibitor,,BRD-K87548127,thaliblastine,DNA inhibitor,,BRD-K87548127,thaliblastine,DNA inhibitor,
ZCTXEAQXZGPWFG,BRD-A65444648,imidurea,other antibiotic,,BRD-A65444648,imidurea,other antibiotic,,BRD-A65444648,imidurea,other antibiotic,,BRD-K00003682,imidurea,other antibiotic,
ZCVMWBYGMWKGHF,BRD-K28936863,ketotifen,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B|PDE8A|PDE8B|PGD,BRD-K28936863,ketotifen,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B|PDE8A|PDE8B|PGD,BRD-K28936863,ketotifen,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1|PDE4A|PDE4B|PDE4C|PDE4D|PDE7A|PDE7B|PDE8A|PDE8B|PGD,,,,
ZCVMXWPQAQXWFO,BRD-K76786967,fimasartan,angiotensin receptor antagonist,AGTR1,BRD-K76786967,fimasartan,angiotensin receptor antagonist,AGTR1,,,,,,,,
ZCXUVYAZINUVJD,BRD-A53037300,2-fluoro-2-deoxy-D-galactose,,LCT,BRD-A53037300,2-fluoro-2-deoxy-D-galactose,,LCT,BRD-A53037300,2-fluoro-2-deoxy-D-galactose,,LCT,BRD-A53037300,2-fluoro-2-deoxy-D-galactose,,LCT
ZCZGSEXBXXYQQC,BRD-K55487946,WEHI-345-analog,src inhibitor,,BRD-K55487946,WEHI-345-analog,src inhibitor,,BRD-K55487946,WEHI-345-analog,src inhibitor,,BRD-K55487946,WEHI-345-analog,SRC inhibitor,
ZDASUJMDVPTNTF,BRD-K23301018,broxyquinoline,antiprotozoal agent,,BRD-K23301018,broxyquinoline,antiprotozoal agent,,BRD-K23301018,broxyquinoline,antiprotozoal agent,,BRD-K23301018,broxyquinoline,antiprotozoal agent,
ZDIGNSYAACHWNL,BRD-A68723818,brompheniramine,histamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1,BRD-A68723818,brompheniramine,histamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1,BRD-A68723818,brompheniramine,histamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1,BRD-K01825159,brompheniramine,histamine receptor antagonist,HRH1
ZDOYGJNADZJRFB,BRD-A92960111,chlorophyllin-copper,cytochrome P450 inhibitor,,BRD-A92960111,chlorophyllin-copper,cytochrome P450 inhibitor,,BRD-A92960111|BRD-U98640356,chlorophyllin-copper,cytochrome P450 inhibitor,,BRD-A92960111|BRD-U98640356,chlorophyllin-copper,cytochrome P450 inhibitor,
ZDPIZLCVJAAHHR,BRD-K80036624,clopidol,,,BRD-K80036624,clopidol,,,BRD-K80036624,clopidol,,,BRD-K80036624,clopidol,,
ZDQSOHOQTUFQEM,BRD-A72381333,ascomycin,calcineurin inhibitor,FKBP1A,BRD-A72381333,ascomycin,calcineurin inhibitor,FKBP1A,BRD-A72381333,ascomycin,calcineurin inhibitor,FKBP1A,BRD-K88882192,ascomycin,calcineurin inhibitor,FKBP1A
ZDRQMXCSSAPUMM,BRD-K43449605,oncrasin-1,apoptosis stimulant,,BRD-K43449605,oncrasin-1,apoptosis stimulant,,BRD-K43449605,oncrasin-1,apoptosis stimulant,,BRD-K43449605,oncrasin-1,apoptosis stimulant,
ZDWVWKDAWBGPDN,BRD-K14821965,propidium-iodide,,ACHE,BRD-K14821965,propidium-iodide,,ACHE,BRD-K14821965,propidium-iodide,,ACHE,BRD-K14821965,propidium-iodide,,ACHE
ZDXPYRJPNDTMRX,BRD-K83896451,glutamine-(l),,CTPS1|GLUL|GPRC6A|PPAT,BRD-K83896451,glutamine-(l),,CTPS1|GLUL|GPRC6A|PPAT,BRD-K83896451,glutamine-(l),,CTPS1|GLUL|GPRC6A|PPAT,BRD-K83896451,L-glutamine,,CTPS1|GLUL|GPRC6A|PPAT
ZDXUKAKRHYTAKV,BRD-A18992208,lercanidipine,calcium channel blocker,CACNA2D1|CACNG1,BRD-A18992208,lercanidipine,calcium channel blocker,CACNA2D1|CACNG1,BRD-A18992208,lercanidipine,calcium channel blocker,CACNA2D1|CACNG1,BRD-A18992208,lercanidipine,calcium channel blocker,CACNA2D1
ZDZOTLJHXYCWBA,BRD-A05821830|BRD-A28612473,docetaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1,BRD-A05821830|BRD-K63265447,docetaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1,BRD-A05821830|BRD-K30577245|BRD-K63265447,docetaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1,BRD-A05821830|BRD-K30577245|BRD-K63265447,docetaxel,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
ZEFNOZRLAWVAQF,BRD-K93240442,dinitolmide,,,BRD-K93240442,dinitolmide,,,BRD-K93240442,dinitolmide,,,BRD-K93240442,dinitolmide,,
ZEKZLJVOYLTDKK,BRD-A75850590,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A75850590,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-A75850590,lomefloxacin,bacterial DNA gyrase inhibitor,TOP2A,BRD-K01825701,lomefloxacin,bacterial DNA gyrase inhibitor,
ZEMGGZBWXRYJHK,BRD-K58819470,2-thiouracil,,,BRD-K58819470,2-thiouracil,,,BRD-K58819470,2-thiouracil,,,BRD-K58819470,2-thiouracil,,
ZEMIJUDPLILVNQ,BRD-K32791151,pivampicillin,bacterial cell wall synthesis inhibitor,,BRD-K32791151,pivampicillin,bacterial cell wall synthesis inhibitor,,BRD-K32791151,pivampicillin,bacterial cell wall synthesis inhibitor,,BRD-K32791151,pivampicillin,bacterial cell wall synthesis inhibitor,
ZESFDAKNYJQYKO,BRD-K18289362,PF-915275,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,BRD-K18289362,PF-915275,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,BRD-K18289362,PF-915275,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,BRD-K18289362,PF-915275,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1
ZESRJSPZRDMNHY,BRD-K98521173,desoxycortone,mineralocorticoid receptor agonist,NR3C1|NR3C2,BRD-K98521173,desoxycortone,mineralocorticoid receptor agonist,NR3C1|NR3C2,BRD-K98521173,desoxycortone,mineralocorticoid receptor agonist,NR3C1|NR3C2,BRD-K98521173,desoxycortone,mineralocorticoid receptor agonist,NR3C1|NR3C2
ZEUITGRIYCTCEM,BRD-K71103788,duloxetine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,BRD-K71103788,duloxetine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,BRD-K71103788,duloxetine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,BRD-K71103788,duloxetine,norepinephrine reuptake inhibitor|serotoninnorepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4
ZEUXAIYYDDCIRX,BRD-K23533833,carboxylosartan,angiotensin antagonist,AGTR1,BRD-K23533833,carboxylosartan,angiotensin antagonist,AGTR1,BRD-K23533833,carboxylosartan,angiotensin antagonist,AGTR1,BRD-K23533833,carboxylosartan,angiotensin antagonist,AGTR1
ZEWQUBUPAILYHI,BRD-K89732114,trifluoperazine,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,BRD-K89732114,trifluoperazine,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,BRD-K89732114,trifluoperazine,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,BRD-K89732114,trifluoperazine,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1
ZEYYDOLCHFETHQ,BRD-K12852738,veliflapon,leukotriene synthesis inhibitor,ALOX5AP,BRD-K12852738,veliflapon,leukotriene synthesis inhibitor,ALOX5AP,BRD-K12852738,veliflapon,leukotriene synthesis inhibitor,ALOX5AP,BRD-K12852738,veliflapon,leukotriene synthesis inhibitor,ALOX5AP
ZFGXZJKLOFCECI,BRD-K20755323,SKI-II,sphingosine kinase inhibitor,SPHK1,BRD-K20755323,SKI-II,sphingosine kinase inhibitor,SPHK1,BRD-K20755323,SKI-II,sphingosine kinase inhibitor,SPHK1,BRD-K20755323,SKI-II,sphingosine kinase inhibitor,SPHK1
ZFLJHSQHILSNCM,BRD-K77286328,reversine,Aurora kinase inhibitor,AURKB|INCENP|MAP2K1,BRD-K77286328,reversine,Aurora kinase inhibitor,AURKB|INCENP|MAP2K1,BRD-K77286328,reversine,Aurora kinase inhibitor,AURKB|INCENP|MAP2K1,BRD-K77286328,reversine,Aurora kinase inhibitor,AURKB|INCENP|MAP2K1
ZFLWDHHVRRZMEI,BRD-A05457250|BRD-K14329163,BAY-K-8644-(+/-)|BAY-K-8644-(s)-(-),L-type calcium channel activator,|CACNA1C,BRD-A05457250|BRD-K14329163,BAY-K-8644-(+/-)|BAY-K-8644-(s)-(-),L-type calcium channel activator,|CACNA1C,BRD-A05457250|BRD-K14329163,BAY-K-8644-(+/-)|BAY-K-8644-(s)-(-),L-type calcium channel activator,|CACNA1C,BRD-A05457250|BRD-K14329163,BAY-K-8644-(+/-)|BAY-K-8644-(s)-(-),L-type calcium channel activator|L-type calcium channel blocker,|CACNA1C
ZFMITUMMTDLWHR,BRD-K06902185,minoxidil,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,BRD-K06902185,minoxidil,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,BRD-K06902185|BRD-K14888893,minoxidil,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,BRD-K06902185|BRD-K14888893,minoxidil,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1
ZFMVWAWSKLAVOE,BRD-A75769826,SDM25N,opioid receptor antagonist,OPRD1,BRD-A75769826,SDM25N,opioid receptor antagonist,OPRD1,BRD-A75769826,SDM25N,opioid receptor antagonist,OPRD1,BRD-K01826797,SDM25N,opioid receptor antagonist,OPRD1
ZFPGARUNNKGOBB,BRD-K08288352,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,,BRD-K08288352,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,,BRD-K08288352,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,,BRD-K08288352,1-ethyl-2-pyrrolidone,transdermal absorption-enhancing compound,
ZFPZEYHRWGMJCV,BRD-K07790550,mavoglurant,glutamate receptor antagonist,GRM5,BRD-K07790550,mavoglurant,glutamate receptor antagonist,GRM5,BRD-K07790550,mavoglurant,glutamate receptor antagonist,GRM5,BRD-K07790550,mavoglurant,glutamate receptor antagonist,GRM5
ZFQMTVNLDNXRNQ,BRD-K34122555,denatonium-benzoate,,,BRD-K34122555,denatonium-benzoate,,,BRD-K34122555,denatonium-benzoate,,,BRD-K34122555,denatonium-benzoate,,
ZFVRYNYOPQZKDG,BRD-K71281111,SNX-2112,HSP inhibitor,,BRD-K71281111,SNX-2112,HSP inhibitor,,BRD-K71281111,SNX-2112,HSP inhibitor,,BRD-K71281111,SNX-2112,HSP inhibitor,
ZFXYFBGIUFBOJW,BRD-K97799481,aminophylline|oxtriphylline|theophylline,adenosine receptor antagonist,|ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-K97799481,aminophylline|oxtriphylline|theophylline,adenosine receptor antagonist,|ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-K97799481|BRD-M53001068,aminophylline|oxtriphylline|theophylline,adenosine receptor antagonist,|ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-K97799481|BRD-M53001068,aminophylline,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
ZGBGPEDJXCYQPH,BRD-K05804044,AZ-628,RAF inhibitor,BRAF|RAF1,BRD-K05804044,AZ-628,RAF inhibitor,BRAF|RAF1,BRD-K05804044,AZ-628,RAF inhibitor,BRAF|RAF1,BRD-K05804044,AZ-628,RAF inhibitor,BRAF|RAF1
ZGGNJJJYUVRADP,BRD-K07507905,BRL-37344,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K07507905,BRL-37344,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K07507905,BRL-37344,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,BRD-K07507905,BRL-37344,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3
ZGLHBRQAEXKACO,BRD-K84163249,ercalcitriol,vitamin D receptor agonist,VDR,BRD-K84163249,ercalcitriol,vitamin D receptor agonist,VDR,BRD-K84163249,ercalcitriol,vitamin D receptor agonist,VDR,BRD-K84163249,ercalcitriol,vitamin D receptor agonist,VDR
ZGRDYKFVDCFJCZ,BRD-K82894950,AZD8835,PI3K inhibitor,PIK3CA|PIK3CD,BRD-K82894950,AZD8835,PI3K inhibitor,PIK3CA|PIK3CD,BRD-K82894950,AZD8835,PI3K inhibitor,PIK3CA|PIK3CD,BRD-K82894950,AZD8835,PI3K inhibitor,PIK3CA|PIK3CD
ZGSDGGRVFIYKKE,BRD-K77552740,tiquizium,acetylcholine receptor antagonist,,BRD-K77552740,tiquizium,acetylcholine receptor antagonist,,BRD-K77552740,tiquizium,acetylcholine receptor antagonist,,BRD-K77552740,tiquizium,acetylcholine receptor antagonist,
ZGSXEXBYLJIOGF,BRD-K61314889,endo-IWR-1,PARP inhibitor,TNKS|TNKS2,BRD-K61314889|BRD-K96155658|BRD-M14816435,endo-IWR-1|exo-IWR-1,PARP inhibitor|WNT signaling inhibitor negative control,TNKS|TNKS2,BRD-K27544219|BRD-K61314889|BRD-K96155658|BRD-M14816435,endo-IWR-1|exo-IWR-1,PARP inhibitor|WNT signaling inhibitor negative control,TNKS|TNKS2,BRD-K27544219|BRD-K61314889|BRD-K96155658|BRD-M14816435,endo-IWR-1|exo-IWR-1,PARP inhibitor|WNT signaling inhibitor negative control,TNKS|TNKS2
ZGUGWUXLJSTTMA,BRD-K06980535,promazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C,BRD-K06980535,promazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C,BRD-K06980535,promazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C,BRD-K06980535,promazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C
ZGXJTSGNIOSYLO,BRD-K57631554,5-aminolevulinic-acid,oxidizing agent,ALAD,BRD-K57631554,5-aminolevulinic-acid,oxidizing agent,ALAD,BRD-K57631554,5-aminolevulinic-acid,oxidizing agent,ALAD,BRD-K57631554,5-aminolevulinic-acid,oxidizing agent,ALAD
ZHJGWYRLJUCMRT,BRD-K92428232,GSK461364,PLK inhibitor,PLK1,BRD-K92428232,GSK461364,PLK inhibitor,PLK1,BRD-K92428232,GSK461364,PLK inhibitor,PLK1,BRD-K92428232,GSK461364,PLK inhibitor,PLK1
ZHQRPIRGSWEALJ,BRD-K71266197,PSB-06126,NTPDase inhibitor,ENTPD3,BRD-K71266197,PSB-06126,NTPDase inhibitor,ENTPD3,BRD-K71266197,PSB-06126,NTPDase inhibitor,ENTPD3,BRD-K71266197,PSB-06126,NTPDase inhibitor,ENTPD3
ZHUJMSMQIPIPTF,BRD-K57927309,BW-180C,opioid receptor agonist,OPRD1|OPRM1,BRD-K57927309,BW-180C,opioid receptor agonist,OPRD1|OPRM1,BRD-K57927309,BW-180C,opioid receptor agonist,OPRD1|OPRM1,BRD-K00003548,BW-180C,opioid receptor agonist,OPRD1|OPRM1
ZHVWWEYETMPAMX,BRD-A19102171,naltriben,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A19102171,naltriben,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-A19102171,naltriben,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,BRD-K81275354,naltriben,opioid receptor antagonist,OPRD1|OPRK1|OPRM1
ZHXRDXTYPCPBTI,BRD-K60241851,isodibut,aldehyde reductase inhibitor,,BRD-K60241851,isodibut,aldehyde reductase inhibitor,,BRD-K60241851,isodibut,aldehyde reductase inhibitor,,BRD-K60241851,isodibut,aldehyde reductase inhibitor,
ZIEWSZYVEDTXGH,BRD-K04552268,4-pyrimidinecarbonitrile,,,BRD-K04552268,4-pyrimidinecarbonitrile,,,BRD-K04552268,4-pyrimidinecarbonitrile,,,BRD-K04552268,4-pyrimidinecarbonitrile,,
ZIGMMUKDYCABPW,BRD-K80778372,Ro-19-4605,,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K80778372,Ro-19-4605,,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K80778372,Ro-19-4605,,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K80778372,Ro-19-4605,GABA benzodiazepine site receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5
ZIIQCSMRQKCOCT,BRD-A67006024,SNAP,nitric oxide donor,PTPN1,BRD-A67006024,SNAP,nitric oxide donor,PTPN1,BRD-A67006024,SNAP,nitric oxide donor,PTPN1,,,,
ZIIUUSVHCHPIQD,BRD-K09635314,m-3M3FBS,,PLCB2|PLCB3|PLCD1|PLCG1|PLCG2,BRD-K09635314,m-3M3FBS,,PLCB2|PLCB3|PLCD1|PLCG1|PLCG2,BRD-K09635314,m-3M3FBS,,PLCB2|PLCB3|PLCD1|PLCG1|PLCG2,BRD-K09635314,m-3M3FBS,phospholipase activator,PLCB2|PLCB3|PLCD1|PLCG1|PLCG2
ZIJKGAXBCRWEOL,BRD-K01294196,sucrose-octaacetate,,,BRD-K01294196,sucrose-octaacetate,,,BRD-K01294196,sucrose-octaacetate,,,BRD-K01294196,sucrose-octaacetate,,
ZIMGGGWCDYVHOY,BRD-K14888893,minoxidil,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,BRD-K14888893,minoxidil,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,,,,,,,,
ZINFAXPQMLDEEJ,BRD-K02689172|BRD-K37910175,cefoselis,bacterial cell wall synthesis inhibitor,,BRD-K02689172|BRD-K37910175|BRD-K72339976,cefoselis,bacterial cell wall synthesis inhibitor,,BRD-K02689172|BRD-K20284063|BRD-K37910175|BRD-K72339976,cefoselis,bacterial cell wall synthesis inhibitor,,BRD-K02689172|BRD-K20284063|BRD-K37910175|BRD-K72339976,cefoselis,bacterial cell wall synthesis inhibitor,
ZISSAWUMDACLOM,BRD-K19427720,triptan,serotonin receptor agonist,HTR1B|HTR1D,BRD-K19427720,triptan,serotonin receptor agonist,HTR1B|HTR1D,BRD-K19427720,triptan,serotonin receptor agonist,HTR1B|HTR1D,BRD-K19427720,triptan,serotonin receptor agonist,HTR1B|HTR1D
ZIUDADZJCKGWKR,BRD-K02554563,PF-05190457,growth hormone secretagogue receptor inverse agonist,GHSR,BRD-K02554563,PF-05190457,growth hormone secretagogue receptor inverse agonist,GHSR,BRD-K02554563,PF-05190457,growth hormone secretagogue receptor inverse agonist,GHSR,BRD-K02554563,PF-05190457,growth hormone secretagogue receptor inverse agonist,GHSR
ZJAOAACCNHFJAH,BRD-K85146014,foscarnet,DNA polymerase inhibitor,,BRD-K85146014,foscarnet,DNA polymerase inhibitor,,BRD-K85146014,foscarnet,DNA polymerase inhibitor,,BRD-K85146014,foscarnet,DNA polymerase inhibitor,
ZJDCGVDEEHWEIG,BRD-A51078674,diclofensine,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,BRD-A51078674,diclofensine,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,BRD-A51078674,diclofensine,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,BRD-A51078674,diclofensine,dopamine reuptake inhibitor,DRD1|MAOA|MAOB
ZJDOESGVOWAULF,BRD-K02342990|BRD-K73771095,geniposidic-acid,cyclooxygenase inhibitor,,BRD-K73771095,geniposidic-acid,cyclooxygenase inhibitor,,BRD-K02342990|BRD-K73771095,geniposidic-acid,cyclooxygenase inhibitor,,BRD-K02342990|BRD-K73771095,geniposidic-acid,cyclooxygenase inhibitor,
ZJJXGWJIGJFDTL,BRD-K12219985,glipizide,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,BRD-K12219985,glipizide,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,BRD-K12219985,glipizide,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,BRD-K12219985,glipizide,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG
ZJKNESGOIKRXQY,BRD-K21152241,enoximone,phosphodiesterase inhibitor,PDE3A,BRD-K21152241,enoximone,phosphodiesterase inhibitor,PDE3A,BRD-K21152241,enoximone,phosphodiesterase inhibitor,PDE3A,BRD-K21152241,enoximone,phosphodiesterase inhibitor,PDE3A
ZJQHPWUVQPJPQT,BRD-K60441002,muscimol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,BRD-K60441002,muscimol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,BRD-K60441002,muscimol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,BRD-K60441002,muscimol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3
ZJRCIQAMTAINCB,BRD-K87573013,CL-225385,,,BRD-K87573013,CL-225385,,,BRD-K87573013,CL-225385,,,BRD-K87573013,CL-225385,,
ZJVFLBOZORBYFE,BRD-K16444452,ibudilast,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-K16444452,ibudilast,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-K16444452,ibudilast,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,BRD-K16444452,ibudilast,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A
ZKDXRFMOHZVXSG,BRD-K41564320,purvalanol-b,tyrosine kinase inhibitor,CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2,BRD-K41564320,purvalanol-b,tyrosine kinase inhibitor,CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2,BRD-K41564320,purvalanol-b,tyrosine kinase inhibitor,CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2,BRD-K41564320,purvalanol-B,tyrosine kinase inhibitor,CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2
ZKFQEACEUNWPMT,BRD-A01098288,azelnidipine,calcium channel blocker,CACNA1C,BRD-A01098288,azelnidipine,calcium channel blocker,CACNA1C,BRD-A01098288,azelnidipine,calcium channel blocker,CACNA1C,BRD-A01098288,azelnidipine,calcium channel blocker,CACNA1C
ZKHQWZAMYRWXGA,BRD-A31990649|BRD-A76560018,adenosine-triphosphate,adenosine receptor agonist,ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7,BRD-A31990649|BRD-A76560018,adenosine-triphosphate,adenosine receptor agonist,ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7,BRD-A31990649|BRD-A48310747|BRD-A76560018,adenosine-triphosphate,adenosine receptor agonist,ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7,BRD-K00003709,adenosine-triphosphate,adenosine receptor agonist,ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7
ZKIAIYBUSXZPLP,BRD-K00911143,brexpiprazole,dopamine receptor partial agonist,DRD2,BRD-K00911143,brexpiprazole,dopamine receptor partial agonist,DRD2,BRD-K00911143,brexpiprazole,dopamine receptor partial agonist,DRD2,BRD-K00911143,brexpiprazole,dopamine receptor partial agonist,DRD2
ZKLPARSLTMPFCP,BRD-A42571354|BRD-K27184429,cetirizine|levocetirizine,histamine receptor antagonist,HRH1,BRD-A42571354|BRD-K27184429,cetirizine|levocetirizine,histamine receptor antagonist,HRH1,BRD-A42571354|BRD-K18097163|BRD-K27184429,cetirizine|levocetirizine,histamine receptor antagonist,HRH1,BRD-K01826520|BRD-K18097163|BRD-K27184429,cetirizine|levocetirizine,histamine receptor antagonist,HRH1
ZKMNUMMKYBVTFN,BRD-K50938786,ropivacaine,sodium channel blocker,SCN10A,BRD-K50938786,ropivacaine,sodium channel blocker,SCN10A,BRD-K50938786,ropivacaine,sodium channel blocker,SCN10A,BRD-K50938786,ropivacaine,sodium channel blocker,SCN10A
ZKWQQXZUCOBISE,BRD-A91366704,eprinomectin,benzodiazepine receptor agonist,,BRD-A91366704,eprinomectin,benzodiazepine receptor agonist,,BRD-A91366704,eprinomectin,benzodiazepine receptor agonist,,BRD-K00003555,eprinomectin,benzodiazepine receptor agonist,
ZKXZLIFRWWKZRY,BRD-K70446295,EPZ015666,protein arginine N-methyltransferase inhibitor,PRMT5,BRD-K70446295,EPZ015666,protein arginine N-methyltransferase inhibitor,PRMT5,BRD-K70446295,EPZ015666,protein arginine N-methyltransferase inhibitor,PRMT5,BRD-K70446295,EPZ015666,protein arginine N-methyltransferase inhibitor,PRMT5
ZKZXNDJNWUTGDK,BRD-K27737647,H-89,PKA inhibitor,GSG2|PKIA|PRKACA,BRD-K27737647,H-89,PKA inhibitor,GSG2|PKIA|PRKACA,BRD-K27737647,H-89,PKA inhibitor,GSG2|PKIA|PRKACA,BRD-K27737647,H-89,PKA inhibitor,GSG2|PKIA|PRKACA
ZLHFILGSQDJULK,BRD-K75295174,alisertib,Aurora kinase inhibitor,AURKA,BRD-K75295174,alisertib,Aurora kinase inhibitor,AURKA,BRD-K75295174,alisertib,Aurora kinase inhibitor,AURKA,BRD-K75295174,alisertib,Aurora kinase inhibitor,AURKA
ZLHNYULRKIEGAY,BRD-K38145871,PDE10-IN-1,phosphodiesterase inhibitor,PDE10A,BRD-K38145871,PDE10-IN-1,phosphodiesterase inhibitor,PDE10A,BRD-K38145871,PDE10-IN-1,phosphodiesterase inhibitor,PDE10A,BRD-K38145871,PDE10-IN-1,phosphodiesterase inhibitor,PDE10A
ZLHZLMOSPGACSZ,BRD-K96671969,PA-824,nitric oxide donor,FASN,BRD-K96671969,PA-824,nitric oxide donor,FASN,BRD-K96671969,PA-824,nitric oxide donor,FASN,BRD-K96671969,pretomanid,nitric oxide donor,FASN
ZLKSFXYIUFVQRH,BRD-M82226456,lobeline,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2,BRD-M82226456,lobeline,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2,,,,,,,,
ZLVXBBHTMQJRSX,BRD-K95837862,JDTic,opioid receptor antagonist,OPRK1,BRD-K95837862,JDTic,opioid receptor antagonist,OPRK1,BRD-K95837862,JDTic,opioid receptor antagonist,OPRK1,BRD-K95837862,JDTic,opioid receptor antagonist,OPRK1
ZMELOYOKMZBMRB,BRD-K17555800,talmapimod,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K17555800,talmapimod,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K17555800,talmapimod,p38 MAPK inhibitor,MAPK11|MAPK14,BRD-K17555800,talmapimod,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF
ZMEULISFKSVRLQ,BRD-A26503646|BRD-A87468186,formestane,aromatase inhibitor,CYP19A1,BRD-A26503646|BRD-A87468186,formestane,aromatase inhibitor,CYP19A1,BRD-A26503646|BRD-A87468186,formestane,aromatase inhibitor,CYP19A1,BRD-A26503646|BRD-A87468186,formestane,aromatase inhibitor,CYP19A1
ZMISODWVFHHWNR,BRD-K97061094,azacyclonol,histamine receptor antagonist,HRH1,BRD-K97061094,azacyclonol,histamine receptor antagonist,HRH1,BRD-K97061094,azacyclonol,histamine receptor antagonist,HRH1,BRD-K97061094,azacyclonol,histamine receptor antagonist,HRH1
ZMXBIIQMSGOIRZ,BRD-K88165431,integrin-antagonist-1,integrin antagonist,ITGAV|ITGB6,BRD-K88165431,integrin-antagonist-1,integrin antagonist,ITGAV|ITGB6,BRD-K88165431,integrin-antagonist-1,integrin antagonist,ITGAV|ITGB6,BRD-K88165431,integrin-antagonist-1,integrin antagonist,ITGAV|ITGB6
ZNAPADWWBWFMCQ,BRD-K20714604,RS-56812,serotonin receptor partial agonist,HTR3A,BRD-K20714604,RS-56812,serotonin receptor partial agonist,HTR3A,BRD-K20714604,RS-56812,serotonin receptor partial agonist,HTR3A,BRD-K00004219,RS-56812,serotonin receptor partial agonist,HTR3A
ZNEWHQLOPFWXOF,BRD-K49954789,mesna,antioxidant,,BRD-K49954789,mesna,antioxidant,,BRD-K49954789|BRD-M40783228,mesna,antioxidant,,BRD-K49954789|BRD-M40783228,mesna,antioxidant,
ZNFMHLDBJPAFEQ,BRD-K95600043,NPY-5RA972,neuropeptide receptor antagonist,NPY5R,BRD-K95600043,NPY-5RA972,neuropeptide receptor antagonist,NPY5R,BRD-K95600043,NPY-5RA972,neuropeptide receptor antagonist,NPY5R,BRD-K95600043,NPY-5RA972,neuropeptide receptor antagonist,NPY5R
ZNLVYSJQUMALEO,BRD-K45519571,RN-1747,TRPV agonist,TRPV4,BRD-K45519571,RN-1747,TRPV agonist,TRPV4,BRD-K45519571,RN-1747,TRPV agonist,TRPV4,BRD-K45519571,RN-1747,TRPV agonist,TRPV4
ZNNLBTZKUZBEKO,BRD-K36927236,glyburide,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,BRD-K36927236,glyburide,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,BRD-K36927236,glyburide,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,BRD-K36927236,glyburide,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1
ZNOVTXRBGFNYRX,BRD-K28580965,metafolin,,AMT,BRD-K28580965,metafolin,,AMT,BRD-K28580965,metafolin,,AMT,BRD-K28580965,metafolin,,
ZNSIZMQNQCNRBW,BRD-M22581557,sevelamer,phosphate antagonist,,BRD-M22581557,sevelamer,phosphate antagonist,,BRD-M22581557,sevelamer,phosphate antagonist,,,,,
ZNSVOHSYDRPBGI,BRD-K94420399,PF-04136309,CC chemokine receptor antagonist,,BRD-K94420399,PF-04136309,CC chemokine receptor antagonist,,BRD-K94420399,PF-04136309,CC chemokine receptor antagonist,,BRD-K94420399,PF-04136309,CC chemokine receptor antagonist,
ZOBKPJRHDMKXQG,BRD-K91874254,CBS-1114,lipoxygenase inhibitor,ALOX5,BRD-K91874254,CBS-1114,lipoxygenase inhibitor,ALOX5,BRD-K91874254,CBS-1114,lipoxygenase inhibitor,ALOX5,BRD-K91874254,CBS-1114,lipoxygenase inhibitor,ALOX5
ZOCKGBMQLCSHFP,BRD-K72951360,valrubicin,DNA inhibitor|topoisomerase inhibitor,TOP2A,BRD-K72951360,valrubicin,DNA inhibitor|topoisomerase inhibitor,TOP2A,BRD-K72951360,valrubicin,DNA inhibitor|topoisomerase inhibitor,TOP2A,BRD-K72951360,valrubicin,DNA inhibitor|topoisomerase inhibitor,TOP2A
ZOCSXAVNDGMNBV,BRD-A50675702,fipronil,GABA gated chloride channel blocker|chloride channel blocker,,BRD-A50675702,fipronil,GABA gated chloride channel blocker|chloride channel blocker,,BRD-A50675702,fipronil,GABA gated chloride channel blocker|chloride channel blocker,,BRD-A50675702,fipronil,GABA gated chloride channel blocker|chloride channel blocker,
ZOCUOMKMBMEYQV,BRD-K29173907,isoflupredone-acetate,,NR3C1,BRD-K29173907,isoflupredone-acetate,,NR3C1,BRD-K29173907,isoflupredone-acetate,,NR3C1,BRD-K29173907,isoflupredone-acetate,,NR3C1
ZODSPDOOCZZEIM,BRD-A89672324,CGP-55845,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A89672324,CGP-55845,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-A89672324,CGP-55845,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,BRD-K00004232,CGP-55845,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8
ZOIBZSZLMJDVDQ,BRD-K57754230,EPZ005687,histone lysine methyltransferase inhibitor,EZH2,BRD-K57754230,EPZ005687,histone lysine methyltransferase inhibitor,EZH2,BRD-K57754230,EPZ005687,histone lysine methyltransferase inhibitor,EZH2,BRD-K57754230,EPZ005687,histone lysine methyltransferase inhibitor,EZH2
ZOJBYZNEUISWFT,BRD-K33219225,allylisothiocyanate,TRPV agonist,TRPA1,BRD-K33219225,allylisothiocyanate,TRPV agonist,TRPA1,BRD-K33219225,allylisothiocyanate,TRPV agonist,TRPA1,BRD-K33219225,allylisothiocyanate,TRPV agonist,TRPA1
ZOPBZHLJXQAQON,BRD-A75975749,bafetinib,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,ABL1|BCR|LYN,BRD-A75975749,bafetinib,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,ABL1|BCR|LYN,BRD-A75975749,bafetinib,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,ABL1|BCR|LYN,,,,
ZOPNBMMVVZRSGH,BRD-K43802723,AMG-837,free fatty acid receptor agonist,FFAR1,BRD-K43802723,AMG-837,free fatty acid receptor agonist,FFAR1,BRD-K43802723|BRD-M56591481,AMG-837,free fatty acid receptor agonist,FFAR1,BRD-K43802723|BRD-M56591481,AMG-837,free fatty acid receptor agonist,FFAR1
ZOWYFYXTIWQBEP,BRD-K36756879,ethaverine,calcium channel blocker,,BRD-K36756879,ethaverine,calcium channel blocker,,BRD-K36756879,ethaverine,calcium channel blocker,,BRD-K36756879,ethaverine,calcium channel blocker,
ZPACYDRSPFRDHO,BRD-K02780233,geranyl-farnesylacetate,mucin production enhancer,,BRD-K02780233,geranyl-farnesylacetate,mucin production enhancer,,BRD-K02780233,geranyl-farnesylacetate,mucin production enhancer,,BRD-K02780233,geranyl-farnesylacetate,mucin production enhancer,
ZPAKPRAICRBAOD,BRD-K12513978,fenbufen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K12513978,fenbufen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K12513978,fenbufen,cyclooxygenase inhibitor,PTGS1|PTGS2,BRD-K12513978,fenbufen,cyclooxygenase inhibitor,PTGS1|PTGS2
ZPANWZBSGMDWON,BRD-K73524797,ST-1859,antiamyloidogenic agent,,BRD-K73524797,ST-1859,antiamyloidogenic agent,,BRD-K73524797,ST-1859,antiamyloidogenic agent,,BRD-K73524797,ST-1859,antiamyloidogenic agent,
ZPBLNADJHWHOEP,BRD-K01773083,denotivir,antiviral,,BRD-K01773083,denotivir,antiviral,,BRD-K01773083,denotivir,antiviral,,BRD-K01773083,denotivir,antiviral,
ZPBYVFQJHWLTFB,BRD-K81647657,3-methyladenine,PI3K inhibitor,PI3,BRD-K81647657,3-methyladenine,PI3K inhibitor,PI3,BRD-K81647657,3-methyladenine,PI3K inhibitor,PI3,BRD-K81647657,3-methyladenine,PI3K inhibitor,PI3
ZPDFIIGFYAHNSK,BRD-A67181951,gadobutrol,radiopaque medium,,BRD-A67181951,gadobutrol,radiopaque medium,,BRD-A67181951|BRD-M08398761,gadobutrol,radiopaque medium,,BRD-K00003579,gadobutrol,radiopaque medium,
ZPEIMTDSQAKGNT,BRD-K89997465,chlorpromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,BRD-K89997465,chlorpromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,BRD-K89997465,chlorpromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,BRD-K89997465,chlorpromazine,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5
ZPFXAOWNKLFJDN,BRD-K89055274,alverine,muscle relaxant,HTR1A,BRD-K89055274,alverine,muscle relaxant,HTR1A,BRD-K89055274,alverine,muscle relaxant,HTR1A,BRD-K89055274,alverine,muscle relaxant,HTR1A
ZPLQIPFOCGIIHV,BRD-K35687421,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD,BRD-K35687421,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD,BRD-K35687421,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD,BRD-K35687421,gimeracil,dihydropyrimidine dehydrogenase inhibitor,DPYD
ZPMNHBXQOOVQJL,BRD-K33681278,prucalopride,serotonin receptor agonist,HTR4,BRD-K33681278,prucalopride,serotonin receptor agonist,HTR4,BRD-K33681278,prucalopride,serotonin receptor agonist,HTR4,BRD-K33681278,prucalopride,serotonin receptor agonist,HTR4
ZPPSNKXLCHJTDP,BRD-M29626677,netilmicin,protein synthesis inhibitor,,,,,,,,,,,,,
ZPXCEHMKUTXHRZ,BRD-K26305185,K-Ras(G12C)-inhibitor-6,K-ras inhibitor,,BRD-K26305185,K-Ras(G12C)-inhibitor-6,K-ras inhibitor,,BRD-K26305185,K-Ras(G12C)-inhibitor-6,K-ras inhibitor,,BRD-K26305185,K-Ras(G12C)-inhibitor-6,K-Ras inhibitor,
ZPXSCAKFGYXMGA,BRD-A68464583,mazindol,dopamine reuptake inhibitor|selective serotonin reuptake inhibitor (SSRI),SLC6A2|SLC6A3|SLC6A4,BRD-A68464583,mazindol,dopamine reuptake inhibitor|selective serotonin reuptake inhibitor (SSRI),SLC6A2|SLC6A3|SLC6A4,BRD-A68464583,mazindol,dopamine reuptake inhibitor|selective serotonin reuptake inhibitor (SSRI),SLC6A2|SLC6A3|SLC6A4,,,,
ZQBAKBUEJOMQEX,BRD-K44091963,phenyl-salicylate,antiseptic,,BRD-K44091963,phenyl-salicylate,antiseptic,,BRD-K44091963,phenyl-salicylate,antiseptic,,BRD-K44091963,phenyl-salicylate,antiseptic,
ZQDWXGKKHFNSQK,BRD-A62428732,hydroxyzine,antihistamine,HRH1,BRD-A62428732,hydroxyzine,antihistamine,HRH1,BRD-A62428732,hydroxyzine,antihistamine,HRH1,BRD-K01826510,hydroxyzine,antihistamine,HRH1
ZQHFZHPUZXNPMF,BRD-K22421059,ebrotidine,histamine receptor antagonist,HRH2,BRD-K22421059,ebrotidine,histamine receptor antagonist,HRH2,BRD-K22421059,ebrotidine,histamine receptor antagonist,HRH2,BRD-K22421059,ebrotidine,histamine receptor antagonist,HRH2
ZQPXSRTZFYHSFB,BRD-A28958257,centpropazine,inositol monophosphatase inhibitor,,BRD-A28958257,centpropazine,inositol monophosphatase inhibitor,,BRD-A28958257,centpropazine,inositol monophosphatase inhibitor,,BRD-A28958257,centpropazine,inositol monophosphatase inhibitor,
ZQSIJRDFPHDXIC,BRD-K42095107,daidzein,estrogen receptor agonist,ESRRA|ESRRB|ESRRG|TRPC5,BRD-K42095107,daidzein,estrogen receptor agonist,ESRRA|ESRRB|ESRRG|TRPC5,BRD-K42095107,daidzein,estrogen receptor agonist,ESRRA|ESRRB|ESRRG|TRPC5,BRD-K42095107,daidzein,estrogen receptor agonist,ESRRA|ESRRB|ESRRG|TRPC5
ZQTNQVWKHCQYLQ,BRD-K05524748,dronedarone,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,BRD-K05524748,dronedarone,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,BRD-K05524748,dronedarone,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,BRD-K05524748,dronedarone,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A
ZQUSFAUAYSEREK,BRD-K82091397,SB-239063,p38 MAPK inhibitor,MAPK11|MAPK14|PTGS2,BRD-K82091397,SB-239063,p38 MAPK inhibitor,MAPK11|MAPK14|PTGS2,BRD-K82091397,SB-239063,p38 MAPK inhibitor,MAPK11|MAPK14|PTGS2,BRD-K82091397,SB-239063,p38 MAPK inhibitor,MAPK11|MAPK14|PTGS2
ZQWBOKJVVYNKTL,BRD-K53263234,CITCO,constitutive androstane receptor (CAR) agonist,NR1I3,BRD-K53263234,CITCO,constitutive androstane receptor (CAR) agonist,NR1I3,BRD-K53263234,CITCO,constitutive androstane receptor (CAR) agonist,NR1I3,BRD-K53263234,CITCO,constitutive androstane receptor (CAR) agonist,NR1I3
ZQZFYGIXNQKOAV,BRD-K38477637,droloxifene,selective estrogen receptor modulator (SERM),ESR1,BRD-K38477637,droloxifene,selective estrogen receptor modulator (SERM),ESR1,BRD-K38477637,droloxifene,selective estrogen receptor modulator (SERM),ESR1,BRD-K38477637,droloxifene,selective estrogen receptor modulator (SERM),ESR1
ZRALSGWEFCBTJO,BRD-K76037122,guanidine,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,BRD-K76037122,guanidine,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,BRD-K76037122|BRD-M47712611,guanidine,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,BRD-K76037122|BRD-M47712611,guanidine,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1
ZRCVYEYHRGVLOC,BRD-A40787240,gemifloxacin,bacterial DNA gyrase inhibitor,,BRD-A40787240,gemifloxacin,bacterial DNA gyrase inhibitor,,BRD-A40787240,gemifloxacin,bacterial DNA gyrase inhibitor,,BRD-A40787240,gemifloxacin,bacterial DNA gyrase inhibitor,
ZREIPSZUJIFJNP,BRD-K80528473,bismuth-subsalicylate,antacid,,BRD-K80528473,bismuth-subsalicylate,antacid,,BRD-K80528473|BRD-M10663475,bismuth-subsalicylate,antacid,,BRD-K80528473|BRD-M10663475,bismuth-subsalicylate,antacid,
ZRJBHWIHUMBLCN,BRD-K45888792|BRD-K97618845,huperzine-a,acetylcholinesterase inhibitor,ACHE,BRD-K45888792|BRD-K97618845,huperzine-a,acetylcholinesterase inhibitor,ACHE,BRD-K45888792|BRD-K62240499|BRD-K97618845,huperzine-a,acetylcholinesterase inhibitor,ACHE,BRD-K45888792|BRD-K62240499|BRD-K97618845,huperzine-A,acetylcholinesterase inhibitor,ACHE
ZRRGOUHITGRLBA,BRD-K17061841,stattic,,,BRD-K17061841,stattic,,,BRD-K17061841,stattic,,,BRD-K17061841,stattic,,
ZRTQSJFIDWNVJW,BRD-A54275602,lanoconazole,sterol demethylase inhibitor,,BRD-A54275602,lanoconazole,sterol demethylase inhibitor,,BRD-A54275602,lanoconazole,sterol demethylase inhibitor,,BRD-A54275602,lanoconazole,sterol demethylase inhibitor,
ZRVAAGAZUWXRIP,BRD-K75385383,DIPT,dopamine reuptake inhibitor|serotonin reuptake inhibitor,HTR1A|HTR2A|HTR2C,BRD-K75385383,DIPT,dopamine reuptake inhibitor|serotonin reuptake inhibitor,HTR1A|HTR2A|HTR2C,BRD-K75385383,DIPT,dopamine reuptake inhibitor|serotonin reuptake inhibitor,HTR1A|HTR2A|HTR2C,BRD-K75385383,DIPT,dopamine reuptake inhibitor|serotonin reuptake inhibitor,HTR1A|HTR2A|HTR2C
ZSBOMTDTBDDKMP,BRD-A27084604|BRD-K83003151,alogliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A27084604|BRD-K83003151,alogliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-A27084604|BRD-K83003151,alogliptin,dipeptidyl peptidase inhibitor,DPP4,BRD-K83003151,alogliptin,dipeptidyl peptidase inhibitor,DPP4
ZSBXGIUJOOQZMP,BRD-K25312248,matrine,opioid receptor agonist,OPRK1,BRD-K25312248,matrine,opioid receptor agonist,OPRK1,BRD-K25312248,matrine,opioid receptor agonist,OPRK1,BRD-K08623988,matrine,opioid receptor agonist,OPRK1
ZSCDBOWYZJWBIY,BRD-A19195498,trimipramine,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR1D|HTR2A|HTR2C|HTR3A|SLC6A2|SLC6A3|SLC6A4,BRD-A19195498,trimipramine,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR1D|HTR2A|HTR2C|HTR3A|SLC6A2|SLC6A3|SLC6A4,BRD-A19195498,trimipramine,norepinephrine reputake inhibitor|tricyclic antidepressant,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR1D|HTR2A|HTR2C|HTR3A|SLC6A2|SLC6A3|SLC6A4,BRD-K01825162,trimipramine,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4
ZSDCIRYNTCVTMF,BRD-K54936858,DMP-777,elastase inhibitor,MPO,BRD-K54936858,DMP-777,elastase inhibitor,MPO,BRD-K54936858,DMP-777,elastase inhibitor,MPO,BRD-K54936858,DMP-777,elastase inhibitor,MPO
ZSJLQEPLLKMAKR,BRD-A25576662|BRD-K34411947,streptozotocin,DNA alkylating agent,SLC2A2,BRD-A25576662|BRD-K34411947,streptozotocin,DNA alkylating agent,SLC2A2,BRD-A25576662|BRD-A94713674|BRD-K34411947,streptozotocin,DNA alkylating agent,SLC2A2,,,,
ZSJNJAJDBNFVCA,BRD-K39160765,4-chlorophenylguanidine,urokinase inhibitor,PLAUR,BRD-K39160765,4-chlorophenylguanidine,urokinase inhibitor,PLAUR,BRD-K39160765,4-chlorophenylguanidine,urokinase inhibitor,PLAUR,BRD-K39160765,4-chlorophenylguanidine,urokinase inhibitor,PLAUR
ZSKVGTPCRGIANV,BRD-K23200955,imipenem,bacterial cell wall synthesis inhibitor,,BRD-K23200955,imipenem,bacterial cell wall synthesis inhibitor,,BRD-K23200955,imipenem,bacterial cell wall synthesis inhibitor,,BRD-K23200955,imipenem,bacterial cell wall synthesis inhibitor,
ZSTCZWJCLIRCOJ,BRD-K42816473|BRD-K85285268,RU-42173|zilpaterol,adrenergic receptor agonist,ADRB2,BRD-K42816473|BRD-K85285268,RU-42173|zilpaterol,adrenergic receptor agonist,ADRB2,BRD-K42816473|BRD-K85285268,RU-42173|zilpaterol,adrenergic receptor agonist,ADRB2,BRD-K42816473|BRD-K85285268,RU-42173|zilpaterol,adrenergic receptor agonist,ADRB2
ZSZFUDFOPOMEET,BRD-A06426627,diclazuril,antiprotozoal agent,,BRD-A06426627,diclazuril,antiprotozoal agent,,BRD-A06426627,diclazuril,antiprotozoal agent,,BRD-A06426627,diclazuril,antiprotozoal agent,
ZTCJXHNJVLUUMR,BRD-K25690923,4-iodo-6-phenylpyrimidine,macrophage migration inhibiting factor inhibitor,MIF,BRD-K25690923,4-iodo-6-phenylpyrimidine,macrophage migration inhibiting factor inhibitor,MIF,BRD-K25690923,4-iodo-6-phenylpyrimidine,macrophage migration inhibiting factor inhibitor,MIF,BRD-K25690923,4-iodo-6-phenylpyrimidine,macrophage migration inhibiting factor inhibitor,MIF
ZTFBIUXIQYRUNT,BRD-K19061412,mubritinib,protein tyrosine kinase inhibitor,EGFR|ERBB2,BRD-K19061412,mubritinib,protein tyrosine kinase inhibitor,EGFR|ERBB2,BRD-K19061412,mubritinib,protein tyrosine kinase inhibitor,EGFR|ERBB2,BRD-K19061412,mubritinib,protein tyrosine kinase inhibitor,EGFR|ERBB2
ZTQSADJAYQOCDD,BRD-K58775955|BRD-K75189747,gynostemma-extract,calcium channel modulator,,BRD-K58775955|BRD-K75189747,gynostemma-extract,calcium channel modulator,,BRD-K58775955|BRD-K75189747,gynostemma-extract,calcium channel modulator,,BRD-K58775955|BRD-K75189747,gynostemma-extract,calcium channel modulator,
ZTVIKZXZYLEVOL,BRD-A09539288|BRD-A35196708,homatropine|homatropine-bromide,acetylcholine receptor antagonist,|CES1|CHRM1,BRD-A09539288|BRD-A35196708,homatropine,acetylcholine receptor antagonist,CES1|CHRM1,BRD-A09539288|BRD-A35196708|BRD-A74975734,homatropine,acetylcholine receptor antagonist,CES1|CHRM1,BRD-A09539288|BRD-A35196708|BRD-K01826529,homatropine,acetylcholine receptor antagonist,CHRM1
ZUELZXZJXUXJCH,BRD-K91147684,m-THP,,,BRD-K91147684,m-THP,,,BRD-K91147684,m-THP,,,,,,
ZUHIXXCLLBMBDW,BRD-A66116161,AM-1241,cannabinoid receptor agonist,CNR1|CNR2,BRD-A66116161,AM-1241,cannabinoid receptor agonist,CNR1|CNR2,BRD-A66116161,AM-1241,cannabinoid receptor agonist,CNR1|CNR2,BRD-A66116161,AM-1241,cannabinoid receptor agonist,CNR1|CNR2
ZULJGOSFKWFVRX,BRD-K21123171,pramiracetam,acetylcholine receptor agonist,,BRD-K21123171,pramiracetam,acetylcholine receptor agonist,,BRD-K21123171,pramiracetam,acetylcholine receptor agonist,,BRD-K21123171,pramiracetam,acetylcholine receptor agonist,
ZUQBAQVRAURMCL,BRD-K66036108,lometrexol,glycinamide ribonucleotide formyltransferase inhibitor,GART|MTHFD1,BRD-K66036108,lometrexol,glycinamide ribonucleotide formyltransferase inhibitor,GART|MTHFD1,BRD-K66036108,lometrexol,glycinamide ribonucleotide formyltransferase inhibitor,GART|MTHFD1,BRD-K66036108,lometrexol,glycinamide ribonucleotide formyltransferase inhibitor,GART
ZUZPCOQWSYNWLU,BRD-A02473266,cevipabulin,microtubule stimulant|tubulin polymerization inhibitor,TUBB,BRD-A02473266,cevipabulin,microtubule stimulant|tubulin polymerization inhibitor,TUBB,BRD-A02473266,cevipabulin,microtubule stimulant|tubulin polymerization inhibitor,TUBB,BRD-K00003570,cevipabulin,microtubule stimulant|tubulin polymerization inhibitor,TUBB
ZVGNESXIJDCBKN,BRD-K57371763,fidaxomicin,RNA polymerase inhibitor,,BRD-K57371763,fidaxomicin,RNA polymerase inhibitor,,BRD-K57371763,fidaxomicin,RNA polymerase inhibitor,,BRD-K00003591,fidaxomicin,RNA polymerase inhibitor,
ZVHNDZWQTBEVRY,BRD-K87737963,cyt387,,JAK1|JAK2|JAK3,BRD-K87737963,cyt387,,JAK1|JAK2|JAK3,BRD-K87737963,cyt387,,JAK1|JAK2|JAK3,BRD-K87737963,cyt387,JAK inhibitor,JAK1|JAK2|JAK3
ZVNYJIZDIRKMBF,BRD-K13414800,vesnarinone,phosphodiesterase inhibitor,KCNH2|PDE3A,BRD-K13414800,vesnarinone,phosphodiesterase inhibitor,KCNH2|PDE3A,BRD-K13414800,vesnarinone,phosphodiesterase inhibitor,KCNH2|PDE3A,BRD-K13414800,vesnarinone,phosphodiesterase inhibitor,KCNH2|PDE3A
ZVPDNRVYHLRXLX,BRD-K47598052,PP-1,src inhibitor,HCK|RET,BRD-K47598052,PP-1,src inhibitor,HCK|RET,BRD-K47598052,PP-1,src inhibitor,HCK|RET,BRD-K47598052,PP-1,SRC inhibitor,HCK|RET
ZVQUCWXZCKWZBP,BRD-K41662846,tecalcet,calcium-sensing receptor agonist,CASR,BRD-K41662846,tecalcet,calcium-sensing receptor agonist,CASR,BRD-K41662846,tecalcet,calcium-sensing receptor agonist,CASR,BRD-K41662846,tecalcet,calcium-sensing receptor agonist,CASR
ZVTDLPBHTSMEJZ,BRD-K08111240,danoprevir,HCV inhibitor,,BRD-K08111240,danoprevir,HCV inhibitor,,BRD-K08111240,danoprevir,HCV inhibitor,,BRD-K08111240,danoprevir,HCV inhibitor,
ZVXBAHLOGZCFTP,BRD-K55166090,efloxate,vasodilator,,BRD-K55166090,efloxate,vasodilator,,BRD-K55166090,efloxate,vasodilator,,BRD-K55166090,efloxate,vasodilator,
ZVXNYZWXUADSRV,BRD-K04568635,octenidine,membrane integrity inhibitor,,BRD-K04568635,octenidine,membrane integrity inhibitor,,BRD-K04568635,octenidine,membrane integrity inhibitor,,BRD-K04568635,octenidine,membrane integrity inhibitor,
ZVYIJXLMBWCGHP,BRD-A14316475,SN-6,sodium/calcium exchange inhibitor,,BRD-A14316475,SN-6,sodium/calcium exchange inhibitor,,BRD-A14316475,SN-6,sodium/calcium exchange inhibitor,,BRD-K01825672,SN-6,sodium/calcium exchange inhibitor,
ZVYVPGLRVWUPMP,BRD-K92150287,exatecan-mesylate,topoisomerase inhibitor,TOP1,BRD-K92150287,exatecan-mesylate,topoisomerase inhibitor,TOP1,BRD-K92150287,exatecan-mesylate,topoisomerase inhibitor,TOP1,BRD-K92150287,exatecan-mesylate,topoisomerase inhibitor,TOP1
ZWAOHEXOSAUJHY,BRD-A68537732|BRD-K83057217,doxifluridine,thymidylate synthase inhibitor,TYMS,BRD-A68537732|BRD-K83057217,doxifluridine,thymidylate synthase inhibitor,TYMS,BRD-A68537732|BRD-K58262659|BRD-K83057217,doxifluridine,thymidylate synthase inhibitor,TYMS,BRD-A68537732|BRD-K58262659|BRD-K83057217,doxifluridine,thymidylate synthase inhibitor,TYMS
ZWAVGFSZMACJHA,BRD-K29133151,"ICI-185,282",,,BRD-K29133151,"ICI-185,282",thromboxane receptor antagonist,,BRD-K29133151,"ICI-185,282",thromboxane receptor antagonist,,BRD-K29133151,"ICI-185,282",thromboxane receptor antagonist,
ZWCXYZRRTRDGQE,BRD-A52977603,gramicidin,bacterial permeability inducer,,BRD-A52977603,gramicidin,bacterial permeability inducer,,BRD-A52977603,gramicidin,bacterial permeability inducer,,BRD-K45170529,gramicidin,bacterial permeability inducer,
ZWFKJFUFYPOTKL,BRD-K98710228,cot-inhibitor-1,MAPK-interacting kinase inhibitor,MAP3K8,BRD-K98710228,cot-inhibitor-1,MAPK-interacting kinase inhibitor,MAP3K8,BRD-K98710228,cot-inhibitor-1,MAPK-interacting kinase inhibitor,MAP3K8,BRD-K98710228,cot-inhibitor-1,MAPK-interacting kinase inhibitor,MAP3K8
ZWKJWVSEDISQIS,BRD-A18279961,TEPP-46,pyruvate kinase isozyme activator,PKM,BRD-A18279961,TEPP-46,pyruvate kinase isozyme activator,PKM,BRD-A18279961,TEPP-46,pyruvate kinase isozyme activator,PKM,BRD-K01826017,TEPP-46,pyruvate kinase isozyme activator,PKM
ZWNGSOLJLMBZFZ,BRD-K43647122,nerbacadol,cyclooxygenase inhibitor,,BRD-K43647122,nerbacadol,cyclooxygenase inhibitor,,BRD-K43647122,nerbacadol,cyclooxygenase inhibitor,,BRD-K43647122,nerbacadol,cyclooxygenase inhibitor,
ZWODABSNRKVFCK,BRD-K47169076,rhodamine-123,,,BRD-K47169076,rhodamine-123,,,BRD-K47169076,rhodamine-123,,,BRD-K47169076,rhodamine-123,,
ZWPODSUQWXAZNC,BRD-A65797496,deptropine,histamine receptor antagonist,HRH1,BRD-A65797496,deptropine,histamine receptor antagonist,HRH1,BRD-A65797496,deptropine,histamine receptor antagonist,HRH1,BRD-K00005351,deptropine,histamine receptor antagonist,HRH1
ZWRRJEICIPUPHZ,BRD-K18878288,schisandrol-b,lipid peroxidase inhibitor,,BRD-K18878288,schisandrol-b,lipid peroxidase inhibitor,,BRD-K18878288,schisandrol-b,lipid peroxidase inhibitor,,BRD-K18878288,schisandrol-B,lipid peroxidase inhibitor,
ZWVZORIKUNOTCS,BRD-K34581968,BMS-536924,IGF-1 inhibitor,AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB,BRD-K34581968,BMS-536924,IGF-1 inhibitor,AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB,BRD-K34581968,BMS-536924,IGF-1 inhibitor,AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB,BRD-K34581968,BMS-536924,IGF-1 inhibitor,AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB
ZWWMEDURALZMEV,BRD-K50653584,EG00229,neuropilin receptor antagonist,NRP1,BRD-K50653584,EG00229,neuropilin receptor antagonist,NRP1,BRD-K50653584,EG00229,neuropilin receptor antagonist,NRP1,BRD-K50653584,EG00229,neuropilin receptor antagonist,NRP1
ZXERDUOLZKYMJM,BRD-A75838038|BRD-K30968378,INT-747|obeticholic-acid,FXR agonist,|NR1H4,BRD-A75838038|BRD-K30968378,INT-747|obeticholic-acid,FXR agonist,|NR1H4,BRD-A75838038|BRD-K30968378,INT-747|obeticholic-acid,FXR agonist,|NR1H4,BRD-A75838038|BRD-K30968378,INT-747|obeticholic-acid,FXR agonist,|NR1H4
ZXFRFPSZAKNPQQ,BRD-K34313798,LY215490,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,BRD-K34313798,LY215490,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,BRD-K34313798,LY215490,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,BRD-K34313798,LY215490,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1
ZXNRTKGTQJPIJK,BRD-K88611939,aniracetam,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,BRD-K88611939,aniracetam,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,BRD-K88611939,aniracetam,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,BRD-K88611939,aniracetam,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A
ZXOBLNBVNROVLC,BRD-K54395039,PR-619,DUB inhibitor,,BRD-K54395039,PR-619,DUB inhibitor,,BRD-K54395039,PR-619,DUB inhibitor,,BRD-K54395039,PR-619,DUB inhibitor,
ZXRSVNHYTSSFMN,BRD-K56115039,BU226,imidazoline receptor ligand,,BRD-K56115039,BU226,imidazoline receptor ligand,,BRD-K56115039,BU226,imidazoline receptor ligand,,BRD-K56115039,BU226,imidazoline receptor ligand,
ZXRVKCBLGJOCEE,BRD-K89104321,gaboxadol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,BRD-K89104321,gaboxadol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,BRD-K89104321,gaboxadol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,BRD-K89104321,gaboxadol,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3
ZXSGSFMORAILEY,BRD-K56405978,TBA-354,,,BRD-K56405978,TBA-354,,,BRD-K56405978,TBA-354,,,BRD-K56405978,TBA-354,,
ZXUYYZPJUGQHLQ,BRD-A15435692,BMY-14802,sigma receptor antagonist,HTR1A,BRD-A15435692,BMY-14802,sigma receptor antagonist,HTR1A,BRD-A15435692,BMY-14802,sigma receptor antagonist,HTR1A,BRD-A15435692,BMY-14802,sigma receptor antagonist,HTR1A
ZXVNMYWKKDOREA,BRD-K81326768,zomepirac,prostaglandin synthesis inhibitor,PTGDR2,BRD-K81326768,zomepirac,prostaglandin synthesis inhibitor,PTGDR2,BRD-K81326768,zomepirac,prostaglandin synthesis inhibitor,PTGDR2,BRD-K81326768,zomepirac,prostaglandin synthesis inhibitor,PTGDR2
ZYGHJZDHTFUPRJ,BRD-K23913458,coumarin,vitamin K antagonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6,BRD-K23913458,coumarin,vitamin K antagonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6,BRD-K23913458,coumarin,vitamin K antagonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6,BRD-K23913458,coumarin,vitamin K antagonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6
ZYQXEVJIFYIBHZ,BRD-K80343549,TAK-285,EGFR inhibitor,ERBB2,BRD-K80343549,TAK-285,EGFR inhibitor,ERBB2,BRD-K80343549,TAK-285,EGFR inhibitor,ERBB2,BRD-K80343549,TAK-285,EGFR inhibitor,ERBB2
ZYRLHJIMTROTBO,BRD-A06916187,CPI-613,pyruvate dehydrogenase inhibitor,PDHA1,BRD-A06916187,CPI-613,pyruvate dehydrogenase inhibitor,PDHA1,BRD-A06916187,CPI-613,pyruvate dehydrogenase inhibitor,PDHA1,BRD-A06916187,CPI-613,pyruvate dehydrogenase inhibitor,PDHA1
ZYVXTMKTGDARKR,BRD-K80935598,AZ191,DYRK inhibitor,DYRK1B,BRD-K80935598,AZ191,DYRK inhibitor,DYRK1B,BRD-K80935598,AZ191,DYRK inhibitor,DYRK1B,BRD-K80935598,AZ191,DYRK inhibitor,DYRK1B
ZZHLYYDVIOPZBE,BRD-A49225603,alimemazine,histamine receptor agonist,HRH1,BRD-A49225603,alimemazine,histamine receptor agonist,HRH1,BRD-A49225603,alimemazine,histamine receptor agonist,HRH1,BRD-K01827280,alimemazine,histamine receptor agonist|histamine receptor antagonist,HRH1
ZZJYIKPMDIWRSN,BRD-K23082237,butaclamol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,BRD-K23082237,butaclamol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,BRD-K23082237,butaclamol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,BRD-K20620780,butaclamol,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A
ZZKNRXZVGOYGJT,BRD-A81539525,sparfosate,aspartate carbamoyltransferase inhibitor,CA2|CA4|CAD,BRD-A81539525,sparfosate,aspartate carbamoyltransferase inhibitor,CA2|CA4|CAD,BRD-A81539525,sparfosate,aspartate carbamoyltransferase inhibitor,CA2|CA4|CAD,BRD-A81539525,sparfosate,aspartate carbamoyltransferase inhibitor,CA2|CA4
ZZOBLCHCPLOXCE,BRD-K69216798,iodoantipyrine,,,BRD-K69216798,iodoantipyrine,,,BRD-K69216798,iodoantipyrine,,,BRD-K69216798,iodoantipyrine,,
ZZORFUFYDOWNEF,BRD-K71125014,sulphadimethoxine,dihydropteroate synthetase inhibitor,,BRD-K71125014,sulphadimethoxine,dihydropteroate synthetase inhibitor,,BRD-K71125014,sulphadimethoxine,dihydropteroate synthetase inhibitor,,BRD-K71125014,sulphadimethoxine,dihydropteroate synthetase inhibitor,
ZZPKZRHERLGEKA,BRD-K85603128,resorcinol,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,BRD-K85603128,resorcinol,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,BRD-K85603128,resorcinol-monoacetate,antiseptic,,BRD-K85603128,resorcinol-monoacetate,antiseptic,
ZZUBHVMHNVYXRR,BRD-K74671368,idronoxil,XIAP inhibitor,ENOX2|SPHK1,BRD-K74671368,idronoxil,XIAP inhibitor,ENOX2|SPHK1,BRD-K74671368,idronoxil,XIAP inhibitor,ENOX2|SPHK1,BRD-K74671368,idronoxil,XIAP inhibitor,ENOX2|SPHK1
ZZUFCTLCJUWOSV,BRD-K78010432,furosemide,diuretic,CA2|GPR35|SLC12A1|SLC12A2,BRD-K78010432,furosemide,diuretic,CA2|GPR35|SLC12A1|SLC12A2,BRD-K78010432,furosemide,diuretic,CA2|GPR35|SLC12A1|SLC12A2,BRD-K78010432,furosemide,diuretic,CA2|GPR35|SLC12A1|SLC12A2
ZZUKALQMHNSWTK,BRD-K25991633,BMS-649,retinoid receptor agonist,RXRA,BRD-K25991633,BMS-649,retinoid receptor agonist,RXRA,BRD-K25991633,BMS-649,retinoid receptor agonist,RXRA,BRD-K25991633,BMS-649,retinoid receptor agonist,RXRA
ZZUZYEMRHCMVTB,BRD-K96799727,pifithrin-mu,HSP inhibitor,HSPA1A|TP53,BRD-K96799727,pifithrin-mu,HSP inhibitor,HSPA1A|TP53,BRD-K96799727,pifithrin-mu,HSP inhibitor,HSPA1A|TP53,BRD-K96799727,pifithrin-mu,HSP inhibitor,HSPA1A|TP53
ZZVUWRFHKOJYTH,BRD-K47278471,diphenhydramine,histamine receptor antagonist,HRH1,BRD-K47278471,diphenhydramine,histamine receptor antagonist,HRH1,BRD-K47278471,diphenhydramine,histamine receptor antagonist,HRH1,BRD-K47278471,diphenhydramine,histamine receptor antagonist,HRH1
ZZXUNAFAKNKXFW,BRD-K31086665|BRD-K70344361,NH125,eukaryotic translation elongation factor 2 inhibitor,,BRD-K31086665|BRD-K70344361,NH125,eukaryotic translation elongation factor 2 inhibitor,,BRD-K31086665|BRD-K70344361,NH125,eukaryotic translation elongation factor 2 inhibitor,,BRD-K31086665|BRD-K70344361,NH125,eukaryotic translation elongation factor 2 inhibitor,
ZZZQXCUPAJFVBN,BRD-K90825648,RS-127445,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K90825648,RS-127445,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K90825648,RS-127445,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,BRD-K90825648,RS-127445,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C
ZZZRUAITSXLWBH,BRD-A69651145,minocycline,bacterial 30S ribosomal subunit inhibitor,ALOX5|CASP1|CASP3|CYCS|IL1B|MMP9|VEGFA,BRD-A69651145,minocycline,bacterial 30S ribosomal subunit inhibitor,ALOX5|CASP1|CASP3|CYCS|IL1B|MMP9|VEGFA,BRD-A05311824|BRD-A69651145,minocycline,bacterial 30S ribosomal subunit inhibitor,ALOX5|CASP1|CASP3|CYCS|IL1B|MMP9|VEGFA,BRD-K00003346,minocycline,bacterial 30S ribosomal subunit inhibitor,
AABFWJDLCCDJJN,,,,,BRD-K28571773,SP-141,ubiquitin ligase inhibitor,MDM2,BRD-K28571773,SP-141,ubiquitin ligase inhibitor,MDM2,BRD-K28571773,SP-141,ubiquitin ligase inhibitor,MDM2
ABACVOXFUHDKNZ,,,,,BRD-K33059059,A-867744,acetylcholine receptor allosteric modulator,CHRNA3|CHRNA4|CHRNA7,BRD-K33059059,A-867744,acetylcholine receptor allosteric modulator,CHRNA3|CHRNA4|CHRNA7,BRD-K33059059,A-867744,acetylcholine receptor allosteric modulator,CHRNA3|CHRNA4|CHRNA7
ACLUEOBQFRYTQS,,,,,BRD-A90751343,CaCCinh-A01,calcium-activated chloride channel inhibitor,CLCA1,BRD-A90751343,CaCCinh-A01,calcium-activated chloride channel inhibitor,CLCA1,BRD-A90751343,CaCCinh-A01,calcium-activated chloride channel inhibitor,CLCA1
ADCDUDFEGFKKQH,,,,,BRD-A83792282,TC-I-2000,transient receptor potential channel antagonist,TRPM8,BRD-A83792282,TC-I-2000,transient receptor potential channel antagonist,TRPM8,BRD-A83792282,TC-I-2000,transient receptor potential channel antagonist,TRPM8
AEENEMOEBJOKGN,,,,,BRD-A33603104,RU-SKI-43,hedgehog pathway inhibitor,HHAT,BRD-A33603104,RU-SKI-43,hedgehog pathway inhibitor,HHAT,BRD-A33603104,RU-SKI-43,hedgehog pathway inhibitor,HHAT
AFOFVIBWSLOHFR,,,,,BRD-A62743154,BIMU-8,serotonin receptor agonist,HTR4,BRD-A62743154,BIMU-8,serotonin receptor agonist,HTR4,BRD-K00004300,BIMU-8,serotonin receptor agonist,HTR4
AFVLVVWMAFSXCK,,,,,BRD-K60302405,CHC,monocarboxylate transporter inhibitor,SLC16A1,BRD-K60302405,CHC,monocarboxylate transporter inhibitor,SLC16A1,BRD-K60302405,CHC,monocarboxylate transporter inhibitor,SLC16A1
AFZWZVLPIMHLSE,,,,,BRD-K34411045,HJC-0350,GTPase inhibitor,RAPGEF4,BRD-K34411045,HJC-0350,GTPase inhibitor,RAPGEF4,BRD-K34411045,HJC-0350,GTPase inhibitor,RAPGEF4
AGORGFNWYAUYSU,,,,,BRD-K92435527,PF-04885614,voltage-gated sodium channel blocker,SCN10A,BRD-K92435527,PF-04885614,voltage-gated sodium channel blocker,SCN10A,BRD-K92435527,PF-04885614,voltage-gated sodium channel blocker,SCN10A
AIXMJTYHQHQJLU,,,,,BRD-A94055480,ISO-1,macrophage migration inhibiting factor inhibitor,MIF,BRD-A94055480,ISO-1,macrophage migration inhibiting factor inhibitor,MIF,BRD-A94055480,ISO-1,macrophage migration inhibiting factor inhibitor,MIF
AJVXVYTVAAWZAP,,,,,BRD-A22713669,BVT-948,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,BRD-A22713669,BVT-948,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,,,,
AKIIPHDGVCFVCC,,,,,BRD-K49389158,WWL-113,carboxylesterase inhibitor,CES3,BRD-K49389158,WWL-113,carboxylesterase inhibitor,CES3,BRD-K49389158,WWL-113,carboxylesterase inhibitor,CES3
AOZPVMOOEJAZGK,,,,,BRD-K61845293,DDR1-IN-1,discoidin domain receptor inhibitor,DDR1|DDR2,BRD-K61845293,DDR1-IN-1,discoidin domain receptor inhibitor,DDR1|DDR2,BRD-K61845293,DDR1-IN-1,discoidin domain receptor inhibitor,DDR1|DDR2
APIXJSLKIYYUKG,,,,,BRD-K94979336,IBMX,phosphodiesterase inhibitor,ADORA1|PDE2A|PDE3B|PDE4D|PDE5A|PDE6G|PDE7A|PDE8A|PDE9A,BRD-K94979336,IBMX,phosphodiesterase inhibitor,ADORA1|PDE2A|PDE3B|PDE4D|PDE5A|PDE6G|PDE7A|PDE8A|PDE9A,BRD-K94979336,IBMX,phosphodiesterase inhibitor,ADORA1|PDE2A|PDE3B|PDE4D|PDE5A|PDE6G|PDE7A|PDE8A|PDE9A
APYYTEJNOZQZNA,,,,,BRD-K91106808,SU-16f,PDGFR tyrosine kinase receptor inhibitor,PDGFRB,BRD-K91106808,SU-16f,PDGFR tyrosine kinase receptor inhibitor,PDGFRB,BRD-K91106808,SU16f,PDGFR tyrosine kinase receptor inhibitor,PDGFRB
AQTPWCUIYUOEMG,,,,,BRD-K95123482,GSK2194069,fatty acid synthase inhibitor,FASN,BRD-K95123482,GSK2194069,fatty acid synthase inhibitor,FASN,BRD-K95123482,GSK2194069,fatty acid synthase inhibitor,FASN
ATKZKAYWARYLBW,,,,,BRD-K03988082,SB-399885,serotonin receptor antagonist,HTR6,BRD-K03988082,SB-399885,serotonin receptor antagonist,HTR6,BRD-K03988082,SB-399885,serotonin receptor antagonist,HTR6
ATOAHNRJAXSBOR,,,,,BRD-K32033120,BAY-41-2272,guanylyl cyclase activator,GUCY1A3|GUCY1B3,BRD-K32033120,BAY-41-2272,guanylyl cyclase activator,GUCY1A3|GUCY1B3,BRD-K32033120,BAY-41-2272,guanylyl cyclase activator,GUCY1A3|GUCY1B3
AUMDBEHGJRZSOO,,,,,BRD-K43428468,PF-4800567,casein kinase inhibitor,CSNK1D|CSNK1E,BRD-K43428468,PF-4800567,casein kinase inhibitor,CSNK1D|CSNK1E,BRD-K43428468,PF-4800567,casein kinase inhibitor,CSNK1D|CSNK1E
AVEVJMZJJJDOCI,,,,,BRD-K08657056,WAY-207024,gonadotropin releasing factor hormone receptor antagonist,GNRHR|HRH2|TACR2,BRD-K08657056,WAY-207024,gonadotropin releasing factor hormone receptor antagonist,GNRHR|HRH2|TACR2,BRD-K08657056,WAY-207024,gonadotropin releasing factor hormone receptor antagonist,GNRHR|HRH2|TACR2
AVSCNEOUWSVZEY,,,,,BRD-K48424871,JW-642,monoacylglycerol lipase inhibitor,MGLL,BRD-K48424871,JW-642,monoacylglycerol lipase inhibitor,MGLL,BRD-K48424871,JW-642,monoacylglycerol lipase inhibitor,MGLL
AWIVHRPYFSSVOG,,,,,BRD-K84964099,spautin-1,deubiquitinase inhibitor,USP10|USP13,BRD-K84964099,spautin-1,deubiquitinase inhibitor,USP10|USP13,BRD-K84964099,spautin-1,deubiquitinase inhibitor,USP10|USP13
AXJQVVLKUYCICH,,,,,BRD-A54228901,SLV-319-(+/-),cannabinoid receptor antagonist,CNR1|DRD2|HTR1A,BRD-A54228901,SLV-319-(+/-),cannabinoid receptor antagonist,CNR1|DRD2|HTR1A,BRD-K00004304,SLV-319-(+/-),cannabinoid receptor antagonist,CNR1|DRD2|HTR1A
AXNUEXXEQGQWPA,,,,,BRD-K48112880,FH-535,PPAR receptor antagonist|WNT signaling inhibitor,PPARD|PPARG,BRD-K48112880,FH-535,PPAR receptor antagonist|WNT signaling inhibitor,PPARD|PPARG,BRD-K48112880,FH-535,PPAR receptor antagonist|WNT signaling inhibitor,PPARD|PPARG
AYQBYSPEGRYKFA,,,,,BRD-K24570280,CINPA-1,CAR antagonist,NR1H4|NR1I3|PPARG,BRD-K24570280,CINPA-1,CAR antagonist,NR1H4|NR1I3|PPARG,BRD-K24570280,CINPA-1,CAR antagonist,NR1H4|NR1I3|PPARG
AZSQSUWXVPHQLM,,,,,BRD-M55852627,abacavir,nucleoside reverse transcriptase inhibitor,,,,,,,,,
AZYDQCGCBQYFSE,,,,,BRD-A54139254,4-CMTB,free fatty acid receptor agonist,FFAR2,BRD-A54139254,4-CMTB,free fatty acid receptor agonist,FFAR2,BRD-A54139254,4-CMTB,free fatty acid receptor agonist,FFAR2
BAOQJSULMWXFRK,,,,,BRD-K51528698,Teijin-compound-1,CC chemokine receptor antagonist,CCR2,BRD-K51528698,Teijin-compound-1,CC chemokine receptor antagonist,CCR2,BRD-K51528698,teijin-compound-1,CC chemokine receptor antagonist,CCR2
BASFYRLYJAZPPL,,,,,BRD-K33521504,GSK-LSD-1,histone lysine demethylase inhibitor,KDM1A,BRD-K33521504,GSK-LSD-1,histone lysine demethylase inhibitor,KDM1A,BRD-K33521504,GSK-LSD-1,histone lysine demethylase inhibitor,KDM1A
BCPOLXUSCUFDGE,,,,,BRD-K08478539,SMER-28,autophagy inducer,SNCA,BRD-K08478539,SMER-28,autophagy inducer,SNCA,BRD-K08478539,SMER-28,autophagy inducer,SNCA
BDOQBXDAWKJOML,,,,,BRD-M18497616,aliskiren-hemifumarate,renin inhibitor,REN,,,,,,,,
BEZXGSZPWXRHIN,,,,,BRD-K16107558,SB-297006,CC chemokine receptor antagonist,CCR3,BRD-K16107558,SB-297006,CC chemokine receptor antagonist,CCR3,BRD-K16107558,SB-297006,CC chemokine receptor antagonist,CCR3
BHJJWVDKNXABFS,,,,,BRD-K34362291,TC-S-7003,src inhibitor,LCK,BRD-K34362291,TC-S-7003,src inhibitor,LCK,BRD-K34362291,TC-S-7003,SRC inhibitor,LCK
BIODYGOZWZNCAG,,,,,BRD-K83213911,PF-750,FAAH inhibitor,FAAH,BRD-K83213911,PF-750,FAAH inhibitor,FAAH,BRD-K83213911,PF-750,FAAH inhibitor,FAAH
BIOVSNWTCKRADD,,,,,BRD-K26358347,PDP-EA,FAAH activator,FAAH,BRD-K26358347,PDP-EA,FAAH activator,FAAH,BRD-K26358347,PDP-EA,FAAH activator,FAAH
BIXYYZIIJIXVFW,,,,,BRD-K79511609,2-chloroadenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B,BRD-K79511609,2-chloroadenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B,BRD-K79511609,2-chloroadenosine,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B
BIZNHCWFGNKBBZ,,,,,BRD-K19558579,UK-5099,monocarboxylate transporter inhibitor,SLC16A1,BRD-K19558579,UK-5099,monocarboxylate transporter inhibitor,SLC16A1,BRD-K19558579,UK-5099,monocarboxylate transporter inhibitor,SLC16A1
BJGBAZAEWKCPHZ,,,,,BRD-M94983326,atorvastatin,HMGCR inhibitor,AHR|DPP4|HMGCR,,,,,,,,
BJVRNXSHJLDZJR,,,,,BRD-K15858023,ETP-45658,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K15858023,ETP-45658,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,BRD-K15858023,ETP-45658,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
BKUIZWILNWHFHD,,,,,BRD-K02213468,CDPPB,glutamate receptor positive allosteric modulator,GRM5,BRD-K02213468,CDPPB,glutamate receptor positive allosteric modulator,GRM5,BRD-K02213468,CDPPB,glutamate receptor positive allosteric modulator,GRM5
BNALUYKEGYUHQC,,,,,BRD-K32031961,TC-LPA5-4,lysophosphatidic acid receptor antagonist,LPAR5,BRD-K32031961,TC-LPA5-4,lysophosphatidic acid receptor antagonist,LPAR5,BRD-K32031961,TC-LPA5-4,lysophosphatidic acid receptor antagonist,LPAR5
BPOWQJYAMDEAFF,,,,,BRD-K68633027,SB-706375,urotensin receptor antagonist,UTS2R,BRD-K68633027,SB-706375,urotensin receptor antagonist,UTS2R,BRD-K68633027,SB-706375,urotensin receptor antagonist,UTS2R
BQDUNOMMYOKHEP,,,,,BRD-K46647427,L-838417,GABA receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K46647427,L-838417,GABA receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K46647427,L-838417,GABA receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA5
BQNXBSYSQXSXPT,,,,,BRD-K88570498,yoda-1,piezo channel activator,PIEZO1,BRD-K88570498,yoda-1,piezo channel activator,PIEZO1,BRD-K88570498,yoda-1,piezo channel activator,PIEZO1
BRAZLURTFMCAHU,,,,,BRD-K48371964,VU1545,glutamate receptor positive allosteric modulator,GRM5,BRD-K48371964,VU1545,glutamate receptor positive allosteric modulator,GRM5,BRD-K48371964,VU1545,glutamate receptor positive allosteric modulator,GRM5
BSPMYKLEFGUTSI,,,,,BRD-K06496777,AT-1015,serotonin receptor antagonist,HTR2A,BRD-K06496777,AT-1015,serotonin receptor antagonist,HTR2A,BRD-K06496777,AT-1015,serotonin receptor antagonist,HTR2A
BTXRSHKJNDFHGA,,,,,BRD-K24554037,JW-67,Wnt pathway inhibitor,APC|AXIN1|GSK3B,BRD-K24554037,JW-67,Wnt pathway inhibitor,APC|AXIN1|GSK3B,BRD-K24554037,JW-67,WNT pathway inhibitor,APC|AXIN1|GSK3B
BVQCFCYPFJOOAV,,,,,BRD-K20480395,UF-010,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K20480395,UF-010,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K20480395,UF-010,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8
CAIDFDPKOGBHAT,,,,,BRD-A63866086,chlorophyllide-cu-complex-na-salt,,,BRD-A09283158|BRD-A63866086,chlorophyllide-cu-complex-na-salt,,,,,,
CAMGZGMEPKFVMF,,,,,BRD-K72748448,APcK-110,KIT inhibitor,KIT|STAT3,BRD-K72748448,APcK-110,KIT inhibitor,KIT|STAT3,BRD-K72748448,APcK-110,KIT inhibitor,KIT|STAT3
CDQUJZKBRAFWNG,,,,,BRD-K21894922,TC-S-7009,hypoxia inducible factor inhibitor,EPAS1,BRD-K21894922,TC-S-7009,hypoxia inducible factor inhibitor,EPAS1,BRD-K21894922,TC-S-7009,hypoxia inducible factor inhibitor,EPAS1
CDUDZZGLFOFINU,,,,,BRD-K13039700,GW-438014A,neuropeptide receptor antagonist,NPY5R,BRD-K13039700,GW-438014A,neuropeptide receptor antagonist,NPY5R,BRD-K13039700,GW-438014A,neuropeptide receptor antagonist,NPY5R
CHSDJDLAKKAWCI,,,,,BRD-K58726989,HTH-01-015,protein kinase inhibitor,NUAK1,BRD-K58726989,HTH-01-015,protein kinase inhibitor,NUAK1,BRD-K58726989,HTH-01-015,protein kinase inhibitor,NUAK1
CJZGRIRZVHNUSM,,,,,BRD-K44043890,PK-THPP,potassium channel blocker,KCNK9,BRD-K44043890,PK-THPP,potassium channel blocker,KCNK9,BRD-K44043890,PK-THPP,potassium channel blocker,KCNK9
CLGRAWDGLMENOD,,,,,BRD-K49461364,TCS-21311,JAK inhibitor,JAK3,BRD-K49461364,TCS-21311,JAK inhibitor,JAK3,BRD-K49461364,TCS-21311,JAK inhibitor,JAK3
CLGWUCNXOBLWFM,,,,,BRD-K87021635,CZC-54252,leucine rich repeat kinase inhibitor,LRRK2,BRD-K87021635,CZC-54252,leucine rich repeat kinase inhibitor,LRRK2,BRD-K87021635,CZC-54252,leucine rich repeat kinase inhibitor,LRRK2
CLKOFPXJLQSYAH,,,,,BRD-A23712469,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,BRD-A21002158|BRD-A23712469,bacitracin,bacterial cell wall synthesis inhibitor,A2M|IDE,BRD-K14079729,bacitracin,bacterial cell wall synthesis inhibitor,IDE
CMYHZFCJPORPHY,,,,,BRD-K90747162,KG-5,RAF inhibitor,BRAF|FLT3|KIT|PDGFRB,BRD-K90747162,KG-5,RAF inhibitor,BRAF|FLT3|KIT|PDGFRB,BRD-K90747162,KG-5,RAF inhibitor,BRAF|FLT3|KIT|PDGFRB
CNGHPXKWPGIDSK,,,,,BRD-K10596918,DC-260126,free fatty acid receptor antagonist,FFAR1,BRD-K10596918,DC-260126,free fatty acid receptor antagonist,FFAR1,BRD-K10596918,DC-260126,free fatty acid receptor antagonist,FFAR1
COFVZFLCAOUMJT,,,,,BRD-K29424831,TCS-OX2-29,orexin receptor antagonist,HCRTR2,BRD-K29424831,TCS-OX2-29,orexin receptor antagonist,HCRTR2,BRD-K29424831,TCS-OX2-29,orexin receptor antagonist,HCRTR2
CQKBSRPVZZLCJE,,,,,BRD-K89517477,TC-S-7004,DYRK inhibitor,DYRK1A|DYRK1B,BRD-K89517477,TC-S-7004,DYRK inhibitor,DYRK1A|DYRK1B,BRD-K89517477,TC-S-7004,DYRK inhibitor,DYRK1A|DYRK1B
CSKKSNNRKWZLAM,,,,,BRD-K70759443,idazoxane,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,BRD-K70759443,idazoxane,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,,,,
CUWACJNSCBGMGF,,,,,BRD-M14495474,cyanocobalamin,methylmalonyl CoA mutase stimulant|vitamin B,MMAA|MMACHC|MTHFR|MTR|MTRR|MUT,,,,,,,,
CVOUSAVHMDXCKG,,,,,BRD-K37602296,NS-309,calcium-activated potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,BRD-K37602296,NS-309,calcium-activated potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,BRD-K00004295,NS-309,calcium-activated potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4
CWJJHESJXJQCJA,,,,,BRD-K03019184,AMD-3465,CC chemokine receptor antagonist,CXCR4,BRD-K03019184,AMD-3465,CC chemokine receptor antagonist,CXCR4,BRD-K03019184,AMD-3465,CC chemokine receptor antagonist,CXCR4
CWLQNPHAUWMLEE,,,,,BRD-K26122255,VLX-600,antitumor agent,TP53,BRD-K26122255,VLX-600,antitumor agent,TP53,,,,
CYNLZIBKERMMOA,,,,,BRD-K06405316,CID-2745687,G protein-coupled receptor antagonist,GPR35,BRD-K06405316,CID-2745687,G protein-coupled receptor antagonist,GPR35,BRD-K06405316,CID-2745687,G protein-coupled receptor antagonist,GPR35
CYYNMPPFEJPBJD,,,,,BRD-K73276278,MCOPPB,nociceptin/orphanin FQ (NOP) receptor agonist,OPRL1,BRD-K73276278,MCOPPB,nociceptin/orphanin FQ (NOP) receptor agonist,OPRL1,BRD-K73276278,MCOPPB,nociceptin/orphanin FQ receptor agonist,OPRL1
CZSLEMCYYGEGKP,,,,,BRD-K36804890,NAB-2,ubiquitin ligase transport promoter,NEDD4,BRD-K36804890,NAB-2,ubiquitin ligase transport promoter,NEDD4,BRD-K36804890,NAB-2,ubiquitin ligase transport promoter,NEDD4
DAAGOCSHXCDWDY,,,,,BRD-K89584803,TC-S-7005,PLK inhibitor,PLK2,BRD-K89584803,TC-S-7005,PLK inhibitor,PLK2,BRD-K89584803,TC-S-7005,PLK inhibitor,PLK2
DAEHFYNGSSBGSS,,,,,BRD-K91333421,Ro-67-7476,glutamate receptor positive allosteric modulator,GRM1,BRD-K91333421,Ro-67-7476,glutamate receptor positive allosteric modulator,GRM1,BRD-K91333421,Ro-67-7476,glutamate receptor positive allosteric modulator,GRM1
DDFLFKTXUWPNMV,,,,,BRD-K66998413,EB-47,PARP inhibitor,PARP1,BRD-K66998413,EB-47,PARP inhibitor,PARP1,BRD-K66998413,EB-47,PARP inhibitor,PARP1
DGRJOOOHPBSAHD,,,,,BRD-K78978711,KHS-101,neural stem cell inducer,TACC3,BRD-K78978711,KHS-101,neural stem cell inducer,TACC3,BRD-K78978711,KHS-101,neural stem cell inducer,TACC3
DJKJVWJQAVGLHJ,,,,,BRD-K68982262,A-987306,histamine receptor antagonist,ADORA1|AVPR1A|CCR1|CHRM1|CHRM2|CHRM3|CHRM4|DRD3|HTR1A|HTR1B|HTR2A|HTR2B|HTR3A|TACR2,BRD-K68982262,A-987306,histamine receptor antagonist,ADORA1|AVPR1A|CCR1|CHRM1|CHRM2|CHRM3|CHRM4|DRD3|HTR1A|HTR1B|HTR2A|HTR2B|HTR3A|TACR2,BRD-K68982262,A-987306,histamine receptor antagonist,ADORA1|AVPR1A|CCR1|CHRM1|CHRM2|CHRM3|CHRM4|DRD3|HTR1A|HTR1B|HTR2A|HTR2B|HTR3A|TACR2
DJOVLOYCGXNVPI,,,,,BRD-K94083718,OICR-9429,WDR5/MLL interaction inhibitor,WDR5,BRD-K94083718,OICR-9429,WDR5/MLL interaction inhibitor,WDR5,BRD-K94083718,OICR-9429,WDR5/MLL interaction inhibitor,WDR5
DMIDPTCQPIJYFE,,,,,BRD-K86718786,SGC-707,protein arginine N-methyltransferase inhibitor,PRMT3,BRD-K86718786,SGC-707,protein arginine N-methyltransferase inhibitor,PRMT3,BRD-K86718786,SGC-707,protein arginine N-methyltransferase inhibitor,PRMT3
DNVZYSMOLXCOLY,,,,,BRD-K38966689,UAMC-00039,dipeptidyl peptidase inhibitor,DPP4|DPP7,BRD-K38966689,UAMC-00039,dipeptidyl peptidase inhibitor,DPP4|DPP7,BRD-K38966689,UAMC-00039,dipeptidyl peptidase inhibitor,DPP4|DPP7
DPBKLIVPNYGQQG,,,,,BRD-K69211575,XD-14,bromodomain inhibitor,BRD2|BRD3|BRD4|BRDT,BRD-K69211575,XD-14,bromodomain inhibitor,BRD2|BRD3|BRD4|BRDT,BRD-K69211575,XD-14,bromodomain inhibitor,BRD2|BRD3|BRD4|BRDT
DPVGXUNWCVEIGT,,,,,BRD-K98353094,MM-11253,retinoid receptor antagonist,RARG,BRD-K98353094,MM-11253,retinoid receptor antagonist,RARG,BRD-K98353094,MM-11253,retinoid receptor antagonist,RARG
DPYTYQFYDLYWHZ,,,,,BRD-K99308908,A-939572,stearoyl-CoA desaturase inhibitor,SCD,BRD-K99308908,A-939572,stearoyl-CoA desaturase inhibitor,SCD,BRD-K99308908,A-939572,stearoyl-CoA desaturase inhibitor,SCD
DQZMLPMCOMRJOR,,,,,BRD-K68358632,TCS-HDAC6-20b,HDAC inhibitor,HDAC6,BRD-K68358632,TCS-HDAC6-20b,HDAC inhibitor,HDAC6,BRD-K68358632,TCS-HDAC6-20b,HDAC inhibitor,HDAC6
DRSZMILOMUPIBJ,,,,,BRD-K87199310,TC-G-1008,G protein-coupled receptor agonist,GPR39,BRD-K87199310,TC-G-1008,G protein-coupled receptor agonist,GPR39,BRD-K87199310,TC-G-1008,G protein-coupled receptor agonist,GPR39
DSEIKQVUTKGLGT,,,,,BRD-K36009368,NNC-63-0532,opioid receptor agonist,OPRL1,,,,,,,,
DSMXVSGJIDFLKP,,,,,BRD-A79726147,CCG-1423,apoptosis stimulant,RHOC|SRF,BRD-A79726147,CCG-1423,apoptosis stimulant,RHOC|SRF,BRD-A79726147,CCG-1423,apoptosis stimulant,RHOC|SRF
DTQNEFOKTXXQKV,,,,,BRD-K09946180,CP-99994,tachykinin antagonist,TACR1,BRD-K09946180,CP-99994,tachykinin antagonist,TACR1,BRD-K09946180,CP-99994,tachykinin antagonist,TACR1
DUKPGOOUJNUIOI,,,,,BRD-K07656463,AS-1269574,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K07656463,AS-1269574,glucose dependent insulinotropic receptor agonist,GPR119,BRD-K07656463,AS-1269574,glucose dependent insulinotropic receptor agonist,GPR119
DUUFLTUTPZFOAH,,,,,BRD-M92675308,efonidipine-monoethanolate,L-type calcium channel blocker|T-type calcium channel blocker,CACNA1C|CACNA1G,BRD-A39845846|BRD-M92675308,efonidipine-monoethanolate,L-type calcium channel blocker|T-type calcium channel blocker,CACNA1C|CACNA1G,,,,
DUXWIYXHHGNUJU,,,,,BRD-K26501486,SR-1078,retinoid receptor agonist,RORA|RORC,BRD-K26501486,SR-1078,retinoid receptor agonist,RORA|RORC,BRD-K26501486,SR-1078,retinoid receptor agonist,RORA|RORC
DXBJGDVBQPEMOB,,,,,BRD-K29328421,GSK9027,glucocorticoid receptor agonist,NR3C1,BRD-K29328421,GSK9027,glucocorticoid receptor agonist,NR3C1,BRD-K29328421,GSK9027,glucocorticoid receptor agonist,NR3C1
DYIRSNMPIZZNBK,,,,,BRD-K19002914,EED226,polycomb protein inhibitor,EED,BRD-K19002914,EED226,polycomb protein inhibitor,EED,BRD-K19002914,EED226,polycomb protein inhibitor,EED
FEQUIPXIENTMJN,,,,,BRD-A73891132,OXF-BD-02,bromodomain inhibitor,BRD4,BRD-A73891132,OXF-BD-02,bromodomain inhibitor,BRD4,BRD-A73891132,OXF-BD-02,bromodomain inhibitor,BRD4
FHPOTBQOUBMMCI,,,,,BRD-K69877120,CYM-50260,sphingosine 1 phosphate receptor agonist,S1PR4,BRD-K69877120,CYM-50260,sphingosine 1 phosphate receptor agonist,S1PR4,BRD-K69877120,CYM-50260,sphingosine 1-phosphate receptor agonist,S1PR4
FJNJHZQMQRVZEE,,,,,BRD-K64880136,BIRT-377,lymphocyte function-associated antigen negative modulator,ICAM1,BRD-K64880136,BIRT-377,lymphocyte function-associated antigen negative modulator,ICAM1,BRD-K64880136,BIRT-377,lymphocyte function-associated antigen negative modulator,ICAM1
FMYGNANMYYHBSU,,,,,BRD-K29151923,CYM-5520,sphingosine 1 phosphate receptor agonist,S1PR2,BRD-K29151923,CYM-5520,sphingosine 1 phosphate receptor agonist,S1PR2,BRD-K29151923,CYM-5520,sphingosine 1-phosphate receptor agonist,S1PR2
FNSCFQXZZNCDAI,,,,,BRD-K47441935,NK-252,NRF2 activator,NFE2L2,BRD-K47441935,NK-252,NRF2 activator,NFE2L2,BRD-K47441935,NK-252,like (NRF2) activator|nuclear factor erythroid derived,NFE2L2
FOYOGIUAMYSVIT,,,,,BRD-K71686520,ICA-110381,voltage-gated potassium channel activator,KCNQ2,BRD-K71686520,ICA-110381,voltage-gated potassium channel activator,KCNQ2,BRD-K71686520,ICA-110381,voltage-gated potassium channel activator,KCNQ2
FPRULFHDSFKYBV,,,,,BRD-K12483104,VU10010,acetylcholine receptor allosteric modulator,CHRM4,BRD-K12483104,VU10010,acetylcholine receptor allosteric modulator,CHRM4,BRD-K12483104,VU10010,acetylcholine receptor allosteric modulator,CHRM4
FQMZXMVHHKXGTM,,,,,BRD-K09907507,AZ-10606120,purinergic receptor antagonist,P2RX7,BRD-K09907507,AZ-10606120,purinergic receptor antagonist,P2RX7,BRD-K09907507,AZ-10606120,purinergic receptor antagonist,P2RX7
FQUAFMNPXPXOJE,,,,,BRD-K26514105,GSK-37647,free fatty acid receptor agonist,FFAR4,BRD-K26514105,GSK-37647,free fatty acid receptor agonist,FFAR4,BRD-K26514105,GSK37647,free fatty acid receptor agonist,FFAR4
FRKXOBMDEXCHHD,,,,,BRD-K91403886,YIL-781,ghrelin receptor antagonist,GHSR,BRD-K91403886,YIL-781,ghrelin receptor antagonist,GHSR,BRD-K91403886,YIL-781,ghrelin receptor antagonist,GHSR
FZHHRERIIVOATI,,,,,BRD-A09487507,P7C3,NAMPT inhibitor,NAMPT,BRD-A09487507,P7C3,NAMPT inhibitor,NAMPT,BRD-A09487507,P7C3,NAMPT inhibitor,NAMPT
GCDHMGROXQUFNR,,,,,BRD-K04426574,PD-173212,calcium channel blocker,CACNA1B,BRD-K04426574,PD-173212,calcium channel blocker,CACNA1B,BRD-K04426574,PD-173212,calcium channel blocker,CACNA1B
GDXBRVCQGGKXJY,,,,,BRD-K43992824,zoniporide,sodium/hydrogen exchanger inhibitor,SLC9A1,BRD-K43992824,zoniporide,sodium/hydrogen exchanger inhibitor,SLC9A1,BRD-K43992824,zoniporide,sodium/hydrogen exchanger inhibitor,SLC9A1
GHMKQBWHPQMXSH,,,,,BRD-K71900389,SP-100030,NFkB pathway inhibitor,JUN|NFKB1,BRD-K71900389,SP-100030,NFkB pathway inhibitor,JUN|NFKB1,BRD-K71900389,SP-100030,NFkB pathway inhibitor,JUN|NFKB1
GMJUPMONHWAZCP,,,,,BRD-K71223042,PCI-29732,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K71223042,PCI-29732,Bruton's tyrosine kinase (BTK) inhibitor,BTK,BRD-K71223042,PCI-29732,Bruton's tyrosine kinase (BTK) inhibitor,BTK
GMVNBKZQJFRFAR,,,,,BRD-K60427831,A-839977,purinergic receptor antagonist,P2RX7,BRD-K60427831,A-839977,purinergic receptor antagonist,P2RX7,BRD-K60427831,A-839977,purinergic receptor antagonist,P2RX7
GSJIGYLGKSBYBC,,,,,BRD-K92995792,ML-218,T-type calcium channel binder,CACNA1G|CACNA1H|CACNA1I,BRD-K92995792,ML-218,T-type calcium channel binder,CACNA1G|CACNA1H|CACNA1I,BRD-K92995792,ML218,T-type calcium channel blocker,CACNA1G|CACNA1H|CACNA1I
GTMRUYCIJSNXGB,,,,,BRD-K79743788,A-582941,nicotinic receptor agonist,CHRNA7,BRD-K79743788,A-582941,nicotinic receptor agonist,CHRNA7,BRD-K79743788,A-582941,nicotinic receptor agonist,CHRNA7
GULVVTHHUIIMRL,,,,,BRD-K22000702,BMS-470539,melanocortin receptor agonist,MC1R,BRD-K22000702,BMS-470539,melanocortin receptor agonist,MC1R,BRD-K22000702,BMS-470539,melanocortin receptor agonist,MC1R
GUWOSEVHCSNYFK,,,,,BRD-A81603255,CPSI-1306-(+/-),macrophage migration inhibiting factor inhibitor,MIF,BRD-A81603255,CPSI-1306-(+/-),macrophage migration inhibiting factor inhibitor,MIF,BRD-A81603255,CPSI-1306-(+/-),macrophage migration inhibiting factor inhibitor,MIF
GVPAGJWVBUZHNQ,,,,,BRD-K00652956,BAG-956,phosphoinositide dependent kinase inhibitor,PIK3CG,BRD-K00652956,BAG-956,phosphoinositide dependent kinase inhibitor,PIK3CG,BRD-K00652956,BAG-956,phosphoinositide dependent kinase inhibitor,PIK3CG
GVXGVDIXINMAAL,,,,,BRD-K87461578,TC-SP-14,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K87461578,TC-SP-14,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-K87461578,TC-SP-14,sphingosine 1-phosphate receptor agonist,S1PR1
GXEGTVQATHKFDH,,,,,BRD-K52644305,ML-786,RAF inhibitor,BRAF|RAF1,BRD-K52644305,ML-786,RAF inhibitor,BRAF|RAF1,BRD-K52644305,ML786,RAF inhibitor,BRAF|RAF1
GYQRHHQPEMOLKH,,,,,BRD-K72514671,PPY-A,Abl kinase inhibitor,ABL1|BCR,BRD-K72514671,PPY-A,Abl kinase inhibitor,ABL1|BCR,BRD-K72514671,PPY-A,Abl kinase inhibitor,ABL1|BCR
GYYRMJMXXLJZAB,,,,,BRD-K77220725,Ro-1138452,prostanoid receptor antagonist,PTGIR,BRD-K77220725,Ro-1138452,prostanoid receptor antagonist,PTGIR,BRD-K77220725,Ro-1138452,prostanoid receptor antagonist,PTGIR
HAAXAFNSRADSMK,,,,,BRD-A25182582,edaglitazone,PPAR receptor agonist,PPARG,BRD-A25182582,edaglitazone,PPAR receptor agonist,PPARG,BRD-K00004306,edaglitazone,PPAR receptor agonist,PPARG
HDAYFSFWIPRJSO,,,,,BRD-K33502629,PSNCBAM-1,cannabinoid receptor modulator,CNR1,BRD-K33502629,PSNCBAM-1,cannabinoid receptor modulator,CNR1,BRD-K33502629,PSNCBAM-1,cannabinoid receptor modulator,CNR1
HDVYXILCBYGKGU,,,,,BRD-K34675210,CBiPES,glutamate receptor positive allosteric modulator,GRM2,BRD-K34675210,CBiPES,glutamate receptor positive allosteric modulator,GRM2,BRD-K34675210,CBiPES,glutamate receptor positive allosteric modulator,GRM2
HECQGWSAKVGEID,,,,,BRD-M56587789,ibutilide,potassium channel blocker,CACNA1C|CACNA2D1|CACNB1|CACNG1|KCNH2|KCNH6|KCNH7|KCNJ11|KCNK1|KCNK6,,,,,,,,
HFDLVJPCRXIRGU,,,,,BRD-M62817595,pitavastatin,HMGCR inhibitor,HMGCR,,,,,,,,
HFYPTENHTPNXGP,,,,,BRD-K26439554,H2L-5765834,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,BRD-K26439554,H2L-5765834,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,BRD-K26439554,H2L-5765834,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3
HGFXDSQLRSWUBO,,,,,BRD-K40176866,NS-9283,acetylcholine receptor allosteric modulator,CHRNA4,BRD-K40176866,NS-9283,acetylcholine receptor allosteric modulator,CHRNA4,BRD-K40176866,NS-9283,acetylcholine receptor allosteric modulator,CHRNA4
HGVHSNXRZYOTPD,,,,,BRD-K96798615,S4,carbonic anhydrase inhibitor,CA12|CA9,BRD-K96798615,S4,carbonic anhydrase inhibitor,CA12|CA9,BRD-K96798615,S4,carbonic anhydrase inhibitor,CA12|CA9
HGWLTZOMQZIUBW,,,,,BRD-K03808106,NS-19504,calcium-activated potassium channel activator,KCNMA1,BRD-K03808106,NS-19504,calcium-activated potassium channel activator,KCNMA1,BRD-K03808106,NS-19504,calcium-activated potassium channel activator,KCNMA1
HKROEBDHHKMNBZ,,,,,BRD-K70744942,A-967079,transient receptor potential channel antagonist,TRPA1,BRD-K70744942,A-967079,transient receptor potential channel antagonist,TRPA1,BRD-K70744942,A-967079,transient receptor potential channel antagonist,TRPA1
HOFGTYCLOKDAES,,,,,BRD-K94623186,RWJ-50271,integrin inhibitor,ICAM1,BRD-K94623186,RWJ-50271,integrin inhibitor,ICAM1,BRD-K94623186,RWJ-50271,integrin inhibitor,ICAM1
HOQAVGZLYRYHSO,,,,,BRD-A50062753,LY-404187,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A50062753,LY-404187,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,BRD-A50062753,LY404187,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4
HSAOETBFVAWNRP,,,,,BRD-K31144453,AC-261066,retinoid receptor agonist,RARB,BRD-K31144453,AC-261066,retinoid receptor agonist,RARB,BRD-K31144453,AC-261066,retinoid receptor agonist,RARB
HSMUKSLNDJOZQG,,,,,BRD-K53788420,AC-186,estrogen receptor agonist,ESR2,BRD-K53788420,AC-186,estrogen receptor agonist,ESR2,BRD-K53788420,AC-186,estrogen receptor agonist,ESR2
HSYCMGWPPRTNKH,,,,,BRD-K99819791,SA-47,FAAH inhibitor,FAAH,BRD-K99819791,SA-47,FAAH inhibitor,FAAH,BRD-K99819791,SA-47,FAAH inhibitor,FAAH
HTSLEZOTMYUPLU,,,,,BRD-K27539181,ML-193,G protein-coupled receptor antagonist,GPR55,BRD-K27539181,ML-193,G protein-coupled receptor antagonist,GPR55,BRD-K27539181,ML193,G protein-coupled receptor antagonist,GPR55
HWOYIOLMBQSTQS,,,,,BRD-K48188942,ML-281,serine/threonine kinase inhibitor,STK33,BRD-K48188942,ML-281,serine/threonine kinase inhibitor,STK33,BRD-K48188942,ML281,serine/threonine kinase inhibitor,STK33
HZEVDVGPBUFIAW,,,,,BRD-K32892871,JHW-007,dopamine uptake inhibitor,SLC6A3,BRD-K32892871,JHW-007,dopamine uptake inhibitor,SLC6A3,BRD-K32892871,JHW-007,dopamine reuptake inhibitor,SLC6A3
IAASQMCXDRISAV,,,,,BRD-K58234744,CU-CPT-4a,toll-like receptor inhibitor,TLR3,BRD-K58234744,CU-CPT-4a,toll-like receptor inhibitor,TLR3,BRD-K58234744,CU-CPT-4a,toll-like receptor inhibitor,TLR3
IBPXYDUJQWENPM,,,,,BRD-K15119094,BMS-CCR2-22,CC chemokine receptor antagonist,CCR2,BRD-K15119094,BMS-CCR2-22,CC chemokine receptor antagonist,CCR2,BRD-K15119094,BMS-CCR2-22,CC chemokine receptor antagonist,CCR2
ICGMZCVSHDKQTE,,,,,BRD-A84202322,NAV-26,voltage-gated sodium channel blocker,SCN9A,BRD-A84202322,NAV-26,voltage-gated sodium channel blocker,SCN9A,BRD-A84202322,NAV-26,voltage-gated sodium channel blocker,SCN9A
IDQPVOFTURLJPT,,,,,BRD-K54729176,SBHA,HDAC inhibitor,HDAC1|HDAC3,BRD-K54729176,SBHA,HDAC inhibitor,HDAC1|HDAC3,BRD-K54729176,SBHA,HDAC inhibitor,HDAC1|HDAC3
IEKSMUSSYJUQMY,,,,,BRD-K51137250,ML-297,inward rectifier potassium channel activator,KCNJ3,BRD-K51137250,ML-297,inward rectifier potassium channel activator,KCNJ3,BRD-K51137250,ML297,inward rectifier potassium channel activator,KCNJ3
IETDBZQIWIJQJG,,,,,BRD-K53438416,YZ9,phosphofructokinase inhibitor,MIF|PFKFB3,BRD-K53438416,YZ9,phosphofructokinase inhibitor,MIF|PFKFB3,BRD-K53438416,YZ9,phosphofructokinase inhibitor,MIF|PFKFB3
IFJYEGJUQIBBQV,,,,,BRD-K03665769,SB-452533,TRPV antagonist,TRPV1,BRD-K03665769,SB-452533,TRPV antagonist,TRPV1,BRD-K03665769,SB-452533,TRPV antagonist,TRPV1
IFPPYSWJNWHOLQ,,,,,BRD-K93217218,PD-166285,src inhibitor,EGFR|FGFR1|PDGFRB|PKMYT1|SRC|WEE1,BRD-K93217218,PD-166285,src inhibitor,EGFR|FGFR1|PDGFRB|PKMYT1|SRC|WEE1,BRD-K93217218,PD-166285,SRC inhibitor,EGFR|FGFR1|PDGFRB|PKMYT1|SRC|WEE1
IIBSHMFXVWTQSJ,,,,,BRD-K59839632,ICA-069673,voltage-gated potassium channel activator,KCNQ2|KCNQ3,BRD-K59839632,ICA-069673,voltage-gated potassium channel activator,KCNQ2|KCNQ3,BRD-K59839632,ICA-069673,voltage-gated potassium channel activator,KCNQ2|KCNQ3
IIJDFXNUWZTHIM,,,,,BRD-K62814487,SR-1664,PPAR receptor ligand,PPARG,BRD-K62814487,SR-1664,PPAR receptor ligand,PPARG,BRD-K62814487,SR-1664,PPAR receptor ligand,PPARG
IIQUYGWWHIHOCF,,,,,BRD-K87632963,GNF-5,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K87632963,GNF-5,Bcr-Abl kinase inhibitor,ABL1|BCR,BRD-K87632963,GNF-5,Bcr-Abl kinase inhibitor,ABL1|BCR
IJGQFZYYEHCCIZ,,,,,BRD-K87973152,RQ-00203078,transient receptor potential channel antagonist,TRPM8,BRD-K87973152,RQ-00203078,transient receptor potential channel antagonist,TRPM8,BRD-K87973152,RQ-00203078,transient receptor potential channel antagonist,TRPM8
IJYPHMXWKKKHGT,,,,,BRD-K38905597,SIS3,serine/threonine kinase inhibitor,SMAD3|TGFBR1,BRD-K38905597,SIS3,serine/threonine kinase inhibitor,SMAD3|TGFBR1,BRD-K38905597,SIS3,serine/threonine kinase inhibitor,SMAD3|TGFBR1
IMUKUMUNZJILCG,,,,,BRD-K31792052,pifithrin-cyclic,TP53 inhibitor,TP53,BRD-K31792052,pifithrin-cyclic,TP53 inhibitor,TP53,BRD-K31792052,pifithrin-cyclic,TP53 inhibitor,TP53
INAICWLVUAKEPB,,,,,BRD-K61524559,PFI-3,bromodomain inhibitor,PBRM1|SMARCA4,BRD-K61524559,PFI-3,bromodomain inhibitor,PBRM1|SMARCA4,BRD-K61524559,PFI-3,bromodomain inhibitor,PBRM1|SMARCA4
IOXMDBQCUCDLAF,,,,,BRD-K76725781,ONO-8130,prostanoid receptor antagonist,PTGER1,BRD-K76725781,ONO-8130,prostanoid receptor antagonist,PTGER1,BRD-K76725781,ONO-8130,prostanoid receptor antagonist,PTGER1
ISKHMDNIWXPUGR,,,,,BRD-K21306330,CJ-033466,serotonin receptor agonist,HTR4,BRD-K21306330,CJ-033466,serotonin receptor agonist,HTR4,BRD-K21306330,CJ-033466,serotonin receptor agonist,HTR4
ITACCRHKSPSKKL,,,,,BRD-K17539220,NDT-9513727,complement antagonist,C5AR1,BRD-K17539220,NDT-9513727,complement antagonist,C5AR1,BRD-K17539220,NDT-9513727,complement antagonist,C5AR1
ITXAAOWFOURIHK,,,,,BRD-K55216666,TCS-2314,integrin inhibitor,ITGA4|ITGB1,BRD-K55216666,TCS-2314,integrin inhibitor,ITGA4|ITGB1,BRD-K55216666,TCS-2314,integrin inhibitor,ITGA4|ITGB1
IVUGBSGLHRJSSP,,,,,BRD-K75373031,LIMKi-3,LIM kinase inhibitor,LIMK1,BRD-K75373031,LIMKi-3,LIM kinase inhibitor,LIMK1,BRD-K75373031,LIMKi-3,LIM kinase inhibitor,LIMK1
IXPROWGEHNVJOY,,,,,BRD-K01363385,antalarmin,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K01363385,antalarmin,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K01363385,antalarmin,corticotropin releasing factor receptor antagonist,CRHR1
IYAYHZZWYNXHEQ,,,,,BRD-K09143580,AK-7,SIRT inhibitor,SIRT2,BRD-K09143580,AK-7,SIRT inhibitor,SIRT2,BRD-K09143580,AK-7,SIRT inhibitor,SIRT2
IYNDTACKOAXKBJ,,,,,BRD-K79090631,CGP-60474,CDK inhibitor,CDK1|CDK2,BRD-K79090631,CGP-60474,CDK inhibitor,CDK1|CDK2,BRD-K79090631,CGP-60474,CDK inhibitor,CDK1|CDK2
IZPMWFSVTDOCDI,,,,,BRD-K99916169,GS-143,ubiquitin ligase inhibitor,BTRC|NFKBIA,BRD-K99916169,GS-143,ubiquitin ligase inhibitor,BTRC|NFKBIA,BRD-K99916169,GS-143,ubiquitin ligase inhibitor,BTRC|NFKBIA
JANBIXNDYNRYQP,,,,,BRD-K73565918,AS-2444697,interleukin inhibitor,IRAK4,BRD-K73565918,AS-2444697,interleukin inhibitor,IRAK4,BRD-K73565918,AS-2444697,interleukin inhibitor,IRAK4
JENSDTKXNVHSSN,,,,,BRD-K76989898,TC-G-1004,adenosine receptor antagonist,ADORA2A,BRD-K76989898,TC-G-1004,adenosine receptor antagonist,ADORA2A,BRD-K76989898,TC-G-1004,adenosine receptor antagonist,ADORA2A
JFCDMGGMCUKHST,,,,,BRD-K62066682,A-412997,dopamine receptor agonist,DRD4,BRD-K62066682,A-412997,dopamine receptor agonist,DRD4,BRD-K62066682,A-412997,dopamine receptor agonist,DRD4
JGGQWSXZZQPZTR,,,,,BRD-K04635846,PNU-177864,dopamine receptor antagonist,DRD3,BRD-K04635846,PNU-177864,dopamine receptor antagonist,DRD3,BRD-K04635846,PNU-177864,dopamine receptor antagonist,DRD3
JHNRTPKGSCVKKC,,,,,BRD-K81341251,TRAM-39,calcium-activated potassium channel activator,KCNN4,BRD-K81341251,TRAM-39,calcium-activated potassium channel activator,KCNN4,BRD-K81341251,TRAM-39,calcium-activated potassium channel activator,KCNN4
JJHRUUKMPWUYIB,,,,,BRD-K57011718,UK-356618,metalloproteinase inhibitor,MMP13|MMP14|MMP2|MMP3|MMP9,BRD-K57011718,UK-356618,metalloproteinase inhibitor,MMP13|MMP14|MMP2|MMP3|MMP9,BRD-K57011718,UK-356618,metalloproteinase inhibitor,MMP13|MMP14|MMP2|MMP3|MMP9
JJUUTJCZMGZJDZ,,,,,BRD-K11428250,PA-452,retinoid receptor antagonist,RXRA,BRD-K11428250,PA-452,retinoid receptor antagonist,RXRA,BRD-K11428250,PA-452,retinoid receptor antagonist,RXRA
JPCYSKNELCOPKJ,,,,,BRD-K90999434,CCT-031374,WNT signaling inhibitor,CTNNB1,BRD-K90999434,CCT-031374,WNT signaling inhibitor,CTNNB1,BRD-K90999434,CCT-031374,WNT signaling inhibitor,CTNNB1
JPJGFWKHSMUKFO,,,,,BRD-K20239555,A-887826,sodium channel blocker,SCN10A,BRD-K20239555,A-887826,sodium channel blocker,SCN10A,BRD-K20239555,A-887826,sodium channel blocker,SCN10A
JQGOCCALXFSRHZ,,,,,BRD-K83904070,R-268712,serine/threonine kinase inhibitor,TGFBR1,BRD-K83904070,R-268712,serine/threonine kinase inhibitor,TGFBR1,BRD-K83904070,R-268712,serine/threonine kinase inhibitor,TGFBR1
JQOIRTDBHMDWMT,,,,,BRD-K63253858,SPP-86,receptor tyrosine protein kinase inhibitor,RET,BRD-K63253858,SPP-86,receptor tyrosine protein kinase inhibitor,RET,BRD-K63253858,SPP86,receptor tyrosine protein kinase inhibitor,RET
JQULIQJSYPZQMA,,,,,BRD-K16939217,TC-G-1005,G protein-coupled receptor agonist,GPBAR1,BRD-K16939217,TC-G-1005,G protein-coupled receptor agonist,GPBAR1,BRD-K16939217,TC-G-1005,G protein-coupled receptor agonist,GPBAR1
JTRXWCLQFAZHGP,,,,,BRD-K79700588,reversan,MRP inhibitor,ABCC1,BRD-K79700588,reversan,MRP inhibitor,ABCC1,BRD-K79700588,reversan,MRP inhibitor,ABCC1
JVCWPUFNLFSKFS,,,,,BRD-K15819326,AC-710,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,BRD-K15819326,AC-710,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,BRD-K15819326,AC-710,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB
JVPVEAZJBAQNRB,,,,,BRD-M50913522,oxotremorine-sesquifumarate,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,,,,,,,,
JVRRRKAXHMGUHZ,,,,,BRD-A93717708,VUF11207,CC chemokine receptor agonist,ACKR3,BRD-A93717708,VUF11207,CC chemokine receptor agonist,ACKR3,BRD-A93717708,VUF11207,CC chemokine receptor agonist,ACKR3
JXPULDIATMTIIN,,,,,BRD-K24434292,NS-3623,voltage-gated potassium channel activator,KCNH2,BRD-K24434292,NS-3623,voltage-gated potassium channel activator,KCNH2,BRD-K24434292,NS-3623,voltage-gated potassium channel activator,KCNH2
JZMLHJRKSJXARY,,,,,BRD-K52087522,YM-244769,sodium/calcium exchange inhibitor,,BRD-K52087522,YM-244769,sodium/calcium exchange inhibitor,,BRD-K52087522,YM-244769,sodium/calcium exchange inhibitor,
KCIMKTNQCUDTFI,,,,,BRD-K84068331,CW-008,PKA activator,PRKACA,BRD-K84068331,CW-008,PKA activator,PRKACA,BRD-K84068331,CW-008,PKA activator,PRKACA
KCODNOOPOPTZMO,,,,,BRD-K71250460,SUN-11602,fibroblast growth factor mimetic,FGFR1,BRD-K71250460,SUN-11602,fibroblast growth factor mimetic,FGFR1,BRD-K71250460,SUN-11602,fibroblast growth factor mimetic,FGFR1
KDDXOGDIPZSCTM,,,,,BRD-K60298136,ITE,aryl hydrocarbon receptor agonist,AHR,BRD-K60298136,ITE,aryl hydrocarbon receptor agonist,AHR,BRD-K60298136,ITE,aryl hydrocarbon receptor agonist,AHR
KDQVMGQHPAKJAN,,,,,BRD-K14646328,BC-11,urokinase inhibitor,PLAU,BRD-K14646328,BC-11,urokinase inhibitor,PLAU,BRD-K14646328,BC-11,urokinase inhibitor,PLAU
KIALCSMRIHRFPL,,,,,BRD-K54783522,VU29,glutamate receptor potentiator,GRM5,BRD-K54783522,VU29,glutamate receptor potentiator,GRM5,BRD-K54783522,VU29,glutamate receptor potentiator,GRM5
KLFVWQCQUXXLOU,,,,,BRD-K42536037,EPPTB,trace amine associated receptor antagonist,TAAR1,BRD-K42536037,EPPTB,trace amine associated receptor antagonist,TAAR1,BRD-K42536037,EPPTB,trace amine associated receptor antagonist,TAAR1
KMIQMFHPUJUDMC,,,,,BRD-K43167535,C34,toll-like receptor inhibitor,TLR4,BRD-K43167535,C34,toll-like receptor inhibitor,TLR4,BRD-K43167535,C34,toll-like receptor inhibitor,TLR4
KMKBEESNZAPKMP,,,,,BRD-A13293292,BINA,glutamate receptor positive allosteric modulator,GRM2,BRD-A13293292,BINA,glutamate receptor positive allosteric modulator,GRM2,BRD-K00004296,BINA,glutamate receptor positive allosteric modulator,GRM2
KMSKKYBHDQYHMC,,,,,BRD-K05973499,AZ-12080282,hedgehog pathway inhibitor,DHH,BRD-K05973499,AZ-12080282,hedgehog pathway inhibitor,DHH,BRD-K05973499,AZ-12080282,hedgehog pathway inhibitor,DHH
KPTMSQHTGZMEFU,,,,,BRD-K54297077,TC-O-9311,G protein-coupled receptor agonist,GPR139,BRD-K54297077,TC-O-9311,G protein-coupled receptor agonist,GPR139,BRD-K54297077,TC-O-9311,G protein-coupled receptor agonist,GPR139
KSEXDSJYVSEVGF,,,,,BRD-A75514485,CIM-0216,transient receptor potential channel agonist,TRPM3,BRD-A75514485,CIM-0216,transient receptor potential channel agonist,TRPM3,BRD-A75514485,CIM-0216,transient receptor potential channel agonist,TRPM3
KSNHHKZYKYNBEI,,,,,BRD-K55013981,TC-OT-39,oxytocin receptor agonist|vasopressin receptor agonist,AVPR1A|OXT,BRD-K55013981,TC-OT-39,oxytocin receptor agonist|vasopressin receptor agonist,AVPR1A|OXT,BRD-K55013981,TC-OT-39,oxytocin receptor agonist|vasopressin receptor agonist,AVPR1A|OXT
KVHGJAKTBPFFNV,,,,,BRD-A30000356,A12B4C3,polynucleotide kinase/phosphatase inhibitor,PNKP,BRD-A30000356,A12B4C3,polynucleotide kinase/phosphatase inhibitor,PNKP,BRD-A30000356,A12B4C3,polynucleotide kinase/phosphatase inhibitor,PNKP
KVHKWAZUPPBMLL,,,,,BRD-K11641193,SR-2211,retinoid receptor inverse agonist,RORC,BRD-K11641193,SR-2211,retinoid receptor inverse agonist,RORC,BRD-K11641193,SR-2211,retinoid receptor inverse agonist,RORC
KVQOGDQTWWCZFX,,,,,BRD-K09485525,GANT-61,GLI antagonist,GLI1|GLI2,BRD-K09485525,GANT-61,GLI antagonist,GLI1|GLI2,BRD-K09485525,GANT-61,GLI antagonist,GLI1|GLI2
KWDBQJRWPWTGPF,,,,,BRD-K17617556,NIDA-41020,cannabinoid receptor antagonist,CNR1,BRD-K17617556,NIDA-41020,cannabinoid receptor antagonist,CNR1,BRD-K17617556,NIDA-41020,cannabinoid receptor antagonist,CNR1
KWJRSHZSULRJHE,,,,,BRD-K64103579,ZLN-024,AMPK activator,PRKAA1|PRKAB1|PRKAG1,BRD-K64103579,ZLN-024,AMPK activator,PRKAA1|PRKAB1|PRKAG1,BRD-K64103579,ZLN024,AMPK activator,PRKAA1|PRKAB1|PRKAG1
LBPNOEAFWYTTEB,,,,,BRD-K44400149,PhiKan-083,p53 stabilizing agent,TP53,BRD-K44400149,PhiKan-083,p53 stabilizing agent,TP53,BRD-K44400149,PhiKan-083,p53 stabilizing agent,TP53
LEXDAVFCJPDCNA,,,,,BRD-K17751100,CC4,nicotinic receptor agonist,CHRNB2,BRD-K17751100,CC4,nicotinic receptor agonist,CHRNB2,BRD-K17751100,CC4,nicotinic receptor agonist,CHRNB2
LHABRXRGDLASIH,,,,,BRD-K61560897,FIPI,phospholipase inhibitor,PLD1|PLD2,BRD-K61560897,FIPI,phospholipase inhibitor,PLD1|PLD2,BRD-K61560897,FIPI,phospholipase inhibitor,PLD1|PLD2
LIPWZZYFIVYJSI,,,,,BRD-K04035716,PK-44,dipeptidyl peptidase inhibitor,DPP4,BRD-K04035716,PK-44,dipeptidyl peptidase inhibitor,DPP4,BRD-K04035716,PK-44,dipeptidyl peptidase inhibitor,DPP4
LITXVDAFEYLWQE,,,,,BRD-K89462779,CU-T12-9,toll-like receptor agonist,TLR1|TLR2,BRD-K89462779,CU-T12-9,toll-like receptor agonist,TLR1|TLR2,BRD-K89462779,CU-T12-9,toll-like receptor agonist,TLR1|TLR2
LJBBMCNHIUJBDU,,,,,BRD-A02532772,talopram,adrenergic inhibitor,SLC6A2,BRD-A02532772,talopram,adrenergic inhibitor,SLC6A2,BRD-A02532772,talopram,adrenergic inhibitor,SLC6A2
LNUXNUNUGIHCPA,,,,,BRD-K77915400,TCN-238,glutamate receptor positive allosteric modulator,GRM4,BRD-K77915400,TCN-238,glutamate receptor positive allosteric modulator,GRM4,BRD-K77915400,TCN238,glutamate receptor positive allosteric modulator,GRM4
LOSJNRBXNQTUNT,,,,,BRD-A06700447,SCH-221510,nociceptin/orphanin FQ (NOP) receptor agonist,OPRL1,BRD-A06700447,SCH-221510,nociceptin/orphanin FQ (NOP) receptor agonist,OPRL1,BRD-K00004286,SCH-221510,nociceptin/orphanin FQ receptor agonist,OPRL1
LPGBXHWIQNZEJB,,,,,BRD-K24282351,TUG-891,free fatty acid receptor agonist,FFAR4,BRD-K24282351,TUG-891,free fatty acid receptor agonist,FFAR4,BRD-K24282351,TUG-891,free fatty acid receptor agonist,FFAR4
LQPGVGSKBNXQDU,,,,,BRD-K55438324,GSK-J5,histone demethylase control,,BRD-K55438324,GSK-J5,histone demethylase control,,BRD-K55438324,GSK-J5,histone demethylase control,
LSGNKLDHMQVTEK,,,,,BRD-K18347943,ER-50891,retinoid receptor antagonist,RARA,BRD-K18347943,ER-50891,retinoid receptor antagonist,RARA,BRD-K18347943,ER-50891,retinoid receptor antagonist,RARA
LTGLGIQQZXSLLF,,,,,BRD-K73610817,UC-112,XIAP inhibitor,XIAP,BRD-K73610817,UC-112,XIAP inhibitor,XIAP,BRD-K73610817,UC-112,XIAP inhibitor,XIAP
LTWQQWSXYYXVGA,,,,,BRD-K81053848,KS-176,BCRP inhibitor,ABCG2,BRD-K81053848,KS-176,BCRP inhibitor,ABCG2,BRD-K81053848,KS-176,BCRP inhibitor,ABCG2
LTZKEDSUXKTTTC,,,,,BRD-K90830492,deltarasin,phosphodiesterase inhibitor,KRAS,BRD-K90830492,deltarasin,phosphodiesterase inhibitor,KRAS,BRD-K90830492,deltarasin,phosphodiesterase inhibitor,KRAS
LUVXHMJTVXZFPD,,,,,BRD-K48053228,PHA-568487,nicotinic receptor agonist,CHRNA7,BRD-K48053228,PHA-568487,nicotinic receptor agonist,CHRNA7,BRD-K48053228,PHA-568487,nicotinic receptor agonist,CHRNA7
MBCJUIJWPYUEBX,,,,,BRD-K49597925,SB-747651A,kinase inhibitor,AKT1|AKT3|ROCK1|RPS6KA5|RPS6KB1,BRD-K49597925,SB-747651A,kinase inhibitor,AKT1|AKT3|ROCK1|RPS6KA5|RPS6KB1,BRD-K49597925,SB-747651A,kinase inhibitor,AKT1|AKT3|ROCK1|RPS6KA5|RPS6KB1
MDKAFDIKYQMOMF,,,,,BRD-K94342292,NS-11021,calcium-activated potassium channel activator,KCNMA1,BRD-K94342292,NS-11021,calcium-activated potassium channel activator,KCNMA1,BRD-K94342292,NS-11021,calcium-activated potassium channel activator,KCNMA1
MDNWGCQSCGNTKH,,,,,BRD-K87727457,VU-152100,acetylcholine receptor allosteric modulator,CHRM4,BRD-K87727457,VU-152100,acetylcholine receptor allosteric modulator,CHRM4,BRD-K87727457,VU152100,acetylcholine receptor allosteric modulator,CHRM4
MDYKTGNHXNTATG,,,,,BRD-K18530250,Mps-BAY-2a,monopolar spindle 1 kinase inhibitor,TTK,BRD-K18530250,Mps-BAY-2a,monopolar spindle 1 kinase inhibitor,TTK,BRD-K18530250,Mps-BAY-2a,monopolar spindle 1 kinase inhibitor,TTK
MEAQCLPMSVEOQF,,,,,BRD-K59060513,A-1120,retinoid receptor ligand,RBP4,BRD-K59060513,A-1120,retinoid receptor ligand,RBP4,BRD-K59060513,A-1120,retinoid receptor ligand,RBP4
MEDCLNYIYBERKO,,,,,BRD-K77911775,ADX-10059,glutamate receptor negative allosteric modulator,GRM5,BRD-K77911775,ADX-10059,glutamate receptor negative allosteric modulator,GRM5,BRD-K77911775,ADX-10059,glutamate receptor negative allosteric modulator,GRM5
MENNDDDTIIZDDN,,,,,BRD-K16472653,SirReal-2,SIRT inhibitor,SIRT2,BRD-K16472653,SirReal-2,SIRT inhibitor,SIRT2,BRD-K16472653,SirReal-2,SIRT inhibitor,SIRT2
MEOTUCBFWIQPRL,,,,,BRD-K57773246,colistin-sulfate,bacterial permeability inducer,,BRD-K57773246|BRD-M52026403,colistin-sulfate,bacterial permeability inducer,,,,,
MFABFKUNLDYKGH,,,,,BRD-K77547509,ML-179,liver receptor homolog inverse agonist,NR5A2,BRD-K77547509,ML-179,liver receptor homolog inverse agonist,NR5A2,BRD-K77547509,ML179,liver receptor homolog inverse agonist,NR5A2
MFEADGGBEDIZRE,,,,,BRD-M14816435,endo-IWR-1,PARP inhibitor,TNKS|TNKS2,,,,,,,,
MFPAAKZZUIRMKR,,,,,BRD-K70614402,SEN-1269,beta amyloid inhibitor,APP,BRD-K70614402,SEN-1269,beta amyloid inhibitor,APP,BRD-K70614402,SEN-1269,beta amyloid inhibitor,APP
MGKYEWWFHSESJN,,,,,BRD-K28567778,neuropathiazol,neural stem cell inducer,BMP2|LIF,BRD-K28567778,neuropathiazol,neural stem cell inducer,BMP2|LIF,BRD-K28567778,neuropathiazol,neural stem cell inducer,BMP2|LIF
MHTJEUOFLVQMCL,,,,,BRD-K32143970,AP-18,transient receptor potential channel antagonist,TRPA1,BRD-K32143970,AP-18,transient receptor potential channel antagonist,TRPA1,BRD-K32143970,AP-18,transient receptor potential channel antagonist,TRPA1
MKILROQBJOOZKC,,,,,BRD-K89329876,BRD-9876,kinesin inhibitor,KIF11,BRD-K89329876,BRD-9876,kinesin inhibitor,KIF11,BRD-K89329876,BRD9876,kinesin inhibitor,KIF11
MMPAULQSJLVKHP,,,,,BRD-K13223831,A-438079,purinergic receptor antagonist,P2RX7,BRD-K13223831,A-438079,purinergic receptor antagonist,P2RX7,BRD-K13223831,A-438079,purinergic receptor antagonist,P2RX7
MNQBPRHHZPXCKZ,,,,,BRD-K21318844,BIO-5192,integrin inhibitor,ITGA4|ITGB1,BRD-K21318844,BIO-5192,integrin inhibitor,ITGA4|ITGB1,BRD-K21318844,BIO-5192,integrin inhibitor,ITGA4|ITGB1
MQTUXRKNJYPMCG,,,,,BRD-K26169680,robalzotan,serotonin receptor antagonist,HTR1A,BRD-K26169680,robalzotan,serotonin receptor antagonist,HTR1A,BRD-K26169680,robalzotan,serotonin receptor antagonist,HTR1A
MQYLFDNDDBYJJI,,,,,BRD-M00539986,formoterol,adrenergic receptor agonist,ADRB2,,,,,,,,
MSJISJDTJJYBFT,,,,,BRD-K74965187,COR-170,cannabinoid receptor inverse agonist,CNR2,BRD-K74965187,COR-170,cannabinoid receptor inverse agonist,CNR2,BRD-K74965187,COR-170,cannabinoid receptor inverse agonist,CNR2
MSTXJJGAXXJCBY,,,,,BRD-K93317811,VU-0364739,phospholipase inhibitor,PLD2,BRD-K93317811,VU-0364739,phospholipase inhibitor,PLD2,BRD-K93317811,VU0364739,phospholipase inhibitor,PLD2
MSWIQSFUBYCFJE,,,,,BRD-K83970940,Lu-AA-47070,adenosine receptor antagonist,ADORA2A,BRD-K83970940,Lu-AA-47070,adenosine receptor antagonist,ADORA2A,BRD-K83970940,Lu-AA-47070,adenosine receptor antagonist,ADORA2A
MTDIMKNAJUQTIO,,,,,BRD-A80567330,ONO-AE3-208,prostanoid receptor antagonist,PTGER4,BRD-A80567330,ONO-AE3-208,prostanoid receptor antagonist,PTGER4,BRD-A80567330,ONO-AE3-208,prostanoid receptor antagonist,PTGER4
MTFAYLZZDJGFGV,,,,,BRD-K50378376,SR-3576,JNK inhibitor,MAPK10,BRD-K50378376,SR-3576,JNK inhibitor,MAPK10,BRD-K50378376,SR-3576,JNK inhibitor,MAPK10
MVYNQMRZRULRIE,,,,,BRD-A67976398,DQP-1105,glutamate receptor antagonist,GRIN2C|GRIN2D,BRD-A67976398,DQP-1105,glutamate receptor antagonist,GRIN2C|GRIN2D,BRD-A67976398,DQP-1105,glutamate receptor antagonist,GRIN2C|GRIN2D
MWGXGTJJAOZBNW,,,,,BRD-K20976221,NU-2058,cyclin D inhibitor,CCNA2|CDK2,BRD-K20976221,NU-2058,cyclin D inhibitor,CCNA2|CDK2,BRD-K20976221,NU-2058,cyclin D inhibitor,CCNA2|CDK2
MYIMRONQBLZJFI,,,,,BRD-K23479488,dynole-34-2,dynamin inhibitor,DNM1,BRD-K23479488,dynole-34-2,dynamin inhibitor,DNM1,BRD-K23479488,dynole-34-2,dynamin inhibitor,DNM1
MYTRGTBDVGKKRO,,,,,BRD-K60635008,UNC-2327,protein arginine N-methyltransferase inhibitor,PRMT3,BRD-K60635008,UNC-2327,protein arginine N-methyltransferase inhibitor,PRMT3,BRD-K60635008,UNC2327,protein arginine N-methyltransferase inhibitor,PRMT3
MZRLPXFGQKQHST,,,,,BRD-K68674163,VU-0422288,glutamate receptor allosteric modulator,GRM3,BRD-K68674163,VU-0422288,glutamate receptor allosteric modulator,GRM3,BRD-K68674163,VU0422288,glutamate receptor positive allosteric modulator,GRM3
NBTNHSGBRGTFJS,,,,,BRD-K50199947,WH-4-023,src inhibitor,LCK|SRC,BRD-K50199947,WH-4-023,src inhibitor,LCK|SRC,BRD-K50199947,WH-4-023,SRC inhibitor,LCK|SRC
NCSHZXNGQYSKLR,,,,,BRD-K18634484,iCRT-14,WNT signaling inhibitor|beta catenin inhibitor,CTNNB1|TCF4,BRD-K18634484,iCRT-14,WNT signaling inhibitor|beta catenin inhibitor,CTNNB1|TCF4,BRD-K18634484,iCRT-14,WNT signaling inhibitor|beta catenin inhibitor,CTNNB1|TCF4
NCZYSQOTAYFTNM,,,,,BRD-K03391209,HC-067047,transient receptor potential channel antagonist,TRPV4,BRD-K03391209,HC-067047,transient receptor potential channel antagonist,TRPV4,BRD-K03391209,HC-067047,transient receptor potential channel antagonist,TRPV4
NDKGACIWVAOUQH,,,,,BRD-K75940276,CYM-5541,sphingosine 1 phosphate receptor agonist,S1PR3,BRD-K75940276,CYM-5541,sphingosine 1 phosphate receptor agonist,S1PR3,BRD-K75940276,CYM-5541,sphingosine 1-phosphate receptor agonist,S1PR3
NEHSERYKENINRH,,,,,BRD-K15256258,TC-E-5002,histone demethylase inhibitor,KDM2A|KDM4A|KDM4C|KDM5A|KDM6A|KDM7A|PHF8,BRD-K15256258,TC-E-5002,histone demethylase inhibitor,KDM2A|KDM4A|KDM4C|KDM5A|KDM6A|KDM7A|PHF8,BRD-K15256258,TC-E-5002,histone demethylase inhibitor,KDM2A|KDM4A|KDM4C|KDM5A|KDM6A|KDM7A|PHF8
NEMHWVUKNWAKTM,,,,,BRD-K83649660,VU0360172,glutamate receptor positive allosteric modulator,GRM5,BRD-K83649660,VU0360172,glutamate receptor positive allosteric modulator,GRM5,BRD-K83649660,VU0360172,glutamate receptor positive allosteric modulator,GRM5
NGEBYTLALFOQKI,,,,,BRD-K73984371,AZD3988,diacylglycerol kinase inhibitor,DGAT1,BRD-K73984371,AZD3988,diacylglycerol kinase inhibitor,DGAT1,BRD-K73984371,AZD3988,diacylglycerol kinase inhibitor,DGAT1
NGQPRVWTFNBUHA,,,,,BRD-K22477529,STF-31,NAMPT inhibitor,NAMPT|SLC2A1,BRD-K22477529,STF-31,NAMPT inhibitor,NAMPT|SLC2A1,BRD-K22477529,STF-31,NAMPT inhibitor,NAMPT|SLC2A1
NIJGWJIOMPHDBP,,,,,BRD-K90082312,VUF10460,histamine receptor agonist,HRH4,BRD-K90082312,VUF10460,histamine receptor agonist,HRH4,BRD-K90082312,VUF10460,histamine receptor agonist,HRH4
NJFVQMRYJZHGME,,,,,BRD-K73738482,NS-1643,voltage-gated potassium channel activator,KCNH2|KCNH6|KCNMA1,BRD-K73738482,NS-1643,voltage-gated potassium channel activator,KCNH2|KCNH6|KCNMA1,BRD-K73738482,NS-1643,voltage-gated potassium channel activator,KCNH2|KCNH6|KCNMA1
NJLHHCITDFZZSE,,,,,BRD-A64004759,LY266097,serotonin receptor antagonist,HTR2B,BRD-A64004759,LY266097,serotonin receptor antagonist,HTR2B,BRD-A64004759,LY266097,serotonin receptor antagonist,HTR2B
NLSSUSRERAMBTA,,,,,BRD-K57708067,TFC-007,prostaglandin inhibitor,HPGDS,BRD-K57708067,TFC-007,prostaglandin inhibitor,HPGDS,BRD-K57708067,TFC-007,prostaglandin inhibitor,HPGDS
NMEUKWOOQOHUNA,,,,,BRD-K51776215,TC-S-7006,MAP kinase inhibitor,MAP3K8,BRD-K51776215,TC-S-7006,MAP kinase inhibitor,MAP3K8,BRD-K51776215,TC-S-7006,MAP kinase inhibitor,MAP3K8
NMJMRSQTDLRCRQ,,,,,BRD-K94853001,Mps1-IN-1,monopolar spindle 1 kinase inhibitor,TTK,BRD-K94853001,Mps1-IN-1,monopolar spindle 1 kinase inhibitor,TTK,BRD-K94853001,Mps1-IN-1,monopolar spindle 1 kinase inhibitor,TTK
NMKJFZCBCIUYHI,,,,,BRD-K06890060,alda-1,aldehyde dehydrogenase activator,ALDH2,BRD-K06890060,alda-1,aldehyde dehydrogenase activator,ALDH2,BRD-K06890060,alda-1,aldehyde dehydrogenase activator,ALDH2
NODCQQSEMCESEC,,,,,BRD-K79294107,PLX-647,receptor tyrosine protein kinase inhibitor,CSF1R|KIT,BRD-K79294107,PLX-647,receptor tyrosine protein kinase inhibitor,CSF1R|KIT,BRD-K79294107,PLX647,receptor tyrosine protein kinase inhibitor,CSF1R|KIT
NOQGZXFMHARMLW,,,,,BRD-K83452553,daminozide,KDM2A inhibitor,KDM2A|KDM7A|PHF8,BRD-K83452553,daminozide,KDM2A inhibitor,KDM2A|KDM7A|PHF8,BRD-K83452553,daminozide,KDM2A inhibitor,KDM2A|KDM7A|PHF8
NSLIQOPYDUKWTA,,,,,BRD-K01492390,BTT-3033,integrin inhibitor,ITGA2|ITGB1,BRD-K01492390,BTT-3033,integrin inhibitor,ITGA2|ITGB1,BRD-K01492390,BTT-3033,integrin inhibitor,ITGA2|ITGB1
NSQNZEUFHPTJME,,,,,BRD-K76365178,SC-236,cyclooxygenase inhibitor,PTGS2,BRD-K76365178,SC-236,cyclooxygenase inhibitor,PTGS2,BRD-K76365178,SC-236,cyclooxygenase inhibitor,PTGS2
NTDFYGSSDDMNHI,,,,,BRD-A60153876,BETP,glucagon-like peptide receptor positive allosteric modulator,GLP1R,BRD-A60153876,BETP,glucagon-like peptide receptor positive allosteric modulator,GLP1R,BRD-K00004305,BETP,GLP receptor positive allosteric modulator,GLP1R
NTFPDEDRMYYPAC,,,,,BRD-A25625670,GGsTop,gamma glutamyltransferase Inhibitors,GGT1,BRD-A25625670,GGsTop,gamma glutamyltransferase Inhibitors,GGT1,BRD-A25625670,GGsTop,gamma glutamyltransferase Inhibitor,GGT1
NUIKTBLZSPQGCP,,,,,BRD-A43005764,CYM-5442,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-A43005764,CYM-5442,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-A43005764,CYM-5442,sphingosine 1-phosphate receptor agonist,S1PR1
NVNLLIYOARQCIX,,,,,BRD-A41063939,nisin,bacterial cell wall synthesis inhibitor,,BRD-A41063939|BRD-U59029435,nisin,bacterial cell wall synthesis inhibitor,,BRD-A41063939|BRD-U59029435,nisin,bacterial cell wall synthesis inhibitor,
NXTBLPPTZRPJCA,,,,,BRD-K26041695,TC-F-2,FAAH inhibitor,FAAH,BRD-K26041695,TC-F-2,FAAH inhibitor,FAAH,BRD-K26041695,TC-F-2,FAAH inhibitor,FAAH
NXUHVWMBPOFLMA,,,,,BRD-K51102532,SD-2590,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2,BRD-K51102532,SD-2590,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2,BRD-K51102532,SD-2590,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2
OCBMECSFDVUYQN,,,,,BRD-K03827870,GKA-50,glucokinase activator,GCK,BRD-K03827870,GKA-50,glucokinase activator,GCK,BRD-K03827870,GKA-50,glucokinase activator,GCK
OFHKDLYFKPBXER,,,,,BRD-K67079690,LUF-5834,adenosine receptor agonist,ADORA2A|ADORA2B,BRD-K67079690,LUF-5834,adenosine receptor agonist,ADORA2A|ADORA2B,BRD-K67079690,LUF-5834,adenosine receptor agonist,ADORA2A|ADORA2B
OFYVIGTWSQPCLF,,,,,BRD-A24208517,bicifadine,dopamine reuptake inhibitor|serotonin receptor antagonist,DRD2|SLC6A2|SLC6A4,BRD-A24208517,bicifadine,dopamine reuptake inhibitor|serotonin receptor antagonist,DRD2|SLC6A2|SLC6A4,BRD-K00004299,bicifadine,dopamine reuptake inhibitor|serotonin receptor antagonist,
OGKYMFFYOWUTKV,,,,,BRD-K34303607,CKI-7,casein kinase inhibitor,CSNK1G2,BRD-K34303607,CKI-7,casein kinase inhibitor,CSNK1G2,BRD-K34303607,CKI-7,casein kinase inhibitor,CSNK1G2
OHRDCQFCAWLDBP,,,,,BRD-K08333979,SB-612111,nociceptin/orphanin FQ (NOP) receptor antagonist,OPRL1,BRD-K08333979,SB-612111,nociceptin/orphanin FQ (NOP) receptor antagonist,OPRL1,BRD-K08333979,SB-612111,nociceptin/orphanin FQ receptor antagonist,OPRL1
OINGHOPGNMYCAB,,,,,BRD-K28132190,NVS-PAK1-1,p21 activated kinase inhibitor,PAK1,BRD-K28132190,NVS-PAK1-1,p21 activated kinase inhibitor,PAK1,BRD-K28132190,NVS-PAK1-1,p21 activated kinase inhibitor,PAK1
OISHBINQIFNIPV,,,,,BRD-K96843359,CP-775146,PPAR receptor agonist,PPARA,BRD-K96843359,CP-775146,PPAR receptor agonist,PPARA,BRD-K96843359,CP-775146,PPAR receptor agonist,PPARA
ONCSSPOCYKWCTO,,,,,BRD-A67101513,hygromycin-b,polypeptide synthesis inhibitor,,BRD-A26049141|BRD-A67101513,hygromycin-b,polypeptide synthesis inhibitor,,,,,
ONYWALXTZFPKAS,,,,,BRD-A66521565,TC-E-5006,gamma secretase modulator,APP,BRD-A66521565,TC-E-5006,gamma secretase modulator,APP,BRD-A66521565,TC-E-5006,gamma secretase modulator,APP
OOSUDWRRWZVFEB,,,,,BRD-K73499906,IT1t,CC chemokine receptor antagonist,CXCR4,BRD-K73499906,IT1t,CC chemokine receptor antagonist,CXCR4,BRD-K73499906,IT1t,CC chemokine receptor antagonist,CXCR4
OQAFDLPAPSSOHY,,,,,BRD-A94580299,KL-001,proteasome inhibitor,CRY1|CRY2,BRD-A94580299,KL-001,proteasome inhibitor,CRY1|CRY2,BRD-A94580299,KL-001,proteasome inhibitor,CRY1|CRY2
OQQVFCKUDYMWGV,,,,,BRD-K60476892,YC-1,guanylyl cyclase activator,GUCY1A2|GUCY1A3|GUCY1B3|HIF1A,BRD-K60476892,YC-1,guanylyl cyclase activator,GUCY1A2|GUCY1A3|GUCY1B3|HIF1A,BRD-K60476892,YC-1,guanylyl cyclase activator,GUCY1A2|GUCY1A3|GUCY1B3|HIF1A
OQWZIAVXCYIZNN,,,,,BRD-A86468475,SR-3677,rho associated kinase inhibitor,ROCK2,BRD-A86468475,SR-3677,rho associated kinase inhibitor,ROCK2,BRD-A86468475,SR-3677,rho associated kinase inhibitor,ROCK2
OVHCTHHFOHMNFV,,,,,BRD-K05419687,PSB-603,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K05419687,PSB-603,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K05419687,PSB-603,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
OVZUSPADPSOQQN,,,,,BRD-K42332878,indium-tri(2-propanolate),,,BRD-K42332878,indium-tri(2-propanolate),,,BRD-K42332878,indium-tri(2-propanolate),,
OWGLFIKZKQOYHZ,,,,,BRD-K22229656,UNC-926,MBT inhibitor,L3MBTL1,BRD-K22229656,UNC-926,MBT inhibitor,L3MBTL1,BRD-K22229656,UNC926,MBT inhibitor,L3MBTL1
OXKNHBBDOIMFFQ,,,,,BRD-K81044214,ML-348,lysophospholipase inhibitor,LYPLA1,BRD-K81044214,ML-348,lysophospholipase inhibitor,LYPLA1,BRD-K81044214,ML348,lysophospholipase inhibitor,LYPLA1
OXQNLLVUVDAEHC,,,,,BRD-K60020910,ML-277,potassium channel activator,KCNQ1,BRD-K60020910,ML-277,potassium channel activator,KCNQ1,BRD-K60020910,ML277,potassium channel activator,KCNQ1
OZCQEUZTOAAWDK,,,,,BRD-K10852420,AH-7614,free fatty acid receptor antagonist,FFAR4,BRD-K10852420,AH-7614,free fatty acid receptor antagonist,FFAR4,BRD-K10852420,AH-7614,free fatty acid receptor antagonist,FFAR4
PAEBEUZTAPIOIO,,,,,BRD-K16497916,TC-FPR-43,formyl peptide receptor agonist,FPR2,BRD-K16497916,TC-FPR-43,formyl peptide receptor agonist,FPR2,BRD-K16497916,TC-FPR-43,formyl peptide receptor agonist,FPR2
PHWHNHYZZNJPLB,,,,,BRD-K49110935,SB-772077B,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K49110935,SB-772077B,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K49110935,SB-772077B,rho associated kinase inhibitor,ROCK1|ROCK2
PJBFVWGQFLYWCB,,,,,BRD-A95683721,KW-3902,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-A95683721,KW-3902,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-A95683721,KW-3902,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
PJEIKJFNEFJFLA,,,,,BRD-K71315565,MJ-15,cannabinoid receptor antagonist,CNR1,BRD-K71315565,MJ-15,cannabinoid receptor antagonist,CNR1,BRD-K71315565,MJ-15,cannabinoid receptor antagonist,CNR1
PMEQBGAGFZDWQX,,,,,BRD-K42629487,SF-11,neuropeptide receptor antagonist,MCOLN3|NPY2R,BRD-K42629487,SF-11,neuropeptide receptor antagonist,MCOLN3|NPY2R,BRD-K42629487,SF-11,neuropeptide receptor antagonist,MCOLN3|NPY2R
POJZIZBONPAWIV,,,,,BRD-K93788137,PF-431396,focal adhesion kinase inhibitor,PTK2|PTK2B,BRD-K93788137,PF-431396,focal adhesion kinase inhibitor,PTK2|PTK2B,BRD-K93788137,PF-431396,focal adhesion kinase inhibitor,PTK2|PTK2B
PQQZHQGUKPKDBU,,,,,BRD-M39942365,xamoterol,adrenergic receptor agonist,ADRB1,,,,,,,,
PQYCRDPLPKGSME,,,,,BRD-K76894955,A-804598,purinergic receptor antagonist,P2RX7,BRD-K76894955|BRD-K94313941,A-804598,purinergic receptor antagonist,P2RX7,BRD-K76894955|BRD-K94313941,A-804598,purinergic receptor antagonist,P2RX7
PSTAJIONBVMKLA,,,,,BRD-K26726854,MI-14,PI4K inhibitor,PI4KB,BRD-K26726854,MI-14,PI4K inhibitor,PI4KB,BRD-K26726854,MI-14,PI4K inhibitor,PI4KB
PSUFQBRCUSJTDO,,,,,BRD-K81779590,NGD-98-2,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K81779590,NGD-98-2,corticosteroid releasing factor receptor antagonist,CRHR1,BRD-K81779590,NGD-98-2,corticotropin releasing factor receptor antagonist,CRHR1
PXOYOCNNSUAQNS,,,,,BRD-K53731810,alantolactone,STAT inhibitor|apoptosis stimulant,STAT3,BRD-K53731810,alantolactone,STAT inhibitor|apoptosis stimulant,STAT3,BRD-K53731810,alantolactone,STAT inhibitor|apoptosis stimulant,STAT3
PYNPWUIBJMVRIG,,,,,BRD-K00354853,RO-3,purinergic receptor antagonist,P2RX3,BRD-K00354853,RO-3,purinergic receptor antagonist,P2RX3,BRD-K00354853,Ro-3,purinergic receptor antagonist,P2RX3
QBNZBMVRFYREHK,,,,,BRD-A28422330,ML-141,GTPase inhibitor,CDC42,BRD-A28422330,ML-141,GTPase inhibitor,CDC42,BRD-A28422330,ML141,GTPase inhibitor,CDC42
QCIJLRJBZDBVDB,,,,,BRD-K13106865,PFI-4,bromodomain inhibitor,BRPF1,BRD-K13106865,PFI-4,bromodomain inhibitor,BRPF1,BRD-K13106865,PFI-4,bromodomain inhibitor,BRPF1
QCOQJYRPDUMCNP,,,,,BRD-K33234937,CP-471474,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,BRD-K33234937,CP-471474,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,BRD-K33234937,CP-471474,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9
QDERNBXNXJCIQK,,,,,BRD-K88120876,EIPA,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,ADRA2A|ASIC1|PKD2L1,BRD-K88120876,EIPA,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,ADRA2A|ASIC1|PKD2L1,BRD-K88120876,EIPA,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,ADRA2A|ASIC1|PKD2L1
QDUMEBKFKOODFN,,,,,BRD-K36697397,GSK-1562590,urotensin receptor antagonist,UTS2R,BRD-K36697397,GSK-1562590,urotensin receptor antagonist,UTS2R,BRD-K36697397,GSK1562590,urotensin receptor antagonist,UTS2R
QGBIWSABMNWWNB,,,,,BRD-M82363962,asenapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,BRD-M82363962,asenapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|HRH1|HRH2|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,,,,
QHVSQUYCVUHYKT,,,,,BRD-K27732927,CYM-50769,neuropeptide receptor antagonist,NPBWR1,BRD-K27732927,CYM-50769,neuropeptide receptor antagonist,NPBWR1,BRD-K27732927,CYM-50769,neuropeptide receptor antagonist,NPBWR1
QJEJLARVLKHYFW,,,,,BRD-K53849769,O4I1,Oct inducer,POU5F1,BRD-K53849769,O4I1,Oct inducer,POU5F1,BRD-K53849769,O4I1,Oct inducer,POU5F1
QLKAFHZJICDACE,,,,,BRD-K78161388,TC-N-1752,sodium channel blocker,SCN9A,BRD-K78161388,TC-N-1752,sodium channel blocker,SCN9A,BRD-K78161388,TC-N-1752,sodium channel blocker,SCN9A
QLPHOXTXAKOFMU,,,,,BRD-K70642949,GSK2334470,phosphoinositide dependent kinase inhibitor,AURKA|AURKB|PDPK1,BRD-K70642949,GSK2334470,phosphoinositide dependent kinase inhibitor,AURKA|AURKB|PDPK1,BRD-K70642949,GSK2334470,phosphoinositide dependent kinase inhibitor,AURKA|AURKB|PDPK1
QMBUCWVILCOIEG,,,,,BRD-K93666001,cyclopiazonic-acid,ATPase inhibitor,ATP2A1,,,,,,,,
QNRODODTMXCRKU,,,,,BRD-K44432556,ML-228,hypoxia inducible factor activator,HIF1A,BRD-K44432556,ML-228,hypoxia inducible factor activator,HIF1A,BRD-K44432556,ML228,hypoxia inducible factor activator,HIF1A
QNYRAEKLMNDRFY,,,,,BRD-K38875233,JZL-195,FAAH inhibitor|monoacylglycerol lipase inhibitor,FAAH|MGLL,BRD-K38875233,JZL-195,FAAH inhibitor|monoacylglycerol lipase inhibitor,FAAH|MGLL,BRD-K38875233,JZL-195,FAAH inhibitor|monoacylglycerol lipase inhibitor,FAAH|MGLL
QRJTZIJWDLJKQO,,,,,BRD-K94659840,pyrintegrin,integrin signaling activator,,BRD-K94659840,pyrintegrin,integrin signaling activator,,BRD-K94659840,pyrintegrin,integrin signaling activator,
QUGDTMONBLMLLD,,,,,BRD-K31170746,ANR-94,A1 adenosine receptor antagonist,ADORA2A,BRD-K31170746,ANR-94,A1 adenosine receptor antagonist,ADORA2A,BRD-K31170746,ANR-94,adenosine receptor antagonist,ADORA2A
QWJOPXDAQCDRRM,,,,,BRD-K80666802,CYM-50358,sphingosine 1-phosphate receptor antagonist,S1PR4,BRD-K80666802,CYM-50358,sphingosine 1-phosphate receptor antagonist,S1PR4,BRD-K80666802,CYM-50358,sphingosine 1-phosphate receptor antagonist,S1PR4
QXHVGEXNEZRSGG,,,,,BRD-K18573821,PAOPA,dopamine receptor modulator,DRD2,BRD-K18573821,PAOPA,dopamine receptor modulator,DRD2,BRD-K18573821,PAOPA,dopamine receptor modulator,DRD2
RAOULLCLLOGTDA,,,,,BRD-K64852730,TTP-22,casein kinase inhibitor,CSNK2A1,BRD-K64852730,TTP-22,casein kinase inhibitor,CSNK2A1,BRD-K64852730,TTP-22,casein kinase inhibitor,CSNK2A1
RAYDUSPLSJVROR,,,,,BRD-M45038741,metoprolol,adrenergic receptor antagonist,ADRB1|ADRB2,,,,,,,,
RBKIJGLHFFQHBE,,,,,BRD-K61721596,JNJ-10397049,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K61721596,JNJ-10397049,orexin receptor antagonist,HCRTR1|HCRTR2,BRD-K61721596,JNJ-10397049,orexin receptor antagonist,HCRTR1|HCRTR2
RBSPCALDSNXWEP,,,,,BRD-K61043483,AZD9272,glutamate receptor antagonist,GRM5,BRD-K61043483,AZD9272,glutamate receptor antagonist,GRM5,BRD-K61043483,AZD9272,glutamate receptor antagonist,GRM5
RGWJKANXFYJKHN,,,,,BRD-K70404782,LM-22A4,tropomyosin receptor kinase inhibitor,NTRK2,BRD-K70404782,LM-22A4,tropomyosin receptor kinase inhibitor,NTRK2,BRD-K70404782,LM-22A4,tropomyosin receptor kinase inhibitor,NTRK2
RIRDSZBDOHSJGT,,,,,BRD-K13142315,A-61603,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,BRD-K13142315,A-61603,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,,,,
RLKWQKZPCMICPS,,,,,BRD-K27010807,TC-G-1000,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K27010807,TC-G-1000,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,BRD-K27010807,TC-G-1000,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C
ROGUAPYLUCHQGK,,,,,BRD-K66541497,BCTC,TRPV antagonist,TRPV1,BRD-K66541497,BCTC,TRPV antagonist,TRPV1,BRD-K66541497,BCTC,TRPV antagonist,TRPV1
RPDFDSQFBCJTDY,,,,,BRD-K60931454,SR-140333,neurokinin receptor antagonist,TACR1,BRD-K60931454,SR-140333,neurokinin receptor antagonist,TACR1,BRD-K60931454,SR-140333,neurokinin receptor antagonist,TACR1
RRZVGDGTWNQAPW,,,,,BRD-K66830666,BAZ2-ICR,bromodomain inhibitor,ZNF215,BRD-K66830666,BAZ2-ICR,bromodomain inhibitor,ZNF215,BRD-K66830666,BAZ2-ICR,bromodomain inhibitor,ZNF215
RVFIAQAAZUEPPE,,,,,BRD-K69343602,ML-10302,serotonin receptor partial agonist,HTR3A|HTR3B|HTR4,BRD-K69343602,ML-10302,serotonin receptor partial agonist,HTR3A|HTR3B|HTR4,BRD-K69343602,ML10302,serotonin receptor partial agonist,HTR3A|HTR3B|HTR4
RVNOANDLZIIFHB,,,,,BRD-A11069678,rac-BHFF,GABA receptor positive allosteric modulator,GABBR1,BRD-A11069678,rac-BHFF,GABA receptor positive allosteric modulator,GABBR1,BRD-A11069678,rac-BHFF,GABA receptor positive allosteric modulator,GABBR1
RXIUMAOXORBRCY,,,,,BRD-A25043798,casin,GTPase inhibitor,CDC42,BRD-A25043798,casin,GTPase inhibitor,CDC42,BRD-A25043798,casin,GTPase inhibitor,CDC42
RXLOZRCLQMJJLC,,,,,BRD-K02782351,SSR-180711,acetylcholine receptor agonist,CHRNA7,BRD-K02782351,SSR-180711,acetylcholine receptor agonist,CHRNA7,BRD-K00004316,SSR180711,acetylcholine receptor agonist,CHRNA7
RZBCPMYJIARMGV,,,,,BRD-K50679358,GSK-2837808A,lactate dehydrogenase inhibitor,LDHA,BRD-K50679358,GSK-2837808A,lactate dehydrogenase inhibitor,LDHA,BRD-K50679358,GSK2837808A,lactate dehydrogenase inhibitor,LDHA
RZCNASHHHSKTGP,,,,,BRD-K46344388,UNC-3230,phosphatidyl-inositol activator,PIP5K1C,BRD-K46344388,UNC-3230,phosphatidyl-inositol activator,PIP5K1C,BRD-K46344388,UNC3230,phosphatidyl-inositol activator,PIP5K1C
SAXGSDIZIYFNKD,,,,,BRD-K36485341,GW-542573X,calcium channel activator,KCNN1,BRD-K36485341,GW-542573X,calcium channel activator,KCNN1,BRD-K36485341,GW-542573X,calcium channel activator,KCNN1
SBTRHJHOLCAPFT,,,,,BRD-A39794701,DR-4485,serotonin receptor antagonist,HTR7,BRD-A39794701,DR-4485,serotonin receptor antagonist,HTR7,BRD-A39794701,DR-4485,serotonin receptor antagonist,HTR7
SCOOTUMXCXKEAD,,,,,BRD-K13944729,AA-29504,GABA receptor positive allosteric modulator,GABRA1|GABRA4|GABRB3,BRD-K13944729,AA-29504,GABA receptor positive allosteric modulator,GABRA1|GABRA4|GABRB3,BRD-K13944729,AA-29504,GABA receptor positive allosteric modulator,GABRA1|GABRA4|GABRB3
SDUAWRFBHRAFBM,,,,,BRD-K87665527,A-784168,transient receptor potential channel antagonist,TRPV1,BRD-K87665527,A-784168,transient receptor potential channel antagonist,TRPV1,BRD-K87665527,A-784168,transient receptor potential channel antagonist,TRPV1
SFNLLCUAISZNRV,,,,,BRD-K24527118,TMN-355,cyclophilin inhibitor,PPIA,BRD-K24527118,TMN-355,cyclophilin inhibitor,PPIA,BRD-K24527118,TMN-355,cyclophilin inhibitor,PPIA
SFRQIPRTNYHJHP,,,,,BRD-A63344375,SHA-68,neuropeptide receptor antagonist,NPSR1,BRD-A63344375,SHA-68,neuropeptide receptor antagonist,NPSR1,BRD-A63344375,SHA-68,neuropeptide receptor antagonist,NPSR1
SFSFIDVAEMDPIP,,,,,BRD-K63483542,WAY-208466,serotonin receptor agonist,DRD2|HTR2A|HTR2C|HTR6|HTR7,BRD-K63483542,WAY-208466,serotonin receptor agonist,DRD2|HTR2A|HTR2C|HTR6|HTR7,BRD-K63483542,WAY-208466,serotonin receptor agonist,DRD2|HTR2A|HTR2C|HTR6|HTR7
SHPFDGWALWEPGS,,,,,BRD-A88787317,KI-20227,c-Fms inhibitor,CSF1R|KDR|KIT|PDGFRB,BRD-A88787317,KI-20227,c-Fms inhibitor,CSF1R|KDR|KIT|PDGFRB,BRD-A88787317,KI-20227,c-Fms inhibitor,CSF1R|KDR|KIT|PDGFRB
SIQGKPGBLYKQBB,,,,,BRD-A12633378,ML-213,potassium channel activator,KCNQ4,BRD-A12633378,ML-213,potassium channel activator,KCNQ4,BRD-K00004301,ML213,potassium channel activator,KCNQ4
SJMMDWXJSSJHOQ,,,,,BRD-K87941707,TP-003,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K87941707,TP-003,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,BRD-K87941707,TP-003,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5
SJOLTIOPWDLDEB,,,,,BRD-K83289131,GPP-78,NAMPT inhibitor,NAMPT,BRD-K83289131,GPP-78,NAMPT inhibitor,NAMPT,BRD-K83289131,GPP-78,NAMPT inhibitor,NAMPT
SJRVJRYZAQYCEE,,,,,BRD-K87956243,BMS-309403,fatty acid binding protein inhibitor,FABP4,BRD-K87956243,BMS-309403,fatty acid binding protein inhibitor,FABP4,BRD-K87956243,BMS-309403,fatty acid binding protein inhibitor,FABP4
SKQMMYRRRQVSEQ,,,,,BRD-M66874015,quetiapine,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,,,,,,,,
SKZQZGSPYYHTQG,,,,,BRD-K40575944,DMH4,VEGFR inhibitor,KDR,BRD-K40575944,DMH4,VEGFR inhibitor,KDR,BRD-K40575944,DMH4,VEGFR inhibitor,KDR
SLUINPGXGFUMLL,,,,,BRD-K27584835,kartogenin,chondrocyte differentiation stimulator,FLNA,BRD-K27584835,kartogenin,chondrocyte differentiation stimulator,FLNA,BRD-K27584835,kartogenin,chondrocyte differentiation stimulator,FLNA
SMJAMOAYGIVKRI,,,,,BRD-K29660062,TC-ASK-10,MAP kinase inhibitor,MAP3K5|MAP3K6,BRD-K29660062,TC-ASK-10,MAP kinase inhibitor,MAP3K5|MAP3K6,BRD-K29660062,TC-ASK-10,MAP kinase inhibitor,MAP3K5|MAP3K6
SOJUSNIBPPMLCC,,,,,BRD-A75015151,NKY-80,adenylyl cyclase inhibitor,ADCY5,BRD-A75015151,NKY-80,adenylyl cyclase inhibitor,ADCY5,BRD-A75015151,NKY-80,adenylyl cyclase inhibitor,ADCY5
SOOLLEBJNGCDOZ,,,,,BRD-K07788774,NTRC-824,neurotensin receptor antagonist,NTSR2,BRD-K07788774,NTRC-824,neurotensin receptor antagonist,NTSR2,BRD-K07788774,NTRC-824,neurotensin receptor antagonist,NTSR2
SPBWHPXCWJLQRU,,,,,BRD-K97840621,API-1,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K97840621,API-1,AKT inhibitor,AKT1|AKT2|AKT3,BRD-K97840621,API-1,AKT inhibitor,AKT1|AKT2|AKT3
SPDQRCUBFSRAFI,,,,,BRD-K72868067,SAR405,PI3K inhibitor,PIK3C3,BRD-K72868067,SAR405,PI3K inhibitor,PIK3C3,BRD-K72868067,SAR405,PI3K inhibitor,PIK3C3
SPTWXRJNCFIDRQ,,,,,BRD-K49788188,heclin,ubiquitin ligase inhibitor,NEDD4|SMURF2|WWP1,BRD-K49788188,heclin,ubiquitin ligase inhibitor,NEDD4|SMURF2|WWP1,BRD-K49788188,heclin,ubiquitin ligase inhibitor,NEDD4|SMURF2|WWP1
SQWGHMPVSMSPNY,,,,,BRD-K09317629,Y-11,focal adhesion kinase inhibitor,PTK2,BRD-K09317629,Y-11,focal adhesion kinase inhibitor,PTK2,BRD-K09317629,Y-11,focal adhesion kinase inhibitor,PTK2
SSZHESNDOMBSRV,,,,,BRD-K46384285,DSR-6434,toll-like receptor agonist,TLR7,BRD-K46384285,DSR-6434,toll-like receptor agonist,TLR7,BRD-K46384285,DSR-6434,toll-like receptor agonist,TLR7
STAFRSGTRKNXHF,,,,,BRD-K79337272,LSN-2463359,glutamate receptor positive allosteric modulator,GRM5,BRD-K79337272,LSN-2463359,glutamate receptor positive allosteric modulator,GRM5,BRD-K79337272,LSN-2463359,glutamate receptor positive allosteric modulator,GRM5
SVSYJTYGPLVUOZ,,,,,BRD-K08902330,TCS-PIM-1-1,Pim kinase inhibitor,PIM1,BRD-K08902330,TCS-PIM-1-1,Pim kinase inhibitor,PIM1,BRD-K08902330,TCS-PIM-1-1,Pim kinase inhibitor,PIM1
SWTUPSNBTSPBIH,,,,,BRD-K50905564,cardionogen-1,WNT signaling inhibitor,CTNNB1,BRD-K50905564,cardionogen-1,WNT signaling inhibitor,CTNNB1,BRD-K50905564,cardionogen-1,WNT signaling inhibitor,CTNNB1
SYARXICKXVXWNA,,,,,BRD-K41895652,JNJ-27141491,CC chemokine receptor antagonist,CCR2,BRD-K41895652,JNJ-27141491,CC chemokine receptor antagonist,CCR2,BRD-K41895652,JNJ-27141491,CC chemokine receptor antagonist,CCR2
SYENTKHGMVKGAQ,,,,,BRD-K53903639,ISX-9,neural stem cell inducer,NEUROD1,BRD-K53903639,ISX-9,neural stem cell inducer,NEUROD1,BRD-K53903639,ISX-9,neural stem cell inducer,NEUROD1
SZNYUUZOQHNEKB,,,,,BRD-K69075588,GNF-7,glucokinase inhibitor|protein kinase inhibitor,GCK|TNK2,BRD-K69075588,GNF-7,glucokinase inhibitor|protein kinase inhibitor,GCK|TNK2,BRD-K69075588,GNF-7,glucokinase inhibitor|protein kinase inhibitor,GCK|TNK2
TUSCYCAIGRVBMD,,,,,BRD-A19609491,ANA-12,tropomyosin receptor kinase inhibitor,NTRK2,BRD-A19609491,ANA-12,tropomyosin receptor kinase inhibitor,NTRK2,BRD-A19609491,ANA-12,tropomyosin receptor kinase inhibitor,NTRK2
TXDIRJCYNAWBOS,,,,,BRD-K40604024,KRCA-0008,ALK inihibitor,ALK,BRD-K40604024,KRCA-0008,ALK inihibitor,ALK,BRD-K40604024,KRCA-0008,ALK inihibitor,ALK
UEMQPCYDWCSVCU,,,,,BRD-K03042257,NI-57,bromodomain inhibitor,BRD1|BRPF1|BRPF3,BRD-K03042257,NI-57,bromodomain inhibitor,BRD1|BRPF1|BRPF3,BRD-K03042257,NI-57,bromodomain inhibitor,BRD1|BRPF1|BRPF3
UFOBDFMYJABXGK,,,,,BRD-K18745919,Gue-1654,oxoeicosanoid receptor modulator,OXER1,BRD-K18745919,Gue-1654,oxoeicosanoid receptor modulator,OXER1,BRD-K18745919,Gue-1654,oxoeicosanoid receptor modulator,OXER1
UGFHIPBXIWJXNA,,,,,BRD-A57133765,liarozole,cytochrome P450 inhibitor,CYP19A1|CYP26A1,BRD-A57133765,liarozole,cytochrome P450 inhibitor,CYP19A1|CYP26A1,BRD-K00004284,liarozole,cytochrome P450 inhibitor,CYP19A1|CYP26A1
UHEYIOPHTBWBQN,,,,,BRD-K07460388,PHP-501,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,BRD-K07460388,PHP-501,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,BRD-K07460388,PHP-501,GABA receptor antagonist,GABRA1|GABRB2|GABRG2
UHIZYQVRKSWIFO,,,,,BRD-K88154110,KB-SRC-4,src inhibitor,SRC,BRD-K88154110,KB-SRC-4,src inhibitor,SRC,BRD-K88154110,KB-SRC-4,SRC inhibitor,SRC
UICNBXVDHCBKCE,,,,,BRD-A90201073,GPi-688,glycogen phosphorylase inhibitor,,BRD-A90201073,GPi-688,glycogen phosphorylase inhibitor,,BRD-A90201073,GPi-688,glycogen phosphorylase inhibitor,
UITFWLJMEZPXOF,,,,,BRD-K37635256,S-07662,CAR antagonist,NR1I3,BRD-K37635256,S-07662,CAR antagonist,NR1I3,BRD-K37635256,S-07662,CAR antagonist,NR1I3
UIVOZBSCHXCGPS,,,,,BRD-K90737788,GSK-2193874,transient receptor potential channel antagonist,TRPV4,BRD-K90737788,GSK-2193874,transient receptor potential channel antagonist,TRPV4,BRD-K90737788,GSK2193874,transient receptor potential channel antagonist,TRPV4
ULFUJLFTRWWLPO,,,,,BRD-A56690687,ITD-1,TGF beta receptor inhibitor,TGFBR2,BRD-A56690687,ITD-1,TGF beta receptor inhibitor,TGFBR2,BRD-A56690687,ITD-1,TGF beta receptor inhibitor,TGFBR2
UOGGWHBYFVBUIY,,,,,BRD-K90410034,M8-B,transient receptor potential channel antagonist,TRPM8,BRD-K90410034,M8-B,transient receptor potential channel antagonist,TRPM8,BRD-K90410034,M8-B,transient receptor potential channel antagonist,TRPM8
UPROBLPRPWYJGN,,,,,BRD-K96418224,R-1485,serotonin receptor antagonist,HTR6,BRD-K96418224,R-1485,serotonin receptor antagonist,HTR6,BRD-K96418224,R-1485,serotonin receptor antagonist,HTR6
URSQNPPONHUJDL,,,,,BRD-K03149601,ICA-121431,sodium channel blocker,SCN1A|SCN3A,BRD-K03149601,ICA-121431,sodium channel blocker,SCN1A|SCN3A,BRD-K03149601,ICA-121431,sodium channel blocker,SCN1A|SCN3A
USRYEHHMJIRICK,,,,,BRD-K30425481,L-760735,tachykinin antagonist,TACR1,BRD-K30425481,L-760735,tachykinin antagonist,TACR1,BRD-K30425481,L-760735,tachykinin antagonist,TACR1
USWLOKMMUTWFMD,,,,,BRD-K64451768,GANT-58,GLI antagonist,GLI1,BRD-K64451768,GANT-58,GLI antagonist,GLI1,BRD-K64451768,GANT-58,GLI antagonist,GLI1
UTAJHKSGYJSZBR,,,,,BRD-K02160913,ML-365,potassium channel blocker,KCNK3|KCNK9,BRD-K02160913,ML-365,potassium channel blocker,KCNK3|KCNK9,BRD-K02160913,ML365,potassium channel blocker,KCNK3|KCNK9
UTBSBSOBZHXMHI,,,,,BRD-K56239177,CGP-74514,CDK inhibitor,CDK1,BRD-K56239177,CGP-74514,CDK inhibitor,CDK1,BRD-K56239177,CGP-74514,CDK inhibitor,CDK1
UUJGYRHAOHORFC,,,,,BRD-K83176916,WWL-123,monoacylglycerol lipase inhibitor,ABHD6,BRD-K83176916,WWL-123,monoacylglycerol lipase inhibitor,ABHD6,BRD-K83176916,WWL-123,monoacylglycerol lipase inhibitor,ABHD6
UZWJWROOLOOCPQ,,,,,BRD-K93314017,NS-5806,voltage-gated potassium channel activator,KCND3,BRD-K93314017,NS-5806,voltage-gated potassium channel activator,KCND3,BRD-K93314017,NS-5806,voltage-gated potassium channel activator,KCND3
VDOCQQKGPJENHJ,,,,,BRD-K49900195,WYE-687,mTOR inhibitor,MTOR,BRD-K49900195,WYE-687,mTOR inhibitor,MTOR,BRD-K49900195,WYE-687,mTOR inhibitor,MTOR
VENOXIKBBUVHRY,,,,,BRD-K75254015,AS-2034178,free fatty acid receptor agonist,FFAR1,BRD-K75254015,AS-2034178,free fatty acid receptor agonist,FFAR1,BRD-K75254015,AS-2034178,free fatty acid receptor agonist,FFAR1
VFRROHXSMXFLSN,,,,,BRD-K67760597,barium-6-O-phosphonato-D-glucose,,GPI,BRD-K67760597,barium-6-O-phosphonato-D-glucose,,GPI,BRD-K67760597,barium-6-O-phosphonato-D-glucose,,
VFSUUTYAEQOIMW,,,,,BRD-K99433989,SAG,smoothened receptor agonist,SMO|TRPC6,BRD-K99433989,SAG,smoothened receptor agonist,SMO|TRPC6,BRD-K99433989,SAG,smoothened receptor agonist,SMO|TRPC6
VGUQVYZXABOXCX,,,,,BRD-A59391172,CID-16020046,G protein-coupled receptor antagonist,GPR55,BRD-A59391172,CID-16020046,G protein-coupled receptor antagonist,GPR55,BRD-K00004311,CID-16020046,G protein-coupled receptor antagonist,GPR55
VOASEWXFCTZRDF,,,,,BRD-K41705163,EC-144,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K41705163,EC-144,HSP inhibitor,HSP90AA1|HSP90AB1,BRD-K41705163,EC-144,HSP inhibitor,HSP90AA1|HSP90AB1
VQPBIJGXSXEOCU,,,,,BRD-K70329400,A-1070722,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K70329400,A-1070722,glycogen synthase kinase inhibitor,GSK3A|GSK3B,BRD-K70329400,A-1070722,glycogen synthase kinase inhibitor,GSK3A|GSK3B
VRYZCEONIWEUAV,,,,,BRD-K49921286,LMK-235,HDAC inhibitor,HDAC4|HDAC5,BRD-K49921286,LMK-235,HDAC inhibitor,HDAC4|HDAC5,BRD-K49921286,LMK-235,HDAC inhibitor,HDAC4|HDAC5
VSMFCZZEKTVDHM,,,,,BRD-K05262258,TC-I-2014,transient receptor potential channel antagonist,TRPM8,BRD-K05262258,TC-I-2014,transient receptor potential channel antagonist,TRPM8,BRD-K05262258,TC-I-2014,transient receptor potential channel antagonist,TRPM8
VTNKMYWFWQTEHE,,,,,BRD-K64452997,HA-130,autotaxin inhibitor,ENPP2,BRD-K64452997,HA-130,autotaxin inhibitor,ENPP2,BRD-K64452997,HA-130,autotaxin inhibitor,ENPP2
VVSDVODGMCQUHR,,,,,BRD-K58239851,naloxone-benzoylhydrazone,opioid receptor antagonist,OPRK1|OPRM1,,,,,,,,
VXPWQNBKEIVYIS,,,,,BRD-A29014990,ML-3403,MAP kinase inhibitor,CYP3A4|MAPK11|MAPK12|MAPK14,BRD-A29014990,ML-3403,MAP kinase inhibitor,CYP3A4|MAPK11|MAPK12|MAPK14,BRD-A29014990,ML3403,MAP kinase inhibitor,CYP3A4|MAPK11|MAPK12|MAPK14
VYMILMYEENZHAR,,,,,BRD-A35425966,CIQ,glutamate receptor potentiator,GRIN2C|GRIN2D,BRD-A35425966,CIQ,glutamate receptor potentiator,GRIN2C|GRIN2D,BRD-A35425966,CIQ,glutamate receptor potentiator,GRIN2C|GRIN2D
VZDUQPHKUBZMLW,,,,,BRD-K89000287,BTB1,mitotic kinesin inhibitor,KIF18A,BRD-K89000287,BTB1,mitotic kinesin inhibitor,KIF18A,BRD-K89000287,BTB1,mitotic kinesin inhibitor,KIF18A
WATNXVHKRRTUFK,,,,,BRD-K51265828,M-25,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K51265828,M-25,smoothened receptor antagonist,DHH|IHH|SMO,BRD-K51265828,M-25,smoothened receptor antagonist,DHH|IHH|SMO
WCIGMFCFPXZRMQ,,,,,BRD-K30185465,GSK2578215A,leucine rich repeat kinase inhibitor,LRRK2,BRD-K30185465,GSK2578215A,leucine rich repeat kinase inhibitor,LRRK2,BRD-K30185465,GSK2578215A,leucine rich repeat kinase inhibitor,LRRK2
WDTFYYZHMRBVHK,,,,,BRD-K27051047,AS-1892802,rho associated kinase inhibitor,ROCK1,BRD-K27051047,AS-1892802,rho associated kinase inhibitor,ROCK1,BRD-K27051047,AS-1892802,rho associated kinase inhibitor,ROCK1
WDZVWDXOIGQJIO,,,,,BRD-K68795758,MRK-560,gamma secretase inhibitor,APP,BRD-K68795758,MRK-560,gamma secretase inhibitor,APP,BRD-K68795758,MRK-560,gamma secretase inhibitor,APP
WEQLRDLTRCEUHG,,,,,BRD-K53913008,CP-316819,glycogen phosphorylase inhibitor,PYGL,BRD-K53913008,CP-316819,glycogen phosphorylase inhibitor,PYGL,BRD-K53913008,CP-316819,glycogen phosphorylase inhibitor,PYGL
WJNBSTLIALIIEW,,,,,BRD-K17511755,APY-29,serine/threonine kinase inhibitor,ERN1,BRD-K17511755,APY-29,serine/threonine kinase inhibitor,ERN1,BRD-K17511755,APY-29,serine/threonine kinase inhibitor,ERN1
WKLZNTYMDOPBSE,,,,,BRD-A64319165,SN-2,transient receptor potential channel agonist,MCOLN3,BRD-A64319165,SN-2,transient receptor potential channel agonist,MCOLN3,BRD-K00004310,SN-2,transient receptor potential channel agonist,MCOLN3
WLBUICQBNZXIDJ,,,,,BRD-K51485109,LDN-27219,tissue transglutaminase inhibitor,TGM2,BRD-K51485109,LDN-27219,tissue transglutaminase inhibitor,TGM2,BRD-K51485109,LDN-27219,tissue transglutaminase inhibitor,TGM2
WNDDDFYFTSGSEC,,,,,BRD-A29148886,RP-001,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-A29148886,RP-001,sphingosine 1 phosphate receptor agonist,S1PR1,BRD-A29148886,RP-001,sphingosine 1-phosphate receptor agonist,S1PR1
WPOXAFXHRJYEIC,,,,,BRD-K51329597,AZM-475271,src inhibitor,SRC,BRD-K51329597,AZM-475271,src inhibitor,SRC,BRD-K51329597,AZM-475271,SRC inhibitor,SRC
WQEPZBNLBWDIRZ,,,,,BRD-A82013137,PD-168568,dopamine receptor antagonist,DRD2|DRD4,BRD-A82013137,PD-168568,dopamine receptor antagonist,DRD2|DRD4,BRD-A82013137,PD-168568,dopamine receptor antagonist,DRD2|DRD4
WTKBRPXPNAKVEQ,,,,,BRD-K45044657,TC-H-106,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K45044657,TC-H-106,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,BRD-K45044657,TC-H-106,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8
WXMCOLGPDOYHNK,,,,,BRD-K81935556,TCS-3035,G protein-coupled receptor agonist,GPR35,BRD-K81935556,TCS-3035,G protein-coupled receptor agonist,GPR35,BRD-K81935556,TCS-3035,G protein-coupled receptor agonist,GPR35
WYVBISCFCHREDA,,,,,BRD-K98179423,C-021,CC chemokine receptor antagonist,CCR4,BRD-K98179423,C-021,CC chemokine receptor antagonist,CCR4,BRD-K98179423,C-021,CC chemokine receptor antagonist,CCR4
XAEJIFARBQJLML,,,,,BRD-K75349868,remodelin,transferase inhibitor,NAT10,BRD-K75349868,remodelin,transferase inhibitor,NAT10,BRD-K75349868,remodelin,transferase inhibitor,NAT10
XAPVAKKLQGLNOY,,,,,BRD-K24600306,ML-298,phospholipase inhibitor,PLD2,BRD-K24600306,ML-298,phospholipase inhibitor,PLD2,BRD-K24600306,ML298,phospholipase inhibitor,PLD2
XASCINRGTHLHGM,,,,,BRD-K15107389,BRD-7389,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3,BRD-K15107389,BRD-7389,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3,BRD-K15107389,BRD7389,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3
XDEFNAWAKYQBQY,,,,,BRD-K76792630,TC-Mps1-12,monopolar spindle 1 kinase inhibitor,TTK,BRD-K76792630,TC-Mps1-12,monopolar spindle 1 kinase inhibitor,TTK,BRD-K76792630,TC-Mps1-12,monopolar spindle 1 kinase inhibitor,TTK
XDJPQOUDGROSEU,,,,,BRD-K62715847,SC-51089,prostanoid receptor antagonist,PTGER1,BRD-K62715847,SC-51089,prostanoid receptor antagonist,PTGER1,BRD-K62715847,SC-51089,prostanoid receptor antagonist,PTGER1
XEVJUIZOZCFECP,,,,,BRD-K56932272,BMS-566419,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,BRD-K56932272,BMS-566419,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,BRD-K56932272,BMS-566419,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2
XHBVYDAKJHETMP,,,,,BRD-K54233340,dorsomorphin,AMPK inhibitor,ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC,BRD-K54233340,dorsomorphin,AMPK inhibitor,ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC,BRD-K54233340,dorsomorphin,AMPK inhibitor,ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC
XHHRGYCOEVNAKV,,,,,BRD-A12147465,TC-A-2317,Aurora kinase inhibitor,AURKA,BRD-A12147465,TC-A-2317,Aurora kinase inhibitor,AURKA,BRD-A12147465,TC-A-2317,Aurora kinase inhibitor,AURKA
XKLHCUGVLCGKKX,,,,,BRD-K17621556,TC-I-15,integrin inhibitor,ITGA2|ITGB1,BRD-K17621556,TC-I-15,integrin inhibitor,ITGA2|ITGB1,BRD-K17621556,TC-I-15,integrin inhibitor,ITGA2|ITGB1
XKPJTOHUPQWSOJ,,,,,BRD-K11821338,PF-429242,SREBP inhibitor,MBTPS1,BRD-K11821338,PF-429242,SREBP inhibitor,MBTPS1,BRD-K11821338,PF-429242,SREBP inhibitor,MBTPS1
XMMAOXMYUGQGJD,,,,,BRD-K61795638,LDN-209929,haspin kinase inhibitor,GSG2,BRD-K61795638,LDN-209929,haspin kinase inhibitor,GSG2,BRD-K61795638,LDN-209929,haspin kinase inhibitor,GSG2
XMRGQUDUVGRCBS,,,,,BRD-A86523169,NBI-74330-(+/-),CC chemokine receptor antagonist,CXCR3,BRD-A86523169,NBI-74330-(+/-),CC chemokine receptor antagonist,CXCR3,BRD-A86523169,NBI-74330-(+/-),CC chemokine receptor antagonist,CXCR3
XNFHHOXCDUAYSR,,,,,BRD-K85139301,AIM-100,tyrosine kinase inhibitor,TNK2,BRD-K85139301,AIM-100,tyrosine kinase inhibitor,TNK2,BRD-K85139301,AIM-100,tyrosine kinase inhibitor,TNK2
XNPRQBVQOJZMMA,,,,,BRD-K71667152,SBE-13,PLK inhibitor,PLK1,BRD-K71667152,SBE-13,PLK inhibitor,PLK1,BRD-K71667152,SBE-13,PLK inhibitor,PLK1
XOLMRFUGOINFDQ,,,,,BRD-K78373679,Ro-3306,CDK inhibitor,CDK1,BRD-K78373679,Ro-3306,CDK inhibitor,CDK1,BRD-K78373679,Ro-3306,CDK inhibitor,CDK1
XQJWTJLJEYIUDZ,,,,,BRD-K92781136,CID-2011756,protein kinase inhibitor,PKD1,BRD-K92781136,CID-2011756,protein kinase inhibitor,PKD1,BRD-K92781136,CID-2011756,protein kinase inhibitor,PKD1
XREFXUCWSYMIOG,,,,,BRD-K83547600,JNJ-47965567,purinergic receptor antagonist,P2RX7,BRD-K83547600,JNJ-47965567,purinergic receptor antagonist,P2RX7,BRD-K83547600,JNJ-47965567,purinergic receptor antagonist,P2RX7
XREWXJVMYAXCJV,,,,,BRD-K50005760,GW-627368,prostanoid receptor antagonist,PTGER4,BRD-K50005760,GW-627368,prostanoid receptor antagonist,PTGER4,BRD-K50005760,GW-627368,prostanoid receptor antagonist,PTGER4
XUBJEDZHBUPBKL,,,,,BRD-A18579359,wiskostatin,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,WAS|WASL,BRD-A18579359,wiskostatin,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,WAS|WASL,BRD-A18579359,wiskostatin,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,WASL
XUIUXXQVHPEQNM,,,,,BRD-K98736329,OXA-06,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K98736329,OXA-06,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K98736329,OXA-06,rho associated kinase inhibitor,ROCK1|ROCK2
XVOKFRPKSAWELK,,,,,BRD-K83492904,T-5601640,LIM kinase inhibitor,LIMK2,BRD-K83492904,T-5601640,LIM kinase inhibitor,LIMK2,BRD-K83492904,T-5601640,LIM kinase inhibitor,LIMK2
XZIZUQSOFMLIIR,,,,,BRD-K34624869,NS-8593,calcium-activated potassium channel modulator,KCNN1|KCNN2|KCNN3,BRD-K34624869,NS-8593,calcium-activated potassium channel modulator,KCNN1|KCNN2|KCNN3,BRD-K34624869,NS-8593,calcium-activated potassium channel modulator,KCNN1|KCNN2|KCNN3
YAMSXCOVJUUMCT,,,,,BRD-K41415459,RN-1,histone demethylase inhibitor,KDM1A,BRD-K41415459,RN-1,histone demethylase inhibitor,KDM1A,BRD-K41415459,RN-1,histone demethylase inhibitor,KDM1A
YBEZORYMVISYOA,,,,,BRD-K40656405,L-165041,PPAR receptor agonist,PPARD,,,,,,,,
YBHQCJILTOVLHD,,,,,BRD-K55420858,mirin,MRE11A exonuclease inhibitor,MRE11A,BRD-K55420858,mirin,MRE11A exonuclease inhibitor,MRE11A,BRD-K55420858,mirin,MRE11A exonuclease inhibitor,MRE11A
YGUFCDOEKKVKJK,,,,,BRD-K00818915,SHP099,protein tyrosine kinase inhibitor,PTPN11,BRD-K00818915,SHP099,protein tyrosine kinase inhibitor,PTPN11,BRD-K00818915,SHP099,protein tyrosine kinase inhibitor,PTPN11
YKNAKDFZAWQEEO,,,,,BRD-K57090026,I-CBP-112,bromodomain inhibitor,CREBBP|EP300,BRD-K57090026,I-CBP-112,bromodomain inhibitor,CREBBP|EP300,BRD-K57090026,I-CBP-112,bromodomain inhibitor,CREBBP|EP300
YNCXHXYZTLIZTO,,,,,BRD-A18598741,4BP-TQS,nicotinic receptor agonist,CHRNA7,BRD-A18598741,4BP-TQS,nicotinic receptor agonist,CHRNA7,BRD-A18598741,4BP-TQS,nicotinic receptor agonist,CHRNA7
YOVNFNXUCOWYSG,,,,,BRD-K89464729,GSK269962,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K89464729,GSK269962,rho associated kinase inhibitor,ROCK1|ROCK2,BRD-K89464729,GSK269962,rho associated kinase inhibitor,ROCK1|ROCK2
YPPFWRWCZNXINO,,,,,BRD-K05653025,NHI-2,lactate dehydrogenase inhibitor,LDHA,BRD-K05653025,NHI-2,lactate dehydrogenase inhibitor,LDHA,BRD-K05653025,NHI-2,lactate dehydrogenase inhibitor,LDHA
YPPSMYLMSKHYAY,,,,,BRD-K04374714,AMG-PERK-44,PERK inhibitor,EIF2AK4,BRD-K04374714,AMG-PERK-44,PERK inhibitor,EIF2AK4,BRD-K04374714,AMG-PERK-44,PERK inhibitor,EIF2AK4
YTFUQWWKTIWYEY,,,,,BRD-K19811997,Calhex-231,calcium sensing receptor negative allosteric modulator,CASR,BRD-K19811997,Calhex-231,calcium sensing receptor negative allosteric modulator,CASR,BRD-K19811997,Calhex-231,calcium sensing receptor negative allosteric modulator,CASR
YUNQZQREIHWDQT,,,,,BRD-K92658264,OF-1,bromodomain inhibitor,BRD1,BRD-K92658264,OF-1,bromodomain inhibitor,BRD1,BRD-K92658264,OF-1,bromodomain inhibitor,BRD1
YWEGXZZAORIRQR,,,,,BRD-K02460719,SCH-51344,MTH1 inhibitor,NUDT1,BRD-K02460719,SCH-51344,MTH1 inhibitor,NUDT1,BRD-K02460719,SCH-51344,MTH1 inhibitor,NUDT1
YXHLPJQQPOMPGE,,,,,BRD-A91031770,SB-268262,calcitonin antagonist,CALCA,BRD-A91031770,SB-268262,calcitonin antagonist,CALCA,BRD-A91031770,SB-268262,calcitonin antagonist,CALCA
YYDUWLSETXNJJT,,,,,BRD-K19975102,GNF-5837,growth factor receptor inhibitor,NTRK1|NTRK2|NTRK3,BRD-K19975102,GNF-5837,growth factor receptor inhibitor,NTRK1|NTRK2|NTRK3,BRD-K19975102,GNF-5837,growth factor receptor inhibitor,NTRK1|NTRK2|NTRK3
YYZPXBXVBQSBDG,,,,,BRD-K61120504,NSC636819,histone demethylase inhibitor,KDM4A|KDM4B,BRD-K61120504,NSC636819,histone demethylase inhibitor,KDM4A|KDM4B,BRD-K61120504,NSC-636819,histone demethylase inhibitor,KDM4A|KDM4B
ZCYOBMASPXQBSZ,,,,,BRD-K32853922,Org-25543,glycine transporter inhibitor,GLRB|SLC6A5,BRD-K32853922,Org-25543,glycine transporter inhibitor,GLRB|SLC6A5,BRD-K32853922,ORG-25543,glycine transporter inhibitor,GLRB|SLC6A5
ZETBBVYSBABLHL,,,,,BRD-K99968849,SB-243213,serotonin receptor inverse agonist,HTR2A|HTR2B|HTR2C|HTR6,BRD-K99968849,SB-243213,serotonin receptor inverse agonist,HTR2A|HTR2B|HTR2C|HTR6,BRD-K99968849,SB-243213,serotonin receptor inverse agonist,HTR2A|HTR2B|HTR2C|HTR6
ZIXNJVGTAXRKAP,,,,,BRD-K67397687,GPBAR-A,G protein coupled receptor agonist,GPBAR1,BRD-K67397687,GPBAR-A,G protein coupled receptor agonist,GPBAR1,BRD-K67397687,GPBAR-A,G protein-coupled receptor agonist,GPBAR1
ZJCNRVHZJADROC,,,,,BRD-A23155040,NS-3861,acetylcholine receptor agonist,CHRNA3|CHRNB4,BRD-A23155040,NS-3861,acetylcholine receptor agonist,CHRNA3|CHRNB4,BRD-K00004309,NS-3861,acetylcholine receptor agonist,CHRNA3|CHRNB4
ZJHZBDRZEZEDGB,,,,,BRD-K77758223,furamidine,protein arginine N-methyltransferase inhibitor,PRMT1,BRD-K77758223,furamidine,protein arginine N-methyltransferase inhibitor,PRMT1,BRD-K77758223,furamidine,protein arginine N-methyltransferase inhibitor,PRMT1
ZJMDTBBCNMGFMS,,,,,BRD-K75748943,DG-172,PPAR receptor inverse agonist,PPARD,BRD-K75748943,DG-172,PPAR receptor inverse agonist,PPARD,BRD-K75748943,DG-172,PPAR receptor inverse agonist,PPARD
ZJZWZIXSGNFWQQ,,,,,BRD-K53328210,JW-55,tankyrase inhibitor,TNKS|TNKS2,BRD-K53328210,JW-55,tankyrase inhibitor,TNKS|TNKS2,BRD-K53328210,JW-55,tankyrase inhibitor,TNKS|TNKS2
ZNRGQMMCGHDTEI,,,,,BRD-K50866992,tropisetron,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,BRD-A79226577|BRD-K50866992|BRD-M19407551,tropisetron,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,BRD-A79226577|BRD-K50866992|BRD-M19407551,tropisetron,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4
ZOFZKGFBKISZRI,,,,,BRD-K19958299,TCS-2210,neural stem cell inducer,,BRD-K19958299,TCS-2210,neural stem cell inducer,,BRD-K19958299,TCS-2210,neural stem cell inducer,
ZPLBXOVTSNRBFB,,,,,BRD-K47726410,WDR5-0103,histone lysine methyltransferase inhibitor,WDR5,BRD-K47726410,WDR5-0103,histone lysine methyltransferase inhibitor,WDR5,BRD-K47726410,WDR5-0103,histone lysine methyltransferase inhibitor,WDR5
ZQPXNYLXYNRFNP,,,,,BRD-K72063794,VU591,potassium channel blocker,KCNJ1,BRD-K72063794,VU591,potassium channel blocker,KCNJ1,BRD-K72063794,VU591,potassium channel blocker,KCNJ1
ZQUSYVORYNBGLG,,,,,BRD-K79608170,TC-NTR1-17,neurotensin agonist,NTSR1,BRD-K79608170,TC-NTR1-17,neurotensin agonist,NTSR1,BRD-K79608170,TC-NTR1-17,neurotensin agonist,NTSR1
ZTAZUCRXCRXNSU,,,,,BRD-K09597601,UBP-310,glutamate receptor antagonist,GRIK1|GRIK5,BRD-K09597601,UBP-310,glutamate receptor antagonist,GRIK1|GRIK5,BRD-K09597601,UBP-310,glutamate receptor antagonist,GRIK1|GRIK5
ZTYHZMAZUWOXNC,,,,,BRD-K32952627,BAY-60-6583,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K32952627,BAY-60-6583,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K32952627,BAY-60-6583,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3
ZUTUWJYMCADJHD,,,,,BRD-A16560607,TCS-5861528,transient receptor potential channel antagonist,TRPA1,BRD-A16560607,TCS-5861528,transient receptor potential channel antagonist,TRPA1,BRD-A16560607,TCS-5861528,transient receptor potential channel antagonist,TRPA1
ZUXNHFFVQWADJL,,,,,BRD-K53030960,eact,calcium-activated chloride channel inhibitor,ANO1,BRD-K53030960,eact,calcium-activated chloride channel inhibitor,ANO1,BRD-K53030960,eact,calcium-activated chloride channel inhibitor,ANO1
ZVBTZTQYHOXIBC,,,,,BRD-K44731351,AL-8697,p38 MAPK inhibitor,MAPK14,BRD-K44731351,AL-8697,p38 MAPK inhibitor,MAPK14,BRD-K44731351,AL-8697,p38 MAPK inhibitor,MAPK14
ZXGGCBQORXDVTE,,,,,BRD-K32330832,VER-155008,HSP inhibitor,HSPA1A,BRD-K32330832,VER-155008,HSP inhibitor,HSPA1A,BRD-K32330832,VER-155008,HSP inhibitor,HSPA1A
ZYVKEIQGOGHCFB,,,,,BRD-M86143595,MRS-3777,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-M86143595,MRS-3777,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,BRD-K10575656,MRS-3777,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3
ZZLQPWXVZCPUGC,,,,,BRD-A47940219,CE3F4,rap guanine nucleotide exchange factor inhibitor,RAPGEF3,BRD-A47940219,CE3F4,rap guanine nucleotide exchange factor inhibitor,RAPGEF3,BRD-A47940219,CE3F4,rap guanine nucleotide exchange factor inhibitor,RAPGEF3
ZZMFJJDBKSYGRM,,,,,BRD-K84924479,Rec-15/2615,adrenergic receptor antagonist,ADRA1A,BRD-K84924479,Rec-15/2615,adrenergic receptor antagonist,ADRA1A,BRD-K84924479,Rec-15/2615,adrenergic receptor antagonist,ADRA1A
DVUJFSXMTBOIKW,,,,,,,,,BRD-K38820178|BRD-U66818247,nedaplatin,DNA inhibitor,,,,,
IRPYFWIZKIOHQN,,,,,,,,,BRD-K73841932|BRD-U68276368,auranofin,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,,,,
JFAHBAVHONXXFG,,,,,,,,,BRD-M31395033|BRD-U22164625,satraplatin,DNA alkylating agent,,,,,
KNLORLKZMHLRBH,,,,,,,,,BRD-K74796838|BRD-U77299140,NKP-1339,HSP inhibitor,,BRD-K74796838|BRD-U77299140,NKP-1339,HSP inhibitor,
NOSAJPUYIASWEH,,,,,,,,,BRD-A52946717|BRD-K10549975|BRD-K64120610,vinflunine,microtubule inhibitor,,BRD-A52946717|BRD-K10549975|BRD-K64120610,vinflunine,microtubule inhibitor,
RMRCNWBMXRMIRW,,,,,,,,,BRD-A18627414|BRD-A59561452|BRD-M14495474,cyanocobalamin,methylmalonyl CoA mutase stimulant|vitamin B,MMAA|MMACHC|MTHFR|MTR|MTRR|MUT,BRD-A18627414|BRD-A59561452|BRD-K00003629|BRD-M14495474,cyanocobalamin|vitamin-B12,|methylmalonyl CoA mutase stimulant|vitamin B,|MUT
VPZCKRKZFRCZMX,,,,,,,,,BRD-A09838294|BRD-K23925186|BRD-K35776642,oridonin,BCL inhibitor,BCL2,,,,
XTLSVXWJVRKFIP,,,,,,,,,BRD-K79233274|BRD-K81190290,meprednisone,,NR3C1,,,,
AALSSIXXBDPENJ,,,,,,,,,,,,,BRD-K00004649,E3330,NFkB pathway inhibitor,
ABZSPJVXTTUFAA,,,,,,,,,,,,,BRD-K04466929,Merck60,HDAC inhibitor,HDAC1|HDAC2
ACWKGTGIJRCOOM,,,,,,,,,,,,,BRD-K00003144,atuveciclib,CDK9 inhibitor,
ADZBMFGQQWPHMJ,,,,,,,,,,,,,BRD-K83157152,BLZ945,CSF1R inhibitor,
AEHLCVKEOAFFJC,,,,,,,,,,,,,BRD-K00004683,MS-424,glutamate transporter modulator,
AEXFXNFMSAAELR,,,,,,,,,,,,,BRD-K00003398,AZD7986,dipeptidyl peptidase inhibitor,
AFDPFLDWOXXHQM,,,,,,,,,,,,,BRD-K00004614,GSK3117391,HDAC inhibitor,
AGBSXNCBIWWLHD,,,,,,,,,,,,,BRD-K65480835,siremadlin,MDM inhibitor,
AHJUHHDDCJQACA,,,,,,,,,,,,,BRD-K74319597,HM-30181,P glycoprotein inhibitor,
AIWRTTMUVOZGPW,,,,,,,,,,,,,BRD-K00003158,abarelix,gonadotropin releasing factor hormone receptor antagonist,GNRHR
ALIVXCSEERJYHU,,,,,,,,,,,,,BRD-K00004724,flurbiprofen-axetil,analgesic agent,
AMAOXEGBJHLCSF,,,,,,,,,,,,,BRD-K00005330,AUT-1,potassium channel activator,
AMFDITJFBUXZQN,,,,,,,,,,,,,BRD-K00003270,galidesivir,antiviral,
AMSUHYUVOVCWTP,,,,,,,,,,,,,BRD-K00003099,PLX51107,bromodomain inhibitor,
ANNRUWYFVIGKHA,,,,,,,,,,,,,BRD-K00004717,R-121919,CRF receptor antagonist,
ANZJBCHSOXCCRQ,,,,,,,,,,,,,BRD-K00003293,mertansine,microtubule inhibitor,
AOMXMOCNKJTRQP,,,,,,,,,,,,,BRD-K00003216,relugolix,gonadotropin releasing factor hormone receptor antagonist,
AOTRIQLYUAFVSC,,,,,,,,,,,,,BRD-K69555850,AZD0156,ATM kinase inhibitor,
APUDBKTWDCXQJA,,,,,,,,,,,,,BRD-K00003530,pirmenol,acetylcholine receptor inhibitor,
APWZIFIAVVFPNT,,,,,,,,,,,,,BRD-K00004712,PF-06305591,sodium channel blocker,
AQDWDWAYVBQMAM,,,,,,,,,,,,,BRD-K00003499,adavivint,WNT pathway inhibitor,
AQLVRTWKJDTWQQ,,,,,,,,,,,,,BRD-K00004698,trabodenoson,adenosine receptor agonist,
AREYWCZYVPSHGS,,,,,,,,,,,,,BRD-K00003147,S49076,tyrosine kinase inhibitor,
ARGKVCXINMKCAZ,,,,,,,,,,,,,BRD-K00003712,neohesperidin,,
ASKZRYGFUPSJPN,,,,,,,,,,,,,BRD-K00003506,risdiplam,RNA splicing inhibitor,
ATEBXHFBFRCZMA,,,,,,,,,,,,,BRD-K31484631,rifabutin,protein synthesis inhibitor,
ATFXVNUWQOXRRU,,,,,,,,,,,,,BRD-K00004682,taminadenant,adenosine receptor antagonist,
ATMNQRRJNBCQJO,,,,,,,,,,,,,BRD-K00003389,HTHQ,antioxidant,
AUIHHZBJBKRDIE,,,,,,,,,,,,,BRD-K00003382,nicainoprol,angiotensin converting enzyme inhibitor,
AUZDMWWRYCUANI,,,,,,,,,,,,,BRD-K34751753|BRD-K73469236,nedaplatin,DNA inhibitor,
AVIWDYSJSPOOAR,,,,,,,,,,,,,BRD-K00003106,AZD4573,CDK9 inhibitor,
AWDJJMXJUOHGLC,,,,,,,,,,,,,BRD-K00004711,GSK356278,phosphodiesterase inhibitor,
AYOUDDAETNMCBW,,,,,,,,,,,,,BRD-K29343434,BMS-906024,gamma secretase inhibitor,
AZNHWXAFPBYFGH,,,,,,,,,,,,,BRD-K00003492,apararenone,mineralocorticoid receptor antagonist,
BAPRUDZDYCKSOQ,,,,,,,,,,,,,BRD-K65230684,oxaceprol,anti-inflammatory agent,
BAWMMJAUVBLLEE,,,,,,,,,,,,,BRD-K00004551,efletirizine,antihistamine,
BAZRWWGASYWYGB,,,,,,,,,,,,,BRD-K00003112,GDC-0575,CHK inhibitor,
BBAOKSZCULLDIW,,,,,,,,,,,,,BRD-K00005337,DIM-C-pPhCO2Me,nuclear receptor antagonist,
BBLXLHYPDOMJMO,,,,,,,,,,,,,BRD-K00003109,AB-423,HBV capsid assembly inhibitor,
BBTFKAOFCSOZMB,,,,,,,,,,,,,BRD-K00003137,lotamilast,phosphodiesterase inhibitor,
BCSVCWVQNOXFGL,,,,,,,,,,,,,BRD-K47710001,zopolrestat,,AKR1B1|AKR1B10
BDXXSFOJPYSYOC,,,,,,,,,,,,,BRD-K00002423,PF-05175157,acetyl-CoA carboxylase inhibitor,
BGMVOROUOUVVRV,,,,,,,,,,,,,BRD-K00003390,YL0919,selective serotonin reuptake inhibitor (SSRI),
BGULJNMSWJQIEK,,,,,,,,,,,,,BRD-K56483981,chicago-sky-blue-6b,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MIF
BGYHLZZASRKEJE,,,,,,,,,,,,,BRD-K00004549,irganox-1010,antioxidant,
BHKDKKZMPODMIQ,,,,,,,,,,,,,BRD-K00003424,roblitinib,FGFR inhibitor,
BHZFZYLBVSWUMT,,,,,,,,,,,,,BRD-K63631219,quazinone,phosphodiesterase inhibitor,PDE3A|PDE3B
BICRTLVBTLFLRD,,,,,,,,,,,,,BRD-K00003472,voclosporin,calcineurin inhibitor,
BJDZBXGJNBMCAV,,,,,,,,,,,,,BRD-K16343284,macozinone,DPRE1 inhibitor,
BJJVCNWHNQAAGB,,,,,,,,,,,,,BRD-A08840375,CID-5458317,MAP kinase phosphatase inhibitor,MAPK3
BKWHZSFINQBEQH,,,,,,,,,,,,,BRD-A25576662|BRD-K34411947,streptozotocin,DNA alkylating agent,
BMUDPLZKKRQECS,,,,,,,,,,,,,BRD-K74057164,hemin,enzyme inducer,
BNMGUJRJUUDLHW,,,,,,,,,,,,,BRD-K00003328,madecassoside,anti-inflammatory agent,
BOTHKNZTGGXFEQ,,,,,,,,,,,,,BRD-K00003435,AVex-73,sigma receptor agonist,
BPIWZDNVMQQBQX,,,,,,,,,,,,,BRD-K00004638,PF-06273340,tyrosine kinase receptor inhibitor,
BSLXKMCHXRCBIH,,,,,,,,,,,,,BRD-K00004616,PRX-07034,serotonin receptor antagonist,
BTCRKOKVYTVOLU,,,,,,,,,,,,,BRD-K00003246,bexagliflozin,solute carrier family member inhibitor,
BUPRVECGWBHCQV,,,,,,,,,,,,,BRD-K00004578,KAF-156,antimalarial agent,
BUWVEXMRBAWBPJ,,,,,,,,,,,,,BRD-K00003299,F-16915,,
BVAHPPKGOOJSPU,,,,,,,,,,,,,BRD-K00003379,GSK2256098,kinase inhibitor,
BWAKMLKESHKOHK,,,,,,,,,,,,,BRD-K00004583,AC260584,cholinergic receptor agonist,
BWKBPVRNWJFLSC,,,,,,,,,,,,,BRD-A52169337,"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",,
BXNCIERBDJYIQT,,,,,,,,,,,,,BRD-K00004631,T-1095,sodium/glucose cotransporter inhibitor,
BZTIJCSHNVZMES,,,,,,,,,,,,,BRD-K00003120,BI-409306,phosphodiesterase inhibitor,
CATQHDWESBRRQA,,,,,,,,,,,,,BRD-K00003093,SD-0006,p38 MAPK inhibitor,
CAVRKWRKTNINFF,,,,,,,,,,,,,BRD-K00003222,tradipitant,neurokinin receptor antagonist,
CBOKZNLSFMZJJA,,,,,,,,,,,,,BRD-A26105646,3-deazauridine,cytidine deaminase inhibitor,
CBRJPFGIXUFMTM,,,,,,,,,,,,,BRD-K47084954,PF-06651600,JAK inhibitor,
CCDHHPOGWLYHAX,,,,,,,,,,,,,BRD-K00003272,dextrorotation-nimorazole-phosphate-ester,antiinfective drug,
CEFJVGZHQAGLHS,,,,,,,,,,,,,BRD-K00005241,ripretinib,receptor tyrosine protein kinase inhibitor,
CHFSOFHQIZKQCR,,,,,,,,,,,,,BRD-K81881550,licostinel,NMDA receptor antagonist ,
CHNJCELMWMIDSC,,,,,,,,,,,,,BRD-K92980438,3-bromopyruvate,hexokinase inhibitor,HK2
CJCYTUJOSMYXLE,,,,,,,,,,,,,BRD-K00004751,inarigivir-soproxil,antiviral,
CKFBRGLGTWAVLG,,,,,,,,,,,,,BRD-K00003150,segesterone-acetate,progesterone receptor agonist,PGR
CKLPLPZSUQEDRT,,,,,,,,,,,,,BRD-K27811785,cipargamin,antimalarial agent,
CKTWQGHVNRYNCM,,,,,,,,,,,,,BRD-K00003304,MK-1064,orexin receptor antagonist,
CLAUJSRBKSRTGQ,,,,,,,,,,,,,BRD-K00005331,BAY-8002,monocarboxylate transporter inhibitor,
CLGCHUKGBICQTE,,,,,,,,,,,,,BRD-K00003097,PF-05180999,phosphodiesterase inhibitor,
CLOMYZFHNHFSIQ,,,,,,,,,,,,,BRD-K18399440,clonixin,cyclooxygenase inhibitor,PTGS1|PTGS2
CMCCHHWTTBEZNM,,,,,,,,,,,,,BRD-K00003522,bromisoval,anti-inflammatory agent,
CMVHFGNTABZQJU,,,,,,,,,,,,,BRD-K00003512,BMS-813160,CC chemokine receptor antagonist,
CONYTTFKIUJZOF,,,,,,,,,,,,,BRD-K00005344,DCP-LA,protein kinase activator,
COOGVHJHSCBOQT,,,,,,,,,,,,,BRD-K00003403,JNJ-39758979,histamine receptor antagonist,
COSPVUFTLGQDQL,,,,,,,,,,,,,BRD-K00003466,nelotanserin,serotonin receptor inverse agonist,
CQMCOBQPZDLWIX,,,,,,,,,,,,,BRD-K00004685,TS-011,delayed vasospasm antagonist,
CQVAQQNDZCZBSU,,,,,,,,,,,,,BRD-K00005245,KM-0118,anticancer agent,
CRNIKQQPTHSPBA,,,,,,,,,,,,,BRD-K00003242,sancycline,antitumor agent,
CTSNHMQGVWXIEG,,,,,,,,,,,,,BRD-K56839624,CQS,,
CTUICISGLKIJLG,,,,,,,,,,,,,BRD-K00004664,NDD-094,,
CUEPJIGXQLIOIK,,,,,,,,,,,,,BRD-K00003171,DWK-1339,beta amyloid aggregation inhibitor,
CUNDRHORZHFPLY,,,,,,,,,,,,,BRD-K00004617,imidazoacridinone,anticancer agent,
CUTZNERBKDMLAP,,,,,,,,,,,,,BRD-K00004660,MK-1903,niacin receptor agonist,
CUWODFFVMXJOKD,,,,,,,,,,,,,BRD-K00003161,buserelin,gonadotropin releasing factor hormone receptor agonist,
CVPTTZZCRDVGSU,,,,,,,,,,,,,BRD-K00004647,NB-001,antiviral,
CWFVVQFVGMFTBD,,,,,,,,,,,,,BRD-K00004575,JNJ-54175446,purinergic receptor antagonist,
CXHCNOMGODVIKB,,,,,,,,,,,,,BRD-K00003380,GLPG0187,integrin antagonist,
CYPGNVSXMAUSJY,,,,,,,,,,,,,BRD-K00003165,sardomozide,S-adenosylmethionine decarboxylase inhibitor,
CYYQMAWUIRPCNW,,,,,,,,,,,,,BRD-K00004706,ST-1535,adenosine receptor antagonist,
DADASRPKWOGKCU,,,,,,,,,,,,,BRD-K27040396,CFI-400945,serine/threonine kinase inhibitor,
DAIGSUHCWOZEQG,,,,,,,,,,,,,BRD-K49962337|BRD-K98733875|BRD-K99455969,baicalin,beta glucuronidase inhibitor,PREP
DBPPRLRVDVJOCL,,,,,,,,,,,,,BRD-K00003257,cefiderocol,antibacterial ,
DBSMLQTUDJVICQ,,,,,,,,,,,,,BRD-K30421675,JNJ-64619178,protein arginine N-methyltransferase inhibitor,
DCGDPJCUIKLTDU,,,,,,,,,,,,,BRD-K00003457,IDH-305,isocitrate dehydrogenase inhibitor,
DCXFIOLWWRXEQH,,,,,,,,,,,,,BRD-K00003493,padsevonil,antiepileptic,
DDINXHAORAAYAD,,,,,,,,,,,,,BRD-K00004574,aripiprazole-lauroxil,serotonin receptor agonist,
DDVAZOPRCKAYOV,,,,,,,,,,,,,BRD-K00005248,WP921,,
DECBQELQORZLLP,,,,,,,,,,,,,BRD-K00003314,furagin,antibacterial,
DEMKZLAVQYISIA,,,,,,,,,,,,,BRD-K39084158,liquiritin,antioxidant,
DENYZIUJOTUUNY,,,,,,,,,,,,,BRD-K00003461,pamiparib,PARP inhibitor,
DFPYHQJPGCODSB,,,,,,,,,,,,,BRD-K00004747,KME-4,prostaglandin inhibitor,
DIEPFYNZGUUVHD,,,,,,,,,,,,,BRD-K00003192,PSI-697,P selectin inhibitor,
DIIBXMIIOQXTHW,,,,,,,,,,,,,BRD-K00004581,pirozadil,hypolipidemic,
DIKSYHCCYVYKRO,,,,,,,,,,,,,BRD-K00003371,paquinimod,S100A9 inhibitor,
DJUOWOXTPXUHDQ,,,,,,,,,,,,,BRD-K00003483,GSK656,leucyl-tRNA synthetase inhibitor,
DKSVBVKHUICELN,,,,,,,,,,,,,BRD-K00004577,vapendavir,antiviral,
DLNWBHHJUACHNB,,,,,,,,,,,,,BRD-M15413738,dihydrostreptomycin,bacterial 30S ribosomal subunit inhibitor,
DLPIYBKBHMZCJI,,,,,,,,,,,,,BRD-K00003404,CYC065,CDK inhibitor,
DLVXFZWSPCOWSN,,,,,,,,,,,,,BRD-K00003401,THK5351,PET radiotracer ,
DLWSRGHNJVLJAH,,,,,,,,,,,,,BRD-K00004737,nitroflurbiprofen,cyclooxygenase inhibitor,
DNHPDWGIXIMXSA,,,,,,,,,,,,,BRD-K00003201,tenapanor,sodium/hydrogen exchanger inhibitor,
DOBNVUFHFMVMDB,,,,,,,,,,,,,BRD-K00003252,sacubitrilat,neprilysin inhibitor,
DOWVMJFBDGWVML,,,,,,,,,,,,,BRD-K00004735,BIA-10-2474,Fatty acid hydrolase inhibitor,
DQEWVIJXZPUPQA,,,,,,,,,,,,,BRD-K00004686,NPS-2407,glutamate receptor antagonist,
DQOYUDHAZMAVLD,,,,,,,,,,,,,BRD-K00004567,florifenine,anti-inflammatory agent,
DUGBYNJMBYPWGS,,,,,,,,,,,,,BRD-A44500574,FLI-06,notch signaling inhibitor,
DUPWHXBITIZIKZ,,,,,,,,,,,,,BRD-K00004716,radotinib,Bcr-Abl kinase inhibitor,
DUYNJNWVGIWJRI,,,,,,,,,,,,,BRD-K00004720,acolbifene,estrogen receptor antagonist,
DVJXNXPFYJIACK,,,,,,,,,,,,,BRD-K00003254,tavilermide,tyrosine kinase partial agonist,
DVNQWYLVSNPCJZ,,,,,,,,,,,,,BRD-K00004633,PF-4191834,lipoxygenase inhibitor,
DWYRIWUZIJHQKQ,,,,,,,,,,,,,BRD-K00003419,avapritinib,KIT inhibitor,
DWZDGMDDUHAIQA,,,,,,,,,,,,,BRD-K01825010,hematoporphyrin,,
DXIOOXFZLKCVHK,,,,,,,,,,,,,BRD-K00003516,emamectin,GABA receptor agonist,
DXZRBHUCOHBAHP,,,,,,,,,,,,,BRD-K66430217,KH-CB19,CDC inhibitor,CLK1|CLK3|DYRK1A
DYDCPNMLZGFQTM,,,,,,,,,,,,,BRD-K90991629,delafloxacin,antiinfective drug,
DYOKDAQBNHPJFD,,,,,,,,,,,,,BRD-K00003733,ganoderic-acid-a,JAK inhibitor,
DZMVCVHATYROOS,,,,,,,,,,,,,BRD-K00003174,soblidotin,microtubule inhibitor,
FASLTMSUPQDLIB,,,,,,,,,,,,,BRD-K00003302,adomeglivant,glucagon receptor antagonist,
FBQPGGIHOFZRGH,,,,,,,,,,,,,BRD-K00003521,lucanthone,endonuclease inhibitor,APEX1|TOP1|TOP2A
FDBYIYFVSAHJLY,,,,,,,,,,,,,BRD-K00003123,resmetirom,thyroid hormone receptor agonist,
FEVBKJITJDHASC,,,,,,,,,,,,,BRD-K26526496,GS-967,voltage-gated sodium channel blocker,
FEWFXBUNENSNBQ,,,,,,,,,,,,,BRD-K86587225,2-oxopropanoate,pyruvate dehydrogenase kinase inhibitor,ABAT
FFGSXKJJVBXWCY,,,,,,,,,,,,,BRD-K00004726,ametantrone,anticancer agent,
FGBGXESDYFKUFX,,,,,,,,,,,,,BRD-K00004732,camobucol,anti-inflammatory agent,
FHCUMDQMBHQXKK,,,,,,,,,,,,,BRD-K00003133,velpatasvir,antiviral,
FHQXLWCFSUSXBF,,,,,,,,,,,,,BRD-K00003731,PF-06409577,protein kinase activator,
FIDLLEYNNRGVFR,,,,,,,,,,,,,BRD-K00003496,baloxavir,endonuclease inhibitor,
FIKPXCOQUIZNHB,,,,,,,,,,,,,BRD-K00003447,repotrectinib,receptor tyrosine protein kinase inhibitor,
FIVSJYGQAIEMOC,,,,,,,,,,,,,BRD-K00003175,rolapitant,neurokinin receptor antagonist,
FJMQJSUOOGOWBD,,,,,,,,,,,,,BRD-K00004642,PF-514273,cannabinoid receptor antagonist,
FJNLCHNQVJVCPY,,,,,,,,,,,,,BRD-K00003410,GAL-021,calcium channel blocker,
FKCWHHYUMFGOPY,,,,,,,,,,,,,BRD-K00003396,CEP-40783,AXL kinase inhibitor,
FLFGNMFWNBOBGE,,,,,,,,,,,,,BRD-K00004609,elacytarabine,antineoplastic agent,DCK
FLSUCZWOEMTFAQ,,,,,,,,,,,,,BRD-K00004713,sulopenem,antibacterial,
FOPALECPEUVCTL,,,,,,,,,,,,,BRD-K00004613,GM-1485,immunophilin ligand,FKBP1A
FTBQORVNHOIASH,,,,,,,,,,,,,BRD-K00003484,mirogabalin-besylate,calcium channel antagonist,
FTPHYXGWMIZVMP,,,,,,,,,,,,,BRD-K00005327,scabertopin,anticancer agent,
FTQHGWIXJSSWOY,,,,,,,,,,,,,BRD-K00003315,nelociguat,guanylate cyclase stimulant,
FTSCEGKYKXESFF,,,,,,,,,,,,,BRD-K00004640,NN-DNJ,glucosidase inhibitor,GBA
FVJCUZCRPIMVLB,,,,,,,,,,,,,BRD-K00004612,verdiperstat,myeloperoxidase inhibitor,
FWRFPHJSGLYXTD,,,,,,,,,,,,,BRD-K00003115,ETC-206,MAPK-interacting kinase inhibitor,
FXQIIDINBDJDKL,,,,,,,,,,,,,BRD-K00003130,epetraborole,leucyl-tRNA synthetase inhibitor,
FYDWDCIFZSGNBU,,,,,,,,,,,,,BRD-K00003198,revefenacin,cholinergic receptor antagonist,
FYJLDICZGDFWKP,,,,,,,,,,,,,BRD-K00004611,olumacostat-glasaretil,acetyl-CoA carboxylase inhibitor,
FYNMINFUAIDIFL,,,,,,,,,,,,,BRD-K00010389,RAF709,RAF inhibitor,
FYOVZCDHYOEKDE,,,,,,,,,,,,,BRD-K00004553,SAM-315,serotonin receptor antagonist,
FZEXGDDBXLBRTD,,,,,,,,,,,,,BRD-K00003316,eldecalcitol,bone formation stimulant,VDR
GAMRBCZMOOMBSQ,,,,,,,,,,,,,BRD-K77817104,N-(p-amylcinnamoyl)-anthranilic-acid,phospholipase inhibitor,
GDTQLZHHDRRBEB,,,,,,,,,,,,,BRD-K00003168,BMS-582949,p38 MAPK inhibitor,
GEJDGVNQKABXKG,,,,,,,,,,,,,BRD-K00003233,valbenazine,vesicular monoamine transporter inhibitor,
GERJIEKMNDGSCS,,,,,,,,,,,,,BRD-K00003255,acebilustat,leukotriene inhibitor,
GETAAWDSFUCLBS,,,,,,,,,,,,,BRD-K00003402,T-807,PET radiotracer,
GFHAXPJGXSQLPT,,,,,,,,,,,,,BRD-K00003249,cenobamate,GABA receptor modulator|voltage-gated sodium channel blocker,
GFPPXZDRVCSVNR,,,,,,,,,,,,,BRD-K00003232,fevipiprant,prostaglandin inhibitor,
GFYRZTLCYQQVHZ,,,,,,,,,,,,,BRD-K45152786,merbarone,topoisomerase inhibitor,TOP2A
GGAKLYWEFZCVIT,,,,,,,,,,,,,BRD-K00003300,LTX-315,anticancer agent,
GGTYBZJRPHEQDG,,,,,,,,,,,,,BRD-K01825132,ornithine,NFkB pathway modulator,GPRC6A
GHBCIXGRCZIPNQ,,,,,,,,,,,,,BRD-K00003151,olodanrigan,angiotensin antagonist,
GHJWNRRCRIGGIO,,,,,,,,,,,,,BRD-K00003384,fosfluconazole,other antifungal,
GHTGYZMBQPXTCQ,,,,,,,,,,,,,BRD-K00003095,GLPG1837,CFTR channel potentiator,
GHVIMBCFLRTFHI,,,,,,,,,,,,,BRD-K00003366,linaprazan,ATP-sensitive potassium channel inhibitor,
GISXTRIGVCKQBX,,,,,,,,,,,,,BRD-K00003432,EDO-S101,HDAC inhibitor,
GJKXGJCSJWBJEZ,,,,,,,,,,,,,BRD-K00003134,deslorelin,gonadotropin releasing factor hormone receptor agonist,
GKGRZLGAQZPEHO,,,,,,,,,,,,,BRD-K00005328,radiprodil,acetylcholine receptor antagonist,
GNLZNQJBZNOUBM,,,,,,,,,,,,,BRD-K00004636,DpC,,
GOJJWDOZNKBUSR,,,,,,,,,,,,,BRD-K00004739,hepsulfam,DNA cross-linking,
GOWRRBABHQUJMX,,,,,,,,,,,,,BRD-K00004571,fasoracetam,GABA receptor antagonist,
GQBRZBHEPUQRPL,,,,,,,,,,,,,BRD-K00004586,BMS-986020,lysophosphatidic acid receptor antagonist,LPAR1
GRHBODILPPXVKN,,,,,,,,,,,,,BRD-K00004688,evenamide,voltage-gated sodium channel blocker,
GRKYRJREJPZXIU,,,,,,,,,,,,,BRD-K00010938,BTS-71321,,
GROMEQPXDKRRIE,,,,,,,,,,,,,BRD-K00004645,rimeporide,sodium/hydrogen exchanger inhibitor,
GRUVVLWKPGIYEG,,,,,,,,,,,,,BRD-K00004555,HBED,chelating agent,
GTBKISRCRQUFNL,,,,,,,,,,,,,BRD-K00003277,vatinoxan,adrenergic receptor antagonist,
GTCSIQFTNPTSLO,,,,,,,,,,,,,BRD-K00003271,JD-5037,cannabinoid receptor antagonist,
GTQTUABHRCWVLL,,,,,,,,,,,,,BRD-K00004600,JNJ-678,RSV fusion inhibitor,
GULSIMHVQYBADX,,,,,,,,,,,,,BRD-K00003458,cintirorgon,ROR agonist,
GUWXKKAWLCENJA,,,,,,,,,,,,,BRD-K00003187,guadecitabine,DNA methyltransferase inhibitor,
GVGUCRAJNQYOSE,,,,,,,,,,,,,BRD-K03326591,amyl-nitrite,atrial natriuretic peptide receptor agonist,
GWNHAOBXDGOXRR,,,,,,,,,,,,,BRD-K00003119,pradefovir,cytochrome P450 activator,
GXGXSVFKGDVBMD,,,,,,,,,,,,,BRD-K03635852,U-0124,MEK inhibitor,
GYFRQCMDLBNZSF,,,,,,,,,,,,,BRD-K00004590,RG7800,RNA splicing modifier,
HABROHXUHNHQMY,,,,,,,,,,,,,BRD-K00003470,Neu2000,ionotropic glutamate receptor antagonist,
HARRKNSQXBRBGZ,,,,,,,,,,,,,BRD-K00003448,zuranolone,GABA receptor agonist,
HBZBAMXERPYTFS,,,,,,,,,,,,,BRD-K00005335,CycLuc1,,
HDAMOICMOAXFLJ,,,,,,,,,,,,,BRD-K00003518,methylbenactyzium-bromide,cholinergic receptor antagonist,
HDHDTKMUACZDAA,,,,,,,,,,,,,BRD-K00003298,setmelanotide,melanocortin receptor agonist,
HDXDQPRPFRKGKZ,,,,,,,,,,,,,BRD-K00003263,tenalisib,PI3K inhibitor,
HEDFFPYRFJKXQP,,,,,,,,,,,,,BRD-K00005338,VL285,PROTAC,
HFZITXBUTWITPT,,,,,,,,,,,,,BRD-K00003450,AAI101,lactamase inhibitor,
HGXFBVDWWKPUKZ,,,,,,,,,,,,,BRD-K26813314,protoporphyrin-IX,heme oxygenase inhibitor,HMOX1
HIUPRQPBWVEQJJ,,,,,,,,,,,,,BRD-K00003428,pagoclone,GABA receptor agonist,
HJFSVYUFOXAVAA,,,,,,,,,,,,,BRD-K00003510,FLT3-IN-1,FLT3 inhibitor,
HKHCSWPSUSWGLI,,,,,,,,,,,,,BRD-K00004588,centanafadine,dopamine reuptake inhibitor,
HKJMCBYPVCGZFB,,,,,,,,,,,,,BRD-K00003132,LGD-6972,glucagon receptor antagonist,
HKTBYUWLRDZAJK,,,,,,,,,,,,,BRD-K00003361,tomivosertib,MAPK-interacting kinase inhibitor,
HLKYSQGBIIIQJN,,,,,,,,,,,,,BRD-K00004548,NS-11394,GABA receptor agonist,
HLUBVUICXYRPPM,,,,,,,,,,,,,BRD-A96503329,safflower-yellow,anti-inflammatory agent,
HLWURFKMDLAKOD,,,,,,,,,,,,,BRD-K00004589,gefapixant,purinergic receptor antagonist,
HMHVCUVYZFYAJI,,,,,,,,,,,,,BRD-K00003488,sultiame,carbonic anhydrase inhibitor,CA2
HMPQTEPEMQZWQH,,,,,,,,,,,,,BRD-K00004668,freselestat,elastase inhibitor,CELA1|ELANE
HNAJDMYOTDNOBK,,,,,,,,,,,,,BRD-K00003439,XL041,LXR agonist,
HNLRRJSKGXOYNO,,,,,,,,,,,,,BRD-K00003358,rogaratinib,FGFR inhibitor,
HNQSZPBGDAJIJO,,,,,,,,,,,,,BRD-K00003411,bamaquimast,proton pump inhibitor,
HNXGIFYHJKEXNA,,,,,,,,,,,,,BRD-K00004655,BMS-770767,11-beta-HSD1 inhibitor,
HPKYRXAEGNUARA,,,,,,,,,,,,,BRD-K00004743,nuvenzepine,acetylcholine receptor antagonist,
HPODOLXTMDHLLC,,,,,,,,,,,,,BRD-K00003360,CPI-1205,EZH2 inhibitor,
HQNACSFBDBYLJP,,,,,,,,,,,,,BRD-K00003259,edonerpic-maleate,beta amyloid inhibitor,
HQWGBIUMYSOPFP,,,,,,,,,,,,,BRD-K86727142,embelin,HCV inhibitor|XIAP inhibitor,XIAP
HRNLPPBUBKMZMT,,,,,,,,,,,,,BRD-K00004629,pralmorelin,growth hormone releasing peptide ligand agonist,
HROMYAWHLUOUPY,,,,,,,,,,,,,BRD-K00003212,omtriptolide,ERK1 and ERK2 phosphorylation inhibitor,
HRRXCXABAPSOCP,,,,,,,,,,,,,BRD-K00003427,ilaprazole,proton pump inhibitor,
HSQAARMBHJCUOK,,,,,,,,,,,,,BRD-K13699028,AZD9056,purinergic receptor antagonist,
HTJGLYIJVSDQAE,,,,,,,,,,,,,BRD-K00003204,celgosivir,glucosidase inhibitor,
HTQBXNHDCUEHJF,,,,,,,,,,,,,BRD-K00003559,exenatide,GLP receptor agonist,GLP1R
HUASEDVYRABWCV,,,,,,,,,,,,,BRD-K00003218,upamostat,serine protease inhibitor,
HULMNSIAKWANQO,,,,,,,,,,,,,BRD-K00004559,convallatoxin,cardiac glycoside,
HVRZAFDJOWIDMM,,,,,,,,,,,,,BRD-K42607789,pyrazoloacridine,topoisomerase inhibitor,TOP1|TOP2A
HWJPWWYTGBZDEG,,,,,,,,,,,,,BRD-K00003415,iclaprim,dihydrofolate reductase inhibitor,
HWJWNWZJUYCGKV,,,,,,,,,,,,,BRD-K00003105,IACS-10759,mitochondrial complex I inhibitor,
HXHAJRMTJXHJJZ,,,,,,,,,,,,,BRD-K00004719,CP-547632,kinase inhibitor,
HXSDFQWQRCUQHF,,,,,,,,,,,,,BRD-K00003590,ardeparin,thrombin inhibitor,SERPIND1
HYMZAYGFKNNHDN,,,,,,,,,,,,,BRD-K00004699,J147,BDNF inducer,
HYOLQGVNMQNERE,,,,,,,,,,,,,BRD-K00004569,ICI-169369,serotonin receptor antagonist,
HZDQUOWQHHSPIE,,,,,,,,,,,,,BRD-K23728266,chlorophyllin,,
HZLAWYIBLZNRFZ,,,,,,,,,,,,,BRD-K00003434,miridesap,amyloid protein inhibitor,
ICYNYWFGIDGBRD,,,,,,,,,,,,,BRD-K00003279,PF-06282999,myeloperoxidase inhibitor,
IDIUJOHYYBNCPC,,,,,,,,,,,,,BRD-K00004652,PF-06412562,dopamine receptor partial agonist,
IDRGFNPZDVBSSE,,,,,,,,,,,,,BRD-K00005246,CK-101,EGFR inhibitor,
IDXKJSSOUXWLDB,,,,,,,,,,,,,BRD-K00003373,GSK3179106,RET tyrosine kinase inhibitor,
IESDGNYHXIOKRW,,,,,,,,,,,,,BRD-K00003336,tuftsin,macrophage activator,
IFWUBRBMMNTBRZ,,,,,,,,,,,,,BRD-K00021095,PDD-00017273,PARG inhibitor,
IIJOAQBKDPUMEO,,,,,,,,,,,,,BRD-K36234266,carmustine,DNA alkylating agent|DNA inhibitor,GSR
IJHWVENTEFSNBC,,,,,,,,,,,,,BRD-K00003131,LY2510924,CC chemokine receptor antagonist,
IJPXOPBVXVPPEW,,,,,,,,,,,,,BRD-K00005340,SBI-115,G protein-coupled receptor antagonist,
IKRKQQLJYBAPQT,,,,,,,,,,,,,BRD-K00003452,desidustat,hypoxia inducible factor prolyl hydroxylase inhibitor,
IKUYEYLZXGGCRD,,,,,,,,,,,,,BRD-K00010386,RMC-4550,SHIP2 phosphatase inhibitor,
IKWTVSLWAPBBKU,,,,,,,,,,,,,BRD-K32786395,arsenic-trioxide,apoptosis stimulant,AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1
ILUKRINUNLAVMH,,,,,,,,,,,,,BRD-K00003116,CC-90003,MAP kinase inhibitor,
IMMBLRJLSYJQIZ,,,,,,,,,,,,,BRD-K00005238,alpha-glucosyl-hesperidin,antioxidant,
IOHOUWIYOVWGHV,,,,,,,,,,,,,BRD-K00004623,Ro-5263397,trace amine associated receptor agonist,
IOOWNWLVCOUUEX,,,,,,,,,,,,,BRD-K00003306,vaborbactam,beta lactamase inhibitor,
IPKZCLGGYKRDES,,,,,,,,,,,,,BRD-K00004641,PHA-543613,nicotinic receptor agonist,
IPOBOOXFSRWSHL,,,,,,,,,,,,,BRD-A20742938,cibenzoline,sodium channel blocker,
IQHAKYLSMONFMT,,,,,,,,,,,,,BRD-K00004657,motapizone,phosphodiesterase inhibitor,
IQIKXZMPPBEWAD,,,,,,,,,,,,,BRD-K86677390,MK-8998,T-type calcium channel blocker,
IRKXGKIPOMIQOD,,,,,,,,,,,,,BRD-K00004677,2-fluorofucose,,
IRNJSRAGRIZIHD,,,,,,,,,,,,,BRD-K00003381,MSDC-0160,insulin sensitizer,
IRZRJANZDIOOIF,,,,,,,,,,,,,BRD-K00004557,MK-0608,antiviral,
ISJSHQTWOHGCMM,,,,,,,,,,,,,BRD-K00003367,uki-1,urokinase inhibitor,
ITAMRBIZWGDOHW,,,,,,,,,,,,,BRD-K00003465,fantofarone,calcium channel blocker,
IVQOFBKHQCTVQV,,,,,,,,,,,,,BRD-K85030058,benactyzine,butyrylcholinesterase inhibitor,
IXIGWKNBFPKCCD,,,,,,,,,,,,,BRD-K00004681,5-octanoylsalicylic-acid,protein kinase activator,
IXWNTLSTOZFSCM,,,,,,,,,,,,,BRD-K00003267,ombrabulin,tubulin polymerization inhibitor,
IXZOHGPZAQLIBH,,,,,,,,,,,,,BRD-K00003408,iberdomide,cereblon modulator,
IYFNEFQTYQPVOC,,,,,,,,,,,,,BRD-K00003266,udenafil,phosphodiesterase inhibitor,
IZJJFUQKKZFVLH,,,,,,,,,,,,,BRD-K00003146,MIW-815,interferon inducer,
IZTQOLKUZKXIRV,,,,,,,,,,,,,BRD-K00003334,sincalide,cholecystokinin agonist,
InChI=1S/C10H7,,,,,,,,,,,,,BRD-K60302405,CHC,monocarboxylate transporter inhibitor,SLC16A1
InChI=1S/C10H8,,,,,,,,,,,,,BRD-K55420858,mirin,MRE11A exonuclease inhibitor,MRE11A
InChI=1S/C11H1,,,,,,,,,,,,,BRD-K11696279,BU-239,imidazoline receptor agonist|imidazoline receptor ligand,
InChI=1S/C12H6,,,,,,,,,,,,,BRD-K39120595,bithionol,autotaxin inhibitor,ESR1|ESR2|MCL1
InChI=1S/C13H1,,,,,,,,,,,,,BRD-A12994259,pomalidomide,angiogenesis inhibitor|tumor necrosis factor production inhibitor,
InChI=1S/C14H1,,,,,,,,,,,,,BRD-K48735772,PD-158780,EGFR inhibitor,EGFR
InChI=1S/C14H2,,,,,,,,,,,,,BRD-K33521504,GSK-LSD-1,histone lysine demethylase inhibitor,KDM1A
InChI=1S/C15H1,,,,,,,,,,,,,BRD-K11636097|BRD-K17743125,JNJ-7706621|belinostat,CDK inhibitor|HDAC inhibitor,AURKA|AURKB|CDK1|CDK2|HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
InChI=1S/C15H2,,,,,,,,,,,,,BRD-K21396683|BRD-K49921286,LMK-235|marimastat,HDAC inhibitor|matrix metalloprotease inhibitor,HDAC4|HDAC5|MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9
InChI=1S/C16H1,,,,,,,,,,,,,BRD-K43449605,oncrasin-1,apoptosis stimulant,
InChI=1S/C17H1,,,,,,,,,,,,,BRD-K05104363|BRD-K17702546|BRD-K24240364|BRD-K51137250|BRD-K89053832,GYKI-52466|ML297|PD-168393|PD-184352|VLX600,EGFR inhibitor|MEK inhibitor|antitumor agent|glutamate receptor antagonist|inward rectifier potassium channel activator|ubiquitin C-terminal hydrolase inhibitor,EGFR|ERBB2|GRIA1|GRIA2|GRIA3|GRIA4|KCNJ3|MAP2K1|MAP3K1|MAP3K2|SRC|TP53|USP14
InChI=1S/C18H2,,,,,,,,,,,,,BRD-K40255344|BRD-K72414522,AZD5438|tyrphostin-A9,CDK inhibitor|protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,|KCNH2
InChI=1S/C18H3,,,,,,,,,,,,,BRD-K05048137,phytosphingosine,,
InChI=1S/C19H1,,,,,,,,,,,,,BRD-K28567778|BRD-K44827188|BRD-K67868012|BRD-K73319509,PF-04217903|PI-103|neuropathiazol|vismodegib,PI3K inhibitor|c-Met inhibitor|hedgehog pathway inhibitor|mTOR inhibitor|neural stem cell inducer|smoothened receptor antagonist,BMP2|LIF|MET|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SMO
InChI=1S/C19H2,,,,,,,,,,,,,BRD-K01825674|BRD-K24576554|BRD-K53734668,AT-9283|PRT062607|TC1,Aurora kinase inhibitor|JAK inhibitor|SYK inhibitor|beta-secretase inhibitor,AURKA|AURKB|BACE1|FGR|JAK2|JAK3|MAP3K9|RPS6KA6|STK17A|SYK
InChI=1S/C19H3,,,,,,,,,,,,,BRD-A19633847,perhexiline,carnitine palmitoyltransferase inhibitor,CPT1A
InChI=1S/C20H1,,,,,,,,,,,,,BRD-K59060513,A-1120,retinoid receptor ligand,RBP4
InChI=1S/C20H2,,,,,,,,,,,,,BRD-K39484304|BRD-K45044657,TC-H-106|triptolide,HDAC inhibitor|RNA polymerase inhibitor,HDAC1|HDAC2|HDAC3|HDAC8|RELA
InChI=1S/C20H3,,,,,,,,,,,,,BRD-K64054020,epoprostenol,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS
InChI=1S/C21H1,,,,,,,,,,,,,BRD-K16730910,regorafenib,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK
InChI=1S/C21H2,,,,,,,,,,,,,BRD-K13662825|BRD-K67844266,dinaciclib|pevonedistat,CDK inhibitor|nedd activating enzyme inhibitor,CDK1|CDK2|CDK5|CDK9|NAE1|UBA3
InChI=1S/C22H1,,,,,,,,,,,,,BRD-K60866521,idelalisib,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG
InChI=1S/C22H2,,,,,,,,,,,,,BRD-K08109215|BRD-K36627727|BRD-K70401845|BRD-K73838513,I-BET-762|cinacalcet|erlotinib|tamibarotene,EGFR inhibitor|bromodomain inhibitor|calcium channel activator|retinoid receptor agonist,BRD2|BRD3|BRD4|CASR|EGFR|NR1I2|RARA|RARB
InChI=1S/C22H3,,,,,,,,,,,,,BRD-K52256627,chlorhexidine,membrane integrity inhibitor,
InChI=1S/C23H2,,,,,,,,,,,,,BRD-A74914197|BRD-K25630527|BRD-K41783120|BRD-K52911425|BRD-K66538826,GDC-0941|LY2784544|STA-5326|amuvatinib|pralatrexate,FLT3 inhibitor|JAK inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|PI3K inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor|dihydrofolate reductase inhibitor|interleukin synthesis inhibitor,DHFR|IL12A|JAK2|JAK3|KIT|MET|PIK3CA|PIK3CB|PIK3CD|PIK3CG
InChI=1S/C23H3,,,,,,,,,,,,,BRD-K29424831,TCS-OX2-29,orexin receptor antagonist,HCRTR2
InChI=1S/C24H1,,,,,,,,,,,,,BRD-K15107389,BRD7389,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3
InChI=1S/C24H2,,,,,,,,,,,,,BRD-K13810148|BRD-K44844162|BRD-K50168500|BRD-K51313569|BRD-K54233340,canertinib|dorsomorphin|givinostat|palbociclib|taselisib,AMPK inhibitor|CDK inhibitor|EGFR inhibitor|HDAC inhibitor|PI3K inhibitor,ACVR1|AKT1|BMPR1A|BMPR1B|CDK4|CDK6|EGFR|EPHA2|ERBB2|ERBB4|FKBP1A|FLT1|FLT3|HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|KDR|LCK|MKNK1|PIK3CA|PRKAA1|RPS6KA1|SRC
InChI=1S/C24H3,,,,,,,,,,,,,BRD-K61397605,romidepsin,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9
InChI=1S/C25H1,,,,,,,,,,,,,BRD-K00337317,NU-7441,DNA dependent protein kinase inhibitor,PRKDC
InChI=1S/C25H2,,,,,,,,,,,,,BRD-K31342827|BRD-K68065987|BRD-K70301465,GF109203X|MK-2206|ibrutinib,AKT inhibitor|Bruton's tyrosine kinase (BTK) inhibitor|PKC inhibitor,AKT1|AKT2|AKT3|BLK|BMX|BTK|PDPK1|PIM1|PRKCI|PRKCZ
InChI=1S/C25H3,,,,,,,,,,,,,BRD-K32289541|BRD-K37764012,EHop-016|PF-03758309,Ras GTPase inhibitor|p21 activated kinase inhibitor,PAK4|RAC1|RAC3
InChI=1S/C26H2,,,,,,,,,,,,,BRD-K29968218|BRD-K31309378,KX2-391|lucitanib,FGFR inhibitor|SRC inhibitor|VEGFR inhibitor|tubulin polymerization inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET|SRC
InChI=1S/C26H3,,,,,,,,,,,,,BRD-K28392481|BRD-K63923597,AZD4547|barasertib-HQPA,Aurora kinase inhibitor|FGFR inhibitor,AURKB|FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR
InChI=1S/C27H2,,,,,,,,,,,,,BRD-K04548931|BRD-K33610132|BRD-K44432556|BRD-K62965247|BRD-K75295174,ML228|alisertib|epirubicin|rociletinib|tipifarnib,Aurora kinase inhibitor|EGFR inhibitor|farnesyltransferase inhibitor|hypoxia inducible factor activator|topoisomerase inhibitor,AURKA|CHD1|EGFR|FNTA|FNTB|HIF1A|TOP2A
InChI=1S/C27H3,,,,,,,,,,,,,BRD-K19540840|BRD-K41599323|BRD-K54256913,MK-1775|lonafarnib|saracatinib,SRC inhibitor|WEE1 kinase inhibitor|farnesyltransferase inhibitor,ABL1|FNTA|HRAS|KRAS|LCK|NRAS|SRC|WEE1|YES1
InChI=1S/C28H2,,,,,,,,,,,,,BRD-K19975102|BRD-K51544265,GNF-5837|cabozantinib,RET tyrosine kinase inhibitor|VEGFR inhibitor|growth factor receptor inhibitor,KDR|MET|NTRK1|NTRK2|NTRK3|RET
InChI=1S/C28H3,,,,,,,,,,,,,BRD-K64890080,BI-2536,PLK inhibitor,BRD4|PLK1|PLK2|PLK3
InChI=1S/C30H2,,,,,,,,,,,,,BRD-K24556407,ETP-46464,ATR kinase inhibitor,
InChI=1S/C30H3,,,,,,,,,,,,,BRD-K72827473,CEP-37440,ALK tyrosine kinase receptor inhibitor,ALK
InChI=1S/C31H2,,,,,,,,,,,,,BRD-K62627508,idasanutlin,MDM inhibitor,MDM2|TP53
InChI=1S/C31H4,,,,,,,,,,,,,BRD-K20545304,bardoxolone,like (NRF2) activator|nuclear factor erythroid derived,NOS2|PPARG
InChI=1S/C32H4,,,,,,,,,,,,,BRD-K69694239|BRD-K74117820,bardoxolone-methyl|nelfinavir,HIV protease inhibitor|like (NRF2) activator|nuclear factor erythroid derived,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7|PPARG|STAT3
InChI=1S/C34H3,,,,,,,,,,,,,BRD-K03449891,foretinib,VEGFR inhibitor,FLT1|FLT4|KDR|MET
InChI=1S/C34H4,,,,,,,,,,,,,BRD-K57011718,UK-356618,metalloproteinase inhibitor,MMP13|MMP14|MMP2|MMP3|MMP9
InChI=1S/C34H5,,,,,,,,,,,,,BRD-K69776681,volasertib,PLK inhibitor,PLK1
InChI=1S/C36H4,,,,,,,,,,,,,BRD-K33226500,indinavir,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7
InChI=1S/C38H3,,,,,,,,,,,,,BRD-K09353376,tariquidar,P glycoprotein inhibitor,ABCB1
InChI=1S/C42H4,,,,,,,,,,,,,BRD-K56301217,ABT-737,BCL inhibitor,BCL2|BCL2L1|BCL2L2
InChI=1S/C42H5,,,,,,,,,,,,,BRD-K71221037,birinapant,XIAP inhibitor,BIRC2|XIAP
InChI=1S/C8H9N,,,,,,,,,,,,,BRD-K41524689,paracetamol,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1
InChI=1S/C9H11,,,,,,,,,,,,,BRD-K47832606,floxuridine,DNA synthesis inhibitor,TYMS
InChI=1S/C9H13,,,,,,,,,,,,,BRD-K71847383,cytidine,,
JBGYKRAZYDNCNV,,,,,,,,,,,,,BRD-K00003357,BAY1125976,AKT inhibitor,
JBIWCJUYHHGXTC,,,,,,,,,,,,,BRD-K01825679|BRD-M28128163,doxycycline,bacterial 30S ribosomal subunit inhibitor|metalloproteinase inhibitor,MMP8
JCINBYQJBYJGDM,,,,,,,,,,,,,BRD-K00003189,BMS-911543,JAK inhibitor,
JCSREICEMHWFAY,,,,,,,,,,,,,BRD-K00004670,naxagolide,dopamine receptor agonist,
JDJALSWDQPEHEJ,,,,,,,,,,,,,BRD-K00005332,calcitonin,calcitonin agonist,
JDKLPDJLXHXHNV,,,,,,,,,,,,,BRD-K75989555,melanotan-ii,melanocortin receptor agonist,
JEMKCYHUYUPGFN,,,,,,,,,,,,,BRD-K00003372,CGP-25454A,dopamine receptor antagonist,
JENBDJGHNIOHAJ,,,,,,,,,,,,,BRD-K00004663,tinazoline,adrenergic receptor agonist,
JESCETIFNOFKEU,,,,,,,,,,,,,BRD-K00003141,vixotrigine,sodium channel blocker,
JEWJRMKHSMTXPP,,,,,,,,,,,,,BRD-K00003534,methylcobalamin,vitamin B,
JEZGPBWIZWPDHP,,,,,,,,,,,,,BRD-K00010388,PTC-028,BMI-1 inhibitor,
JFAYRTHYLOZRNL,,,,,,,,,,,,,BRD-A85424553,thioperamide,histamine receptor antagonist,HRH3|HRH4
JFBAVWVBLRIWHM,,,,,,,,,,,,,BRD-K00003369,eltanexor,exportin inhibitor,
JFIWEPHGRUDAJN,,,,,,,,,,,,,BRD-K00003207,ethynylcytidine,antimetabolite,
JFOZKMSJYSPYLN,,,,,,,,,,,,,BRD-K60265345,lifitegrast,lymphocyte function-associated antigen negative modulator,
JGGDSDPOPRWSCX,,,,,,,,,,,,,BRD-K00004643,EF5,cytochrome P450 activator,
JGLSWAGTNWZKQU,,,,,,,,,,,,,BRD-K63712959,temoporfin,radical formation stimulant,
JGPXDNKSIXAZEQ,,,,,,,,,,,,,BRD-K00003127,pimodivir,antiviral,
JGRXMPYUTJLTKT,,,,,,,,,,,,,BRD-K00003407,vadadustat,hypoxia inducible factor prolyl hydroxylase inhibitor,
JHCFQXNWYDLBOG,,,,,,,,,,,,,BRD-K00005240,tulrampator,antidepressant ,
JHDZMASHNBKTPS,,,,,,,,,,,,,BRD-K00003388,CXD101,HDAC inhibitor,
JHLHNYVMZCADTC,,,,,,,,,,,,,BRD-K00003477,asimadoline,opioid receptor agonist,OPRK1
JIJXYXYLGRAIGV,,,,,,,,,,,,,BRD-K00004703,MSDC-0602K,mitochondrial pyruvate carrier modulator,
JIWDGIYBLGMPRV,,,,,,,,,,,,,BRD-K00004665,SY-640,,
JKCSODVERGVDLT,,,,,,,,,,,,,BRD-K00003273,cbl0137,histone chaperone inhibitor,
JKDGKIBAOAFRPJ,,,,,,,,,,,,,BRD-K00003296,PF-06650833,kinase inhibitor,
JKVNJTYHRABHIY,,,,,,,,,,,,,BRD-K00004731,Gln-1062,cholinesterase inhibitor,
JLCCNYVTIWRPIZ,,,,,,,,,,,,,BRD-K00003421,GSK3326595,protein arginine N-methyltransferase inhibitor,
JLPURTXCSILYLW,,,,,,,,,,,,,BRD-K00003305,BMS-779788,LXR agonist,
JNLSTLQFDDAULK,,,,,,,,,,,,,BRD-K00003368,BFH772,VEGFR inhibitor,
JNPRPMBJODOFEC,,,,,,,,,,,,,BRD-K00003416,LY3214996,ERK inhibitor,
JOMHSQGEWSNUKU,,,,,,,,,,,,,BRD-K00004560,pipotiazine,dopamine receptor antagonist,DRD1|DRD2|HTR1A|HTR2A
JQLBBYLGWHUHRW,,,,,,,,,,,,,BRD-K00003258,edasalonexent,NFkB pathway inhibitor,
JQNINBDKGLWYMU,,,,,,,,,,,,,BRD-K43900408,AMG-176,MCL1 inhibitor,
JTCAGRAKUAAYDY,,,,,,,,,,,,,BRD-K00003199,MK-7246,CRTH receptor antagonist,
JUTBAVRYDAKVGQ,,,,,,,,,,,,,BRD-K00003226,emeramide,antioxidant,
JUUWEJHZVBABHQ,,,,,,,,,,,,,BRD-K13281575,semustine,DNA alkylating agent,
JUVQLZBJFOGEEO,,,,,,,,,,,,,BRD-K00003194,MK-7622,cholinergic receptor agonist,
JVCPIJKPAKAIIP,,,,,,,,,,,,,BRD-K00003223,amiselimod,sphingosine 1-phosphate receptor modulator,
JWHYSEDOYMYMNM,,,,,,,,,,,,,BRD-K00003284,seladelpar,PPAR receptor agonist,
JXONINOYTKKXQQ,,,,,,,,,,,,,BRD-K00003162,crolibulin,tubulin polymerization inhibitor,
JYIUNVOCEFIUIU,,,,,,,,,,,,,BRD-K00004648,PF-06747775,EGFR inhibitor,
JZWUKILTKYJLCN,,,,,,,,,,,,,BRD-K00004673,LP-533401,tryptophan hydroxylase inhibitor,
KAIYFJUWIBTYPK,,,,,,,,,,,,,BRD-K00004704,DBPR-211,cannabinoid receptor antagonist,
KANJSNBRCNMZMV,,,,,,,,,,,,,BRD-K00003513,fondaparinux,coagulation factor inhibitor,F10|SERPINC1
KBEMFSMODRNJHE,,,,,,,,,,,,,BRD-K00004554,lodenosine,antiretroviral ,
KBKUJJFDSHBPPA,,,,,,,,,,,,,BRD-K00003354,cinobufotalin,anticancer agent,
KBQCEQAXHPIRTF,,,,,,,,,,,,,BRD-K00005264,AZD5991,MCL1 inhibitor,
KBXLMOYQNDMHQT,,,,,,,,,,,,,BRD-K00004573,RG7834,antiviral,
KDCSRTPNDBPWQZ,,,,,,,,,,,,,BRD-K09109825,indole-3-pyrubate,melatonin receptor agonist,
KEIPNCCJPRMIAX,,,,,,,,,,,,,BRD-K00003392,futibatinib,FGFR inhibitor,
KFQUAMTWOJHPEJ,,,,,,,,,,,,,BRD-A93407926|BRD-K00004728,allopurinol-riboside,anti-leishmanial agent|phosphorylase inhibitor,
KGERZPVQIRYWRK,,,,,,,,,,,,,BRD-K00003423,BMS-986158,bromodomain inhibitor,
KIIBBJKLKFTNQO,,,,,,,,,,,,,BRD-K03871161,5-hydroxyectoine,,
KIOOLNRTWPFVHX,,,,,,,,,,,,,BRD-K00004556,WAY-255348,progesterone receptor antagonist,
KJAAPZIFCQQQKX,,,,,,,,,,,,,BRD-K00003101,GDC-0927,estrogen receptor antagonist,
KJDAGXLMHXUAGV,,,,,,,,,,,,,BRD-K00003376,TAK-243,ubiquitin activating enzyme inhibitor,
KJKKMMMRWISKRF,,,,,,,,,,,,,BRD-K00003248,cenerimod,sphingosine 1-phosphate receptor modulator,
KKHPNPMTPORSQE,,,,,,,,,,,,,BRD-K00003537,chlorphenoxamine,histamine receptor antagonist,
KKKRKRMVJRHDMG,,,,,,,,,,,,,BRD-K00004710,R-1487,p38 MAPK inhibitor,
KMNLXCBYBKHKSK,,,,,,,,,,,,,BRD-K00004654,"CP-105,696",leukotriene receptor antagonist,
KNVJMHHAXCPZHF,,,,,,,,,,,,,BRD-K22379844,BAY-2402234,dihydroorotate dehydrogenase inhibitor,
KOAWAWHSMVKCON,,,,,,,,,,,,,BRD-K00003094,JNJ-38877618,c-Met inhibitor,
KPJDVVCDVBFRMU,,,,,,,,,,,,,BRD-K00003310,derazantinib,tyrosine kinase inhibitor,
KPWYNAGOBXLMSE,,,,,,,,,,,,,BRD-K00004627,tipelukast,leukotriene receptor antagonist,
KRTIYQIPSAGSBP,,,,,,,,,,,,,BRD-K00003418,BMS-986205,"indoleamine 2,3-dioxygenase inhibitor",
KRVOJOCLBAAKSJ,,,,,,,,,,,,,BRD-K47289124,nemonapride,dopamine receptor antagonist,DRD2|DRD3|DRD4
KSPDSMOWMQFPBL,,,,,,,,,,,,,BRD-K00004679,5-fluoropyrimidine,kinase inhibitor,
KSPYMJJKQMWWNB,,,,,,,,,,,,,BRD-K00004625,cipamfylline,phosphodiesterase inhibitor,
KSUUMAWCGDNLFK,,,,,,,,,,,,,BRD-K00003524,apronal,cytochrome P450 modulator,
KTGRHKOEFSJQNS,,,,,,,,,,,,,BRD-A47598013|BRD-K01825597,escitalopram,selective serotonin reuptake inhibitor (SSRI),SLC6A4
KTUXFHGUHYRDNF,,,,,,,,,,,,,BRD-A56621826|BRD-A78694248|BRD-K01826559,oxytetracycline,bacterial 30S ribosomal subunit inhibitor,
KUQWGLQLLVFLSM,,,,,,,,,,,,,BRD-K00003445,vaniprevir,serine protease inhibitor,
KURQKNMKCGYWRJ,,,,,,,,,,,,,BRD-K00003442,CPI-444,adenosine receptor antagonist,
KVLLHLWBPNCVNR,,,,,,,,,,,,,BRD-K00003188,capromorelin,growth hormone secretagogue receptor agonist,
KWUFTKVMXUYTBF,,,,,,,,,,,,,BRD-K00004738,apyramide,cyclooxygenase inhibitor,
KXBCLNRMQPRVTP,,,,,,,,,,,,,BRD-K00004562,deazaguanine,DNA synthesis inhibitor,
KYQZWONCHDNPDP,,,,,,,,,,,,,BRD-K12979078,daidzin,antioxidant,ALDH2
KYYKGSDLXXKQCR,,,,,,,,,,,,,BRD-K00005244,CCT196969,RAF inhibitor,
KZEUBCUXBNEMSQ,,,,,,,,,,,,,BRD-K94882685,tolonium,,
KZSKGLFYQAYZCO,,,,,,,,,,,,,BRD-K00004595,cilofexor,FXR agonist,
LBEJYFVJIPQSNX,,,,,,,,,,,,,BRD-K00003417,MRX-2843,MER tyrosine kinase inhibitor,
LBGFKUUHOPIEMA,,,,,,,,,,,,,BRD-K00003214,sapacitabine,DNA synthesis inhibitor,
LBSRZVRITCRLIU,,,,,,,,,,,,,BRD-K00004746,YS-201,calcium receptor antagonist,
LCFFREMLXLZNHE,,,,,,,,,,,,,BRD-K00004599,PRN1008,Bruton's tyrosine kinase (BTK) inhibitor,
LGDCROILDUSHQX,,,,,,,,,,,,,BRD-K92726801,hydrastinine,hemostatic agent,
LGGDLPSXAGQFSG,,,,,,,,,,,,,BRD-K00003307,COH29,ribonucleotide reductase inhibitor,
LGLVVVCSQBZONM,,,,,,,,,,,,,BRD-K00003337,ALX-40-4C,CC chemokine receptor antagonist,
LGWACEZVCMBSKW,,,,,,,,,,,,,BRD-K00003309,GDC-0084,PI3K inhibitor|mTOR inhibitor,
LGWDVWIZDPGCFG,,,,,,,,,,,,,BRD-K00005336,PZ-2891,pantothenate kinase activator,
LIRUWPZKVZZTHC,,,,,,,,,,,,,BRD-K24548560,evans-blue,glutamate receptor negative allosteric modulator,GRIA1|PTPN1
LJIUXAHLYIPHOK,,,,,,,,,,,,,BRD-K00004610,entasobulin,tubulin polymerization inhibitor,
LKBFFDOJUKLQNY,,,,,,,,,,,,,BRD-K68332390,statil,aldose reductase inhibitor,
LKIIIESDXWZZRE,,,,,,,,,,,,,BRD-K14401183,avobenzone,topical sunscreen agent,
LLEUXCDZPQOJMY,,,,,,,,,,,,,BRD-K00003164,oglufanide,VEGF antagonist,
LNHWXBUNXOXMRL,,,,,,,,,,,,,BRD-K00003160,belotecan,topoisomerase inhibitor,
LNLJHGXOFYUARS,,,,,,,,,,,,,BRD-K00003228,seletalisib,PI3K inhibitor,
LOOCZNLSXJHWTG,,,,,,,,,,,,,BRD-K00003195,LY2795050,opioid receptor antagonist,
LOWWYYZBZNSPDT,,,,,,,,,,,,,BRD-K00003500,delgocitinib,JAK inhibitor,
LQFRYKBDZNPJSW,,,,,,,,,,,,,BRD-K00004659,dapansutrile,anti-inflammatory agent,
LQPFCYWRBQRRGE,,,,,,,,,,,,,BRD-K00003108,ABBV-744,bromodomain inhibitor,
LSXUTRRVVSPWDZ,,,,,,,,,,,,,BRD-K83030136,AT-406,IAP antagonist ,
LSZZJAUTRJAFCO,,,,,,,,,,,,,BRD-K00003240,eravacycline,antibacterial,
LUJDHCXCWJFNOJ,,,,,,,,,,,,,BRD-K00004745,HSR6071,antiallergic agent,
LVRLSYPNFFBYCZ,,,,,,,,,,,,,BRD-K00003265,omapatrilat,metalloproteinase inhibitor,ACE|MME
LWGUASZLXHYWIV,,,,,,,,,,,,,BRD-K00003172,E7820,angiogenesis inhibitor,
LYMICVBGNUEHGE,,,,,,,,,,,,,BRD-K00003532,inarigivir,antiviral,
LYPAFUINURXJSG,,,,,,,,,,,,,BRD-K00003429,GSK2982772,RIPK inhibitor,
LZLBRISQTJVZNP,,,,,,,,,,,,,BRD-K00003292,GSK2981278,ROR modulator,
LZNWYQJJBLGYLT,,,,,,,,,,,,,BRD-A22844106,tenoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2
LZWZPGLVHLSWQX,,,,,,,,,,,,,BRD-K00003235,veledimex,cytochrome P450 inhibitor,
MARIUIDCPUZLKZ,,,,,,,,,,,,,BRD-K00003185,EMD534085,kinesin inhibitor,
MCIDWGZGWVSZMK,,,,,,,,,,,,,BRD-K00003285,nemiralisib,,
MDEJTPWQNNMAQF,,,,,,,,,,,,,BRD-K00003494,rosiptor,SHIP1 phosphatase activator,
MDGIEDNDSFMSLP,,,,,,,,,,,,,BRD-K00005341,ogerin,G protein-coupled receptor modulator,
MDMJLMDBRQXOOI,,,,,,,,,,,,,BRD-K00003451,LY334370,serotonin receptor agonist,
MDUYWDNWFXSMJJ,,,,,,,,,,,,,BRD-K00003341,ketohexokinase-inhibitor-1,kinase inhibitor,
MDYVZYDNBUAVCN,,,,,,,,,,,,,BRD-K00003344,incyclinide,matrix metalloprotease inhibitor,
MEFKOOXNVFALTA,,,,,,,,,,,,,BRD-A07600638,meclocycline-sulfosalicylate,bacterial 50S ribosomal subunit inhibitor,
MGZKYOAQVGSSGC,,,,,,,,,,,,,BRD-K00003377,fisogatinib,fibroblast growth factor inhibitor,
MJCKISCWHDATBN,,,,,,,,,,,,,BRD-K00004744,lintopride,serotonin receptor antagonist,
MJHOMTRKVMKCNE,,,,,,,,,,,,,BRD-K71500795,TAK-659,spleen associated tyrosine kinase inhibitor,
MJHYBJOMJPGNMM,,,,,,,,,,,,,BRD-K00004749,NCX-1015,interleukin sythesis stimulator,
MJNIWUJSIGSWKK,,,,,,,,,,,,,BRD-K74227494,riboflavin-tetrabutyrate,antioxidant,
MJPPGVVIDGQOQT,,,,,,,,,,,,,BRD-K00004693,furvina,quorum sensing signaling inhibitor,
MJVKYGMNSQJLIN,,,,,,,,,,,,,BRD-K00004605,ALS-8176,RNA polymerase inhibitor,
MKLKAQMPKHNQPR,,,,,,,,,,,,,BRD-K00003449,E7046,prostanoid receptor antagonist,
MLBZKOGAMRTSKP,,,,,,,,,,,,,BRD-K00003239,fluralaner,GABA receptor antagonist,
MLFKVJCWGUZWNV,,,,,,,,,,,,,BRD-K00004718,alanosine,antimetabolite,
MLSQGNCUYAMAHD,,,,,,,,,,,,,BRD-K00003260,glecaprevir,serine protease inhibitor,
MLXCQEWOIZBBDM,,,,,,,,,,,,,BRD-A67006024,SNAP,nitric oxide donor,PTPN1
MNHNIVNAFBSLLX,,,,,,,,,,,,,BRD-K00004966,amenamevir,helicase primase inhibitor,
MNLHFGXIUJNDAF,,,,,,,,,,,,,BRD-K29066607,D-157495,decapping scavenger enzyme inhibitor,
MOLOJNHYNHBPCW,,,,,,,,,,,,,BRD-K65840970,GW274150,nitric oxide synthase inhibitor,
MOWXJLUYGFNTAL,,,,,,,,,,,,,BRD-K00003426,peposertib,DNA dependent protein kinase inhibitor,
MQMCZGVMQZPYQA,,,,,,,,,,,,,BRD-K21450440,benzthiazide,carbonic anhydrase inhibitor,CA2
MRFOPLWJZULAQD,,,,,,,,,,,,,BRD-K00004701,KPT-9274,NAMPT inhibitor,
MRNMYWNBLVJWKG,,,,,,,,,,,,,BRD-K00003455,S-38093,histamine receptor antagonist,
MRPGRAKIAJJGMM,,,,,,,,,,,,,BRD-K00004725,voruciclib,CDK9 inhibitor,
MRXBCEQZNKUUIP,,,,,,,,,,,,,BRD-K00004606,AZD3839,beta-secretase inhibitor,BACE1
MSPRUJDUTKRMLM,,,,,,,,,,,,,BRD-K70161083,caroverin,cytochrome P450 inhibitor,
MSYUMPGNGDNTIQ,,,,,,,,,,,,,BRD-K00003339,dixyrazine,antipsychotic,
MUNMIGOEDGHVLE,,,,,,,,,,,,,BRD-K00003333,ornipressin,vasoconstrictor,
MVGWUTBTXDYMND,,,,,,,,,,,,,BRD-K00003139,etrasimod,sphingosine 1-phosphate receptor antagonist,
MVHWZNBAQIGPOQ,,,,,,,,,,,,,BRD-K00003444,BT-11,cAMP stimulant,
MVLOQULXIYSERZ,,,,,,,,,,,,,BRD-K00003393,BGP-15,PARP inhibitor,
MVSQDUZRRVBYLA,,,,,,,,,,,,,BRD-K00003454,seclidemstat,histone demethylase inhibitor,
MWKYMZXCGYXLPL,,,,,,,,,,,,,BRD-K00003261,leniolisib,PI3K inhibitor,
MXKLDYKORJEOPR,,,,,,,,,,,,,BRD-K00003400,PF-06840003,"indoleamine 2,3-dioxygenase inhibitor",
MYMWDZLPEPMSCN,,,,,,,,,,,,,BRD-K00004729,manitimus,dehydrogenase inhibitor,
MZAGXDHQGXUDDX,,,,,,,,,,,,,BRD-K00005243,FK-409,guanylyl cyclase activator,
NBGABHGMJVIVBW,,,,,,,,,,,,,BRD-K00003505,nemorexant,orexin receptor antagonist,
NCPLTAGJJVCHOW,,,,,,,,,,,,,BRD-K00003365,AQ-13,antimalarial agent,
NCVXEYAKRVJMTQ,,,,,,,,,,,,,BRD-K00633793,drotaverine,phosphodiesterase inhibitor,
NCWQLHHDGDXIJN,,,,,,,,,,,,,BRD-K00003443,AZD4635,adenosine receptor antagonist,
NEBUOXBYNAHKFV,,,,,,,,,,,,,BRD-K00004702,funapide,sodium channel blocker,
NEXPKUGJJKVILF,,,,,,,,,,,,,BRD-K51768138,lomustine,DNA synthesis inhibitor,
NFHRQQKPEBFUJK,,,,,,,,,,,,,BRD-K31238592,devazepide,CCK receptor antagonist,
NGFFVZQXSRKHBM,,,,,,,,,,,,,BRD-K00003275,lifirafenib,RAF inhibitor,
NHTKGYOMICWFQZ,,,,,,,,,,,,,BRD-K00003531,acelarin,anticancer agent,
NJSMWLQOCQIOPE,,,,,,,,,,,,,BRD-K00003395,bisantrene,topoisomerase inhibitor,
NKHAVTQWNUWKEO,,,,,,,,,,,,,BRD-K00004695,monomethyl-fumarate,,
NMLMACJWHPHKGR,,,,,,,,,,,,,BRD-K00003514,diquafosol,purinergic receptor activator,
NNBGCSGCRSCFEA,,,,,,,,,,,,,BRD-K00004676,rilapladib,phospholipase inhibitor,
NNDIXBJHNLFJJP,,,,,,,,,,,,,BRD-K00005345,20-HETE,ion channel antagonist,
NOQIYRGMEFBZTI,,,,,,,,,,,,,BRD-K00004572,Ro-48-6791,GABA receptor modulator,
NOSNHVJANRODGR,,,,,,,,,,,,,BRD-K00003374,esaxerenone,mineralocorticoid receptor antagonist,
NOYPYLRCIDNJJB,,,,,,,,,,,,,BRD-K13642819,trimetrexate,dihydrofolate reductase inhibitor,DHFR
NOZIJMHMKORZBA,,,,,,,,,,,,,BRD-K93228461,lusutrombopag,thrombopoietin receptor agonist,
NPDKXVKJRHPDQT,,,,,,,,,,,,,BRD-K00003227,ralinepag,IP1 prostacyclin receptor agonist,
NPDLTEZXGWRMLQ,,,,,,,,,,,,,BRD-K00004705,AQW-051,nicotinic receptor agonist,
NRJAVPSFFCBXDT,,,,,,,,,,,,,BRD-K00004570,DSPC,,
NSUDGNLOXMLAEB,,,,,,,,,,,,,BRD-K00004580,velaresol,,
NSWGELWYFNCPHU,,,,,,,,,,,,,BRD-A42379279,viomycin,protein synthesis inhibitor,
NVTKJBXOBFRPLQ,,,,,,,,,,,,,BRD-K06455935,daprodustat,hypoxia inducible factor inhibitor,EGLN1
NVWKNQGHVMMAJW,,,,,,,,,,,,,BRD-K00004592,PI3Kd-IN-2,PI3K inhibitor,
NWWORXYTJRPSMC,,,,,,,,,,,,,BRD-K00003206,emiglitate,alpha glucoside inhibitor,
NWWZMECSQFUIGC,,,,,,,,,,,,,BRD-K00003278,TCV-309,platelet activating factor receptor antagonist,
NXQKSXLFSAEQCZ,,,,,,,,,,,,,BRD-K00010385,AMG-510,K-Ras inhibitor,
NXSXRIHXEQSYEZ,,,,,,,,,,,,,BRD-K00004618,S-17092,prolyl endopeptidase inhibitor,
NZVYCXVTEHPMHE,,,,,,,,,,,,,BRD-K00004602,thymalfasin,immune response modulator,
NZXHFDXOCVIYLO,,,,,,,,,,,,,BRD-K00004687,pelrinone,phosphodiesterase inhibitor,
OALHHIHQOFIMEF,,,,,,,,,,,,,BRD-K07549832,erythrosine,coloring agent,
OBAICMYWONZOSZ,,,,,,,,,,,,,BRD-K82239282,ASP-6537,cyclooxygenase inhibitor,
OBWOSMGNXYUDFB,,,,,,,,,,,,,BRD-K00004604,PRLX-93936,voltage-dependent anion selective channel protein inhibitor,
OCOKWVBYZHBHLU,,,,,,,,,,,,,BRD-K87595680,sobuzoxane,topoisomerase inhibitor,
ODGXXYXJORZPHE,,,,,,,,,,,,,BRD-K00003481,PAT-1251,lysyl oxidase inhibitor,
ODMXWZROLKITMS,,,,,,,,,,,,,BRD-K00003311,PF-06459988,receptor tyrosine protein kinase inhibitor,
OEBIHOVSAMBXIB,,,,,,,,,,,,,BRD-K00003441,selitrectinib,protein tyrosine kinase inhibitor,
OEOYJZUHFXEJEI,,,,,,,,,,,,,BRD-K00004662,nemazoline,adrenergic receptor agonist|adrenergic receptor antagonist,
OESBDSFYJMDRJY,,,,,,,,,,,,,BRD-K00003289,tecadenoson,adenosine receptor agonist,ADORA1
OIIMUKXVVLRCAF,,,,,,,,,,,,,BRD-K00003362,mitoquinone,antioxidant,
OIZSVTOIBNSVOS,,,,,,,,,,,,,BRD-K35498911,DSM265,dihydroorotate dehydrogenase inhibitor,
OKCJNSDIVCXYAL,,,,,,,,,,,,,BRD-K00004734,AVE-3085,nitric oxide synthase stimulant,
OKDOWCKDTWNRCB,,,,,,,,,,,,,BRD-K00004626,CGP-39551,NMDA receptor antagonist,
OKVOKULYZXODKU,,,,,,,,,,,,,BRD-K43055376,ADD-233089,benzodiazepine receptor agonist,
OLCWFLWEHWLBTO,,,,,,,,,,,,,BRD-K00003203,BMS-214662,farnesyltransferase inhibitor,
OLROWHGDTNFZBH,,,,,,,,,,,,,BRD-K00003135,alisporivir,cyclophilin inhibitor,
ONCZDRURRATYFI,,,,,,,,,,,,,BRD-K00005342,trifloxystrobin,mitochondrial electron transport inhibitor,
ONNMDRQRSGKZCN,,,,,,,,,,,,,BRD-K00004650,SGS-742,GABA receptor antagonist,GABBR1|GABBR2
OPAKEJZFFCECPN,,,,,,,,,,,,,BRD-K00004674,verdinexor,exportin antagonist,
OPMVDWXPLVKNQN,,,,,,,,,,,,,BRD-K05218031|BRD-K88061624,mizoribine,immunosuppressant|inosine monophosphate dehydrogenase inhibitor,IMPDH1
OPWQYOUZRHDKBR,,,,,,,,,,,,,BRD-K00004565,LY311727,phospholipase inhibitor,
OPXIRFWNLBDKQB,,,,,,,,,,,,,BRD-K00003152,AM211,prostaglandin inhibitor,
OPYGFNJSCUDTBT,,,,,,,,,,,,,BRD-K00004694,sultamicillin,antibacterial ,
OQDQIFQRNZIEEJ,,,,,,,,,,,,,BRD-K00003462,lanifibranor,PPAR receptor agonist,
ORDHXXHTBUZRCN,,,,,,,,,,,,,BRD-K00003237,mavatrep,transient receptor potential channel antagonist,
ORFLZNAGUTZRLQ,,,,,,,,,,,,,BRD-K00003469,larazotide-acetate,tight junction regulator,
ORJRYNKVKJAJPY,,,,,,,,,,,,,BRD-K00004634,BMS-207940,endothelin receptor antagonist,
ORVNHOYNEHYKJG,,,,,,,,,,,,,BRD-K00003459,dilmapimod,p38 MAPK inhibitor,
OSQAKHSYTKBSPB,,,,,,,,,,,,,BRD-K00003487,tomeglovir,antiviral,
OSZMNJRKIPAVOS,,,,,,,,,,,,,BRD-A40504327,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",dopamine release inhibitor,
OVJRNFMIYGGLDL,,,,,,,,,,,,,BRD-K28936863,ketotifen,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1
OXBBIHZWNDPBMQ,,,,,,,,,,,,,BRD-K00003318,decloxizine,histamine receptor antagonist,
OXPLANUPKBHPMS,,,,,,,,,,,,,BRD-K00003103,desisobutyryl-ciclesonide,cytochrome P450 inhibitor,
OXSCPDKUZWPWFR,,,,,,,,,,,,,BRD-K00003301,ASP-9521,aldo-keto reductase inhibitor,
OXTYVEUAQHPPMV,,,,,,,,,,,,,BRD-K00004709,alinidine,bradycardic effect ,
OZBDTKLWBSATSN,,,,,,,,,,,,,BRD-K00003167,macitentan-n-butyl-analogue,endothelin receptor antagonist,
OZOGDCZJYVSUBR,,,,,,,,,,,,,BRD-K00003394,ABX464,antiviral,
PAEBIVWUMLRPSK,,,,,,,,,,,,,BRD-K00004669,cangrelor,purinergic receptor antagonist,
PAJMKGZZBBTTOY,,,,,,,,,,,,,BRD-K19706299,treprostinil,prostanoid receptor agonist,P2RY12|PPARD|PTGIR
PANKHBYNKQNAHN,,,,,,,,,,,,,BRD-K00003217,transcrocetinate,glutamate receptor antagonist,
PDGKHKMBHVFCMG,,,,,,,,,,,,,BRD-K00003412,trilaciclib,CDK inhibitor,
PEGQOIGYZLJMIB,,,,,,,,,,,,,BRD-K00003391,PBI-4050,free fatty acid receptor agonist,
PFENFDGYVLAFBR,,,,,,,,,,,,,BRD-K84313779,tinoridine,anti-inflammatory agent,
PHGTYMRDHDEHLI,,,,,,,,,,,,,BRD-K00005326,PF-06928215,cyclic GMP-AMP synthase inhibitor,
PJZPDFUUXKKDNB,,,,,,,,,,,,,BRD-K00004667,ciluprevir,serine protease inhibitor,
PKLPQOJFHFGVBS,,,,,,,,,,,,,BRD-K00025573,dehydroacetic-acid,,
PKQXLRYFPSZKDU,,,,,,,,,,,,,BRD-K00005242,TEN-010,bromodomain inhibitor,
PKVRCIRHQMSYJX,,,,,,,,,,,,,BRD-K00003313,trabectedin,antitumor agent,
PMHVFNYNPNKNRO,,,,,,,,,,,,,BRD-K01109406,nitisinone,hydroxyphenylpyruvate dioxygenase inhibitor,
PMQUGSPFUBGJCZ,,,,,,,,,,,,,BRD-K00003409,CFI-402257,dual specificity protein kinase inhibitor,
PMWVYONICYRLNY,,,,,,,,,,,,,BRD-K16605796,T-025,CLK inhibitor,
PNDKCRDVVKJPKG,,,,,,,,,,,,,BRD-K00003181,cenicriviroc,CC chemokine receptor antagonist,
PNPFMWIDAKQFPY,,,,,,,,,,,,,BRD-K00003446,LY3200882,TGF beta receptor inhibitor,
POADTFBBIXOWFJ,,,,,,,,,,,,,BRD-K00003176,karenitecin,topoisomerase inhibitor,TOP1
POERAARDVFVDLO,,,,,,,,,,,,,BRD-K00003269,LEQ506,G protein signaling inhibitor,
PPSNFPASKFYPMN,,,,,,,,,,,,,BRD-K00003287,fezolinetant,neurokinin receptor antagonist,
PSWFFKRAVBDQEG,,,,,,,,,,,,,BRD-K43977121,thymopentin,immune response stimulator,
PSYUBHDPOIZRST,,,,,,,,,,,,,BRD-K47738867,ethyl-pyruvate,tumor necrosis factor production inhibitor,
PTQGBRPUALXNCZ,,,,,,,,,,,,,BRD-K01666924,colistimethate,bacterial permeability inducer,
PTYGDEXEGLDNAZ,,,,,,,,,,,,,BRD-K00003303,acoziborole,antitrypanosomal,
PUIXMSRTTHLNKI,,,,,,,,,,,,,BRD-K00003430,PRN1371,protein tyrosine kinase inhibitor,
PUKBOVABABRILL,,,,,,,,,,,,,BRD-K00003256,avacopan,complement inhibitor,
PVCTYSQBVIGZRU,,,,,,,,,,,,,BRD-K00003486,DG051,leukotriene synthesis inhibitor,
PVTHJAPFENJVNC,,,,,,,,,,,,,BRD-K91644281,kasugamycin,bacterial 30S ribosomal subunit inhibitor,
PVXGCBZIVFCMJK,,,,,,,,,,,,,BRD-K00003730,HPPH,photosensitizing agent,
PWAOOJDMFUQOKB,,,,,,,,,,,,,BRD-K00003326,ginsenoside-RE,anti-inflammatory agent,
PWDYHMBTPGXCSN,,,,,,,,,,,,,BRD-K21237892,semapimod,cytokine production inhibitor|p38 MAPK inhibitor,MAPK14
PWILYDZRJORZDR,,,,,,,,,,,,,BRD-K00004585,soraprazan,proton pump inhibitor,
PXQCVBRDIZZRGM,,,,,,,,,,,,,BRD-K70053378,SM-108,,
PXWLVJLKJGVOKE,,,,,,,,,,,,,BRD-K06520168,propyphenazone,anti-inflammatory agent,
PZFAZQUREQIODZ,,,,,,,,,,,,,BRD-K33499285,gepotidacin,topoisomerase inhibitor,
PZZRDJXEMZMZFD,,,,,,,,,,,,,BRD-K00005343,reynoutrin,antioxidant,
QAOAOVKBIIKRNL,,,,,,,,,,,,,BRD-K20168484,MK-886,lipoxygenase inhibitor,
QASFUMOKHFSJGL,,,,,,,,,,,,,BRD-K58938839,cyclopamine,hedgehog pathway inhibitor,
QCCHBHSAIQIQGO,,,,,,,,,,,,,BRD-K00003208,imirestat,aldose reductase inhibitor,
QCTBMLYLENLHLA,,,,,,,,,,,,,BRD-K00003517,4-(aminomethyl)benzoic-acid,hemostatic agent,
QCZAWDGAVJMPTA,,,,,,,,,,,,,BRD-K00003460,vorasidenib,isocitrate dehydrogenase inhibitor,
QDCJDYWGYVPBDO,,,,,,,,,,,,,BRD-K00003114,C188-9,STAT inhibitor,
QDWKGEFGLQMDAM,,,,,,,,,,,,,BRD-K00003244,amcasertib,kinase inhibitor,
QFUFJOJDXRWBNA,,,,,,,,,,,,,BRD-A40257118,BQU57,Ras GTPase inhibitor,RALA|RALB
QGBBBLPWBSWERZ,,,,,,,,,,,,,BRD-K00003098,IDF-11774,hypoxia inducible factor inhibitor,
QGWIQIAWOCJRPI,,,,,,,,,,,,,BRD-K00003186,SSR240612,bradykinin receptor antagonist,
QIEKHLDZKRQLLN,,,,,,,,,,,,,BRD-K00004750,PF-06873600,CDK inhibitor,
QJPPEMXOOWNICQ,,,,,,,,,,,,,BRD-K00004653,S15535,serotonin receptor agonist,
QKDCLUARMDUUKN,,,,,,,,,,,,,BRD-K64114733,naquotinib,EGFR inhibitor,
QLRRJMOBVVGXEJ,,,,,,,,,,,,,BRD-K00003503,vecabrutinib,Bruton's tyrosine kinase (BTK) inhibitor,
QLUWQAFDTNAYPN,,,,,,,,,,,,,BRD-K00003363,delpazolid,antibacterial,
QMAZPCHGABINAB,,,,,,,,,,,,,BRD-K13240081,nimustine,DNA alkylating agent,
QQKNSPHAFATFNQ,,,,,,,,,,,,,BRD-K82908348,darglitazone,PPAR receptor antagonist,PPARG
QQMKTHUGOQDEIL,,,,,,,,,,,,,BRD-K00003438,CM-4620,calcium release activated channel modulator,
QRORCRWSRPKEHR,,,,,,,,,,,,,BRD-K64414150,tymazoline,,
QSFGZNVRVZHUGV,,,,,,,,,,,,,BRD-K00004632,PF-02413873,progesterone receptor antagonist,
QUIWHXQETADMGN,,,,,,,,,,,,,BRD-K00003405,evobrutinib,Bruton's tyrosine kinase (BTK) inhibitor,
QVCMHGGNRFRMAD,,,,,,,,,,,,,BRD-K65508953,monocrotaline,antitumor agent,
QYSPLQLAKJAUJT,,,,,,,,,,,,,BRD-K01826746,piroxicam,cyclooxygenase inhibitor,PTGS1|PTGS2
QYTBBBAHNIWFOD,,,,,,,,,,,,,BRD-K00003170,pavinetant,neurokinin receptor antagonist,
QZECRCLSIGFCIO,,,,,,,,,,,,,BRD-K00003297,AZD5069,CC chemokine receptor antagonist,CXCR2
QZFHIXARHDBPBY,,,,,,,,,,,,,BRD-K00003234,vericiguat,guanylate cyclase stimulant,
QZWYXEBIQWJXAR,,,,,,,,,,,,,BRD-K35984734,ZSET1446,nicotinic receptor agonist,
QZXVLRCMAHJVIP,,,,,,,,,,,,,BRD-K00003149,Ro-5028442,vasopressin receptor antagonist,
RCUSTCPNMVCLLN,,,,,,,,,,,,,BRD-K08927448,nitrosodimethylurea,DNA synthesis inhibitor,
RCXMQNIDOFXYDO,,,,,,,,,,,,,BRD-K00004678,DOTMP,,
RDONXGFGWSSFMY,,,,,,,,,,,,,BRD-K00003356,mivebresib,bromodomain inhibitor,
RDXUCTYBYOIJGA,,,,,,,,,,,,,BRD-K61041538,AZD1080,glycogen synthase kinase inhibitor,GSK3A|GSK3B
RECBFDWSXWAXHY,,,,,,,,,,,,,BRD-K00003471,rislenemdaz,ionotropic glutamate receptor antagonist,
REQQVBGILUTQNN,,,,,,,,,,,,,BRD-K00003431,ziritaxestat,autotaxin inhibitor,
RFEAEBNMNYRJFD,,,,,,,,,,,,,BRD-A67036568,RBC8,Ral GTPase inhibitor,RALA|RALB
RIRGCFBBHQEQQH,,,,,,,,,,,,,BRD-K25521961,L-phenylisopropyladenosine,,
RIUPLDUFZCXCHM,,,,,,,,,,,,,BRD-K00003383,urolithin-A,antioxidant,
RJZNPROJTJSYLC,,,,,,,,,,,,,BRD-K00003332,argireline,neurotransmitter release inhibitor,
RKSMVPNZHBRNNS,,,,,,,,,,,,,BRD-K00003183,succinobucol,antioxidant,VCAM1
RLCLASQCAPXVLM,,,,,,,,,,,,,BRD-K00003497,mavacamten,myosin inhibitor ,
RMYZIRFUCOMQRH,,,,,,,,,,,,,BRD-K00003190,MK-0557,neuropeptide receptor antagonist,
RNMAUIMMNAHKQR,,,,,,,,,,,,,BRD-K00003359,BAY-1436032,isocitrate dehydrogenase inhibitor,
RNOAOAWBMHREKO,,,,,,,,,,,,,BRD-K00003413,zanubrutinib,Bruton's tyrosine kinase (BTK) inhibitor,
RNRYULFRLCBRQS,,,,,,,,,,,,,BRD-K00003283,roluperidone,,
ROODZSDSPAHHIS,,,,,,,,,,,,,BRD-K61230716,sodium-nitrite,nitric oxide donor,
ROVGZAWFACYCSP,,,,,,,,,,,,,BRD-K00010129,pyrethrins,,
RPJPZDVUUKWPGT,,,,,,,,,,,,,BRD-K00003331,NIM811,mitochondrial permeability transition inhibitor,
RRMJMHOQSALEJJ,,,,,,,,,,,,,BRD-K00003501,lazertinib,tyrosine kinase inhibitor,
RRTPWQXEERTRRK,,,,,,,,,,,,,BRD-K00004596,telratolimod,toll-like receptor agonist,
RSBPYSTVZQAADE,,,,,,,,,,,,,BRD-K00004708,OP-0595,beta lactamase inhibitor,
RSMYFSPOTCDHHJ,,,,,,,,,,,,,BRD-K00003528,AZD5153,bromodomain inhibitor,
RSNPAKAFCAAMBH,,,,,,,,,,,,,BRD-A88644406,avadomide,antitumor agent,
RTJQABCNNLMCJF,,,,,,,,,,,,,BRD-K78973789,MMV-390048,PI4K inhibitor,
RTKDBEOSPDFLGD,,,,,,,,,,,,,BRD-K00004235,NAS-181,serotonin receptor antagonist,HTR1B
RUVMMEREJMHLOS,,,,,,,,,,,,,BRD-K00004620,ZD-0947,potassium channel activator,
RVJIQAYFTOPTKK,,,,,,,,,,,,,BRD-K00003157,Debio-0932,HSP inhibitor,
RWIMETUXCNDSLE,,,,,,,,,,,,,BRD-K00003511,CA-4948,kinase inhibitor,
RWZVMMQNDHPRQD,,,,,,,,,,,,,BRD-K00003173,SJG-136,DNA intercalating agent,
RYAYYVTWKAOAJF,,,,,,,,,,,,,BRD-K00003406,milademetan,MDM inhibitor,
RYJXBGGBZJGVQF,,,,,,,,,,,,,BRD-K00003433,veralipride,dopamine receptor antagonist,
RZNUIYPHQFXBAN,,,,,,,,,,,,,BRD-K00003250,evocalcet,calcium sensitizer,
RZVPBGBYGMDSBG,,,,,,,,,,,,,BRD-K00003495,baloxavir-marboxil,endonuclease inhibitor,
SADXACCFNXBCFY,,,,,,,,,,,,,BRD-K00003463,pyrotinib,kinase inhibitor,
SAQMCVDGOIRQTC,,,,,,,,,,,,,BRD-K00005339,A-381393,dopamine receptor antagonist,
SCKXBVLYWLLALY,,,,,,,,,,,,,BRD-K00003343,VLX1570,deubiquitinase inhibitor,
SCVHJVCATBPIHN,,,,,,,,,,,,,BRD-K00023644,emricasan,caspase inhibitor,CASP1|CASP3|CASP7
SDYYIRPAZHJOLM,,,,,,,,,,,,,BRD-K00003317,pipofezine,selective serotonin reuptake inhibitor (SSRI),
SEJLPXCPMNSRAM,,,,,,,,,,,,,BRD-K00003197,ONO-4059,Bruton's tyrosine kinase (BTK) inhibitor,BTK
SFKQVVDKFKYTNA,,,,,,,,,,,,,BRD-K00003319,felypressin,vasopressin receptor agonist,
SFPFZQKYPOWCSI,,,,,,,,,,,,,BRD-K00003526,uprifosbuvir,antiviral,
SGEUNORSOZVTOL,,,,,,,,,,,,,BRD-K00003420,GDC-0077,PI3K inhibitor,
SGWLRDAOCLITOM,,,,,,,,,,,,,BRD-K00003111,BOS-172722,monopolar spindle 1 kinase inhibitor,
SHKXZIQNFMOPBS,,,,,,,,,,,,,BRD-K00004646,aramchol,stearoyl-CoA desaturase inhibitor,
SIEXFRDYNDREBM,,,,,,,,,,,,,BRD-K00004965,talaporfin,photosensitizing agent,
SIFNOOUKXBRGGB,,,,,,,,,,,,,BRD-K00003295,elacestrant,estrogen receptor degrader,
SJWWTRQNNRNTPU,,,,,,,,,,,,,BRD-K00003355,fucoxanthin,anticancer agent,
SJXNPGGVGZXKKI,,,,,,,,,,,,,BRD-K00004675,LSZ-102,selective estrogen receptor modulator (SERM),
SKDVMPZQJMZEAC,,,,,,,,,,,,,BRD-K97656802,GSK2881078,androgen receptor modulator,
SLKURXRZHJOZOD,,,,,,,,,,,,,BRD-K00004700,CORT-108297,glucocorticoid receptor antagonist,
SNPPEHMSSOEYDH,,,,,,,,,,,,,BRD-K00003436,AVN-492,serotonin receptor antagonist,
SOLUWJRYJLAZCX,,,,,,,,,,,,,BRD-K00003247,bictegravir,HIV integrase inhibitor,
SPQUOZYCYRJYJU,,,,,,,,,,,,,BRD-K60842365,theaflavin,antiviral,
SPSNKQVUYDXOGY,,,,,,,,,,,,,BRD-K00003437,BTK-IN-1,Bruton's tyrosine kinase (BTK) inhibitor,
SQGRDKSRFFUBBU,,,,,,,,,,,,,BRD-K00003491,morphothiadin,antiinfective drug,
SQZJGTOZFRNWCX,,,,,,,,,,,,,BRD-K00004603,ABX-1431,monoacylglycerol lipase inhibitor,
SRLPZQAEBMZCIJ,,,,,,,,,,,,,BRD-K62378877,clanfenur,anticancer agent,
SRPXSILJHWNFMK,,,,,,,,,,,,,BRD-K00003142,dasotraline,dopamine-norepinephrine-serotonin reuptake inhibitor,
SUYRLXYYZQTJHF,,,,,,,,,,,,,BRD-K00003321,dalfopristin,antibacterial ,
SWMDAPWAQQTBOG,,,,,,,,,,,,,BRD-K00003191,fostemsavir,antiviral,
SXWMIXPJPNCXQQ,,,,,,,,,,,,,BRD-K00003126,G-749,tyrosine kinase inhibitor,
SYNOVMDJYWJCON,,,,,,,,,,,,,BRD-K30816563,ranitidine,histamine receptor antagonist,HRH2
SZINUGQCTHLQAZ,,,,,,,,,,,,,BRD-A10420615|BRD-K93666001,cyclopiazonic-acid,ATPase inhibitor,ATP2A1
SZMJVTADHFNAIS,,,,,,,,,,,,,BRD-K95216408,tucidinostat,HDAC inhibitor,
TTZSNFLLYPYKIL,,,,,,,,,,,,,BRD-K00003125,sulfatinib,tyrosine kinase inhibitor,
TUWMKPVJGGWGNL,,,,,,,,,,,,,BRD-K00003224,avoralstat,kallikrein inhibitor,
TVJRDCQUZMGBAB,,,,,,,,,,,,,BRD-K00004721,BMS-935177,Bruton's tyrosine kinase (BTK) inhibitor,
TWHPPRXFYWSOQF,,,,,,,,,,,,,BRD-K83146339|BRD-K88014802|BRD-M65265990,strontium-ranelate,bone formation stimulant|bone resorption inhibitor,CASR
TWJZFXHSPBBPNI,,,,,,,,,,,,,BRD-K00003291,BEBT-908,PI3K inhibitor,
TXCGMRVPXUBHAL,,,,,,,,,,,,,BRD-K00003386,HT-2157,galanin receptor 3 antagonist,
TYWUGCGYWNSRPS,,,,,,,,,,,,,BRD-K00004552,sameridine,opioid receptor modulator,
TZIZWYVVGLXXFV,,,,,,,,,,,,,BRD-K00003338,triamcinolone-hexacetonide,anti-inflammatory agent,
UADMBZFZZOBWBB,,,,,,,,,,,,,BRD-K00004568,eniporide,sodium/hydrogen antiport inhibitor,
UAHFGYDRQSXQEB,,,,,,,,,,,,,BRD-K00003330,afamelanotide,melanocyte-stimulating hormone mimetic,
UBLOHCIYTDRGJH,,,,,,,,,,,,,BRD-K00004579,RV1729,PI3K inhibitor,
UBLXQFIFWUEVGJ,,,,,,,,,,,,,BRD-K68103045,CGS-20625,GABA benzodiazepine site receptor partial agonist|benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6
UCMNDPDJRSEZPL,,,,,,,,,,,,,BRD-K00005249,LY2828360,cannabinoid receptor agonist,
UCQSBGOFELXYIN,,,,,,,,,,,,,BRD-K00004582,sufugolix,gonadotropin releasing factor hormone receptor antagonist,
UCTRAOBQFUDCSR,,,,,,,,,,,,,BRD-K00004707,solriamfetol,dopamine reuptake inhibitor,
UEPXBTCUIIGYCY,,,,,,,,,,,,,BRD-K00003107,LXH254,RAF inhibitor,
UETIXAMLWBFWOE,,,,,,,,,,,,,BRD-A62893078,fotemustine,thioredoxin inhibitor,
UFNVPOGXISZXJD,,,,,,,,,,,,,BRD-K00003156,eribulin,microtubule inhibitor,
UHKZNDVUBSEJJO,,,,,,,,,,,,,BRD-K00004723,HP-228,nitric oxide synthase inhibitor,
UHQFBTAJFNVZIV,,,,,,,,,,,,,BRD-K77897005,ridinilazole,antibacterial,
UIRKNQLZZXALBI,,,,,,,,,,,,,BRD-K00003215,squalamine,antiviral,
UIWSCWBHZRPIKR,,,,,,,,,,,,,BRD-K00004671,panipenem,antibacterial ,
UIWZIDIJCUEOMT,,,,,,,,,,,,,BRD-K00003378,FT011,TGF beta receptor inhibitor,
UJNWGFBJUHIJKK,,,,,,,,,,,,,BRD-K00004619,centhaquin,analgesic agent,
UJZDIKVQFMCLBE,,,,,,,,,,,,,BRD-K00005333,H-151,STING antagonist,
UKGJZDSUJSPAJL,,,,,,,,,,,,,BRD-K00003138,asivatrep,transient receptor potential channel antagonist,
UMKFEPPTGMDVMI,,,,,,,,,,,,,BRD-A91386192,trofosfamide,DNA alkylating agent,
UNRHXEPDKXPRTM,,,,,,,,,,,,,BRD-K00003312,sultopride,dopamine receptor antagonist,
UOFYSRZSLXWIQB,,,,,,,,,,,,,BRD-K00003294,avitinib,EGFR inhibitor,
UOJMXHLMOUOGPY,,,,,,,,,,,,,BRD-K98157055,SIB-1757,glutamate receptor antagonist,GRM5
URJQSMIFSMHWSP,,,,,,,,,,,,,BRD-K00003523,tauroglycocholate,membrane permeability enhancer,
URLYINUFLXOMHP,,,,,,,,,,,,,BRD-K00004666,triciribine-phosphate,AKT inhibitor,
URWYQGVSPQJGGB,,,,,,,,,,,,,BRD-K00003148,batefenterol,acetylcholine receptor antagonist|adrenergic receptor agonist,
USUZGMWDZDXMDG,,,,,,,,,,,,,BRD-K00003210,osilodrostat,cytochrome P450 inhibitor,
UTDAKQMBNSHJJB,,,,,,,,,,,,,BRD-K00003348,COTI-2,anticancer agent,
UTMVACIBQLDZLP,,,,,,,,,,,,,BRD-K00004545,crisdesalazine,free radical scavenger,
UUROSJLZNDSXRF,,,,,,,,,,,,,BRD-K76911699,ITX5061,SR-BI inhibitor,
UUTYCZUIECRVAL,,,,,,,,,,,,,BRD-K84924563,6-diazo-5-oxo-L-norleucine,glutamate receptor antagonist|glutaminase inhibitor,
UVBUBMSSQKOIBE,,,,,,,,,,,,,BRD-K61915943,fumonisin-B1,,CERS1
UWYSKLMRWPKZES,,,,,,,,,,,,,BRD-K00003154,imisopasem-manganese,superoxide dismutase mimetic,
UWYVPFMHMJIBHE,,,,,,,,,,,,,BRD-K61279411,oxaloacetate,glutamate release inhibitor,
UXCAQJAQSWSNPQ,,,,,,,,,,,,,BRD-K00004697,alovudine,DNA synthesis marker,
UZTPLPOYSVSMBU,,,,,,,,,,,,,BRD-K00003281,ferroquine,antimalarial agent,
VAPSMQAHNAZRKC,,,,,,,,,,,,,BRD-K00003478,epristeride,5 alpha reductase inhibitor,
VBHDYBCWTAXBNA,,,,,,,,,,,,,BRD-K00003535,polaprezinc,chelating agent,
VCGRFBXVSFAGGA,,,,,,,,,,,,,BRD-K00003221,basmisanil,GABA receptor inverse agonist,
VCMMXZQDRFWYSE,,,,,,,,,,,,,BRD-K36137799,plumbagin,anticancer agent,
VDRYGTNDKXIPSK,,,,,,,,,,,,,BRD-K14661019,AZ-7371,antibacterial ,
VEBVPUXQAPLADL,,,,,,,,,,,,,BRD-K00003329,ingenol,PKC activator,PRKCD|PRKCE
VEYJKJORLPYVLO,,,,,,,,,,,,,BRD-K00004630,val-tyr,angiotensin converting enzyme inhibitor,
VFPOVCXWKBYDNF,,,,,,,,,,,,,BRD-K01827291,CGP-20712A,adrenergic receptor antagonist,ADRB1|ADRB3
VGUSQKZDZHAAEE,,,,,,,,,,,,,BRD-K00003220,acumapimod,p38 MAPK inhibitor,
VHSBBVZJABQOSG,,,,,,,,,,,,,BRD-K00004656,denopamine,adrenergic receptor agonist,
VJCLAPUACUQZOV,,,,,,,,,,,,,BRD-K00003140,hPGDS-IN-1,prostaglandin inhibitor,
VJPPLCNBDLZIFG,,,,,,,,,,,,,BRD-K00003110,BMS-986195,Bruton's tyrosine kinase (BTK) inhibitor,
VKCPFWKTFZAOTO,,,,,,,,,,,,,BRD-K34798115,SJ-733,ATPase inhibitor,
VKHVAUKFLBBZFJ,,,,,,,,,,,,,BRD-K00003180,verucerfont,corticotropin releasing factor receptor antagonist,
VLGTZPSSBIXGAI,,,,,,,,,,,,,BRD-K81849500,verteporfin,photosensitizing agent,
VLIUIBXPEDFJRF,,,,,,,,,,,,,BRD-K00003202,citarinostat,HDAC inhibitor,
VMMKGVRPILDZML,,,,,,,,,,,,,BRD-K00003479,AX-024,cytokine production inhibitor,
VOAZJEPQLGBXGO,,,,,,,,,,,,,BRD-K00003117,ceftobiprole,antiinfective drug,
VOVZXURTCKPRDQ,,,,,,,,,,,,,BRD-K00003456,asciminib,Bcr-Abl kinase inhibitor,
VPTONMHDLLMOOV,,,,,,,,,,,,,BRD-K00004624,CJ-13610,lipoxygenase inhibitor,
VQSZIPCGAGVRRP,,,,,,,,,,,,,BRD-K00003509,AZD1390,ATM kinase inhibitor,
VQYYQSZNRVQLIS,,,,,,,,,,,,,BRD-K00003476,ningetinib-tosylate,protein tyrosine kinase inhibitor,
VRQXRVAKPDCRCI,,,,,,,,,,,,,BRD-K00003280,PIM-447,Pim kinase inhibitor,
VRVJKILQRBSEAG,,,,,,,,,,,,,BRD-K30233223,A-485,histone acetyltransferase inhibitor,
VSEWBFSTIMFCDL,,,,,,,,,,,,,BRD-K00004733,NSP-805,phosphodiesterase inhibitor,
VUVHIMLGTHRGQZ,,,,,,,,,,,,,BRD-A55902763,2-deoxy-2-([methyl(nitroso)carbamoyl]amino)hexose,,
VWAMTBXLZPEDQO,,,,,,,,,,,,,BRD-K00003489,gamithromycin,antibacterial ,
VWBOQFANCXZMAU,,,,,,,,,,,,,BRD-K40767677,RP67580,,
VXIMPSPISRVBPZ,,,,,,,,,,,,,BRD-K00004691,megestrol,progesterone receptor agonist,
VXLAKHWYGRKCGI,,,,,,,,,,,,,BRD-K00003096,FN-1501,tyrosine kinase inhibitor,
VXMYWVMXSWJFCV,,,,,,,,,,,,,BRD-K96298462,Imazodan,phosphodiesterase inhibitor,
VXOWJCTXWVWLLC,,,,,,,,,,,,,BRD-K00004736,betamethasone-butyrate-propionate,,
VXTKXGKPBOLHRY,,,,,,,,,,,,,BRD-K00004576,clamikalant,ATP-sensitive potassium channel antagonist,
VYJPVPHNGWEIBT,,,,,,,,,,,,,BRD-K00004601,HC-070,transient receptor potential channel antagonist,
VYLOOGHLKSNNEK,,,,,,,,,,,,,BRD-K00003480,tropifexor,FXR agonist,
VZUGVMQFWFVFBX,,,,,,,,,,,,,BRD-K00004714,vedaprofen,anti-inflammatory agent,PTGS2
VZVGEDRCVUKSEL,,,,,,,,,,,,,BRD-K00005334,guancydine,antihypertensive agent,
WAKQLZVLNOKKHE,,,,,,,,,,,,,BRD-K00003527,sofosbuvir-impurity-m,antiviral,
WBLXZPHICYCDGN,,,,,,,,,,,,,BRD-K00004566,febuprol,choleretic agent,
WDBNGXLHMZSUEI,,,,,,,,,,,,,BRD-K00003482,MK-4074,acetyl-CoA carboxylase inhibitor,
WDEKUGNKKOGFOA,,,,,,,,,,,,,BRD-K00003490,NGP555,gamma secretase modulator,
WDJHHCAKBRKCLW,,,,,,,,,,,,,BRD-K00003213,PCI-27483,ERK1 and ERK2 phosphorylation inhibitor,
WEDWLYRQKUTOAX,,,,,,,,,,,,,BRD-K00003113,O-304,AMPK activator,
WEQLWGNDNRARGE,,,,,,,,,,,,,BRD-K15241725,NBI-98782,vesicular monoamine transporter inhibitor,
WETRBJOSGIDJHQ,,,,,,,,,,,,,BRD-K00004563,napamezole,adrenergic receptor antagonist|monoamine reuptake inhibitor,
WHRODDIHRRDWEW,,,,,,,,,,,,,BRD-K00003322,sugammadex,neuromuscular blockade reversal agent,
WIIAMRXFUJLYEF,,,,,,,,,,,,,BRD-K00003118,retagliptin,dipeptidyl peptidase inhibitor,
WJIGGYYSZBWCGC,,,,,,,,,,,,,BRD-K00003290,emixustat,retinoid isomerohydrolase inhibitor,
WKDNQONLGXOZRG,,,,,,,,,,,,,BRD-K00003387,lanabecestat,beta secretase inhibitor,
WLAVZAAODLTUSW,,,,,,,,,,,,,BRD-K00003238,sitravatinib,receptor tyrosine protein kinase inhibitor,
WLHQHAUOOXYABV,,,,,,,,,,,,,BRD-A90551241,lornoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2
WLLOFQROROXOMO,,,,,,,,,,,,,BRD-K00004635,PF-04995274,serotonin receptor agonist,
WMBOCUXXNSOQHM,,,,,,,,,,,,,BRD-K02260986,butylidenephthalide,cyclooxygenase inhibitor,
WNEILUNVMHVMPH,,,,,,,,,,,,,BRD-K00003143,BAY1217389,kinase inhibitor,
WNEODWDFDXWOLU,,,,,,,,,,,,,BRD-K25290930,fenebrutinib,Bruton's tyrosine kinase (BTK) inhibitor,
WNGSUWLDMZFYNZ,,,,,,,,,,,,,BRD-K00004696,leonurine,anti-inflammatory agent,
WNUQCGWXPNGORO,,,,,,,,,,,,,BRD-K69857269,sonepiprazole,dopamine receptor antagonist,
WPFPDSUMDURRRW,,,,,,,,,,,,,BRD-K00004561,E-2001,antioxidant,
WQRPBKUCJBWQRT,,,,,,,,,,,,,BRD-K00004547,prisotinol,,
WQXNXVUDBPYKBA,,,,,,,,,,,,,BRD-K34566599,ectoine,anti-inflammatory agent,
WRFHGDPIDHPWIQ,,,,,,,,,,,,,BRD-K00003253,sparsentan,angiotensin receptor antagonist,
WROHEWWOCPRMIA,,,,,,,,,,,,,BRD-K00003166,GSK189254,histamine receptor antagonist,
WRYIIOKOQSICTB,,,,,,,,,,,,,BRD-K00004546,perfluorohexyloctane,,
WSNODXPBBALQOF,,,,,,,,,,,,,BRD-K65059905,tafluprost,prostaglandin inhibitor,PTGFR
WSOHOUHPUOAXIN,,,,,,,,,,,,,BRD-K00004690,SKLB-1028,Abl kinase inhibitor|EGFR inhibitor|FLT3 inhibitor,
WSTUJEXAPHIEIM,,,,,,,,,,,,,BRD-K00003245,belizatinib,receptor tyrosine protein kinase inhibitor,
WTERNLDOAPYGJD,,,,,,,,,,,,,BRD-K00004607,monepantel,mTOR inhibitor,
WTNAEULBGCSUSK,,,,,,,,,,,,,BRD-K72327355,baicalein,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH
WUJVPODXELZABP,,,,,,,,,,,,,BRD-K00003124,trodusquemine,tyrosine phosphatase inhibitor,
WUTYZMFRCNBCHQ,,,,,,,,,,,,,BRD-K00004291,cevimeline,acetylcholine receptor agonist,CHRM3
WXJFKKQWPMNTIM,,,,,,,,,,,,,BRD-K00004672,brincidofovir,antiviral,
WXLPERVDMILVIF,,,,,,,,,,,,,BRD-K00003397,MK-8617,hypoxia inducible factor prolyl hydroxylase inhibitor,
WYQFJHHDOKWSHR,,,,,,,,,,,,,BRD-K00003286,upadacitinib,JAK inhibitor,
XAEPFBXVLMACNN,,,,,,,,,,,,,BRD-K91147684,m-THP,,
XAYGBKHKBBXDAK,,,,,,,,,,,,,BRD-K00003136,mitapivat,pyruvate kinase isozyme activator,
XBRWELTXMQSEIN,,,,,,,,,,,,,BRD-K00004684,squaric-acid-dibutyl-ester,oxidative stress inducer,
XCFLWTZSJYBCPF,,,,,,,,,,,,,BRD-K33963447,GNE-7915,leucine rich repeat kinase inhibitor,
XDBHURGONHZNJF,,,,,,,,,,,,,BRD-K00004564,tetomilast,phosphodiesterase inhibitor,PDE4D
XDHNQDDQEHDUTM,,,,,,,,,,,,,BRD-K00010387,bafilomycin-a1,ATPase inhibitor,
XDZAHHULFQIBFE,,,,,,,,,,,,,BRD-K00004584,remetinostat,HDAC inhibitor,
XEDHVZKDSYZQBF,,,,,,,,,,,,,BRD-K00003178,lasmiditan,serotonin receptor agonist,
XFJAMQQAAMJFGB,,,,,,,,,,,,,BRD-K00003504,licogliflozin,sodium/glucose cotransporter inhibitor,
XFVRBYKKGGDPAJ,,,,,,,,,,,,,BRD-K00003507,farampator,ionotropic glutamate receptor agonist,
XGVXKJKTISMIOW,,,,,,,,,,,,,BRD-K00004727,simurosertib,kinase inhibitor,
XJSFLOJWULLJQS,,,,,,,,,,,,,BRD-K00003705,josamycin,bacterial 50S ribosomal subunit inhibitor,
XLHBYAVMDSNIEM,,,,,,,,,,,,,BRD-K00003219,deferasirox-iron-chelate,,
XMBUPPIEVAFYHO,,,,,,,,,,,,,BRD-K00003169,RAD140,androgen receptor modulator,
XMCJWIFCIIXRGI,,,,,,,,,,,,,BRD-K12413266,casanthranol-variant,,
XMOCLSLCDHWDHP,,,,,,,,,,,,,BRD-K27529556,epigallocatechin-(-),,
XMZSTQYSBYEENY,,,,,,,,,,,,,BRD-K00004730,ABT-072,RNA polymerase inhibitor,
XNHZXMPLVSJQFK,,,,,,,,,,,,,BRD-K00003155,TAK-779,CC chemokine receptor antagonist,
XNRZJPQTMQZBCE,,,,,,,,,,,,,BRD-K00003340,JPH203,solute carrier family member inhibitor,
XNULRSOGWPFPBL,,,,,,,,,,,,,BRD-K51041191,PF-03882845,mineralocorticoid receptor antagonist,
XOJFFEJRKAIVCH,,,,,,,,,,,,,BRD-K39576764,mivobulin,microtubule inhibitor,
XPIJWUTXQAGSLK,,,,,,,,,,,,,BRD-K00003184,ozenoxacin,antiinfective drug,
XPXZTVWPRKJTAA,,,,,,,,,,,,,BRD-K00003468,delcasertib,PKC inhibitor,
XPYBSIWDXQFNMH,,,,,,,,,,,,,BRD-K27963513,fosfructose,fructose diphosphate stimulant,
XQKYUBTUOHHNDV,,,,,,,,,,,,,BRD-K00003474,letrazuril,antiinfective drug,
XQRVCODIGHFXKQ,,,,,,,,,,,,,BRD-K12244279,MEK1-2-inhibitor,MEK inhibitor,MAP2K2
XRISENIKJUKIHD,,,,,,,,,,,,,BRD-K00004715,butaprost,prostaglandin receptor agonist,
XRNVABDYQLHODA,,,,,,,,,,,,,BRD-K00005239,TP-3654,"1,4,5-trisphosphate inhibitor",
XUMALORDVCFWKV,,,,,,,,,,,,,BRD-K00003385,IPI549,PI3K inhibitor,
XVFJONKUSLSKSW,,,,,,,,,,,,,BRD-K00004651,talsaclidine,acetylcholine receptor agonist,
XWFCFMXQTBGXQW,,,,,,,,,,,,,BRD-K00003370,cadazolid,antibacterial ,
XXAKBYBCWYYQTL,,,,,,,,,,,,,BRD-K32942258,RG1530,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2
XXJXHXJWQSCNPX,,,,,,,,,,,,,BRD-K00003425,LXS196,PKC inhibitor,
XXMDDBVNWRWNCW,,,,,,,,,,,,,BRD-K00003464,pocapavir,Enterovirus capsid inhibitor,
XZEUAXYWNKYKPL,,,,,,,,,,,,,BRD-K00004639,ormeloxifene,selective estrogen receptor modulator (SERM),
YBXRSCXGRPSTMW,,,,,,,,,,,,,BRD-K00003422,BAY-1895344,ATR kinase inhibitor,
YBYYWUUUGCNAHQ,,,,,,,,,,,,,BRD-K00003276,CCT245737,kinase inhibitor,
YCBAQKQAINQRFW,,,,,,,,,,,,,BRD-K00003129,crenigacestat,notch signaling inhibitor,
YCNCRLKXSLARFT,,,,,,,,,,,,,BRD-K00003325,topilutamide,androgen receptor antagonist,
YCVGLKWJKIKVBI,,,,,,,,,,,,,BRD-K00003453,CT7001,CDK inhibitor,
YCXOHEXZVKOGEV,,,,,,,,,,,,,BRD-K00003508,ASTX660,apoptosis inhibitor,
YDDMIZRDDREKEP,,,,,,,,,,,,,BRD-K00003211,lurbinectedin,DNA binding agent,
YDSVAKPJAOSZJA,,,,,,,,,,,,,BRD-K00004658,etrabamine,dopamine receptor agonist,
YDZYKNJZCVIKPP,,,,,,,,,,,,,BRD-K00004608,sograzepide,gastrin inhibitor,
YEHCEZXUSLIKDU,,,,,,,,,,,,,BRD-A62336573,rolitetracycline,bacterial 30S ribosomal subunit inhibitor,
YEYAKZXEBSVURO,,,,,,,,,,,,,BRD-K00004661,declopramide,cell cycle inhibitor,
YFHRCLAKZBDRHN,,,,,,,,,,,,,BRD-K14063023,ibiglustat,glucosylceramidase inhibitor,
YFRBKEVUUCQYOW,,,,,,,,,,,,,BRD-K00004689,GSK239512,histamine receptor antagonist,
YFXGICNMLCGLHJ,,,,,,,,,,,,,BRD-K00004752,INX-08189,antiviral,
YFYNOWXBIBKGHB,,,,,,,,,,,,,BRD-K00004205,cis-ACPD,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM7|GRM8
YGIDGBAHDZEYMT,,,,,,,,,,,,,BRD-K00003308,TD139,anti-inflammatory agent,
YGKUEOZJFIXDGI,,,,,,,,,,,,,BRD-K00003473,pridopidine,dopamine receptor antagonist,
YGPSJZOEDVAXAB,,,,,,,,,,,,,BRD-K20497775,L-kynurenine,aryl hydrocarbon receptor agonist,
YHTTWXCDIRTOQX,,,,,,,,,,,,,BRD-K00003335,iRGD-peptide,integrin signaling activator,
YHYKUSGACIYRML,,,,,,,,,,,,,BRD-K00003229,verubecestat,beta secretase inhibitor,
YIDDLAAKOYYGJG,,,,,,,,,,,,,BRD-K00003274,selonsertib,MAP kinase activator,
YKPYIPVDTNNYCN,,,,,,,,,,,,,BRD-K00003122,prinomastat,matrix metalloprotease inhibitor,
YMGFTDKNIWPMGF,,,,,,,,,,,,,BRD-K00005247,salvianolic-acid-A,matrix metalloprotease inhibitor,
YMPALHOKRBVHOJ,,,,,,,,,,,,,BRD-K00003177,indeglitazar,PPAR receptor agonist,NCOA1|PPARA|PPARD|PPARG
YNUAEEJQYHYLMS,,,,,,,,,,,,,BRD-K00003225,eleclazine,late sodium current inhibitor,
YOLTZIVRJAPVPH,,,,,,,,,,,,,BRD-K00004290,G-15,estrogen receptor antagonist,GPER1
YOZNUFWCRFCGIH,,,,,,,,,,,,,BRD-K00003525,hydroxocobalamin,vitamin B,
YQQZZYYQTCPEAS,,,,,,,,,,,,,BRD-K00004722,LY3295668,Aurora kinase inhibitor,
YRALAIOMGQZKOW,,,,,,,,,,,,,BRD-K00003320,ceruletide,CCK receptor agonist,CCKAR
YRCHYHRCBXNYNU,,,,,,,,,,,,,BRD-K00003288,glesatinib,tyrosine kinase inhibitor,
YRSSFEUQNAXQMX,,,,,,,,,,,,,BRD-K00003282,esonarimod,antirheumatic drug,
YTEVTHHGQMUPHC,,,,,,,,,,,,,BRD-K00003364,GSK2239633A,CC chemokine receptor antagonist,
YTLQFZVCLXFFRK,,,,,,,,,,,,,BRD-K60379054,bendazol,nitric oxide synthase stimulant,
YWCLDDLVLSQGSZ,,,,,,,,,,,,,BRD-K00003475,S-3304,matrix metalloprotease inhibitor,
YXEASJLRXGZRHS,,,,,,,,,,,,,BRD-K47464228,azaserine,purine antagonist,
YXYXCSOJKUAPJI,,,,,,,,,,,,,BRD-K00004741,estradiol-3-O-sulfamate,steryl sulfatase inhibitor,
YYLKOELWSMRYHV,,,,,,,,,,,,,BRD-K00004593|BRD-K57027742,BW-348U87|N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,|antiviral,
YYQALOWPCKMFDQ,,,,,,,,,,,,,BRD-K00003262,nicodicosapent,sterol regulatory element binding protein (SREBP) inhibitor,
YYUAYBYLJSNDCX,,,,,,,,,,,,,BRD-A75552914,isoxicam,cyclooxygenase inhibitor,PTGS1|PTGS2
YZBAXVICWUUHGG,,,,,,,,,,,,,BRD-K00003159,banoxantrone,topoisomerase inhibitor,TOP2A
YZCUMZWULWOUMD,,,,,,,,,,,,,BRD-K00003533,BAY-1251152,CDK9 inhibitor,
YZMCKZRAOLZXAZ,,,,,,,,,,,,,BRD-K52416806,sulfisomidin,antibacterial,
YZPOQCQXOSEMAZ,,,,,,,,,,,,,BRD-K00004615,PBT-1033,chelating agent,
ZAPRLADYRFPQSH,,,,,,,,,,,,,BRD-K00004740,parcetasal,anti-inflammatory agent,
ZCBUQCWBWNUWSU,,,,,,,,,,,,,BRD-K27677357,ruboxistaurin,PKC inhibitor,
ZCHZSBUNJOCWCW,,,,,,,,,,,,,BRD-K18787491|BRD-M37437038|BRD-M92812175,U-0126,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1
ZEOQUKRCASTCFR,,,,,,,,,,,,,BRD-K00003467,temanogrel,serotonin receptor antagonist,
ZFBHXVOCZBPADE,,,,,,,,,,,,,BRD-K91876515,S63845,MCL1 inhibitor,
ZFUDULLGKXSPPH,,,,,,,,,,,,,BRD-K00003375,visomitin,antioxidant,
ZFUKERYTFURFGA,,,,,,,,,,,,,BRD-K00004970,abamectin,benzodiazepine receptor agonist,GABBR1|GABBR2
ZGBAJMQHJDFTQJ,,,,,,,,,,,,,BRD-K82196541,bafetinib,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,ABL1|BCR|LYN
ZGCYVRNZWGUXNQ,,,,,,,,,,,,,BRD-K00004680,bevenopran,opioid receptor antagonist,
ZGTYTFYRCIRWBL,,,,,,,,,,,,,BRD-K00003205,D-3263,transient receptor potential channel agonist,
ZHKNLJLMDFQVHJ,,,,,,,,,,,,,BRD-K00003251,pemafibrate,PPAR receptor agonist,
ZHPMYDSXGRRERG,,,,,,,,,,,,,BRD-K00003342,aticaprant,opioid receptor antagonist,
ZIAOVIPSKUPPQW,,,,,,,,,,,,,BRD-K00003231,doravirine,non-nucleoside reverse transcriptase inhibitor,
ZISJNXNHJRQYJO,,,,,,,,,,,,,BRD-K00003498,tapinarof,aryl hydrocarbon receptor agonist,
ZIUSSTSXXLLKKK,,,,,,,,,,,,,BRD-K07572174|BRD-K69690935,curcumin,NFkB pathway inhibitor|cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH
ZJXIUGNEAIHSBI,,,,,,,,,,,,,BRD-K00003485,SB-649868,orexin receptor antagonist,
ZKAVFOXYJCREBQ,,,,,,,,,,,,,BRD-K00004644,PF-06260414,androgen receptor modulator,
ZLJZDYOBXVOTSA,,,,,,,,,,,,,BRD-K00004597,RGX-104,LXR agonist,
ZLZUHACSRMOLLV,,,,,,,,,,,,,BRD-K00004598,PF-06751979,beta secretase inhibitor,
ZMGUKFHHNQMKJI,,,,,,,,,,,,,BRD-K30331124,ASC-J9,androgen receptor enhancer,AR
ZMQMTKVVAMWKNY,,,,,,,,,,,,,BRD-K00003414,emodepside,nematocide,
ZMQSLMZOWVGBSM,,,,,,,,,,,,,BRD-K03336321,AZD8797,CC chemokine receptor antagonist,
ZMZNWNTZRWXTJU,,,,,,,,,,,,,BRD-K00003230,asapiprant,prostaglandin inhibitor,
ZNFWPFHSBWLNSO,,,,,,,,,,,,,BRD-K00003102,INCB-057643,bromodomain inhibitor,
ZPCCSZFPOXBNDL,,,,,,,,,,,,,BRD-K00004968,acetylspiramycin,other antibiotic,
ZQHDVMCIDXEICF,,,,,,,,,,,,,BRD-A12417644|BRD-A99182808,usniacin-(+),MAP kinase activator,PTPN1
ZQPDJCIXJHUERQ,,,,,,,,,,,,,BRD-K00004594,parsaclisib,PI3K inhibitor,
ZRLJEHIUGYTTSZ,,,,,,,,,,,,,BRD-K00004587,KR-33494,cell death inhibitor ,
ZROCWKZRGJYPTG,,,,,,,,,,,,,BRD-K00003515,AZ7550,insulin growth factor receptor inhibitor,
ZROGCCBNZBKLEL,,,,,,,,,,,,,BRD-K44845912,astilbin,like (NRF2) activator|nuclear factor erythroid derived,
ZRVUJXDFFKFLMG,,,,,,,,,,,,,BRD-K01826742,meloxicam,cyclooxygenase inhibitor,PTGS1|PTGS2
ZRYMMWAJAFUANM,,,,,,,,,,,,,BRD-K00004591,BMS-986142,Bruton's tyrosine kinase (BTK) inhibitor,
ZSBWDKCIIZYQIR,,,,,,,,,,,,,BRD-K00004748,CI-953,voltage-gated sodium channel blocker,
ZSDBFLMJVAGKOU,,,,,,,,,,,,,BRD-K00003520,glycerol-phenylbutyrate,sigma receptor ligand,
ZSOGGZWFKNMGJN,,,,,,,,,,,,,BRD-M01344114,threo-2-methylisocitrate-(DL),isocitrate lyase substrate,
ZSWMIFNWDQEXDT,,,,,,,,,,,,,BRD-K00003264,zoliflodacin,antibacterial ,
ZSZPLBNCHKXQRY,,,,,,,,,,,,,BRD-K65814004,diphenyleneiodonium,nitric oxide synthase inhibitor,NOS2|NOS3
ZTTKEBYSXUCBSE,,,,,,,,,,,,,BRD-K00003128,beclabuvir,antiviral,
ZTVSGQPHMUYCRS,,,,,,,,,,,,,BRD-K00003732,atractylenolide-i,JAK inhibitor,
ZUMNJDGBYXHASJ,,,,,,,,,,,,,BRD-K00003502,rovazolac,LXR agonist,
ZVMMVSSEAMUNGI,,,,,,,,,,,,,BRD-K00003121,GSK369796,potassium channel antagonist,
ZWPRRQZNBDYKLH,,,,,,,,,,,,,BRD-K00003182,gemigliptin,dipeptidyl peptidase inhibitor,
ZXBFYBLSJMEBEP,,,,,,,,,,,,,BRD-K00003209,JI-101,kinase inhibitor,
ZXJHEANDHXHGMV,,,,,,,,,,,,,BRD-K00004622,MM-206,STAT inhibitor,
ZYSCOUXLBXGGIM,,,,,,,,,,,,,BRD-K00003145,PF-05089771,sodium channel blocker,
ZYXHQIPQIKTEDI,,,,,,,,,,,,,BRD-K00004742,lusaperidone,adrenergic receptor antagonist,
ZZQNEJILGNNOEP,,,,,,,,,,,,,BRD-K00003399,ocaperidone,serotonin receptor antagonist,
ZZWJKLGCDHYVMB,,,,,,,,,,,,,BRD-K00003100,AZD7594,glucocorticoid receptor modulator,
ZZWWXIBKLBMSCS,,,,,,,,,,,,,BRD-K00003236,firsocostat,acetyl-CoA carboxylase inhibitor,
ZZZJRULMCGMYRH,,,,,,,,,,,,,BRD-K00004550,BMS-626531,p38 MAPK inhibitor,
